Citrus Sinensis ID: 018532

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350----
Protein Sequence
MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHHcccccccHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccEcHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHccccEEEEEEEEEcccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEccccccEEcccccccEEEEcccHHHccHHHHHcccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHHcccHHHHHHccccccccccccccc
Coil and Loop (DISEMBL)
mrtktplkqlklsvpvqetpitsfltasgtfhdgdlllnqkglrliseenesrpsdykefdfefsleDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKinqasqcsHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLvylhnerhvihrdikpsnllvnhkgevkitdfgvsamlgssmgqrdtfvgtynymsperisgstydyssdIWSLGLVVLECAigrfpymqsedqqsWPSFYELLEAIvesppptappdqfspefcSFVSACiqkdprdrsssldllshpfikkfedkdidlgilvgsldppvncpr
Flexible Loop (DISEMBL)
mrtktplkqlklsvpvqeTPITSFLTASGTFHDGDLLLNQKGLRLISeenesrpsdykEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIhrdikpsnllvnhKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLgilvgsldppvncpr
Low Complexity Region (SEG)
MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKefdfefsledleTikvigkgsggvvQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPrdrsssldllsHPFIKKFEDKDIDLGILVGSLDPPVNCPR
Disordered region (IsUnstruct)
******************TPITSFLTASGTFHDGDLLLNQKGLRLI***********KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV**************EFCSFVSACI***********DLLSHPFIKKFEDKDIDLGILVGS*********
Disordered Region (DISOPRED)
**************************************************************EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT****QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV****
Disordered Region (DISEMBL)
MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR
Disordered Region (DISPRO)
*************************************************************FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	354	2.2.26 [Sep-21-2011]
Q9FJV0	356	Mitogen-activated protein	yes	no	1.0	0.994	0.861	0.0
Q5QN75	355	Mitogen-activated protein	yes	no	0.988	0.985	0.764	1e-160
Q9S7U9	363	Mitogen-activated protein	no	no	0.940	0.917	0.595	1e-118
Q94A06	354	Mitogen-activated protein	no	no	0.957	0.957	0.567	1e-114
Q55CL6	660	Dual specificity mitogen-	yes	no	0.579	0.310	0.543	2e-62
Q24324	396	Dual specificity mitogen-	yes	no	0.833	0.744	0.419	4e-62
P36506	400	Dual specificity mitogen-	yes	no	0.779	0.69	0.378	5e-58
Q63932	401	Dual specificity mitogen-	yes	no	0.779	0.688	0.374	8e-58
P36507	400	Dual specificity mitogen-	yes	no	0.779	0.69	0.369	4e-57
Q90321	397	Dual specificity mitogen-	N/A	no	0.779	0.695	0.378	4e-57

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  635 bits (1637), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/355 (86%), Positives = 328/355 (92%), Gaps = 1/355 (0%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           ++ K+ LKQLKLSVP QE+PI+SFLTASGTFHDGD LLNQKGLRL S+E +SR SD KE 
Sbjct: 2   VKIKSNLKQLKLSVPAQESPISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKEL 61

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           DFE + EDLET+KVIGKGSGGVVQLVRHKWVG+ FA+K+IQMNIQEEIRKQIVQELKINQ
Sbjct: 62  DFEITAEDLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQ 121

Query: 121 AS-QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
           AS QC HVVVCYHSFYHNG  SLVLEYMDRGSLAD+IRQVKTILEPYLAVVCKQVL GLV
Sbjct: 122 ASSQCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLV 181

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           YLHNERHVIHRDIKPSNLLVNHKGEVKI+DFGVSA L SSMGQRDTFVGTYNYMSPERIS
Sbjct: 182 YLHNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERIS 241

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
           GSTYDYSSDIWSLG+ VLECAIGRFPY++SEDQQ+ PSFYELL AIVE+PPPTAP DQFS
Sbjct: 242 GSTYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFS 301

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           PEFCSFVSACIQKDP  R+SSLDLLSHPFIKKFEDKDIDLGILVG+L+PPVN  R
Sbjct: 302 PEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDIDLGILVGTLEPPVNYLR 356

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 270/353 (76%), Positives = 312/353 (88%), Gaps = 3/353 (0%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRP--SDYK 58
           MR K P K+LKLSVP QETP+  FLTASGTF DG+L LNQ+GL+LISEE    P  ++ K
Sbjct: 1   MRGKKPHKELKLSVPAQETPVDKFLTASGTFKDGELRLNQRGLQLISEETADEPQSTNLK 60

Query: 59  EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI 118
             D + S++DLE I+VIGKGSGG+VQLVRHKWVG L+ALK IQMNIQE +RKQIVQELKI
Sbjct: 61  VEDVQLSMDDLEMIQVIGKGSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELKI 120

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
           NQA+Q +H+V+C+ SFYHNGVI LVLEYMDRGSLADII+QVKTILEPYLAV+CKQVL+GL
Sbjct: 121 NQATQNAHIVLCHQSFYHNGVIYLVLEYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGL 180

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           +YLH+ERHVIHRDIKPSNLLVN KGEVKITDFGVSA+L SSMGQRDTFVGTYNYM+PERI
Sbjct: 181 LYLHHERHVIHRDIKPSNLLVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERI 240

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
           SGS+YDY SDIWSLGLV+LECAIGRFPY+ SE  + W SFYELLEAIV+ PPP+AP DQF
Sbjct: 241 SGSSYDYKSDIWSLGLVILECAIGRFPYIPSEG-EGWLSFYELLEAIVDQPPPSAPADQF 299

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN 351
           SPEFC+F+S+CIQKDP +R S+ +LL+HPFIKKFEDKD+DL ILV SL+PP+N
Sbjct: 300 SPEFCAFISSCIQKDPAERMSASELLNHPFIKKFEDKDLDLRILVESLEPPMN 352

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  426 bits (1096), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 199/334 (59%), Positives = 252/334 (75%), Gaps = 1/334 (0%)

Query: 8   KQLKLSVPVQ-ETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSL 66
             LKL++PV  E  IT FLT SGTF DGDL +N+ G+R+IS+      S  K  D + SL
Sbjct: 8   NNLKLAIPVAGEQSITKFLTQSGTFKDGDLRVNKDGVRIISQLEPEVLSPIKPADDQLSL 67

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
            DL+ +KVIGKGS GVVQLV+HKW G+ FALK+IQ+NI E IRK I QELKINQ+SQC +
Sbjct: 68  SDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQCPN 127

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V  Y SFY NG ISL+LEYMD GSLAD ++ VK I + YL+ + +QVLQGL+YLH++RH
Sbjct: 128 LVTSYQSFYDNGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLHHDRH 187

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +IHRD+KPSNLL+NH+GEVKITDFGVS ++ ++ G  +TFVGTYNYMSPERI G+ Y   
Sbjct: 188 IIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLANTFVGTYNYMSPERIVGNKYGNK 247

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           SDIWSLGLVVLECA G+FPY     +++W S +EL+EAIV+ PPP  P   FSPE  SF+
Sbjct: 248 SDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSGNFSPELSSFI 307

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLG 340
           S C+QKDP  RSS+ +L+ HPF+ K++   I+L 
Sbjct: 308 STCLQKDPNSRSSAKELMEHPFLNKYDYSGINLA 341

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  412 bits (1060), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 194/342 (56%), Positives = 253/342 (73%), Gaps = 3/342 (0%)

Query: 12  LSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLET 71
           + +P  E  I+ FLT SGTF DGDL +N+ G++ +S      P   +  D + SL DLE 
Sbjct: 11  ICLPPLEQSISKFLTQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPIEPLDNQLSLADLEV 70

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           IKVIGKGS G VQLV+HK   + FALK+IQ+N +E   + I QEL+IN +SQC ++V CY
Sbjct: 71  IKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPYLVSCY 130

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
            SFYHNG++S++LE+MD GSLAD++++V  + E  L+ +CK+VL+GL Y+H+ER +IHRD
Sbjct: 131 QSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERRIIHRD 190

Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           +KPSNLL+NH+GEVKITDFGVS +L S+    ++FVGTY YMSPERISGS Y   SDIWS
Sbjct: 191 LKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNKSDIWS 250

Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LGLV+LECA G+FPY   E ++ W S YEL++AIVE+PPP AP + FSPEFCSF+S C+Q
Sbjct: 251 LGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCSFISQCVQ 310

Query: 312 KDPRDRSSSLDLLSHPFIKKFEDKDIDLGIL---VGSLDPPV 350
           KDPRDR S+ +LL H F+K FED D +L       GSL PP+
Sbjct: 311 KDPRDRKSAKELLEHKFVKMFEDSDTNLSAYFTDAGSLIPPL 352

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q55CL6|MP2K1_DICDI Dual specificity mitogen-activated protein kinase kinase 1 OS=Dictyostelium discoideum GN=mekA PE=1 SV=1

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/206 (54%), Positives = 151/206 (73%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           +  + L+DL+ I+V+G+G+GGVV+L  H+  G   ALK+I ++IQE IRKQI+ ELK   
Sbjct: 284 NLSYDLKDLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQIILELKTLH 343

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
            +   ++V  Y +FY  G I + LE+M+ GSL+DI+++  TI EP L  +  QVLQGLVY
Sbjct: 344 KTSYPYIVSFYDAFYTEGSIFIALEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVY 403

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH + H+IHRDIKPSN+LVN+KGE KI DFGVS  L  ++ +  T+VGT  YMSPERISG
Sbjct: 404 LHRKLHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLSKAVTWVGTVTYMSPERISG 463

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPY 266
            +Y + S+IWSLGL +LECAIG+FPY
Sbjct: 464 RSYSFDSEIWSLGLTILECAIGKFPY 489

Required for cAMP-mediated activation of guanylyl cyclase activity and plays an essential role in aggregation, morphogenesis, and chemotaxis. Appears to act upstream of erk1 but not erk2.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q24324|DSOR1_DROME Dual specificity mitogen-activated protein kinase kinase dSOR1 OS=Drosophila melanogaster GN=Dsor1 PE=2 SV=2

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 133/317 (41%), Positives = 187/317 (58%), Gaps = 22/317 (6%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK 117
           KE   E S EDLE +  +G G+GGVV  VRH     + A K+I + ++  I+KQI++ELK
Sbjct: 76  KEKIGELSDEDLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILRELK 135

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
           +       H+V  Y +FY +G IS+ +EYMD GSL  I+++   I E  L  +   VL+G
Sbjct: 136 VLHECNFPHIVGFYGAFYSDGEISICMEYMDGGSLDLILKRAGRIPESILGRITLAVLKG 195

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L YL +   +IHRD+KPSN+LVN  GE+KI DFGVS  L  SM   ++FVGT +YMSPER
Sbjct: 196 LSYLRDNHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMA--NSFVGTRSYMSPER 253

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPY-------------------MQSEDQQSWPSF 278
           + G+ Y   SDIWSLGL ++E AIG +P                     Q  D+    + 
Sbjct: 254 LQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPNTATLESIFADNAEESGQPTDEPRAMAI 313

Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
           +ELL+ IV  PPP      FS EF  FV  C++K P +R+    LLSHP+I+K E +++D
Sbjct: 314 FELLDYIVNEPPPKLEHKIFSTEFKDFVDICLKKQPDERADLKTLLSHPWIRKAELEEVD 373

Query: 339 L-GILVGSLDPPVNCPR 354
           + G +  ++D P + P+
Sbjct: 374 ISGWVCKTMDLPPSTPK 390

Required downstream of Raf in the sevenless (sev), torso (tor), and Drosophila EGF receptor homolog (DER) signal transduction pathways. Involved in both positive regulation (at the posterior terminus) and negative regulation (at the anterior domain) of tll, as in other terminal class gene products, maybe via the ERK-A kinase.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P36506|MP2K2_RAT Dual specificity mitogen-activated protein kinase kinase 2 OS=Rattus norvegicus GN=Map2k2 PE=2 SV=1

 Score =  225 bits (573), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 120/317 (37%), Positives = 177/317 (55%), Gaps = 41/317 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   +D E I  +G G+GGVV   RH+  G + A K+I + I+  +R QI++EL++    
Sbjct: 66  ELKDDDFERISELGAGNGGVVTKARHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHEC 125

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++ K I E  L  V   VL+GL YL 
Sbjct: 126 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLR 185

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ 
Sbjct: 186 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH 243

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF------------------------ 278
           Y   SDIWS+GL ++E AIGR+P    + ++   SF                        
Sbjct: 244 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASFGRPVVDGADGEPHSVSPRPRPPGR 303

Query: 279 ---------------YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                          +ELL+ IV  PPP  P   FS +F  FV+ C+ K+P +R+    L
Sbjct: 304 PISGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVFSSDFQEFVNKCLIKNPAERADLKLL 363

Query: 324 LSHPFIKKFEDKDIDLG 340
            +H FIK+ E +D+D  
Sbjct: 364 TNHAFIKRSEGEDVDFA 380

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q63932|MP2K2_MOUSE Dual specificity mitogen-activated protein kinase kinase 2 OS=Mus musculus GN=Map2k2 PE=1 SV=2

 Score =  224 bits (571), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 119/318 (37%), Positives = 178/318 (55%), Gaps = 42/318 (13%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   +D E I  +G G+GGVV   RH+  G + A K+I + I+  +R QI++EL++    
Sbjct: 66  ELKDDDFERISELGAGNGGVVTKARHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHEC 125

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++ K I E  L  V   VL+GL YL 
Sbjct: 126 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLR 185

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ 
Sbjct: 186 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH 243

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF------------------------ 278
           Y   SDIWS+GL ++E AIGR+P    + ++   SF                        
Sbjct: 244 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASFGRPVVDGADGEPHSVSPRPRPPGR 303

Query: 279 ----------------YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD 322
                           +ELL+ IV  PPP  P   FS +F  FV+ C+ K+P +R+    
Sbjct: 304 PISVGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVFSSDFQEFVNKCLIKNPAERADLKL 363

Query: 323 LLSHPFIKKFEDKDIDLG 340
           L++H FIK+ E +++D  
Sbjct: 364 LMNHAFIKRSEGEEVDFA 381

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P36507|MP2K2_HUMAN Dual specificity mitogen-activated protein kinase kinase 2 OS=Homo sapiens GN=MAP2K2 PE=1 SV=1

 Score =  222 bits (565), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 117/317 (36%), Positives = 178/317 (56%), Gaps = 41/317 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   +D E I  +G G+GGVV  V+H+  G + A K+I + I+  IR QI++EL++    
Sbjct: 66  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 125

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++ K I E  L  V   VL+GL YL 
Sbjct: 126 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 185

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YM+PER+ G+ 
Sbjct: 186 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMAPERLQGTH 243

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSE-------------------------------- 270
           Y   SDIWS+GL ++E A+GR+P    +                                
Sbjct: 244 YSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 303

Query: 271 -------DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                  D +   + +ELL+ IV  PPP  P   F+P+F  FV+ C+ K+P +R+    L
Sbjct: 304 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 363

Query: 324 LSHPFIKKFEDKDIDLG 340
            +H FIK+ E +++D  
Sbjct: 364 TNHTFIKRSEVEEVDFA 380

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q90321|MP2K2_CYPCA Dual specificity mitogen-activated protein kinase kinase 2 OS=Cyprinus carpio GN=map2k2 PE=2 SV=1

 Score =  222 bits (565), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 120/317 (37%), Positives = 176/317 (55%), Gaps = 41/317 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   ED + I  +G G+GGVV  VRHK    + A K+I + I+  IR QI++EL++    
Sbjct: 63  ELKDEDFDPICELGAGNGGVVHKVRHKPSRLVMARKLIHLEIKPAIRNQIIRELQVLHEC 122

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++ + I E  L  V   VL+GLVYL 
Sbjct: 123 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEARRIPEEILGKVSIAVLRGLVYLR 182

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ 
Sbjct: 183 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH 240

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSE-------------------------------- 270
           Y   SD+WS+GL ++E AIGRFP    +                                
Sbjct: 241 YSVQSDVWSMGLSLVELAIGRFPIPPPDAKELEAIFGRPVLDKGGAEGHSMSPRQRPPGR 300

Query: 271 -------DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                  D +   + +ELL+ IV  PPP  P   F+ +F  FV  C+ K+P DR+    L
Sbjct: 301 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPHGVFTTDFEEFVMKCLMKNPADRADLKML 360

Query: 324 LSHPFIKKFEDKDIDLG 340
           + H FIK+ E +++D  
Sbjct: 361 MGHTFIKRAEVEEVDFA 377

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases.

Cyprinus carpio (taxid: 7962)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	354
313103463	354	mitogen-activated protein kinase kinase	1.0	1.0	0.926	0.0
356534696	356	PREDICTED: mitogen-activated protein kin	1.0	0.994	0.915	0.0
356500523	354	PREDICTED: mitogen-activated protein kin	1.0	1.0	0.915	0.0
449446532	358	PREDICTED: mitogen-activated protein kin	1.0	0.988	0.892	0.0
12718822	354	NQK1 MAPKK [Nicotiana tabacum]	1.0	1.0	0.898	0.0
315258239	354	mitogen activated protein kinase kinase	1.0	1.0	0.895	0.0
187761609	354	MAP kinase [Nicotiana benthamiana]	1.0	1.0	0.889	0.0
449487973	358	PREDICTED: mitogen-activated protein kin	1.0	0.988	0.887	0.0
225445061	354	PREDICTED: mitogen-activated protein kin	1.0	1.0	0.901	0.0
12331300	354	MAP kinase [Nicotiana tabacum]	1.0	1.0	0.892	0.0

>gi|313103463|gb|ADR31547.1| mitogen-activated protein kinase kinase 6 [Gossypium hirsutum] gi|313103465|gb|ADR31548.1| mitogen-activated protein kinase kinase 6 [Gossypium hirsutum]

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/354 (92%), Positives = 343/354 (96%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M++K PLKQLKL+VP QETPI+SFLTASGTFHDGDLLLNQKGLRLISEE ESRPSD KE 
Sbjct: 1   MKSKKPLKQLKLAVPAQETPISSFLTASGTFHDGDLLLNQKGLRLISEEKESRPSDAKEL 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK+IQMNIQEEIRKQIVQELKINQ
Sbjct: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKVIQMNIQEEIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQCSHVVVCYHSFYHNG ISLVLEYMDRGSLAD+IRQV TILEPYLAVVCKQVLQGLVY
Sbjct: 121 ASQCSHVVVCYHSFYHNGAISLVLEYMDRGSLADVIRQVNTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYMSPERISG
Sbjct: 181 LHHERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMSPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDYSSDIWSLG+VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE PPPTAP DQFSP
Sbjct: 241 STYDYSSDIWSLGMVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVEKPPPTAPSDQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACI+K+P++R+SSLDLLSHPFI+KFEDKDIDLGILVGSL+PPVN PR
Sbjct: 301 EFCSFVSACIKKNPKERASSLDLLSHPFIRKFEDKDIDLGILVGSLEPPVNYPR 354

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534696|ref|XP_003535888.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Glycine max]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/354 (91%), Positives = 342/354 (96%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+TKTPLKQLKL+VP QETPITSFLTASGTFHDGDLLLNQKGLRLISEE ESRPSD KE 
Sbjct: 3   MKTKTPLKQLKLAVPAQETPITSFLTASGTFHDGDLLLNQKGLRLISEEKESRPSDGKEL 62

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           +F+F L+DLETIKVIGKGSGGVVQLVRHKWVGRLFALK+IQMNIQE+IRKQIVQELKINQ
Sbjct: 63  EFDFLLDDLETIKVIGKGSGGVVQLVRHKWVGRLFALKVIQMNIQEDIRKQIVQELKINQ 122

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQC HVVVCYHSFYHNGVISLVLEYMDRGSLAD+I+QVKTILEPYLAVVCKQVLQGLVY
Sbjct: 123 ASQCPHVVVCYHSFYHNGVISLVLEYMDRGSLADVIKQVKTILEPYLAVVCKQVLQGLVY 182

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYMSPERISG
Sbjct: 183 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMSPERISG 242

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDYSSDIWSLG+VVLECAIGRFPY+QSEDQQSWPSFYELL AIVESPPP+APPDQFSP
Sbjct: 243 STYDYSSDIWSLGMVVLECAIGRFPYIQSEDQQSWPSFYELLAAIVESPPPSAPPDQFSP 302

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFC+FVS+CIQKDPRDR +SL+LL HPFIKKFEDKD+DLGILVG L+PPVN PR
Sbjct: 303 EFCTFVSSCIQKDPRDRLTSLELLDHPFIKKFEDKDLDLGILVGGLEPPVNFPR 356

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500523|ref|XP_003519081.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Glycine max]

 Score =  679 bits (1752), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/354 (91%), Positives = 340/354 (96%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+TK PLKQLKL+VP QETPITSFLTASGTFHDGDLLLNQKGLRLISEE ESRPSD KE 
Sbjct: 1   MKTKMPLKQLKLAVPAQETPITSFLTASGTFHDGDLLLNQKGLRLISEEKESRPSDGKEL 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           +F+FSL+DLETIKVIGKGSGGVVQLVRHKWVGRLFALK+IQMNIQE+IRKQIVQELKINQ
Sbjct: 61  EFDFSLDDLETIKVIGKGSGGVVQLVRHKWVGRLFALKVIQMNIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQC HVVVCYHSFYHNGVISLVLEYMDRGSLAD+I+QVKTILEPYLAVV KQVLQGLVY
Sbjct: 121 ASQCPHVVVCYHSFYHNGVISLVLEYMDRGSLADVIKQVKTILEPYLAVVSKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYMSPERISG
Sbjct: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMSPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDYSSDIWSLG+VVLECAIGRFPY+QSEDQQSWPSFYELL AIVESPPP+APPDQFSP
Sbjct: 241 STYDYSSDIWSLGMVVLECAIGRFPYIQSEDQQSWPSFYELLAAIVESPPPSAPPDQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVS+CIQKDPRDR +SL LL HPFIKKFEDKD+DLGIL GSL+PPVN PR
Sbjct: 301 EFCSFVSSCIQKDPRDRLTSLKLLDHPFIKKFEDKDLDLGILAGSLEPPVNFPR 354

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446532|ref|XP_004141025.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Cucumis sativus]

 Score =  670 bits (1729), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/354 (89%), Positives = 340/354 (96%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+TKTPLKQLKLSVPVQET I SFLTASGTFHDG+LLLNQKG+RLISEE ES+ +D KE 
Sbjct: 1   MKTKTPLKQLKLSVPVQETSIRSFLTASGTFHDGNLLLNQKGMRLISEEKESQTTDSKEL 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLET+KVIGKGSGGVVQLVRHKWVG+LFALK+IQMNIQE+IRKQIVQELKINQ
Sbjct: 61  DVDFSLEDLETVKVIGKGSGGVVQLVRHKWVGKLFALKVIQMNIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           A+QCSH+VVCYHSFYHNG ISLVLEYMDRGSLAD++RQVKTILEPYLAVVCKQVLQGLVY
Sbjct: 121 AAQCSHIVVCYHSFYHNGAISLVLEYMDRGSLADVVRQVKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYMSPERISG
Sbjct: 181 LHHERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMSPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
            TYDYSSDIWSLGLVVLECAIGRFPY+QSE+QQSWPSFYELLEAIV  PPP+APPDQFSP
Sbjct: 241 GTYDYSSDIWSLGLVVLECAIGRFPYLQSEEQQSWPSFYELLEAIVAKPPPSAPPDQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACI+KDP++RSSSLDLL+HPFIKKFEDKDID+GILV SLDPPV+ PR
Sbjct: 301 EFCSFVSACIKKDPKERSSSLDLLNHPFIKKFEDKDIDVGILVASLDPPVSFPR 354

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12718822|dbj|BAB32405.1| NQK1 MAPKK [Nicotiana tabacum]

 Score =  670 bits (1728), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/354 (89%), Positives = 336/354 (94%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+T  PLK+LKLSVP Q+TPI+SFLTASGTFHDGDLLLNQKGLRLISEENES  S+ KE 
Sbjct: 1   MKTTKPLKELKLSVPAQDTPISSFLTASGTFHDGDLLLNQKGLRLISEENESPASETKEI 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLETIKVIGKGSGGVVQLVRHKWVG LFALK+IQM IQE+IRKQIVQELKINQ
Sbjct: 61  DLQFSLEDLETIKVIGKGSGGVVQLVRHKWVGTLFALKVIQMTIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQCSHVVVCYHSFYHNG ISLVLEYMDRGSLAD+IRQ+KTILEPYLAVVCKQVLQGLVY
Sbjct: 121 ASQCSHVVVCYHSFYHNGAISLVLEYMDRGSLADVIRQLKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYM+PERISG
Sbjct: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMAPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDY SDIWSLG+V+LECAIGRFPY+QSEDQQ+WPSFYELLEAIV SPPP+AP DQFSP
Sbjct: 241 STYDYKSDIWSLGMVILECAIGRFPYIQSEDQQAWPSFYELLEAIVSSPPPSAPADQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACIQKDPRDRSS+LDLLSHPFIKKFEDKDID GILV SL+PPVN PR
Sbjct: 301 EFCSFVSACIQKDPRDRSSALDLLSHPFIKKFEDKDIDFGILVSSLEPPVNFPR 354

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|315258239|gb|ADT91698.1| mitogen activated protein kinase kinase [Nicotiana attenuata]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/354 (89%), Positives = 336/354 (94%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+T  PLK+LKLSVP Q+TPI+SFLTASGTFHDGDLLLNQKGLRLISEENES  S+ KE 
Sbjct: 1   MKTTKPLKELKLSVPAQDTPISSFLTASGTFHDGDLLLNQKGLRLISEENESPASETKEI 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLETIKVIGKGSGGVVQLVRHKW+G LFALK+IQM IQE+IRKQIVQELKINQ
Sbjct: 61  DLQFSLEDLETIKVIGKGSGGVVQLVRHKWIGTLFALKVIQMTIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQCSHVVVCYHSFYHNG ISLVLEYMDRGSLAD+IRQ+KTILEPYLAVVCKQVLQGLVY
Sbjct: 121 ASQCSHVVVCYHSFYHNGAISLVLEYMDRGSLADVIRQLKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYM+PERISG
Sbjct: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMAPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDY SDIWSLG+V+LECAIGRFPY+QSEDQQ+WPSFYELLEAIV SPPP+AP DQFSP
Sbjct: 241 STYDYKSDIWSLGMVILECAIGRFPYIQSEDQQAWPSFYELLEAIVSSPPPSAPADQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACIQKDPRDRSS+LDLLSHPFIKKFEDKDID GILV SL+PPVN PR
Sbjct: 301 EFCSFVSACIQKDPRDRSSALDLLSHPFIKKFEDKDIDFGILVSSLEPPVNFPR 354

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|187761609|dbj|BAG31943.1| MAP kinase [Nicotiana benthamiana]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/354 (88%), Positives = 335/354 (94%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+T  PLK+LKLSVP Q+TPI+SFLTASGTFHDGDLLLNQKGLRLISEENES  S+ KE 
Sbjct: 1   MKTTKPLKELKLSVPAQDTPISSFLTASGTFHDGDLLLNQKGLRLISEENESPASETKEI 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLETIKVIGKGSGGVVQLVRHKW+G LFALK+IQM IQE+IRKQIVQELKINQ
Sbjct: 61  DLQFSLEDLETIKVIGKGSGGVVQLVRHKWIGTLFALKVIQMTIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           +SQCSHVVVCYHSFYHNG ISLVLEYMDRGSLAD+IRQ+KTILEPYLAVVCKQVLQGLVY
Sbjct: 121 SSQCSHVVVCYHSFYHNGAISLVLEYMDRGSLADVIRQLKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLL NHKGEVKITDFGVSAML SSMGQRDTFVGTYNYM+PERISG
Sbjct: 181 LHNERHVIHRDIKPSNLLXNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMAPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDY SDIWSLG+V+LECAIGRFPY+QSEDQQ+WPSFYELLEAIV SPPP+AP DQFSP
Sbjct: 241 STYDYKSDIWSLGMVILECAIGRFPYIQSEDQQAWPSFYELLEAIVSSPPPSAPADQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACIQKDPRDRSS+LDLLSHPFIKKFEDKDID GILV SL+PPVN PR
Sbjct: 301 EFCSFVSACIQKDPRDRSSALDLLSHPFIKKFEDKDIDFGILVSSLEPPVNFPR 354

Source: Nicotiana benthamiana

Species: Nicotiana benthamiana

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449487973|ref|XP_004157893.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Cucumis sativus]

 Score =  665 bits (1717), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/354 (88%), Positives = 339/354 (95%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+TKTPLKQLKLSVPVQET I SFLTASGTFHDG+LLLNQKG+RLI+EE ES+ +D KE 
Sbjct: 1   MKTKTPLKQLKLSVPVQETSIRSFLTASGTFHDGNLLLNQKGMRLITEEKESQTTDSKEL 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLET+KVIGKGSGGVVQLVRHKWVG+LFALK+IQMNIQE+IRKQIVQELKINQ
Sbjct: 61  DVDFSLEDLETVKVIGKGSGGVVQLVRHKWVGKLFALKVIQMNIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           A+QCSH+VVCYHSFYHNG ISLVLEYMDRGSLAD++RQVKTILEPYLAVVCKQVLQGLVY
Sbjct: 121 AAQCSHIVVCYHSFYHNGAISLVLEYMDRGSLADVVRQVKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML SSMGQRDTFVGTYNYMSPERISG
Sbjct: 181 LHHERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLASSMGQRDTFVGTYNYMSPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
            TYDYSSDIWSLGLVVLECAIGRFPY+QSE+QQSWPSFYELLEAIV  PPP+APPDQFSP
Sbjct: 241 GTYDYSSDIWSLGLVVLECAIGRFPYLQSEEQQSWPSFYELLEAIVAKPPPSAPPDQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFC FVSACI+KDP++RSSSLDLL+HPFIKKFEDKDID+GILV SLDPPV+ PR
Sbjct: 301 EFCCFVSACIKKDPKERSSSLDLLNHPFIKKFEDKDIDVGILVASLDPPVSFPR 354

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225445061|ref|XP_002283491.1| PREDICTED: mitogen-activated protein kinase kinase 6 [Vitis vinifera] gi|147852632|emb|CAN79548.1| hypothetical protein VITISV_041078 [Vitis vinifera] gi|297738739|emb|CBI27984.3| unnamed protein product [Vitis vinifera]

 Score =  665 bits (1716), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/354 (90%), Positives = 335/354 (94%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M++K PLKQLKLSVP QETPITSFLTASGTF DGDLLLNQKGLRLISEE E RPS+ KE 
Sbjct: 1   MKSKKPLKQLKLSVPAQETPITSFLTASGTFQDGDLLLNQKGLRLISEEKEPRPSEAKEL 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLETIKVIGKGSGGVVQLVRHKWVG LFALK+IQMNIQE  RKQIVQELKINQ
Sbjct: 61  DVQFSLEDLETIKVIGKGSGGVVQLVRHKWVGTLFALKVIQMNIQENFRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQCSH+VVCYHSFYHNGVISLVLEYMDRGSL D+IRQVKTILEPYLAV+CKQVLQGLVY
Sbjct: 121 ASQCSHIVVCYHSFYHNGVISLVLEYMDRGSLVDVIRQVKTILEPYLAVLCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI G
Sbjct: 181 LHHERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIKG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDYSSDIWSLG+V LECAIG FPYMQSEDQQS PSFYELLEAIVESPPP+APPDQFSP
Sbjct: 241 STYDYSSDIWSLGMVALECAIGHFPYMQSEDQQSGPSFYELLEAIVESPPPSAPPDQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSF+SACIQK+P+DR SSLDL+SHPFIKKFEDKDIDL ILVGSL+PPVN PR
Sbjct: 301 EFCSFISACIQKNPQDRLSSLDLVSHPFIKKFEDKDIDLEILVGSLEPPVNFPR 354

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12331300|emb|CAC24705.1| MAP kinase [Nicotiana tabacum]

 Score =  664 bits (1713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/354 (89%), Positives = 334/354 (94%)

Query: 1   MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEF 60
           M+T  PLK+LKLSVP Q+TPI+SFLTASGTFHDGDLLLNQKGLRLISEENES  S+ KE 
Sbjct: 1   MKTTKPLKELKLSVPAQDTPISSFLTASGTFHDGDLLLNQKGLRLISEENESPASETKEI 60

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           D +FSLEDLETIKVIGKGSGGVVQLVRHKWVG LFALK+IQM IQE+IRKQIVQELKINQ
Sbjct: 61  DLQFSLEDLETIKVIGKGSGGVVQLVRHKWVGTLFALKVIQMTIQEDIRKQIVQELKINQ 120

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           ASQCSHVVVCYHSFYHNG ISLVLEYMDRGSLAD+IRQ+KTILEPYLAVVCKQVLQGLVY
Sbjct: 121 ASQCSHVVVCYHSFYHNGAISLVLEYMDRGSLADVIRQLKTILEPYLAVVCKQVLQGLVY 180

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LHNERHVIHRDIKPSNLLVNHKGEVKITDF VSAML SSMGQRDTFVGTYNYM+PERISG
Sbjct: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFXVSAMLASSMGQRDTFVGTYNYMAPERISG 240

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
           STYDY SDIWSLG+V+LECAIGRFPY+QSEDQQ+WPSFYELLEAIV SPPP+AP  QFSP
Sbjct: 241 STYDYKSDIWSLGMVILECAIGRFPYIQSEDQQAWPSFYELLEAIVSSPPPSAPAVQFSP 300

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
           EFCSFVSACIQKDPRDRSS+LDLLSHPFIKKFEDKDID GILV SL+PPVN PR
Sbjct: 301 EFCSFVSACIQKDPRDRSSALDLLSHPFIKKFEDKDIDFGILVSSLEPPVNFPR 354

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	354
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.991	0.985	0.789	6.4e-147
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.957	0.957	0.502	4.5e-91
DICTYBASE|DDB_G0269152	660	mekA "MAP kinase kinase (MAP2K	0.545	0.292	0.536	3.2e-70
TAIR|locus:2170578	520	MKK3 "AT5G40440" [Arabidopsis	0.703	0.478	0.484	9.3e-59
RGD|61888	400	Map2k2 "mitogen activated prot	0.536	0.475	0.437	7.7e-52
UNIPROTKB|P36506	400	Map2k2 "Dual specificity mitog	0.536	0.475	0.437	7.7e-52
FB|FBgn0010269	396	Dsor1 "Downstream of raf1" [Dr	0.502	0.449	0.477	7.7e-52
MGI|MGI:1346867	401	Map2k2 "mitogen-activated prot	0.536	0.473	0.437	2.6e-51
UNIPROTKB|Q17QH2	400	MAP2K2 "MAP2K2 protein" [Bos t	0.587	0.52	0.414	4.2e-51
UNIPROTKB|P36507	400	MAP2K2 "Dual specificity mitog	0.502	0.445	0.45	4.2e-51

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1435 (510.2 bits), Expect = 6.4e-147, P = 6.4e-147
 Identities = 278/352 (78%), Positives = 297/352 (84%)

Query:     1 MRTKTPLKQLKLSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKXX 60
             ++ K+ LKQLKLSVP QE+PI+SFLTASGTFHDGD LLNQKGLRL S+E +SR SD K  
Sbjct:     2 VKIKSNLKQLKLSVPAQESPISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKEL 61

Query:    61 XXXXXXXXXXTXXXXXXXXXXXXQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
                       T            QLVRHKWVG+ FA+K+IQMNIQEEIRKQIVQELKINQ
Sbjct:    62 DFEITAEDLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQ 121

Query:   121 AS-QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
             AS QC HVVVCYHSFYHNG  SLVLEYMDRGSLAD+IRQVKTILEPYLAVVCKQVL GLV
Sbjct:   122 ASSQCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLV 181

Query:   180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
             YLHNERHVIHRDIKPSNLLVNHKGEVKI+DFGVSA L SSMGQRDTFVGTYNYMSPERIS
Sbjct:   182 YLHNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERIS 241

Query:   240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
             GSTYDYSSDIWSLG+ VLECAIGRFPY++SEDQQ+ PSFYELL AIVE+PPPTAP DQFS
Sbjct:   242 GSTYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFS 301

Query:   300 PEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLGILVGSLDPPVN 351
             PEFCSFVSACIQKDP           HPFIKKFEDKDIDLGILVG+L+PPVN
Sbjct:   302 PEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDIDLGILVGTLEPPVN 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
 Identities = 172/342 (50%), Positives = 228/342 (66%)

Query:    12 LSVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKXXXXXXXXXXXXT 71
             + +P  E  I+ FLT SGTF DGDL +N+ G++ +S      P   +             
Sbjct:    11 ICLPPLEQSISKFLTQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPIEPLDNQLSLADLEV 70

Query:    72 XXXXXXXXXXXXQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCY 131
                         QLV+HK   + FALK+IQ+N +E   + I QEL+IN +SQC ++V CY
Sbjct:    71 IKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPYLVSCY 130

Query:   132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
              SFYHNG++S++LE+MD GSLAD++++V  + E  L+ +CK+VL+GL Y+H+ER +IHRD
Sbjct:   131 QSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERRIIHRD 190

Query:   192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
             +KPSNLL+NH+GEVKITDFGVS +L S+    ++FVGTY YMSPERISGS Y   SDIWS
Sbjct:   191 LKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNKSDIWS 250

Query:   252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
             LGLV+LECA G+FPY   E ++ W S YEL++AIVE+PPP AP + FSPEFCSF+S C+Q
Sbjct:   251 LGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCSFISQCVQ 310

Query:   312 KDPXXXXXXXXXXXHPFIKKFEDKDIDLGIL---VGSLDPPV 350
             KDP           H F+K FED D +L       GSL PP+
Sbjct:   311 KDPRDRKSAKELLEHKFVKMFEDSDTNLSAYFTDAGSLIPPL 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

DICTYBASE|DDB_G0269152 mekA "MAP kinase kinase (MAP2K)" [Dictyostelium discoideum (taxid:44689)]

 Score = 527 (190.6 bits), Expect = 3.2e-70, Sum P(3) = 3.2e-70
 Identities = 104/194 (53%), Positives = 136/194 (70%)

Query:    84 QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
             +L  H+  G   ALK+I ++IQE IRKQI+ ELK    +   ++V  Y +FY  G I + 
Sbjct:   307 KLAYHETSGTYIALKVITLDIQENIRKQIILELKTLHKTSYPYIVSFYDAFYTEGSIFIA 366

Query:   144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
             LE+M+ GSL+DI+++  TI EP L  +  QVLQGLVYLH + H+IHRDIKPSN+LVN+KG
Sbjct:   367 LEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVYLHRKLHLIHRDIKPSNILVNNKG 426

Query:   204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
             E KI DFGVS  L  ++ +  T+VGT  YMSPERISG +Y + S+IWSLGL +LECAIG+
Sbjct:   427 EAKIADFGVSGQLQHTLSKAVTWVGTVTYMSPERISGRSYSFDSEIWSLGLTILECAIGK 486

Query:   264 FPYMQS-EDQQSWP 276
             FPY  +   QQ  P
Sbjct:   487 FPYGSNLPHQQQQP 500

GO:0030587 "sorocarp development" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016020 "membrane" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2170578 MKK3 "AT5G40440" [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
 Identities = 126/260 (48%), Positives = 167/260 (64%)

Query:    93 RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH-SFYH--NGVISLVLEYMDR 149
             R+ ALK I +  + E R+Q++ E++    + C   +V +H +FY   +G IS+ LEYM+ 
Sbjct:   107 RILALKKINI-FEREKRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNG 165

Query:   150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
             GSLADI++  K I EP L+ +  ++LQGL YLH  RH++HRDIKP+NLL+N KGE KITD
Sbjct:   166 GSLADILKVTKKIPEPVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITD 225

Query:   210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS 269
             FG+SA L +SM    TFVGT  YMSPERI   +Y Y +DIWSLGL + EC  G FPY+ +
Sbjct:   226 FGISAGLENSMAMCATFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIAN 285

Query:   270 EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
             E     P    L+  I++ P PT P  +FSPEFCSF+ AC+QKDP           HPFI
Sbjct:   286 EG----P--VNLMLQILDDPSPTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFI 339

Query:   330 KKFEDKDIDLGILVGSL-DP 348
              K E + +DL   V S+ DP
Sbjct:   340 TKHEKERVDLATFVQSIFDP 359

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IEP

GO:0009866 "induced systemic resistance, ethylene mediated signaling pathway" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=IDA

RGD|61888 Map2k2 "mitogen activated protein kinase kinase 2" [Rattus norvegicus (taxid:10116)]

 Score = 428 (155.7 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 84/192 (43%), Positives = 126/192 (65%)

Query:    87 RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
             RH+  G + A K+I + I+  +R QI++EL++       ++V  Y +FY +G IS+ +E+
Sbjct:    90 RHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 149

Query:   147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+K
Sbjct:   150 MDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 209

Query:   207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
             + DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E AIGR+P 
Sbjct:   210 LCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 267

Query:   267 MQSEDQQSWPSF 278
                + ++   SF
Sbjct:   268 PPPDAKELEASF 279

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IDA;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005778 "peroxisomal membrane" evidence=IEA;ISO

GO:0005783 "endoplasmic reticulum" evidence=IEA;ISO

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005874 "microtubule" evidence=IEA;ISO

GO:0005911 "cell-cell junction" evidence=IEA;ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0009898 "internal side of plasma membrane" evidence=IEA;ISO

GO:0030165 "PDZ domain binding" evidence=IEA;ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032947 "protein complex scaffold" evidence=IEA;ISO

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA;ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0097110 "scaffold protein binding" evidence=IEA;ISO

GO:2000147 "positive regulation of cell motility" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

UNIPROTKB|P36506 Map2k2 "Dual specificity mitogen-activated protein kinase kinase 2" [Rattus norvegicus (taxid:10116)]

 Score = 428 (155.7 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 84/192 (43%), Positives = 126/192 (65%)

Query:    87 RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
             RH+  G + A K+I + I+  +R QI++EL++       ++V  Y +FY +G IS+ +E+
Sbjct:    90 RHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 149

Query:   147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+K
Sbjct:   150 MDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 209

Query:   207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
             + DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E AIGR+P 
Sbjct:   210 LCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 267

Query:   267 MQSEDQQSWPSF 278
                + ++   SF
Sbjct:   268 PPPDAKELEASF 279

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:2000147 "positive regulation of cell motility" evidence=IEA

FB|FBgn0010269 Dsor1 "Downstream of raf1" [Drosophila melanogaster (taxid:7227)]

 Score = 420 (152.9 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 86/180 (47%), Positives = 118/180 (65%)

Query:    86 VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
             VRH     + A K+I + ++  I+KQI++ELK+       H+V  Y +FY +G IS+ +E
Sbjct:   104 VRHTHTHLIMARKLIHLEVKPAIKKQILRELKVLHECNFPHIVGFYGAFYSDGEISICME 163

Query:   146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
             YMD GSL  I+++   I E  L  +   VL+GL YL +   +IHRD+KPSN+LVN  GE+
Sbjct:   164 YMDGGSLDLILKRAGRIPESILGRITLAVLKGLSYLRDNHAIIHRDVKPSNILVNSSGEI 223

Query:   206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
             KI DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWSLGL ++E AIG +P
Sbjct:   224 KICDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 281

GO:0007165 "signal transduction" evidence=IGI;IMP

GO:0004708 "MAP kinase kinase activity" evidence=ISS;NAS;TAS

GO:0008595 "anterior/posterior axis specification, embryo" evidence=TAS

GO:0008592 "regulation of Toll signaling pathway" evidence=NAS

GO:0008293 "torso signaling pathway" evidence=NAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=NAS

GO:0045500 "sevenless signaling pathway" evidence=NAS

GO:0004707 "MAP kinase activity" evidence=NAS

GO:0007362 "terminal region determination" evidence=IMP

GO:0000165 "MAPK cascade" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS;TAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0042386 "hemocyte differentiation" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007298 "border follicle cell migration" evidence=IGI

MGI|MGI:1346867 Map2k2 "mitogen-activated protein kinase kinase 2" [Mus musculus (taxid:10090)]

 Score = 428 (155.7 bits), Expect = 2.6e-51, Sum P(2) = 2.6e-51
 Identities = 84/192 (43%), Positives = 126/192 (65%)

Query:    87 RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
             RH+  G + A K+I + I+  +R QI++EL++       ++V  Y +FY +G IS+ +E+
Sbjct:    90 RHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 149

Query:   147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+K
Sbjct:   150 MDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 209

Query:   207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
             + DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E AIGR+P 
Sbjct:   210 LCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 267

Query:   267 MQSEDQQSWPSF 278
                + ++   SF
Sbjct:   268 PPPDAKELEASF 279

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005778 "peroxisomal membrane" evidence=ISO

GO:0005783 "endoplasmic reticulum" evidence=ISO

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005874 "microtubule" evidence=ISO

GO:0005911 "cell-cell junction" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0009898 "internal side of plasma membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032947 "protein complex scaffold" evidence=IDA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0097110 "scaffold protein binding" evidence=ISO

GO:2000147 "positive regulation of cell motility" evidence=IDA

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

UNIPROTKB|Q17QH2 MAP2K2 "MAP2K2 protein" [Bos taurus (taxid:9913)]

 Score = 432 (157.1 bits), Expect = 4.2e-51, Sum P(2) = 4.2e-51
 Identities = 87/210 (41%), Positives = 132/210 (62%)

Query:    86 VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
             V+H+  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct:    89 VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 148

Query:   146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
             +MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct:   149 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 208

Query:   206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
             K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E +IGR+P
Sbjct:   209 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELSIGRYP 266

Query:   266 YMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
                 + ++    F   +    E  PP+  P
Sbjct:   267 IPPPDAKELEAIFGRPMVDGAEGEPPSISP 296

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P36507 MAP2K2 "Dual specificity mitogen-activated protein kinase kinase 2" [Homo sapiens (taxid:9606)]

 Score = 423 (154.0 bits), Expect = 4.2e-51, Sum P(2) = 4.2e-51
 Identities = 81/180 (45%), Positives = 122/180 (67%)

Query:    86 VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
             V+H+  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct:    89 VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 148

Query:   146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
             +MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct:   149 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 208

Query:   206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
             K+ DFGVS  L  SM   ++FVGT +YM+PER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct:   209 KLCDFGVSGQLIDSMA--NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 266

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0005524 "ATP binding" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

GO:0005911 "cell-cell junction" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IDA

GO:0005778 "peroxisomal membrane" evidence=IDA

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0030165 "PDZ domain binding" evidence=IDA

GO:0097110 "scaffold protein binding" evidence=IPI

GO:0009898 "internal side of plasma membrane" evidence=IDA

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0070371 "ERK1 and ERK2 cascade" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FJV0	M2K6_ARATH	2, ., 7, ., 1, 2, ., 2	0.8619	1.0	0.9943	yes	no
Q5QN75	M2K1_ORYSJ	2, ., 7, ., 1, 2, ., 2	0.7648	0.9887	0.9859	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.994
3rd Layer	2.7.12	0.998
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	354
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-149
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-121
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-95
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-86
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-85
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-83
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-82
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-79
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-77
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-77
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-74
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-74
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-71
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-70
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-70
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-70
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-68
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-68
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-63
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-61
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-61
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-61
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-60
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-59
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-58
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-57
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-57
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-56
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-56
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-52
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-51
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-48
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-48
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-47
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-46
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-46
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-45
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-45
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-44
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-43
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-43
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-43
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-41
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-41
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-41
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-40
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-40
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-40
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-40
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-40
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-40
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-40
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-40
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-39
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-39
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-39
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-38
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-38
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-38
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-37
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-36
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-36
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-35
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-34
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-34
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-32
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-32
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-32
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-32
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-32
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-31
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-31
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-31
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-31
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-30
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-30
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-30
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-29
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-29
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-29
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-29
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-29
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-29
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-28
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-28
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-28
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-27
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-27
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-27
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-27
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-27
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-26
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-26
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-26
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-25
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-25
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-25
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-25
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-25
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-25
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-24
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-24
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-24
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-24
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-24
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-23
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-23
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-23
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-23
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-23
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-22
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-22
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-22
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-22
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-22
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-22
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-22
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-21
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-21
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-21
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-19
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-15
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-15
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  420 bits (1082), Expect = e-149
 Identities = 150/267 (56%), Positives = 205/267 (76%), Gaps = 4/267 (1%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
            DLE +KV+G+GS GVV  VRHK  G+++ALK I ++  EE RKQ+++ELK  ++ +  +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           VV CY +FY  G IS+VLEYMD GSLAD++++V  I EP LA + +Q+L+GL YLH +RH
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +IHRDIKPSNLL+N KGEVKI DFG+S +L +++ Q +TFVGT  YMSPERI G +Y Y+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           +DIWSLGL +LECA+G+FP++        PSF+EL++AI + PPP+ P ++FSPEF  F+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKKFE 333
           SAC+QKDP+ R S+ +LL HPFIKK +
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  349 bits (898), Expect = e-121
 Identities = 129/269 (47%), Positives = 178/269 (66%), Gaps = 5/269 (1%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +DLE +  +G G+ GVV  V H+  G++ A+K I++ I E I+KQI++EL I       +
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNER 185
           +V  Y +FY+NG IS+ +EYMD GSL  I+++V   I E  L  +   VL+GL YLH + 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
            +IHRD+KPSN+LVN +G++K+ DFGVS  L +S+ +  TFVGT +YM+PERI G+ Y  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSV 178

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            SDIWSLGL ++E A GRFPY            +ELL+ IV  PPP  P  +FSP+F  F
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPE--NDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKKFED 334
           V+ C+ KDPR+R S  +LL HPFIKK+E 
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  285 bits (732), Expect = 2e-95
 Identities = 119/302 (39%), Positives = 177/302 (58%), Gaps = 31/302 (10%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +D E +  +G G+GGVV  V H+  G + A K+I + I+  IR QI++ELK+       +
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V  Y +FY +G IS+ +E+MD GSL  ++++   I E  L  +   VL+GL YL  +  
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYTVQ 178

Query: 247 SDIWSLGLVVLECAIGRFPY------------------MQSEDQQSWPSFY--------- 279
           SDIWSLGL ++E AIGR+P                    ++++     S +         
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238

Query: 280 --ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
             ELL+ IV  PPP  P   FS EF  FV  C++K+P++R+   +L  HPFIK+ E +++
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Query: 338 DL 339
           D 
Sbjct: 299 DF 300

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  259 bits (665), Expect = 5e-86
 Identities = 87/261 (33%), Positives = 143/261 (54%), Gaps = 9/261 (3%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           E ++ +G+GS G V L R K  G+L A+K+I+    ++ R++I++E+KI +  +  ++V 
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y  F     + LV+EY + G L D++++   + E       +Q+L  L YLH  + ++H
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH-SKGIVH 120

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+KP N+L++  G VK+ DFG++  L     +  TFVGT  YM+PE + G  Y  + DI
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAPPDQFSPEFCSFVSA 308
           WSLG+++ E   G+ P+   +         EL + I +  PP   P    SPE    +  
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 309 CIQKDPRDRSSSLDLLSHPFI 329
            + KDP  R ++ + L HPF 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  257 bits (658), Expect = 7e-85
 Identities = 102/265 (38%), Positives = 158/265 (59%), Gaps = 16/265 (6%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH- 126
             E ++ IGKG  G V   RHK  G+  A+K+I++  +E+ +++I+ E++I    +C H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQI--LKKCKHP 57

Query: 127 -VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNE 184
            +V  Y S+     + +V+E+   GSL D+++     L E  +A VCK++L+GL YLH+ 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
             +IHRDIK +N+L+   GEVK+ DFG+SA L  +   R+T VGT  +M+PE I+G  YD
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGKPYD 175

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFC 303
           Y +DIWSLG+  +E A G+ PY +           + L  I  + PP    P+++S EF 
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIATNGPPGLRNPEKWSDEFK 228

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPF 328
            F+  C+QK+P  R ++  LL HPF
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  255 bits (652), Expect = 1e-83
 Identities = 115/278 (41%), Positives = 167/278 (60%), Gaps = 7/278 (2%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           EDLETI  +G G+GG V  V+H   G + A K++ +  +  +RKQI++EL+I    +  +
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V  Y +F +   I + +E+MD GSL  I ++   I    L  +   V++GL YL+N   
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           ++HRDIKPSN+LVN +G++K+ DFGVS  L +S+   DTFVGT  YMSPERI G  Y   
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGKYTVK 182

Query: 247 SDIWSLGLVVLECAIGRFPYMQSE---DQQSWP-SFYELLEAIVESPPPTAPPDQFSPEF 302
           SD+WSLG+ ++E A+G+FP+  S    D Q  P    +LL+ IV+ PPP  P   F  + 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 303 CSFVSACIQKDPRDRSSSLDLL-SHPFIKKFEDKDIDL 339
             FV AC+ KDP +R +   L    PFI+     ++DL
Sbjct: 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  253 bits (649), Expect = 2e-82
 Identities = 125/270 (46%), Positives = 169/270 (62%), Gaps = 15/270 (5%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC 124
           SL +LE +  IG G+GG V  V H+  GRL+ALK+I  N ++ +R+QI +E++I +    
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH 131

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            +VV C+  F HNG I ++LE+MD GSL      +    E +LA V +Q+L G+ YLH  
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIAD--EQFLADVARQILSGIAYLH-R 186

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS--- 241
           RH++HRDIKPSNLL+N    VKI DFGVS +L  +M   ++ VGT  YMSPERI+     
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246

Query: 242 -TYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
             YD Y+ DIWSLG+ +LE  +GRFP+     Q  W S   L+ AI  S PP AP    S
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWAS---LMCAICMSQPPEAPATA-S 301

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
            EF  F+S C+Q++P  R S++ LL HPFI
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  244 bits (625), Expect = 2e-79
 Identities = 114/285 (40%), Positives = 167/285 (58%), Gaps = 16/285 (5%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           E +  +  +G+G+GG V   R K  G +FALK I  +   +++KQI++EL+IN++ +  +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 127 VVVCYHSFY--HNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVVCKQVLQGLVY 180
           +V  Y +F    +  I + +EY + GSL  I ++VK     I E  L  + + VL+GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH  R +IHRDIKPSN+L+  KG+VK+ DFGVS  L +S+    TF GT  YM+PERI G
Sbjct: 121 LH-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQG 177

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD---- 296
             Y  +SD+WSLGL +LE A  RFP+    +    P   ELL  IV  P P    +    
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP--IELLSYIVNMPNPELKDEPGNG 235

Query: 297 -QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLG 340
            ++S EF  F+  C++KDP  R +  D+L HP+IK    K +++ 
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMA 280

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  238 bits (610), Expect = 3e-77
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 18/272 (6%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV 128
            + ++ IG+G+ G V     +  G+  A+K  +M ++++ ++ I+ E+ I +  +  ++V
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIK--KMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHV 187
             Y S+     + +V+EYMD GSL DII Q    + EP +A VC++VLQGL YLH+ ++V
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNV 137

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS 247
           IHRDIK  N+L++  G VK+ DFG +A L     +R++ VGT  +M+PE I    Y    
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV 197

Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI----VESPPPTAPPDQFSPEFC 303
           DIWSLG++ +E A G  PY++             L A+     +  PP   P+++SPEF 
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLR----------EPPLRALFLITTKGIPPLKNPEKWSPEFK 247

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
            F++ C+ KDP  R S+ +LL HPF+KK   K
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  237 bits (606), Expect = 4e-77
 Identities = 101/265 (38%), Positives = 161/265 (60%), Gaps = 13/265 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           E  + ++ +G+GS G V    HK  G++ A+K++ +   E++ ++I++E+ I +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDL-QEIIKEISILKQCDSPY 59

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNER 185
           +V  Y S++ N  + +V+EY   GS++DI++   KT+ E  +A +  Q L+GL YLH+  
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-N 118

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
             IHRDIK  N+L+N +G+ K+ DFGVS  L  +M +R+T +GT  +M+PE I    Y+ 
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCS 304
            +DIWSLG+  +E A G+ PY  S+       F      I   PPPT + P+++SPEF  
Sbjct: 179 KADIWSLGITAIEMAEGKPPY--SDIHPMRAIF-----MIPNKPPPTLSDPEKWSPEFND 231

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFI 329
           FV  C+ KDP +R S++ LL HPFI
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  231 bits (592), Expect = 1e-74
 Identities = 101/271 (37%), Positives = 155/271 (57%), Gaps = 9/271 (3%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           E    ++ IGKGS G V     K   ++ A+K+I +   E+  + I QE++     +  +
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +   Y SF     + +++EY   GS  D+++  K + E Y+A + ++VL GL YLH E  
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEG- 118

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
            IHRDIK +N+L++ +G+VK+ DFGVS  L S+M +R+TFVGT  +M+PE I  S YD  
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           +DIWSLG+  +E A G  P       +       +L  I ++ PP+   ++FS  F  FV
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPSLEGNKFSKPFKDFV 231

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
           S C+ KDP++R S+ +LL H FIKK +    
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKKAKKTSY 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  230 bits (588), Expect = 2e-74
 Identities = 80/263 (30%), Positives = 133/263 (50%), Gaps = 5/263 (1%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHV 127
            E ++ +G GS G V   +HK  G++ A+KI++  + + +  +   +E++I +     ++
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           V    +F     + LV+EY + G L D + +   + E     +  Q+L+GL YLH    +
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH-SNGI 119

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYS 246
           IHRD+KP N+L++  G VKI DFG++  L  S     TFVGT  YM+PE + G   Y   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
            D+WSLG+++ E   G+ P+              +L   +E   P       S E    +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK--WSSGSEEAKDLI 237

Query: 307 SACIQKDPRDRSSSLDLLSHPFI 329
             C+ KDP  R ++ ++L HP+ 
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  223 bits (571), Expect = 1e-71
 Identities = 109/273 (39%), Positives = 174/273 (63%), Gaps = 7/273 (2%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +D++  +++G G+GG V    H    R+ A+K+I ++I  E++KQI+ EL+I       +
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           ++  Y +F+    IS+  E+MD GSL D+ R+   I E  L  +   V++GL YL + + 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLK- 115

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           ++HRD+KPSN+LVN +G+VK+ DFGVS  L +S+ +  T+VGT  YM+PERISG  Y   
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIH 173

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           SD+WSLG+  +E A+GRFPY Q +  Q      +LL+ IV+  PP  P  QFS +F  F+
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL 339
           + C++K P++R +  +L+ HPFI ++ D + ++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  223 bits (570), Expect = 1e-70
 Identities = 120/317 (37%), Positives = 179/317 (56%), Gaps = 41/317 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   +D E I  +G G+GGVV  V+HK  G + A K+I + I+  IR QI++EL++    
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++ K I E  L  V   VL+GL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ 
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH 178

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSE-------------------------------- 270
           Y   SDIWS+GL ++E AIGR+P    +                                
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238

Query: 271 -------DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                  D +   + +ELL+ IV  PPP  P   F+P+F  FV+ C+ K+P +R+    L
Sbjct: 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298

Query: 324 LSHPFIKKFEDKDIDLG 340
           ++H FIK+ E +++D  
Sbjct: 299 MNHTFIKRSEVEEVDFA 315

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  221 bits (564), Expect = 2e-70
 Identities = 103/282 (36%), Positives = 164/282 (58%), Gaps = 16/282 (5%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +++E +  +GKG+ G V  V H+  G   A+K I++ + E    QI+ EL I   +   +
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADII---RQVKTILEPYLAVVCKQVLQGLVYLHN 183
           +V  Y +F+  G + + +EYMD GSL  +       + I E  L  +   V++GL +L  
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--- 240
           E ++IHRD+KP+N+LVN  G+VK+ DFGVS  L +S+ +  T +G  +YM+PERI     
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSGGP 178

Query: 241 ---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
               TY   SD+WSLGL +LE A+GR+PY      +++ + +  L AIV+  PPT P   
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLPSG- 233

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL 339
           +S +   FV+ C+ K P  R +   LL HP++ K+++ D+D+
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  220 bits (562), Expect = 3e-70
 Identities = 84/264 (31%), Positives = 143/264 (54%), Gaps = 16/264 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ---IVQELKINQASQCSHVVV 129
           +++G+GS G V L   K  G L A+K   + +  +  ++   + +E++I  + Q  ++V 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVK--SVELSGDSEEELEALEREIRILSSLQHPNIVR 63

Query: 130 CYHSFYHN--GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
            Y S        +++ LEY+  GSL+ ++++   + EP +    +Q+L+GL YLH    +
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-SNGI 122

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDY 245
           +HRDIK +N+LV+  G VK+ DFG +  LG         +  GT  +M+PE I G  Y  
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
           ++DIWSLG  V+E A G+ P+ +  +  +       L  I  S  P   P+  S E   F
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMA------ALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 306 VSACIQKDPRDRSSSLDLLSHPFI 329
           +  C+++DP+ R ++ +LL HPF+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  216 bits (552), Expect = 1e-68
 Identities = 103/281 (36%), Positives = 167/281 (59%), Gaps = 17/281 (6%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCS 125
           +DLE I+ +G+G+ GVV  +RH   G + A+K I+  +  + +K+++ +L I+ ++  C 
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYL 181
           + V  Y + +  G + + +E MD  SL    ++V     TI E  L  +   +++ L YL
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
           H++  VIHRD+KPSN+L+N  G+VK+ DFG+S  L  S+  +    G   YM+PERI+  
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-KTIDAGCKPYMAPERINPE 178

Query: 242 T----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
                YD  SD+WSLG+ ++E A GRFPY       SW + ++ L+ +VE P P  P ++
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPY------DSWKTPFQQLKQVVEEPSPQLPAEK 232

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
           FSPEF  FV+ C++K+ ++R +  +LL HPF +    K+ D
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  217 bits (553), Expect = 3e-68
 Identities = 120/315 (38%), Positives = 175/315 (55%), Gaps = 39/315 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
           E   +D E I  +G G+GGVV  V HK  G + A K+I + I+  IR QI++EL++    
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              ++V  Y +FY +G IS+ +E+MD GSL  ++++   I E  L  V   V++GL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ 
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH 178

Query: 243 YDYSSDIWSLGLVVLECAIGRFPY-----------------------------------M 267
           Y   SDIWS+GL ++E AIGR+P                                    +
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238

Query: 268 QSEDQQSWP--SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
            S    S P  + +ELL+ IV  PPP  P   F  EF  FV+ C+ K+P +R+    L+ 
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298

Query: 326 HPFIKKFEDKDIDLG 340
           H FIK+ E +++D  
Sbjct: 299 HAFIKRSEAEEVDFA 313

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  203 bits (517), Expect = 2e-63
 Identities = 100/275 (36%), Positives = 164/275 (59%), Gaps = 20/275 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--V 127
           E I  +G G+ G V   +HK  G   A KIIQ+  +EE+   +V+   I+  S+C H  +
Sbjct: 8   EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE---IDILSECKHPNI 64

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERH 186
           V  Y ++++   + +++E+ D G+L  I+ +++  L EP +  VC+Q+L+ L +LH+ + 
Sbjct: 65  VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK- 123

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST---- 242
           VIHRD+K  N+L+   G+VK+ DFGVSA   S++ +RDTF+GT  +M+PE ++  T    
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183

Query: 243 -YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSP 300
            YDY +DIWSLG+ ++E A    P+ +        +   +L  I++S PPT   P ++S 
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-------NPMRVLLKILKSEPPTLDQPSKWSS 236

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
            F  F+ +C+ KDP DR ++ +LL HPF+    D 
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  196 bits (501), Expect = 3e-61
 Identities = 97/275 (35%), Positives = 150/275 (54%), Gaps = 26/275 (9%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
            ED E I+ IG G+ G V   R    G L A+K+I++   ++  + I QE+ + +  +C 
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF-EIIQQEISMLK--ECR 58

Query: 126 H--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLH 182
           H  +V  + S+     + +V+EY   GSL DI +  +  L E  +A VC++ L+GL YLH
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI---S 239
            E   IHRDIK +N+L+   G+VK+ DFGVSA L +++ +R +F+GT  +M+PE      
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPY-----MQSEDQQSWPSFYELLEAIVESPPPT-A 293
              YD   DIW+LG+  +E A  + P      M++    S  +F          PPP   
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----------PPPKLK 227

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
             +++SP F  F+  C+ KDP+ R ++  LL HPF
Sbjct: 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  197 bits (502), Expect = 3e-61
 Identities = 102/278 (36%), Positives = 159/278 (57%), Gaps = 29/278 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--V 127
           E ++VIG+G+ G V   RHK  G+L A+KI  M+I E+  ++I +E  I +    +H  +
Sbjct: 9   ELVEVIGEGTYGKVYKARHKKTGQLVAIKI--MDIIEDEEEEIKEEYNILRK-YSNHPNI 65

Query: 128 VVCYHSFYHNGV------ISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQG 177
              Y +F           + LV+E    GS+ D+++ +    K + E ++A + ++ L+G
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L YLH E  VIHRDIK  N+L+    EVK+ DFGVSA L S++G+R+TF+GT  +M+PE 
Sbjct: 126 LAYLH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 238 IS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           I+      ++YD  SD+WSLG+  +E A G+ P     D     + ++    I  +PPPT
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLC---DMHPMRALFK----IPRNPPPT 237

Query: 293 -APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
              P+ +S +F  F+S C+ K+   R    +LL HPFI
Sbjct: 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  196 bits (500), Expect = 4e-61
 Identities = 102/266 (38%), Positives = 149/266 (56%), Gaps = 20/266 (7%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHV-VV 129
           IK IGKGS G V LVR K  G+L+ LK I + N+ E+ R+  + E+KI    + +H  ++
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI--LKKLNHPNII 62

Query: 130 CYH-SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCK---QVLQGLVYLHNE 184
            Y+ SF   G + +V+EY D G L+  I++ K   +P+    +     Q+   L YLH  
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-S 121

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           R ++HRDIKP N+ +   G VK+ DFG+S +L S++    T VGT  Y+SPE      Y+
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFC 303
           Y SDIWSLG V+ E    + P+ + E      +  EL   I++   P  P P Q+S E  
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPF-EGE------NLLELALKILKGQYP--PIPSQYSSELR 232

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFI 329
           + VS+ +QKDP +R S   +L  PFI
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  195 bits (498), Expect = 3e-60
 Identities = 101/285 (35%), Positives = 158/285 (55%), Gaps = 17/285 (5%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA 121
           +   L DLE +  IG G+ G V  +R K  G + A+K ++    +E  K+I+ +L +   
Sbjct: 10  YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69

Query: 122 SQ-CSHVVVCYHSFYHNGVISLVLEYMDRGSLAD--IIRQVKTILEPYLAVVCKQVLQGL 178
           S  C ++V CY  F  +  + + +E M   +  D  + R    I E  L  +   +++ L
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            YL  +  VIHRD+KPSN+L++  G VK+ DFG+S  L  S   +    G   YM+PERI
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERI 186

Query: 239 ----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
                   YD  +D+WSLG+ ++E A G+FPY   + +      +E+L  I++  PP+ P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPPSLP 240

Query: 295 PDQ-FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
           P++ FSP+FCSFV  C+ KD R R    +LL HPFI+++E  ++D
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVD 285

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  193 bits (493), Expect = 1e-59
 Identities = 101/288 (35%), Positives = 160/288 (55%), Gaps = 22/288 (7%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK-INQAS 122
           F+ EDL+ +  IG+G+ G V  + HK  G + A+K I+  + E+ +K+++ +L  + ++S
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV-----KTILEPYLAVVCKQVLQG 177
            C ++V  Y + +  G   + +E MD  SL    + V       I E  L  +    ++ 
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-RDTFVGTYNYMSPE 236
           L YL  E  +IHRD+KPSN+L++  G +K+ DFG+S  L  S+ + RD   G   YM+PE
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPE 177

Query: 237 RISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
           RI  S    YD  SD+WSLG+ + E A G+FPY        W S ++ L  +V+  PP  
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPIL 231

Query: 294 PPD---QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
                 +FSP F +F++ C+ KD   R    +LL HPFIK +E++++D
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  187 bits (478), Expect = 8e-58
 Identities = 102/282 (36%), Positives = 146/282 (51%), Gaps = 34/282 (12%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQ-EEIRKQIVQELKINQA- 121
           +D E I+VIG G+  VV            A+K I   +     +E+RK++       QA 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEV-------QAM 53

Query: 122 SQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQ 176
           SQC+H  VV  Y SF     + LV+ Y+  GSL DI++       + E  +A V K+VL+
Sbjct: 54  SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTFVGTYNY 232
           GL YLH+    IHRDIK  N+L+   G VKI DFGVSA L      +   R TFVGT  +
Sbjct: 114 GLEYLHSNGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 233 MSPERIS-GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP 291
           M+PE +     YD+ +DIWS G+  +E A G  PY        +P   ++L   +++ PP
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY------SKYPPM-KVLMLTLQNDPP 225

Query: 292 TAPPD----QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           +        ++S  F   +S C+QKDP  R ++ +LL H F 
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  187 bits (477), Expect = 1e-57
 Identities = 96/258 (37%), Positives = 133/258 (51%), Gaps = 12/258 (4%)

Query: 74  VIGKGSGGVVQLVRHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH 132
           +IG+G+ GVV    +   G   A+K I    I+EE  K I+QE+ + +  +  ++V  Y 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK-YI 65

Query: 133 SFYHNG-VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
                   + ++LEY + GSL  II++     E  +AV   QVLQGL YLH +  VIHRD
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRD 124

Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           IK +N+L    G VK+ DFGV+  L        + VGT  +M+PE I  S    +SDIWS
Sbjct: 125 IKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWS 184

Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG  V+E   G  PY    D     + +     IV+   P  P    SPE   F+  C Q
Sbjct: 185 LGCTVIELLTGNPPYY---DLNPMAALF----RIVQDDHPPLPEG-ISPELKDFLMQCFQ 236

Query: 312 KDPRDRSSSLDLLSHPFI 329
           KDP  R ++  LL HP+I
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  185 bits (471), Expect = 2e-57
 Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 44/256 (17%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF 134
           +G+G  G V L R K  G+  A+KII+      + +++++E++I +     ++V  Y  F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 135 YHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
                + LV+EY + GSL D++++ +  L E  +  +  Q+L+GL YLH    +IHRD+K
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNGIIHRDLK 119

Query: 194 PSNLLVNHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWS 251
           P N+L++   G+VK+ DFG+S +L S      T VGT  YM+PE + G   Y   SDIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG++                       YEL                  PE    +   +Q
Sbjct: 180 LGVI----------------------LYEL------------------PELKDLIRKMLQ 199

Query: 312 KDPRDRSSSLDLLSHP 327
           KDP  R S+ ++L H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  185 bits (472), Expect = 9e-57
 Identities = 93/269 (34%), Positives = 155/269 (57%), Gaps = 25/269 (9%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--------IQEEIRKQIVQELKINQASQ 123
           +++IG+G+ G V   +H   GR+ ALKII ++        IQ E+   ++ +L+ +Q   
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREV--ALLSQLRQSQPPN 63

Query: 124 CSHVVVCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
               +  Y+  Y  G  + +++EY + GS+  +++    I E Y++V+ ++VL  L Y+H
Sbjct: 64  ----ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIH 118

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS-GS 241
               VIHRDIK +N+LV + G VK+ DFGV+A+L  +  +R TFVGT  +M+PE I+ G 
Sbjct: 119 KV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            YD  +DIWSLG+ + E A G  PY   +  ++       +  I +S PP    + +S  
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIPKSKPPRLEDNGYSKL 230

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
              FV+AC+ ++P++R S+ +LL   +IK
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  185 bits (471), Expect = 2e-56
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 13/267 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV-QELKINQASQCS 125
             L+    IG+GS G+V +   K  GR  A+K  +M+++++ R++++  E+ I +  Q  
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK--KMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++V  Y S+     + +V+E+++ G+L DI+   + + E  +A VC  VL+ L +LH  +
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHA-Q 134

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
            VIHRDIK  ++L+   G VK++DFG  A +   + +R + VGT  +M+PE IS   Y  
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFCS 304
             DIWSLG++V+E   G  PY      Q+       ++ I ++ PP      + SP   S
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQA-------MKRIRDNLPPKLKNLHKVSPRLRS 247

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
           F+   + +DP  R+++ +LL+HPF+ K
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  182 bits (465), Expect = 5e-56
 Identities = 86/265 (32%), Positives = 142/265 (53%), Gaps = 27/265 (10%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQ----ELKINQASQCSHVVVC 130
           +GKGS G V LVR K  G+L+A+K+  +  ++ I+++ V+    E  I        +V  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQGLVYLHNERH 186
           +++F     + LVLEY   G L   + +     E     Y A    +++  L YLH+   
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA----EIVLALEYLHS-LG 113

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +I+RD+KP N+L++  G +K+TDFG++  L S   + +TF GT  Y++PE + G  Y  +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
            D WSLG+++ E   G+ P+  +ED++      E+ E I++ P     P+  SPE    +
Sbjct: 174 VDWWSLGVLLYEMLTGKPPF-YAEDRK------EIYEKILKDPLRF--PEFLSPEARDLI 224

Query: 307 SACIQKDPRDRSSSL---DLLSHPF 328
           S  +QKDP  R  S    ++ +HPF
Sbjct: 225 SGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  174 bits (442), Expect = 3e-52
 Identities = 100/277 (36%), Positives = 156/277 (56%), Gaps = 28/277 (10%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH-- 126
            E ++V+G G+ G V   RH   G+L A+K+  M++ E+  ++I  E  IN   + SH  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTEDEEEEIKLE--INMLKKYSHHR 73

Query: 127 -VVVCYHSFY------HNGVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQG 177
            +   Y +F       H+  + LV+E+   GS+ D+++  K   + E ++A +C+++L+G
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L +LH    VIHRDIK  N+L+    EVK+ DFGVSA L  ++G+R+TF+GT  +M+PE 
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192

Query: 238 IS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           I+      +TYDY SDIWSLG+  +E A G  P       ++       L  I  +PPP 
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPPPK 245

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
               ++S +F  F+  C+ K+   R S+  LL HPFI
Sbjct: 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  170 bits (432), Expect = 7e-51
 Identities = 87/275 (31%), Positives = 139/275 (50%), Gaps = 23/275 (8%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQC 124
           D E ++ IGKGS G V+ VR K  G++   K I    M  +E  ++Q+V E+ I +  + 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKH 58

Query: 125 SHVVVCYHSFY--HNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVVCKQVLQGL 178
            ++V  Y       N  + +V+EY + G LA +I++ K     I E ++  +  Q+L  L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 179 VYLHNERH----VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
              HN       V+HRD+KP+N+ ++    VK+ DFG++ +LG       T+VGT  YMS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           PE+++  +YD  SDIWSLG ++ E      P+          +  +L   I E      P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-------NQLQLASKIKEGKFRRIP 231

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
             ++S E    + + +  DP  R S+ +LL  P I
Sbjct: 232 Y-RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  165 bits (418), Expect = 1e-48
 Identities = 93/274 (33%), Positives = 155/274 (56%), Gaps = 26/274 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           E I  +G G+ G V   ++K  G L A K+I+   +EE+   +V E++I       ++V 
Sbjct: 15  EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVK 73

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVI 188
              +FY +G + +++E+   G++  I+ ++ + + EP + V+C+Q+L+ L YLH+ + +I
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK-II 132

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----Y 243
           HRD+K  N+L+   G++K+ DFGVSA    ++ +RD+F+GT  +M+PE +   T     Y
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-----LEAIVESPPPT-APPDQ 297
           DY +DIWSLG+ ++E A            Q  P  +EL     L  I +S PPT + P +
Sbjct: 193 DYKADIWSLGITLIEMA------------QIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           +S EF  F+   + K P  R S+  LL HPF+  
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  163 bits (413), Expect = 4e-48
 Identities = 95/261 (36%), Positives = 149/261 (57%), Gaps = 10/261 (3%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF 134
           IGKGS G V          + A+KII +   E+  + I QE+ +       ++   Y S+
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 135 YHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKP 194
                + +++EY+  GS  D+++    + E Y+A + +++L+GL YLH+ER  IHRDIK 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK-IHRDIKA 129

Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           +N+L++ +G+VK+ DFGV+  L  +  +R+TFVGT  +M+PE I  S YD+ +DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189

Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
             +E A G  P       +       +L  I ++ PPT    Q+S  F  FV AC+ KDP
Sbjct: 190 TAIELAKGEPPNSDLHPMR-------VLFLIPKNSPPTL-EGQYSKPFKEFVEACLNKDP 241

Query: 315 RDRSSSLDLLSHPFIKKFEDK 335
           R R ++ +LL H FI ++  K
Sbjct: 242 RFRPTAKELLKHKFITRYTKK 262

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  162 bits (411), Expect = 9e-48
 Identities = 88/268 (32%), Positives = 138/268 (51%), Gaps = 24/268 (8%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR---KQIVQELKINQASQCSH--VVV 129
           IG G+ G V    +   G L A+K I   IQ+      K+I  E+K+       H  +V 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKV--LELLKHPNLVK 63

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y    H   + + +EY   G+L +++   + + E  + V   Q+L+GL YLH    ++H
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH-SHGIVH 122

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSS---MGQR-DTFVGTYNYMSPERISGSTYDY 245
           RDIKP+N+ ++H G +K+ DFG +  L ++   MG+   +  GT  YM+PE I+G     
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 246 ---SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPE 301
              ++DIWSLG VVLE A G+ P+  SE    +   +     +     P  P   Q SPE
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMF----HVGAGHKPPIPDSLQLSPE 236

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFI 329
              F+  C++ DP+ R ++ +LL HPF+
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  160 bits (406), Expect = 3e-47
 Identities = 97/277 (35%), Positives = 158/277 (57%), Gaps = 28/277 (10%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH-- 126
            E ++++G G+ G V   RH   G+L A+K++ +   EE  ++I QE  IN   + SH  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQE--INMLKKYSHHR 63

Query: 127 -VVVCYHSFYH------NGVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQG 177
            +   Y +F        +  + LV+E+   GS+ D+I+  K  T+ E ++A +C+++L+G
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L +LH  + VIHRDIK  N+L+    EVK+ DFGVSA L  ++G+R+TF+GT  +M+PE 
Sbjct: 124 LSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 238 IS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           I+      +TYD+ SD+WSLG+  +E A G  P       ++       L  I  +P P 
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAPR 235

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
               ++S +F SF+ +C+ K+   R ++  L+ HPFI
Sbjct: 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  160 bits (405), Expect = 1e-46
 Identities = 91/262 (34%), Positives = 151/262 (57%), Gaps = 11/262 (4%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV 128
           LE    IG+GS G+V + R K  GR  A+K++ +  Q+  R+ +  E+ I +  Q  +VV
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVV 81

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             Y S+     + +++E++  G+L DI+ Q + + E  +A VC+ VLQ L YLH++  VI
Sbjct: 82  EMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQ-GVI 139

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           HRDIK  ++L+   G VK++DFG  A +   + +R + VGT  +M+PE IS + Y    D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFCSFVS 307
           IWSLG++V+E   G  PY      Q+       ++ + +SPPP      + SP    F+ 
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKLKNAHKISPVLRDFLE 252

Query: 308 ACIQKDPRDRSSSLDLLSHPFI 329
             + ++P++R+++ +LL HPF+
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  157 bits (398), Expect = 5e-46
 Identities = 83/262 (31%), Positives = 137/262 (52%), Gaps = 14/262 (5%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQEL--KINQASQCSH--VV 128
           +++G GS G V    +   G  FA+K + +    +  ++ V++L  +I   S+  H  +V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
               +      + + LE +  GSLA ++++  +  EP + +  +Q+L GL YLH+ R+ +
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNTV 124

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSS 247
           HRDIK +N+LV+  G VK+ DFG++  +        +F G+  +M+PE I     Y  ++
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS 307
           DIWSLG  VLE A G+ P+ Q E           +  I  S      PD  S E   F+ 
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236

Query: 308 ACIQKDPRDRSSSLDLLSHPFI 329
            C+Q+DP  R ++ +LL HPF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  155 bits (393), Expect = 4e-45
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 18/267 (6%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYH 132
           +G G  G V+LV+ K   R FALK ++    ++   ++ I  E +I +      +V  Y 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRD 191
           +F     I +++EY   G L  I+R  + + + Y A      V+    YLHN R +I+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRD 118

Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSSDIW 250
           +KP NLL++  G VK+ DFG +  L S  GQ+  TF GT  Y++PE I    YD+S D W
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 251 SLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI 310
           SLG+++ E   GR P+ + ++        E+   I++       P+         +   +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231

Query: 311 QKDPRDR-----SSSLDLLSHPFIKKF 332
           +++P +R         D+  H +   F
Sbjct: 232 RRNPEERLGNLKGGIKDIKKHKWFNGF 258

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  155 bits (393), Expect = 5e-45
 Identities = 95/280 (33%), Positives = 155/280 (55%), Gaps = 26/280 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           E I  +G G+ G V   ++K  G L A K+I    +EE+   +V E+ I  +    ++V 
Sbjct: 8   EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVK 66

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVI 188
              +FY+   + +++E+   G++  ++ ++ + + EP + VVCKQ L+ L YLH E  +I
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH-ENKII 125

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----Y 243
           HRD+K  N+L    G++K+ DFGVSA    ++ +RD+F+GT  +M+PE +   T     Y
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-----LEAIVESPPPT-APPDQ 297
           DY +D+WSLG+ ++E A            Q  P  +EL     L  I +S PPT A P +
Sbjct: 186 DYKADVWSLGITLIEMA------------QIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 233

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
           +S EF  F+  C++K+   R ++  LL HPF+    +K I
Sbjct: 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  153 bits (388), Expect = 2e-44
 Identities = 96/261 (36%), Positives = 146/261 (55%), Gaps = 10/261 (3%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF 134
           IGKGS G V         ++ A+KII +   E+  + I QE+ +       +V   Y S+
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 135 YHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKP 194
                + +++EY+  GS  D++R      E  +A + K++L+GL YLH+E+  IHRDIK 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK-IHRDIKA 129

Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           +N+L++ +G+VK+ DFGV+  L  +  +R+TFVGT  +M+PE I  S YD  +DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189

Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
             +E A G  P   + D         +L  I ++ PPT   + FS  F  F+ AC+ KDP
Sbjct: 190 TAIELAKGEPP---NSDMHP----MRVLFLIPKNNPPTLTGE-FSKPFKEFIDACLNKDP 241

Query: 315 RDRSSSLDLLSHPFIKKFEDK 335
             R ++ +LL H FI K   K
Sbjct: 242 SFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  151 bits (384), Expect = 1e-43
 Identities = 85/257 (33%), Positives = 140/257 (54%), Gaps = 11/257 (4%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHS 133
           IG+G+ G V        G+  A+K  QMN+Q++ +K+ I+ E+ + + ++  ++V    S
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--QMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           +     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH+   VIHRDIK
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIK 142

Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y    DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++ +E   G  PY+     ++      L        P    P++ S  F  F++ C++ D
Sbjct: 203 IMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256

Query: 314 PRDRSSSLDLLSHPFIK 330
              R S+ +LL HPF+K
Sbjct: 257 VEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  151 bits (382), Expect = 2e-43
 Identities = 83/258 (32%), Positives = 131/258 (50%), Gaps = 12/258 (4%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQ 123
           L + +  K IGKG   VV        GR+ ALK +Q+   +  + R+  ++E+ + +   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVLQGLV 179
             +V+    SF  N  +++VLE  D G L+ +I+    Q + I E  +     Q+   L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           ++H++R ++HRDIKP+N+ +   G VK+ D G+     S      + VGT  YMSPERI 
Sbjct: 121 HMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
            + Y++ SDIWSLG ++ E A  + P+   +      + Y L + I +   P  P D +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEKCDYPPLPADHYS 234

Query: 300 PEFCSFVSACIQKDPRDR 317
            E    VS CI  DP  R
Sbjct: 235 EELRDLVSRCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 91/300 (30%), Positives = 150/300 (50%), Gaps = 24/300 (8%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQA-SQCSH 126
             ++ +G+GS G V L R +   +L ALK++  ++  + +  ++ ++E++I  + +   +
Sbjct: 3   RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIR---QVKTILEPYLAVVCKQVLQGLVYLHN 183
           +V  Y  F   G + LV+EY+D GSL D+++   +   + E     +  Q+L  L YLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118

Query: 184 ERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMGQR------DTFVGTYNYMSPE 236
            + +IHRDIKP N+L++  G  VK+ DFG++ +L              T VGT  YM+PE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 237 RISGST---YDYSSDIWSLGLVVLECAIGRFPYM----QSEDQQSWPSFYELLEAIVESP 289
            + G +      SSDIWSLG+ + E   G  P+      S   Q+     EL    + SP
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
              + P+  S      +   + KDP++R SS   LSH  +   + K+ DL  L+   D  
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  148 bits (376), Expect = 2e-42
 Identities = 79/302 (26%), Positives = 139/302 (46%), Gaps = 58/302 (19%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           DF+F        K+IG+GS   V L + K   + +A+KI+        ++Q+++E K+  
Sbjct: 2   DFKF-------GKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKY 47

Query: 121 A-------SQCSH---VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV 170
                   ++ +    ++  Y++F     +  VLEY   G L   IR+  ++ E      
Sbjct: 48  VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY 107

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS----------- 219
             ++L  L YLH+ + +IHRD+KP N+L++    +KITDFG + +L  +           
Sbjct: 108 AAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 220 --------MGQR-DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
                     +R  +FVGT  Y+SPE ++      SSD+W+LG ++ +   G+ P+  S 
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226

Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD----LLSH 326
           +       Y   + I++       P  F P+    +   +  DP+DR    +    L +H
Sbjct: 227 E-------YLTFQKILKLEYSF--PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277

Query: 327 PF 328
           PF
Sbjct: 278 PF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  145 bits (369), Expect = 1e-41
 Identities = 80/267 (29%), Positives = 133/267 (49%), Gaps = 18/267 (6%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQASQCS 125
           E ++VIGKG+ G V +V+ +   ++FA+K   MN Q+ + K     ++ E +I Q     
Sbjct: 3   ELLRVIGKGAFGKVCIVQKRDTKKMFAMKY--MNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLA-DIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            +V  ++SF     + LV++ +  G L   + ++VK   E     +C+ VL  L YLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL-ALEYLH-S 118

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           + +IHRDIKP N+L++ +G V ITDF ++  +        +  GT  YM+PE +    Y 
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYS 177

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            + D WSLG+   EC  G+ PY             + + A  E+     P    S E   
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPY---RGHSRTIR--DQIRAKQETADVLYPATW-STEAID 231

Query: 305 FVSACIQKDPRDR--SSSLDLLSHPFI 329
            ++  +++DP+ R   +  DL +HP+ 
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  144 bits (367), Expect = 5e-41
 Identities = 94/294 (31%), Positives = 145/294 (49%), Gaps = 30/294 (10%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQ---IVQELKINQAS 122
           +D E IK +G GS G V LVRHK  G+ +ALKI  ++  + ++ KQ   ++ E +I Q+ 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI--LSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
           +   +V  Y SF  +  + LV+EY+  G L   +R+     EP       QV+  L YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
           +   +++RD+KP NLL++  G +KITDFG +  +    G+  T  GT  Y++PE I    
Sbjct: 119 S-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLCGTPEYLAPEIILSKG 174

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-LEAIVESPPPTAPPDQFSPE 301
           Y  + D W+LG+++ E   G  P+      Q     YE  LE  V  P        FSP+
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSF------FSPD 224

Query: 302 FCSFVSACIQKDPRDRSSSL-----DLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
               +   +Q D   R  +L     D+ +HP+   F   D    +L   ++ P 
Sbjct: 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW---FAGIDWI-ALLQRKIEAPF 274

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  144 bits (364), Expect = 7e-41
 Identities = 72/265 (27%), Positives = 130/265 (49%), Gaps = 15/265 (5%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQM-----NIQEEIRKQIVQELKINQASQCSHV 127
           + +G G+       R    G L A+K +       + QEE+ + + +E+++       H+
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +    +   +   +L +E+M  GS++ ++ +     E  +    +Q+L+GL YLH E  +
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH-ENQI 124

Query: 188 IHRDIKPSNLLVNHKGE-VKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGST 242
           IHRD+K +NLL++  G+ ++I DFG +A L +       F    +GT  +M+PE + G  
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           Y  S D+WS+G V++E A  + P+   +        +++  A   + P    P+  SP  
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--TAPSI--PEHLSPGL 240

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHP 327
                 C++  P DR  S +LL HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  143 bits (362), Expect = 9e-41
 Identities = 86/269 (31%), Positives = 144/269 (53%), Gaps = 24/269 (8%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----- 122
           D E +  IGKGS GVV  V  K   R++A+K  Q+++ +  R++  +E  I++A      
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMK--QIDLSKMNRRE--REEAIDEARVLAKL 56

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTIL-EPYLAVVCKQVLQGLVY 180
             S+++  Y SF   G +++V+EY + G L  +++ Q    L E  +     Q+L GL +
Sbjct: 57  DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+++ ++HRDIK  NL ++    VKI D GV+ +L  +    +T VGT  Y+SPE    
Sbjct: 117 LHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--PPPTAPPDQF 298
             Y+  SD+W+LG+V+ EC  G+ P+  + +Q +      L+  I+    PP +     +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPF-DANNQGA------LILKIIRGVFPPVSQM---Y 225

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHP 327
           S +    +  C+ KD R R  +  LL +P
Sbjct: 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  144 bits (363), Expect = 1e-40
 Identities = 93/264 (35%), Positives = 151/264 (57%), Gaps = 11/264 (4%)

Query: 67  EDLET-IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           E+L T ++ IGKGS G V         ++ A+KII +   E+  + I QE+ +       
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           +V   Y S+  +  + +++EY+  GS  D++ +   + E  +A + +++L+GL YLH+E+
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEK 121

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
             IHRDIK +N+L++  GEVK+ DFGV+  L  +  +R+TFVGT  +M+PE I  S YD 
Sbjct: 122 K-IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            +DIWSLG+  +E A G  P+ +    +       +L  I ++ PPT   + +S     F
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNPPTLEGN-YSKPLKEF 232

Query: 306 VSACIQKDPRDRSSSLDLLSHPFI 329
           V AC+ K+P  R ++ +LL H FI
Sbjct: 233 VEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  144 bits (365), Expect = 1e-40
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 23/278 (8%)

Query: 64  FSLEDLETI----KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRK--QIVQELK 117
           FS +D E +    + IG GS G V   R      + A+K +  + ++   K   I++E++
Sbjct: 8   FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQ 176
             Q  +  + +     +       LV+EY   GS +DI+   K  L E  +A +C   LQ
Sbjct: 68  FLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
           GL YLH+    IHRDIK  N+L+   G VK+ DFG ++++  +    ++FVGT  +M+PE
Sbjct: 127 GLAYLHSHER-IHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPE 181

Query: 237 RISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
            I       YD   D+WSLG+  +E A  + P     +  +  + Y     I ++  PT 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQNDSPTL 234

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             + +S  F +FV +C+QK P+DR SS +LL H F+ +
Sbjct: 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  143 bits (363), Expect = 2e-40
 Identities = 100/280 (35%), Positives = 149/280 (53%), Gaps = 32/280 (11%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQ--IVQELKINQASQCS 125
           E I+ IGKG+ G V  V +K  G L A+KI+    ++ EEI  +  I+Q L         
Sbjct: 25  EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-----PNHP 79

Query: 126 HVVVCYHSFYH-----NGVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQ 176
           +VV  Y  FY       G + LVLE  + GS+ ++++ +    + + E  ++ +    L 
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
           GL +LHN R +IHRD+K +N+L+  +G VK+ DFGVSA L S+  +R+T VGT  +M+PE
Sbjct: 140 GLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 237 RIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP 291
            I+       +YD   D+WSLG+  +E   G  P       ++       L  I  +PPP
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------LFKIPRNPPP 251

Query: 292 T-APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
           T   P+++   F  F+S C+ KD   R S   LL HPFIK
Sbjct: 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 2e-40
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 29/285 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVV 128
           E ++ +G+G+ GVV   R K  G + ALK I+++ +EE I    ++E+ + +  +  ++V
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVC--KQVLQGLVYLHNERH 186
                 +    + LV EY D   L   + +    L P L +     Q+L+GL Y H    
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKSIMYQLLRGLAYCH-SHR 118

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDY 245
           ++HRD+KP N+L+N  G +K+ DFG++   G  +      V T  Y +PE + GS  Y  
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178

Query: 246 SSDIWSLGLVVLECAIGR--FPYMQSE-DQ-------------QSWPSFYELLEAIVESP 289
           + DIWS+G +  E   G+  FP   SE DQ             +SWP   +L +     P
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFP-GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237

Query: 290 PPTAPPDQ-----FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
                  +       PE    +S  +Q +P  R S+ + L HP+ 
Sbjct: 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  143 bits (362), Expect = 2e-40
 Identities = 86/257 (33%), Positives = 140/257 (54%), Gaps = 11/257 (4%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHS 133
           IG+G+ G V        G+  A+K  Q+N+Q++ +K+ I+ E+ + +  +  ++V    S
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIK--QINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           F     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH  + VIHRDIK
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ-VIHRDIK 142

Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y    DIWSLG
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++ +E   G  PY+     ++      L        P    P++ SP F  F++ C++ D
Sbjct: 203 IMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256

Query: 314 PRDRSSSLDLLSHPFIK 330
              R S+ +LL HPF+K
Sbjct: 257 VEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  141 bits (358), Expect = 5e-40
 Identities = 88/273 (32%), Positives = 137/273 (50%), Gaps = 23/273 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELK--INQASQCS 125
           ++IGKG+ G V L  +   G + A+K +++           +K +V+ L+  I       
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 126 HV-VVCYHSFYH-NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN 183
           H+ +V Y  F      +S+ LEY+  GS+   +R      E  +    +QVL+GL YLH+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGS 241
            + ++HRD+K  NLLV+  G  KI+DFG+S          Q  +  G+  +M+PE I   
Sbjct: 127 -KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 242 TYDYSS--DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--- 296
           +  YS+  DIWSLG VVLE   GR P+   E      +   + +   +   P  PPD   
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------AIAAMFKLGNKRSAPPIPPDVSM 239

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
             SP    F++AC   +P +R ++ +LL HPFI
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  142 bits (359), Expect = 7e-40
 Identities = 85/257 (33%), Positives = 141/257 (54%), Gaps = 11/257 (4%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHS 133
           IG+G+ G V        G+  A+K  QMN+Q++ +K+ I+ E+ + + ++  ++V    S
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           +     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH+ + VIHRDIK
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIK 142

Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y    DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++ +E   G  PY+     ++      L        P    P++ S  F  F++ C++ D
Sbjct: 203 IMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256

Query: 314 PRDRSSSLDLLSHPFIK 330
              R S+ +LL HPF+K
Sbjct: 257 VDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  142 bits (359), Expect = 7e-40
 Identities = 87/258 (33%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHS 133
           IG+GS G+V +   K  G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           +     + +V+E+++ G+L DI+   + + E  +A VC  VL+ L  LH +  VIHRDIK
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIK 143

Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             ++L+ H G VK++DFG  A +   + +R + VGT  +M+PE IS   Y    DIWSLG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++V+E   G  PY      ++     + L      PP      + SP    F+   + +D
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNL------PPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 314 PRDRSSSLDLLSHPFIKK 331
           P  R+++ +LL HPF+ K
Sbjct: 258 PAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 1e-39
 Identities = 83/295 (28%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSH-- 126
           E I  IG+G+ G V   R+K  G L ALK I+M N +E      ++E+K+ Q  +  H  
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQ--KLRHPN 59

Query: 127 ------VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLV 179
                 +V         G I +V EYMD   L  ++   +    E  +    KQ+L+GL 
Sbjct: 60  IVRLKEIVTSKG----KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF-VGTYNYMSPERI 238
           YLH+   ++HRDIK SN+L+N+ G +K+ DFG++           T  V T  Y  PE +
Sbjct: 115 YLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 239 SGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ----------------SWPSFYEL 281
            G+T Y    D+WS+G ++ E  +G+ P  Q   +                 +WP   +L
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 282 LEAIVESPPPTAPP---DQF----SPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
                  P         + F     P     +   +  DP+ R S+   L H + 
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 2e-39
 Identities = 80/267 (29%), Positives = 135/267 (50%), Gaps = 21/267 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQ---ELKINQASQCSHVV 128
           K++G+G+ G V L      GR  A+K +       E +K++     E+++ +  Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             Y     +  +S+ +EYM  GS+ D ++    + E       +Q+L+G+ YLH+   ++
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN-MIV 126

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGTYNYMSPERISGSTYDY 245
           HRDIK +N+L +  G VK+ DFG S  L    SS     +  GT  +MSPE ISG  Y  
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAP--PDQFSPEF 302
            +D+WS+G  V+E    + P+ +          +E + AI + +  PT P  P   SP+ 
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAE----------FEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFI 329
            +F+     ++ + R S+ +LL H F+
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  139 bits (351), Expect = 6e-39
 Identities = 100/276 (36%), Positives = 148/276 (53%), Gaps = 26/276 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVV 128
           E I+ IGKG+ G V  V +K  G   A+KI  ++   +I ++I  E  I +A S   +VV
Sbjct: 21  EIIETIGKGTYGKVFKVLNKKNGSKAAVKI--LDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 129 VCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLV 179
             Y  +Y   V +     LVLE  + GS+ D+++      + + EP +A +  + L GL 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           +LH  +  IHRD+K +N+L+  +G VK+ DFGVSA L S+  +R+T VGT  +M+PE I+
Sbjct: 139 HLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 240 -----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-A 293
                 STYD   D+WSLG+  +E   G  P       ++       L  I  +PPPT  
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKIPRNPPPTLH 250

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
            P+ +S EF  F+  C+ KD   R +  DLL H FI
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  139 bits (350), Expect = 1e-38
 Identities = 86/265 (32%), Positives = 148/265 (55%), Gaps = 11/265 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV-QELKINQASQCS 125
           E L++   IG+GS G+V +   K  G+  A+K  +M+++++ R++++  E+ I +     
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHE 79

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           +VV  Y+S+     + +V+E+++ G+L DI+   + + E  +A VC  VL+ L YLHN+ 
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQ- 137

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
            VIHRDIK  ++L+   G +K++DFG  A +   + +R + VGT  +M+PE IS   Y  
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
             DIWSLG++V+E   G  PY      Q+     + L      PP      + S     F
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL------PPRVKDSHKVSSVLRGF 251

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIK 330
           +   + ++P  R+++ +LL HPF+K
Sbjct: 252 LDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (348), Expect = 1e-38
 Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 22/268 (8%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQC 124
           D + +K +GKGS G V  V+     + +ALK +    M+ +E  R+  V E++I  AS  
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE--REDAVNEIRI-LASVN 57

Query: 125 SHVVVCYH-SFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVVCKQVLQGLV 179
              ++ Y  +F     + +V+EY   G L+  I + K     I E  +  +  Q+L+GL 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
            LH E+ ++HRD+K +N+L+     VKI D G+S +L  +M +  T +GT +YM+PE   
Sbjct: 118 ALH-EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWK 174

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
           G  Y Y SDIWSLG ++ E A    P  ++   Q      +L   +     P  PP  +S
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP-FEARSMQ------DLRYKVQRGKYPPIPP-IYS 226

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHP 327
            +  +F+ + +Q  P+ R +   +L+ P
Sbjct: 227 QDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  137 bits (347), Expect = 2e-38
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 13/267 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           ED E I+ IG G+ G V   R+   G L A+K+I++   E+    + QE+ + +  + S+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-AVVQQEIIMMKDCKHSN 67

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V  + S+     + + +E+   GSL DI      + E  +A V ++ LQGL YLH+ + 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KG 126

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP-----ERISGS 241
            +HRDIK +N+L+   G VK+ DFGVSA + +++ +R +F+GT  +M+P     ER  G 
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG- 185

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            Y+   DIW++G+  +E A  + P     D     + + + ++  + PP      ++S  
Sbjct: 186 -YNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMTKSNFQ-PPKLKDKMKWSNS 240

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPF 328
           F  FV   + K+P+ R ++  LL HPF
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  135 bits (342), Expect = 9e-38
 Identities = 83/267 (31%), Positives = 144/267 (53%), Gaps = 13/267 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
            D E I+ +G G+ G V   R+   G L A+KII++   ++    ++Q+ +I    +C H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF--SLIQQ-EIFMVKECKH 65

Query: 127 --VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             +V  + S+     + + +EY   GSL DI      + E  +A VC++ LQGL YLH+ 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS- 124

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS---GS 241
           +  +HRDIK +N+L+   G+VK+ DFGV+A + +++ +R +F+GT  +M+PE  +     
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            Y+   DIW++G+  +E A  + P     D     + + L+      PP      ++S  
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALF-LMSKSNFQPPKLKDKTKWSST 240

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPF 328
           F +FV   + K+P+ R ++  LL+H F
Sbjct: 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  136 bits (342), Expect = 2e-37
 Identities = 83/257 (32%), Positives = 139/257 (54%), Gaps = 11/257 (4%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHS 133
           IG+G+ G V        G+  A++  QMN+Q++ +K+ I+ E+ + + ++  ++V    S
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           +     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH+ + VIHRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIK 143

Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y    DIWSLG
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++ +E   G  PY+     ++      L        P    P++ S  F  F++ C+  D
Sbjct: 204 IMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 314 PRDRSSSLDLLSHPFIK 330
              R S+ +LL H F+K
Sbjct: 258 VEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  133 bits (338), Expect = 7e-37
 Identities = 79/293 (26%), Positives = 136/293 (46%), Gaps = 45/293 (15%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVV 128
           + +  IG+G+ G+V   + +  G   ALK + +   E  I  Q ++E+K  QA Q  +VV
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIR---------QVKTILEPYLAVVCKQVLQGLV 179
                F H     LV+EYM    L++++R         QVK+ +        + +L+G+ 
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM--------RMLLKGVA 113

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF-VGTYNYMSPERI 238
           Y+H    ++HRD+KP+NLL++  G +KI DFG++ +      +  +  V T  Y +PE +
Sbjct: 114 YMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 239 SGS-TYDYSSDIWSLGLVVLECAIGR--FP----YMQ---------SEDQQSWPSFYEL- 281
            G+  YD   D+W++G +  E   G   FP      Q         + ++++WP    L 
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 282 -LEAIVESPPPTAPPDQFSPEFCS-----FVSACIQKDPRDRSSSLDLLSHPF 328
               I        P ++  P+  S      +   +  DP  R S+ + L HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  132 bits (334), Expect = 1e-36
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 16/265 (6%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV 128
             I+V+GKG+ G   L R      L   K + +  + E+ R+  + E+ I    Q  +++
Sbjct: 3   IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLVYLHNERH 186
             Y+ F  +  + + +EY + G+L D I + K  L  E  +     Q++  + Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-G 121

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           ++HRDIK  N+ +   G +K+ DFG+S +LGS     +T VGT  YMSPE   G  Y++ 
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181

Query: 247 SDIWSLGLVVLE-CAIGR-FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
           SDIW+LG V+ E   + R F         + P    L+  IV+    T     +S E  S
Sbjct: 182 SDIWALGCVLYELLTLKRTF-------DATNPL--NLVVKIVQG-NYTPVVSVYSSELIS 231

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFI 329
            V + +Q+DP  R ++ ++L  P +
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 83/270 (30%), Positives = 140/270 (51%), Gaps = 23/270 (8%)

Query: 74  VIGKGSGGVVQLVRHKWVGRLFALKIIQM---NIQEEIRKQ-----IVQELKINQASQCS 125
           +IG GS G V L  +   G L A+K +++   +   + RK+     + +E+ + +  Q  
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++V    S      +++ LEY+  GS+A ++       E  +    +Q+L+GL YLHN R
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-R 125

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML------GSSMGQRDTFVGTYNYMSPERIS 239
            +IHRDIK +N+LV++KG +KI+DFG+S  L        + G R +  G+  +M+PE + 
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
            ++Y   +DIWSLG +V+E   G+ P+      Q+       +  I E+  P   P   S
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IFKIGENASPE-IPSNIS 237

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
            E   F+    + D   R ++ +LL HPF+
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  131 bits (331), Expect = 4e-36
 Identities = 91/285 (31%), Positives = 141/285 (49%), Gaps = 32/285 (11%)

Query: 59  EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI 118
           E+++E+  E+ E + V+GKG+ G+V   R        A+K I       + + + +E+ +
Sbjct: 2   EYEYEYD-ENGERV-VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIAL 58

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVVCKQVL 175
           +   +  ++V    S   NG   + +E +  GSL+ ++R     L   E  +    KQ+L
Sbjct: 59  HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
           +GL YLH +  ++HRDIK  N+LVN + G VKI+DFG S  L       +TF GT  YM+
Sbjct: 119 EGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177

Query: 235 PERISGSTYDY--SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA-------- 284
           PE I      Y   +DIWSLG  ++E A G+            P F EL E         
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK------------PPFIELGEPQAAMFKVG 225

Query: 285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           + +  P    P+  S E  +F+  C + DP  R+S+ DLL  PF+
Sbjct: 226 MFKIHPEI--PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  130 bits (329), Expect = 1e-35
 Identities = 85/282 (30%), Positives = 137/282 (48%), Gaps = 36/282 (12%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK----INQASQCSHVVVC 130
           I KG+ G V L + K  G ++A+K+I     + IRK  V ++     I   +Q  +VV  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVI--KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVC-KQVLQGLVYLHNERHVIH 189
           Y+SF     + LV+EY+  G LA ++  V + L+  +A +   +++  L YLH+   +IH
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNG-IIH 116

Query: 190 RDIKPSNLLVNHKGEVKITDFGVS--------AMLGSSMGQRDTFVGTYNYMSPERISGS 241
           RD+KP N+L++  G +K+TDFG+S          L     +    VGT +Y++PE I G 
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--PPPTAPPDQFS 299
            +  + D WSLG ++ E  +G  P+   E  +      E+ + I+      P       S
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPF-HGETPE------EIFQNILNGKIEWPEDVEV--S 227

Query: 300 PEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKFEDKDID 338
            E    +S  +  DP  R    S  ++ +HPF      K ID
Sbjct: 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF-----KGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 5e-35
 Identities = 88/313 (28%), Positives = 146/313 (46%), Gaps = 59/313 (18%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQ 123
           +D E IKVIG+G+ G V LVR K  G+++A+K++    M  + +I   +  E  I   + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADAD 59

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEP-----YLAVVCKQVLQG 177
              +V  Y+SF     + LV+EYM  G L + +IR  K +        Y+A    +++  
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIA----ELVLA 113

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS------------------ 219
           L  +H     IHRDIKP N+L++  G +K+ DFG+   +  +                  
Sbjct: 114 LDSVHKLGF-IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 220 -----------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ 268
                        + ++ VGT +Y++PE + G+ Y    D WSLG+++ E   G  P+  
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232

Query: 269 SEDQQSWP---SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL-DLL 324
              Q+++    ++ E L       PP  P    SPE    +   +  DP DR  S  ++ 
Sbjct: 233 DTLQETYNKIINWKESLRF-----PPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIK 283

Query: 325 SHPFIKKFEDKDI 337
           SHPF K  + +++
Sbjct: 284 SHPFFKGIDWENL 296

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 1e-34
 Identities = 89/290 (30%), Positives = 145/290 (50%), Gaps = 37/290 (12%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCSHVV 128
           E + V+G+G+ GVV   R+K  G + A+K   +    E+++K  ++E+K+ +  +  ++V
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK---QVLQGLVYLHNER 185
               +F   G + LV EY++R +L +++      L P    V     Q+LQ + Y H   
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPP--DAVRSYIWQLLQAIAYCH--S 118

Query: 186 H-VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGST- 242
           H +IHRDIKP N+LV+  G +K+ DFG +  L +      T +V T  Y +PE + G T 
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 243 YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW----------PSFYELLE-----AI 285
           Y    D+W++G ++ E   G   FP   S+  Q +          PS  EL       A 
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 286 VESPPPTAP-------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
           V  P P+ P       P + S     F+ AC++ DP++R +  +LL HP+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  127 bits (320), Expect = 1e-34
 Identities = 85/264 (32%), Positives = 137/264 (51%), Gaps = 17/264 (6%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHV-VV 129
           ++V+GKGS G V LVRH+  G+ + +K + + N     RK   QE ++   SQ  H  +V
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQL--LSQLKHPNIV 62

Query: 130 CYHSFYH--NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNER 185
            Y   +   +G++ +V+ + + G L   +++ K  L P   VV    Q+   L YLH E+
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-EK 121

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           H++HRD+K  N+ +     +K+ D G++ +L +      T +GT  YMSPE  S   Y+Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            SD+W+LG  V E A  +  +  ++D  S      L+  I+E   P  P D +SPE    
Sbjct: 182 KSDVWALGCCVYEMATLKHAF-NAKDMNS------LVYRIIEGKLPPMPKD-YSPELGEL 233

Query: 306 VSACIQKDPRDRSSSLDLLSHPFI 329
           ++  + K P  R S   +L  P+I
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 2e-34
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 28/285 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQI-VQELKINQASQCSHVV 128
           + +  IG+G+ GVV   R K  G + A+K I++  + E   +  ++E+K+ +     +++
Sbjct: 2   QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHV 187
                F H G + LV E+MD   L  +I+  +  L E  +     Q+LQGL + H+   +
Sbjct: 62  KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG-I 119

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYS 246
           +HRD+KP NLL+N +G +K+ DFG++   GS +     +V T  Y +PE + G   Y   
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 247 SDIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELLEAIVES--- 288
            DIWS+G +  E    R  FP     DQ             + WP F  L      S   
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239

Query: 289 ----PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
               P P   P+  SP+    +S  +  DP  R ++   L+HP+ 
Sbjct: 240 KAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  124 bits (312), Expect = 3e-33
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 25/271 (9%)

Query: 73  KVIGKGSGGVV--QLVRHKWVGRLFALKIIQMNIQ-----EEIRKQIVQELKINQASQCS 125
           +V+GKG+ G V   L      G+L A+K ++++       E+  +++ +E+ + ++ +  
Sbjct: 6   EVLGKGAYGTVYCGLTNQ---GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++V    +   +  IS+ +E++  GS++ I+ +   + EP      KQ+L G+ YLHN  
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN- 121

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVS---AMLGSSMGQRD---TFVGTYNYMSPERIS 239
            V+HRDIK +N+++   G +K+ DFG +   A +G      +   +  GT  +M+PE I+
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQF 298
            S Y   SDIWS+G  V E A G+ P + S D+ +   FY     I          PD F
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK-PPLASMDRLA-AMFY-----IGAHRGLMPRLPDSF 234

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           S     FV++C+ +D  +R S+L LL H F+
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 1e-32
 Identities = 83/270 (30%), Positives = 133/270 (49%), Gaps = 26/270 (9%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA-----SQCSH 126
           +K I KG+ G V L + +  G  FA+K+++ +  + I K  V  +K  +A      +  +
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS--DMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           V   Y+SF     + LV+EY++ G  A +I+ +  + E +      +V+ G+  LH +R 
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH-QRG 117

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +IHRDIKP NLL++  G +K+TDFG+S        ++  FVGT +Y++PE I G   D  
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK--FVGTPDYLAPETILGVGDDKM 173

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF---SPEFC 303
           SD WSLG V+ E   G  P+        +          + S     P +     SPE  
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVF--------DNILSRRINWPEEVKEFCSPEAV 225

Query: 304 SFVSACIQKDPRDRSSS---LDLLSHPFIK 330
             ++  +  DP  R  +    ++ SHPF K
Sbjct: 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  123 bits (310), Expect = 1e-32
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 45/295 (15%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQI----VQELKINQASQCS 125
           E  K +G+G+  VV   R K  GR+ A+K I++  ++E +  I    ++E+K+ Q  +  
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP-----YLAVVCKQVLQGLVY 180
           +++     F H   I+LV E+M+   L  +I+    +L P     Y+       L+GL Y
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM----LMTLRGLEY 117

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH+   ++HRD+KP+NLL+   G +K+ DFG++   GS   +    V T  Y +PE + G
Sbjct: 118 LHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 241 STYDYSS--DIWSLGLVVLECAIGRFPYMQSE---DQ-------------QSWPSFYELL 282
           + + Y    D+WS+G +  E  + R P++  +   DQ             ++WP    L 
Sbjct: 177 ARH-YGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234

Query: 283 EAIVESPPPTAPPDQFSPEF-------CSFVSACIQKDPRDRSSSLDLLSHPFIK 330
           + +        PP      F          +   +  +P  R ++   L HP+  
Sbjct: 235 DYV---EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  121 bits (304), Expect = 2e-32
 Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 26/267 (9%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQ------MNIQEEIRKQIVQELKINQASQCSH-- 126
           +GKGS G V LV+ K       LK+++      +N  E ++     +L     S+  H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL----LSKLDHPA 63

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGLVYLH 182
           +V  + SF       ++ EY +   L   + ++K    T+ E  +     Q+L G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
            +R ++HRD+K  N+ +     +KI DFGVS +L  S     TF GT  YMSPE +    
Sbjct: 124 -QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           YD  SDIWSLG ++ E       +          +F  ++  IVE P P+  P+ +S + 
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQ-------NFLSVVLRIVEGPTPSL-PETYSRQL 233

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFI 329
            S + + + KDP  R S+ ++L +PFI
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  121 bits (304), Expect = 4e-32
 Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 24/288 (8%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-----IVQELKINQASQCSHVVV 129
           +GKG  G V   + K  G+++A K +    ++ ++K+      + E KI +      +V 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLD---KKRLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHV 187
             ++F     + LV+  M+ G L   I  V      E        Q++ GL +LH  R +
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-I 116

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGSTYDYS 246
           ++RD+KP N+L++  G V+I+D G++  L    G++     GT  YM+PE + G  YD+S
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
            D ++LG  + E   GR P+ Q +++       EL    +E       PD+FSPE     
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEM--AVEYPDKFSPEAKDLC 229

Query: 307 SACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
            A +QKDP  R      S+ ++  HP  K    + ++ G+L     P 
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  122 bits (307), Expect = 5e-32
 Identities = 82/283 (28%), Positives = 139/283 (49%), Gaps = 31/283 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKI-NQASQCSHVVV 129
           KV+GKGS G V L   K    L+A+K+++ +  +Q++  +  + E ++   A +   +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            +  F     +  V+EY++ G L   I++     EP       +++ GL +LH ER +I+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH-ERGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD---TFVGTYNYMSPERISGSTYDYS 246
           RD+K  N+L++ +G +KI DFG   M    +       TF GT +Y++PE +S   Y  +
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFG---MCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA 176

Query: 247 SDIWSLGLVVLECAIGRFPY-MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            D W+LG+++ E   G+ P+    ED        EL ++I+E       P   S E  S 
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEV--RYPRWLSKEAKSI 226

Query: 306 VSACIQKDPRDRSSSL-----DLLSHPFIK-----KFEDKDID 338
           + + + K+P  R   L     D+  HPF +     K E K+I 
Sbjct: 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  120 bits (301), Expect = 6e-32
 Identities = 80/264 (30%), Positives = 133/264 (50%), Gaps = 19/264 (7%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----EEIRKQIVQELKINQASQ 123
               ++V+G+GS G   LV+H    + +A+K I++       E+ RK+ V   K+   + 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVC--KQVLQGLVYL 181
              +V    SF  +G + +V+EY D G L   I+  +  L P   ++    Q+  G+ ++
Sbjct: 60  ---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
           H +R V+HRDIK  N+ +   G+VK+ DFG + +L S      T+VGT  Y+ PE     
Sbjct: 117 HEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            Y+  SDIWSLG ++ E    + P+  +    SW +   +L+    S  P   P  +S E
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNL--ILKVCQGSYKPL--PSHYSYE 227

Query: 302 FCSFVSACIQKDPRDRSSSLDLLS 325
             S +    +++PR R S+  +LS
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  121 bits (305), Expect = 8e-32
 Identities = 81/286 (28%), Positives = 145/286 (50%), Gaps = 18/286 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           K++GKG+ G V LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTA 59

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
             +SF  +  +  V+EY + G L   + + +   E        +++  L YLH+E++V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+K  NL+++  G +KITDFG+            TF GT  Y++PE +  + Y  + D 
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
           W LG+V+ E   GR P+   + ++     +EL+  ++E       P   SPE  S +S  
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEK----LFELI--LMEE---IRFPRTLSPEAKSLLSGL 230

Query: 310 IQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
           ++KDP+ R       + +++ H F      +D+    LV    P V
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQV 276

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 85/292 (29%), Positives = 135/292 (46%), Gaps = 40/292 (13%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQE---LKINQASQCS 125
           E +  IG+G+ G V   R    GR  ALK +++ + EE I    ++E   LK  ++ +  
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 126 HVV----VCYHSFYHNG-VISLVLEYMDRGSLADIIRQV-KTILEPYLAV-VCKQVLQGL 178
           ++V    VC+         ++LV E++D+  LA  + +  K  L P     + +Q+L+G+
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            +LH+ R ++HRD+KP N+LV   G+VKI DFG++ +    M    + V T  Y +PE +
Sbjct: 121 DFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVL 178

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQ--------------SWPSFYELL 282
             S+Y    D+WS+G +  E    R  F    SE  Q               WP    L 
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFR-GTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237

Query: 283 EAIVESPPPTAPPD--QFSPEFCS----FVSACIQKDPRDRSSSLDLLSHPF 328
                S P   P     F PE C      +   +  +P  R S+ + L HP+
Sbjct: 238 R---SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  120 bits (303), Expect = 2e-31
 Identities = 84/321 (26%), Positives = 142/321 (44%), Gaps = 58/321 (18%)

Query: 70  ETIKVIGKG--SGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSH 126
           E + +IGK      +V L +HK    L A+K I ++   +E  K + QE+  ++  Q  +
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV--VCKQVLQGLVYLHNE 184
           ++    SF  +  + +V   M  GS  D+++       P LA+  + K VL  L Y+H++
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--------NYMSPE 236
              IHR +K S++L++  G+V ++    S  +    G+R   V  +         ++SPE
Sbjct: 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 237 ----RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-- 290
                + G  Y+  SDI+S+G+   E A G  P+      +  P+   LLE +  + P  
Sbjct: 179 VLQQNLQG--YNEKSDIYSVGITACELANGHVPF------KDMPATQMLLEKVRGTVPCL 230

Query: 291 ---PTAPPDQ--------------------------FSPEFCSFVSACIQKDPRDRSSSL 321
               T P  +                          FS  F  FV  C+Q+DP  R S+ 
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290

Query: 322 DLLSHPFIKKFEDKDIDLGIL 342
            LL+H F K+ + ++  L  L
Sbjct: 291 QLLNHSFFKQCKRRNTSLLDL 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 91/296 (30%), Positives = 137/296 (46%), Gaps = 52/296 (17%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-----NIQEEIRKQIVQEL-KINQASQ 123
           + IK +G G+ G V L R+K  G L A+K  +M     + +E +  + V+ L K+N    
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLN---- 55

Query: 124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV--VCKQVLQGLV 179
             H  +V     F  N  +  V EYM+ G+L  +++  K        +  +  Q+LQGL 
Sbjct: 56  -EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 180 YLHNERH-VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF---VGTYNYMSP 235
           ++H  +H   HRD+KP NLLV+    VKI DFG    L   +  R  +   V T  Y +P
Sbjct: 114 HIH--KHGFFHRDLKPENLLVSGPEVVKIADFG----LAREIRSRPPYTDYVSTRWYRAP 167

Query: 236 ERISGSTYDYSS--DIWSLGLVVLECAIGR--FP-------------YMQSEDQQSWPSF 278
           E +  ST  YSS  DIW+LG ++ E    R  FP              + +  +Q WP  
Sbjct: 168 EILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226

Query: 279 YELLEAIVESPPPTAP--PDQF----SPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
           Y+L   +    P  AP    Q     SPE    +   ++ DP+ R ++   L HP+
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  118 bits (298), Expect = 2e-31
 Identities = 80/258 (31%), Positives = 126/258 (48%), Gaps = 12/258 (4%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQ 123
           L +    K IG+G    V        G   ALK +Q+   +  + R   ++E+ + +   
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVLQGLV 179
             +V+  Y SF  +  +++VLE  D G L+ +I+    Q + I E  +     Q+   L 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           ++H+ R V+HRDIKP+N+ +   G VK+ D G+     S      + VGT  YMSPERI 
Sbjct: 121 HMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
            + Y++ SDIWSLG ++ E A  + P+   +      + Y L + I +   P  P D +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEQCDYPPLPSDHYS 234

Query: 300 PEFCSFVSACIQKDPRDR 317
            E    V+ CI  DP  R
Sbjct: 235 EELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (297), Expect = 4e-31
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 39/277 (14%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLF------ALKIIQMNIQEEIRKQIVQELKINQAS 122
           LE  K +G+G+ G V   +    G         A+K ++    EE R++ ++E  I +  
Sbjct: 1   LELGKKLGEGAFGEV--YKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYL 181
              ++V           + +V EYM  G L D +R+    +    L  +  Q+ +G+ YL
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY--------- 232
              ++ +HRD+   N LV     VKI+DFG+S         RD +   Y           
Sbjct: 119 E-SKNFVHRDLAARNCLVTENLVVKISDFGLS---------RDIYEDDYYRKRGGGKLPI 168

Query: 233 --MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESP 289
             M+PE +    +   SD+WS G+++ E   +G  PY          S  E+LE + +  
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY-------PGMSNEEVLELLEDGY 221

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                P+    E    +  C   DP DR +  +L+  
Sbjct: 222 RL-PRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  117 bits (295), Expect = 6e-31
 Identities = 75/261 (28%), Positives = 134/261 (51%), Gaps = 12/261 (4%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVC 130
           +K IG+GS G   LV+ K  G+ + +K I ++ +  + R++  +E+ +    +  ++V  
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNERHVI 188
             SF  NG + +V++Y + G L   I   + +L P   ++    Q+   L ++H +R ++
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH-DRKIL 123

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           HRDIK  N+ +   G +K+ DFG++ +L S++    T +GT  Y+SPE      Y+  SD
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
           IW+LG V+ E    +  +     +        +L+ I  S PP      +S +  + VS 
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGSYPPV--SSHYSYDLRNLVSQ 235

Query: 309 CIQKDPRDRSSSLDLLSHPFI 329
             +++PRDR S   +L   FI
Sbjct: 236 LFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  119 bits (300), Expect = 6e-31
 Identities = 81/301 (26%), Positives = 138/301 (45%), Gaps = 42/301 (13%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVVVC 130
           +K IG G+ GVV     K  GR  A+K I     + I  K+I++E+K+ +  +  +++  
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 131 YHSFYHN-----GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
                         + +V E M+   L  +I+  + + + ++     Q+L+GL YLH   
Sbjct: 65  LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH-SA 122

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTYNYMSPERI-SGS 241
           +VIHRD+KPSN+LVN   ++KI DFG++  +     ++     +V T  Y +PE + S S
Sbjct: 123 NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS 182

Query: 242 TYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ----------QSWPSFYELLEAI---- 285
            Y  + DIWS+G +  E    +  FP     DQ           S     E L+ I    
Sbjct: 183 RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE----EDLKFITSEK 238

Query: 286 ----VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
               ++S P              SPE    +   +  DP+ R ++ + L+HP++ +  D 
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298

Query: 336 D 336
           +
Sbjct: 299 E 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-30
 Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 15/285 (5%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI--RKQIVQELKINQASQCS 125
           D + +  +G+G  G V L + K  G + ALK ++ ++  ++   + ++ E  I   ++  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            +V   ++F  +  + L +EY+  G    ++  +  + E +      ++ + +  LH E 
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH-EL 120

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
             IHRD+KP N L++  G +K+TDFG+S      +   ++ VG+ +YM+PE + G  YD+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDF 177

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
           + D WSLG ++ E   G  P+  S   ++W +     E  ++ P    P    S E    
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDDPRFNLSDEAWDL 236

Query: 306 VSACIQKDPRDRSSSL-DLLSHPFIKKFEDKDIDLGILVGSLDPP 349
           ++  I  DP  R  SL D+ +HPF K+     +D   L   L PP
Sbjct: 237 ITKLIN-DPSRRFGSLEDIKNHPFFKE-----VDWNELR-ELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (292), Expect = 2e-30
 Identities = 80/271 (29%), Positives = 140/271 (51%), Gaps = 28/271 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSH 126
           E I+V+G+G+ G+V L R K   +L  +K I   QM   E  R     E ++ +     +
Sbjct: 3   EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE--RLAAQNECQVLKLLSHPN 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV-------KTILEPYLAVVCKQVLQGLV 179
           ++  Y +F  +  + +V+EY   G+LA+ I++         TIL  ++     Q+L  L 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-----QILLALH 115

Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           ++H  + ++HRD+K  N+L++ HK  VKI DFG+S +L S   +  T VGT  Y+SPE  
Sbjct: 116 HVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELC 173

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
            G  Y+  SDIW+LG V+ E A       ++ +  + P+   +L+ +  +  P +  D++
Sbjct: 174 EGKPYNQKSDIWALGCVLYELA----SLKRAFEAANLPAL--VLKIMSGTFAPIS--DRY 225

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           SP+    + + +  DP  R     +++ P  
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  117 bits (294), Expect = 2e-30
 Identities = 87/281 (30%), Positives = 145/281 (51%), Gaps = 20/281 (7%)

Query: 56  DYKEFDFEFSLEDLET-IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRK--QI 112
           +  E  F+   E L T ++ IG GS G V   R      + A+K +  + ++   K   I
Sbjct: 13  EIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 72

Query: 113 VQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEPYLAVVC 171
           ++E+K  Q  +  + +     +       LV+EY   GS +D++    K + E  +A + 
Sbjct: 73  IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAIT 131

Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN 231
              LQGL YLH+  ++IHRDIK  N+L+   G+VK+ DFG +++   +    ++FVGT  
Sbjct: 132 HGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPY 186

Query: 232 YMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           +M+PE I       YD   D+WSLG+  +E A  + P     +  +  + Y     I ++
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQN 239

Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
             PT   +++S  F +FV +C+QK P+DR +S +LL H F+
Sbjct: 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  116 bits (292), Expect = 3e-30
 Identities = 82/286 (28%), Positives = 149/286 (52%), Gaps = 33/286 (11%)

Query: 68  DLETIKVIGKGSGGVVQLVRH---KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-- 122
           + E ++V+G G+ G V LVR       G+L+A+K+++       +  IVQ+ K  + +  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-------KATIVQKAKTAEHTRT 53

Query: 123 ---------QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQ 173
                    +C  +V  +++F  +  + L+L+Y++ G L   + Q +   E  + V   +
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE 113

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNY 232
           ++  L +LH +  +I+RDIK  N+L++ +G V +TDFG+S    +   +R  +F GT  Y
Sbjct: 114 IVLALDHLH-QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 233 MSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
           M+PE I G +  +D + D WSLG++  E   G  P+    +Q S     E+   I++S P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS---EISRRILKSKP 229

Query: 291 PTAPPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKFE 333
           P   P   S E   F+   ++KDP+ R   + + ++ +HPF +  +
Sbjct: 230 PF--PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (288), Expect = 7e-30
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 47/279 (16%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLF------ALKIIQMNIQEEIRKQIVQELKINQAS 122
           L   K +G+G+ G V   +    G+        A+K ++ +  E+  ++ ++E +I +  
Sbjct: 1   LTLGKKLGEGAFGEV--YKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVY 180
              ++V           + +V+EYM  G L D +R  + K +    L     Q+ +G+ Y
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN--------- 231
           L   ++ IHRD+   N LV     VKI+DFG+S         RD +   Y          
Sbjct: 119 LE-SKNFIHRDLAARNCLVGENLVVKISDFGLS---------RDLYDDDYYKVKGGKLPI 168

Query: 232 -YMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVE-- 287
            +M+PE +    +   SD+WS G+++ E   +G  PY          S  E+LE + +  
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY-------PGMSNAEVLEYLKKGY 221

Query: 288 --SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
               PP  P     PE    +  C  +DP DR +  +L+
Sbjct: 222 RLPKPPNCP-----PELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  115 bits (290), Expect = 8e-30
 Identities = 84/278 (30%), Positives = 142/278 (51%), Gaps = 23/278 (8%)

Query: 64  FSLEDLETIKV----IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELK 117
           F  +D E I V    IG GS G V    +     + A+K +  + ++  E  + I++E+K
Sbjct: 14  FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEPYLAVVCKQVLQ 176
             Q  +  + +     +       LV+EY   GS +D++    K + E  +A +    LQ
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQ 132

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
           GL YLH+  ++IHRDIK  N+L+   G+VK+ DFG ++    +    ++FVGT  +M+PE
Sbjct: 133 GLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPE 187

Query: 237 RISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
            I       YD   D+WSLG+  +E A  + P     +  +  + Y     I ++  PT 
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQNDSPTL 240

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             ++++  F  FV  C+QK P++R +S +LL H F+++
Sbjct: 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  114 bits (286), Expect = 1e-29
 Identities = 86/269 (31%), Positives = 134/269 (49%), Gaps = 26/269 (9%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQ---ELKINQASQCSHVV 128
           K++G+G+ G V L      GR  A K +Q + +  E  K++     E+++ +  Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 129 VCYHSFYHNG--VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
             Y          +++ +EYM  GS+ D ++    + E       +Q+L+G+ YLH+   
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM- 126

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLG----SSMGQRDTFVGTYNYMSPERISGST 242
           ++HRDIK +N+L +  G VK+ DFG S  L     S  G R +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVTGTPYWMSPEVISGEG 185

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAP--PDQFS 299
           Y   +D+WSLG  V+E    + P+ +          YE + AI + +  PT P  P   S
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTNPQLPSHIS 235

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
                F+  CI  + R R S+ +LL HPF
Sbjct: 236 EHARDFL-GCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (287), Expect = 1e-29
 Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 34/267 (12%)

Query: 69  LETIKVIGKGSGGVVQL----VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC 124
           L   K +G+G+ G V       +        A+K ++ +  E+  ++ ++E +I +    
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHN 183
            +VV           + +V+EYM+ G L   +R+ +  +    L     Q+ +G+ YL  
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN----------YM 233
            ++ IHRD+   N LV     VKI+DFG+S         RD +   Y           +M
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS---------RDLYDDDYYRKRGGKLPIRWM 170

Query: 234 SPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           +PE +    +   SD+WS G+++ E   +G  PY       S     E L+      P  
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----PGMSNEEVLEYLKNG-YRLP-- 223

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSS 319
             P    PE    +  C  +DP DR +
Sbjct: 224 -QPPNCPPELYDLMLQCWAEDPEDRPT 249

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  115 bits (289), Expect = 1e-29
 Identities = 82/286 (28%), Positives = 142/286 (49%), Gaps = 19/286 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           K++GKG+ G V LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTA 59

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
             ++F  +  +  V+EY + G L   + + +   E        +++  L YLH+ R V++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVY 118

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RDIK  NL+++  G +KITDFG+     S      TF GT  Y++PE +  + Y  + D 
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
           W LG+V+ E   GR P+   + ++       L E I+        P   SPE  S ++  
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHER-------LFELILME--EIRFPRTLSPEAKSLLAGL 229

Query: 310 IQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
           ++KDP+ R     S + +++ H F      +D+    L+    P V
Sbjct: 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 1e-29
 Identities = 76/293 (25%), Positives = 125/293 (42%), Gaps = 72/293 (24%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEIRKQIVQELKINQASQ 123
           K +G+G+ G V      + G+L          A+K ++ +  EE RK  ++E ++ +   
Sbjct: 1   KKLGEGAFGEV------YKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54

Query: 124 CSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVK---------TILEPYLA 168
             +VV         GV +      LVLEYM+ G L D +R+ +         T+    L 
Sbjct: 55  HPNVVRLL------GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108

Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG 228
               Q+ +G+ YL   +  +HRD+   N LV     VKI+DFG+S         RD +  
Sbjct: 109 SFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDLVVKISDFGLS---------RDVYDD 158

Query: 229 TYNY-----------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY--MQSEDQQS 274
            Y             M+PE +    +   SD+WS G+++ E   +G  PY  + +E    
Sbjct: 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---- 214

Query: 275 WPSFYELLEAIVE-SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                E+LE + +    P   P+    E    + +C Q DP DR +  +L+  
Sbjct: 215 -----EVLEYLRKGYRLP--KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  114 bits (287), Expect = 2e-29
 Identities = 79/286 (27%), Positives = 136/286 (47%), Gaps = 25/286 (8%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKI-IQMNIQEEIRKQIVQELKINQASQCS 125
           E  E + ++G+GS G+V   +HK  G++ A+K  ++    + ++K  ++E+++ +  +  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++V     F     + LV E++D   L D+ +    + E  +     Q+L+G+ + H+  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YD 244
           ++IHRDIKP N+LV+  G VK+ DFG +  L +       +V T  Y +PE + G T Y 
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 245 YSSDIWSLGLVVLECAIGR--FPYMQSEDQ-----QSWPSFYELLEAIVESPPPTAP--- 294
            + DIW++G +V E   G   FP     DQ     +   +     + I +  P  A    
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 295 PD------------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
           P+            + S         C++ DP DR SS  LL H F
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  115 bits (289), Expect = 2e-29
 Identities = 79/274 (28%), Positives = 137/274 (50%), Gaps = 24/274 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVV 129
           +VIG+GS   V LV  K   R++A+K+I+   +N  E+I     ++     AS    +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            +  F     +  V+E++  G L   +++ + + E +      ++   L +LH ER +I+
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH-ERGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD---TFVGTYNYMSPERISGSTYDYS 246
           RD+K  N+L++ +G +K+TD+G   M    +   D   TF GT NY++PE + G  Y +S
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 247 SDIWSLGLVVLECAIGRFPY----MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
            D W+LG+++ E   GR P+    M     Q+   +  L + I+E       P   S + 
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--LFQVILEK--QIRIPRSLSVKA 232

Query: 303 CSFVSACIQKDPRDR------SSSLDLLSHPFIK 330
            S +   + KDP++R      +   D+ SHPF +
Sbjct: 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  114 bits (286), Expect = 4e-29
 Identities = 75/263 (28%), Positives = 134/263 (50%), Gaps = 17/263 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVC 130
           K++GKG+ G V LVR K  G+ +A+KI++    I ++     + E ++ Q ++   +   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHR 190
            +SF  +  +  V+EY + G L   + + +   E        +++  L YLH    V++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH-SCDVVYR 119

Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIW 250
           D+K  NL+++  G +KITDFG+     S      TF GT  Y++PE +  + Y  + D W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 251 SLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI 310
            LG+V+ E   GR P+  ++D +     +EL+  ++E       P   SPE  S ++  +
Sbjct: 180 GLGVVMYEMMCGRLPFY-NQDHE---KLFELI--LMEE---IRFPRTLSPEAKSLLAGLL 230

Query: 311 QKDPRDR-----SSSLDLLSHPF 328
           +KDP+ R       + +++ H F
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  114 bits (286), Expect = 4e-29
 Identities = 85/281 (30%), Positives = 143/281 (50%), Gaps = 23/281 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVV 129
           +VIG+GS   V LVR K   R++A+K+++   +N  E+I     ++    QAS    +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            +  F     +  V+EY++ G L   +++ + + E +      ++   L YLH ER +I+
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTYNYMSPERISGSTYDYS 246
           RD+K  N+L++ +G +K+TD+G   M    +   DT   F GT NY++PE + G  Y +S
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 247 SDIWSLGLVVLECAIGRFPY--MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            D W+LG+++ E   GR P+  + S D     +   L + I+E       P   S +  S
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAAS 234

Query: 305 FVSACIQKDPRDRSSSL------DLLSHPFIKKFEDKDIDL 339
            + + + KDP++R          D+  HPF   F + D DL
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPF---FRNVDWDL 272

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  113 bits (285), Expect = 4e-29
 Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 25/278 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           KV+GKGS G V L   K     FA+K ++ ++    +++   +V+   +  A +   +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            + +F     +  V+EY++ G L   I+      E        +++ GL +LH  + +I+
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS 247
           RD+K  N+L++  G +KI DFG+    M G       TF GT +Y++PE + G  Y+ S 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYNESV 177

Query: 248 DIWSLGLVVLECAIGRFPYM-QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           D WS G+++ E  IG+ P+  + ED        EL ++I+   P    P   S E    +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRPHF--PRWISKEAKDCL 227

Query: 307 SACIQKDPRDR-SSSLDLLSHPFIK-----KFEDKDID 338
           S   ++DP  R     D+  HPF +     + E ++I 
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIP 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  112 bits (282), Expect = 5e-29
 Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQ 123
           L + +  K IG+G    V         +  ALK +Q+   +  + R+  V+E+ + +   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADII----RQVKTILEPYLAVVCKQVLQGLV 179
             +V+    SF  +  +++VLE  D G L+ +I    +Q + I E  +     Q+   + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           ++H+ R V+HRDIKP+N+ +   G VK+ D G+     S      + VGT  YMSPERI 
Sbjct: 121 HMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
            + Y++ SDIWSLG ++ E A  + P+   +      + + L + I +   P  P + +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 300 PEFCSFVSACIQKDPRDR 317
            +    VS CI  DP  R
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  112 bits (281), Expect = 5e-29
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 23/269 (8%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEE--IRKQIVQELKINQASQC 124
           E IK IG+GS G + L + K       +K I   +M ++E+   +K+++   K+   +  
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN-- 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVC--KQVLQGLVYLH 182
             +V  + SF  NG + +V+EY D G L   I + + +L     ++    Q+  GL ++H
Sbjct: 61  --IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 183 NERHVIHRDIKPSNLLVNHKGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
            +R ++HRDIK  N+ ++  G V K+ DFG++  L  SM    T VGT  Y+SPE     
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-PPTAPPDQFSP 300
            Y+  +DIWSLG V+ E    + P+  +       + ++L+  I +    P +P   FS 
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQGYFAPISP--NFSR 228

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           +  S +S   +  PRDR S   +L  PF+
Sbjct: 229 DLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  113 bits (284), Expect = 9e-29
 Identities = 83/293 (28%), Positives = 140/293 (47%), Gaps = 36/293 (12%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKI 118
           DF F       + V+GKGS G V L   K    L+A+KI++ +  IQ++  +  + E ++
Sbjct: 1   DFNF-------LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV 53

Query: 119 NQASQCSHVVVCYHS-FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
                    +   HS F     +  V+EY++ G L   I+QV    EP+      ++  G
Sbjct: 54  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTYNYMS 234
           L +LH+ + +I+RD+K  N++++ +G +KI DFG   M   ++    T   F GT +Y++
Sbjct: 114 LFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIA 169

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           PE I+   Y  S D W+ G+++ E   G+ P+   ED+       EL ++I+E     + 
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDED------ELFQSIMEHNV--SY 220

Query: 295 PDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIK-----KFEDKDI 337
           P   S E  S     + K P  R     +   D+  H F +     K E ++I
Sbjct: 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREI 273

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  112 bits (282), Expect = 1e-28
 Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 19/266 (7%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVV 129
           ++ IG GS G V   R      + A+K +  + ++  E  + I++E++  Q  +  + + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
               +       LV+EY   GS +D++    K + E  +A V    LQGL YLH+  ++I
Sbjct: 80  YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMI 137

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG---STYDY 245
           HRD+K  N+L++  G VK+ DFG ++++  +    + FVGT  +M+PE I       YD 
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
             D+WSLG+  +E A  + P     +  +  + Y     I ++  P      +S  F +F
Sbjct: 194 KVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQNESPALQSGHWSEYFRNF 246

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKK 331
           V +C+QK P+DR +S  LL H F+ +
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  111 bits (278), Expect = 5e-28
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQ---ELKINQAS 122
           ED ETIK+I  G+ G V LVRHK   + FA+K  ++N Q  I R QI Q   E  I   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--KINKQNLILRNQIQQVFVERDILTFA 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
           +   VV  + SF     + +V+EY++ G  A +++ +  +      +   + +  L YLH
Sbjct: 59  ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--------QRDT--FV----- 227
           N   ++HRD+KP NLL+   G +K+TDFG+S +   S+         ++DT  F+     
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE 287
           GT  Y++PE I    Y    D W++G+++ E  +G  P+     ++    F +++   +E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDIE 234

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKFE 333
            P      +    +    +S  ++++P +R     + ++  H F    +
Sbjct: 235 WPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  110 bits (277), Expect = 8e-28
 Identities = 79/273 (28%), Positives = 138/273 (50%), Gaps = 18/273 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           +VIG+GS   V LVR K   +++A+K+++  +    E+I     ++    QAS    +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            +  F     + LV+EY++ G L   +++ + + E +      ++   L +LH ER +I+
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH-ERGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTYNYMSPERISGSTYDYS 246
           RD+K  N+L++  G +K+TD+G   M    +G  DT   F GT NY++PE + G  Y +S
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
            D W+LG+++ E   GR P+    D     +   L + I+E   P   P   S +    +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVL 234

Query: 307 SACIQKDPRDR------SSSLDLLSHPFIKKFE 333
              + KDP++R      +   D+ SH F +  +
Sbjct: 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  110 bits (276), Expect = 1e-27
 Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 33/292 (11%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ------CSH 126
           KVIGKGS G V L +HK  G+ +A+K++Q   ++ I K+  +E K   A +        H
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKK--KEQKHIMAERNVLLKNVKH 55

Query: 127 --VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             +V  ++SF     +  VL+Y++ G L   +++ ++  EP       ++   L YLH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH-S 114

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
            ++I+RD+KP N+L++ +G V +TDFG+            TF GT  Y++PE +    YD
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            + D W LG V+ E   G  P+  S D        E+ + I+  P    P    S     
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFY-SRDTA------EMYDNILNKPLRLKP--NISVSARH 225

Query: 305 FVSACIQKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVG-SLDPPVN 351
            +   +QKD   R  +    L++ +H F        I+   LV   + PP N
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS-----INWDDLVNKKITPPFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 67/311 (21%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA------ 121
             + IK++GKG  G V LVR K  G+LFALK++        +K++++  K+ +       
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-------DKKEMIKRNKVKRVLTEQEI 54

Query: 122 -SQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADII-RQVKTILEP-----YLAVVCK 172
            +   H  +   Y SF     + LV++Y   G L  ++ RQ    L       Y A    
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---- 110

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--------- 223
           +VL  L YLH    +++RD+KP N+L++  G + ++DF +S                   
Sbjct: 111 EVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 224 --------------------DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
                               ++FVGT  Y++PE ISG  +  + D W+LG+++ E   G 
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL-- 321
            P+  S   ++          I++           S      +   + KDP  R  S   
Sbjct: 230 TPFKGSNRDET-------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282

Query: 322 --DLLSHPFIK 330
             ++  HPF +
Sbjct: 283 AAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  107 bits (269), Expect = 6e-27
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 30/284 (10%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           ++ +G+GS   V     +  G+L ALK+I M  +E +    ++E  + +  + +++V+ +
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHR 190
              +    ++ V EYM    LA  + Q    L PY + +   Q+L+GL Y+H  +H++HR
Sbjct: 70  DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHR 127

Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--D 248
           D+KP NLL+++ GE+K+ DFG++           + V T  Y  P+ + G+T DYSS  D
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-DYSSALD 186

Query: 249 IWSLGLVVLECAIGR--FPYMQSEDQQ--------------SWPSFYELLEAIVESPPPT 292
           IW  G + +E   G+  FP +    +Q              +WP   +L     E   P 
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246

Query: 293 APP------DQFS--PEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            P        + S  P+     S  +   P+DR S+ D L HP+
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  107 bits (269), Expect = 6e-27
 Identities = 82/281 (29%), Positives = 133/281 (47%), Gaps = 32/281 (11%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF 134
           +G+G+   V   R++  G + ALK I ++ +E      ++E+ + +  +  ++V  +   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 135 YHNGVISLVLEYMDRGSLADI-----IRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVI 188
           +    + LV EYMD+    D+        V+  L+P        Q+L+G+ + H  R V+
Sbjct: 68  HTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-VL 122

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSS 247
           HRD+KP NLL+N +GE+K+ DFG++   G  +      V T  Y +P+ + GS TY  S 
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 248 DIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELLEAIVESPP-P 291
           DIWS+G ++ E   GR  FP   +EDQ              +WP   +L E     P  P
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYP 242

Query: 292 TAPPDQFSPEF----CSFVSACIQKDPRDRSSSLDLLSHPF 328
                Q  P         +   +Q +P  R S+ D L HP+
Sbjct: 243 PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 7e-27
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 54/302 (17%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRK-QIVQELKI 118
           LE  + +  +G+GS   V   R K  G+L ALK I++   EE      IR+  ++++LK 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE-HEEGAPFTAIREASLLKDLK- 61

Query: 119 NQASQCSHV-VVCYHSFYH-NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV-CKQVL 175
                  H  +V  H   H    ++LV EY+D   L   +      L  +   +   Q+L
Sbjct: 62  -------HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF---VGTYNY 232
           +GL Y H +R V+HRD+KP NLL++ +GE+K+ DFG++     S+  + T+   V T  Y
Sbjct: 114 RGLAYCH-QRRVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSK-TYSNEVVTLWY 169

Query: 233 MSPERISGSTYDYSS--DIWSLGLVVLECAIGR--FPYM-QSEDQ-------------QS 274
             P+ + GST +YS+  D+W +G +  E A GR  FP     EDQ             ++
Sbjct: 170 RPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228

Query: 275 WPSFYELLEAIVES---PPP-----TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
           WP      E    S    PP      AP     P         +Q +P+ R S+ + + H
Sbjct: 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288

Query: 327 PF 328
           P+
Sbjct: 289 PY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  106 bits (265), Expect = 4e-26
 Identities = 74/282 (26%), Positives = 129/282 (45%), Gaps = 38/282 (13%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK------IIQMNIQEEI--RKQIVQ 114
            + L D E  + +G GS G V++ +HK  G  +A+K      I++M   + +   K I+ 
Sbjct: 14  SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 115 ELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK 172
           EL        SH  +V    SF     +  +LE++  G L   +R+              
Sbjct: 74  EL--------SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA 125

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYN 231
           +++    YLH+ + +I+RD+KP NLL+++KG VK+TDFG        +  R  T  GT  
Sbjct: 126 ELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPE 180

Query: 232 YMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP 291
           Y++PE I    +  + D W++G+++ E   G  P+    D   +  + ++L   ++    
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF---DDTPFRIYEKILAGRLKF--- 234

Query: 292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSL-----DLLSHPF 328
              P+ F       V   +Q D   R  +L     D+ +HP+
Sbjct: 235 ---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  105 bits (262), Expect = 4e-26
 Identities = 80/293 (27%), Positives = 146/293 (49%), Gaps = 37/293 (12%)

Query: 68  DLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS- 122
           + E +KV+G G+ G V LVR    H   G+L+A+K+++       +  IVQ+ K  + + 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHD-SGKLYAMKVLK-------KATIVQKAKTTEHTR 52

Query: 123 ----------QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK 172
                     Q   +V  +++F  +  + L+L+Y++ G L   + Q +   E  + +   
Sbjct: 53  TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYN 231
           +++  L +LH +  +I+RDIK  N+L++  G V +TDFG+S        +R  +F GT  
Sbjct: 113 EIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171

Query: 232 YMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP 289
           YM+P+ + G    +D + D WS+G+++ E   G  P+    ++ S     E+   I++S 
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSE 228

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDI 337
           PP   P + S      +   + KDP+ R     S + ++  HPF +K    D+
Sbjct: 229 PPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  104 bits (262), Expect = 5e-26
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 23/288 (7%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQ----ELKINQASQCSHVVVC 130
           +GKG  G V   + +  G+L+A K  ++N +   +++  +    E +I        +V  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK--KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVVCKQVLQGLVYLHNERH 186
            ++F     + LV+  M+ G L   I  V        EP       Q++ GL +LH +R 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRR 117

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +I+RD+KP N+L+++ G V+I+D G++  L     +   + GT  +M+PE + G  YD+S
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177

Query: 247 SDIWSLGLVVLECAIGRFPY-MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            D ++LG+ + E    R P+  + E  ++     EL + I+        PD+FSP   SF
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILND--SVTYPDKFSPASKSF 231

Query: 306 VSACIQKDPRDRSSSLD-----LLSHPFIKKFEDKDIDLGILVGSLDP 348
             A + KDP  R    D     L +HP  +    + ++ G+L     P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-26
 Identities = 77/295 (26%), Positives = 141/295 (47%), Gaps = 31/295 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-----QCSHV 127
           +V+GKG  G V   + +  G+++A K ++   ++ I+K+  + + +N+           V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNER 185
           V   +++     + LVL  M+ G L   I  +      E        ++  GL  LH ER
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTY 243
            +++RD+KP N+L++  G ++I+D G++  +  G ++  R   VGT  YM+PE +    Y
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERY 178

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
            +S D W LG ++ E   G+ P+ Q +++       E +E  V+        ++FS    
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----EEVERRVKEDQEEY-SEKFSEAAR 233

Query: 304 SFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
           S     + KDP  R       + ++ +HPF +    K ++ G+    L+PP  CP
Sbjct: 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM----LEPPF-CP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  103 bits (260), Expect = 1e-25
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 25/286 (8%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCS 125
           E  E +  IG+GS GVV   R++  G++ A+K  ++      I+K  ++E+++ +  +  
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++V     F     + LV EY D   L ++ +  + + E  +  +  Q LQ + + H + 
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KH 119

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YD 244
           + IHRD+KP N+L+  +G++K+ DFG + +L         +V T  Y +PE + G T Y 
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 245 YSSDIWSLGLVVLECAIGR--FPYMQSEDQ-----QSWPSFYELLEAIVES--------- 288
              D+W++G V  E   G+  +P     DQ     ++        + I  +         
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239

Query: 289 --PPPTAP-PDQF---SPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
             P    P   +F   S    SF+  C+Q DP +R S  +LL HP+
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 9/213 (4%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKI 118
           D     ED E +KVIG+G+ G VQLVRHK   +++A+K++     I+        +E  I
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
              +    VV  +++F  +  + +V+EYM  G L +++     + E +      +V+  L
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLAL 155

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPER 237
             +H+    IHRD+KP N+L++  G +K+ DFG    M    M + DT VGT +Y+SPE 
Sbjct: 156 DAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 238 ISGST----YDYSSDIWSLGLVVLECAIGRFPY 266
           +        Y    D WS+G+ + E  +G  P+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  104 bits (261), Expect = 1e-25
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 21/206 (10%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE----------EIRKQIVQ 114
           S+ + E +  IG+G+ G+V   R    G + ALK ++M+  E          EI   ++ 
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-NERDGIPISSLREIT--LLL 61

Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQ 173
            L+     +   VVV  H       I LV+EY ++  LA ++  + T   E  +  +  Q
Sbjct: 62  NLRHPNIVELKEVVVGKHL----DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQ 116

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM 233
           +L+GL YLH E  +IHRD+K SNLL+  KG +KI DFG++   G         V T  Y 
Sbjct: 117 LLRGLQYLH-ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175

Query: 234 SPERISGS-TYDYSSDIWSLGLVVLE 258
           +PE + G  TY  + D+W++G ++ E
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  104 bits (260), Expect = 2e-25
 Identities = 75/286 (26%), Positives = 141/286 (49%), Gaps = 19/286 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           K++GKG+ G V LVR K  G+ +A+KI++  +   ++E+    + E ++ + ++   +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEV-AHTLTESRVLKNTRHPFLTS 59

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
             +SF     +  V+EY++ G L   + + +   E        +++  L YLH+ + +++
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-IVY 118

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+K  NL+++  G +KITDFG+     +      TF GT  Y++PE +  + Y  + D 
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
           W LG+V+ E   GR P+   + ++     +EL+  ++E       P   S +  S +S  
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEK----LFELI--LMED---IKFPRTLSADAKSLLSGL 229

Query: 310 IQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
           + KDP  R       + +++ H F      +D+    LV    P V
Sbjct: 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQV 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  103 bits (257), Expect = 2e-25
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQI------VQELKINQASQCS 125
           K++G+G+ G V L      GR  A+K +Q + +  E  K++      +Q LK    +   
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK----NLLH 63

Query: 126 HVVVCYHSFYHNG---VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
             +V Y+    +     +S+ +E+M  GS+ D ++    + E       +Q+L+G+ YLH
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG----SSMGQRDTFVGTYNYMSPERI 238
           +   ++HRDIK +N+L +  G VK+ DFG S  L     S  G + +  GT  +MSPE I
Sbjct: 124 SNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPYWMSPEVI 181

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAP--P 295
           SG  Y   +DIWS+G  V+E    + P+ +          +E + AI + +  PT P  P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAE----------FEAMAAIFKIATQPTNPVLP 231

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
              S     F+   I  + + R S+ +LL H F+
Sbjct: 232 PHVSDHCRDFLKR-IFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  103 bits (257), Expect = 3e-25
 Identities = 75/291 (25%), Positives = 142/291 (48%), Gaps = 30/291 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-----QCSHV 127
           +V+GKG  G V   + +  G+++A K ++   ++ I+K+  + + +N+           V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMALNEKQILEKVNSRFV 62

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNER 185
           V   +++     + LVL  M+ G L   I  +      E        ++  GL  LH ER
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTY 243
            +++RD+KP N+L++  G ++I+D G++  +  G ++  R   VGT  YM+PE +    Y
Sbjct: 123 -IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
            +S D W+LG ++ E   G+ P+ Q + +        L++ + E        ++FSP+  
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE-----YSEKFSPDAR 233

Query: 304 SFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
           S     + KDP++R       + ++  HP  K+   K ++ G+    L+PP
Sbjct: 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGM----LEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  102 bits (256), Expect = 3e-25
 Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 58/299 (19%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRK-QIVQELKINQAS 122
           + ++ IG+G+ GVV   R+K  G + ALK I+++ + E      IR+  +++EL      
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62

Query: 123 QCSHVVVCYHSFYHNGVISLVLE--------YMDRGSLADI-IRQVKTILEPYLAVVCKQ 173
           +   V+   +  Y      LV E        +MD   L+ I +  +K+ L         Q
Sbjct: 63  KLLDVIHTENKLY------LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF--------Q 108

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM 233
           +LQGL + H+ R V+HRD+KP NLL+N +G +K+ DFG++   G  +      V T  Y 
Sbjct: 109 LLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167

Query: 234 SPERISGSTYDYSS--DIWSLGLVVLECAIGR---------------FPYMQSEDQQSWP 276
           +PE + G  Y YS+  DIWSLG +  E    R               F  + + D+  WP
Sbjct: 168 APEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226

Query: 277 SFYELLEAIVESPPPTAPPDQFS-------PEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
               L +   +   P      FS        +    +S  +  DP  R S+   L+HPF
Sbjct: 227 GVTSLPD--YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  103 bits (259), Expect = 4e-25
 Identities = 82/310 (26%), Positives = 143/310 (46%), Gaps = 50/310 (16%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQC 124
           +D E++KVIG+G+ G V+LV+ K  G ++A+KI++    +++E    I  E  I   +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
           + VV  ++SF     + L++E++  G +  ++ +  T+ E        + +  +  +H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH-Q 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF------------------ 226
              IHRDIKP NLL++ KG VK++DFG+    G     R  F                  
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 227 -------------------VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
                              VGT +Y++PE    + Y+   D WSLG+++ E  IG  P+ 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD-LLSH 326
               Q+++       E +V   PP  P  + + +    +  C   + R  S+ ++ + SH
Sbjct: 238 SETPQETYRKVMNWKETLVF--PPEVPISEKAKDL--ILRFCTDSENRIGSNGVEEIKSH 293

Query: 327 PFIKKFEDKD 336
           PF   FE  D
Sbjct: 294 PF---FEGVD 300

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 7e-25
 Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 18/208 (8%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQI--VQELKINQASQ 123
           +DLE IK +G G+ G V LVR +     +ALK+  M I E IR KQ   V   K     +
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQEQHVHNEK-RVLKE 57

Query: 124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
            SH  ++  + + +    + +++EY+  G L   +R               +++  L YL
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD---TFVGTYNYMSPERI 238
           H+ + +++RD+KP N+L++ +G +K+TDFG +  L      RD   T  GT  Y++PE I
Sbjct: 118 HS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPEVI 170

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPY 266
               ++ + D W+LG+++ E  +G  P+
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  101 bits (252), Expect = 1e-24
 Identities = 73/271 (26%), Positives = 132/271 (48%), Gaps = 26/271 (9%)

Query: 74  VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCS 125
           +IG+G  G V   R    G+++A+K +    ++ I+ +  + L +N+           C 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            +V   ++F+    +  +L+ M+ G L   + Q     E  +     +++ GL ++HN R
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-R 116

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS-GSTYD 244
            V++RD+KP+N+L++  G V+I+D G++     S  +    VGT+ YM+PE +  G+ YD
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGTAYD 174

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            S+D +SLG ++ +   G  P+ Q + +         L   VE       PD FSPE  S
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL------PDSFSPELKS 228

Query: 305 FVSACIQKDPRDR-----SSSLDLLSHPFIK 330
            +   +Q+D   R       + ++  H F K
Sbjct: 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  101 bits (253), Expect = 2e-24
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 17/288 (5%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVC 130
           KVIGKGS G V L RHK   + +A+K++Q    ++++  K I+ E  +   +     +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 131 YH-SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            H SF     +  VL+Y++ G L   +++ +  LEP       ++   L YLH+  ++++
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+KP N+L++ +G + +TDFG+        G   TF GT  Y++PE +    YD + D 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
           W LG V+ E   G  P+             E+ + I+  P    P    +      +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPLQLKP--NITNSARHLLEGL 230

Query: 310 IQKDPRDRSSSLD----LLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
           +QKD   R  + D    + +H F       D+    +    +P V+ P
Sbjct: 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGP 278

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  100 bits (252), Expect = 2e-24
 Identities = 89/314 (28%), Positives = 140/314 (44%), Gaps = 72/314 (22%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKI 118
           S+++ E +  I +G+ GVV   R K  G + ALK ++M  ++E      +R+       I
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLRE-------I 55

Query: 119 NQASQCSH--------VVV--CYHSFYHNGVISLVLEYM--DRGSLADIIRQ------VK 160
           N   +  H        VVV       Y      +V+EY+  D  SL + ++Q      VK
Sbjct: 56  NILLKLQHPNIVTVKEVVVGSNLDKIY------MVMEYVEHDLKSLMETMKQPFLQSEVK 109

Query: 161 TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
            ++         Q+L G+ +LH +  ++HRD+K SNLL+N++G +KI DFG++   GS +
Sbjct: 110 CLM--------LQLLSGVAHLH-DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160

Query: 221 GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGR--FPYMQSE-DQ---- 272
                 V T  Y +PE + G   Y  + D+WS+G +  E    +  FP  +SE DQ    
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKI 219

Query: 273 ---------QSWPSFYELLEA---IVESPPPTAPPDQFSPEFCS-----FVSACIQKDPR 315
                    + WP F EL  A        P      +F     S      ++  +  DP 
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279

Query: 316 DRSSSLDLLSHPFI 329
            R S+ D L HP+ 
Sbjct: 280 KRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  101 bits (252), Expect = 2e-24
 Identities = 76/283 (26%), Positives = 137/283 (48%), Gaps = 23/283 (8%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQC 124
           D   + V+GKGS G V L   K    L+A+KI++ ++    +++   +V++  +  + + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             +   +  F     +  V+EY++ G L   I+QV    EP+      ++  GL +LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS- 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           + +I+RD+K  N++++ +G +KI DFG+            TF GT +Y++PE I+   Y 
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            S D W+ G+++ E   G+ P+ + ED+       EL ++I+E     A P   S E  +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPF-EGEDED------ELFQSIMEH--NVAYPKSMSKEAVA 230

Query: 305 FVSACIQKDPRDR-----SSSLDLLSHPFIK-----KFEDKDI 337
                + K P  R         D+  H F +     K E K++
Sbjct: 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV 273

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 86/323 (26%), Positives = 142/323 (43%), Gaps = 76/323 (23%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK----INQAS 122
           +D E+IKVIG+G+ G V+LV+ K  G ++A+K   +   E + K+ V  ++    I   +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEA 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLA------DIIRQVKT---ILEPYLAVVCKQ 173
               VV  Y+SF     + L++EY+  G +       D   + +T   I E  LA+    
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI---D 115

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---------------- 217
            +  L Y       IHRDIKP NLL++ KG +K++DFG+   L                 
Sbjct: 116 SIHKLGY-------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168

Query: 218 -----------SSMGQRDTF-----------VGTYNYMSPERISGSTYDYSSDIWSLGLV 255
                      SS  + +T+           VGT +Y++PE    + Y+   D WSLG++
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228

Query: 256 VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE----FCSFVSACIQ 311
           + E  +G  P+     Q+++       E +    P   P    SPE           C +
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQF--PDEVP---LSPEAKDLIKRL---CCE 280

Query: 312 KDPRDRSSSLDLL-SHPFIKKFE 333
            + R  ++ ++ + SHPF K  +
Sbjct: 281 AERRLGNNGVNEIKSHPFFKGVD 303

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  100 bits (251), Expect = 4e-24
 Identities = 74/271 (27%), Positives = 136/271 (50%), Gaps = 21/271 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           +V+GKGS G V L R K  GRL+A+K+++ ++    +++   + ++  ++ A     +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y  F     +  V+E+++ G L   I++ +   E        ++   L++LH ++ +I+
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH-DKGIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+K  N+L++H+G  K+ DFG+      +     TF GT +Y++PE +    Y  S D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 250 WSLGLVVLECAIGRFPY-MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
           W++G+++ E   G  P+  ++ED        +L EAI+        P   S +    + A
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENED--------DLFEAILND--EVVYPTWLSQDAVDILKA 229

Query: 309 CIQKDPRDRSSSLDL------LSHPFIKKFE 333
            + K+P  R  SL L      L HPF K+ +
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  100 bits (250), Expect = 4e-24
 Identities = 77/288 (26%), Positives = 136/288 (47%), Gaps = 17/288 (5%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQAS-QCSHVVV 129
           KVIGKGS G V L + K  G  +A+K++Q    ++++ +  I+ E  +   + +   +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            ++SF     +  VL+Y++ G L   +++ +  LEP       +V   + YLH+  ++I+
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL-NIIY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           RD+KP N+L++ +G V +TDFG+            TF GT  Y++PE +    YD + D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 250 WSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
           W LG V+ E   G  P+   +  Q + +        +   P   P  + +   C  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDN--------ILHKPLQLPGGK-TVAACDLLVGL 230

Query: 310 IQKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
           + KD R R  +    L++ +H F       D+    +    +P V  P
Sbjct: 231 LHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGP 278

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 76/286 (26%), Positives = 134/286 (46%), Gaps = 32/286 (11%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVV 128
           E ++ IG+G+ G V   +++    + ALK ++++  +E +    ++E+ + +  +  ++V
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK----QVLQGLVYLHNE 184
             Y   + +  ++LV EY D+    D+ +   +        + K    Q+L+GL + H  
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQ----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH-S 117

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
            +V+HRD+KP NLL+N  GE+K+ DFG++   G  +      V T  Y  P+ + G+  Y
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177

Query: 244 DYSSDIWSLGLVVLECA-IGR--FPYMQSEDQ-------------QSWPSFYELLE-AIV 286
             S D+WS G +  E A  GR  FP    +DQ             +SWP   +L +    
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237

Query: 287 ESPPPTAPPDQFSPEFCSFVSACIQK----DPRDRSSSLDLLSHPF 328
              P T       P+  S     +Q     +P  R S+ + L HP+
Sbjct: 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  100 bits (250), Expect = 4e-24
 Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 20/275 (7%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQC 124
           D   + V+GKGS G V L   K    L+A+KI++ ++    +++   +V++  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             +   +  F     +  V+EY++ G L   I+QV    EP       ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-R 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGV-SAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
           R +I+RD+K  N++++ +G +KI DFG+    +   +  R TF GT +Y++PE I+   Y
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR-TFCGTPDYIAPEIIAYQPY 178

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
             S D W+ G+++ E   G+ P+   ED+       EL ++I+E     + P   S E  
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPF-DGEDED------ELFQSIMEH--NVSYPKSLSKEAV 229

Query: 304 SFVSACIQKDPRDR-----SSSLDLLSHPFIKKFE 333
           S     + K P  R         D+  H F ++ +
Sbjct: 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 41/293 (13%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSH 126
           D   I+ IG+G+ GVV   R+K  G++ A+K I++  +EE +    ++E+ + +  Q  +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 127 VVVCYHSFYHNGVISLVLEY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
           +V           + L+ E+  MD     D + + + +    +     Q+LQG+++ H+ 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
           R V+HRD+KP NLL+++KG +K+ DFG++   G  +      V T  Y +PE + GS  Y
Sbjct: 121 R-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 244 DYSSDIWSLGLVVLECAIGR---------------FPYMQSEDQQSWPSFYELLEAIVES 288
               DIWS+G +  E A  +               F  + +  +  WP         V S
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG--------VTS 231

Query: 289 PP---PTAPP----------DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            P    T P                +    +   +  DP  R S+   L+HP+
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  100 bits (249), Expect = 5e-24
 Identities = 69/263 (26%), Positives = 129/263 (49%), Gaps = 17/263 (6%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           IGKGS G V  VR +   R++ALK I+   +  + E+   + +   + Q + C  +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
            SF     + LVL +++ G L   +++              ++L  L  LH + +VI+RD
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVIYRD 118

Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           +KP N+L++++G + + DFG+  +      + +TF GT  Y++PE + G  Y  + D W+
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178

Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG+++ E   G  P+    D+     + ++L+       P   PD F  +    +   + 
Sbjct: 179 LGVLLYEMLTGLPPFY---DENVNEMYRKILQE------PLRFPDGFDRDAKDLLIGLLS 229

Query: 312 KDPRDR---SSSLDLLSHPFIKK 331
           +DP  R   + + ++ +HPF  +
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  100 bits (251), Expect = 6e-24
 Identities = 67/211 (31%), Positives = 114/211 (54%), Gaps = 13/211 (6%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV----QELKINQ 120
             ED + IKVIG+G+ G VQLVRHK   +++A+K   ++  E I++       +E  I  
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAFFWEERDIMA 98

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
            +    +V  +++F  +  + +V+EYM  G L +++     I E +      +V+  L  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-MGQRDTFVGTYNYMSPE--R 237
           +H+    IHRD+KP N+L++  G +K+ DFG    + ++ M + DT VGT +Y+SPE  +
Sbjct: 158 IHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216

Query: 238 ISGSTYDYSS--DIWSLGLVVLECAIGRFPY 266
             G    Y    D WS+G+ + E  +G  P+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 48/294 (16%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRK-QIVQELKINQAS 122
           + ++ IG+G+ GVV   R K  G + ALK I++  ++E      IR+  +++EL      
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYL--AVVCK---QVLQG 177
           +   VV   +  Y      LV E++D     D+ + + +     L   ++     Q+LQG
Sbjct: 62  RLLDVVHSENKLY------LVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           + Y H+ R V+HRD+KP NLL++ +G +K+ DFG++   G  +      V T  Y +PE 
Sbjct: 112 IAYCHSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 170

Query: 238 ISGSTYDYSS--DIWSLGLVVLECAIGR---------------FPYMQSEDQQSWPSFYE 280
           + GS   YS+  DIWS+G +  E    R               F  + + D+  WP    
Sbjct: 171 LLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV-T 228

Query: 281 LLEAIVESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            L     + P  A  D          +    +S  +  DP  R S+   L HP+
Sbjct: 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 49/309 (15%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK-IIQMNIQE--------EIRKQIVQE 115
            L D E +  +G+G+ G V   R    GR+ ALK I+  N ++        EI+  I+++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK--ILKK 63

Query: 116 LKINQASQCSHVVVCYHSFYHN--GVISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCK 172
           LK         + V          G + +V  YMD   L+ ++      L    +     
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYML 122

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV---------SAMLGSSMGQR 223
           Q+L+G+ YLH E H++HRDIK +N+L++++G +KI DFG+         +   G   G R
Sbjct: 123 QLLEGINYLH-ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 224 D--TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGR---------------FP 265
                V T  Y  PE + G   Y  + DIW +G V  E    R               F 
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241

Query: 266 YMQSEDQQSWPSFYEL--LEAIVESPPPTAPPDQ----FSPEFCSFVSACIQKDPRDRSS 319
              +  +++WP +  L   E +          ++      PE    +S  +  DP  R +
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Query: 320 SLDLLSHPF 328
           + D L HP+
Sbjct: 302 ASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 8e-24
 Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 69/302 (22%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQL-----VRHKWVGRLFALKIIQMNIQEEIRKQIVQELK 117
           E   E +  I+ +G+GS G+V       V         A+K +  N     R + + E  
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61

Query: 118 INQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQ------------V 159
           + +   C HVV         GV+S      +V+E M +G L   +R              
Sbjct: 62  VMKEFNCHHVVRLL------GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 160 KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
            T+ +     +  ++  G+ YL   +  +HRD+   N +V     VKI DFG++      
Sbjct: 116 PTLQKFIQ--MAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMT------ 166

Query: 220 MGQRDTFVGTY-----------NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYM 267
              RD +   Y            +M+PE +    +   SD+WS G+V+ E   +   PY 
Sbjct: 167 ---RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223

Query: 268 -QSEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
             S ++        +L+ +++      P   PD+        +  C Q +P+ R + L++
Sbjct: 224 GLSNEE--------VLKFVIDGGHLDLPENCPDKLL----ELMRMCWQYNPKMRPTFLEI 271

Query: 324 LS 325
           +S
Sbjct: 272 VS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 81/273 (29%), Positives = 131/273 (47%), Gaps = 32/273 (11%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQI------VQELKINQASQCS 125
           K++G+G+ G V L      GR  A+K +  +   +E  K++      +Q LK  +  +  
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
               C         +S+ +EYM  GS+ D ++    + E       +Q+LQG+ YLH+  
Sbjct: 68  QYYGCLRD-PEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSA------MLGSSMGQRDTFVGTYNYMSPERIS 239
            ++HRDIK +N+L +  G VK+ DFG S       M G+ +    +  GT  +MSPE IS
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI---KSVTGTPYWMSPEVIS 182

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAP--PD 296
           G  Y   +D+WS+   V+E    + P+ +          YE + AI + +  PT P  PD
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTKPMLPD 232

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
             S     F+     ++ R R ++  LL HPF+
Sbjct: 233 GVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 9/212 (4%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKIN 119
            +   ED + +KVIG+G+ G VQLVRHK   +++A+K++     I+        +E  I 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
             +    VV  + +F  +  + +V+EYM  G L +++     + E +      +V+  L 
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALD 156

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERI 238
            +H+   +IHRD+KP N+L++  G +K+ DFG    M  + M + DT VGT +Y+SPE +
Sbjct: 157 AIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215

Query: 239 SGST----YDYSSDIWSLGLVVLECAIGRFPY 266
                   Y    D WS+G+ + E  +G  P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 73/277 (26%), Positives = 139/277 (50%), Gaps = 23/277 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVV 129
           K++GKGS G V L   K   + FA+K ++ ++    +++   +V++  ++ A +   +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y +F     +  V+EY++ G L   I+       P       +++ GL +LH+ + +++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGV--SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS 247
           RD+K  N+L++  G +KI DFG+    MLG +  +  TF GT +Y++PE + G  Y+ S 
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS 307
           D WS G+++ E  IG+ P+   +++       EL ++I    P    P   + E    + 
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNP--CYPRWLTREAKDILV 228

Query: 308 ACIQKDPRDR-SSSLDLLSHPFIK-----KFEDKDID 338
               ++P  R     D+  HPF +       E+++I+
Sbjct: 229 KLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIE 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  101 bits (252), Expect = 2e-23
 Identities = 90/311 (28%), Positives = 143/311 (45%), Gaps = 47/311 (15%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQI 112
           P  Y   D E  L + E IK IG G  G V LV+HK     F  K I    ++E  + Q+
Sbjct: 2   PGKYD--DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL 59

Query: 113 VQELKINQASQCSHVVVCYHSFYH--NGVISLVLEYMDRGSLADIIRQV----KTILEPY 166
           V E+ + +  +  ++V     F +  N  + +++E+ D G L+  I++       I E  
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 167 LAVVCKQVLQGLVYLHN-------ERHVIHRDIKPSNLL----VNHKGEV---------- 205
           +  + +Q+L  L Y HN       ER V+HRD+KP N+     + H G++          
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 206 ---KITDFGVSAMLG-SSMGQRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLEC 259
              KI DFG+S  +G  SM    + VGT  Y SPE +   T  YD  SD+W+LG ++ E 
Sbjct: 179 PIAKIGDFGLSKNIGIESMAH--SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS 319
             G+ P+ ++ +      F +L+  +     P  P    S E    +   +    ++R S
Sbjct: 237 CSGKTPFHKANN------FSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPS 288

Query: 320 SLDLLSHPFIK 330
           +L  L +  IK
Sbjct: 289 ALQCLGYQIIK 299

Length = 1021

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 19/289 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSH--VV 128
           KVIGKGS G V L + K  G+ +A+K++Q  I    + +K I+ E  +       H  +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             ++SF     +  VL++++ G L   +++ ++  EP       ++   L YLH+   ++
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-IV 118

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           +RD+KP N+L++ +G V +TDFG+     +      TF GT  Y++PE I    YD + D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
            W LG V+ E   G  P+   +         E+ + I+  P    P    S    S +  
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHKPLVLRP--GASLTAWSILEE 229

Query: 309 CIQKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
            ++KD + R  +    L++  HPF +     D++   +    +P V  P
Sbjct: 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGP 278

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 97.7 bits (243), Expect = 4e-23
 Identities = 82/283 (28%), Positives = 140/283 (49%), Gaps = 22/283 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN---IQEEIRKQIVQELKINQASQCSHVVV 129
           KV+GKGS G V L   K  G  FA+K ++ +   I +++   +V++  +  A +   +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV-CKQVLQGLVYLHNERHVI 188
            Y +F     +  V+E+++ G L   I Q K   + Y A     +++ GL +LH+ + +I
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHS-KGII 118

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           +RD+K  N++++  G +KI DFG+         +  TF GT +Y++PE + G  Y +S D
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVD 178

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
            WS G+++ E  IG+ P+   +D+       EL E+I    P    P   + E    +  
Sbjct: 179 WWSFGVLLYEMLIGQSPF-HGDDED------ELFESIRVDTPHY--PRWITKESKDILEK 229

Query: 309 CIQKDPRDRSSSL-DLLSHPFIKKFEDKDIDLGILVG-SLDPP 349
             ++DP  R   + ++  HPF K      I+   L    LDPP
Sbjct: 230 LFERDPTRRLGVVGNIRGHPFFKT-----INWTALEKRELDPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 39/301 (12%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ-----ASQCSH 126
           + V+G+G  G V L  +K  G L+A+K ++    + I +  V+ L   +     A+   H
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALKK--GDIIARDEVESLMCEKRIFETANSERH 61

Query: 127 --VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             +V  +  F     +  V+EY   G L   I       EP        V+ GL YLH E
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLH-E 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD---TFVGTYNYMSPERISGS 241
             +++RD+K  NLL++ +G VKI DFG   +    MG  D   TF GT  +++PE ++ +
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
           +Y  + D W LG+++ E  +G  P+   +D++      E+ ++IV        P   S E
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPF-PGDDEE------EVFDSIVNDEVRY--PRFLSRE 227

Query: 302 FCSFVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPP----VNC 352
             S +   ++++P  R  S      D+   PF   F D + D  +L   + PP    +  
Sbjct: 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPF---FRDINWD-DLLARKIKPPFVPTIKG 283

Query: 353 P 353
           P
Sbjct: 284 P 284

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 96.5 bits (240), Expect = 5e-23
 Identities = 75/290 (25%), Positives = 141/290 (48%), Gaps = 26/290 (8%)

Query: 74  VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCS 125
           +IG+G  G V   R    G+++A+K +    ++ I+ +  + L +N+           C 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            +V   ++F+    +S +L+ M+ G L   + Q     E  +     +++ GL ++HN R
Sbjct: 58  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-R 116

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS-GSTYD 244
            V++RD+KP+N+L++  G V+I+D G++     S  +    VGT+ YM+PE +  G  YD
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYD 174

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            S+D +SLG ++ +   G  P+ Q + +         ++ +  +      PD FSPE  S
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVEL-PDSFSPELRS 228

Query: 305 FVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
            +   +Q+D   R       + ++  HPF +  + + + L      L PP
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 5e-23
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 40/283 (14%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSH--V 127
           +V+G G+ G V   +    G  FA+K++    M+  ++ R Q      +N    C    +
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN----CDFFSI 93

Query: 128 VVCYHSFYHNG--------VISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVL 175
           V C+  F            +I+LVL+Y + G L   I+      +T  E    ++  QVL
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFVGTYNYM 233
             + ++H+ +H+IHRDIK +N+L+   G VK+ DFG S M  +++      TF GT  Y+
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 234 SPERISGSTYDYSSDIWSLGLVVLECAIGRFPY----MQSEDQQSWPSFYELLEAIVESP 289
           +PE      Y   +D++SLG+++ E    + P+    M+    ++    Y+ L       
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL------- 265

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
                P   SPE    V+A +  DP+ R SS  LL+ P  K F
Sbjct: 266 -----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303

Length = 496

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 97.3 bits (242), Expect = 6e-23
 Identities = 77/279 (27%), Positives = 136/279 (48%), Gaps = 24/279 (8%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNIQEEIRKQIVQELKINQASQC 124
           + E +KV+G G+ G V LVR       G+L+A+K++Q      ++K    E    + +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK--AALVQKAKTVEHTRTERNVL 58

Query: 125 SHV------VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            HV      V  +++F     + L+L+Y+  G +   + Q     E  +     +++  L
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYNYMSPER 237
            +LH +  +++RDIK  N+L++ +G V +TDFG+S    S   +R  +F GT  YM+PE 
Sbjct: 119 EHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 238 ISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
           I G   +  + D WSLG+++ E   G  P+    ++ +     E+   I++  PP   P 
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKCDPPF--PS 232

Query: 297 QFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIK 330
              PE    +   ++KDP+ R       + ++  HPF K
Sbjct: 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 86/314 (27%), Positives = 142/314 (45%), Gaps = 73/314 (23%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII------QMNIQEEIRKQI-VQELKINQAS 122
           E ++ +GKG+ G+V     +    + ALK I        + Q   R+ + +QEL      
Sbjct: 10  EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----- 64

Query: 123 QCSHVVVCYHSF--YHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
              ++V   +     ++  I LV EYM+   L  +IR    ILE     Y+     Q+L+
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR--ANILEDVHKRYIMY---QLLK 118

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT------FVGTY 230
            L Y+H+  +VIHRD+KPSN+L+N    VK+ DFG++  L S + +         +V T 
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYVATR 176

Query: 231 NYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVE 287
            Y +PE + GST Y    D+WS+G ++ E  +G+  FP   + +Q         LE I+E
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---------LEKIIE 227

Query: 288 S-PPPTA------------------------PPDQF----SPEFCSFVSACIQKDPRDRS 318
              PP+A                        P D+     S +    +   +  +P  R 
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287

Query: 319 SSLDLLSHPFIKKF 332
           ++ + L HP++ +F
Sbjct: 288 TAEEALEHPYVAQF 301

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 45/289 (15%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQ------------IVQELKIN 119
             +G+G+ G V+       G++ A+K +++  I  ++ K              ++ELKI 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
              +  +++     +     I+LV++ M    L  ++ +   + E  +  +  Q+L GL 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF------------- 226
            LH   + +HRD+ P+N+ +N KG  KI DFG++   G                      
Sbjct: 134 VLHK-WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 227 -VGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELL 282
            V T  Y +PE + G+  Y ++ D+WS+G +  E   G+  FP     DQ      +ELL
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG--RIFELL 250

Query: 283 EAIVESPPPTAPPDQFS-PEFCSFVSACIQKD-----PRDRSSSLDLLS 325
                +P     P     P +  F +    KD     P     ++DLL 
Sbjct: 251 ----GTPNEDNWPQAKKLPLYTEF-TPRKPKDLKTIFPNASDDAIDLLQ 294

Length = 335

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 40/265 (15%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQC 124
           ED E++KVIG+G+ G V+LV+ K  G ++A+KI++    +++E    I  E  I   +  
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
             VV  ++SF     + L++E++  G +  ++ +  T+ E        + +  +  +H +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH-Q 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA------------MLGSSMGQRDTF------ 226
              IHRDIKP NLL++ KG VK++DFG+               L  S+    TF      
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 227 -----------------VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS 269
                            VGT +Y++PE    + Y+   D WSLG+++ E  IG  P+   
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 270 EDQQSWPSFYELLEAIVESPPPTAP 294
             Q+++       E ++   PP  P
Sbjct: 240 TPQETYKKVMNWKETLIF--PPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 76/274 (27%), Positives = 144/274 (52%), Gaps = 35/274 (12%)

Query: 72  IKVIGKGSGGVVQLVRHKW---VGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCS 125
           +KV+G+GS G V LVR       G+L+A+K+++   + +++ +R ++  E  I       
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHP 58

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL------EPYLAVVCKQVLQGLV 179
            +V  +++F   G + L+L+++  G L    R  K ++      + YLA    ++   L 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA----ELALALD 112

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           +LH+   +I+RD+KP N+L++ +G +K+TDFG+S        +  +F GT  YM+PE ++
Sbjct: 113 HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
              +  S+D WS G+++ E   G  P+ Q +D++      E +  I+++      P   S
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRK------ETMTMILKA--KLGMPQFLS 222

Query: 300 PEFCSFVSACIQKDPRDRSSS-----LDLLSHPF 328
           PE  S + A  +++P +R  +      ++  HPF
Sbjct: 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQAS---QCSHVVV 129
           IGKG+ G V  VR K   R++A+K++  +  + ++     + E  I   +   +   +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
              SF  +  + LV +YM  G L   +++     E        +++  L +LH +  +++
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-KYDIVY 119

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSD 248
           RD+KP N+L++  G + + DFG+S    +     +TF GT  Y++PE  +    Y    D
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
            WSLG++V E   G  P+   + QQ     Y      +       P +  S E   FV  
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQ----MYRN----IAFGKVRFPKNVLSDEGRQFVKG 231

Query: 309 CIQKDPRDRSSSLD----LLSHPFIKKFEDKDIDL 339
            + ++P+ R  +      L  HPF   F D D DL
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPF---FADIDWDL 263

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 77/301 (25%), Positives = 145/301 (48%), Gaps = 43/301 (14%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-----IVQELKINQASQCSHV 127
           +V+GKG  G V   + +  G+++A K ++   ++ I+K+      + E +I +      V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQV--------KTILEPYLAVVCKQVLQGLV 179
           V   +++     + LVL  M+ G L   I  +        + I   Y A +C     GL 
Sbjct: 63  VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--YAAELC----CGLE 116

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPER 237
            L  ER +++RD+KP N+L++ +G ++I+D G++  +  G ++  R   VGT  YM+PE 
Sbjct: 117 DLQRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEV 172

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
           I+   Y +S D W LG ++ E   G+ P+ + +++       E+   + E     +  ++
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQEEYS--EK 227

Query: 298 FSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC 352
           FS +  S     + K+P++R     + +  +  HP  K    K ++  +    L+PP  C
Sbjct: 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM----LEPPF-C 282

Query: 353 P 353
           P
Sbjct: 283 P 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 19/214 (8%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQC 124
           +D +   ++G+G  G VQ+VR K  G ++A+K+++ ++   +E      +E  I   S  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP-----YLAVVCKQVLQGLV 179
             +    ++F     + LV+EY   G L  ++ + +   +      YLA    +++  + 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA----ELVLAIH 116

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-MGQRDTFVGTYNYMSPERI 238
            +H   +V HRDIKP N+L++  G +K+ DFG +A L ++ M      VGT +Y++PE +
Sbjct: 117 SVHQMGYV-HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175

Query: 239 ------SGSTYDYSSDIWSLGLVVLECAIGRFPY 266
                    TY    D WSLG++  E   GR P+
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 82/289 (28%), Positives = 142/289 (49%), Gaps = 42/289 (14%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWV----GRLFALKIIQMNIQEEIRKQIVQELKIN 119
           F    L+ I+ +GKG+ G V+L R+  +    G + A+K +Q +  E +R    +E++I 
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEIL 59

Query: 120 QASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQV 174
           ++ Q  ++V    VCY +   N  + LV+EY+  GSL D +++ +  L+   L +   Q+
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--------GQRDTF 226
            +G+ YL ++R+V HRD+   N+LV  +  VKI DFG++ +L            G+   F
Sbjct: 118 CKGMEYLGSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLE----CAIGRFP---YMQ--SEDQQSWPS 277
                + +PE ++ S +  +SD+WS G+V+ E          P   +M+    D+Q    
Sbjct: 177 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231

Query: 278 FYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
            Y L+E +  +   P P   P     E  + +  C   DP  R S  +L
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPA----EIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 81/296 (27%), Positives = 131/296 (44%), Gaps = 37/296 (12%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQA-SQC 124
           +  E ++ IG+G+ G V   R K  G+L ALK  ++ + EE I    ++E+ + Q  S+ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 125 SHVV---VCYHSFYHNGVISL--VLEYMDRGSLADIIRQVKT----ILEPYLAVVCKQVL 175
            ++V      H    NG  SL  V EY+D      +    +     +    +     Q+L
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
           +G+ + H +  V+HRD+KP NLLV+  KG +KI D G+       +      + T  Y +
Sbjct: 121 KGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 235 PERISGST-YDYSSDIWSLGLVVLECAIGR---------------FPYMQSEDQQSWPSF 278
           PE + GST Y    DIWS+G +  E +  +               F  + +  +Q WP  
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239

Query: 279 YELLEAIVESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            +L +      P   P D        SPE    +   ++ DP  R S+   L+HP+
Sbjct: 240 SKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.0 bits (234), Expect = 5e-22
 Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 36/286 (12%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKW----VGRLFALKIIQMNIQEEIRKQIVQELKIN 119
           F    L+ IK +G+G  G V+L R+       G   A+K +  + +E+ R    +E++I 
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 120 QASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQV 174
           +     ++V    VC         + L++EY+  GSL D +++ +  I    L +   Q+
Sbjct: 61  RTLDHENIVKYKGVCEKP--GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG------QRDTFVG 228
            +G+ YL + +  IHRD+   N+LV  +  VKI+DFG++ +L             ++ + 
Sbjct: 119 CKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLEC---------AIGRFPYM--QSEDQQSWPS 277
            Y   +PE +  S +  +SD+WS G+ + E              F  M   ++ Q     
Sbjct: 178 WY---APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234

Query: 278 FYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
             ELL+     P P + PD    E    +  C + +P+DR S  DL
Sbjct: 235 LLELLKEGERLPRPPSCPD----EVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 5e-22
 Identities = 79/300 (26%), Positives = 145/300 (48%), Gaps = 45/300 (15%)

Query: 72  IKVIGKGSGGVVQLVRH---KWVGRLFALKIIQMNIQEEIRKQIVQELK----------I 118
           +KV+GKG  G V  VR       G++FA+K+++       +  IV+  K          I
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNI 53

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            +A +   +V   ++F   G + L+LEY+  G L   + +    +E        ++   L
Sbjct: 54  LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV---SAMLGSSMGQRDTFVGTYNYMSP 235
            +LH ++ +I+RD+KP N+L++ +G VK+TDFG+   S   G+      TF GT  YM+P
Sbjct: 114 EHLH-QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAP 169

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E +  S +  + D WSLG ++ +   G  P+  +E+++   +  ++L+  +  PP     
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAENRKK--TIDKILKGKLNLPP----- 221

Query: 296 DQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
              +PE    +   ++++P  R       + ++ SHPF +     D    +L   ++PP 
Sbjct: 222 -YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD----LLARKVEPPF 276

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 77/289 (26%), Positives = 135/289 (46%), Gaps = 44/289 (15%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSH- 126
           + I++IGKG  G V L       R  ALK I+ ++ E   ++K+ ++E KI  A+   H 
Sbjct: 5   DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKI--AADLIHP 62

Query: 127 VVVCYHSFYHNG-VISLVLEYMDRGSLADIIRQV------------KTILEPYLAVVCKQ 173
            +V  +S   +G  +   + Y++  +L  +++ V            KT +  +L++  K 
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK- 121

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM------------------ 215
           +   + Y+H+ + V+HRD+KP N+L+   GEV I D+G +                    
Sbjct: 122 ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
             SSM      VGT +YM+PER+ G     S+DI++LG+++ +     FPY + + ++  
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI- 239

Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
                    ++ SP   AP  +  P         +  DP +R SS+  L
Sbjct: 240 -----SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 93/324 (28%), Positives = 144/324 (44%), Gaps = 67/324 (20%)

Query: 60  FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR--KQIVQELK 117
           FD     + +E I   G G+ GVV        G+  A+K I  +  +     K+ ++ELK
Sbjct: 1   FDVGSRYKPIENI---GSGAYGVVCSAIDTRSGKKVAIKKIP-HAFDVPTLAKRTLRELK 56

Query: 118 INQASQCSHVVVCYHSFYHNGVIS----------------LVLEYMDRGSLADIIRQVKT 161
           I               F H+ +I+                +V++ M+   L  II   + 
Sbjct: 57  I------------LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP 103

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
           + E ++     Q+L+GL Y+H+  +VIHRD+KPSNLLVN   E++I DFG++  L SS  
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 222 QRDTF----VGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR---FPYMQSEDQQ 273
           +   F    V T  Y +PE  +S   Y  + D+WS+G +  E  +GR   FP      Q 
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQLFPGKNYVHQL 221

Query: 274 SW-------PSFYELLEAI--------VESPPPTAPPD------QFSPEFCSFVSACIQK 312
                    PS  E+L  I        +++ P   P        + SPE    +S  +Q 
Sbjct: 222 KLILSVLGSPS-EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280

Query: 313 DPRDRSSSLDLLSHPFIKKFEDKD 336
           DP +R +    L HPF+ ++ D D
Sbjct: 281 DPEERITVEQALQHPFLAQYHDPD 304

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 83/308 (26%), Positives = 137/308 (44%), Gaps = 49/308 (15%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQA 121
           +  ++  + I  IG+G+ G V   R K  G L ALK +++ N +E      ++E+KI   
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKI--L 60

Query: 122 SQCSH-VVVCYHSFYHN-----------GVISLVLEYMDRGSLADIIRQVKTILEPYLAV 169
            Q +H  +V       +           G   LV EYMD   +  +   +    E ++  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFV 227
             KQ+L+GL Y H  ++ +HRDIK SN+L+N+KG++K+ DFG+ A L +S   R     V
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNKV 178

Query: 228 GTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV 286
            T  Y  PE + G   Y  + D+WS G ++ E    + P  Q+  + +     EL+  + 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK-PIFQANQELAQ---LELISRLC 234

Query: 287 ESPPPTAPPD----------------------QFS---PEFCSFVSACIQKDPRDRSSSL 321
            SP P   PD                      +FS         +   +  DP  R ++ 
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 322 DLLSHPFI 329
           + L+ P++
Sbjct: 295 EALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 93.1 bits (231), Expect = 9e-22
 Identities = 61/208 (29%), Positives = 111/208 (53%), Gaps = 5/208 (2%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHV 127
            E + V+G+G+ GVV   RHK    + A+K  + + + EE+++  ++ELK+ +  +  ++
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           V    +F   G + LV EY+++  L  +      +    +     Q+++ + + H +  +
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH-KNDI 121

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGSTYDYS 246
           +HRDIKP NLL++H   +K+ DFG +  L        T +V T  Y SPE + G+ Y  +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 247 SDIWSLGLVVLECAIGR--FPYMQSEDQ 272
            D+WS+G ++ E + G+  FP     DQ
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQ 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 27/294 (9%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           LE    +  +G+G+   V   R K    L ALK I++  +E      ++E+ + +  + +
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNE 184
           ++V  +   +    ++LV EY+D+  L   +      +  + + +   Q+L+GL Y H  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH-R 122

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           R V+HRD+KP NLL+N +GE+K+ DFG++             V T  Y  P+ + GST D
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST-D 181

Query: 245 YSS--DIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELLEAIVE 287
           YS+  D+W +G +  E + GR  FP    E+Q             ++WP      E    
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241

Query: 288 SPPPTAP------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
           + P            +   +    +S  +Q + R R S+ + + HP+     ++
Sbjct: 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
            F  + E ++ +K+I  G  G V +++HK   +LF  KII+      I      E  ++Q
Sbjct: 11  QFLKNCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQ 63

Query: 121 ASQC-SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
             +   + +  Y+S        L+++Y+  G L D++++   + E  +  + +Q+++ L 
Sbjct: 64  LMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            LH   ++IH DIK  N+L +  K  + + D+G    L   +G    + GT +Y SPE+I
Sbjct: 124 DLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYFSPEKI 178

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
            G  YD S D W++G++  E   G+ P+ + ED+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212

Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 92.3 bits (229), Expect = 2e-21
 Identities = 76/291 (26%), Positives = 140/291 (48%), Gaps = 30/291 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-----QCSHV 127
           +V+GKG  G V   + +  G+++A K ++   ++ I+K+  + + +N+           V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLE---KKRIKKRKGESMALNEKQILEKVNSQFV 62

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNER 185
           V   +++     + LVL  M+ G L   I  +      E        ++L GL  LH E 
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE- 121

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTY 243
           + ++RD+KP N+L++  G ++I+D G++  +  G S+  R   VGT  YM+PE ++   Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRY 178

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
             S D W LG ++ E   G+ P+   +++       E+   ++E+    +   +FS E  
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETEEVYSA--KFSEEAK 233

Query: 304 SFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
           S     + KDP+ R       + ++  HPF +    K ++ G+    LDPP
Sbjct: 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM----LDPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 57/259 (22%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ-----IVQELKINQA 121
           ED  T+KVIGKG+ G V+LV+ K  G+++A+K +   ++ E+ K+     +  E  +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL---LKSEMFKKDQLAHVKAERDVLAE 57

Query: 122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
           S    VV  Y+SF     + L++E++  G L  ++ +  T  E        + +  +  +
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA--------------------------- 214
           H +   IHRDIKP N+L++  G +K++DFG+S                            
Sbjct: 118 H-KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 215 ---MLGS---SMGQRDTF--------------VGTYNYMSPERISGSTYDYSSDIWSLGL 254
               + S   +M  +D                VGT +Y++PE      Y    D WSLG 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 255 VVLECAIGRFPYMQSEDQQ 273
           ++ EC IG +P   SE+  
Sbjct: 237 IMFECLIG-WPPFCSENSH 254

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 72/290 (24%), Positives = 133/290 (45%), Gaps = 25/290 (8%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           +E    ++ +G+G+   V   R K    L ALK I++  +E      ++E+ + +  + +
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNE 184
           ++V  +   + +  ++LV EY+D+  L   +     I+  + + +   Q+L+GL Y H  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH-R 122

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
           R V+HRD+KP NLL+N +GE+K+ DFG++             V T  Y  P+ + GS+ Y
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 244 DYSSDIWSLGLVVLECAIGR--FPYMQSED-------------QQSWPSFYELLEAIVES 288
               D+W +G +  E A GR  FP    ED             +++WP      E    +
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242

Query: 289 PPPTAP------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
            P   P        +   E    ++  +Q + + R S+ + + H + +  
Sbjct: 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 28/275 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKI-NQASQCSHVVV 129
           KV+GKGS G V L   K    ++A+K+++ +  +Q++     + E +I   A++   +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-VI 188
            +  F     +  V+EY++ G L   I++ +   EP       +V   L++LH  RH VI
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH--RHGVI 118

Query: 189 HRDIKPSNLLVNHKGEVKITDFGV--SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           +RD+K  N+L++ +G  K+ DFG+    +L        TF GT +Y++PE +    Y  S
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT--TFCGTPDYIAPEILQELEYGPS 176

Query: 247 SDIWSLGLVVLECAIGRFPY-MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
            D W+LG+++ E   G+ P+   +ED        +L E+I+        P   S E  S 
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHD--DVLYPVWLSKEAVSI 226

Query: 306 VSACIQKDPRDR-----SSSLD--LLSHPFIKKFE 333
           + A + K+P  R     S   +  +  HPF K+ +
Sbjct: 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 5e-21
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 33/270 (12%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +L  +K +G G  GVV L   KW G++  A+K+I+     E     ++E K+       +
Sbjct: 5   ELTFLKELGSGQFGVVHL--GKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPN 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNER 185
           +V  Y        I +V EYM  G L + +R+ K  L   +L  +C  V + + YL  E 
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL--ES 118

Query: 186 H-VIHRDIKPSNLLVNHKGEVKITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERIS 239
           +  IHRD+   N LV     VK++DFG++  +      SS G +  F     +  PE   
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK--F--PVKWAPPEVFD 174

Query: 240 GSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPP 295
            S +   SD+WS G+++ E  + G+ PY      + + S  E++E++        P   P
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPY------ERF-SNSEVVESVSAGYRLYRPKLAP 227

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                E  + + +C  + P DR +   LLS
Sbjct: 228 ----TEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 90.9 bits (225), Expect = 6e-21
 Identities = 77/279 (27%), Positives = 135/279 (48%), Gaps = 17/279 (6%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           LE    +  +G+G+   V   R K    L ALK I++  +E      ++E+ + +  + +
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNE 184
           ++V  +   +    ++LV EY+D   L   +     ++  + + +   Q+L+GL Y H +
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH-K 121

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           R ++HRD+KP NLL+N KGE+K+ DFG++             V T  Y  P+ + GST +
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST-E 180

Query: 245 YSS--DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           YS+  D+W +G ++ E A GR  +  S  ++     + LL    E   P    ++   EF
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE---EF 237

Query: 303 CSFVSAC------IQKDPRDRSSSLDLLSHPFIKKFEDK 335
            S++         I   PR  +  +DLLS   +  +E K
Sbjct: 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSS--LLLYETK 274

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 69  LETIKVIGKGSGGVVQLVRHK--WVGRL------FALKIIQMNIQEEIRKQIVQELKINQ 120
           LE IKV+G G+ G V    +K  W+          A+K+++     +  K+I+ E  +  
Sbjct: 9   LEKIKVLGSGAFGTV----YKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA 64

Query: 121 ASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVL 175
           +    HVV    +C  S      + L+ + M  G L D +R  K  +     +  C Q+ 
Sbjct: 65  SVDHPHVVRLLGICLSS-----QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYM 233
           +G+ YL  E+ ++HRD+   N+LV     VKITDFG++ +L     +     G     +M
Sbjct: 120 KGMSYL-EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 234 SPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           + E I    Y + SD+WS G+ V E    G  PY
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 43/302 (14%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQC 124
           ++  E ++ IG+G+ GVV   R +      ALK I++  ++E +    ++E+ + +  Q 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMD---------RGSLADIIRQVKTILEPYLAVVCKQVL 175
            ++V      +    + LV EY+D             A   R +KT L         Q+L
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL--------YQIL 112

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
           +G+ Y H+ R V+HRD+KP NLL++ +   +K+ DFG++   G  +      V T  Y +
Sbjct: 113 RGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171

Query: 235 PERISGS-TYDYSSDIWSLGLVVLECAIGR---------------FPYMQSEDQQSWPSF 278
           PE + GS  Y    DIWS+G +  E    +               F  + + ++++WP  
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231

Query: 279 YELLEAIVESP--PP----TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
             L +     P  PP    T  P    P     +S  ++ DP  R ++   L H + K  
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Query: 333 ED 334
            D
Sbjct: 291 GD 292

Length = 294

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 16/212 (7%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQAS 122
           +D E IKVIG+G+ G V +V+ K   R++A+KI  +N  E +++       +E  +    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNG 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA--VVCKQVLQGLVY 180
            C  +   +++F     + LV++Y   G L  ++ + +  L   +A   + + VL   ++
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA--IH 116

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERIS 239
             ++ H +HRDIKP N+L++  G +++ DFG    M      Q    VGT +Y+SPE + 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 240 G-----STYDYSSDIWSLGLVVLECAIGRFPY 266
                   Y    D WSLG+ + E   G  P+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 80/295 (27%), Positives = 122/295 (41%), Gaps = 44/295 (14%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQE---LKINQASQCS 125
           E +  IG G+ G V   R    G   ALK +++   E+ +    V+E   LK  +A    
Sbjct: 3   EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62

Query: 126 HVV----VCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVL 175
           ++V    VC  S       ++LV E++D+    D+   +  +  P L       + +Q L
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
           +GL +LH    ++HRD+KP N+LV   G+VK+ DFG++ +    M      V T  Y +P
Sbjct: 119 RGLDFLHANC-IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-TPVVVTLWYRAP 176

Query: 236 ERISGSTYDYSSDIWSLGLVVLE-----------------CAIGRFPYMQSEDQQSWPSF 278
           E +  STY    D+WS+G +  E                   I     +  ED   WP  
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRD 234

Query: 279 YELLEAIVESPPPTAPPDQFSPEF----CSFVSACIQKDPRDRSSSLDLLSHPFI 329
             L      SP    P     PE        +   +  +P  R S+   L HPF 
Sbjct: 235 VTLPRGAF-SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 71/296 (23%), Positives = 137/296 (46%), Gaps = 44/296 (14%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +  E ++ +G+GS   V   + K  G+L ALK+I++  +E      ++E  + +  + ++
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V+ +   +    ++LV EY+       + +    +    + +   Q+L+GL Y+H +R+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-QRY 123

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDY 245
           ++HRD+KP NLL++  GE+K+ DFG++             V T  Y  P+ + GST Y  
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 246 SSDIWSLGLVVLEC--AIGRFPYMQ--------------SEDQQSWPSFYELLEAIVESP 289
             D+W +G + +E    +  FP M+              + ++ +WP  + L        
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL-------- 235

Query: 290 PPTAPPDQFSP----------EFCSFV-------SACIQKDPRDRSSSLDLLSHPF 328
            P   P++F+              S+V       S  +Q  P++R S+   LSH +
Sbjct: 236 -PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 66/259 (25%), Positives = 119/259 (45%), Gaps = 25/259 (9%)

Query: 75  IGKGSGGVVQLVRHKWVG-RLFALKIIQM---NIQEEIRKQ------IVQELKINQASQC 124
           +G G+ G V  VR K  G  L ALK I +      ++ R++      IV E+ I +  Q 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK-EQL 66

Query: 125 SH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGL 178
            H  +V  Y +F  N  + +V++ ++   L +    +K       E  +  +  Q++  L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            YLH E+ ++HRD+ P+N+++    +V ITDFG+ A       +  + VGT  Y  PE +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYSCPEIV 185

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
               Y   +D+W+ G ++ +    + P+  +       +   L   IVE+     P   +
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPPFYST-------NMLSLATKIVEAVYEPLPEGMY 238

Query: 299 SPEFCSFVSACIQKDPRDR 317
           S +    +++C+  D   R
Sbjct: 239 SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 8e-19
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 17/215 (7%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           +DL  +K +G G  GVV+    KW G+   A+K+I+     E   + ++E K+       
Sbjct: 4   KDLTFLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLSHE 59

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNE 184
            +V  Y        I +V EYM  G L + +R+     +P  L  +CK V +G+ YL ++
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERIS 239
           +  IHRD+   N LV+ +G VK++DFG+S  +      SS+G +        +  PE + 
Sbjct: 120 QF-IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK----FPVRWSPPEVLL 174

Query: 240 GSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQ 273
            S +   SD+W+ G+++ E  ++G+ PY +  + +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 28/235 (11%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQAS 122
           +D E +KVIG+G+ G V +V+ K  G+++A+KI  +N  E +++       +E  +    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNG 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA--VVCKQVLQGLVY 180
               +   +++F     + LV++Y   G L  ++ + +  L   +A   + + VL  +  
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL-AIDS 117

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERIS 239
           +H   +V HRDIKP N+L++  G +++ DFG    +L     Q +  VGT +Y+SPE + 
Sbjct: 118 VHQLGYV-HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 240 G-----STYDYSSDIWSLGLVVLECAIGRFPY------------MQSEDQQSWPS 277
                   Y    D WSLG+ + E   G  P+            M  ++   +P 
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 78/310 (25%), Positives = 132/310 (42%), Gaps = 62/310 (20%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVV 128
           + +  +G G+ G V        GR  A+K +    Q  I  K+  +EL++ +        
Sbjct: 18  QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD----- 72

Query: 129 VCYHSFYHNGVISL------------------VLEYMDRGSLADIIRQVKTILEPYLAVV 170
                  H  VI L                  V   M    L +I++  K + + ++  +
Sbjct: 73  -------HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQK-LSDDHIQFL 123

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
             Q+L+GL Y+H+   +IHRD+KPSN+ VN   E+KI DFG++      M     +V T 
Sbjct: 124 VYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG---YVATR 179

Query: 231 NYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYE 280
            Y +PE + +   Y+ + DIWS+G ++ E   G+  FP     DQ          P   E
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EE 238

Query: 281 LLEAI--------VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
           LL+ I        ++S P     D        +P     +   +  DP  R ++ + L+H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298

Query: 327 PFIKKFEDKD 336
           P++ ++ D +
Sbjct: 299 PYLAEYHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGR------LFALKIIQMNIQEEIRKQIVQELKINQA 121
           + + IKV+G G+ G V   +  W+          A+K ++     +  K+I+ E  +  +
Sbjct: 8   EFKKIKVLGSGAFGTVY--KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 65

Query: 122 SQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQ 176
               HV     +C  S      + L+ + M  G L D +R+ K  I   YL   C Q+ +
Sbjct: 66  VDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMS 234
           G+ YL  ER ++HRD+   N+LV     VKITDFG++ +LG+   +     G     +M+
Sbjct: 121 GMNYLE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 235 PERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            E I    Y + SD+WS G+ V E    G  PY
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 57/295 (19%)

Query: 66  LEDLETIKVIGKGSGGVVQL--VRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQ 120
            + +   + +G+G+ G V L    H        L A+K ++     + RK   +E ++  
Sbjct: 4   RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--------------QVKTILEPY 166
             Q  ++V  Y          +V EYM+ G L   +R               +  +    
Sbjct: 64  NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123

Query: 167 LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF 226
           L  +  Q+  G+VYL ++ H +HRD+   N LV +   VKI DFG+S         RD +
Sbjct: 124 LLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGMS---------RDVY 173

Query: 227 VGTY-----------NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQS 274
              Y            +M PE I    +   SD+WS G+V+ E    G+ P+    ++  
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-- 231

Query: 275 WPSFYELLEAI----VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                E++E I    +   P T P      E    +  C ++DP+ R +  D+  
Sbjct: 232 -----EVIECITQGRLLQRPRTCP-----SEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 57/312 (18%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWV--GRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSH 126
           E IK +G+G+ G+V   R+         A+K I     ++I  K+ ++ELK+ +  +   
Sbjct: 3   ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHK 62

Query: 127 VVVC--------YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            + C          +F  N +  L  E M+   L  IIR  + + + +      Q+L GL
Sbjct: 63  NITCLYDMDIVFPGNF--NELY-LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGL 118

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMS 234
            Y+H+  +V+HRD+KP NLLVN   E+KI DFG++     + G+   F    V T  Y +
Sbjct: 119 KYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 235 PE-RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE---SPP 290
           PE  +S  +Y  + D+WS+G ++ E  +GR P  + +D      + + L  I++   +P 
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGKD------YVDQLNQILQVLGTPD 230

Query: 291 -------------------PTAPPDQF-------SPEFCSFVSACIQKDPRDRSSSLDLL 324
                              P  P   F       +P     +   +  DP  R S  + L
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 325 SHPFIKKFEDKD 336
            HP++  + D D
Sbjct: 291 EHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 61/307 (19%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSH 126
           D+E  + IG G+ GVV  V     G+  ALK +    Q  +  K++ +ELK+        
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKM-------- 52

Query: 127 VVVCYHSFYHNGVISL----------------VLEYMDRGSLADIIRQVKTILEPYLAVV 170
             +C+  F H+ V+S                 V+  + +  L  II   + +   ++ V 
Sbjct: 53  --LCF--FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTF 226
             Q+L+GL YLH+   ++HRDIKP NLLVN    +KI DFG++ +        M Q    
Sbjct: 109 LYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE--- 164

Query: 227 VGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYM-QSEDQQ--------SWP 276
           V T  Y +PE + GS  Y  + DIWS+G +  E    R  +  QS  QQ          P
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224

Query: 277 SFYELLEA-------IVESP--PPTAP-----PDQFSPEFCSFVSACIQKDPRDRSSSLD 322
           S   +  A       I+  P  PP+ P       Q + E    +   +  DP  R S+ D
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284

Query: 323 LLSHPFI 329
            L+HP++
Sbjct: 285 ALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 81/310 (26%), Positives = 132/310 (42%), Gaps = 67/310 (21%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVC 130
           IK IG+G+ G+V   ++       A+K I       I  K+ ++E+K+       H    
Sbjct: 10  IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKL-----LRH---- 60

Query: 131 YHSFYHNGVIS-----------------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQ 173
                H  VI+                 +V E MD   L  IIR  +T+ + +      Q
Sbjct: 61  ---LDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQ 116

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM 233
           +L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++            +V T  Y 
Sbjct: 117 LLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175

Query: 234 SPERI-SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED--QQSWPSFYELLEAIVESPP 290
           +PE + + S Y  + D+WS+G +  E  +GR P    +D   Q      +L+  ++ SP 
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAEL-LGRKPLFPGKDYVHQ-----LKLITELLGSPS 229

Query: 291 -------------------PTAPPDQFS---PEFCSFVSACIQK----DPRDRSSSLDLL 324
                              P  P   F+   P         ++K    DP  R +  + L
Sbjct: 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289

Query: 325 SHPFIKKFED 334
           +HP++    D
Sbjct: 290 AHPYLASLHD 299

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 78/304 (25%), Positives = 125/304 (41%), Gaps = 54/304 (17%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV 128
           E +  IG+G+ G V   RHK   ++ ALK + M N +E      ++E+KI Q  +  +VV
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 129 ----VCYH--SFYHN--GVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLV 179
               +C    + Y+   G   LV E+ +   LA ++           +  V K +L GL 
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTF---VGTYNYMSP 235
           Y+H  + ++HRD+K +N+L+   G +K+ DFG++ A   S   + + +   V T  Y  P
Sbjct: 134 YIHRNK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 236 ERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS----------------WPSF 278
           E + G   Y    D+W  G ++ E    R P MQ   +Q                 WP  
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 279 --YELLEAIVESPPPTAPPDQF------------SPEFCSFVSACIQKDPRDRSSSLDLL 324
              EL + +        P  Q              P     +   +  DP  R  +   L
Sbjct: 252 DKLELFKKME------LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305

Query: 325 SHPF 328
           +H F
Sbjct: 306 NHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.3 bits (201), Expect = 9e-18
 Identities = 64/271 (23%), Positives = 115/271 (42%), Gaps = 40/271 (14%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLF-----ALKIIQMNIQEEIRKQIVQELKINQASQCSHV 127
           K +G GS GVV+  R +W          A+K ++ +   +I    ++E  I  +    ++
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 128 VVCYHSFYHNGV-----ISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVY 180
           +  Y      GV     + +V E    GSL D +R+      L   L     Q+  G+ Y
Sbjct: 59  IRLY------GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMS 234
           L   +  IHRD+   N+L+    +VKI DFG+   L  +    D +V   +      + +
Sbjct: 113 LE-SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN---EDHYVMEEHLKVPFAWCA 168

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP--SFYELLEAIVESPPPT 292
           PE +   T+ ++SD+W  G+ + E        M +  ++ W   S  ++L+ I +     
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWE--------MFTYGEEPWAGLSGSQILKKIDKEGERL 220

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
             P+    +  + +  C   +P DR +   L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 66/257 (25%), Positives = 116/257 (45%), Gaps = 29/257 (11%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF 134
           IG+G+ G V   R +      A+K  +  +  +++ + +QE +I +     ++V      
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 135 YHNGVISLVLEYMDRGSLADIIR------QVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
                I +V+E +  G     +R      +VK +++     + +    G+ YL + +H I
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ-----MVENAAAGMEYLES-KHCI 116

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVS-----AMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
           HRD+   N LV  K  +KI+DFG+S      +  S+ G +   V    + +PE ++   Y
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV---KWTAPEALNYGRY 173

Query: 244 DYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
              SD+WS G+++ E  ++G  PY    +QQ+     E +E  V  P P   PD      
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQT----REAIEQGVRLPCPELCPD----AV 225

Query: 303 CSFVSACIQKDPRDRSS 319
              +  C + DP  R S
Sbjct: 226 YRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 9/154 (5%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ---- 120
           S+E+   +K I +G+ G V L R K   +L+A+K+  +   + I K +V +++  +    
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKV--VKKADMINKNMVHQVQAERDALA 59

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
            S+   +V  Y+S      + LV+EY+  G +  ++       E        +V   L Y
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDY 119

Query: 181 LHNERH-VIHRDIKPSNLLVNHKGEVKITDFGVS 213
           LH  RH +IHRD+KP N+L++++G +K+TDFG+S
Sbjct: 120 LH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 35/270 (12%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +L  +K +G G  GVV L   KW  ++  A+K I      E  +  ++E K+        
Sbjct: 5   ELTFMKELGSGQFGVVHL--GKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPK 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNER 185
           +V  Y        + +V E+M+ G L + +RQ +  L    L  +C+ V +G+ YL  ER
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL--ER 118

Query: 186 H-VIHRDIKPSNLLVNHKGEVKITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERIS 239
           +  IHRD+   N LV+  G VK++DFG++  +      SS G +        +  PE  +
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV----KWSPPEVFN 174

Query: 240 GSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES----PPPTAP 294
            S Y   SD+WS G+++ E    G+ P+ +        S YE++E I        P  A 
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-------SNYEVVEMISRGFRLYRPKLAS 227

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
              +       + +C  + P  R +  +LL
Sbjct: 228 MTVY-----EVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 39/191 (20%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
           Q+L+GL Y+H+   V+HRD+KPSN+L+N   ++KI DFG++ +    M     +V T  Y
Sbjct: 116 QILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---TGYVSTRYY 171

Query: 233 MSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESP 289
            +PE  ++   YD   DIWS G +  E   G+  FP     +Q     F  + + ++ +P
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-----FSIITD-LLGTP 225

Query: 290 P-------------------PTAPPDQFS-------PEFCSFVSACIQKDPRDRSSSLDL 323
           P                   P   P  FS       P     +   +  DP+ R S+ + 
Sbjct: 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285

Query: 324 LSHPFIKKFED 334
           L+HP++  + D
Sbjct: 286 LAHPYLAPYHD 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQAS 122
           ED E +KVIG+G+ G V +V+ K   ++FA+KI  +N  E +++       +E  +    
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNG 58

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYL 181
               +   +++F     + LV++Y   G L  ++ + +  L   +A     +++  +  +
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG 240
           H + H +HRDIKP N+L++  G +++ DFG    ++     Q    VGT +Y+SPE +  
Sbjct: 119 H-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 241 -----STYDYSSDIWSLGLVVLECAIGRFPY 266
                  Y    D WSLG+ + E   G  P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 70/317 (22%), Positives = 125/317 (39%), Gaps = 71/317 (22%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK----INQASQCS 125
             IK IG G+ G V LVR      L+A+K ++    + + +     +K    I   +   
Sbjct: 4   VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRK--ADVLMRNQAAHVKAERDILAEADNE 61

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            VV  Y+SF     +  V++Y+  G +  ++ ++    E        ++   +  +H   
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-M 120

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGV----------------SAMLGSSMGQRDTF--- 226
             IHRDIKP N+L++  G +K+TDFG+                      SM   + +   
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 227 ------------------------VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
                                   VGT NY++PE +  + Y    D WS+G+++ E  +G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 263 RFPYMQ---SEDQQ---SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRD 316
           + P++    +E Q    +W +   +        P  A   + S E    +         D
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHI--------PSQA---KLSREASDLILRLC-CGAED 288

Query: 317 R---SSSLDLLSHPFIK 330
           R   + + ++ +HPF K
Sbjct: 289 RLGKNGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 65/259 (25%), Positives = 129/259 (49%), Gaps = 21/259 (8%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ 123
            +L+ L   ++IG+G  G V  ++ ++ G+  A+K I+ ++  +     ++E  +     
Sbjct: 3   LNLQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVTAQ---AFLEETAVMTKLH 57

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYL 181
             ++V       HNG + +V+E M +G+L + +R     L   + ++     V +G+ YL
Sbjct: 58  HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
            +++ ++HRD+   N+LV+  G  K++DFG++ +   SMG  D       + +PE +   
Sbjct: 117 ESKK-LVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGV-DNSKLPVKWTAPEALKHK 172

Query: 242 TYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
            +   SD+WS G+++ E  + GR PY +        S  E+ E  VE      PP+    
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKM-------SLKEVKEC-VEKGYRMEPPEGCPA 224

Query: 301 EFCSFVSACIQKDPRDRSS 319
           +    +++C + +P+ R S
Sbjct: 225 DVYVLMTSCWETEPKKRPS 243

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 75/269 (27%), Positives = 119/269 (44%), Gaps = 31/269 (11%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVG-RLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
            +L  ++ IG G  G+V L    W+  R  A+K I+     E  +  ++E ++       
Sbjct: 4   SELTLVQEIGSGQFGLVWL--GYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHP 59

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNE 184
            +V  Y        I LV E+M+ G L+D +R  +    +  L  +C  V +G+ YL   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-S 118

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGS 241
            +VIHRD+   N LV     VK++DFG++  +     Q  +  GT     + SPE  S S
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFS 176

Query: 242 TYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
            Y   SD+WS G+++ E  + G+ PY    +        E++E I       A    + P
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETI------NAGFRLYKP 223

Query: 301 EFCS-----FVSACIQKDPRDRSSSLDLL 324
              S      +  C ++ P DR S   LL
Sbjct: 224 RLASQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAML---GSSMGQRDT- 225
           QVL  L   HN + ++HRD+KP N++V+  G     K+ DFG+  +L     +     T 
Sbjct: 87  QVLDALACAHN-QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145

Query: 226 ---FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
               +GT  Y +PE++ G     +SD+++ GL+ LEC  G+   +Q          Y+ L
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAE--ILYQQL 202

Query: 283 EAIVESPPPTA-PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGI 341
                SP   + PP          +   + KDPR R++S   L+  F      + ++L  
Sbjct: 203 -----SPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF------RALELCA 251

Query: 342 LVGSLD 347
           LVG L 
Sbjct: 252 LVGILR 257

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.5 bits (193), Expect = 9e-17
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 25/266 (9%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI---RKQIVQELKINQ 120
            ++++L+ ++ IGKG  G V L  ++  G   A+K I+ +   +       ++ +L+ + 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 60

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGL 178
             Q   V+V        G + +V EYM +GSL D +R + +++L    L      V + +
Sbjct: 61  LVQLLGVIV-----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            YL    + +HRD+   N+LV+     K++DFG++    S+   +DT      + +PE +
Sbjct: 116 EYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEAL 171

Query: 239 SGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
               +   SD+WS G+++ E  + GR PY +   +   P         VE       PD 
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMDAPDG 223

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDL 323
             P     +  C   D   R S L L
Sbjct: 224 CPPVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 45/298 (15%)

Query: 67  EDLETIKVIGKGSGGVVQLVRH-KWVGRLFALKIIQMNIQEE------IRKQIVQELKIN 119
           +  E +  IG+G+ G V   R  K  GR  ALK +++   EE      IR+  V  L+  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHL 58

Query: 120 QASQCSHVV----VCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTILEP-----YLAV 169
           +  +  +VV    VC  S       ++LV E++D+    D+   +  + EP      +  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKD 114

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT 229
           +  Q+L+GL +LH+ R V+HRD+KP N+LV   G++K+ DFG++ +    M      V T
Sbjct: 115 MMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-T 172

Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC--------------AIGR-FPYMQSEDQQS 274
             Y +PE +  S+Y    D+WS+G +  E                +G+    +    ++ 
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEF----CSFVSACIQKDPRDRSSSLDLLSHPF 328
           WP    L            P ++F  +        +  C+  +P  R S+   LSHP+
Sbjct: 233 WPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 64/251 (25%), Positives = 118/251 (47%), Gaps = 18/251 (7%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHK-------WVGRLFALK 98
           + ++ +S  +   +   +   ED   I+ +G GS G V L  +K        + R    K
Sbjct: 9   LHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK 68

Query: 99  IIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ 158
           II+   Q+++   +  E KI         V  Y SF     + LVLE++  G     +R+
Sbjct: 69  IIK---QKQV-DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR 124

Query: 159 VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS 218
            K            Q++    YL +  ++++RD+KP NLL++  G +K+TDFG + ++ +
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183

Query: 219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
              +  T  GT  Y++PE +    +  ++D W+LG+ + E  +G  P+  +E       +
Sbjct: 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIY 237

Query: 279 YELLEAIVESP 289
            ++LE I+  P
Sbjct: 238 QKILEGIIYFP 248

Length = 340

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 22/285 (7%)

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYH 132
           +GKG  G V  V+ K  G+++A K +      ++   K  + E +I +      +V   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNERHVIHR 190
           +F     + LV+  M+ G L   I  V         V+    Q+  G+++LH    +++R
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-SMDIVYR 119

Query: 191 DIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           D+KP N+L++ +G  +++D G++  L  G ++ QR    GT  YM+PE +    Y Y  D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVD 176

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
            +++G  + E   GR P+   +D +   +  EL    +E          F+ E       
Sbjct: 177 WFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRL 232

Query: 309 CIQKDPRDR----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
            + K P DR      + D   H F K      ++ G+    + PP
Sbjct: 233 FLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGL----IPPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 40/256 (15%)

Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++    E  R+   +E ++    Q  H+V  Y        + +V EYM  G L 
Sbjct: 37  LVAVKALK-EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 154 DIIRQV---KTILE------------PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
             +R       IL               +  +  Q+  G+VYL +  H +HRD+   N L
Sbjct: 96  RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCL 154

Query: 199 VNHKGEVKITDFGVSAMLGSS----MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           V     VKI DFG+S  + S+    +G R        +M PE I    +   SDIWS G+
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDIWSFGV 212

Query: 255 VVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSAC 309
           V+ E    G+ P+ Q  +        E +E I +      P T PP+ +     + +  C
Sbjct: 213 VLWEIFTYGKQPWYQLSNT-------EAIECITQGRELERPRTCPPEVY-----AIMQGC 260

Query: 310 IQKDPRDRSSSLDLLS 325
            Q++P+ R    D+ S
Sbjct: 261 WQREPQQRMVIKDIHS 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 73/302 (24%), Positives = 134/302 (44%), Gaps = 46/302 (15%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           ++ +G GS G+V         +  A+K I +   + + K  ++E+KI +     ++V  Y
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVY 68

Query: 132 HSFYHNG--------------VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
                +G               + +V EYM+   LA+++ Q   + E +  +   Q+L+G
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRG 126

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEV-KITDFGVSAMLG---SSMGQRDTFVGTYNYM 233
           L Y+H+  +V+HRD+KP+N+ +N +  V KI DFG++ ++    S  G     + T  Y 
Sbjct: 127 LKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 234 SPERI-SGSTYDYSSDIWSLGLVVLECAIGR------------------FPYMQSEDQQS 274
           SP  + S + Y  + D+W+ G +  E   G+                   P ++ ED+  
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245

Query: 275 W----PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
                PSF          P     P   +PE   F+   +  +P DR ++ + L HP++ 
Sbjct: 246 LLNVIPSFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304

Query: 331 KF 332
            +
Sbjct: 305 CY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 43/299 (14%)

Query: 71  TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVV- 128
           ++K +G G+ G V     K  G   A+K +    Q EI  K+  +EL + +  Q  +V+ 
Sbjct: 19  SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 129 --------VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
                   V    F       LV+ YM +  L  I+     + E  +  +  Q+L GL Y
Sbjct: 79  LLDVFTSAVSGDEFQD---FYLVMPYM-QTDLQKIMGH--PLSEDKVQYLVYQMLCGLKY 132

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-S 239
           +H+   +IHRD+KP NL VN   E+KI DFG++    + M     +V T  Y +PE I +
Sbjct: 133 IHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILN 188

Query: 240 GSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW---------PSFYELLEAI--- 285
              Y+ + DIWS+G ++ E   G+  F      DQ +          P F + LE     
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248

Query: 286 --VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
             ++S P     D      + SP+    +   ++ D   R ++ + L HP+   F D D
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 52/268 (19%)

Query: 75  IGKGSGGVVQLVRHKWVGRL-----FALKIIQMNIQEEIRKQIVQELKINQASQCSH--- 126
           IGKG+ G V      + G L      A+K  +  +  +++++ +QE +I    Q  H   
Sbjct: 3   IGKGNFGDV------YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEI--LKQYDHPNI 54

Query: 127 ---VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQG 177
              + VC         I +V+E +  GSL   +R+      VK +L+     +      G
Sbjct: 55  VKLIGVCVQKQ----PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ-----MSLDAAAG 105

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-----AMLGSSMGQRDTFVGTYNY 232
           + YL + ++ IHRD+   N LV     +KI+DFG+S      +   S G +   +    +
Sbjct: 106 MEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KW 161

Query: 233 MSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPP 291
            +PE ++   Y   SD+WS G+++ E  ++G  PY    +QQ+     E +E+    P P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT----RERIESGYRMPAP 217

Query: 292 TAPPDQFSPEFCSFVSACIQKDPRDRSS 319
              P++        +  C   DP +R S
Sbjct: 218 QLCPEEIY----RLMLQCWAYDPENRPS 241

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 46/226 (20%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQELKINQA 121
              + +  IG+G+ G+V    HK  G   A+K I     Q   Q  +R     E+KI   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-----EIKI--- 56

Query: 122 SQCSHVVVCYHSFYHNGVISL--VLEYMDRGSLADIIRQVKTILEPYLAVVCK------- 172
                       F H  +I +  ++      S  D+   V+ ++E  L  + K       
Sbjct: 57  ---------LRRFKHENIIGILDIIRPPSFESFNDVY-IVQELMETDLYKLIKTQHLSND 106

Query: 173 -------QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG---VSAMLGSSMGQ 222
                  Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG   ++       G 
Sbjct: 107 HIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 223 RDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FP 265
              +V T  Y +PE  ++   Y  + DIWS+G ++ E    R  FP
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 51/278 (18%)

Query: 73  KVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           KVIG G  G V     K  GR     A+K ++    E+ R+  + E  I    Q SH   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI--MGQFSH--- 65

Query: 130 CYHSFYHN-----GVIS------LVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQG 177
                 HN     GV++      ++ EYM+ G+L   +R        Y L  + + +  G
Sbjct: 66  ------HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------ 231
           + YL +  +V HRD+   N+LVN   E K++DFG+S +L       D   GTY       
Sbjct: 120 MKYLSDMNYV-HRDLAARNILVNSNLECKVSDFGLSRVL------EDDPEGTYTTSGGKI 172

Query: 232 ---YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE 287
              + +PE I+   +  +SD+WS G+V+ E  + G  PY    +        E+++AI +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAIND 225

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                AP D  S  +   +  C Q+D   R   +D+++
Sbjct: 226 GFRLPAPMDCPSAVY-QLMLQCWQQDRARRPRFVDIVN 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 49/311 (15%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQC 124
           L+  + +K IG G+ G+V       + R  A+K +    Q +   K+  +EL + +    
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 125 SHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            +++   + F     +       LV+E MD  +L  +I+    +    ++ +  Q+L G+
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGI 132

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            +LH+   +IHRD+KPSN++V     +KI DFG++   G+S      +V T  Y +PE I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI 190

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-----------PSFYELLEAI 285
            G  Y  + DIWS+G ++ E    +  FP     DQ  W           P F + L+  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPT 248

Query: 286 ----VESPP-------PTAPPDQFSP-----------EFCSFVSACIQKDPRDRSSSLDL 323
               VE+ P       P   PD   P           +    +S  +  DP  R S  + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 324 LSHPFIKKFED 334
           L HP+I  + D
Sbjct: 309 LQHPYINVWYD 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 30/254 (11%)

Query: 78  GSGGVVQLVRHKWVGRL-FALKIIQ---MNIQEEIRKQIVQELK-INQASQCSHVVVCYH 132
           GSG   ++    W  R+  A+KI++   +  Q++ +K++ Q LK +      S   VC  
Sbjct: 15  GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEV-QALKRLRHKHLISLFAVCSV 73

Query: 133 S--FYHNGVISLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVLQGLVYLHNERH 186
               Y      ++ E M++GSL   +R    QV   +   + + C QV +G+ YL  E++
Sbjct: 74  GEPVY------IITELMEKGSLLAFLRSPEGQVLP-VASLIDMAC-QVAEGMAYLE-EQN 124

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
            IHRD+   N+LV      K+ DFG++ ++   +         Y + +PE  S  T+   
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 247 SDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
           SD+WS G+++ E    G+ PY    + +     Y+ + A    P P   P     E    
Sbjct: 185 SDVWSFGILLYEMFTYGQVPYPGMNNHEV----YDQITAGYRMPCPAKCP----QEIYKI 236

Query: 306 VSACIQKDPRDRSS 319
           +  C   +P DR S
Sbjct: 237 MLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 36/237 (15%)

Query: 96  ALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHS--FYHNGVISLVLEYMDRGSL 152
            LK   M ++E +++  +++E+K     Q   + VC     FY      ++ E+M  G+L
Sbjct: 38  TLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--LGVCTREPPFY------IITEFMTYGNL 89

Query: 153 ADIIRQV-KTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D +R+  +  +    L  +  Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 90  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 148

Query: 211 GVSAMLGSSMGQRDTFVG------TYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GR 263
           G+S ++       DT+           + +PE ++ + +   SD+W+ G+++ E A  G 
Sbjct: 149 GLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203

Query: 264 FPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS 319
            PY   +  Q     YELLE       P   PP  +       + AC Q +P DR S
Sbjct: 204 SPYPGIDLSQ----VYELLEKGYRMERPEGCPPKVY-----ELMRACWQWNPSDRPS 251

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 84/329 (25%), Positives = 141/329 (42%), Gaps = 60/329 (18%)

Query: 75  IGKGSGGV--VQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVVVCY 131
           IG+G   +  V L RH   G L  ++I  + N  EE  K +  E+ ++   +  +++  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
             F     + ++  +M  GS   +++    + + E  +  +    L+GL YLH +   IH
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH-QNGYIH 124

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAMLG-SSMGQRDTFVGTYN--------YMSPE--RI 238
           R+IK S++L++  G V ++  G+S +      GQ+   V  +         ++SPE  R 
Sbjct: 125 RNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ------SWPSFYELL---------- 282
               Y+  SDI+S+G+   E A GR P+      Q        P +  L           
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242

Query: 283 -------------EAIVESPPP---------TAPPDQFSPEFCSFVSACIQKDPRDRSSS 320
                        E++V +            T     FSP F + V  C+Q+DP  R S+
Sbjct: 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302

Query: 321 LDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
             LLSH F K+ +++     IL  SL PP
Sbjct: 303 SSLLSHAFFKQVKEQTQG-SIL--SLLPP 328

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 80/323 (24%), Positives = 141/323 (43%), Gaps = 68/323 (21%)

Query: 70  ETIKVIGKGSGG--VVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSH 126
           E + VIG+G      V L R+K  G    ++ I +     E+   +  EL +++     +
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNE 184
           +V    +F  +  + +V  +M  GS  D+I    +  + E  +A + + VL+ L Y+H+ 
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS-SMGQRDTFVGTYN--------YMSP 235
            +V HR +K S++L++  G+V ++  G+ + L   + GQR   V  +         ++SP
Sbjct: 121 GYV-HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 236 ERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--- 290
           E +  +   YD  SDI+S+G+   E A G  P+      +  P+   LLE +  + P   
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPF------KDMPATQMLLEKLNGTVPCLL 231

Query: 291 --PTAPPDQ--------------------------------------FSPEFCSFVSACI 310
              T P ++                                      FSP F  FV  C+
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291

Query: 311 QKDPRDRSSSLDLLSHPFIKKFE 333
           Q++P  R S+  LL+H F K+ +
Sbjct: 292 QRNPDARPSASTLLNHSFFKQIK 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 13/182 (7%)

Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I ++ EYM+ GSL D ++  +   +    L  +  Q+ +G+ ++   ++ IHRD++ +N+
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANI 133

Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G+++
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 193

Query: 257 LE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPR 315
            E    GR PY    +    P   + LE     P P   P+    E    +  C ++ P 
Sbjct: 194 TEIVTYGRIPYPGMTN----PEVIQNLERGYRMPRPDNCPE----ELYELMRLCWKEKPE 245

Query: 316 DR 317
           +R
Sbjct: 246 ER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 71.7 bits (176), Expect = 6e-15
 Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 28/196 (14%)

Query: 150 GSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
            SLADI+      L E  +  VC Q L  L  LH       R  K  N+L+   G +K+ 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH-------RQAKSGNILLTWDGLLKL- 52

Query: 209 DFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ 268
             G  A       + D +      M+PE I G +Y   +DI+SLG+ + E      PY +
Sbjct: 53  -DGSVAFKTPEQSRPDPYF-----MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE-------FCSFVSACIQKDPRDRSSSL 321
                       +LE ++   P   P D+ + E       F  F+  C  + P+ R ++ 
Sbjct: 107 E------RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN 160

Query: 322 DLLSHPFIKKFEDKDI 337
             L+H      E  ++
Sbjct: 161 HYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 77/302 (25%), Positives = 135/302 (44%), Gaps = 50/302 (16%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVC 130
           +K +G G+ G V     +  G   A+K +    Q E+  K+  +EL++ +  +  +V+  
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 131 ------------YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
                       +H FY      LV+ +M  G+    + + + + E  +  +  Q+L+GL
Sbjct: 80  LDVFTPDLSLDRFHDFY------LVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            Y+H    +IHRD+KP NL VN   E+KI DFG++    S M     +V T  Y +PE I
Sbjct: 132 KYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---TGYVVTRWYRAPEVI 187

Query: 239 -SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ----------QSWPS--FYELLEA- 284
            +   Y  + DIWS+G ++ E   G+ P  +  D              PS  F + L++ 
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246

Query: 285 ----IVESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
                V+  P     D        +P   + +   +  D   R ++ + L+HP+ ++F D
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306

Query: 335 KD 336
            +
Sbjct: 307 PE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 72/272 (26%), Positives = 115/272 (42%), Gaps = 30/272 (11%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKW------VGRLFALKIIQMNIQEEIRKQIVQELKINQA 121
           +L+ +KV+G G+ G V   +  W      V    A+K+++ N   +  K+I+ E  +   
Sbjct: 8   ELKKVKVLGSGAFGTV--YKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65

Query: 122 SQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQ 176
               +V     +C  S      + LV + M  G L D +R+ K  I    L   C Q+ +
Sbjct: 66  VGSPYVCRLLGICLTS-----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMS 234
           G+ YL   R ++HRD+   N+LV     VKITDFG++ +L     +     G     +M+
Sbjct: 121 GMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 235 PERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
            E I    + + SD+WS G+ V E    G  PY      +  P   E  E +    PP  
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLEKGERL--PQPPIC 236

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
             D +       +  C   D   R    +L+ 
Sbjct: 237 TIDVY-----MIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 39/193 (20%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
           Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI DFG++      M     +V T  Y
Sbjct: 128 QILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWY 183

Query: 233 MSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESP 289
            +PE  ++   Y+ + DIWS+G ++ E   GR  FP     DQ       +L+  +V +P
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ------LKLILRLVGTP 237

Query: 290 P-------------------PTAPPDQFS-------PEFCSFVSACIQKDPRDRSSSLDL 323
                                  P   F+       P     +   +  D   R ++   
Sbjct: 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297

Query: 324 LSHPFIKKFEDKD 336
           L+H +  ++ D D
Sbjct: 298 LAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 68/231 (29%), Positives = 98/231 (42%), Gaps = 43/231 (18%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V  
Sbjct: 98  LVMELMD-ANLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKS 153

Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
              +KI DFG++   G+S       V  Y Y +PE I G  Y  + DIWS+G ++ E   
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIR 212

Query: 262 GR--FPYMQSEDQQSWPSFYELL---------------EAIVESPPPTA--------PPD 296
           G   FP     DQ  W    E L                  VE+ P  A        P  
Sbjct: 213 GTVLFPGTDHIDQ--WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDV 270

Query: 297 QFSPEFCSFVSACIQK-----------DPRDRSSSLDLLSHPFIKKFEDKD 336
            F P+  S       +           DP  R S  D L HP+I  + D  
Sbjct: 271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 51/305 (16%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRK--QIVQELKINQASQCSHVVVC 130
           +VIGKGS GVV        G   A+K I  ++ E +    +I++E+K+ +  +   +V  
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 131 YH-----SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            H     S      I +V E M+   L  +I+    +   +      Q+L+ L Y+H   
Sbjct: 65  KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQR--DTFVGTYNYMSPERISGST 242
           +V HRD+KP N+L N   ++KI DFG++      +        +V T  Y +PE + GS 
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSF 181

Query: 243 YD-YSS--DIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESPPPTA---- 293
           +  Y+   DIWS+G +  E   G+  FP      Q       +L+  ++ +P P      
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ------LDLITDLLGTPSPETISRV 235

Query: 294 ---------------PPDQFSPEF-------CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                           P  FS +F          +   +  DP+DR ++ + L+ P+ K 
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295

Query: 332 FEDKD 336
               +
Sbjct: 296 LAKVE 300

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 33/285 (11%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQ------LVRHKWVGRLFALKIIQMNIQEEIRKQIVQE 115
           +E + E +   + +G+GS G+V       +V+ +   R+ A+K +        R + + E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNE 59

Query: 116 LKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE-------PYLA 168
             + +   C HVV             +++E M RG L   +R ++  +E       P L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 169 VVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            + +   ++  G+ YL N    +HRD+   N +V     VKI DFG++  +  +   R  
Sbjct: 120 KMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 226 FVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYE-- 280
             G     +MSPE +    +   SD+WS G+V+ E A +   PY    ++Q      E  
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238

Query: 281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
           LL+           PD         +  C Q +P+ R S L+++S
Sbjct: 239 LLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 32/288 (11%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGS-GGVVQ-----LVRHKWVGRLFALKIIQMNIQEE 107
           P D K   +EF   +L   K +G G+ G VV+     L +   V ++ A+K+++      
Sbjct: 25  PYDLK---WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSS 80

Query: 108 IRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY 166
            R+ ++ ELKI +      ++V    +    G I ++ EY   G L + +R+ +      
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 167 LAVVC--KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS--AMLGSSMGQ 222
             ++    QV +G+ +L + ++ IHRD+   N+L+ H   VKI DFG++   M  S+   
Sbjct: 141 EDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199

Query: 223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY----MQSEDQQSWPS 277
           +        +M+PE I    Y + SD+WS G+++ E  ++G  PY    + S        
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------K 252

Query: 278 FYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
           FY+L++       P   P     E    +  C   DP  R +   ++ 
Sbjct: 253 FYKLIKEGYRMAQPEHAPA----EIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 25/235 (10%)

Query: 75  IGKGSGGVVQLVRHK--WVGRLFALKIIQ--MNIQEEIRKQIVQELKINQASQCSHVVVC 130
           IG+G+ G V   + K    G+ +A+K  +        I +   +E+ + +  +  +VV  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 131 YHSFYHNGV--ISLVLEYMDRGSLADII---RQVKTILEPYLAV--VCKQVLQGLVYLHN 183
              F  +    + L+ +Y +   L  II   RQ K +  P   V  +  Q+L G+ YLH 
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125

Query: 184 ERHVIHRDIKPSNLLV----NHKGEVKITDFGVS----AMLGSSMGQRDTFVGTYNYMSP 235
              V+HRD+KP+N+LV      +G VKI D G++    A L   +   D  V T  Y +P
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL-KPLADLDPVVVTIWYRAP 184

Query: 236 ERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVE 287
           E + G+  Y  + DIW++G +  E       F   +++ ++S P   + LE I E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 17/184 (9%)

Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V E M  GSL + ++    + +  P L  +  QV  G+ YL   ++ IHRD+   N+
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNV 134

Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGL 254
           LV      K+ DFG++ ++   +   +   G      + +PE    + +   SD+WS G+
Sbjct: 135 LVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 255 VVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           ++ E    GR PY    + +      + ++     P P   P     E    +  C ++D
Sbjct: 193 LLTEIVTYGRMPYPGMTNAE----VLQQVDQGYRMPCPPGCP----KELYDIMLDCWKED 244

Query: 314 PRDR 317
           P DR
Sbjct: 245 PDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 29/271 (10%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
             + ++L+    IGKG  G V L    + G+  A+K ++ +      +  + E  +   +
Sbjct: 2   AINSKELKLGATIGKGEFGDVML--GDYRGQKVAVKCLKDDST--AAQAFLAEASV--MT 55

Query: 123 QCSH---VVVCYHSFYHNGVISLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVL 175
              H   V +       N  + +V EYM +GSL D +R     V T+ +         V 
Sbjct: 56  TLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQ--QLGFALDVC 112

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
           +G+ YL  E++ +HRD+   N+LV+     K++DFG++    +S GQ D+      + +P
Sbjct: 113 EGMEYLE-EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQ-DSGKLPVKWTAP 168

Query: 236 ERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           E +    +   SD+WS G+++ E  + GR PY +           +++   VE       
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPH-VEKGYRMEA 220

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
           P+   PE    +  C + DP  R +   L  
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 71/316 (22%), Positives = 132/316 (41%), Gaps = 63/316 (19%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI--RKQIVQ---ELKINQASQCSH 126
           IK +G G+ G V L        L+A+K ++   ++++  R Q+     E  I   +    
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLR---KKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           VV  Y+SF     +  V++Y+  G +  ++ +++   E        ++   +  +H +  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH-KMG 121

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGV----------------SAMLGSSMGQRD------ 224
            IHRDIKP N+L++  G +K+TDFG+                S +   SM   D      
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 225 -------------------------TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                                    + VGT NY++PE +    Y    D WS+G+++ E 
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS--ACIQKDPRDR 317
            +G+ P++        P+  +L     E+     P  + SPE    ++   C  ++   R
Sbjct: 242 LVGQPPFLAPT-----PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296

Query: 318 SSSLDLLSHPFIKKFE 333
           + + D+ +HPF  + +
Sbjct: 297 NGADDIKAHPFFSEVD 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 65/304 (21%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWV--GRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           E+   ++E ++ IG+G+ G V   R   +     F +  ++M ++EE    +  + +   
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQ--- 56

Query: 121 ASQCSHVVVCYHSFYHNGVISLV------------LEYMDRGSLADIIR----------- 157
                        F H  ++ L+             EYM  G L + +R           
Sbjct: 57  -----REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111

Query: 158 ----QVKTILEPYLAVVC-------KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
                 +      L + C       KQV  G+ YL +ER  +HRD+   N LV     VK
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVK 170

Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLEC- 259
           I DFG+S  + S+    D +  + N      +M PE I  + Y   SD+W+ G+V+ E  
Sbjct: 171 IADFGLSRNIYSA----DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226

Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS 319
           + G  PY     ++     Y + +  V S P   P      E  + +  C  K P DR S
Sbjct: 227 SYGMQPYYGMAHEE---VIYYVRDGNVLSCPDNCP-----LELYNLMRLCWSKLPSDRPS 278

Query: 320 SLDL 323
              +
Sbjct: 279 FASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 65/249 (26%), Positives = 109/249 (43%), Gaps = 40/249 (16%)

Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++ +  +  RK   +E ++    Q  H+V  Y        + +V EYM  G L 
Sbjct: 37  LVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 154 DIIRQ-------------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
             +R                 + +  +  + +Q+  G+VYL ++ H +HRD+   N LV 
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVG 154

Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYN-----YMSPERISGSTYDYSSDIWSLGLV 255
               VKI DFG+S  + S+   R   VG +      +M PE I    +   SD+WSLG+V
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211

Query: 256 VLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACI 310
           + E    G+ P+ Q  +        E++E I +      P T P + +       +  C 
Sbjct: 212 LWEIFTYGKQPWYQLSNN-------EVIECITQGRVLQRPRTCPKEVY-----DLMLGCW 259

Query: 311 QKDPRDRSS 319
           Q++P  R +
Sbjct: 260 QREPHMRLN 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 13/186 (6%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E    G L   +++ + I    L  +  QV  G+ YL   +H +HRD+   N+L+ +
Sbjct: 72  LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVN 130

Query: 202 KGEVKITDFGVSAMLGS-SMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           + + KI+DFG+S  LG+ S   R T  G +   + +PE I+   +   SD+WS G+ + E
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Query: 259 C-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             + G  PY + +  +        + A++ES      P++   E  S + +C +  P DR
Sbjct: 191 AFSYGAKPYGEMKGAE--------VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242

Query: 318 SSSLDL 323
            +  +L
Sbjct: 243 PTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 69  LETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC 124
           L+ I+V+G+G  G V L  +       G + A+K ++    ++      +E+ I +    
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 125 SHVVVCYHSFYHNG--VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
            ++V         G   + L++EY+  GSL D + + K  L   L +  +Q+ +G+ YLH
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-LFAQQICEGMAYLH 124

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG--------SSMGQRDTFVGTYNYMS 234
           ++ H IHRD+   N+L+++   VKI DFG++  +            G    F     + +
Sbjct: 125 SQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYA 178

Query: 235 PERISGSTYDYSSDIWSLGLVVLE 258
            E +  + + Y+SD+WS G+ + E
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYE 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 31/193 (16%)

Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++  + K +  P L  +  Q+ +G+ YL   R+ IHRD+   N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNI 134

Query: 198 LVNHKGEVKITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
           LV      KI DFG++ ++      +  G +     T    +PE  +   +   SD+WS 
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIKSDVWSF 190

Query: 253 GLVVLEC-AIGRFPY--MQSEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFV 306
           G+++ E    GR PY  M +          E+LE +      P P   P+    E    +
Sbjct: 191 GILLTEIVTYGRVPYPGMTNR---------EVLEQVERGYRMPRPPNCPE----ELYDLM 237

Query: 307 SACIQKDPRDRSS 319
             C  KDP +R +
Sbjct: 238 LQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 24/217 (11%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVG--------RLFALKIIQMNIQEEIRKQIV 113
           +E   E ++ +K +G G  G V      W+G         +  LK   M++Q       +
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEV------WMGYYNNSTKVAVKTLKPGTMSVQ-----AFL 49

Query: 114 QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVC 171
           +E  + +  Q   +V  Y        I ++ EYM +GSL D ++  +   +L P L    
Sbjct: 50  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS 109

Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTY 230
            Q+ +G+ Y+   ++ IHRD++ +N+LV+     KI DFG++ ++  +    R+      
Sbjct: 110 AQIAEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
            + +PE I+  ++   SD+WS G+++ E    G+ PY
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 27/267 (10%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRL-FALKIIQ---MNIQEEIRK-QIVQEL 116
           +E   E L+ IK +G G  G V      W G    A+K ++   M+ +  + + QI+++L
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVW--MGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL 58

Query: 117 KINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQV 174
           + ++  Q  + VV     Y      +V EYM +GSL D ++  + + +  P L  +  QV
Sbjct: 59  RHDKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV 111

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYM 233
             G+ Y+    + IHRD++ +N+LV      KI DFG++ ++  +    R        + 
Sbjct: 112 AAGMAYIERMNY-IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170

Query: 234 SPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           +PE      +   SD+WS G+++ E    GR PY    +++      E +E     P P 
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----VLEQVERGYRMPCPQ 226

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSS 319
             P          +  C +KDP +R +
Sbjct: 227 DCP----ISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 75/309 (24%), Positives = 131/309 (42%), Gaps = 45/309 (14%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQC 124
           L+  + +K IG G+ G+V       + R  A+K +    Q +   K+  +EL + +    
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 125 SHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            +++   + F     +       +V+E MD  +L  +I+    +    ++ +  Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGI 139

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            +LH+   +IHRD+KPSN++V     +KI DFG++   G+S       V  Y Y +PE I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVI 197

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-----------PSFYELLEAIVE 287
            G  Y  + DIWS+G ++ E   G   +  ++    W           P F + L+  V 
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257

Query: 288 SPPPTAP-----------PDQFSP-----------EFCSFVSACIQKDPRDRSSSLDLLS 325
           +     P           PD   P           +    +S  +  D   R S  + L 
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317

Query: 326 HPFIKKFED 334
           HP+I  + D
Sbjct: 318 HPYINVWYD 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 13/184 (7%)

Query: 140 ISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++ ++   L  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 75  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 133

Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 134 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193

Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPR 315
            E    GR PY    +++      + +E     P P   P+      C     C +K+P 
Sbjct: 194 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEPE 245

Query: 316 DRSS 319
           +R +
Sbjct: 246 ERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 32/202 (15%)

Query: 137 NGVISLVLEYMDRGSLADIIR--QVKTILEPYLAVV-----CKQVLQGLVYLHNERHVIH 189
           N    +++E M+ G L   +R  +V+    P L +      C  V +G VYL  + H IH
Sbjct: 71  NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIH 129

Query: 190 RDIKPSNLLVNHKGE-----VKITDFGVSAMLGSSMGQRDTFVGTYN--YMSPERISGST 242
           RD+   N LV+ KG      VKI DFG++  +  S   R    G     +M+PE +    
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189

Query: 243 YDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQ 297
           +   SD+WS G+++ E   +G+ PY    +Q       E+L+ +        P   P   
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHVTAGGRLQKPENCPDKI 242

Query: 298 FSPEFCSFVSACIQKDPRDRSS 319
           +       ++ C  +DP +R +
Sbjct: 243 Y-----QLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 39/264 (14%)

Query: 73  KVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           KVIG G  G V   R K  G+     A+K ++    E+ R+  + E  I    Q  H  +
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI--MGQFDHPNI 67

Query: 130 CYHSFYHNGVIS------LVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVY 180
                +  GV++      +V EYM+ GSL   +R+     T+++  L  + + +  G+ Y
Sbjct: 68  ----IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKY 121

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG---TYNYMSPER 237
           L +  +V HRD+   N+LVN     K++DFG+S +L        T  G      + +PE 
Sbjct: 122 LSDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 238 ISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTA 293
           I+   +  +SD+WS G+V+ E  + G  PY +  +Q       ++++AI E    P P  
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYRLPAPMD 233

Query: 294 PPDQFSPEFCSFVSACIQKDPRDR 317
            P          +  C QKD  +R
Sbjct: 234 CPAALH----QLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 13/184 (7%)

Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I ++ E+M +GSL D ++  +      P L     Q+ +G+ ++  +R+ IHRD++ +N+
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 133

Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV+     KI DFG++ ++  +    R+       + +PE I+  ++   SD+WS G+++
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193

Query: 257 LE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPR 315
           +E    GR PY       S P     LE     P P   P+    E  + +  C +  P 
Sbjct: 194 MEIVTYGRIPY----PGMSNPEVIRALERGYRMPRPENCPE----ELYNIMMRCWKNRPE 245

Query: 316 DRSS 319
           +R +
Sbjct: 246 ERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.2 bits (166), Expect = 6e-13
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGR------LFALKIIQMNIQEEIRKQIVQELKINQA 121
           +L+ +KV+G G+ G V   +  WV          A+KI+      +   + + E  I  +
Sbjct: 8   ELKRVKVLGSGAFGTV--YKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 122 SQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQ 176
               H+V    VC      +  I LV + M  G L D + + K  I    L   C Q+ +
Sbjct: 66  MDHPHLVRLLGVCL-----SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMS 234
           G++YL  ER ++HRD+   N+LV     VKITDFG++ +L     + +   G     +M+
Sbjct: 121 GMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Query: 235 PERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            E I    + + SD+WS G+ + E    G  PY
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 36/243 (14%)

Query: 73  KVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           +VIG G  G V   R K  G+     A+K ++    E+ R+  + E  I       +++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERH 186
                  +  + ++ E+M+ G+L   +RQ     T+++  L  + + +  G+ YL +E +
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL-SEMN 126

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN----------YMSPE 236
            +HRD+   N+LVN     K++DFG+S  L     + DT   TY           + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFL-----EDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 237 RISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES----PPP 291
            I+   +  +SD+WS G+V+ E  + G  PY    +Q       +++ AI +     PP 
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQDYRLPPPM 234

Query: 292 TAP 294
             P
Sbjct: 235 DCP 237

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 41/121 (33%), Positives = 63/121 (52%), Gaps = 13/121 (10%)

Query: 155 IIRQVKTILEPYLA-----VVC------KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           I+ + KT L  YLA      +C      + VL+ + YLH  R +IHRDIK  N+ +NH G
Sbjct: 161 ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR-IIHRDIKAENIFINHPG 219

Query: 204 EVKITDFGVSAM-LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           +V + DFG +   +  +  +   + GT    +PE ++   Y  + DIWS G+V+ E A  
Sbjct: 220 DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Query: 263 R 263
            
Sbjct: 280 H 280

Length = 391

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 50/242 (20%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-------RLFALKIIQMNIQEEIRKQIVQ 114
           +E   + L   K +G+G+ G  Q+V+ + VG          A+K+++ +  E+    +V 
Sbjct: 7   WELPRDRLTLGKPLGEGAFG--QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64

Query: 115 ELK-----------INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ----- 158
           E++           IN    C+            G + +V+EY   G+L D +R      
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQ----------EGPLYVVVEYAAHGNLRDFLRARRPPG 114

Query: 159 -----------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
                       +T+ +  L     QV +G+ +L +++  IHRD+   N+LV     +KI
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKI 173

Query: 208 TDFGVSAMLGSSMGQRDTFVG--TYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRF 264
            DFG++  +      R T  G     +M+PE +    Y + SD+WS G+++ E   +G  
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233

Query: 265 PY 266
           PY
Sbjct: 234 PY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 29/221 (13%)

Query: 124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYL-------AVVCKQV 174
           C H  +V  +  F  +  + L++EY   GS  D+ +Q+K  L+ +L        ++  Q+
Sbjct: 122 CDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQI 178

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--MGQRDTFVGTYNY 232
           +  L  +H+ R ++HRD+K +N+ +   G +K+ DFG S     S  +    +F GT  Y
Sbjct: 179 VLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV---ESP 289
           ++PE      Y   +D+WSLG+++ E      P+         PS  E+++ ++     P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPF-------KGPSQREIMQQVLYGKYDP 290

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
            P            + +   + K+P  R ++  LL   F+K
Sbjct: 291 FPCPVSSGMK----ALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 34/270 (12%)

Query: 73  KVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           KVIG G  G V   R K  G+     A+K ++    ++ R   + E  I       +++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 130 CYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLH 182
                   GV++      ++ EYM+ GSL   +R+         L  + + +  G+ YL 
Sbjct: 70  LE------GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL- 122

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG--TYNYMSPERISG 240
           +E + +HRD+   N+LVN     K++DFG+S  L  S     T  G     + +PE I+ 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 241 STYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPD 296
             +  +SD+WS G+V+ E  + G  PY    +Q       ++++A+ +    PPP   P 
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGYRLPPPMDCPS 235

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                    +  C QKD  +R +   ++S 
Sbjct: 236 ALY----QLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 12/224 (5%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQC 124
           L+  + +K IG G+ G+V       +G   A+K +    Q +   K+  +EL + +    
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 125 SHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            +++   + F     +       LV+E MD  +L  +I     +    ++ +  Q+L G+
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGI 136

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            +LH+   +IHRD+KPSN++V     +KI DFG+ A    +      +V T  Y +PE I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
            G  Y  + DIWS+G ++ E   G   +  ++    W    E L
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 30/165 (18%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           Q+  G+ YLH    VIH+DI   N +++ + +VKITD  +S         RD F   Y+ 
Sbjct: 125 QIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALS---------RDLFPMDYHC 174

Query: 232 ----------YMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYE 280
                     +M+ E +    Y  +SD+WS G+++ E   +G+ PY++ +  +       
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MAA 230

Query: 281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
            L+       P   PD    E  + ++ C   DP +R S   L+ 
Sbjct: 231 YLKDGYRLAQPINCPD----ELFAVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 14/143 (9%)

Query: 136 HNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-----------VVCKQVLQGLVYLHNE 184
           H  +I+L+  Y  + ++  ++ + K  L  Y+             + +++L+ L YLH  
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH-G 203

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF--VGTYNYMSPERISGST 242
           R +IHRD+K  N+ ++      + DFG +  L +       +   GT    SPE ++   
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263

Query: 243 YDYSSDIWSLGLVVLECAIGRFP 265
           Y   +DIWS GLV+ E ++    
Sbjct: 264 YCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 29/188 (15%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
           Q+L+GL Y+H+   +IHRD+KPSN+ VN   E++I DFG++      M     +V T  Y
Sbjct: 126 QLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM---TGYVATRWY 181

Query: 233 MSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ-------QSWPSFYELL 282
            +PE  ++   Y+ + DIWS+G ++ E   G+  FP     DQ          PS  E+L
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS-PEVL 240

Query: 283 EAI--------VESPPPTAPPDQFS------PEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
           + I        ++S P     D         P     +   +  D   R S+ + L+HP+
Sbjct: 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Query: 329 IKKFEDKD 336
             ++ D +
Sbjct: 301 FSQYHDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 157 RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
            +++ +    +  V +Q+L  + Y+H E  +IHRDIK  N+LVN   ++ + DFG +   
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACF- 309

Query: 217 GSSMGQRDT-----FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
             + G   T       GT +  +PE ++G  Y  S DIWS GLV+ E A+
Sbjct: 310 --ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV 357

Length = 461

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 64/289 (22%), Positives = 126/289 (43%), Gaps = 49/289 (16%)

Query: 73  KVIGKGS-GGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHV 127
           K +G+G  G VV+    +  GR      A+K+++ N      + ++ E  + +     HV
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYL-----------------AVV 170
           +  Y +   +G + L++EY   GSL   +R+ + +   YL                 A+ 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 171 CK-------QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR 223
                    Q+ +G+ YL  E  ++HRD+   N+LV    ++KI+DFG+S      + + 
Sbjct: 126 MGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLVAEGRKMKISDFGLS----RDVYEE 180

Query: 224 DTFVG------TYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWP 276
           D++V          +M+ E +    Y   SD+WS G+++ E   +G  PY     ++ + 
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF- 239

Query: 277 SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                   ++++      P+  S E  + +  C +++P  R +  D+  
Sbjct: 240 -------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 58/295 (19%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVG-----RLFALKIIQ----MNIQEEIRKQIVQ 114
           F   +L+ I  +G+G  G V L + K +       L  +K +Q     N+Q E R+++  
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA------ 168
             K++  +    + +C  +  H     ++LEY D G L   +R  K+  E          
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 169 ---VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
               +C Q+  G+ +L N R  +HRD+   N LV+ + EVK++   +S         +D 
Sbjct: 118 QKVALCTQIALGMDHLSNAR-FVHRDLAARNCLVSSQREVKVSLLSLS---------KDV 167

Query: 226 FVGTY----------NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQS 274
           +   Y           +++PE +    +   SD+WS G+++ E    G  P+    D+  
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-- 225

Query: 275 WPSFYELLEAI----VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                E+L  +    +E P P   P +        ++ C   +P+DR S  +L+S
Sbjct: 226 -----EVLNRLQAGKLELPVPEGCPSRLY----KLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 13/184 (7%)

Query: 140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V E+M +GSL D +++   K +  P L  +  Q+  G+ Y+    + IHRD++ +N+
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY-IHRDLRAANI 133

Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      KI DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193

Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPR 315
            E    GR PY    +++      E +E     P P   P+         +  C +KDP 
Sbjct: 194 TELVTKGRVPYPGMVNRE----VLEQVERGYRMPCPQGCPESLH----ELMKLCWKKDPD 245

Query: 316 DRSS 319
           +R +
Sbjct: 246 ERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 69/288 (23%), Positives = 130/288 (45%), Gaps = 41/288 (14%)

Query: 62  FEFSLEDLETIKVIGKGSGGVV------QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQE 115
           +E S E +  ++ +G+GS G+V       +++ +   R+ A+K +  +     R + + E
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFLNE 59

Query: 116 LKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILE----- 164
             + +   C HVV         GV+S      +V+E M  G L   +R ++   E     
Sbjct: 60  ASVMKGFTCHHVVRLL------GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113

Query: 165 --PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
             P L  + +   ++  G+ YL N +  +HRD+   N +V H   VKI DFG++  +  +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 220 MGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWP 276
              R    G     +M+PE +    +  SSD+WS G+V+ E  ++   PY    ++Q   
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--- 229

Query: 277 SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
               +L+ +++       PD         +  C Q +P+ R + L+++
Sbjct: 230 ----VLKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 28/220 (12%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHK--WVGRLFALKI---IQMNIQEEIRKQIVQELKI 118
               +L  +K++G G  G V    HK  W+    ++KI   I+  IQ+   +Q  QE+  
Sbjct: 4   LKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKT-IQDRSGRQTFQEITD 58

Query: 119 NQASQCS----HVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV- 169
           +  +  S    ++V    +C  +      + LV +    GSL D +RQ +  L+P   + 
Sbjct: 59  HMLAMGSLDHAYIVRLLGICPGA-----SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFV 227
            C Q+ +G+ YL  E  ++HR++   N+L+     V+I DFGV+ +L     +       
Sbjct: 114 WCVQIAKGMYYLE-EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
               +M+ E I    Y + SD+WS G+ V E  + G  PY
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 18/118 (15%)

Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-------AMLGSSMG 221
           ++ KQ+L+GL YLH +R +IHRD+K  N+ +N   +V I D G +       A LG    
Sbjct: 161 IIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---- 215

Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY 279
                 GT    +PE ++   Y+  +DIWS G+V+ E     +P    ED  S P  Y
Sbjct: 216 ----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEY 267

Length = 357

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 30/224 (13%)

Query: 67  EDLETIKVIGKGSGGVV--QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQ 123
           ED++   VIG+G+ G V   +++   +    A+K+++    E   +    EL++  +   
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLA--------VVCKQV 174
             +++    +  + G + + +EY   G+L D +R+ + +  +P  A        +  +Q+
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 175 LQ-------GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQR 223
           LQ       G+ YL +E+  IHRD+   N+LV      KI DFG+S      +  +MG+ 
Sbjct: 122 LQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
                   +M+ E ++ S Y   SD+WS G+++ E  ++G  PY
Sbjct: 181 PV-----RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 56/235 (23%), Positives = 95/235 (40%), Gaps = 56/235 (23%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-----------ALKIIQMNIQEEIRKQ 111
           E  L  +  ++ +G+G+ G V      + G L            A+K ++ N + +++++
Sbjct: 1   EIPLSAVRFLEELGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPKVQQE 54

Query: 112 IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL---------------ADII 156
             QE ++    Q  ++V             ++ EY+  G L                   
Sbjct: 55  FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114

Query: 157 RQVKTILEP--YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
             VK+ L+   +L +   Q+  G+ YL +  H +HRD+   N LV     VKI+DFG+S 
Sbjct: 115 ETVKSSLDCSDFLHIAI-QIAAGMEYL-SSHHFVHRDLAARNCLVGEGLTVKISDFGLS- 171

Query: 215 MLGSSMGQRDTFVGTY-----------NYMSPERISGSTYDYSSDIWSLGLVVLE 258
                   RD +   Y            +M PE I    +   SDIWS G+V+ E
Sbjct: 172 --------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 62  FEFSLEDLETIKVIGKGS-GGVVQLVRHKWVGRLF--ALKIIQMNIQEEIRKQIVQELKI 118
           +E   ED+   + IG+G  G V Q V           A+K  +      +R++ +QE  I
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 119 NQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVKTILE-PYLAVVCK 172
            +     H+V         GVI+     +V+E    G L   ++  K  L+   L +   
Sbjct: 61  MRQFDHPHIVKLI------GVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSY 114

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYN 231
           Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S  +   S  +         
Sbjct: 115 QLSTALAYLESKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173

Query: 232 YMSPERISGSTYDYSSDIWSLGLVVLE 258
           +M+PE I+   +  +SD+W  G+ + E
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWE 200

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 55/257 (21%), Positives = 101/257 (39%), Gaps = 62/257 (24%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQL--------------VRHKWVG--RLFALKIIQMNIQE 106
           EF  + L  ++ +G+G  G V L                +       L A+K+++ +  +
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 107 EIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQ---- 158
             R+  ++E+KI       ++     VC         + +++EYM+ G L   +++    
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVD----PPLCMIMEYMENGDLNQFLQKHVAE 116

Query: 159 -------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
                   K++    L  +  Q+  G+ YL    + +HRD+   N LV     +KI DFG
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCLVGKNYTIKIADFG 175

Query: 212 VSAMLGSSMGQRDTFVGTY-----------NYMSPERISGSTYDYSSDIWSLGLVVLE-- 258
           +S         R+ +   Y            +M+ E +    +   SD+W+ G+ + E  
Sbjct: 176 MS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Query: 259 --CAIGRFPYMQSEDQQ 273
             C     PY    DQQ
Sbjct: 227 TLCR--EQPYEHLTDQQ 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 36/232 (15%)

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR----------- 157
           RK   +E ++    Q  H+V  Y        + +V EYM  G L   +R           
Sbjct: 51  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 110

Query: 158 ----QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
               Q K  L    +  +  Q+  G+VYL ++ H +HRD+   N LV     VKI DFG+
Sbjct: 111 GQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 213 SAMLGSSMGQRDTFVGTYN-----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           S  + S+   R   VG +      +M PE I    +   SD+WS G+++ E    G+ P+
Sbjct: 170 SRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP-EFCSFVSACIQKDPRDR 317
            Q  +        E++E I +      P  +  P E    +  C Q++P+ R
Sbjct: 227 FQLSNT-------EVIECITQGRVLERP--RVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 36/236 (15%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR-------LFALKIIQMNIQEEIRKQIVQ 114
           +EFS + L   K +G+G  G V +     + +         A+K+++ +  E+    +V 
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69

Query: 115 ELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY------- 166
           E+++ +   +  +++    +   +G + +++EY  +G+L + +R  +     Y       
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 167 ---------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG 217
                    L     QV +G+ YL +++  IHRD+   N+LV     +KI DFG    L 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQK-CIHRDLAARNVLVTENNVMKIADFG----LA 184

Query: 218 SSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
             +   D +  T N      +M+PE +    Y + SD+WS G+++ E   +G  PY
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 67/288 (23%), Positives = 122/288 (42%), Gaps = 35/288 (12%)

Query: 69  LETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC 124
           L+ I+ +G+G  G V+L R+       G   A+K ++          + +E++I +    
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65

Query: 125 SHVV----VCYHSFYHNGVISLVLEYMDRGSLADII-RQVKTILEPYLAVVCKQVLQGLV 179
            ++V    +C      NG I L++E++  GSL + + R    I          Q+ +G+ 
Sbjct: 66  ENIVKYKGICTED-GGNG-IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMSPE 236
           YL   R  +HRD+   N+LV  + +VKI DFG++  + +       +D       + +PE
Sbjct: 124 YL-GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 237 RISGSTYDYSSDIWSLGLVVLE----CAIGRFPYMQ-------SEDQQSWPSFYELLEAI 285
            +  S +  +SD+WS G+ + E    C     P          +  Q +      +LE  
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE 333
              P P   P++        +  C +  P  R++  +L     I+ FE
Sbjct: 243 KRLPRPPNCPEEVY----QLMRKCWEFQPSKRTTFQNL-----IEGFE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 9e-11
 Identities = 57/256 (22%), Positives = 115/256 (44%), Gaps = 25/256 (9%)

Query: 75  IGKGSGGVVQ--LVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV--- 128
           +G G+ G V+  + + K   +  A+KI++  N    ++ ++++E  + Q     ++V   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 129 -VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
            +C    +      LV+E  + G L   +++ K + E  +  +  QV  G+ YL  E + 
Sbjct: 63  GICEAESW-----MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETNF 116

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---QRDTFVGTYNYMSPERISGSTYD 244
           +HRD+   N+L+  +   KI+DFG+S  LG+       +        + +PE ++   + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 245 YSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
             SD+WS G+++ E  + G+ PY   +  +        +  ++ES      P +  PE  
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGERMECPQRCPPEMY 228

Query: 304 SFVSACIQKDPRDRSS 319
             +  C      +R  
Sbjct: 229 DLMKLCWTYGVDERPG 244

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 31/158 (19%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV QG+ +L   ++ IHRD+   N+L+      KI DFG    L   +     +V   N 
Sbjct: 220 QVAQGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDFG----LARDIMNDSNYVVKGNA 274

Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPS------FY 279
                +M+PE I    Y   SD+WS G+++ E  ++G+ PY         P       FY
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY---------PGILVNSKFY 325

Query: 280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           ++    V+     + PD   PE  S +  C   +P +R
Sbjct: 326 KM----VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 36/204 (17%)

Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++   +  +R++   E  +    Q  ++V           +S++  Y     L + 
Sbjct: 39  AIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF 98

Query: 156 I---------------RQVKTILEP--YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +               + VK+ LEP  ++ +V  Q+  G+ +L +  HV+H+D+   N+L
Sbjct: 99  LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV-TQIAAGMEFL-SSHHVVHKDLATRNVL 156

Query: 199 VNHKGEVKITDFGV---------SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           V  K  VKI+D G+           ++G+S+           +MSPE I    +   SDI
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLL-------PIRWMSPEAIMYGKFSIDSDI 209

Query: 250 WSLGLVVLEC-AIGRFPYMQSEDQ 272
           WS G+V+ E  + G  PY    +Q
Sbjct: 210 WSYGVVLWEVFSYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 30/223 (13%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLF--ALKIIQMNIQEEIRKQIVQELKI-NQASQC 124
           D++   VIG+G+ G V   R K  G     A+K ++    ++  +    EL++  +    
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLAVV------------- 170
            +++    +  H G + L +EY   G+L D +R+ + +  +P  A+              
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 171 --CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQRD 224
                V +G+ YL +++  IHRD+   N+LV      KI DFG+S      +  +MG+  
Sbjct: 128 HFAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
                  +M+ E ++ S Y  +SD+WS G+++ E  ++G  PY
Sbjct: 187 V-----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 48/211 (22%)

Query: 142 LVLEYMDRGSLADIIRQVKTILE-PY------LAVVCKQVLQGLVYLHNERHVIHRDIKP 194
           ++LE M  G L   +R+ +   E P       L    + V +G  YL  E H IHRDI  
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAA 144

Query: 195 SNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTY-----------NYMSPERISG 240
            N L+  KG     KI DFG++         RD +  +Y            +M PE    
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKGGRAMLPIKWMPPEAFLD 195

Query: 241 STYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPP 295
             +   +D+WS G+++ E  ++G  PY    +Q       E++E +       PP   P 
Sbjct: 196 GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFVTGGGRLDPPKGCPG 248

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
             +       ++ C Q  P DR +   +L  
Sbjct: 249 PVY-----RIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 29/202 (14%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALK--------IIQMNIQEEIRKQIVQELKINQASQ 123
           +  IG+G+   V   + +  G+ +A+K        + Q+N   EI  Q ++ L       
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREI--QALRRLS------ 55

Query: 124 CSHV-VVCYHSFYH---NGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGL 178
             H  ++           G ++LV E MD  +L ++I+  K  L E  +     Q+L+ L
Sbjct: 56  -PHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 179 VYLHNERH-VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
            ++H  R+ + HRDIKP N+L+     +K+ DFG S     S      ++ T  Y +PE 
Sbjct: 114 DHMH--RNGIFHRDIKPENILI-KDDILKLADFG-SCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 238 I-SGSTYDYSSDIWSLGLVVLE 258
           + +   Y    DIW++G V  E
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFE 191

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 2/90 (2%)

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-TFVG 228
           + KQ+L  + Y+H+++ +IHRDIK  N+ +N  G++ + DFG +          D  +VG
Sbjct: 272 IMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           T    SPE ++G  Y   +DIWS GL++L+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLD 360

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 36/195 (18%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-VKITDFGVSAMLGSSMGQRD-TFVGTY 230
           Q+ + L Y+H+ + + HRD+KP NLL++     +K+ DFG +  L +  GQR  +++ + 
Sbjct: 178 QLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA--GQRSVSYICSR 234

Query: 231 NYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQ------------------SED 271
            Y +PE + G+T Y    D+WSLG ++ E  +G +P                     +ED
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTED 293

Query: 272 QQSW--PSFYELLEAIVESPP-----PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
           Q     P++ ++    V+        P   PD    +  +F+S  ++ +P  R + ++ L
Sbjct: 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD----DAINFISQFLKYEPLKRLNPIEAL 349

Query: 325 SHPFIKKFEDKDIDL 339
           + PF     D  I L
Sbjct: 350 ADPFFDDLRDPCIKL 364

Length = 440

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 40/239 (16%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVG---------RLFALKIIQMNIQEEIRKQ 111
            +EF  + L   K +G+G  G  Q+VR +  G            A+K+++ N  ++    
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFG--QVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD 63

Query: 112 IVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-----------QV 159
           ++ E+++ +   +  +++         G + +++EY  +G+L + +R            +
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 160 KTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
             + E  L+    V C  QV +G+ YL + R  IHRD+   N+LV     +KI DFG   
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CIHRDLAARNVLVTEDNVMKIADFG--- 179

Query: 215 MLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            L   +   D +  T N      +M+PE +    Y + SD+WS G+++ E   +G  PY
Sbjct: 180 -LARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 36/117 (30%), Positives = 54/117 (46%), Gaps = 19/117 (16%)

Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL----------VNHKG------EVKITD 209
           +LA +  Q    L Y H E H++H D+KP N+L          V ++        V+I D
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
            G           R   V T +Y SPE + G  + YS+D+WS+G ++ E   G+  Y
Sbjct: 292 LGGCC---DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345

Length = 467

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 57/240 (23%), Positives = 106/240 (44%), Gaps = 30/240 (12%)

Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  + ++ +E++ + + E +I +     ++V           I +V+E +  G     
Sbjct: 23  AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSF 82

Query: 156 IRQVKTILEPYLAVVCKQVLQ-------GLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
           +R+ K  L+       KQ+++       G+ YL + ++ IHRD+   N LV     +KI+
Sbjct: 83  LRKKKDELK------TKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKIS 135

Query: 209 DFGVSAM----LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGR 263
           DFG+S      + SS G +   +    + +PE ++   Y   SD+WS G+++ E  ++G 
Sbjct: 136 DFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVWSYGILLWETFSLGV 192

Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
            PY    +QQ+     E +E       P   PD         +  C    P +R    +L
Sbjct: 193 CPYPGMTNQQA----REQVEKGYRMSCPQKCPDDVY----KVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 74  VIGKGSGGVV--QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
           VIG+G+ G V    ++   +    A+K ++    ++  +    EL++  +     +++  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLA--------VVCKQVLQ----- 176
             +  H G + L +EY   G+L D +R+ + +  +P  A        +  +Q+L      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 177 --GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQRDTFVGTY 230
             G+ YL +++  IHRD+   N+LV      KI DFG+S      +  +MG+        
Sbjct: 122 ARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV----- 175

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
            +M+ E ++ S Y  +SD+WS G+++ E  ++G  PY
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 11/123 (8%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAMLGS---SMGQRDT 225
           Q+L G+ YLH    V+HRD+KP+N+LV      +G VKI D G + +  S    +   D 
Sbjct: 116 QILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 226 FVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELL 282
            V T+ Y +PE + G+  Y  + DIW++G +  E       F   Q + + S P  ++ L
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234

Query: 283 EAI 285
           + I
Sbjct: 235 DRI 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 12/183 (6%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQ---ELKINQASQCS 125
              IK +G G+ G V L R      L+A+K ++      +R Q+     E  I   +   
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEADNE 61

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
            VV  Y+SF     +  V++Y+  G +  ++ ++    E        ++   +  +H + 
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH-KM 120

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
             IHRDIKP N+L++  G +K+TDFG+        G R T    Y Y S + +   + D+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCT------GFRWTHDSKY-YQSGDHVRQDSMDF 173

Query: 246 SSD 248
           S++
Sbjct: 174 SNE 176

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 11/123 (8%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAMLGS---SMGQRDT 225
           Q+L G+ YLH    V+HRD+KP+N+LV      +G VKI D G + +  S    +   D 
Sbjct: 116 QILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 226 FVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELL 282
            V T+ Y +PE + G+  Y  + DIW++G +  E       F   Q + + S P  ++ L
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234

Query: 283 EAI 285
           + I
Sbjct: 235 DRI 237

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 60/246 (24%), Positives = 113/246 (45%), Gaps = 43/246 (17%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVG---------RLFALKIIQMNI 104
           P+D K   +E S   L   K +G+G  G  Q+V  + +G            A+K+++ + 
Sbjct: 2   PADPK---WELSRTRLTLGKPLGEGCFG--QVVMAEAIGIDKDKPNKPVTVAVKMLKDDA 56

Query: 105 QEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL 163
            ++    +V E+++ +   +  +++    +   +G + +++EY  +G+L + +R  +   
Sbjct: 57  TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116

Query: 164 EPYLAVVCK----------------QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             Y    CK                QV +G+ YL +++  IHRD+   N+LV     +KI
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNVLVTEDNVMKI 175

Query: 208 TDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
            DFG    L   +   D +  T N      +M+PE +    Y + SD+WS G+++ E   
Sbjct: 176 ADFG----LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Query: 261 IGRFPY 266
           +G  PY
Sbjct: 232 LGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 19/159 (11%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + R  IHRD+   N+L++    VKI DFG    L   + +   +V   + 
Sbjct: 182 QVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGSA 236

Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAI 285
                +M+PE I    Y   SD+WS G+++ E  ++G  PY   +  +      E  + +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRL 290

Query: 286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
            +     A P+  +PE    + AC Q DP++R +   L+
Sbjct: 291 KDGTRMRA-PENATPEIYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 25/157 (15%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 222 QVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARDIRNDSNYVVKGNA 276

Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+++ E  ++G  PY  M  + +     FY+++ 
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIK 331

Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS 319
           E      P  AP + +       + +C   DP  R +
Sbjct: 332 EGYRMLSPECAPSEMY-----DIMKSCWDADPLKRPT 363

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K+++   ++ +R ++++E +I       ++V    VC         + LV+E    G 
Sbjct: 26  AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EAEALMLVMEMASGGP 80

Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L   +   K  I    +  +  QV  G+ YL   ++ +HRD+   N+L+ ++   KI+DF
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKISDF 139

Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G+S  LG   S    R        + +PE I+   +   SD+WS G+ + E  + G+ PY
Sbjct: 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Query: 267 --MQSEDQQSWPSFYELLEAIVESPP 290
             M+  +  S+    + L+   E PP
Sbjct: 200 KKMKGPEVMSFIEQGKRLDCPAECPP 225

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 29/166 (17%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG---- 228
           QV +G+ +L + R  IHRD+   N+L++    VKI DFG++         RD +      
Sbjct: 187 QVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLA---------RDIYKDPDYV 236

Query: 229 -------TYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYE 280
                     +M+PE I    Y   SD+WS G+++ E  ++G  PY   +  +      E
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------E 290

Query: 281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
               + E     A PD  +PE    +  C   +P  R +  +L+ H
Sbjct: 291 FCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 33/168 (19%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG---- 228
           QV +G+ +L + R  IHRD+   N+L++    VKI DFG++         RD +      
Sbjct: 181 QVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLA---------RDIYKDPDYV 230

Query: 229 -------TYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSF 278
                     +M+PE I    Y   SD+WS G+++ E  ++G  PY  +Q +++     F
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----F 285

Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
              L+           P+  +PE  S +  C   +P DR +  +L+  
Sbjct: 286 CRRLKEGTR----MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 53/263 (20%)

Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDR 149
           L A+K+++ +  +  R   ++E+KI    +  +++    VC  S      + ++ EYM+ 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS----DPLCMITEYMEN 103

Query: 150 GSL-----------ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           G L           A     V TI    L  +  Q+  G+ YL +  + +HRD+   N L
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL-SSLNFVHRDLATRNCL 162

Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY-----------NYMSPERISGSTYDYSS 247
           V     +KI DFG+S         R+ + G Y            +MS E I    +  +S
Sbjct: 163 VGKNYTIKIADFGMS---------RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213

Query: 248 DIWSLGLVVLE----CAIGRFPYMQSEDQQ---SWPSFYELLEAIVESPPPTAPPDQFSP 300
           D+W+ G+ + E    C     PY Q  D+Q   +   F+      V  P P   PD    
Sbjct: 214 DVWAFGVTLWEILTLCK--EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY- 270

Query: 301 EFCSFVSACIQKDPRDRSSSLDL 323
                + +C +++ ++R S  ++
Sbjct: 271 ---KLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 27/257 (10%)

Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K+++ ++ +  R   ++E+KI    +  +++        +  + ++ EYM+ G L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 154 DIIRQ------------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
             + Q            + ++    L  +  Q+  G+ YL +  + +HRD+   N LV +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNCLVGN 164

Query: 202 KGEVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
              +KI DFG+S  L S    R     V    +M+ E I    +  +SD+W+ G+ + E 
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Query: 260 AI--GRFPYMQSEDQQSWPSFYELLEA----IVESPPPTAPPDQFSPEFCSFVSACIQKD 313
                  PY    D+Q   +  E        I  S  P  P    SP F   +  C  +D
Sbjct: 225 FTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP----SPVF-KLMMRCWSRD 279

Query: 314 PRDRSSSLDLLSHPFIK 330
            +DR  + + + H   +
Sbjct: 280 IKDR-PTFNKIHHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 46/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)

Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 54  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113

Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 172

Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 173 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228

Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 229 GVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 41/251 (16%)

Query: 101 QMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISL------------- 142
           Q+N  + I K  V+ +KI   ++          VC   F H  V+ L             
Sbjct: 19  QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78

Query: 143 -----VLEYMDRGSLADIIRQVKTILEP------YLAVVCKQVLQGLVYLHNERHVIHRD 191
                +L +M  G L   +   +    P       L      +  G+ YL ++   IHRD
Sbjct: 79  PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-FIHRD 137

Query: 192 IKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           +   N ++N    V + DFG+S  +  G    Q         +++ E ++   Y   SD+
Sbjct: 138 LAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197

Query: 250 WSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA 308
           WS G+ + E A  G+ PY   E+        E+ + + +      PPD     + S +S+
Sbjct: 198 WSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGNRLKQPPDCLDGLY-SLMSS 249

Query: 309 CIQKDPRDRSS 319
           C   +P+DR S
Sbjct: 250 CWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS--AMLGSSMGQRDTFVGTY 230
           QV +G+ +L + ++ +HRD+   N+L+     VKI DFG++   M  S+   + +     
Sbjct: 245 QVARGMEFLAS-KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELLEAIVE 287
            +M+PE I  + Y   SD+WS G+++ E  ++G  PY  M  +      +FY      ++
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----TFYNK----IK 354

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
           S    A PD  + E    +  C   +P  R S L L
Sbjct: 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 53/272 (19%)

Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+KI++ +  +  R   ++E+KI    +  +++           + ++ EYM+ G L 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 154 DIIR-------------------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKP 194
             +                     +  I    L  V  Q+  G+ YL +  + +HRD+  
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-SSLNFVHRDLAT 166

Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY-----------NYMSPERISGSTY 243
            N LV     +KI DFG+S         R+ + G Y            +M+ E I    +
Sbjct: 167 RNCLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217

Query: 244 DYSSDIWSLGLVVLECAI--GRFPYMQSEDQQSWPSFYELL----EAIVESPPPTAPPDQ 297
             +SD+W+ G+ + E  +     PY +  D+Q   +  E        +    PP  P   
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGL 277

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           +       +  C  +D R+R S  D+  H F+
Sbjct: 278 Y-----ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGT 229
           Q+  G+ YL +    +H+D+   N+L+  +  VKI+D G+S  + S+     Q  + +  
Sbjct: 132 QIAAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-P 189

Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES 288
             +M PE I    +   SDIWS G+V+ E  + G  PY    +Q       E++E + + 
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVIEMVRKR 242

Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                  D   P   S ++ C Q+ P  R    D+
Sbjct: 243 QLLPCSED-CPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 40/202 (19%)

Query: 138 GVIS------LVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHR 190
           GVI+      +V EYM  G+L   +R+ +  L    L  +   +  G+ YL +E   +H+
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL-SEMGYVHK 131

Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS---------PERISGS 241
            +    +LVN     KI+ F           Q D     Y  MS         PE I   
Sbjct: 132 GLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 242 TYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
            +  +SD+WS G+V+ E  + G  PY     Q       ++++A+ +    P P   P  
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFRLPAPRNCP-- 234

Query: 298 FSPEFCSFVSACIQKDPRDRSS 319
                   +  C QK+  +R  
Sbjct: 235 --NLLHQLMLDCWQKERGERPR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 32/253 (12%)

Query: 83  VQLVRHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY-HNGVI 140
           V LV      + F LK + + +     R  I+          C   +VC H +      +
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYSRERLTII--------PHCVPNMVCLHKYIVSEDSV 60

Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
            LVL++ + G L   I +   I E  +     +++  L  LH E  ++ RD+ P+N+L++
Sbjct: 61  FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLD 119

Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            +G +++T F   + +  S    D       Y +PE    S    + D WSLG ++ E  
Sbjct: 120 DRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR--- 317
            G+             +  E   + + +      P+  S E  S +   +Q +P +R   
Sbjct: 177 TGK-------------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 318 --SSSLDLLSHPF 328
             +   D+ SHPF
Sbjct: 224 GVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 47/158 (29%)

Query: 133 SFYHNGVISL-------------VLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQ 173
            F H  V+SL             VL YM  G L + IR       VK ++   L     Q
Sbjct: 52  DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-----Q 106

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--- 230
           V +G+ YL +++ V HRD+   N +++    VK+ DFG++         RD +   Y   
Sbjct: 107 VAKGMEYLASKKFV-HRDLAARNCMLDESFTVKVADFGLA---------RDIYDKEYYSV 156

Query: 231 ----------NYMSPERISGSTYDYSSDIWSLGLVVLE 258
                      +M+ E +    +   SD+WS G+++ E
Sbjct: 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 25/44 (56%), Positives = 30/44 (68%), Gaps = 1/44 (2%)

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
           V +QVL GL  LH    ++HRDIKP NLLV   G+VKI DFG +
Sbjct: 314 VMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 18/187 (9%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL------QGLVYLHNERHVIHRDIKPS 195
           ++L +M  G L   +   +    P    +   +        G+ YL N R+ IHRD+   
Sbjct: 84  VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAAR 142

Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLG 253
           N ++     V + DFG+S  + S    R   +      +++ E ++   Y   SD+W+ G
Sbjct: 143 NCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202

Query: 254 LVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK 312
           + + E A  G+ PY   E+ +     Y+ L        P    D    E    + +C + 
Sbjct: 203 VTMWEIATRGQTPYPGVENHE----IYDYLRHGNRLKQPEDCLD----ELYDLMYSCWRA 254

Query: 313 DPRDRSS 319
           DP+DR +
Sbjct: 255 DPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 4/97 (4%)

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS--AMLGSSMGQRDTFVGTY 230
           QV  G+ +L + ++ +HRD+   N+L+     VKI DFG++   M  S+   + +     
Sbjct: 247 QVANGMEFLAS-KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +M+PE I  + Y   SD+WS G+++ E   +G  PY
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 18/193 (9%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPY------LAVVCKQVLQGLVYLHNERHVIHRDIKPS 195
           ++L +M  G L   +   +   EP+      L      +  G+ YL + ++ IHRD+   
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAAR 142

Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLG 253
           N ++N    V + DFG+S  + S    R          +++ E ++ + Y   SD+W+ G
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202

Query: 254 LVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK 312
           + + E    G+ PY   E+        E+   +++      PPD    +    +  C   
Sbjct: 203 VTMWEIMTRGQTPYAGVENS-------EIYNYLIKGNRLKQPPDCLE-DVYELMCQCWSP 254

Query: 313 DPRDRSSSLDLLS 325
           +P+ R S   L  
Sbjct: 255 EPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +  +I +++K   +  +  + K +L  L Y+H E  + H DIKP N++V+      I D+
Sbjct: 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNNRGYIIDY 170

Query: 211 GVSAM-------LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
           G+++        +  S  Q+D   GT  Y   +  +G+      D+ SLG  +L+ A  +
Sbjct: 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230

Query: 264 FPY 266
            P+
Sbjct: 231 LPW 233

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 24/151 (15%)

Query: 142 LVLEYMDRGSLADIIR--QVKTILEPYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSN 196
           LVLE+   G L + +R  +          V+ +   +V  GL++LH +   IH D+   N
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRN 130

Query: 197 LLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------YNYMSPE-------RISGSTY 243
             +     VKI D+G    L       D ++          +++PE        +     
Sbjct: 131 CQLTADLSVKIGDYG----LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186

Query: 244 DYSSDIWSLGLVVLECA-IGRFPYMQSEDQQ 273
              S+IWSLG+ + E       PY    D+Q
Sbjct: 187 TKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 14/188 (7%)

Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +SL+LEY  RG L +++ + K +       +     +GL  L+   +  ++++   + LV
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVL 257
               ++KI   G+  +L S   +    V    Y S + ++   S Y    DI+SLG+V+ 
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213

Query: 258 ECAIGRFPYMQSEDQQSWPSFYELL-EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRD 316
           E   G+ P+    +  +    Y+L+         P   P     E    V AC   D   
Sbjct: 214 EIFTGKIPF----ENLTTKEIYDLIINKNNSLKLPLDCPL----EIKCIVEACTSHDSIK 265

Query: 317 RSSSLDLL 324
           R +  ++L
Sbjct: 266 RPNIKEIL 273

Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 15/115 (13%)

Query: 225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS---EDQQSWPSFYEL 281
           + VGT NY++PE +  + Y    D WS+G+++ E  +G+ P++     E Q    ++   
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS 266

Query: 282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKFE 333
           L       PP A   + SPE    +   + + P DR   + + ++ +HPF K  +
Sbjct: 267 LHI-----PPQA---KLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 28/124 (22%)

Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMG-QRDTFVGT 229
           +Q+L  L  LH+   ++HRD+KP N++ +   G  KI D G +A L   +      F+  
Sbjct: 262 RQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD 320

Query: 230 YNYMSPERISGSTYDYSS----------------------DIWSLGLVVLECAIGRFPYM 267
             Y +PE+   ST   S+                      DI+S GL+ L+ A   FP +
Sbjct: 321 PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA---FPNL 377

Query: 268 QSED 271
           +S+ 
Sbjct: 378 RSDS 381

Length = 566

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.3 bits (90), Expect = 0.002
 Identities = 19/73 (26%), Positives = 38/73 (52%), Gaps = 6/73 (8%)

Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
            +V+EY++   L D+I             + + V  G   LH+   +IH D+  SN++++
Sbjct: 75  IIVMEYIEGEPLKDLINSNGMEELELSREIGRLV--GK--LHS-AGIIHGDLTTSNMILS 129

Query: 201 HKGEVKITDFGVS 213
             G++ + DFG++
Sbjct: 130 -GGKIYLIDFGLA 141

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	354
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG1243	690	consensus Protein kinase [General function predict	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
KOG3087	229	consensus Serine/threonine protein kinase [General	99.37
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.06
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.01
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.94
PRK09902	216	hypothetical protein; Provisional	98.85
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.84
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.79
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.28
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
KOG2270	520	consensus Serine/threonine protein kinase involved	98.23
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.14
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.79
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PRK05231	319	homoserine kinase; Provisional	97.78
PRK10593	297	hypothetical protein; Provisional	97.73
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.71
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.39
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.36
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.26
PLN02236	344	choline kinase	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.85
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.84
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.8
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.75
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.71
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.44
PRK06148	1013	hypothetical protein; Provisional	96.37
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.22
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.18
PLN02756	418	S-methyl-5-thioribose kinase	96.17
PRK12396	409	5-methylribose kinase; Reviewed	95.96
PRK11768	325	serine/threonine protein kinase; Provisional	95.73
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.69
PTZ00384	383	choline kinase; Provisional	95.5
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.17
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.99
PRK10271	188	thiK thiamine kinase; Provisional	94.84

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-69  Score=469.72  Aligned_cols=330  Identities=51%  Similarity=0.804  Sum_probs=284.9

Q ss_pred             CCCcccccccCCceecCCeeeccCCccccccccCCCCCCCcccccccCcccccccccccccCceEEEEEEEccCCcEEEE
Q 018532           18 ETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFAL   97 (354)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vai   97 (354)
                      ...++...+..++++..+...++...............+.++.+..+..++++.++.||+|..|+||+|+|+.|++.+|+
T Consensus        30 ~~~ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~Al  109 (364)
T KOG0581|consen   30 SAILSARDTLPSTSESLELTDNSPPLSKISLSSSSANSELSEDDNGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYAL  109 (364)
T ss_pred             cccccccccCCccccccccccccccccccccccccccccccccccccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEE
Confidence            34444444455555555444444433333322222222222235567788999999999999999999999999999999


Q ss_pred             EEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHH
Q 018532           98 KIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQ  176 (354)
Q Consensus        98 K~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~  176 (354)
                      |++..+.+...++++.+|+++++..+||+||.+|++|..++ .++++||||+||+|..++...+.++|.....++.+++.
T Consensus       110 K~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~  189 (364)
T KOG0581|consen  110 KVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLR  189 (364)
T ss_pred             EeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence            99988889999999999999999999999999999999999 59999999999999999999899999999999999999


Q ss_pred             HHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHH
Q 018532          177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV  256 (354)
Q Consensus       177 ~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  256 (354)
                      ||.|||.+++||||||||+|||++..|+|||||||.+..+.+.  ...+++||..|||||.+.+..|+.++||||||+++
T Consensus       190 GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsl  267 (364)
T KOG0581|consen  190 GLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSL  267 (364)
T ss_pred             HHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHH
Confidence            9999996699999999999999999999999999999988665  56788999999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       257 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +|+++|++||...  .+.+..+.+++..+..+.++..+...+|+++++|+..||++||.+|||+.|+++|||+++....+
T Consensus       268 lE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  268 LELAIGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            9999999999776  34456788999999998877776667999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCCCC
Q 018532          337 IDLGILVGSLDPPVN  351 (354)
Q Consensus       337 ~~~~~~~~~~~~~~~  351 (354)
                      +++..|+..+.+|..
T Consensus       346 vd~~~~~~~~~~~~~  360 (364)
T KOG0581|consen  346 VDMASFVRKALSPPR  360 (364)
T ss_pred             ccHHHHHHHhcccCC
Confidence            998889988877765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-62  Score=426.85  Aligned_cols=279  Identities=29%  Similarity=0.493  Sum_probs=252.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|+++++||+|+||+|+.++.++|++.||+|++++..  .....+....|..|+..++||+||.++..|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            45789999999999999999999999999999999997654  2335678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +|+||+.||.|...|++.+.++++.++.++.+|+.||.|||+ .|||||||||+|||+|.+|+++|+|||+|+.......
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999998 9999999999999999999999999999998777767


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...++|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+..       +..+.+.... ....+..++.+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~~~~~I~~~k-~~~~p~~ls~~  252 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------KMYDKILKGK-LPLPPGYLSEE  252 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------HHHHHHhcCc-CCCCCccCCHH
Confidence            778899999999999999999999999999999999999999999887654       4455555554 23344558999


Q ss_pred             HHHHHHHhhhhCCCCCC----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRS----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rp----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      ++++++++|+.||++|.    ++.+|-+||||+.++|+++......+|+.|-+.
T Consensus       253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~  306 (357)
T KOG0598|consen  253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVT  306 (357)
T ss_pred             HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCC
Confidence            99999999999999996    688999999999999999988788787777554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-61  Score=425.66  Aligned_cols=260  Identities=30%  Similarity=0.457  Sum_probs=229.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH------HHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .+.|.+.+.||+|+||.|-+|..+.||+.||||++++.....      ....+.+|++++++++|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            467788999999999999999999999999999997653221      22336799999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeeccccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAML  216 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~  216 (354)
                      .|+||||++||+|.+.+-.++.+.+...+.+++|++.|+.|||+ +||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999999999999999999999999999999998 999999999999999877   57999999999988


Q ss_pred             CCCcCCCcccccCCcccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      + ......+.||||.|.|||++.+..   +..++|||||||+||.+++|.+||.......      .+.+++..+.....
T Consensus       330 g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  330 G-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKGRYAFG  402 (475)
T ss_pred             c-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcCccccc
Confidence            7 457778899999999999998865   3347899999999999999999998765543      24566777765544


Q ss_pred             --CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          294 --PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       294 --~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                        .+..++++..+||.+||..||++|||++|+|+||||+...
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence              4567999999999999999999999999999999999665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-59  Score=398.08  Aligned_cols=274  Identities=30%  Similarity=0.510  Sum_probs=248.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ..+++|+.++.||.|+||.|.+++++.+|..||+|++++..  .-...+...+|.++++.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56789999999999999999999999999999999997654  2345567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||.+||.|..++++.+++++..++.++.||+.||+|||+ ++|++|||||+|||+|.+|.+||+|||+|+.+...  
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            999999999999999999999999999999999999999998 99999999999999999999999999999987543  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                       ..+.||||.|+|||++..+.|+.++|+||||+++|||+.|.+||...++.       .+.++|..+..  ..|..++++
T Consensus       198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v--~fP~~fs~~  267 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKV--KFPSYFSSD  267 (355)
T ss_pred             -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcc--cCCcccCHH
Confidence             56789999999999999999999999999999999999999999887654       55666766643  346788999


Q ss_pred             HHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      +.+||+++|+.|-.+|.     ...+|..||||+.+.|.++.....-.|+.||.
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~  321 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPN  321 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCcc
Confidence            99999999999999993     56789999999999999998778888888754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-59  Score=431.68  Aligned_cols=255  Identities=30%  Similarity=0.524  Sum_probs=234.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .+|+..+.||+|||+.||.+++..+|..||+|++.+..  ....+..+.+|++|.+.++|+|||+++++|++.+++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            57999999999999999999999999999999998653  3456788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+|..++|.+++++.+.++|.+++++++||+.||.|||+ .+|+|||||..|++++++.+|||+|||+|+.+..+.....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            999999999999998999999999999999999999998 8899999999999999999999999999999998888888


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      +.||||.|.|||++....++..+||||+||++|.||+|++||....       ..+....+.....  ..|..++.++.+
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y--~~P~~ls~~A~d  247 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEY--SMPSHLSAEAKD  247 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCc--ccccccCHHHHH
Confidence            9999999999999999999999999999999999999999997553       3355555555543  345589999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ||.++|+.||.+|||+++||.|+||+.
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999999999943

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.5e-58  Score=414.96  Aligned_cols=280  Identities=29%  Similarity=0.502  Sum_probs=241.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|+++++||+|+||.||+|+.+.||..||+|+++++.  .....+.+..|-.+|....++.||++|.+|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            567899999999999999999999999999999999998764  345667899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC-
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  219 (354)
                      ||||||++||++..+|.+.+.+++..++.++.+++.|++-||+ .|+|||||||+|+|||..|++||+|||+|.-+... 
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999999999999999999999999999999999998 99999999999999999999999999998543110 


Q ss_pred             ----------------------cC----C--------------------CcccccCCcccccccccCCCCCcchhHHHHH
Q 018532          220 ----------------------MG----Q--------------------RDTFVGTYNYMSPERISGSTYDYSSDIWSLG  253 (354)
Q Consensus       220 ----------------------~~----~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  253 (354)
                                            ..    .                    ..+.+|||.|||||++.+..|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                  00    0                    1235799999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCcccc
Q 018532          254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIK  330 (354)
Q Consensus       254 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~  330 (354)
                      ||+||||.|-+||.+.++.+.+..+......+     .......+++++.|||.+||. ||++|..   ++||.+||||+
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK  449 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence            99999999999999998886655544332222     222234578999999999999 9999986   89999999999


Q ss_pred             ccccccccccccccCCCCCCC
Q 018532          331 KFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      .+.|..+.-  ..+|+-|-++
T Consensus       450 ~v~W~~l~~--~~apfvP~v~  468 (550)
T KOG0605|consen  450 GVDWDHLRE--MPAPFVPQVN  468 (550)
T ss_pred             cCCcchhhc--CCCCCCCCCC
Confidence            999999853  2355555554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=413.24  Aligned_cols=265  Identities=29%  Similarity=0.526  Sum_probs=234.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      ....+||...+.||.|+|++|++|+++.+++.||||++.+..-  +.-.+.+..|-.+|..| .||.|+++|..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3467899999999999999999999999999999999876532  22234567777788888 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+|+||+++|+|.++|++.+.+.+..+++++.||+.||+|||+ +|||||||||+|||+|++|++||+|||.|..+...
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999998 99999999999999999999999999999877532


Q ss_pred             cC-------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          220 MG-------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       220 ~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ..             ...+++||..|.+||++.++..+..+|+|+|||+||+|+.|.+||.+.++.       .+++.++
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqkI~  300 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQKIQ  300 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHHHH
Confidence            11             125689999999999999999999999999999999999999999887654       3444444


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      .-.  ...+..+++.+.+||+++|..||++|+|+.+|.+||||..+.|+++
T Consensus       301 ~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  301 ALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             Hhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            433  3345678999999999999999999999999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-58  Score=387.18  Aligned_cols=251  Identities=33%  Similarity=0.568  Sum_probs=227.4

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeee-eeeecCe-
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYH-SFYHNGV-  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~-~~~~~~~-  139 (354)
                      ...+.+|+++++||+|.||+||++++..+|..+|.|.++... +...++.+..|+.+++.|+|||||++++ .+.+++. 
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            446789999999999999999999999999999999987543 5567788999999999999999999998 5665555 


Q ss_pred             EEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--CCC-ceecCCCCCCEEEccCCcEEEeeccc
Q 018532          140 ISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHN--ERH-VIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~~-iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      +++|||+|++|+|..+++..    +.+++..+|.++.|++.||..+|+  .+| |+||||||.||+++.+|.|||+|||+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            99999999999999999753    568999999999999999999997  333 89999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ++.+........+++|||+||+||.+.+.+|+.+|||||+||++|||+.-+.||.+.       ++.++.+++..+..++
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDYPP  247 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCCCC
Confidence            999988888888899999999999999999999999999999999999999999876       4567888888887766


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSS  320 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~  320 (354)
                      .+...+|.++..||..|+.+||+.||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            6667899999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-56  Score=391.22  Aligned_cols=263  Identities=30%  Similarity=0.500  Sum_probs=232.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ...+|...+.||+|+||+||+|+++.++..||||.+.+.. ..+..+.+..|+.+++.++|+|||.++++....+.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3578888999999999999999999999999999997664 667788899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC------CcEEEeecccccccC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK------GEVKITDFGVSAMLG  217 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfg~a~~~~  217 (354)
                      ||||+||+|.+++++.+.+++..++.++.||+.||++||+ ++||||||||+|||++.+      -.+||+|||+|+.+.
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999999999999999999999999999999999999998 999999999999999875      358999999999886


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPD  296 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  296 (354)
                      . .....+.||++.|||||++....|+.|+|+||+|++||+|++|+.||......       +++..+..+ ...+..+.
T Consensus       167 ~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-------eL~~~~~k~~~~~~~~~~  238 (429)
T KOG0595|consen  167 P-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-------ELLLYIKKGNEIVPVLPA  238 (429)
T ss_pred             c-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHHHhccccccCchhh
Confidence            4 35556789999999999999999999999999999999999999999776544       444444433 23344456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .++....+|+-..|+.+|..|.+..+-+.|+++..-..++
T Consensus       239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~  278 (429)
T KOG0595|consen  239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR  278 (429)
T ss_pred             hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence            6788888999999999999999999999999988755433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-56  Score=416.35  Aligned_cols=282  Identities=26%  Similarity=0.468  Sum_probs=254.6

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~  138 (354)
                      ..+..++|.++++||+|+||+|+++..+.+++.||||++++..  ..+.....+.|.+|+... +||.++.++..|+..+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3567899999999999999999999999999999999998764  455667788898888776 5999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|+||||+.||++..+ +..+.+++..+..++..|+.||.|||+ +||||||||.+|||+|.+|++||+|||+++..-.
T Consensus       443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999999995444 344789999999999999999999998 9999999999999999999999999999998776


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      ......++||||.|||||++.+..|+..+|+|||||+||||+.|..||.+.+.+       ++...|......  .|..+
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------e~FdsI~~d~~~--yP~~l  591 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------EVFDSIVNDEVR--YPRFL  591 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCCC--CCCcc
Confidence            667888999999999999999999999999999999999999999999988765       566777666443  46689


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCCCCCCC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR  354 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (354)
                      +.++.++++++|.+||++|..+     .+|.+||||+.+.|.++.....-||+-|.+++||
T Consensus       592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~  652 (694)
T KOG0694|consen  592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPE  652 (694)
T ss_pred             cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChh
Confidence            9999999999999999999876     6888999999999999998889999999998875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-56  Score=378.82  Aligned_cols=267  Identities=27%  Similarity=0.470  Sum_probs=225.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +.|+.+.++|+|+||.||+|+++.||+.||||++..+.+ ....+-.++|+++++.++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            678999999999999999999999999999999876554 5667778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+. ++.+.++.. ..+++..+..++.|++.|+.|||+ +++|||||||+|||++.+|.+||||||+|+.+..+....+
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            9987 555555554 578999999999999999999998 8999999999999999999999999999999987777777


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH-------HHHHcCCC------
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL-------EAIVESPP------  290 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~------  290 (354)
                      .++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+-+..-.+...+       ..+....+      
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            8899999999999998 579999999999999999999999998877653221111110       01111100      


Q ss_pred             -C-----C---CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          291 -P-----T---APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       291 -~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                       |     .   .-...++.-+.+|++.||+.||++|++.+|++.||||..+.++
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence             0     0   0012456779999999999999999999999999999876554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-54  Score=397.22  Aligned_cols=259  Identities=31%  Similarity=0.533  Sum_probs=228.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----EEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~  138 (354)
                      ...+.|.+.+.||+|+||+|+.+.+..++..||+|++++...    ....+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            446789999999999999999999999999999998876411    134566778999999999 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-CcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  217 (354)
                      .+|+||||+.||+|.+++.+.+++.+..+..+++|++.|++|||+ +||+||||||+|||++.+ +++||+|||++....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            999999999999999999998999999999999999999999998 999999999999999999 999999999999874


Q ss_pred             CCcCCCcccccCCcccccccccCCC-CC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGST-YD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      .......+.|||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...+..       .+...+..+...  .+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l~~ki~~~~~~--~p  243 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NLYRKIRKGEFK--IP  243 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HHHHHHhcCCcc--CC
Confidence            3445667789999999999999987 86 6899999999999999999999874332       444555555433  34


Q ss_pred             CCC-CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          296 DQF-SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       296 ~~~-~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ..+ +.++.+|+.+||..||.+|+|+.+++.||||+..
T Consensus       244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            556 9999999999999999999999999999999973

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-55  Score=399.36  Aligned_cols=261  Identities=32%  Similarity=0.590  Sum_probs=236.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ....|....+||+|+.|.||.|+...+++.||||.+....+.. +..+.+|+.+++..+|+|||.+++.|...+.+++||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            3567888899999999999999999999999999998765443 456899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||++||+|.+.+.. -.++|.++..|+++++.||+|||. +||+|||||.+|||++.+|.+||+|||+|..+........
T Consensus       350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            99999999999876 459999999999999999999998 9999999999999999999999999999999988877888


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      +.+|||+|||||+...+.|+++.||||||++++||+.|.+||...++.      ..+......+.+....+..+|+.+.+
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCCCCcCCccccCHHHHH
Confidence            899999999999999999999999999999999999999999875543      23344445666777778899999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      |+.+||+.|+++|+++.|+|+||||+....
T Consensus       502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            999999999999999999999999976544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-54  Score=392.71  Aligned_cols=255  Identities=31%  Similarity=0.536  Sum_probs=235.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|.+.+.||+|+||.||+++.+.|.+.||+|.+.+.. .++..+.+.+|++|++.++|+|||.+++.|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            68999999999999999999999999999999996543 45567889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      ||.| +|..++...+.++++.+..++.+++.||.|||+ .+|+|||+||.|||++.+|.+|+||||+|+...........
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9987 999999999999999999999999999999998 88999999999999999999999999999998877666777


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..|||.|||||...+++|+..+|+|||||++|||.+|++||...       .+.++.+.|......  .+...+..+.+|
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~v~--~p~~~S~~f~nf  230 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDPVK--PPSTASSSFVNF  230 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCCCC--CcccccHHHHHH
Confidence            88999999999999999999999999999999999999999654       456777777766443  355899999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +..+|.+||.+|.|..+++.|||++.-
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhhh
Confidence            999999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-54  Score=397.01  Aligned_cols=262  Identities=29%  Similarity=0.495  Sum_probs=236.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ..-|++.+.||.|+.|.|.+|++..||+..|||++.+.  ........+.+|+-|++.+.|||++.+|+++.+..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            34567889999999999999999999999999999754  3445567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      .||++||.|++++-..+.+++.++..+++||+.|+.|||. .+|+||||||+|+|+|..+++||+|||.|.... +....
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklL  168 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLL  168 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeeccc-CCccc
Confidence            9999999999999999999999999999999999999998 999999999999999999999999999998643 44566


Q ss_pred             cccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .+.||+|.|+|||++.|.+|+ .++||||.|||||.||+|++||.+.       ++..++.++..+...  .|..++.++
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir~LLlKV~~G~f~--MPs~Is~ea  239 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIRVLLLKVQRGVFE--MPSNISSEA  239 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHHHHHHHHHcCccc--CCCcCCHHH
Confidence            778999999999999999985 6899999999999999999999743       455778888877654  458999999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ++||.+||.+||++|+|.+||++|||+..+.....+
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            999999999999999999999999999998776554

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-54  Score=369.27  Aligned_cols=282  Identities=25%  Similarity=0.382  Sum_probs=236.2

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeec--Ce
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHN--GV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~  139 (354)
                      ..+.++|+++..|++|+||.||+|+++.|++.||+|.++.+... .+--.-++|+.++...+|+|||.+-.+....  +.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            45688999999999999999999999999999999999876532 3344568999999999999999998887653  57


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      +|+|||||+. +|..++...+ +++..++..++.|++.|++|||+ +.|+||||||+|+|++..|.+||+|||+|+.+++
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999999986 9999998875 89999999999999999999998 9999999999999999999999999999999999


Q ss_pred             CcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC------
Q 018532          219 SMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP------  291 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------  291 (354)
                      +.......+.|.+|+|||.+.+. .|+...|+||+|||+.||+++++.|.+....++...++.++-.-.....+      
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            88888888999999999999986 49999999999999999999999998877655444444332111111000      


Q ss_pred             --------C---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc--ccccccccccccCC
Q 018532          292 --------T---------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF--EDKDIDLGILVGSL  346 (354)
Q Consensus       292 --------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~--~~~~~~~~~~~~~~  346 (354)
                              .         .....+++...+|+..+|.+||.+|.|+.|.|+|+||.+.  ......+++|+.+.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~  383 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKS  383 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccc
Confidence                    0         0011256889999999999999999999999999999994  33334566666554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-54  Score=384.79  Aligned_cols=268  Identities=25%  Similarity=0.402  Sum_probs=224.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecC-eEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNG-VISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~-~~~l  142 (354)
                      ..++|.++++||.|+||.||+|+.+.+|..||||.++.....-..-.-++|++.+++++ |+|||++.+++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            36789999999999999999999999999999999876653322334578999999998 999999999999887 9999


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |||||+. +|.++++.. +.++++.++.|+.||+.||+|+|. +|++|||+||+|||+..+..+||+|||+|+.+.+. .
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-p  164 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-P  164 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEecccccccccccC-C
Confidence            9999975 999999875 579999999999999999999998 99999999999999999999999999999988754 4


Q ss_pred             CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC---------------hhhHHHHHHHH
Q 018532          222 QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS---------------WPSFYELLEAI  285 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~~~~~~~~~  285 (354)
                      ..+.++.|.+|+|||++... -|+.+.||||+|||++|+.+-++.|.+.++.++               |..-.++...+
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            55678999999999998664 599999999999999999999999988765432               22222222222


Q ss_pred             HcCCCCCCC-------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          286 VESPPPTAP-------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       286 ~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .-. .+...       ....+.++.+||.+||..||++||||.++|+||||+....-+
T Consensus       245 nf~-~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~  301 (538)
T KOG0661|consen  245 NFR-FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG  301 (538)
T ss_pred             ccC-CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence            111 11111       134789999999999999999999999999999999865543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-53  Score=376.67  Aligned_cols=273  Identities=34%  Similarity=0.548  Sum_probs=236.2

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +..|....++|++..+||.|..++||+|+..-++..||||+++.+......+.+.+|+..++.++||||+.++..|..+.
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            34566778999999999999999999999999999999999988766666788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+|+||.||.+|++.++++..  ..++|..+..|+++++.||.|||+ +|-||||||+.||||+.+|.|||+|||.+..+
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999999999875  469999999999999999999998 99999999999999999999999999998776


Q ss_pred             CCCcCCC----cccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          217 GSSMGQR----DTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       217 ~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      .......    .+++||++|||||++...  .|+.|+||||||++..||.+|..||....+.      .-++..+....+
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp  250 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPP  250 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCC
Confidence            5543322    556899999999996553  5999999999999999999999999766544      234444444433


Q ss_pred             -------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          291 -------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       291 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                             +......++..+..++..||++||.+|||++++|+|+||++...++.-
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence                   112223567789999999999999999999999999999998776643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=377.36  Aligned_cols=260  Identities=33%  Similarity=0.547  Sum_probs=219.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC--eEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~  144 (354)
                      .++...+.||+|+||+||++.+..+|..+|||.+....... .+.+.+|+++++.++|+|||++++......  .+++.|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            45667888999999999999999999999999987764333 677999999999999999999999754444  699999


Q ss_pred             eccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccCC---C
Q 018532          145 EYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGS---S  219 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~---~  219 (354)
                      ||+++|+|.+++.+.+ .++++.+..+++||+.||+|||+ +|++|+||||+|||++. ++.+||+|||++.....   .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            9999999999999877 79999999999999999999998 99999999999999999 79999999999987763   1


Q ss_pred             cCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      ........||+.|||||++.++ ....++|||||||++.||+||+.||....  .   .. +.+-.+......+..+..+
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~---~~-~~~~~ig~~~~~P~ip~~l  248 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E---EA-EALLLIGREDSLPEIPDSL  248 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c---hH-HHHHHHhccCCCCCCCccc
Confidence            2223457899999999999963 23459999999999999999999997631  0   11 2222223233334667789


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +.++.+||.+|+..||++||||.++|.|||.+....
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999999988655

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-53  Score=356.11  Aligned_cols=265  Identities=26%  Similarity=0.448  Sum_probs=224.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+|...+.||+|+||.||+|++..||+.||||+++..... .......+|++.++.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788899999999999999999999999999999876433 345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |++. +|...++.. ..++..++..++.+++.||+|||+ +.|+||||||+|+|++++|.+||+|||+|+.+..+.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            9985 999999865 468899999999999999999998 9999999999999999999999999999999988776666


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------HHHHcC
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------EAIVES  288 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------~~~~~~  288 (354)
                      ..+.|.+|+|||.+.|. .|+..+||||.||++.||+.|.+-|.+.++-++...++..+               ....-.
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            66899999999999986 59999999999999999999998888776543322222111               111100


Q ss_pred             CCCCC----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          289 PPPTA----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       289 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ..+..    .-...+.++.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            01111    1234678899999999999999999999999999999743

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-54  Score=385.91  Aligned_cols=266  Identities=27%  Similarity=0.442  Sum_probs=227.2

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--Ce
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~  139 (354)
                      ....+.|+.+++||+|+||.||+|++..||+.||+|+++... .+++...+.+|+.|+++++|+||+++.+...+.  +.
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            346788999999999999999999999999999999998765 456677889999999999999999999988876  79


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      +|+|+|||+. +|..++... -.|++.++..++.||+.||+|||+ +||+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999999987 999998874 379999999999999999999998 9999999999999999999999999999998765


Q ss_pred             CcCC-CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-----
Q 018532          219 SMGQ-RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-----  291 (354)
Q Consensus       219 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  291 (354)
                      .... ....+-|.+|+|||.+.|. .|+.++|+||.||||.||++|++.|.+..+.++...++.+.-.....-++     
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            4433 5667889999999999986 59999999999999999999999999887765544444332111111000     


Q ss_pred             -------C--------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          292 -------T--------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       292 -------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                             .        .....++....+|+..||..||++|.|+.++|.|+||.
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                   0        00134678899999999999999999999999999993

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-55  Score=359.56  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=227.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.++||+|.|+.|+++.+..||+.+|+|+++... .....+.+.+|++|-+.++||||+++.+.+.+.+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467889999999999999999999999999999986543 2334577999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |+++|++|..-+-...-+++..+..+++||+.||.|+|. +||||||+||+|+++.+.   .-+||+|||+|..++ ...
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~  167 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE  167 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence            999999998877766778999999999999999999998 999999999999999654   359999999999988 445


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  299 (354)
                      ...+.+|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+..       .+.+.+..+...  ...++.++
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd~~~~~w~~is  240 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYDYPSPEWDTVT  240 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccCCCCcccCcCC
Confidence            566789999999999999999999999999999999999999999875433       455566655433  33467899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      +++.+|+++||..||.+|+|+.|.|+|||+++
T Consensus       241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  241 PEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            99999999999999999999999999999986

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-51  Score=377.77  Aligned_cols=277  Identities=42%  Similarity=0.761  Sum_probs=234.9

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||.||++++..++..||+|++...........+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            45789999999999999999999999999999999987666666778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+..+|+||||||+||+++.++.+||+|||++......  ...
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  160 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  160 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccc
Confidence            999999999999988889999999999999999999997446999999999999999999999999998766432  223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC------------------------------
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS------------------------------  274 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------------------------------  274 (354)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.                              
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence            45799999999999998999999999999999999999999965432100                              


Q ss_pred             ---------hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          275 ---------WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       275 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                               .....+....+.....+......+++++.+||.+||+.||++|||+.++++||||+.......++..++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~  318 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGWL  318 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccccHHHHH
Confidence                     001122233333333333334467899999999999999999999999999999999888777655443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-52  Score=381.90  Aligned_cols=256  Identities=29%  Similarity=0.510  Sum_probs=221.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||.||+|++..+|+.||+|+++...  .......+.+|+.+++.++|+||+++++.+...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999997643  2334456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      +|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.............+||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            999999888889999999999999999999998 9999999999999999999999999999876544334445568999


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||++.+..++.++|||||||++|||++|..||...+..       .....+....  ...+..+++++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~--~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE--IRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence            999999999999999999999999999999999999765432       2333333332  2335678999999999999


Q ss_pred             hhCCCCCC-----CHHHHhcCcccccccccccc
Q 018532          311 QKDPRDRS-----SSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       311 ~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~  338 (354)
                      +.||++||     ++.++++||||+...+....
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~  263 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV  263 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            99999999     89999999999987765553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-54  Score=382.83  Aligned_cols=258  Identities=36%  Similarity=0.588  Sum_probs=234.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ..|..++.||+|+||.||+|.+..+++.||+|+++....++....+.+|+.++..++++||.++|+.|..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34666788999999999999999999999999999988888889999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      |.||++.+.++....+.+..+..++++++.|+.|||+ .+.+|||||+.||++..+|.+||+|||.+.++........++
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            9999999999987777999999999999999999998 889999999999999999999999999999998877777899


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      +||+.|||||++.+..|+.++||||||++.+||++|.+|+....+..       .+..+-+.. ++.....+++.+++|+
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlflIpk~~-PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLFLIPKSA-PPRLDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEEeccCCC-CCccccccCHHHHHHH
Confidence            99999999999998899999999999999999999999998877642       122233333 3444458999999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ..||++||+.||||.++|+|+|++...
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            999999999999999999999999854

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-52  Score=375.96  Aligned_cols=270  Identities=23%  Similarity=0.424  Sum_probs=229.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....  .+....+.+|+.+++.++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            468889999999999999999999999999999875432  234466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.+|.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            999999999999988889999999999999999999998 99999999999999999999999999999866432   23


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+.....  ..+..++..+.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~  227 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAGKL--EFPRHLDLYAKD  227 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCc--CCCccCCHHHHH
Confidence            457999999999999988999999999999999999999999765432       33344443332  234567899999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCC
Q 018532          305 FVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       305 li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      ||.+||+.||.+|++     +.++++||||+.+.+.........++.-|+
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~  277 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPK  277 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCC
Confidence            999999999999995     999999999998877655443333443343

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-52  Score=380.12  Aligned_cols=262  Identities=26%  Similarity=0.436  Sum_probs=227.5

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|++.+.||+|+||.||+|+++.+++.||+|+++...  .......+.+|+.+++.++|+||+++++.+..++..
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            345688999999999999999999999999999999997542  223446688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+.|++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999999988889999999999999999999998 99999999999999999999999999999866432 


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                        ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +..+.+.....  ..+..++.
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~  240 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRL--KFPNWFDG  240 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCc--CCCCCCCH
Confidence              23457999999999999999999999999999999999999999765432       33344444432  23456899


Q ss_pred             HHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~  337 (354)
                      .+.+||.+||+.||++|++     ++++++||||+...+...
T Consensus       241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~  282 (329)
T PTZ00263        241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL  282 (329)
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            9999999999999999997     799999999998766543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-51  Score=362.00  Aligned_cols=269  Identities=27%  Similarity=0.421  Sum_probs=234.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..+.++.|++++.||.|.-|+||+|+.+.++..+|+|++.+..-  .+...++..|..||..++||.+..+|..|+.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            45677899999999999999999999999999999999987643  3345667889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .|++||||+||+|..+++++  +.++++.++.++.+++.||+|||- .|||+|||||+||||.++|++-|+||.++....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            99999999999999999876  579999999999999999999997 999999999999999999999999999875431


Q ss_pred             C---------------------------------C-c----------------------CCCcccccCCcccccccccCC
Q 018532          218 S---------------------------------S-M----------------------GQRDTFVGTYNYMSPERISGS  241 (354)
Q Consensus       218 ~---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~  241 (354)
                      .                                 . .                      ....+++||-.|+|||++.|.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            1                                 0 0                      011346799999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC--
Q 018532          242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS--  319 (354)
Q Consensus       242 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps--  319 (354)
                      ..+.++|+|+||+++|||+.|..||.+.+..+       .+..++...........++..++|||+++|.+||.+|..  
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            99999999999999999999999999998774       344445444444444478899999999999999999999  


Q ss_pred             --HHHHhcCcccccccccccc
Q 018532          320 --SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       320 --~~eil~hp~~~~~~~~~~~  338 (354)
                        +.||.+||||+.++|.-+.
T Consensus       384 rGA~eIK~HpFF~gVnWaLir  404 (459)
T KOG0610|consen  384 RGAAEIKRHPFFEGVNWALIR  404 (459)
T ss_pred             cchHHhhcCccccCCChhhee
Confidence              9999999999999998544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-51  Score=373.31  Aligned_cols=255  Identities=29%  Similarity=0.470  Sum_probs=221.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcE-EEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRL-FALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .+.+..+++.+.+.||+|+||+||++..+  |.. ||+|++.... .....+.+.+|+.++.+++|||||.+++++....
T Consensus        35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34566677788888999999999988865  666 9999997543 2333788999999999999999999999999887


Q ss_pred             -eEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecCCCCCCEEEccCC-cEEEeecccc
Q 018532          139 -VISLVLEYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNHKG-EVKITDFGVS  213 (354)
Q Consensus       139 -~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfg~a  213 (354)
                       .+++||||+++|+|..++..  .+.++...+..++.||+.||.|||+ ++ ||||||||+|||++.++ ++||+|||++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence             79999999999999999988  5789999999999999999999998 88 99999999999999998 9999999999


Q ss_pred             cccCCCcCCCcccccCCccccccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERIS--GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      +.............||+.|||||++.  ...|+.|+||||||+++|||+||+.||......       +....+......
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~R  264 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLR  264 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCC
Confidence            87765433334468999999999999  568999999999999999999999999877653       445555555566


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..+..+++.+..|+.+||..||+.||++.+++.
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            6666679999999999999999999999998875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-51  Score=375.43  Aligned_cols=266  Identities=30%  Similarity=0.516  Sum_probs=225.5

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||.||++++..+|..||+|+++...  .......+.+|+.+++.++|+||+++++.+...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997643  2334456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      +|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..............||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            999999888889999999999999999999998 9999999999999999999999999999876443333344567999


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..       .....+....  ...+..+++++.++|.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~--~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEE--IRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence            999999999999999999999999999999999999765432       2233333322  2234578999999999999


Q ss_pred             hhCCCCCC-----CHHHHhcCccccccccccccccccccCCCC
Q 018532          311 QKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDP  348 (354)
Q Consensus       311 ~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~  348 (354)
                      +.||++|+     ++.++++||||....+.........+++.|
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~  273 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP  273 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCC
Confidence            99999998     899999999999987766544444444433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.2e-51  Score=366.89  Aligned_cols=271  Identities=24%  Similarity=0.410  Sum_probs=225.3

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      |+..+.||+|+||+||++.+..+|+.||+|.+.....  ......+.+|+.+++.++|+|++.+++.+...+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            6678899999999999999999999999999875432  22334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +++|+|..++...  ..+++..+..++.|++.||.|||+ .||+||||||+||++++++.+||+|||++...... ....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            9999999888653  358899999999999999999998 99999999999999999999999999999875432 2223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||..........   .....+..  .....+..++.++.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~--~~~~~~~~~s~~~~~  234 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKE--DQEEYSEKFSEDAKS  234 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhc--ccccCCccCCHHHHH
Confidence            4578999999999999999999999999999999999999998765432111   12222221  122344568999999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCC
Q 018532          305 FVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSL  346 (354)
Q Consensus       305 li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~  346 (354)
                      ||.+||+.||++||+     ++++++||||+...++........+|+
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~  281 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPF  281 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCC
Confidence            999999999999997     899999999999998887754333333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-52  Score=344.16  Aligned_cols=258  Identities=32%  Similarity=0.504  Sum_probs=230.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .++.++|++.+.||+|-||.||+|+.+.++..||+|++.++.  ......++.+|+.|...|+||||+++|+.|.+...+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            467899999999999999999999999999999999987653  233456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      |+++||..+|+|...++  ..+.+++..++.++.|++.|+.|+|. +++|||||||+|+|++.+|.+||+|||.+.... 
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999999999  55789999999999999999999998 889999999999999999999999999987654 


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                       .+...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......       +..+.+.+-.  ...+..+
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k~~--~~~p~~i  245 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRKVD--LKFPSTI  245 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHHcc--ccCCccc
Confidence             46677889999999999999999999999999999999999999999776533       3333443332  2334789


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.++.|+|.+||.++|.+|.+..|++.|||+...
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999999999764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-51  Score=372.40  Aligned_cols=253  Identities=27%  Similarity=0.469  Sum_probs=218.8

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||+|+||+||+|++..+++.||+|+++...  .......+.+|+.++..++|+||+++++.+...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999987542  234456688899999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcc
Q 018532          153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY  232 (354)
Q Consensus       153 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  232 (354)
                      .+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.............+||+.|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            9999888889999999999999999999998 999999999999999999999999999988654333334456899999


Q ss_pred             cccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018532          233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK  312 (354)
Q Consensus       233 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  312 (354)
                      +|||++.+..++.++|||||||++|+|++|..||......       +....+....  ...+..+++++.+||.+||+.
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQEP--LRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCC
Confidence            9999999999999999999999999999999999765432       3334444332  334567899999999999999


Q ss_pred             CCCCCC---CHHHHhcCccccccccccc
Q 018532          313 DPRDRS---SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       313 ~p~~Rp---s~~eil~hp~~~~~~~~~~  337 (354)
                      ||++||   ++.++++||||++....+.
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~~~~~~  258 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQLSWKKL  258 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence            999997   5799999999998755443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.7e-51  Score=372.52  Aligned_cols=271  Identities=27%  Similarity=0.463  Sum_probs=226.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCC-ceEEeeeeeeecCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCS-HVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~-~iv~~~~~~~~~~~~~lv~  144 (354)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  .......+..|..++..+.|+ +++.+++.+...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999999999999999997643  233446678888888888765 5788888999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999875433333344


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..       +....+....  ...+..++.++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~--~~~~~~~~~~~~~  230 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHN--VSYPKSLSKEAVS  230 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC--CCCCCCCCHHHHH
Confidence            567999999999999999999999999999999999999999765432       3344444332  2334578999999


Q ss_pred             HHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCC
Q 018532          305 FVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDP  348 (354)
Q Consensus       305 li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~  348 (354)
                      ++.+||..||.+|++.     .++++||||+...+.........+++.|
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~  279 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKP  279 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccC
Confidence            9999999999999986     8999999999987765543333344433

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-51  Score=375.44  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=226.8

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCC-cEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-RLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .....++|.+.+.||+|+||.||+|.+..++ ..||+|++....  .......+.+|+.+++.++|+||+++++.+.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4556789999999999999999999876655 689999986543  2334566889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999986543


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      .   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..       .....+.....  ..+..+
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~  251 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII--YFPKFL  251 (340)
T ss_pred             C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC--CCCCCC
Confidence            2   23468999999999999988999999999999999999999999765432       22333443322  234568


Q ss_pred             CHHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~  337 (354)
                      ++.+.++|++||+.||++|+     +++++++||||+...+...
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~  295 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL  295 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            99999999999999999995     8999999999998876554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.5e-51  Score=373.84  Aligned_cols=256  Identities=27%  Similarity=0.495  Sum_probs=220.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+...+.+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999999999999999997543  2334567888999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      +|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            999999887889999999999999999999998 9999999999999999999999999999876443333344567999


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..       +....+....  ...+..++.++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~--~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMED--IKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccCC--ccCCCCCCHHHHHHHHHHc
Confidence            999999999989999999999999999999999999765432       2233333222  2345678999999999999


Q ss_pred             hhCCCCCC-----CHHHHhcCcccccccccccc
Q 018532          311 QKDPRDRS-----SSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       311 ~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~  338 (354)
                      +.||++|+     ++.++++||||....+..+.
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  263 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY  263 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            99999997     89999999999987765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=357.61  Aligned_cols=270  Identities=28%  Similarity=0.417  Sum_probs=223.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee-----cCeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH-----NGVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~  140 (354)
                      ..|...+.||+|+||.|+.+.++.+|+.||||++..... .-..++..+|+++++.++|+||+.+++.+..     -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            345557899999999999999999999999999874332 3345778999999999999999999998865     4579


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC-
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  219 (354)
                      |+|+|+|+ .+|...++....+++..+..++.|++.||.|+|+ .||+||||||+|++++.+..+||||||+|+..... 
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999995 5999999998889999999999999999999998 99999999999999999999999999999987542 


Q ss_pred             -cCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH----------------
Q 018532          220 -MGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL----------------  281 (354)
Q Consensus       220 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------  281 (354)
                       ....+.++.|.+|.|||++.. ..|+.+.||||+|||+.||++|++.|.+.+...+...+.+.                
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             233466789999999999865 46999999999999999999999999887654332222111                


Q ss_pred             -HHHHHcCCCCCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          282 -LEAIVESPPPTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       282 -~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                       ...+...+..+.     .-.+.++.+.+|+.+||..||.+|+|++|+|+|||+..+.+.+-+
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence             111111111111     123678999999999999999999999999999999998776654

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.3e-51  Score=371.95  Aligned_cols=256  Identities=28%  Similarity=0.497  Sum_probs=218.9

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|+++.+++.||+|+++...  .......+..|..++..+ +|+||+++++.+...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999987543  223345567788777765 799999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++..............||
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987654333344456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..       +..+.+.....  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEV--VYPTWLSQDAVDILKAF  230 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999999765432       33444444332  23456899999999999


Q ss_pred             hhhCCCCCCCH------HHHhcCcccccccccccc
Q 018532          310 IQKDPRDRSSS------LDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rps~------~eil~hp~~~~~~~~~~~  338 (354)
                      |+.||++||++      +++++||||+.+.+....
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~  265 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN  265 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            99999999998      899999999988765543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-50  Score=376.46  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=219.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++...  .......+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999999999999999997542  2334467888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999875432100   


Q ss_pred             --------------------------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 018532          222 --------------------------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS  269 (354)
Q Consensus       222 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  269 (354)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012357999999999999999999999999999999999999999765


Q ss_pred             CcCCChhhHHHHHHHHHcCCCC--CCCCCCCCHHHHHHHHHhhhh--CCCCCCCHHHHhcCcccccccccccc
Q 018532          270 EDQQSWPSFYELLEAIVESPPP--TAPPDQFSPEFCSFVSACIQK--DPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ...       +....+......  ......+++++.++|.+|+..  ++..||+++|+++||||+...++.+.
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~  305 (363)
T cd05628         240 TPQ-------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIR  305 (363)
T ss_pred             CHH-------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHH
Confidence            432       233334332211  111234789999999997652  33356899999999999998776653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=373.38  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=223.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++....  ......+.+|+.++..++|+||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368899999999999999999999999999999976532  234566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....   ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            999999999999988889999999999999999999998 9999999999999999999999999999976543   234


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC---CCCC---CCCCC
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP---PPTA---PPDQF  298 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~  298 (354)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+       ....+....   ..+.   ....+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~~~~~~  229 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------TWENLKYWKETLQRPVYDDPRFNL  229 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------HHHHHHhccccccCCCCCcccccc
Confidence            4579999999999999999999999999999999999999997655432       122222111   1111   11256


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      +.++.+||.+||..+|++||++.++++||||+...+....
T Consensus       230 s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~  269 (333)
T cd05600         230 SDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELR  269 (333)
T ss_pred             CHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHh
Confidence            8999999999999999999999999999999987665443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-52  Score=355.75  Aligned_cols=279  Identities=28%  Similarity=0.493  Sum_probs=249.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ....++|..+++||+|+||.|-+|+.+.+++.||||++++..  ..+....-+.|-++++.-+||.+..+...|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            346789999999999999999999999999999999998764  455667778899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||..||.|.-.+.+.+.+++..++.+-..|+.||.|||+ ++||+||||.+|.|+|++|++||+|||+++..-...
T Consensus       244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999999999999998999999999999999999999998 999999999999999999999999999999887777


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....++||||.|+|||++....|+..+|+|.+|+++|||+||+.||...+..       .+.+-+...  ....|..+++
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~e--d~kFPr~ls~  393 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILME--DLKFPRTLSP  393 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhh--hccCCccCCH
Confidence            8888999999999999999999999999999999999999999999887665       222333222  2345678999


Q ss_pred             HHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCCC
Q 018532          301 EFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      ++..|+..+|.+||.+|..     +.||.+|+||+.+.|...-.....+|+.|-|.
T Consensus       394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt  449 (516)
T KOG0690|consen  394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT  449 (516)
T ss_pred             HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence            9999999999999999975     78999999999999988766566777777553

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.5e-51  Score=373.53  Aligned_cols=257  Identities=30%  Similarity=0.515  Sum_probs=219.9

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||+||++.+..+|+.||+|+++...  .......+..|++++..++|+||+++++.+...+.+++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999997643  2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      +|..++...+.+++..+..++.||+.||.|||+..||+||||||+|||++.++.+||+|||++..............||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            99999988788999999999999999999999647899999999999999999999999999876443333344567999


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+..       +....+....  ...+..+++++.+||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE--IRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999765432       2233333222  2335578999999999999


Q ss_pred             hhCCCCCC-----CHHHHhcCcccccccccccc
Q 018532          311 QKDPRDRS-----SSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       311 ~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~  338 (354)
                      +.||++|+     ++.++++||||+...+....
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            99999997     89999999999987765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-50  Score=371.29  Aligned_cols=263  Identities=27%  Similarity=0.454  Sum_probs=218.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||+|++..+++.||+|+++...  ..+....+..|..++..+ +|+||+++++.+...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999999999999999997643  233445678899988887 799999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|..++...+.+++..+..++.||+.||.|||+ +|++||||||+||+++.++.+||+|||++.............+||
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987543333344456899


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC--ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ--SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||.......  .........+.+....  ...+..++.++.++|.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~  237 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence            99999999999999999999999999999999999996432211  0011111223333332  2345678999999999


Q ss_pred             HhhhhCCCCCCC------HHHHhcCcccccccccccc
Q 018532          308 ACIQKDPRDRSS------SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       308 ~~l~~~p~~Rps------~~eil~hp~~~~~~~~~~~  338 (354)
                      +||+.||++|++      ++++++||||+.+.+....
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~  274 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLE  274 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence            999999999987      7899999999987665443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-50  Score=370.20  Aligned_cols=256  Identities=28%  Similarity=0.446  Sum_probs=220.1

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||+|++..+++.||+|+++...  ..+....+..|..++..+ +|+||+++++.+...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999999999999999997643  233445677788888755 899999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..............||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987654443444556799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..       +....+.....  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDDV--LYPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999999766543       33444444332  23456899999999999


Q ss_pred             hhhCCCCCC-------CHHHHhcCcccccccccccc
Q 018532          310 IQKDPRDRS-------SSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rp-------s~~eil~hp~~~~~~~~~~~  338 (354)
                      |+.||++|+       ++.++++||||....+....
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~  266 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE  266 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence            999999999       89999999999988776554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-51  Score=361.36  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=229.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ..+|++.+.||+|+||.|-+|.....|+.||||.++++.  ++...-.+.+|++|+..|+||||+.+|++|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            568999999999999999999999999999999998765  334456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |||..+|.|++++.+.+.+++.+++.+++||..|+.|||+ ++++|||||.+|||+|.++++||+|||++..+... ...
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfL  209 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFL  209 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccchhhhhccc-cHH
Confidence            9999999999999999999999999999999999999998 88999999999999999999999999999877543 566


Q ss_pred             cccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .++||++-|.+||++.|.+|. +.+|.||||++||.|+.|..||.+.+..       .+.+++..+......   -+.++
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP~---~PSdA  279 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREPE---TPSDA  279 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCCC---CCchH
Confidence            789999999999999999985 7899999999999999999999887643       567777777654432   36788


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      .-||+.||.+||++|.|+.+|..|-|++-
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            99999999999999999999999999873

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.3e-51  Score=366.95  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=213.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||.|+||+||+|.+..++..||+|+++..........+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            57899999999999999999999999999999998765433334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+++...+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            9975 9999887654 57889999999999999999998 9999999999999999999999999999976544333344


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------HH------HHcCC
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------EA------IVESP  289 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~------~~~~~  289 (354)
                      ...+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....        ..      .....
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            5578999999999876 468999999999999999999999997654332111111000        00      00000


Q ss_pred             CC-------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          290 PP-------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       290 ~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+       ......++.++.+||.+||+.||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00       00123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-50  Score=370.12  Aligned_cols=258  Identities=27%  Similarity=0.483  Sum_probs=218.3

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHH---hhcCCCceEEeeeeeeecCeEEEE
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKIN---QASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~---~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      |.+++.||+|+||.||+|.+..+++.||||+++...  .....+.+.+|.+++   +.++|+||+++++.+...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999999999999999997543  223345566676654   467899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |||++|++|..++.. +.+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++..........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988865 679999999999999999999998 999999999999999999999999999987654433444


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ...+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..       +....+.....  ..+..++..+.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~  229 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDEV--RYPRFLSREAI  229 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--CCCCCCCHHHH
Confidence            5568999999999999989999999999999999999999999765432       33344443332  23456899999


Q ss_pred             HHHHHhhhhCCCCCC-----CHHHHhcCccccccccccc
Q 018532          304 SFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       304 ~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~  337 (354)
                      ++|.+||+.||++||     ++.++++||||+...+...
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~  268 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL  268 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence            999999999999999     6999999999998765443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.7e-50  Score=368.33  Aligned_cols=277  Identities=42%  Similarity=0.748  Sum_probs=230.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||.|+||.||++.+..++..+|+|++...........+.+|+++++.++|+||+++++.+...+.+++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            45789999999999999999999999999999999887666666678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++......  ...
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  160 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  160 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccc
Confidence            999999999999988889999999999999999999997457999999999999999999999999998765332  223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh-----------------------------
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-----------------------------  275 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------------------------  275 (354)
                      ...|+..|+|||++.+..++.++|||||||++|+|++|+.||......+..                             
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence            457899999999999988999999999999999999999999654321100                             


Q ss_pred             --------hhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          276 --------PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       276 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                              .........+.....+.......+.++.+||.+||++||++|||+.|++.||||+.......+...|.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~  316 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWL  316 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccccccHHHHH
Confidence                    00111222222333333333456889999999999999999999999999999998766655544443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-50  Score=368.95  Aligned_cols=267  Identities=26%  Similarity=0.444  Sum_probs=221.3

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhh-cCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||+|.++.+|+.||+|+++....  .........|..++.. .+|+||+++++.+...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999976432  2234456677777765 5899999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            9999999887889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..       +..+.+....  ...+..++.++.+||.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDT--PHYPRWITKESKDILEKL  230 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765432       2333333332  223456899999999999


Q ss_pred             hhhCCCCCCCH-HHHhcCccccccccccccccccccCCCCC
Q 018532          310 IQKDPRDRSSS-LDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       310 l~~~p~~Rps~-~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      |+.||++|+++ +++++||||+...+.......+.+++.|+
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~  271 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPK  271 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence            99999999998 58889999999876655444444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-50  Score=370.27  Aligned_cols=274  Identities=27%  Similarity=0.463  Sum_probs=222.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|+++...  .......+..|+.++..+ +|+||+++++.+...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999997643  233445677888887665 899999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..............||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987644333334456899


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC--ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ--SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.......  .........+.+....  ...+..++..+.++|.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~  237 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence            99999999999999999999999999999999999996322111  0011112223333322  2345678999999999


Q ss_pred             HhhhhCCCCCCC------HHHHhcCccccccccccccccccccCCCCC
Q 018532          308 ACIQKDPRDRSS------SLDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       308 ~~l~~~p~~Rps------~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      +||..||++||+      +.++++||||+...+.........+++.|.
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~  285 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPN  285 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCC
Confidence            999999999998      589999999998876544433344444443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-50  Score=369.22  Aligned_cols=272  Identities=27%  Similarity=0.455  Sum_probs=227.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +|.+.+.||+|+||+||+|++..+++.||+|+++...  ..........|..++..+ .|++++.+++.+...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999999999999999997643  223334566677777666 5788999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999976543333444


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..       +....+.....  ..+..++.++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~~~~  230 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV--AYPKSMSKEAVA  230 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--CCCCcCCHHHHH
Confidence            568999999999999999999999999999999999999999765433       33444443332  234578999999


Q ss_pred             HHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCC
Q 018532          305 FVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       305 li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      ++.+||+.+|++|+++     .++++||||+.+.+.........++..|+
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPK  280 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence            9999999999999984     89999999998887665544444444443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-51  Score=366.48  Aligned_cols=262  Identities=31%  Similarity=0.483  Sum_probs=222.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-------------HHHHHHHHHHHHHhhcCCCceEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-------------EIRKQIVQELKINQASQCSHVVV  129 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv~  129 (354)
                      ...+++|++.+.||+|.||.|-+|++..+++.||||++.+....             ...+.+.+|+.+++++.|+|||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45678999999999999999999999999999999999653210             11357899999999999999999


Q ss_pred             eeeeeee--cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          130 CYHSFYH--NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       130 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                      ++++..+  .+.+|+|+|||..|.+...-.....+++.+++.++++++.||+|||. +|||||||||+|+|++++|+|||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcEEe
Confidence            9999876  46899999999988875432222238999999999999999999998 99999999999999999999999


Q ss_pred             eecccccccCCC-----cCCCcccccCCcccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH
Q 018532          208 TDFGVSAMLGSS-----MGQRDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF  278 (354)
Q Consensus       208 ~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  278 (354)
                      +|||.+......     .......+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+..       .
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-------~  324 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-------E  324 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-------H
Confidence            999999876322     11223358999999999987733    3578999999999999999999998764       3


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      .++..+|+...........+.+++.+||.+||++||++|.+..+|..|||+..-
T Consensus       325 ~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            477788887776666666789999999999999999999999999999998765

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-49  Score=368.40  Aligned_cols=263  Identities=45%  Similarity=0.756  Sum_probs=219.4

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ....++|+.++.||+|+||+||++++..+++.||||++...........+.+|+.+++.++|+||+++++.+...+.+++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            34567899999999999999999999999999999999766666667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||+++++|...    ....+..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.........
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            9999999998643    345677888999999999999998 99999999999999999999999999999876544333


Q ss_pred             CcccccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          223 RDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .....||..|+|||++...     ..+.++|||||||++|||++|+.||......    .+......+... .....+..
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~-~~~~~~~~  299 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG----DWASLMCAICMS-QPPEAPAT  299 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc----cHHHHHHHHhcc-CCCCCCCc
Confidence            4456899999999988532     2456899999999999999999999743322    122222222222 22333457


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ++.++.+||.+||+.||++|||+.|+++||||......
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            89999999999999999999999999999999987443

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=375.75  Aligned_cols=263  Identities=30%  Similarity=0.519  Sum_probs=224.8

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++...  .......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999999999999999997543  1234566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc----
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM----  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----  220 (354)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999988889999999999999999999998 999999999999999999999999999998765433    


Q ss_pred             -------------------------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh
Q 018532          221 -------------------------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW  275 (354)
Q Consensus       221 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  275 (354)
                                               .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---  236 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---
Confidence                                     1233457999999999999999999999999999999999999999876532   


Q ss_pred             hhHHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC-HHHHhcCcccccccccccc
Q 018532          276 PSFYELLEAIVE--SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS-SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       276 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~eil~hp~~~~~~~~~~~  338 (354)
                          +....+..  ..........+++++.+||.+||. ||.+|++ +.++++||||+...+....
T Consensus       237 ----~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~  297 (350)
T cd05573         237 ----ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR  297 (350)
T ss_pred             ----HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHh
Confidence                22333333  111222223479999999999998 9999999 9999999999987665443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-50  Score=375.74  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=217.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .|++++.||+|+||+||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999999999999999997542  23445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-----
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-----  220 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----  220 (354)
                      |++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999988889999999999999999999998 999999999999999999999999999975431100     


Q ss_pred             ------------------------------------------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHH
Q 018532          221 ------------------------------------------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE  258 (354)
Q Consensus       221 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  258 (354)
                                                                ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123579999999999999899999999999999999


Q ss_pred             HHcCCCCCCCCCcCCChhhHHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhh--hhCCCCCCCHHHHhcCcccccccc
Q 018532          259 CAIGRFPYMQSEDQQSWPSFYELLEAIVES--PPPTAPPDQFSPEFCSFVSACI--QKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       259 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      |++|..||......       +....+...  .........+++++.+||.+|+  ..++..|+++.++++||||+.+.+
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         241 MLVGQPPFLAPTPT-------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHhCCCCCcCCCHH-------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            99999999765532       122222221  1122223468999999999955  456666999999999999998766


Q ss_pred             cc
Q 018532          335 KD  336 (354)
Q Consensus       335 ~~  336 (354)
                      ..
T Consensus       314 ~~  315 (381)
T cd05626         314 SS  315 (381)
T ss_pred             hH
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.9e-50  Score=366.88  Aligned_cols=256  Identities=28%  Similarity=0.497  Sum_probs=216.1

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhh-cCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|+++...  ..........|..++.. .+|+||+++++.+...+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997643  22233445556666554 5899999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999998654433444556899


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+....  ...+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~--~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDSILNDR--PHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC--CCCCCCCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999999876532       3333333332  233456899999999999


Q ss_pred             hhhCCCCCCCH-HHHhcCcccccccccccc
Q 018532          310 IQKDPRDRSSS-LDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rps~-~eil~hp~~~~~~~~~~~  338 (354)
                      |+.||++||++ .++++||||+...+....
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~  260 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGIDWERLE  260 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCCHHHHH
Confidence            99999999986 488899999988765544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.7e-51  Score=354.55  Aligned_cols=270  Identities=28%  Similarity=0.470  Sum_probs=226.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCc-eEEeeeeeeecC-----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSH-VVVCYHSFYHNG-----  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~-iv~~~~~~~~~~-----  138 (354)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|+++.... +..-....+|+.+++.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5678888999999999999999999999999999987654 334456789999999999999 999999998877     


Q ss_pred             -eEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          139 -VISLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       139 -~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                       .+++|+||++. +|..++....    .++...++.+++||+.||+|||+ ++|+||||||+|||+++.|.+||+|||+|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccchH
Confidence             89999999975 9999998765    47778899999999999999998 99999999999999999999999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-  291 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  291 (354)
                      +...-+......-++|.+|.|||++.+. .|+...||||+|||++||++++..|.+..+.+....+++.+..-.....+ 
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9887666666677899999999999997 69999999999999999999999998877644333333322111111000 


Q ss_pred             -------------CC-------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          292 -------------TA-------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       292 -------------~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                                   ..       .....+.+..+++.+||+.+|.+|.|++.++.||||.......-
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence                         00       01123358999999999999999999999999999999866543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.7e-50  Score=364.31  Aligned_cols=264  Identities=25%  Similarity=0.409  Sum_probs=214.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..........+.+|+.+++.++|+||+++++.+......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            46899999999999999999999999999999998765443334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+. ++|.+++... +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            996 5888887654 568999999999999999999998 9999999999999999999999999999876544333344


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-------------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-------------  290 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------  290 (354)
                      ...+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+...  .... .........             
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLER-IFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHH-HHHHhCCCChhhccchhhcccc
Confidence            56789999999998764 588899999999999999999999976543210  0001 100000000             


Q ss_pred             -C----C---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          291 -P----T---------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       291 -~----~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                       +    .         ......+.++.+|+.+||+.||++|||+.|+++||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence             0    0         001124578999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-50  Score=374.74  Aligned_cols=261  Identities=29%  Similarity=0.471  Sum_probs=220.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||+|++..+++.||||++....  .......+.+|+.++..++|+||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999999999999999997542  2334566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            999999999999988889999999999999999999998 9999999999999999999999999999875432110   


Q ss_pred             -----------------------------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 018532          222 -----------------------------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY  266 (354)
Q Consensus       222 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  266 (354)
                                                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011346999999999999999999999999999999999999999


Q ss_pred             CCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCcccccccccc
Q 018532          267 MQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~  336 (354)
                      ......       +....+........  ....+++++.+||.+||. +|.+|++   +.++++||||+...+..
T Consensus       240 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         240 CSDNPQ-------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             CCCCHH-------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            765432       22333333222211  223578999999999997 8999998   99999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7e-50  Score=365.13  Aligned_cols=268  Identities=26%  Similarity=0.465  Sum_probs=221.9

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhh-cCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|+++....  .........|..++.. ++|+||+++++.+.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976531  2233455667777765 5999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            9999999887889999999999999999999998 999999999999999999999999999987543333333456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..       +..+.+....+  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNP--CYPRWLTREAKDILVKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999999765432       33333333322  23446899999999999


Q ss_pred             hhhCCCCCCCHH-HHhcCccccccccccccccccccCCCCCC
Q 018532          310 IQKDPRDRSSSL-DLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       310 l~~~p~~Rps~~-eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      |+.||++||++. +++.||||+...+.......+.+++.|+.
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~  272 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKV  272 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCCC
Confidence            999999999996 89999999998876554434444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.6e-50  Score=365.71  Aligned_cols=256  Identities=28%  Similarity=0.482  Sum_probs=218.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|.+..+++.||+|+++...  ..+....+..|..++..+ +|+||+++++.+...+.+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997643  233445677888888776 799999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.|++.||.|||+ .||+||||||+||++++++.+||+|||++.............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+..       .....+.....  ..+..++.++.+||.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEV--RYPRWLSKEAKSILKSF  230 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765432       23333333322  23456899999999999


Q ss_pred             hhhCCCCCCCH-----HHHhcCcccccccccccc
Q 018532          310 IQKDPRDRSSS-----LDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~  338 (354)
                      |+.||++|||+     .++++||||+...+....
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~  264 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLE  264 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            99999999999     999999999998765433

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.9e-50  Score=358.14  Aligned_cols=265  Identities=28%  Similarity=0.476  Sum_probs=220.1

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||+|+||+||++.+..+++.||+|++.....  ......+..|+.+++.++|+||+++++.+...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999865432  22335678899999999999999999999999999999999999999


Q ss_pred             HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          153 ADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       153 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      ..++..    ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++.++|+|||++..............|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            988753    2468999999999999999999998 99999999999999999999999999999876554444445679


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      |+.|+|||.+.+..++.++|||||||++|+|++|+.||........   .......+...  +...+..++..+.+++.+
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  234 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRILND--SVTYPDKFSPASKSFCEA  234 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhccc--CCCCcccCCHHHHHHHHH
Confidence            9999999999999999999999999999999999999976543211   11222222222  223345689999999999


Q ss_pred             hhhhCCCCCC-----CHHHHhcCccccccccccccccccccC
Q 018532          309 CIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGS  345 (354)
Q Consensus       309 ~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~  345 (354)
                      ||+.||++||     +++++++||||+...+..+.....+.|
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~  276 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP  276 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCC
Confidence            9999999999     889999999999988877654333333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-50  Score=366.75  Aligned_cols=256  Identities=29%  Similarity=0.477  Sum_probs=215.9

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHH-HHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELK-INQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~-~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+|+.||+|++.....  ......+..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            369999999999999999999999999975431  222344455544 56779999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            9999999988889999999999999999999998 999999999999999999999999999987654333444456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..       +....+.....  ..+..++..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNILNKPL--RLKPNISVSARHLLEGL  230 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765432       33344443322  23446799999999999


Q ss_pred             hhhCCCCCCCH----HHHhcCcccccccccccc
Q 018532          310 IQKDPRDRSSS----LDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rps~----~eil~hp~~~~~~~~~~~  338 (354)
                      |+.||++||++    .++++||||+...+..+.
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~  263 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLV  263 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHh
Confidence            99999999997    699999999987765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-50  Score=374.81  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=217.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+++.||+|+||+||++.+..+++.||||++....  ..+....+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999999999999999986542  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999863321000   


Q ss_pred             --------------------------------------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHH
Q 018532          222 --------------------------------------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL  257 (354)
Q Consensus       222 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  257 (354)
                                                                  .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999989999999999999999


Q ss_pred             HHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHhhhhCCCCC---CCHHHHhcCcccccc
Q 018532          258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKF  332 (354)
Q Consensus       258 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~hp~~~~~  332 (354)
                      ||++|..||......       +....+........  ....++.++.+||.+||. +|.+|   +++.+++.||||+..
T Consensus       240 elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         240 ECLIGWPPFCSENSH-------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhcCCCCCCCCCHH-------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999765432       22333332221111  223578999999999998 67765   599999999999976


Q ss_pred             cccc
Q 018532          333 EDKD  336 (354)
Q Consensus       333 ~~~~  336 (354)
                      .+..
T Consensus       312 ~~~~  315 (377)
T cd05629         312 DWDT  315 (377)
T ss_pred             CHHH
Confidence            5533

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-49  Score=365.05  Aligned_cols=272  Identities=27%  Similarity=0.461  Sum_probs=226.6

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCC-CceEEeeeeeeecCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQC-SHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +|...+.||+|+||+||+|.++.+|+.||+|+++...  .....+.+..|..++..+.| ++++.+++.+...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667889999999999999999999999999997543  22334567778888877754 66778888999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...........
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999876543333344


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       .....+.....  ..+..++.++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~~  230 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHNV--SYPKSLSKEAVS  230 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--CCCccCCHHHHH
Confidence            567999999999999989999999999999999999999999765432       23333433322  234568999999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCC
Q 018532          305 FVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       305 li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      ++.+||+.+|.+|++     ..++++||||+...+..+......+++.|.
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~  280 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPK  280 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCc
Confidence            999999999999998     478999999999887666554445555444

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-50  Score=375.54  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=218.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++++.||+|+||+||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46899999999999999999999999999999986532  1233466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC-----
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-----  219 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----  219 (354)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+|..+...     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999999988889999999999999999999998 99999999999999999999999999997532100     


Q ss_pred             --------------------------------------cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc
Q 018532          220 --------------------------------------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI  261 (354)
Q Consensus       220 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  261 (354)
                                                            .......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                  000123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcCCChhhHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHHhhhhCCCCCC---CHHHHhcCcccccccccc
Q 018532          262 GRFPYMQSEDQQSWPSFYELLEAIVESP--PPTAPPDQFSPEFCSFVSACIQKDPRDRS---SSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       262 g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~eil~hp~~~~~~~~~  336 (354)
                      |+.||.+....       +....+....  ........+++++.++|.+|+ .+|.+|+   ++.++++||||+.+....
T Consensus       240 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~  311 (376)
T cd05598         240 GQPPFLADTPA-------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFAS  311 (376)
T ss_pred             CCCCCCCCCHH-------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence            99999776533       2222222221  112223468999999999976 5999999   999999999999865433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-49  Score=364.39  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=218.1

Q ss_pred             cccccccCceEEEEEEEc---cCCcEEEEEEeecccc---HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           72 IKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQ---EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++.||+|+||.||+|++.   .+++.||+|+++....   ......+.+|+.+++.++|+||+++++.+..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            357999999999999864   4788999999975421   2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+++++|.+++...+.+.+..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++............
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999999888889999999999999999999998 99999999999999999999999999998765433333445


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..       .....+....  ...+..+++.+.++
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~l  230 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKGK--LNLPPYLTPEARDL  230 (323)
T ss_pred             cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC--CCCCCCCCHHHHHH
Confidence            67999999999999988999999999999999999999999765432       2333443332  23355689999999


Q ss_pred             HHHhhhhCCCCCC-----CHHHHhcCccccccccccc
Q 018532          306 VSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       306 i~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~  337 (354)
                      |.+||+.+|++||     ++.++++||||+...+...
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~  267 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL  267 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999999999999     8999999999988655443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-49  Score=364.22  Aligned_cols=263  Identities=27%  Similarity=0.460  Sum_probs=220.3

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|+++....  .+..+.+..|+.++..+ +|+||+.+++.+...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            369999999999999999999999999986532  23456678888888777 699999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            9999999887889999999999999999999998 999999999999999999999999999987543333334456899


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||..................+...  +...+..++..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHH
Confidence            99999999999999999999999999999999999997543322212222223333332  2234567899999999999


Q ss_pred             hhhCCCCCCC------HHHHhcCcccccccccccc
Q 018532          310 IQKDPRDRSS------SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       310 l~~~p~~Rps------~~eil~hp~~~~~~~~~~~  338 (354)
                      |..||++|++      +.++++||||+...+....
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~  272 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE  272 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHH
Confidence            9999999998      5799999999998765543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-49  Score=370.86  Aligned_cols=264  Identities=28%  Similarity=0.447  Sum_probs=221.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ....++|++.+.||+|+||+||++++..+++.||+|+++...  .......+.+|+.+++.++|+||+++++.+.+++.+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456789999999999999999999999999999999997532  122334577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999999876 468899999999999999999998 999999999999999999999999999998764332


Q ss_pred             C-CCcccccCCcccccccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          221 G-QRDTFVGTYNYMSPERISGS----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      . .....+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.+....       .....+.........+
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~  269 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKNSLTFP  269 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCCcCCCC
Confidence            2 22345799999999998754    3789999999999999999999999765432       2334444332222222


Q ss_pred             --CCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccc
Q 018532          296 --DQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       296 --~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~  335 (354)
                        ..++.++.+||.+||+.+|.+  |+|++++++||||+...+.
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence              357999999999999999988  9999999999999976543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-50  Score=367.77  Aligned_cols=259  Identities=32%  Similarity=0.535  Sum_probs=234.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe-EEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-ISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~lv  143 (354)
                      .++|..++++|+|+||.+++++++.+++.|++|.+.... .+..+....+|+.+++++.|||||.+.+.|..++. +++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            578999999999999999999999999999999998664 34455689999999999999999999999999888 9999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          144 LEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |+||+||+|.+.+.+.+  .++++.+..|+.|++.|+.|||+ +.|+|||||+.||++++++.|||+|||+|+.++....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            99999999999998754  68999999999999999999996 8899999999999999999999999999999988876


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...+.+||+.||.||.+.+.+|+.|+|||||||++|||++-+.+|.+.+-.       .+..++.... -...+..++.+
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------~Li~ki~~~~-~~Plp~~ys~e  233 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------ELILKINRGL-YSPLPSMYSSE  233 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-------HHHHHHhhcc-CCCCCccccHH
Confidence            778889999999999999999999999999999999999999999877543       5666666655 33446678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      +..+|..||..+|+.||++.++|.+|.+....
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999999999988654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-49  Score=365.23  Aligned_cols=257  Identities=32%  Similarity=0.498  Sum_probs=228.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+.|++.+.||+|.||.||.|+++.||+.+|+|++.+....  .....+.+|+.+++.+. |+|||.+++.|.+...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            46788889999999999999999999999999999765432  24577999999999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC----CcEEEeecccccccCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK----GEVKITDFGVSAMLGS  218 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~~~  218 (354)
                      |||+|.||.|.+.+... .+++..+..++.|++.|+.|||+ .||+||||||+|+|+...    +.+|++|||+|.....
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999876 59999999999999999999998 999999999999999654    4799999999998876


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--CCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPD  296 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  296 (354)
                       .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+....       +....+..+..  ....+.
T Consensus       192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-------~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  192 -GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-------EIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             -CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-------HHHHHHHcCCCCCCCCCcc
Confidence             45667789999999999999999999999999999999999999999887654       23334554433  344567


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      .++..+.++|.+||..||..|+|+.++|+|||++..
T Consensus       264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            789999999999999999999999999999999875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-51  Score=342.41  Aligned_cols=264  Identities=27%  Similarity=0.471  Sum_probs=228.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeec
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-------QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHN  137 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~  137 (354)
                      .+.|.-.+.||.|..++|.++.++.+|..+|+|++....       ..+.+..-.+|+.|++.+ .||+|+.+.+.|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            456777788999999999999999999999999986432       234556678899999885 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..+++|+|.|+.|.|++++...-.++++..+.|++|++.|++|||. ++|+||||||+|||++++.++||+|||+|+.+.
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999999998889999999999999999999998 999999999999999999999999999999986


Q ss_pred             CCcCCCcccccCCcccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISG------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      .. ......||||+|+|||.+.-      ..|+..+|+||+|+++|.|+.|.+||-...       -.-+++.+..+...
T Consensus       175 ~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  175 PG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGKYQ  246 (411)
T ss_pred             Cc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhcccc
Confidence            54 44566799999999998843      258889999999999999999999995432       12455667777655


Q ss_pred             CC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          292 TA--PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       292 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ..  .+.+++....+||.+||+.||.+|.|++|+|.||||..+......
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence            43  356789999999999999999999999999999999877554443

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-49  Score=365.34  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=217.8

Q ss_pred             cccccccccccCceEEEEEEEc---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNI---QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +|++.+.||+|+||+||++++.   .+++.||+|++....   .....+.+..|+.++..+ +|+||+.+++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998864   478999999997542   223345678899999998 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+++|+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999998654322


Q ss_pred             C-CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 G-QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      . .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..........   .....+....  ...+..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~~--~~~~~~~  234 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKCD--PPFPSFI  234 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcCC--CCCCCCC
Confidence            2 22346799999999999875 47889999999999999999999997554332221   2223333322  2334568


Q ss_pred             CHHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~  335 (354)
                      +..+.+++.+||+.||++||     +++++++||||+...+.
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            99999999999999999999     88899999999976543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-49  Score=372.55  Aligned_cols=260  Identities=25%  Similarity=0.429  Sum_probs=218.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +|.+++.||+|+||+||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+++.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999999999999999987542  23445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC------
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS------  219 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------  219 (354)
                      |+++|+|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++......      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999888889999999999999999999998 89999999999999999999999999997532100      


Q ss_pred             -----------------------------------------cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHH
Q 018532          220 -----------------------------------------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE  258 (354)
Q Consensus       220 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  258 (354)
                                                               .......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                     000123479999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCccccccc
Q 018532          259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESP--PPTAPPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFE  333 (354)
Q Consensus       259 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~  333 (354)
                      |++|+.||.+.+..       +....+....  ........+++++.++|.+|+ .+|++|++   +.++++||||+...
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         241 MLVGQPPFLAQTPL-------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHhCCCCCCCCCHH-------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            99999999765432       2222222221  122223468999999999976 59999997   99999999999876


Q ss_pred             ccc
Q 018532          334 DKD  336 (354)
Q Consensus       334 ~~~  336 (354)
                      +..
T Consensus       313 ~~~  315 (382)
T cd05625         313 FSS  315 (382)
T ss_pred             hHH
Confidence            543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-49  Score=365.24  Aligned_cols=267  Identities=28%  Similarity=0.473  Sum_probs=220.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHH-HHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELK-INQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+|+.||+|++....  .......+..|.. +++.++|+||+++++.+..++..++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997543  2223344555554 56779999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|..++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987644333344456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..       +....+.....  ......+..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHKPL--VLRPGASLTAWSILEEL  230 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcCCc--cCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765432       33333333322  22335789999999999


Q ss_pred             hhhCCCCCCCH----HHHhcCccccccccccccccccccCCCCC
Q 018532          310 IQKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       310 l~~~p~~Rps~----~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      |..+|.+||++    .++++||||+...+.........+++.|.
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~  274 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPN  274 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence            99999999986    59999999998877665544444444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.7e-49  Score=368.47  Aligned_cols=264  Identities=27%  Similarity=0.449  Sum_probs=219.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ....++|++.+.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+++.+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            445688999999999999999999999999999999986532  223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999976 468999999999999999999998 999999999999999999999999999998764332


Q ss_pred             C-CCcccccCCcccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC-
Q 018532          221 G-QRDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-  294 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (354)
                      . .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||......       .....+......... 
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~p  269 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNSLNFP  269 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcccCCC
Confidence            2 224567999999999997643    788999999999999999999999765432       233344433222222 


Q ss_pred             -CCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccc
Q 018532          295 -PDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       295 -~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~  335 (354)
                       ...++..+.+++..||..++.+  |+++.++++||||+...+.
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~  313 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN  313 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence             2357999999999999865543  8999999999999986543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-49  Score=357.08  Aligned_cols=262  Identities=24%  Similarity=0.418  Sum_probs=212.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||+||+|+++.+++.||+|+++.... ......+.+|+.+++.++|+||+++++.+...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            468899999999999999999999999999999875432 3345667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CCc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~  224 (354)
                      |++++.+..+......+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99987776655555679999999999999999999998 9999999999999999999999999999987643222 223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HHHHHcC------CC
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LEAIVES------PP  290 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~------~~  290 (354)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...        .......      ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            457899999999999988999999999999999999999999765432111111000        0000000      00


Q ss_pred             CC---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          291 PT---------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       291 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +.         .....++..+.+||.+||++||++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00         0012368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-49  Score=370.00  Aligned_cols=262  Identities=29%  Similarity=0.463  Sum_probs=220.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++...  ..+....+.+|+.++..++|++|+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999999999999997532  2334567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc----
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM----  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----  220 (354)
                      ||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .||+||||||+||+++.+|.+||+|||++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999999888889999999999999999999998 999999999999999999999999999987542210    


Q ss_pred             -------------------------------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 018532          221 -------------------------------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS  269 (354)
Q Consensus       221 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  269 (354)
                                                     ......+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                           0012357999999999999999999999999999999999999999766


Q ss_pred             CcCCChhhHHHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCccccccccccc
Q 018532          270 EDQQSWPSFYELLEAIVESPPPT--APPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~~  337 (354)
                      ...       +....+.......  .....+++++.+||.+|+ .||.+|++   +.++++||||+.+.+..+
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         240 TPQ-------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             CHH-------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence            543       2233333221111  112247899999999977 49999984   899999999999877665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-49  Score=366.23  Aligned_cols=263  Identities=25%  Similarity=0.450  Sum_probs=221.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|+++....  .+..+.+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            368899999999999999999999999999999976432  334566888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            999999999999876 679999999999999999999998 99999999999999999999999999999876543222 


Q ss_pred             CcccccCCccccccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CC
Q 018532          223 RDTFVGTYNYMSPERIS------GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--AP  294 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  294 (354)
                      .....||+.|+|||++.      +..++.++|||||||++|+|++|..||......       .....+.......  ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~  232 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLKFPE  232 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccCCCC
Confidence            22347899999999987      456789999999999999999999999765432       2223333222111  12


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ...++.++.+||.+||+ +|++|||+.++++||||+...+..+.
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~  275 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIR  275 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHh
Confidence            23578999999999998 99999999999999999988776543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-49  Score=362.85  Aligned_cols=255  Identities=29%  Similarity=0.484  Sum_probs=214.1

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHH-HHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQEL-KINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|++.....  ......+..|. .+++.++|+||+++++.+...+.+++||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            369999999999999999999999999975431  12223344444 456778999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999997654333344556899


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||......       +....+....  ......++..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~--~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKP--LQLKPNITNSARHLLEGL  230 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC--cCCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765432       2233333332  223446899999999999


Q ss_pred             hhhCCCCCCCHH----HHhcCccccccccccc
Q 018532          310 IQKDPRDRSSSL----DLLSHPFIKKFEDKDI  337 (354)
Q Consensus       310 l~~~p~~Rps~~----eil~hp~~~~~~~~~~  337 (354)
                      |+.||.+|+++.    ++++|+||....+..+
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence            999999999876    8999999988776554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-50  Score=334.36  Aligned_cols=273  Identities=34%  Similarity=0.657  Sum_probs=236.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~  141 (354)
                      ....++++.+..||.|+.|+|++++.+.+|...|||.+.++...+..++++..+.+.... .+|.||+++++|..+..++
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            345678889999999999999999999999999999999988888889999999876655 4899999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +.||.|. ..+..+++.. ++++|..+-++...++.||.||....+|+|||+||+|||+|..|++||||||++..+-+..
T Consensus       168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9999995 4788877765 5788888999999999999999988899999999999999999999999999998876554


Q ss_pred             CCCcccccCCcccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC-C
Q 018532          221 GQRDTFVGTYNYMSPERISGS---TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP-D  296 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  296 (354)
                      .. ....|.+.|||||.+.-.   .|+.++||||||++++||.||.+||.+.+.+      ++.+-.+....++.... .
T Consensus       247 Ah-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------Fe~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  247 AH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------FEVLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             cc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------HHHHHHHHhcCCCCCCccc
Confidence            33 334899999999999754   5899999999999999999999999987654      35666666655544333 3


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                      .+|+.+++|+..||++|+.+||...++|+|||++..+.-+.+...|-
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF  366 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWF  366 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHH
Confidence            48999999999999999999999999999999999988777766653

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-49  Score=363.22  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=217.2

Q ss_pred             ccccccCceEEEEEEE---ccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           73 KVIGKGSGGVVQLVRH---KWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      +.||+|+||.||++++   ..+|+.||+|+++.... ......+.+|+.+++.++|+||+++++.+..++.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999886   35789999999976432 2234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      +++|.+++.+...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..............|
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999887889999999999999999999998 99999999999999999999999999999876544344445689


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      |+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..       +....+.....  ..+..+++++.+||.+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~~li~~  231 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKAKL--GMPQFLSPEAQSLLRA  231 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence            99999999999988999999999999999999999999765432       23333333322  2345689999999999


Q ss_pred             hhhhCCCCCCC-----HHHHhcCcccccccccc
Q 018532          309 CIQKDPRDRSS-----SLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       309 ~l~~~p~~Rps-----~~eil~hp~~~~~~~~~  336 (354)
                      ||+.||++||+     +.++++||||+...+..
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~  264 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK  264 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence            99999999999     77899999998875543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.9e-48  Score=353.32  Aligned_cols=275  Identities=43%  Similarity=0.774  Sum_probs=229.8

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|+++++.++|+||+++++.+..++.++++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999999999999999987765666667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  158 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  158 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence            9999999999988889999999999999999999997458999999999999999999999999998765332  22345


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh-----------------------------hh
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-----------------------------PS  277 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------------------------~~  277 (354)
                      .++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.....                             ..
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            7899999999998888999999999999999999999998644321100                             01


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          278 FYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                      ..+..........+......++.++.+|+.+||..+|++|||+.++++||||.+....+..+.-|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~  304 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVDFAGWV  304 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccchhhhhh
Confidence            112222222222233233347889999999999999999999999999999998777766655553

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.2e-49  Score=359.38  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=214.2

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHH-HHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELK-INQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~-~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||+||+|++..+++.||+|++.....  ......+..|.. +++.++|+||+++++.+.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999999999999999875432  223344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|...+...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.+|.+||+|||++.............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            9999999887889999999999999999999998 999999999999999999999999999987643333334456799


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+..       .....+....  ...+...+..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~--~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------QMYDNILHKP--LQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-------HHHHHHhcCC--CCCCCCCCHHHHHHHHHH
Confidence            9999999999989999999999999999999999999765432       2333343332  233456789999999999


Q ss_pred             hhhCCCCCCCH----HHHhcCccccccccccc
Q 018532          310 IQKDPRDRSSS----LDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       310 l~~~p~~Rps~----~eil~hp~~~~~~~~~~  337 (354)
                      |+.||++|+++    .++++|+||....+...
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPINWDDL  262 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHH
Confidence            99999999975    59999999988766443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.6e-48  Score=347.82  Aligned_cols=266  Identities=40%  Similarity=0.741  Sum_probs=225.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..+...+....+.+|+.++..++|+|++++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999999999999999997665555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|..+    ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            999998654    457888999999999999999998 99999999999999999999999999999765432  23345


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .|+..|+|||++.+..++.++|+|||||++|+|++|+.||..................+.....+.......++++.+++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            78999999999999899999999999999999999999997644332222222333333333333333456789999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                      .+||+.+|++||++.++++||||.....+.+++
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~  266 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV  266 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcCcccccccCccHHH
Confidence            999999999999999999999999998877764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-48  Score=352.08  Aligned_cols=265  Identities=25%  Similarity=0.404  Sum_probs=222.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .|++.+.||+|+||+||++.+..+++.||+|++.....  ......+.+|+.+++.++|+||+.+++.+...+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            37788999999999999999999999999999875432  2223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          146 YMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||++++++.++|+|||++...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Ccc
Confidence            99999999888654  458999999999999999999998 89999999999999999999999999998765432 222


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ....|++.|+|||++.+..++.++||||+||++|+|++|..||.+.......   .+....+...  ....+..++..+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~  233 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED--QEEYSEKFSEAAR  233 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc--ccccCcccCHHHH
Confidence            3457899999999999888999999999999999999999999865433211   1222222222  2223456899999


Q ss_pred             HHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccc
Q 018532          304 SFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       304 ~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~  339 (354)
                      +||.+||..||++||     +++++++||||+...+++...
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            999999999999999     899999999999988877664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-48  Score=364.60  Aligned_cols=261  Identities=20%  Similarity=0.303  Sum_probs=211.5

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +...+|.+++.||+|+||.||+|.+..+++.||+|...       ...+.+|+.+++.++|+||+++++.+..+...+++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            45678999999999999999999999999999999743       23467899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC-cCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-MGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~  222 (354)
                      +|++. ++|..++.....+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+|...... ...
T Consensus       162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            99995 6999999887889999999999999999999998 89999999999999999999999999999754322 122


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC----hhhH--------------------
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS----WPSF--------------------  278 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~--------------------  278 (354)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........    ...+                    
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            3345799999999999999999999999999999999999988754322110    0000                    


Q ss_pred             --HHHHHHHHcCCC--CCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          279 --YELLEAIVESPP--PTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       279 --~~~~~~~~~~~~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                        .+..........  +..     ....++.++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence              000000000000  000     0113567899999999999999999999999999998743

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=358.81  Aligned_cols=281  Identities=26%  Similarity=0.431  Sum_probs=242.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ....+.|..-++||+||||.||.++.+.||+.||.|.+.+....  ......+.|-.|+..++.+.||.+-.+|++.+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            45677888899999999999999999999999999988654322  2234578899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|+..|.||+|.-+|.+.+  .+++..+..++.+|+.||++||. .+||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999999888765  79999999999999999999998 8899999999999999999999999999998865


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      . ....+.+||.+|||||++.+..|+...|+|||||+||||+.|+.||........+.   ++.+.+...  +...++..
T Consensus       340 g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~~--~~ey~~kF  413 (591)
T KOG0986|consen  340 G-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLED--PEEYSDKF  413 (591)
T ss_pred             C-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhcc--hhhccccc
Confidence            4 33445599999999999999999999999999999999999999997665443221   223333332  23345789


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCCC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      |+++.+|.+.+|++||++|...     +++-+||||+.++++.+..+.+.||+-|+.
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp  470 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP  470 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence            9999999999999999999864     699999999999999999988888888775

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.2e-48  Score=361.47  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=219.4

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .....++|++.+.||+|+||.||+|+++.+++.||+|++....  .......+.+|+.+++.++|+||+++++.+...+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            4566789999999999999999999999999999999986532  22334557889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +++||||++||+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999999999876 468999999999999999999998 99999999999999999999999999999876433


Q ss_pred             cC-CCcccccCCcccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--CC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PT  292 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  292 (354)
                      .. .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+..       .....+.....  ..
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~  268 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLTF  268 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCcccC
Confidence            22 233567999999999997643    788999999999999999999999765432       23334433222  22


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCcccccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~  334 (354)
                      .....++..+.++|..||..++.+  |+++.++++|+||+...+
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            223468999999999999844433  789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-48  Score=358.89  Aligned_cols=266  Identities=25%  Similarity=0.373  Sum_probs=212.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~  141 (354)
                      +|++.+.||+|+||.||+|++..++..||||.+.... .......+.+|+.+++.++|+||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5788999999999999999999999999999986432 223345688999999999999999999987543     3589


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++........
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 6999999888889999999999999999999998 9999999999999999999999999999976432211


Q ss_pred             ---CCcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH------------------
Q 018532          222 ---QRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF------------------  278 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------------  278 (354)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+                  
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234579999999999876  57899999999999999999999999765422110000                  


Q ss_pred             --HHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          279 --YELLEAIVESPPPT--APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       279 --~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                        ......+....+..  .....+++.+.++|.+||+.||++|||++++++||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence              00011111111100  0112467889999999999999999999999999999886653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.1e-49  Score=356.83  Aligned_cols=269  Identities=25%  Similarity=0.427  Sum_probs=217.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||+|+||+||+++++.+++.||+|.++..........+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            47799999999999999999999999999999998765443334557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            9975 888888765 357889999999999999999998 9999999999999999999999999999976544433344


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------HHH------HcCC
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------EAI------VESP  289 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~------~~~~  289 (354)
                      ...+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....        ..+      ....
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            4578999999999876 458899999999999999999999997665432111111100        000      0000


Q ss_pred             CCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          290 PPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 ~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+.       .....++.++.+||.+||+.||.+|||+.|+++||||+....+-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence            000       01134788999999999999999999999999999999876443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-49  Score=360.73  Aligned_cols=254  Identities=27%  Similarity=0.440  Sum_probs=211.2

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      ||+|+||+||+|++..+++.||+|++.....  .........|..++...   .|+||+.+++.+...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999865321  22233445566665554   799999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      |+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987654443444556899


Q ss_pred             CcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          230 YNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       230 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||...+..       +....+...... .....+++++.+||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~-~~~~~~~~~~~~li~~  231 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKVR-FPKNVLSDEGRQFVKG  231 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence            999999998765 4899999999999999999999999765432       333344333222 2233578999999999


Q ss_pred             hhhhCCCCCC----CHHHHhcCccccccccccc
Q 018532          309 CIQKDPRDRS----SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       309 ~l~~~p~~Rp----s~~eil~hp~~~~~~~~~~  337 (354)
                      ||..||.+||    ++.++++||||+...+...
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~  264 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADIDWDLL  264 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCCCHHHH
Confidence            9999999998    6899999999998765443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-49  Score=347.63  Aligned_cols=262  Identities=30%  Similarity=0.455  Sum_probs=214.3

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--C---eEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--G---VISL  142 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~---~~~l  142 (354)
                      .|.-.+++|+|+||+||.+....++..||||.+-.+..     .--+|+.+++.+.|||||++..+|...  +   ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            46677899999999999999999999999998743321     234689999999999999999888753  2   4558


Q ss_pred             EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-CcEEEeecccccccC
Q 018532          143 VLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLG  217 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  217 (354)
                      ||||++. +|...++.    ...++...++.+..||++||.|||+ .||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            9999985 99999985    4678888999999999999999998 999999999999999976 899999999999876


Q ss_pred             CCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH-----HHHH-----
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL-----EAIV-----  286 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----~~~~-----  286 (354)
                      ... ...++..|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.+..++...+..++     +.+.     
T Consensus       178 ~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            543 34567889999999999986 59999999999999999999999999876554333322221     0111     


Q ss_pred             ----------cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          287 ----------ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       287 ----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                                ............++++.+|+.++|+++|.+|.++.|++.||||..+++.+.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~  317 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT  317 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence                      001111134567899999999999999999999999999999999988653

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.8e-48  Score=347.53  Aligned_cols=271  Identities=25%  Similarity=0.442  Sum_probs=222.7

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      |+..+.||+|+||+||++.+..+++.||+|.+.....  ......+.+|+.+++.++|++++.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            5677889999999999999999999999999865432  22335577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +.|++|.+++...  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....... ...
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK  159 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence            9999999988654  358899999999999999999998 999999999999999999999999999987654322 223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...|+..|+|||.+.+..++.++|||||||++|+|++|..||............    ....... ....+..+++++.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  234 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----ERLVKEV-QEEYSEKFSPDARS  234 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----Hhhhhhh-hhhcCccCCHHHHH
Confidence            457899999999999989999999999999999999999999765432211111    1111111 12234568899999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCC
Q 018532          305 FVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSL  346 (354)
Q Consensus       305 li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~  346 (354)
                      |+.+||+.||++|||     +.|+++||||+......+......+++
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~  281 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF  281 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCC
Confidence            999999999999999     899999999999877766653333333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-49  Score=357.37  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=218.0

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      -.|++..+.+..++.||+|-||.||.+..+ ....||+|.++.....  ...+.+|+.++++|+|++||++++++..++.
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            346778888999999999999999999976 3337999998764221  2457799999999999999999999999889


Q ss_pred             EEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      +||||||++.|+|.++++.  ...+...+...++.||++|++||++ +++|||||...||||++++.+||+|||+|+...
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEcccccccccC
Confidence            9999999999999999997  4678899999999999999999998 889999999999999999999999999999655


Q ss_pred             CCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          218 SSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       218 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      +... .....--+..|.|||++..+.++.+|||||||++||||+| |+.||.+....       ++++.+..+. ....|
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-------ev~~~le~Gy-Rlp~P  426 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-------EVLELLERGY-RLPRP  426 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-------HHHHHHhccC-cCCCC
Confidence            4332 2223345779999999999999999999999999999998 99999887654       5566655554 45556


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..||+++.+++..||..+|++|||++.+..
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            789999999999999999999999987643

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-48  Score=370.19  Aligned_cols=267  Identities=22%  Similarity=0.387  Sum_probs=209.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-------  137 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-------  137 (354)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++.....     ...+|+.+++.++|+||+++++.+...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            45689999999999999999999999999999998854322     234699999999999999998876432       


Q ss_pred             -CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecc
Q 018532          138 -GVISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFG  211 (354)
Q Consensus       138 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg  211 (354)
                       ..+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             257799999975 78777653    3568999999999999999999998 9999999999999999765 79999999


Q ss_pred             cccccCCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------
Q 018532          212 VSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------  282 (354)
Q Consensus       212 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------  282 (354)
                      +|....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+...+        
T Consensus       217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            998764332 23345789999999998764 68999999999999999999999998765432211111100        


Q ss_pred             HHH----HcCCCC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          283 EAI----VESPPP--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       283 ~~~----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                      ...    .....+        ...+...++++.+||.+||++||.+|||+.|+++||||+.+.+.....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~  364 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKL  364 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccC
Confidence            000    000000        012335688999999999999999999999999999999887755443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-48  Score=356.84  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=210.1

Q ss_pred             cccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFY  135 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~  135 (354)
                      |.+..++|++.+.||+|+||.||+|.+     ..+++.||+|+++..........+.+|+.++..+ +|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            567788999999999999999999975     2346789999997655555567789999999998 8999999999877


Q ss_pred             ec-CeEEEEEeccCCCCHHHHHHHh-------------------------------------------------------
Q 018532          136 HN-GVISLVLEYMDRGSLADIIRQV-------------------------------------------------------  159 (354)
Q Consensus       136 ~~-~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  159 (354)
                      .. +.++++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 4689999999999999999753                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--CCcccccCC
Q 018532          160 -------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTY  230 (354)
Q Consensus       160 -------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~  230 (354)
                             ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++........  ......++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                   236777888999999999999998 9999999999999999999999999999986533211  122334567


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      .|+|||++.+..++.++|||||||++|||++ |..||.+....+      .....+..+ .....+..+++.+.+++.+|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDG-TRMRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcC-CCCCCCCCCCHHHHHHHHHH
Confidence            8999999999899999999999999999997 999997654321      122222222 23334567899999999999


Q ss_pred             hhhCCCCCCCHHHHhc
Q 018532          310 IQKDPRDRSSSLDLLS  325 (354)
Q Consensus       310 l~~~p~~Rps~~eil~  325 (354)
                      |+.||++|||+.++++
T Consensus       314 l~~dp~~RPs~~el~~  329 (338)
T cd05102         314 WQGDPKERPTFSALVE  329 (338)
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-47  Score=344.44  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=215.7

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||+|+||+||+++++.+|+.||+|.+.....  ......+..|+.+++.++|+||+++++.+..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999864322  12234566799999999999999999999999999999999999999


Q ss_pred             HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          153 ADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       153 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      .+++....  .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++....... ......|+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence            98886543  57888899999999999999998 999999999999999999999999999987664432 223347899


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||++.+..++.++|||||||++|+|++|..||........   ..+........... .....++.++.+|+.+||
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTLEDEVK-FEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhhccccc-cccccCCHHHHHHHHHHh
Confidence            99999999998899999999999999999999999976443211   11222222222221 223468999999999999


Q ss_pred             hhCCCCCCCH----HHHhcCccccccccccccccccccC
Q 018532          311 QKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVGS  345 (354)
Q Consensus       311 ~~~p~~Rps~----~eil~hp~~~~~~~~~~~~~~~~~~  345 (354)
                      ++||++||++    ++++.||||+...+.........+|
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~  273 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPP  273 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCC
Confidence            9999999999    6788999999887766655444433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.1e-48  Score=362.11  Aligned_cols=262  Identities=27%  Similarity=0.478  Sum_probs=217.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-C-----CceEEeeeeeeecCeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-C-----SHVVVCYHSFYHNGVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h-----~~iv~~~~~~~~~~~~  140 (354)
                      .+|++++.||+|+||.|-+|.+..|++.||||+++..  ..+..+...|++++..++ |     -|+|+++++|...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3889999999999999999999999999999999753  566777889999999987 3     4799999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC--cEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG--EVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~  216 (354)
                      |||+|.+.. +|.++++.+  ..++...++.++.||+.||.+||+ .+|||+||||+||||...+  .|||+|||.|+..
T Consensus       264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999964 999999976  468899999999999999999997 9999999999999997655  6999999999987


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH--------H----
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE--------A----  284 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~----  284 (354)
                      ....   .+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+....+.+++-        .    
T Consensus       342 ~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  342 SQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             CCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            6543   367899999999999999999999999999999999999999988775543332222110        0    


Q ss_pred             -----------------------------------HHcCCCCCC-------CCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 018532          285 -----------------------------------IVESPPPTA-------PPDQFSPEFCSFVSACIQKDPRDRSSSLD  322 (354)
Q Consensus       285 -----------------------------------~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~e  322 (354)
                                                         ......+..       ........+.+||++||..||.+|+|+.+
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence                                               000000000       00122356899999999999999999999


Q ss_pred             HhcCccccccccc
Q 018532          323 LLSHPFIKKFEDK  335 (354)
Q Consensus       323 il~hp~~~~~~~~  335 (354)
                      +|+|||+......
T Consensus       499 al~Hpfl~~~~~~  511 (586)
T KOG0667|consen  499 ALNHPFLTGTSLE  511 (586)
T ss_pred             HhcCccccccccc
Confidence            9999999965443

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=352.16  Aligned_cols=258  Identities=28%  Similarity=0.476  Sum_probs=227.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .=|.+.+.||+|.|+.|-+|+|..||..||||++.+.. +.-....+.+|++.++.++|||||++|++......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45778899999999999999999999999999997654 33345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE-ccCCcEEEeecccccccCCCcCCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV-NHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +-++|+|+++|-++ ..++++.+.+++.||+.|+.|||+ ..+|||||||+||.+ .+-|-|||+|||++..+... ...
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL  175 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL  175 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence            99999999999776 579999999999999999999998 889999999999765 56789999999999877543 556


Q ss_pred             cccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .+.||+..|-|||++.|..|+ +++||||||||||.|+||+.||...++.+       .+-.++.-.  ...|+.++.++
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------TLTmImDCK--YtvPshvS~eC  246 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------TLTMIMDCK--YTVPSHVSKEC  246 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------hhhhhhccc--ccCchhhhHHH
Confidence            678999999999999999987 57999999999999999999998887764       344444433  44577899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ++||.+||..||.+|.|.++|..|+|++.....
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            999999999999999999999999999987553

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.6e-48  Score=353.98  Aligned_cols=263  Identities=25%  Similarity=0.427  Sum_probs=217.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+.+.||+|+||+||++++..+++.||+|++....  .......+.+|..++..++|++|+.+++.+.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999987532  2233455788899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      ||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......... 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999874 678999999999999999999998 99999999999999999999999999999766543222 


Q ss_pred             CcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC---CCC
Q 018532          223 RDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP---TAP  294 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  294 (354)
                      .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...+..       +....+......   +..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~  232 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERFQFPSH  232 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCcccCCCc
Confidence            223579999999999876     45788999999999999999999999765432       223333332211   112


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ...++.++.++|.+||..++++  |++++++++||||+...+..+
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            2357899999999999876544  568999999999998766444

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-47  Score=352.35  Aligned_cols=263  Identities=24%  Similarity=0.396  Sum_probs=215.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+..  .....+.+.+|+.++..++|+||+.+++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999999999999999987532  2233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      ||++||+|.+++.+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999763 578999999999999999999998 99999999999999999999999999998765443222 


Q ss_pred             CcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC---CCCC
Q 018532          223 RDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP---PTAP  294 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  294 (354)
                      .....||+.|+|||++..     ..++.++|||||||++|+|++|+.||......       +....+.....   ....
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~  232 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQFPPD  232 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCcccCCCc
Confidence            223469999999999873     35788999999999999999999999765432       22223322211   1112


Q ss_pred             CCCCCHHHHHHHHHhhhhCCC--CCCCHHHHhcCccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPR--DRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~--~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ...++..+.++|.+||..+++  .|+++.++++||||+...+...
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence            235799999999998875443  3789999999999988765443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=341.62  Aligned_cols=262  Identities=38%  Similarity=0.623  Sum_probs=226.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|.+.+.||.|++|.||++.+..+++.||+|++...........+.+|+.+++.++|+|++++++.+.++..+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999999999999999997665445556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.............
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            9999999999874 78999999999999999999998 899999999999999999999999999998876554444556


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..       .....+.....+......++.++.+++
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCcccccCHHHHHHH
Confidence            7889999999999988999999999999999999999999765432       222223333333222223889999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      .+||..+|++|||++++++||||++...+++
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  262 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKTSY  262 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcccH
Confidence            9999999999999999999999999877754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-51  Score=344.87  Aligned_cols=261  Identities=36%  Similarity=0.637  Sum_probs=230.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +-|.++.+||+|+||.||+|.|+.+|+.+|||.+...   ...+++..|+.|++..+.+++|++|+.|.....+++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            4467899999999999999999999999999998754   3357789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |..|++.++++.. +++++.++..+++.-+.||+|||. ..-||||||..|||++.+|.+||+|||.|.++.+......+
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            9999999999854 789999999999999999999998 55789999999999999999999999999999887777888


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..|||.|||||++..-.|+.++||||||++..||..|++||....+..      .++.--...++....+..++.++.++
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeEeccCCCCCCCCChHhhhhHHHHH
Confidence            999999999999999999999999999999999999999998766542      11111222333344456789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      +++||-++|++|-|+.++++|||+++...-.+
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I  294 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHTFIKNAPGCDI  294 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhhhhcCCCcccH
Confidence            99999999999999999999999998766554

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-47  Score=351.84  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=216.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....  .......+.+|+.++..++|++|+.+++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999999999999999986432  2233445788899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-C
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-Q  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~  222 (354)
                      ||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999874 678999999999999999999998 9999999999999999999999999999876543222 2


Q ss_pred             CcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC---CCC
Q 018532          223 RDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP---TAP  294 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  294 (354)
                      ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..       +....+......   +..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~  232 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQFPAQ  232 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCccccCCCc
Confidence            23357999999999986     345889999999999999999999999765432       233333332211   122


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ...+++++.+||.+||..++++  |++++++++||||+.+.+..+
T Consensus       233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence            3467999999999999664444  789999999999998776544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-47  Score=336.51  Aligned_cols=255  Identities=29%  Similarity=0.484  Sum_probs=218.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++|.+.+.||+|++|.||.+.+..+++.||+|.+.....    ....+.+.+|+.+++.++|+||+++++.+..+..+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            468889999999999999999999999999999865421    2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ++||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999888889999999999999999999998 99999999999999999999999999998765432111


Q ss_pred             C---cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          223 R---DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       223 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..       ...............+..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLPSHVS  233 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCCCccCC
Confidence            1   2346788999999999988999999999999999999999999754322       22222333333344556789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ..+.++|.+||..+|++|||+.++++|+||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.2e-48  Score=348.04  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             ccccccccccccCceEEEEEEEcc-CCcEEEEEEeeccccH-HHHHHHHHHHHHHhhc---CCCceEEeeeeee-----e
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNIQE-EIRKQIVQELKINQAS---QCSHVVVCYHSFY-----H  136 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~-----~  136 (354)
                      ++|++.+.||+|+||+||+|++.. +++.||+|+++..... .......+|+.+++.+   .|+||+++++.+.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368899999999999999999854 5788999998754322 2233455666666554   7999999999875     2


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ...+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            457899999997 5999998764  358899999999999999999998 999999999999999999999999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC-----
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-----  289 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  289 (354)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+..+.+....+   ........     
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i---~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPGEEDWP  234 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHHhCCCChhhch
Confidence            66443 2334457899999999999889999999999999999999999999876543211111   11100000     


Q ss_pred             -------------C---CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          290 -------------P---PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       290 -------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                                   .   .......++..+.+|+.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                         0   000112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.1e-47  Score=342.83  Aligned_cols=272  Identities=31%  Similarity=0.501  Sum_probs=233.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++....  ..+....+.+|+++++.+.|+||+++++.+...+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999999999999999987543  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            999999999999988889999999999999999999998 99999999999999999999999999999876543   33


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..       ...+.+..+..  ..+..++..+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~--~~~~~~~~~l~~  227 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV--RFPSFFSPDAKD  227 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc--cCCccCCHHHHH
Confidence            457899999999998888899999999999999999999999765421       22333333322  234567999999


Q ss_pred             HHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          305 FVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       305 li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +|.+||..||.+|+     +++++++||||+...+..........++.|+..
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK  279 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCC
Confidence            99999999999999     899999999999998877665566666666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.3e-48  Score=349.19  Aligned_cols=267  Identities=26%  Similarity=0.430  Sum_probs=216.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|.+.+.||.|+||.||++.+..++..||+|.++..........+.+|+.+++.++|+||+++++.+...+..++||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            35789999999999999999999999999999999876544444456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      ||++ ++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++..........
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            9997 5999888764 568899999999999999999998 999999999999999999999999999997654433333


Q ss_pred             cccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------HHHHcC------
Q 018532          224 DTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------EAIVES------  288 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~------  288 (354)
                      ....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+....        ..+...      
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            445678999999998764 47889999999999999999999997655322111111000        000000      


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          289 PPPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       289 ~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ..+.       .....+++++.+||.+||+.||.+|||++|+++||||+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0000       01235788999999999999999999999999999998876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-47  Score=342.36  Aligned_cols=270  Identities=38%  Similarity=0.667  Sum_probs=227.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++++.||+|+||.||++.+..++..||+|.+...........+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999999999999999987665555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          147 MDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       147 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +++++|..++...   ..+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence            9999999998763   378999999999999999999996468999999999999999999999999998765432  22


Q ss_pred             cccccCCcccccccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          224 DTFVGTYNYMSPERISGS------TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ....++..|+|||.+.+.      .++.++|+|||||++|+|++|+.||......    ........+..... ...+..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~-~~~~~~  233 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSAIVDGDP-PTLPSG  233 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHHHhhcCC-CCCCcc
Confidence            334688899999998554      3578999999999999999999999654322    22233333333332 333455


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                      ++.++.++|.+||+.+|++||++.+++.||||........++..|+
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~~  279 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV  279 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHHH
Confidence            8999999999999999999999999999999999887776665554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-47  Score=340.98  Aligned_cols=276  Identities=40%  Similarity=0.697  Sum_probs=230.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++++.||+|+||+||++.+..+++.||+|++.........+.+.+|+.+++.++|+||+++++.+...+.+++|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            45789999999999999999999999999999999876655666778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~~  160 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--AD  160 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--cC
Confidence            9999999999998878899999999999999999999974689999999999999999999999999987553322  23


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC----CChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ----QSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ...|+..|+|||++.+..++.++|+|||||++|+|++|..||......    .......+....+.....+......++.
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            457899999999998888999999999999999999999999765432    1112233344444443333333334788


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc-cccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED-KDIDLGIL  342 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~-~~~~~~~~  342 (354)
                      ++.+|+.+||+.||++|||+.|+++|+||.+... .+.+.-.|
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~~~~  283 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW  283 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCcccc
Confidence            9999999999999999999999999998876543 33343344

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-49  Score=345.55  Aligned_cols=279  Identities=27%  Similarity=0.469  Sum_probs=247.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      .+...+|..+.+||+|+||.|.++..+.|.+.||||++++..  +.+..+--+.|-+++... +.|.++.++..|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            456788999999999999999999999999999999998764  333344456666777665 56788999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||+.||+|--.+++.+.+.+..+..++..|+.||-+||+ +|||+||||.+||+++.+|++||+|||++...--.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999999999999999999999999999999999999998 99999999999999999999999999999887666


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .....++||||.|+|||++..++|+..+|+||+|++||||+.|++||.+.+..       ++.+.+.+..  ...+..+|
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------elF~aI~ehn--vsyPKslS  574 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQAIMEHN--VSYPKSLS  574 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHcc--CcCccccc
Confidence            67778899999999999999999999999999999999999999999988765       5555655543  34567899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      .++.++++..|.++|.+|..+     .+|-.||||+.+.|.+++-.-..+|+.|-+-
T Consensus       575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k  631 (683)
T KOG0696|consen  575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK  631 (683)
T ss_pred             HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence            999999999999999999875     5899999999999999988777888887763

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-49  Score=380.86  Aligned_cols=280  Identities=27%  Similarity=0.436  Sum_probs=237.0

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .....++|+++++||+|+||.|.+++++.|++.||+|++++-.  .......|..|-.++..-+.+-|+.++.+|+++.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3567899999999999999999999999999999999987521  12234568888899988899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|..++.+...++++.+++++..|+.||..||+ .|+|||||||+|||+|..|++||+|||.+-.+...
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            99999999999999999998899999999999999999999998 99999999999999999999999999999888754


Q ss_pred             cC-CCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      +. .....+|||.|.+||++..     +.|+..+|+||+||++|||+.|..||....-.+       ....|........
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-------TY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-------TYGKIMNHKESLS  301 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-------HHHHHhchhhhcC
Confidence            44 3456789999999999853     458999999999999999999999998765433       3333333322222


Q ss_pred             CC--CCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          294 PP--DQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       294 ~~--~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      .|  ..+|+++.+||.+.+.. |+.|..   ++++-.||||....|.++.  .-++|+-|-++.
T Consensus       302 FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR--~~~pP~vPevss  362 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIR--ESVPPVVPEVSS  362 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhh--hcCCCCCCcCCC
Confidence            22  45999999999998875 899999   9999999999999997775  445666666554

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-47  Score=339.40  Aligned_cols=256  Identities=34%  Similarity=0.615  Sum_probs=214.4

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHH-HHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      |++.+.||+|+||+||++++..+++.||+|++........ .....+|+.+++.++|+||+++++.+......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999999999999999987654433 334566999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccc
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV  227 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  227 (354)
                      ++++|.+++...+.+++..+..++.|++.||.+||+ .|++|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999977899999999999999999999998 8999999999999999999999999999986433334445568


Q ss_pred             cCCccccccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCCHHHHH
Q 018532          228 GTYNYMSPERIS-GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFSPEFCS  304 (354)
Q Consensus       228 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  304 (354)
                      ++..|+|||++. +..++.++||||||+++|+|++|..||.......    ...............  ......+..+.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD----QLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH----HHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchh----hhhhhhhcccccccccccccchhHHHHHH
Confidence            899999999998 7789999999999999999999999998662211    111222211111100  001122489999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-47  Score=365.18  Aligned_cols=261  Identities=30%  Similarity=0.458  Sum_probs=220.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-----
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-----  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----  138 (354)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||++.... .......+.+|+.++..++|+|+++++..+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            4578999999999999999999999999999999987543 3455667889999999999999999988765332     


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          139 ---VISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       139 ---~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                         .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence               478999999999999998753    468899999999999999999998 999999999999999999999999999


Q ss_pred             cccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          212 VSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       212 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...       .+....+....
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~~~  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLAGR  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCC
Confidence            998654321  223456799999999999999999999999999999999999999976532       23344444433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .. ..+..+++++.+++.+||+.||++||++.++++|||++....
T Consensus       262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            32 235578999999999999999999999999999999887544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.5e-47  Score=354.44  Aligned_cols=264  Identities=29%  Similarity=0.379  Sum_probs=213.7

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-----eEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-----VIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~  141 (354)
                      +|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++.+...+     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4678899999999999999999999999999986532 2234467889999999999999999999988766     899


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-  220 (354)
                      +|+||+. ++|.+++...+.+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999996 5899988877889999999999999999999998 999999999999999999999999999998654322 


Q ss_pred             CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH----------------HHH
Q 018532          221 GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE----------------LLE  283 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----------------~~~  283 (354)
                      .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+                ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            222334688999999999875 478999999999999999999999977654322111110                001


Q ss_pred             HHHcCCCCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          284 AIVESPPPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       284 ~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .+.......       ......++++.+||.+||+.||++|||+.++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            111111110       12234688999999999999999999999999999998853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-47  Score=353.31  Aligned_cols=263  Identities=26%  Similarity=0.410  Sum_probs=210.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+.+.||+|+||.||++.+..+|..||+|++.... .......+.+|+.+++.++|+||+++++.+...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            578999999999999999999999999999999986543 234456678999999999999999999988644      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+++ +|...+.  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            57999999975 6777664  358889999999999999999998 9999999999999999999999999999976533


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH---------------HHH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE---------------LLE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------------~~~  283 (354)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+....+               ...
T Consensus       176 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         176 N-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             C-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            2 222345789999999999999999999999999999999999999987654322111110               001


Q ss_pred             HHHcCCCCC------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          284 AIVESPPPT------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       284 ~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ......+..                  ......++++.+||.+||+.||++|||+.|+++||||....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence            111110000                  01112467899999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.8e-47  Score=362.69  Aligned_cols=257  Identities=22%  Similarity=0.355  Sum_probs=218.8

Q ss_pred             cccccccccccccCceEEEEEEEccC-CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWV-GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++|+||+++++.+..++..|+||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34589999999999999999998877 7889999875443 344456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||++||+|.+++...    ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999987642    468899999999999999999998 999999999999999999999999999998765432


Q ss_pred             C--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 G--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......       +....+..+... ..+..+
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~-~~~~~~  295 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYD-PFPCPV  295 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-CCCccC
Confidence            2  234557999999999999999999999999999999999999999765432       334444433332 234568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.++.++|.+||..||++||++.+++.|+|++.+
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            8999999999999999999999999999998754

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.9e-47  Score=340.53  Aligned_cols=271  Identities=25%  Similarity=0.416  Sum_probs=223.5

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      |...+.||+|+||+||++.+..+++.||+|.+.....  ......+.+|+.+++.++|+|++.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            5667889999999999999999999999999865432  22335578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ .||+||||||+||++++++.++|+|||++...... ....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            9999999888654  368999999999999999999998 99999999999999999999999999998765432 2223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...|+..|+|||++.+..++.++|+|||||++|+|++|..||........   ...........  ....+..++.++.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~  234 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET--EEVYSAKFSEEAKS  234 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc--ccccCccCCHHHHH
Confidence            45789999999999988899999999999999999999999976543211   11112222221  12234568899999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCC
Q 018532          305 FVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSL  346 (354)
Q Consensus       305 li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~  346 (354)
                      |+.+||+.||++||+     +.+++.|+||+.+..+++......+++
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  281 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF  281 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCC
Confidence            999999999999999     889999999999988776654444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6e-47  Score=363.46  Aligned_cols=268  Identities=22%  Similarity=0.350  Sum_probs=205.2

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC------CCceEEeeeeeeec
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ------CSHVVVCYHSFYHN  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------h~~iv~~~~~~~~~  137 (354)
                      ...++|++++.||+|+||+||+|.+..+++.||||+++...  ........|+.++..+.      |.+++.+++++..+
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34578999999999999999999999999999999986432  22233455666555544      45588888887754


Q ss_pred             -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-------------
Q 018532          138 -GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-------------  203 (354)
Q Consensus       138 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-------------  203 (354)
                       +++++|||++ |++|.+++.+.+.+++..+..++.||+.||.|||++.||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 6799999988888999999999999999999999735899999999999998765             


Q ss_pred             ---cEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH
Q 018532          204 ---EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE  280 (354)
Q Consensus       204 ---~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  280 (354)
                         .+||+|||.+.....   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..
T Consensus       283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence               499999998864322   23356899999999999999999999999999999999999999977554321111100


Q ss_pred             HH----------------HHHHcC-C--CCCC--------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCc
Q 018532          281 LL----------------EAIVES-P--PPTA--------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP  327 (354)
Q Consensus       281 ~~----------------~~~~~~-~--~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp  327 (354)
                      .+                ..+... .  .+..              .....++.+.+||.+||++||++|||++|+|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            00                000000 0  0000              0001245688999999999999999999999999


Q ss_pred             cccccccccc
Q 018532          328 FIKKFEDKDI  337 (354)
Q Consensus       328 ~~~~~~~~~~  337 (354)
                      ||++......
T Consensus       440 ~~~~~~~~~~  449 (467)
T PTZ00284        440 YVLKYYPECR  449 (467)
T ss_pred             cccccCCccc
Confidence            9998755443

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-46  Score=335.50  Aligned_cols=256  Identities=32%  Similarity=0.549  Sum_probs=215.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|+++...... ...+.+|+.+++.++|+|++++++.+...+..+++|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            4568999999999999999999999999999999987654333 355788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999999888899999999999999999999998 8999999999999999999999999999877654444444


Q ss_pred             ccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCC
Q 018532          225 TFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFS  299 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  299 (354)
                      ...|+..|+|||++.   ...++.++|+|||||++|+|++|..||.......      ...........+  ......++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcccccCCCC
Confidence            567999999999974   4458899999999999999999999996554321      111111111111  11122578


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      ..+.++|.+||..+|++|||++++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-46  Score=342.94  Aligned_cols=265  Identities=28%  Similarity=0.467  Sum_probs=224.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.+......  ...+.+..|+.+++.++|+||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688899999999999999999999999999999765432  35567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-
Q 018532          145 EYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  221 (354)
                      ||+.|++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999998764  468999999999999999999998 9999999999999999999999999999876532211 


Q ss_pred             ----------------------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC
Q 018532          222 ----------------------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ  273 (354)
Q Consensus       222 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  273 (354)
                                                  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence                                        111346788999999999988999999999999999999999999766543 


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC----HHHHhcCccccccccccccc
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS----SLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~eil~hp~~~~~~~~~~~~  339 (354)
                            .....+............++..+.++|.+||..||++|||    +++++.||||+...+..++.
T Consensus       239 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         239 ------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             ------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence                  2222233332222223347899999999999999999999    99999999999988888776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.4e-47  Score=335.95  Aligned_cols=263  Identities=49%  Similarity=0.874  Sum_probs=225.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|+..+.||.|+||.||++.++.+++.+|+|.+...........+.+|+.+++.+.|+|++++++.+...+.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999999999999999998766566677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      +++++|.+++... ..+++..+..++.|++.||.|||+..|++|+||||+||+++.++.++|+|||.+.........  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--T  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--c
Confidence            9999999999876 788999999999999999999996478999999999999999999999999998765433222  2


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|..||......  .....+....+.....+......++.++.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence            57889999999999989999999999999999999999999655321  1223344444544444333333489999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      |.+||..||++|||+.+++.||||++..
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            9999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=358.91  Aligned_cols=261  Identities=32%  Similarity=0.587  Sum_probs=229.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +-+.|+..||.|+||.||+|.++.++-.-|.|++... .++....++-|+.|+....||+||++++.|+.++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4457889999999999999999999999999998654 345567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |.||-...++-.- ..++++++..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+...........+
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            9999998887664 579999999999999999999998 88999999999999999999999999999877666666788


Q ss_pred             cccCCcccccccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          226 FVGTYNYMSPERI-----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       226 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ++|||+|||||+.     ...+|+.++||||||++|.||..+.+|-...++      +.-++......++....|+.++.
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcCCCcccCcchhhh
Confidence            9999999999986     456799999999999999999999999755443      33444445556666777889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+.||+.+||.+||+.||+++++|+||||.++...
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            99999999999999999999999999999976443

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-46  Score=337.29  Aligned_cols=263  Identities=33%  Similarity=0.596  Sum_probs=221.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|++++.||.|+||.||++++..+++.||+|.+.... .+....+.+|+.+++.++|+|++++++.+..++.+++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            367899999999999999999999999999999987543 3445678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++++|..++.+ ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...........
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            9999999988765 3568999999999999999999998 9999999999999999999999999999876544333344


Q ss_pred             ccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCCCC
Q 018532          225 TFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPDQF  298 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  298 (354)
                      ...+++.|+|||.+.     ...++.++|+|||||++|+|++|..||......       .....+... .+....+..+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLSQPSKW  241 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCCccCCCCccc
Confidence            557889999999985     344788999999999999999999999654322       122222222 2223334568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      +.++.++|.+||..+|++||++.++++||||..+...+.
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  280 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence            899999999999999999999999999999999887664

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=337.84  Aligned_cols=261  Identities=36%  Similarity=0.645  Sum_probs=222.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||.|+||+||++.+..++..||+|++.... ......+.+|+.+++.++|+|++++++.+...+..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            467999999999999999999998899999999987543 3344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++++|.+++... +.+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||++...........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999999998774 568999999999999999999998 8999999999999999999999999999876654444444


Q ss_pred             ccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCC
Q 018532          225 TFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQF  298 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  298 (354)
                      ...+++.|+|||.+.     ...++.++|+|||||++|+|++|+.||...+..       .....+..... ....+..+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  234 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEPPTLDQPSKW  234 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCCCCcCCcccC
Confidence            567899999999975     345778999999999999999999999765432       22233333322 22334568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +.++.++|.+||+.+|++||++.++++||||.+..+.
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence            8999999999999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-49  Score=354.08  Aligned_cols=282  Identities=26%  Similarity=0.434  Sum_probs=254.4

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ...+++++.+..||-||||.|-++........+|+|++++..  ..+....+..|-+|+.....+.||++|..|.++..+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            456788899999999999999999887666679999987543  445567789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |++||-|-||.|+..++..+.+.+..++.++.+++.|++|||+ +|||+|||||+|.+++.+|.+||.|||+|+.++.. 
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            9999999999999999999999999999999999999999998 99999999999999999999999999999998765 


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...       .+.+.++......|..++.
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkGid~i~~Pr~I~k  646 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKGIDKIEFPRRITK  646 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhhhhhhhcccccch
Confidence            455679999999999999999999999999999999999999999999987743       3444555555566788999


Q ss_pred             HHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCCCCC
Q 018532          301 EFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP  353 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (354)
                      .+.+||+++...+|.+|..     +.+|-+|-||..+.|.+.....+.+|+-||+..|
T Consensus       647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p  704 (732)
T KOG0614|consen  647 TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP  704 (732)
T ss_pred             hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence            9999999999999999987     7899999999999999999889999999998754

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-46  Score=338.73  Aligned_cols=261  Identities=30%  Similarity=0.563  Sum_probs=221.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|.+....... ...+.+|+.+++.+.|+|++++++.+......++||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            4568899999999999999999999999999999987654433 366889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++.. ..+++.++..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            99999999999865 568999999999999999999998 9999999999999999999999999999886544333334


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......      ..........+....+..++..+.+
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCCCCCCCccccCHHHHH
Confidence            4578999999999998889999999999999999999999997654321      1111122222222334568899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ++.+||..+|++||++.++++||||...+.
T Consensus       249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            999999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-46  Score=330.23  Aligned_cols=253  Identities=32%  Similarity=0.591  Sum_probs=219.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+... ........+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999999999999999998653 2345567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ++|++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            9999999999875  568899999999999999999998 9999999999999999999999999999887665444444


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|+.||......       .....+.....+. .+..++..+.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPP-VSQMYSQQLAQ  231 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCC-CccccCHHHHH
Confidence            567899999999999988999999999999999999999999765432       2333344333322 33468899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ++.+||+.+|++||++.++++|||+
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-46  Score=339.98  Aligned_cols=263  Identities=31%  Similarity=0.567  Sum_probs=223.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ...+|.+++.||+|+||.||++.+..+++.||+|.+....... ...+.+|+.+++.++|+|++++++.+...+..++||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            3478899999999999999999999999999999987654332 356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...........
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            99999999999875 568899999999999999999998 8999999999999999999999999999876654433334


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....      .........+....+..++..+.+
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eeeeccCCCCCCCCccccCHHHHH
Confidence            45789999999999998899999999999999999999999976544321      111111222233345568899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      |+.+||..+|++||++.++++||||+......
T Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            99999999999999999999999999876643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.5e-47  Score=341.44  Aligned_cols=259  Identities=24%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhh---cCCCceEEeeeeeee-----cC
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQA---SQCSHVVVCYHSFYH-----NG  138 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~---l~h~~iv~~~~~~~~-----~~  138 (354)
                      +|++.+.||+|+||+||+|.++.+++.||+|.++..... .......+|+.+++.   ++|+||+++++.+..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            478899999999999999999999999999998754321 112234556665554   479999999998764     34


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+++++||+.+ +|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            68999999975 899988764  348999999999999999999998 89999999999999999999999999999866


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH-----HHHc----
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-----AIVE----  287 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----~~~~----  287 (354)
                      .... ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+.....     .+..    
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            4332 22335689999999999998999999999999999999999999976544321111111100     0000    


Q ss_pred             --CCCC-------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          288 --SPPP-------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       288 --~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                        ....       ......++..+.++|.+||++||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              0000       00112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-46  Score=348.76  Aligned_cols=265  Identities=26%  Similarity=0.424  Sum_probs=211.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+.+++.+...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            578999999999999999999999999999999987543 233456678899999999999999999877543      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+++ +|...+..  .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            68999999975 78877754  58889999999999999999998 9999999999999999999999999999986543


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH---------------HHH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE---------------LLE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------------~~~  283 (354)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..               ...
T Consensus       179 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         179 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            32 23345789999999999999999999999999999999999999977654322111110               000


Q ss_pred             HHHcCCCCC------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          284 AIVESPPPT------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       284 ~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ......+..                  ......+..+.+||.+||+.||++|||+.++|+||||....+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence            000110000                  0011235678999999999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-46  Score=337.91  Aligned_cols=261  Identities=32%  Similarity=0.577  Sum_probs=222.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ...+|.+.+.||.|++|.||++.+..+++.||+|.+...... ....+.+|+.+++.++|+|++++++.+...+.+++|+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            346789999999999999999999999999999998754433 2466888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++.. ..+++.++..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++...........
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            99999999998876 568999999999999999999998 9999999999999999999999999999887654433334


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++|..||...+...      ...............+..++..+.+
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSPIFRD  247 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCcccCCcccCCHHHHH
Confidence            4578899999999998889999999999999999999999997654321      1111111222233345678999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +|.+||..||++||++.++++||||+....
T Consensus       248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7e-47  Score=351.00  Aligned_cols=265  Identities=27%  Similarity=0.421  Sum_probs=211.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------  137 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------  137 (354)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++.+...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3578999999999999999999999999999999987543 334456778899999999999999999987643      


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ...++||||+++ +|.+.+..  .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            357999999975 77777654  58889999999999999999998 999999999999999999999999999998654


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH---------------HH
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE---------------LL  282 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------------~~  282 (354)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+....+               ..
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            33 223345789999999999998999999999999999999999999976543221111110               00


Q ss_pred             HHHHcCCCC------------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          283 EAIVESPPP------------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       283 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .......+.                  .......+.++.+||.+||+.||++|||+.|+++||||....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence            001100000                  0011224568899999999999999999999999999986544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-46  Score=352.64  Aligned_cols=266  Identities=20%  Similarity=0.314  Sum_probs=216.2

Q ss_pred             cccccccccccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ..+|.+++.||+|+||.||++...  .++..||+|.+...      ....+|+.+++.++|+||+++++.+......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457999999999999999999754  35678999987643      2345799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--  221 (354)
                      ||++. ++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++........  
T Consensus       165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            99996 5999999777889999999999999999999998 9999999999999999999999999999976654322  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-------------
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-------------  288 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  288 (354)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..+.......             
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            2234579999999999999999999999999999999999999997765433222222222211100             


Q ss_pred             ----------CCCCCC-----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          289 ----------PPPTAP-----PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       289 ----------~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                                .++...     ...++.++.++|.+||..||++|||+.++|.||||++.......+
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~  388 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNI  388 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcC
Confidence                      000001     124567899999999999999999999999999998876665543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.4e-46  Score=328.37  Aligned_cols=253  Identities=29%  Similarity=0.533  Sum_probs=215.4

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cCeEEEEEe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGVISLVLE  145 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e  145 (354)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++|+|++++++.+.. ++.++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999999999999999987543 33445678899999999999999999988764 446899999


Q ss_pred             ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          146 YMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |+++++|.+++...  ..+++.++..++.|++.||.+||+ .|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            99999999999763  458999999999999999999998 899999999999999999999999999998765444444


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..       .....+..... ...+..+++.+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~  231 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRIIEGKL-PPMPKDYSPELG  231 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCC-CCCccccCHHHH
Confidence            5567899999999999999999999999999999999999999754322       22223333322 223456889999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +++.+||+.||++||++.++++||||
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=325.73  Aligned_cols=272  Identities=35%  Similarity=0.598  Sum_probs=235.5

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHH-HhhcCCCceEEeeeeeeec
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~~  137 (354)
                      +..+.+..++++-+..||.|+||+|++..++.+|+..|||.++....+...++++.|... ++.-+++|||++|++...+
T Consensus        56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            344667788899999999999999999999999999999999988877777888888875 5556899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      +..++.||+|+ .+|..+.+.     ...++|..+..|....+.||.||..+..|||||+||+|||++..|.+||||||+
T Consensus       136 GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  136 GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence            99999999996 488776542     357899999999999999999999888899999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      +..+-.+... +...|...|||||.+...  .|+.+||+||||++|||+.||++||.      .|...++.+.++..+.+
T Consensus       215 cGqLv~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr------~w~svfeql~~Vv~gdp  287 (361)
T KOG1006|consen  215 CGQLVDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR------KWDSVFEQLCQVVIGDP  287 (361)
T ss_pred             hHhHHHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc------hHHHHHHHHHHHHcCCC
Confidence            9887654332 334789999999999754  48999999999999999999999994      45667788888888776


Q ss_pred             CCCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          291 PTAPPD----QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       291 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      +....+    .++..+..+|..||.+|-+.||...+++++||++.....+.+
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~  339 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD  339 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence            654432    378999999999999999999999999999999998776654

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.1e-46  Score=332.85  Aligned_cols=254  Identities=35%  Similarity=0.652  Sum_probs=211.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~------~  138 (354)
                      .+.|.+.+.||+|+||+||++.+..+++.||+|++.....  ....+.+|+.++..+ +|+|++++++.+...      .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            3568888999999999999999999999999999875432  234677888888887 799999999988753      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .++++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            689999999999999999864  358899999999999999999998 89999999999999999999999999999876


Q ss_pred             CCCcCCCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ...........|+..|+|||++.+     ..++.++|||||||++|+|++|..||.......       ...........
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~  234 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPAP  234 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCCCC
Confidence            544344455678999999999863     358889999999999999999999996543221       11122223333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ......++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            33445678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.7e-46  Score=333.46  Aligned_cols=261  Identities=34%  Similarity=0.598  Sum_probs=219.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      .|++.+.||.|+||.||++.+..++..+|+|.+.... ......+.+|+.+++.++|+|++++++.+...+..++|+||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            3678899999999999999999999999999986543 334566888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          148 DRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       148 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      ++++|..++.+ ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.............
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            99999988765 3568999999999999999999998 999999999999999999999999999987654443334456


Q ss_pred             ccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCCCCCH
Q 018532          227 VGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPDQFSP  300 (354)
Q Consensus       227 ~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  300 (354)
                      .++..|+|||++.     +..++.++|||||||++|+|++|+.||......       +....+... ......+..++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLAQPSRWSS  236 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhcCCCCCCCccccCH
Confidence            7899999999984     345788999999999999999999999664422       222222222 222334456889


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ++.++|.+||+.||++||++.++++||||+......+
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  273 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI  273 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCCCH
Confidence            9999999999999999999999999999998766554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-48  Score=352.30  Aligned_cols=250  Identities=25%  Similarity=0.454  Sum_probs=219.8

Q ss_pred             cccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           58 KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        58 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ....|++.++.+.-++-||+|+.|.||+++..  ++.||||+++.-        -..+++.+++|+|+||+.+.+++...
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            34568899999999999999999999999875  889999987421        23467889999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      -.+|+|||||..|.|.++|+....++......|..+|+.|+.|||. +.|||||||.-||||..+..|||+|||.++...
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            9999999999999999999999999999999999999999999998 889999999999999999999999999998876


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. .....++||..|||||++.+.+.+.|+|||||||+|||||||..||...+...       ++-.+-.+..-...+..
T Consensus       264 ~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsNsL~LpvPst  335 (904)
T KOG4721|consen  264 DK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSNSLHLPVPST  335 (904)
T ss_pred             hh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCCcccccCccc
Confidence            65 55667899999999999999999999999999999999999999997765431       11111122223445678


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +++.+.-||++||+-.|.+|||+.+++.|
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            99999999999999999999999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-46  Score=349.35  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=212.1

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .|.+..++|++.+.||+|+||.||+|++..+     +..||+|+++.....+....+.+|+.+++.+ +|+||+++++.+
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            3567788999999999999999999986443     4579999998766556667789999999998 899999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC------------------------------------------------------
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK------------------------------------------------------  160 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  160 (354)
                      ...+..++||||+++|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999986431                                                      


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--C
Q 018532          161 ----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--Q  222 (354)
Q Consensus       161 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~  222 (354)
                                      .+++..+..++.||+.||.|||+ +||+||||||+||++++++.+||+|||++........  .
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                            36778889999999999999998 9999999999999999999999999999986543321  1


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......       ..............+..++++
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  343 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSRPDFAPPE  343 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccCCCCCCHH
Confidence            122235668999999998899999999999999999997 999997654321       111222222333344567899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +.+++.+||+.||++|||+.++++
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.7e-46  Score=329.30  Aligned_cols=263  Identities=57%  Similarity=1.026  Sum_probs=228.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+|+.++..++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999999999999999997765545567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++.....+++..+..++.|++.|+.|||+..+++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  160 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF  160 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence            99999999998878899999999999999999999953789999999999999999999999999998776544444455


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ...+....+.....+......++..+.++|
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            7889999999999988999999999999999999999999766531    223444555544433333333899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .+||..+|++||++.++++|||++.++
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-46  Score=335.24  Aligned_cols=269  Identities=38%  Similarity=0.713  Sum_probs=218.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHH-HhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|.++.....+....+..|+.+ ++.++|+|++++++.+..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4688899999999999999999999999999999876543334455566654 666899999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       146 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |++ ++|.+++...    ..+++..+..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            997 5888887653    368899999999999999999998 6 89999999999999999999999999988654322


Q ss_pred             CCCcccccCCcccccccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                       ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......      .+..........+.....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~  231 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEEPSPQLPAE  231 (283)
T ss_pred             -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHHhcCCCCCCcc
Confidence             2223468889999999865    34688999999999999999999999643221      122223333333333345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccccccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVG  344 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~  344 (354)
                      .++.++.++|.+||..+|++||++.++++||||++.......+..++.
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~  279 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVS  279 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHHHHHHHH
Confidence            689999999999999999999999999999999998877666554443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-46  Score=332.33  Aligned_cols=258  Identities=31%  Similarity=0.549  Sum_probs=213.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++|+|++++++.+...+..++||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            346799999999999999999999999999999998754332 2356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            999999999999887889999999999999999999998 9999999999999999999999999999987654433344


Q ss_pred             ccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          225 TFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...|+..|+|||.+.   ...++.++|+|||||++|+|++|..||......+..   .. ................++..
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FL-MSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---ee-eecCCCCCCCCccccccCHH
Confidence            557899999999985   344788999999999999999999999654322110   00 00000011111122357899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      +.++|.+||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.3e-46  Score=329.94  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=219.7

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||.|++|.||++.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999999999999999997644  234557799999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcc
Q 018532          153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY  232 (354)
Q Consensus       153 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  232 (354)
                      .+++.+...+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            9999887789999999999999999999998 999999999999999999999999999998765432 22335788999


Q ss_pred             cccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018532          233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK  312 (354)
Q Consensus       233 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  312 (354)
                      +|||.+.+..++.++|+||||+++|+|++|..||.......     .+....+.........+...+.++.++|.+||+.
T Consensus       159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            99999988889999999999999999999999997765321     2334444433334444555689999999999999


Q ss_pred             CCCCCCC-----HHHHhcCccccccccc
Q 018532          313 DPRDRSS-----SLDLLSHPFIKKFEDK  335 (354)
Q Consensus       313 ~p~~Rps-----~~eil~hp~~~~~~~~  335 (354)
                      +|++||+     ++|+++||||+..+++
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            9999999     9999999999988765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=351.03  Aligned_cols=255  Identities=31%  Similarity=0.525  Sum_probs=224.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..|.-++.||.|+||.||.|++..+...||||++..+-  ..+....++.|++.++.++|||+|.+-++|..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            34566789999999999999999999999999987553  3345578999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |||- |+-.+++.-. +++.+.++..|+.+.+.||.|||+ .+.||||||..|||+++.|.|||+|||.|....    +.
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PA  179 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----PA  179 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCeeeeccccchhhcC----ch
Confidence            9996 4888888755 689999999999999999999999 889999999999999999999999999997653    44


Q ss_pred             cccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          224 DTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .+++|||+|||||++.   .+.|+-++||||||++..||...++|+...+..       ..+-.|..+..|......++.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNesPtLqs~eWS~  252 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPTLQSNEWSD  252 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcCCCCCCCchhHH
Confidence            6789999999999974   467999999999999999999999998766432       234456666666666778999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .|++|+..||++-|.+|||.+++|+|+|+.+-+.
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            9999999999999999999999999999987544

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.5e-46  Score=328.04  Aligned_cols=253  Identities=38%  Similarity=0.686  Sum_probs=216.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+.....   ...+.+|+.+++.++|+|++++++.+......++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            3678999999999999999999998899999999865432   5678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999763 568999999999999999999998 8999999999999999999999999999987755443344


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAPPDQFSPEFC  303 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  303 (354)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||......+       ....+.. .......+..++.++.
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFMIPNKPPPTLSDPEKWSPEFN  230 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhhhccCCCCCCCchhhcCHHHH
Confidence            4568899999999999899999999999999999999999997654321       1111111 1112223345788999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ++|.+||+.||++|||+.++++||||
T Consensus       231 ~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         231 DFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-46  Score=346.26  Aligned_cols=265  Identities=24%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            47899999999999999999999999999999998754322 3345677899999999999999999877543      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            578999998 6799888764 679999999999999999999998 9999999999999999999999999999987543


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------H-------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------L-------  282 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~-------  282 (354)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+.        .       
T Consensus       171 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             C---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence            2   234578999999999977 46899999999999999999999999765432111111000        0       


Q ss_pred             -HHHHcCCCCC------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          283 -EAIVESPPPT------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       283 -~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                       .......+..      ......++.+.+||.+||+.||++|||+.|+++||||.......
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence             0000000000      00124567889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.8e-46  Score=331.90  Aligned_cols=259  Identities=36%  Similarity=0.567  Sum_probs=222.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ..|+..+.||.|+||.||.+.+..++..||+|++...........+.+|+.+++.+.|+|++++++.+.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999999999999999998665555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      ++|++|.+++.. +.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.............
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            999999999875 578899999999999999999998 999999999999999999999999999997765443333445


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+... .+......++..+.+++
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~li  233 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFLIPKN-NPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhhhhhcC-CCCCCchhhhHHHHHHH
Confidence            6888999999999888999999999999999999999999765432       111122112 22333446788999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+||+.+|++||++.++++|+||.+...+
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            99999999999999999999999877654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8e-46  Score=340.11  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=206.9

Q ss_pred             cccccccc--CceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           71 TIKVIGKG--SGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        71 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      ++++||+|  +||+||++.++.+|+.||+|.++... ..+....+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999999999999999997653 3445567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC----
Q 018532          148 DRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG----  221 (354)
Q Consensus       148 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----  221 (354)
                      ++++|.+++...  +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++++||+.+........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999999753  458999999999999999999998 9999999999999999999999999986544321111    


Q ss_pred             ---CCcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC------
Q 018532          222 ---QRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP------  290 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  290 (354)
                         ......++..|+|||++.+  ..++.++|||||||++|+|++|..||......+.      .........+      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~  234 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM------LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH------HHHHhcCCcccccccc
Confidence               1122356778999999976  3589999999999999999999999975432210      0000000000      


Q ss_pred             -------------------------------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          291 -------------------------------------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       291 -------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                                                           .......+++.+.+||.+||+.||++|||++++++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                 0001123577899999999999999999999999999999865


Q ss_pred             c
Q 018532          334 D  334 (354)
Q Consensus       334 ~  334 (354)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.1e-46  Score=332.84  Aligned_cols=241  Identities=20%  Similarity=0.263  Sum_probs=204.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeEEEEEec
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVISLVLEY  146 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~  146 (354)
                      ..||+|++|.||++..  +|+.||||+++...  .....+.+.+|+.+++.++|+||+++++.+.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999986  69999999987543  23345678899999999999999999998876    3578999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++|+|.+++...+.+++.....++.|++.||.|||+..+++||||||+||++++++.+||+|||++.......   ...
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccc
Confidence            99999999999888899999999999999999999974589999999999999999999999999988654321   234


Q ss_pred             ccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          227 VGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       227 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      .|+..|+|||++.+  ..++.++|||||||++|||++|+.||......       +....+.........+..+++.+.+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCCCcCcHHHHH
Confidence            68899999999976  67999999999999999999999999765432       3344444333334445568999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhc
Q 018532          305 FVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~  325 (354)
                      |+.+||+.||++|||+.++++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999985

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-46  Score=335.87  Aligned_cols=259  Identities=36%  Similarity=0.612  Sum_probs=221.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +.|...+.||+|+||.||++.+..++..||+|.++........+.+.+|+.+++.++|+|++++++.+..++..++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45778889999999999999999999999999987665555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+ +|++|+||+|+||++++++.++|+|||++.............
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999998865 578999999999999999999998 999999999999999999999999999997765433333345


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+.... .......++.++.++|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li  233 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLIPKNS-PPTLEGQYSKPFKEFV  233 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhhhcCC-CCCCCcccCHHHHHHH
Confidence            6889999999999988999999999999999999999999754432       1112222222 2233456788999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+||+.+|++||++.++++||||.+....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence            99999999999999999999999876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-46  Score=343.56  Aligned_cols=258  Identities=21%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ...+|.+++.||+|+||.||+|++..+++.||+|+....       ....|+.+++.++|+||+++++.+...+..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            345799999999999999999999999999999985433       2345889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |++. ++|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++...... ...
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  213 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAF  213 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccc
Confidence            9996 5888888653 678999999999999999999998 89999999999999999999999999998754322 222


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh-------hhHHHHHHHHHcCCC--C---
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-------PSFYELLEAIVESPP--P---  291 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~--~---  291 (354)
                      ....||+.|+|||++.+..++.++|||||||++|||+++..|+....+....       ..+............  +   
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            3457999999999999999999999999999999999865554332221100       001111111000000  0   


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          292 -----------------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       292 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                                             ......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                   00012456778889999999999999999999999999864

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-45  Score=328.13  Aligned_cols=255  Identities=36%  Similarity=0.593  Sum_probs=216.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++.+.||.|+||+||++....++..+|+|++.........+.+.+|+.+++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999998899999999987655444667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          147 MDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       147 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9999999999864   358999999999999999999998 99999999999999999999999999998876544322 


Q ss_pred             ---CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC----
Q 018532          223 ---RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP----  294 (354)
Q Consensus       223 ---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  294 (354)
                         .....|+..|+|||.+... .++.++|+|||||++|+|++|+.||......+       ..........+...    
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCCCCCcCCccc
Confidence               2334689999999998877 78999999999999999999999997654432       12222222211111    


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ...+++.+.+++.+||..||++||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            13578999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.7e-46  Score=347.55  Aligned_cols=258  Identities=23%  Similarity=0.372  Sum_probs=211.3

Q ss_pred             ccccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .+.+..++|.+.+.||+|+||+||+|.+     ..++..||+|+++..........+.+|+.++..+ +|+||+++++.+
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            3566678999999999999999999974     3467789999997655445567788999999999 899999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC------------------------------------------------------
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK------------------------------------------------------  160 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  160 (354)
                      ...+..++||||+++|+|.++++...                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999986532                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          161 ---------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       161 ---------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                                           .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                 36777889999999999999998 99999999999999999999999999999866433


Q ss_pred             cCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......      .....+... .....+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~-~~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEG-YRMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhC-ccCCCCC
Confidence            221  112335668999999999999999999999999999997 889997654321      122222222 2223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..+.++.+|+.+||+.||++|||+.++++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-45  Score=328.06  Aligned_cols=255  Identities=30%  Similarity=0.493  Sum_probs=212.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~  140 (354)
                      .+|+..+.||+|+||.||++.+..++..||+|++....    ..+....+.+|+.+++.++|+||+++++.+..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36788899999999999999999999999999886432    22345678899999999999999999998765  3678


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++++||+++++|.+++...+.+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999999887889999999999999999999998 999999999999999999999999999987653221


Q ss_pred             ---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 ---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                         .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......       ...............+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~  233 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTNPQLPSH  233 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCCCCCchh
Confidence               1122346888999999999988999999999999999999999999755322       112222222223334556


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      +++.+.+++ +||..+|++||+++|+++||||+
T Consensus       234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         234 ISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             cCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            788899999 68888999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-46  Score=328.72  Aligned_cols=254  Identities=36%  Similarity=0.625  Sum_probs=217.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++|+|++++++.+...+.++++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            36788999999999999999999999999999999765443 45778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++...........
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            99999999999876 789999999999999999999998 9999999999999999999999999999987655433344


Q ss_pred             ccccCCcccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC---CCCCCCCCCC
Q 018532          225 TFVGTYNYMSPERISGS---TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQF  298 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  298 (354)
                      ...++..|+|||.+.+.   .++.++|+|||||++|+|++|..||......+       ........   .........+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLISKSNFPPPKLKDKEKW  232 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCCCccccchhhh
Confidence            55788999999999877   78999999999999999999999997654321       11111111   1111223356


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      +.++.+++.+||..+|.+|||+.+++.|+|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-45  Score=330.15  Aligned_cols=255  Identities=26%  Similarity=0.460  Sum_probs=206.9

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHH---HHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELK---INQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~---~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      .||+|+||.||++.+..+++.||+|.+.....  ........+|..   ++....|+|++.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999865432  111222334433   3344579999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      +++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......  .....|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCC
Confidence            99999999888889999999999999999999998 999999999999999999999999999987654322  223478


Q ss_pred             CCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          229 TYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       229 t~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      +..|+|||.+.+ ..++.++||||+||++|+|++|..||....... .    ........ ......+..++.++.++|.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~----~~~~~~~~-~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K----HEIDRMTL-TVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-H----HHHHHHhh-cCCcCCccccCHHHHHHHH
Confidence            999999999864 568999999999999999999999997654321 1    11111111 1223345568999999999


Q ss_pred             HhhhhCCCCCC-----CHHHHhcCccccccccccc
Q 018532          308 ACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       308 ~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~  337 (354)
                      +||..||++|+     |++++++||||+.......
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            99999999999     6999999999999876554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-46  Score=336.00  Aligned_cols=260  Identities=25%  Similarity=0.453  Sum_probs=209.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||+|++|.||+|.+..++..||+|+++.... ......+.+|+.+++.++|+|++++++.+..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            47888999999999999999999999999999865432 22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          147 MDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       147 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +. ++|.+++...   ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            97 5898888653   468899999999999999999998 999999999999999999999999999997665443333


Q ss_pred             cccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------------HHHHHcC
Q 018532          224 DTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------------LEAIVES  288 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------------~~~~~~~  288 (354)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.............              .......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            344678999999998764 4788999999999999999999999765432110000000              0000000


Q ss_pred             ------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 ------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                            .........+++++.++|.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                  00011123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-45  Score=328.11  Aligned_cols=258  Identities=27%  Similarity=0.517  Sum_probs=218.0

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      +|+..+.||+|++|.||++.+..+++.||+|++....     .....+.+.+|+.+++.++|+|++++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            3677789999999999999999999999999986432     12345778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  221 (354)
                      |+||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .+||+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999888889999999999999999999998 9999999999999998776 599999999877654321


Q ss_pred             ----CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          222 ----QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       222 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........    ................+..
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccCCCCCCchh
Confidence                12234688899999999888899999999999999999999999965443221    1222222223333444567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      +++++.+++.+||..+|++||++.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-45  Score=332.37  Aligned_cols=259  Identities=28%  Similarity=0.498  Sum_probs=212.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||.||++.++.+++.||+|++..... ....+.+.+|+.+++.++|+|++++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            468889999999999999999999999999999865432 2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |++++.|..++.....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99998888887766789999999999999999999998 99999999999999999999999999999876554333344


Q ss_pred             cccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc----------------C
Q 018532          226 FVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE----------------S  288 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------~  288 (354)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+.   ..........                .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccccccccc
Confidence            568889999999876 4578999999999999999999999976553311   1111100000                0


Q ss_pred             --CCCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 --PPPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 --~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                        .+..       .....++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0000       0013468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-45  Score=331.01  Aligned_cols=255  Identities=36%  Similarity=0.662  Sum_probs=211.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeee------c
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYH------N  137 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~------~  137 (354)
                      ..+.|++.+.||.|+||.||++.+..+++.+|+|++....  .....+..|+.+++.+ +|+|++++++.+..      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            3467888999999999999999999999999999986542  3345678888888887 79999999998853      4


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ..++++|||+.+++|.+++...  ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++..
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            6789999999999999999764  357888899999999999999998 9999999999999999999999999999886


Q ss_pred             cCCCcCCCcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      ............|++.|+|||.+.     +..++.++|+|||||++|+|++|..||....+..       ..........
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPP  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-------hhhhHhhCCC
Confidence            654333344567899999999986     3458889999999999999999999997554321       1122223333


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .......++.++.+||.+||+.||.+||++.++++||||
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            333445689999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-45  Score=326.58  Aligned_cols=254  Identities=30%  Similarity=0.514  Sum_probs=213.5

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      +|++.+.||.|+||+||++.. .+++.+|+|.+....     ..+....+.+|+.+++.++|+|++++++.+.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            467888999999999999987 478899999886432     22334668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC---
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS---  219 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---  219 (354)
                      ++||+++++|.+++.+...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999887889999999999999999999998 89999999999999999999999999998765321   


Q ss_pred             ---cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 ---MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                         ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+...      ...............+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~  232 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGLMPRLPD  232 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCCCCCCCC
Confidence               112234568999999999999889999999999999999999999997543221      11111111122333456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .++.++.++|.+||+.+|++||++.++++||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-45  Score=331.59  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=215.5

Q ss_pred             cCcccccccccccccCceEEEEEEEccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVG-----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +..++|++++.||+|+||.||++.+...+     ..||+|.++..........+.+|+.++..++|+||+++++.+...+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            35678999999999999999999976554     6799999876666666778999999999999999999999999889


Q ss_pred             eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK  202 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~  202 (354)
                      ..+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+ +|++|+||||+||+++++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEcCC
Confidence            999999999999999999764                347788899999999999999998 999999999999999999


Q ss_pred             CcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHH
Q 018532          203 GEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       203 ~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  279 (354)
                      +.++|+|||++.......  .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....       
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence            999999999987653321  12233456889999999998889999999999999999998 99999765432       


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +....+..... ...+..++.++.+|+.+||+.||++||++.+++++
T Consensus       234 ~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33344443333 33456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-45  Score=334.87  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=206.9

Q ss_pred             CcccccccccccccCceEEEEEEEcc----------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW----------------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv  128 (354)
                      ..++|.+.+.||+|+||.||+|.+..                ++..||+|++...........+.+|+.++..++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            45688999999999999999998542                34479999998766666677899999999999999999


Q ss_pred             EeeeeeeecCeEEEEEeccCCCCHHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 018532          129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-------------------TILEPYLAVVCKQVLQGLVYLHNERHVIH  189 (354)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH  189 (354)
                      ++++.+...+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+ .||+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ivH  161 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LNFVH  161 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence            99999999999999999999999999986532                   35677889999999999999998 89999


Q ss_pred             cCCCCCCEEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 018532          190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI--GRFP  265 (354)
Q Consensus       190 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p  265 (354)
                      |||||+||+++.++.+||+|||++........  ......++..|+|||++.+..++.++|||||||++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999976543221  1223345788999999998889999999999999999986  6688


Q ss_pred             CCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          266 YMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       266 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      |......+............. .......+..++..+.+|+.+||+.||++|||+.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQG-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhcc-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            876544322111111111110 11111223467899999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-45  Score=326.78  Aligned_cols=253  Identities=31%  Similarity=0.522  Sum_probs=214.5

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc--------HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--------EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +|.+...||.|+||.||+|.+..+++.||+|.+.....        .+..+.+.+|+.+++.++|+||+++++.+...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            35677899999999999999998999999998864321        1234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .++++||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||++++++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999888889999999999999999999998 89999999999999999999999999998876532


Q ss_pred             cC------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          220 MG------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       220 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ..      ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......       .....+... ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~~~  231 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGEN-ASPE  231 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhcc-CCCc
Confidence            11      112346888999999999988999999999999999999999999765432       111222222 2223


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+..++..+.++|.+||+.||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            445689999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-45  Score=330.00  Aligned_cols=261  Identities=34%  Similarity=0.613  Sum_probs=220.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC---CCceEEeeeeeeecCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ---CSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++..........+.+|+.+++.+.   |+|++++++.+..+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47788899999999999999999999999999877655555677888999988886   999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.++++. +.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence            99999999999876 578999999999999999999998 9999999999999999999999999999987765444444


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ...|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.......       ....+....++......++.++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMMLIPKSKPPRLEDNGYSKLLR  232 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhccccCCCCCCCcccCCHHHH
Confidence            55789999999998754 47899999999999999999999997654321       11112222222222334789999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      +++.+||+.||++||++.++++|+||++......
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~  266 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV  266 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccccCch
Confidence            9999999999999999999999999988665443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-45  Score=325.85  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=213.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~  140 (354)
                      .+|++.+.||+|+||.||.+.+..+++.||+|.+....    .....+.+.+|+.+++.+.|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999999999999999886432    223456788999999999999999999988763  578


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +++|||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999999887788999999999999999999998 899999999999999999999999999987653211


Q ss_pred             ---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 ---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                         .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......       ...............+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcCCCCCCCchh
Confidence               1223346889999999999888999999999999999999999999754322       112223333333334556


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      ++..+.++|.+||. +|++||+++++++|||++
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            78899999999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-45  Score=330.13  Aligned_cols=258  Identities=30%  Similarity=0.464  Sum_probs=215.9

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||+|+||+||+|.+..+|+.||+|++.....  ......+..|+.+++.++|+|++++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6999999999999999999999999875431  22344567899999999999999999999999999999999999999


Q ss_pred             HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCC
Q 018532          153 ADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY  230 (354)
Q Consensus       153 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  230 (354)
                      .+++...+  .+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++...... .......++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence            99998765  68999999999999999999998 89999999999999999999999999998765432 2223446788


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      .|+|||.+.+..++.++|||||||++|+|++|+.||.........   ..+......  .+...+..+++.+.++|.+||
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLE--MAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhcccc--ccccCCccCCHHHHHHHHHHc
Confidence            999999998888999999999999999999999999765542211   111122111  122334567999999999999


Q ss_pred             hhCCCCCC-----CHHHHhcCccccccccccccc
Q 018532          311 QKDPRDRS-----SSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       311 ~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~  339 (354)
                      +.||++||     ++.++++||||+...+.....
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~  267 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA  267 (277)
T ss_pred             cCChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence            99999999     888999999999988876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.2e-45  Score=322.86  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=219.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|+.++.||.|+||.||.+++..+++.+++|.+.... .......+.+|+.+++.++|+||+++++.+.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999999999999999999987543 445566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            9999999999875  458899999999999999999998 8999999999999999999999999999987655443344


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||......       +....+..+.... ....++.++.+
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIVQGNYTP-VVSVYSSELIS  231 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCC-CccccCHHHHH
Confidence            567899999999999888899999999999999999999999764432       3333333333332 23567999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ++.+||..+|++||++.++++|+|+
T Consensus       232 ~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         232 LVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.4e-46  Score=334.87  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=207.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||+|+||.||+|++..+|+.||+|.++.... ......+.+|+.+++.++|+|++++++.+.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            47888999999999999999999999999999875432 22335577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      +++ +|.+++.. .+.+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++............
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            975 88888765 4678999999999999999999998 99999999999999999999999999999876544333444


Q ss_pred             cccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHH-----------H---cCC-
Q 018532          226 FVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI-----------V---ESP-  289 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------~---~~~-  289 (354)
                      ..++..|+|||.+.+.. ++.++|||||||++|+|++|..|+....+.+  .....+....           .   ... 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            56789999999987754 7899999999999999999998865433211  0000000000           0   000 


Q ss_pred             CC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          290 PP--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       290 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+        ......+++++.+||.+||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00        00113478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-45  Score=324.39  Aligned_cols=253  Identities=28%  Similarity=0.484  Sum_probs=217.0

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||+|+||+||.+.+..+|+.||+|.+.... .....+.+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999999999999999987532 334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +.+++|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            99999999987643  57889999999999999999998 9999999999999999999999999999987654433333


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..       +....+..+..+ ..+..++.++.+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~  231 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------NLVLKIIRGSYP-PVSSHYSYDLRN  231 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------HHHHHHhcCCCC-CCcccCCHHHHH
Confidence            456888999999999988999999999999999999999999654322       233333333332 234568999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +|.+||+.+|++||++.++++||||
T Consensus       232 li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         232 LVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-45  Score=331.44  Aligned_cols=266  Identities=36%  Similarity=0.679  Sum_probs=217.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|...+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++..+. |+||+++++.+..++..+++|
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4577788899999999999999999999999999876554555677889999888886 999999999999999999999


Q ss_pred             eccCCCCHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          145 EYMDRGSLADIIR-----QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       145 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ||+.+ ++.++..     ....+++..+..++.|++.||+|||+..+++||||||+||+++.++.+||+|||++......
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            99864 6655432     23568999999999999999999997458999999999999999999999999999765433


Q ss_pred             cCCCcccccCCcccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC--
Q 018532          220 MGQRDTFVGTYNYMSPERISGS---TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP--  294 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  294 (354)
                      .. .....|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||....      ...+..........+...  
T Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         162 IA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             Cc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCCCcCCCc
Confidence            22 2234688999999999876   68999999999999999999999996543      112222333222222211  


Q ss_pred             -CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          295 -PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       295 -~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                       ...++.++.+||.+||+.+|++|||+.++++||||+.....++..
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~  280 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV  280 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhH
Confidence             234889999999999999999999999999999999987766543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3e-46  Score=356.64  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=225.0

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      .++...+....+.||+|+||+||+++...     ....||||.++.......+++|.+|+.++..++|+|||+++|.+..
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            46778888999999999999999998542     3467999999988888789999999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK----------T----ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK  202 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~----------~----~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~  202 (354)
                      ++.+++|+|||..|||.++|....          .    ++..+...|+.||+.|++||-+ +.+|||||.+.|+||.++
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccc
Confidence            999999999999999999997542          2    7788999999999999999998 889999999999999999


Q ss_pred             CcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHH
Q 018532          203 GEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       203 ~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  279 (354)
                      ..|||+|||+++...+...-  .....-+.+|||||.+..++||.+|||||+||+|||+++ |+.||.+..++       
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------
Confidence            99999999999987543221  112345789999999999999999999999999999997 99999998876       


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL  324 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil  324 (354)
                      +.++.+..+.. ...+.++|.++.+|+..||+.+|.+||++.||-
T Consensus       713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            66777777765 667889999999999999999999999999984

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.8e-45  Score=332.41  Aligned_cols=262  Identities=27%  Similarity=0.482  Sum_probs=219.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368889999999999999999999999999999876532  234467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999998864211000   


Q ss_pred             ------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          222 ------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       222 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                                  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....       +.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~~~~~  232 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISDD  232 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcc
Confidence                        011235788999999999888999999999999999999999999765432       2333333332


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCcccccccccc
Q 018532          290 P-PTAPPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~  336 (354)
                      . .+.....++.++.++|.+||+.+|++||+   +.++++||||....+..
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            1 12222367899999999999999999998   79999999998876655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-45  Score=365.42  Aligned_cols=263  Identities=30%  Similarity=0.502  Sum_probs=216.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~  139 (354)
                      +...++|.+++.||+|+||+||+|++..++..||+|++.... .......+..|+.++..++|+|||++++.|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445689999999999999999999999999999999987542 34456778999999999999999999998865  357


Q ss_pred             EEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC------CCceecCCCCCCEEEcc--------
Q 018532          140 ISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNE------RHVIHRDIKPSNLLVNH--------  201 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~------~~iiH~Dlkp~NIll~~--------  201 (354)
                      +|+||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.      .+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999999999753    5689999999999999999999972      24999999999999964        


Q ss_pred             ---------CCcEEEeecccccccCCCcCCCcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 018532          202 ---------KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSE  270 (354)
Q Consensus       202 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  270 (354)
                               .+.+||+|||++....... ......||+.|+|||++.+  ..++.++|||||||+||+|++|..||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     2359999999998764332 2234579999999999865  358899999999999999999999996543


Q ss_pred             cCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..      ..+...+....  .......+.++.+||..||..+|.+||++.|+|.|+|++....
T Consensus       248 ~~------~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 NF------SQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cH------HHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            22      23333333222  2223457899999999999999999999999999999987654

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.9e-45  Score=327.08  Aligned_cols=258  Identities=34%  Similarity=0.571  Sum_probs=220.4

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      -|...+.||.|+||.||++.+..++..||+|++...........+.+|+.++..++|+|++++++.+..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            46778899999999999999998999999999876555555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccc
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV  227 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  227 (354)
                      ++++|.+++.. ..+++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||++..............
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            99999999875 568999999999999999999998 9999999999999999999999999999876644332333456


Q ss_pred             cCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       228 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      ++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+... ........++.++.+++.
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKN-NPPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcC-CCCCCCcccCHHHHHHHH
Confidence            888999999998888899999999999999999999999754322       122222222 223344568899999999


Q ss_pred             HhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          308 ACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       308 ~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +||+.+|++||++.++++||||.+...+
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence            9999999999999999999999886443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-45  Score=324.80  Aligned_cols=259  Identities=32%  Similarity=0.530  Sum_probs=211.4

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++..+.......||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3344555555689999999999999999999999998875543 334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccCC
Q 018532          143 VLEYMDRGSLADIIRQV-KTI--LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGS  218 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||+++++|.+++... ..+  ++..+..++.||+.||.|||+ .||+||||||+||+++. ++.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999999864 445  788888999999999999998 99999999999999976 67999999999876543


Q ss_pred             CcCCCcccccCCcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      .........++..|+|||.+.+..  ++.++|+||||+++|+|++|..||........     ... ...........+.
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~-~~~~~~~~~~~~~  235 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMF-KVGMFKIHPEIPE  235 (268)
T ss_pred             CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHh-hhhhhccCCCCCc
Confidence            333333446889999999987643  78899999999999999999999965432210     111 1111111223355


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+++++.+++.+||+.+|++|||+.+++.||||
T Consensus       236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            688999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-45  Score=326.58  Aligned_cols=253  Identities=19%  Similarity=0.278  Sum_probs=211.8

Q ss_pred             cCcccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|++.+.||+|+||.||++...   ..+..||+|.++..........+.+|+.++..++|+||+++++.+...+..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34578899999999999999999865   346789999998766666667789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++++|||.+......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999999874 578999999999999999999998 99999999999999999999999999987654322


Q ss_pred             cC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. ......++..|+|||.+.+..++.++|||||||++||+++ |..||......       +..+.+..... ...+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~  232 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFR-LPAPRN  232 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCC-CCCCCC
Confidence            11 1112345678999999999999999999999999999775 99999765432       23344433322 234567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         233 CPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-45  Score=326.07  Aligned_cols=262  Identities=27%  Similarity=0.469  Sum_probs=210.9

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHH---HHHHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQE---LKINQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e---~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      .||+|+||.||++.+..+++.||+|.+......  ........|   ...++...|++++.+++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998654211  111122233   344555689999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      |++|..++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......  ......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence            99999999887889999999999999999999998 99999999999999999999999999998765432  2234578


Q ss_pred             CCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          229 TYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       229 t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      +..|+|||.+.++ .++.++||||+||++|+|++|+.||........    .........  .....+..++.++.+++.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~~~~s~~~~~li~  231 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT--MAVELPDSFSPELRSLLE  231 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhc--cCCCCCCcCCHHHHHHHH
Confidence            9999999999754 589999999999999999999999976533211    111111211  122334567999999999


Q ss_pred             HhhhhCCCCCC-----CHHHHhcCcccccccccccccccccc
Q 018532          308 ACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVG  344 (354)
Q Consensus       308 ~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~  344 (354)
                      +||..+|++||     ++.++++||||+...+..+......+
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~  273 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP  273 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccCC
Confidence            99999999999     99999999999998876665433333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-45  Score=335.40  Aligned_cols=253  Identities=23%  Similarity=0.376  Sum_probs=194.5

Q ss_pred             cccccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEEEEEecc
Q 018532           72 IKVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVISLVLEYM  147 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~  147 (354)
                      .++||+|+||+||+|+++  .+++.||+|.+.....   ...+.+|+.+++.++|+||+++++.+..  ...+++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            357999999999999976  3678999999865422   2346789999999999999999998854  45789999999


Q ss_pred             CCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE----ccCCcEEEeeccccc
Q 018532          148 DRGSLADIIRQV---------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSA  214 (354)
Q Consensus       148 ~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~  214 (354)
                      . ++|.+++...         ..+++..+..++.||+.||.|||+ .||+||||||+|||+    +.++.+||+|||++.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            6 4898887642         247889999999999999999998 899999999999999    456789999999998


Q ss_pred             ccCCCcC---CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC------hhhHHHHHH-
Q 018532          215 MLGSSMG---QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS------WPSFYELLE-  283 (354)
Q Consensus       215 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~-  283 (354)
                      .......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........      ......+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            7654322   22345789999999999874 589999999999999999999999975443210      000000000 


Q ss_pred             -----------------------HHHcCCCC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          284 -----------------------AIVESPPP--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       284 -----------------------~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                                             ........        .......+.++.+||.+||+.||++|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                   00000000        00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=345.20  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=228.7

Q ss_pred             CCcccccccCcccccccccccccCceEEEEEEEccCCc---E-EEEEEeec--cccHHHHHHHHHHHHHHhhcCCCceEE
Q 018532           56 DYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---L-FALKIIQM--NIQEEIRKQIVQELKINQASQCSHVVV  129 (354)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~iv~  129 (354)
                      +.....|++..++..+.++||+|+||.||+++.+..+.   . ||+|..+.  ....+..+++.+|+++++.++|+|||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            44556789999999999999999999999999876432   3 89999874  356778899999999999999999999


Q ss_pred             eeeeeeecCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEe
Q 018532          130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT  208 (354)
Q Consensus       130 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~  208 (354)
                      +||+......+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+ +++|||||..+|+|++.++.+||+
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999999999876 49999999999999999999998 889999999999999999999999


Q ss_pred             ecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          209 DFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       209 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      |||+++.............-+..|+|||.+....|+.++|||||||++||+++ |..||.+....       +....+..
T Consensus       305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~  377 (474)
T KOG0194|consen  305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVK  377 (474)
T ss_pred             ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHh
Confidence            99998866422221112235789999999999999999999999999999998 88999887654       56666767


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ...+...+...+.++..++.+||..+|+.||++.++.+
T Consensus       378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            67777777788999999999999999999999998865

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-45  Score=350.08  Aligned_cols=257  Identities=22%  Similarity=0.301  Sum_probs=205.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ...|.+.+.||+|+||.||++.+..+++.||||....       ..+.+|+++++.++|+||+++++.+...+..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3478999999999999999999999999999996432       235689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--C
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--Q  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~  222 (354)
                      ++. ++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.......  .
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            995 6898888764 468999999999999999999998 9999999999999999999999999999986543221  1


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC-CC---hhhHHHHHHHHHcC---C------
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ-QS---WPSFYELLEAIVES---P------  289 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~---~~~~~~~~~~~~~~---~------  289 (354)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..   ...+...+......   .      
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            23457999999999999999999999999999999999988665432211 10   01111111111000   0      


Q ss_pred             --------------CCCC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          290 --------------PPTA------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       290 --------------~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                                    .+..      ....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                          0000      00135668999999999999999999999999999974

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-45  Score=322.66  Aligned_cols=250  Identities=28%  Similarity=0.468  Sum_probs=215.3

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      +|++.+.||.|+||.||++.+..++..||+|.++........+.+.+|+.+++.++|+|++++++.+...+.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            47888999999999999999999999999999876555555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          148 DRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       148 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||++++++.++|+|||.+............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            999999988753  457899999999999999999998 99999999999999999999999999999876554444445


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..       .....+..+... ..+..++..+.++
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~l  231 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-------NLILKVCQGSYK-PLPSHYSYELRSL  231 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-------HHHHHHhcCCCC-CCCcccCHHHHHH
Confidence            67899999999999888999999999999999999999999754321       223333333322 2345688999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcC
Q 018532          306 VSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~h  326 (354)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=320.99  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=216.6

Q ss_pred             ccccccc-ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hhcCCCceEEeeeeeee----cCe
Q 018532           66 LEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVVVCYHSFYH----NGV  139 (354)
Q Consensus        66 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~----~~~  139 (354)
                      .++|.+- ++||-|-.|.|..|.++.||+.+|+|++...      ....+|+++. ....|+|||.++++|..    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4566544 6799999999999999999999999998543      3455677653 34689999999998864    457


Q ss_pred             EEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeeccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSA  214 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~  214 (354)
                      +.+|||.++||.|+..++..+.  +++.++..|++||..|+.|||+ .+|.||||||+|+|...+   ..+||+|||+|+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccc
Confidence            8899999999999999998765  9999999999999999999998 889999999999999754   479999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--CCC
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP--PPT  292 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  292 (354)
                      .-... ....+.|-||+|.|||++-...|+...|+||+||++|-|+||-+||.........+.+.   ..+..+.  .+.
T Consensus       213 ~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk---~rI~~gqy~FP~  288 (400)
T KOG0604|consen  213 ETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---RRIRTGQYEFPE  288 (400)
T ss_pred             ccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH---hHhhccCccCCC
Confidence            76543 34456799999999999999999999999999999999999999998877654434333   3344333  234


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..++.+|+.+.++|+.+|..+|.+|.|+.+++.|||+.....
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            456789999999999999999999999999999999987643

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.9e-45  Score=328.36  Aligned_cols=256  Identities=37%  Similarity=0.578  Sum_probs=210.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeec-----C
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHN-----G  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~-----~  138 (354)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.+ +|+|++++++.+...     +
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            4678999999999999999999999999999999986432  2234567888888888 899999999988753     4


Q ss_pred             eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ..++|+||+++++|.++++.    ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            68999999999999998863    3568999999999999999999998 999999999999999999999999999988


Q ss_pred             ccCCCcCCCcccccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-  288 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  288 (354)
                      .............|+..|+|||.+...     .++.++|||||||++|+|++|+.||......       .....+... 
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~~~~~~~  249 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFKIPRNP  249 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHHHHhcCC
Confidence            765433333345788999999998653     3688999999999999999999999765432       112222222 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      ......+..++..+.++|.+||+.+|++||++.++++||||+
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            222223445778899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-45  Score=325.67  Aligned_cols=255  Identities=37%  Similarity=0.651  Sum_probs=212.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecC-----
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNG-----  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~-----  138 (354)
                      ..++|++.+.||.|++|+||+|.+..+++.+++|++.....  ....+.+|+.+++.+ .|+|++++++.+....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35789999999999999999999998999999999876533  235688999999988 7999999999987644     


Q ss_pred             -eEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          139 -VISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       139 -~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                       .+++||||+++++|.+++...    ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence             589999999999999998753    478999999999999999999998 99999999999999999999999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      ..............|+..|+|||.+..     ..++.++|||||||++|+|++|..||......       .....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~  233 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKIPRN  233 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHhhcc
Confidence            876544444455678999999998854     24778999999999999999999999654322       112222222


Q ss_pred             CC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 PP-PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .. ....+..++.++.+||.+||..||++|||+.++++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22 222233478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-44  Score=321.74  Aligned_cols=253  Identities=34%  Similarity=0.563  Sum_probs=216.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~  144 (354)
                      +|++.+.||.|+||.||++.+..++..||+|++.... .....+.+..|+.+++.++|+|++++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999999999999999987543 34556778899999999999999999987754  45789999


Q ss_pred             eccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLH-----NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       145 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||     + .+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999763    57899999999999999999999     7 8899999999999999999999999999988


Q ss_pred             cCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..       +....+.... ....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~  231 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGK-FRRIP  231 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCC-CCCCc
Confidence            765544344567899999999999988999999999999999999999999765421       2333333332 33345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ..++..+.+++.+||+.+|++||++.++++|||+
T Consensus       232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            6788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-45  Score=336.69  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=210.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFY  135 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~  135 (354)
                      |++..++|++.+.||.|+||.||+|.+.     .+++.||+|+++........+.+.+|+.++..+ +|+||+++++.+.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            5667789999999999999999999743     345789999997655555556788899999998 8999999999876


Q ss_pred             e-cCeEEEEEeccCCCCHHHHHHHh-------------------------------------------------------
Q 018532          136 H-NGVISLVLEYMDRGSLADIIRQV-------------------------------------------------------  159 (354)
Q Consensus       136 ~-~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  159 (354)
                      . +..+++++||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            5 45788999999999999998642                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--CCcccccCCc
Q 018532          160 ------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYN  231 (354)
Q Consensus       160 ------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~  231 (354)
                            ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.++|+|||++..+.....  ......++..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                  257888899999999999999998 9999999999999999999999999999987643221  1223345678


Q ss_pred             ccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 018532          232 YMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       232 y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  310 (354)
                      |+|||++.+..++.++|||||||++|+|++ |..||.+....+      .....+. .......+...++++.+++.+||
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLK-EGTRMRAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHh-ccCCCCCCccCCHHHHHHHHHHc
Confidence            999999999999999999999999999997 999997644321      1122222 22233334567899999999999


Q ss_pred             hhCCCCCCCHHHHhcC
Q 018532          311 QKDPRDRSSSLDLLSH  326 (354)
Q Consensus       311 ~~~p~~Rps~~eil~h  326 (354)
                      +.+|++||++.++++|
T Consensus       314 ~~~p~~RPs~~ell~~  329 (337)
T cd05054         314 HNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-44  Score=326.62  Aligned_cols=267  Identities=42%  Similarity=0.730  Sum_probs=219.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~  144 (354)
                      ++|+..+.||.|++|.||++.+..+++.||+|.+...........+.+|+++++.++|+||+++++.+...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999999999999999998665555667789999999999999999999988653  4789999


Q ss_pred             eccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99999999988754    2457889999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC---C--C
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA---P--P  295 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~  295 (354)
                      .  ....++..|+|||.+.+..++.++|||||||++|+|++|..||.......  ....+....+.....+..   .  .
T Consensus       160 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         160 A--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP--LGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             c--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC--CChHHHHHHHhcCCchhhccCCCCC
Confidence            2  23467889999999999899999999999999999999999997653311  111223333332111111   1  1


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ..+++.+.++|.+||+.+|++|||+.|+++||||++...+++.
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~  278 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVN  278 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhh
Confidence            2356789999999999999999999999999999888777654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.2e-45  Score=327.71  Aligned_cols=256  Identities=38%  Similarity=0.562  Sum_probs=209.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeee-----ec
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFY-----HN  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~-----~~  137 (354)
                      ...++|++.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.+ +|+|++++++.+.     .+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            35678999999999999999999999999999999876432  2234577889988888 6999999999874     34


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      +..++||||++|++|.+++...    ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCce
Confidence            6799999999999999987632    467888999999999999999998 89999999999999999999999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      ..............|++.|+|||++..     ..++.++|||||||++|+|++|+.||.......       ........
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------~~~~~~~~  244 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------ALFKIPRN  244 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------HHhhcccc
Confidence            876543333344578999999999853     347889999999999999999999997654321       11111122


Q ss_pred             C-CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 P-PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      . .....+..++..+.++|.+||+.||++|||+.++++|+||
T Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1 2222344568899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-44  Score=326.10  Aligned_cols=257  Identities=33%  Similarity=0.596  Sum_probs=218.0

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      .|...+.||.|++|.||++.+..+++.+|+|+++.... ...+.+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            34556789999999999999998999999999865432 33466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccc
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV  227 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  227 (354)
                      +|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+..............
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            99999999987 678999999999999999999998 9999999999999999999999999998876554433344457


Q ss_pred             cCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCCCHHHHHHH
Q 018532          228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQFSPEFCSFV  306 (354)
Q Consensus       228 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  306 (354)
                      |++.|+|||.+.+..++.++|||||||++|+|++|..||...+..       +....+..... .......++..+.+++
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNLPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence            899999999999888999999999999999999999999764432       22223332221 1222334789999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .+||+.+|++||++.++++||||++...
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHcccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999999999775

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=349.94  Aligned_cols=251  Identities=33%  Similarity=0.539  Sum_probs=218.6

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHH
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA  153 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  153 (354)
                      +||+|+||+||.+++..|....|||.+.... .+..+-+..|+.+.+.++|.|||++++.+..++++-+.||-.+||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            6999999999999999999999999986543 344577899999999999999999999999999999999999999999


Q ss_pred             HHHHH-hCCC--CHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccCCCcCCCcccccC
Q 018532          154 DIIRQ-VKTI--LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       154 ~~l~~-~~~~--~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++++. ++++  ++..+.++.+||++||.|||. +.|||||||-+|||++. .|.+||+|||.++.+..-.....++.||
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            99985 4777  788999999999999999997 88999999999999976 5899999999999987776777889999


Q ss_pred             CcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 018532          230 YNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       230 ~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  307 (354)
                      ..|||||++..++  |+.++|||||||++.||.||++||......+.  .   +++.-.. .--+..|..++.++..+|.
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--A---MFkVGmy-KvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--A---MFKVGMY-KVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--h---hhhhcce-ecCCCCcHHHHHHHHHHHH
Confidence            9999999998764  89999999999999999999999976654431  1   1111111 1123345678999999999


Q ss_pred             HhhhhCCCCCCCHHHHhcCcccccc
Q 018532          308 ACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       308 ~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +|+.++|..||++.++|..||++.-
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999876

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.8e-45  Score=330.55  Aligned_cols=260  Identities=31%  Similarity=0.575  Sum_probs=219.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||+||++.+..+++.||+|.+...... ....+.+|+.+++.++|+|++++++.+...+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            47889999999999999999999889999999998644322 34668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+++++|.+++.+ ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9999999999876 468899999999999999999998 99999999999999999999999999998766544334444


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..+++.|+|||.+.+..++.++|+|||||++|++++|..||........      .........+....+..++..+.++
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFRDF  248 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCCCCCCCccccCHHHHHH
Confidence            5788999999999888899999999999999999999999976543211      1111112222223344578899999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      |.+||..+|++||++.+++.|+||+..+.
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            99999999999999999999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-44  Score=320.88  Aligned_cols=253  Identities=33%  Similarity=0.519  Sum_probs=216.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +|+..+.||+|+||+||+|.+..++..|++|.+....    ..+..+.+.+|+.+++.++|+|++++++.+.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667788999999999999999899999999986543    234557789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            9999999999999887789999999999999999999998 999999999999999999999999999987764432 23


Q ss_pred             cccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....++..|+|||.+.... ++.++|+|||||++|+|++|..||......       .....+.........+..+++.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPPIPDHLSDEA  231 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCCcCCCcCHHH
Confidence            4457889999999998776 899999999999999999999999665422       11222222222333455689999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+++.+||+.+|++||++.+++.|||+
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.6e-45  Score=323.82  Aligned_cols=254  Identities=29%  Similarity=0.482  Sum_probs=215.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||++++..+++.||+|.++..  ...+....+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999999999999999987642  23455567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988642    347889999999999999999998 999999999999999999999999999988765443


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......     .......+.....+......++.
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHHhcCCCCCCChhhcCH
Confidence            3333457889999999999888999999999999999999999999654321     12333344443444444456789


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+.+++.+||+.+|++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.7e-46  Score=333.53  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=212.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++|+|++++++.+...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468889999999999999999998999999998865432 2345668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+++++|..+......+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99998998887766679999999999999999999998 89999999999999999999999999998876544343444


Q ss_pred             cccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH-------HHHH------HcCCCC
Q 018532          226 FVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-------LEAI------VESPPP  291 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------~~~~------~~~~~~  291 (354)
                      ..++..|+|||++.+. .++.++||||||+++|+|++|+.||...............       ....      ......
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            5688999999998764 4788999999999999999999999654422111010000       0000      000000


Q ss_pred             C---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          292 T---------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       292 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .         .....++..+.+|+.+||+.+|++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0         0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-45  Score=331.68  Aligned_cols=260  Identities=33%  Similarity=0.597  Sum_probs=218.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +.|.....||.|+||.||++.+..++..||||.+..... ...+.+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            445556789999999999999999999999999865433 3346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++.. +.+++..+..++.||+.||.|||+ .|++||||||+||++++++.++|+|||++.............
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998865 568999999999999999999998 899999999999999999999999999987654444444456


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCCCCCHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  305 (354)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..||......       .....+... .........++..+.++
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  251 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIRDNLPPRVKDSHKVSSVLRGF  251 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCccccccccCHHHHHH
Confidence            7899999999998888999999999999999999999999765432       111222221 11122233578899999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +.+||..||++|||+.++++||||+......
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999999999876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=340.72  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=216.1

Q ss_pred             cccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           58 KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        58 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      ...+|++..+++.+...||+|.||+||++++-  |. ||||+++... ..+..+.|.+|+.++++-+|.||+-+.|++..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--Gd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            34678999999999999999999999999853  54 8999998664 45577889999999999999999999999988


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ... .+|+.+|+|-+|+.+++.. ..|.......|++|++.|+.|||. ++|||||||..||++.++++|||+|||++..
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceee
Confidence            777 9999999999999999854 468888899999999999999998 9999999999999999999999999999976


Q ss_pred             cCC--CcCCCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC--
Q 018532          216 LGS--SMGQRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--  288 (354)
Q Consensus       216 ~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  288 (354)
                      ...  .........|...|||||++..   .+|++.+||||||+++|||++|.+||.....++       ++-++-.+  
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG~l  610 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRGYL  610 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccccc
Confidence            432  2233445578899999999864   469999999999999999999999998544332       22222233  


Q ss_pred             -CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          289 -PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       289 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                       ........++++++.+|+..||.+++++||.+.+||.
T Consensus       611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence             2233345678889999999999999999999999987

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-44  Score=320.93  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=215.9

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|.+.+.||+|+||.||++.+..+++.||+|+++.... ....+.+..|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47888999999999999999998999999999876543 34667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC---
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR---  223 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---  223 (354)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.+||+|||++..........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999887778999999999999999999998 999999999999999999999999999988765433222   


Q ss_pred             -cccccCCcccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCC
Q 018532          224 -DTFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQF  298 (354)
Q Consensus       224 -~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  298 (354)
                       ....++..|+|||.+.+..   ++.++||||||+++|++++|..||...+...      .....+..... .......+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHHHhcCCCCCCCccccc
Confidence             2356788999999998766   8899999999999999999999997554221      11222222211 12222345


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +..+.++|.+||+.+|++|||+.+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-44  Score=325.84  Aligned_cols=264  Identities=23%  Similarity=0.389  Sum_probs=215.2

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      |+...++|++.+.||+|+||.||+|.++.     .+..||+|.++..........+.+|+.+++.++|+||+++++.+..
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            45667899999999999999999987653     3557999998755544445567889999999999999999999998


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      .+..++||||+++|+|.+++...+          ..+...+..++.|++.||.|||+ ++++||||||+||+++.++.++
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCcEE
Confidence            899999999999999999997532          23566788999999999999998 9999999999999999999999


Q ss_pred             EeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          207 ITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      |+|||+++........  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....       +...
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLK  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            9999998765332211  112245678999999998889999999999999999998 78899765432       2233


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc------Ccccccccc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS------HPFIKKFED  334 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~------hp~~~~~~~  334 (354)
                      .+..... ...+..+++.+.+++.+||+.+|++|||+.++++      ||||+.+.+
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         233 FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            3333322 2234467899999999999999999999999987      899987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=331.33  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=207.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||.|++|+||++.++.+++.||+|.+...........+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999999989999999998765433333456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+.+ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence            9975 999988764 467899999999999999999998 8999999999999999999999999999876543322223


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC---------------
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES---------------  288 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  288 (354)
                      ...++..|+|||.+.+ ..++.++||||+||++|+|++|..||.......  .............               
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            3457889999999876 458899999999999999999999996554210  0000000000000               


Q ss_pred             ---------CCCCCCCCCCC--HHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 ---------PPPTAPPDQFS--PEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ---------~~~~~~~~~~~--~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                               .........++  .++.+++.+||+.+|++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     00000001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-46  Score=318.51  Aligned_cols=290  Identities=26%  Similarity=0.436  Sum_probs=247.3

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHH-hhcCCCceEEeeeeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKIN-QASQCSHVVVCYHSFYH  136 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~  136 (354)
                      ..+...+.+|.++++||+|+|++|.+++++.|.+.||+|++++...  .+...-+..|-.+. ...+||.+|-++..|+.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            5677889999999999999999999999999999999999987542  22233344444443 34689999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +..+++|.||.+||+|--.+++.+.++++.++.+...|+.||.|||+ +|||+||||.+|||+|..|++||+|+|.++..
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999999999999999999999999999999999999999997 99999999999999999999999999999988


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH-HHHHHHHHcCCCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF-YELLEAIVESPPPTAPP  295 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  295 (354)
                      -.+....+++||||.|.|||++.+..|...+|+|+||++++||+.|+.||.-..-.....+. .-+.+.+.+..  ...+
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--irip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccc
Confidence            77788889999999999999999999999999999999999999999999643221111111 12334444433  3345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCC------HHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSS------SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps------~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      ..++-.+..+++.-|.+||.+|..      +.++..|+||+.+.|.-.++...++|+.|-+.+
T Consensus       480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~  542 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITD  542 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcccc
Confidence            678888999999999999999965      579999999999999999999999999887764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.7e-44  Score=325.06  Aligned_cols=261  Identities=39%  Similarity=0.671  Sum_probs=222.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|+..+.||.|++|.||++.+..++..||+|++.....  ....+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888999999999999999998999999999976543  45668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++++|.+++...+ .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            999999999999876 89999999999999999999998 9999999999999999999999999999876554433333


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC-CCCCCCCCCCHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-PPTAPPDQFSPEFC  303 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  303 (354)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+.... ........++..+.
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCcchhhCCHHHH
Confidence            446788999999999888999999999999999999999999755432       1122222222 22222334889999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ++|.+||+.+|.+||++.++++|+||++..+++
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  280 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE  280 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence            999999999999999999999999999976644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=320.80  Aligned_cols=250  Identities=32%  Similarity=0.510  Sum_probs=206.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHH-HhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||.|+||.||+|.+..+++.||+|+++....  ......+..|..+ ....+|+|++++++.+..++.+++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999999999999999865421  1222334444443 4456899999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|.++++..+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....    .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence            9999999988889999999999999999999998 8999999999999999999999999999875433    2334688


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP--PPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~  307 (354)
                      ..|+|||.+.+..++.++||||||+++|+|++|..||...+..       .....+....  .+......+++++.+++.
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRINWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence            8999999998888899999999999999999999999765433       1222222221  122233467999999999


Q ss_pred             HhhhhCCCCCCC---HHHHhcCcccccccc
Q 018532          308 ACIQKDPRDRSS---SLDLLSHPFIKKFED  334 (354)
Q Consensus       308 ~~l~~~p~~Rps---~~eil~hp~~~~~~~  334 (354)
                      +||+.+|++||+   ++|+++||||++..+
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            999999999995   579999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8e-45  Score=327.95  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+++.||+|+||.||+|.+..++..||+|++...........+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46799999999999999999999999999999998765443334456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+. ++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            996 5787776543 567888899999999999999998 8999999999999999999999999999876544333334


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHH-----------H------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI-----------V------  286 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------~------  286 (354)
                      ...+++.|+|||.+.+. .++.++|||||||++|+|++|..||....+..  ..+.+....+           .      
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            45678999999998764 47889999999999999999999997554310  0010100000           0      


Q ss_pred             ----cCCCCCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          287 ----ESPPPTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       287 ----~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                          ....+..     .....+.++.+++.+||..||++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                0000000     001236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-44  Score=323.24  Aligned_cols=258  Identities=31%  Similarity=0.521  Sum_probs=210.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc---------HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---------EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +|.+.+.||.|+||.||++.+..+|+.||+|.++....         ....+.+.+|+.+++.++|+|++++++.+...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46778899999999999999998999999998864321         122356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999888889999999999999999999998 8999999999999999999999999999876543


Q ss_pred             CcC--CCcccccCCcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          219 SMG--QRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       219 ~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ...  ......++..|+|||.+....  ++.++|+||||+++|++++|..||......   ....+..........+...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccccCCcCCccc
Confidence            211  123346888999999987754  789999999999999999999999644321   1111111111111111222


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ...++..+.++|.+||..+|++|||++++++|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            33578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-45  Score=322.87  Aligned_cols=254  Identities=28%  Similarity=0.469  Sum_probs=218.5

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +|++.+.||.|+||.||+|.+..++..||+|++....  .....+.+.+|+.+++.++|+|++++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999999999999999997543  22456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+.|++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            99999999999887789999999999999999999998 899999999999999999999999999988765432 2334


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    ...........  .....+..++..+.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence            56888999999999888999999999999999999999999766532    11122222221  2233445688999999


Q ss_pred             HHHhhhhCCCCCCCH--HHHhcCccc
Q 018532          306 VSACIQKDPRDRSSS--LDLLSHPFI  329 (354)
Q Consensus       306 i~~~l~~~p~~Rps~--~eil~hp~~  329 (354)
                      |.+||+.||.+||++  .|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=351.11  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=214.5

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeee-eee-
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHS-FYH-  136 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~-~~~-  136 (354)
                      ..+.+...++++.++|.+|||+.||+|++...|..||+|.+-.. ++...+.+.+|+.+++.|+ |+|||.+++. ... 
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            44566778889999999999999999999988899999998665 6777889999999999996 9999999993 321 


Q ss_pred             -----cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCcEEE
Q 018532          137 -----NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       137 -----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl  207 (354)
                           .-.++|+||||.||.|-+++...  ..|++.++++|+.|+++|+.+||. ..  |||||||-+||||+.+|..||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEe
Confidence                 12688999999999999999854  469999999999999999999998 55  999999999999999999999


Q ss_pred             eecccccccCCCcCCCc---------ccccCCcccccccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh
Q 018532          208 TDFGVSAMLGSSMGQRD---------TFVGTYNYMSPERI---SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW  275 (354)
Q Consensus       208 ~Dfg~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  275 (354)
                      ||||.|+..........         ...-|+.|+|||.+   .+..++.|+|||+|||+||-|+....||......   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            99999986544332111         12368999999987   4567999999999999999999999999876443   


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                              +|..+.........++..+.+||+.||+.||++||++.+++.+
T Consensus       265 --------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  265 --------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             --------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                    3444444454556899999999999999999999999998864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-44  Score=321.86  Aligned_cols=252  Identities=30%  Similarity=0.494  Sum_probs=214.0

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||.|+||.||++.+..+|+.||+|++.....  ......+.+|+.+++.++|+|++++++.+...+..|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999865432  24556789999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--------CCc
Q 018532          153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--------QRD  224 (354)
Q Consensus       153 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--------~~~  224 (354)
                      .+++...+.+++..+..++.||+.||.|||+ .|++|+||+|+||++++++.++|+|||++........        ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999987889999999999999999999998 9999999999999999999999999999876543311        223


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||......       +.................++..+.+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGKIEWPEDVEVSDEAID  232 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCcCCCccccCCHHHHH
Confidence            346788999999998888999999999999999999999999755432       2233333332222222235899999


Q ss_pred             HHHHhhhhCCCCCCCH---HHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSS---LDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~---~eil~hp~~~~~~~  334 (354)
                      ++.+||+.+|++|||+   .++++||||+.+.+
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            9999999999999999   99999999997754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=339.85  Aligned_cols=264  Identities=26%  Similarity=0.413  Sum_probs=233.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +.......|.+.+.||+|.|+.|.++++..|+..||||++++.. ....+..+.+|+++++.++|||||+++.+......
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            44556788999999999999999999999999999999998764 33444569999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||+.+|.+++++.+++...+..+..++.|++.|++|||+ ++|+|||||++|||++.+.++||+|||++..+. .
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~  207 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y  207 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccceeec-c
Confidence            99999999999999999999999999999999999999999998 889999999999999999999999999999887 4


Q ss_pred             cCCCcccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      .....+.||++.|.|||++.+..|+ +.+|+||+|+++|-|++|.+||.+..-.       ++......+...  .+..+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------~Lr~rvl~gk~r--Ip~~m  278 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------ELRPRVLRGKYR--IPFYM  278 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------cccchheeeeec--cccee
Confidence            4566788999999999999998864 7899999999999999999999876533       233333333322  34457


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +.++.++|+++|-.+|.+|++++++.+|.|.......
T Consensus       279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            8899999999999999999999999999999987766

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.2e-45  Score=329.29  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=213.6

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +|++.+.||.|+||.||+|.+..+++.||+|.++....    ......+..|+.+++.++|+|++++++.+.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47778899999999999999999999999999976532    23345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |||+ +++|.+++.... .+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            9999 889999998765 79999999999999999999998 89999999999999999999999999999877654333


Q ss_pred             CcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-------------
Q 018532          223 RDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-------------  288 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  288 (354)
                      .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..+...   +..........             
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhcccccc
Confidence            344467889999999865 4578999999999999999999888866543211   11111100000             


Q ss_pred             ---------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          289 ---------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       289 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                               ..........+.++.++|.+||+.+|++|||+.+++.||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                     0000011345788999999999999999999999999999998644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-44  Score=323.10  Aligned_cols=256  Identities=24%  Similarity=0.382  Sum_probs=209.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      |....++|++.+.||+|+||.||++.+..     ++..||+|++...........+.+|+.+++.++|+||+++++.+..
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            34567889999999999999999998652     4567999998655444455678899999999999999999999998


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      .+..++||||+++++|.+++....          .++...+..++.|++.||.|||+ .|++|+||||+||++++++.++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCCEE
Confidence            899999999999999999997632          24667888999999999999998 9999999999999999999999


Q ss_pred             EeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          207 ITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      |+|||++.........  .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....       +...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLR  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence            9999998765432211  112345778999999998889999999999999999999 78898765432       2233


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+..... ...+..++..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         233 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333322 23345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.5e-45  Score=328.54  Aligned_cols=256  Identities=35%  Similarity=0.637  Sum_probs=215.8

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      |.....||.|+||.||++.+..+++.||+|++...... ..+.+.+|+.+++.+.|+|++++++.+..++..++++||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            34455799999999999999999999999998754332 34568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      +++|..++.. ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++..............|
T Consensus       102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence            9999998765 678999999999999999999998 89999999999999999999999999998765544333445678


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC-CCCCCCCCCCHHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-PPTAPPDQFSPEFCSFVS  307 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~  307 (354)
                      +..|+|||.+.+..++.++|||||||++|+|++|..||......       +....+.... ........++..+.++|.
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            99999999999888999999999999999999999999754432       1222222221 122223467889999999


Q ss_pred             HhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          308 ACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       308 ~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +||+.+|++||++.++++||||.+...
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCCC
Confidence            999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-44  Score=338.45  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=212.5

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHS  133 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~  133 (354)
                      ..|++..++|.+.+.||+|+||.||+|.+...     +..||||+++........+.+.+|+.++..+. |+||++++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            34667788999999999999999999987533     34699999976666666678999999999996 9999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHh------------------------------------------------------
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQV------------------------------------------------------  159 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------  159 (354)
                      +...+.+|+||||+++|+|.+++...                                                      
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            99999999999999999999988653                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          160 ------------------------------------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       160 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                                                                ..+++..+..++.|++.||.|||+ .+|+||||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence                                                      136677788999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      +++.++.+||+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999999986543221  1223356788999999999899999999999999999997 999997643221 


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                           .....+... .....+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 -----~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 -----TFYNKIKSG-YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             -----HHHHHHhcC-CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                 122222222 223344578999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=293.77  Aligned_cols=265  Identities=24%  Similarity=0.425  Sum_probs=222.3

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+|...++||+|+||+|++++++.+++.||+|.++..... .......+|+.+++.++|.|||++++....++.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            4577888999999999999999999999999999876533 344668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+. +|..+.... +.+..+.++.++.|++.||.++|+ +++.||||||.|.+++.+|++||+|||+++.++-+....+
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            9975 999888764 678888999999999999999998 9999999999999999999999999999999887776666


Q ss_pred             ccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC---------
Q 018532          225 TFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA---------  293 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  293 (354)
                      .-+.|.+|.+|.++.+.. |+...|+||.||++.|+.. |++.|.+.+-.++...++.++....+...+..         
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            668899999999999865 8999999999999999986 88888877655444444433322222221110         


Q ss_pred             --C---------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          294 --P---------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       294 --~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                        .         -.+++..-++|+.++|.-+|..|+++++.++||||....
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence              0         013345578999999999999999999999999998764

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-44  Score=329.70  Aligned_cols=266  Identities=26%  Similarity=0.410  Sum_probs=211.0

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~  141 (354)
                      ..++|++.+.||.|+||.||++.+..+|+.||+|+++..... .....+.+|+.+++.++|+|++++++.+...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            467899999999999999999999999999999998754322 2233456799999999999999999988764  5789


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999975 898888764 578999999999999999999998 999999999999999999999999999998775443


Q ss_pred             CCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH--------HHHc----
Q 018532          221 GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE--------AIVE----  287 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~~----  287 (354)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.++.+....+.....        ....    
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            33333456788999999876 4578999999999999999999999976654321111111000        0000    


Q ss_pred             CCC--CCC-------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          288 SPP--PTA-------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       288 ~~~--~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ...  ...       .....++.+.++|.+||+.||++|||+.+++.||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            000  000       012257889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-44  Score=326.88  Aligned_cols=262  Identities=27%  Similarity=0.454  Sum_probs=211.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~l  142 (354)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.++.... ......+.+|+.+++.++|+||+++++.+...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999999999999999975432 23334567899999999999999999998877  89999


Q ss_pred             EEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |+||+++ +|.+++.... .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999975 9999887654 58999999999999999999998 8999999999999999999999999999987765433


Q ss_pred             CCcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------------HHHH
Q 018532          222 QRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------------EAIV  286 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------------~~~~  286 (354)
                      ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+.........              ....
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            344456788999999987654 6889999999999999999999997654332111110000              0000


Q ss_pred             cC--------CCCCCCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          287 ES--------PPPTAPPDQ-FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       287 ~~--------~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ..        ......+.. +++.+.++|.+||+.+|++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            00        000111122 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-44  Score=322.84  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=212.4

Q ss_pred             CcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|.+.+.||+|+||.||+|.+..     ++..||+|+++.....+..+.+.+|+++++.+.|+|++++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            35678999999999999999998753     4678999999876666567889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          140 ISLVLEYMDRGSLADIIRQVK--------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                      .+++|||+++++|.+++...+              .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCCCeE
Confidence            999999999999999997642              36788899999999999999998 899999999999999999999


Q ss_pred             EEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHH
Q 018532          206 KITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELL  282 (354)
Q Consensus       206 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  282 (354)
                      ||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......       +..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence            9999999876532211  1223345788999999999999999999999999999998 99999765433       233


Q ss_pred             HHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+..+.. ...+..++..+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33333332 2334578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-44  Score=320.64  Aligned_cols=253  Identities=31%  Similarity=0.507  Sum_probs=214.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....  .......+.+|+.+++.++|+|++++++.+..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999999999999999876432  3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999999999874    2457899999999999999999998 999999999999999999999999999988765443


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....     .......+.....+......++.
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhhcCCCCCCCcccccH
Confidence            3334557899999999999988999999999999999999999999754322     12333344334444444556889


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.4e-44  Score=328.72  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcE----EEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRL----FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ...+|++.+.||+|+||+||+|.+..++..    ||+|+++..........+.+|+.+++.++|+||+++++.+... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            456789999999999999999997666654    8999987665556667889999999999999999999988764 56


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++++||+++|+|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            7999999999999999875 468888999999999999999998 99999999999999999999999999999876543


Q ss_pred             cCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....       +.. .+.........+.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~-~~~~~~~~~~~~~  234 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EIS-SILEKGERLPQPP  234 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH-HHHhCCCCCCCCC
Confidence            221  122234678999999999999999999999999999997 99999765322       122 2222222223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .++.++.+++.+||..+|++||++.+++.+
T Consensus       235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.6e-44  Score=316.58  Aligned_cols=252  Identities=29%  Similarity=0.490  Sum_probs=214.5

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|...+.||+|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999999999999999987543 334567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcCCC
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .+||+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence            9999999999864  358899999999999999999998 9999999999999998654 68999999998765432 22


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..       .....+..... ...+..++.++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~  230 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMSGTF-APISDRYSPDLR  230 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHhcCC-CCCCCCcCHHHH
Confidence            3357889999999999888999999999999999999999999765432       22223332222 233456899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +++.+||+.+|++|||+.++++||||
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-44  Score=319.55  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=203.5

Q ss_pred             ccccccccc--cccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-hcCCCceEEeeeeeeecCeEEEE
Q 018532           67 EDLETIKVI--GKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ-ASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        67 ~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ++|++.+.+  |.|+||.||++.++.++..+|+|++........      |+.... ..+|+|++++++.+...+..++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            456666666  999999999999999999999999865321111      222222 12799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......   
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            9999999999999887789999999999999999999998 8899999999999999998 9999999998765432   


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                       ....++..|+|||++.+..++.++||||||+++|+|++|..||........  .........   .........+++.+
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~  237 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ---QKKLPFIKNVSKNA  237 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh---cccCCcccccCHHH
Confidence             234688999999999998899999999999999999999999975433211  111111111   12223345789999


Q ss_pred             HHHHHHhhhhCCCCCCC-HHHHhcCccccc
Q 018532          303 CSFVSACIQKDPRDRSS-SLDLLSHPFIKK  331 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps-~~eil~hp~~~~  331 (354)
                      .++|.+||+.+|.+||+ ++++++||||+.
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999974

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=337.13  Aligned_cols=250  Identities=28%  Similarity=0.468  Sum_probs=218.2

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      ++||+|.||+||-++++.+|+.||||++.+.. .......+.+|+.|++.+.||.||.+-..|+..+.+++|||-+.| +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence            68999999999999999999999999997542 334447799999999999999999999999999999999999965 7


Q ss_pred             HHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeecccccccCCCcCCCccc
Q 018532          152 LADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       152 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +.+++-.  .+++++.....++.||+.||.|||. +||+|+||||+|||+.+..   .+||||||+|+.++.. ....+.
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV  726 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV  726 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence            7776643  3789999999999999999999998 9999999999999997654   6999999999988754 456678


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      +|||.|+|||++.++.|+..-|+||.|+|+|.-++|.+||....+-      .+.++ ......++.++..++.++.|||
T Consensus       727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI------ndQIQ-NAaFMyPp~PW~eis~~AidlI  799 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI------NDQIQ-NAAFMYPPNPWSEISPEAIDLI  799 (888)
T ss_pred             cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch------hHHhh-ccccccCCCchhhcCHHHHHHH
Confidence            9999999999999999999999999999999999999999765432      11111 1233556777889999999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ..+|++.-++|.|.++.|.|||++..
T Consensus       800 n~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  800 NNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999999975

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-44  Score=325.16  Aligned_cols=257  Identities=27%  Similarity=0.488  Sum_probs=208.7

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|+..+.||.|++|.||+|++..+++.||||.++.... ......+.+|+.+++.++|+|++++++.+.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            47788999999999999999999999999999865432 22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +. ++|.+++...  ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            96 5899988753  468899999999999999999998 8999999999999999999999999999876654433334


Q ss_pred             ccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc----------------
Q 018532          225 TFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE----------------  287 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  287 (354)
                      ...++..|+|||.+.+.. ++.++|||||||++|+|+||+.||...+....   .....+....                
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            446788999999987654 68899999999999999999999976543211   1111110000                


Q ss_pred             -CCCC------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          288 -SPPP------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       288 -~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                       ....      ......++.++.++|.+||+.||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence             0000      00112468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=324.42  Aligned_cols=258  Identities=28%  Similarity=0.494  Sum_probs=213.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+.+|+.+++.+.|+||+++++.+...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999999999999999987543 33445778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CCc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~  224 (354)
                      |++++.+..+......+++..+..++.||+.||.|||+ .+++|+||+|+||++++++.+||+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99987777666665679999999999999999999998 8999999999999999999999999999987655432 334


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC---------------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES---------------  288 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  288 (354)
                      ...++..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+   ...... .....               
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQ-KCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-HHhCCCCHHHhhhcccCccc
Confidence            45788999999999888 78999999999999999999999997653321   111100 00000               


Q ss_pred             ---CC-C--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 ---PP-P--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ---~~-~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                         .. .        ...+..++.++.+||.+||..+|++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               00 0        01123358899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-44  Score=325.92  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=210.6

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      +|++.+.||.|++|.||+|++..+|..||+|+++..........+.+|+.+++.++|+|++++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            47889999999999999999999999999999976544444456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          148 DRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       148 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||+ .|++||||+|+||++++++.++|+|||++...........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            85 899888764   358999999999999999999998 8999999999999999999999999999976654433333


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HHHHHcCC-----C
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LEAIVESP-----P  290 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~-----~  290 (354)
                      ...++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+......+.        ++.+....     .
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            44678899999998764 4788999999999999999999999876543221111110        00000000     0


Q ss_pred             CC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          291 PT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       291 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +.       .....++..+.+++.+||+.||++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00       0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-44  Score=325.50  Aligned_cols=273  Identities=36%  Similarity=0.699  Sum_probs=220.7

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +.+..++|++.+.||+|+||+||++.+..+++.||+|.++..........+..|+.++... .|+||+++++.+......
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            3456788999999999999999999999899999999997655444456666777655555 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+..||+||||+|+||++++++.+||+|||++......
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99999995 488887765 3568899999999999999999997458999999999999999999999999998765433


Q ss_pred             cCCCcccccCCcccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC-CC
Q 018532          220 MGQRDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-AP  294 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  294 (354)
                      ... ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......      .+....+.....+. ..
T Consensus       169 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  241 (296)
T cd06618         169 KAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPPSLPP  241 (296)
T ss_pred             Ccc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCCCCCCC
Confidence            222 2335788999999987654    788999999999999999999999653221      12233333332222 22


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGIL  342 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~  342 (354)
                      ...++.++.+|+.+||..||++||++.+++.||||+....++.++..|
T Consensus       242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~  289 (296)
T cd06618         242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGW  289 (296)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHHHHH
Confidence            235789999999999999999999999999999999988877665544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-44  Score=322.25  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=211.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||.|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            57889999999999999999999999999999876542 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CCc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~  224 (354)
                      + +++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            9 89999998753 568999999999999999999998 8999999999999999999999999999887654321 123


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC---------------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES---------------  288 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  288 (354)
                      ...++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+..+...+.   .........               
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHhhccCcchhh
Confidence            45789999999998764 46899999999999999999988886654322111   111110000               


Q ss_pred             --CCC-------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          289 --PPP-------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       289 --~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                        ..+       .......+..+.++|.+||+.+|++|||++++++||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              000       001124578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-44  Score=320.88  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=213.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      |++..++|.+.+.||+|+||.||++.+...     +..||+|.+...........+.+|+.+++.++|+|++++++.+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            456678999999999999999999998654     378999998766555556778899999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCCCEE
Confidence            999999999999999999997532          36778899999999999999998 9999999999999999999999


Q ss_pred             EeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          207 ITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      |+|||++........  ......++..|+|||.+.+..++.++|||||||++|++++ |..||......       +...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~  232 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLK  232 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHH
Confidence            999999876543321  1223456789999999988889999999999999999998 99999765432       2233


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+... .....+..++..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         233 FVIDG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33333 233345567999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5e-44  Score=321.45  Aligned_cols=253  Identities=21%  Similarity=0.346  Sum_probs=210.6

Q ss_pred             CcccccccccccccCceEEEEEEEc----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+++|++.+.||+|+||+||+|...    .++..||+|.+...........+.+|+.+++.++|+|++++++.+...+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4578899999999999999999853    456789999987655555567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG  203 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  203 (354)
                      +++|||+++++|.+++...                 ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEcCCC
Confidence            9999999999999998632                 236788889999999999999998 8999999999999999999


Q ss_pred             cEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHH
Q 018532          204 EVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYE  280 (354)
Q Consensus       204 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  280 (354)
                      .+||+|||++.......  .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....       +
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence            99999999997654321  11233356778999999998889999999999999999998 99999765422       2


Q ss_pred             HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..+.+.... ....+..+++.+.+++.+||+.||++||++.+++++
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         235 VIEMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333333332 233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=316.30  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=214.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecc----ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN----IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~  140 (354)
                      .+|.+.+.||+|+||.||++.+..++..||+|.+...    ........+.+|+.+++.++|+||+++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999999999999999987532    1234456788999999999999999999988653  568


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++++||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            8999999999999999887788999999999999999999998 999999999999999999999999999998654321


Q ss_pred             ---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 ---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                         .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......       +....+.........+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCCCCCCcc
Confidence               1122356889999999999888999999999999999999999999754322       222333334344455678


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +++.+.++|.+||+ +|..||++.+++.|||+
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            89999999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.9e-44  Score=324.02  Aligned_cols=256  Identities=33%  Similarity=0.549  Sum_probs=214.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ...|.+.+.||+|+||+||++.+..+++.||+|++....  ..+..+.+.+|+.+++.++|+|++++++.+...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888999999999999999999999999999986432  234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      +||+. |+|.+++.. .+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......   
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            99997 478777764 3578999999999999999999998 99999999999999999999999999998755322   


Q ss_pred             CcccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          223 RDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                       ....++..|+|||++.   ...++.++||||||+++|+|++|..||...+..       .....+.....+......++
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  240 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLSSNDWS  240 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCCCCCCCchhhC
Confidence             2346888999999884   356889999999999999999999999765432       11222333333333345678


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..+.++|.+||..+|++||++.+++.||||.....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence            89999999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-44  Score=323.60  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=206.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCe-----
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~-----  139 (354)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++..... .....+.+|+.+++.+. |+|++++++.+.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999999999999999998654322 23356788999999985 6999999998877655     


Q ss_pred             EEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccc
Q 018532          140 ISLVLEYMDRGSLADIIRQV-----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVS  213 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a  213 (354)
                      .|++|||+++ +|.+++...     ..+++..+..++.||+.||.|||+ +|++||||+|+||+++. ++.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            8999999986 898888653     347899999999999999999998 99999999999999998 889999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC---
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP---  289 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  289 (354)
                      ..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.......   ......+....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~  235 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LHIFKLLGTPTEQV  235 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHhCCCChhh
Confidence            866443333333467889999998865 45789999999999999999999999765433211   11111110000   


Q ss_pred             ----------------C---CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          290 ----------------P---PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       290 ----------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                                      .   .......++.++.+||.+||..||.+||++.+++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                            0   0001134788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=340.16  Aligned_cols=253  Identities=25%  Similarity=0.485  Sum_probs=222.7

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEe---eccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC--eEEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVL  144 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~---~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~  144 (354)
                      +...+||+|+|-+||+|.|..+|..||.-.+   +.....+...++..|+.+++.|+|+||+++|+.|.+..  .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456799999999999999999999885433   33345566788999999999999999999999998765  488999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecCCCCCCEEEcc-CCcEEEeecccccccCCCcCC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |++..|+|..|+++.+.++...+..|++||+.||.|||+ ...|||||||.+||+|+. .|.|||+|+|+|+....... 
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence            999999999999999999999999999999999999998 345999999999999986 48999999999998865433 


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                       ...+|||.|||||.+. ..|+..+||||||+++.||+|+.+||......      .++.+++..+..|.....--++++
T Consensus       202 -ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  202 -KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             -ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhccCCHHH
Confidence             3479999999999988 58999999999999999999999999877654      367788888888777766668999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++||.+||.. .++|+|+.|+|+||||..-
T Consensus       274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  274 REFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999999 9999999999999999874

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.9e-44  Score=323.26  Aligned_cols=257  Identities=24%  Similarity=0.384  Sum_probs=213.3

Q ss_pred             ccccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .+.+..++|.+.+.||+|+||.||++.+     ..++..||+|.++..........+.+|+.+++.+ +|+||+++++.+
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3566778999999999999999999975     3355689999987665555667789999999999 799999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ...+..+++|||+.+++|.++++...  .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999999997643  38999999999999999999998 8999999999999999999999999999


Q ss_pred             ccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          213 SAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       213 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      +........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +.........
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~~~~  260 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLIKEG  260 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHHHcC
Confidence            986543321  1122345778999999999899999999999999999998 99999765432       1122222222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .....+...++++.+++.+||..+|++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333344567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.5e-44  Score=314.78  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      +.||+|+||.||++.+..+++.||+|.+......+....+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999999999999999987666666677899999999999999999999999999999999999999999


Q ss_pred             HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC--cccccC
Q 018532          153 ADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFVGT  229 (354)
Q Consensus       153 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt  229 (354)
                      .+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........  .....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            9999764 358899999999999999999998 999999999999999999999999999987643221111  111234


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      ..|+|||.+.+..++.++|||||||++|+|++ |..||......       .....+... .....+..++..+.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~li~~  231 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQG-VRLPCPELCPDAVYRLMER  231 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcC-CCCCCcccCCHHHHHHHHH
Confidence            57999999999889999999999999999997 88998654332       122222222 2233455779999999999


Q ss_pred             hhhhCCCCCCCHHHHhc
Q 018532          309 CIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       309 ~l~~~p~~Rps~~eil~  325 (354)
                      ||+.+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-44  Score=329.74  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=210.4

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +.+.-..|+++++||+||-+.||++.....+-.++.|+.....+.....-+.+|+..|.++ .|.+||.++++-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            4456678999999999999999999986555444444444555666778899999999988 579999999998899999


Q ss_pred             EEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      |+||||-+ .+|..+|++... .+...+..+..|++.|+.++|+ .||||.||||.|+|+ -.|.+||+|||+|..+...
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            99999985 599999998654 3435788899999999999998 899999999999988 5689999999999987655


Q ss_pred             cCC--CcccccCCcccccccccCCC-----------CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGST-----------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ...  ..+-+||+.||+||.+....           .++++||||||||||+|+.|+.||...      .+....+..+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~aI~  586 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLHAIT  586 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHHhhc
Confidence            432  34568999999999985432           567899999999999999999999543      23344455555


Q ss_pred             cCCCCCCCCCCCC-HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          287 ESPPPTAPPDQFS-PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       287 ~~~~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ...-....+..-+ .++.++++.||..||.+|||+.++|+|||++-+
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            5433223332222 339999999999999999999999999999874

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.1e-44  Score=314.76  Aligned_cols=253  Identities=39%  Similarity=0.614  Sum_probs=219.9

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|.+.+.||.|+||.||++.+..++..||+|++.... ..+....+.+|+++++.++|+|++++++.+...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999999999999999987643 235567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          147 MDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       147 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            9999999999874    678999999999999999999998 89999999999999999999999999999877655434


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       .......... ....+..++..+
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~  231 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKILKGQ-YPPIPSQYSSEL  231 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHHhcCC-CCCCCCCCCHHH
Confidence            44567899999999999888999999999999999999999999655422       2333333332 233345789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+++.+||..+|++|||+.++++||||
T Consensus       232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         232 RNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.6e-45  Score=322.39  Aligned_cols=247  Identities=28%  Similarity=0.504  Sum_probs=203.3

Q ss_pred             cccccccccCceEEEEEEEc----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           70 ETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++.+.||.|+||.||+|...    ..+..|+||.++.....+....+.+|+++++.++|+||+++++.+...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35678999999999999987    45678999999766666667889999999999999999999999998888999999


Q ss_pred             ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc--C
Q 018532          146 YMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--G  221 (354)
Q Consensus       146 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~  221 (354)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||+ ++++|+||+++||+++.++.+||+|||++.......  .
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999986  678999999999999999999998 889999999999999999999999999998763221  1


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ..........|+|||.+.+..++.++||||||+++|||++ |+.||......       +....+..... ...+..++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~  232 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-------EIIEKLKQGQR-LPIPDNCPK  232 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-------HHHHHHHTTEE-TTSBTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccc-ceeccchhH
Confidence            1233356779999999999889999999999999999999 78998665432       34445544433 334567899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.++|.+||..+|++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.9e-44  Score=319.64  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=210.5

Q ss_pred             CcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|.+.+.||+|+||.||+|.+..     ++..||+|.+...........+.+|+.+++.++|+||+++++.+.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45678999999999999999999987     7788999998765555555678899999999999999999999998899


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEee
Q 018532          140 ISLVLEYMDRGSLADIIRQVK-------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITD  209 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~D  209 (354)
                      .+++|||++|++|.+++...+       .+++..+..++.||+.||.|||+ ++++|+||||+||+++.++   .+||+|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999999997653       47889999999999999999998 8999999999999998765   599999


Q ss_pred             cccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          210 FGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       210 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ||++.........  ......+..|+|||++.+..++.++|||||||++|+|++ |..||......       +....+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~  235 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFVT  235 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHH
Confidence            9999866322111  112233568999999998899999999999999999997 99999765432       2233333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ... ....+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       236 ~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         236 GGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            332 223355789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-43  Score=315.41  Aligned_cols=253  Identities=32%  Similarity=0.533  Sum_probs=214.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..  ......+.+.+|+.+++.++|+|++++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5788999999999999999999999999999988642  23344677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999998653    357899999999999999999998 999999999999999999999999999987665443


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....     ...+....+.....+......++.
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcCCCCCCChhhcCH
Confidence            334445789999999999988899999999999999999999999965432     122333333333333333346788


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.3e-44  Score=316.66  Aligned_cols=253  Identities=22%  Similarity=0.359  Sum_probs=212.0

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++...+|.+.+.||.|+||.||++.+..+++.||+|++..+.  .....+.+|+.+++.++|+|++++++.+...+.++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            3456678899999999999999999999999999999986542  22456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||++++++.+||+|||++......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999999999764  358889999999999999999998 99999999999999999999999999999876443


Q ss_pred             cCCC-cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MGQR-DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....       +....+... .....+..
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~  229 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKG-YRMERPEG  229 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC-CCCCCCCC
Confidence            2111 12234568999999999899999999999999999998 99999765332       223333332 23334567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ++..+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-44  Score=316.77  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=212.7

Q ss_pred             CcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ..++|++.+.||+|+||+||+|....+   ...||+|.++..........+.+|+.+++.++|+||+++++.+...+..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            356789999999999999999998654   45799999877666666778899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++|||+++++|.+++... +.+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++.......
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999999764 468999999999999999999998 999999999999999999999999999998775222


Q ss_pred             CCC--cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 GQR--DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......       +....+.... ....+..
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~  232 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGY-RLPPPMD  232 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCC
Confidence            211  12245678999999998899999999999999999998 99999654332       2333333332 2233456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++..+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2e-44  Score=334.24  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=209.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+|++++++.+...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            478999999999999999999999999999999986532 233445677899999999999999999987643      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999965 898888653  8999999999999999999998 8999999999999999999999999999987644


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH-----------HH----HH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY-----------EL----LE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-----------~~----~~  283 (354)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+.           ..    ..
T Consensus       171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            32 2234568899999999999999999999999999999999999997654321111110           00    00


Q ss_pred             HHHcCCCCC-------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          284 AIVESPPPT-------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       284 ~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ......+..                   ..+...++.+.++|.+||+.||++|||+.|+|.||||+.-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            000000000                   0012346678999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5e-44  Score=326.61  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=192.9

Q ss_pred             ccccccCceEEEEEEEcc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEEEEEeccC
Q 018532           73 KVIGKGSGGVVQLVRHKW--VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVISLVLEYMD  148 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~  148 (354)
                      ..||+|+||+||+|++..  ++..||+|.+.....   ...+.+|+.+++.++|+||+++++.+..  +..+++++||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            579999999999999754  568899998865422   2346789999999999999999998854  568899999996


Q ss_pred             CCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE----ccCCcEEEeecccccc
Q 018532          149 RGSLADIIRQV---------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAM  215 (354)
Q Consensus       149 ~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  215 (354)
                      + +|.+++...         ..+++..+..++.||+.||.|||+ .||+||||||+||++    +.++.+||+|||++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 888887532         247888999999999999999998 999999999999999    4567899999999987


Q ss_pred             cCCCcC---CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh------hhHHHHH---
Q 018532          216 LGSSMG---QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW------PSFYELL---  282 (354)
Q Consensus       216 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~---  282 (354)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........      .......   
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            654322   22345789999999999774 5899999999999999999999999754322100      0000000   


Q ss_pred             --------HH-------------HHcCCC--------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          283 --------EA-------------IVESPP--------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       283 --------~~-------------~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                              ..             ......        ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    00             000000        000111345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-44  Score=330.75  Aligned_cols=266  Identities=24%  Similarity=0.403  Sum_probs=210.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~  141 (354)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++...........+.+|+.+++.++|+|++++++.+...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            67999999999999999999999999999999986543444556678899999999999999999876543     3689


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +++||+.+ +|..++.. +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            99999975 88888754 679999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             ---CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH--------HHHHHH---
Q 018532          222 ---QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE--------LLEAIV---  286 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~---  286 (354)
                         ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..        ....+.   
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence               1223568999999998765 4689999999999999999999999976432211110000        000000   


Q ss_pred             -----cCCC-CCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          287 -----ESPP-PTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       287 -----~~~~-~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                           ...+ ...     .....+.++.++|.+||+.+|++|||+.++++||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                 0000 000     112457889999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-43  Score=312.25  Aligned_cols=255  Identities=34%  Similarity=0.597  Sum_probs=220.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~  144 (354)
                      +|...+.||+|++|.||++.+..+++.|++|++..... ....+.+.+|+.+++.++|+|++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            46778899999999999999999999999999876542 34567789999999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--C
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--Q  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~  222 (354)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999987889999999999999999999998 9999999999999999999999999999987765432  1


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .....++..|+|||.+.+...+.++||||||+++|+|++|..||....+.      ................+..++..+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCCCcCCCcccCHHH
Confidence            33457889999999999888999999999999999999999999766521      122223332233344556779999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .++|.+||+.||++||++.+++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.8e-44  Score=316.10  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=213.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||.|+||.||++.++.+|..||+|.+.... .....+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999999999999999986542 223345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc-EEEeecccccccCCCcCCC
Q 018532          147 MDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-VKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       147 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~  223 (354)
                      +++++|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++. +||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            99999999997643  47899999999999999999998 99999999999999998864 6999999998775544333


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||......       +.......... ......++.++.
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~  231 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKICQGYF-APISPNFSRDLR  231 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhcccC-CCCCCCCCHHHH
Confidence            4456899999999998888999999999999999999999999654322       22223333222 222346788999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +++.+||..+|++|||+.++++||||
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         232 SLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.1e-44  Score=333.51  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=212.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~  134 (354)
                      .|++..++|.+.+.||+|+||.||+|++.     .++..||+|+++..........+.+|+.++..+. |+||+++++.+
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            47778889999999999999999999854     3556899999987655555567889999999997 99999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC------------------------------------------------------
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK------------------------------------------------------  160 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  160 (354)
                      ...+..++||||+++|+|.++++..+                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999997532                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          161 --------------------------------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       161 --------------------------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                                                                  .+++..+..++.||+.||.|||+ .+++||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~N  269 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARN  269 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcce
Confidence                                                        24566778899999999999998 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      |++++++.+||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533211  1223456789999999998889999999999999999998 899996554321


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            .....+..+ .....+..++.++.+|+.+||..+|++||++++|+..
T Consensus       350 ------~~~~~~~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 ------QFYNAIKRG-YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             ------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                  112222222 2333455689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.4e-44  Score=353.51  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=207.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|+++...  .....+.+.+|+.+++.++|+||+++++.+.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            67999999999999999999999999999999987543  2345677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          145 EYMDRGSLADIIRQV-----------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ||++|++|.+++...           ...+...+..++.||+.||.|||+ .||+||||||+||+++.+|.++|+|||++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecCcc
Confidence            999999999998642           234456778899999999999998 89999999999999999999999999999


Q ss_pred             cccCCC------------------cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh
Q 018532          214 AMLGSS------------------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW  275 (354)
Q Consensus       214 ~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  275 (354)
                      ......                  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ 
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence            865211                  0111234799999999999999999999999999999999999999976433210 


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                           .................+++.+.+++.+||..||++|++..+.+.+
T Consensus       240 -----~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 -----SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             -----hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 1111111111122234688999999999999999999887665543

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.7e-44  Score=328.99  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=208.5

Q ss_pred             cccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFY  135 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~  135 (354)
                      |.+..++|++.+.||+|+||+||+|.+     ..+++.||||+++.....+....+.+|+.++..+ +|+||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            567788999999999999999999984     3567899999998765555567788999999998 6899999999876


Q ss_pred             ec-CeEEEEEeccCCCCHHHHHHHh-------------------------------------------------------
Q 018532          136 HN-GVISLVLEYMDRGSLADIIRQV-------------------------------------------------------  159 (354)
Q Consensus       136 ~~-~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  159 (354)
                      .. ..++++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 5688999999999999998652                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--CCcc
Q 018532          160 ------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDT  225 (354)
Q Consensus       160 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~  225 (354)
                                  ..++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........  ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                        135677788899999999999998 9999999999999999999999999999876533211  1122


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      .......... ....+...++++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~  313 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT-RMRAPDYTTPEMYQ  313 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccC-CCCCCCCCCHHHHH
Confidence            345678999999998889999999999999999996 999996643321      1222222222 22334457889999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcC
Q 018532          305 FVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++..||+.||++|||+.++++|
T Consensus       314 ~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=311.64  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=219.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      +.||+|+|+.|-.+....+|..||||++.+. ....+.++.+|+.++..- .|+||+.++++|+++..+|||||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            5799999999999999999999999999876 445567889999988774 79999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeecccccccCCC-------cC
Q 018532          152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSS-------MG  221 (354)
Q Consensus       152 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~-------~~  221 (354)
                      |...|++.+.+++.++..+.++|+.||.+||. +||.||||||+|||-.+...   ||||||.+.......       ..
T Consensus       163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  163 LLSHIQKRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            99999999999999999999999999999998 99999999999999976654   899999887653211       11


Q ss_pred             CCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC-Chh-------hHHHHHHHHHcC
Q 018532          222 QRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ-SWP-------SFYELLEAIVES  288 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~-------~~~~~~~~~~~~  288 (354)
                      ...+.+|+..|||||+..-     ..|+.++|.||||+++|-|++|-+||.+.-..+ .|.       --..+++.|.++
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            2345689999999998632     248999999999999999999999998754321 111       122455666666


Q ss_pred             CCC--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          289 PPP--TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       289 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ...  ...+..+|.+..++++.+|..++.+|.++.+++.|||++.+...
T Consensus       322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            443  33456789999999999999999999999999999999998665

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.1e-44  Score=323.79  Aligned_cols=263  Identities=25%  Similarity=0.438  Sum_probs=210.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||.|++|+||++.+..+|+.||+|.+..... ......+.+|+.+++.++|+|++++++.+...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578999999999999999999999999999999865432 2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |++ ++|.+++.....  +++..+..++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++.........
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            996 488888765443  5778888999999999999998 89999999999999985 557999999999766544333


Q ss_pred             CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-------------
Q 018532          223 RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-------------  288 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  288 (354)
                      .....+++.|+|||++.+. .++.++|||||||++|+|++|..||......+   ...+........             
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccccccchh
Confidence            3445678899999998764 57899999999999999999999997654321   111111110000             


Q ss_pred             ----CC--CC----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          289 ----PP--PT----APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       289 ----~~--~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                          .+  ..    .....++.++.+++.+||+.+|++||++.++++||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                00  00    011346888999999999999999999999999999998754

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-43  Score=310.79  Aligned_cols=252  Identities=39%  Similarity=0.735  Sum_probs=214.7

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      +|...+.||+|++|.||++.+..++..+++|++..... ...+.+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            47788899999999999999998999999999976544 45577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          148 DRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       148 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      ++++|.+++... +.+++..+..++.|++.||.+||+ .|++||||+|+||++++++.++|+|||.+........ ....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            999999999876 578999999999999999999998 9999999999999999999999999999987654432 3445


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...      ..................++..+.++|
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~i  231 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIATNGPPGLRNPEKWSDEFKDFL  231 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcCCCCcCcccccCHHHHHHH
Confidence            78899999999998889999999999999999999999997653221      111111122222222233489999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      .+||+.||++|||+.++++|||
T Consensus       232 ~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         232 KKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHccCChhhCCCHHHHhcCCC
Confidence            9999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-43  Score=320.34  Aligned_cols=265  Identities=28%  Similarity=0.476  Sum_probs=218.2

Q ss_pred             cccccccccccCceEEEEEEEc---cCCcEEEEEEeecccc---HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQ---EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +|++.+.||.|+||.||.|.+.   .+|..||+|+++....   ....+.+.+|+.++..+ +|+||+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3778899999999999999875   4789999999875422   23346678899999998 689999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999987654322


Q ss_pred             -CCCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 -GQRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                       .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||........   ..+..........  ..+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~~~  234 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSEP--PYPQE  234 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHHHHhhccCC--CCCcc
Confidence             122345689999999998763  467899999999999999999999975433222   1222233322222  22456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCC-----CHHHHhcCcccccccccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~  338 (354)
                      ++..+.+++.+||+.||++||     ++.++++||||++..+....
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  280 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA  280 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence            889999999999999999997     89999999999999876654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.4e-44  Score=320.15  Aligned_cols=253  Identities=30%  Similarity=0.509  Sum_probs=217.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.+. |+||+++++.+...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999999999999999987532  2344567888999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc---
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM---  220 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---  220 (354)
                      ||++++++|.+++.+.+.+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            9999999999999988889999999999999999999998 999999999999999999999999999988665432   


Q ss_pred             -----------------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH
Q 018532          221 -----------------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       221 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                                       .......++..|+|||.+.+..++.++|+||||++++++++|..||......       ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~  232 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------LTFQ  232 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHH
Confidence                             1223346788999999999888999999999999999999999999766532       2222


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCH----HHHhcCccc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSS----LDLLSHPFI  329 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~eil~hp~~  329 (354)
                      .....  ....+..+++.+.++|.+||+.+|++||++    .++++||||
T Consensus       233 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         233 KILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            22222  223345679999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-44  Score=329.61  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=214.8

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~  140 (354)
                      .+|.+.+.||+|+||+||++.+..+++.||||.+.... .......+.+|+.+++.++|+||+++++.+...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57889999999999999999999999999999987542 222345677899999999999999999877643     358


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+++||+. ++|.+++...+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999996 6999999887889999999999999999999998 899999999999999999999999999998765433


Q ss_pred             CCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH--------------------
Q 018532          221 GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY--------------------  279 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------------------  279 (354)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.                    
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            33344578899999998865 468899999999999999999999997643211000000                    


Q ss_pred             HHHHHHHcCCCC--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          280 ELLEAIVESPPP--TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       280 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ............  ......+++++.++|.+||+.+|++|||+.++++||||+.+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            000000000000  0112357899999999999999999999999999999998766554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-43  Score=314.78  Aligned_cols=252  Identities=23%  Similarity=0.412  Sum_probs=210.2

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |.+..++|++++.||+|+||.||++... ++..||+|.+.....  ..+.+.+|+.+++.++|+|++++++.+...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            4567789999999999999999999875 567799998765322  2467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++...  ..++...+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999999999764  467888999999999999999998 99999999999999999999999999999876432


Q ss_pred             cC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. ......++..|+|||++.+..++.++|||||||++|+|++ |..||......       .....+.... .......
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~  228 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGY-RMPRMEN  228 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCC
Confidence            21 1222345678999999998889999999999999999998 99999765432       2233333332 2233456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ++.++.+++.+||..+|++||+++++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            8899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.8e-44  Score=316.61  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=213.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      +....+|.+.+.||.|+||+||+|.+.. +..+|+|++..... .....+.+|+.+++.++|+|++++++.+...+..++
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            3456789999999999999999999987 88999999876533 234568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          143 VLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999999763  468899999999999999999998 999999999999999999999999999998765433


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......       +....+.... ....+..++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~  230 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYDQITAGY-RMPCPAKCP  230 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHHhCC-cCCCCCCCC
Confidence            33334456778999999998889999999999999999998 89999765432       2333333332 223345789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.7e-44  Score=319.55  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=211.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +...+|.+.+.||.|+||.||++.+..+     +..||+|+++..........+.+|+.++..++|+||+++++.+...+
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            3467889999999999999999987543     57899999986655566677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK  202 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~  202 (354)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+ .|++||||||+||+++++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecCC
Confidence            999999999999999998532                246778889999999999999998 999999999999999999


Q ss_pred             CcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHH
Q 018532          203 GEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       203 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  279 (354)
                      +.+||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....       
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------  233 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------  233 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence            9999999999876543221  1223356789999999988889999999999999999998 88888765432       


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +....+..... ...+..++..+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            33444444332 23456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.4e-44  Score=324.06  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=207.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcE--EEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRL--FALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|++.+.||+|+||.||+|.++.++..  +|+|.++..........+.+|+.++..+ +|+||+++++.+...+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            3467899999999999999999999877764  5777766544555667788999999998 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      +++|||+++++|.+++...+                .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCCCc
Confidence            99999999999999997543                46788999999999999999998 99999999999999999999


Q ss_pred             EEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      +||+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +...
T Consensus       163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~  234 (303)
T cd05088         163 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  234 (303)
T ss_pred             EEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH
Confidence            99999999864322111 111234667999999988889999999999999999998 99999655432       2222


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+... .....+..++.++.+|+.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33222 2222344578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-43  Score=320.03  Aligned_cols=253  Identities=22%  Similarity=0.361  Sum_probs=210.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCC----------------cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVG----------------RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv  128 (354)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.........+.+.+|+.+++.++|+|++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4578999999999999999999876544                558999988766666678899999999999999999


Q ss_pred             EeeeeeeecCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      ++++.+..++..++++|++++++|.+++....           .+++..+..++.|++.||.|||+ .|++|+||||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp~Ni  161 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccchhce
Confidence            99999999999999999999999999998765           68999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCcCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI--GRFPYMQSEDQQ  273 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  273 (354)
                      +++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|||||||++|+|++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999987654322  11223456788999999998889999999999999999998  778886554332


Q ss_pred             ChhhHHHHHHHHHc------CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          274 SWPSFYELLEAIVE------SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       274 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                             .+.....      .......+..++.++.+++.+||+.||++|||+.++++
T Consensus       242 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 -------VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             -------HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                   1121111      11112223457889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.2e-44  Score=319.24  Aligned_cols=257  Identities=21%  Similarity=0.343  Sum_probs=202.2

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeec--CeEEEEEe
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHN--GVISLVLE  145 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~--~~~~lv~e  145 (354)
                      |++.+.||+|+||.||++.+..+++.||+|.++............+|+.++..+. |+|++++++.+.+.  +.+++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5678899999999999999999999999999875433222234457888887774 99999999999887  89999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+.+... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++. +.+||+|||++........ ..
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cC
Confidence            9975 888888764 568999999999999999999998 99999999999999999 9999999999987644322 23


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HHHHHcCC-CCCC-
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LEAIVESP-PPTA-  293 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~-  293 (354)
                      ...++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+........        ........ .... 
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3467899999998754 45788999999999999999999999765432211111000        00000000 0000 


Q ss_pred             ----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          294 ----------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       294 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                                ....++..+.++|.+||.++|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                      012468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-43  Score=320.46  Aligned_cols=255  Identities=34%  Similarity=0.593  Sum_probs=214.9

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      .....||+|+||.||++....+++.||+|++..... .....+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            334679999999999999999999999999865432 3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccC
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT  229 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  229 (354)
                      ++|.+++.. ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..............|+
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            999998754 568999999999999999999998 899999999999999999999999999987665443334445789


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  308 (354)
                      ..|+|||.+.+..++.++|+||+|+++|+|++|..||.+....       +....+....+ .......++..+.+++.+
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            9999999998888999999999999999999999999764332       11222222211 111234578999999999


Q ss_pred             hhhhCCCCCCCHHHHhcCcccccccc
Q 018532          309 CIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       309 ~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ||+.+|.+||++.++++||||.+...
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=355.01  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=220.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVG-----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +..+..+..+.||+|+||.||.+......     ..||||.+++..+.+....|.+|..+++.++|||||++++++.+.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            44667788899999999999999876432     2499999998888888899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          139 VISLVLEYMDRGSLADIIRQV-------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                      ..++++|||+||+|..+|++.       ..++..++..++.||+.|+.||++ +++|||||..+|+|++....|||+|||
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999999976       357889999999999999999998 889999999999999999999999999


Q ss_pred             cccccCCCcCCCc-c-cccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          212 VSAMLGSSMGQRD-T-FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       212 ~a~~~~~~~~~~~-~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      +|+.+........ . ..-+..|||||.+..+.++.|+|||||||++||++| |..||.+.++.       +++.....+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------EVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------HHHHHHHhC
Confidence            9996543222111 1 134579999999999999999999999999999998 99999877654       455555555


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      . ....+..|+..+.++|..||+.+|++||++..|++
T Consensus       921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            5 66677899999999999999999999999999987

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-43  Score=313.22  Aligned_cols=245  Identities=28%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             ccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||+|.+...   +..||+|++...........+.+|+.++..++|+|++++++.+.....++++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999866   8999999998766555567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          150 GSLADIIRQV---------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       150 ~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++|.+++...         ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            9999999875         678999999999999999999998 999999999999999999999999999998765432


Q ss_pred             --CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 --GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +....+... .....+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~  231 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKG-YRLPKPEY  231 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-CCCCCCcc
Confidence              22334467889999999998889999999999999999998 69999776432       233333332 23344556


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++.++.+++.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            79999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-44  Score=328.96  Aligned_cols=269  Identities=28%  Similarity=0.419  Sum_probs=219.0

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-----eEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-----VIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~  141 (354)
                      +|.+.+.||.|++|.||+|++..+++.||+|++..... ....+.+.+|+.+++.++|+|++++++.+....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47888999999999999999998999999999876542 344567889999999999999999999887765     799


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-  220 (354)
                      ++|||+. ++|.+++.....+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9999997 4899999887789999999999999999999998 999999999999999999999999999998775543 


Q ss_pred             --CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------
Q 018532          221 --GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------  282 (354)
Q Consensus       221 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  282 (354)
                        .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+....+....               
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence              123345688999999999888 78999999999999999999999997665332111110000               


Q ss_pred             -HHHHcCCCC------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          283 -EAIVESPPP------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       283 -~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                       .........      ......++.++.++|.+||+.+|++||++.+++.||||+.......+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence             000000000      00113468899999999999999999999999999999998776544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-43  Score=322.33  Aligned_cols=262  Identities=26%  Similarity=0.389  Sum_probs=206.7

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC--
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--  138 (354)
                      +.-..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++.+....  
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            4445678999999999999999999999999999999986543 2223345678999999999999999999876543  


Q ss_pred             ------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          139 ------VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       139 ------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                            ..++||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCC
Confidence                  46999999964 888888764 368999999999999999999998 899999999999999999999999999


Q ss_pred             cccccCCCcC----CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          212 VSAMLGSSMG----QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       212 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ++........    ......++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+.....    .....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~----~~~~~~~  240 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL----TLISQLC  240 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHh
Confidence            9976643221    12234678899999998765 4788999999999999999999999765432111    1111111


Q ss_pred             cCCCCC---------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          287 ESPPPT---------------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       287 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ...++.                           ......+..+.+||.+||..||++|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            100000                           0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=320.02  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=208.9

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      |++.+.||.|++|+||++.+..+|..||+|++..... ......+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5678899999999999999999999999999875532 223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          148 DRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       148 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      + ++|.+++....  .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++............
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            5 59999998765  68999999999999999999998 89999999999999999999999999999765443333333


Q ss_pred             cccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHH--------------------
Q 018532          226 FVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA--------------------  284 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------------  284 (354)
                      ..++..|+|||++.+. .++.++|+||||+++|+|++|+.||...++...   .......                    
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            4678899999988764 578999999999999999999999976543211   1111110                    


Q ss_pred             -HHcCC--CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          285 -IVESP--PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       285 -~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                       .....  ........++..+.++|.+||+.+|++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             00000  0011124577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=309.46  Aligned_cols=253  Identities=37%  Similarity=0.560  Sum_probs=218.9

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||+|++|.||++.+..+++.||+|.+..... ......+.+|+.++..+.|+|++++++.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999999999999999876532 24557799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +++++|.+++.....+++..+..++.|++.||.+||+ .|++||||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999888889999999999999999999998 899999999999999999999999999998776554434455


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      .++..|+|||...+..++.++|+||||+++|+|++|..||......       ......... .....+..++..+.+++
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQD-DHPPLPEGISPELKDFL  231 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhcc-CCCCCCCCCCHHHHHHH
Confidence            7899999999998888899999999999999999999999754421       111122222 22234557899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+||..+|++|||+.++++||||
T Consensus       232 ~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-43  Score=316.46  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=208.0

Q ss_pred             CcccccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ..++|++.+.||+|+||+||+|.+..+++    .||+|+++..........+.+|+.+++.++|+||+++++.+.. ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            45788899999999999999999877776    4899998776666667788999999999999999999998765 457


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++++||+++|+|.+++... +.+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||++......
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            8999999999999999874 568999999999999999999998 99999999999999999999999999999876432


Q ss_pred             cCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......       .....+... .....+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~  234 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLEKG-ERLPQPP  234 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC-CcCCCCc
Confidence            221  112234678999999998889999999999999999998 89998654322       122222222 2223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .++.++.+++.+||..||++||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         235 ICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            68999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-43  Score=320.82  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=212.9

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-----RLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .+.+..++|++.+.||+|+||.||++.....+     ..+|+|.+...........+.+|+.++..+ +|+||+++++.+
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35667788999999999999999999976443     789999987655555556788999999999 899999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEE
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL  198 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIl  198 (354)
                      ..++.++++|||+++++|.++++..                +.+++..+..++.|++.||.|||+ .+|+||||||+||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence            9999999999999999999999642                457888999999999999999998 99999999999999


Q ss_pred             EccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCCh
Q 018532          199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSW  275 (354)
Q Consensus       199 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  275 (354)
                      ++.++.+||+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......   
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence            99999999999999987643221  1122235678999999998889999999999999999997 99999755432   


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                          +....+... .....+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       242 ----~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 ----ELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ----HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                222333333 2233445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-43  Score=321.81  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=210.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      |+...++|.+.+.||+|+||.||++++..       ++..+|+|.++..........+.+|+.+++.+ +|+|++++++.
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            45566899999999999999999998643       23579999998655455556788899999998 79999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +...+..++||||+++++|.+++...+                .++...+..++.|++.||.|||+ +|++||||||+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence            999999999999999999999997642                37788899999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      +++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......  
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence            9999999999999998765432111  111234568999999999889999999999999999998 88998654321  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                           +....+... .....+..++.++.+|+.+||..+|++|||+.+++++
T Consensus       250 -----~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 -----ELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             -----HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                 223333333 2333455688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-43  Score=312.21  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=206.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||.||++..+ ++..+|+|.+......  ...+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            3467888999999999999999875 4567999987643222  346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      ||+++|+|.+++... +.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||.+......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999998753 468899999999999999999998 99999999999999999999999999998765432221 


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......       +....+...... ..+...+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~i~~~~~~-~~~~~~~~~  229 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEMISRGFRL-YRPKLASMT  229 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCCC-CCCCCCCHH
Confidence            122245668999999998889999999999999999999 89999665432       334444443322 234457889


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +.+++.+||+.+|++|||++++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.6e-43  Score=315.34  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=205.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ..++|++.+.||+|+||+||++....+++    .+++|.+...........+..|+.++..+.|+||+++++.+. ....
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            45788899999999999999999877776    477777754444444567888888899999999999999765 4567


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++++||+++|+|.+++... +.+++..+..++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            8899999999999999764 568999999999999999999998 99999999999999999999999999999865432


Q ss_pred             cC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....       .. ..+.........+.
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~-~~~~~~~~~~~~~~  234 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EV-PDLLEKGERLAQPQ  234 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH-HHHHHCCCcCCCCC
Confidence            21  1223456778999999998899999999999999999998 99999765432       11 22222323333445


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .++.++.+++.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         235 ICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-44  Score=345.83  Aligned_cols=270  Identities=19%  Similarity=0.255  Sum_probs=201.7

Q ss_pred             cccccccccccccCceEEEEEEEccCC-cEEEEEEe--------------ec--cccHHHHHHHHHHHHHHhhcCCCceE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVG-RLFALKII--------------QM--NIQEEIRKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~--------------~~--~~~~~~~~~~~~e~~~~~~l~h~~iv  128 (354)
                      .++|++++.||+|+||+||+|..+... ...+.|.+              .+  .........+.+|+.+++.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            578999999999999999998765432 22222211              00  11223445688999999999999999


Q ss_pred             EeeeeeeecCeEEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC
Q 018532          129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQV-----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG  203 (354)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  203 (354)
                      ++++++...+..|++++++. ++|.+++...     .......+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC
Confidence            99999999999999999996 5888877542     223456788899999999999998 9999999999999999999


Q ss_pred             cEEEeecccccccCCCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH
Q 018532          204 EVKITDFGVSAMLGSSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL  282 (354)
Q Consensus       204 ~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  282 (354)
                      .+||+|||++........ ......||..|+|||++.+..++.++|||||||++|||++|..++...........+.+.+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            999999999987654322 2234679999999999999999999999999999999999886543322211111111111


Q ss_pred             HH------------------HHcCCC---C-----CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          283 EA------------------IVESPP---P-----TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       283 ~~------------------~~~~~~---~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ..                  +.....   +     ......++.++.++|.+||+.||.+|||+.|+|+||||.....+.
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~  464 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE  464 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence            11                  000000   0     001123567888999999999999999999999999998876554


Q ss_pred             c
Q 018532          337 I  337 (354)
Q Consensus       337 ~  337 (354)
                      .
T Consensus       465 ~  465 (501)
T PHA03210        465 I  465 (501)
T ss_pred             H
Confidence            4

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.9e-44  Score=327.58  Aligned_cols=285  Identities=25%  Similarity=0.405  Sum_probs=221.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeec--CeEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHN--GVIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~~~~  141 (354)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+.+++.+ +|+||+++++.+...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            468899999999999999999999899999999885432 223345677899999999 999999999987653  4689


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||++ ++|..++... .+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.+||+|||++........
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            9999997 4999988774 78888999999999999999998 9999999999999999999999999999986643321


Q ss_pred             -----CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH---------------
Q 018532          222 -----QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE---------------  280 (354)
Q Consensus       222 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------------  280 (354)
                           ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..               
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2233568999999998865 4578899999999999999999999976543211000000               


Q ss_pred             -----HHHHHHcCC--CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccccCCCCCCCCC
Q 018532          281 -----LLEAIVESP--PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP  353 (354)
Q Consensus       281 -----~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (354)
                           .+.......  ........++.++.++|.+||+.||++|||+.++++|||++.+....... ....++.+|...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  321 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP-VLPYPITIPLDDN  321 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC-CCCCCccCCcccc
Confidence                 000000000  00111223788999999999999999999999999999999987765554 3356666676655


Q ss_pred             C
Q 018532          354 R  354 (354)
Q Consensus       354 ~  354 (354)
                      |
T Consensus       322 ~  322 (337)
T cd07852         322 V  322 (337)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.7e-44  Score=328.31  Aligned_cols=269  Identities=29%  Similarity=0.420  Sum_probs=214.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~  141 (354)
                      ++|++.+.||.|+||.||++.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++.+..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            678889999999999999999999999999999875432 2344667789999999999999999987753    35789


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +|+||+. ++|.+++...+.+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 5999999877789999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             C----CcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH----------------
Q 018532          222 Q----RDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE----------------  280 (354)
Q Consensus       222 ~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----------------  280 (354)
                      .    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1    123478899999999866 4588999999999999999999999976543211110000                


Q ss_pred             -HHHHHHcCCCCCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          281 -LLEAIVESPPPTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       281 -~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                       ..+.+........     .....+.++.++|.+||+.+|++|||+.+++.||||++......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence             0000000000001     11346899999999999999999999999999999998766554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.8e-43  Score=316.61  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=209.0

Q ss_pred             CcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|.+.+.||+|+||+||++...     .++..+|+|.+.... ......+.+|+.+++.++|+|++++++.+...+.
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            3467889999999999999999853     345679999886543 3445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          140 ISLVLEYMDRGSLADIIRQVK-------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      .++++||+++++|.+++...+             .+++..+..++.|++.||+|||+ .|++||||||+||++++++.+|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCCcEE
Confidence            999999999999999997643             38899999999999999999998 9999999999999999999999


Q ss_pred             EeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          207 ITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      |+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            999999976533211  1122345778999999998889999999999999999998 99999765432       3344


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+... ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       234 ~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         234 CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            44444332 234568899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8e-44  Score=324.89  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=206.0

Q ss_pred             ccccc--CceEEEEEEEccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           74 VIGKG--SGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        74 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +||+|  ++|.||.+++..+++.||+|+++.. ...+..+.+.+|+.+++.++|+||+++++.+...+..+++|||++++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34444  5566777777789999999999765 34455678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-------
Q 018532          151 SLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-------  221 (354)
Q Consensus       151 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------  221 (354)
                      +|.+++...  ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+........       
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999999864  458899999999999999999998 8999999999999999999999999998875532211       


Q ss_pred             CCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC----------
Q 018532          222 QRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP----------  289 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  289 (354)
                      ......++..|+|||++...  .++.++|+|||||++|+|++|..||.......      ...+......          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCccccccCchh
Confidence            12234577889999998764  58899999999999999999999997654321      1111111000          


Q ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          290 ---------------------PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       290 ---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                                           ........++.++.+|+.+||+.||++|||+.++++||||+.+.+.+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~  308 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSL  308 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhH
Confidence                                 00001122356789999999999999999999999999999987655543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.4e-43  Score=319.40  Aligned_cols=250  Identities=25%  Similarity=0.372  Sum_probs=206.2

Q ss_pred             ccccccccccccCceEEEEEEEccCCc--EEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGR--LFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++........+.+.+|+.++.++ +|+||+++++.+...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999999887765  46888877544445556788999999888 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          144 LEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                      +||+++++|.+++....                .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeEEE
Confidence            99999999999997642                47788999999999999999998 99999999999999999999999


Q ss_pred             eecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       208 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      +|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||......       +....+.
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~~~~  232 (297)
T cd05089         161 ADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYEKLP  232 (297)
T ss_pred             CCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHh
Confidence            99999864322211 111233567999999998889999999999999999997 99999765432       2333333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ... ....+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       233 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332 233345689999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=325.68  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-eE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-VI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~  140 (354)
                      +....++|.....||+|+||+||++... +|..||||.+....... .+++..|+.++..++|+|+|+++|+|.+.+ ..
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            3456778888899999999999999886 44899999877654432 456999999999999999999999999988 59


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--CceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNER--HVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +||+||+++|+|.+++....  .++|..+.+|+.++|.||+|||...  .|||||||++|||+|++.++||+|||+|...
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            99999999999999998764  7899999999999999999999844  4999999999999999999999999999655


Q ss_pred             CCCcCCCccc-ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--CCChhhHHHHHHHHHcC----C
Q 018532          217 GSSMGQRDTF-VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED--QQSWPSFYELLEAIVES----P  289 (354)
Q Consensus       217 ~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~----~  289 (354)
                      .......... .||.+|+|||++..+..+.++||||||++|.|++||+.+......  .+....+.  ...+...    .
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~--~~~~~~~~~~ei  305 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA--KPLLEEGKLREI  305 (361)
T ss_pred             CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH--HHHHHCcchhhe
Confidence            4311222222 799999999999998999999999999999999999988875431  11111111  1111111    1


Q ss_pred             CCCCCC-CCCC-----HHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          290 PPTAPP-DQFS-----PEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       290 ~~~~~~-~~~~-----~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+... ...+     ..+..+..+|++.+|.+||++.|+++
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111 2223     23667888999999999999999754

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-43  Score=310.87  Aligned_cols=242  Identities=22%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             cccccCceEEEEEEE--ccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           74 VIGKGSGGVVQLVRH--KWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      .||+|+||.||+|..  ..++..+|+|+++... .....+.+.+|+.+++.+.|+||+++++.+. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999864  4578899999986543 3345677899999999999999999998765 45678999999999


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC---Ccccc
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFV  227 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~  227 (354)
                      +|.+++...+.+++..+..++.|++.||.|||+ +|++||||||.||+++.++.+||+|||++.........   .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999887889999999999999999999998 99999999999999999999999999999876543221   11223


Q ss_pred             cCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       228 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      ++..|+|||.+....++.++|+|||||++|||++ |..||......       +....+..... ...+..+++++.++|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~-~~~~~~~~~~l~~li  231 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGER-MECPQRCPPEMYDLM  231 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCC-CCCCCCCCHHHHHHH
Confidence            4578999999988889999999999999999998 99999765432       33344443332 334557899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhc
Q 018532          307 SACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~  325 (354)
                      .+||+.||++||++++|.+
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=324.87  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=209.5

Q ss_pred             cccc-ccccccccCceEEEEEEEccCCcEEEEEEeeccccHH-------------HHHHHHHHHHHHhhcCCCceEEeee
Q 018532           67 EDLE-TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-------------IRKQIVQELKINQASQCSHVVVCYH  132 (354)
Q Consensus        67 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~l~h~~iv~~~~  132 (354)
                      ++|. +.+.||.|+||+||+|.+..+++.||+|+++......             ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4567999999999999999999999999986543221             1124778999999999999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      .+...+..+++|||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999999999997 5999999887789999999999999999999998 9999999999999999999999999999


Q ss_pred             ccccCCC--------------cCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh
Q 018532          213 SAMLGSS--------------MGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS  277 (354)
Q Consensus       213 a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  277 (354)
                      +......              ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.++.+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8765411              1112233568899999998765 478999999999999999999999987654321111


Q ss_pred             HHHHHHHHHcCCCC----------------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          278 FYELLEAIVESPPP----------------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       278 ~~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.   .........                      .......+.++.++|.+||+.+|++|||+++++.||||+..
T Consensus       246 i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        246 IF---ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HH---HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            11   111000000                      00113457889999999999999999999999999999865

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=300.00  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=209.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec---
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN---  137 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---  137 (354)
                      ++.+..++|.+.+.||+|||+.||++++..+++.||+|++.... .+..+..++|+...++.+|+|++++++....+   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34566789999999999999999999999999999999998776 34467899999999999999999998865433   


Q ss_pred             --CeEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCcEEEee
Q 018532          138 --GVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGEVKITD  209 (354)
Q Consensus       138 --~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~D  209 (354)
                        ...|+++.|...|+|.+.++..    ..+++.++..|+.+|+.||++||+ ..  .+||||||.||++.+.+.++|.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEe
Confidence              3599999999999999999764    368999999999999999999997 66  99999999999999999999999


Q ss_pred             cccccccCCCcCCC---------cccccCCcccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh
Q 018532          210 FGVSAMLGSSMGQR---------DTFVGTYNYMSPERISGS---TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS  277 (354)
Q Consensus       210 fg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  277 (354)
                      ||.++...-.....         ..-..|..|+|||.+.-+   ..+.++|||||||+||.|+.|..||...-..-.   
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg---  249 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG---  249 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC---
Confidence            99988753221111         112368899999998643   578899999999999999999999953211000   


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          278 FYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                        .+.-++............+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       250 --SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 --SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             --eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              00111222222333344589999999999999999999999999874

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.4e-43  Score=319.54  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=209.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      |.+..++|.+.+.||+|+||.||++++..       ....+|+|.++..........+.+|+.+++.+ .|+||+++++.
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            45667899999999999999999998642       34579999987655555567788999999988 69999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +...+.++++|||+++|+|.+++...                ..++...+..++.|++.||.|||+ +|++||||||+||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  165 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARNV  165 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccceeE
Confidence            99989999999999999999999763                247788899999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      +++.++.+||+|||++.........  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999999865432111  112234567999999998889999999999999999999 89999655432  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                           +....+.... ....+..++.++.+++.+||..+|++|||+.++++
T Consensus       244 -----~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 -----ELFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -----HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                 2233333332 22334578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5e-43  Score=309.80  Aligned_cols=251  Identities=30%  Similarity=0.505  Sum_probs=215.7

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999999999999999987543 334456778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          147 MDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       147 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++......  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            999999999876    2568899999999999999999998 99999999999999999999999999999876554  2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..       +....+.....+ ..+..++.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~  229 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYP-PIPPIYSQDL  229 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCC-CCchhhCHHH
Confidence            23346889999999999988999999999999999999999999765432       223333333322 2334788999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+++.+||..+|++||++.++++||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.3e-43  Score=312.14  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=210.1

Q ss_pred             CcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ..++|++.+.||+|+||.||+|.+..++.   .+|+|.++........+.+.+|+.+++.++|+||+++++.+..++..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            34678899999999999999998865543   799999876655556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999999765 468999999999999999999998 999999999999999999999999999998765432


Q ss_pred             CCC---cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          221 GQR---DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       221 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...   ....++..|+|||.+.+..++.++|+|||||++|++++ |..||......       +....+.... ....+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~  232 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGY-RLPAPM  232 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCC-cCCCCC
Confidence            211   11223568999999998889999999999999999886 99999765432       2233333332 223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.5e-43  Score=313.16  Aligned_cols=257  Identities=21%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             ccc-cccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCe
Q 018532           67 EDL-ETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGV  139 (354)
Q Consensus        67 ~~~-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~  139 (354)
                      ++| ++.+.||+|+||+||++.    ...++..||+|+++..........+.+|+.+++.++|+|++++++.+..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 888999999999998765    3357889999999766554556778899999999999999999998765  346


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++++|||+++++|.+++.. ..+++..+..++.|++.||.|||+ +|++||||||+||++++++.++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            8999999999999999976 469999999999999999999998 99999999999999999999999999999866432


Q ss_pred             cCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC------h-hhHHHHHHHHHcCC
Q 018532          220 MGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS------W-PSFYELLEAIVESP  289 (354)
Q Consensus       220 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~-~~~~~~~~~~~~~~  289 (354)
                      ...   .....++..|+|||.+.+..++.++|||||||++|+|++|..||........      . ..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            221   1222456779999999988899999999999999999999999865432100      0 00000011111111


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .....+..++..+.+++.+||+.+|++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222234568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=308.41  Aligned_cols=243  Identities=24%  Similarity=0.363  Sum_probs=202.8

Q ss_pred             ccccccCceEEEEEEEccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVG---RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||+|....++   ..+|+|.+.........+.+.+|+.+++.+.|+|++++++.+. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999876554   7899999876655455677899999999999999999998765 4568999999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc---cc
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD---TF  226 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~---~~  226 (354)
                      ++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...........   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            9999999987789999999999999999999998 8999999999999999999999999999987644332211   11


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..       +....+.... ....+..++..+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~l~~l  230 (257)
T cd05060         159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGE-RLPRPEECPQEIYSI  230 (257)
T ss_pred             cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCC-cCCCCCCCCHHHHHH
Confidence            23567999999998899999999999999999998 99999765432       2233333332 333456788999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhc
Q 018532          306 VSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~  325 (354)
                      |.+||..+|++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=321.57  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             cccccccccccCceEEEEEEEcc--CCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKW--VGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~  141 (354)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+....  .......+.+|+.++..++|+|++++++.+...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999988  89999999987632  123345678899999999999999999999988  8899


Q ss_pred             EEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc----CCcEEEeeccc
Q 018532          142 LVLEYMDRGSLADIIRQV-----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH----KGEVKITDFGV  212 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg~  212 (354)
                      +||||+++ +|.+++...     ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.    ++.+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999975 787777543     257899999999999999999998 89999999999999999    89999999999


Q ss_pred             ccccCCCcC---CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC------hhhHHHHH
Q 018532          213 SAMLGSSMG---QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS------WPSFYELL  282 (354)
Q Consensus       213 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~  282 (354)
                      +........   ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+......      ...+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987644322   22344678999999988764 588999999999999999999999976554320      00011111


Q ss_pred             HHHH--------------------cCCCCCCCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          283 EAIV--------------------ESPPPTAPP-----------DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       283 ~~~~--------------------~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ..+.                    ........+           ...+.++.+++.+||+.||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1000                    000000000           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=318.25  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             cCcccccccccccccCceEEEEEEEccCC--------------cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVG--------------RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV  129 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  129 (354)
                      +...+|++.+.||+|+||.||+|.+..++              ..||+|.++..........+.+|+++++.++|+|+++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            34568999999999999999999875432              3589999976655666677999999999999999999


Q ss_pred             eeeeeeecCeEEEEEeccCCCCHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVK------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       130 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +++.+...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||+ .|++|+||||+||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Ni  160 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNC  160 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChhhE
Confidence            9999999999999999999999999986532            36778889999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCcCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI--GRFPYMQSEDQQ  273 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  273 (354)
                      +++.++.+||+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999876533211  1122345678999999998889999999999999999988  667886654332


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......+..... ........+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQ-GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhc-cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            111111111100 011112223457899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=308.33  Aligned_cols=247  Identities=23%  Similarity=0.390  Sum_probs=209.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+..++|++.+.||.|+||.||++...  |+.||+|.++....  ..+.+.+|+.+++.++|+|++++++.+...+..++
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            345678999999999999999999864  88999999976543  45678999999999999999999999998999999


Q ss_pred             EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          143 VLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            999999999999998765  68999999999999999999998 999999999999999999999999999998763322


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .   ....+..|+|||.+.+..++.++||||||+++|+|++ |..||......       +....+.... ....+..++
T Consensus       157 ~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~  225 (256)
T cd05039         157 D---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGY-RMEAPEGCP  225 (256)
T ss_pred             c---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCC-CCCCccCCC
Confidence            1   2345668999999988889999999999999999997 99999655322       2333333332 233345689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +.+.++|.+||..+|++|||+.++++
T Consensus       226 ~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         226 PEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHH
Confidence            99999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-43  Score=310.04  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++..++|.+.+.||+|++|.||++.+. +++.||+|.++....  ..+.+.+|+.+++.++|+|++++++.+...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            3456778999999999999999999875 457899999875432  2356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.+||+ .|++|+||||+||++++++.+||+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999999997654  68999999999999999999998 99999999999999999999999999999876532


Q ss_pred             cCC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MGQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....       .....+.... ....+..
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~  228 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGY-RMPCPPG  228 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCc
Confidence            211 111223457999999998889999999999999999999 99999765432       2333333332 2233456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-43  Score=322.88  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=204.4

Q ss_pred             cccccc--CceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKG--SGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      ..||+|  +||+||++.+..+|+.||+|++.... ..+..+.+.+|+.+++.++|+||+++++.+...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999999999999999987543 334457789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-----
Q 018532          150 GSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-----  222 (354)
Q Consensus       150 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-----  222 (354)
                      ++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++++||+.+.........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            9999999875  358899999999999999999998 99999999999999999999999999865432211111     


Q ss_pred             --CcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC---------
Q 018532          223 --RDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP---------  289 (354)
Q Consensus       223 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  289 (354)
                        .....++..|+|||++.+.  .++.++|||||||++|+|++|..||......+      ..........         
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCcccccc
Confidence              0112345679999999764  47899999999999999999999997654221      0111100000         


Q ss_pred             -----------------------------------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          290 -----------------------------------PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       290 -----------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                                         ........++..+.+||.+||+.||++|||+.++++||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                               000112235678999999999999999999999999999998876


Q ss_pred             cc
Q 018532          335 KD  336 (354)
Q Consensus       335 ~~  336 (354)
                      .-
T Consensus       317 ~~  318 (328)
T cd08226         317 QT  318 (328)
T ss_pred             hc
Confidence            53

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-42  Score=316.49  Aligned_cols=255  Identities=31%  Similarity=0.527  Sum_probs=212.1

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      |...+.||+|+||+||+|++..++..||+|++....  .......+.+|+.+++.++|+|++++++.+.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566778999999999999999999999999986532  233446688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      +. ++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++....    ....
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~~  176 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS  176 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCcccC----CCCC
Confidence            96 4888877653 568999999999999999999998 899999999999999999999999999986432    2234


Q ss_pred             cccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          226 FVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       226 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ..|+..|+|||++.   +..++.++|||||||++|+|++|..||...+..       ...........+......++..+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l  249 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNEWTDSF  249 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccccCHHH
Confidence            57889999999984   356888999999999999999999999765432       12222233333333345678899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+|+.+||+.+|.+||++.+++.||||+.....+
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCchhH
Confidence            9999999999999999999999999999865444

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.9e-43  Score=316.99  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=211.8

Q ss_pred             cccCcccccccccccccCceEEEEEEEc-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHK-------WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      |.+..++|.+.+.||+|+||.||++++.       .++..||+|.+...........+.+|+.+++.+ +|+||+++++.
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            5667889999999999999999999753       234579999987655455567789999999998 89999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +...+..+++|||+++++|.+++....                .++...+..++.||+.||.|||+ +|++||||||+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  168 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNV  168 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccceE
Confidence            999999999999999999999997642                36677889999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      +++.++.+||+|||++.........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....  
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence            9999999999999999876433221  122345678999999998889999999999999999998 78888655322  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                           +....+.... ....+..++..+.+|+.+||..+|++|||+.++++.
T Consensus       247 -----~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 -----ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             -----HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                 3333333332 223345789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.4e-43  Score=315.53  Aligned_cols=272  Identities=29%  Similarity=0.496  Sum_probs=219.9

Q ss_pred             cccccccccccCceEEEEEEEc---cCCcEEEEEEeecccc---HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQ---EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +|++.+.||.|++|.||++++.   .++..||+|+++....   ......+.+|+.++..+ +|+|++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778889999999999998864   4678899999875432   23345678899999998 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999999877789999999999999999999998 999999999999999999999999999987654332


Q ss_pred             C-CCcccccCCcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 G-QRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      . ......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||.........   .+..+.......  ..+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~--~~~~~  234 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRILKSKP--PFPKT  234 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHHHccCC--CCCcc
Confidence            2 122346899999999987765  788999999999999999999999654322211   222233333322  23456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCC---HHHHhcCccccccccccccccccccC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKDIDLGILVGS  345 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~~~~~~~~~~  345 (354)
                      ++..+.+++.+||+.||++|||   +.++++||||+...+..+......++
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  285 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAP  285 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCCC
Confidence            7899999999999999999998   56779999999998866655444333

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7e-43  Score=309.54  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=206.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|.+.+.||+|+||+||.+... .+..+|+|.+......  ...+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3467889999999999999999875 3456999988644321  345888999999999999999999999888999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||.+......... 
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999999999764 468999999999999999999998 99999999999999999999999999998765432211 


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +....+...... ..+...+..
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~  229 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLRL-YRPHLASEK  229 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCCC-CCCCCCCHH
Confidence            112245678999999998889999999999999999998 99999655432       223333333222 234457899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-42  Score=309.93  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=210.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ..++|+..+.||+|+||.||+|.+..++.   .+|+|.++..........+.+|+.+++.++|+|++++.+.+...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            45678888999999999999999876654   799999876655555677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++.......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999999764 578999999999999999999998 999999999999999999999999999987664322


Q ss_pred             CCCc---ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          221 GQRD---TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       221 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ....   ....+..|+|||++.+..++.++|||||||++|+|++ |..||......       +....+.... ......
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~-~~~~~~  233 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGF-RLPAPM  233 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCC-CCCCCC
Confidence            2111   1123457999999998889999999999999999997 99999655432       3334443332 222344


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .++..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-43  Score=308.71  Aligned_cols=249  Identities=25%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ..+|++.+.||+|+||.||++.++ ++..+|+|++......  ...+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            457889999999999999999886 5667999998654321  2357789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-C
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-R  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~  223 (354)
                      |++|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++......... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999999764 468899999999999999999998 99999999999999999999999999998765432211 1


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.       +....+.... ....+..++..+
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~  230 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAGY-RLYRPKLAPTEV  230 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcCC-cCCCCCCCCHHH
Confidence            11234457999999999899999999999999999998 89999765433       2233333332 223345689999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+++.+||..+|++|||+.++++.
T Consensus       231 ~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         231 YTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-42  Score=313.75  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             cccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      +|.+.+.||+|+||.||+|.+..     ....+|+|.+...........+.+|+.+++.++|+||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46788899999999999998753     2356999988766555556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEE
Q 018532          143 VLEYMDRGSLADIIRQV------------------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL  198 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIl  198 (354)
                      ++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+ .+++||||||+||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~nil  159 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVL  159 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhheEE
Confidence            99999999999998653                        236788899999999999999998 99999999999999


Q ss_pred             EccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCCh
Q 018532          199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSW  275 (354)
Q Consensus       199 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  275 (354)
                      +++++.+||+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....   
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---  236 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---  236 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence            99999999999999976533221  1122345678999999988889999999999999999998 99999665432   


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                          ++.+..... .....+..++.++.+++.+||+.+|++||+++++++
T Consensus       237 ----~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 ----RLFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ----HHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                222222222 223345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=317.50  Aligned_cols=256  Identities=29%  Similarity=0.506  Sum_probs=210.1

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      |++.+.||.|++|.||++.+..+++.+|+|.++..... .....+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778899999999999999999999999998755432 34567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          148 DRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       148 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      ++ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            75 888888764 578999999999999999999998 899999999999999999999999999998776543233345


Q ss_pred             ccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-----------------
Q 018532          227 VGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-----------------  288 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------  288 (354)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....   ........                 
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhhhhh
Confidence            678899999999876 789999999999999999999999976553221111   11110000                 


Q ss_pred             -----C--CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 -----P--PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 -----~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                           .  ........++.++.++|.+||+.||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                 0  0001123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.8e-43  Score=316.20  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=206.6

Q ss_pred             CcccccccccccccCceEEEEEEEcc----------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW----------------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv  128 (354)
                      ..++|++.+.||+|+||+||++.+..                ++..||+|++...........+.+|+.+++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            45679999999999999999986432                34569999987665566667899999999999999999


Q ss_pred             EeeeeeeecCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      ++++.+...+..+++|||+++++|.+++....           .+++..+..++.|++.||.|||+ .|++|+||||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~Ni  161 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChheE
Confidence            99999999999999999999999999997642           35677899999999999999998 8999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCcCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI--GRFPYMQSEDQQ  273 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  273 (354)
                      +++.++.++|+|||++........  ......++..|+|||...+..++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999876543221  1122344678999999988889999999999999999998  778997655433


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......+...... .......+..+++.+.+|+.+||+.||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQG-RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhcc-ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2221111111110 11111223457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=307.76  Aligned_cols=245  Identities=33%  Similarity=0.553  Sum_probs=212.8

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      ||.|+||.||++.+..+++.||+|++.....  ......+..|+.+++.++|+|++++++.+..++..+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999998999999999876532  23456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcc
Q 018532          153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY  232 (354)
Q Consensus       153 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  232 (354)
                      .+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..............++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999987789999999999999999999998 999999999999999999999999999998765443334455788999


Q ss_pred             cccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018532          233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK  312 (354)
Q Consensus       233 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  312 (354)
                      +|||...+...+.++|+||||+++|++++|..||...+..       +....+...  ....+...+..+.+++.+||..
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------EIYEKILKD--PLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999888899999999999999999999999655432       223333332  2334556789999999999999


Q ss_pred             CCCCCCCH---HHHhcCccc
Q 018532          313 DPRDRSSS---LDLLSHPFI  329 (354)
Q Consensus       313 ~p~~Rps~---~eil~hp~~  329 (354)
                      ||++||++   .++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.1e-43  Score=309.89  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+..++|.+.+.||+|+||+||+|++..+ ..||+|+++....  ....+.+|+.+++.++|+||+++++.+. ....++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            44567899999999999999999988755 4599999875332  1246788999999999999999998764 456899


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          143 VLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999999999999763  357889999999999999999998 999999999999999999999999999997654332


Q ss_pred             CC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 GQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      .. .....++..|+|||+..+..++.++|||||||++|+|++ |..||......       +....+..... ......+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~  228 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR-MPCPPEC  228 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCC-CCCcccc
Confidence            21 123346678999999998889999999999999999999 88898765432       22333333222 2234568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..+.+++.+||+.+|++||++.++++
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-42  Score=315.42  Aligned_cols=256  Identities=32%  Similarity=0.526  Sum_probs=214.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..|...+.||+|+||.||++++..++..||+|++....  ..+....+.+|+.+++.++|+|++++++.+..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44778899999999999999999999999999986432  3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      ||+.| +|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....    .
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence            99975 88777754 3568999999999999999999998 9999999999999999999999999999865432    2


Q ss_pred             cccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          224 DTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....++..|+|||.+.   +..++.++|||||||++|+|++|..||......       .....+.....+......+++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPTLQSNEWSD  251 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhccCCCCCCccccH
Confidence            3346889999999974   456889999999999999999999999765322       223333334334444556788


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+.+++.+||+.+|.+||++.++++|+|+.....+
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            99999999999999999999999999999765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-42  Score=307.16  Aligned_cols=242  Identities=23%  Similarity=0.349  Sum_probs=200.4

Q ss_pred             cccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           74 VIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      .||+|+||.||++...  .++..||+|++.........+.+.+|+.+++.++|+||+++++.+. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999998765  4456799999977666666678999999999999999999999875 457899999999999


Q ss_pred             HHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC---cccc
Q 018532          152 LADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR---DTFV  227 (354)
Q Consensus       152 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~  227 (354)
                      |.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........   ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            9999875 3578999999999999999999998 999999999999999999999999999997654332211   1123


Q ss_pred             cCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       228 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      ++..|+|||.+.+..++.++|||||||++|++++ |..||......       +....+..+. ....+..+++++.++|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~l~~li  231 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGK-RLDCPAECPPEMYALM  231 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCC-CCCCCCCCCHHHHHHH
Confidence            3578999999988889999999999999999996 99999765432       2233333333 2334557899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhc
Q 018532          307 SACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~  325 (354)
                      .+||..+|++||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-42  Score=313.93  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             CcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ...+|.+.+.||+|+||.||++.+.     .++..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4567888999999999999999854     345668999876443 3334668899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG  203 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  203 (354)
                      .++||||+++++|.+++...+                .+++..+..++.||+.||.|||+ +|++||||||+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            999999999999999997642                37889999999999999999998 9999999999999999999


Q ss_pred             cEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHH
Q 018532          204 EVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYE  280 (354)
Q Consensus       204 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  280 (354)
                      .++|+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence            999999999976543221  1223456788999999999899999999999999999998 99999765432       2


Q ss_pred             HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+.+...... ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         234 VIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            33334333322 234567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-42  Score=310.99  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=211.9

Q ss_pred             CcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|.+.+.||.|+||+||+|+.+.     +.+.||+|.+...........+.+|+++++.++|+|++++++.+.+.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            34678899999999999999999754     3467999988765555567789999999999999999999999988899


Q ss_pred             EEEEEeccCCCCHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          140 ISLVLEYMDRGSLADIIRQVK---------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                      .++||||+++++|.+++....         .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999998765         68999999999999999999998 89999999999999999999999999


Q ss_pred             ccccccCCC-cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          211 GVSAMLGSS-MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       211 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      |++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.       .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLNRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHHHHHcC
Confidence            998654321 112233456778999999988888999999999999999998 88899654432       223333333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ......+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33333445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-42  Score=313.11  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=209.7

Q ss_pred             CcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++...........+.+|+.+++.+.|+|++++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            45788999999999999999998753     6788999999876666666779999999999999999999999998899


Q ss_pred             EEEEEeccCCCCHHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          140 ISLVLEYMDRGSLADIIRQVK----------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      .++++||+++++|.+++....                      .+++..+..++.|++.||.|||+ ++++||||||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~ni  161 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRNC  161 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccHhhe
Confidence            999999999999999997532                      36778889999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      +++.++.++|+|||++........  .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999876533211  1122345678999999998899999999999999999997 88898655432  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                           +....+..... ...+..++.++.+|+.+||+.+|++|||+.|+++
T Consensus       240 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 -----EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             -----HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                 33333333332 2234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-42  Score=311.57  Aligned_cols=251  Identities=28%  Similarity=0.416  Sum_probs=207.4

Q ss_pred             CcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ...+|...++||+|+||+||++...     .++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            4567888999999999999999743     356789999886543 3445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          140 ISLVLEYMDRGSLADIIRQVK---------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      .+++|||+++++|.+++...+               .+++..+..++.|++.||.|||+ .|++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCCC
Confidence            999999999999999997643               37888999999999999999998 99999999999999999999


Q ss_pred             EEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHH
Q 018532          205 VKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYEL  281 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  281 (354)
                      +||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......       +.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EA  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HH
Confidence            99999999876532211  1122345678999999999899999999999999999998 99999654432       22


Q ss_pred             HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......... ...+..+++.+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         234 IECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            333333322 2334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-42  Score=307.60  Aligned_cols=251  Identities=24%  Similarity=0.428  Sum_probs=207.0

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++..++|++.+.||+|+||.||+|... +++.||+|.+......  ...+.+|+.+++.++|+|++++++.+ ..+..+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcE
Confidence            3456788999999999999999999865 6778999998754332  34678899999999999999999876 456789


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999999998764  367889999999999999999998 99999999999999999999999999999766522


Q ss_pred             -cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 -MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                       ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....       +....+... .....+..
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~  227 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERG-YRMPRPDN  227 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcC-CCCCCCCC
Confidence             122223356778999999998889999999999999999998 99999765432       222233222 22334566


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.++.+++.+||..+|++||+++++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-42  Score=311.90  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=206.6

Q ss_pred             ccccccccccccCceEEEEEEE----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRH----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~  140 (354)
                      .-|++++.||+|+||.||+++.    ..++..||+|.++..........+.+|+.+++.+.|+|++++++.+...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3468899999999999999974    4578899999987665555667899999999999999999999988765  578


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||++|++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            9999999999999999765 358899999999999999999998 99999999999999999999999999999876433


Q ss_pred             cC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC--------ChhhHHHHHHHHHcC
Q 018532          220 MG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ--------SWPSFYELLEAIVES  288 (354)
Q Consensus       220 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~  288 (354)
                      ..   ......++..|+|||.+.+..++.++|||||||++|+|+++..|+.......        ...............
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            21   1223456778999999998889999999999999999999877653321100        000011112222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                       .....+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus       243 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 -KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             2223345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-42  Score=315.59  Aligned_cols=257  Identities=31%  Similarity=0.512  Sum_probs=213.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ...|...+.||.|+||.||++++..++..+|+|.+...  ........+.+|+.+++.++|+|++++++.+......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34577889999999999999999999999999998643  2334446688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      +||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......   
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            99997 588887754 3568999999999999999999998 99999999999999999999999999998765432   


Q ss_pred             CcccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          223 RDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                       ....++..|+|||.+.   ...++.++|||||||++|+|++|..||...+..       +....+.....+......++
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  240 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWS  240 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcCCCCcCccccc
Confidence             3346889999999975   345788999999999999999999998654322       22223333333333345688


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ..+.+||.+||+.+|++||++.++++|||+......
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence            999999999999999999999999999999886543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-42  Score=307.41  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=205.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++..++|++.+.||+|+||.||+|.+. ++..+|+|.+......  ...+.+|+.+++.++|+|++++++.+. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            3456788999999999999999999876 5667999998754322  245889999999999999999998775 45689


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||++++++.++|+|||++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            999999999999999764  358899999999999999999998 99999999999999999999999999999765432


Q ss_pred             cC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..       +....+.... ....+..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~  227 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVLEQVERGY-RMPCPQD  227 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCc
Confidence            21 1122345678999999988889999999999999999999 89999764432       2333333332 2233456


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+.+|+.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            8899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.7e-44  Score=306.49  Aligned_cols=266  Identities=25%  Similarity=0.416  Sum_probs=210.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCc----EEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cCe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~  139 (354)
                      +..|+..+.||+|+||.||+|..+.++.    .||||.++-+.+ ........+|+.+++.++|+|++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4678999999999999999997665543    689999875422 2344567899999999999999999998887 789


Q ss_pred             EEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC----CcEEEeec
Q 018532          140 ISLVLEYMDRGSLADIIRQV-----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK----GEVKITDF  210 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~Df  210 (354)
                      +++++||.+. +|..+++-+     +.++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+    |.|||+||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeecc
Confidence            9999999986 999999743     468889999999999999999998 889999999999999888    89999999


Q ss_pred             ccccccCCCcCCC---cccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcC--------------
Q 018532          211 GVSAMLGSSMGQR---DTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQ--------------  272 (354)
Q Consensus       211 g~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~--------------  272 (354)
                      |+++.+.++....   ...+.|.+|+|||.+.|.. |+.+.||||.|||+.||++-.+.|.+....              
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999987665443   4557899999999999975 999999999999999999999888664321              


Q ss_pred             ----------CChhhHH------HHHHHHHcCCCCCC-------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          273 ----------QSWPSFY------ELLEAIVESPPPTA-------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       273 ----------~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                                +.|+.+.      ..+..+........       ....-++...+|+.+||++||-+|.|++++++|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence                      1111111      11111110000000       011124458999999999999999999999999999


Q ss_pred             cccc
Q 018532          330 KKFE  333 (354)
Q Consensus       330 ~~~~  333 (354)
                      ..-.
T Consensus       341 ~~d~  344 (438)
T KOG0666|consen  341 TEDP  344 (438)
T ss_pred             ccCC
Confidence            9763

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-42  Score=309.57  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=209.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .++|++.+.||+|+||.||+|.+..+++   .||+|++...........+..|+.+++.++|+||+++++.+..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4678899999999999999999887665   5999998766556667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999999999764 568999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             CC---ccc--ccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          222 QR---DTF--VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       222 ~~---~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ..   ...  ..+..|+|||.+.+..++.++|||||||++|||++ |..||......       +....+... .....+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i~~~-~~~~~~  233 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQD-YRLPPP  233 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC-CcCCCc
Confidence            11   111  12457999999998899999999999999999886 99999765432       223333322 222334


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..++..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-43  Score=314.15  Aligned_cols=259  Identities=29%  Similarity=0.456  Sum_probs=207.6

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEEEEEe
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVISLVLE  145 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e  145 (354)
                      |++.+.||.|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|+|++++++.+...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999999999999999998664 334456688899999999999999999999888  89999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~  223 (354)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||++++++.++|+|||++........ ..
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            9975 999988765 578999999999999999999998 8999999999999999999999999999987654421 12


Q ss_pred             cccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHH--------------HcC
Q 018532          224 DTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI--------------VES  288 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~  288 (354)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.......              ...
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            234568899999987754 57899999999999999999999997654322111111100000              000


Q ss_pred             CCC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 PPP--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 ~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      ...        ......++..+.+++.+||+.+|++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            000        00011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-42  Score=318.61  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=211.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC-------CcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-------GRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYH  132 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~  132 (354)
                      .|++...+|.+.+.||+|+||.||+|.+...       +..||+|.++..........+.+|+.+++.+ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3566677899999999999999999986432       2368999987665555667889999999998 8999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      .+...+..++++||+++|+|.+++....                .++...+..++.|++.||.|||+ +|++||||||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence            9999999999999999999999997532                36677888999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      |+++.++.+||+|||+++........  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... 
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  243 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-  243 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999999765432211  122234567999999999899999999999999999998 88999665432 


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            +....+.... ....+..++.++.+++.+||+.+|++|||+.+++++
T Consensus       244 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ------ELFKLLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ------HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                  2333333332 223345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=316.01  Aligned_cols=259  Identities=27%  Similarity=0.482  Sum_probs=210.4

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      |+..+.||+|++|.||++++..+++.||+|++.... .......+..|+.+++.++|+|++++++.+.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999999999999999997654 2334466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          148 DRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       148 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      + ++|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||++++++.++|+|||++.............
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            7 5999999886 579999999999999999999998 899999999999999999999999999998765544334444


Q ss_pred             ccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------HHHH-----cCCCCC
Q 018532          227 VGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------EAIV-----ESPPPT  292 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~  292 (354)
                      .++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+....        ..+.     ....+.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            667889999999776 78999999999999999999999997654321111111000        0000     000000


Q ss_pred             -------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          293 -------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       293 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                             ......+..+.++|.+||..+|++||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   0112347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-42  Score=321.28  Aligned_cols=263  Identities=23%  Similarity=0.402  Sum_probs=205.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec---------
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN---------  137 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---------  137 (354)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++|+|++++++.+...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            678999999999999999999999999999999865543 3346688899999999999999999766543         


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecc
Q 018532          138 -----GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFG  211 (354)
Q Consensus       138 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg  211 (354)
                           ...++++||++ ++|.+++.. ..+++..+..++.||+.||.|||+ .|++||||||+||+++. ++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 35899999997 599888865 578999999999999999999998 99999999999999975 5578999999


Q ss_pred             cccccCCCcC---CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH--------
Q 018532          212 VSAMLGSSMG---QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY--------  279 (354)
Q Consensus       212 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------  279 (354)
                      .+........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+........        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9976543211   1122357889999998755 458889999999999999999999997654321110000        


Q ss_pred             -------HHH-HHHH-cCCCCC----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          280 -------ELL-EAIV-ESPPPT----APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       280 -------~~~-~~~~-~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                             ... .... ......    .....++.++.+||.+||+.||++|||+.++++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence                   000 0000 000000    01135788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=307.94  Aligned_cols=249  Identities=21%  Similarity=0.335  Sum_probs=203.8

Q ss_pred             ccccccccccCceEEEEEEEccC---CcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe-----
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-----  139 (354)
                      |.+.+.||+|+||.||.|....+   +..||+|.++... .......+.+|+.+++.++|+|++++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987653   4789999987543 33445678999999999999999999998765443     


Q ss_pred             -EEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          140 -ISLVLEYMDRGSLADIIRQV------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       140 -~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                       .++++||+++++|..++...      ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccc
Confidence             79999999999999998543      257889999999999999999998 8999999999999999999999999999


Q ss_pred             ccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          213 SAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       213 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      +.........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....       +....+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYDYLRHGN  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC
Confidence            9876433221  112235678999999988889999999999999999999 88999665432       2333343333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                       ....+..++..+.+++.+||+.||++|||+.+++++
T Consensus       233 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             333456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-42  Score=308.85  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             cccccccccCceEEEEEEEccCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee------cCeE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGR--LFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH------NGVI  140 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------~~~~  140 (354)
                      .+.+.||+|+||.||++....++.  .+|+|.++... .......+.+|+.+++.++|+||+++++.+..      ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            466889999999999999887775  68999887543 34445778899999999999999999987643      2357


Q ss_pred             EEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          141 SLVLEYMDRGSLADIIRQV------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      +++|||+.+|+|.+++...      ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            8999999999999987432      347889999999999999999998 999999999999999999999999999998


Q ss_pred             ccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          215 MLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       215 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      .......  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......       +....+..+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGNR-  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCC-
Confidence            7643321  1122346778999999999899999999999999999999 88999764432       23333333332 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-42  Score=305.31  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=205.2

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee-ecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY-HNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~  140 (354)
                      |.+..++|++.+.||+|+||.||++...  |..||+|.++...   ..+.+.+|+.+++.++|+|++++++.+. ..+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            3456778999999999999999999764  8889999986432   2456889999999999999999998754 45679


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++++||+++++|.+++...+  .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999999999999998653  47889999999999999999998 9999999999999999999999999999876543


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ..   ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......       +....+... .....+..
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~  223 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKG-YKMDAPDG  223 (256)
T ss_pred             cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcC-CCCCCCCC
Confidence            22   22345678999999998889999999999999999997 99999654321       233333333 23334567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +++.+.+++.+||+.+|++|||+.++++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            8999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=320.04  Aligned_cols=266  Identities=25%  Similarity=0.420  Sum_probs=212.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------  138 (354)
                      .++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++.+....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            567999999999999999999999999999999986543 2334566889999999999999999999887543      


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..++||||+ |++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            468999999 6799988865 678999999999999999999998 9999999999999999999999999999986543


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH--------HHHHHH----
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY--------ELLEAI----  285 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------~~~~~~----  285 (354)
                      .   .....+++.|+|||.+.+ ..++.++|+|||||++|++++|..||...+.........        +....+    
T Consensus       171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         171 E---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             C---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence            2   233467889999999876 358899999999999999999999997654321100000        000000    


Q ss_pred             ----HcCCCC------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          286 ----VESPPP------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       286 ----~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                          ....+.      ......++..+.++|.+||..||++|||+.+++.||||+.......
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence                000000      0112357888999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.5e-42  Score=304.61  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             cccccccccCceEEEEEEEccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVG----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.+.||.|+||.||++.+..++    ..||+|++......+..+.+.+|+.++..++|+|++++++.+...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            46678999999999999998766    89999999776655566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          146 YMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |+++++|.+++.....  +++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||++..........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            9999999999986544  8999999999999999999998 899999999999999999999999999998765432211


Q ss_pred             c-ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          224 D-TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       224 ~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      . ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||......       ...+.+..... ...+..++.+
T Consensus       161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~  232 (258)
T smart00219      161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-------EVLEYLKKGYR-LPKPENCPPE  232 (258)
T ss_pred             cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCC-CCCCCcCCHH
Confidence            1 2236789999999988889999999999999999998 78888664322       23333333332 3334568999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +.+++.+||..+|++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-42  Score=305.39  Aligned_cols=244  Identities=24%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             ccccccCceEEEEEEEcc-CC--cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKW-VG--RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|++|.||++.+.. .+  ..||+|.+.........+.+.+|+.+++.++|+||+++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999865 33  36999999776554667789999999999999999999999888 899999999999


Q ss_pred             CCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC---Cc
Q 018532          150 GSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RD  224 (354)
Q Consensus       150 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~  224 (354)
                      ++|.+++....  .+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||++.........   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            99999998754  68899999999999999999998 99999999999999999999999999999876542211   12


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +..+.+.........+..++..+.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEGERLERPEACPQDIY  231 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCcCCCCccCCHHHH
Confidence            3456789999999999899999999999999999998 99999655432       223333322233333456789999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=306.07  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=209.2

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++..++|.+.+.||+|+||+||++.+. +++.||+|.+.....  ..+.+.+|+.+++.++|+|++++++.+......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            4567789999999999999999999976 557799999875432  2356888999999999999999999999889999


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+ +|++|+||||+||++++++.+||+|||++......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999999999764  368899999999999999999998 89999999999999999999999999998766432


Q ss_pred             cC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+....       .....+.... ....+..
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~  228 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------EVLEQVERGY-RMPRPPN  228 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCC
Confidence            11 1112234568999999998889999999999999999998 99999765432       2333333332 2223445


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.++.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=325.58  Aligned_cols=265  Identities=23%  Similarity=0.375  Sum_probs=220.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +-|..++.||-|+||+|.+++..+|...||+|.+++..  .......+..|-.||..-..+-||++|..|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34566788999999999999999999999999987543  2334566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC------
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS------  218 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~------  218 (354)
                      ||++||++-.+|-+.+-|.|+.+++++.++.+|+++.|. .|+|||||||+|||||.+|++||+|||+++-+.-      
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999999999999999999999999999999999998 9999999999999999999999999999865310      


Q ss_pred             --CcC----------------------------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC
Q 018532          219 --SMG----------------------------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG  262 (354)
Q Consensus       219 --~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  262 (354)
                        ...                                  .....+||+.|+|||++....|+..+|+||.|||||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence              000                                  01235799999999999999999999999999999999999


Q ss_pred             CCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC---HHHHhcCcccccccccccc
Q 018532          263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS---SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       263 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~eil~hp~~~~~~~~~~~  338 (354)
                      +.||....+.+..-.+.+ +    ....-.....++++++.+||.++. -+++.|..   ++++..||||+.+...++.
T Consensus       868 ~~pf~~~tp~~tq~kv~n-w----~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslR  940 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVIN-W----RNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLR  940 (1034)
T ss_pred             CCCccCCCCCcceeeeee-h----hhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhh
Confidence            999988776643211111 0    111223345689999999999854 45788875   6789999999998876653

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-42  Score=308.76  Aligned_cols=252  Identities=31%  Similarity=0.455  Sum_probs=209.4

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +|.+.+.||+|+||+||++.+..++..+++|+++...    .......+..|+.+++.++|+|++++++.+.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999998887777777765322    122334566788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          144 LEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. +.++|+|||++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            999999999998864    2468999999999999999999998 99999999999999975 67999999998876544


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....       ........... ....+..++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~  230 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIVEGP-TPSLPETYS  230 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCC-CCCCcchhc
Confidence            3444455688999999999888889999999999999999999999964332       12233333332 333455788


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .++.++|.+||+.+|++||++.++++||||
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-42  Score=314.44  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=208.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC----
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG----  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----  138 (354)
                      ...++|++.+.||+|+||+||++.++.+|+.||+|+++.... ......+.+|+.+++.++|+|++++++.+.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            346789999999999999999999999999999999875432 233356778999999999999999999887644    


Q ss_pred             ------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          139 ------VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       139 ------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                            .+++++||+++ ++...+... ..+++..+..++.|++.||.|||+ .||+|+||||+||++++++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCccc
Confidence                  79999999986 777777654 468999999999999999999998 899999999999999999999999999


Q ss_pred             cccccCCCcC-CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          212 VSAMLGSSMG-QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       212 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      ++........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+    ..+.+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~~~~~~~~~  237 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLELISRLCGSP  237 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCC
Confidence            9987644322 12223567889999988654 57889999999999999999999997544321    111112221111


Q ss_pred             CCC-------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          290 PPT-------------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       290 ~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+.                         .....++..+.+++.+||+.+|++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            100                         0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.1e-42  Score=301.72  Aligned_cols=243  Identities=22%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      +.||+|+||.||++... ++..+|+|+++.....+....+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999865 68899999987766666666789999999999999999999999999999999999999999


Q ss_pred             HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC-cccccCC
Q 018532          153 ADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTY  230 (354)
Q Consensus       153 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~gt~  230 (354)
                      .+++... ..+.+..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.......... ....++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            9998764 457899999999999999999998 999999999999999999999999999987543322111 1223456


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 018532          231 NYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC  309 (354)
Q Consensus       231 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  309 (354)
                      .|+|||++.+..++.++||||||+++|++++ |..||......       .....+... .....+..++..+.+++.+|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  230 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKG-YRMSCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHH
Confidence            7999999998889999999999999999998 99999755332       222233222 23334556899999999999


Q ss_pred             hhhCCCCCCCHHHHhc
Q 018532          310 IQKDPRDRSSSLDLLS  325 (354)
Q Consensus       310 l~~~p~~Rps~~eil~  325 (354)
                      |..+|++||++.++++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=306.97  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             ccccccCceEEEEEEEccCCc--EEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGR--LFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      +.||+|+||.||++++..++.  .+|+|.++.....+....+.+|+.++..+ +|+||+++++.+...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999999988776  46888887555555567788999999998 899999999999999999999999999


Q ss_pred             CCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          150 GSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       150 ~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ++|.+++...+                .+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCCc
Confidence            99999997643                36788999999999999999998 99999999999999999999999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||......       +....+... ...
T Consensus       160 ~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~-~~~  230 (270)
T cd05047         160 RGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQG-YRL  230 (270)
T ss_pred             cccchhhh-ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhCC-CCC
Confidence            64322111 111234567999999988889999999999999999997 99999654322       223333332 222


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+..++.++.+++.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            334567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.1e-42  Score=308.48  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=210.0

Q ss_pred             cCcccccccccccccCceEEEEEEEcc----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKW----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~  138 (354)
                      +..++|++.+.||+|+||.||+|.+..    ++..||+|.+...........+.+|+.+++.++|+|++++++.+.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456789999999999999999999876    3578999998766666667888999999999999999999997665 56


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          139 VISLVLEYMDRGSLADIIRQV--------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                      ..++++||+++++|.+++...        ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEECCC
Confidence            789999999999999999764        347899999999999999999998 99999999999999999999999999


Q ss_pred             ccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          211 GVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       211 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      |+++.+.....  ......++..|+|||++.+..++.++|||||||++|++++ |+.||......       +....+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EMAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHc
Confidence            99976533211  1122345678999999998889999999999999999998 99999765332       22333333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .. .......+++.+.+++.+||..+|++|||+.++++
T Consensus       235 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GY-RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CC-CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            32 22234567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-42  Score=307.51  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             ccccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeE
Q 018532           67 EDLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~  140 (354)
                      .+|++.+.||+|+||+||.+.    +..++..||+|.+.... ....+.+.+|+.+++.++|+|++++++.+..  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            568889999999999999987    44578899999986543 3445678899999999999999999987653  3478


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||++++++.+||+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999999764 468999999999999999999998 99999999999999999999999999999876433


Q ss_pred             cCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC---------ChhhHHHHHHHHHc
Q 018532          220 MGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------SWPSFYELLEAIVE  287 (354)
Q Consensus       220 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~~~~~~~~~~~  287 (354)
                      ...   .....++..|+|||++.+..++.++|||||||++|||++|..|+.......         .......+.. ...
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-HHh
Confidence            221   111234456999999998889999999999999999999887764332110         0001111112 222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .......+..++.++.+|+.+||..+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22233344568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=306.85  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=209.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +...+|++.+.||+|+||+||+|.++.+|.    .+|+|.............+.+|+.++..++|+|++++++.+.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            345788999999999999999999877665    5899988776655666778999999999999999999998877 78


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++++||+++|+|.+++... ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            89999999999999999874 468999999999999999999998 9999999999999999999999999999987653


Q ss_pred             CcCCC--cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          219 SMGQR--DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       219 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      .....  ....++..|+|||.+....++.++|+|||||++|++++ |..||......       +....+.... ....+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~  233 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLEKGE-RLPQP  233 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhCCC-CCCCC
Confidence            32211  11223568999999988889999999999999999998 99999765432       2233333332 23334


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..++..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         234 PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            467889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=321.39  Aligned_cols=266  Identities=24%  Similarity=0.417  Sum_probs=212.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe-----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-----  139 (354)
                      .++|.+.+.||+|++|.||++++..+++.||+|++.... .......+.+|+.+++.+.|+|++++++.+...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            467999999999999999999999999999999986543 23344667889999999999999999987765544     


Q ss_pred             -EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 -ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                       .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence             89999999 5699998876 579999999999999999999998 9999999999999999999999999999986643


Q ss_pred             CcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------H------
Q 018532          219 SMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------E------  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~------  283 (354)
                      .   .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.+..        .      
T Consensus       171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             c---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            2   2345678899999998663 67899999999999999999999997654321111111000        0      


Q ss_pred             --HHHcCCCCC------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          284 --AIVESPPPT------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       284 --~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                        .........      .....++.++.++|.+||+.+|++|||+.++++||||++......
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence              000000000      011245889999999999999999999999999999998866653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.6e-42  Score=304.38  Aligned_cols=250  Identities=25%  Similarity=0.406  Sum_probs=204.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++..++|.+.+.||+|++|.||++.+..+ ..+|+|.+.....  ....+.+|+.+++.++|+|++++++.+. .+..++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            34457789999999999999999988654 4599998764332  2356788999999999999999988764 456889


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          143 VLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||++++++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            99999999999999764  347889999999999999999998 999999999999999999999999999997654322


Q ss_pred             C-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 G-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      . ......++..|+|||...+..++.++||||||+++|+|++ |..||.+..+.       +....+.... ....+...
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~  228 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGY-RMPCPQGC  228 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCccc
Confidence            1 1223346678999999998889999999999999999999 99999765432       2233333332 22334568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..+.+++.+||..||++||+++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-42  Score=321.26  Aligned_cols=268  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++..... ....+.+.+|+.+++.++|+||+++++.+...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            4789999999999999999999999999999999875432 23345678899999999999999999887543      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||++++++.+||+|||++.....
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            578888887 6799888765 568999999999999999999998 9999999999999999999999999999876533


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH--------HH-------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE--------LL-------  282 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~-------  282 (354)
                      .   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..        ..       
T Consensus       173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         173 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             c---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence            2   234578899999999876 4688999999999999999999999965443211000000        00       


Q ss_pred             -HHHH---cCCCCC---CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          283 -EAIV---ESPPPT---APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       283 -~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                       ....   ...+..   ......++++.++|.+||+.||.+||++.+++.||||++......+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~  313 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  313 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence             0000   000000   01124578899999999999999999999999999999877655443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=310.98  Aligned_cols=258  Identities=25%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCe-----
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~-----  139 (354)
                      |++.+.||+|+||.||++.++.+++.||+|.++..... .....+.+|+.+++.+   +|+|++++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            56788999999999999999988999999999754322 2234456677666554   69999999999988776     


Q ss_pred             EEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .+++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999999975 8999887643  58999999999999999999998 899999999999999999999999999998764


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHH---H---------
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA---I---------  285 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~---------  285 (354)
                      .... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......+....+.+....   .         
T Consensus       159 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         159 FEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             CCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            4322 22345788999999999988999999999999999999999999765543221111110000   0         


Q ss_pred             ---HcCCCC---CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          286 ---VESPPP---TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       286 ---~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                         ......   ......++..+.++|.+||+.||++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence               000000   00012346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=300.89  Aligned_cols=243  Identities=24%  Similarity=0.356  Sum_probs=203.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      +.||.|+||.||++.+.. ++.||+|.+......+....+.+|+.+++.++|+||+++++.+...+..++|+||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            369999999999999887 9999999987765555667899999999999999999999999999999999999999999


Q ss_pred             HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC--cccccC
Q 018532          153 ADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFVGT  229 (354)
Q Consensus       153 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt  229 (354)
                      .+++... ..++...+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..........  .....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9999764 467889999999999999999998 899999999999999999999999999987654221111  112335


Q ss_pred             CcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       230 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      ..|+|||.+.+..++.++|+|||||++|+|++ |..||......       .....+.. ......+..++..+.+++.+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~~li~~  230 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIES-GYRMPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhc-CCCCCCCccCCHHHHHHHHH
Confidence            67999999998889999999999999999998 88898665432       12222222 22333456788999999999


Q ss_pred             hhhhCCCCCCCHHHHhc
Q 018532          309 CIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       309 ~l~~~p~~Rps~~eil~  325 (354)
                      ||..+|++|||+.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5e-42  Score=340.92  Aligned_cols=148  Identities=30%  Similarity=0.479  Sum_probs=136.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||||+++...  .......+..|+.++..++|+||+++++.+...+.+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999987532  344556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999998 899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.2e-42  Score=315.48  Aligned_cols=266  Identities=27%  Similarity=0.395  Sum_probs=207.9

Q ss_pred             cccccccccccCceEEEEEEEccC--CcEEEEEEeecccc-HHHHHHHHHHHHHHhhc-CCCceEEeeeeeee----cCe
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWV--GRLFALKIIQMNIQ-EEIRKQIVQELKINQAS-QCSHVVVCYHSFYH----NGV  139 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~----~~~  139 (354)
                      +|++.+.||+|+||.||++++..+  +..||+|.+..... ....+.+.+|+.+++.+ +|+||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999888  89999999865332 23345678899999888 59999999986432    246


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +++++|++. ++|.+++.....+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            789999986 5999999887889999999999999999999998 99999999999999999999999999999865432


Q ss_pred             cC----CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH--------HHHHHH-
Q 018532          220 MG----QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY--------ELLEAI-  285 (354)
Q Consensus       220 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------~~~~~~-  285 (354)
                      ..    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.........        +....+ 
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            21    1233578999999998866 468999999999999999999999997654211000000        000000 


Q ss_pred             ----------HcCCCC---CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          286 ----------VESPPP---TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       286 ----------~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                                ......   ......++..+.+++.+||+.||++|||+.+++.|||+++..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                      000000   01123467899999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.9e-42  Score=311.14  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=206.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ..++|+..+.||+|+||.||++.+..+|.    .||+|.+...........+.+|+.+++.++|+||+++++.+... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            45678889999999999999999887776    47889887655555556788999999999999999999988654 46


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++++||+++|+|.+++.... .+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccccCc
Confidence            78999999999999987754 68899999999999999999998 99999999999999999999999999999865432


Q ss_pred             cCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....       +....+. .......+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------~~~~~~~-~~~~~~~~~  234 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------EIPDLLE-KGERLPQPP  234 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH-CCCCCCCCC
Confidence            221  222345778999999998889999999999999999997 99999664321       1122222 222223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .++..+.+++.+||..+|++||++.++++.
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.9e-42  Score=304.46  Aligned_cols=251  Identities=24%  Similarity=0.456  Sum_probs=207.7

Q ss_pred             cccccccccccCceEEEEEEEcc-CCcEEEEEEeeccc---------cHHHHHHHHHHHHHHhh-cCCCceEEeeeeeee
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNI---------QEEIRKQIVQELKINQA-SQCSHVVVCYHSFYH  136 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~  136 (354)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....         .......+.+|+.++.. ++|+|++++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999987 68899999875321         22334557788887764 799999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ++..+++|||++|++|.+++..    ...+++..++.++.|++.||.|||+.++++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998754    246889999999999999999999647899999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      +....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......       .....+.......
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~  232 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLATKIVEAVYEP  232 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHHHHHhhccCCc
Confidence            98765433 334457899999999999888999999999999999999999999654322       2233333333333


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .....++..+.++|.+||+.||++||++.|+.++
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3334678999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-42  Score=318.53  Aligned_cols=265  Identities=27%  Similarity=0.433  Sum_probs=208.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------Ce
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------GV  139 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~~  139 (354)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.+.|+||+++++.+...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            57889999999999999999999999999999987543 233345678999999999999999999988654      35


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .++|+||+.+ +|..+.  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++..... 
T Consensus        95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            6999999964 777664  2468999999999999999999998 8999999999999999999999999999876532 


Q ss_pred             cCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HH-------
Q 018532          220 MGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LE-------  283 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~-------  283 (354)
                        ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...        ..       
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence              2234567889999999876 45889999999999999999999999765422111100000        00       


Q ss_pred             -HHHcCCCCC------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          284 -AIVESPPPT------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       284 -~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                       ......+..      ......+.++.+||.+||+.||++||++.+++.||||+.+.+.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~  309 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE  309 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence             000000000      0012467889999999999999999999999999999998775544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=307.61  Aligned_cols=258  Identities=28%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      |++.+.||+|++|+||+|....+++.||||.+.............+|+..+..+. |+|++++++.+..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5678899999999999999998999999999875543222334557888888998 999999999999999999999999


Q ss_pred             CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          148 DRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       148 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                       +++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCC
Confidence             679999888764  78999999999999999999998 999999999999999999999999999998664432 2233


Q ss_pred             cccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH---------------HHHHHHHcC-
Q 018532          226 FVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY---------------ELLEAIVES-  288 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------------~~~~~~~~~-  288 (354)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.............               ......... 
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            568889999998854 457899999999999999999999997654321110000               000000000 


Q ss_pred             --CCC---CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          289 --PPP---TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       289 --~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                        ...   .......+.++.++|.+||+.+|++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence              000   00011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9e-42  Score=304.65  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=208.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ...++|.+.+.||.|+||.||+|.+...   ...||+|........+..+.+.+|+.+++.+.|+|++++++.+.+ +..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            3456788899999999999999987644   356999998766656666789999999999999999999998765 567


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            89999999999999998743 58999999999999999999998 99999999999999999999999999998765433


Q ss_pred             cCC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MGQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ... .....++..|+|||.+.+..++.++|||||||++|++++ |..||......       +....+.... ....+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~-~~~~~~~  232 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGE-RLPMPPN  232 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCC-cCCCCCC
Confidence            211 112234568999999988889999999999999999986 99999765433       2223333332 2234567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++..+.+++.+||..+|++|||+.++++.
T Consensus       233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.9e-42  Score=315.62  Aligned_cols=268  Identities=24%  Similarity=0.425  Sum_probs=212.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~l  142 (354)
                      ..++|.+.+.||.|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++|+|++++++.+.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3567999999999999999999999999999999876432 22344667889999999999999999998875 567899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ++||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......   
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence            99999 5699888865 568888899999999999999998 89999999999999999999999999998754322   


Q ss_pred             CcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH--------------------H
Q 018532          223 RDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE--------------------L  281 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------------------~  281 (354)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.............+                    .
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            233467889999999866 5689999999999999999999999976543211000000                    0


Q ss_pred             HHHHHcCCC--CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          282 LEAIVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       282 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      .........  .......++..+.++|.+||+.+|++||++++++.||||.....+-.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            000000000  001113468899999999999999999999999999999888776544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.4e-42  Score=301.67  Aligned_cols=229  Identities=23%  Similarity=0.290  Sum_probs=192.7

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHH
Q 018532           78 GSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR  157 (354)
Q Consensus        78 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  157 (354)
                      |.+|.||+|++..+++.||+|.++...      ...+|...+....|+|++++++.+...+..+++|||++|++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987542      12234444455679999999999999999999999999999999998


Q ss_pred             HhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCccccccc
Q 018532          158 QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER  237 (354)
Q Consensus       158 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  237 (354)
                      ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++++|||.+......   .....++..|+|||.
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~  153 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEV  153 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcc
Confidence            87789999999999999999999998 99999999999999999999999999987665432   223356778999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCC
Q 018532          238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR  317 (354)
Q Consensus       238 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  317 (354)
                      +.+..++.++|+||+||++|+|++|..|+......             .........+..+++.+.++|.+||+.||++|
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence            98888999999999999999999999887543211             00011122345688999999999999999999


Q ss_pred             CCH-----HHHhcCccc
Q 018532          318 SSS-----LDLLSHPFI  329 (354)
Q Consensus       318 ps~-----~eil~hp~~  329 (354)
                      |++     +++++||||
T Consensus       221 ~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         221 LGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCCccchHHHHcCCCC
Confidence            996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-41  Score=302.66  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=193.3

Q ss_pred             ccccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||.||++...  .++..+|+|.++..........+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999754  3567799999876655455567888999999999999999999999888999999999999


Q ss_pred             CHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--CC
Q 018532          151 SLADIIRQVK-----TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QR  223 (354)
Q Consensus       151 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~  223 (354)
                      +|.+++....     ..++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            9999997532     34567788899999999999998 9999999999999999999999999999875433211  12


Q ss_pred             cccccCCcccccccccCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          224 DTFVGTYNYMSPERISGS-------TYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ....++..|+|||++.+.       .++.++|||||||++|+|++ |..||......+.   ..............+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhhcccCCCCCCccC
Confidence            234577889999998643       35789999999999999996 9999966543211   000001111111112222


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ...++.+.+++.+|+ .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356888999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=354.41  Aligned_cols=258  Identities=32%  Similarity=0.538  Sum_probs=221.4

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      .-...||.|.||.||.|.+..+|...|+|-++... .....+.+.+|..++..++|||+|++|++=.+.+.+++.||||+
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence            44567999999999999999999999999886443 23445678999999999999999999999989999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC----CCc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG----QRD  224 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~  224 (354)
                      ||+|.++++..+...+-....+..|++.|+.|||+ .|||||||||+||+++.+|.+|++|||.|..+.....    ...
T Consensus      1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            99999999987777777788899999999999998 9999999999999999999999999999988765432    234


Q ss_pred             ccccCCcccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          225 TFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...||+-|||||++.+..   ...++|||||||++.||+||+.||...+..      +.++-....+..|. .|..++++
T Consensus      1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~gh~Pq-~P~~ls~~ 1469 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAGHKPQ-IPERLSSE 1469 (1509)
T ss_pred             hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhccCCCC-CchhhhHh
Confidence            568999999999998753   567899999999999999999999877654      24444444444444 34559999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ..+||..||..||+.|.++.|+++|-|-+...+.
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence            9999999999999999999999999998876554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=324.60  Aligned_cols=244  Identities=26%  Similarity=0.366  Sum_probs=210.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHH-HhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .+.|.....+|.|+||.|..+.+..+++.+++|++....     ....+|+.+ +..-+|+|++++.+.+.+..+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            577888888999999999999999999999999997652     123345544 34458999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE-ccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV-NHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |.+.|+-+.+.+...+.+. ..+..|+.+|+.|+.|||+ .|++||||||+|||+ ++.|+++|+|||.++.....   .
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~  470 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---C  470 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---h
Confidence            9999999988887766555 7888999999999999998 999999999999999 58899999999999887654   4


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      .+.+-|..|.|||++....|+.++||||||++||+||+|..||......      .++...+..+..    ...+|.+++
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~----s~~vS~~AK  540 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKF----SECVSDEAK  540 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcc----ccccCHHHH
Confidence            4557899999999999999999999999999999999999999876654      234444433322    267999999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +||.+||+.||.+|+++.+++.|||+
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.7e-42  Score=313.14  Aligned_cols=262  Identities=28%  Similarity=0.446  Sum_probs=203.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeec-------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHN-------  137 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-------  137 (354)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++|+||+++++.+...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57899999999999999999999999999999998654322 2234567899999999999999999877543       


Q ss_pred             -CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          138 -GVISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       138 -~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                       ..+++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||+ .|++|+||||+||++++++.++|+|||++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence             357999999975 78777764 3579999999999999999999998 8999999999999999999999999999976


Q ss_pred             cCCCcCC-----------CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH
Q 018532          216 LGSSMGQ-----------RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       216 ~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      .......           .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            5432211           1223568889999988764 588999999999999999999999976554321111110000


Q ss_pred             H-----------HHcCC-------CCC---CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          284 A-----------IVESP-------PPT---APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       284 ~-----------~~~~~-------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .           +....       .+.   .....+++.+.++|.+||+.||++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0           00000       000   0012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-41  Score=303.86  Aligned_cols=244  Identities=22%  Similarity=0.330  Sum_probs=193.0

Q ss_pred             ccccccCceEEEEEEEcc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKW--VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      +.||+|+||.||++....  ....+|+|.+...........+.+|+.+++.++|+||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999996532  345788898766555555677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--CC
Q 018532          151 SLADIIRQVK-----TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QR  223 (354)
Q Consensus       151 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~  223 (354)
                      +|.+++....     ..++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999997643     24567788999999999999998 8999999999999999999999999999865432211  12


Q ss_pred             cccccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcC----CCC
Q 018532          224 DTFVGTYNYMSPERISG-------STYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVES----PPP  291 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~  291 (354)
                      ....++..|+|||++..       ..++.++|||||||++|+|++ |..||....+.       +........    .+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDIKLPK  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCccCCC
Confidence            23345778999998743       356889999999999999998 78888655432       112222211    122


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +.....++..+.+++..|| .||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2334568889999999999 59999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-41  Score=300.96  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             ccccccCceEEEEEEEcc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee-ecCeEEEEEeccC
Q 018532           73 KVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY-HNGVISLVLEYMD  148 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  148 (354)
                      +.||+|+||.||+|.+..   .+..||+|.+...........+.+|+.+++.++|+|++++++.+. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998653   345799998865444455677889999999999999999999765 4567899999999


Q ss_pred             CCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc----CCC
Q 018532          149 RGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM----GQR  223 (354)
Q Consensus       149 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----~~~  223 (354)
                      +++|.+++... ...+...+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......    ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            99999999764 346777888899999999999998 899999999999999999999999999987653321    111


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....++..|+|||.+.+..++.++|||||||++|||++| .+||...+..       +......... ....+..++..+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~  231 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------DITVYLLQGR-RLLQPEYCPDPL  231 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhcCC-CCCCCCcCCHHH
Confidence            233457789999999888899999999999999999995 5566543221       2233333332 233345678999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+++.+||..+|++||++.++++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=312.30  Aligned_cols=274  Identities=26%  Similarity=0.418  Sum_probs=224.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc------cHHHHHHHHHHHHHHhhcCCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI------QEEIRKQIVQELKINQASQCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  134 (354)
                      +...-.++|-++..||+|||+.||+|.+....+.||+|+-..+.      .+...+...+|.+|.+.|.|+.||++|++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            34455678999999999999999999999999999999976543      234556789999999999999999999988


Q ss_pred             e-ecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCCceecCCCCCCEEEcc---CCcEEEee
Q 018532          135 Y-HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLLVNH---KGEVKITD  209 (354)
Q Consensus       135 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~iiH~Dlkp~NIll~~---~~~~kl~D  209 (354)
                      . +.+.+|-|+|||+|.+|.-+++.++.+++.+++.|+.||+.||.||.. ...|||-||||.|||+.+   -|.+||+|
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            6 456889999999999999999999999999999999999999999986 356999999999999955   36899999


Q ss_pred             cccccccCCCcC-------CCcccccCCcccccccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH
Q 018532          210 FGVSAMLGSSMG-------QRDTFVGTYNYMSPERISGS----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF  278 (354)
Q Consensus       210 fg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  278 (354)
                      ||++..+.....       ......||.+|++||++.-+    .++.++||||+|||+|.++.|+.||......+..-..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            999998765432       24557899999999998654    4788999999999999999999999877655422111


Q ss_pred             HHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          279 YELLEAIVESPP-PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       279 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      .    .+..... .......+++++.+||++||.+--+.|....++..||||.--..+..+
T Consensus       697 N----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s  753 (775)
T KOG1151|consen  697 N----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVS  753 (775)
T ss_pred             h----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccc
Confidence            1    1221111 122234589999999999999999999999999999999864444433

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-41  Score=305.20  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             cccccccccccccCceEEEEEEEc----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~  139 (354)
                      ..+|++.+.||+|+||.||++...    .++..||+|++...........+.+|+.+++.+.|+|++++++.+..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            456788899999999999999864    34889999999766554456789999999999999999999998876  558


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999998754 58999999999999999999998 8999999999999999999999999999987653


Q ss_pred             CcCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh-------hhHHHHHHHHHcC
Q 018532          219 SMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-------PSFYELLEAIVES  288 (354)
Q Consensus       219 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~  288 (354)
                      ....   .....++..|+|||.+.+..++.++|||||||++|+|++|..|+.........       .............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211   11224556799999998888999999999999999999999998654322100       0001112222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......+..++.++.+++.+||+.+|++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2333334567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-41  Score=299.66  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |++..++|.+.+.||+|+||.||++.+. .+..+|+|.+...  ......+.+|+.+++.++|+|++++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            4566789999999999999999999865 5566999987643  2334668889999999999999999998877 7889


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++|||+++++|.+++...  ..++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999999999763  356788899999999999999998 99999999999999999999999999998765432


Q ss_pred             cC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. ......++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..       .....+... .....+..
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~  227 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERG-YRMPRPEN  227 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCC-CCCCCccc
Confidence            21 1222345677999999998889999999999999999998 99999765432       223333333 22333457


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.++.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            8899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=308.01  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=211.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC--Cc----eEEeeeeeeec
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC--SH----VVVCYHSFYHN  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~----iv~~~~~~~~~  137 (354)
                      .-.++|.++..+|+|+||.|..+.+..++..||||+++  .....+...+-|++++.++.+  |+    +|.+.++|.-.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            34789999999999999999999999999999999986  345566777888998888732  22    67777889999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--------------
Q 018532          138 GVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--------------  201 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--------------  201 (354)
                      ++.|+|+|.+ |.++.+++.++  .+++...++.++.|++.++++||+ .+++|.||||+|||+.+              
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCccc
Confidence            9999999999 56999999875  468899999999999999999998 88999999999999842              


Q ss_pred             ------CCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCCh
Q 018532          202 ------KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW  275 (354)
Q Consensus       202 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  275 (354)
                            +..++|+|||.|+.....   ..+.+.|..|+|||++.+-.++.++||||+||||+|+.+|...|...++.+..
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                  235999999999875543   25678899999999999999999999999999999999999999877654321


Q ss_pred             hhHHHHHHHHHcCCCCCCC-----------------------------------------CCCCCHHHHHHHHHhhhhCC
Q 018532          276 PSFYELLEAIVESPPPTAP-----------------------------------------PDQFSPEFCSFVSACIQKDP  314 (354)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~l~~li~~~l~~~p  314 (354)
                          ++++.+....+....                                         .+.-..++.|||++||.+||
T Consensus       319 ----aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  319 ----AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             ----HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence                333333332111000                                         00112358899999999999


Q ss_pred             CCCCCHHHHhcCccccccc
Q 018532          315 RDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       315 ~~Rps~~eil~hp~~~~~~  333 (354)
                      .+|+|+.|+|.||||+...
T Consensus       395 ~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccHHHHhcCHHhhcCC
Confidence            9999999999999999764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.1e-42  Score=338.85  Aligned_cols=256  Identities=30%  Similarity=0.521  Sum_probs=206.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee---------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH---------  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---------  136 (354)
                      ..+|+.++.||+||||.||+|+++-+|+.||||++....+......+.+|++++.+++|||||++|.++.+         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            56789999999999999999999999999999999888777778889999999999999999999986500         


Q ss_pred             --------------------------------------------------------------------------------
Q 018532          137 --------------------------------------------------------------------------------  136 (354)
Q Consensus       137 --------------------------------------------------------------------------------  136 (354)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------c--------CeEEEEEeccCCCCHHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 018532          137 ----------------------N--------GVISLVLEYMDRGSLADIIRQVKTI-LEPYLAVVCKQVLQGLVYLHNER  185 (354)
Q Consensus       137 ----------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~  185 (354)
                                            +        ..+|+-||||+.-.|.+++..+... ....++.+++||++||.|+|+ +
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-Q  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-C
Confidence                                  0        1367899999986666666664443 367899999999999999998 9


Q ss_pred             CceecCCCCCCEEEccCCcEEEeecccccccC------------------CCcCCCcccccCCcccccccccCCC---CC
Q 018532          186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG------------------SSMGQRDTFVGTYNYMSPERISGST---YD  244 (354)
Q Consensus       186 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~~  244 (354)
                      |||||||||.||++++++.|||+|||+|+...                  ......++.+||.-|+|||++.+..   |+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                  0111234578999999999998754   99


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 018532          245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFSPEFCSFVSACIQKDPRDRSSSLD  322 (354)
Q Consensus       245 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~e  322 (354)
                      .|+|+||||++++||+.   ||.-.-      .....+..+..+..+..  ....--+.-..+|..||+.||++||||.|
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsM------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSM------ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchH------HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            99999999999999994   453221      11233444444444433  12223345678999999999999999999


Q ss_pred             HhcCccccc
Q 018532          323 LLSHPFIKK  331 (354)
Q Consensus       323 il~hp~~~~  331 (354)
                      +|++.|+-.
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999983

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.8e-41  Score=298.10  Aligned_cols=249  Identities=28%  Similarity=0.420  Sum_probs=205.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ..+|.+.+.||+|+||.||++.+. .+..+|+|.+......  ...+.+|+.+++.++|+|++++++.+......++++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            467888999999999999999875 4778999988654322  2457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~  223 (354)
                      |+++++|.+++... ..++++.+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999999764 458899999999999999999998 8999999999999999999999999999876543211 11


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......       +....+..... ...+...+..+
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~  230 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGFR-LYKPRLASQSV  230 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCCCC-CCCCCCCCHHH
Confidence            22345678999999998889999999999999999998 99999654422       33333333322 22344578999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+|+.+||+.+|++|||+.+++++
T Consensus       231 ~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         231 YELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-41  Score=302.19  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=200.5

Q ss_pred             ccccccCceEEEEEEEccCC------cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           73 KVIGKGSGGVVQLVRHKWVG------RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +.||+|+||.||+++.....      ..+|+|.+...........+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            35899999999999976544      689999887655445566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-----cEEEeeccccc
Q 018532          147 MDRGSLADIIRQV-------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-----EVKITDFGVSA  214 (354)
Q Consensus       147 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~a~  214 (354)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++     .++|+|||++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999999753       236788899999999999999998 8999999999999999887     89999999987


Q ss_pred             ccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          215 MLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       215 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      .......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......       +....+... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~-~~  231 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHVTAG-GR  231 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHHhcC-Cc
Confidence            6532211  1122345678999999999899999999999999999998 99999654332       222222222 22


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ...+..++..+.++|.+||..+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3344568899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.1e-41  Score=298.53  Aligned_cols=244  Identities=24%  Similarity=0.450  Sum_probs=202.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ...++|.+.+.||+|+||.||.+.  .+++.||+|.++...   ....+.+|+.+++.++|+|++++++.+..+ ..+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            345789999999999999999886  478889999986543   235678899999999999999999988654 47999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          144 LEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++......  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            99999999999998653  47889999999999999999998 99999999999999999999999999998764322  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......       +....+... .....+..++.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~  224 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEKG-YRMEPPEGCPA  224 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhCC-CCCCCCCcCCH
Confidence             122234668999999998889999999999999999997 99999765432       223333333 23334557899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+.+++.+||+.+|++||++++++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=326.29  Aligned_cols=257  Identities=39%  Similarity=0.664  Sum_probs=223.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeee-----cCe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYH-----NGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~-----~~~  139 (354)
                      .+.+++.++||.|.+|.||+++++.+++..|+|+.......  ..++..|..+++.+ .|+|++.+|++|.-     ++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            45667889999999999999999999999999998765443  35677788888886 68999999998863     568


Q ss_pred             EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ++||||||.||+..++++..  ..+.|+.+.+|++.++.|+.+||. +.++|||||-.|||++.+|.|||+|||.+.++.
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999999999865  468899999999999999999998 779999999999999999999999999999998


Q ss_pred             CCcCCCcccccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .......+.+|||.|||||++.-.     .|+..+|+||||++..||.-|.+|+....+.       ..+-.+...+++.
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------raLF~IpRNPPPk  247 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNPPPK  247 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hhhccCCCCCCcc
Confidence            887888889999999999998543     4788999999999999999999999887764       2233333343333


Q ss_pred             -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          293 -APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       293 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                       .-+.++++++.++|..||.+|-++||+..++|+|||+++.
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence             3367889999999999999999999999999999999854

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-41  Score=302.08  Aligned_cols=238  Identities=20%  Similarity=0.332  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEEccCCc-------EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           73 KVIGKGSGGVVQLVRHKWVGR-------LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +.||+|+||.||++.+..++.       .+|+|.+.... ....+.+.+|+.+++.+.|+|++++++.+..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999999865543       38888875432 3345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc--------EEEeeccccccc
Q 018532          146 YMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--------VKITDFGVSAML  216 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfg~a~~~  216 (354)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.        ++++|||++...
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999998654 58899999999999999999998 99999999999999987764        699999998755


Q ss_pred             CCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCC-CCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR-FPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..    .....++..|+|||++.+. .++.++|||||||++|+|++|. .||...+..       .... ....  ....
T Consensus       159 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~-~~~~--~~~~  224 (258)
T cd05078         159 LP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQ-FYED--RHQL  224 (258)
T ss_pred             CC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHH-HHHc--cccC
Confidence            32    2334678899999999874 5799999999999999999985 666443321       1111 1111  1223


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +...+.++.+|+.+||+.||++|||++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            34567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-41  Score=297.65  Aligned_cols=235  Identities=21%  Similarity=0.311  Sum_probs=192.0

Q ss_pred             ccccccCceEEEEEEEccCC----------cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           73 KVIGKGSGGVVQLVRHKWVG----------RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      +.||+|+||.||++.+..++          ..+++|++......  ...+.+|+.+++.++|+|++++++.+.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36899999999999998776          35788876544322  5678899999999999999999998887 77899


Q ss_pred             EEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-------cEEEeeccccc
Q 018532          143 VLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-------EVKITDFGVSA  214 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-------~~kl~Dfg~a~  214 (354)
                      ||||+++++|.+++.... .++...+..++.||+.||.|||+ +||+||||||+||+++.++       .+||+|||++.
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999998765 78999999999999999999998 9999999999999999888       79999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ....    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.......       ......... .
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~~~~~~~~-~  224 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KERFYQDQH-R  224 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HHHHHhcCC-C
Confidence            6543    2234567789999999876  78999999999999999999 578886654221       111111111 1


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                        .+......+.+++.+||..+|++|||+.++++
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 --LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence              11122478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-40  Score=301.66  Aligned_cols=256  Identities=18%  Similarity=0.212  Sum_probs=194.1

Q ss_pred             CcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHH----------HHHHHHHHHHHhhcCCCceEEee
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEI----------RKQIVQELKINQASQCSHVVVCY  131 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~h~~iv~~~  131 (354)
                      ..++|++.+.||+|+||+||+|.+..+   +..+|+|+.........          ......+...+..+.|++++.++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998877   66778886543221100          11122333455667899999999


Q ss_pred             eeeeecC----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          132 HSFYHNG----VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       132 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                      +......    ..+++++++. .++.+.+......++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcEEE
Confidence            8665433    4467888875 4788877766667888999999999999999998 89999999999999999999999


Q ss_pred             eecccccccCCCc-------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH--
Q 018532          208 TDFGVSAMLGSSM-------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF--  278 (354)
Q Consensus       208 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--  278 (354)
                      +|||+|+......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..........  
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999998664221       1122346999999999999999999999999999999999999999876432211110  


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+....+..+.   .....+++.+.+++..|++.+|++||++.++++
T Consensus       248 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11222222221   123456899999999999999999999999875

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-40  Score=296.59  Aligned_cols=247  Identities=17%  Similarity=0.266  Sum_probs=190.7

Q ss_pred             cccccCceEEEEEEEccC--CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           74 VIGKGSGGVVQLVRHKWV--GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      .||+|+||+||++....+  ...+++|.+.........+.+.+|+.+++.++|+|++++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999875433  335677777665555566789999999999999999999999999999999999999999


Q ss_pred             HHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC--cCCCcc
Q 018532          152 LADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--MGQRDT  225 (354)
Q Consensus       152 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~  225 (354)
                      |.+++.+.    ....+..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++......  ......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            99999764    235566788899999999999998 89999999999999999999999999998643221  112234


Q ss_pred             cccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          226 FVGTYNYMSPERISG-------STYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ..++..|+|||++..       ..++.++|||||||++|||++ |..||......+   .+.............+.....
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcccccCCCccCCC
Confidence            568899999999853       235789999999999999997 577886544321   111111111111122233345


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +++.+.+++..|| .+|++||++.++++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.9e-41  Score=297.12  Aligned_cols=238  Identities=19%  Similarity=0.344  Sum_probs=190.5

Q ss_pred             ccccccCceEEEEEEEcc------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           73 KVIGKGSGGVVQLVRHKW------------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +.||+|+||.||++....            ....+|+|++... ..+....+.+|+.++..++|+||+++++.+..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999998532            2235888887543 234456788889999999999999999999998999


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc-------EEEeeccc
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-------VKITDFGV  212 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-------~kl~Dfg~  212 (354)
                      +++|||+++++|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.       ++++|||+
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            9999999999999988764 568999999999999999999998 99999999999999987664       89999999


Q ss_pred             ccccCCCcCCCcccccCCccccccccc-CCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERIS-GSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      +......    ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......       +. ........
T Consensus       159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~-~~~~~~~~  226 (262)
T cd05077         159 PITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK-ERFYEGQC  226 (262)
T ss_pred             CccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH-HHHHhcCc
Confidence            8755322    2346788999999987 456899999999999999997 588888654322       11 11111111


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .  .....+.++.+||.+||+.||++||++.+|+.+
T Consensus       227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            1  122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=298.44  Aligned_cols=237  Identities=20%  Similarity=0.338  Sum_probs=189.3

Q ss_pred             cccccCceEEEEEEEccC------------------------CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEE
Q 018532           74 VIGKGSGGVVQLVRHKWV------------------------GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV  129 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  129 (354)
                      .||+|+||.||++....+                        ...||+|++.... .+....+.+|+.+++.++|+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            599999999999875322                        2358889886432 234456788899999999999999


Q ss_pred             eeeeeeecCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-----
Q 018532          130 CYHSFYHNGVISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-----  203 (354)
Q Consensus       130 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-----  203 (354)
                      +++.+...+..++||||+++++|..++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||+++..+     
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccCcccCc
Confidence            99999999999999999999999999875 4578999999999999999999998 9999999999999997654     


Q ss_pred             --cEEEeecccccccCCCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHH-cCCCCCCCCCcCCChhhHH
Q 018532          204 --EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       204 --~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~  279 (354)
                        .+|++|||++......    ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+      
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------  229 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE------  229 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH------
Confidence              4899999987654322    22357888999998876 46899999999999999994 7999997654321      


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                       ..... ....  ..+...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 -~~~~~-~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 -KERFY-EKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HHHHH-Hhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             11111 1111  1223356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=307.40  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=217.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++..+.+.+.++||+|-||.|.+|.-. .+..||+|.++.......++.|.+|++++.+++||||+.+++++..++.+++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            567788899999999999999999865 4689999999988888888999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          143 VLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||+++|+|.+++.++.  .........|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||.++.+....
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999999999873  33455667799999999999998 889999999999999999999999999998664332


Q ss_pred             C--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHH--cCCCCCCCCCcCCChhhHHHHHHHHHcCCCC---CC
Q 018532          221 G--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA--IGRFPYMQSEDQQSWPSFYELLEAIVESPPP---TA  293 (354)
Q Consensus       221 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~  293 (354)
                      .  .....+-+.+|||+|.+..++++.++|+|+||+++||++  +...||....+++..    +-.......+.+   ..
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcceecc
Confidence            2  223345678999999999999999999999999999985  688999887765322    222333333322   22


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .|.-++.++.++|.+||..+-++|||++++-.
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            34568999999999999999999999999843

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=324.64  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=229.5

Q ss_pred             cccccccCcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee
Q 018532           58 KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF  134 (354)
Q Consensus        58 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  134 (354)
                      .+|..+++.+...+.++||.|.||.||.++.+..|+   .||||.++....++.+..|+.|+.|+-...||||+++-++.
T Consensus       620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             HHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            345667788889999999999999999999987774   59999999999999999999999999999999999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      .....+++|+|||++|+|+.+|+.+ +.++.-++..+++.|+.|+.||-+ .|.|||||...||||+.+..+|++|||++
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccce
Confidence            9999999999999999999999876 679999999999999999999997 99999999999999999999999999999


Q ss_pred             cccCCCcCCCccc---ccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          214 AMLGSSMGQRDTF---VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       214 ~~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      +.+.++.....+.   .=+.+|.|||.+...+++.+|||||+|+++||.++ |..||-...++       +.++.+.++-
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-------dVIkaIe~gy  851 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVIKAIEQGY  851 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-------HHHHHHHhcc
Confidence            9886554322221   12579999999999999999999999999999875 99999877665       5666665554


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      . ..+|-++|..+.+|+..||++|-.+||.+.||+.+
T Consensus       852 R-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  852 R-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             C-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            3 34456799999999999999999999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=293.54  Aligned_cols=266  Identities=26%  Similarity=0.374  Sum_probs=213.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH-------  136 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-------  136 (354)
                      ..+.|+.+.+||+|.||.||+|+.+.+|+.||+|++-... .+.+-...++|++++..++|+|++.+++.+..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            4577888999999999999999999999999998765432 33445567899999999999999998887643       


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          137 -NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       137 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                       ...+|+|+++|+. +|..++.+. -+++..++..++.++..||.|+|. ..|+|||+|++|+|++.+|.+||+|||+++
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence             2459999999986 999999775 579999999999999999999998 889999999999999999999999999997


Q ss_pred             ccCCCcCC----CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH-------
Q 018532          215 MLGSSMGQ----RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL-------  282 (354)
Q Consensus       215 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------  282 (354)
                      .+......    ....+.|.+|++||.+.|. .|+++.|||+.||++.||.+|.+-+.+....++...+..+.       
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            76543222    2344679999999999885 59999999999999999999999998877654433332222       


Q ss_pred             ----------HHHHcCCCCCCC---------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          283 ----------EAIVESPPPTAP---------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       283 ----------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                                +.+...+.+...         +-.-++++.+|+.++|..||.+|+++++++.|.||..-
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                      222111111000         11125578999999999999999999999999999863

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.9e-40  Score=294.37  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             ccccccccccCceEEEEEEEcc---CCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC------
Q 018532           69 LETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------  138 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------  138 (354)
                      |.+.+.||+|+||.||+|....   ++..||||++.... .....+.+.+|+.+++.++|+|++++++.+....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998643   57899999987543 3344567889999999999999999999876432      


Q ss_pred             eEEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ..+++++|+.+|+|.+++...      ..++...+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccc
Confidence            347889999999999887532      146888899999999999999998 8999999999999999999999999999


Q ss_pred             ccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          213 SAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       213 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      +........  ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+..       +....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYLIKGN  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHHHHHcCC
Confidence            986543221  1122345678999999998889999999999999999999 88998755432       2333333332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      . ...+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       233 ~-~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 R-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 22334578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=308.00  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=215.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV----GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      ++++..+.....+.||.|-||.||.+....-    .-.||||..+.+...+..+.|++|+.+++.+.|||||+++|.+.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3455666777788999999999999885432    235999999887777778999999999999999999999998865


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                       ..+++|||+++.|.|..+++.. ..++......++.||+.||.|||+ ..+|||||...|||+.+...|||+|||+++.
T Consensus       463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcceeeecccchhhh
Confidence             5789999999999999999976 468888889999999999999999 7799999999999999999999999999998


Q ss_pred             cCCCcCCC-cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          216 LGSSMGQR-DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       216 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      +.+..... +...-+..|||||.+.-..++.++|||-|||.+||++. |..||.+..+.+.       +..+. .+....
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iE-nGeRlP  612 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIE-NGERLP  612 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEec-CCCCCC
Confidence            76553322 22345679999999999999999999999999999986 9999998876642       22232 334455


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .|.+||+.+..|+.+||.++|.+||.+.++..
T Consensus       613 ~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            56789999999999999999999999977654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=291.55  Aligned_cols=266  Identities=26%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC--------CCceEEeeeeee
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ--------CSHVVVCYHSFY  135 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------h~~iv~~~~~~~  135 (354)
                      +...+|.+.++||.|.|+|||+|.+..+.+.||+|+.+..  ....+..+.|+++++.+.        ..+||++++.|.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            4457999999999999999999999999999999998643  445567889999988752        245999999987


Q ss_pred             e----cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--------
Q 018532          136 H----NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--------  201 (354)
Q Consensus       136 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--------  201 (354)
                      .    ..++|+|+|++ |-+|..+|...  +.++...++.|++||+.||.|||.+.||||.||||+|||+..        
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence            5    45999999999 67999999865  679999999999999999999999999999999999999920        


Q ss_pred             --------------------------------------------------------------------------------
Q 018532          202 --------------------------------------------------------------------------------  201 (354)
Q Consensus       202 --------------------------------------------------------------------------------  201 (354)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             --------------------------C----------------------------------------------------C
Q 018532          202 --------------------------K----------------------------------------------------G  203 (354)
Q Consensus       202 --------------------------~----------------------------------------------------~  203 (354)
                                                .                                                    -
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                      0                                                    0


Q ss_pred             cEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC------CChhh
Q 018532          204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ------QSWPS  277 (354)
Q Consensus       204 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~  277 (354)
                      .|||+|||-|+-...   .....+.|..|+|||++.+..|+..+||||++|++|||+||.+.|......      +-...
T Consensus       392 ~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~  468 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL  468 (590)
T ss_pred             eEEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence            156666666654322   223346788999999999999999999999999999999999999653322      11222


Q ss_pred             HHHHHHHH----Hc-CCCC----------------------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q 018532          278 FYELLEAI----VE-SPPP----------------------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL  324 (354)
Q Consensus       278 ~~~~~~~~----~~-~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil  324 (354)
                      +.+++-.+    .. +...                            ...+.....++.+|+.-||+.+|++||||.++|
T Consensus       469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl  548 (590)
T KOG1290|consen  469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL  548 (590)
T ss_pred             HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence            22322111    00 0000                            000111234688999999999999999999999


Q ss_pred             cCccccccccc
Q 018532          325 SHPFIKKFEDK  335 (354)
Q Consensus       325 ~hp~~~~~~~~  335 (354)
                      +|||++.....
T Consensus       549 ~hPwLn~~~~~  559 (590)
T KOG1290|consen  549 KHPWLNPVAGP  559 (590)
T ss_pred             cCccccCCCCC
Confidence            99999976543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=307.16  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=219.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|+....++....+||-|.||.||.+.++.-.-.||||.++...  -...+|+.|+.+++.++|+|+|+++++|..+-.+
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            46777788888999999999999999999999999999987543  3357799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      |+|+|||..|+|.+++++..  .++...+.+++.||..|++||.. +++|||||...|.|+.++..||++|||+++.+..
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999999999999763  46677788999999999999998 8999999999999999999999999999998765


Q ss_pred             CcCC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          219 SMGQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       219 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      +... ..+.--++.|.|||-+..+.++.|+|||+|||+|||+.| |-.||.+.+..    ..+.    +.+.......+.
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----qVY~----LLEkgyRM~~Pe  489 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYG----LLEKGYRMDGPE  489 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHH----HHhccccccCCC
Confidence            4322 222334678999999999999999999999999999987 88999887644    2233    344556667788


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHH
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDL  323 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~ei  323 (354)
                      .|++.+.+|++.||+.+|.+||+++|+
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            999999999999999999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=267.13  Aligned_cols=231  Identities=39%  Similarity=0.697  Sum_probs=196.7

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh-cCCCceEEeeeeeeecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~  140 (354)
                      ++...+++.-...||+|++|.|-+.++..+|...|+|.++.....+..+++++|+.+... ..+|.+|.+|+.+.+++.+
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            345566777788899999999999999999999999999888777778889999986544 6899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ++.||.|+. +|..+.+    ..+.++|..+-+|+..++.||.|||+...+||||+||+|||++.+|.+|+||||++..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999974 8887654    34789999999999999999999999888999999999999999999999999999877


Q ss_pred             CCCcCCCcccccCCcccccccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .++... +...|.-.|||||.+..    ..|+.++||||||+++.||.++++||.      +|..-++.+.++++...+.
T Consensus       200 ~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~------~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  200 VDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE------SWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             hhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc------ccCCHHHHHHHHhcCCCCC
Confidence            654322 22478889999999865    369999999999999999999999994      4445568888888887776


Q ss_pred             CCCCCCCH
Q 018532          293 APPDQFSP  300 (354)
Q Consensus       293 ~~~~~~~~  300 (354)
                      .+...+|.
T Consensus       273 Lp~~~FS~  280 (282)
T KOG0984|consen  273 LPADTFSP  280 (282)
T ss_pred             CcccccCC
Confidence            66555543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=307.44  Aligned_cols=258  Identities=22%  Similarity=0.371  Sum_probs=217.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccC-C--cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWV-G--RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +..+++...+.||+|.||.|+++.+... |  ..||||.++..........|++|+.++..|.|+|++++|+...+ ..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            4567778889999999999999987653 3  35899999876555577889999999999999999999999887 778


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+|+++.|+|.+.|++.  ..|....+..++.||+.|+.||.+ +++|||||...|+++.....|||+|||+.+.++.
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            8999999999999999873  457788899999999999999998 8899999999999999999999999999998765


Q ss_pred             CcCCC---cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          219 SMGQR---DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       219 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      .....   ....-...|.|||.+....++.++|||++||+||||++ |..||.+....       .+++.+. ......-
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------qIL~~iD-~~erLpR  336 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------QILKNID-AGERLPR  336 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------HHHHhcc-ccccCCC
Confidence            43221   11234568999999999999999999999999999998 89999988754       4555555 3344445


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      +..|++++++++..||..+|.+|||+..|.+.-+..+
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            6679999999999999999999999999875544443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.6e-40  Score=318.04  Aligned_cols=263  Identities=23%  Similarity=0.257  Sum_probs=181.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEccC----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeee----
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWV----GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHS----  133 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~----  133 (354)
                      ..+..++|.+.+.||+|+||.||+|.+..+    +..||+|.+......+.   ...+ . ++...+.++..+...    
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~---~~~e-~-l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI---WMNE-R-VRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH---HHHH-H-HHhhchhhHHHHHHhhhcc
Confidence            345678999999999999999999999988    89999998754322111   1111 1 111112222211111    


Q ss_pred             --eeecCeEEEEEeccCCCCHHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          134 --FYHNGVISLVLEYMDRGSLADIIRQVKT--------------------ILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       134 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                        .......++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+ ++|+|||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRD  280 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRD  280 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCc
Confidence              2345689999999999999999875321                    1233466799999999999998 8999999


Q ss_pred             CCCCCEEEcc-CCcEEEeecccccccCCCc-CCCcccccCCcccccccccCCC----------------------CCcch
Q 018532          192 IKPSNLLVNH-KGEVKITDFGVSAMLGSSM-GQRDTFVGTYNYMSPERISGST----------------------YDYSS  247 (354)
Q Consensus       192 lkp~NIll~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~  247 (354)
                      |||+|||++. ++.+||+|||+|....... .......+++.|+|||.+....                      ++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999998654322 2234568899999999764322                      33456


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH----------HHHcCCCC------CCCCCCCCHHHHHHHHHhhh
Q 018532          248 DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE----------AIVESPPP------TAPPDQFSPEFCSFVSACIQ  311 (354)
Q Consensus       248 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------~~~~~~~~------~~~~~~~~~~l~~li~~~l~  311 (354)
                      |||||||++|||+++..++....     ..+...+.          ........      ....+..+....+||.+||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999999877653211     01111110          00000000      00011223456699999999


Q ss_pred             hCCCCCCCHHHHhcCccccccccc
Q 018532          312 KDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       312 ~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +||++|||+.++|+||||+.....
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999999886654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.6e-39  Score=279.20  Aligned_cols=243  Identities=35%  Similarity=0.622  Sum_probs=206.8

Q ss_pred             CceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHHH
Q 018532           79 SGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ  158 (354)
Q Consensus        79 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  158 (354)
                      +||.||++.+..+++.+|+|++.........+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999997654433357889999999999999999999999999999999999999999999988


Q ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccc
Q 018532          159 VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI  238 (354)
Q Consensus       159 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  238 (354)
                      ...++...+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence            6668999999999999999999998 899999999999999999999999999998765442 33445788899999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC-CCHHHHHHHHHhhhhCCCCC
Q 018532          239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ-FSPEFCSFVSACIQKDPRDR  317 (354)
Q Consensus       239 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~R  317 (354)
                      .+..++.++||||||++++++++|..||......      ................... ++.++.+++.+||..+|++|
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            9888999999999999999999999999763222      1223333333322222222 88999999999999999999


Q ss_pred             CCHHHHhcCccc
Q 018532          318 SSSLDLLSHPFI  329 (354)
Q Consensus       318 ps~~eil~hp~~  329 (354)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=310.04  Aligned_cols=243  Identities=26%  Similarity=0.457  Sum_probs=196.6

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------CeEEEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------GVISLVL  144 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~~~~lv~  144 (354)
                      ..+.||+||||.||+++++.||+.||||.++.......++...+|+.++++++|+|||++++.=.+.      ....++|
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            3456999999999999999999999999998766666778899999999999999999999875543      3577999


Q ss_pred             eccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--CC--cEEEeecccccccC
Q 018532          145 EYMDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--KG--EVKITDFGVSAMLG  217 (354)
Q Consensus       145 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~--~~kl~Dfg~a~~~~  217 (354)
                      |||.||+|...+++.   ..+++.+...++..+..||.|||. +||+||||||.||++-.  +|  ..||+|||.|+.+.
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            999999999999753   579999999999999999999996 99999999999999843  23  48999999999987


Q ss_pred             CCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-----
Q 018532          218 SSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-----  291 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  291 (354)
                      +.. ...+.+||+.|++||.+.. +.|+..+|.|||||++|+++||..||.......   +..+.+-.+....+.     
T Consensus       176 d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk---~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  176 DNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK---NNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             CCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc---ccchhhhhhhccCCCceeEe
Confidence            664 6778899999999999984 789999999999999999999999996544332   111222222221111     


Q ss_pred             --------------CCCCCCCCH----HHHHHHHHhhhhCCCCCC
Q 018532          292 --------------TAPPDQFSP----EFCSFVSACIQKDPRDRS  318 (354)
Q Consensus       292 --------------~~~~~~~~~----~l~~li~~~l~~~p~~Rp  318 (354)
                                    ...+..++.    .+..++..+|..+|++|.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                          111222333    355788889999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=9.6e-40  Score=267.80  Aligned_cols=262  Identities=21%  Similarity=0.401  Sum_probs=209.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeec--CeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHN--GVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~--~~~~  141 (354)
                      ..++|++++++|+|.+++|+.+.+..+++.++||+++.-    ..+.+.+|++|+..+. |+||+.+++...+.  ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            578999999999999999999999999999999998642    2467899999999996 99999999988764  5678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  220 (354)
                      +|+||+++.+...+.   ..++.-.+..++.+++.||.|||+ .||+|||+||.|+++|... .++|+|+|+|..+... 
T Consensus       112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  186 (338)
T ss_pred             hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence            999999988777665   458889999999999999999999 9999999999999998764 6999999999887543 


Q ss_pred             CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcC-CChhhHHHH---------HHH-----
Q 018532          221 GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ-QSWPSFYEL---------LEA-----  284 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~---------~~~-----  284 (354)
                      ....-.+.+..|--||.+..- .|+..-|+|||||++..|+..+-||....+. ++...+...         +.+     
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            334445778889999998764 5899999999999999999999998654432 221111110         000     


Q ss_pred             ------HHcC----CC----CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          285 ------IVES----PP----PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       285 ------~~~~----~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                            +...    ..    ......-.++++.||+.++|.+|-.+|+|+.|++.||||....+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence                  0000    00    011112246899999999999999999999999999999876543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.6e-38  Score=297.70  Aligned_cols=268  Identities=22%  Similarity=0.232  Sum_probs=191.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEc----------------cCCcEEEEEEeeccccHHH-------------HHHHH
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK----------------WVGRLFALKIIQMNIQEEI-------------RKQIV  113 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~-------------~~~~~  113 (354)
                      .+..++|.+.++||+|+||+||++...                ..++.||||.+........             .....
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            456889999999999999999998642                3456799999865432111             11233


Q ss_pred             HHHHHHhhcCCCce-----EEeeeeee--------ecCeEEEEEeccCCCCHHHHHHHhC--------------------
Q 018532          114 QELKINQASQCSHV-----VVCYHSFY--------HNGVISLVLEYMDRGSLADIIRQVK--------------------  160 (354)
Q Consensus       114 ~e~~~~~~l~h~~i-----v~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~--------------------  160 (354)
                      .|+.++..++|.++     +.+++++.        ..+..++|+||+++++|.++++...                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            45666666666554     45555443        2457899999999999999886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC-cccccCCccccc
Q 018532          161 ----TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP  235 (354)
Q Consensus       161 ----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~gt~~y~aP  235 (354)
                          .+.+..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......... ....+|+.|+||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                13456788899999999999998 899999999999999999999999999997654322111 122347899999


Q ss_pred             ccccCCC--------------------CC--cchhHHHHHHHHHHHHcCCC-CCCCCCcCCC----hhhHHHHHHHHHcC
Q 018532          236 ERISGST--------------------YD--YSSDIWSLGLVVLECAIGRF-PYMQSEDQQS----WPSFYELLEAIVES  288 (354)
Q Consensus       236 E~~~~~~--------------------~~--~~~DiwslG~il~ell~g~~-pf~~~~~~~~----~~~~~~~~~~~~~~  288 (354)
                      |.+....                    |+  .+.||||+||++|+|++|.. ||........    .......++.....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9986432                    11  24799999999999999885 7653221110    01111112222233


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCC---CCCCCHHHHhcCccccc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDP---RDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~eil~hp~~~~  331 (354)
                      .......+..++...+|+.+||..+|   .+|+|++|+|+||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            33344456788999999999999866   68999999999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=309.10  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=218.2

Q ss_pred             ccccCcccccccccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYH  132 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~  132 (354)
                      .|++..++..+.+.||+|+||.|+++....       ....||||..+........+.+..|+.+++.+ .|+|++.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            577888888888999999999999887431       14569999998877777888999999999987 6999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      ++...+.+++|+||+..|+|.++++..+                .++..+...++.||+.|++||++ .+++||||...|
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARN  448 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhh
Confidence            9999999999999999999999998765                38888999999999999999998 889999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcCCC-cccc--cCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMGQR-DTFV--GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQ  272 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  272 (354)
                      ||+..+..+||+|||+|+......... ....  -+..|||||.+....|+.++||||+|++|||+++ |..||.+....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            999999999999999998654332221 1112  3557999999999999999999999999999998 99999774311


Q ss_pred             CChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                            .++.+ ....+.....|..+++++.++++.||+.+|++||++.++.+
T Consensus       529 ------~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 ------EELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ------HHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                  24444 44555566667788999999999999999999999998865

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-39  Score=294.19  Aligned_cols=258  Identities=27%  Similarity=0.413  Sum_probs=211.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC------CceEEeeeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC------SHVVVCYHSFYH  136 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------~~iv~~~~~~~~  136 (354)
                      +.--++|.+....|+|-||+|..|.+..-|..||||++..+.  -..+.=+.|+.||+.|+.      -|.++++..|..
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            344578999999999999999999999999999999998653  334556789999999853      578999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeeccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGV  212 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~  212 (354)
                      .+++|||+|-+. .+|.+++++.+   .+....+..++.|++.||..|.. .||+|.||||+||||++.. .+||||||.
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcc
Confidence            999999999996 59999999875   47788899999999999999997 9999999999999998765 689999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      |...+.  +....+..+..|.|||++.|.+|+...|+||.||+||||.||+..|.+..+.+....+.++     ++..+.
T Consensus       584 A~~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~-----KGk~p~  656 (752)
T KOG0670|consen  584 ASFASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL-----KGKFPN  656 (752)
T ss_pred             cccccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh-----cCCCcH
Confidence            987654  3344566778999999999999999999999999999999999999887765432222211     111110


Q ss_pred             ---------------------------------------CC----------CCCC-------CHHHHHHHHHhhhhCCCC
Q 018532          293 ---------------------------------------AP----------PDQF-------SPEFCSFVSACIQKDPRD  316 (354)
Q Consensus       293 ---------------------------------------~~----------~~~~-------~~~l~~li~~~l~~~p~~  316 (354)
                                                             .+          ...+       -..+.+|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence                                                   00          0011       234889999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 018532          317 RSSSLDLLSHPFIKK  331 (354)
Q Consensus       317 Rps~~eil~hp~~~~  331 (354)
                      |.|..++|+||||..
T Consensus       737 Rit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  737 RITVNQALKHPFITE  751 (752)
T ss_pred             cCCHHHHhcCCcccC
Confidence            999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=276.29  Aligned_cols=259  Identities=29%  Similarity=0.432  Sum_probs=208.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeee------cC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYH------NG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------~~  138 (354)
                      ..+|.-++.+|.|+- .|..|.+.-+++.||+|+....... ...++..+|..++..++|+|+++++.+|.-      ..
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            457888899999999 7888999899999999987544321 224667899999999999999999998864      34


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..|+|||+++. +|...+.  -.+.-+.+.+++.|++.|+.|||+ .||+||||||+||++..++.+||+|||+|+....
T Consensus        95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccCc
Confidence            78999999975 9999887  356677899999999999999998 9999999999999999999999999999987655


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH-----------HH---
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL-----------EA---  284 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------~~---  284 (354)
                      . -..+.++.|..|.|||++.+-.|...+||||+||++.||++|+..|.+.+.-++|..+.+.+           ..   
T Consensus       171 ~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 D-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             c-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            4 34456789999999999999889999999999999999999999998776555444333221           10   


Q ss_pred             -HHcCCCC-------CCCC----------C-CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          285 -IVESPPP-------TAPP----------D-QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       285 -~~~~~~~-------~~~~----------~-~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                       .....+.       ...+          . .-...+++++.+||-.||++|.|++++|.|||++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence             0110000       0000          0 1234588999999999999999999999999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=269.77  Aligned_cols=261  Identities=26%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVISLV  143 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv  143 (354)
                      +-.+.||.|+||.||.+.+..+|+.||+|++..-... -..+.+.+|++++...+|.|++..++..+..     ..+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4456899999999999999999999999987533221 2346788999999999999999988877643     357889


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC-
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  222 (354)
                      +|++. .+|..++-....++.+.++-+++||+.||+|||+ .+|.||||||.|.|++++..+||||||+++........ 
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            99996 4999888887889999999999999999999998 99999999999999999999999999999976543322 


Q ss_pred             CcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------H--------HH
Q 018532          223 RDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------E--------AI  285 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~--------~~  285 (354)
                      ...-+.|-+|+|||++.|.. |+.+.||||.||++.|++..+..|....+-+....+.+++        +        .+
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~  293 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV  293 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence            23346788999999999864 9999999999999999999999997766554433332221        1        11


Q ss_pred             HcCCC-CCCC--------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          286 VESPP-PTAP--------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       286 ~~~~~-~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ..... ++..        +..-..+..+++.++|..||++|.+..+.+.|++..+.
T Consensus       294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            11111 1111        11233468889999999999999999999999998763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=297.65  Aligned_cols=264  Identities=31%  Similarity=0.554  Sum_probs=228.9

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|+.+..+|+|+||.||+++++.+++..|+|+++.....+ .+-+.+|+-+++.-+|+||+.+++.|.....+++.|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            3578999999999999999999999999999999998865544 356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |||.||+|.+.-+-.+.+++.++.++++..+.|++|||+ .|-+|||||-.||++++.|.+|+.|||.+.+++.......
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999998888999999999999999999999998 8889999999999999999999999999999988778888


Q ss_pred             ccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCC
Q 018532          225 TFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFS  299 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  299 (354)
                      .+.||++|||||+..   .+.|...+|||++|+...|+-.-+.|.....+.+      .+.-.-..+..++  ......+
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHHhhccCCCCCcccCCccch
Confidence            999999999999863   4569999999999999999988888865544331      2222223333332  2345688


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +-+.+|++.+|.++|.+||+++.+|.|||+..-...+
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~r  281 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRR  281 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccchhhH
Confidence            9999999999999999999999999999998764433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=316.01  Aligned_cols=245  Identities=18%  Similarity=0.246  Sum_probs=189.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ..+...+.||+|+||.||+|++..++..||+|.++.....     ...|+.+++.++|||||++++++.+.+..++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            4556677899999999999999999999999998643221     12457788899999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--CCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN--ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +++|+|.++++   .+++..+..++.|++.||+|||.  ..+|+||||||+||+++.++..++. ||.+......    .
T Consensus       765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~  836 (968)
T PLN00113        765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----T  836 (968)
T ss_pred             CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----C
Confidence            99999999996   38889999999999999999993  1689999999999999999888776 6655433211    2


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH---------cCCCCC--C
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV---------ESPPPT--A  293 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~--~  293 (354)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....+......         ......  .
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhheeCccccCCCC
Confidence            2368899999999999999999999999999999999999995432211  11111111110         000000  0


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .......++.+++.+||+.||++|||+.|+++.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            011122357789999999999999999999875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=291.42  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=212.4

Q ss_pred             cccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +.+..++||+|+||+||++..--.|+    +||||++......+...+++.|+.++..+.|+|++++++++.... +.||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            44567899999999999988654444    589999987777777788999999999999999999999988766 8899


Q ss_pred             EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ++|+++|+|.++++.+ ..+-......|..||+.|+.|||. +.++||||...||||.+-..+||.|||+|.........
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999876 568888999999999999999997 88999999999999999999999999999988765544


Q ss_pred             Ccc--cccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          223 RDT--FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       223 ~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      ...  ..-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....       + +....+.+.....|..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------e-I~dlle~geRLsqPpiCt  926 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------E-IPDLLEKGERLSQPPICT  926 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------H-hhHHHhccccCCCCCCcc
Confidence            332  234678999999999999999999999999999997 99999877543       2 333334444466677899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .++..++.+||..|++.||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=273.05  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=194.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh--cCCCceEEeeeeeeecC----e
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA--SQCSHVVVCYHSFYHNG----V  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~iv~~~~~~~~~~----~  139 (354)
                      ......++.||+|.||.||+|+..  ++.||||++..    +..+.+..|-.|...  ++|+||+++++.-....    .
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            566788899999999999999865  79999999864    345566777776665  69999999998765544    8


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceecCCCCCCEEEccCCcEEEeecc
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE--------RHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                      ++||++|.+.|+|.+++.. ..+++.....++..+++||+|||++        .+|+|||||..||||.+++++.|+|||
T Consensus       283 ywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            9999999999999999987 6789999999999999999999974        249999999999999999999999999


Q ss_pred             cccccCCCcCC--CcccccCCcccccccccCCC-CC-----cchhHHHHHHHHHHHHcCCCCCC-C-CCcCC--------
Q 018532          212 VSAMLGSSMGQ--RDTFVGTYNYMSPERISGST-YD-----YSSDIWSLGLVVLECAIGRFPYM-Q-SEDQQ--------  273 (354)
Q Consensus       212 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~~pf~-~-~~~~~--------  273 (354)
                      +|..+......  .-.-+||.+|||||++.+.. +.     .+.||||+|.+||||+++..-+. + ..+.+        
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99987643322  22358999999999998753 22     35899999999999998664332 1 11111        


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHH
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQ-----FSPEFCSFVSACIQKDPRDRSSSL  321 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~  321 (354)
                      .-+.+.++....+.....+..++.     -...+++.+..||+.|++.|.|+.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            122344445555554444444432     245689999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=269.10  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=194.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh--cCCCceEEeeeeeeec----Ce
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA--SQCSHVVVCYHSFYHN----GV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~iv~~~~~~~~~----~~  139 (354)
                      ..+..+.+.||+|.||+||+++.+  |+.||||++....    .+...+|.+|.+.  ++|+||+.++.+-..+    ..
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            356778899999999999999865  9999999985432    2345566666655  7999999998765432    37


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE-------RHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ++||++|.+.|+|+++|.+ ..++.+...+++..++.||++||.+       ..|.|||||..||||.++|.+-|+|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            9999999999999999998 7899999999999999999999963       3499999999999999999999999999


Q ss_pred             ccccCCCcC----CCcccccCCcccccccccCCC----C-C-cchhHHHHHHHHHHHHcC----------CCCCCCCCcC
Q 018532          213 SAMLGSSMG----QRDTFVGTYNYMSPERISGST----Y-D-YSSDIWSLGLVVLECAIG----------RFPYMQSEDQ  272 (354)
Q Consensus       213 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwslG~il~ell~g----------~~pf~~~~~~  272 (354)
                      |........    .....+||.+|||||++....    + + ..+||||||.++||++..          ++||...-+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            987655432    234568999999999997753    2 2 358999999999999653          3788765443


Q ss_pred             CChhhHHHHHHHHHcCCCCCCCCCCCC-----HHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          273 QSWPSFYELLEAIVESPPPTAPPDQFS-----PEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +  +.+.++.+.+......+..+..+.     ..+..+++.||..||.-|.|+--+.+
T Consensus       443 D--Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  443 D--PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             C--CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            3  345455544444444444443332     24678899999999999999876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=292.92  Aligned_cols=245  Identities=28%  Similarity=0.363  Sum_probs=194.0

Q ss_pred             ccccccccCceEE-EEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEeccC
Q 018532           71 TIKVIGKGSGGVV-QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        71 ~~~~lg~G~~g~V-~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      -.+.+|.|+-|+| |++..  .|+.||||.+-    .+....+.+|+..++.. .|+|||++|+.=.+.+..|+..|.|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3457899999865 67764  59999999764    34456678999988876 79999999999899999999999997


Q ss_pred             CCCHHHHHHHh-CC---CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---C--CcEEEeecccccccCCC
Q 018532          149 RGSLADIIRQV-KT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---K--GEVKITDFGVSAMLGSS  219 (354)
Q Consensus       149 ~~~L~~~l~~~-~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~~  219 (354)
                      . +|.++++.. ..   ........+..|++.||++||+ .+||||||||.||||+.   +  .+++|+|||+++.+...
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            5 999999874 11   1113467789999999999999 99999999999999976   3  37999999999988644


Q ss_pred             cC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC-
Q 018532          220 MG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-  294 (354)
Q Consensus       220 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (354)
                      ..   ...+..||.+|+|||.+.+..-+.++|||||||++|+.++| ..||......+         ..+..+...... 
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTLVHL  735 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccceeee
Confidence            32   34566899999999999998888899999999999999985 89997654321         122222221111 


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ......++.+||.+|+.++|..||+|.++|.||||...
T Consensus       736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            11112289999999999999999999999999999763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=270.95  Aligned_cols=201  Identities=30%  Similarity=0.464  Sum_probs=177.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHH-----HHHHHHHHHHHhhcC---CCceEEeeeee
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEI-----RKQIVQELKINQASQ---CSHVVVCYHSF  134 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~-----~~~~~~e~~~~~~l~---h~~iv~~~~~~  134 (354)
                      .+.+|..++.+|.|+||.|++|.++.....|+||.+.++..  ...     .-.+-.|++|+..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            45679999999999999999999999999999999876421  111     112567899999987   99999999999


Q ss_pred             eecCeEEEEEecc-CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          135 YHNGVISLVLEYM-DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       135 ~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ++++++|++||-. +|.+|++++...+.++|.++..|++|++.|+++||+ .||||||||-+||+++.+|.+||+|||.|
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEeeccch
Confidence            9999999999975 578999999999999999999999999999999998 99999999999999999999999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQ  268 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~  268 (354)
                      ....+  .....++||..|.|||++.|..|- ..-|||+||++||.++....||..
T Consensus       718 a~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            76543  456778999999999999998874 568999999999999999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=253.81  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=212.6

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      ..+...++.....+-+|+||.||.+..+...     +.|-+|.++...+.-....++.|...+....|+|+..+.+....
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            4455677888889999999999999765433     33667777666666667788999999999999999999987765


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          137 -NGVISLVLEYMDRGSLADIIRQV--------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       137 -~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                       ....++++.+...|+|..++...        ..++..++..++.|++.|++|||+ .|+||.||...|.++++...+||
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhheeEEe
Confidence             45788899999889999999843        246667788899999999999998 99999999999999999999999


Q ss_pred             eecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHH
Q 018532          208 TDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEA  284 (354)
Q Consensus       208 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  284 (354)
                      +|=.+++.+......  ...--.+..||+||.+.+..|+.++|+||||+++|||+| |+.||...++.       + +..
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------E-m~~  509 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------E-MEH  509 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------H-HHH
Confidence            999999887543222  122245779999999999999999999999999999987 99999887764       3 344


Q ss_pred             HHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+.+.....|-++|+++..++.-||...|++||+++|+..
T Consensus       510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            55566677778899999999999999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.9e-33  Score=238.79  Aligned_cols=212  Identities=37%  Similarity=0.647  Sum_probs=189.6

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHH
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD  154 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  154 (354)
                      ||+|++|.||++....+++.+++|++...........+.+|+..++.+.|++++++++.+......++++|+++|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999999766543345678999999999999999999999999899999999999899999


Q ss_pred             HHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccCCCcCCCcccccCCcc
Q 018532          155 IIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMGQRDTFVGTYNY  232 (354)
Q Consensus       155 ~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  232 (354)
                      ++... ..++...+..++.+++.++.+||+ .|++|+||+|.||+++. ++.++|+|||.+..............+...|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            99875 478999999999999999999998 89999999999999999 8999999999998765443223345678899


Q ss_pred             cccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 018532          233 MSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ  311 (354)
Q Consensus       233 ~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  311 (354)
                      ++||.+... .++.++|+|++|+++++|                                        ..+.+++..|++
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHHHHHhh
Confidence            999999887 788999999999999998                                        578899999999


Q ss_pred             hCCCCCCCHHHHhcCc
Q 018532          312 KDPRDRSSSLDLLSHP  327 (354)
Q Consensus       312 ~~p~~Rps~~eil~hp  327 (354)
                      .+|++||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.7e-35  Score=261.18  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEcc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecC
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNG  138 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~  138 (354)
                      ....+.|..+++||.|+|++||++.+..   .++.||+|.+......   ..+..|++++..+ .+.||+++.+.+..++
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3456788999999999999999999887   7889999998654333   4588899988887 5789999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~  217 (354)
                      ...+|+||++.....++...   ++...+..+++.++.||.++|+ +|||||||||+|++.+. .+.-.|+|||+|....
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHHH
Confidence            99999999999888888754   6788899999999999999998 99999999999999986 4678999999987211


Q ss_pred             CCc-------------C-------------------------------CCcccccCCcccccccccCC-CCCcchhHHHH
Q 018532          218 SSM-------------G-------------------------------QRDTFVGTYNYMSPERISGS-TYDYSSDIWSL  252 (354)
Q Consensus       218 ~~~-------------~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl  252 (354)
                      ...             .                               ......||++|.|||++... ..+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            000             0                               01124699999999999875 47889999999


Q ss_pred             HHHHHHHHcCCCCCCCCCcCCC-hh------------------------------hHHHHH--------HHHHcCCC---
Q 018532          253 GLVVLECAIGRFPYMQSEDQQS-WP------------------------------SFYELL--------EAIVESPP---  290 (354)
Q Consensus       253 G~il~ell~g~~pf~~~~~~~~-~~------------------------------~~~~~~--------~~~~~~~~---  290 (354)
                      |+|+..++++.+||....+.-. ..                              .+.+..        +.+.....   
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999999976543311 00                              000100        00000000   


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          291 -PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       291 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                       .....+..+..+.+|+.+||..||.+|.|++++|+||||..+.+
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence             01112334568999999999999999999999999999997644

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=238.57  Aligned_cols=256  Identities=22%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hhcCCCceEEeee-eeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVVVCYH-SFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~h~~iv~~~~-~~~~~~~~~lv  143 (354)
                      .+.|.+.+.||+|.||.+.+|.|+.+...+++|.+.....  ..+.+.+|..-- ....|.||+..|+ .|+..+.++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4678999999999999999999999999999999876533  346677777643 3346899999886 56778899999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC--CcEEEeecccccccCCCcC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK--GEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||++.|+|.+-+.. ..+-+.....++.|+++|+.|+|+ .++||||||.+|||+-..  -++||||||.++..+.-..
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999988766 568888999999999999999998 889999999999999543  3799999999886654322


Q ss_pred             CCcccccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCC
Q 018532          222 QRDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAP  294 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  294 (354)
                      .   ..-+..|.|||.....     ...+.+|+|.||+++|.++||++||.......  +.+.+.. ++.....+  +..
T Consensus       179 ~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y~~~~-~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  179 Y---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPYWEWE-QWLKRKNPALPKK  252 (378)
T ss_pred             h---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chHHHHH-HHhcccCccCchh
Confidence            2   2345678899876442     25678999999999999999999997433221  1222322 22222221  222


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCC---CCHHHHhcCccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKK  331 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~hp~~~~  331 (354)
                      -..+++.+..+.++-|..++++|   -++++..+.-|...
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            24578999999999999999999   56666666777654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=7.3e-32  Score=233.32  Aligned_cols=199  Identities=33%  Similarity=0.560  Sum_probs=176.4

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccC
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.........+.+.+|+..++.++|+|++++++.+......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45678899999999999999988999999999765544356788899999999999999999999998899999999999


Q ss_pred             CCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-CCCccc
Q 018532          149 RGSLADIIRQVKT-ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-GQRDTF  226 (354)
Q Consensus       149 ~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  226 (354)
                      +++|.+++..... +++..+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999988766 8999999999999999999998 899999999999999999999999999998765442 122345


Q ss_pred             ccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018532          227 VGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGRFPYMQ  268 (354)
Q Consensus       227 ~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~  268 (354)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            778899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.4e-32  Score=279.36  Aligned_cols=195  Identities=19%  Similarity=0.190  Sum_probs=142.4

Q ss_pred             ceEEeeeee-------eecCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          126 HVVVCYHSF-------YHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       126 ~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      ||+.+++.+       .....+++++|++ +++|.+++... ..+++.++..++.||+.||.|||+ +||+||||||+||
T Consensus        34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHrDlKP~Ni  111 (793)
T PLN00181         34 YVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeeeccCCchhE
Confidence            555555555       2234677888988 56999999753 468999999999999999999998 9999999999999


Q ss_pred             EEccCC-------------------cEEEeecccccccCCCc----------------CCCcccccCCcccccccccCCC
Q 018532          198 LVNHKG-------------------EVKITDFGVSAMLGSSM----------------GQRDTFVGTYNYMSPERISGST  242 (354)
Q Consensus       198 ll~~~~-------------------~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~  242 (354)
                      ||+..|                   .+|++|||+++......                ......+||++|||||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            996544                   45556666654321100                0001235889999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 018532          243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD  322 (354)
Q Consensus       243 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  322 (354)
                      |+.++|||||||+||||++|..|+.....     .+......    ..+.... .......+++.+||+++|.+||++.|
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR----VLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh----hcChhhh-hcCHHHHHHHHHhCCCChhhCcChHH
Confidence            99999999999999999999888743211     11111111    1111111 12456778999999999999999999


Q ss_pred             HhcCcccccc
Q 018532          323 LLSHPFIKKF  332 (354)
Q Consensus       323 il~hp~~~~~  332 (354)
                      +++||||...
T Consensus       262 il~h~~~~~~  271 (793)
T PLN00181        262 LLQSEFINEP  271 (793)
T ss_pred             Hhhchhhhhh
Confidence            9999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=4.4e-31  Score=220.51  Aligned_cols=167  Identities=27%  Similarity=0.396  Sum_probs=130.0

Q ss_pred             CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          150 GSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       150 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      |+|.+++... +.+++..++.++.|++.||.|||+ .+      ||+||+++.++.+|+  ||++.......     ..|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceee--ccceEeecccc-----CCC
Confidence            6899999874 469999999999999999999998 65      999999999999999  99987654322     268


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC-CCCCCCCH--HHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSP--EFCSF  305 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~l~~l  305 (354)
                      |+.|||||++.+..++.++|||||||++|||++|+.||.......  ................. .....++.  ++.++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            999999999999999999999999999999999999996543321  11111111111110000 11122333  69999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.+||..+|++||++.++++|+|+...
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHHH
Confidence            999999999999999999999998653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.1e-32  Score=262.76  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=209.7

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEee----cc-ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ----MN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .....+|.|++|.|+.+........++.|.++    .. ........+..|+.+-..+.|+|++..+..+.......-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988888877777767776554    22 22333344788888889999999988888777766656669


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      |||++ +|+.++...+.++..++..++.|++.|+.|||+ .||.|||+|++|+++..+|.+||+|||.+.....+..   
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 999999987789999999999999999999998 9999999999999999999999999999987654433   


Q ss_pred             -CCcccccCCcccccccccCCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          222 -QRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       222 -~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                       .....+|+..|+|||++.+..|++. .||||.|++++.|++|++||......+.................+......++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             3456789999999999999999864 89999999999999999999776544321000000111111111222334578


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+.+.+|.+||+.||.+|.|+++|++.+||+.+..-
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            889999999999999999999999999999987653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-28  Score=220.85  Aligned_cols=252  Identities=23%  Similarity=0.245  Sum_probs=196.1

Q ss_pred             cccccccccccCceEEEEEEEccCC-cEEEEEEeeccccHHHHHHHHHHHHHHhhcC----CCceEEeeeee-eecCeEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVG-RLFALKIIQMNIQEEIRKQIVQELKINQASQ----CSHVVVCYHSF-YHNGVIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~----h~~iv~~~~~~-~~~~~~~  141 (354)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|..++..+.    .+++..+++.. ..+..-|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            7999999999999999999998775 67899987654322222 5677888777775    36888888888 4777899


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-----CcEEEeeccccc
Q 018532          142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-----GEVKITDFGVSA  214 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg~a~  214 (354)
                      +||+.+ |.+|.++....  +.++...+..++.|++.+|++||+ .|++||||||+|+++...     ..+.|.|||+|+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            999998 78999988654  579999999999999999999998 999999999999999765     369999999999


Q ss_pred             --ccCCCcC-------C-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHH
Q 018532          215 --MLGSSMG-------Q-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA  284 (354)
Q Consensus       215 --~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  284 (354)
                        .......       . ...+.||..|+++++..+...+.+.|+||++.++.+++.|..||.+.........+......
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3221111       1 22456999999999999999999999999999999999999999776543222222211111


Q ss_pred             HHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .....    .....+.++.++...+-..+...+|....+...
T Consensus       256 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111    233456788888888888899999999887664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=239.93  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=214.0

Q ss_pred             cccccCceEEEEEE---EccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEEeccC
Q 018532           74 VIGKGSGGVVQLVR---HKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        74 ~lg~G~~g~V~~~~---~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      ++|.|+||.|++++   ....|..||+|+.++.... ..+..-..|..++...+ |+.+|++...++.++..++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999998765   3346788999998765421 12224456667777776 9999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      ||+|...+.....+.+.....+...++.|++++|+ .+|+|||+|++||+++.+|.+++.|||+++..-.....    ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence            99999999888888899999999999999999998 99999999999999999999999999999876443222    99


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      |..|||||++.  .....+|.||+|++.++|++|..||..           +....+....  ...+..++..+.+++..
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~--~~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAE--LEMPRELSAEARSLFRQ  220 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhc--cCCchhhhHHHHHHHHH
Confidence            99999999998  568899999999999999999999966           2344444432  23356789999999999


Q ss_pred             hhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCCCCC
Q 018532          309 CIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       309 ~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      ++..+|.+|...     .++++|+||+.+.+.++.-....+++.|-+.+
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~  269 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSIT  269 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccc
Confidence            999999999765     79999999999999877665666666655443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=1.2e-26  Score=211.13  Aligned_cols=260  Identities=33%  Similarity=0.554  Sum_probs=209.4

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH--HHHHHHHHHHHHhhcCCC-ceEEeeeeeeecCeEEEEEe
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCS-HVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~-~iv~~~~~~~~~~~~~lv~e  145 (354)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.......  ....+.+|+.++..+.|+ +++.+++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667888999999999999987   889999987665443  467899999999999988 79999999987778899999


Q ss_pred             ccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcC
Q 018532          146 YMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  221 (354)
                      ++.++++.+++....   .+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999998777654   78999999999999999999998 8899999999999999998 799999999986544332


Q ss_pred             ------CCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-
Q 018532          222 ------QRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-  291 (354)
Q Consensus       222 ------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  291 (354)
                            ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||.......   ........+.....+ 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~  234 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELPTPS  234 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---cHHHHHHHHHhcCCcc
Confidence                  2456789999999999988   578899999999999999999999976654310   111222333222222 


Q ss_pred             C--CCCCCC----CHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          292 T--APPDQF----SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       292 ~--~~~~~~----~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .  ......    ...+.+++..|+..+|..|.+..+...++|.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            1  111111    2578999999999999999999999988776665443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8e-28  Score=219.83  Aligned_cols=166  Identities=16%  Similarity=0.159  Sum_probs=131.5

Q ss_pred             CcccccccccccccCceEEEEEEEcc-CCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..++|.+.+.||+|+||+||+|++.. +++.||||++....    .......+.+|+++++.++|+|++..+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            45679999999999999999999876 67888999865331    23345679999999999999999853322   256


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCC-CCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDI-KPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .|+||||++|++|... .   ...   ...++.|++.||.|||+ .||+|||| ||+|||++.++.+||+|||+|+....
T Consensus        93 ~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             cEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            8999999999999632 1   111   14678999999999998 99999999 99999999999999999999997654


Q ss_pred             CcCC--------CcccccCCcccccccccCC
Q 018532          219 SMGQ--------RDTFVGTYNYMSPERISGS  241 (354)
Q Consensus       219 ~~~~--------~~~~~gt~~y~aPE~~~~~  241 (354)
                      ....        ..+..+++.|+|||.+...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            3211        1345688899999998664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=198.61  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC-CceEEeeeeeeecCeEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC-SHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~l  142 (354)
                      +...+|.++++||+|+||.+|++....+|..||||+-....   ....+.-|.++.+.+.+ ..|..+..+..+...-.+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            34678999999999999999999999999999999865432   23457778888888865 567777777778888899


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeecccccccCC
Q 018532          143 VLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGS  218 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~  218 (354)
                      |||++ |.+|.++..-. +.++..++.-++-|++.-++|+|. ++.|||||||+|+|+.-+   ..+.|+|||+|+.+.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            99999 78999998754 679999999999999999999997 999999999999999654   4699999999998755


Q ss_pred             CcC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          219 SMG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       219 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ..+       ......||..|.+-....+...+.+.|+-|+|.+|.+..-|..||.+.........+ +.+.+.....+.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-EkI~EkK~s~~i  245 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-EKISEKKMSTPI  245 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-HHHHHhhcCCCH
Confidence            432       234567999999998888888899999999999999999999999887654322222 223333333344


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSS  320 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~  320 (354)
                      .......|.++.-.+.=|-..--++-|..
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            45567788899888888877777777775

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-27  Score=201.47  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      -.|.+.++||+|+||.++.+.+..++++||||.-.....   ..++..|.+..+.| ..++|...|.+..+..+-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            368899999999999999999999999999998654332   34567788877776 45888888888888888889999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-----cEEEeecccccccCCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-----EVKITDFGVSAMLGSS  219 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~a~~~~~~  219 (354)
                      ++ |.+|.++..-+ +.|+.+.+..++.|++.-++|+|+ +++|+|||||+|+||...+     .+.|+|||+|+.+.++
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            99 78999988755 579999999999999999999998 9999999999999997543     5999999999998765


Q ss_pred             cC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          220 MG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       220 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .+       ...+..||..||+-....+...+.+.|+-|||-++++.|-|.+||.+...... ...++.+-.-....+..
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRSTPIE  261 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhccccccCCHH
Confidence            43       34567899999999999999999999999999999999999999988654321 11112111111122222


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSS  320 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~  320 (354)
                      ....++|.++..-+.=.-..+-.+-|..
T Consensus       262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  262 VLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            3344567676666655555555555664

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=4e-26  Score=222.61  Aligned_cols=226  Identities=30%  Similarity=0.527  Sum_probs=173.3

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .-++|..++.|..|+||.||+++|+.+.+.+|+|+-+.+.       +.+-  ++.....+.               +| 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------ilRn--ilt~a~npf---------------vv-  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------ILRN--ILTFAGNPF---------------VV-  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccch-------hhhc--cccccCCcc---------------ee-
Confidence            4568889999999999999999999999999995422211       1100  222222222               22 


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                           |+-...++..+.++...        +.+++|||+ -||+|||+||+|.+|+.=|++|++|||++........   
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 45566666666666543        889999998 9999999999999999999999999999876432111   


Q ss_pred             ------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          222 ------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       222 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                                  .....+||+.|.|||++..+.|...+|+|++|+|+||.+.|+.||.+..++       +++.+++...
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-------elfg~visd~  274 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISDD  274 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------HHHhhhhhhh
Confidence                        123468999999999999999999999999999999999999999998776       3333333221


Q ss_pred             -CCCCCCCCCCHHHHHHHHHhhhhCCCCCC---CHHHHhcCcccccccccc
Q 018532          290 -PPTAPPDQFSPEFCSFVSACIQKDPRDRS---SSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~eil~hp~~~~~~~~~  336 (354)
                       .-+.....++++++++|.++|+.+|..|.   .+.++.+|+||+.+.+++
T Consensus       275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence             11122456789999999999999999995   467888999999999874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=2.2e-25  Score=195.63  Aligned_cols=232  Identities=21%  Similarity=0.287  Sum_probs=151.1

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcC----------CCceEEeeeeee
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQ----------CSHVVVCYHSFY  135 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~----------h~~iv~~~~~~~  135 (354)
                      .+.....||.|++|.||.+++..||+.+|+|++....  .....+.+.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456678999999999999999999999999985443  2233455555554333321          111222222211


Q ss_pred             ---------ec---C-----eEEEEEeccCCCCHHHHHHH---hCCC----CHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          136 ---------HN---G-----VISLVLEYMDRGSLADIIRQ---VKTI----LEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       136 ---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~----~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                               ..   +     +.+++|+-+. ++|.+++..   ....    .......+..|++..+++||+ .|++|+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd  170 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD  170 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence                     11   1     3467888885 488888653   2222    122234566999999999999 9999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccC--------CCCCcchhHHHHHHHHHHHHcCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--------STYDYSSDIWSLGLVVLECAIGR  263 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~  263 (354)
                      |+|+|++++.+|.++|+||+.....+.....   ...+..|.+||....        -.++.+.|.|+||+++|.|.||.
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999999988766543322   244578999997643        24788999999999999999999


Q ss_pred             CCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCC
Q 018532          264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR  317 (354)
Q Consensus       264 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  317 (354)
                      .||...........             ......++|+.+.+||..+|+.||++|
T Consensus       248 lPf~~~~~~~~~~~-------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99987655432211             122234789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=7.1e-25  Score=184.60  Aligned_cols=141  Identities=20%  Similarity=0.187  Sum_probs=109.8

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccH--H-----------------------HHHHHHHHHHHHhhcCCCc
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--E-----------------------IRKQIVQELKINQASQCSH  126 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-----------------------~~~~~~~e~~~~~~l~h~~  126 (354)
                      ...||+|+||.||+|.+. +|+.||+|+++.....  .                       .......|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999997 8999999999754211  0                       0123345888888887766


Q ss_pred             eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCCceecCCCCCCEEEccCCcE
Q 018532          127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL-HNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       127 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                      +...... .... .++||||++|+++.........++...+..++.|++.+|.++ |+ .||+||||||+||+++ ++.+
T Consensus        81 v~~p~~~-~~~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPI-LLKS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEE-EecC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE-CCcE
Confidence            5332222 2222 389999999887766544457889999999999999999999 66 8999999999999998 5889


Q ss_pred             EEeecccccccC
Q 018532          206 KITDFGVSAMLG  217 (354)
Q Consensus       206 kl~Dfg~a~~~~  217 (354)
                      +|+|||+|....
T Consensus       157 ~LiDFG~a~~~~  168 (190)
T cd05147         157 YIIDVSQSVEHD  168 (190)
T ss_pred             EEEEccccccCC
Confidence            999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-26  Score=224.01  Aligned_cols=242  Identities=22%  Similarity=0.218  Sum_probs=182.8

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++...+.||++.|=+|.+|++. .|. |+||++-+..   +-+...+.+.|++ ...+++||.+.+.-.-..+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6777889999999999999886 454 8999985443   2223344455555 56779999999888877888889999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  221 (354)
                      +|... +|.+.+....-+..-+.+.|+.||+.||..+|. .||+|||||.+|||++.-+.+.|+||..-+...-+..   
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            99976 999999887778888899999999999999998 9999999999999999999999999975543211111   


Q ss_pred             ----CCcccccCCcccccccccCC----------C-CCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCCh----hhHHHH
Q 018532          222 ----QRDTFVGTYNYMSPERISGS----------T-YDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSW----PSFYEL  281 (354)
Q Consensus       222 ----~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~----~~~~~~  281 (354)
                          ...+.....+|.|||.+...          . .+++.||||+||+++||++ |++||.-+.-....    ......
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence                11223345689999998542          1 5678999999999999987 89999533210000    000011


Q ss_pred             HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++++            -+..+++||..|++.||++|.|+++.|+.
T Consensus       259 Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111            24478999999999999999999999975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-24  Score=192.11  Aligned_cols=273  Identities=21%  Similarity=0.313  Sum_probs=192.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCc-----------------------------------EEEEEEe-ec--
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR-----------------------------------LFALKII-QM--  102 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----------------------------------~vaiK~~-~~--  102 (354)
                      +-.+..++|++...||+|.-..||.++...+|.                                   +.|||.+ +.  
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            445778999999999999999999888653221                                   1345543 11  


Q ss_pred             -cccHHHHHHHHHHHH-------H----------H-----hhcCCCceEEeeeeeee-----------------------
Q 018532          103 -NIQEEIRKQIVQELK-------I----------N-----QASQCSHVVVCYHSFYH-----------------------  136 (354)
Q Consensus       103 -~~~~~~~~~~~~e~~-------~----------~-----~~l~h~~iv~~~~~~~~-----------------------  136 (354)
                       +.+....+.+.+|.-       .          +     +.-+|||||++..+|.+                       
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence             112333444444431       0          0     11369999999988742                       


Q ss_pred             ----cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc--cCC--cEEEe
Q 018532          137 ----NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN--HKG--EVKIT  208 (354)
Q Consensus       137 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~--~~~--~~kl~  208 (354)
                          +..+|+||...+. +|.+++-. ...+.....-++.|+++|+.|||+ .||.|||+|.+|||+.  +++  .+.|+
T Consensus       311 g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             ccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEc
Confidence                3468999999875 99999876 567778888899999999999998 9999999999999984  444  48899


Q ss_pred             ecccccccCCC------cCCCcccccCCcccccccccCCC-----C-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChh
Q 018532          209 DFGVSAMLGSS------MGQRDTFVGTYNYMSPERISGST-----Y-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP  276 (354)
Q Consensus       209 Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  276 (354)
                      |||.+-.-...      .+..-..-|...-||||+....+     . -.++|.|+.|.+.||++....||.......-  
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--  465 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--  465 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--
Confidence            99976432221      11112234778899999986543     1 2479999999999999999999987432210  


Q ss_pred             hHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCH---HHHhc------Ccccccccccc-ccccccc
Q 018532          277 SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSS---LDLLS------HPFIKKFEDKD-IDLGILV  343 (354)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~eil~------hp~~~~~~~~~-~~~~~~~  343 (354)
                         + ... ......+..++.+++.+++++..+|+.||++|+|.   +.+++      |.|++...++. +++..|+
T Consensus       466 ---~-~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~~~~~~~wL  537 (598)
T KOG4158|consen  466 ---D-TRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKCGISQMTWL  537 (598)
T ss_pred             ---c-hhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccccHHHHHHH
Confidence               0 011 12223345577899999999999999999999995   45554      77888876655 4566554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=9e-24  Score=178.42  Aligned_cols=143  Identities=19%  Similarity=0.164  Sum_probs=111.9

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccH-----H--------------------HHHHHHHHHHHHhhcCCCc
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----E--------------------IRKQIVQELKINQASQCSH  126 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~--------------------~~~~~~~e~~~~~~l~h~~  126 (354)
                      .+.||+|+||.||+|.+. +|+.||||+++.....     +                    ....+..|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            567999999999999987 8999999998764210     0                    0122457888888888887


Q ss_pred             eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       127 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      +.........  ..++||||++|+++.........++...+..++.|++.++.++|++.||+||||||+||+++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            6433332222  24899999998765444333467888899999999999999999757899999999999998 89999


Q ss_pred             EeecccccccCC
Q 018532          207 ITDFGVSAMLGS  218 (354)
Q Consensus       207 l~Dfg~a~~~~~  218 (354)
                      |+|||+|.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.6e-24  Score=184.85  Aligned_cols=174  Identities=18%  Similarity=0.240  Sum_probs=133.5

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHH------HHHHHHHHhhcCCCceEEeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQ------IVQELKINQASQCSHVVVCYHSF  134 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~------~~~e~~~~~~l~h~~iv~~~~~~  134 (354)
                      .+-.++|.+.+.+|.|+||.||++..  ++..+|+|+++....  +.....      +.+|+..+..+.|+++..+.+.+
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            34568899999999999999999755  466899999975432  222222      57899999999999998888776


Q ss_pred             eec--------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          135 YHN--------GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       135 ~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      ...        +..+++|||++|.+|.++.    .+++    ....+++.++..||+ .|++|||+||+||+++++| ++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-EE
Confidence            533        3588999999999998873    2333    245699999999998 9999999999999999999 99


Q ss_pred             EeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHH
Q 018532          207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA  260 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  260 (354)
                      |+|||.......... .           ..+.....|+.++|+||||+++....
T Consensus       175 liDfg~~~~~~e~~a-~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA-K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh-H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            999998765422110 0           11344456778999999999987543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-25  Score=184.03  Aligned_cols=245  Identities=16%  Similarity=0.261  Sum_probs=194.0

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++.+++.+..+|.....|+.|+++..  |..++.|+++... .....+.+..|.-.++-..||||+.+++.+....++.+
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~  264 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI  264 (448)
T ss_pred             cchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence            45566777788999999999998854  6667788876432 34455678888888999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCC-ceecCCCCCCEEEccCCcEEEe--ecccccccC
Q 018532          143 VLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNHKGEVKIT--DFGVSAMLG  217 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~-iiH~Dlkp~NIll~~~~~~kl~--Dfg~a~~~~  217 (354)
                      +..|++.|+|+..++....  ....++..++.+++.|++|||+... |-..-|....+++|++.+++|+  |-.++-+  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--  342 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence            9999999999999987643  4567899999999999999999333 4445789999999999876664  4333321  


Q ss_pred             CCcCCCcccccCCcccccccccCCCCC---cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYD---YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                           ..+..-.|.||+||.++.++-+   .++|+|||++++||+.|...||....+.       +.-.++.-.+.....
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-------ecgmkialeglrv~i  410 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-------ECGMKIALEGLRVHI  410 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-------hhhhhhhhccccccC
Confidence                 1223457899999999887643   4799999999999999999999876654       333344444455566


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLL  324 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil  324 (354)
                      +..++..+..|+.-|+..||.+||.++.++
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            778999999999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=9.2e-23  Score=170.45  Aligned_cols=187  Identities=14%  Similarity=0.053  Sum_probs=138.8

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhhcCC-CceEEeeeeeeecCeEEEEEec
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---EEIRKQIVQELKINQASQC-SHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +...|++|+||+|+.+..  .+..++.+.+.....   .-....+.+|+++++.+.| +++..+++.    +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            456799999999997765  577788776654332   1123357899999999954 778888774    446999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCC-CCCCEEEccCCcEEEeecccccccCCCcCC---
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDI-KPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---  222 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---  222 (354)
                      +.|.+|...+..      . ...++.|++.+|.++|+ .||+|||| ||+|||++.+|.++|+|||+|.........   
T Consensus        80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            999998654321      1 13578899999999998 99999999 799999999999999999999865433221   


Q ss_pred             -C---------cccccCCcccccccccCC-CCC-cchhHHHHHHHHHHHHcCCCCCCCCCc
Q 018532          223 -R---------DTFVGTYNYMSPERISGS-TYD-YSSDIWSLGLVVLECAIGRFPYMQSED  271 (354)
Q Consensus       223 -~---------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~ell~g~~pf~~~~~  271 (354)
                       .         .-...++.|++|+...-. ..+ ...++++.|+.+|.++|+..++.+...
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence             0         001246677777654332 233 578999999999999999988765543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=9.9e-23  Score=202.32  Aligned_cols=200  Identities=27%  Similarity=0.328  Sum_probs=161.2

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHH--HHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR--KQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +++...+.|.|.+.||.|+||.||.|.+.. |+.||+|+-+....-++.  .+++..++   ..--+-|..+..++.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCC
Confidence            455667889999999999999999999987 999999997655433321  11211111   111233555566666677


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-------CCcEEEeecc
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-------KGEVKITDFG  211 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-------~~~~kl~Dfg  211 (354)
                      ..++|+||.+.|+|.++++..+.+.+..+..++.|++..++.||. .+||||||||+|.||..       .--++|+|||
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            788999999999999999988899999999999999999999998 99999999999999943       2359999999


Q ss_pred             cccccCC--CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 018532          212 VSAMLGS--SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP  265 (354)
Q Consensus       212 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  265 (354)
                      .|..+..  ........++|-.+-.+|...|..+++.+|.|.|+.+++.||.|++-
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9987642  23345567889999999999999999999999999999999999853

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.4e-21  Score=166.18  Aligned_cols=135  Identities=19%  Similarity=0.195  Sum_probs=107.3

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-----CCCceEEeeeeeeecC---eEE-
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-----QCSHVVVCYHSFYHNG---VIS-  141 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~---~~~-  141 (354)
                      -.+.||+|+||.||.  ++.++.. +||++...... ..+.+.+|+.+++.+     .|+||+++++++.++.   .++ 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            346799999999995  7777766 69998764322 346689999999998     6799999999998863   444 


Q ss_pred             EEEec--cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHhCCCceecCCCCCCEEEccC----CcEEEeecccc
Q 018532          142 LVLEY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGL-VYLHNERHVIHRDIKPSNLLVNHK----GEVKITDFGVS  213 (354)
Q Consensus       142 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a  213 (354)
                      +|+||  +.+++|.+++++ ..+++.  ..++.|++.++ +|||+ .+|+||||||+||+++.+    +.++|+||+.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  557999999976 446655  35678888777 89998 999999999999999743    37999995444

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1.3e-21  Score=170.24  Aligned_cols=144  Identities=21%  Similarity=0.131  Sum_probs=113.0

Q ss_pred             cccccccccccCceEEEEEE-EccCCcEEEEEEeeccccH-----------------------HHHHHHHHHHHHHhhcC
Q 018532           68 DLETIKVIGKGSGGVVQLVR-HKWVGRLFALKIIQMNIQE-----------------------EIRKQIVQELKINQASQ  123 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  123 (354)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|+++.....                       .....+..|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788899999999999998 6679999999998754210                       01234678999988887


Q ss_pred             CCc--eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceecCCCCCCEEEc
Q 018532          124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVN  200 (354)
Q Consensus       124 h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-iiH~Dlkp~NIll~  200 (354)
                      +.+  +...+.   . +..++||||++|.+|.........+....+..++.|++.++.+||+ .| ++||||||+||+++
T Consensus       109 ~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeE---e-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEEEE
Confidence            533  233332   2 2358999999998887765444556666778999999999999998 88 99999999999999


Q ss_pred             cCCcEEEeecccccccC
Q 018532          201 HKGEVKITDFGVSAMLG  217 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~  217 (354)
                       ++.++|+|||.|....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=6.2e-22  Score=181.49  Aligned_cols=177  Identities=26%  Similarity=0.462  Sum_probs=140.5

Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .++|+.|++|.-.+|.+++....   ..+......++.|++.|++|    ++.+|+|+||.||+...++.+||.|||+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhhee
Confidence            36889999999999999997543   45677889999999999999    669999999999999999999999999998


Q ss_pred             ccCCCc------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          215 MLGSSM------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       215 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      ......      .......||..||+||.+.+..|+.++||||||++|+|++. -...+.-.          ..+..+..
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r~  474 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIRD  474 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhhc
Confidence            765443      12345589999999999999999999999999999999987 33333211          22333444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      +..++....+.+ +-..|+.++|.+.|.+||++.+.--|+|.
T Consensus       475 g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  475 GIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            444433333333 45689999999999999988888878775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-22  Score=196.04  Aligned_cols=259  Identities=25%  Similarity=0.329  Sum_probs=209.4

Q ss_pred             cccccccccccccCceEEEEEEEcc-CCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNI-QEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...|.+.+.||+|+|+.|-.+.... ....+|.|.+.... .......+..|..+.+.+. |.|++..++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4567778889999999998777643 34557777665443 3445566677888888877 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-hCCCceecCCCCCCEEEccCC-cEEEeecccccccCC
Q 018532          143 VLEYMDRGSLADII-RQVK-TILEPYLAVVCKQVLQGLVYLH-NERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGS  218 (354)
Q Consensus       143 v~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  218 (354)
                      .+++.+|+++.+.+ .... ..+...+..++.|+..++.|+| . .++.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            99999999999988 5443 6778889999999999999999 6 9999999999999999999 999999999998766


Q ss_pred             -CcC--CCccccc-CCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc--CCCC
Q 018532          219 -SMG--QRDTFVG-TYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE--SPPP  291 (354)
Q Consensus       219 -~~~--~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  291 (354)
                       ...  .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||.........      ...+..  ....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~  251 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKGRFT  251 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeecccccccc
Confidence             222  2234578 99999999999854 467799999999999999999999776544311      111111  2223


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ...+..++....+++.+++..+|+.|.+..++-.++|+..
T Consensus       252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            4556788999999999999999999999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.2e-19  Score=155.84  Aligned_cols=135  Identities=21%  Similarity=0.295  Sum_probs=112.3

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc--H-----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--E-----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +.||+|++|.||++..  .|..+++|+......  .     .....+.+|+.++..+.|+++......+...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999986  678899998653221  1     123457889999999999888766666667778899999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      |++|++|.+++.....    ....++.+++.+|.++|+ .|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999875332    778899999999999998 9999999999999999 88999999998864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7.8e-20  Score=170.57  Aligned_cols=203  Identities=22%  Similarity=0.344  Sum_probs=156.4

Q ss_pred             hhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEE
Q 018532          120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL  198 (354)
Q Consensus       120 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIl  198 (354)
                      +.+.|.|+.++++...+...++.|.+||.-|+|.+.+... -.+..-....++++|+.||.|||+.....|+.++..|.+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL   81 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence            5678999999999999999999999999999999999873 456666777899999999999998333399999999999


Q ss_pred             EccCCcEEEeecccccccCC--CcCCCcccccCCcccccccccCCC-------CCcchhHHHHHHHHHHHHcCCCCCCCC
Q 018532          199 VNHKGEVKITDFGVSAMLGS--SMGQRDTFVGTYNYMSPERISGST-------YDYSSDIWSLGLVVLECAIGRFPYMQS  269 (354)
Q Consensus       199 l~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~~pf~~~  269 (354)
                      ++....+||+|||+......  .........-..-|.|||.+.+..       .+.+.|+||+|++++|+++...||...
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~  161 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR  161 (484)
T ss_pred             eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence            99999999999999876632  111111122345789999997742       466799999999999999999999765


Q ss_pred             CcCCChhhHHHHHHHHHcCCCC----CCC-CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          270 EDQQSWPSFYELLEAIVESPPP----TAP-PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......   .++...+......    ... ....++++..++..||..+|++||+++++-.
T Consensus       162 ~~~~~~---~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  162 NLVEDP---DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccCCh---HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            443322   2333333331211    111 1245668999999999999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.9e-19  Score=153.18  Aligned_cols=131  Identities=19%  Similarity=0.288  Sum_probs=105.7

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeeccc---c----HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---Q----EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      .||+|+||.||++.  .++..+++|+.....   .    ......+.+|++++..+.++++......+...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            38999999999998  467889999864321   1    11235678899999999887765444445566677899999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ++|++|.+++.....       .++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       789999999999998 9999999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.8e-19  Score=153.28  Aligned_cols=138  Identities=21%  Similarity=0.170  Sum_probs=107.6

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccH---------------------HHHHHHHHHHHHHhhcCCCc-
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE---------------------EIRKQIVQELKINQASQCSH-  126 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~e~~~~~~l~h~~-  126 (354)
                      |.+.+.||+|+||.||++... +|+.||||+++.+...                     ........|+.++..+.+.+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            667788999999999999875 8999999997653210                     01123567888888887764 


Q ss_pred             -eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          127 -VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       127 -iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                       +...++    ....+++|||++|++|..+...      .....++.+++.++.++|+ .|++||||||+||++++++.+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcCCCcE
Confidence             333332    3456899999999998765431      3456788999999999998 999999999999999999999


Q ss_pred             EEeecccccccCC
Q 018532          206 KITDFGVSAMLGS  218 (354)
Q Consensus       206 kl~Dfg~a~~~~~  218 (354)
                      +|+|||.+.....
T Consensus       165 ~liDfg~~~~~~~  177 (198)
T cd05144         165 YIIDWPQMVSTDH  177 (198)
T ss_pred             EEEECCccccCCC
Confidence            9999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2e-18  Score=168.18  Aligned_cols=136  Identities=18%  Similarity=0.215  Sum_probs=109.2

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeec-c-cc-----HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-N-IQ-----EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~-~~-----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|...+.||+|+||+||++...  +..+++|+... . ..     ......+.+|+++++.++|++++............
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3456789999999999998764  33445544321 1 11     11235688999999999999988777666666778


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+ .|++||||||+||++ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            89999999999999886        346789999999999998 999999999999999 678999999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=5.3e-18  Score=142.85  Aligned_cols=139  Identities=20%  Similarity=0.228  Sum_probs=97.3

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHH---------------------HHHHHHHHhhcCCCc--
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQ---------------------IVQELKINQASQCSH--  126 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~---------------------~~~e~~~~~~l~h~~--  126 (354)
                      .+.||+|+||+||+|.+. +++.||||+++.....  .....                     ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 8999999998754221  11110                     134455554443332  


Q ss_pred             eEEeeeeeeecCeEEEEEeccCCCCHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          127 VVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       127 iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                      +.+.+..    ...+++|||++|+.+.. .+.... . ...+..++.+++.++.++|++.||+|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            2333322    24589999999854321 111111 1 1668889999999999999758899999999999999 8999


Q ss_pred             EEeecccccccCC
Q 018532          206 KITDFGVSAMLGS  218 (354)
Q Consensus       206 kl~Dfg~a~~~~~  218 (354)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=6.8e-17  Score=140.92  Aligned_cols=135  Identities=16%  Similarity=0.261  Sum_probs=104.0

Q ss_pred             cccc-ccCceEEEEEEEccCCcEEEEEEeeccc------------cHHHHHHHHHHHHHHhhcCCCce--EEeeeeeeec
Q 018532           73 KVIG-KGSGGVVQLVRHKWVGRLFALKIIQMNI------------QEEIRKQIVQELKINQASQCSHV--VVCYHSFYHN  137 (354)
Q Consensus        73 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~h~~i--v~~~~~~~~~  137 (354)
                      ..|| .||.|+||.+...  +..++||.+....            .......+.+|+.++..+.|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4687 8899999988764  7789999885321            11234568889999999988775  5555543332


Q ss_pred             -C---eEEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          138 -G---VISLVLEYMDR-GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       138 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                       +   ..++|||+++| .+|.+++.. ..+++.    .+.|++.+|.+||+ .||+|+||||.|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence             2   23599999997 689988865 445544    35789999999998 9999999999999999999999999998


Q ss_pred             ccc
Q 018532          213 SAM  215 (354)
Q Consensus       213 a~~  215 (354)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=6.4e-18  Score=157.96  Aligned_cols=258  Identities=22%  Similarity=0.263  Sum_probs=197.7

Q ss_pred             cccccccccccc--cCceEEEEEEE--ccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           66 LEDLETIKVIGK--GSGGVVQLVRH--KWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      ...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.... ......-.+|+...+.+ .|.+.++.+..+.+.+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345567788999  99999999988  88999999998433222 11122233444444443 58899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHHhCCCceecCCCCCCEEEccC-CcEEEeecccc
Q 018532          140 ISLVLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVLQ----GLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVS  213 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a  213 (354)
                      .|+-+|+|. .+|..+...... +++..++..+.+...    ||.++|+ ++++|-|+||.||++..+ ...+++|||+.
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecCCccee
Confidence            999999995 688888877644 888899999999999    9999998 999999999999999999 88999999999


Q ss_pred             cccCCCcCCC-----cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          214 AMLGSSMGQR-----DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       214 ~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      ..+....-..     ....|...|++||...+ .++...|+|+||.++.+..++..+....... .|       ..+...
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W-------~~~r~~  341 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-SW-------SQLRQG  341 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-Cc-------cccccc
Confidence            8876543221     22267789999998876 5788999999999999999887665443211 11       111122


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..+.......+..+...+.+|++.+|-.|++++.+..|+++....-
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~  387 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF  387 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence            2333334456777888999999999999999999999999985443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=3.8e-17  Score=132.12  Aligned_cols=133  Identities=23%  Similarity=0.259  Sum_probs=110.0

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC--CceEEeeeeeeecCeEEEEEeccC
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC--SHVVVCYHSFYHNGVISLVLEYMD  148 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~  148 (354)
                      +++.||.|.++.||++...  +..+++|.......   ...+.+|+.++..+.+  .++.+++......+..++++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            4567999999999999975  37899999865543   4567788888888876  478888887777788999999999


Q ss_pred             CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC--CCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE--RHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       149 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      |+.+..+       +......++.+++.++.++|..  .+++|+|++|+||++++.+.++++|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777654       4556677899999999999973  3699999999999999989999999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.70  E-value=6.4e-16  Score=146.09  Aligned_cols=171  Identities=18%  Similarity=0.272  Sum_probs=137.7

Q ss_pred             EEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCH
Q 018532           85 LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE  164 (354)
Q Consensus        85 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  164 (354)
                      .+..+.++.+|.|.+++.+.. .....+.+.++.++.++||+|+++++.+..++.+|+|+|.+.  .|..++++.+   .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---K  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---H
Confidence            355667889999999887665 445667888899999999999999999999999999999994  8888887643   6


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCC
Q 018532          165 PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD  244 (354)
Q Consensus       165 ~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  244 (354)
                      .....-+.||+.||.+||+.++++|++|.-..|+|+..|..||++|-++...............-..|..|+.+....  
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence            677788999999999999778999999999999999999999999998876543332222222333566776654433  


Q ss_pred             cchhHHHHHHHHHHHHcCC
Q 018532          245 YSSDIWSLGLVVLECAIGR  263 (354)
Q Consensus       245 ~~~DiwslG~il~ell~g~  263 (354)
                      -..|.|.|||++++++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            4579999999999999993

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=4.6e-18  Score=166.82  Aligned_cols=269  Identities=23%  Similarity=0.338  Sum_probs=209.6

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +..+.+.+.+.+-+-+|++|.++.+.-..+|...++|+......  ....+.+..+-.++....+|.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            45667888889999999999999999888898888887643211  1111223333333333455666666655666778


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .+|+++|..+++|...++..+..+.+.+...+..+..++++||+ ..+.|+|++|.|++...+|..+++|||.....+..
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCccccccccccc
Confidence            99999999999999999998888888888888999999999998 77999999999999999999999999843322110


Q ss_pred             -------------------------------cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018532          220 -------------------------------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ  268 (354)
Q Consensus       220 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  268 (354)
                                                     ........||+.|.+||.+.+......+|+|++|++++|.++|..||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                           0001234689999999999999999999999999999999999999988


Q ss_pred             CCcCCChhhHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHH---HHhcCcccccccccccc
Q 018532          269 SEDQQSWPSFYELLEAIVE-SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL---DLLSHPFIKKFEDKDID  338 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~---eil~hp~~~~~~~~~~~  338 (354)
                      ...++.       .+.+.. ..+.+..+...+.++.+++...+..+|.+|..+.   ++-.|+||+...+..+.
T Consensus      1038 ~tpq~~-------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1038 ETPQQI-------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             cchhhh-------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            877632       222222 2233334556789999999999999999999987   88899999999998874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.61  E-value=1.2e-15  Score=146.12  Aligned_cols=144  Identities=23%  Similarity=0.340  Sum_probs=97.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH---------------------------------HHHHHH
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE---------------------------------EIRKQI  112 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------------~~~~~~  112 (354)
                      +.+|+. +.||+|++|.||+|+.+.+|+.||||+.+....+                                 +..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445666 7899999999999999988999999999754211                                 222233


Q ss_pred             HHHHH------HHhhc----CCCceEEeeeeeee-cCeEEEEEeccCCCCHHHH--HHHhC----CCCHHHHHHHHHHHH
Q 018532          113 VQELK------INQAS----QCSHVVVCYHSFYH-NGVISLVLEYMDRGSLADI--IRQVK----TILEPYLAVVCKQVL  175 (354)
Q Consensus       113 ~~e~~------~~~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~----~~~~~~~~~i~~qi~  175 (354)
                      .+|+.      ....+    .+.+.+.+-..+.+ .+.-++||||++|+++.++  +...+    .+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            33333      22222    23333444343332 4566799999999999874  23322    233344444555543


Q ss_pred             HHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeecccccccCC
Q 018532          176 QGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAMLGS  218 (354)
Q Consensus       176 ~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~  218 (354)
                             . .|++|+|+||.||+++.+|    .++++|||++..+..
T Consensus       278 -------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3 7799999999999999988    999999999987654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=1.2e-14  Score=137.58  Aligned_cols=141  Identities=21%  Similarity=0.284  Sum_probs=98.0

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHH---------------------------------HH------HHH
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI---------------------------------RK------QIV  113 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------~~------~~~  113 (354)
                      +.||+|++|.||+|+.+ +|+.||||+.+....+..                                 ..      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999975 799999999865432111                                 11      133


Q ss_pred             HHHHHHhhc----CCCceEEeeeeee-ecCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 018532          114 QELKINQAS----QCSHVVVCYHSFY-HNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQ-GLVYLHNERH  186 (354)
Q Consensus       114 ~e~~~~~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~LH~~~~  186 (354)
                      +|++.+..+    .+.+-+.+-..+. ..+.-++||||++|++|.++.... ...   ....++.+++. .+..+|. .|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~-~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR-DG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh-CC
Confidence            344433332    3333333333332 234568999999999998876532 122   23445666655 4678897 89


Q ss_pred             ceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       187 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|+|+||.||+++.+|.++++|||++..+..
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=6.1e-14  Score=117.34  Aligned_cols=140  Identities=17%  Similarity=0.171  Sum_probs=99.3

Q ss_pred             cccccccCceEEEEEEEcc------CCcEEEEEEeecccc---------------------HHHHHH----HHHHHHHHh
Q 018532           72 IKVIGKGSGGVVQLVRHKW------VGRLFALKIIQMNIQ---------------------EEIRKQ----IVQELKINQ  120 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~---------------------~~~~~~----~~~e~~~~~  120 (354)
                      ...||.|--+.||.|....      .+..+|||+++.+..                     ...++.    ..+|++.+.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998653      357899999864310                     011222    347888888


Q ss_pred             hcCCC--ceEEeeeeeeecCeEEEEEeccCCCCHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCCceecCCCCCC
Q 018532          121 ASQCS--HVVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYL-HNERHVIHRDIKPSN  196 (354)
Q Consensus       121 ~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~iiH~Dlkp~N  196 (354)
                      ++...  ++...+..    ..-++||||+.+..+.. .++. ..+++.....+..+++.+|..| |+ .|++|+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHH
Confidence            76432  33444432    44578999997644422 2222 3455666778889999999999 76 899999999999


Q ss_pred             EEEccCCcEEEeecccccccCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~  218 (354)
                      |+++ ++.+.|+|||.+.....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCCC
Confidence            9996 57899999999876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=6.9e-14  Score=115.71  Aligned_cols=127  Identities=15%  Similarity=0.149  Sum_probs=92.9

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE-EeeeeeeecCeEEEEEeccCCC
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV-VCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      ++.|+.|.++.||++...  +..|++|+.......  ......|+.+++.+.+.+++ +++..  .....++|||+++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCC
Confidence            356899999999999864  788999997554321  22356778877777554443 33333  233457999999998


Q ss_pred             CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-----VIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ++...     .   .....++.+++.+|..||+ .+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~-----~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-----D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc-----c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87643     0   1123457899999999998 66     49999999999998 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4e-14  Score=123.27  Aligned_cols=205  Identities=20%  Similarity=0.335  Sum_probs=142.9

Q ss_pred             HHhhcCCCceEEeeeeeeec-----CeEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh-CCCc
Q 018532          118 INQASQCSHVVVCYHSFYHN-----GVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHN-ERHV  187 (354)
Q Consensus       118 ~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~-~~~i  187 (354)
                      .+-.+.|.|+|+++.++.+.     ....++.||+..|+|..+|++.    ..+......+|+-||+.||.|||+ ...|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34456788999998877653     3578899999999999999864    467888899999999999999998 3459


Q ss_pred             eecCCCCCCEEEccCCcEEEeecccccccCCCc-----CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC
Q 018532          188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-----GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG  262 (354)
Q Consensus       188 iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  262 (354)
                      +|+++..+.|++..+|-+|+.---.... ....     .....-.+-++|.|||.=.....+..+|||++|....+|..+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888752111100 0000     011112456789999976666677899999999999999877


Q ss_pred             CCCCC-CCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          263 RFPYM-QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       263 ~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ..--. +......   -......+. +     .   -...-+.++.+|++..|..||++.+++-||-.-++.-.
T Consensus       279 Eiq~tnseS~~~~---ee~ia~~i~-~-----l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl  340 (458)
T KOG1266|consen  279 EIQSTNSESKVEV---EENIANVII-G-----L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL  340 (458)
T ss_pred             eeccCCCcceeeh---hhhhhhhee-e-----c---cCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence            64322 1111100   001111110 0     0   01123468899999999999999999999987665443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=3.2e-14  Score=133.31  Aligned_cols=250  Identities=21%  Similarity=0.190  Sum_probs=183.3

Q ss_pred             CcccccccccccccCceEEEEEEEc-cCCcEEEEEEeeccccHHH-HHHHHHHHHHHhh-cCCCceEEeeeeeeecCeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK-WVGRLFALKIIQMNIQEEI-RKQIVQELKINQA-SQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...+|..+..||.|.|+.|+.+..+ .++..|++|.......... ...-..|+.+... ..|.+++..+..+......|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567889999999999999987755 6788899998765442221 1223444444443 46889999999998888889


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-CcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~  220 (354)
                      +-.|||+++++...+.....+.+...+.+..|++.++.++|+ ..++|+|++|+||++..+ +..++.|||..+.+....
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccccccceec
Confidence            999999999888777554567788899999999999999997 889999999999999886 788999999987532211


Q ss_pred             CCCcccccCCccc--ccccccCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYM--SPERISGSTYDYSSDIWSLGLVVLECAIGRFP-YMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .   ...+.-+++  +++......+..+.|++|||..+.+.+++... ..+..           ...+..+..+.  ...
T Consensus       422 ~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------~~~i~~~~~p~--~~~  485 (524)
T KOG0601|consen  422 G---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------SLTIRSGDTPN--LPG  485 (524)
T ss_pred             c---cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------ceeeecccccC--CCc
Confidence            1   112333444  45555556788899999999999999988642 22211           11222222222  123


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ....+..+.+.+...++..||.+.++..|.=|..
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            3478889999999999999999999988865544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=4.3e-12  Score=102.84  Aligned_cols=132  Identities=20%  Similarity=0.277  Sum_probs=97.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEee-cc-----ccHH-HHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MN-----IQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----~~~~-~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ..+++|+-+.++.+..  -|..+++|.=. +.     .+.. .+....+|++++..+.--.|...+-...+.+...++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3588999999998854  45566666521 11     1222 23457888988888755454444444556777789999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      |++|..|.+++...       ...++..+-.-+.-||. .||+|+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998998888774       24577777788889998 9999999999999996655 99999999863

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.37  E-value=1.1e-11  Score=100.12  Aligned_cols=142  Identities=21%  Similarity=0.290  Sum_probs=103.5

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEe-----eccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-----~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .+..|-+|+-+.|+++..  .|+.+.||.=     +...  ..-.+++..+|++.+.+..--.|.-..-.+.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            456788999999998875  5888888752     1111  122356688899988776544443333345555666789


Q ss_pred             EeccCC-CCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeecccccc
Q 018532          144 LEYMDR-GSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAM  215 (354)
Q Consensus       144 ~e~~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  215 (354)
                      |||++| .++.+++...-  .........++.+|-..+.-||. ++|+|+||.++||++..+|.   +.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 58888887652  23333347889999999999998 99999999999999987763   68999999853

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=1.1e-11  Score=107.01  Aligned_cols=141  Identities=16%  Similarity=0.212  Sum_probs=101.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc--eEEeeeeeeec---CeEEEEEecc
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHN---GVISLVLEYM  147 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~~~~~---~~~~lv~e~~  147 (354)
                      +.||.|..+.||++... +|..+++|+............+..|+.++..+.+.+  +.+++......   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999875 367899999765432223456788999888886644  34455544442   3678999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN--------------------------------------------  183 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  183 (354)
                      +|.++.+.+.. ..++......++.+++.+|..||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99887665421 345666666677777777777763                                            


Q ss_pred             -----------CCCceecCCCCCCEEEcc--CCcEEEeecccccc
Q 018532          184 -----------ERHVIHRDIKPSNLLVNH--KGEVKITDFGVSAM  215 (354)
Q Consensus       184 -----------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~  215 (354)
                                 ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       133699999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=1.5e-12  Score=124.01  Aligned_cols=163  Identities=21%  Similarity=0.328  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC---------CcccccCCcccccccccCCC
Q 018532          172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---------RDTFVGTYNYMSPERISGST  242 (354)
Q Consensus       172 ~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~  242 (354)
                      .+++.|+.|+|...++||++|.|++|.++.+|.+||+.|+++.........         ..-......|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            345599999999889999999999999999999999999987655432111         01112456899999999988


Q ss_pred             CCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q 018532          243 YDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL  321 (354)
Q Consensus       243 ~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  321 (354)
                      .+.++|+||+||++|.+.. |+.-+.........     -......+........++++++.+=+.+++..++.-||++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            8999999999999999984 55444443322111     11122222233334578999999999999999999999999


Q ss_pred             HHhcCccccccccccccc
Q 018532          322 DLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       322 eil~hp~~~~~~~~~~~~  339 (354)
                      .++..|||....-+.+.+
T Consensus       261 ~l~~~~ff~D~~~~aLrf  278 (700)
T KOG2137|consen  261 LLLSIPFFSDPGLKALRF  278 (700)
T ss_pred             hhhcccccCCchhhhhhh
Confidence            999999999876655544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=4.7e-10  Score=103.83  Aligned_cols=213  Identities=19%  Similarity=0.216  Sum_probs=152.7

Q ss_pred             ceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeEEEEEeccCC-CCHHH
Q 018532           80 GGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVISLVLEYMDR-GSLAD  154 (354)
Q Consensus        80 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~  154 (354)
                      -.+.|++....+|..|++|.+.-.... .......-+..++++.|.|+|++.++|..    +..+++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            357899999999999999998322111 11123345677889999999999998873    5689999999875 57777


Q ss_pred             HHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          155 IIRQV---------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       155 ~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +--..               ...++..+|.++.|+..||.++|+ .|+..+-|.|.+|+++.+.+++|+..|+...+..+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            65321               235678999999999999999998 99999999999999999999999988876554332


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .            .  |-+.+   -.+-|.=.||.++..|.||..--...+..++     ..+..+         ...++
T Consensus       447 ~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-----s~~~~I---------~~~yS  495 (655)
T KOG3741|consen  447 P------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS-----SHLTRI---------TTTYS  495 (655)
T ss_pred             C------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHH-----HHHHHh---------hhhhh
Confidence            2            0  11111   2357999999999999999643211111110     001111         23578


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .++++++.-+...++++ -++.+++.+
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            88999999888888887 577777764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=2.8e-10  Score=94.90  Aligned_cols=127  Identities=21%  Similarity=0.248  Sum_probs=82.7

Q ss_pred             EEEEEEEccCCcEEEEEEeeccc-------------------------cHHHHHHHHHHHHHHhhcCCCc--eEEeeeee
Q 018532           82 VVQLVRHKWVGRLFALKIIQMNI-------------------------QEEIRKQIVQELKINQASQCSH--VVVCYHSF  134 (354)
Q Consensus        82 ~V~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~~  134 (354)
                      .||.|... .|..+|+|+.+...                         ..-......+|.+.|..+..-+  +.+.+.. 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48888874 67799999985321                         0112345788999999987664  4444432 


Q ss_pred             eecCeEEEEEeccC--CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          135 YHNGVISLVLEYMD--RGSLADIIRQVKTILEPYLAVVCKQVLQGLVY-LHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       135 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                       ..  -++||||++  |..+..+...  .++.+....++.+++..+.. +|. .||+|+||++.||+++++ .+.|+|||
T Consensus        79 -~~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   79 -NR--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             -ET--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             -eC--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEecC
Confidence             22  359999998  6556544332  22244567788888886666 566 999999999999999877 99999999


Q ss_pred             cccccC
Q 018532          212 VSAMLG  217 (354)
Q Consensus       212 ~a~~~~  217 (354)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.18  E-value=9.5e-10  Score=99.53  Aligned_cols=242  Identities=14%  Similarity=0.216  Sum_probs=152.2

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEE--------eeeeeeecCeEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV--------CYHSFYHNGVISL  142 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~--------~~~~~~~~~~~~l  142 (354)
                      ..+.||+|+-+.+|-.-.-  +. .+.|++.........+.. .|  +.+.-.||-+-.        +++. .....+.+
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~-a~--la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKV-AE--LAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHH-HH--hccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence            3457999999999865322  22 345888655433222211 11  111223332211        1111 12233778


Q ss_pred             EEeccCCCC-HHHHHH------HhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          143 VLEYMDRGS-LADIIR------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       143 v~e~~~~~~-L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      +|..+.|.. +..+..      ......+..+...++.++.+...||. .|.+-+|+.++|+|+++++.|.|.|=..-. 
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq-  165 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ-  165 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEccccee-
Confidence            888887642 222221      22346788899999999999999997 999999999999999999999999743221 


Q ss_pred             cCCCcCCCcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCCChhhHHH--H------
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQSWPSFYE--L------  281 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~--~------  281 (354)
                      +..........+|...|.+||.-.     +-.-+...|.|.||+++++++.| +.||.+..-....+.-.+  +      
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            223334445568999999999754     23356789999999999999885 999987532111111111  0      


Q ss_pred             -HHH---HHcCCCCCCCCCCCCHHHHHHHHHhhhh--CCCCCCCHH
Q 018532          282 -LEA---IVESPPPTAPPDQFSPEFCSFVSACIQK--DPRDRSSSL  321 (354)
Q Consensus       282 -~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~  321 (354)
                       ...   -....+...+..-+++.+..|..+|+..  ++.-|||++
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence             000   0111122233356789999999999986  466899985

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=9.6e-10  Score=97.14  Aligned_cols=129  Identities=16%  Similarity=0.061  Sum_probs=90.4

Q ss_pred             EEEEEEccCCcEEEEEEeeccccHHHHH----------HHHHHHHHHhhcCCCce--EEeeeeeee-----cCeEEEEEe
Q 018532           83 VQLVRHKWVGRLFALKIIQMNIQEEIRK----------QIVQELKINQASQCSHV--VVCYHSFYH-----NGVISLVLE  145 (354)
Q Consensus        83 V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~e~~~~~~l~h~~i--v~~~~~~~~-----~~~~~lv~e  145 (354)
                      |.++.  ..|+.|.||........+..+          .+.+|...+..+...+|  .....+...     ...-++|+|
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            44443  457789999764333222222          36788877766533222  222222221     235789999


Q ss_pred             ccCCC-CHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-------CCcEEEeeccccc
Q 018532          146 YMDRG-SLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-------KGEVKITDFGVSA  214 (354)
Q Consensus       146 ~~~~~-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-------~~~~kl~Dfg~a~  214 (354)
                      ++++. +|.+++...  ..........++.+++..+.-||+ .||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99875 799998653  345667778899999999999998 99999999999999975       4579999999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.06  E-value=1.7e-09  Score=93.06  Aligned_cols=136  Identities=18%  Similarity=0.195  Sum_probs=99.2

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeecccc---------------------HHHHHHHHHHHHHHhhcCCC--c
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---------------------EEIRKQIVQELKINQASQCS--H  126 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~e~~~~~~l~h~--~  126 (354)
                      .+...||-|--|.||.|.+. .|..+|||.-+....                     .-.+....+|..+|..+...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34578999999999999886 788999998643211                     11234577888888887655  4


Q ss_pred             eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       127 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      +.+.++    .+.-.+|||+++|..|...-     +..+....++..|+.-+..+-. .|+||+|+++-||+++++|.+.
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEecCCCEE
Confidence            444443    34557999999997775432     2344455566666666666555 8999999999999999999999


Q ss_pred             Eeeccccccc
Q 018532          207 ITDFGVSAML  216 (354)
Q Consensus       207 l~Dfg~a~~~  216 (354)
                      ++||--+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999776543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=3.4e-09  Score=90.50  Aligned_cols=105  Identities=16%  Similarity=0.147  Sum_probs=80.5

Q ss_pred             HHHHHHHHHHhhcCCCc--eEEeeeeeeec----CeEEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 018532          110 KQIVQELKINQASQCSH--VVVCYHSFYHN----GVISLVLEYMDR-GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH  182 (354)
Q Consensus       110 ~~~~~e~~~~~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH  182 (354)
                      ....+|...+..+...+  ....+.+....    ...++|+|++++ .+|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34667777665553322  22333333321    346899999987 489999987666777888899999999999999


Q ss_pred             hCCCceecCCCCCCEEEccCC---cEEEeecccccc
Q 018532          183 NERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAM  215 (354)
Q Consensus       183 ~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  215 (354)
                      . .||+|+|+++.|||++.++   .+.++||+.+..
T Consensus       136 ~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 D-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8 9999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.94  E-value=1.5e-10  Score=109.47  Aligned_cols=255  Identities=19%  Similarity=0.191  Sum_probs=178.1

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc-eEEeeeeeeecCeEEEEEecc
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH-VVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~-iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      +.....+++|+++.+++.+...+...+ .+++...      ....-++.++.+.+||| .+..++.+..+....+.++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            445566899999999999887666665 6666443      33455788899999999 788888888889999999999


Q ss_pred             CCC-C-HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          148 DRG-S-LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       148 ~~~-~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      .++ + ........-.+..-+...+.+.-..+++++|+ -.-+|+|    ||+..+ +..+..||+....+.... ...+
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t  389 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRT  389 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccc-cccccccccCCcccCccc-cccc
Confidence            876 2 21111111233444556677888899999998 4347888    777644 789999999988776543 4556


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC-CCCCCC-CCCCHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-PPTAPP-DQFSPEFC  303 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~l~  303 (354)
                      ..+|+.++|||+..++.+....|.|++|.--.+|.-|-+|-.......         ..+-.+. .+.... ...+....
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~---------~~~g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL---------PMIGNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc---------CCCCCCCCccccchhhhcCcccc
Confidence            789999999999999999999999999987777777777754422110         0000000 000000 11111222


Q ss_pred             -HHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccccCC
Q 018532          304 -SFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSL  346 (354)
Q Consensus       304 -~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~  346 (354)
                       ++...|+...|..|+....++.|.+|+.+.-+-=-..+|+-|.
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aaswIhp~  504 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAASWIHPS  504 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhccCcccceecccccCcc
Confidence             4677899999999999999999999998776554455666554

>PRK09902 hypothetical protein; Provisional

Probab=98.85  E-value=5.8e-08  Score=81.70  Aligned_cols=138  Identities=19%  Similarity=0.113  Sum_probs=97.5

Q ss_pred             ccccCceEEEEEEEccCCcEEEEEEeecccc-----HHHHHHHHHHHHHHhhcCCCc--eEEee-eeeee---cCeEEEE
Q 018532           75 IGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-----EEIRKQIVQELKINQASQCSH--VVVCY-HSFYH---NGVISLV  143 (354)
Q Consensus        75 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~h~~--iv~~~-~~~~~---~~~~~lv  143 (354)
                      -|+||.|-|+.....  |+.|-+|.-.....     .--...+.+|...+..+...+  +.... +....   .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            367999999987643  45677886431111     112456888888877764333  22222 11111   2246789


Q ss_pred             EeccCC-CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc--EEEeecccccc
Q 018532          144 LEYMDR-GSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAM  215 (354)
Q Consensus       144 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  215 (354)
                      +|-++| .+|.+++.+.  .+.+......++.+++.++.-||+ .|+.|+|+.+.||+++.+|.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 6899988763  345777778999999999999998 99999999999999987777  99999987654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.84  E-value=3.3e-08  Score=84.34  Aligned_cols=140  Identities=21%  Similarity=0.208  Sum_probs=92.6

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHH-----------------------HHHHHHHHHHHHhhcCCCc--e
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-----------------------IRKQIVQELKINQASQCSH--V  127 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~e~~~~~~l~h~~--i  127 (354)
                      ..|.+|--++||+|.. .++..+|+|+++......                       ...-..+|...|.++.-.+  +
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3678899999999876 468899999997543211                       0111455666665543222  2


Q ss_pred             EEeeeeeeecCeEEEEEeccCCCCH-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          128 VVCYHSFYHNGVISLVLEYMDRGSL-ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       128 v~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      .+.+.+    ..-.|||||+..... .=.|+. -.+..+++..+..+++..+.-|-...++||+||+.-|||+. ++.+.
T Consensus       133 P~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAF----RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceee----cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            222222    123589999854210 001111 12333467888889999998887668899999999999998 89999


Q ss_pred             EeecccccccCCC
Q 018532          207 ITDFGVSAMLGSS  219 (354)
Q Consensus       207 l~Dfg~a~~~~~~  219 (354)
                      |+|||-|.....+
T Consensus       207 iID~~QaV~~~hp  219 (268)
T COG1718         207 IIDVSQAVTIDHP  219 (268)
T ss_pred             EEECccccccCCC
Confidence            9999998766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=5.7e-08  Score=92.99  Aligned_cols=141  Identities=23%  Similarity=0.270  Sum_probs=90.8

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc---------------------------------HHHHHHH------H
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---------------------------------EEIRKQI------V  113 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------------~~~~~~~------~  113 (354)
                      ..|+.++-|.||.|+.+ +|+.||||+.+.+..                                 ++..+.+      .
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56999999999999987 599999999764421                                 1222222      2


Q ss_pred             HHHHHHhh----cCCCceEEeeeee-eecCeEEEEEeccCCCCHHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018532          114 QELKINQA----SQCSHVVVCYHSF-YHNGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERH  186 (354)
Q Consensus       114 ~e~~~~~~----l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  186 (354)
                      +|+..+..    .+...-+.+=..| .-.+.-.++|||++|..+.+..  +. ..++.+.+.....++.-  ..+-. .|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~-dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLR-DG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHh-cC
Confidence            33332222    2232233333333 2345668999999999998874  33 34553333332222211  11222 56


Q ss_pred             ceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       187 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999877654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=1.4e-07  Score=79.66  Aligned_cols=139  Identities=21%  Similarity=0.262  Sum_probs=86.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHH------HHHHHHH---HhhcCCCceEEeee
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQ------IVQELKI---NQASQCSHVVVCYH  132 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~------~~~e~~~---~~~l~h~~iv~~~~  132 (354)
                      +...+|.+.+++-......|.+..  -.|..+++|..+.....  .....      ..+++..   +..........++-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            345667777777777766665554  45788999987543211  10010      1222222   22222233333332


Q ss_pred             eee-----ecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          133 SFY-----HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       133 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                      +..     -....+++|||++|..|.+...    +.+    .++..+..++.-||+ .|+.|+|.+|.|+++++++ +++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~-i~i  175 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG-IRI  175 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc-EEE
Confidence            222     1235568999999988876532    232    245667788999998 9999999999999998555 999


Q ss_pred             eeccccc
Q 018532          208 TDFGVSA  214 (354)
Q Consensus       208 ~Dfg~a~  214 (354)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.74  E-value=2.2e-07  Score=94.05  Aligned_cols=209  Identities=22%  Similarity=0.293  Sum_probs=148.3

Q ss_pred             HHHHHHHHHHHhhcCCCceEEeeeeeeecCe----EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018532          109 RKQIVQELKINQASQCSHVVVCYHSFYHNGV----ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE  184 (354)
Q Consensus       109 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  184 (354)
                      .....-|...+....|+|++.++.+......    +.+..++|.+.++...++.....+....+.+..++..|+.|+|+ 
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            3444556667778899999999887654432    33566889999999999998999999999999999999999998 


Q ss_pred             CCceecCCCCC---CEEEccCCcEEEe--ecccccccCCCcCCCcccccCCcccccccccCCCCCcc--hhHHHHHHHHH
Q 018532          185 RHVIHRDIKPS---NLLVNHKGEVKIT--DFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS--SDIWSLGLVVL  257 (354)
Q Consensus       185 ~~iiH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~il~  257 (354)
                      ....|.-+..+   +--.+..+.+.++  ||+.+......... .....+..+.|+|......++.+  .|+|++|..+.
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            54444444433   3333455666666  88888766544322 22345567788888887765544  79999999999


Q ss_pred             HHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       258 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      .+..|..+-....          ....+        .+........+++.+|+.-++++|+++.+++.|+|.+-..+...
T Consensus       384 ~~~~~~~i~~~~~----------~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA----------VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhcCccccccc----------chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            9998765432111          01111        11112226788999999999999999999999999987655544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=8.2e-07  Score=76.86  Aligned_cols=134  Identities=16%  Similarity=0.204  Sum_probs=81.0

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc--eEEeeeeeeecCeEEEEEeccCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      ..||.|..+.||+.    .+..+++|........   ..+.+|.++++.+...+  +.+.+......+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            46899999999974    2556788987654322   33577888887765433  345566666667788999999986


Q ss_pred             C-HHHHH---------------------HHh--CCCCHHH-HHHHHH----------HHHHH-HHHHH--h-CCCceecC
Q 018532          151 S-LADII---------------------RQV--KTILEPY-LAVVCK----------QVLQG-LVYLH--N-ERHVIHRD  191 (354)
Q Consensus       151 ~-L~~~l---------------------~~~--~~~~~~~-~~~i~~----------qi~~~-l~~LH--~-~~~iiH~D  191 (354)
                      + +...+                     +..  ....... ...+..          .+... ..+|.  . ...++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111                     000  0011000 000100          01111 11222  1 23478999


Q ss_pred             CCCCCEEEccCCcEEEeeccccc
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      +.|.||++++++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=1.5e-06  Score=75.28  Aligned_cols=138  Identities=22%  Similarity=0.266  Sum_probs=79.9

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC--ceEEeeeee---eecCeEEEEEec
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS--HVVVCYHSF---YHNGVISLVLEY  146 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~--~iv~~~~~~---~~~~~~~lv~e~  146 (354)
                      ++.|+.|..+.||.+....  ..+++|+....   .....+.+|..+++.+...  .+..++...   ......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            3568999999999998764  48999987544   3445667777777666433  234444422   234468999999


Q ss_pred             cCCCCHHH----------------HHH---Hh-CC---CCHHH---------H-----HHH-------HHHHHH-HHHHH
Q 018532          147 MDRGSLAD----------------IIR---QV-KT---ILEPY---------L-----AVV-------CKQVLQ-GLVYL  181 (354)
Q Consensus       147 ~~~~~L~~----------------~l~---~~-~~---~~~~~---------~-----~~i-------~~qi~~-~l~~L  181 (354)
                      ++|..+..                .+.   .. ..   +....         .     ...       ...+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99987777                111   11 00   01000         0     000       111222 23333


Q ss_pred             Hh------CCCceecCCCCCCEEEc-cCCcEEEeeccccc
Q 018532          182 HN------ERHVIHRDIKPSNLLVN-HKGEVKITDFGVSA  214 (354)
Q Consensus       182 H~------~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~  214 (354)
                      ++      ...++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            32      24599999999999999 66777899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=2.2e-06  Score=69.43  Aligned_cols=133  Identities=23%  Similarity=0.238  Sum_probs=90.6

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      .....+.||+|++|.||++..  .|..+|+|+-+.+   +.+..+..|++++..+...++..-...+   +..++.|||+
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i   94 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYI   94 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhh
Confidence            345667899999999999985  4779999986543   4457789999999998887765433222   2234559999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCC-CCCEEEccCCcEEEeeccccccc
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK-PSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlk-p~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +|.+|.++....   ...    -+..++.+---|- ..||-|+.|+ |...++..++.+.|+||..|+..
T Consensus        95 ~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---DRK----HLLRVLEKAYKLD-RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---cHH----HHHHHHHHHHHHH-HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            998887765431   112    2233444433343 4788888876 44455556669999999998744

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.33  E-value=8e-06  Score=71.63  Aligned_cols=134  Identities=16%  Similarity=0.052  Sum_probs=79.3

Q ss_pred             ccccCc-eEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSG-GVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      |-.|.. +.||++...  +..+.+|+.....    ...+.+|+.+++.+. +-.+.+++......+..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            445555 788988653  4678888875432    234567887777663 23344666666555678899999999777


Q ss_pred             HHHHH----------------HhCCCCH----------HHHHHHHH-------------------HHHHHHHHHHh----
Q 018532          153 ADIIR----------------QVKTILE----------PYLAVVCK-------------------QVLQGLVYLHN----  183 (354)
Q Consensus       153 ~~~l~----------------~~~~~~~----------~~~~~i~~-------------------qi~~~l~~LH~----  183 (354)
                      .....                +-..++.          ........                   .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64320                0001100          00000000                   01111122211    


Q ss_pred             --CCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          184 --ERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       184 --~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                        ...++|+|+.|.||++++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              1348999999999999998888999999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=7.2e-06  Score=78.56  Aligned_cols=141  Identities=21%  Similarity=0.289  Sum_probs=88.6

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeecccc------------------------------HHHHHHH------HHHH
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ------------------------------EEIRKQI------VQEL  116 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~~~~------~~e~  116 (354)
                      +.||.-+.|.||+|+.+. |+.||||+-+....                              ++..+.+      .+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999985 99999998653311                              1222222      2333


Q ss_pred             H----HHhhcCCCc---eEEeeeeeee-cCeEEEEEeccCCCCHHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018532          117 K----INQASQCSH---VVVCYHSFYH-NGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERH  186 (354)
Q Consensus       117 ~----~~~~l~h~~---iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  186 (354)
                      +    +.+.+.|-+   -|.+=.+|.+ ...-.|+|||++|..+.+.-  .+ ..++...+...+.+...-.- +  ..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qI-f--~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQI-F--KTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHH-H--hcC
Confidence            2    233344544   2223233322 34668999999998776543  33 34555444443333322222 2  256


Q ss_pred             ceecCCCCCCEEEcc----CCcEEEeecccccccCC
Q 018532          187 VIHRDIKPSNLLVNH----KGEVKITDFGVSAMLGS  218 (354)
Q Consensus       187 iiH~Dlkp~NIll~~----~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|+|=+|.||++..    ++.+.+.|||+......
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999984    56899999999876643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.28  E-value=7.6e-06  Score=84.19  Aligned_cols=80  Identities=15%  Similarity=0.202  Sum_probs=54.7

Q ss_pred             cccccccCceEEEEEEEccCC--cEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCce--EEeeeeeeec---CeEEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVG--RLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHV--VVCYHSFYHN---GVISLV  143 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i--v~~~~~~~~~---~~~~lv  143 (354)
                      ++.++.|.+..+|++.....+  ..+++|+............+.+|+++++.+. |.++  .+++..+.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            466899999999998765432  4678887654322122346789999998885 5554  5666655443   568899


Q ss_pred             EeccCCCC
Q 018532          144 LEYMDRGS  151 (354)
Q Consensus       144 ~e~~~~~~  151 (354)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=6.6e-06  Score=71.78  Aligned_cols=73  Identities=8%  Similarity=-0.042  Sum_probs=43.6

Q ss_pred             ccccccCceE-EEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC---ceEEeeeeeeec---CeEEEEEe
Q 018532           73 KVIGKGSGGV-VQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS---HVVVCYHSFYHN---GVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~---~iv~~~~~~~~~---~~~~lv~e  145 (354)
                      +.|+.|+... ||++     +..+++|+.+...   ....+.+|.+++..+...   .+...+......   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            4578777775 8876     2347788755422   234678888888776432   223333322221   24588999


Q ss_pred             ccCCCCHH
Q 018532          146 YMDRGSLA  153 (354)
Q Consensus       146 ~~~~~~L~  153 (354)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.23  E-value=1.2e-05  Score=72.48  Aligned_cols=144  Identities=19%  Similarity=0.212  Sum_probs=96.7

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccc------------------------cH-HHHHHHHHHHHHHhhcCCCc
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI------------------------QE-EIRKQIVQELKINQASQCSH  126 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------~~-~~~~~~~~e~~~~~~l~h~~  126 (354)
                      -..|..|--+.||.|... +|..+|||+++.+.                        .. -...-...|++.+.+++...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            356788899999998875 78889999986431                        00 11223566777777765544


Q ss_pred             eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEE
Q 018532          127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK  206 (354)
Q Consensus       127 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  206 (354)
                      |... .-..- ..-.|||+|+....-..-.-+.-.++...+..+-.|++.-+.-|-+..++||.||+--|+|+ .+|.+.
T Consensus       228 IP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  228 IPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             CCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence            3211 11111 12358999995321111111123577778888889999999888877889999999999999 568899


Q ss_pred             EeecccccccCCC
Q 018532          207 ITDFGVSAMLGSS  219 (354)
Q Consensus       207 l~Dfg~a~~~~~~  219 (354)
                      |+|-+-+.....+
T Consensus       305 iIDVSQSVE~DHP  317 (520)
T KOG2270|consen  305 IIDVSQSVEHDHP  317 (520)
T ss_pred             EEEccccccCCCh
Confidence            9999988765443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.14  E-value=5.2e-07  Score=93.46  Aligned_cols=214  Identities=11%  Similarity=-0.005  Sum_probs=143.9

Q ss_pred             HHHHHHHHHHhhcCCCceEEeeeeeee--cCeEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh
Q 018532          110 KQIVQELKINQASQCSHVVVCYHSFYH--NGVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHN  183 (354)
Q Consensus       110 ~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~  183 (354)
                      +....|..-++...|+++...+.-...  +...+..++++.+|.+.+.+-++    ..+....+.....+.+.+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334444445556688888777665543  34677899999999999998764    223333344444454777777776


Q ss_pred             CCC----ceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHH
Q 018532          184 ERH----VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC  259 (354)
Q Consensus       184 ~~~----iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  259 (354)
                      ..+    .+|+++|+.|.++..+-++|++++|+.+.............+++.|++|+....-.++.++|+|..|+.+|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            333    6899999999999999999999999998555555556667889999999999888889889999999999999


Q ss_pred             HcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       260 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ..|..+|...        ....+..+.........+.-.|.+.......+|-..-.+||.-...+.-+.+.-
T Consensus      1434 s~~n~~fi~f--------lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1434 SDGNAYFIFF--------LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             hcccHHHHHH--------HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            8888776211        001111122222222222222344444445555555677888887777665543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=7.3e-05  Score=63.02  Aligned_cols=131  Identities=21%  Similarity=0.326  Sum_probs=88.4

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc---------------cHHHHHHHHHHHHHHhhc------CCCceEEee
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---------------QEEIRKQIVQELKINQAS------QCSHVVVCY  131 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~~~~l------~h~~iv~~~  131 (354)
                      ..||+|+.=.||.  |. ......||+.....               .....++..+|+.-...+      .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4699999999985  33 33345789887654               011234455555544443      378899999


Q ss_pred             eeeeecCeEEEEEeccCC------CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC--
Q 018532          132 HSFYHNGVISLVLEYMDR------GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG--  203 (354)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--  203 (354)
                      |..+++.-+.+|+|.+.+      .+|.+++.+ +.+++ .....   +-.-..||-+ .+|+.+|++|.||++..++  
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLD-HHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHH-cCCeecCCCcccEEEEecCCC
Confidence            999999888999998632      468888855 45655 33333   3344556666 7799999999999996543  


Q ss_pred             --cEEEee-ccc
Q 018532          204 --EVKITD-FGV  212 (354)
Q Consensus       204 --~~kl~D-fg~  212 (354)
                        .+.|+| ||.
T Consensus       158 ~~~lvlIDG~G~  169 (199)
T PF10707_consen  158 EFRLVLIDGLGE  169 (199)
T ss_pred             ceEEEEEeCCCC
Confidence              477777 454

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=0.00014  Score=61.00  Aligned_cols=126  Identities=25%  Similarity=0.371  Sum_probs=87.6

Q ss_pred             ccccccccccccCc-eEEEEEEEccCCcEEEEEEeec---cc-------cH----------HHHHHHHHHHHHHhhc---
Q 018532           67 EDLETIKVIGKGSG-GVVQLVRHKWVGRLFALKIIQM---NI-------QE----------EIRKQIVQELKINQAS---  122 (354)
Q Consensus        67 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~-------~~----------~~~~~~~~e~~~~~~l---  122 (354)
                      .+++.++.||.|.- |.||+++..  |+.||+|+++.   ..       ..          ....-+..|.+...++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67888999999999 999999864  88999999421   00       00          1223477788765554   


Q ss_pred             CCCce--EEeeeeeeec------------------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 018532          123 QCSHV--VVCYHSFYHN------------------GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH  182 (354)
Q Consensus       123 ~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH  182 (354)
                      .+.++  |+++++..-.                  ....+|-||.+...         .++    ..-+.+|..-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence            44455  8888876422                  12356777776533         222    234566777888899


Q ss_pred             hCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       183 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      . .||+-+|+++.|..     .-||+|||.+
T Consensus       182 k-~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K-LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H-CCeeeccCcccccc-----CCEEEecccC
Confidence            8 99999999999986     3478999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.79  E-value=8.6e-05  Score=62.22  Aligned_cols=99  Identities=24%  Similarity=0.154  Sum_probs=76.9

Q ss_pred             HHHHHHhhcCC-CceEEeeeeeeecCeEEEEEeccCCCCHHH---HHHHhCCCCHHHHHHHHHHHHHHHHHHHh--CCCc
Q 018532          114 QELKINQASQC-SHVVVCYHSFYHNGVISLVLEYMDRGSLAD---IIRQVKTILEPYLAVVCKQVLQGLVYLHN--ERHV  187 (354)
Q Consensus       114 ~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~i  187 (354)
                      .|.-+++.+.+ +++.+++|.+-   . +++.||...+++..   .+......++..+.+|+.+++..+.+++.  ...+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46777777766 58899998872   2 56889998666542   12222456899999999999999999986  1338


Q ss_pred             eecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          188 IHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       188 iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .-.|++++|+-++++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88899999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.0002  Score=62.33  Aligned_cols=75  Identities=16%  Similarity=0.169  Sum_probs=45.4

Q ss_pred             cccccccCceEEEEEEEcc-CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCce-EEeeeeeeecCeEEEEEeccCC
Q 018532           72 IKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      ++.|..|-...+|++.... .+..|++|+.......  .-...+|+.+++.+...++ .+++....  +  .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            3457788888999987543 3568899987543221  1123467777776644333 33333222  2  379999998


Q ss_pred             CCH
Q 018532          150 GSL  152 (354)
Q Consensus       150 ~~L  152 (354)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=97.78  E-value=0.0012  Score=60.22  Aligned_cols=31  Identities=29%  Similarity=0.338  Sum_probs=26.5

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .++||+|++|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999998666668999998753

>PRK10593 hypothetical protein; Provisional

Probab=97.73  E-value=0.0008  Score=60.81  Aligned_cols=78  Identities=14%  Similarity=0.018  Sum_probs=52.8

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC---CceEEeeeeeee---cCeEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC---SHVVVCYHSFYH---NGVISLV  143 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---~~iv~~~~~~~~---~~~~~lv  143 (354)
                      ...+.||.|..+.||..... ++ .+++|+.+....   ...+..|...++.+..   -.+.++++.+..   .+..++|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcC-CC-CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34567999999999998643 23 467787533111   2457788888877643   245666665543   4678999


Q ss_pred             EeccCCCCH
Q 018532          144 LEYMDRGSL  152 (354)
Q Consensus       144 ~e~~~~~~L  152 (354)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.00095  Score=60.68  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=78.7

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-----CCceEEeee---eeeecCeE
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-----CSHVVVCYH---SFYHNGVI  140 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~iv~~~~---~~~~~~~~  140 (354)
                      ....+.++.|....+|++...  +..+++|+.......+   .+..|..++..+.     .+.++...+   .....+..
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ceeccccCCccccceEEEEeC--CCcEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            344667888888899988643  3357889876532222   2334455544442     223332211   11224677


Q ss_pred             EEEEeccCCCCHH-----------HHH---HH-hCCC--------CHHH----HH-----------HHHHHHHHHHHHHH
Q 018532          141 SLVLEYMDRGSLA-----------DII---RQ-VKTI--------LEPY----LA-----------VVCKQVLQGLVYLH  182 (354)
Q Consensus       141 ~lv~e~~~~~~L~-----------~~l---~~-~~~~--------~~~~----~~-----------~i~~qi~~~l~~LH  182 (354)
                      +++++|++|..+.           ..+   +. ...+        ....    ..           .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999885431           111   11 0111        0000    00           00112233444453


Q ss_pred             h------CCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          183 N------ERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       183 ~------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .      ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            2      2679999999999999988877999999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.71  E-value=3e-05  Score=68.92  Aligned_cols=136  Identities=18%  Similarity=0.215  Sum_probs=91.8

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc--------HH-------------HHHHHHHHHHHHhhcCCCc-
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--------EE-------------IRKQIVQELKINQASQCSH-  126 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~-------------~~~~~~~e~~~~~~l~h~~-  126 (354)
                      +.+.+.||-|.-+.||.+-+. .|.+.++|.-+....        .+             .+-...+|...++.+.-.. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456788999999999998875 788889997543210        00             0112456666666664321 


Q ss_pred             -eEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          127 -VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       127 -iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                       +.+.+    +.+.-++|||+++|-+|...-+-      ..+..+...+..-+.-|-. .|+||+|..--||++++++.+
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHH-cCceecccchheeEEecCCCE
Confidence             22333    23556889999999887654321      1123344455555666665 999999999999999999999


Q ss_pred             EEeeccccccc
Q 018532          206 KITDFGVSAML  216 (354)
Q Consensus       206 kl~Dfg~a~~~  216 (354)
                      +++||--....
T Consensus       242 ~vIDFPQmvS~  252 (465)
T KOG2268|consen  242 VVIDFPQMVST  252 (465)
T ss_pred             EEeechHhhcc
Confidence            99999765443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.71  E-value=0.00014  Score=64.28  Aligned_cols=134  Identities=16%  Similarity=0.172  Sum_probs=73.8

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE-EeeeeeeecCeEEEEEeccCCCCH
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV-VCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      .+..|-.+.+|++.  .++..+++|....... ...-...+|..+++.+...+++ +++..  ..  -++|+||++|..+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK-ALGVDRQREYQILQALSALGLAPKPILV--NE--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc-cccCcHHHHHHHHHHHHhcCCCCceEEE--eC--CEEEEEeccCccc
Confidence            35667778899886  4567788997643321 1101245677777776543332 22222  22  2689999998665


Q ss_pred             HH--------------HHHHh---C----CCCH-HHHHHHHHHH---------HHHHHHHHh-------CCCceecCCCC
Q 018532          153 AD--------------IIRQV---K----TILE-PYLAVVCKQV---------LQGLVYLHN-------ERHVIHRDIKP  194 (354)
Q Consensus       153 ~~--------------~l~~~---~----~~~~-~~~~~i~~qi---------~~~l~~LH~-------~~~iiH~Dlkp  194 (354)
                      ..              .+.+-   .    .+.. ..+..+..++         ...+..+-.       ...++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            32              11111   1    1111 1111211111         111222211       12489999999


Q ss_pred             CCEEEccCCcEEEeecccccc
Q 018532          195 SNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       195 ~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .||++++++ +.|+||..|..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.68  E-value=0.00077  Score=60.84  Aligned_cols=138  Identities=14%  Similarity=0.132  Sum_probs=79.0

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc--eEEeeee------eeecCeEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHS------FYHNGVISL  142 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~------~~~~~~~~l  142 (354)
                      ..+.|..|....+|++..  .+..+++|+... ..   ...+..|+.++..+...+  +.+++..      ....+..++
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCC-CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            355688888889998864  345688998764 21   233555666655553222  3333221      123456789


Q ss_pred             EEeccCCCCHHH----HH----------HHh-CCCCH--------HHHH------------HHHHHHHHHHHHHHh----
Q 018532          143 VLEYMDRGSLAD----II----------RQV-KTILE--------PYLA------------VVCKQVLQGLVYLHN----  183 (354)
Q Consensus       143 v~e~~~~~~L~~----~l----------~~~-~~~~~--------~~~~------------~i~~qi~~~l~~LH~----  183 (354)
                      |+++++|..+..    ..          +.. ..+..        ....            .....+..++.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999999866421    11          110 00000        0000            011112233444432    


Q ss_pred             --CCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          184 --ERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       184 --~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                        ..+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence              2469999999999999988778999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.47  E-value=0.00094  Score=60.50  Aligned_cols=75  Identities=17%  Similarity=0.139  Sum_probs=44.0

Q ss_pred             ccccccCceEEEEEEEcc------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE-EeeeeeeecCeEEEEEe
Q 018532           73 KVIGKGSGGVVQLVRHKW------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV-VCYHSFYHNGVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~~lv~e  145 (354)
                      +.+..|-...+|++....      +++.|++|+......  ......+|..++..+...++. +++..+. +   ..|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence            345566666888887543      257899999765432  123456677776666443332 3333332 2   35789


Q ss_pred             ccCCCCHH
Q 018532          146 YMDRGSLA  153 (354)
Q Consensus       146 ~~~~~~L~  153 (354)
                      |++|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            98886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.39  E-value=0.0064  Score=56.94  Aligned_cols=77  Identities=17%  Similarity=0.110  Sum_probs=49.2

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccc----c--HHHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCeEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----Q--EEIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~--~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+.||.|.+..||++.....++.++||.-....    .  .-...+...|...++.+   ...++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            356999999999999986444689999743110    0  11234455666666654   23345556554  4456789


Q ss_pred             EEeccCCC
Q 018532          143 VLEYMDRG  150 (354)
Q Consensus       143 v~e~~~~~  150 (354)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999763

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.36  E-value=0.0011  Score=60.22  Aligned_cols=108  Identities=19%  Similarity=0.184  Sum_probs=72.1

Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ....|++|++- |++|.-.    +.-..+++..++.+.+..+.-+...-..-|||+...||+++ +|+|-|+||.+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34667778876 5555432    33456778889999888888888766789999999999999 999999999999843


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHH
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV  256 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  256 (354)
                      .......     --..--|-.+.|.. +..-|||-+--.+
T Consensus       372 ~~q~~is-----y~rldhp~lF~G~d-d~QFeIYrlMr~l  405 (488)
T COG5072         372 YSQGIIS-----YNRLDHPDLFNGVD-DYQFEIYRLMRRL  405 (488)
T ss_pred             cCCceee-----ccccCchhhhcCcc-ceeeeHHHHHHHH
Confidence            2221111     11222344444433 6667777654433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.26  E-value=0.0028  Score=56.61  Aligned_cols=30  Identities=17%  Similarity=0.532  Sum_probs=25.2

Q ss_pred             CceecCCCCCCEEEccCCc-EEEeecccccc
Q 018532          186 HVIHRDIKPSNLLVNHKGE-VKITDFGVSAM  215 (354)
Q Consensus       186 ~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~  215 (354)
                      .++|+|+++.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 57999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.13  E-value=0.0039  Score=57.59  Aligned_cols=136  Identities=16%  Similarity=0.193  Sum_probs=74.9

Q ss_pred             ccccccCceEEEEEEEcc----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE-EeeeeeeecCeEEEEEecc
Q 018532           73 KVIGKGSGGVVQLVRHKW----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV-VCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~~lv~e~~  147 (354)
                      ..|-.|-.-.+|++....    +++.|++|+...... ... .-.+|..+++.+...++. ++++.+. ++   .|.+|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFF-DRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eee-chHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEee
Confidence            345557778889886432    346899998765432 111 125677777666544443 3344432 22   578888


Q ss_pred             CCCCHHHH-------H-------H---HhC-C----CC-HHHHHHHHHHH-----------------HHHHHHH----Hh
Q 018532          148 DRGSLADI-------I-------R---QVK-T----IL-EPYLAVVCKQV-----------------LQGLVYL----HN  183 (354)
Q Consensus       148 ~~~~L~~~-------l-------~---~~~-~----~~-~~~~~~i~~qi-----------------~~~l~~L----H~  183 (354)
                      +|.+|...       +       .   +.. .    .. ...+..+..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665311       1       1   101 0    10 12222222111                 1111111    11


Q ss_pred             ---CCCceecCCCCCCEEEcc-CCcEEEeeccccc
Q 018532          184 ---ERHVIHRDIKPSNLLVNH-KGEVKITDFGVSA  214 (354)
Q Consensus       184 ---~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~  214 (354)
                         ...++|+|+++.||++++ ++.+.++||..|.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence               135899999999999986 4689999998875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.85  E-value=0.019  Score=52.13  Aligned_cols=30  Identities=13%  Similarity=0.245  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .+++|+|+.+.||+++.++.+.++||..++
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            479999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.84  E-value=0.0072  Score=55.53  Aligned_cols=29  Identities=28%  Similarity=0.559  Sum_probs=25.5

Q ss_pred             ceecCCCCCCEEEcc-CCcEEEeecccccc
Q 018532          187 VIHRDIKPSNLLVNH-KGEVKITDFGVSAM  215 (354)
Q Consensus       187 iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  215 (354)
                      ++|+|+.+.||++++ ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999998853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.80  E-value=0.011  Score=53.60  Aligned_cols=31  Identities=19%  Similarity=0.484  Sum_probs=28.0

Q ss_pred             CceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       186 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .++|+|+++.||+++.++-+-+.||+.+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            3899999999999999999999999998754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.75  E-value=0.0034  Score=59.52  Aligned_cols=166  Identities=19%  Similarity=0.235  Sum_probs=100.4

Q ss_pred             HHHHHHHHHHhhcCCCceEEeeeeeeec-CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCce
Q 018532          110 KQIVQELKINQASQCSHVVVCYHSFYHN-GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI  188 (354)
Q Consensus       110 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ii  188 (354)
                      ..+.....+++.+.|+|....++.-... ....+|+|++. .+|.+++..+. +-.....              . .++.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~-~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------A-HGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------c-cccc
Confidence            4466778889999999998888766542 35889999995 69999987744 2211111              1 2232


Q ss_pred             ecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018532          189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ  268 (354)
Q Consensus       189 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  268 (354)
                      |-     |+       ++.+| -++.   ..    ..                ...+|+||||+|.++.++.-|...+..
T Consensus        90 ~~-----~~-------~~~td-~~~t---~~----~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   90 HL-----NI-------IYITD-HFLT---KY----PS----------------PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             ee-----hh-------hhccc-cccc---cC----CC----------------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            21     12       22233 0000   00    01                112499999999999999988876643


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ....    +..+.+.+........       .....++..+.++..+|+-..|..||...++.+++-|.+.
T Consensus       134 ~~~s----~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTES----EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHH----HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            3221    1111111110000000       0112357778899999999999999999999999988765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.71  E-value=0.034  Score=51.19  Aligned_cols=74  Identities=15%  Similarity=0.072  Sum_probs=42.7

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEee----c-c-ccHHHHHHHHHHHHHHhhcC--CC-ceEEeeeeeeecCeEEEEE
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQ----M-N-IQEEIRKQIVQELKINQASQ--CS-HVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~-~-~~~~~~~~~~~e~~~~~~l~--h~-~iv~~~~~~~~~~~~~lv~  144 (354)
                      .||-|....||++.+...++.++||.-.    . . .-.-...+..-|...++...  .| .+.++|.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            5799999999999986444689999642    1 0 00111223334555554432  23 3444443  3455566899


Q ss_pred             eccCC
Q 018532          145 EYMDR  149 (354)
Q Consensus       145 e~~~~  149 (354)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.44  E-value=0.014  Score=49.59  Aligned_cols=86  Identities=15%  Similarity=0.261  Sum_probs=58.8

Q ss_pred             HHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCCce
Q 018532          110 KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN-ERHVI  188 (354)
Q Consensus       110 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ii  188 (354)
                      +.+..+.+++.++.  .|+++...  ..-.+.++.|+|-.....             ...++.-=+.+|.-.|+ ..+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-------------~~N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-------------FSNFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-------------hhHHHHHhHHHHHHhhccCCCee
Confidence            33566777776653  46777633  344677999999542110             11222223567888895 56799


Q ss_pred             ecCCCCCCEEEccCCcEEEeeccc
Q 018532          189 HRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       189 H~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      |||-.|+||+-|+.|.+||.|-+.
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhh
Confidence            999999999999999999999764

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=96.37  E-value=0.13  Score=54.56  Aligned_cols=31  Identities=32%  Similarity=0.576  Sum_probs=26.1

Q ss_pred             CCceecCCCCCCEEEccCC--cEE-Eeecccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKG--EVK-ITDFGVSAM  215 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~--~~k-l~Dfg~a~~  215 (354)
                      .++||+|+.+.||+++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5699999999999999875  554 999998754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.22  E-value=0.017  Score=53.51  Aligned_cols=62  Identities=23%  Similarity=0.312  Sum_probs=45.2

Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH  201 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~  201 (354)
                      ...++-+|..|.++..++.. +..++.....++.-.+.|+..+---.+.+|.|++|.||++-.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            34567788889999988876 445555666676666666665443356999999999999954

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.18  E-value=0.032  Score=50.07  Aligned_cols=75  Identities=16%  Similarity=0.056  Sum_probs=44.3

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCeEEEEEec
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +..+.++-|....+|++.  .+++.+.+|+-....    ...+..|..-++.+   ..-.+.+.+......+.-++||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            344568889999999887  578889999876322    23456676666665   344566777777666677999999


Q ss_pred             cCCC
Q 018532          147 MDRG  150 (354)
Q Consensus       147 ~~~~  150 (354)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.17  E-value=0.1  Score=48.93  Aligned_cols=74  Identities=22%  Similarity=0.234  Sum_probs=44.7

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccc---cH---HHHHHHHHHHHHHhhcC---CCceEEeeeeeeecCeEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QE---EIRKQIVQELKINQASQ---CSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~---~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+.||-|....||++.+.  +..++||.-....   ..   -...+...|+..++.+.   ..++.+++....  +.-++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            567899999999999873  4568899754110   01   01222333455544432   345666666544  44677


Q ss_pred             EEeccCC
Q 018532          143 VLEYMDR  149 (354)
Q Consensus       143 v~e~~~~  149 (354)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.96  E-value=0.082  Score=49.34  Aligned_cols=76  Identities=18%  Similarity=0.104  Sum_probs=44.6

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEee----cccc-HHHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCeEEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQ----MNIQ-EEIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~-~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .+.||-|.-..||++.+...++.++||.-.    ...+ .-...+..-|...++..   ...++.++|.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            567899999999999985446678998632    1111 11123344455555543   2234445543  244555678


Q ss_pred             EeccCC
Q 018532          144 LEYMDR  149 (354)
Q Consensus       144 ~e~~~~  149 (354)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888853

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.73  E-value=0.68  Score=42.39  Aligned_cols=28  Identities=21%  Similarity=0.312  Sum_probs=23.8

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .+++|+|+.+.||+++ + .+.|+||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            5689999999999995 4 57899999774

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.69  E-value=0.023  Score=51.07  Aligned_cols=87  Identities=22%  Similarity=0.244  Sum_probs=63.7

Q ss_pred             cCCCceEEeeeeeeecCeEEEEEeccCCCCHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc
Q 018532          122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN  200 (354)
Q Consensus       122 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~  200 (354)
                      +.+|-+|.+-.       -.|||-|+...-+.. -++. -.++..+....-.|+..++.-|..+.-+||-|++--|+|..
T Consensus       347 lpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~-v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~  418 (531)
T KOG2269|consen  347 LPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKN-VELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWT  418 (531)
T ss_pred             CCCCceeeeec-------ceEEEEeecCCCCCCccccc-cccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheec
Confidence            46677776642       357888874322211 1221 34888888888899999999888778899999999999997


Q ss_pred             cCCcEEEeecccccccC
Q 018532          201 HKGEVKITDFGVSAMLG  217 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~  217 (354)
                      .+ .+.++|..-+....
T Consensus       419 ~g-Kvw~IDVsQsvep~  434 (531)
T KOG2269|consen  419 PG-KVWVIDVSQSVEPS  434 (531)
T ss_pred             CC-ceEEEechhccCCC
Confidence            76 99999987765443

>PTZ00384 choline kinase; Provisional

Probab=95.50  E-value=0.14  Score=47.88  Aligned_cols=29  Identities=21%  Similarity=0.252  Sum_probs=23.9

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ...+|.|+-+.||+.+ ++.+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            3579999999999875 4569999998774

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.17  E-value=0.19  Score=43.20  Aligned_cols=74  Identities=20%  Similarity=0.078  Sum_probs=46.8

Q ss_pred             cccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc---CCCceEEeeeeeeecCeEEEEEeccCCC
Q 018532           74 VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS---QCSHVVVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        74 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      .+.-|.--.-|.+.+  ....|.+|+-.    .+....+..|+.-+..+   +.-.+.+.+....+.++.|+|+||++.+
T Consensus        23 ~v~gG~inea~~v~d--g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          23 EVSGGDINEAWRLRD--GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccCCccccceeEeec--CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            344444444454443  35668888633    34445567777655554   3345667777777889999999999876


Q ss_pred             CHH
Q 018532          151 SLA  153 (354)
Q Consensus       151 ~L~  153 (354)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.99  E-value=0.054  Score=49.11  Aligned_cols=29  Identities=31%  Similarity=0.494  Sum_probs=25.5

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.84  E-value=0.027  Score=46.91  Aligned_cols=29  Identities=21%  Similarity=0.416  Sum_probs=25.7

Q ss_pred             ceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          187 VIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       187 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+|+|+.|.||+++++| ++|+||+.|...
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            69999999999998777 899999988643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	354
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-54
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-53
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-52
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-51
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-50
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-50
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-50
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-50
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-50
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-50
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-39
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-39
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-37
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-36
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-35
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-35
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-34
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-34
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-34
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-33
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-33
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-31
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-31
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-31
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-31
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-31
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-31
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-30
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-30
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-29
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-29
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-29
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-29
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-29
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-29
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-29
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-28
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-28
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-28
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-28
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-28
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-27
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-25
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-24
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-23
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-23
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-23
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-23
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-23
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-23
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-23
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-23
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-22
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-22
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-22
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-22
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-22
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-22
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-21
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-21
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-21
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-21
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-21
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-21
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-21
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-21
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-21
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-21
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-21
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-21
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-21
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-21
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-21
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-21
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-21
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-21
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-21
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-21
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-21
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-21
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-21
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-21
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-21
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-21
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-21
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-20
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-20
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-20
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-20
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-20
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-20
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-20
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-20
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-20
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-20
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-20
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-20
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-20
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-20
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-20
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-20
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-20
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-20
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-20
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-20
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-19
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-18
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-18
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-17
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-17
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-17
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-16
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-16
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-16
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-16
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-16
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-16
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-15
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-15
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-15
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-10
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-10
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-08
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-07
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-07
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-07
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-07
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-07
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-07
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-07
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-07
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-07

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/258 (41%), Positives = 157/258 (60%), Gaps = 5/258 (1%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 145 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 266 YM---QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXX 322
                  ED +   + +ELL+ IV  PPP  P   FS EF  FV+ C+ K+P        
Sbjct: 203 IPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 262
Query: 323 XXXHPFIKKFEDKDIDLG 340
              H FIK+ + +++D  
Sbjct: 263 LMVHAFIKRSDAEEVDFA 280

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 104/254 (40%), Positives = 154/254 (60%), Gaps = 5/254 (1%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 44  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 103
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 104 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 163
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 164 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221
Query: 266 YMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
                      + +ELL+ IV  PPP  P   FS EF  FV+ C+ K+P           
Sbjct: 222 IGSGSGSM---AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278
Query: 326 HPFIKKFEDKDIDL 339
           H FIK+ + +++D 
Sbjct: 279 HAFIKRSDAEEVDF 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 103/255 (40%), Positives = 153/255 (60%), Gaps = 9/255 (3%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 28  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 87
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 88  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 147
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L   M   + FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 148 KLCDFGVSGQLIDEMA--NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205
Query: 266 YMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
                  +   + +ELL+ IV  PPP  P   FS EF  FV+ C+ K+P           
Sbjct: 206 -------RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258
Query: 326 HPFIKKFEDKDIDLG 340
           H FIK+ + +++D  
Sbjct: 259 HAFIKRSDAEEVDFA 273

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 159/294 (54%), Gaps = 41/294 (13%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V+H+  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 35  VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 94
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++ K I E  L  V   VL+GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 95  HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 154
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YM+PER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 155 KLCDFGVSGQLIDSMA--NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212
Query: 266 Y---------------------------------------MQSEDQQSWPSFYELLEAIV 286
                                                       D +   + +ELL+ IV
Sbjct: 213 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIV 272
Query: 287 ESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
             PPP  P   F+P+F  FV+ C+ K+P           H FIK+ E +++D  
Sbjct: 273 NEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFA 326

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 158/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 87  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 146
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 147 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 206
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 207 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             + S    S P  + +ELL+ IV  PP
Sbjct: 265 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 324
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 325 PKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 374

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 158/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 145 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             + S    S P  + +ELL+ IV  PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 158/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 145 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             + S    S P  + +ELL+ IV  PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 158/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 145 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             + S    S P  + +ELL+ IV  PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 158/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 145 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             + S    S P  + +ELL+ IV  PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 312

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  194 bits (492), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 106/290 (36%), Positives = 157/290 (54%), Gaps = 37/290 (12%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V HK  G + A K+I + I+  IR QI++EL++       ++V  Y +FY +G IS+ +E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +MD GSL  ++++   I E  L  V   V++GL YL  +  ++HRD+KPSN+LVN +GE+
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+ Y   SDIWS+GL ++E A+GR+P
Sbjct: 172 KLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 266 ---------------------------------YMQSEDQQSWP--SFYELLEAIVESPP 290
                                             +      S P  + +ELL+ IV  PP
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDIDLG 340
           P  P   FS EF  FV+ C+ K+P           H FIK+ + +++D  
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFA 339

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL 144
           +RH   G++ A+K I+  +  + +K+++ +L I+  +  C   V  Y + +  G + + +
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85
Query: 145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           E MD  SL    +QV    +TI E  L  +   +++ L +LH++  VIHRD+KPSN+L+N
Sbjct: 86  ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI----SGSTYDYSSDIWSLGLVV 256
             G+VK+ DFG+S  L   +  +D   G   YM+PERI    +   Y   SDIWSLG+ +
Sbjct: 145 ALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203
Query: 257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXX 316
           +E AI RFPY       SW + ++ L+ +VE P P  P D+FS EF  F S C++K+   
Sbjct: 204 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 317 XXXXXXXXXHPFIKKFEDKDIDLGILV 343
                    HPF    E K  D+   V
Sbjct: 258 RPTYPELMQHPFFTLHESKGTDVASFV 284

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL 144
           +RH   G++ A+K I+  +  + +K+++ +L I+  +  C   V  Y + +  G + + +
Sbjct: 70  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 129
Query: 145 EYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           E MD  SL    +QV    +TI E  L  +   +++ L +LH++  VIHRD+KPSN+L+N
Sbjct: 130 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 188
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI----SGSTYDYSSDIWSLGLVV 256
             G+VK+ DFG+S  L  S+  +    G   YM+PERI    +   Y   SDIWSLG+ +
Sbjct: 189 ALGQVKMCDFGISGYLVDSVA-KTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 247
Query: 257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXX 316
           +E AI RFPY       SW + ++ L+ +VE P P  P D+FS EF  F S C++K+   
Sbjct: 248 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 301
Query: 317 XXXXXXXXXHPFIKKFEDKDIDLGILV 343
                    HPF    E K  D+   V
Sbjct: 302 RPTYPELMQHPFFTLHESKGTDVASFV 328

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/245 (35%), Positives = 138/245 (56%), Gaps = 13/245 (5%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           HK  G++ A+K  Q+ ++ ++ ++I++E+ I Q     HVV  Y S++ N  + +V+EY 
Sbjct: 50  HKETGQIVAIK--QVPVESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 148 DRGSLADIIR-QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             GS++DIIR + KT+ E  +A + +  L+GL YLH  R  IHRDIK  N+L+N +G  K
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-IHRDIKAGNILLNTEGHAK 165
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFGV+  L   M +R+  +GT  +M+PE I    Y+  +DIWSLG+  +E A G+ PY
Sbjct: 166 LADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
Query: 267 MQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
                 ++       +  I  +PPPT   P+ +S  F  FV  C+ K P           
Sbjct: 226 ADIHPMRA-------IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
Query: 326 HPFIK 330
           HPF++
Sbjct: 279 HPFVR 283

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 139/266 (52%), Gaps = 17/266 (6%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLE 145
           RH   G++ A+K I+  +  + +K+++ +L I+  +  C   V  Y + +  G + +  E
Sbjct: 54  RHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE 113
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
             D  SL    +QV    +TI E  L  +   +++ L +LH++  VIHRD+KPSN+L+N 
Sbjct: 114 LXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 172
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI----SGSTYDYSSDIWSLGLVVL 257
            G+VK  DFG+S  L   +  +D   G   Y +PERI    +   Y   SDIWSLG+  +
Sbjct: 173 LGQVKXCDFGISGYLVDDVA-KDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXI 231
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXX 317
           E AI RFPY       SW + ++ L+ +VE P P  P D+FS EF  F S C++K+    
Sbjct: 232 ELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 285
Query: 318 XXXXXXXXHPFIKKFEDKDIDLGILV 343
                   HPF    E K  D+   V
Sbjct: 286 PTYPELXQHPFFTLHESKGTDVASFV 311

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 144/258 (55%), Gaps = 24/258 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELK-INQASQCSHVVVCYHSFYH------NGV 139
           RH   G+L A+K++ +   EE  ++I QE+  + + S   ++   Y +F        +  
Sbjct: 44  RHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101
Query: 140 ISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           + LV+E+   GS+ D+I+  K  T+ E ++A +C+++L+GL +LH  + VIHRDIK  N+
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNV 160
Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSL 252
           L+    EVK+ DFGVSA L  ++G+R+TF+GT  +M+PE I+      +TYD+ SD+WSL
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 253 GLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK 312
           G+  +E A G  P       ++       L  I  +P P     ++S +F SF+ +C+ K
Sbjct: 221 GITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVK 273
Query: 313 DPXXXXXXXXXXXHPFIK 330
           +            HPFI+
Sbjct: 274 NHSQRPATEQLMKHPFIR 291

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 143/270 (52%), Gaps = 23/270 (8%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEY 146
           HK  G++ A+K I+  + E+ +KQ++ +L +  ++S C ++V  Y + +  G   + +E 
Sbjct: 43  HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 147 MDRGSLADIIRQVKTIL-----EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           M   S     + V ++L     E  L  +    ++ L +L     +IHRDIKPSN+L++ 
Sbjct: 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161
Query: 202 KGEVKITDFGVSAMLGSSMGQ-RDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVV 256
            G +K+ DFG+S  L  S+ + RD   G   YM+PERI  S     YD  SD+WSLG+ +
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219
Query: 257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP---TAPPDQFSPEFCSFVSACIQKD 313
            E A GRFPY +      W S ++ L  +V+  PP    +   +FSP F +FV+ C+ KD
Sbjct: 220 YELATGRFPYPK------WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKD 273
Query: 314 PXXXXXXXXXXXHPFIKKFEDKDIDLGILV 343
                       HPFI  +E++ +++   V
Sbjct: 274 ESKRPKYKELLKHPFILMYEERAVEVACYV 303

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 145/253 (57%), Gaps = 20/253 (7%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLV 143
            ++K  G L A K+I+   +EE+   IV+   I   + C H  +V    ++YH+G + ++
Sbjct: 38  AKNKETGALAAAKVIETKSEEELEDYIVE---IEILATCDHPYIVKLLGAYYHDGKLWIM 94
Query: 144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +E+   G++  I+ ++ + + EP + VVC+Q+L+ L +LH++R +IHRD+K  N+L+  +
Sbjct: 95  IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLE 153
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----YDYSSDIWSLGLVVL 257
           G++++ DFGVSA    ++ +RD+F+GT  +M+PE +   T     YDY +DIWSLG+ ++
Sbjct: 154 GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXX 316
           E A    P+ +    +       +L  I +S PPT   P ++S EF  F+   + K+P  
Sbjct: 214 EMAQIEPPHHELNPMR-------VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPET 266
Query: 317 XXXXXXXXXHPFI 329
                    HPF+
Sbjct: 267 RPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 145/253 (57%), Gaps = 20/253 (7%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLV 143
            ++K  G L A K+I+   +EE+   IV+   I   + C H  +V    ++YH+G + ++
Sbjct: 30  AKNKETGALAAAKVIETKSEEELEDYIVE---IEILATCDHPYIVKLLGAYYHDGKLWIM 86
Query: 144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +E+   G++  I+ ++ + + EP + VVC+Q+L+ L +LH++R +IHRD+K  N+L+  +
Sbjct: 87  IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLE 145
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----YDYSSDIWSLGLVVL 257
           G++++ DFGVSA    ++ +RD+F+GT  +M+PE +   T     YDY +DIWSLG+ ++
Sbjct: 146 GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 205
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXX 316
           E A    P+ +    +       +L  I +S PPT   P ++S EF  F+   + K+P  
Sbjct: 206 EMAQIEPPHHELNPMR-------VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPET 258
Query: 317 XXXXXXXXXHPFI 329
                    HPF+
Sbjct: 259 RPSAAQLLEHPFV 271

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/243 (35%), Positives = 134/243 (55%), Gaps = 10/243 (4%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL 152
           ++ A+KII +   E+  + I QE+ +      S+V   Y S+     + +++EY+  GS 
Sbjct: 49  QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA 108
Query: 153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
            D++R      E  +A + K++L+GL YLH+E+  IHRDIK +N+L++ +G+VK+ DFGV
Sbjct: 109 LDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK-IHRDIKAANVLLSEQGDVKLADFGV 166
Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           +  L  +  +R+TFVGT  +M+PE I  S YD  +DIWSLG+  +E A G  P   + D 
Sbjct: 167 AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP---NSDM 223
Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKF 332
                   +L  I ++ PPT   D F+  F  F+ AC+ KDP           H FI K 
Sbjct: 224 HP----MRVLFLIPKNNPPTLVGD-FTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 278
Query: 333 EDK 335
             K
Sbjct: 279 SKK 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/240 (34%), Positives = 133/240 (55%), Gaps = 10/240 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+KII +   E+  + I QE+ +       ++   + S+  +  + +++EY+  GS  D+
Sbjct: 48  AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDL 107
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           ++    + E Y+A + +++L+GL YLH+ER  IHRDIK +N+L++ +G+VK+ DFGV+  
Sbjct: 108 LKP-GPLEETYIATILREILKGLDYLHSERK-IHRDIKAANVLLSEQGDVKLADFGVAGQ 165
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           L  +  +R+ FVGT  +M+PE I  S YD+ +DIWSLG+  +E A G  P       +  
Sbjct: 166 LTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-- 223
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDK 335
                +L  I ++ PPT    Q S  F  FV AC+ KDP           H FI ++  K
Sbjct: 224 -----VLFLIPKNSPPTL-EGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 277

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 147/278 (52%), Gaps = 18/278 (6%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVVVCYHSFYHNGVISLVL 144
           +R +  G + A+K ++ +  +E  K+I+ +L +  ++  C ++V C+ +F  N  + + +
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E M  G+ A+ +  R    I E  L  +   +++ L YL  +  VIHRD+KPSN+L++ +
Sbjct: 104 ELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-----SGSTYDYSSDIWSLGLVVL 257
           G++K+ DFG+S  L      +D   G   YM+PERI     +   YD  +D+WSLG+ ++
Sbjct: 162 GQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ-FSPEFCSFVSACIQKDPXX 316
           E A G+FPY      ++  + +E+L  +++  PP  P    FS +F SFV  C+ KD   
Sbjct: 221 ELATGQFPY------KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 317 XXXXXXXXXHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
                    H FIK++E  ++D+      +      PR
Sbjct: 275 RPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR 312

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 84/246 (34%), Positives = 131/246 (53%), Gaps = 11/246 (4%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L R K  GR  A+K++ +  Q+  R+ +  E+ I +  Q  +VV  Y S+     + +++
Sbjct: 63  LAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE 204
           E++  G+L DI+ QV+ + E  +A VC+ VLQ L YLH +  VIHRDIK  ++L+   G 
Sbjct: 122 EFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGR 179
Query: 205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRF 264
           VK++DFG  A +   + +R   VGT  +M+PE IS S Y    DIWSLG++V+E   G  
Sbjct: 180 VKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 265 PYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFCSFVSACIQKDPXXXXXXXXX 323
           PY      Q+       ++ + +SPPP      + SP    F+   + +DP         
Sbjct: 240 PYFSDSPVQA-------MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
Query: 324 XXHPFI 329
             HPF+
Sbjct: 293 LDHPFL 298

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 132/237 (55%), Gaps = 10/237 (4%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL 152
           ++ A+KII +   E+  + I QE+ +       +V   Y S+  +  + +++EY+  GS 
Sbjct: 33  KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 92
Query: 153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
            D++ +   + E  +A + +++L+GL YLH+E+  IHRDIK +N+L++  GEVK+ DFGV
Sbjct: 93  LDLL-EPGPLDETQIATILREILKGLDYLHSEKK-IHRDIKAANVLLSEHGEVKLADFGV 150
Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           +  L  +  +R+TFVGT  +M+PE I  S YD  +DIWSLG+  +E A G  P+ +    
Sbjct: 151 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 210
Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           +       +L  I ++ PPT   + +S     FV AC+ K+P           H FI
Sbjct: 211 K-------VLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 132/237 (55%), Gaps = 10/237 (4%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL 152
           ++ A+KII +   E+  + I QE+ +       +V   Y S+  +  + +++EY+  GS 
Sbjct: 53  KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 112
Query: 153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
            D++ +   + E  +A + +++L+GL YLH+E+  IHRDIK +N+L++  GEVK+ DFGV
Sbjct: 113 LDLL-EPGPLDETQIATILREILKGLDYLHSEKK-IHRDIKAANVLLSEHGEVKLADFGV 170
Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           +  L  +  +R+TFVGT  +M+PE I  S YD  +DIWSLG+  +E A G  P+ +    
Sbjct: 171 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 230
Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           +       +L  I ++ PPT   + +S     FV AC+ K+P           H FI
Sbjct: 231 K-------VLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 137/253 (54%), Gaps = 20/253 (7%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLV 143
            ++K    L A K+I    +EE+   +V+   I+  + C H  +V    +FY+   + ++
Sbjct: 56  AQNKETSVLAAAKVIDTKSEEELEDYMVE---IDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +E+   G++  ++ ++ + + E  + VVCKQ L  L YLH+ + +IHRD+K  N+L    
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLD 171
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----YDYSSDIWSLGLVVL 257
           G++K+ DFGVSA    ++ +RD+F+GT  +M+PE +   T     YDY +D+WSLG+ ++
Sbjct: 172 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXX 316
           E A    P+ +    +       +L  I +S PPT A P ++S  F  F+  C++K+   
Sbjct: 232 EMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 284
Query: 317 XXXXXXXXXHPFI 329
                    HPF+
Sbjct: 285 RWTTSQLLQHPFV 297

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 131/237 (55%), Gaps = 10/237 (4%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL 152
           ++ A+KII +   E+  + I QE+ +       +V   Y S+  +  + +++EY+  GS 
Sbjct: 48  KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107
Query: 153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
            D++ +   + E  +A + +++L+GL YLH+E+  IHRDIK +N+L++  GEVK+ DFGV
Sbjct: 108 LDLL-EPGPLDETQIATILREILKGLDYLHSEKK-IHRDIKAANVLLSEHGEVKLADFGV 165
Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           +  L  +  +R+ FVGT  +M+PE I  S YD  +DIWSLG+  +E A G  P+ +    
Sbjct: 166 AGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225
Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           +       +L  I ++ PPT   + +S     FV AC+ K+P           H FI
Sbjct: 226 K-------VLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 131/237 (55%), Gaps = 10/237 (4%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL 152
           ++ A+KII +   E+  + I QE+ +       +V   Y S+  +  + +++EY+  GS 
Sbjct: 33  KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 92
Query: 153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
            D++ +   + E  +A + +++L+GL YLH+E+  IHRDIK +N+L++  GEVK+ DFGV
Sbjct: 93  LDLL-EPGPLDETQIATILREILKGLDYLHSEKK-IHRDIKAANVLLSEHGEVKLADFGV 150
Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           +  L  +  +R+ FVGT  +M+PE I  S YD  +DIWSLG+  +E A G  P+ +    
Sbjct: 151 AGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 210
Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           +       +L  I ++ PPT   + +S     FV AC+ K+P           H FI
Sbjct: 211 K-------VLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 136/253 (53%), Gaps = 20/253 (7%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLV 143
            ++K    L A K+I    +EE+   +V+   I+  + C H  +V    +FY+   + ++
Sbjct: 56  AQNKETSVLAAAKVIDTKSEEELEDYMVE---IDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +E+   G++  ++ ++ + + E  + VVCKQ L  L YLH+ + +IHRD+K  N+L    
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLD 171
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----YDYSSDIWSLGLVVL 257
           G++K+ DFGVSA     + +RD+F+GT  +M+PE +   T     YDY +D+WSLG+ ++
Sbjct: 172 GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXX 316
           E A    P+ +    +       +L  I +S PPT A P ++S  F  F+  C++K+   
Sbjct: 232 EMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 284
Query: 317 XXXXXXXXXHPFI 329
                    HPF+
Sbjct: 285 RWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 135/253 (53%), Gaps = 20/253 (7%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLV 143
            ++K    L A K+I    +EE+   +V+   I+  + C H  +V    +FY+   + ++
Sbjct: 56  AQNKETSVLAAAKVIDTKSEEELEDYMVE---IDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 144 LEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +E+   G++  ++ ++ + + E  + VVCKQ L  L YLH+ + +IHRD+K  N+L    
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLD 171
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-----YDYSSDIWSLGLVVL 257
           G++K+ DFGVSA     + +RD F+GT  +M+PE +   T     YDY +D+WSLG+ ++
Sbjct: 172 GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSFVSACIQKDPXX 316
           E A    P+ +    +       +L  I +S PPT A P ++S  F  F+  C++K+   
Sbjct: 232 EMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 284
Query: 317 XXXXXXXXXHPFI 329
                    HPF+
Sbjct: 285 RWTTSQLLQHPFV 297

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 45  GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 103 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 160
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 161 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 221 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274
Query: 331 K 331
           K
Sbjct: 275 K 275

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 54  GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 111
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 112 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 169
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 170 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 229
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 230 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 283
Query: 331 K 331
           K
Sbjct: 284 K 284

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 49  GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 106
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 107 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 164
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 165 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 224
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 225 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 278
Query: 331 K 331
           K
Sbjct: 279 K 279

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 56  GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 113
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 114 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 171
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 172 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 231
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 232 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 285
Query: 331 K 331
           K
Sbjct: 286 K 286

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 176 GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 233
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 234 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 291
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 292 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 352 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405
Query: 331 K 331
           K
Sbjct: 406 K 406

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 92  GRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G+L A+K  +M+++++ R++++  E+ I +  Q  +VV  Y+S+     + +V+E+++ G
Sbjct: 99  GKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +L DI+   + + E  +A VC  VLQ L  LH +  VIHRDIK  ++L+ H G VK++DF
Sbjct: 157 ALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDF 214
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY    
Sbjct: 215 GFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274
Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             ++     + L      PP      + SP    F+   + +DP           HPF+ 
Sbjct: 275 PLKAMKMIRDNL------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328
Query: 331 K 331
           K
Sbjct: 329 K 329

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 124/235 (52%), Gaps = 9/235 (3%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           + I QMN+Q++ +K+ I+ E+ + + ++  ++V    S+     + +V+EY+  GSL D+
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           + +   + E  +A VC++ LQ L +LH+   VIHRDIK  N+L+   G VK+TDFG  A 
Sbjct: 108 VTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           +     +R T VGT  +M+PE ++   Y    DIWSLG++ +E   G  PY+   ++   
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPL 222
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            + Y +        P    P++ S  F  F++ C+  D            H F+K
Sbjct: 223 RALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 125/235 (53%), Gaps = 9/235 (3%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           + I QMN+Q++ +K+ I+ E+ + + ++  ++V    S+     + +V+EY+  GSL D+
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           + +   + E  +A VC++ LQ L +LH+   VIHR+IK  N+L+   G VK+TDFG  A 
Sbjct: 109 VTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           +     +R T VGT  +M+PE ++   Y    DIWSLG++ +E   G  PY+   ++   
Sbjct: 167 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPL 223
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            + Y +        P    P++ S  F  F++ C++ D            H F+K
Sbjct: 224 RALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 120/245 (48%), Gaps = 34/245 (13%)
Query: 117 KINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV--------KTILEPY 166
           +I   SQC H  +V  Y SF     + LV++ +  GS+ DII+ +          + E  
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 167 LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-----MG 221
           +A + ++VL+GL YLH     IHRD+K  N+L+   G V+I DFGVSA L +        
Sbjct: 123 IATILREVLEGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 222 QRDTFVGTYNYMSP---ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            R TFVGT  +M+P   E++ G  YD+ +DIWS G+  +E A G  PY        +P  
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRG--YDFKADIWSFGITAIELATGAAPY------HKYPPM 233
Query: 279 YELLEAIVESPPP--TAPPD-----QFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
             L+  +   PP   T   D     ++   F   +S C+QKDP           H F +K
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
Query: 332 FEDKD 336
            ++K+
Sbjct: 294 AKNKE 298

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 124/235 (52%), Gaps = 9/235 (3%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           + I QMN+Q++ +K+ I+ E+ + + ++  ++V    S+     + +V+EY+  GSL D+
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           + +   + E  +A VC++ LQ L +LH+   VIHRDIK  N+L+   G VK+TDFG  A 
Sbjct: 108 VTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           +     +R   VGT  +M+PE ++   Y    DIWSLG++ +E   G  PY+   ++   
Sbjct: 166 ITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPL 222
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            + Y +        P    P++ S  F  F++ C++ D            H F+K
Sbjct: 223 RALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 124/235 (52%), Gaps = 9/235 (3%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           + I QMN+Q++ +K+ I+ E+ + + ++  ++V    S+     + +V+EY+  GSL D+
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           + +   + E  +A VC++ LQ L +LH+   VIHRDIK  N+L+   G VK+TDFG  A 
Sbjct: 109 VTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           +     +R   VGT  +M+PE ++   Y    DIWSLG++ +E   G  PY+   ++   
Sbjct: 167 ITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPL 223
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            + Y +        P    P++ S  F  F++ C++ D            H F+K
Sbjct: 224 RALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 123/235 (52%), Gaps = 9/235 (3%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           + I QMN+Q++ +K+ I+ E+ + + ++  ++V    S+     + +V+EY+  GSL D+
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 156 IRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
           + +   + E  +A VC++ LQ L +LH+   VIHRDIK  N+L+   G VK+TDFG  A 
Sbjct: 108 VTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           +     +R   VGT  +M+PE ++   Y    DIWSLG++ +E   G  PY+   ++   
Sbjct: 166 ITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPL 222
Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            + Y +        P    P++ S  F  F++ C+  D            H F+K
Sbjct: 223 RALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 126/261 (48%), Gaps = 36/261 (13%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLA 153
           A+K I +   +    ++++E  I   SQC H  +V  Y SF     + LV++ +  GS+ 
Sbjct: 39  AIKRINLEKCQTSMDELLKE--IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 154 DIIRQV--------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           DII+ +          + E  +A + ++VL+GL YLH     IHRD+K  N+L+   G V
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ-IHRDVKAGNILLGEDGSV 155
Query: 206 KITDFGVSAMLGSS-----MGQRDTFVGTYNYMSP---ERISGSTYDYSSDIWSLGLVVL 257
           +I DFGVSA L +         R TFVGT  +M+P   E++ G  YD+ +DIWS G+  +
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG--YDFKADIWSFGITAI 213
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPD-----QFSPEFCSFVSACI 310
           E A G  PY        +P    L+  +   PP   T   D     ++   F   +S C+
Sbjct: 214 ELATGAAPY------HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL 267
Query: 311 QKDPXXXXXXXXXXXHPFIKK 331
           QKDP           H F +K
Sbjct: 268 QKDPEKRPTAAELLRHKFFQK 288

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 126/243 (51%), Gaps = 11/243 (4%)
Query: 89  KWVGRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           K  G+  A+K  +M+++++ R++++  E+ I +     +VV  Y S+     + +V+E++
Sbjct: 67  KHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFL 124
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
           + G+L DI+   + + E  +A VC  VL+ L YLHN+  VIHRDIK  ++L+   G +K+
Sbjct: 125 EGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKL 182
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           +DFG  A +   + +R   VGT  +M+PE IS   Y    DIWSLG++V+E   G  PY 
Sbjct: 183 SDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 242
Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHP 327
                Q+     + L      PP      + S     F+   + ++P           HP
Sbjct: 243 NEPPLQAMRRIRDSL------PPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHP 296
Query: 328 FIK 330
           F+K
Sbjct: 297 FLK 299

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 12/225 (5%)
Query: 96  ALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           ALK +Q+   +  + R   ++E+ + +     +V+  Y SF  +  +++VLE  D G L+
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 154 DIIR----QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            +I+    Q + I E  +     Q+   L ++H+ R V+HRDIKP+N+ +   G VK+ D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGD 179
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS 269
            G+     S      + VGT  YMSPERI  + Y++ SDIWSLG ++ E A  + P+   
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 270 EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           +      + Y L + I +   P  P D +S E    V+ CI  DP
Sbjct: 240 K-----MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 120/233 (51%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +    +SF  +  + 
Sbjct: 169 LVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 227
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+E++V++RD+K  NL+++ 
Sbjct: 228 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 287
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+            TF GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 288 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 347
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++     +EL+  ++E       P    PE  S +S  ++KDP
Sbjct: 348 GRLPFYNQDHEK----LFELI--LMEE---IRFPRTLGPEAKSLLSGLLKKDP 391

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 120/233 (51%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +    +SF  +  + 
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+E++V++RD+K  NL+++ 
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+            TF GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 285 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++     +EL+  ++E       P    PE  S +S  ++KDP
Sbjct: 345 GRLPFYNQDHEK----LFELI--LMEE---IRFPRTLGPEAKSLLSGLLKKDP 388

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 26  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 84
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 143
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S      TF GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 144 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 203
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P   SPE  S ++  ++KDP
Sbjct: 204 GRLPFYNQDHERLFELI--LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 140
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S      TF GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P   SPE  S ++  ++KDP
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 244

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 140
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S      TF GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P   SPE  S ++  ++KDP
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 244

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 31  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY  RG +   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 91  ILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 149
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 150 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 208 KPPFEANTYQETY 220

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 27  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 87  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 145
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +RDT  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 146 GELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 204 KPPFEANTYQETY 216

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 105/184 (57%), Gaps = 3/184 (1%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA K++   M ++   ++++  E+ I+++    HVV  +  F  +  + +VLE   R S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q +QG+ YLHN R VIHRD+K  NL +N   +VKI DFG
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++ T  GT NY++PE +    + +  DIWSLG ++    +G+ P+  S  
Sbjct: 188 LATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247
Query: 272 QQSW 275
           ++++
Sbjct: 248 KETY 251

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +    +SF  +  + 
Sbjct: 26  LVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 84
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+E++V++RD+K  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 144
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+             F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 145 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 204
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P    PE  S +S  ++KDP
Sbjct: 205 GRLPFYNQDHEKLFELI--LMEEI-------RFPRTLGPEAKSLLSGLLKKDP 248

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +    +SF  +  + 
Sbjct: 28  LVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 86
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+E++V++RD+K  NL+++ 
Sbjct: 87  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 146
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+             F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 147 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 206
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P    PE  S +S  ++KDP
Sbjct: 207 GRLPFYNQDHEKLFELI--LMEEI-------RFPRTLGPEAKSLLSGLLKKDP 250

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LV+ K  GR +A+KI++  +   ++E+    + E ++ Q S+   +    +SF  +  + 
Sbjct: 27  LVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 85
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+E++V++RD+K  NL+++ 
Sbjct: 86  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 145
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+             F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 146 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P    PE  S +S  ++KDP
Sbjct: 206 GRLPFYNQDHEKLFELI--LMEEI-------RFPRTLGPEAKSLLSGLLKKDP 249

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++ T  GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 223 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 256

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 104 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++ T  GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 223 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 108 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 166
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++ T  GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 167 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 226
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 227 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 52  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 170
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +RD   GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 171 GELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 229 KPPFEANTYQETY 241

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 117/233 (50%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 140
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S       F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P   SPE  S ++  ++KDP
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 244

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 114 QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVV 170
           +E+ +++  +  ++V    SF  NG I + +E +  GSL+ ++R     L   E  +   
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGT 229
            KQ+L+GL YLH+ + ++HRDIK  N+L+N + G +KI+DFG S  L       +TF GT
Sbjct: 114 TKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 172
Query: 230 YNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE 287
             YM+PE I      Y  ++DIWSLG  ++E A G+ P+ +  + Q+  + +++   + +
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKV--GMFK 228
Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDP 314
             P    P+  S E  +F+  C + DP
Sbjct: 229 VHPEI--PESMSAEAKAFILKCFEPDP 253

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 116/233 (49%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 28  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 86
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 87  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 145
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S       F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 146 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++       L E I+        P   SPE  S ++  ++KDP
Sbjct: 206 GRLPFYNQDHER-------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDP 249

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 117/233 (50%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 140
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S       F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++ +     L+E I         P   SPE  S ++  ++KDP
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 244

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 114 QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVV 170
           +E+ +++  +  ++V    SF  NG I + +E +  GSL+ ++R     L   E  +   
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGT 229
            KQ+L+GL YLH+ + ++HRDIK  N+L+N + G +KI+DFG S  L       +TF GT
Sbjct: 128 TKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
Query: 230 YNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE 287
             YM+PE I      Y  ++DIWSLG  ++E A G+ P+ +  + Q+  + +++   + +
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKV--GMFK 242
Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDP 314
             P    P+  S E  +F+  C + DP
Sbjct: 243 VHPEI--PESMSAEAKAFILKCFEPDP 267

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 116/233 (49%), Gaps = 14/233 (6%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K  GR +A+KI++  +   ++E+    V E ++ Q ++   +    ++F  +  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY + G L   + + +   E        +++  L YLH+ R V++RDIK  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK 140
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG+     S       F GT  Y++PE +  + Y  + D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+   + ++       L E I+        P   SPE  S ++  ++KDP
Sbjct: 201 GRLPFYNQDHER-------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDP 244

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 52  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 111
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 112 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 170
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 171 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 229 KPPFEANTYQETY 241

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 31  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY  RG +   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 91  ILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 149
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 150 GELKIADFGWSVHAPSS--RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 208 KPPFEANTYQETY 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +RD   GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 206 KPPFEANTYQETY 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 104/184 (56%), Gaps = 3/184 (1%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA K++   M ++   ++++  E+ I+++    HVV  +  F  +  + +VLE   R S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q +QG+ YLHN R VIHRD+K  NL +N   +VKI DFG
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +    + +  DIWSLG ++    +G+ P+  S  
Sbjct: 188 LATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247
Query: 272 QQSW 275
           ++++
Sbjct: 248 KETY 251

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 104/184 (56%), Gaps = 3/184 (1%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA K++   M ++   ++++  E+ I+++    HVV  +  F  +  + +VLE   R S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q +QG+ YLHN R VIHRD+K  NL +N   +VKI DFG
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +    + +  DIWSLG ++    +G+ P+  S  
Sbjct: 188 LATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247
Query: 272 QQSW 275
           ++++
Sbjct: 248 KETY 251

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 31  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 91  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 149
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 150 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG 207
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 208 KPPFEANTYQETY 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 186
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 247 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 280

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 126 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 184
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 185 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 244
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 245 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 278

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 43  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 102
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 103 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 161
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 162 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 219
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 220 KPPFEANTYQETY 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 104/184 (56%), Gaps = 3/184 (1%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA K++   M ++   ++++  E+ I+++    HVV  +  F  +  + +VLE   R S
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q +QG+ YLHN R VIHRD+K  NL +N   +VKI DFG
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFG 171
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +    + +  DIWSLG ++    +G+ P+  S  
Sbjct: 172 LATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 231
Query: 272 QQSW 275
           ++++
Sbjct: 232 KETY 235

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 206 KPPFEANTYQETY 218

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 31  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 91  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 149
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 150 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 208 KPPFEANTYQETY 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 25  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 84
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 85  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 143
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 144 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 201
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 202 KPPFEANTYQETY 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 119/247 (48%), Gaps = 14/247 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXX 322
           + P+  +  Q+++            S      PD  +      +S  ++ +P        
Sbjct: 206 KPPFEANTYQETYKRI---------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 256
Query: 323 XXXHPFI 329
              HP+I
Sbjct: 257 VLEHPWI 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 27  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 87  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 145
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 146 GELKIADFGWSCHAPSS--RRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 204 KPPFEANTYQETY 216

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 30  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 89
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 90  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 148
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 149 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 207 KPPFEANTYQETY 219

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R +    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 30  LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 89
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 90  ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSN 148
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +RDT  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 149 GELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
Query: 263 RFPYMQSEDQQSW 275
             P+     Q+++
Sbjct: 207 MPPFEAHTYQETY 219

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 119/247 (48%), Gaps = 14/247 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 23  LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 82
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 83  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 141
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 142 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 199
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXX 322
           + P+  +  Q+++            S      PD  +      +S  ++ +P        
Sbjct: 200 KPPFEANTYQETYKRI---------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 250
Query: 323 XXXHPFI 329
              HP+I
Sbjct: 251 VLEHPWI 257

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 94  LFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGS 151
           +FA KI+   + ++   R+++  E+ I+++    HVV  +  F  N  + +VLE   R S
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           L ++ ++ K + EP      +Q++ G  YLH  R VIHRD+K  NL +N   EVKI DFG
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFG 160
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           ++  +     ++    GT NY++PE +S   + +  D+WS+G ++    +G+ P+  S  
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++++    +   +I         P   +P   S +   +Q DP
Sbjct: 221 KETYLRIKKNEYSI---------PKHINPVAASLIQKMLQTDP 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/185 (34%), Positives = 100/185 (54%), Gaps = 7/185 (3%)
Query: 85  LVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L R K    + ALK++   Q+  +E +  Q+ +E++I    +  +++  Y+ F+    I 
Sbjct: 33  LAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE+  RG L   +++     E   A   +++   L Y H ER VIHRDIKP NLL+ +
Sbjct: 92  LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGY 150
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           KGE+KI DFG S    S   +R    GT +Y+ PE I G T+D   D+W  G++  E  +
Sbjct: 151 KGELKIADFGWSVHAPSL--RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 208
Query: 262 GRFPY 266
           G  P+
Sbjct: 209 GMPPF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/185 (34%), Positives = 100/185 (54%), Gaps = 7/185 (3%)
Query: 85  LVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L R K    + ALK++   Q+  +E +  Q+ +E++I    +  +++  Y+ F+    I 
Sbjct: 32  LAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE+  RG L   +++     E   A   +++   L Y H ER VIHRDIKP NLL+ +
Sbjct: 91  LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGY 149
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           KGE+KI DFG S    S   +R    GT +Y+ PE I G T+D   D+W  G++  E  +
Sbjct: 150 KGELKIADFGWSVHAPSL--RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 262 GRFPY 266
           G  P+
Sbjct: 208 GMPPF 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 28  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 87
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 88  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 146
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI +FG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 147 GELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 205 KPPFEANTYQETY 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI +FG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 206 KPPFEANTYQETY 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 206 KPPFEANTYQETY 218

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 31  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 91  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 149
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 150 GELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 208 KPPFEANTYQETY 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 28  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 87
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 88  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 146
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 147 GELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 205 KPPFEANTYQETY 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 27  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 87  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 145
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 146 GELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 204 KPPFEANTYQETY 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 26  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q+++
Sbjct: 203 KPPFEANTYQETY 215

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 118/247 (47%), Gaps = 14/247 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 29  LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 89  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSA 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 148 GELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXX 322
           + P+  +  Q+++            S      PD  +      +S  ++ +P        
Sbjct: 206 KPPFEANTYQETYKRI---------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 256
Query: 323 XXXHPFI 329
              HP+I
Sbjct: 257 VLEHPWI 263

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 103/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R +    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+    + L
Sbjct: 30  LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 89
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H++R VIHRDIKP NLL+   
Sbjct: 90  ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSN 148
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R T  GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 149 GELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206
Query: 263 RFPYMQSEDQQSW 275
             P+     Q+++
Sbjct: 207 MPPFEAHTYQETY 219

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  FA+KI+  Q  ++ +  +  + E +I QA     +V   +SF  N  + +
Sbjct: 59  LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  FA+KI+  Q  ++ +  +  + E +I QA     +V   +SF  N  + +
Sbjct: 59  LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  FA+KI+  Q  ++ +  +  + E +I QA     +V   +SF  N  + +
Sbjct: 59  LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 120/235 (51%), Gaps = 8/235 (3%)
Query: 85  LVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K   R++A+++++   +N  E+I     ++    QAS    +V  +  F     + 
Sbjct: 70  LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   +++ + + E +      ++   L YLH ER +I+RD+K  N+L++ 
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDS 188
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +K+TD+G+            TF GT NY++PE + G  Y +S D W+LG+++ E   
Sbjct: 189 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 262 GRFPY--MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+  + S D     +   L + I+E       P   S +  S + + + KDP
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDP 301

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 104/193 (53%), Gaps = 5/193 (2%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++     E+  +  Q+ +E++I    +  +++  Y  F+ +  + L
Sbjct: 26  LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYL 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY   G++   ++++    E   A    ++   L Y H+++ VIHRDIKP NLL+   
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK-VIHRDIKPENLLLGSA 144
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    SS  +R    GT +Y+ PE I G  +D   D+WSLG++  E  +G
Sbjct: 145 GELKIADFGWSVHAPSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202
Query: 263 RFPYMQSEDQQSW 275
           + P+  +  Q ++
Sbjct: 203 KPPFEANTYQDTY 215

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           VLEY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+ DFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 8/235 (3%)
Query: 85  LVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K   R++A+K+++   +N  E+I     ++    QAS    +V  +  F     + 
Sbjct: 27  LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   +++ + + E +      ++   L YLH ER +I+RD+K  N+L++ 
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDS 145
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +K+TD+G+             F GT NY++PE + G  Y +S D W+LG+++ E   
Sbjct: 146 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 262 GRFPY--MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+  + S D     +   L + I+E       P   S +  S + + + KDP
Sbjct: 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDP 258

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 80  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 140 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 198
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G   T  GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 199 GYIQVTDFGFAKRV---KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 256 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   E  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADEPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 111
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 112 VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 170
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 171 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 228 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 269

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 8/235 (3%)
Query: 85  LVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K   R++A+K+++   +N  E+I     ++    QAS    +V  +  F     + 
Sbjct: 23  LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 82
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   +++ + + E +      ++   L YLH ER +I+RD+K  N+L++ 
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDS 141
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +K+TD+G+             F GT NY++PE + G  Y +S D W+LG+++ E   
Sbjct: 142 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 201
Query: 262 GRFPY--MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+  + S D     +   L + I+E       P   S +  S + + + KDP
Sbjct: 202 GRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDP 254

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 8/235 (3%)
Query: 85  LVRHKWVGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           LVR K   R++A+K+++   +N  E+I     ++    QAS    +V  +  F     + 
Sbjct: 38  LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 97
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   +++ + + E +      ++   L YLH ER +I+RD+K  N+L++ 
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDS 156
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +K+TD+G+             F GT NY++PE + G  Y +S D W+LG+++ E   
Sbjct: 157 EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 216
Query: 262 GRFPY--MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           GR P+  + S D     +   L + I+E       P   S +  S + + + KDP
Sbjct: 217 GRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSMSVKAASVLKSFLNKDP 269

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 54  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 113
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 114 VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 172
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 173 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 230 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 271

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 120 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 111
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 112 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 170
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 171 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 228 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 269

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 80  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 140 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 198
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 199 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 256 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 80  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 140 VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 198
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 199 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 256 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 45  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 104
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 105 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 163
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+  T  GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 164 GYIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 221 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 262

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+  T  GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 46  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 105
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 106 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDEQ 164
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 165 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 222 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 263

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EYM  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+ DFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EYM  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+ DFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLIIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCSHVVVCYHSFYHNGVISL 142
            G+++A+K +    ++ I+ +  + L +N+           C  +V   ++F+    +S 
Sbjct: 213 TGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +L+ M+ G L   + Q     E  +     +++ GL ++HN R V++RD+KP+N+L++  
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEH 328
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAI 261
           G V+I+D G++     S  +    VGT+ YM+PE +  G  YD S+D +SLG ++ +   
Sbjct: 329 GHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  P+ Q + +         L   VE       PD FSPE  S +   +Q+D
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTMAVEL------PDSFSPELRSLLEGLLQRD 432

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCSHVVVCYHSFYHNGVISL 142
            G+++A+K +    ++ I+ +  + L +N+           C  +V   ++F+    +S 
Sbjct: 212 TGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 268
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +L+ M+ G L   + Q     E  +     +++ GL ++HN R V++RD+KP+N+L++  
Sbjct: 269 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEH 327
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAI 261
           G V+I+D G++     S  +    VGT+ YM+PE +  G  YD S+D +SLG ++ +   
Sbjct: 328 GHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 385
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  P+ Q + +         L   VE       PD FSPE  S +   +Q+D
Sbjct: 386 GHSPFRQHKTKDKHEIDRMTLTMAVEL------PDSFSPELRSLLEGLLQRD 431

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 15/238 (6%)
Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVV 170
           E KI        +V   ++F     + LV+  M+ G +   I  V        EP     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
             Q++ GL +LH +R++I+RD+KP N+L++  G V+I+D G++  L +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            +M+PE + G  YD+S D ++LG+ + E    R P+    ++       EL + ++E   
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRVLEQ-- 408
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXX-----XHPFIKKFEDKDIDLGILV 343
               PD+FSP    F  A +QKDP                HP  +    + ++ G+L 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 15/238 (6%)
Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVV 170
           E KI        +V   ++F     + LV+  M+ G +   I  V        EP     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
             Q++ GL +LH +R++I+RD+KP N+L++  G V+I+D G++  L +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            +M+PE + G  YD+S D ++LG+ + E    R P+    ++       EL + ++E   
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRVLEQ-- 408
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXX-----XHPFIKKFEDKDIDLGILV 343
               PD+FSP    F  A +QKDP                HP  +    + ++ G+L 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 15/238 (6%)
Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVV 170
           E KI        +V   ++F     + LV+  M+ G +   I  V        EP     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
             Q++ GL +LH +R++I+RD+KP N+L++  G V+I+D G++  L +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            +M+PE + G  YD+S D ++LG+ + E    R P+    ++       EL + ++E   
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRVLEQ-- 408
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXX-----XHPFIKKFEDKDIDLGILV 343
               PD+FSP    F  A +QKDP                HP  +    + ++ G+L 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ + A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG++  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCSHVVVCYHSFYHNGVISL 142
            G+++A+K +    ++ I+ +  + L +N+           C  +V   ++F+    +S 
Sbjct: 213 TGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +L+ M+ G L   + Q     E  +     +++ GL ++HN R V++RD+KP+N+L++  
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEH 328
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAI 261
           G V+I+D G++     S  +    VGT+ YM+PE +  G  YD S+D +SLG ++ +   
Sbjct: 329 GHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  P+ Q + +         L   VE       PD FSPE  S +   +Q+D
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTMAVEL------PDSFSPELRSLLEGLLQRD 432

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQ--------ASQCSHVVVCYHSFYHNGVISL 142
            G+++A+K +    ++ I+ +  + L +N+           C  +V   ++F+    +S 
Sbjct: 213 TGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +L+ M+ G L   + Q     E  +     +++ GL ++HN R V++RD+KP+N+L++  
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEH 328
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAI 261
           G V+I+D G++     S  +    VGT+ YM+PE +  G  YD S+D +SLG ++ +   
Sbjct: 329 GHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  P+ Q + +         L   VE       PD FSPE  S +   +Q+D
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTMAVEL------PDSFSPELRSLLEGLLQRD 432

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 15/238 (6%)
Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVV 170
           E KI        +V   ++F     + LV+  M+ G +   I  V        EP     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
             Q++ GL +LH +R++I+RD+KP N+L++  G V+I+D G++  L +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            +M+PE + G  YD+S D ++LG+ + E    R P+    ++       EL + ++E   
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRVLEQ-- 408
Query: 291 PTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXX-----XHPFIKKFEDKDIDLGILV 343
               PD+FSP    F  A +QKDP                HP  +    + ++ G+L 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 26/266 (9%)
Query: 92  GRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           GR+ ALK I+++ ++E I    ++E+ + +     ++V      +    ++LV E+M++ 
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 151 SLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            L  ++ + KT L +  + +   Q+L+G+ + H  R ++HRD+KP NLL+N  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  +      V T  Y +P+ + GS  Y  S DIWS+G +  E   G+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 267 MQSEDQ-------------QSWPSFYEL------LEAIVESPPPTAPPDQFSPEFCSFVS 307
           +  +DQ             + WP   EL         + E  P ++    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 308 ACIQKDPXXXXXXXXXXXHPFIKKFE 333
             +  DP           HP+ K  +
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++P  I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 26/266 (9%)
Query: 92  GRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           GR+ ALK I+++ ++E I    ++E+ + +     ++V      +    ++LV E+M++ 
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 151 SLADIIRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            L  ++ + KT L+   + +   Q+L+G+ + H  R ++HRD+KP NLL+N  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  +      V T  Y +P+ + GS  Y  S DIWS+G +  E   G+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 267 MQSEDQ-------------QSWPSFYEL------LEAIVESPPPTAPPDQFSPEFCSFVS 307
           +  +DQ             + WP   EL         + E  P ++    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 308 ACIQKDPXXXXXXXXXXXHPFIKKFE 333
             +  DP           HP+ K  +
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +     SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 120 VMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE-- 145
           +K  G   ALK ++++ +E      ++E+ + +  +  ++V  Y   +    ++LV E  
Sbjct: 26  NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 146 ------YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
                 YMD  ++ +  R ++  L  Y      Q+LQGL + H E  ++HRD+KP NLL+
Sbjct: 86  DNDLKKYMDSRTVGNTPRGLELNLVKYFQW---QLLQGLAFCH-ENKILHRDLKPQNLLI 141
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLE 258
           N +G++K+ DFG++   G  +    + V T  Y +P+ + GS TY  S DIWS G ++ E
Sbjct: 142 NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 259 CAIGR--FPYMQSEDQQS-------------WPSFYEL--LEAIVESPPPTAPPDQFSP- 300
              G+  FP    E+Q               WPS  +L      ++  PP        P 
Sbjct: 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 301 -------EFCSFVSACIQKDPXXXXXXXXXXXHPFIKKF 332
                      F+   +Q +P           HP+  ++
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+ DFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + ++FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG++  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +     SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 120 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 7/187 (3%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +V+     +++A+K +  Q  ++    + + +EL+I Q  +   +V  ++SF     + +
Sbjct: 33  IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V++ +  G L   ++Q     E  + +   +++  L YL N+R +IHRD+KP N+L++  
Sbjct: 93  VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR-IIHRDMKPDNILLDEH 151
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLEC 259
           G V ITDF ++AML     Q  T  GT  YM+PE  S   G+ Y ++ D WSLG+   E 
Sbjct: 152 GHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
Query: 260 AIGRFPY 266
             GR PY
Sbjct: 211 LRGRRPY 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +     SF  N  + +
Sbjct: 60  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYM 119
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 120 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 178
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +K+TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 179 GYIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 236 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 277

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY+  G +   +R++    EP+      Q++    YLH+   +I+RD+KP NLL++ +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT   ++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 113/231 (48%), Gaps = 15/231 (6%)
Query: 85  LVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           LV+H   G  +A+KI+  Q  ++ +  +  + E +I QA     +V    SF  N  + +
Sbjct: 59  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G +   +R++    EP+      Q++    YLH+   +I+RD+KP NL+++ +
Sbjct: 119 VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLMIDQQ 177
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           G +++TDFG +  +    G+     GT  Y++PE I    Y+ + D W+LG+++ E A G
Sbjct: 178 GYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
             P+   +  Q       + E IV        P  FS +    +   +Q D
Sbjct: 235 YPPFFADQPIQ-------IYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + ++FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 261 IGRFPY 266
            G  P+
Sbjct: 230 AGLPPF 235

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 28  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 87
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 88  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 146
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 147 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 261 IGRFPY 266
            G  P+
Sbjct: 207 AGLPPF 212

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 121/225 (53%), Gaps = 13/225 (5%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDR 149
           G L+A+K+++     ++R ++  +++ +  +  +H  VV  +++F   G + L+L+++  
Sbjct: 56  GHLYAMKVLK-KATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRG 114
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G L   + +     E  +     ++  GL +LH+   +I+RD+KP N+L++ +G +K+TD
Sbjct: 115 GDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS-LGIIYRDLKPENILLDEEGHIKLTD 173
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS 269
           FG+S        +  +F GT  YM+PE ++   + +S+D WS G+++ E   G  P+ Q 
Sbjct: 174 FGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF-QG 232
Query: 270 EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           +D++      E +  I+++      P   S E  S + A  +++P
Sbjct: 233 KDRK------ETMTLILKA--KLGMPQFLSTEAQSLLRALFKRNP 269

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 27  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 86
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 87  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 145
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 146 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 261 IGRFPY 266
            G  P+
Sbjct: 206 AGLPPF 211

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 125/248 (50%), Gaps = 14/248 (5%)
Query: 85  LVRHKWVGRLFALKII-QMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R K    + ALK++ +  I++E +  Q+ +E++I       +++  Y+ FY    I L
Sbjct: 41  LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYL 100
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +LEY  RG L   +++  T  E   A + +++   L+Y H ++ VIHRDIKP NLL+  K
Sbjct: 101 ILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK-VIHRDIKPENLLLGLK 159
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
           GE+KI DFG S    S   +R T  GT +Y+ PE I G  ++   D+W +G++  E  +G
Sbjct: 160 GELKIADFGWSVHAPSL--RRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXX 322
             P+  +   +++    + ++    +  PT   D         +S  ++ +P        
Sbjct: 218 NPPFESASHNETYRRIVK-VDLKFPASVPTGAQD--------LISKLLRHNPSERLPLAQ 268
Query: 323 XXXHPFIK 330
              HP+++
Sbjct: 269 VSAHPWVR 276

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 261 IGRFPY 266
            G  P+
Sbjct: 227 AGLPPF 232

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 92  GRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G  FALK I++  ++E I    ++E+ I +  + S++V  Y   +    + LV E++D+ 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 151 SLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            L  ++   +  LE   A     Q+L G+ Y H +R V+HRD+KP NLL+N +GE+KI D
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIAD 143
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  + +    V T  Y +P+ + GS  Y  + DIWS+G +  E   G   FP 
Sbjct: 144 FGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203
Query: 267 MQSEDQ-------------QSWPSFYELLE-----AIVESPPPTAPPDQFSPEFCSFVSA 308
           +   DQ             ++WP+  EL +      + E  P  +            +S 
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 309 CIQKDPXXXXXXXXXXXHPFIKK 331
            ++ DP           H + K+
Sbjct: 264 MLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 92  GRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G  FALK I++  ++E I    ++E+ I +  + S++V  Y   +    + LV E++D+ 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 151 SLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            L  ++   +  LE   A     Q+L G+ Y H +R V+HRD+KP NLL+N +GE+KI D
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIAD 143
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  + +    V T  Y +P+ + GS  Y  + DIWS+G +  E   G   FP 
Sbjct: 144 FGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPG 203
Query: 267 MQSEDQ-------------QSWPSFYELLE-----AIVESPPPTAPPDQFSPEFCSFVSA 308
           +   DQ             ++WP+  EL +      + E  P  +            +S 
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 309 CIQKDPXXXXXXXXXXXHPFIKK 331
            ++ DP           H + K+
Sbjct: 264 MLKLDPNQRITAKQALEHAYFKE 286

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 261 IGRFPY 266
            G  P+
Sbjct: 230 AGLPPF 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 261 IGRFPY 266
            G  P+
Sbjct: 227 AGLPPF 232

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 25  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 84
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 85  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 143
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 144 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 261 IGRFPY 266
            G  P+
Sbjct: 204 AGLPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 26  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 86  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 144
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 261 IGRFPY 266
            G  P+
Sbjct: 205 AGLPPF 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 261 IGRFPY 266
            G  P+
Sbjct: 227 AGLPPF 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 53  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 112
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 113 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 171
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 172 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 261 IGRFPY 266
            G  P+
Sbjct: 232 AGLPPF 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 261 IGRFPY 266
            G  P+
Sbjct: 227 AGLPPF 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G   A+KII+ +          ++ E+ + +     +++  Y  F       L
Sbjct: 22  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 81
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+E    G L D I   +   E   AV+ KQVL G  YLH + +++HRD+KP NLL+  K
Sbjct: 82  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH-KHNIVHRDLKPENLLLESK 140
Query: 203 GE---VKITDFGVSAM--LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
                +KI DFG+SA   +G  M +R   +GT  Y++PE +    YD   D+WS G+++ 
Sbjct: 141 SRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAPEVLR-KKYDEKCDVWSCGVILY 196
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDPX 315
               G  P+    DQ       E+L+ + +      PPD  Q S E    V   +  +P 
Sbjct: 197 ILLCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPS 249
Query: 316 XXXXXXXXXXHPFIKKF-EDKDIDLG--ILVGSL 346
                     HP+I KF   K  D+G   L G+L
Sbjct: 250 KRISAEEALNHPWIVKFCSQKHTDVGKHALTGAL 283

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 261 IGRFPY 266
            G  P+
Sbjct: 229 AGLPPF 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + ++FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 261 IGRFPY 266
            G  P+
Sbjct: 226 AGLPPF 231

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 92  GRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           G  FALK I++  ++E I    ++E+ I +  + S++V  Y   +    + LV E++D+ 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 151 SLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            L  ++   +  LE   A     Q+L G+ Y H +R V+HRD+KP NLL+N +GE+KI D
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIAD 143
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  + +    + T  Y +P+ + GS  Y  + DIWS+G +  E   G   FP 
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203
Query: 267 MQSEDQ-------------QSWPSFYELLE-----AIVESPPPTAPPDQFSPEFCSFVSA 308
           +   DQ             ++WP+  EL +      + E  P  +            +S 
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 309 CIQKDPXXXXXXXXXXXHPFIKK 331
            ++ DP           H + K+
Sbjct: 264 MLKLDPNQRITAKQALEHAYFKE 286

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 116/232 (50%), Gaps = 15/232 (6%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVIS 141
            L+R +  GR +A+K+++  I   +++      +    S  +H  ++  + +F     I 
Sbjct: 23  HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           ++++Y++ G L  ++R+ +    P       +V   L YLH+ + +I+RD+KP N+L++ 
Sbjct: 83  MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK 141
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G +KITDFG +  +           GT +Y++PE +S   Y+ S D WS G+++ E   
Sbjct: 142 NGHIKITDFGFAKYVPDVTY---XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  P+    D  +  ++ ++L A +  PP       F+ +    +S  I +D
Sbjct: 199 GYTPFY---DSNTMKTYEKILNAELRFPP------FFNEDVKDLLSRLITRD 241

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 32  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 91
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 92  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 150
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 151 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 261 IGRFPY 266
            G  P+
Sbjct: 211 AGLPPF 216

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 261 IGRFPY 266
            G  P+
Sbjct: 226 AGLPPF 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 5/186 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L R     R +A+KI++    I+E     + +E  +         V  Y  F  +  +  
Sbjct: 55  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYF 114
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
            L Y   G L   IR++ +  E        +++  L YLH  + +IHRD+KP N+L+N  
Sbjct: 115 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 173
Query: 203 GEVKITDFGVSAMLG--SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
             ++ITDFG + +L   S   + + FVGT  Y+SPE ++  +   SSD+W+LG ++ +  
Sbjct: 174 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 261 IGRFPY 266
            G  P+
Sbjct: 234 AGLPPF 239

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 17/227 (7%)
Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEP 165
           E  + I++E++  Q  +  + +     +       LV+EY   GS +D++    K + E 
Sbjct: 96  EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEV 154
Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            +A V    LQGL YLH+  ++IHRD+K  N+L++  G VK+ DFG ++++  +    + 
Sbjct: 155 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NX 209
Query: 226 FVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
           FVGT  +M+PE I       YD   D+WSLG+  +E A  + P     +  +  + Y   
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH-- 264
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
             I ++  P      +S  F +FV +C+QK P           H F+
Sbjct: 265 --IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 17/227 (7%)
Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEP 165
           E  + I++E++  Q  +  + +     +       LV+EY   GS +D++    K + E 
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEV 115
Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            +A V    LQGL YLH+  ++IHRD+K  N+L++  G VK+ DFG ++++  +    + 
Sbjct: 116 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NX 170
Query: 226 FVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
           FVGT  +M+PE I       YD   D+WSLG+  +E A  + P        +       L
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------L 223
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
             I ++  P      +S  F +FV +C+QK P           H F+
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 21/257 (8%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G   A+KII+ +          ++ E+ + +     +++  Y  F       L
Sbjct: 39  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 98
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+E    G L D I   +   E   AV+ KQVL G  YLH + +++HRD+KP NLL+  K
Sbjct: 99  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH-KHNIVHRDLKPENLLLESK 157
Query: 203 GE---VKITDFGVSAM--LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
                +KI DFG+SA   +G  M +R   +GT  Y++PE +    YD   D+WS G+++ 
Sbjct: 158 SRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAPEVLR-KKYDEKCDVWSCGVILY 213
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDPX 315
               G  P+    DQ       E+L+ + +      PPD  Q S E    V   +  +P 
Sbjct: 214 ILLCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPS 266
Query: 316 XXXXXXXXXXHPFIKKF 332
                     HP+I KF
Sbjct: 267 KRISAEEALNHPWIVKF 283

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 103/191 (53%), Gaps = 8/191 (4%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
           + K    L ALK I++  +E      ++E+ + +  + +++V  +   +    ++LV EY
Sbjct: 22  KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +D+  L   +     I+  + + +   Q+L+GL Y H ++ V+HRD+KP NLL+N +GE+
Sbjct: 82  LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGEL 139
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECAIGR 263
           K+ DFG++          D  V T  Y  P+ + GST DYS+  D+W +G +  E A GR
Sbjct: 140 KLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
Query: 264 --FPYMQSEDQ 272
             FP    E+Q
Sbjct: 199 PLFPGSTVEEQ 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 27/238 (11%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-----------QCSHVVVCYHSFYHNGV 139
            G+L+A+K+++       +  IVQ+ K  + +           Q   +V  +++F     
Sbjct: 81  TGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + L+L+Y++ G L   + Q +   E  + +   +++  L +LH +  +I+RDIK  N+L+
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILL 192
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISG--STYDYSSDIWSLGLVV 256
           +  G V +TDFG+S    +   +R   F GT  YM+P+ + G  S +D + D WSLG+++
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E   G  P+    ++ S     E+   I++S PP   P + S      +   + KDP
Sbjct: 253 YELLTGASPFTVDGEKNSQA---EISRRILKSEPPY--PQEMSALAKDLIQRLLMKDP 305

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 18/245 (7%)
Query: 113 VQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV-- 170
           + E +I +      VV   +++     + LVL  M+ G L   I  +     P    V  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVG 228
             ++  GL  LH ER +++RD+KP N+L++  G ++I+D G++  +  G ++  R   VG
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VG 347
Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           T  YM+PE +    Y +S D W+LG ++ E   G+ P+ Q + +        L++ +   
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 404
Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPXXX-----XXXXXXXXHPFIKKFEDKDIDLGILV 343
             P    ++FSP+  S  S  + KDP                HP  KK   K +  G+L 
Sbjct: 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLE 462
Query: 344 GSLDP 348
               P
Sbjct: 463 PPFKP 467

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 24/253 (9%)
Query: 87  RHKWVGRLFALKIIQ------MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI 140
           +H+  G   A+KI+       +++  +IR++I Q LK+ +     H++  Y        I
Sbjct: 36  KHELTGHKVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRHP---HIIKLYQVISTPSDI 91
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLV 199
            +V+EY+  G L D I +   + E     + +Q+L G+ Y H  RH V+HRD+KP N+L+
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLL 149
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLE 258
           +     KI DFG+S M+      R +  G+ NY +PE ISG  Y     DIWS G+++  
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
              G  P+   +D      F ++ + I  +      P   +P   S +   +Q DP    
Sbjct: 209 LLCGTLPF---DDDHVPTLFKKICDGIFYT------PQYLNPSVISLLKHMLQVDPMKRA 259
Query: 319 XXXXXXXHPFIKK 331
                  H + K+
Sbjct: 260 TIKDIREHEWFKQ 272

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 18/245 (7%)
Query: 113 VQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV-- 170
           + E +I +      VV   +++     + LVL  M+ G L   I  +     P    V  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVG 228
             ++  GL  LH ER +++RD+KP N+L++  G ++I+D G++  +  G ++  R   VG
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VG 347
Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           T  YM+PE +    Y +S D W+LG ++ E   G+ P+ Q + +        L++ +   
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 404
Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPXXX-----XXXXXXXXHPFIKKFEDKDIDLGILV 343
             P    ++FSP+  S  S  + KDP                HP  KK   K +  G+L 
Sbjct: 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLE 462
Query: 344 GSLDP 348
               P
Sbjct: 463 PPFKP 467

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 117/230 (50%), Gaps = 15/230 (6%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE----IRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
            R K   ++ A+K I++  + E    I +  ++E+K+ Q     +++    +F H   IS
Sbjct: 29  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88
Query: 142 LVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           LV ++M+   L  II+    +L P ++       LQGL YLH +  ++HRD+KP+NLL++
Sbjct: 89  LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLD 146
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLEC 259
             G +K+ DFG++   GS        V T  Y +PE + G+  Y    D+W++G ++ E 
Sbjct: 147 ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 260 AIGRFPYMQSE-DQQSWPSFYELLEAIVESPPPTAPPDQFS-PEFCSFVS 307
            + R P++  + D       +E L     +P     PD  S P++ +F S
Sbjct: 207 LL-RVPFLPGDSDLDQLTRIFETL----GTPTEEQWPDMCSLPDYVTFKS 251

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 97/179 (54%), Gaps = 15/179 (8%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP+N++++
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMIS 150
Query: 201 HKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
               VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++SLG V+ 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 258 ECAIGRFPYM-QSEDQQSWPSFYELLEAIVESP-PPTAPPDQFSPEFCSFVSACIQKDP 314
           E   G  P+   S D  ++       + + E P PP+A  +  S +  + V   + K+P
Sbjct: 211 EVLTGEPPFTGDSPDSVAY-------QHVREDPIPPSARHEGLSADLDAVVLKALAKNP 262

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYH--NGVI 140
           Q +R K  G++   K +      E  KQ +V E+ + +  +  ++V  Y       N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 141 SLVLEYMDRGSLADII----RQVKTILEPYLAVVCKQVLQGLVYLHNERH----VIHRDI 192
            +V+EY + G LA +I    ++ + + E ++  V  Q+   L   H        V+HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 193 KPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
           KP+N+ ++ K  VK+ DFG++ +L        TFVGT  YMSPE+++  +Y+  SDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 253 GLVVLE-CAI 261
           G ++ E CA+
Sbjct: 203 GCLLYELCAL 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 122/227 (53%), Gaps = 19/227 (8%)
Query: 93  RLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYM 147
           +L+A+K+++   + +++ +R ++ +++ +    + +H  +V  +++F   G + L+L+++
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILV----EVNHPFIVKLHYAFQTEGKLYLILDFL 108
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             G L   + +     E  +     ++   L +LH+   +I+RD+KP N+L++ +G +K+
Sbjct: 109 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKL 167
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           TDFG+S        +  +F GT  YM+PE ++   +  S+D WS G+++ E   G  P+ 
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF- 226
Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           Q +D++      E +  I+++      P   SPE  S +    +++P
Sbjct: 227 QGKDRK------ETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 122/227 (53%), Gaps = 19/227 (8%)
Query: 93  RLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYM 147
           +L+A+K+++   + +++ +R ++ +++ +    + +H  +V  +++F   G + L+L+++
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILV----EVNHPFIVKLHYAFQTEGKLYLILDFL 109
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             G L   + +     E  +     ++   L +LH+   +I+RD+KP N+L++ +G +K+
Sbjct: 110 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKL 168
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           TDFG+S        +  +F GT  YM+PE ++   +  S+D WS G+++ E   G  P+ 
Sbjct: 169 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF- 227
Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           Q +D++      E +  I+++      P   SPE  S +    +++P
Sbjct: 228 QGKDRK------ETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNP 266

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 122/227 (53%), Gaps = 19/227 (8%)
Query: 93  RLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYM 147
           +L+A+K+++   + +++ +R ++ +++ +    + +H  +V  +++F   G + L+L+++
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILV----EVNHPFIVKLHYAFQTEGKLYLILDFL 108
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             G L   + +     E  +     ++   L +LH+   +I+RD+KP N+L++ +G +K+
Sbjct: 109 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKL 167
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           TDFG+S        +  +F GT  YM+PE ++   +  S+D WS G+++ E   G  P+ 
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF- 226
Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           Q +D++      E +  I+++      P   SPE  S +    +++P
Sbjct: 227 QGKDRK------ETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 11/177 (6%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP+N+L++
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANILIS 150
Query: 201 HKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
               VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++SLG V+ 
Sbjct: 151 ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E   G  P+  + D     ++  + E  +   PP+A  +  S +  + V   + K+P
Sbjct: 211 EVLTGEPPF--TGDSPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALAKNP 262

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 10/248 (4%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L   K  G+LFA+K I     +     I  E+ + +  +  ++V     +     + LV+
Sbjct: 40  LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVM 99
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NH 201
           + +  G L D I +     E   + + +QVL  + YLH    ++HRD+KP NLL    + 
Sbjct: 100 QLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDE 158
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           + ++ I+DFG+S M G       T  GT  Y++PE ++   Y  + D WS+G++      
Sbjct: 159 ESKIMISDFGLSKMEGKG-DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 217
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXX 321
           G  P+    D +    F ++L+A  E   P    D  S     F+   ++KDP       
Sbjct: 218 GYPPFYDENDSK---LFEQILKAEYEFDSPYW--DDISDSAKDFIRNLMEKDPNKRYTCE 272
Query: 322 XXXXHPFI 329
               HP+I
Sbjct: 273 QAARHPWI 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 117/260 (45%), Gaps = 25/260 (9%)
Query: 88  HKWVGRLFALKIIQMNIQ-------EEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGV 139
           H+  G  FA+KI+++  +       EE+R+   +E  I  Q +   H++    S+  +  
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV + M +G L D + +   + E     + + +L+ + +LH   +++HRD+KP N+L+
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILL 233
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST------YDYSSDIWSLG 253
           +   +++++DFG S  L      R+   GT  Y++PE +  S       Y    D+W+ G
Sbjct: 234 DDNMQIRLSDFGFSCHLEPGEKLRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACIQ 311
           +++     G  P+              +L  I+E     + P  D  S      +S  +Q
Sbjct: 293 VILFTLLAGSPPFWHRRQ-------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQ 345
Query: 312 KDPXXXXXXXXXXXHPFIKK 331
            DP           HPF ++
Sbjct: 346 VDPEARLTAEQALQHPFFER 365

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 4/185 (2%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYH-SFYHNGVIS 141
           L RHK     +A+K++Q    ++++  K I+ E  +   +     +V  H SF     + 
Sbjct: 56  LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            VL+Y++ G L   +++ +  LEP       ++   L YLH+  ++++RD+KP N+L++ 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS 174
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G + +TDFG+            TF GT  Y++PE +    YD + D W LG V+ E   
Sbjct: 175 QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 262 GRFPY 266
           G  P+
Sbjct: 235 GLPPF 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 119/243 (48%), Gaps = 21/243 (8%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-- 141
            L R   + R  A+K+++ ++  +    +    +   A+  +H  +   + Y  G     
Sbjct: 29  HLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV--AVYDTGEAETP 86
Query: 142 ------LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKP 194
                 +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP
Sbjct: 87  AGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKP 144
Query: 195 SNLLVNHKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           +N++++    VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG V+ E   G  P+  + D     ++  + E  +   PP+A  +  S +  + V   + 
Sbjct: 205 LGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALA 259
Query: 312 KDP 314
           K+P
Sbjct: 260 KNP 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 95/187 (50%), Gaps = 4/187 (2%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQ---ELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
            G++FA+K+++  +     K       E  I +  +   +V   ++F   G + L+LEY+
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL 103
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             G L   + +    +E        ++   L +LH ++ +I+RD+KP N+++NH+G VK+
Sbjct: 104 SGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKL 162
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           TDFG+            TF GT  YM+PE +  S ++ + D WSLG ++ +   G  P+ 
Sbjct: 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222
Query: 268 QSEDQQS 274
               +++
Sbjct: 223 GENRKKT 229

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 119/243 (48%), Gaps = 21/243 (8%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-- 141
            L R   + R  A+K+++ ++  +    +    +   A+  +H  +   + Y  G     
Sbjct: 29  HLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV--AVYATGEAETP 86
Query: 142 ------LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKP 194
                 +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP
Sbjct: 87  AGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKP 144
Query: 195 SNLLVNHKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           +N++++    VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG V+ E   G  P+  + D     ++  + E  +   PP+A  +  S +  + V   + 
Sbjct: 205 LGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALA 259
Query: 312 KDP 314
           K+P
Sbjct: 260 KNP 262

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 119/243 (48%), Gaps = 21/243 (8%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-- 141
            L R   + R  A+K+++ ++  +    +    +   A+  +H  +   + Y  G     
Sbjct: 46  HLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV--AVYDTGEAETP 103
Query: 142 ------LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKP 194
                 +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP
Sbjct: 104 AGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKP 161
Query: 195 SNLLVNHKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
           +N++++    VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++S
Sbjct: 162 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 221
Query: 252 LGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQ 311
           LG V+ E   G  P+  + D     ++  + E  +   PP+A  +  S +  + V   + 
Sbjct: 222 LGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALA 276
Query: 312 KDP 314
           K+P
Sbjct: 277 KNP 279

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 12/190 (6%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYH--NGVI 140
           Q +R K  G++   K +      E  KQ +V E+ + +  +  ++V  Y       N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 141 SLVLEYMDRGSLADII----RQVKTILEPYLAVVCKQVLQGLVYLHNERH----VIHRDI 192
            +V+EY + G LA +I    ++ + + E ++  V  Q+   L   H        V+HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 193 KPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
           KP+N+ ++ K  VK+ DFG++ +L         FVGT  YMSPE+++  +Y+  SDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 253 GLVVLE-CAI 261
           G ++ E CA+
Sbjct: 203 GCLLYELCAL 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 11/177 (6%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP+N++++
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMIS 150
Query: 201 HKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
               VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+  G + D  SD++SLG V+ 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E   G  P+  + D     ++  + E  +   PP+A  +  S +  + V   + K+P
Sbjct: 211 EVLTGEPPF--TGDSPVSVAYQHVREDPI---PPSARHEGLSADLDAVVLKALAKNP 262

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 22  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 82  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 140
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 201 AGELPWDQPSD 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 114/251 (45%), Gaps = 18/251 (7%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQ-ELKINQASQCSHVVVCYHSFYHNGVISLV 143
           LV+ +  G+LFALK I+ +     R   ++ E+ + +  +  ++V     +       LV
Sbjct: 27  LVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---N 200
           ++ +  G L D I +     E   ++V +QVL  + YLH E  ++HRD+KP NLL     
Sbjct: 85  MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPE 143
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
              ++ ITDFG+S M     G   T  GT  Y++PE ++   Y  + D WS+G++     
Sbjct: 144 ENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACIQKDPXXXX 318
            G  P+ +  + +       L E I E       P  D  S     F+   ++KDP    
Sbjct: 202 CGYPPFYEETESK-------LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY 254
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 255 TCEKALSHPWI 265

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN+     +VV  Y       +  L 
Sbjct: 23  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 82
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 141
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 202 AGELPWDQPSD 212

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G+  A+K+I      Q+  ++ +++E+++ +     +++  Y  F   G   L
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V E    G L D I   K   E   A + +QVL G+ Y+H  + ++HRD+KP NLL+  K
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 162
Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
            +   ++I DFG+S    +S   +D  +GT  Y++PE + G TYD   D+WS G+++
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G+  A+K+I      Q+  ++ +++E+++ +     +++  Y  F   G   L
Sbjct: 68  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 127
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V E    G L D I   K   E   A + +QVL G+ Y+H  + ++HRD+KP NLL+  K
Sbjct: 128 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 186
Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
            +   ++I DFG+S    +S   +D  +GT  Y++PE + G TYD   D+WS G+++
Sbjct: 187 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G+  A+K+I      Q+  ++ +++E+++ +     +++  Y  F   G   L
Sbjct: 67  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 126
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V E    G L D I   K   E   A + +QVL G+ Y+H  + ++HRD+KP NLL+  K
Sbjct: 127 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 185
Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
            +   ++I DFG+S    +S   +D  +GT  Y++PE + G TYD   D+WS G+++
Sbjct: 186 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 240

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 12/190 (6%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYH--NGVI 140
           Q +R K  G++   K +      E  KQ +V E+ + +  +  ++V  Y       N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 141 SLVLEYMDRGSLADII----RQVKTILEPYLAVVCKQVLQGLVYLHNERH----VIHRDI 192
            +V+EY + G LA +I    ++ + + E ++  V  Q+   L   H        V+HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 193 KPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
           KP+N+ ++ K  VK+ DFG++ +L         FVGT  YMSPE+++  +Y+  SDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 253 GLVVLE-CAI 261
           G ++ E CA+
Sbjct: 203 GCLLYELCAL 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G+  A+K+I      Q+  ++ +++E+++ +     +++  Y  F   G   L
Sbjct: 50  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 109
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V E    G L D I   K   E   A + +QVL G+ Y+H  + ++HRD+KP NLL+  K
Sbjct: 110 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 168
Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
            +   ++I DFG+S    +S   +D  +GT  Y++PE + G TYD   D+WS G+++
Sbjct: 169 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 28/240 (11%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISL 142
           + + KW  +  A+K I+    E  RK  + EL+  Q S+ +H  +V  Y +  +   + L
Sbjct: 24  VCKAKWRAKDVAIKQIE---SESERKAFIVELR--QLSRVNHPNIVKLYGACLNP--VCL 76
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVV-----CKQVLQGLVYLHN--ERHVIHRDIKPS 195
           V+EY + GSL +++   + +  PY         C Q  QG+ YLH+   + +IHRD+KP 
Sbjct: 77  VMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 196 NLLVNHKGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           NLL+   G V KI DFG +  + + M       G+  +M+PE   GS Y    D++S G+
Sbjct: 135 NLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++ E    R P+    D+   P+F  +      + PP            S ++ C  KDP
Sbjct: 192 ILWEVITRRKPF----DEIGGPAFRIMWAVHNGTRPPLI--KNLPKPIESLMTRCWSKDP 245

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 4/191 (2%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           QL  ++      A+KI+ M    +  + I +E+ IN      +VV  Y       +  L 
Sbjct: 24  QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLF 83
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           LEY   G L D I     + EP       Q++ G+VYLH    + HRDIKP NLL++ + 
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD 142
Query: 204 EVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
            +KI+DFG++ +   +  +R  +   GT  Y++PE +    +     D+WS G+V+    
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 261 IGRFPYMQSED 271
            G  P+ Q  D
Sbjct: 203 AGELPWDQPSD 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 28/240 (11%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISL 142
           + + KW  +  A+K I+    E  RK  + EL+  Q S+ +H  +V  Y +  +   + L
Sbjct: 25  VCKAKWRAKDVAIKQIE---SESERKAFIVELR--QLSRVNHPNIVKLYGACLNP--VCL 77
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVV-----CKQVLQGLVYLHN--ERHVIHRDIKPS 195
           V+EY + GSL +++   + +  PY         C Q  QG+ YLH+   + +IHRD+KP 
Sbjct: 78  VMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 135
Query: 196 NLLVNHKGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           NLL+   G V KI DFG +  + + M       G+  +M+PE   GS Y    D++S G+
Sbjct: 136 NLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWGI 192
Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           ++ E    R P+    D+   P+F  +      + PP            S ++ C  KDP
Sbjct: 193 ILWEVITRRKPF----DEIGGPAFRIMWAVHNGTRPPLI--KNLPKPIESLMTRCWSKDP 246

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L   K   + FA+K ++ ++    +++   +V++  ++ A +   +   + +F     + 
Sbjct: 35  LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   I+               +++ GL +LH+ + +++RD+K  N+L++ 
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK 153
Query: 202 KGEVKITDFGV--SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
            G +KI DFG+    MLG +  + + F GT +Y++PE + G  Y++S D WS G+++ E 
Sbjct: 154 DGHIKIADFGMCKENMLGDA--KTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211
Query: 260 AIGRFPYMQSEDQQSWPS 277
            IG+ P+   ++++ + S
Sbjct: 212 LIGQSPFHGQDEEELFHS 229

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 94/187 (50%), Gaps = 4/187 (2%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQ---ELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
            G++FA+K+++  +     K       E  I +  +   +V   ++F   G + L+LEY+
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL 103
Query: 148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             G L   + +    +E        ++   L +LH ++ +I+RD+KP N+++NH+G VK+
Sbjct: 104 SGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKL 162
Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           TDFG+             F GT  YM+PE +  S ++ + D WSLG ++ +   G  P+ 
Sbjct: 163 TDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222
Query: 268 QSEDQQS 274
               +++
Sbjct: 223 GENRKKT 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L   K   + FA+K ++ ++    +++   +V++  ++ A +   +   + +F     + 
Sbjct: 36  LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 95
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   I+               +++ GL +LH+ + +++RD+K  N+L++ 
Sbjct: 96  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK 154
Query: 202 KGEVKITDFGV--SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
            G +KI DFG+    MLG +  + + F GT +Y++PE + G  Y++S D WS G+++ E 
Sbjct: 155 DGHIKIADFGMCKENMLGDA--KTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 212
Query: 260 AIGRFPYMQSEDQQSWPS 277
            IG+ P+   ++++ + S
Sbjct: 213 LIGQSPFHGQDEEELFHS 230

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 9/202 (4%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-LVLEY 146
           HK   + FA+KII   ++   +K+I   LK+ +       +V  H  +H+ + + LV+E 
Sbjct: 32  HKKSNQAFAVKIISKRMEANTQKEITA-LKLCEGHP---NIVKLHEVFHDQLHTFLVMEL 87
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKG 203
           ++ G L + I++ K   E   + + ++++  + ++H +  V+HRD+KP NLL    N   
Sbjct: 88  LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNL 146
Query: 204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
           E+KI DFG + +         T   T +Y +PE ++ + YD S D+WSLG+++     G+
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 264 FPYMQSEDQQSWPSFYELLEAI 285
            P+   +   +  S  E+++ I
Sbjct: 207 VPFQSHDRSLTCTSAVEIMKKI 228

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 4/185 (2%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   GR  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 29  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           ++EY   G + D +     + E       +Q++  + Y H +R ++HRD+K  NLL++  
Sbjct: 89  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDAD 147
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY-SSDIWSLGLVVLECAI 261
             +KI DFG S    +  G+ DTF G+  Y +PE   G  YD    D+WSLG+++     
Sbjct: 148 MNIKIADFGFSNEF-TVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206
Query: 262 GRFPY 266
           G  P+
Sbjct: 207 GSLPF 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 94/177 (53%), Gaps = 8/177 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           L + K  G+  A+K+I      Q+  ++ +++E+++ +     ++   Y  F   G   L
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYL 103
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V E    G L D I   K   E   A + +QVL G+ Y H  + ++HRD+KP NLL+  K
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESK 162
Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
            +   ++I DFG+S    +S   +D  +GT  Y++PE + G TYD   D+WS G+++
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDK-IGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 84  QLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           QLVRHK   +++A+K++     I+        +E  I   +    VV  +++F  +  + 
Sbjct: 86  QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EYM  G L +++     + E +      +V+  L  +H+    IHRD+KP N+L++ 
Sbjct: 146 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK 203
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVV 256
            G +K+ DFG    M    M + DT VGT +Y+SPE +        Y    D WS+G+ +
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 257 LECAIGRFPY 266
            E  +G  P+
Sbjct: 264 YEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 84  QLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           QLVRHK   +++A+K++     I+        +E  I   +    VV  +++F  +  + 
Sbjct: 91  QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 150
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EYM  G L +++     + E +      +V+  L  +H+    IHRD+KP N+L++ 
Sbjct: 151 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK 208
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVV 256
            G +K+ DFG    M    M + DT VGT +Y+SPE +        Y    D WS+G+ +
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 257 LECAIGRFPY 266
            E  +G  P+
Sbjct: 269 YEMLVGDTPF 278

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 87  RHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           R +W G   A+KI+ + +   E   + ++E+ I +  +  ++V+   +      +S+V E
Sbjct: 55  RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114
Query: 146 YMDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNH 201
           Y+ RGSL  ++ +    + + E     +   V +G+ YLHN    ++HRD+K  NLLV+ 
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDK 174
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           K  VK+ DFG+S +  S         GT  +M+PE +     +  SD++S G+++ E A 
Sbjct: 175 KYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            + P+      Q       ++ A+         P   +P+  + +  C   +P
Sbjct: 235 LQQPWGNLNPAQ-------VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP 280

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 84  QLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           QLVRHK   +++A+K++     I+        +E  I   +    VV  +++F  +  + 
Sbjct: 91  QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 150
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EYM  G L +++     + E +      +V+  L  +H+    IHRD+KP N+L++ 
Sbjct: 151 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK 208
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVV 256
            G +K+ DFG    M    M + DT VGT +Y+SPE +        Y    D WS+G+ +
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 257 LECAIGRFPY 266
            E  +G  P+
Sbjct: 269 YEMLVGDTPF 278

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 95/186 (51%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   GR  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 32  KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H +++++HRD+K  NLL++  
Sbjct: 92  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKYIVHRDLKAENLLLDGD 150
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     ++G + DTF G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 151 MNIKIADFGFSNEF--TVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 261 IGRFPY 266
            G  P+
Sbjct: 209 SGSLPF 214

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 113/233 (48%), Gaps = 12/233 (5%)
Query: 87  RHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           R +W G   A+KI+ + +   E   + ++E+ I +  +  ++V+   +      +S+V E
Sbjct: 55  RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114
Query: 146 YMDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNH 201
           Y+ RGSL  ++ +    + + E     +   V +G+ YLHN    ++HR++K  NLLV+ 
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           K  VK+ DFG+S +  S+     +  GT  +M+PE +     +  SD++S G+++ E A 
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            + P+      Q       ++ A+         P   +P+  + +  C   +P
Sbjct: 235 LQQPWGNLNPAQ-------VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP 280

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E+  MD     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 85  EFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTE 142
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 201
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 259
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 82
Query: 145 EY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E+  MD     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 83  EFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTE 140
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 141 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 199
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 257
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 86/155 (55%), Gaps = 4/155 (2%)
Query: 115 ELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK 172
           E +++ +SQ SH  +V        +    LV+EY++  +L++ I     +          
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG-SSMGQRDTFVGTYN 231
           Q+L G+ + H+ R ++HRDIKP N+L++    +KI DFG++  L  +S+ Q +  +GT  
Sbjct: 119 QILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 232 YMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           Y SPE+  G   D  +DI+S+G+V+ E  +G  P+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 83
Query: 145 EY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E+  MD     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 84  EFLSMDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 141
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 142 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 200
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 258
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EY--MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E+  MD     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 85  EFLSMDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 142
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 201
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 259
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++ +  L D +    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 113/233 (48%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L   K    L+A+KI++ ++    +++   +V++  +    +   +   +  F     + 
Sbjct: 38  LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   I+QV    EP+      ++  GL +L + + +I+RD+K  N++++ 
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS 156
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +KI DFG+             F GT +Y++PE I+   Y  S D W+ G+++ E   
Sbjct: 157 EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           G+ P+ + ED+       EL ++I+E     A P   S E  +     + K P
Sbjct: 217 GQAPF-EGEDED------ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHP 260

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 24/258 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISL 142
           ++  G+ FA+KI+ +           ++LK  +AS C      H+V    ++  +G++ +
Sbjct: 45  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 143 VLEYMDRGSLA-DIIRQVKTIL---EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           V E+MD   L  +I+++        E   +   +Q+L+ L Y H+  ++IHRD+KP N+L
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPENVL 162
Query: 199 VNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +  K     VK+ DFGV+  LG S       VGT ++M+PE +    Y    D+W  G++
Sbjct: 163 LASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 256 VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACIQKD 313
           +     G  P+  ++++        L E I++      P      S      V   +  D
Sbjct: 223 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274
Query: 314 PXXXXXXXXXXXHPFIKK 331
           P           HP++K+
Sbjct: 275 PAERITVYEALNHPWLKE 292

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L   K    L+A+KI++ ++    +++   +V++  +    +   +   +  F     + 
Sbjct: 37  LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLY 96
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   I+QV    EP       ++  GL +LH +R +I+RD+K  N++++ 
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH-KRGIIYRDLKLDNVMLDS 155
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +KI DFG+             F GT +Y++PE I+   Y  S D W+ G+++ E   
Sbjct: 156 EGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 215
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           G+ P+   ED+       EL ++I+E     + P   S E  S     + K P
Sbjct: 216 GQPPF-DGEDED------ELFQSIMEH--NVSYPKSLSKEAVSICKGLMTKHP 259

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 15/234 (6%)
Query: 84  QLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L  H    +  ALK I  Q+  + ++  ++ +E+   +  +  H++  Y        I 
Sbjct: 26  KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EY   G L D I + K + E       +Q++  + Y H  + ++HRD+KP NLL++ 
Sbjct: 86  MVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDD 143
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
              VKI DFG+S ++      + T  G+ NY +PE I+G  Y     D+WS G+V+    
Sbjct: 144 NLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           +GR P+    D +  P+ ++ + + V        PD  SP   S +   I  DP
Sbjct: 203 VGRLPF----DDEFIPNLFKKVNSCV-----YVMPDFLSPGAQSLIRRMIVADP 247

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 84  QLVRHKWVGRLFALKIIQM--NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           QLVRHK   +++A+K++     I+        +E  I   +    VV  + +F  +  + 
Sbjct: 92  QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 151
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EYM  G L +++     + E +      +V+  L  +H+   +IHRD+KP N+L++ 
Sbjct: 152 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK 209
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG----STYDYSSDIWSLGLVV 256
            G +K+ DFG    M  + M   DT VGT +Y+SPE +        Y    D WS+G+ +
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 257 LECAIGRFPY 266
            E  +G  P+
Sbjct: 270 FEMLVGDTPF 279

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 119/250 (47%), Gaps = 12/250 (4%)
Query: 85  LVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           LV+    GR + +K I ++ +  + R++  +E+ +    +  ++V    SF  NG + +V
Sbjct: 42  LVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101
Query: 144 LEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           ++Y + G L   I   K +L  E  +     Q+   L ++H +R ++HRDIK  N+ +  
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTK 160
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G V++ DFG++ +L S++      +GT  Y+SPE      Y+  SDIW+LG V+ E   
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXX 321
            +  +     +        +L+ I  S PP +    +S +  S VS   +++P       
Sbjct: 221 LKHAFEAGSMKNL------VLKIISGSFPPVSL--HYSYDLRSLVSQLFKRNPRDRPSVN 272
Query: 322 XXXXHPFIKK 331
                 FI K
Sbjct: 273 SILEKGFIAK 282

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 113/233 (48%), Gaps = 13/233 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L   K    L+A+KI++ ++    +++   +V++  +    +   +   +  F     + 
Sbjct: 359 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+EY++ G L   I+QV    EP+      ++  GL +L + + +I+RD+K  N++++ 
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS 477
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G +KI DFG+             F GT +Y++PE I+   Y  S D W+ G+++ E   
Sbjct: 478 EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           G+ P+ + ED+       EL ++I+E     A P   S E  +     + K P
Sbjct: 538 GQAPF-EGEDED------ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHP 581

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D  +  D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 85  EFLHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 142
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 201
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 259
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 44/278 (15%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESPPPTAP--PDQFSPEFC 303
             R               F  + + D+  WP         V S P   P  P     +F 
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--------VTSMPDYKPSFPKWARQDFS 250
Query: 304 -----------SFVSACIQKDPXXXXXXXXXXXHPFIK 330
                      S +S  +  DP           HPF +
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 11/223 (4%)
Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEPYLA 168
           +++  E+KI+   +   ++  Y+ F  +  + LVLE    G +   ++ +VK   E    
Sbjct: 56  QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG 228
               Q++ G++YLH+   ++HRD+  SNLL+     +KI DFG++  L     +  T  G
Sbjct: 116 HFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           T NY+SPE  + S +   SD+WSLG +     IGR P+     + +       L  +V +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVLA 227
Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
                 P   S E    +   ++++P           HPF+ +
Sbjct: 228 DYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 26  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 85
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 86  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 143
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 144 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 202
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESPP-------PTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 203 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 260
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 261 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 88
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 89  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 146
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 147 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY-YSTAVDIWSLGCIFAEMV 205
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 206 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 263
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 264 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 82
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 83  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 140
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 141 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 199
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 257
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 82
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 83  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTE 140
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 141 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 199
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 257
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EYMDRGSLADIIRQVKT-ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           E++D+     +     T I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +G
Sbjct: 85  EHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECAI 261
            +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E   
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVT 202
Query: 262 GR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQFS 299
            R               F  + + D+  WP    + +     P           PP    
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--LD 260
Query: 300 PEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
            +  S +S  +  DP           HPF +
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 83
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 84  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTE 141
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 142 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 200
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 258
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + DTF G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 MNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 88
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 89  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 146
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 147 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 205
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 206 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 263
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 264 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + DTF G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 MNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 4/185 (2%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   GR  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 32  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           ++EY   G + D +     + E       +Q++  + Y H +R ++HRD+K  NLL++  
Sbjct: 92  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDAD 150
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY-SSDIWSLGLVVLECAI 261
             +KI DFG S    +  G+ D F G   Y +PE   G  YD    D+WSLG+++     
Sbjct: 151 MNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 262 GRFPY 266
           G  P+
Sbjct: 210 GSLPF 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 83
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 84  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 141
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 142 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 200
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 258
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 85  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 142
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 201
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 259
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 83
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 84  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 141
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 142 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 200
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 201 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 258
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 259 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 114/243 (46%), Gaps = 16/243 (6%)
Query: 96  ALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+KII + ++      ++++E+ + +     +++  Y  F       LV+E    G L D
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 155 IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFG 211
            I       E   AV+ KQVL G+ YLH + +++HRD+KP NLL+  K +   +KI DFG
Sbjct: 126 EIIHRMKFNEVDAAVIIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           +SA+  +    ++  +GT  Y++PE +    YD   D+WS+G+++     G  P+    D
Sbjct: 185 LSAVFENQKKMKER-LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 272 QQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           Q       E+L  + +       P+    S      +   +Q D            HP+I
Sbjct: 243 Q-------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
Query: 330 KKF 332
           K+ 
Sbjct: 296 KEM 298

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 26  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 85
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 86  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 143
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 144 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 202
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 203 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 260
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 261 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 82
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 83  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 140
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 141 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 199
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 257
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 84
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 85  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 142
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 201
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 202 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 259
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 260 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 82
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 83  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 140
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 141 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 199
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 200 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 257
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 258 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 44/278 (15%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESPPPTAP--PDQFSPEFC 303
             R               F  + + D+  WP         V S P   P  P     +F 
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--------VTSMPDYKPSFPKWARQDFS 250
Query: 304 -----------SFVSACIQKDPXXXXXXXXXXXHPFIK 330
                      S +S  +  DP           HPF +
Sbjct: 251 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 117/252 (46%), Gaps = 24/252 (9%)
Query: 88  HKWVGRLFALKIIQ------MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           H+  G   A+KI+       +++  +I+++I Q LK+ +     H++  Y          
Sbjct: 32  HQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRHP---HIIKLYQVISTPTDFF 87
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVN 200
           +V+EY+  G L D I +   + E     + +Q+L  + Y H  RH V+HRD+KP N+L++
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLD 145
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLEC 259
                KI DFG+S M+      RD+  G+ NY +PE ISG  Y     DIWS G+++   
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRDS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +  P+ ++ +   V        P+  +    + +   +Q DP     
Sbjct: 205 LCGTLPF----DDEHVPTLFKKIRGGV-----FYIPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 320 XXXXXXHPFIKK 331
                 H + K+
Sbjct: 256 IKDIREHEWFKQ 267

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D  +  D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EHVHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 22/158 (13%)
Query: 111 QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD------IIRQVKTILE 164
           QI+ ++K      C  ++  Y   Y      ++ EYM+  S+        ++ +  T   
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVY------IIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 165 PYLAVVC--KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--M 220
           P   + C  K VL    Y+HNE+++ HRD+KPSN+L++  G VK++DFG S  +      
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 221 GQRDTFVGTYNYMSPERISG-STYDYSS-DIWSLGLVV 256
           G R    GTY +M PE  S  S+Y+ +  DIWSLG+ +
Sbjct: 209 GSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 76  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 134
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 193
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 226

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + ALK I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLSFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 194
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 194
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 194
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 83  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 141
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 200
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A++II +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + DTF G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 MNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 202 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 260
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 319
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 24  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 83
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 84  VMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 142
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDY-SSDIWSLGLVVLECA 260
             +KI DFG S     + G + DTF G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 143 MNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 200
Query: 261 IGRFPY 266
            G  P+
Sbjct: 201 SGSLPF 206

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  +
Sbjct: 216 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 274
Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE---RISGS 241
           IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE    +  +
Sbjct: 275 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGTA 333
Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            Y+ + D WSLG+++  C  G  P+ +   Q S
Sbjct: 334 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 366

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + AL  I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 22  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 82  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 139
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 140 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 198
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 199 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 256
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 32/272 (11%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            R+K  G + AL  I+++ + E +    ++E+ + +     ++V      +    + LV 
Sbjct: 21  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80
Query: 145 EYM--DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E++  D     D    +  I  P +     Q+LQGL + H+ R V+HRD+KP NLL+N +
Sbjct: 81  EFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE 138
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLECA 260
           G +K+ DFG++   G  +      V T  Y +PE + G  Y YS+  DIWSLG +  E  
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMV 197
Query: 261 IGR---------------FPYMQSEDQQSWPSFYELLEAIVESP-------PPTAPPDQF 298
             R               F  + + D+  WP    + +     P           PP   
Sbjct: 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP--L 255
Query: 299 SPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
             +  S +S  +  DP           HPF +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + D F G   Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 MNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 37  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 93
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 94  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 152
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 207
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 208 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 259

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 84  QLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L  H   G+  ALKII   +  + +++ +I +E+   +  +  H++  Y        I 
Sbjct: 25  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 84
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EY     L D I Q   + E       +Q++  + Y H  + ++HRD+KP NLL++ 
Sbjct: 85  MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 142
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
              VKI DFG+S ++      + T  G+ NY +PE ISG  Y     D+WS G+++    
Sbjct: 143 HLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 201
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
             R P+    D +S P  ++ +   V + P    P
Sbjct: 202 CRRLPF----DDESIPVLFKNISNGVYTLPKFLSP 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 45  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 101
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 102 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 160
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 215
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 216 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 84  QLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L  H   G+  ALKII   +  + +++ +I +E+   +  +  H++  Y        I 
Sbjct: 21  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 80
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EY     L D I Q   + E       +Q++  + Y H  + ++HRD+KP NLL++ 
Sbjct: 81  MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 138
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
              VKI DFG+S ++      + T  G+ NY +PE ISG  Y     D+WS G+++    
Sbjct: 139 HLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 197
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
             R P+    D +S P  ++ +   V + P    P
Sbjct: 198 CRRLPF----DDESIPVLFKNISNGVYTLPKFLSP 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 43  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 99
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 100 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 158
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 213
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 214 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 265

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 98  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 156
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 263

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 69  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 125
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 184
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 239
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 291

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 44  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 100
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 101 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 159
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 214
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 215 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 266

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 42  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 98
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 99  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 157
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 212
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 213 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 264

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 153
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 260

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 153
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 260

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 153
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 260

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 171
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 278

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 84  QLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L  H   G+  ALKII   +  + +++ +I +E+   +  +  H++  Y        I 
Sbjct: 30  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EY     L D I Q   + E       +Q++  + Y H  + ++HRD+KP NLL++ 
Sbjct: 90  MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 147
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY-SSDIWSLGLVVLECA 260
              VKI DFG+S ++      + T  G+ NY +PE ISG  Y     D+WS G+++    
Sbjct: 148 HLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
             R P+    D +S P  ++ +   V + P    P
Sbjct: 207 CRRLPF----DDESIPVLFKNISNGVYTLPKFLSP 237

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 36  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 92
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 93  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 151
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 206
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 207 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 258

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 171
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 278

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 116/252 (46%), Gaps = 24/252 (9%)
Query: 88  HKWVGRLFALKIIQ------MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           H+  G   A+KI+       +++  +I+++I Q LK+ +     H++  Y          
Sbjct: 32  HQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRHP---HIIKLYQVISTPTDFF 87
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVN 200
           +V+EY+  G L D I +   + E     + +Q+L  + Y H  RH V+HRD+KP N+L++
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLD 145
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLEC 259
                KI DFG+S M+      R T  G+ NY +PE ISG  Y     DIWS G+++   
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +  P+ ++ +   V        P+  +    + +   +Q DP     
Sbjct: 205 LCGTLPF----DDEHVPTLFKKIRGGV-----FYIPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 320 XXXXXXHPFIKK 331
                 H + K+
Sbjct: 256 IKDIREHEWFKQ 267

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 108/194 (55%), Gaps = 9/194 (4%)
Query: 89  KWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHN-GVISLVLEY 146
           K  G+ +A K ++   + ++ R +I+ E+ + + ++    V+  H  Y N   I L+LEY
Sbjct: 51  KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 147 MDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--- 201
              G +  +      + + E  +  + KQ+L+G+ YLH + +++H D+KP N+L++    
Sbjct: 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYP 169
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
            G++KI DFG+S  +G +   R+  +GT  Y++PE ++      ++D+W++G++      
Sbjct: 170 LGDIKIVDFGMSRKIGHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 262 GRFPYMQSEDQQSW 275
              P++  ++Q+++
Sbjct: 229 HTSPFVGEDNQETY 242

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 84  QLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L  H   G+  ALKII   +  + +++ +I +E+   +  +  H++  Y        I 
Sbjct: 31  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V+EY     L D I Q   + E       +Q++  + Y H  + ++HRD+KP NLL++ 
Sbjct: 91  MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 148
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY-SSDIWSLGLVVLECA 260
              VKI DFG+S ++      + T  G+ NY +PE ISG  Y     D+WS G+++    
Sbjct: 149 HLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 207
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
             R P+    D +S P  ++ +   V + P    P
Sbjct: 208 CRRLPF----DDESIPVLFKNISNGVYTLPKFLSP 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A+KII +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V EY   G + D +       E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + D F G   Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 XNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 119/264 (45%), Gaps = 24/264 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQE---LKINQASQCSH-VVVCYHSFYHNGV-IS 141
           R K  G+ +A K I+       R+ + +E    ++N   +  H  ++  H  + N   + 
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH++R + H D+KP N+++  
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLD 143
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  + +    ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     Y+  E    +    A           F+   + KD
Sbjct: 203 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK---------DFIRRLLVKD 253
Query: 314 PXXXXXXXXXXXHPFIKKFEDKDI 337
           P           H +IK    +++
Sbjct: 254 PKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 92/186 (49%), Gaps = 6/186 (3%)
Query: 84  QLVRHKWVGRLFALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
           +L RH   G+  A++II +  +     +++ +E++I +     ++V  +        + L
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           V+EY   G + D +     + E       +Q++  + Y H ++ ++HRD+K  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 203 GEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECA 260
             +KI DFG S     + G + D F G+  Y +PE   G  YD    D+WSLG+++    
Sbjct: 150 MNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 261 IGRFPY 266
            G  P+
Sbjct: 208 SGSLPF 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           L R K  G L+A+K+++ ++    +++   + ++  ++ A     +   +  F     + 
Sbjct: 41  LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
            V+E+++ G L   I++ +   E        +++  L++LH+ + +I+RD+K  N+L++H
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH 159
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
           +G  K+ DFG+      +     TF GT +Y++PE +    Y  + D W++G+++ E   
Sbjct: 160 EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIV 286
           G  P+ ++E++       +L EAI+
Sbjct: 220 GHAPF-EAENED------DLFEAIL 237

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 14/250 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L   K   +L A+K I     E     +  E+ +    +  ++V     +   G + L++
Sbjct: 36  LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL---VNH 201
           + +  G L D I +     E   + +  QVL  + YLH+   ++HRD+KP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDE 154
Query: 202 KGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
             ++ I+DFG+S M   GS +    T  GT  Y++PE ++   Y  + D WS+G++    
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 211
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +    F ++L+A  E   P    D  S     F+   ++KDP     
Sbjct: 212 LCGYPPFYDENDAK---LFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 320 XXXXXXHPFI 329
                 HP+I
Sbjct: 267 CEQALQHPWI 276

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 147 MDRGSLADIIR-QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D ++   + I    L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 98  LPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 156
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 263

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 14/250 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L   K   +L A+K I     E     +  E+ +    +  ++V     +   G + L++
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL---VNH 201
           + +  G L D I +     E   + +  QVL  + YLH+   ++HRD+KP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDE 154
Query: 202 KGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
             ++ I+DFG+S M   GS +    T  GT  Y++PE ++   Y  + D WS+G++    
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 211
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +    F ++L+A  E   P    D  S     F+   ++KDP     
Sbjct: 212 LCGYPPFYDENDAK---LFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 320 XXXXXXHPFI 329
                 HP+I
Sbjct: 267 CEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 14/250 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L   K   +L A+K I     E     +  E+ +    +  ++V     +   G + L++
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL---VNH 201
           + +  G L D I +     E   + +  QVL  + YLH+   ++HRD+KP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDE 154
Query: 202 KGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
             ++ I+DFG+S M   GS +    T  GT  Y++PE ++   Y  + D WS+G++    
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 211
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +    F ++L+A  E   P    D  S     F+   ++KDP     
Sbjct: 212 LCGYPPFYDENDAK---LFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 320 XXXXXXHPFI 329
                 HP+I
Sbjct: 267 CEQALQHPWI 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 6/170 (3%)
Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP 165
           E+  ++I  E+ + ++    +++  +  F       LV E+ + G L + I       E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMGQ 222
             A + KQ+L G+ YLH + +++HRDIKP N+L+ +K     +KI DFG+S+        
Sbjct: 147 DAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
           RD  +GT  Y++PE +    Y+   D+WS G+++     G  P+    DQ
Sbjct: 206 RDR-LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQE---LKINQASQCSH-VVVCYHSFYHNGV-IS 141
           R K  G+ +A K I+       R+ + +E    ++N   +  H  ++  H  + N   + 
Sbjct: 46  RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH++R + H D+KP N+++  
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLD 164
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  + +    ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 165 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 223
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     Y+  E    +    A           F+   + KD
Sbjct: 224 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK---------DFIRRLLVKD 274
Query: 314 PXXXXXXXXXXXHPFIKKFEDKDI 337
           P           H +IK    +++
Sbjct: 275 PKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 14/250 (5%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
           L   K   +L A+K I     E     +  E+ +    +  ++V     +   G + L++
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL---VNH 201
           + +  G L D I +     E   + +  QVL  + YLH+   ++HRD+KP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDE 154
Query: 202 KGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
             ++ I+DFG+S M   GS +    T  GT  Y++PE ++   Y  + D WS+G++    
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 211
Query: 260 AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXX 319
             G  P+    D +    F ++L+A  E   P    D  S     F+   ++KDP     
Sbjct: 212 LCGYPPFYDENDAK---LFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 320 XXXXXXHPFI 329
                 HP+I
Sbjct: 267 CEQALQHPWI 276

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 20/194 (10%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V H+  G +  +K + +   EE ++  ++E+K+ +  +  +V+      Y +  ++ + E
Sbjct: 29  VTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87
Query: 146 YMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           Y+  G+L  II+ + +   P+   V   K +  G+ YLH+  ++IHRD+   N LV    
Sbjct: 88  YIKGGTLRGIIKSMDSQY-PWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK 145
Query: 204 EVKITDFGVSAMLGSSMGQ--------------RDTFVGTYNYMSPERISGSTYDYSSDI 249
            V + DFG++ ++     Q              R T VG   +M+PE I+G +YD   D+
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV 205
Query: 250 WSLGLVVLECAIGR 263
           +S G+V+ E  IGR
Sbjct: 206 FSFGIVLCE-IIGR 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 117/257 (45%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQE---LKINQASQCSH-VVVCYHSFYHNGV-IS 141
           R K  G+ +A K I+       R+ + +E    ++N   +  H  ++  H  + N   + 
Sbjct: 32  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH++R + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  + +    ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     Y+  E    +    A           F+   + KD
Sbjct: 210 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK---------DFIRRLLVKD 260
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           H +IK
Sbjct: 261 PKRRMXIAQSLEHSWIK 277

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++EY
Sbjct: 39  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 95
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL D +++ K  ++   L     Q+ +G+ YL  +R+ IHR++   N+LV ++  V
Sbjct: 96  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRNLATRNILVENENRV 154
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 209
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 210 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 261

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 74/129 (57%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +V E +++G + ++   +K + E       + +++G+ YLH ++ +IHRDIKPSNLLV  
Sbjct: 115 MVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVGE 172
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS---DIWSLGLVVLE 258
            G +KI DFGVS     S       VGT  +M+PE +S +   +S    D+W++G+ +  
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 259 CAIGRFPYM 267
              G+ P+M
Sbjct: 233 FVFGQCPFM 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 103/188 (54%), Gaps = 19/188 (10%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS---- 141
            +H+  G+ + +K ++ N  E+  +++    K++  +   H   C+  F ++   S    
Sbjct: 30  AKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVN-IVHYNGCWDGFDYDPETSSKNS 87
Query: 142 ---------LVLEYMDRGSLADIIRQVK-TILEPYLAV-VCKQVLQGLVYLHNERHVIHR 190
                    + +E+ D+G+L   I + +   L+  LA+ + +Q+ +G+ Y+H+++ +I+R
Sbjct: 88  SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINR 146
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIW 250
           D+KPSN+ +    +VKI DFG+   L +  G+R    GT  YMSPE+IS   Y    D++
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRXRSKGTLRYMSPEQISSQDYGKEVDLY 205
Query: 251 SLGLVVLE 258
           +LGL++ E
Sbjct: 206 ALGLILAE 213

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISL 142
           ++  G+ FA+KI+ +           ++LK  +AS C      H+V    ++  +G++ +
Sbjct: 47  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 105
Query: 143 VLEYMDRGSLA-DIIRQVKTIL---EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           V E+MD   L  +I+++        E   +   +Q+L+ L Y H+  ++IHRD+KP  +L
Sbjct: 106 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVL 164
Query: 199 VNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +  K     VK+  FGV+  LG S       VGT ++M+PE +    Y    D+W  G++
Sbjct: 165 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 224
Query: 256 VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACIQKD 313
           +     G  P+  ++++        L E I++      P      S      V   +  D
Sbjct: 225 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 276
Query: 314 PXXXXXXXXXXXHPFIKK 331
           P           HP++K+
Sbjct: 277 PAERITVYEALNHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISL 142
           ++  G+ FA+KI+ +           ++LK  +AS C      H+V    ++  +G++ +
Sbjct: 45  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 143 VLEYMDRGSLA-DIIRQVKTIL---EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           V E+MD   L  +I+++        E   +   +Q+L+ L Y H+  ++IHRD+KP  +L
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVL 162
Query: 199 VNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +  K     VK+  FGV+  LG S       VGT ++M+PE +    Y    D+W  G++
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 256 VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACIQKD 313
           +     G  P+  ++++        L E I++      P      S      V   +  D
Sbjct: 223 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274
Query: 314 PXXXXXXXXXXXHPFIKK 331
           P           HP++K+
Sbjct: 275 PAERITVYEALNHPWLKE 292

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 75/117 (64%), Gaps = 4/117 (3%)
Query: 144 LEYMDRGSLADIIRQVK-TILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +E+ D+G+L   I + +   L+  LA+ + +Q+ +G+ Y+H+++ +IHRD+KPSN+ +  
Sbjct: 113 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFLVD 171
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
             +VKI DFG+   L +  G+R    GT  YMSPE+IS   Y    D+++LGL++ E
Sbjct: 172 TKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 23/244 (9%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQI---VQELKINQASQCSHVVVCYHSFYHNGVI 140
           ++ R  W+G   A+K  + +  E+I + I    QE K+    +  +++           +
Sbjct: 22  KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV--IHRDIKPSNLL 198
            LV+E+   G L  ++   K I    L     Q+ +G+ YLH+E  V  IHRD+K SN+L
Sbjct: 82  CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140
Query: 199 VNHKGE--------VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIW 250
           +  K E        +KITDFG++     +   + +  G Y +M+PE I  S +   SD+W
Sbjct: 141 ILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVW 198
Query: 251 SLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI 310
           S G+++ E   G  P+   +        Y +    +  P P+  P+ F+      +  C 
Sbjct: 199 SYGVLLWELLTGEVPFRGIDGLA---VAYGVAMNKLALPIPSTCPEPFA----KLMEDCW 251
Query: 311 QKDP 314
             DP
Sbjct: 252 NPDP 255

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 12/244 (4%)
Query: 91  VGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR 149
            G  +A KII    +     +++ +E +I +  + S++V  + S    G   LV + +  
Sbjct: 28  TGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVK 206
           G L + I   +   E   +   +Q+L+ +++ H +  V+HRD+KP NLL+  K     VK
Sbjct: 88  GELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKCKGAAVK 146
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFG++  +         F GT  Y+SPE +    Y    DIW+ G+++    +G +P 
Sbjct: 147 LADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG-YPP 205
Query: 267 MQSEDQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
              EDQ      Y+ ++A   + P P    D  +PE  + ++  +  +P           
Sbjct: 206 FWDEDQH---KLYQQIKAGAYDFPSPEW--DTVTPEAKNLINQMLTINPAKRITAHEALK 260
Query: 326 HPFI 329
           HP++
Sbjct: 261 HPWV 264

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEY 146
            G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L++E+
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEF 97
Query: 147 MDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +  GSL + +++ K  ++   L     Q+ +G+ YL  +R+ IHRD+   N+LV ++  V
Sbjct: 98  LPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-IHRDLATRNILVENENRV 156
Query: 206 KITDFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           KI DFG++ +L            G+   F     + +PE ++ S +  +SD+WS G+V+ 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 258 ECAI---------GRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPPDQ 297
           E              F  M   D+Q     + L+E +  +   P P   PD+
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE 263

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            +++    + ALK ++++  +E +    ++E+ + +  +  ++V  +   + +  ++LV 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80
Query: 145 EYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           E+ D+  L          L+P +      Q+L+GL + H+ R+V+HRD+KP NLL+N  G
Sbjct: 81  EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG 138
Query: 204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIG 262
           E+K+ DFG++   G  +      V T  Y  P+ + G+  Y  S D+WS G +  E A  
Sbjct: 139 ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 263 RFPYMQSED----------------QQSWPSFYEL 281
             P     D                ++ WPS  +L
Sbjct: 199 ARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              +A   +F  E+ S        F+   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 310 IQKDPXXXXXXXXXXXHPFIK 330
           + KDP           HP+IK
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              +A   +F  E+ S        F+   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 310 IQKDPXXXXXXXXXXXHPFIK 330
           + KDP           HP+IK
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 148
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 258
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 259 PKKRMTIQDSLQHPWIK 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 148
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 258
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 259 PKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 88  HKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
           HK  G  FA KII    +     +++ +E +I +  Q  ++V  + S        LV + 
Sbjct: 50  HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-- 204
           +  G L + I   +   E   +   +Q+L+ + Y H+   ++HR++KP NLL+  K +  
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGA 168
Query: 205 -VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
            VK+ DFG++  +  S      F GT  Y+SPE +    Y    DIW+ G+++    +G 
Sbjct: 169 AVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG- 226
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXX 323
           +P    EDQ     + ++     + P P    D  +PE  S + + +  +P         
Sbjct: 227 YPPFWDEDQHRL--YAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQA 282
Query: 324 XXHPFI 329
              P+I
Sbjct: 283 LKVPWI 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 26/262 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELK---------INQASQCSHVVVCYHSFYHNG 138
           HK   + +A+KII +        + VQEL+         + + S   +++    ++  N 
Sbjct: 25  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 84
Query: 139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
              LV + M +G L D + +  T+ E     + + +L+ +  LH + +++HRD+KP N+L
Sbjct: 85  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 143
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST------YDYSSDIWSL 252
           ++    +K+TDFG S  L      R+   GT +Y++PE I  S       Y    D+WS 
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 253 GLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACI 310
           G+++     G  P+   +          +L  I+        P  D +S      VS  +
Sbjct: 203 GVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFL 255
Query: 311 QKDPXXXXXXXXXXXHPFIKKF 332
              P           HPF +++
Sbjct: 256 VVQPQKRYTAEEALAHPFFQQY 277

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 26/262 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELK---------INQASQCSHVVVCYHSFYHNG 138
           HK   + +A+KII +        + VQEL+         + + S   +++    ++  N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
              LV + M +G L D + +  T+ E     + + +L+ +  LH + +++HRD+KP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST------YDYSSDIWSL 252
           ++    +K+TDFG S  L      R+   GT +Y++PE I  S       Y    D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 253 GLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACI 310
           G+++     G  P+   +          +L  I+        P  D +S      VS  +
Sbjct: 216 GVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFL 268
Query: 311 QKDPXXXXXXXXXXXHPFIKKF 332
              P           HPF +++
Sbjct: 269 VVQPQKRYTAEEALAHPFFQQY 290

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 112/260 (43%), Gaps = 32/260 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----QCSHVVVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S       H V+  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              TA    F  EF S        F+   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 310 IQKDPXXXXXXXXXXXHPFI 329
           + K+            HP+I
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 87  RHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           + K   + +ALK+++  + ++I R +I   L+++      +++     F     ISLVLE
Sbjct: 73  KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH----PNIIKLKEIFETPTEISLVLE 128
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---K 202
            +  G L D I +     E   A   KQ+L+ + YLH E  ++HRD+KP NLL       
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPD 187
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV--VLECA 260
             +KI DFG+S ++   +  + T  GT  Y +PE + G  Y    D+WS+G++  +L C 
Sbjct: 188 APLKIADFGLSKIVEHQVLMK-TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 261 IGRFPYMQSEDQ 272
              F Y +  DQ
Sbjct: 247 FEPF-YDERGDQ 257

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 88  HKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
           HK  G  FA KII    +     +++ +E +I +  Q  ++V  + S        LV + 
Sbjct: 27  HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-- 204
           +  G L + I   +   E   +   +Q+L+ + Y H+   ++HR++KP NLL+  K +  
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGA 145
Query: 205 -VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
            VK+ DFG++  +  S      F GT  Y+SPE +    Y    DIW+ G+++    +G 
Sbjct: 146 AVKLADFGLAIEVNDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG- 203
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXX 323
           +P    EDQ     + ++     + P P    D  +PE  S + + +  +P         
Sbjct: 204 YPPFWDEDQHRL--YAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 324 XXHPFI 329
              P+I
Sbjct: 260 LKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 88  HKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
           HK  G  FA KII    +     +++ +E +I +  Q  ++V  + S        LV + 
Sbjct: 27  HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-- 204
           +  G L + I   +   E   +   +Q+L+ + Y H+   ++HR++KP NLL+  K +  
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGA 145
Query: 205 -VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
            VK+ DFG++  +  S      F GT  Y+SPE +    Y    DIW+ G+++    +G 
Sbjct: 146 AVKLADFGLAIEVNDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG- 203
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXX 323
           +P    EDQ     + ++     + P P    D  +PE  S + + +  +P         
Sbjct: 204 YPPFWDEDQHRL--YAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 324 XXHPFI 329
              P+I
Sbjct: 260 LKVPWI 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISLVLEY 146
           G +  +K  Q   Q  ++K  ++  ++ +   C+      +V  Y +      +++ +E 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EV 205
           ++ GSL  +I+Q+  + E        Q L+GL YLH  R ++H D+K  N+L++  G   
Sbjct: 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRA 190
Query: 206 KITDFGVSAM-----LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            + DFG +       LG S+   D   GT  +M+PE + G   D   DIWS   ++L   
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 261 IGRFPYMQ 268
            G  P+ Q
Sbjct: 251 NGCHPWTQ 258

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 112/260 (43%), Gaps = 32/260 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----QCSHVVVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S       H V+  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              TA    F  EF S        F+   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 310 IQKDPXXXXXXXXXXXHPFI 329
           + K+            HP+I
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 86  VRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL 144
            +++    + ALK ++++  +E +    ++E+ + +  +  ++V  +   + +  ++LV 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80
Query: 145 EYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           E+ D+  L          L+P +      Q+L+GL + H+ R+V+HRD+KP NLL+N  G
Sbjct: 81  EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG 138
Query: 204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECA-I 261
           E+K+ +FG++   G  +      V T  Y  P+ + G+  Y  S D+WS G +  E A  
Sbjct: 139 ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 262 GR--FPYMQSEDQ-------------QSWPSFYEL 281
           GR  FP    +DQ             + WPS  +L
Sbjct: 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 26/262 (9%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELK---------INQASQCSHVVVCYHSFYHNG 138
           HK   + +A+KII +        + VQEL+         + + S   +++    ++  N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
              LV + M +G L D + +  T+ E     + + +L+ +  LH + +++HRD+KP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST------YDYSSDIWSL 252
           ++    +K+TDFG S  L      R +  GT +Y++PE I  S       Y    D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLR-SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 253 GLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPEFCSFVSACI 310
           G+++     G  P+   +          +L  I+        P  D +S      VS  +
Sbjct: 216 GVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFL 268
Query: 311 QKDPXXXXXXXXXXXHPFIKKF 332
              P           HPF +++
Sbjct: 269 VVQPQKRYTAEEALAHPFFQQY 290

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 3/178 (1%)
Query: 87  RHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           R++  G++ A+K  ++      I+K  ++E+++ +  +  ++V     F     + LV E
Sbjct: 23  RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           Y D   L ++ R  + + E  +  +  Q LQ + + H + + IHRD+KP N+L+     +
Sbjct: 83  YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVI 141
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIG 262
           K+ DFG + +L       D  V T  Y SPE + G T Y    D+W++G V  E   G
Sbjct: 142 KLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGX 103
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 7/176 (3%)
Query: 95  FALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           +A+K+I + + + +    I++E+++ +     +++  +     +    +V E    G L 
Sbjct: 50  YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 154 DIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDF 210
           D I + K   E   A + KQV  G+ Y+H + +++HRD+KP N+L+  K    ++KI DF
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           G+S     +   +D  +GT  Y++PE + G TYD   D+WS G+++     G  P+
Sbjct: 169 GLSTCFQQNTKMKDR-IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISLVLEY 146
           G +  +K  Q   Q  ++K  ++  ++ +   C+      +V  Y +      +++ +E 
Sbjct: 88  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 147
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EV 205
           ++ GSL  +I+Q+  + E        Q L+GL YLH  R ++H D+K  N+L++  G   
Sbjct: 148 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRA 206
Query: 206 KITDFGVSAM-----LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            + DFG +       LG S+   D   GT  +M+PE + G   D   DIWS   ++L   
Sbjct: 207 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 266
Query: 261 IGRFPYMQ 268
            G  P+ Q
Sbjct: 267 NGCHPWTQ 274

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 103
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 88  HKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY 146
           HK  G  FA KII    +     +++ +E +I +  Q  ++V  + S        LV + 
Sbjct: 26  HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 85
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-- 204
           +  G L + I   +   E   +   +Q+L+ + Y H+   ++HR++KP NLL+  K +  
Sbjct: 86  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGA 144
Query: 205 -VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR 263
            VK+ DFG++  +  S      F GT  Y+SPE +    Y    DIW+ G+++    +G 
Sbjct: 145 AVKLADFGLAIEVNDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG- 202
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXX 323
           +P    EDQ     + ++     + P P    D  +PE  S + + +  +P         
Sbjct: 203 YPPFWDEDQHRL--YAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQA 258
Query: 324 XXHPFI 329
              P+I
Sbjct: 259 LKVPWI 264

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 166 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 105
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISLVLEY 146
           G +  +K  Q   Q  ++K  ++  ++ +   C+      +V  Y +      +++ +E 
Sbjct: 86  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 145
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EV 205
           ++ GSL  +I+Q+  + E        Q L+GL YLH  R ++H D+K  N+L++  G   
Sbjct: 146 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRA 204
Query: 206 KITDFGVSAM-----LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            + DFG +       LG S+   D   GT  +M+PE + G   D   DIWS   ++L   
Sbjct: 205 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 264
Query: 261 IGRFPYMQ 268
            G  P+ Q
Sbjct: 265 NGCHPWTQ 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 109
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 112/260 (43%), Gaps = 32/260 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S    V    ++  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              TA    F  EF S        F+   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 310 IQKDPXXXXXXXXXXXHPFI 329
           + K+            HP+I
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----QCSHVVVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S       H V+  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQS 274
               G  P++    Q++
Sbjct: 210 ILLSGASPFLGDTKQET 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 91  VGRLFALKIIQ---MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
            G   A KII+   M  +EE++ +I    +++ A    +++  Y +F     I LV+EY+
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA----NLIQLYDAFESKNDIVLVMEYV 168
Query: 148 DRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL-VNHKG-E 204
           D G L D II +   + E    +  KQ+ +G+ ++H + +++H D+KP N+L VN    +
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAKQ 227
Query: 205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRF 264
           +KI DFG++         +  F GT  +++PE ++     + +D+WS+G++      G  
Sbjct: 228 IKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 265 PYMQSEDQQS 274
           P++   D ++
Sbjct: 287 PFLGDNDAET 296

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 7/176 (3%)
Query: 95  FALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           +A+K+I + + + +    I++E+++ +     +++  +     +    +V E    G L 
Sbjct: 50  YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 154 DIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDF 210
           D I + K   E   A + KQV  G+ Y+H + +++HRD+KP N+L+  K    ++KI DF
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           G+S     +   +D  +GT  Y++PE + G TYD   D+WS G+++     G  P+
Sbjct: 169 GLSTCFQQNTKMKDR-IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 94/176 (53%), Gaps = 7/176 (3%)
Query: 95  FALKII-QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           +A+K+I + + + +    I++E+++ +     +++  +     +    +V E    G L 
Sbjct: 50  YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109
Query: 154 DIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDF 210
           D I + K   E   A + KQV  G+ Y+H + +++HRD+KP N+L+  K    ++KI DF
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           G+S     +   +D  +GT  Y++PE + G TYD   D+WS G+++     G  P+
Sbjct: 169 GLSTCFQQNTKMKDR-IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-VISLVLEY 146
           HK     FA+KII     ++ ++   +E++I         ++     Y +G  + +V E 
Sbjct: 43  HKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL-VNHKGE- 204
           M  G L D I + K   E   + V   + + + YLH +  V+HRD+KPSN+L V+  G  
Sbjct: 98  MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNP 156
Query: 205 --VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
             ++I DFG +  L +  G   T   T N+++PE +    YD + DIWSLG+++     G
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
Query: 263 RFPYMQSED 271
             P+    D
Sbjct: 217 YTPFANGPD 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 24/259 (9%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF--YHNGVIS 141
            LV  +  G    +K I  +  +   +QI  E+++ ++    +++  +  F  YHN  + 
Sbjct: 39  HLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN--MY 96
Query: 142 LVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           +V+E  + G L + I       K + E Y+A + KQ++  L Y H++ HV+H+D+KP N+
Sbjct: 97  IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENI 155
Query: 198 LVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           L         +KI DFG++ +  S     +   GT  YM+PE +      +  DIWS G+
Sbjct: 156 LFQDTSPHSPIKIIDFGLAELFKSDEHSTNA-AGTALYMAPE-VFKRDVTFKCDIWSAGV 213
Query: 255 VVLECAIGRFPYMQS--EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK 312
           V+     G  P+  +  E+ Q   ++ E   A+   P         +P+    +   + K
Sbjct: 214 VMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP--------LTPQAVDLLKQMLTK 265
Query: 313 DPXXXXXXXXXXXHPFIKK 331
           DP           H + K+
Sbjct: 266 DPERRPSAAQVLHHEWFKQ 284

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----QCSHVVVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S       H V+  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPS 277
               G  P++    Q++  +
Sbjct: 210 ILLSGASPFLGDTKQETLAN 229

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 73  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 127
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 128 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 186
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 187 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 112/260 (43%), Gaps = 32/260 (12%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS----QCSHVVVCYHSFYHNGV-IS 141
           R K  G  +A K I+       R+ + +E    + S       H V+  H  Y N   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+LE +  G L D + Q +++ E       KQ+L G+ YLH ++ + H D+KP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           K      +K+ DFG++  +   +  ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 258 ECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS--------FVSAC 309
               G  P++    Q++  +              T+    F  EF S        F+   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 310 IQKDPXXXXXXXXXXXHPFI 329
           + K+            HP+I
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGX 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 166 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 45  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 99
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 100 LLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 158
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 159 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 58  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 112
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 113 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 171
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 172 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 54  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 108
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 109 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 167
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 168 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 42  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 96
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 97  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 15/229 (6%)
Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHN----GVISLVLEYMDRGSLADIIRQVKTILE 164
           R++  +E +  +  Q  ++V  Y S+         I LV E    G+L   +++ K    
Sbjct: 69  RQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI 128
Query: 165 PYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMGQ 222
             L   C+Q+L+GL +LH     +IHRD+K  N+ +    G VKI D G++ +  +S  +
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
Query: 223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
               +GT  + +PE      YD S D+++ G   LE A   +PY + ++        ++ 
Sbjct: 189 --AVIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYSECQNAA------QIY 239
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
             +     P +      PE    +  CI+++            H F ++
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISLVLEY 146
           G +  ++  Q   Q  ++K  ++  +  +   C+      +V  Y +      +++ +E 
Sbjct: 107 GEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMEL 166
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EV 205
           ++ GSL  ++++   + E        Q L+GL YLH+ R ++H D+K  N+L++  G   
Sbjct: 167 LEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHA 225
Query: 206 KITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            + DFG +  L     G S+   D   GT  +M+PE + G + D   D+WS   ++L   
Sbjct: 226 ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285
Query: 261 IGRFPYMQSEDQQSWPSFYE--LLEAIVESPPPTAP-PDQFSPEFCSFVSACIQKDP 314
            G  P         W  F+   L   I   PPP    P   +P     +   ++K+P
Sbjct: 286 NGCHP---------WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEP 333

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +VL+ M+   L  II   + +   ++     Q+L+GL Y+H+ + VIHRD+KPSNLLV
Sbjct: 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLV 191
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPE-RISGSTYDYSSDIWSLGL 254
           N   E+KI DFG++  L +S  +   F    V T  Y +PE  +S   Y  + D+WS+G 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251
Query: 255 VVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESPPPTA----------------PPD 296
           +  E    R  FP       +++    +L+  ++ +P P                  PP 
Sbjct: 252 IFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPR 305
Query: 297 QFSP----------EFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKD 336
           Q  P          +  S +   ++ +P           HPF+ K+ D D
Sbjct: 306 QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     FV T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K I+     E  +  ++E ++        +V  Y        I LV E+M+ G L+D 
Sbjct: 35  AIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 156 IRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           +R  + +     L  +C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++ 
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYL-EEASVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 215 MLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +     Q  +  GT     + SPE  S S Y   SD+WS G+++ E  + G+ PY
Sbjct: 152 FVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     FV T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 145
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 146 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 206 LTEIVTHGRIPY 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 111/257 (43%), Gaps = 24/257 (9%)
Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV----VVCYHSFYHNGV-IS 141
           R K  G  +A K I+    +  R+ + +E    + S    +    V+  H  Y N   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           L+ E +  G L D + + +++ E       KQ+L G+ YLH+   + H D+KP N+++  
Sbjct: 91  LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD 149
Query: 202 KG----EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           +      +KI DFG++  +      ++ F GT  +++PE ++       +D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 258 ECAIGRFPYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
               G  P++    Q++  +     YE  +    +    A           F+   + KD
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK---------DFIRRLLVKD 259
Query: 314 PXXXXXXXXXXXHPFIK 330
           P           HP+IK
Sbjct: 260 PKKRMTIQDSLQHPWIK 276

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLH 182
           C  + +C  S      + L+ + M  G L D +R+ K  I   YL   C Q+ +G+ YL 
Sbjct: 114 CRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISG 240
           + R ++HRD+   N+LV     VKITDFG++ +LG+   +     G     +M+ E I  
Sbjct: 169 D-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 241 STYDYSSDIWSLGLVVLEC-AIGRFPY 266
             Y + SD+WS G+ V E    G  PY
Sbjct: 228 RIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 148
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 149 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 208
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 209 LTEIVTHGRIPY 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-VISLVLEY 146
           HK     FA+KII     ++ ++   +E++I         ++     Y +G  + +V E 
Sbjct: 43  HKATNXEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL-VNHKGE- 204
              G L D I + K   E   + V   + + + YLH +  V+HRD+KPSN+L V+  G  
Sbjct: 98  XKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNP 156
Query: 205 --VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
             ++I DFG +  L +  G   T   T N+++PE +    YD + DIWSLG+++     G
Sbjct: 157 ESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216
Query: 263 RFPYMQSED 271
             P+    D
Sbjct: 217 YTPFANGPD 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 112/244 (45%), Gaps = 12/244 (4%)
Query: 91  VGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR 149
            G+ +A KII    +     +++ +E +I +  +  ++V  + S    G   L+ + +  
Sbjct: 46  AGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 105
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVK 206
           G L + I   +   E   +   +Q+L+ +++ H +  V+HRD+KP NLL+  K     VK
Sbjct: 106 GELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKLKGAAVK 164
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFG++  +         F GT  Y+SPE +    Y    D+W+ G+++    +G +P 
Sbjct: 165 LADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-YPP 223
Query: 267 MQSEDQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
              EDQ      Y+ ++A   + P P    D  +PE    ++  +  +P           
Sbjct: 224 FWDEDQH---RLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALK 278
Query: 326 HPFI 329
           HP+I
Sbjct: 279 HPWI 282

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 139
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 200 LTEIVTHGRIPY 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 147
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 148 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 207
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 208 LTEIVTHGRIPY 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +VL+ M+   L  II   + +   ++     Q+L+GL Y+H+ + VIHRD+KPSNLLV
Sbjct: 135 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLV 192
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPE-RISGSTYDYSSDIWSLGL 254
           N   E+KI DFG++  L +S  +   F    V T  Y +PE  +S   Y  + D+WS+G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 255 VVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESPPPTA----------------PPD 296
           +  E    R  FP       +++    +L+  ++ +P P                  PP 
Sbjct: 253 IFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPR 306
Query: 297 QFSP----------EFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKD 336
           Q  P          +  S +   ++ +P           HPF+ K+ D D
Sbjct: 307 QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 356

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 164
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     FV T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 165 FGLARHTDDEMA---GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 267 MQSEDQ 272
               DQ
Sbjct: 222 TDHIDQ 227

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 145
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 146 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 206 LTEIVTHGRIPY 217

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 144
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 145 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 204
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 205 LTEIVTHGRIPY 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 140
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 141 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 200
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 201 LTEIVTHGRIPY 212

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 162 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 139
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 200 LTEIVTHGRIPY 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 141
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 142 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 201
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 202 LTEIVTHGRIPY 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 139
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 200 LTEIVTHGRIPY 211

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K ++     +  K+I+ E  +  +    HV     +C  S      + L+ + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ K  I   YL   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G + +LG+   +     G     +M+ E I    Y + SD+WS G+ V E    G  PY
Sbjct: 169 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 149
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 150 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 209
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 210 LTEIVTHGRIPY 221

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K I+     E  +  ++E ++        +V  Y        I LV E+M+ G L+D 
Sbjct: 35  AIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 156 IRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           +R  + +     L  +C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++ 
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 215 MLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +     Q  +  GT     + SPE  S S Y   SD+WS G+++ E  + G+ PY
Sbjct: 152 FVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K I+     E  +  ++E ++        +V  Y        I LV E+M+ G L+D 
Sbjct: 38  AIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 156 IRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           +R  + +     L  +C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++ 
Sbjct: 96  LRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154
Query: 215 MLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +     Q  +  GT     + SPE  S S Y   SD+WS G+++ E  + G+ PY
Sbjct: 155 FVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 139
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 200 LTEIVTHGRIPY 211

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K I+     E  +  ++E ++        +V  Y        I LV E+M+ G L+D 
Sbjct: 33  AIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 156 IRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           +R  + +     L  +C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++ 
Sbjct: 91  LRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 149
Query: 215 MLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +     Q  +  GT     + SPE  S S Y   SD+WS G+++ E  + G+ PY
Sbjct: 150 FVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHRD++ +N
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRDLRAAN 134
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 135 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 194
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 195 LTEIVTHGRIPY 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 87  RHKWVGRLFALK-IIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           R+K  GR+ A+K  ++ +  + ++K  ++E+K+ +  +  ++V             LV E
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           ++D   L D+      +    +     Q++ G+ + H+  ++IHRDIKP N+LV+  G V
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVV 163
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR- 263
           K+ DFG +  L +     D  V T  Y +PE + G   Y  + D+W++G +V E  +G  
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
Query: 264 -FPYMQSEDQ 272
            FP     DQ
Sbjct: 224 LFPGDSDIDQ 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 95  FALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           +A KII    +     +++ +E +I +  +  ++V  + S    G   LV + +  G L 
Sbjct: 59  YAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF 118
Query: 154 DIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDF 210
           + I   +   E   +    Q+L+ + ++H +  ++HRD+KP NLL+  K     VK+ DF
Sbjct: 119 EDIVAREYYSEADASHCIHQILESVNHIH-QHDIVHRDLKPENLLLASKCKGAAVKLADF 177
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           G++  +         F GT  Y+SPE +    Y    DIW+ G+++    +G +P    E
Sbjct: 178 GLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG-YPPFWDE 236
Query: 271 DQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
           DQ      Y+ ++A   + P P    D  +PE  + ++  +  +P           HP++
Sbjct: 237 DQH---KLYQQIKAGAYDFPSPEW--DTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K I+     E  +  ++E ++        +V  Y        I LV E+M+ G L+D 
Sbjct: 36  AIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 156 IRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           +R  + +     L  +C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++ 
Sbjct: 94  LRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152
Query: 215 MLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +     Q  +  GT     + SPE  S S Y   SD+WS G+++ E  + G+ PY
Sbjct: 153 FVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCS-----HVVVCYHSFYHNGVISLVLEY 146
           G +  ++  Q   Q  ++K  ++  +  +   C+      +V  Y +      +++ +E 
Sbjct: 88  GEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMEL 147
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EV 205
           ++ GSL  ++++   + E        Q L+GL YLH+ R ++H D+K  N+L++  G   
Sbjct: 148 LEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHA 206
Query: 206 KITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            + DFG +  L     G  +   D   GT  +M+PE + G + D   D+WS   ++L   
Sbjct: 207 ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266
Query: 261 IGRFPYMQSEDQQSWPSFYE--LLEAIVESPPPTAP-PDQFSPEFCSFVSACIQKDP 314
            G  P         W  F+   L   I   PPP    P   +P     +   ++K+P
Sbjct: 267 NGCHP---------WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEP 314

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           I LV E+M+ G L+D +R  + +     L  +C  V +G+ YL  E  VIHRD+   N L
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACVIHRDLAARNCL 155
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLV 255
           V     +K++DFG++  +     Q  +  GT     + SPE  S S Y   SD+WS G++
Sbjct: 156 VGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 213
Query: 256 VLEC-AIGRFPY 266
           + E  + G+ PY
Sbjct: 214 MWEVFSEGKIPY 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILD 170
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 171 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 267 MQSEDQ 272
               DQ
Sbjct: 228 TDHIDQ 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 175 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 267 MQSEDQ 272
               DQ
Sbjct: 232 TDHIDQ 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 12/244 (4%)
Query: 91  VGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR 149
            G+ +A KII    +     +++ +E +I +  +  ++V  + S    G   LV + +  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VK 206
           G L + I   +   E   +   +Q+L+ + + H    ++HRD+KP NLL+  K +   VK
Sbjct: 88  GELFEDIVAREYYSEADASHCIQQILESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVK 146
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFG++  +         F GT  Y+SPE +    Y    D+W+ G+++    +G +P 
Sbjct: 147 LADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG-YPP 205
Query: 267 MQSEDQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
              EDQ      Y+ ++A   + P P    D  +PE    ++  +  +P           
Sbjct: 206 FWDEDQH---RLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 326 HPFI 329
           HP+I
Sbjct: 261 HPWI 264

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 175
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 176 FGLARHTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 267 MQSEDQ 272
               DQ
Sbjct: 233 TDHIDQ 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 175
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 176 FGLARHTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 267 MQSEDQ 272
               DQ
Sbjct: 233 TDHIDQ 238

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 175
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 176 FGLARHTADEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 267 MQSEDQ 272
               DQ
Sbjct: 233 TDHIDQ 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 8/126 (6%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
             L +I++  K + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 111 ADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 12/244 (4%)
Query: 91  VGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR 149
            G+ +A KII    +     +++ +E +I +  +  ++V  + S    G   LV + +  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VK 206
           G L + I   +   E   +   +Q+L+ + + H    ++HRD+KP NLL+  K +   VK
Sbjct: 88  GELFEDIVAREYYSEADASHCIQQILESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVK 146
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFG++  +         F GT  Y+SPE +    Y    D+W+ G+++    +G +P 
Sbjct: 147 LADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG-YPP 205
Query: 267 MQSEDQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
              EDQ      Y+ ++A   + P P    D  +PE    ++  +  +P           
Sbjct: 206 FWDEDQH---RLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 326 HPFI 329
           HP+I
Sbjct: 261 HPWI 264

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 39/253 (15%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 155 IIRQVKTILE--PYLAVV------------CKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
            +R+   +LE  P  A+               QV QG+ +L + ++ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198
Query: 201 HKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +    KI DFG++   M  S+   +        +M+PE I    Y   SD+WS G+++ E
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 259 C-AIGRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPPTAPPDQFSP 300
             ++G  PY            ++   Q + P+F     Y +++A     P   P  Q   
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ--- 315
Query: 301 EFCSFVSACIQKD 313
           + CSF+    Q+D
Sbjct: 316 QICSFLQEQAQED 328

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILD 173
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 174 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 267 MQSEDQ 272
               DQ
Sbjct: 231 TDHIDQ 236

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILD 173
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 174 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 267 MQSEDQ 272
               DQ
Sbjct: 231 TDHIDQ 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 39/253 (15%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 155 IIRQVKTILE--PYLAVV------------CKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
            +R+   +LE  P  A+               QV QG+ +L + ++ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198
Query: 201 HKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +    KI DFG++   M  S+   +        +M+PE I    Y   SD+WS G+++ E
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 259 C-AIGRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPPTAPPDQFSP 300
             ++G  PY            ++   Q + P+F     Y +++A     P   P  Q   
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ--- 315
Query: 301 EFCSFVSACIQKD 313
           + CSF+    Q+D
Sbjct: 316 QICSFLQEQAQED 328

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 121 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILD 179
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 180 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 267 MQSEDQ 272
               DQ
Sbjct: 237 TDHIDQ 242

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 175 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 267 MQSEDQ 272
               DQ
Sbjct: 232 TDHIDQ 237

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 175 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 267 MQSEDQ 272
               DQ
Sbjct: 232 TDHIDQ 237

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 173
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 174 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 267 MQSEDQ 272
               DQ
Sbjct: 231 TDHIDQ 236

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 109 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 167
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 168 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224
Query: 267 MQSEDQ 272
               DQ
Sbjct: 225 TDHIDQ 230

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 8/126 (6%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
             L +I++  K + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 111 ADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 70/126 (55%), Gaps = 8/126 (6%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
             L +I++  K + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 111 ADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG+       M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLCRHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 120 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 178
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 179 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235
Query: 267 MQSEDQ 272
               DQ
Sbjct: 236 TDHIDQ 241

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 175
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 176 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 267 MQSEDQ 272
               DQ
Sbjct: 233 TDHIDQ 238

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 44  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 160
Query: 207 ITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIG 262
           ++DFG+S  +     +  + VG+     +  PE +  S +   SDIW+ G+++ E  ++G
Sbjct: 161 VSDFGLSRYVLDD--EETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 263 RFPY 266
           + PY
Sbjct: 219 KMPY 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 107 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 165
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 166 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 267 MQSEDQ 272
               DQ
Sbjct: 223 TDHIDQ 228

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-ISLVLEY 146
           HK     +A+K+I     ++ ++   +E++I         ++     Y +G  + LV E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL-VNHKGE- 204
           M  G L D I + K   E   + V   + + + YLH++  V+HRD+KPSN+L V+  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDLKPSNILYVDESGNP 161
Query: 205 --VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
             ++I DFG +  L +  G   T   T N+++PE +    YD   DIWSLG+++     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 263 RFPY 266
             P+
Sbjct: 222 YTPF 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 170
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 171 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 267 MQSEDQ 272
               DQ
Sbjct: 228 TDHIDQ 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 170
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 171 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 267 MQSEDQ 272
               DQ
Sbjct: 228 TDHIDQ 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 175 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 267 MQSEDQ 272
               DQ
Sbjct: 232 TDHIDQ 237

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-ISLVLEY 146
           HK     +A+K+I     ++ ++   +E++I         ++     Y +G  + LV E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL-VNHKGE- 204
           M  G L D I + K   E   + V   + + + YLH++  V+HRD+KPSN+L V+  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDLKPSNILYVDESGNP 161
Query: 205 --VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
             ++I DFG +  L +  G   T   T N+++PE +    YD   DIWSLG+++     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 263 RFPY 266
             P+
Sbjct: 222 YTPF 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 173
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 174 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 267 MQSEDQ 272
               DQ
Sbjct: 231 TDHIDQ 236

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 71/126 (56%), Gaps = 8/126 (6%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
             L +I++  K + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 107 ADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 164
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 165 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 267 MQSEDQ 272
               DQ
Sbjct: 222 TDHIDQ 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 112 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 170
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 171 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 267 MQSEDQ 272
               DQ
Sbjct: 228 TDHIDQ 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 107 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 165
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 166 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 267 MQSEDQ 272
               DQ
Sbjct: 223 TDHIDQ 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 133 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 191
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 192 FGLARHTDDEMX---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 267 MQSEDQ 272
               DQ
Sbjct: 249 TDHIDQ 254

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 164
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 165 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 267 MQSEDQ 272
               DQ
Sbjct: 222 TDHIDQ 227

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 82/161 (50%), Gaps = 5/161 (3%)
Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKTILEPYL 167
           +  ++E  + +  Q   +V  Y        I ++ EYM +GSL D ++  +   +L P L
Sbjct: 53  QAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL 112
Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTF 226
                Q+ +G+ Y+  + + IHRD++ +N+LV+     KI DFG++ ++  +    R+  
Sbjct: 113 IDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 171
Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
                + +PE I+   +   SD+WS G+++ E    G+ PY
Sbjct: 172 KFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 129 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 187
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 188 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 267 MQSEDQ 272
               DQ
Sbjct: 245 TDHIDQ 250

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 121 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 179
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 180 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 267 MQSEDQ 272
               DQ
Sbjct: 237 TDHIDQ 242

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 129 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 187
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 188 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 267 MQSEDQ 272
               DQ
Sbjct: 245 TDHIDQ 250

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 122 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 180
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 181 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 267 MQSEDQ 272
               DQ
Sbjct: 238 TDHIDQ 243

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 122 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 180
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 181 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 267 MQSEDQ 272
               DQ
Sbjct: 238 TDHIDQ 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 164
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 165 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 267 MQSEDQ 272
               DQ
Sbjct: 222 TDHIDQ 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 133 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 191
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 192 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 267 MQSEDQ 272
               DQ
Sbjct: 249 TDHIDQ 254

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 108 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 166
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 167 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223
Query: 267 MQSEDQ 272
               DQ
Sbjct: 224 TDHIDQ 229

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 188
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 189 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 267 MQSEDQ 272
               DQ
Sbjct: 246 TDHIDQ 251

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 122 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 180
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 181 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 267 MQSEDQ 272
               DQ
Sbjct: 238 TDHIDQ 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 188
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 189 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 267 MQSEDQ 272
               DQ
Sbjct: 246 TDHIDQ 251

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 44  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 160
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS+G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGSKFPV----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 217 LGKMPY 222

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           I ++ EYM+ GSL D ++    +K  +   L +   Q+ +G+ ++  ER+ IHR+++ +N
Sbjct: 78  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA-QIAEGMAFIE-ERNYIHRNLRAAN 135
Query: 197 LLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           +LV+     KI DFG++ ++  +    R+       + +PE I+  T+   SD+WS G++
Sbjct: 136 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 195
Query: 256 VLECAI-GRFPY 266
           + E    GR PY
Sbjct: 196 LTEIVTHGRIPY 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 88/175 (50%), Gaps = 9/175 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNER 185
           +V  H+      I ++ E+M +GSL D ++  +   +P   ++    Q+ +G+ ++  +R
Sbjct: 72  LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 130
Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYD 244
           + IHRD++ +N+LV+     KI DFG++ ++  +    R+       + +PE I+  ++ 
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 245 YSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
             SD+WS G++++E    GR PY       S P     LE     P P   P++ 
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGYRMPRPENCPEEL 241

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 24  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 140
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS+G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSK----FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 197 LGKMPY 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 28  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 85
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 144
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS+G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 145 VSDFGLSRYVLDDEYTSSVGSKFPV----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 201 LGKMPY 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 7/119 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 139 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 197
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FP 265
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP
Sbjct: 198 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFP 253

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V  +  G  FA K + M   E  ++ + +E++     +   +V  + +F  +  + ++ E
Sbjct: 176 VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 146 YMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-- 202
           +M  G L + +      +    AV   +QV +GL ++H E + +H D+KP N++   K  
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 293
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            E+K+ DFG++A L      + T  GT  + +PE   G    Y +D+WS+G++      G
Sbjct: 294 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
Query: 263 RFPYMQSEDQQS 274
             P+    D ++
Sbjct: 353 LSPFGGENDDET 364

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 86  VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           V  +  G  FA K + M   E  ++ + +E++     +   +V  + +F  +  + ++ E
Sbjct: 70  VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 128
Query: 146 YMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-- 202
           +M  G L + +      +    AV   +QV +GL ++H E + +H D+KP N++   K  
Sbjct: 129 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 187
Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            E+K+ DFG++A L      + T  GT  + +PE   G    Y +D+WS+G++      G
Sbjct: 188 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246
Query: 263 RFPYMQSEDQQS 274
             P+    D ++
Sbjct: 247 LSPFGGENDDET 258

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 35  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 92
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 151
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS+G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 152 VSDFGLSRYVLDDEYTSSVGSKFPV----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 208 LGKMPY 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 29  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 145
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS+G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 146 VSDFGLSRYVLDDEYTSSVGSKFPV----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 202 LGKMPY 207

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 18/179 (10%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G L A+K +Q +  ++ R    +E++I +A     +V      Y  G   + LV+EY+ 
Sbjct: 39  TGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 149 RGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            G L D +++ +  L+   L +   Q+ +G+ YL   R  +HRD+   N+LV  +  VKI
Sbjct: 98  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCVHRDLAARNILVESEAHVKI 156
Query: 208 TDFGVSAMLG--------SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
            DFG++ +L            GQ   F     + +PE +S + +   SD+WS G+V+ E
Sbjct: 157 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYE 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/166 (34%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 106 EEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTIL 163
           EE+++Q  QE+K+   ++C H  +V    F  +G  + LV  YM  GSL D +  +    
Sbjct: 71  EELKQQFDQEIKV--MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 164 EPYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AML 216
                + CK       G+ +LH E H IHRDIK +N+L++     KI+DFG++       
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            + M  R   VGT  YM+PE + G      SDI+S G+V+LE   G
Sbjct: 188 QTVMXSR--IVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITG 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 18/179 (10%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G L A+K +Q +  ++ R    +E++I +A     +V      Y  G   + LV+EY+ 
Sbjct: 38  TGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 96
Query: 149 RGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            G L D +++ +  L+   L +   Q+ +G+ YL   R  +HRD+   N+LV  +  VKI
Sbjct: 97  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCVHRDLAARNILVESEAHVKI 155
Query: 208 TDFGVSAMLG--------SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
            DFG++ +L            GQ   F     + +PE +S + +   SD+WS G+V+ E
Sbjct: 156 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYE 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 88/175 (50%), Gaps = 9/175 (5%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNER 185
           +V  H+      I ++ E+M +GSL D ++  +   +P   ++    Q+ +G+ ++  +R
Sbjct: 245 LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 303
Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYD 244
           + IHRD++ +N+LV+     KI DFG++ ++  +    R+       + +PE I+  ++ 
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 245 YSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
             SD+WS G++++E    GR PY       S P     LE     P P   P++ 
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGYRMPRPENCPEEL 414

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 8/174 (4%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV--ISLVLEYMD 148
            G L A+K +Q +  ++ R    +E++I +A     +V      Y  G   + LV+EY+ 
Sbjct: 35  TGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLP 93
Query: 149 RGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            G L D +++ +  L+   L +   Q+ +G+ YL   R  +HRD+   N+LV  +  VKI
Sbjct: 94  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCVHRDLAARNILVESEAHVKI 152
Query: 208 TDFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
            DFG++ +L         R+       + +PE +S + +   SD+WS G+V+ E
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 206

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/166 (34%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 106 EEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTIL 163
           EE+++Q  QE+K+   ++C H  +V    F  +G  + LV  YM  GSL D +  +    
Sbjct: 71  EELKQQFDQEIKV--MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 164 EPYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AML 216
                + CK       G+ +LH E H IHRDIK +N+L++     KI+DFG++       
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            + M  R   VGT  YM+PE + G      SDI+S G+V+LE   G
Sbjct: 188 QTVMXXR--IVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITG 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           KW G+   A+K+I+     E   + ++E K+        +V  Y        I ++ EYM
Sbjct: 29  KWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 148 DRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
             G L + +R+++   +   L  +CK V + + YL + +  +HRD+   N LVN +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVK 145
Query: 207 ITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           ++DFG+S  +      SS G +        +  PE +  S +   SDIW+ G+++ E  +
Sbjct: 146 VSDFGLSRYVLDDEYTSSRGSKFPV----RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 202 LGKMPY 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           +G++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 YGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 18/179 (10%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G L A+K +Q +  ++ R    +E++I +A     +V      Y  G   + LV+EY+ 
Sbjct: 51  TGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 149 RGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            G L D +++ +  L+   L +   Q+ +G+ YL   R  +HRD+   N+LV  +  VKI
Sbjct: 110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GSRRCVHRDLAARNILVESEAHVKI 168
Query: 208 TDFGVSAMLG--------SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
            DFG++ +L            GQ   F     + +PE +S + +   SD+WS G+V+ E
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYE 222

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 135 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 191
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 192 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 252 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 288

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M      V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 106 EEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTIL 163
           EE+++Q  QE+K+   ++C H  +V    F  +G  + LV  YM  GSL D +  +    
Sbjct: 65  EELKQQFDQEIKV--MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 164 EPYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
                + CK       G+ +LH E H IHRDIK +N+L++     KI+DFG+ A      
Sbjct: 123 PLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGL-ARASEKF 180
Query: 221 GQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            Q       VGT  YM+PE + G      SDI+S G+V+LE   G
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITG 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 18/255 (7%)
Query: 84  QLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           +L+R K    L A+K I+    I E ++++I+    +       ++V           ++
Sbjct: 37  RLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP----NIVRFKEVILTPTHLA 92
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +++EY   G L + I       E       +Q+L G+ Y H+   + HRD+K  N L++ 
Sbjct: 93  IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG 151
Query: 202 KG--EVKITDFGVS--AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVV 256
                +KI DFG S  ++L S   Q  + VGT  Y++PE +    YD   +D+WS G+ +
Sbjct: 152 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXX 316
               +G +P+   E+ + +    + + ++  S P      + SPE C  +S     DP  
Sbjct: 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI---RISPECCHLISRIFVADPAT 265
Query: 317 XXXXXXXXXHPFIKK 331
                    H +  K
Sbjct: 266 RISIPEIKTHSWFLK 280

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 107
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 164
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 225 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 130 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 188
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M      V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 189 FGLARHTDDEMX---GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 267 MQSEDQ 272
               DQ
Sbjct: 246 TDHIDQ 251

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL ++   +HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYL-SDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 111/244 (45%), Gaps = 12/244 (4%)
Query: 91  VGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR 149
            G+ +A  II    +     +++ +E +I +  +  ++V  + S    G   L+ + +  
Sbjct: 35  AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVK 206
           G L + I   +   E   +   +Q+L+ +++ H +  V+HR++KP NLL+  K     VK
Sbjct: 95  GELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVK 153
Query: 207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           + DFG++  +         F GT  Y+SPE +    Y    D+W+ G+++    +G +P 
Sbjct: 154 LADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-YPP 212
Query: 267 MQSEDQQSWPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXX 325
              EDQ      Y+ ++A   + P P    D  +PE    ++  +  +P           
Sbjct: 213 FWDEDQH---RLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALK 267
Query: 326 HPFI 329
           HP+I
Sbjct: 268 HPWI 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 65  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 124
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 125 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 181
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 182 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 242 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 278

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 78/143 (54%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 78/143 (54%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           + +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 24/183 (13%)
Query: 92  GRLFALKIIQMNIQEE------IRKQIVQELKINQASQCSHVV----VCYHSFYHNGV-I 140
           GR  ALK +++   EE      IR+  V  L+  +  +  +VV    VC  S       +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV--LRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPS 195
           +LV E++D+    D+   +  + EP +       +  Q+L+GL +LH+ R V+HRD+KP 
Sbjct: 95  TLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQ 149
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV   G++K+ DFG++ +    M      V T  Y +PE +  S+Y    D+WS+G +
Sbjct: 150 NILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 256 VLE 258
             E
Sbjct: 209 FAE 211

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 25/198 (12%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH-----SFYHNGVISL 142
           HK  G + A+K I+   +     + ++E+KI +  +  +++  ++     SF +   + +
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 143 VLEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           + E M      D+ R + T +  + ++     Q L+ +  LH   +VIHRD+KPSNLL+N
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLIN 146
Query: 201 HKGEVKITDFGVSAMLGSS-------MGQRD---TFVGTYNYMSPE-RISGSTYDYSSDI 249
              ++K+ DFG++ ++  S        GQ+     FV T  Y +PE  ++ + Y  + D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 250 WSLGLVVLECAIGR--FP 265
           WS G ++ E  + R  FP
Sbjct: 207 WSCGCILAELFLRRPIFP 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 24/183 (13%)
Query: 92  GRLFALKIIQMNIQEE------IRKQIVQELKINQASQCSHVV----VCYHSFYHNGV-I 140
           GR  ALK +++   EE      IR+  V  L+  +  +  +VV    VC  S       +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV--LRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPS 195
           +LV E++D+    D+   +  + EP +       +  Q+L+GL +LH+ R V+HRD+KP 
Sbjct: 95  TLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQ 149
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV   G++K+ DFG++ +    M      V T  Y +PE +  S+Y    D+WS+G +
Sbjct: 150 NILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 256 VLE 258
             E
Sbjct: 209 FAE 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 24/183 (13%)
Query: 92  GRLFALKIIQMNIQEE------IRKQIVQELKINQASQCSHVV----VCYHSFYHNGV-I 140
           GR  ALK +++   EE      IR+  V  L+  +  +  +VV    VC  S       +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV--LRHLETFEHPNVVRLFDVCTVSRTDRETKL 94
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPS 195
           +LV E++D+    D+   +  + EP +       +  Q+L+GL +LH+ R V+HRD+KP 
Sbjct: 95  TLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQ 149
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV   G++K+ DFG++ +    M      V T  Y +PE +  S+Y    D+WS+G +
Sbjct: 150 NILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 256 VLE 258
             E
Sbjct: 209 FAE 211

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 44  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 103
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 104 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 162
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 163 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 223 EQPYQGLSNEQ 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 40/244 (16%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++ +  +  RK   +E ++    Q  H+V  Y        + +V EYM  G L 
Sbjct: 45  LVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 154 DIIRQV-------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
             +R                 + +  +  + +Q+  G+VYL ++ H +HRD+   N LV 
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVG 162
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYN-----YMSPERISGSTYDYSSDIWSLGLV 255
               VKI DFG+S  + S+   R   VG +      +M PE I    +   SD+WSLG+V
Sbjct: 163 ENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 219
Query: 256 VLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES----PPPTAPPDQFSPEFCSFVSACI 310
           + E    G+ P+ Q  +        E++E I +      P T P + +       +  C 
Sbjct: 220 LWEIFTYGKQPWYQLSNN-------EVIECITQGRVLQRPRTCPQEVY-----ELMLGCW 267
Query: 311 QKDP 314
           Q++P
Sbjct: 268 QREP 271

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 86/174 (49%), Gaps = 17/174 (9%)
Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV--CKQVLQGLVYLHNER 185
           +V  H+      I ++ E+M +GSL D ++  +   +P   ++    Q+ +G+ ++  +R
Sbjct: 239 LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 297
Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           + IHRD++ +N+LV+     KI DFG+ A +G+             + +PE I+  ++  
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGL-ARVGAKF--------PIKWTAPEAINFGSFTI 348
Query: 246 SSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
            SD+WS G++++E    GR PY       S P     LE     P P   P++ 
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGYRMPRPENCPEEL 398

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 171
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 172 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 232 EQPYQGLSNEQ 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI  
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILG 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 114 QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQ 173
           QE++I ++    +++  Y +F  N  I LV+E    G L + +   +   E   A + K 
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 114
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           VL  + Y H + +V HRD+KP N L    +    +K+ DFG++A        R T VGT 
Sbjct: 115 VLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTP 172
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            Y+SP+ + G  Y    D WS G+++     G  P+       S P+  E++  I E   
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF-------SAPTDXEVMLKIREGTF 224
Query: 291 PTAPPD--QFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
                D    SP+  S +   + K P           H + +K
Sbjct: 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 114 QELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQ 173
           QE++I ++    +++  Y +F  N  I LV+E    G L + +   +   E   A + K 
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           VL  + Y H + +V HRD+KP N L    +    +K+ DFG++A        R T VGT 
Sbjct: 132 VLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-TKVGTP 189
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            Y+SP+ + G  Y    D WS G+++     G  P+       S P+  E++  I E   
Sbjct: 190 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF-------SAPTDXEVMLKIREGTF 241
Query: 291 PTAPPD--QFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
                D    SP+  S +   + K P           H + +K
Sbjct: 242 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
             +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 21/250 (8%)
Query: 89  KWVGRLFALKIIQMNIQEEIRKQIVQ-ELKINQASQCSHVVVCYHSFYHNGVISLVLEYM 147
           K  GR+F  K I  N    + K  V+ E+ I        ++  + +F     + L+LE++
Sbjct: 73  KATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 148 DRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK--GE 204
             G L D I  +   + E  +    +Q  +GL ++H E  ++H DIKP N++   K    
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASS 189
Query: 205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRF 264
           VKI DFG++  L      + T   T  + +PE +      + +D+W++G++      G  
Sbjct: 190 VKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248
Query: 265 PYMQSEDQQSWPSF----YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXX 320
           P+   +D ++  +     +E  E    S          SPE   F+   +QK+P      
Sbjct: 249 PFAGEDDLETLQNVKRCDWEFDEDAFSS---------VSPEAKDFIKNLLQKEPRKRLTV 299
Query: 321 XXXXXHPFIK 330
                HP++K
Sbjct: 300 HDALEHPWLK 309

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
            G++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 AGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 120 QASQCSHVVV---CYHSFYHN-GVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQ 173
           +ASQC H+V     Y + Y     + +V+E +D G L   I  R  +   E   + + K 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           + + + YLH+  ++ HRD+KP NLL   K     +K+TDFG  A   +S     T   T 
Sbjct: 126 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTP 183
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-AIVESP 289
            Y++PE +    YD S D+WSLG+++     G  P+  +      P     +     E P
Sbjct: 184 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 243
Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            P     + S E    +   ++ +P           HP+I
Sbjct: 244 NPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 111 QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKTILEPYLA 168
           QI+++LK ++  Q  + VV     Y      +V EYM++GSL D ++  + + +  P L 
Sbjct: 56  QIMKKLKHDKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKDGEGRALKLPNLV 108
Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFV 227
            +  QV  G+ Y+    + IHRD++ +N+LV +    KI DFG++ ++  +    R    
Sbjct: 109 DMAAQVAAGMAYIERMNY-IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPY 266
               + +PE      +   SD+WS G+++ E    GR PY
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 49  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 108
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 109 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 167
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 168 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 226
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 227 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 284
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 285 TITEFMNHPWI 295

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 120 QASQCSHVVV---CYHSFYHN-GVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQ 173
           +ASQC H+V     Y + Y     + +V+E +D G L   I  R  +   E   + + K 
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           + + + YLH+  ++ HRD+KP NLL   K     +K+TDFG  A   +S     T   T 
Sbjct: 170 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTP 227
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-AIVESP 289
            Y++PE +    YD S D+WSLG+++     G  P+  +      P     +     E P
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            P     + S E    +   ++ +P           HP+I
Sbjct: 288 NPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 41  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 100
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 101 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 159
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 160 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 219 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 276
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 277 TITEFMNHPWI 287

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 120 QASQCSHVVV---CYHSFYHN-GVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQ 173
           +ASQC H+V     Y + Y     + +V+E +D G L   I  R  +   E   + + K 
Sbjct: 116 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 175
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           + + + YLH+  ++ HRD+KP NLL   K     +K+TDFG  A   +S     T   T 
Sbjct: 176 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTP 233
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-AIVESP 289
            Y++PE +    YD S D+WSLG+++     G  P+  +      P     +     E P
Sbjct: 234 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 293
Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            P     + S E    +   ++ +P           HP+I
Sbjct: 294 NPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 33  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 92
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 93  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 151
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 152 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 210
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 211 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 268
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 269 TITEFMNHPWI 279

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 39  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 98
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 99  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 157
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 158 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 216
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 217 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 274
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 275 TITEFMNHPWI 285

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
            G++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 RGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 169
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 230 EQPYQGLSNEQ 240

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 34  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 93
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 94  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 152
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 153 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 211
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 212 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 269
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 270 TITEFMNHPWI 280

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 40  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 99
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 100 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 158
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 159 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 217
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 218 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 275
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 276 TITEFMNHPWI 286

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           F ++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 FYLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 48  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 107
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 108 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 166
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 167 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 226
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 227 EQPYQGLSNEQ 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 7/173 (4%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL--VLEYMD 148
            G + A+K ++ +   + R    QE+ I +     H++         G  SL  V+EY+ 
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
            GSL D + +  +I    L +  +Q+ +G+ YLH + H IHRD+   N+L+++   VKI 
Sbjct: 119 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIG 176
Query: 209 DFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           DFG++  +         R+       + +PE +    + Y+SD+WS G+ + E
Sbjct: 177 DFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 97  LKIIQMNIQEEIRKQIVQ-------ELKIN-QASQCSHVVV---CYHSFYHN-GVISLVL 144
           L+I     QE+   +++Q       E++++ +ASQC H+V     Y + Y     + +V+
Sbjct: 35  LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 145 EYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           E +D G L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSK 153
Query: 203 ---GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +K+TDFG  A   +S     T   T  Y++PE +    YD S D+WSLG+++   
Sbjct: 154 RPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 212
Query: 260 AIGRFPYMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
             G  P+  +      P     +     E P P     + S E    +   ++ +P    
Sbjct: 213 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRM 270
Query: 319 XXXXXXXHPFI 329
                  HP+I
Sbjct: 271 TITEFMNHPWI 281

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 5/161 (3%)
Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKTILEPYL 167
           +  ++E  + +  Q   +V  Y        I ++ E+M +GSL D ++  +   +L P L
Sbjct: 52  QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL 111
Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTF 226
                Q+ +G+ Y+  + + IHRD++ +N+LV+     KI DFG++ ++  +    R+  
Sbjct: 112 IDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 170
Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
                + +PE I+   +   S++WS G+++ E    G+ PY
Sbjct: 171 KFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 169
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 230 EQPYQGLSNEQ 240

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSNL VN   E+KI D
Sbjct: 110 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILD 168
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
            G++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   GR  FP 
Sbjct: 169 GGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 267 MQSEDQ 272
               DQ
Sbjct: 226 TDHIDQ 231

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 19/245 (7%)
Query: 95  FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHN-GVISLVLEYMDRG 150
           FALK++Q     + R+++  EL   +ASQC H+V     Y + Y     + +V+E +D G
Sbjct: 44  FALKMLQDC--PKARREV--ELHW-RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 98
Query: 151 SLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEV 205
            L   I  R  +   E   + + K + + + YLH+  ++ HRD+KP NLL   K     +
Sbjct: 99  ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAIL 157
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
           K+TDFG +    S     +     Y Y++PE +    YD S D+WSLG+++     G  P
Sbjct: 158 KLTDFGFAKETTSHNSLTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216
Query: 266 YMQSEDQQSWPSFYELLE-AIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXX 324
           +  +      P     +     E P P     + S E    +   ++ +P          
Sbjct: 217 FYSNHGLAISPGMKTRIRMGQYEFPNPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFM 274
Query: 325 XHPFI 329
            HP+I
Sbjct: 275 NHPWI 279

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +V EYM  G+L D 
Sbjct: 65  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDY 118
Query: 156 IRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
           +R+   + +    L  +  Q+   + YL  +++ IHRD+   N LV     VK+ DFG+S
Sbjct: 119 LRECNREEVTAVVLLYMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHVVKVADFGLS 177
Query: 214 A-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSED 271
             M G +            + +PE ++ +T+   SD+W+ G+++ E A  G  PY   + 
Sbjct: 178 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 237
Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            Q     Y+LLE       P   P    P+    + AC +  P
Sbjct: 238 SQ----VYDLLEKGYRMEQPEGCP----PKVYELMRACWKWSP 272

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 25/198 (12%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH-----SFYHNGVISL 142
           HK  G + A+K I+   +     + ++E+KI +  +  +++  ++     SF +   + +
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 143 VLEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           + E M      D+ R + T +  + ++     Q L+ +  LH   +VIHRD+KPSNLL+N
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLIN 146
Query: 201 HKGEVKITDFGVSAMLGSS-------MGQRD---TFVGTYNYMSPE-RISGSTYDYSSDI 249
              ++K+ DFG++ ++  S        GQ+     +V T  Y +PE  ++ + Y  + D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 250 WSLGLVVLECAIGR--FP 265
           WS G ++ E  + R  FP
Sbjct: 207 WSCGCILAELFLRRPIFP 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/128 (35%), Positives = 71/128 (55%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           AD+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 249 PGKHYLDQ 256

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 92  GRLFALKIIQM-NIQEEIRKQIVQE---LKINQASQCSHVV----VCYHSFYHNGV-ISL 142
           G   ALK +++ N +E +    V+E   L+  +A +  +VV    VC  S     + ++L
Sbjct: 29  GHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           V E++D+    D+   +     P L       + +Q L+GL +LH    ++HRD+KP N+
Sbjct: 89  VFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENI 143
Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           LV   G VK+ DFG++ +    M   D  V T  Y +PE +  STY    D+WS+G +  
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMAL-DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 202
Query: 258 E 258
           E
Sbjct: 203 E 203

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 119 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 177
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 238 EQPYQGLSNEQ 248

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E+ R+  + E  I       +V+        +  + ++ E+M+ GSL   
Sbjct: 65  AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 124
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +RQ     T+++  L  + + +  G+ YL +  +V HRD+   N+LVN     K++DFG+
Sbjct: 125 LRQNDGQFTVIQ--LVGMLRGIAAGMKYLADMNYV-HRDLAARNILVNSNLVCKVSDFGL 181
Query: 213 SAMLGSSMGQRDTFVGTYN----------YMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
           S  L     + DT   TY           + +PE I    +  +SD+WS G+V+ E  + 
Sbjct: 182 SRFL-----EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 236
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  PY    +Q         +E     PPP   P          +  C QKD
Sbjct: 237 GERPYWDMTNQ----DVINAIEQDYRLPPPMDCPSALH----QLMLDCWQKD 280

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V+EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 106 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 161
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      FV T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 162 KSDCTLKILDFGLARTAGTSF-MMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 220
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 221 IKGGVLFPGTDHIDQWNKVIEQL 243

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQASQCSHVVVCYHSFYHNGVI 140
           +V+ K   R++A+KI  +N  E +++       +E  +     C  +   +++F     +
Sbjct: 92  VVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHL 149
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
            LV++Y   G L  ++ + +  L   +A     +++  +  +H + H +HRDIKP N+L+
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH-QLHYVHRDIKPDNVLL 208
Query: 200 NHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLG 253
           +  G +++ DFG    M      Q    VGT +Y+SPE +         Y    D WSLG
Sbjct: 209 DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 268
Query: 254 LVVLECAIGRFPY 266
           + + E   G  P+
Sbjct: 269 VCMYEMLYGETPF 281

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S       V  Y Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V+EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 169
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 170 KIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 230 EQPYQGLSNEQ 240

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQASQCSHVVVCYHSFYHNGVI 140
           +V+ K   R++A+KI  +N  E +++       +E  +     C  +   +++F     +
Sbjct: 108 VVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHL 165
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
            LV++Y   G L  ++ + +  L   +A     +++  +  +H + H +HRDIKP N+L+
Sbjct: 166 YLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH-QLHYVHRDIKPDNVLL 224
Query: 200 NHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLG 253
           +  G +++ DFG    M      Q    VGT +Y+SPE +         Y    D WSLG
Sbjct: 225 DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 284
Query: 254 LVVLECAIGRFPY 266
           + + E   G  P+
Sbjct: 285 VCMYEMLYGETPF 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 50  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 109
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 110 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 168
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 228
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 229 EQPYQGLSNEQ 239

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V E M+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL ++   +HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYL-SDMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 4/177 (2%)
Query: 93  RLFALKIIQMNIQEE--IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R+ ALK+    +  +   R +  +E +     Q  HVV  +     +G + +    ++  
Sbjct: 60  RIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGV 119
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            LA  +R+   +  P    + +Q+    +   +     HRD+KP N+LV+      + DF
Sbjct: 120 DLAAXLRRQGPLAPPRAVAIVRQI-GSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
Query: 211 GV-SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           G+ SA     + Q    VGT  Y +PER S S   Y +DI++L  V+ EC  G  PY
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 164
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 225 EQPYQGLSNEQ 235

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V E M+ GSL   
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 290

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L+ +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLSQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +++E+M  G+L D 
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 97
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 98  LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 153
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 214 IDPSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 251

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E  R+  + E  I       +++          +  +V EYM+ GSL   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R      TI++  L  + + V  G+ YL +  +V HRD+   N+LV+     K++DFG+
Sbjct: 141 LRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGL 197
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           S +L        T  G      + +PE I+  T+  +SD+WS G+V+ E  A G  PY
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 171
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 172 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 232 EQPYQGLSNEQ 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K+++ N   +  K+I+ E  +       +V     +C  S      + LV + M  G 
Sbjct: 50  AIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS-----TVQLVTQLMPYGC 104
Query: 152 LADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L D +R+ +  L    L   C Q+ +G+ YL + R ++HRD+   N+LV     VKITDF
Sbjct: 105 LLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR-LVHRDLAARNVLVKSPNHVKITDF 163
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +L     +     G     +M+ E I    + + SD+WS G+ V E    G  PY
Sbjct: 164 GLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 170
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 231 EQPYQGLSNEQ 241

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 46/251 (18%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K+++ N      + ++ E  + +     HV+  Y +   +G + L++EY   GSL   
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 156 IRQVKTILEPYLAV------------------------VCKQVLQGLVYLHNERHVIHRD 191
           +R+ + +   YL                             Q+ QG+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------YNYMSPERISGSTYDY 245
           +   N+LV    ++KI+DFG+S      + + D++V          +M+ E +    Y  
Sbjct: 176 LAARNILVAEGRKMKISDFGLS----RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 246 SSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSF-YELLEAIVESPPPTAPPDQFSPEFC 303
            SD+WS G+++ E   +G  PY         P    E L  ++++      PD  S E  
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPY---------PGIPPERLFNLLKTGHRMERPDNCSEEMY 282
Query: 304 SFVSACIQKDP 314
             +  C +++P
Sbjct: 283 RLMLQCWKQEP 293

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 98  LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 153
Query: 211 GVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLECAI-GR 263
           G+S ++       DTF           + +PE ++ + +   SD+W+ G+++ E A  G 
Sbjct: 154 GLSRLMTG-----DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 208
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            PY   +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 209 SPYPGIDPSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 251

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 97  VYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVV 152
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 153 KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 170
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 231 EQPYQGLSNEQ 241

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +++E+M  G+L D 
Sbjct: 47  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 100
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 101 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 156
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 157 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 217 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 254

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 27/194 (13%)
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR 223
           E  +  +  Q+L+GL Y+H+   V+HRD+KP NL VN   E+KI DFG++    + M   
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 198
Query: 224 DTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE--DQQS------ 274
             +V T  Y +PE I S   Y+ + DIWS+G ++ E   G+  +   +  DQ +      
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 275 ---WPSFYELL-----EAIVESPPPTAPPD------QFSPEFCSFVSACIQKDPXXXXXX 320
                 F + L     ++ ++S P T   D      + SP+    +   ++ D       
Sbjct: 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318
Query: 321 XXXXXHPFIKKFED 334
                HPF + F D
Sbjct: 319 AQALTHPFFEPFRD 332

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL 241

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR 223
           E  +  +  Q+L+GL Y+H+   V+HRD+KP NL VN   E+KI DFG++    + M   
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180
Query: 224 DTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGR 263
             +V T  Y +PE I S   Y+ + DIWS+G ++ E   G+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 105 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 160
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQL 242

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V E M+ GSL   
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 107
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 164
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + SPE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKD 313
             +Q       ++++A+ E    PPP   P          +  C QKD
Sbjct: 225 MSNQ-------DVIKAVDEGYRLPPPMDCP----AALYQLMLDCWQKD 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 116/262 (44%), Gaps = 48/262 (18%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 65  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 124
Query: 155 IIR-QVKTILEPYLAV----------------------VCKQVLQGLVYLHNERHVIHRD 191
            +R + + +L P LA                          QV QG+ +L + ++ IHRD
Sbjct: 125 FLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS-KNCIHRD 183
Query: 192 IKPSNLLVNHKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           +   N+L+ +    KI DFG++   M  S+   +        +M+PE I    Y   SD+
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 243
Query: 250 WSLGLVVLEC-AIGRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPP 291
           WS G+++ E  ++G  PY            ++   Q + P+F     Y +++A     P 
Sbjct: 244 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPT 303
Query: 292 TAPPDQFSPEFCSFVSACIQKD 313
             P  Q   + CSF+    Q+D
Sbjct: 304 HRPTFQ---QICSFLQEQAQED 322

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +++E+M  G+L D 
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 104
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 105 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 160
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 221 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 258

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTSDLKICDF 170
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 171 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 231 PGKHYLDQ 238

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 25/198 (12%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH-----SFYHNGVISL 142
           HK  G + A+K I+   +     + ++E+KI +  +  +++  ++     SF +   + +
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 143 VLEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           + E M      D+ R + T +  + ++     Q L+ +  LH   +VIHRD+KPSNLL+N
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLIN 146
Query: 201 HKGEVKITDFGVSAMLGSS-------MGQRDTF---VGTYNYMSPE-RISGSTYDYSSDI 249
              ++K+ DFG++ ++  S        GQ+      V T  Y +PE  ++ + Y  + D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 250 WSLGLVVLECAIGR--FP 265
           WS G ++ E  + R  FP
Sbjct: 207 WSCGCILAELFLRRPIFP 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVC------YHSFYHNGVIS 141
           H+  G   A+K  +  +  + R++   E++I +     +VV              N +  
Sbjct: 35  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94
Query: 142 LVLEYMDRGSLADIIRQVKT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           L +EY + G L   + Q +    + E  +  +   +   L YLH  R +IHRD+KP N++
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIV 153
Query: 199 VNHKGEV---KITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           +    +    KI D G +  L    G+  T FVGT  Y++PE +    Y  + D WS G 
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 255 VVLECAIGRFPYMQSEDQQSW 275
           +  EC  G  P++ +     W
Sbjct: 212 LAFECITGFRPFLPNWQPVQW 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 69/119 (57%), Gaps = 7/119 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSN+ VN   E++I D
Sbjct: 116 GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDSELRILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FP 265
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   G+  FP
Sbjct: 175 FGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 81  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 140
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 141 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 199
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 259
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 260 EQPYQGLSNEQ 270

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 16/193 (8%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVC------YHSFYHNGVIS 141
           H+  G   A+K  +  +  + R++   E++I +     +VV              N +  
Sbjct: 36  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 95
Query: 142 LVLEYMDRGSLADIIRQVKT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           L +EY + G L   + Q +    + E  +  +   +   L YLH  R +IHRD+KP N++
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIV 154
Query: 199 VNHKGEV---KITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           +    +    KI D G +  L    G+  T FVGT  Y++PE +    Y  + D WS G 
Sbjct: 155 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 212
Query: 255 VVLECAIGRFPYM 267
           +  EC  G  P++
Sbjct: 213 LAFECITGFRPFL 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 156 IRQVKTIL--EPYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +   P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 177
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 238 EQPYQGLSNEQ 248

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 169
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 230 EQPYQGLSNEQ 240

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKIXDF 168
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 229 PGKHYLDQ 236

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I     +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 102 VYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 157
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG+ A   S+      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 158 KSDCTLKILDFGL-ARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 217 VKGSVIFQGTDHIDQWNKVIEQL 239

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 134
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 135 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 194
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 195 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T
Sbjct: 132 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 236

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 111 QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRG-SLADIIRQVKTILEPYLAV 169
           ++  E+ I    + ++++     F + G   LV+E    G  L   I +   + EP  + 
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD----T 225
           + +Q++  + YL   + +IHRDIK  N+++     +K+ DFG +A L     +R     T
Sbjct: 135 IFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-----ERGKLFYT 188
Query: 226 FVGTYNYMSPERISGSTYDYSS-DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA 284
           F GT  Y +PE + G+ Y     ++WSLG+ +        P+ + E         E +EA
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---------ETVEA 239
Query: 285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
            +       PP   S E  S VS  +Q  P            P++ +
Sbjct: 240 AIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 78  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 136
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 137 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 196
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 197 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 247

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDF 168
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 229 PGKHYLDQ 236

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 69/119 (57%), Gaps = 7/119 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSN+ VN   E++I D
Sbjct: 116 GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDSELRILD 174
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FP 265
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   G+  FP
Sbjct: 175 FGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 98  LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 153
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 214 IDPSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 251

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 18/238 (7%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           +L+R K    L A+K I+    E+I + + +E+  +++ +  ++V           +++V
Sbjct: 36  RLMRDKQANELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           +EY   G L + I       E       +Q++ G+ Y H    V HRD+K  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH-AMQVAHRDLKLENTLLDGSP 152
Query: 204 --EVKITDFGVS--AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLE 258
              +KI DFG S  ++L S   Q  + VGT  Y++PE +    YD   +D+WS G+ +  
Sbjct: 153 APRLKIADFGYSKASVLHS---QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDP 314
             +G +P+   ED +   +F + +  I+      A PD    SPE    +S     DP
Sbjct: 210 MLVGAYPF---EDPEEPKNFRKTIHRILNV--QYAIPDYVHISPECRHLISRIFVADP 262

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 73/133 (54%), Gaps = 7/133 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +   +T  E   L  + +Q  +G+ YLH  + +IHRD+K +N+ 
Sbjct: 82  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIF 140
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 141 LHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 200
Query: 254 LVVLECAIGRFPY 266
           +V+ E   G+ PY
Sbjct: 201 IVLYELMTGQLPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +++E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDF 172
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 233 PGKHYLDQ 240

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      +++E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 136
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 197 IVLYELMTGQLPYSNINNRDQ 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE- 258
                +KI DFG++   G+S       V  Y Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 259 -CAIGRFPYMQSEDQQSWPSFYELL 282
            C    FP     DQ  W    E L
Sbjct: 219 VCHKILFPGRDYIDQ--WNKVIEQL 241

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 80  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 138
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 139 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 198
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 199 IVLYELMTGQLPYSNINNRDQ 219

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 136
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 197 IVLYELMTGQLPYSNINNRDQ 217

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T
Sbjct: 132 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 236

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDF 172
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 233 PGKHYLDQ 240

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E  R+  + E  I       +++          +  +V EYM+ GSL   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R      TI++  L  + + V  G+ YL +  +V HRD+   N+LV+     K++DFG+
Sbjct: 141 LRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGL 197
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           S +L        T  G      + +PE I+  T+  +SD+WS G+V+ E  A G  PY
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 141
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 202 IVLYELMTGQLPYSNINNRDQ 222

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNG-VISLV 143
           H+  G+  ALK++  +   + R+++       QAS   H+V     Y + +H    + ++
Sbjct: 50  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIVCILDVYENMHHGKRCLLII 104
Query: 144 LEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +E M+ G L   I  R  +   E   A + + +   + +LH+  ++ HRD+KP NLL   
Sbjct: 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTS 163
Query: 202 KGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           K +   +K+TDFG +     +  Q   +  T  Y++PE +    YD S D+WSLG+++  
Sbjct: 164 KEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 221
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
              G  P+  +  Q   P     +  + +   P     + S +    +   ++ DP    
Sbjct: 222 LLCGFPPFYSNTGQAISPGMKRRIR-LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
Query: 319 XXXXXXXHPFIKK 331
                  HP+I +
Sbjct: 281 TITQFMNHPWINQ 293

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T
Sbjct: 136 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T
Sbjct: 130 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 234

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 166
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 167 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 227 PGKHYLDQ 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T
Sbjct: 134 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 173
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 174 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 234 PGKHYLDQ 241

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 116 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 174
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 175 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 235 PGKHYLDQ 242

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 107 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 165
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 166 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 226 PGKHYLDQ 233

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 233 PGKHYLDQ 240

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+KI+      +   + + E  I  +    H+V    VC      +  I LV + M  G 
Sbjct: 48  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-----SPTIQLVTQLMPHGC 102
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L + + + K  I    L   C Q+ +G++YL  ER ++HRD+   N+LV     VKITDF
Sbjct: 103 LLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDF 161
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +L     + +   G     +M+ E I    + + SD+WS G+ + E    G  PY
Sbjct: 162 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 172
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 233 PGKHYLDQ 240

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 170
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 171 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 231 PGKHYLDQ 238

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 141
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 202 IVLYELMTGQLPYSNINNRDQ 222

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 88  HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNG-VISLV 143
           H+  G+  ALK++  +   + R+++       QAS   H+V     Y + +H    + ++
Sbjct: 31  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIVCILDVYENMHHGKRCLLII 85
Query: 144 LEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +E M+ G L   I  R  +   E   A + + +   + +LH+  ++ HRD+KP NLL   
Sbjct: 86  MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTS 144
Query: 202 KGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           K +   +K+TDFG +     +  Q   +  T  Y++PE +    YD S D+WSLG+++  
Sbjct: 145 KEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 202
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXX 318
              G  P+  +  Q   P     +  + +   P     + S +    +   ++ DP    
Sbjct: 203 LLCGFPPFYSNTGQAISPGMKRRIR-LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 261
Query: 319 XXXXXXXHPFIKK 331
                  HP+I +
Sbjct: 262 TITQFMNHPWINQ 274

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 142 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 197
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 198 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 98  VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 153
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 154 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 211

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 97  VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 152
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 153 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 50  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 109
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HRD+   N +V H   V
Sbjct: 110 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMVAHDFTV 168
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 228
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 229 EQPYQGLSNEQ 239

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+KI+      +   + + E  I  +    H+V    VC      +  I LV + M  G 
Sbjct: 71  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-----SPTIQLVTQLMPHGC 125
Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L + + + K  I    L   C Q+ +G++YL  ER ++HRD+   N+LV     VKITDF
Sbjct: 126 LLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL-EERRLVHRDLAARNVLVKSPNHVKITDF 184
Query: 211 GVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G++ +L     + +   G     +M+ E I    + + SD+WS G+ + E    G  PY
Sbjct: 185 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 142 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 197
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 198 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           G+  + I + + + + ++  +  Q+L+GL Y+H+   +IHRD+KPSN+ VN   E++I D
Sbjct: 108 GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILD 166
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++      M     +V T  Y +PE  ++   Y+ + DIWS+G ++ E   G+  FP 
Sbjct: 167 FGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223
Query: 267 MQSEDQ 272
               DQ
Sbjct: 224 SDYIDQ 229

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K  +  +  +++ + +QE +I +     ++V           I +V+E +  G   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 154 DIIR------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             +R      +VKT+L+     +      G+ YL + +  IHRD+   N LV  K  +KI
Sbjct: 201 TFLRTEGARLRVKTLLQ-----MVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKI 254
Query: 208 TDFGVS-----AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
           +DFG+S      +  +S G R   V    + +PE ++   Y   SD+WS G+++ E  ++
Sbjct: 255 SDFGMSREEADGVXAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
           G  PY    +QQ+     E +E     P P   PD
Sbjct: 312 GASPYPNLSNQQT----REFVEKGGRLPCPELCPD 342

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 118 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 176
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 177 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 237 PGKHYLDQ 244

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 168
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 169 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 229 PGKHYLDQ 236

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 105 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 163
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 164 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223
Query: 254 LVVLECAIGRFPY 266
           +V+ E   G+ PY
Sbjct: 224 IVLYELMTGQLPY 236

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 105 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 160
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 161 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 22/191 (11%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDR 149
           A+K ++    E+ R   + E  I    Q SH    ++     GVIS      ++ EYM+ 
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGI--MGQFSH----HNIIRLEGVISKYKPMMIITEYMEN 130
Query: 150 GSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVK 206
           G+L   +R+     ++L+  L  + + +  G+ YL N  +V HRD+   N+LVN     K
Sbjct: 131 GALDKFLREKDGEFSVLQ--LVGMLRGIAAGMKYLANMNYV-HRDLAARNILVNSNLVCK 187
Query: 207 ITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIG 262
           ++DFG+S +L        T  G      + +PE IS   +  +SD+WS G+V+ E    G
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 263 RFPYMQSEDQQ 273
             PY +  + +
Sbjct: 248 ERPYWELSNHE 258

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 49  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 108
Query: 156 IRQVKTIL--EPYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +   P LA         +  ++  G+ YL N    +HRD+   N +V     V
Sbjct: 109 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTV 167
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 168 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 228 EQPYQGLSNEQ 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++    E  R+   +E ++    Q  H+V  +        + +V EYM  G L 
Sbjct: 44  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 154 DIIRQ----VKTI-----LEP------YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
             +R      K +     + P       L  V  QV  G+VYL    H +HRD+   N L
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCL 161
Query: 199 VNHKGEVKITDFGVSAMLGSS----MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           V     VKI DFG+S  + S+    +G R        +M PE I    +   SD+WS G+
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 219
Query: 255 VVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           V+ E    G+ P+ Q  + ++     + +    E   P A P    PE  + +  C Q++
Sbjct: 220 VLWEIFTYGKQPWYQLSNTEA----IDCITQGRELERPRACP----PEVYAIMRGCWQRE 271
Query: 314 P 314
           P
Sbjct: 272 P 272

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 103 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 158
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 159 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 98  VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 153
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 154 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 211

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K  +  +  +++ + +QE +I +     ++V           I +V+E +  G   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 154 DIIR------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
             +R      +VKT+L+     +      G+ YL + +  IHRD+   N LV  K  +KI
Sbjct: 201 TFLRTEGARLRVKTLLQ-----MVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKI 254
Query: 208 TDFGVS-----AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
           +DFG+S      +  +S G R   V    + +PE ++   Y   SD+WS G+++ E  ++
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
           G  PY    +QQ+     E +E     P P   PD
Sbjct: 312 GASPYPNLSNQQT----REFVEKGGRLPCPELCPD 342

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 105 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 160
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 161 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 221 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 258

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 87/173 (50%), Gaps = 7/173 (4%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G + A+K ++ +   + R    QE+ I +     H++         G   + LV+EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
            GSL D + +  +I    L +  +Q+ +G+ YLH++ H IHR++   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHSQ-HYIHRNLAARNVLLDNDRLVKIG 159
Query: 209 DFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           DFG++  +         R+       + +PE +    + Y+SD+WS G+ + E
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 105 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 160
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 161 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 254 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 312
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG+  ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 313 LVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 372
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 373 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 423

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V+EYM +G L D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 153 ADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
            D+ + +KT  +   ++     Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DF
Sbjct: 130 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDF 188
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--F 264
           G++ +        G    +V T  Y +PE  ++   Y  S DIWS+G ++ E    R  F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 265 PYMQSEDQ 272
           P     DQ
Sbjct: 249 PGKHYLDQ 256

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 77  IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 135
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 136 LVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 195
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 196 TELTTKGRVPY 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQ----IVQELKINQASQCSHVVVCYHSFYHNGVI 140
           +V+ K   ++FA+KI  +N  E +++       +E  +        +   +++F  +  +
Sbjct: 92  VVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
            LV++Y   G L  ++ + +  L   +A     +++  +  +H + H +HRDIKP N+L+
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILM 208
Query: 200 NHKGEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLG 253
           +  G +++ DFG    ++     Q    VGT +Y+SPE +         Y    D WSLG
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 254 LVVLECAIGRFPY 266
           + + E   G  P+
Sbjct: 269 VCMYEMLYGETPF 281

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 38/247 (15%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K+++ N      + ++ E  + +     HV+  Y +   +G + L++EY   GSL   
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 156 IRQVKTILEPYLAV------------------------VCKQVLQGLVYLHNERHVIHRD 191
           +R+ + +   YL                             Q+ QG+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 192 IKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           +   N+LV    ++KI+DFG+S  +    S  +R        +M+ E +    Y   SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 250 WSLGLVVLE-CAIGRFPYMQSEDQQSWPSF-YELLEAIVESPPPTAPPDQFSPEFCSFVS 307
           WS G+++ E   +G  PY         P    E L  ++++      PD  S E    + 
Sbjct: 236 WSFGVLLWEIVTLGGNPY---------PGIPPERLFNLLKTGHRMERPDNCSEEMYRLML 286
Query: 308 ACIQKDP 314
            C +++P
Sbjct: 287 QCWKQEP 293

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++    E  R+   +E ++    Q  H+V  +        + +V EYM  G L 
Sbjct: 73  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 154 DIIRQ----VKTI-----LEP------YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
             +R      K +     + P       L  V  QV  G+VYL    H +HRD+   N L
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCL 190
Query: 199 VNHKGEVKITDFGVSAMLGSS----MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           V     VKI DFG+S  + S+    +G R        +M PE I    +   SD+WS G+
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 255 VVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           V+ E    G+ P+ Q  + ++     + +    E   P A P    PE  + +  C Q++
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEA----IDCITQGRELERPRACP----PEVYAIMRGCWQRE 300
Query: 314 P 314
           P
Sbjct: 301 P 301

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 114 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 171
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 227
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 228 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 94  LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           L A+K ++    E  R+   +E ++    Q  H+V  +        + +V EYM  G L 
Sbjct: 50  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 154 DIIRQ----VKTI-----LEP------YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
             +R      K +     + P       L  V  QV  G+VYL    H +HRD+   N L
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCL 167
Query: 199 VNHKGEVKITDFGVSAMLGSS----MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           V     VKI DFG+S  + S+    +G R        +M PE I    +   SD+WS G+
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 225
Query: 255 VVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           V+ E    G+ P+ Q  + ++     + +    E   P A P    PE  + +  C Q++
Sbjct: 226 VLWEIFTYGKQPWYQLSNTEA----IDCITQGRELERPRACP----PEVYAIMRGCWQRE 277
Query: 314 P 314
           P
Sbjct: 278 P 278

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 164
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++ +     G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 165 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 225 IVLYELMTGQLPYSNINNRDQ 245

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 118 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 175
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 231
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 232 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 92  GRLFALKIIQM-NIQEEIRKQIVQE---LKINQASQCSHVV----VCYHSFYHNGV-ISL 142
           G   ALK +++ N +E +    V+E   L+  +A +  +VV    VC  S     + ++L
Sbjct: 29  GHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           V E++D+    D+   +     P L       + +Q L+GL +LH    ++HRD+KP N+
Sbjct: 89  VFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENI 143
Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           LV   G VK+ DFG++ +    M      V T  Y +PE +  STY    D+WS+G +  
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 202
Query: 258 E 258
           E
Sbjct: 203 E 203

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +        R + + E  + +   C HVV             +++E M RG L   
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 156 IRQVKTILE--PYLA--------VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++  +E  P LA         +  ++  G+ YL N    +HRD+   N  V     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCXVAEDFTV 164
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLECA-IG 262
           KI DFG++  +  +   R    G     +MSPE +    +   SD+WS G+V+ E A + 
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 225 EQPYQGLSNEQ 235

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM++GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV-HRDLRAANI 142
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 143 LVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 202
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 203 TELTTKGRVPY 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 86  VRHKWVGRLFALKIIQ---MNIQEEIRK--QIVQELKINQASQCSHVVVCYHSFYHNGVI 140
           VR K  GRL+A+K         ++  RK  ++    K+ Q   C   V    ++   G++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC---VRLEQAWEEGGIL 132
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
            L  E               ++ E  +    +  L  L +LH++  ++H D+KP+N+ + 
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLG 191
Query: 201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA 260
            +G  K+ DFG+   LG++ G  +   G   YM+PE + GS Y  ++D++SLGL +LE A
Sbjct: 192 PRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVA 249

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + DIWS+G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 38/247 (15%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K+++ N      + ++ E  + +     HV+  Y +   +G + L++EY   GSL   
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 156 IRQVKTILEPYLAV------------------------VCKQVLQGLVYLHNERHVIHRD 191
           +R+ + +   YL                             Q+ QG+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMSLVHRD 175
Query: 192 IKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           +   N+LV    ++KI+DFG+S  +    S  +R        +M+ E +    Y   SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 250 WSLGLVVLE-CAIGRFPYMQSEDQQSWPSF-YELLEAIVESPPPTAPPDQFSPEFCSFVS 307
           WS G+++ E   +G  PY         P    E L  ++++      PD  S E    + 
Sbjct: 236 WSFGVLLWEIVTLGGNPY---------PGIPPERLFNLLKTGHRMERPDNCSEEMYRLML 286
Query: 308 ACIQKDP 314
            C +++P
Sbjct: 287 QCWKQEP 293

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 105 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 160
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 221 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 258

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 134 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 247
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 248 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 50  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 103
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 104 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 159
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 220 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 72  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 131
Query: 155 IIRQV------KTILEPY----LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE 204
            +R+       K    P     L     QV QG+ +L + ++ IHRD+   N+L+ +   
Sbjct: 132 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTNGHV 190
Query: 205 VKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
            KI DFG++   M  S+   +        +M+PE I    Y   SD+WS G+++ E  ++
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 250
Query: 262 GRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPPTAPPDQFSPEFCS 304
           G  PY            ++   Q + P+F     Y +++A     P   P  Q   + CS
Sbjct: 251 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ---QICS 307
Query: 305 FVSACIQKD 313
           F+    Q+D
Sbjct: 308 FLQEQAQED 316

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE- 258
                +KI DFG++   G+S       V  Y Y +PE I G  Y  + D+WS+G ++ E 
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEM 218
Query: 259 -CAIGRFPYMQSEDQQSWPSFYELL 282
            C    FP     DQ  W    E L
Sbjct: 219 VCHKILFPGRDYIDQ--WNKVIEQL 241

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 14/220 (6%)
Query: 120 QASQCSHVVV---CYHSFYHN-GVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQ 173
           +ASQC H+V     Y + Y     + +V E +D G L   I  R  +   E   + + K 
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKS 169
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           + + + YLH+  ++ HRD+KP NLL   K     +K+TDFG  A   +S     T   T 
Sbjct: 170 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTP 227
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF-YELLEAIVESP 289
            Y++PE +    YD S D WSLG++      G  P+  +      P     +     E P
Sbjct: 228 YYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFP 287
Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            P     + S E    +   ++ +P           HP+I
Sbjct: 288 NPEW--SEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 105 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 160
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 221 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 258

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 48  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 101
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 102 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 157
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 218 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 255

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 155 IIRQV------KTILEPY----LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE 204
            +R+       K    P     L     QV QG+ +L + ++ IHRD+   N+L+ +   
Sbjct: 140 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTNGHV 198
Query: 205 VKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
            KI DFG++   M  S+   +        +M+PE I    Y   SD+WS G+++ E  ++
Sbjct: 199 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 258
Query: 262 GRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPPTAPPDQFSPEFCS 304
           G  PY            ++   Q + P+F     Y +++A     P   P  Q   + CS
Sbjct: 259 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ---QICS 315
Query: 305 FVSACIQKD 313
           F+    Q+D
Sbjct: 316 FLQEQAQED 324

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM++GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV-HRDLRAANI 142
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 143 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 202
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 203 TELTTKGRVPY 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 26/227 (11%)
Query: 96  ALKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
            LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D
Sbjct: 58  TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLD 111
Query: 155 IIRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
            +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ D
Sbjct: 112 YLRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVAD 167
Query: 210 FGVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYM 267
           FG+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY 
Sbjct: 168 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 227
Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
             +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 228 GIDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 48  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 101
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 102 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 157
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 218 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 255

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 115 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 228
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 229 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 105 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 160
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 221 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 258

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 72/133 (54%), Gaps = 7/133 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +   +T  E   L  + +Q  +G+ YLH  + +IHRD+K +N+ 
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIF 152
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++       G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 254 LVVLECAIGRFPY 266
           +V+ E   G+ PY
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G     V T
Sbjct: 152 QILRGLKYIHSA-NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 256

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 136
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++       G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 137 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 197 IVLYELMTGQLPYSNINNRDQ 217

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +        +D+ VGT
Sbjct: 134 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 247
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 248 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 92  GRLFALKIIQM-NIQEEIRKQIVQE---LKINQASQCSHVV----VCYHSFYHNGV-ISL 142
           G   ALK +++ N +E +    V+E   L+  +A +  +VV    VC  S     + ++L
Sbjct: 29  GHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAV-----VCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           V E++D+    D+   +     P L       + +Q L+GL +LH    ++HRD+KP N+
Sbjct: 89  VFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENI 143
Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
           LV   G VK+ DFG++ +    M      V T  Y +PE +  STY    D+WS+G +  
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 202
Query: 258 E 258
           E
Sbjct: 203 E 203

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 86/173 (49%), Gaps = 7/173 (4%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G + A+K ++ +   + R    QE+ I +     H++         G   + LV+EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 149 RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
            GSL D + +  +I    L +  +Q+ +G+ YLH + H IHR++   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRNLAARNVLLDNDRLVKIG 159
Query: 209 DFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
           DFG++  +         R+       + +PE +    + Y+SD+WS G+ + E
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 95/191 (49%), Gaps = 28/191 (14%)
Query: 95  FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV------------ISL 142
           +A+K I++  +E  R+++++E+K     +   +V  ++++                 + +
Sbjct: 33  YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 143 VLEYMDRGSLADIIRQVKTILEPYLAV---VCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
            ++   + +L D +    TI E   +V   +  Q+ + + +LH+ + ++HRD+KPSN+  
Sbjct: 93  QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFF 151
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTF------------VGTYNYMSPERISGSTYDYSS 247
                VK+ DFG+   +     ++               VGT  YMSPE+I G++Y +  
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211
Query: 248 DIWSLGLVVLE 258
           DI+SLGL++ E
Sbjct: 212 DIFSLGLILFE 222

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 46  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 99
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 100 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 216 IDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 253

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD+  +N+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLAAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 16/141 (11%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV E M  GS+   I + +   E   +VV + V   L +LHN + + HRD+KP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 202 KGE---VKITDFGVSAMLG-------SSMGQRDTFVGTYNYMSPERI-----SGSTYDYS 246
             +   VKI DFG+ + +         S  +  T  G+  YM+PE +       S YD  
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 247 SDIWSLGLVVLECAIGRFPYM 267
            D+WSLG+++     G  P++
Sbjct: 207 CDLWSLGVILYILLSGYPPFV 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 106 EEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGV-ISLVLEYMDRGSLADIIRQVKTIL 163
           EE+++Q  QE+K+   ++C H  +V    F  +G  + LV  Y   GSL D +  +    
Sbjct: 62  EELKQQFDQEIKV--XAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 164 EPYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
                  CK       G+ +LH E H IHRDIK +N+L++     KI+DFG+ A      
Sbjct: 120 PLSWHXRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGL-ARASEKF 177
Query: 221 GQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG 262
            Q       VGT  Y +PE + G      SDI+S G+V+LE   G
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALRGEITP-KSDIYSFGVVLLEIITG 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 14/188 (7%)
Query: 91  VGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LV 143
            G   A+K +    Q E+  K+  +EL++ +  +  +V+     F  +  +       LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           + +M    L  +++  K + E  +  +  Q+L+GL Y+H    +IHRD+KP NL VN   
Sbjct: 109 MPFMGT-DLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC 165
Query: 204 EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAIG 262
           E+KI DFG++    S M      V T  Y +PE I +   Y  + DIWS+G ++ E   G
Sbjct: 166 ELKILDFGLARQADSEMX---GXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 263 RFPYMQSE 270
           +  +  S+
Sbjct: 223 KTLFKGSD 230

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 72/133 (54%), Gaps = 7/133 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +   +T  E   L  + +Q  +G+ YLH  + +IHRD+K +N+ 
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIF 152
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++       G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 254 LVVLECAIGRFPY 266
           +V+ E   G+ PY
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 162 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 275
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 80  IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 138
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 139 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 198
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 199 TELTTKGRVPY 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 98  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 156
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++       G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 157 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 216
Query: 254 LVVLECAIGRFPY--MQSEDQ 272
           +V+ E   G+ PY  + + DQ
Sbjct: 217 IVLYELMTGQLPYSNINNRDQ 237

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 47  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 100
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 101 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 156
Query: 211 GVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLECAI-GR 263
           G+S ++       DT+           + +PE ++ + +   SD+W+ G+++ E A  G 
Sbjct: 157 GLSRLMTG-----DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 211
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            PY   +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 212 SPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 254

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 48  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 101
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHRD+   N LV     VK+ DF
Sbjct: 102 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADF 157
Query: 211 GVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLECAI-GR 263
           G+S ++       DT+           + +PE ++ + +   SD+W+ G+++ E A  G 
Sbjct: 158 GLSRLMTG-----DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 212
Query: 264 FPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            PY   +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 213 SPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNP 255

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G + A+K ++     ++R    +E++I +     H+V         G   + LV+EY+ 
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 149 RGSLADII-RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            GSL D + R    + +  L +  +Q+ +G+ YLH + H IHR +   N+L+++   VKI
Sbjct: 97  LGSLRDYLPRHCVGLAQ--LLLFAQQICEGMAYLHAQ-HYIHRALAARNVLLDNDRLVKI 153
Query: 208 TDFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE----CA 260
            DFG++  +         R+       + +PE +    + Y+SD+WS G+ + E    C 
Sbjct: 154 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD 213
Query: 261 IGRFPYMQ-------SEDQQSWPSFYELLEAIVESPPPTAPP 295
             + P+ +       ++ Q +     ELLE     P P   P
Sbjct: 214 SNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCP 255

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 73/133 (54%), Gaps = 7/133 (5%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +++V ++ +  SL   +  ++T  E   L  + +Q  QG+ YLH  + +IHRD+K +N+ 
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIF 164
Query: 199 VNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI---SGSTYDYSSDIWSLG 253
           ++    VKI DFG++       G  Q +   G+  +M+PE I     + Y + SD+++ G
Sbjct: 165 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 254 LVVLECAIGRFPY 266
           +V+ E   G+ PY
Sbjct: 225 IVLYELMTGQLPY 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 98  VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 153
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE- 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + D+WS+G ++ E 
Sbjct: 154 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 212
Query: 259 -CAIGRFPYMQSEDQQSWPSFYELL 282
            C    FP     DQ  W    E L
Sbjct: 213 VCHKILFPGRDYIDQ--WNKVIEQL 235

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +G L D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 87  IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 145
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 257 LECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E    GR PY    +++      + +E     P P   P+      C     C +KDP
Sbjct: 206 TELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 311
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 372 TELTTKGRVPY 382

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 18/238 (7%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           +L+R K    L A+K I+    E+I   + +E+  +++ +  ++V           +++V
Sbjct: 36  RLMRDKQSNELVAVKYIERG--EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           +EY   G L + I       E       +Q++ G+ Y H    V HRD+K  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 152
Query: 204 --EVKITDFGVS--AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLE 258
              +KI DFG S  ++L S   Q  + VGT  Y++PE +    YD   +D+WS G+ +  
Sbjct: 153 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDP 314
             +G +P+   ED +   +F + +  I+      A PD    SPE    +S     DP
Sbjct: 210 MLVGAYPF---EDPEEPKNFRKTIHRILNV--QYAIPDYVHISPECRHLISRIFVADP 262

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 91  VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISLVLEYMD 148
            G + A+K ++     ++R    +E++I +     H+V         G   + LV+EY+ 
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 149 RGSLADII-RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI 207
            GSL D + R    + +  L +  +Q+ +G+ YLH + H IHR +   N+L+++   VKI
Sbjct: 96  LGSLRDYLPRHCVGLAQ--LLLFAQQICEGMAYLHAQ-HYIHRALAARNVLLDNDRLVKI 152
Query: 208 TDFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE----CA 260
            DFG++  +         R+       + +PE +    + Y+SD+WS G+ + E    C 
Sbjct: 153 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD 212
Query: 261 IGRFPYMQ-------SEDQQSWPSFYELLEAIVESPPPTAPP 295
             + P+ +       ++ Q +     ELLE     P P   P
Sbjct: 213 SNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCP 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 41/255 (16%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++     + ++ ++ ELKI +   Q  ++V    +  H G + ++ EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R+ +     Y                L     QV QG+ +L + ++ IHRD+   N+L
Sbjct: 140 FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVL 198
Query: 199 VNHKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           + +    KI DFG++   M  S+   +        +M+PE I    Y   SD+WS G+++
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 258
Query: 257 LEC-AIGRFPY------------MQSEDQQSWPSF-----YELLEAIVESPPPTAPPDQF 298
            E  ++G  PY            ++   Q + P+F     Y +++A     P   P  Q 
Sbjct: 259 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ- 317
Query: 299 SPEFCSFVSACIQKD 313
             + CSF+    Q+D
Sbjct: 318 --QICSFLQEQAQED 330

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 311
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 372 TELTTKGRVPY 382

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 109 VYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 164
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE- 258
                +KI DFG++   G+S      +V T  Y +PE I G  Y  + D+WS+G ++ E 
Sbjct: 165 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 223
Query: 259 -CAIGRFPYMQSEDQQSWPSFYELL 282
            C    FP     DQ  W    E L
Sbjct: 224 VCHKILFPGRDYIDQ--WNKVIEQL 246

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT
Sbjct: 162 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 275
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 93/179 (51%), Gaps = 17/179 (9%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + +V EYM+   LA+++ Q   +LE +  +   Q+L+GL Y+H+  +V+HRD+KP+NL +
Sbjct: 97  VYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFI 153
Query: 200 NHKGEV-KITDFGVSAMLG---SSMGQRDTFVGTYNYMSPE-RISGSTYDYSSDIWSLGL 254
           N +  V KI DFG++ ++    S  G     + T  Y SP   +S + Y  + D+W+ G 
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           +  E   G+  +  + +        E ++ I+ES P     D+   E  S +   I+ D
Sbjct: 214 IFAEMLTGKTLFAGAHE-------LEQMQLILESIPVVHEEDR--QELLSVIPVYIRND 263

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 394
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 455 TELTTKGRVPY 465

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMD-RGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
           +S  S V+     F       L+LE M+    L D I +   + E        QVL+ + 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           + HN   V+HRDIK  N+L++ ++GE+K+ DFG  A+L  ++     F GT  Y  PE I
Sbjct: 129 HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 185
Query: 239 SGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSED 271
               Y   S+ +WSLG+++ +   G  P+   E+
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 219

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 18/238 (7%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           +L+R K    L A+K I+    E+I + + +E+  +++ +  ++V           +++V
Sbjct: 35  RLMRDKQSNELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 92
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           +EY   G L + I       E       +Q++ G+ Y H    V HRD+K  N L++   
Sbjct: 93  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 151
Query: 204 --EVKITDFGVS--AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLE 258
              +KI DFG S  ++L S   Q  + VGT  Y++PE +    YD   +D+WS G+ +  
Sbjct: 152 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 208
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDP 314
             +G +P+   ED +   +F + +  I+      A PD    SPE    +S     DP
Sbjct: 209 MLVGAYPF---EDPEEPKNFRKTIHRILNV--QYAIPDYVHISPECRHLISRIFVADP 261

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 52  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 111
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HR++   N +V H   V
Sbjct: 112 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMVAHDFTV 170
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 230
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 231 EQPYQGLSNEQ 241

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 14/191 (7%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +  +     R + + E  + +   C HVV             +V+E M  G L   
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 156 IRQVKTILE-------PYLAVVCK---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
           +R ++   E       P L  + +   ++  G+ YL N +  +HR++   N +V H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMVAHDFTV 169
Query: 206 KITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
           KI DFG++  +  +   R    G     +M+PE +    +  SSD+WS G+V+ E  ++ 
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 263 RFPYMQSEDQQ 273
             PY    ++Q
Sbjct: 230 EQPYQGLSNEQ 240

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G     V T
Sbjct: 136 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT 229
           + +Q L+GL +LH    ++HRD+KP N+LV   G VK+ DFG++ +    M      V T
Sbjct: 125 LMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-T 182
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLE 258
             Y +PE +  STY    D+WS+G +  E
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAE 211

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    ++ R+  + E  I       +++           + ++ EYM+ GSL   
Sbjct: 61  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 120
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL ++   +HRD+   N+LVN     K++DFG+
Sbjct: 121 LRKNDGRFTVIQ--LVGMLRGIGSGMKYL-SDMSAVHRDLAARNILVNSNLVCKVSDFGM 177
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + +PE I+   +  +SD+WS G+V+ E  + G  PY  
Sbjct: 178 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPP 295
             +Q       ++++AI E    PPP   P
Sbjct: 238 MSNQ-------DVIKAIEEGYRLPPPMDCP 260

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG---SSMGQRDTFVGT 229
           Q+L+GL Y+H+  +V+HRD+KPSNLL+N   ++KI DFG++ +        G     V T
Sbjct: 137 QILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 230 YNYMSPE-RISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
             Y +PE  ++   Y  S DIWS+G ++ E    R  FP     DQ
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E+ R+  + E  I       +V+        +  + ++ E+M+ GSL   
Sbjct: 39  AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 98
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +RQ     T+++  L  + + +  G+ YL +  +V HR +   N+LVN     K++DFG+
Sbjct: 99  LRQNDGQFTVIQ--LVGMLRGIAAGMKYLADMNYV-HRALAARNILVNSNLVCKVSDFGL 155
Query: 213 SAMLGSSMGQRDTFVGTYN----------YMSPERISGSTYDYSSDIWSLGLVVLEC-AI 261
           S  L     + DT   TY           + +PE I    +  +SD+WS G+V+ E  + 
Sbjct: 156 SRFL-----EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
           G  PY    +Q         +E     PPP   P          +  C QKD
Sbjct: 211 GERPYWDMTNQ----DVINAIEQDYRLPPPMDCPSALH----QLMLDCWQKD 254

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    ++ R+  + E  I       +++           + ++ EYM+ GSL   
Sbjct: 40  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 99
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+LVN     K++DFG+
Sbjct: 100 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGM 156
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S +L        T  G      + +PE I+   +  +SD+WS G+V+ E  + G  PY  
Sbjct: 157 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216
Query: 269 SEDQQSWPSFYELLEAIVES---PPPTAPP 295
             +Q       ++++AI E    PPP   P
Sbjct: 217 MSNQ-------DVIKAIEEGYRLPPPMDCP 239

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 20/166 (12%)
Query: 140 ISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           + ++ EYM+ GSL   +R+     T+++  L  + + +  G+ YL +  +V HRD+   N
Sbjct: 90  VMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARN 146
Query: 197 LLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLG 253
           +LVN     K++DFG+S +L        T  G      + +PE I+   +  +SD+WS G
Sbjct: 147 ILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYG 206
Query: 254 LVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES---PPPTAPP 295
           +V+ E  + G  PY    +Q       ++++AI E    PPP   P
Sbjct: 207 IVMWEVMSYGERPYWDMSNQ-------DVIKAIEEGYRLPPPMDCP 245

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 5/143 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           + LV+E MD  +L  +I     +    ++ +  Q+L G+ +LH+   +IHRD+KPSN++V
Sbjct: 104 VYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVV 159
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC 259
                +KI DFG+ A    +      +V T  Y +PE I G  Y  + DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 260 AIGRFPYMQSEDQQSWPSFYELL 282
             G   +  ++    W    E L
Sbjct: 219 VKGCVIFQGTDHIDQWNKVIEQL 241

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 123 QCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVY 180
           +  HV ++ +  +     +++V ++ +  SL   +   +T  + + L  + +Q  QG+ Y
Sbjct: 88  KTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDY 147
Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERI 238
           LH  +++IHRD+K +N+ ++    VKI DFG++ +     G  Q +   G+  +M+PE I
Sbjct: 148 LH-AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 239 ---SGSTYDYSSDIWSLGLVVLECAIGRFPY 266
                + + + SD++S G+V+ E   G  PY
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 15/138 (10%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-------VCKQVLQGLVYLHNERHVIHRDIKP 194
           L+ +YM+ G+L    R +     P +++       +C    +GL YLH  R +IHRD+K 
Sbjct: 112 LIYKYMENGNLK---RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKS 167
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWS 251
            N+L++     KITDFG+S   G+ +GQ        GT  Y+ PE          SD++S
Sbjct: 168 INILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 252 LGLVVLECAIGRFPYMQS 269
            G+V+ E    R   +QS
Sbjct: 227 FGVVLFEVLCARSAIVQS 244

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIR--QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
           I +V EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    +V HRD++ +N+
Sbjct: 253 IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-HRDLRAANI 311
Query: 198 LVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           LV      K+ DFG++ ++  +    R        + +PE      +   SD+WS G+++
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 257 LECAI-GRFPY 266
            E    GR PY
Sbjct: 372 TELTTKGRVPY 382

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 253 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 306
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHR++   N LV     VK+ DF
Sbjct: 307 LRECNRQEVSAVVLLYMAT---QISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADF 362
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 423 IDLSQ----VYELLEKDYRMERPEGCPEK----VYELMRACWQWNP 460

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 89  KWVGRL-FALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE 145
           KW G+   A+K+I+     ++E  ++    +K++         VC   +     I +V E
Sbjct: 28  KWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIYIVTE 83
Query: 146 YMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE 204
           Y+  G L + +R     LEP  L  +C  V +G+ +L + +  IHRD+   N LV+    
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLC 142
Query: 205 VKITDFGVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-A 260
           VK++DFG++  +     Q  + VGT     + +PE      Y   SD+W+ G+++ E  +
Sbjct: 143 VKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
Query: 261 IGRFPY 266
           +G+ PY
Sbjct: 201 LGKMPY 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 97  LKIIQMNIQEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           LK   M ++E +++  +++E+K     Q   V      FY      ++ E+M  G+L D 
Sbjct: 292 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 345
Query: 156 IRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           +R+     V  ++  Y+A    Q+   + YL  +++ IHR++   N LV     VK+ DF
Sbjct: 346 LRECNRQEVNAVVLLYMAT---QISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADF 401
Query: 211 GVSA-MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ 268
           G+S  M G +            + +PE ++ + +   SD+W+ G+++ E A  G  PY  
Sbjct: 402 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 461
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +  Q     YELLE       P   P++        + AC Q +P
Sbjct: 462 IDLSQ----VYELLEKDYRMERPEGCPEK----VYELMRACWQWNP 499

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  EE    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 10/184 (5%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +++        +  + +V EYM+ GSL   
Sbjct: 54  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF 113
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +++     T+++  L  + + +  G+ YL +  +V HRD+   N+L+N     K++DFG+
Sbjct: 114 LKKNDGQFTVIQ--LVGMLRGISAGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 170
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQ 268
           S +L        T  G      + +PE I+   +  +SD+WS G+V+ E  + G  PY +
Sbjct: 171 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE 230
Query: 269 SEDQ 272
             +Q
Sbjct: 231 MTNQ 234

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E  R++ + E  I    +  +++       ++  + ++ E+M+ G+L   
Sbjct: 48  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 107
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R      T+++  L  + + +  G+ YL  E   +HRD+   N+LVN     K++DFG+
Sbjct: 108 LRLNDGQFTVIQ--LVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGL 164
Query: 213 SAML--GSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           S  L   SS     + +G      + +PE I+   +  +SD WS G+V+ E  + G  PY
Sbjct: 165 SRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 224
Query: 267 MQSEDQQSWPSFYELLEAIVES----PPPTAP 294
               +Q       +++ AI +     PPP  P
Sbjct: 225 WDMSNQ-------DVINAIEQDYRLPPPPDCP 249

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 5/123 (4%)
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITD 209
            L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLID 154
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQ 268
           FG  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 269 SED 271
            E+
Sbjct: 213 DEE 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K +++   E+ R+  + E  I       +VV           + +V+E+M+ G+L   
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R+     T+++  L  + + +  G+ YL +  +V HRD+   N+LVN     K++DFG+
Sbjct: 135 LRKHDGQFTVIQ--LVGMLRGIAAGMRYLADMGYV-HRDLAARNILVNSNLVCKVSDFGL 191
Query: 213 SAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQ 268
           S ++        T  G      + +PE I    +  +SD+WS G+V+ E  + G  PY  
Sbjct: 192 SRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251
Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPD 296
             +Q       ++++AI E     AP D
Sbjct: 252 MSNQ-------DVIKAIEEGYRLPAPMD 272

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 7/132 (5%)
Query: 138 GVISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPS 195
           G + +V EYM +GSL D +R + +++L    L      V + + YL    + +HRD+   
Sbjct: 79  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAAR 137
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV+     K++DFG++    S+   +DT      + +PE +  + +   SD+WS G++
Sbjct: 138 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREAAFSTKSDVWSFGIL 194
Query: 256 VLEC-AIGRFPY 266
           + E  + GR PY
Sbjct: 195 LWEIYSFGRVPY 206

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 131/303 (43%), Gaps = 54/303 (17%)
Query: 84  QLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
            L R+K  G    ++ I +     E+   +  EL +++     ++V    +F  +  + +
Sbjct: 44  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103
Query: 143 VLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           V  +M  GS  D+I    +  + E  +A + + VL+ L Y+H+  +V HR +K S++L++
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHILIS 162
Query: 201 HKGEVKITDFGVSAMLGS-SMGQRDTFVGTYN--------YMSPERISGS--TYDYSSDI 249
             G+V ++  G+ + L   S GQR   V  +         ++SPE +  +   YD  SDI
Sbjct: 163 VDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220
Query: 250 WSLGLVVLECAIGRFPY-------------------------MQSEDQQSWPS----FYE 280
           +S+G+   E A G  P+                         + +E+    PS       
Sbjct: 221 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSG 280
Query: 281 LLEAIVESPP-------PTAPPDQ-FSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKF 332
           L +++  S P       P+ P  + FSP F  FV  C+Q++P           H F K+ 
Sbjct: 281 LSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340
Query: 333 EDK 335
           + +
Sbjct: 341 KRR 343

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVV 256
           V     +KI DFG++  + +    + T  G     +M+PE +    Y + SD+WS G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 257 LEC-AIGRFPY 266
            E   +G  PY
Sbjct: 250 WEIFTLGGSPY 260

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 131/303 (43%), Gaps = 54/303 (17%)
Query: 84  QLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL 142
            L R+K  G    ++ I +     E+   +  EL +++     ++V    +F  +  + +
Sbjct: 28  NLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 87
Query: 143 VLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           V  +M  GS  D+I    +  + E  +A + + VL+ L Y+H+  +V HR +K S++L++
Sbjct: 88  VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHILIS 146
Query: 201 HKGEVKITDFGVSAMLGS-SMGQRDTFVGTYN--------YMSPERISGS--TYDYSSDI 249
             G+V ++  G+ + L   S GQR   V  +         ++SPE +  +   YD  SDI
Sbjct: 147 VDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 204
Query: 250 WSLGLVVLECAIGRFPY-------------------------MQSEDQQSWPS----FYE 280
           +S+G+   E A G  P+                         + +E+    PS       
Sbjct: 205 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSG 264
Query: 281 LLEAIVESPP-------PTAPPDQ-FSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKF 332
           L +++  S P       P+ P  + FSP F  FV  C+Q++P           H F K+ 
Sbjct: 265 LSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 324
Query: 333 EDK 335
           + +
Sbjct: 325 KRR 327

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 114 QELKINQASQCSHVVVCYHSFYHNG------VISLVLEYMD----RGS--LADIIRQVKT 161
           +EL+I +  +  +VV     FY NG       ++LVLEY+     R S   A + + +  
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSM 220
           +L   + +   Q+L+ L Y+H+   + HRDIKP NLL++   G +K+ DFG + +L +  
Sbjct: 141 LL---IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 221 GQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
                    Y Y +PE I G+T Y  + DIWS G V+ E   G+  FP     DQ
Sbjct: 197 PNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ 250

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 13/98 (13%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF------ 226
           Q+ + + +LH+ + ++HRD+KPSN+       VK+ DFG+   +     ++         
Sbjct: 172 QIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 227 ------VGTYNYMSPERISGSTYDYSSDIWSLGLVVLE 258
                 VGT  YMSPE+I G+ Y +  DI+SLGL++ E
Sbjct: 231 ATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++    E  R++ + E  I    +  +++       ++  + ++ E+M+ G+L   
Sbjct: 46  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 105
Query: 156 IRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
           +R      T+++  L  + + +  G+ YL  E   +HRD+   N+LVN     K++DFG+
Sbjct: 106 LRLNDGQFTVIQ--LVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGL 162
Query: 213 SAML---------GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIG 262
           S  L          SS+G +        + +PE I+   +  +SD WS G+V+ E  + G
Sbjct: 163 SRFLEENSSDPTYTSSLGGKIPI----RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG 218
Query: 263 RFPYMQSEDQQSWPSFYELLEAIVES----PPPTAP 294
             PY    +Q       +++ AI +     PPP  P
Sbjct: 219 ERPYWDMSNQ-------DVINAIEQDYRLPPPPDCP 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVV 256
           V     +KI DFG++  + +    + T  G     +M+PE +    Y + SD+WS G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 257 LEC-AIGRFPY 266
            E   +G  PY
Sbjct: 250 WEIFTLGGSPY 260

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
           + LV +Y+  GSL D +RQ +  L P L +    Q+ +G+ YL  E  ++HR++   N+L
Sbjct: 107 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-EEHGMVHRNLAARNVL 165
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           +    +V++ DFGV+ +L     Q           +M+ E I    Y + SD+WS G+ V
Sbjct: 166 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 225
Query: 257 LEC-AIGRFPY 266
            E    G  PY
Sbjct: 226 WELMTFGAEPY 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 270 ED 271
           E+
Sbjct: 233 EE 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGT 229
           K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VG 
Sbjct: 162 KNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 230 YNYMSPERISGSTYDYSS-----------DIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
            NYM PE I   +    +           D+WSLG ++     G+ P+ Q  +Q S    
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 275
Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIK 330
              L AI++       PD    +    +  C+++DP           HP+++
Sbjct: 276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 270 ED 271
           E+
Sbjct: 261 EE 262

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 270 ED 271
           E+
Sbjct: 233 EE 234

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK--TIL 163
           EEIR  I++ L+        +V+    +F     I +  E +   +L ++I++ K     
Sbjct: 142 EEIR--ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFS 198
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMG 221
            P +      +LQ L  LH  R +IH D+KP N+L+  +G   +K+ DFG S      + 
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV- 256
Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
              T + +  Y +PE I G+ Y    D+WSLG ++ E   G +P +  ED+
Sbjct: 257 --YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 270 ED 271
           E+
Sbjct: 219 EE 220

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 7/132 (5%)
Query: 138 GVISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPS 195
           G + +V EYM +GSL D +R + +++L    L      V + + YL    + +HRD+   
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAAR 318
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV+     K++DFG++    S+   +DT      + +PE +    +   SD+WS G++
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 256 VLEC-AIGRFPY 266
           + E  + GR PY
Sbjct: 376 LWEIYSFGRVPY 387

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 270 ED 271
           E+
Sbjct: 234 EE 235

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 270 ED 271
           E+
Sbjct: 219 EE 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 270 ED 271
           E+
Sbjct: 234 EE 235

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 101 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 160 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217
Query: 270 ED 271
           E+
Sbjct: 218 EE 219

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 14/236 (5%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           +L+R K    L A+K I+    E+I + + +E+  +++ +  ++V           +++V
Sbjct: 36  RLMRDKQSNELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           +EY   G L + I       E       +Q++ G+ Y H    V HRD+K  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 152
Query: 204 --EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLECA 260
              +KI  FG S         +DT VGT  Y++PE +    YD   +D+WS G+ +    
Sbjct: 153 APRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDP 314
           +G +P+   ED +   +F + +  I+      A PD    SPE    +S     DP
Sbjct: 212 VGAYPF---EDPEEPKNFRKTIHRILNV--QYAIPDYVHISPECRHLISRIFVADP 262

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 270 ED 271
           E+
Sbjct: 234 EE 235

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 136 HNGVISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
             G + +V EYM +GSL D +R + +++L    L      V + + YL    + +HRD+ 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLA 144
Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
             N+LV+     K++DFG++    S+   +DT      + +PE +    +   SD+WS G
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFG 201
Query: 254 LVVLEC-AIGRFPY 266
           +++ E  + GR PY
Sbjct: 202 ILLWEIYSFGRVPY 215

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 124 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 183 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240
Query: 270 ED 271
           E+
Sbjct: 241 EE 242

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 270 ED 271
           E+
Sbjct: 219 EE 220

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 7/132 (5%)
Query: 138 GVISLVLEYMDRGSLADIIR-QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPS 195
           G + +V EYM +GSL D +R + +++L    L      V + + YL    + +HRD+   
Sbjct: 73  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAAR 131
Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
           N+LV+     K++DFG++    S+   +DT      + +PE +    +   SD+WS G++
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 256 VLEC-AIGRFPY 266
           + E  + GR PY
Sbjct: 189 LWEIYSFGRVPY 200

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 270 ED 271
           E+
Sbjct: 261 EE 262

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 97/191 (50%), Gaps = 21/191 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVV 256
           V     +KI DFG++  + +    ++T  G     +M+PE +    Y + SD+WS G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 257 LEC-AIGRFPY 266
            E   +G  PY
Sbjct: 250 WEIFTLGGSPY 260

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 270 ED 271
           E+
Sbjct: 246 EE 247

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 100 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 159 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 216
Query: 270 ED 271
           E+
Sbjct: 217 EE 218

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 270 ED 271
           E+
Sbjct: 247 EE 248

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 270 ED 271
           E+
Sbjct: 246 EE 247

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 270 ED 271
           E+
Sbjct: 261 EE 262

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 270 ED 271
           E+
Sbjct: 247 EE 248

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 270 ED 271
           E+
Sbjct: 246 EE 247

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 270 ED 271
           E+
Sbjct: 247 EE 248

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 270 ED 271
           E+
Sbjct: 246 EE 247

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 270 ED 271
           E+
Sbjct: 247 EE 248

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 136 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 270 ED 271
           E+
Sbjct: 253 EE 254

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 16/141 (11%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV E M  GS+   I + +   E   +VV + V   L +LHN + + HRD+KP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 202 KGE---VKITDFGVSAMLG-------SSMGQRDTFVGTYNYMSPERI-----SGSTYDYS 246
             +   VKI DF + + +         S  +  T  G+  YM+PE +       S YD  
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 247 SDIWSLGLVVLECAIGRFPYM 267
            D+WSLG+++     G  P++
Sbjct: 207 CDLWSLGVILYILLSGYPPFV 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
           + LV +Y+  GSL D +RQ +  L P L +    Q+ +G+ YL  E  ++HR++   N+L
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-EEHGMVHRNLAARNVL 147
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           +    +V++ DFGV+ +L     Q           +M+ E I    Y + SD+WS G+ V
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 257 LEC-AIGRFPY 266
            E    G  PY
Sbjct: 208 WELMTFGAEPY 218

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 149 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 208 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265
Query: 270 ED 271
           E+
Sbjct: 266 EE 267

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 270 ED 271
           E+
Sbjct: 214 EE 215

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 20/144 (13%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYN 231
           QV+  + + H+ R V+HRDIK  N+L++  +G  K+ DFG  A+L         F GT  
Sbjct: 147 QVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRV 203
Query: 232 YMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
           Y  PE IS   Y    + +WSLG+++ +   G  P+ + +         E+LEA +    
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILEAELHF-- 252
Query: 291 PTAPPDQFSPEFCSFVSACIQKDP 314
               P   SP+ C+ +  C+   P
Sbjct: 253 ----PAHVSPDCCALIRRCLAPKP 272

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK--TIL 163
           EEIR  I++ L+        +V+    +F     I +  E +   +L ++I++ K     
Sbjct: 142 EEIR--ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFS 198
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMG 221
            P +      +LQ L  LH  R +IH D+KP N+L+  +G   +K+ DFG S      + 
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV- 256
Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
              T + +  Y +PE I G+ Y    D+WSLG ++ E   G +P +  ED+
Sbjct: 257 --YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 5/122 (4%)
Query: 152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF 210
           L D I +   + E        QVL+ + + HN   V+HRDIK  N+L++ ++GE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQS 269
           G  A+L  ++     F GT  Y  PE I    Y   S+ +WSLG+++ +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 270 ED 271
           E+
Sbjct: 214 EE 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 86  VRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV----VCY--HSFYH-- 136
            RH+  G+  ALK + M N +E      ++E+KI Q  +  +VV    +C    S Y+  
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 137 NGVISLVLEYMDR---GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
            G I LV ++ +    G L++++  VK  L   +  V + +L GL Y+H  + ++HRD+K
Sbjct: 97  KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSE-IKRVMQMLLNGLYYIHRNK-ILHRDMK 152
Query: 194 PSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTFVGTYNYMSPERISGSTYDYSS-- 247
            +N+L+   G +K+ DFG++        S   +    V T  Y  PE + G   DY    
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER-DYGPPI 211
Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQ 273
           D+W  G ++ E    R P MQ   +Q
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQ 236

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 235
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 236 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 292 GVLMWEIFTLGGSPY 306

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 18/238 (7%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV 143
           +L+R K    L A+K I+    E+I + + +E+  +++ +  ++V           +++V
Sbjct: 36  RLMRDKQSNELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG 203
           +EY   G L + I       E       +Q++ G+ Y H    V HRD+K  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 152
Query: 204 --EVKITDFGVS--AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLE 258
              +KI  FG S  ++L S   Q  + VGT  Y++PE +    YD   +D+WS G+ +  
Sbjct: 153 APRLKICAFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDP 314
             +G +P+   ED +   +F + +  I+      A PD    SPE    +S     DP
Sbjct: 210 MLVGAYPF---EDPEEPKNFRKTIHRILNV--QYAIPDYVHISPECRHLISRIFVADP 262

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR----------- 157
           RK   +E ++    Q  H+V  Y        + +V EYM  G L   +R           
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 158 ----QVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
               Q K  L    +  +  Q+  G+VYL ++ H +HRD+   N LV     VKI DFG+
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 213 SAMLGSSMGQRDTFVGTYN-----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           S  + S+   R   VG +      +M PE I    +   SD+WS G+++ E    G+ P+
Sbjct: 180 SRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP-EFCSFVSACIQKDP 314
            Q  +        E++E I +      P  +  P E    +  C Q++P
Sbjct: 237 FQLSNT-------EVIECITQGRVLERP--RVCPKEVYDVMLGCWQREP 276

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 27/152 (17%)
Query: 136 HNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLAVV---------------CKQVLQGLV 179
           H G + L +EY   G+L D +R+ + +  +P  A+                   V +G+ 
Sbjct: 87  HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 146
Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQRDTFVGTYNYMSP 235
           YL +++  IHRD+   N+LV      KI DFG+S      +  +MG+         +M+ 
Sbjct: 147 YL-SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAI 200
Query: 236 ERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
           E ++ S Y  +SD+WS G+++ E  ++G  PY
Sbjct: 201 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 63  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 122
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 123 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 181
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 182 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 237
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 238 GVLMWEIFTLGGSPY 252

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 27/152 (17%)
Query: 136 HNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLAVV---------------CKQVLQGLV 179
           H G + L +EY   G+L D +R+ + +  +P  A+                   V +G+ 
Sbjct: 97  HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156
Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQRDTFVGTYNYMSP 235
           YL +++  IHRD+   N+LV      KI DFG+S      +  +MG+         +M+ 
Sbjct: 157 YL-SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAI 210
Query: 236 ERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
           E ++ S Y  +SD+WS G+++ E  ++G  PY
Sbjct: 211 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 83  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 137
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 138 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 195
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 196 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 252
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 253 ELLLGQPIFPGDSGVDQ 269

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 73  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 127
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 128 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 185
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 186 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 242
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 243 ELLLGQPIFPGDSGVDQ 259

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 124 GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 178
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 179 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 236
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 237 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 293
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 294 ELLLGQPIFPGDSGVDQ 310

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 81  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 135
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 136 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 193
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 194 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 250
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 251 ELLLGQPIFPGDSGVDQ 267

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 79  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 191
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 192 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 248
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 249 ELLLGQPIFPGDSGVDQ 265

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 58  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 112
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 113 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 170
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 171 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 227
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 228 ELLLGQPIFPGDSGVDQ 244

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 86  VRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV----VCY--HSFYH-- 136
            RH+  G+  ALK + M N +E      ++E+KI Q  +  +VV    +C    S Y+  
Sbjct: 36  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95
Query: 137 NGVISLVLEYMDR---GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
            G I LV ++ +    G L++++  VK  L   +  V + +L GL Y+H  + ++HRD+K
Sbjct: 96  KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSE-IKRVMQMLLNGLYYIHRNK-ILHRDMK 151
Query: 194 PSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTFVGTYNYMSPERISGSTYDYSS-- 247
            +N+L+   G +K+ DFG++        S   +    V T  Y  PE + G   DY    
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER-DYGPPI 210
Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQ 273
           D+W  G ++ E    R P MQ   +Q
Sbjct: 211 DLWGAGCIMAEMWT-RSPIMQGNTEQ 235

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 58  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 117
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 118 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLTARNVL 176
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 177 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 232
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 233 GVLMWEIFTLGGSPY 247

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 158 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 214
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 215 ELLLGQPIFPGDSGVDQ 231

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 60  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 119
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 120 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 178
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 179 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 234
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 235 GVLMWEIFTLGGSPY 249

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 86  VRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV----VCY--HSFYH-- 136
            RH+  G+  ALK + M N +E      ++E+KI Q  +  +VV    +C    S Y+  
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 137 NGVISLVLEYMDR---GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
            G I LV ++ +    G L++++  VK  L   +  V + +L GL Y+H  + ++HRD+K
Sbjct: 97  KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSE-IKRVMQMLLNGLYYIHRNK-ILHRDMK 152
Query: 194 PSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTFVGTYNYMSPERISGSTYDYSS-- 247
            +N+L+   G +K+ DFG++        S   +    V T  Y  PE + G   DY    
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER-DYGPPI 211
Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQ 273
           D+W  G ++ E    R P MQ   +Q
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQ 236

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 64  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 118
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 119 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 176
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 177 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 234
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 235 LLLGQPIFPGDSGVDQ 250

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q +  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 215
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 216 LLLGQPIFPGDSGVDQ 231

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 105/197 (53%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 50  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 104
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 105 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 162
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 163 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 219
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 220 ELLLGQPIFPGDSGVDQ 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 53  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 107
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 108 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 165
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 166 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 223
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 224 LLLGQPIFPGDSGVDQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 57  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 111
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 112 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 169
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 227
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 228 LLLGQPIFPGDSGVDQ 243

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 215
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 216 LLLGQPIFPGDSGVDQ 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 215
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 216 LLLGQPIFPGDSGVDQ 231

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 46  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 100
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 101 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 158
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 159 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 216
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 217 LLLGQPIFPGDSGVDQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 79  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 191
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 249
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 250 LLLGQPIFPGDSGVDQ 265

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 49  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 103
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 104 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 161
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 162 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 219
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 220 LLLGQPIFPGDSGVDQ 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 215
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 216 LLLGQPIFPGDSGVDQ 231

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q++  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 57  GELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 111
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 112 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 169
Query: 202 KGEV-KITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVLE 258
              V K+ DFG +  L             Y Y +PE I G+T DY+S  D+WS G V+ E
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGAT-DYTSSIDVWSAGCVLAE 227
Query: 259 CAIGR--FPYMQSEDQ 272
             +G+  FP     DQ
Sbjct: 228 LLLGQPIFPGDSGVDQ 243

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 38/205 (18%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++   +  +R++   E  +    Q  +VV        +  +S++  Y   G L + 
Sbjct: 43  AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
Query: 156 I---------------RQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +               R VK+ LEP   V +  Q+  G+ YL +  HV+H+D+   N+LV
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLV 161
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTY-----------NYMSPERISGSTYDYSSD 248
             K  VKI+D G+          R+ +   Y            +M+PE I    +   SD
Sbjct: 162 YDKLNVKISDLGLF---------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 212
Query: 249 IWSLGLVVLEC-AIGRFPYMQSEDQ 272
           IWS G+V+ E  + G  PY    +Q
Sbjct: 213 IWSYGVVLWEVFSYGLQPYCGYSNQ 237

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 38/205 (18%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K ++   +  +R++   E  +    Q  +VV        +  +S++  Y   G L + 
Sbjct: 60  AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 119
Query: 156 I---------------RQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +               R VK+ LEP   V +  Q+  G+ YL +  HV+H+D+   N+LV
Sbjct: 120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLV 178
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTY-----------NYMSPERISGSTYDYSSD 248
             K  VKI+D G+          R+ +   Y            +M+PE I    +   SD
Sbjct: 179 YDKLNVKISDLGLF---------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 229
Query: 249 IWSLGLVVLEC-AIGRFPYMQSEDQ 272
           IWS G+V+ E  + G  PY    +Q
Sbjct: 230 IWSYGVVLWEVFSYGLQPYCGYSNQ 254

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K+++   ++   +++++E +I       ++V    VC         + LV+E    G 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGP 95
Query: 152 LAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L   ++ + + I    +A +  QV  G+ YL  E++ +HRD+   N+L+ ++   KI+DF
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G+S  LG   S    R        + +PE I+   +   SD+WS G+ + E  + G+ PY
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
            + +  +        + A +E       P +  PE  + +S C
Sbjct: 215 KKMKGPE--------VMAFIEQGKRMECPPECPPELYALMSDC 249

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q +  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 158 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 214
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 215 ELLLGQPIFPGDSGVDQ 231

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 15/138 (10%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-------VCKQVLQGLVYLHNERHVIHRDIKP 194
           L+ +YM+ G+L    R +     P +++       +C    +GL YLH  R +IHRD+K 
Sbjct: 112 LIYKYMENGNLK---RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKS 167
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWS 251
            N+L++     KITDFG+S   G+ + Q        GT  Y+ PE          SD++S
Sbjct: 168 INILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 252 LGLVVLECAIGRFPYMQS 269
            G+V+ E    R   +QS
Sbjct: 227 FGVVLFEVLCARSAIVQS 244

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 26/197 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------VISLVLE 145
           G L A+K +   +Q +  K   +EL+I +     ++V   + FY +G       ++LVL+
Sbjct: 45  GELVAIKKV---LQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           Y+   ++  + R      +T+   Y+ +   Q+ + L Y+H+   + HRDIKP NLL++ 
Sbjct: 100 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDP 157
Query: 202 KGEV-KITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDYSS--DIWSLGLVVL 257
              V K+ DFG +  L    G+ + +++ +  Y +PE I G+T DY+S  D+WS G V+ 
Sbjct: 158 DTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA 214
Query: 258 ECAIGR--FPYMQSEDQ 272
           E  +G+  FP     DQ
Sbjct: 215 ELLLGQPIFPGDSGVDQ 231

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     ++I DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMRIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 12/171 (7%)
Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK--TIL 163
           EEIR  I++ L+        +V+    +F     I +  E +   +L ++I++ K     
Sbjct: 142 EEIR--ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFS 198
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMG 221
            P +      +LQ L  LH  R +IH D+KP N+L+  +G   +K+ DFG S      + 
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV- 256
Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ 272
                + +  Y +PE I G+ Y    D+WSLG ++ E   G +P +  ED+
Sbjct: 257 --YXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 86  VRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           V  +WV    A+KII+       Q +I  ++++ +  +      ++V     F     + 
Sbjct: 77  VEQEWV----AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLL 198
           LV E +   +L D++R    + +         +Q+   L++L   E  +IH D+KP N+L
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 199 VNH--KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           + +  +  +KI DFG S  LG  + Q    + +  Y SPE + G  YD + D+WSLG ++
Sbjct: 192 LCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 257 LECAIG 262
           +E   G
Sbjct: 249 VEMHTG 254

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 86  VRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           V  +WV    A+KII+       Q +I  ++++ +  +      ++V     F     + 
Sbjct: 58  VEQEWV----AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 113
Query: 142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLL 198
           LV E +   +L D++R    + +         +Q+   L++L   E  +IH D+KP N+L
Sbjct: 114 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 172
Query: 199 VNH--KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           + +  +  +KI DFG S  LG  + Q    + +  Y SPE + G  YD + D+WSLG ++
Sbjct: 173 LCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLGMPYDLAIDMWSLGCIL 229
Query: 257 LECAIG 262
           +E   G
Sbjct: 230 VEMHTG 235

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQ--IVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           ++ R  W G   A+KI     ++   ++  +   + +   +    +     S + +  + 
Sbjct: 52  EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 111
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-------VIHRDIKP 194
           L+  Y + GSL D + Q+ T+       +   +  GL +LH E         + HRD+K 
Sbjct: 112 LITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 170
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSP----ERISGSTYDYS 246
            N+LV   G+  I D G++ M   S  Q D      VGT  YM+P    E I    +D  
Sbjct: 171 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 230
Query: 247 S--DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
              DIW+ GLV+ E A         ED +  P FY+++
Sbjct: 231 KRVDIWAFGLVLWEVARRMVSNGIVEDYK--PPFYDVV 266

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGS 151
           A+K+++   ++   +++++E +I       ++V    VC         + LV+E    G 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGP 421
Query: 152 LAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L   ++ + + I    +A +  QV  G+ YL  E++ +HR++   N+L+ ++   KI+DF
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 211 GVSAMLG---SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
           G+S  LG   S    R        + +PE I+   +   SD+WS G+ + E  + G+ PY
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
            + +  +        + A +E       P +  PE  + +S C
Sbjct: 541 KKMKGPE--------VMAFIEQGKRMECPPECPPELYALMSDC 575

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-------VIHRDIKP 194
           L+  Y + GSL D + Q+ T+       +   +  GL +LH E         + HRD+K 
Sbjct: 83  LITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDT----FVGTYNYMSP----ERISGSTYDYS 246
            N+LV   G+  I D G++ M   S  Q D      VGT  YM+P    E I    +D  
Sbjct: 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 247 S--DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
              DIW+ GLV+ E A         ED +  P FY+++
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYK--PPFYDVV 237

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-------VIHRDIKP 194
           L+  Y + GSL D + Q+ T+       +   +  GL +LH E         + HRD+K 
Sbjct: 83  LITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDT----FVGTYNYMSP----ERISGSTYDYS 246
            N+LV   G+  I D G++ M   S  Q D      VGT  YM+P    E I    +D  
Sbjct: 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 247 S--DIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
              DIW+ GLV+ E A         ED +  P FY+++
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYK--PPFYDVV 237

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 29/158 (18%)
Query: 140 ISLVLEYMDRGSLADIIRQVKTILEP-YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           + LV +YM+   L  +IR    ILEP +   V  Q+++ + YLH+   ++HRD+KPSN+L
Sbjct: 86  VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNIL 141
Query: 199 VNHKGEVKITDFGVSAMLGS----------SMGQR-----------DTFVGTYNYMSPER 237
           +N +  VK+ DFG+S    +          S+ +              +V T  Y +PE 
Sbjct: 142 LNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI 201
Query: 238 ISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
           + GST Y    D+WSLG ++ E   G+  FP   + +Q
Sbjct: 202 LLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 86  VRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS 141
           V  +WV    A+KII+       Q +I  ++++ +  +      ++V     F     + 
Sbjct: 77  VEQEWV----AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 142 LVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLL 198
           LV E +   +L D++R    + +         +Q+   L++L   E  +IH D+KP N+L
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 199 VNH--KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           + +  +  +KI DFG S  LG  + Q    + +  Y SPE + G  YD + D+WSLG ++
Sbjct: 192 LCNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 257 LECAIG 262
           +E   G
Sbjct: 249 VEMHTG 254

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 45/210 (21%)
Query: 87  RHKWVGRLFALKI-----------IQMNIQEEIRK----QIVQELKINQASQCSHVVVCY 131
           RHK  G LFA+K+           +QM   E ++K     IV+   I + +   H V   
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV--- 85
Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
                     L++E+   GSL  ++ +      + E    +V + V+ G+ +L  E  ++
Sbjct: 86  ----------LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-RENGIV 134
Query: 189 HRDIKPSNLL--VNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-- 242
           HR+IKP N++  +   G+   K+TDFG +  L     Q  +  GT  Y+ P+    +   
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLR 193
Query: 243 ------YDYSSDIWSLGLVVLECAIGRFPY 266
                 Y  + D+WS+G+     A G  P+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 27/152 (17%)
Query: 136 HNGVISLVLEYMDRGSLADIIRQVKTI-LEPYLAVV---------------CKQVLQGLV 179
           H G + L +EY   G+L D +R+ + +  +P  A+                   V +G+ 
Sbjct: 94  HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 153
Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS----AMLGSSMGQRDTFVGTYNYMSP 235
           YL +++  IHR++   N+LV      KI DFG+S      +  +MG+         +M+ 
Sbjct: 154 YL-SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAI 207
Query: 236 ERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
           E ++ S Y  +SD+WS G+++ E  ++G  PY
Sbjct: 208 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 19/133 (14%)
Query: 144 LEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +EY + G+L D+I    +    + Y  +  +Q+L+ L Y+H++  +IHRD+KP N+ ++ 
Sbjct: 94  MEYCENGTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQ-GIIHRDLKPMNIFIDE 151
Query: 202 KGEVKITDFGVSAMLGSSM-----------GQRDTF---VGTYNYMSPERISGST-YDYS 246
              VKI DFG++  +  S+           G  D     +GT  Y++ E + G+  Y+  
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 247 SDIWSLGLVVLEC 259
            D++SLG++  E 
Sbjct: 212 IDMYSLGIIFFEM 224

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 96  ALKIIQMN--IQEEIRKQIVQELKINQASQ-------CSHVVVCYHSFYH---NGV-ISL 142
           A+KI++ +    E    +I    ++N A          +H++     F H   NGV + +
Sbjct: 48  AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM 107
Query: 143 VLEYMDRGSLADIIR-QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV-- 199
           V E +    LA I + + + I   Y+  + KQ+L GL Y+H    +IH DIKP N+L+  
Sbjct: 108 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167
Query: 200 ----NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
                +  ++KI D G +             + T  Y SPE + G+ +   +DIWS   +
Sbjct: 168 VDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACL 224
Query: 256 VLECAIGRFPYMQSE 270
           + E   G F +   E
Sbjct: 225 IFELITGDFLFEPDE 239

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 120 QASQCSHVVV---CYHSFYHN-GVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQ 173
           +ASQC H+V     Y + Y     + +V+E +D G L   I  R  +   E   + + K 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           + + + YLH+  ++ HRD+KP NLL   K     +K+TDFG +                 
Sbjct: 126 IGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------- 167
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-AIVESP 289
                +  +G  YD S D+WSLG+++     G  P+  +      P     +     E P
Sbjct: 168 -----KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            P     + S E    +   ++ +P           HP+I
Sbjct: 223 NPEW--SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++ Y  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 11/123 (8%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVN----HKGEVKITDFGVSAMLGS---SMGQRDT 225
           Q+L G+ YLH    V+HRD+KP+N+LV      +G VKI D G + +  S    +   D 
Sbjct: 136 QILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 226 FVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELL 282
            V T+ Y +PE + G+  Y  + DIW++G +  E       F   Q + + S P  ++ L
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 283 EAI 285
           + I
Sbjct: 255 DRI 257

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 45/210 (21%)
Query: 87  RHKWVGRLFALKI-----------IQMNIQEEIRK----QIVQELKINQASQCSHVVVCY 131
           RHK  G LFA+K+           +QM   E ++K     IV+   I + +   H V   
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV--- 85
Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
                     L++E+   GSL  ++ +      + E    +V + V+ G+ +L  E  ++
Sbjct: 86  ----------LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIV 134
Query: 189 HRDIKPSNLL--VNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-- 242
           HR+IKP N++  +   G+   K+TDFG +  L     Q     GT  Y+ P+    +   
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVXLYGTEEYLHPDMYERAVLR 193
Query: 243 ------YDYSSDIWSLGLVVLECAIGRFPY 266
                 Y  + D+WS+G+     A G  P+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 96  ALKIIQMN--IQEEIRKQIVQELKINQASQ-------CSHVVVCYHSFYH---NGV-ISL 142
           A+KI++ +    E    +I    ++N A          +H++     F H   NGV + +
Sbjct: 48  AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM 107
Query: 143 VLEYMDRGSLADIIR-QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV-- 199
           V E +    LA I + + + I   Y+  + KQ+L GL Y+H    +IH DIKP N+L+  
Sbjct: 108 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167
Query: 200 ----NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV 255
                +  ++KI D G +             + T  Y SPE + G+ +   +DIWS   +
Sbjct: 168 VDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACL 224
Query: 256 VLECAIGRFPYMQSE 270
           + E   G F +   E
Sbjct: 225 IFELITGDFLFEPDE 239

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 151 SLADIIRQVKTILEPY------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +L+  +R  +    PY            L     QV +G+ +L + R  IHRD+   N+L
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLAS-RKXIHRDLAARNIL 176
Query: 199 VNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           ++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS G+++
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 257 LEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            E  ++G  PY   +  +      E    + E     A PD  +PE    +  C   +P
Sbjct: 237 WEIFSLGASPYPGVKIDE------EFXRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEP 288

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 86  VRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVV----VCY--HSFYH-- 136
            RH+  G+  ALK + M N +E      ++E+KI Q  +  +VV    +C    S Y+  
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 137 NGVISLVLEYMDR---GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
              I LV ++ +    G L++++  VK  L   +  V + +L GL Y+H  + ++HRD+K
Sbjct: 97  KASIYLVFDFCEHDLAGLLSNVL--VKFTLSE-IKRVMQMLLNGLYYIHRNK-ILHRDMK 152
Query: 194 PSNLLVNHKGEVKITDFGVSAML----GSSMGQRDTFVGTYNYMSPERISGSTYDYSS-- 247
            +N+L+   G +K+ DFG++        S   +    V T  Y  PE + G   DY    
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGER-DYGPPI 211
Query: 248 DIWSLGLVVLECAIGRFPYMQSEDQQ 273
           D+W  G ++ E    R P MQ   +Q
Sbjct: 212 DLWGAGCIMAEMWT-RSPIMQGNTEQ 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 26/196 (13%)
Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-ISLVLEYMDRG 150
           G+ +A+KII+       R ++ +E++     Q +  ++    F+ +     LV E +  G
Sbjct: 38  GKEYAVKIIEKQAGHS-RSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGG 96
Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV---KI 207
           S+   I++ K   E   + V + V   L +LH  + + HRD+KP N+L     +V   KI
Sbjct: 97  SILAHIQKQKHFNEREASRVVRDVAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKI 155
Query: 208 TDFGVSAMLGSSMGQRD-----------TFVGTYNYMSPERIS-----GSTYDYSSDIWS 251
            DF     LGS M   +           T  G+  YM+PE +       + YD   D+WS
Sbjct: 156 CDFD----LGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWS 211
Query: 252 LGLVVLECAIGRFPYM 267
           LG+V+     G  P++
Sbjct: 212 LGVVLYIMLSGYPPFV 227

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 60  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 151 SLADIIRQVKTILEPY--------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           +L+  +R  +    PY              L     QV +G+ +L + R  IHRD+   N
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLAS-RKXIHRDLAARN 178
Query: 197 LLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
           +L++ K  VKI DFG++  +      + + D  +    +M+PE I    Y   SD+WS G
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 254 LVVLEC-AIGRFPY 266
           +++ E  ++G  PY
Sbjct: 238 VLLWEIFSLGASPY 251

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 90/194 (46%), Gaps = 21/194 (10%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 59  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 151 SLADIIRQVKTILEPYLA-------------VVCK--QVLQGLVYLHNERHVIHRDIKPS 195
           +L+  +R  +    PY               ++C   QV +G+ +L + R  IHRD+   
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAAR 177
Query: 196 NLLVNHKGEVKITDFGVSAMLGS--SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG 253
           N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS G
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 254 LVVLEC-AIGRFPY 266
           +++ E  ++G  PY
Sbjct: 238 VLLWEIFSLGASPY 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 151 SLADIIRQVKTILEPY------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           +L+  +R  +    PY            L     QV +G+ +L + R  IHRD+   N+L
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKXIHRDLAARNIL 176
Query: 199 VNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVV 256
           ++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS G+++
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 257 LEC-AIGRFPY 266
            E  ++G  PY
Sbjct: 237 WEIFSLGASPY 247

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    +V E+++ +   +  +++    +   +G + +++ Y  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLRE 130
Query: 155 IIR-----------QVKTILEPYLA----VVCK-QVLQGLVYLHNERHVIHRDIKPSNLL 198
            +R            +  + E  +     V C  Q+ +G+ YL +++  IHRD+   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 190 VTENNVMKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 246 GVLMWEIFTLGGSPY 260

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 155 IIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +                 +    L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 124 YLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 182
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVV 256
           V     +KI DFG++  +      + T  G     +M+PE +    Y + SD+WS G+++
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 257 LEC-AIGRFPY 266
            E   +G  PY
Sbjct: 243 WEIFTLGGSPY 253

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 53  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 112
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 113 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 171
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 172 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 228 GVLLWEIFTLGGSPY 242

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 85  LVRHKWVGRLFALKIIQMNIQEEIRKQIV----QELKINQASQCSHVVVCYHSFYHNGVI 140
           +V+ K  G+++A+KI  MN  + +++  V    +E  +        +   + +F     +
Sbjct: 79  VVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
            LV+EY   G L  ++ +    +   +A     +++  +  +H   +V HRDIKP N+L+
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV-HRDIKPDNILL 195
Query: 200 NHKGEVKITDFGVSAMLGSSMGQRD-TFVGTYNYMSPERISGSTYDY-------SSDIWS 251
           +  G +++ DFG    L +    R    VGT +Y+SPE +                D W+
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 252 LGLVVLECAIGRFPYMQSEDQQSW 275
           LG+   E   G+ P+      +++
Sbjct: 256 LGVFAYEMFYGQTPFYADSTAETY 279

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 49  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 108
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 109 YLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 167
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 168 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 224 GVLLWEIFTLGGSPY 238

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 176
Query: 195 SNLLVNHKGEVKITDFGVSAMLGS--SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 237 GVLLWEIFSLGASPY 251

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 124 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 182
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 183 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 57  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 116
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 117 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 175
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 176 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 231
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 232 GVLLWEIFTLGGSPY 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 124 YLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 182
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 183 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 56  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 115
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 116 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 174
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 175 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 231 GVLLWEIFTLGGSPY 245

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 16/181 (8%)
Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL--VNHKGEVKITDFGVSAML----- 216
           E  ++ + +Q+   L YLHN+  + HRDIKP N L   N   E+K+ DFG+S        
Sbjct: 167 EKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 217 GSSMGQRDTFVGTYNYMSPERISGSTYDYS--SDIWSLGLVVLECAIGRFPYMQSEDQQS 274
           G   G   T  GT  +++PE ++ +   Y    D WS G+++    +G  P+    D  +
Sbjct: 226 GEYYGM-TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKKFED 334
                   +   E+P         SP     +S  + ++            HP+I +F D
Sbjct: 285 ISQVLN-KKLCFENPNYNV----LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
Query: 335 K 335
           K
Sbjct: 340 K 340

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 155 IIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            ++  +     Y                L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 223
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 224 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 280 GVLLWEIFTLGGSPY 294

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 7/132 (5%)
Query: 137 NGVISLVLEYMD---RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           N  +++++EY+       L   IR  ++I    +++   Q+ + + ++H+   + HRDIK
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIK 168
Query: 194 PSNLLVNHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWS 251
           P NLLVN K   +K+ DFG +  L  S          + Y +PE + G+T Y  S D+WS
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-YRAPELMLGATEYTPSIDLWS 227
Query: 252 LGLVVLECAIGR 263
           +G V  E  +G+
Sbjct: 228 IGCVFGELILGK 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 93/195 (47%), Gaps = 29/195 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++ +  E+    ++ E+++ +   +  +++    +   +G + +++EY  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 155 II--RQVKTILEPY--------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
            +  R+   +   Y              L     QV +G+ YL +++  IHRD+   N+L
Sbjct: 124 YLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVL 182
Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSL 252
           V     +KI DFG    L   +   D +  T N      +M+PE +    Y + SD+WS 
Sbjct: 183 VTEDNVMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E   +G  PY
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 176
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 237 GVLLWEIFSLGASPY 251

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 43/276 (15%)
Query: 96  ALKIIQMNIQEE-IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K I++  +EE +    ++E+ + +  Q  +++      +HN  + L+ EY +   L  
Sbjct: 63  AIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKK 121
Query: 155 IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL--VNHKGE---VKITD 209
            + +   +    +     Q++ G+ + H+ R  +HRD+KP NLL  V+   E   +KI D
Sbjct: 122 YMDKNPDVSMRVIKSFLYQLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 210 FGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPY 266
           FG++   G  + Q    + T  Y  PE + GS  Y  S DIWS+  +  E  +    FP 
Sbjct: 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240
Query: 267 MQSEDQQSWPSFYELLEAI-----VESPPPTAPPD--QFSPEF----------------- 302
               DQ      +++ E +        P  TA PD  Q  P+F                 
Sbjct: 241 DSEIDQ-----LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEG 295
Query: 303 CSFVSACIQKDPXXXXXXXXXXXHPFIKKFEDKDID 338
              ++A ++ DP           HP+   F   D D
Sbjct: 296 LDLLTAMLEMDPVKRISAKNALEHPY---FSHNDFD 328

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 167
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
            N+L++ K  VKI DFG++  +      + + D  +    +M+PE I    Y   SD+WS
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PLKWMAPETIFDRVYTIQSDVWS 226
Query: 252 LGLVVLEC-AIGRFPY 266
            G+++ E  ++G  PY
Sbjct: 227 FGVLLWEIFSLGASPY 242

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 74/137 (54%), Gaps = 17/137 (12%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL-----QGLVYLHN--ERHVIHRDIKP 194
           LV  YM  GS+A  +R+ +   +P L    +Q +     +GL YLH+  +  +IHRD+K 
Sbjct: 112 LVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 170
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV-----GTYNYMSPERISGSTYDYSSDI 249
           +N+L++ + E  + DFG++ +    M  +D  V     GT  +++PE +S       +D+
Sbjct: 171 ANILLDEEFEAVVGDFGLAKL----MDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDV 226
Query: 250 WSLGLVVLECAIGRFPY 266
           +  G+++LE   G+  +
Sbjct: 227 FGYGVMLLELITGQRAF 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 60  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 151 SLADIIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                L     QV +G+ +L + R  IHRD+  
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 178
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 239 GVLLWEIFSLGASPY 253

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 58  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 176
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 237 GVLLWEIFSLGASPY 251

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 14/163 (8%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD--TFVGTY 230
           Q++ GL YLH++  ++H+DIKP NLL+   G +KI+  GV+  L          T  G+ 
Sbjct: 117 QLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 231 NYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
            +  PE  +G  +   +  DIWS G+ +     G +P+          + Y+L E I + 
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-------NIYKLFENIGKG 228
Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFIKK 331
               A P    P     +   ++ +P           H + +K
Sbjct: 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + ++ E+   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 167
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
            N+L++ K  VKI DFG++  +      + + D  +    +M+PE I    Y   SD+WS
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL-PLKWMAPETIFDRVYTIQSDVWS 226
Query: 252 LGLVVLEC-AIGRFPY 266
            G+++ E  ++G  PY
Sbjct: 227 FGVLLWEIFSLGASPY 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + +++E+   G
Sbjct: 95  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 213
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 274 GVLLWEIFSLGASPY 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 100
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 160 YMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 220 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 253

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 9/135 (6%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +LV EY++        +Q+  IL  + +     ++L+ L Y H+ + ++HRD+KP N+++
Sbjct: 111 ALVFEYINNTDF----KQLYQILTDFDIRFYMYELLKALDYCHS-KGIMHRDVKPHNVMI 165
Query: 200 NHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVL 257
           +H+  ++++ D+G++     +  + +  V +  +  PE  +    YDYS D+WSLG ++ 
Sbjct: 166 DHQQKKLRLIDWGLAEFYHPAQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 258 ECAIGRFPYMQSEDQ 272
                R P+   +D 
Sbjct: 225 SMIFRREPFFHGQDN 239

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +LV EY++        +Q+  IL  + +     ++L+ L Y H+ + ++HRD+KP N+++
Sbjct: 116 ALVFEYINNTDF----KQLYQILTDFDIRFYMYELLKALDYCHS-KGIMHRDVKPHNVMI 170
Query: 200 NHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVL 257
           +H+  ++++ D+G++     +  + +  V +  +  PE  +    YDYS D+WSLG ++ 
Sbjct: 171 DHQQKKLRLIDWGLAEFYHPAQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 258 ECAIGRFPYMQSED 271
                R P+   +D
Sbjct: 230 SMIFRREPFFHGQD 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + ++ E+   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 167
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 228 GVLLWEIFSLGASPY 242

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 169 QVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVVKGNA 223
Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+ + E  ++G  PY  M  + +     FY+++ 
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 278
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E      P  AP + +       +  C   DP
Sbjct: 279 EGFRMLSPEHAPAEMY-----DIMKTCWDADP 305

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH---------NERHVIHRDI 192
           L+  + ++GSL+D ++    +    L  + + + +GL YLH         ++  + HRDI
Sbjct: 99  LITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 193 KPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGS-TYDYSS-- 247
           K  N+L+ +     I DFG++     G S G     VGT  YM+PE + G+  +   +  
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 248 --DIWSLGLVVLECA 260
             D++++GLV+ E A
Sbjct: 218 RIDMYAMGLVLWELA 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 93  RLFALKIIQMNIQEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRG 150
           R  A+K+++        + ++ ELKI  +     + V +        G + ++ E+   G
Sbjct: 49  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 151 SLADIIRQVKTILEPYLA--------------VVCK--QVLQGLVYLHNERHVIHRDIKP 194
           +L+  +R  +    PY                ++C   QV +G+ +L + R  IHRD+  
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA 167
Query: 195 SNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSL 252
            N+L++ K  VKI DFG++  +       ++        +M+PE I    Y   SD+WS 
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 253 GLVVLEC-AIGRFPY 266
           G+++ E  ++G  PY
Sbjct: 228 GVLLWEIFSLGASPY 242

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT 229
           + +QV  G+ YL +ER  +HRD+   N LV     VKI DFG+S  + S+    D +   
Sbjct: 179 IARQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA----DYYKAD 233
Query: 230 YN------YMSPERISGSTYDYSSDIWSLGLVVLE 258
            N      +M PE I  + Y   SD+W+ G+V+ E
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 100
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 220 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 253

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 171 QVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVVKGNA 225
Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+ + E  ++G  PY  M  + +     FY+++ 
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 280
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E      P  AP + +       +  C   DP
Sbjct: 281 EGFRMLSPEHAPAEMY-----DIMKTCWDADP 307

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 100
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 220 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 253

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 39  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 97
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 98  LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 217 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 250

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 176 QVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVVKGNA 230
Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+ + E  ++G  PY  M  + +     FY+++ 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 285
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E      P  AP + +       +  C   DP
Sbjct: 286 EGFRMLSPEHAPAEMY-----DIMKTCWDADP 312

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 19/133 (14%)
Query: 144 LEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           +EY +  +L D+I    +    + Y  +  +Q+L+ L Y+H++  +IHRD+KP N+ ++ 
Sbjct: 94  MEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQ-GIIHRDLKPMNIFIDE 151
Query: 202 KGEVKITDFGVSAMLGSSM-----------GQRDTF---VGTYNYMSPERISGST-YDYS 246
              VKI DFG++  +  S+           G  D     +GT  Y++ E + G+  Y+  
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 247 SDIWSLGLVVLEC 259
            D++SLG++  E 
Sbjct: 212 IDMYSLGIIFFEM 224

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 153 QVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVVKGNA 207
Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+ + E  ++G  PY  M  + +     FY+++ 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 262
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E      P  AP + +       +  C   DP
Sbjct: 263 EGFRMLSPEHAPAEMY-----DIMKTCWDADP 289

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 105
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 106 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 225 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 258

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNE-------RHVIHRDIK 193
           L+  Y + GSL D ++  +  LEP+LA+ +      GL +LH E         + HRD K
Sbjct: 83  LITHYHEHGSLYDFLQ--RQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFK 140
Query: 194 PSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT----FVGTYNYMSPERISG-------ST 242
             N+LV    +  I D G++ M        D      VGT  YM+PE +          +
Sbjct: 141 SRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFES 200
Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
           Y + +DIW+ GLV+ E A         ED +  P FY+++
Sbjct: 201 YKW-TDIWAFGLVLWEIARRTIVNGIVEDYR--PPFYDVV 237

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 45  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 103
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 104 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 163 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 223 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 256

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 70  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 128
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 129 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 188 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 248 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 281

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           QV +G+ +L + ++ IHRD+   N+L+ H    KI DFG    L   +     +V   N 
Sbjct: 176 QVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG----LARHIKNDSNYVVKGNA 230
Query: 232 -----YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY--MQSEDQQSWPSFYELL- 282
                +M+PE I    Y + SD+WS G+ + E  ++G  PY  M  + +     FY+++ 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 285
Query: 283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
           E      P  AP + +       +  C   DP
Sbjct: 286 EGFRMLSPEHAPAEMY-----DIMKTCWDADP 312

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 100
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 220 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 253

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 44  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 102
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 103 LQVRKYSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 162 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 222 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 255

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 480
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 600 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 633

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 23/159 (14%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    D +V        
Sbjct: 126 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVP 181
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 220

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 73/137 (53%), Gaps = 17/137 (12%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL-----QGLVYLHN--ERHVIHRDIKP 194
           LV  YM  GS+A  +R+ +   +P L    +Q +     +GL YLH+  +  +IHRD+K 
Sbjct: 104 LVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV-----GTYNYMSPERISGSTYDYSSDI 249
           +N+L++ + E  + DFG++ +    M  +D  V     G   +++PE +S       +D+
Sbjct: 163 ANILLDEEFEAVVGDFGLAKL----MDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDV 218
Query: 250 WSLGLVVLECAIGRFPY 266
           +  G+++LE   G+  +
Sbjct: 219 FGYGVMLLELITGQRAF 235

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 23/159 (14%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    D +V        
Sbjct: 132 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVP 187
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 20/133 (15%)
Query: 137 NGVISLVLEYMDRGSLADIIRQVKTILE-----PYLAVVCKQVLQGLVYLHNERHVIHRD 191
           NG I L++E++  GSL + + + K  +       Y   +CK    G+ YL   R  +HRD
Sbjct: 98  NG-IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK----GMDYL-GSRQYVHRD 151
Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSS------MGQRDTFVGTYNYMSPERISGSTYDY 245
           +   N+LV  + +VKI DFG++  + +          RD+ V  Y   +PE +  S +  
Sbjct: 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY---APECLMQSKFYI 208
Query: 246 SSDIWSLGLVVLE 258
           +SD+WS G+ + E
Sbjct: 209 ASDVWSFGVTLHE 221

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 20/133 (15%)
Query: 137 NGVISLVLEYMDRGSLADIIRQVKTILE-----PYLAVVCKQVLQGLVYLHNERHVIHRD 191
           NG I L++E++  GSL + + + K  +       Y   +CK    G+ YL   R  +HRD
Sbjct: 86  NG-IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK----GMDYL-GSRQYVHRD 139
Query: 192 IKPSNLLVNHKGEVKITDFGVSAMLGSS------MGQRDTFVGTYNYMSPERISGSTYDY 245
           +   N+LV  + +VKI DFG++  + +          RD+ V  Y   +PE +  S +  
Sbjct: 140 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY---APECLMQSKFYI 196
Query: 246 SSDIWSLGLVVLE 258
           +SD+WS G+ + E
Sbjct: 197 ASDVWSFGVTLHE 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 28/198 (14%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD 154
           A+K+++       R+ ++ ELK+  Q     ++V    +   +G I L+ EY   G L +
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 155 IIR---------------QVKTILEPYLAVV--------CKQVLQGLVYLHNERHVIHRD 191
            +R               Q +   E  L V+          QV +G+ +L   +  +HRD
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197
Query: 192 IKPSNLLVNHKGEVKITDFGVSA--MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           +   N+LV H   VKI DFG++   M  S+   R        +M+PE +    Y   SD+
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 250 WSLGLVVLEC-AIGRFPY 266
           WS G+++ E  ++G  PY
Sbjct: 258 WSYGILLWEIFSLGVNPY 275

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 23/159 (14%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    D +V        
Sbjct: 122 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVP 177
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 11/221 (4%)
Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           A+K  +    + +R++ +QE    +     H+V        N V  +++E    G L   
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 480
Query: 156 IRQVKTILE-PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
           ++  K  L+   L +   Q+   L YL ++R V HRDI   N+LV+    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 215 -MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            M  S+  +         +M+PE I+   +  +SD+W  G+ + E  +      Q     
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
                 E  E +    PP  PP  +     S ++ C   DP
Sbjct: 600 DVIGRIENGERL--PMPPNCPPTLY-----SLMTKCWAYDP 633

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 23/159 (14%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    D +V        
Sbjct: 122 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVP 177
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 23/159 (14%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    D +V        
Sbjct: 126 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVP 181
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 504
Query: 202 KGEVKITDFGVSAMLGSSMG-QRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +     +    G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 505 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 565 AFSYGQKPY 573

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 447 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 505
Query: 202 KGEVKITDFGVSAMLGSSMG-QRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +     +    G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 506 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 566 AFSYGQKPY 574

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS----MGQRDTFVGTYN 231
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG+   L  +    + Q    V  + 
Sbjct: 132 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFA 189
Query: 232 YMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
           + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 146
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S A+       +    G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 147 QHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 207 AFSYGQKPY 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 128 VVCYHSFYHNGVISL-----------VLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVL 175
           V   HS  H  +I L           V E    GSL D +R+ +   L   L+    QV 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGT------ 229
           +G+ YL ++R  IHRD+   NLL+  +  VKI DFG    L  ++ Q D           
Sbjct: 122 EGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFG----LMRALPQNDDHXVMQEHRKV 176
Query: 230 -YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYM 267
            + + +PE +   T+ ++SD W  G+ + E    G+ P++
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGT 229
           QV +G+ +L + R  IHRD+   N+L++    VKI DFG++  +  +   + + DT +  
Sbjct: 207 QVARGMEFLSS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL-P 264
Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVES 288
             +M+PE I    Y   SD+WS G+++ E  ++G  PY   +  + + S   L E +   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCS--RLREGMR-- 320
Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDP 314
                 P+  +PE    +  C  +DP
Sbjct: 321 ---MRAPEYSTPEIYQIMLDCWHRDP 343

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 57  EVWRGKWRGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 171
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 232 FESFKRADIYAMGLVFWEIARRCSIG 257

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 102 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 160
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFV-GTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +          G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 161 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 221 AFSYGQKPY 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 162
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFV-GTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +          G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 163 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 223 AFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 162
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFV-GTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +          G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 163 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 223 AFSYGQKPY 231

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 16/104 (15%)
Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--------- 220
           + +Q+L+ L Y+H++  +IHR++KP N+ ++    VKI DFG++  +  S+         
Sbjct: 121 LFRQILEALSYIHSQ-GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 221 --GQRDTF---VGTYNYMSPERISGST-YDYSSDIWSLGLVVLE 258
             G  D     +GT  Y++ E + G+  Y+   D +SLG++  E
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 163 LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVK--ITDFGVSAMLG 217
           LEP    + +Q   GL +LH+  +++HRD+KP N+L+   N  G++K  I+DFG+   L 
Sbjct: 118 LEP--ITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 218 ---SSMGQRDTFVGTYNYMSPERISGSTYD---YSSDIWSLGLVVLEC-AIGRFPYMQSE 270
               S  +R    GT  +++PE +S    +   Y+ DI+S G V     + G  P+ +S 
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 271 DQQSWPSFYELLEAI-VESPPPTAPPDQFSPEFCSFVSACIQKDPXXXXXXXXXXXHPFI 329
            +Q+      LL A  ++   P    D  + E    +   I  DP           HPF 
Sbjct: 235 QRQA----NILLGACSLDCLHPEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLKHPFF 287
Query: 330 KKFED-----KDIDLGILVGSLDPPV 350
              E      +D+   I   SLD P+
Sbjct: 288 WSLEKQLQFFQDVSDRIEKESLDGPI 313

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 146
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S A+       +    G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 147 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 207 AFSYGQKPY 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 152
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFV-GTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +          G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 153 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 213 AFSYGQKPY 221

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVC---YHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 44  EVWRGKWRGEEVAVKI--FSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 99
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 100 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 158
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 159 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 218
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 219 FESFKRADIYAMGLVFWEIARRCSIG 244

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 142
Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFV-GTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S  L +          G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 203 AFSYGQKPY 211

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH 201
           LV+E  + G L   ++Q + + +  +  +  QV  G+ YL  E + +HRD+   N+L+  
Sbjct: 82  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 140
Query: 202 KGEVKITDFGVS-AMLGSSMGQRDTFVGTY--NYMSPERISGSTYDYSSDIWSLGLVVLE 258
           +   KI+DFG+S A+       +    G +   + +PE I+   +   SD+WS G+++ E
Sbjct: 141 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200
Query: 259 C-AIGRFPY 266
             + G+ PY
Sbjct: 201 AFSYGQKPY 209

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 19  EVWRGKWRGEEVAVKI--FSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 74
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 75  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 133
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 134 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 193
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 194 FESFKRADIYAMGLVFWEIARRCSIG 219

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 18  EVWRGKWRGEEVAVKI--FSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 74  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 132
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIG 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 21  EVWRGKWRGEEVAVKI--FSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 76
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 77  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 135
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 136 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 195
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 196 FESFKRADIYAMGLVFWEIARRCSIG 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 20/137 (14%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE-------RHVIHRDIKP 194
           L+ +Y + GSL D ++      +  L +    V  GL +LH E         + HRD+K 
Sbjct: 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSV-SGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRD----TFVGTYNYMSPERISGS-------TY 243
            N+LV   G   I D G++    S   + D    T VGT  YM PE +  S       +Y
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 244 DYSSDIWSLGLVVLECA 260
              +D++S GL++ E A
Sbjct: 231 -IMADMYSFGLILWEVA 246

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV---CYHSFYHNGVI 140
           ++ R KW G   A+KI   + +EE  +   +E +I Q     H  +          NG  
Sbjct: 24  EVWRGKWRGEEVAVKIF--SSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 79
Query: 141 S---LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER-------HVIHR 190
           +   LV +Y + GSL D + +    +E  + +       GL +LH E         + HR
Sbjct: 80  TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHR 138
Query: 191 DIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGSTYD-- 244
           D+K  N+LV   G   I D G++    S+    D      VGT  YM+PE +  S     
Sbjct: 139 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 198
Query: 245 ----YSSDIWSLGLVVLE----CAIG 262
                 +DI+++GLV  E    C+IG
Sbjct: 199 FESFKRADIYAMGLVFWEIARRCSIG 224

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTY 230
           QV +G+ +L + R  IHRD+   N+L++ K  VKI DFG++  +       ++       
Sbjct: 206 QVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +M+PE I    Y   SD+WS G+++ E  ++G  PY
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 301

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 84  QLVRHKWVGRLFALKIIQMNIQEEIRK-QIVQELKINQASQCSHVVVCYHSF-------- 134
           QL + K  G   A+K +  + +   R+ QI+Q+L +        +   +++         
Sbjct: 40  QLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99
Query: 135 YHNGVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLH-NERHVIHRD 191
           Y N V+  V + + R       RQV    IL   + V   Q+++ +  LH    +V HRD
Sbjct: 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL---IKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 192 IKPSNLLVNHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDI 249
           IKP N+LVN   G +K+ DFG +  L  S          Y Y +PE I G+  Y  + DI
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDI 215
Query: 250 WSLGLVVLECAIG 262
           WS+G +  E  +G
Sbjct: 216 WSVGCIFAEMMLG 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTY 230
           QV +G+ +L + R  IHRD+   N+L++ K  VKI DFG++  +       ++       
Sbjct: 201 QVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +M+PE I    Y   SD+WS G+++ E  ++G  PY
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTY 230
           QV +G+ +L + R  IHRD+   N+L++ K  VKI DFG++  +       ++       
Sbjct: 208 QVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +M+PE I    Y   SD+WS G+++ E  ++G  PY
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 303

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 32/203 (15%)
Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH-------NERH---VIHRD 191
           L+  + D+GSL D ++    I    L  V + + +GL YLH        E H   + HRD
Sbjct: 90  LITAFHDKGSLTDYLKG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRD 148
Query: 192 IKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGS-TYDYSS- 247
            K  N+L+       + DFG++     G   G     VGT  YM+PE + G+  +   + 
Sbjct: 149 FKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAF 208
Query: 248 ---DIWSLGLVVLE----CAIGRFP---YMQ--SEDQQSWPSFYELLEAIVESPPPTAPP 295
              D++++GLV+ E    C     P   YM    E+    PS  EL E +V         
Sbjct: 209 LRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIK 268
Query: 296 DQF-----SPEFCSFVSACIQKD 313
           D +       + C  +  C   D
Sbjct: 269 DHWLKHPGLAQLCVTIEECWDHD 291

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTY 230
           QV +G+ +L + R  IHRD+   N+L++ K  VKI DFG++  +       ++       
Sbjct: 199 QVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPY 266
            +M+PE I    Y   SD+WS G+++ E  ++G  PY
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 294

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 30/177 (16%)
Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVKTILE 164
           K+I++E+ I    +  +++  Y     + ++      +VLE  D   L  + +    + E
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTE 128
Query: 165 PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--- 221
            ++  +   +L G  ++H E  +IHRD+KP+N L+N    VK+ DFG++  + S      
Sbjct: 129 EHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 222 -------------------QRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLE 258
                              Q  + V T  Y +PE I     Y  S DIWS G +  E
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 27/192 (14%)
Query: 93  RLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS--LVLEYMDR 149
           R  A+K+    N Q  I ++ +  + + +    +  +V       +G +   LV+EY   
Sbjct: 37  RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96
Query: 150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER--------HVIHRDIKPSNLLVNH 201
           GSL   +  + T        +   V +GL YLH E          + HRD+   N+LV +
Sbjct: 97  GSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155
Query: 202 KGEVKITDFGVSAMLGSSM----GQRDTF----VGTYNYMSPERISGST--YDYSS---- 247
            G   I+DFG+S  L  +     G+ D      VGT  YM+PE + G+    D  S    
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215
Query: 248 -DIWSLGLVVLE 258
            D+++LGL+  E
Sbjct: 216 VDMYALGLIYWE 227

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 20/194 (10%)
Query: 92  GRLFALKIIQMNIQ---EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMD 148
           G  +ALK I  + Q   EE +++       N  +    V  C           L+L +  
Sbjct: 54  GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 149 RGSLADIIRQVKT----ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE 204
           RG+L + I ++K     + E  +  +   + +GL  +H + +  HRD+KP+N+L+  +G+
Sbjct: 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA-HRDLKPTNILLGDEGQ 172
Query: 205 VKITDFG-VSAMLGSSMGQRDTFV--------GTYNYMSPERISGSTY---DYSSDIWSL 252
             + D G ++       G R             T +Y +PE  S  ++   D  +D+WSL
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 253 GLVVLECAIGRFPY 266
           G V+     G  PY
Sbjct: 233 GCVLYAMMFGEGPY 246

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N+L++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVLID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 70/135 (51%), Gaps = 9/135 (6%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +LV E+++        +Q++  L  Y +     ++L+ L Y H+   ++HRD+KP N+++
Sbjct: 110 ALVFEHVNNTDF----KQLRQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMI 164
Query: 200 NHKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVL 257
           +H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++ 
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 258 ECAIGRFPYMQSEDQ 272
                + P+    D 
Sbjct: 224 SMIFRKEPFFHGHDN 238

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 108 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 163
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 223 MIFRKEPFFHGHDN 236

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 109 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 164
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 165 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 224 MIFRKEPFFHGHDN 237

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 109 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 164
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 165 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 224 MIFRKEPFFHGHDN 237

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 115 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 170
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 171 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 229
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 230 MIFRKEPFFHGHDN 243

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 70/134 (52%), Gaps = 7/134 (5%)
Query: 141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +LV E+++     D  +  +T+ +  +     ++L+ L Y H+   ++HRD+KP N++++
Sbjct: 110 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMID 165
Query: 201 HKG-EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER-ISGSTYDYSSDIWSLGLVVLE 258
           H+  ++++ D+G++        + +  V +  +  PE  +    YDYS D+WSLG ++  
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 224
Query: 259 CAIGRFPYMQSEDQ 272
               + P+    D 
Sbjct: 225 MIFRKEPFFHGHDN 238
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	354
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-141
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-138
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-137
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-136
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-135
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-86
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-86
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-85
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-85
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-85
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-84
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-81
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-80
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-80
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-80
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-79
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-78
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-77
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-75
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-74
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-74
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-73
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-71
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-70
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-69
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-68
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-68
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-62
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-59
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-59
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-58
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-57
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-56
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-11
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-51
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-49
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-48
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-47
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-46
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-45
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-45
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-45
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-44
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-44
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-44
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-44
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-44
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-44
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-44
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-44
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-44
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-44
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-44
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-44
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-44
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-43
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-43
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-43
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-43
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-43
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-43
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-43
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-43
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-42
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-42
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-42
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-42
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-42
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-42
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-42
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-42
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-41
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-41
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-41
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-41
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-41
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-41
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-41
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-41
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-41
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-41
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-40
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-40
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-38
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-38
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-38
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-38
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-38
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-38
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-37
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-35
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-35
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-35
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-35
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-32
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-32
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-30
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-27
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-18
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  401 bits (1033), Expect = e-141
 Identities = 105/291 (36%), Positives = 166/291 (57%), Gaps = 17/291 (5%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-Q 120
            E   +DLE I  +G+G+ GVV+ +RH   G++ A+K I+  +  + +K+++ +L I+ +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQ 176
              C   V  Y + +  G + + +E MD  SL    +QV    +TI E  L  +   +++
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
            L +LH++  VIHRD+KPSN+L+N  G+VK+ DFG+S  L   +  +D   G   YM+PE
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPE 179

Query: 237 RISG----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           RI+       Y   SDIWSLG+ ++E AI RFPY       SW + ++ L+ +VE P P 
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPY------DSWGTPFQQLKQVVEEPSPQ 233

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV 343
            P D+FS EF  F S C++K+ ++R +  +L+ HPF    E K  D+   V
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFV 284

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  397 bits (1021), Expect = e-138
 Identities = 118/319 (36%), Positives = 176/319 (55%), Gaps = 37/319 (11%)

Query: 56  DYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQE 115
             K+   E   +D E I  +G G+GGVV  V HK  G + A K+I + I+  IR QI++E
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81

Query: 116 LKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL 175
           L++       ++V  Y +FY +G IS+ +E+MD GSL  ++++   I E  L  V   V+
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 141

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
           +GL YL  +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSP
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSP 199

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPY----------------------------- 266
           ER+ G+ Y   SDIWS+GL ++E A+GR+P                              
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259

Query: 267 ------MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSS 320
                     D +   + +ELL+ IV  PPP  P   FS EF  FV+ C+ K+P +R+  
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319

Query: 321 LDLLSHPFIKKFEDKDIDL 339
             L+ H FIK+ + +++D 
Sbjct: 320 KQLMVHAFIKRSDAEEVDF 338

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  389 bits (1002), Expect = e-136
 Identities = 101/314 (32%), Positives = 166/314 (52%), Gaps = 21/314 (6%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ 105
           +S E+  +     E  ++F+ EDL+ +  IG+G+ G V  + HK  G++ A+K I+  + 
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60

Query: 106 EEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK---- 160
           E+ +KQ++ +L +  ++S C ++V  Y + +  G   + +E M   S     + V     
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD 119

Query: 161 -TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
             I E  L  +    ++ L +L     +IHRDIKPSN+L++  G +K+ DFG+S  L  S
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179

Query: 220 MGQRDTFVGTYNYMSPERISGS----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
           + +     G   YM+PERI  S     YD  SD+WSLG+ + E A GRFPY        W
Sbjct: 180 IAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY------PKW 232

Query: 276 PSFYELLEAIVESPPPT---APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
            S ++ L  +V+  PP    +   +FSP F +FV+ C+ KD   R    +LL HPFI  +
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292

Query: 333 EDKDIDLGILVGSL 346
           E++ +++   V  +
Sbjct: 293 EERAVEVACYVCKI 306

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  385 bits (992), Expect = e-135
 Identities = 93/300 (31%), Positives = 160/300 (53%), Gaps = 14/300 (4%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-Q 120
           ++  + DLE +  +G G+ G V  +R +  G + A+K ++ +  +E  K+I+ +L +  +
Sbjct: 20  YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK 79

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
           +  C ++V C+ +F  N  + + +E M   +     R    I E  L  +   +++ L Y
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI-- 238
           L  +  VIHRD+KPSN+L++ +G++K+ DFG+S  L      +D   G   YM+PERI  
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPERIDP 198

Query: 239 ---SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
              +   YD  +D+WSLG+ ++E A G+FPY      ++  + +E+L  +++  PP  P 
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPY------KNCKTDFEVLTKVLQEEPPLLPG 252

Query: 296 DQ-FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCPR 354
              FS +F SFV  C+ KD R R     LL H FIK++E  ++D+      +      PR
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR 312

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  261 bits (670), Expect = 3e-86
 Identities = 89/296 (30%), Positives = 164/296 (55%), Gaps = 17/296 (5%)

Query: 50  NESRPSDYKEFDFEFSLEDL-ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI 108
           +  +  +Y+    +    ++ E +  +G G+ G V   ++K  G L A K+I+   +EE+
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYL 167
            +  + E++I       ++V    ++YH+G + +++E+   G++  I+ ++   L EP +
Sbjct: 61  -EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119

Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV 227
            VVC+Q+L+ L +LH++  +IHRD+K  N+L+  +G++++ DFGVSA    ++ +RD+F+
Sbjct: 120 QVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 228 GTYNYMSPERI-----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL 282
           GT  +M+PE +       + YDY +DIWSLG+ ++E A    P+ +       P    +L
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----P--MRVL 231

Query: 283 EAIVESPPPT-APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
             I +S PPT   P ++S EF  F+   + K+P  R S+  LL HPF+        
Sbjct: 232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  260 bits (667), Expect = 6e-86
 Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 11/266 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +     + IG+G+ G V        G+  A++ + +  Q +    I+ E+ + + ++  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPN 78

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V    S+     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH+   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN-Q 136

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           VIHRDIK  N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSF 305
            DIWSLG++ +E   G  PY+     ++       L  I  +  P    P++ S  F  F
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPELQNPEKLSAIFRDF 249

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKK 331
           ++ C++ D   R S+ +LL H F+K 
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  260 bits (667), Expect = 1e-85
 Identities = 97/273 (35%), Positives = 153/273 (56%), Gaps = 13/273 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           E  + ++ +G+GS G V    HK  G++ A+K   + ++ ++ ++I++E+ I Q     H
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ--VPVESDL-QEIIKEISIMQQCDSPH 85

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNER 185
           VV  Y S++ N  + +V+EY   GS++DIIR     L E  +A + +  L+GL YLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM- 144

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
             IHRDIK  N+L+N +G  K+ DFGV+  L  +M +R+T +GT  +M+PE I    Y+ 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 246 SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCS 304
            +DIWSLG+  +E A G+ PY         P     +  I  +PPPT   P+ +S  F  
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIH-----P--MRAIFMIPTNPPPTFRKPELWSDNFTD 257

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
           FV  C+ K P  R+++  LL HPF++  +   I
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  260 bits (667), Expect = 1e-85
 Identities = 93/266 (34%), Positives = 151/266 (56%), Gaps = 11/266 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
             L++   IG+GS G+V L R K  GR  A+K++ +  Q+  R+ +  E+ I +  Q  +
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFN 103

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           VV  Y S+     + +++E++  G+L DI+ Q   + E  +A VC+ VLQ L YLH +  
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ-G 161

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           VIHRDIK  ++L+   G VK++DFG  A +   + +R + VGT  +M+PE IS S Y   
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-APPDQFSPEFCSF 305
            DIWSLG++V+E   G  PY      Q+       ++ + +SPPP      + SP    F
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKLKNSHKVSPVLRDF 274

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKK 331
           +   + +DP++R+++ +LL HPF+ +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQ 300

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  260 bits (666), Expect = 2e-85
 Identities = 99/312 (31%), Positives = 164/312 (52%), Gaps = 29/312 (9%)

Query: 50  NESRPSDYKEFDFEFSLEDLETI----KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ 105
           ++S      E D   +L D   I    +++G G+ G V   RH   G+L A+K+  M++ 
Sbjct: 4   SDSPARSLDEIDLS-ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVT 60

Query: 106 EEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIR- 157
            +  ++I QE+ +  + S   ++   Y +F             LV+E+   GS+ D+I+ 
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 158 -QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
            +  T+ E ++A +C+++L+GL +LH    VIHRDIK  N+L+    EVK+ DFGVSA L
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 217 GSSMGQRDTFVGTYNYMSPERI-----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
             ++G+R+TF+GT  +M+PE I       +TYD+ SD+WSLG+  +E A G  P      
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH- 238

Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
               P     L  I  +P P     ++S +F SF+ +C+ K+   R ++  L+ HPFI+ 
Sbjct: 239 ----PM--RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

Query: 332 FEDKDIDLGILV 343
             ++      L 
Sbjct: 293 QPNERQVRIQLK 304

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  257 bits (659), Expect = 1e-84
 Identities = 95/277 (34%), Positives = 152/277 (54%), Gaps = 10/277 (3%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           E    ++ IGKGS G V         ++ A+KII +   E+  + I QE+ +       +
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           V   Y S+  +  + +++EY+  GS  D++     + E  +A + +++L+GL YLH+E+ 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK- 139

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
            IHRDIK +N+L++  GEVK+ DFGV+  L  +  +R+TFVGT  +M+PE I  S YD  
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
           +DIWSLG+  +E A G  P+ +       P   ++L  I ++ PPT     +S     FV
Sbjct: 200 ADIWSLGITAIELARGEPPHSELH-----PM--KVLFLIPKNNPPTL-EGNYSKPLKEFV 251

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV 343
            AC+ K+P  R ++ +LL H FI +   K   L  L+
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 288

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  249 bits (637), Expect = 3e-81
 Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 16/275 (5%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQAS 122
           +L +    K IG+G    V        G   ALK +Q+   +  + R   ++E+ +    
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL--LK 87

Query: 123 QCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQ 176
           Q +H  V+  Y SF  +  +++VLE  D G L+ +I+  K     I E  +     Q+  
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
            L ++H  R V+HRDIKP+N+ +   G VK+ D G+     S      + VGT  YMSPE
Sbjct: 148 ALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 237 RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
           RI  + Y++ SDIWSLG ++ E A  + P+          + Y L + I +   P  P D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCDYPPLPSD 261

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +S E    V+ CI  DP  R     +        
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  249 bits (637), Expect = 1e-80
 Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 16/276 (5%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQ 123
           S+E    ++ IG+GS G   LV+    GR + +K I +  +  + R++  +E+ +   + 
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV--LAN 79

Query: 124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL--EPYLAVVCKQVLQGLV 179
             H  +V    SF  NG + +V++Y + G L   I   K +L  E  +     Q+   L 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           ++H +R ++HRDIK  N+ +   G V++ DFG++ +L S++      +GT  Y+SPE   
Sbjct: 140 HVH-DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
              Y+  SDIW+LG V+ E    +  +          S   L+  I+    P      +S
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAF-------EAGSMKNLVLKIISGSFP-PVSLHYS 250

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
            +  S VS   +++PRDR S   +L   FI K  +K
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  246 bits (631), Expect = 2e-80
 Identities = 94/295 (31%), Positives = 148/295 (50%), Gaps = 34/295 (11%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +D E  +VIG G+  VVQ           A+K I +   +    ++++E  I   SQC H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE--IQAMSQCHH 72

Query: 127 --VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV--------KTILEPYLAVVCKQVLQ 176
             +V  Y SF     + LV++ +  GS+ DII+ +          + E  +A + ++VL+
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-----QRDTFVGTYN 231
           GL YLH     IHRD+K  N+L+   G V+I DFGVSA L +         R TFVGT  
Sbjct: 133 GLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 232 YMSPERIS-GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
           +M+PE +     YD+ +DIWS G+  +E A G  PY +       P   ++L   +++ P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-----PM--KVLMLTLQNDP 244

Query: 291 PT--------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
           P+            ++   F   +S C+QKDP  R ++ +LL H F +K ++K+ 
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  246 bits (631), Expect = 5e-80
 Identities = 79/327 (24%), Positives = 132/327 (40%), Gaps = 23/327 (7%)

Query: 13  SVPVQETPITSFLTASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEF--SLEDLE 70
           S  V      S  + + T+  G   L + G      E        K  D+E+   +  + 
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 71  TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVC 130
               +G+GS G V  ++ K  G   A+K +       +    V+EL          +V  
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPL 115

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHR 190
           Y +      +++ +E ++ GSL  +I+Q+  + E        Q L+GL YLH  R ++H 
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH-TRRILHG 174

Query: 191 DIKPSNLLVNHKG-EVKITDFGVSAML-----GSSMGQRDTFVGTYNYMSPERISGSTYD 244
           D+K  N+L++  G    + DFG +  L     G S+   D   GT  +M+PE + G   D
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP-PDQFSPEFC 303
              DIWS   ++L    G  P+         P        I   PPP    P   +P   
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWT---QYFRGPLCL----KIASEPPPIREIPPSCAPLTA 287

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIK 330
             +   ++K+P  R+S+++L       
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKA 314

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  244 bits (624), Expect = 7e-79
 Identities = 82/268 (30%), Positives = 132/268 (49%), Gaps = 19/268 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHV 127
             ++ IG GS G V   R      + A+K +  + +   E  + I++E++  Q  +  + 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERH 186
           +     +       LV+EY   GS +D++   K  L E  +A V    LQGL YLH+  +
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-N 174

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG---STY 243
           +IHRD+K  N+L++  G VK+ DFG +++    M   ++FVGT  +M+PE I       Y
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAMDEGQY 230

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
           D   D+WSLG+  +E A  + P                L  I ++  P      +S  F 
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMN-----A--MSALYHIAQNESPALQSGHWSEYFR 283

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           +FV +C+QK P+DR +S  LL H F+ +
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  241 bits (617), Expect = 2e-78
 Identities = 85/295 (28%), Positives = 141/295 (47%), Gaps = 18/295 (6%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR 109
            E    +    ++++  ++     V+GKG+ G+V   R        A+K I         
Sbjct: 5   TEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS- 63

Query: 110 KQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK---TILE 164
           + + +E+ +       H  +V    SF  NG I + +E +  GSL+ ++R         E
Sbjct: 64  QPLHEEIAL--HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE 121

Query: 165 PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQR 223
             +    KQ+L+GL YLH +  ++HRDIK  N+L+N + G +KI+DFG S  L       
Sbjct: 122 QTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180

Query: 224 DTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL 281
           +TF GT  YM+PE I      Y  ++DIWSLG  ++E A G+ P+   E  +   + +++
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAMFKV 238

Query: 282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
              + +  P    P+  S E  +F+  C + DP  R+ + DLL   F+K    K 
Sbjct: 239 --GMFKVHPEI--PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  238 bits (609), Expect = 5e-77
 Identities = 76/317 (23%), Positives = 133/317 (41%), Gaps = 19/317 (5%)

Query: 20  PITSFLTASGTFHDGDLLLNQKGLRLISEENESRPS-DYKEFDFE-FSLEDLETIKVIGK 77
                L     +      L  + +    E +E+  S  Y     E F  +  + +  +G 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 78  GSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFY 135
           GS G V  VR K  GRL+A+K         + R + + E+  ++   Q    V    ++ 
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 136 HNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIKP 194
             G++ L  E     SL          L E  +    +  L  L +LH  + ++H D+KP
Sbjct: 128 EGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKP 185

Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           +N+ +  +G  K+ DFG+   L  + G  +   G   YM+PE + GS Y  ++D++SLGL
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGL 243

Query: 255 VVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDP 314
            +LE A               P   E  + + +   P       S E  S +   ++ DP
Sbjct: 244 TILEVACNMEL----------PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293

Query: 315 RDRSSSLDLLSHPFIKK 331
           + R+++  LL+ P +++
Sbjct: 294 KLRATAEALLALPVLRQ 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  231 bits (592), Expect = 6e-75
 Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 23/279 (8%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQC 124
            ED E +  IG GS G  Q +R K  G++   K +   ++ E  ++ +V E+ +    + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL--LREL 62

Query: 125 SH--VVVCYHSFYH--NGVISLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQ 176
            H  +V  Y       N  + +V+EY + G LA +I +       + E ++  V  Q+  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 177 GLVYLHNER----HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
            L   H        V+HRD+KP+N+ ++ K  VK+ DFG++ +L        TFVGT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           MSPE+++  +Y+  SDIWSLG ++ E      P+       +  S  EL   I E     
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-------TAFSQKELAGKIREGKFR- 234

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             P ++S E    ++  +      R S  ++L +P I +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  231 bits (591), Expect = 1e-74
 Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 44/297 (14%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQC 124
             +   ++ IG G  G V     +  G ++A+K  +         +  ++E+    A   
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA-HAVLG 68

Query: 125 SHV-VVCYH-SFYHNGVISLVLEYMDRGSLADIIRQVKTIL----EPYLAVVCKQVLQGL 178
            H  VV Y  ++  +  + +  EY + GSLAD I +   I+    E  L  +  QV +GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGE-------------------VKITDFGVSAMLGSS 219
            Y+H    ++H DIKPSN+ ++                        KI D G    + S 
Sbjct: 129 RYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS- 186

Query: 220 MGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF 278
                   G   +++ E +  + T+   +DI++L L V+  A               P  
Sbjct: 187 ---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----------PLPRN 233

Query: 279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
            +    I +   P  P    S EF   +   I  DP  R S++ L+ H  +     K
Sbjct: 234 GDQWHEIRQGRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  230 bits (588), Expect = 3e-74
 Identities = 64/286 (22%), Positives = 128/286 (44%), Gaps = 42/286 (14%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
             D + I++IG G  G V   +H+  G+ + +K ++ N      ++  +E+K    ++  
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKA--LAKLD 62

Query: 126 H--VVVCYHSF----------------YHNGVISLVLEYMDRGSLADII--RQVKTILEP 165
           H  +V     +                     + + +E+ D+G+L   I  R+ + + + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
               + +Q+ +G+ Y+H  + +I+RD+KPSN+ +    +VKI DFG+   L  + G+R  
Sbjct: 123 LALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR 180

Query: 226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI 285
             GT  YMSPE+IS   Y    D+++LGL++ E         ++          +    +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTDL 231

Query: 286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +        D F  +  + +   + K P DR ++ ++L    + K
Sbjct: 232 RDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  230 bits (588), Expect = 5e-73
 Identities = 72/326 (22%), Positives = 128/326 (39%), Gaps = 56/326 (17%)

Query: 67  EDLETIKVIGKGSG--GVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQ 123
              E + VIGKG      V L R+K  G    ++ I +     E+   +  E  ++ +  
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE--LHVSKL 82

Query: 124 CSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLV 179
            +H  +V    +F  +  + +V  +M  GS  D+I       + E  +A + + VL+ L 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-------FVGTYNY 232
           Y+H+    +HR +K S++L++  G+V ++    +  + S   ++          V    +
Sbjct: 143 YIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 233 MSPERI--SGSTYDYSSDIWSLGLVVLECAIGRFPY-----MQ----------------- 268
           +SPE +  +   YD  SDI+S+G+   E A G  P+      Q                 
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 269 ---------------SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD 313
                          +    S               P       FSP F  FV  C+Q++
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 314 PRDRSSSLDLLSHPFIKKFEDKDIDL 339
           P  R S+  LL+H F K+ + +  + 
Sbjct: 322 PDARPSASTLLNHSFFKQIKRRASEA 347

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  223 bits (570), Expect = 2e-71
 Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 21/296 (7%)

Query: 48  EENESRPSDYKEFDFEFSLED-----LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM 102
           EE   +  D +E + +          L+    IG+GS   V            A   +Q 
Sbjct: 2   EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61

Query: 103 -NIQEEIRKQIVQELKINQASQCSHVVVCYHSFY----HNGVISLVLEYMDRGSLADIIR 157
             + +  R++  +E ++ +  Q  ++V  Y S+         I LV E M  G+L   ++
Sbjct: 62  RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121

Query: 158 QVKTILEPYLAVVCKQVLQGLVYLH-NERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAM 215
           + K +    L   C+Q+L+GL +LH     +IHRD+K  N+ +    G VKI D G++ +
Sbjct: 122 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

Query: 216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW 275
             +S       +GT  +M+PE      YD S D+++ G+ +LE A   +PY + ++    
Sbjct: 182 KRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ- 237

Query: 276 PSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                +   +     P +      PE    +  CI+++  +R S  DLL+H F ++
Sbjct: 238 -----IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  221 bits (565), Expect = 1e-70
 Identities = 66/297 (22%), Positives = 128/297 (43%), Gaps = 42/297 (14%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           L D E I+ +G+G  GVV   ++K     +A+K I++  +E  R+++++E+K    ++  
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA--LAKLE 61

Query: 126 H--VVVCYHSFYHNGVIS------------LVLEYMDRGSLADIIRQVKTILEPYLAVVC 171
           H  +V  ++++                   + ++   + +L D +    TI E   +V  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 172 K---QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-------- 220
               Q+ + + +LH  + ++HRD+KPSN+       VK+ DFG+   +            
Sbjct: 122 HIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 221 ----GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP 276
                +    VGT  YMSPE+I G++Y +  DI+SLGL++ E        M+        
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER------- 233

Query: 277 SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE 333
                L  +     P     Q  P     V   +   P +R  +++++ +   +  +
Sbjct: 234 --VRTLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  217 bits (555), Expect = 7e-69
 Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 26/278 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKI--NQASQCSH 126
             +K IG G    V  V ++   +++A+K + +     +       E+            
Sbjct: 31  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           ++  Y     +  I +V+E  +   L   +++ K+I         K +L+ +  +H    
Sbjct: 90  IIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG- 147

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGST-- 242
           ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT NYM PE I   +  
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 243 ---------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
                        SD+WSLG ++     G+ P+ Q  +Q         L AI++      
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIE 260

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            PD    +    +  C+++DP+ R S  +LL+HP+++ 
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  215 bits (550), Expect = 3e-68
 Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 47/299 (15%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
             D E I V+G+G+ G V   R+    R +A+K I+    EE    I+ E+ +   +  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVML--LASLN 60

Query: 126 H--VVVCYHSFYHNGVIS-------------LVLEYMDRGSLADIIRQVKTIL-EPYLAV 169
           H  VV  Y ++                    + +EY + G+L D+I              
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 170 VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--------- 220
           + +Q+L+ L Y+H  + +IHRD+KP N+ ++    VKI DFG++  +  S+         
Sbjct: 121 LFRQILEALSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 221 -----GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
                    + +GT  Y++ E + G+  Y+   D++SLG++  E        M       
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM------- 232

Query: 275 WPSFYELLEAIVESP--PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                 +L+ +       P    D         +   I  DP  R  +  LL+  ++  
Sbjct: 233 --ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  216 bits (551), Expect = 6e-68
 Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 26/278 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKI--NQASQCSH 126
             +K IG G    V  V ++   +++A+K + +     +       E+            
Sbjct: 12  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           ++  Y     +  I +V+E  +   L   +++ K+I         K +L+ +  +H    
Sbjct: 71  IIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG- 128

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGST-- 242
           ++H D+KP+N L+   G +K+ DFG++  +   ++   +D+ VGT NYM PE I   +  
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 243 ---------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
                        SD+WSLG ++     G+ P+ Q  +Q         L AI++      
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIE 241

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            PD    +    +  C+++DP+ R S  +LL+HP+++ 
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  215 bits (548), Expect = 7e-67
 Identities = 63/302 (20%), Positives = 128/302 (42%), Gaps = 26/302 (8%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NI 104
           +  +++ + S                +K IG G    V  V ++   +++A+K + +   
Sbjct: 35  LGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 93

Query: 105 QEEIRKQIVQELKI--NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI 162
             +       E+            ++  Y     +  I +V+E  +   L   +++ K+I
Sbjct: 94  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI 152

Query: 163 LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSM 220
                    K +L+ +  +H +  ++H D+KP+N L+   G +K+ DFG++  +   ++ 
Sbjct: 153 DPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTS 210

Query: 221 GQRDTFVGTYNYMSPERISGST-----------YDYSSDIWSLGLVVLECAIGRFPYMQS 269
             +D+ VG  NYM PE I   +               SD+WSLG ++     G+ P+   
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--- 267

Query: 270 EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
              Q   +    L AI++       PD    +    +  C+++DP+ R S  +LL+HP++
Sbjct: 268 ---QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

Query: 330 KK 331
           + 
Sbjct: 325 QI 326

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  199 bits (509), Expect = 2e-62
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 14/271 (5%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQ 120
           +++LED E  + +GKG  G V L R K    + ALK++      +  +  Q+ +E++I  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
             +  +++  Y  F+    + L+LEY   G++   ++++    E   A    ++   L Y
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
            H  + VIHRDIKP NLL+   GE+KI DFG S    SS  +R    GT +Y+ PE I G
Sbjct: 125 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEG 181

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
             +D   D+WSLG++  E  +G+ P+ ++   Q      E  + I         PD  + 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQ------ETYKRISRVEFTF--PDFVTE 232

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                +S  ++ +P  R    ++L HP+I  
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  191 bits (488), Expect = 4e-59
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 14/275 (5%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQ 120
           +F+++D +  + +GKG  G V L R K    + ALK++  +   +E +  Q+ +E++I  
Sbjct: 10  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
             +  +++  Y+ F+    I L+LE+  RG L   +++     E   A   +++   L Y
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 129

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
            H ER VIHRDIKP NLL+ +KGE+KI DFG S    S   +R T  GT +Y+ PE I G
Sbjct: 130 CH-ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEG 186

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
            T+D   D+W  G++  E  +G  P+   +      S  E    IV        P   S 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPF---DSP----SHTETHRRIVNVDLKF--PPFLSD 237

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
                +S  ++  P  R     ++ HP++K    +
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  191 bits (488), Expect = 5e-59
 Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 12/269 (4%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQAS 122
           S       + +GKG       +       +FA KI+   + ++   R+++  E+ I+++ 
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              HVV  +  F  N  + +VLE   R SL ++ ++ K + EP      +Q++ G  YLH
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
               VIHRD+K  NL +N   EVKI DFG++  +     ++    GT NY++PE +S   
Sbjct: 133 R-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           + +  D+WS+G ++    +G+ P+ ++   +      E    I ++      P   +P  
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF-ETSCLK------ETYLRIKKNEYSI--PKHINPVA 242

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            S +   +Q DP  R +  +LL+  F   
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTS 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  191 bits (487), Expect = 2e-58
 Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 12/269 (4%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQAS 122
           S       + +GKG       +       +FA KI+   + ++   R+++  E+ I+++ 
Sbjct: 39  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
              HVV  +  F  N  + +VLE   R SL ++ ++ K + EP      +Q++ G  YLH
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
               VIHRD+K  NL +N   EVKI DFG++  +     ++    GT NY++PE +S   
Sbjct: 159 R-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           + +  D+WS+G ++    +G+ P+ ++   +      E    I ++      P   +P  
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF-ETSCLK------ETYLRIKKNEYSI--PKHINPVA 268

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            S +   +Q DP  R +  +LL+  F   
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFTS 297

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  189 bits (483), Expect = 1e-57
 Identities = 67/332 (20%), Positives = 123/332 (37%), Gaps = 45/332 (13%)

Query: 45  LISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII---- 100
           ++S  +     +    + +  + D   I+ + +G    + L       + +ALK      
Sbjct: 9   ILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSL 66

Query: 101 ------------QMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEY 146
                            +        EL+I   +   +   + C     +   + ++ EY
Sbjct: 67  LEKKRDFTKSNNDKISIKSKYDDFKNELQI--ITDIKNEYCLTCEGIITNYDEVYIIYEY 124

Query: 147 MDRGSLADIIR--------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL 198
           M+  S+                 I    +  + K VL    Y+HNE+++ HRD+KPSN+L
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184

Query: 199 VNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVV 256
           ++  G VK++DFG S  +     +     GTY +M PE  S   S      DIWSLG+ +
Sbjct: 185 MDKNGRVKLSDFGESEYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

Query: 257 LECAIGRFPYMQSEDQQ-----------SWPSFYELLEAIVESPPPTAPPDQFSPEFCSF 305
                   P+                   +P         + +   T   +  S E   F
Sbjct: 243 YVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
           +   ++K+P +R +S D L H ++     +D+
Sbjct: 303 LKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  187 bits (477), Expect = 1e-57
 Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 18/283 (6%)

Query: 52  SRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIR 109
           S  +   E      +ED +   ++GKGS   V        G   A+K+I      +  + 
Sbjct: 1   SLATCIGE-----KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV 55

Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR-QVKTILEPYLA 168
           +++  E+KI+   +   ++  Y+ F  +  + LVLE    G +   ++ +VK   E    
Sbjct: 56  QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115

Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG 228
               Q++ G++YLH    ++HRD+  SNLL+     +KI DFG++  L     +  T  G
Sbjct: 116 HFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174

Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           T NY+SPE  + S +   SD+WSLG +     IGR P+  ++  +        L  +V +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVK------NTLNKVVLA 227

Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                 P   S E    +   ++++P DR S   +L HPF+ +
Sbjct: 228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  185 bits (472), Expect = 2e-56
 Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 28/291 (9%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
                 +    I+ +G+G    V LV     G  +ALK I  + +++ R++  +E  +++
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHR 81

Query: 121 ASQCSHVVVCYHSFY----HNGVISLVLEYMDRGSLADIIRQVKT----ILEPYLAVVCK 172
                +++                 L+L +  RG+L + I ++K     + E  +  +  
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD-------- 224
            + +GL  +H  +   HRD+KP+N+L+  +G+  + D G        +            
Sbjct: 142 GICRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 225 -TFVGTYNYMSPERISGSTY---DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE 280
                T +Y +PE  S  ++   D  +D+WSLG V+     G  PY    D        +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----DMVFQKG--D 254

Query: 281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +   V++        + S      +++ +  DP  R     LLS     +
Sbjct: 255 SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  188 bits (479), Expect = 2e-56
 Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 34/311 (10%)

Query: 40  QKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKI 99
                L  ++ +   S        F  +      V+G G+ G + + R  +  R  A+K 
Sbjct: 2   GSSPSLEQDDGDEETSVVIVGKISFCPK-----DVLGHGAEGTI-VYRGMFDNRDVAVKR 55

Query: 100 IQMNIQEEIRK--QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIR 157
           I         +  Q+++E       +  +V+  + +        + +E     +L + + 
Sbjct: 56  ILPECFSFADREVQLLRES-----DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE 109

Query: 158 Q-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-----VKITDFG 211
           Q     L      + +Q   GL +LH   +++HRD+KP N+L++           I+DFG
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168

Query: 212 VSAMLG---SSMGQRDTFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLEC-AIGRF 264
           +   L     S  +R    GT  +++PE +S        Y+ DI+S G V     + G  
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

Query: 265 PYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
           P+ +S  +Q       LL A   S     P           +   I  DP+ R S+  +L
Sbjct: 229 PFGKSLQRQ----ANILLGAC--SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282

Query: 325 SHPFIKKFEDK 335
            HPF    E +
Sbjct: 283 KHPFFWSLEKQ 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  176 bits (448), Expect = 8e-53
 Identities = 49/303 (16%), Positives = 107/303 (35%), Gaps = 27/303 (8%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI- 104
           +     +R    +E      LE    ++          +  + +        +     + 
Sbjct: 41  LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS 100

Query: 105 QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE 164
                     +++        + V           + + ++   + +L D + +  ++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 165 PYLAVV---CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
               V      Q+ + + +LH+ + ++HRD+KPSN+       VK+ DFG+   +     
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219

Query: 222 QRDTF------------VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS 269
           ++               VGT  YMSPE+I G+ Y +  DI+SLGL++ E        M+ 
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME- 278

Query: 270 EDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
                      ++  +     P     Q  P+    V   +   P +R  + D++ +   
Sbjct: 279 --------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

Query: 330 KKF 332
           +  
Sbjct: 330 ENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 18/72 (25%), Positives = 40/72 (55%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           L D E I+ +G+G  GVV   ++K     +A+K I++  +E  R+++++E+K     +  
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 126 HVVVCYHSFYHN 137
            +V  ++++   
Sbjct: 65  GIVRYFNAWLET 76

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  172 bits (437), Expect = 9e-51
 Identities = 42/304 (13%), Positives = 85/304 (27%), Gaps = 42/304 (13%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN----------IQEEIRKQ------ 111
            L+ ++ +  G   VV LVR       FALK+  M           + E           
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 112 ----------IVQELKINQASQCSHVVVCYHSFYHNGVIS--LVLEYMDRGSLADIIRQV 159
                     ++                         V +  L++       L  +   +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181

Query: 160 KTILE-----PYLAV--VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
             +         LA+  +  Q+++    L   + ++H    P NL +   G + + D   
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 213 SAMLGSSMGQRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSE 270
              +G+             Y   E ++ ST  + ++ + W LGL +        P+    
Sbjct: 241 LWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
                      L                     + +   +  D R R   L+ +  P   
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 331 KFED 334
           + ++
Sbjct: 358 QLQN 361

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  171 bits (436), Expect = 6e-50
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 47/310 (15%)

Query: 61  DFEFSLEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN 119
           +FE SL++L    K++G GS G V   +  + GR  A+K + ++  +        E+K+ 
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIAL----MEIKLL 62

Query: 120 QAS-QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ-------VKTILEPYLAVVC 171
             S    +V+  Y S   +  + + LE  +  +L D++         +K   E     + 
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-------------VKITDFGVSAMLG- 217
           +Q+  G+ +LH    +IHRD+KP N+LV+                 + I+DFG+   L  
Sbjct: 122 RQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 218 ---SSMGQRDTFVGTYNYMSPERISGST-------YDYSSDIWSLGLVVLEC-AIGRFPY 266
              S     +   GT  + +PE +  S           S DI+S+G V     + G+ P+
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 267 MQSEDQQSWPSFYELLEAIVE-SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                ++S      ++  I                E    +S  I  DP  R +++ +L 
Sbjct: 241 GDKYSRES-----NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

Query: 326 HPFIKKFEDK 335
           HP       K
Sbjct: 296 HPLFWPKSKK 305

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  168 bits (428), Expect = 3e-49
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 27/290 (9%)

Query: 59  EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQEL 116
           + + + + +  E ++ IGKGS G V +V+     +++A+K +  Q  ++    + + +EL
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 117 KINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCK 172
           +I Q  +   +V  ++SF     + +V++ +  G L   ++Q     E     ++     
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC---- 122

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
           +++  L YL   + +IHRD+KP N+L++  G V ITDF ++AML        T  GT  Y
Sbjct: 123 ELVMALDYLQ-NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMAGTKPY 180

Query: 233 MSPE---RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP 289
           M+PE      G+ Y ++ D WSLG+   E   GR PY       S     E++     + 
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KEIVHTFETTV 236

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL-DLLSHPFIKKFEDKDID 338
                P  +S E  S +   ++ +P  R S L D+ + P+       DI+
Sbjct: 237 VTY--PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY---M--NDIN 279

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  165 bits (419), Expect = 2e-48
 Identities = 65/270 (24%), Positives = 123/270 (45%), Gaps = 21/270 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII----QMNIQEEIRKQIVQELKINQASQCSHVV 128
           K +G+GS  + +   HK   + FA+KII    + N Q+EI    ++           ++V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI--TALKLC-----EGHPNIV 69

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             +  F+      LV+E ++ G L + I++ K   E   + + ++++  + ++H +  V+
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVV 128

Query: 189 HRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           HRD+KP NLL   + +   +KI DFG + +         T   T +Y +PE ++ + YD 
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188

Query: 246 SSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPE 301
           S D+WSLG  L  +    G+ P+   +   +  S  E+++ I +             S E
Sbjct: 189 SCDLWSLGVILYTMLS--GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
               +   +  DP  R     L  + +++ 
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  163 bits (414), Expect = 6e-48
 Identities = 77/286 (26%), Positives = 134/286 (46%), Gaps = 42/286 (14%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA-- 121
              ED +  K++G+GS   V L R     R +A+KI++       ++ I++E K+     
Sbjct: 27  KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTR 79

Query: 122 -----SQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVV 170
                S+  H   V  Y +F  +  +   L Y   G L   IR++ +  E     Y A  
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-- 137

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS--AMLGSSMGQRDTFVG 228
             +++  L YLH  + +IHRD+KP N+L+N    ++ITDFG +      S   + ++FVG
Sbjct: 138 --EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES 288
           T  Y+SPE ++  +   SSD+W+LG ++ +   G  P+ ++ ++      Y + + I++ 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNE------YLIFQKIIKL 247

Query: 289 PPPTAPPDQFSPEFCSFVSACIQKDPRDR------SSSLDLLSHPF 328
                 P++F P+    V   +  D   R           L +HPF
Sbjct: 248 EYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 4e-47
 Identities = 52/295 (17%), Positives = 105/295 (35%), Gaps = 39/295 (13%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
               ++G+G+   V   RHK  G LFA+K+             ++E ++ +     ++V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 130 CYHSF--YHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVVCKQVLQGLVYLHNE 184
            +            L++E+   GSL  ++ +        E    +V + V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-E 130

Query: 185 RHVIHRDIKPSNLLV----NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
             ++HR+IKP N++     + +   K+TDFG +  L     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 241 ST--------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE------------ 280
           +         Y  + D+WS+G+     A G  P+   E  +                   
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 281 --------LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP 327
                    ++   + P   +            ++  ++ D           +  
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  162 bits (411), Expect = 3e-46
 Identities = 84/315 (26%), Positives = 151/315 (47%), Gaps = 30/315 (9%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNI 104
           +   E       +     ++ + E +K++GKG+ G V LV+ K  GR +A+KI++  + +
Sbjct: 128 NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV 187

Query: 105 QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE 164
            ++     + E ++ Q S+   +    +SF  +  +  V+EY + G L   + + +   E
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 247

Query: 165 P----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
                Y A    +++  L YLH+E++V++RD+K  NL+++  G +KITDFG+        
Sbjct: 248 DRARFYGA----EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303

Query: 221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE 280
               TF GT  Y++PE +  + Y  + D W LG+V+ E   GR P+  ++D +      +
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE------K 356

Query: 281 LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDK 335
           L E I+        P    PE  S +S  ++KDP+ R       + +++ H F   F   
Sbjct: 357 LFELILMEEIRF--PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF---F--A 409

Query: 336 DID-LGILVGSLDPP 349
            I    +    L PP
Sbjct: 410 GIVWQHVYEKKLSPP 424

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  159 bits (405), Expect = 4e-46
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 26/274 (9%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIV-QELKINQASQCSHVV 128
           +VIGKG   VV+   ++  G+ FA+KI+   +      +  + + +E  I    +  H+V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYL----AVVCKQVLQGLVYLHNE 184
               ++  +G++ +V E+MD   L   I +       Y     +   +Q+L+ L Y H +
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-D 148

Query: 185 RHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
            ++IHRD+KP  +L+  K     VK+  FGV+  LG S       VGT ++M+PE +   
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208

Query: 242 TYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQ 297
            Y    D+W  G  L +L    G  P+  +++         L E I++      P     
Sbjct: 209 PYGKPVDVWGCGVILFILLS--GCLPFYGTKE--------RLFEGIIKGKYKMNPRQWSH 258

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            S      V   +  DP +R +  + L+HP++K+
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (398), Expect = 7e-46
 Identities = 68/294 (23%), Positives = 135/294 (45%), Gaps = 23/294 (7%)

Query: 53  RPSDYKEFDFEFSLEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRK 110
             S  +   F+ +  +   I  ++GKGS G V   + +   + +A+K+I   + + +   
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 111 QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV 170
            I++E+++ +     +++  +     +    +V E    G L D I + K   E   A +
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTF 226
            KQV  G+ Y+H + +++HRD+KP N+L+  K +   +KI DFG+S         +    
Sbjct: 127 IKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDR 183

Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEA 284
           +GT  Y++PE + G+ YD   D+WS G  L +L    G  P+   +++       ++L+ 
Sbjct: 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS--GTPPF-YGKNEY------DILKR 233

Query: 285 IVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           +               S +    +   +   P  R ++   L HP+I+K+  ++
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  158 bits (402), Expect = 8e-46
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 31/276 (11%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSHVVV 129
           + IG GS  V +   HK     FA+KII   + +  EEI  +I+      +  Q  +++ 
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EILL-----RYGQHPNIIT 80

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
               +     + +V E M  G L D I + K   E   + V   + + + YLH  + V+H
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH-AQGVVH 139

Query: 190 RDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           RD+KPSN+L   +      ++I DFG +  L +  G   T   T N+++PE +    YD 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDA 199

Query: 246 SSDIWSLG--LVVLECAIGRFP-YMQSEDQQSWPSFYELLEAIVES----PPPTAPPDQF 298
           + DIWSLG  L  +    G  P     +D        E+L  I              +  
Sbjct: 200 ACDIWSLGVLLYTMLT--GYTPFANGPDDTPE-----EILARIGSGKFSLSGG--YWNSV 250

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
           S      VS  +  DP  R ++  +L HP+I  ++ 
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  164 bits (416), Expect = 1e-45
 Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 22/279 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           E  + +G G  G V    H+  G   A+K  +  +  + R++   E++I +     +VV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 130 CY------HSFYHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVVCKQVLQGLVY 180
                        N +  L +EY + G L   + Q +      E  +  +   +   L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 181 LHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           LH E  +IHRD+KP N+++    +    KI D G +  L         FVGT  Y++PE 
Sbjct: 137 LH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPEL 194

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
           +    Y  + D WS G +  EC  G  P++                  V           
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLP-------NWQPVQWHGKVREKSNEHIVVY 247

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
                 +   + +   P   S  L      +++      
Sbjct: 248 DDLT-GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  156 bits (397), Expect = 2e-45
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 24/281 (8%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII-QMNIQ 105
           + EN          D +    DL   + IG GS G V   R +W G   A+KI+ + +  
Sbjct: 17  TTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFH 74

Query: 106 EEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIR--QVKT 161
            E   + ++E+ I    +  H  +V+   +      +S+V EY+ RGSL  ++     + 
Sbjct: 75  AERVNEFLREVAI--MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132

Query: 162 ILEPYLAV-VCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
            L+    + +   V +G+ YLHN    ++HR++K  NLLV+ K  VK+ DFG+S +  S+
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192

Query: 220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY 279
                +  GT  +M+PE +     +  SD++S G+++ E A  + P+          +  
Sbjct: 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-------GNLNPA 245

Query: 280 ELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           +++ A+            P   +P+  + +  C   +P  R
Sbjct: 246 QVVAAVGFKCKRLE---IPRNLNPQVAAIIEGCWTNEPWKR 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  156 bits (397), Expect = 2e-45
 Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 34/268 (12%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA 121
                +++E  +V+G+G+ GVV   + KW  +  A+K I+    E  RK  + EL+    
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVC--KAKWRAKDVAIKQIE---SESERKAFIVELRQ--L 55

Query: 122 SQCSH--VV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI--LEPYLAV-VCK 172
           S+ +H  +V     C +         LV+EY + GSL +++   + +       A+  C 
Sbjct: 56  SRVNHPNIVKLYGACLNPVC------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 173 QVLQGLVYLHNE--RHVIHRDIKPSNLLVNHKGEV-KITDFGVSAMLGSSMGQRDTFVGT 229
           Q  QG+ YLH+   + +IHRD+KP NLL+   G V KI DFG +  + + M       G+
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGS 166

Query: 230 YNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP 289
             +M+PE   GS Y    D++S G+++ E    R P+   ++       + ++ A+    
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF---DEIGGPA--FRIMWAVHNGT 221

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            P    +       S ++ C  KDP  R
Sbjct: 222 RPPLIKN-LPKPIESLMTRCWSKDPSQR 248

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  156 bits (397), Expect = 2e-45
 Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 31/274 (11%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
            F   DL   +V+GKG  G    V H+  G +  +K + +   EE ++  ++E+K+    
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKV--MR 62

Query: 123 QCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLV 179
              H  V+      Y +  ++ + EY+  G+L  II+ + +       V   K +  G+ 
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS--------------AMLGSSMGQRDT 225
           YLH   ++IHRD+   N LV     V + DFG++              ++      +R T
Sbjct: 123 YLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLE 283
            VG   +M+PE I+G +YD   D++S G+V+ E        P          P   +   
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL-------PRTMDFGL 234

Query: 284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            +        PP+   P F      C   DP  R
Sbjct: 235 NVRGFLDRYCPPN-CPPSFFPITVRCCDLDPEKR 267

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  158 bits (401), Expect = 4e-45
 Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 22/284 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
               ++G+G+   V   RHK  G LFA+K+             ++E ++ +     ++V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 130 CYHSF--YHNGVISLVLEYMDRGSLADIIRQVKTIL---EPYLAVVCKQVLQGLVYLHNE 184
            +            L++E+   GSL  ++ +        E    +V + V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-E 130

Query: 185 RHVIHRDIKPSNLLV----NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
             ++HR+IKP N++     + +   K+TDFG +  L     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 241 ST--------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           +         Y  + D+WS+G+     A G  P+      +      E++  I+   P  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF---RPFEGPRRNKEVMYKIITGKPSG 246

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           A       E      +         S  L +L  P +    + D
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  155 bits (393), Expect = 5e-45
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 23/285 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           + +GKG+  VV+   HK  G  FA KII    +     +++ +E +I +  Q  ++V  +
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
            S        LV + +  G L + I   +   E   +   +Q+L+ + Y H    ++HR+
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRN 130

Query: 192 IKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS 247
           +KP NLL+  K +   VK+ DFG++  +     +    F GT  Y+SPE +    Y    
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPV 188

Query: 248 DIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFC 303
           DIW+ G  L +L    G  P+   EDQ        L   I       P+   D  +PE  
Sbjct: 189 DIWACGVILYILLV--GYPPF-WDEDQH------RLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKKFE--DKDIDLGILVGSL 346
           S + + +  +P+ R ++   L  P+I   E     I     V  L
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 284

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  159 bits (404), Expect = 8e-45
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 21/278 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHV 127
           +  +V+GKGS G V L + K  G+  A+K+I      Q+  ++ +++E+++ +     ++
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  Y  F   G   LV E    G L D I   K   E   A + +QVL G+ Y+H +  +
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-KNKI 147

Query: 188 IHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
           +HRD+KP NLL+  K +   ++I DFG+S    +S  +    +GT  Y++PE + G+ YD
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT-YD 205

Query: 245 YSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSP 300
              D+WS G  L +L    G  P+  + +        ++L+ + +           + S 
Sbjct: 206 EKCDVWSTGVILYILLS--GCPPFNGANEY-------DILKKVEKGKYTFELPQWKKVSE 256

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
                +   +   P  R S+ D L H +I+ +  + I 
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  155 bits (394), Expect = 1e-44
 Identities = 86/287 (29%), Positives = 146/287 (50%), Gaps = 32/287 (11%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKINQA 121
            ++ D + +K++GKG+ G V LVR K  GR +A+KI++  + I ++     V E ++ Q 
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQG 177
           ++   +    ++F  +  +  V+EY + G L   + + +   E     Y A    +++  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSA 117

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPE 236
           L YLH  R V++RDIK  NL+++  G +KITDFG+    G S G    TF GT  Y++PE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE 175

Query: 237 RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
            +  + Y  + D W LG+V+ E   GR P+  ++D +       L E I+        P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE------RLFELILMEEIRF--PR 226

Query: 297 QFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
             SPE  S ++  ++KDP+ R     S + +++ H F   F    I+
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF---F--LSIN 268

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  154 bits (391), Expect = 1e-44
 Identities = 74/308 (24%), Positives = 142/308 (46%), Gaps = 35/308 (11%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--------Q 101
           + + P  +    F    E+ E  +++G+G   VV+   HK   + +A+KII         
Sbjct: 3   DAALPGSHSTHGFY---ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59

Query: 102 MNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK 160
               +E+R+  ++E+ I  + S   +++    ++  N    LV + M +G L D + +  
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 119

Query: 161 TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
           T+ E     + + +L+ +  LH + +++HRD+KP N+L++    +K+TDFG S  L    
Sbjct: 120 TLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176

Query: 221 GQR-DTFVGTYNYMSPERISGST------YDYSSDIWSLG--LVVLECAIGRFPYMQSED 271
           G++     GT +Y++PE I  S       Y    D+WS G  +  L    G  P+     
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA--GSPPFW-HRK 233

Query: 272 QQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
           Q        +L  I+       +   D +S      VS  +   P+ R ++ + L+HPF 
Sbjct: 234 QM------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

Query: 330 KKFEDKDI 337
           +++  +++
Sbjct: 288 QQYVVEEV 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  156 bits (395), Expect = 2e-44
 Identities = 41/308 (13%), Positives = 93/308 (30%), Gaps = 64/308 (20%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII------QMNIQEEIRKQI-------------- 112
            V+G+           +  G  F + +         N  +++++++              
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 113 -------VQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR--------GSLADIIR 157
                  +    + +  Q   ++          V+S    Y             L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 158 QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG 217
             K+++      +  QV++ L  LH+   ++H  ++P +++++ +G V +T F      G
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 218 SSMGQRDTFVGTYNYMSPERIS-----------GSTYDYSSDIWSLGLVVLECAIGRFPY 266
           +    R     +  +  PE  +            +   +S D W+LGLV+        P 
Sbjct: 258 A----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
            +              E I  S               + +   ++    DR   L  +  
Sbjct: 314 TKDAA-------LGGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 327 PFIKKFED 334
           P  ++   
Sbjct: 361 PEYEQLRT 368

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  155 bits (393), Expect = 2e-44
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 43/305 (14%)

Query: 48  EENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK------IIQ 101
           E N+ RPS   +      +ED    K++GKGS G V L   K   + FA+K      ++ 
Sbjct: 2   ELNKERPSLQIKL----KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM 57

Query: 102 MNIQEEIR--KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQV 159
            +  E     K+++       A +   +   + +F     +  V+EY++ G L   I+  
Sbjct: 58  DDDVECTMVEKRVLS-----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC 112

Query: 160 KTILEP----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
                     Y A    +++ GL +LH  + +++RD+K  N+L++  G +KI DFG+   
Sbjct: 113 HKFDLSRATFYAA----EIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMC-K 166

Query: 216 LGSSMGQR-DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
                  + +TF GT +Y++PE + G  Y++S D WS G+++ E  IG+ P+   +D++ 
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEE- 224

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR-SSSLDLLSHPFIKKFE 333
                EL  +I    P    P     E    +     ++P  R     D+  HP    F 
Sbjct: 225 -----ELFHSIRMDNPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL---F- 273

Query: 334 DKDID 338
            ++I+
Sbjct: 274 -REIN 277

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  155 bits (394), Expect = 2e-44
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 21/268 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRKQIVQELKINQASQCSHVVVCY 131
           + +GKG+  VV+   HK  G  FA KII    +     +++ +E +I +  Q  ++V  +
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
            S        LV + +  G L + I   +   E   +   +Q+L+ + Y H    ++HR+
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRN 153

Query: 192 IKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSS 247
           +KP NLL+  K +   VK+ DFG++  +     +    F GT  Y+SPE +    Y    
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPV 211

Query: 248 DIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFC 303
           DIW+ G  L +L    G +P    EDQ        L   I       P+   D  +PE  
Sbjct: 212 DIWACGVILYILLV--G-YPPFWDEDQH------RLYAQIKAGAYDYPSPEWDTVTPEAK 262

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           S + + +  +P+ R ++   L  P+I  
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICN 290

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  155 bits (393), Expect = 2e-44
 Identities = 81/300 (27%), Positives = 140/300 (46%), Gaps = 36/300 (12%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQ----ELKI 118
              L+  + IK +G GS G V LV+HK  G  +A+KI  ++ Q+ ++ + ++    E +I
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRI 94

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQV 174
            QA     +V    SF  N  + +V+EY+  G +   +R++    EP    Y A    Q+
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA----QI 150

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
           +    YLH    +I+RD+KP NLL++ +G +++TDFG +  +        T  GT   ++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALA 206

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           PE I    Y+ + D W+LG+++ E A G  P+  ++         ++ E IV        
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPI------QIYEKIVSGKV--RF 257

Query: 295 PDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
           P  FS +    +   +Q D   R     +   D+ +H +   F   D    I    ++ P
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW---FATTDWI-AIYQRKVEAP 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  157 bits (400), Expect = 2e-44
 Identities = 67/294 (22%), Positives = 132/294 (44%), Gaps = 23/294 (7%)

Query: 53  RPSDYKEFDFEFSLEDL-ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRK 110
             S  +   F+ +  +    + ++GKGS G V   + +   + +A+K+I   + + +   
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 111 QIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV 170
            I++E+++ +     +++  +     +    +V E    G L D I + K   E   A +
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTF 226
            KQV  G+ Y+H + +++HRD+KP N+L+  K +   +KI DFG+S         +    
Sbjct: 127 IKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDR 183

Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEA 284
           +GT  Y++PE + G+ YD   D+WS G  L +L    G  P+    +        ++L+ 
Sbjct: 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS--GTPPFYGKNEY-------DILKR 233

Query: 285 IVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           +               S +    +   +   P  R ++   L HP+I+K+  + 
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  152 bits (387), Expect = 3e-44
 Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 23/276 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH 132
             IG+GS G V++   K      A K I     E++ +   QE++I ++    +++  Y 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYE 73

Query: 133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDI 192
           +F  N  I LV+E    G L + +   +   E   A + K VL  + Y H + +V HRD+
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH-KLNVAHRDL 132

Query: 193 KPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDYSSD 248
           KP N L         +K+ DFG++A      G+   T VGT  Y+SP+ + G  Y    D
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLEGL-YGPECD 189

Query: 249 IWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCS 304
            WS G  + VL C  G  P+  +          E++  I E     P       SP+  S
Sbjct: 190 EWSAGVMMYVLLC--GYPPF-SAPTDS------EVMLKIREGTFTFPEKDWLNVSPQAES 240

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKKF-EDKDIDL 339
            +   + K P+ R +SL  L H + +K       +L
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  154 bits (391), Expect = 3e-44
 Identities = 64/317 (20%), Positives = 119/317 (37%), Gaps = 62/317 (19%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII----QMNIQEEIRKQIVQELKINQASQCSHVV 128
             IG+GS GVV++        + A+KI+       I  +  ++I  E+++ +     ++ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL------------------------- 163
             Y  +     I LV+E    G L D +                                
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 164 ---------------EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VK 206
                          E  ++ + +Q+   L YLHN + + HRDIKP N L +      +K
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIK 210

Query: 207 ITDFGVSAMLGSSMGQRD----TFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECA 260
           + DFG+S               T  GT  +++PE ++ +   Y    D WS G+++    
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRS 318
           +G  P+    +        + +  ++           +  SP     +S  + ++  +R 
Sbjct: 271 MGAVPFP-GVNDA------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323

Query: 319 SSLDLLSHPFIKKFEDK 335
            ++  L HP+I +F DK
Sbjct: 324 DAMRALQHPWISQFSDK 340

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  157 bits (400), Expect = 3e-44
 Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 20/274 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRKQIVQELKINQASQCSHVV 128
           + +K +G G+ G V L R K      A+KII+  ++      ++++E+ + +     +++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             Y  F       LV+E    G L D I       E   AV+ KQVL G+ YLH + +++
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH-KHNIV 158

Query: 189 HRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           HRD+KP NLL+  K +   +KI DFG+SA+  +   +    +GT  Y++PE +    YD 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRKK-YDE 216

Query: 246 SSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPE 301
             D+WS+G  L +L    G  P+    DQ       E+L  + +      +      S  
Sbjct: 217 KCDVWSIGVILFILLA--GYPPFGGQTDQ-------EILRKVEKGKYTFDSPEWKNVSEG 267

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
               +   +Q D + R S+   L HP+IK+   K
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  153 bits (389), Expect = 4e-44
 Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 28/285 (9%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCY 131
            V+G+G+   VQ   +    + +A+KII+      IR ++ +E+++  Q     +V+   
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
             F       LV E M  GS+   I + +   E   +VV + V   L +LHN + + HRD
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRD 136

Query: 192 IKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRD-------TFVGTYNYMSPE----- 236
           +KP N+L  H  +   VKI DF + + +  +            T  G+  YM+PE     
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196

Query: 237 RISGSTYDYSSDIWSLG--LVVLEC------AIGRFPYMQSEDQQSWPSFYELLEAIVES 288
               S YD   D+WSLG  L +L                    +        L E+I E 
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256

Query: 289 PP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
               P       S      +S  + +D + R S+  +L HP+++ 
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  156 bits (395), Expect = 4e-44
 Identities = 87/340 (25%), Positives = 152/340 (44%), Gaps = 45/340 (13%)

Query: 29  GTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEF-------------SLEDL-ETIKV 74
           GTF + +L+   K  R ++  +E   S  +   F F             +L D     K 
Sbjct: 84  GTFVNTELVGKGKR-RPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKT 142

Query: 75  IGKGSGGVVQLVRHKWVGRLFALKII-------QMNIQEEIRKQIVQELKINQASQCSHV 127
           +G G+ G V+L   +   +  A++II           + +    +  E++I +  + +H 
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK--KLNHP 200

Query: 128 -VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
            ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E  
Sbjct: 201 CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENG 259

Query: 187 VIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST- 242
           +IHRD+KP N+L++ + E   +KITDFG S +LG +   R T  GT  Y++PE +     
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLCGTPTYLAPEVLVSVGT 318

Query: 243 --YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES----PPPTAPPD 296
             Y+ + D WSLG+++  C  G  P+ +   Q        L + I        P      
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPE--VWA 370

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           + S +    V   +  DP+ R ++ + L HP+++  + K 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  153 bits (390), Expect = 5e-44
 Identities = 86/291 (29%), Positives = 148/291 (50%), Gaps = 29/291 (9%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKI-NQ 120
             L+D + ++VIG+GS   V LVR K   R++A+K+++  +   +E    +  E  +  Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
           AS    +V  +  F     +  V+EY++ G L   +++ + + E     Y A    ++  
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EISL 121

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP 235
            L YLH ER +I+RD+K  N+L++ +G +K+TD+G+    G   G    TF GT NY++P
Sbjct: 122 ALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSTFCGTPNYIAP 179

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
           E + G  Y +S D W+LG+++ E   GR  F  + S D     +   L + I+E      
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 238

Query: 294 PPDQFSPEFCSFVSACIQKDPRDR------SSSLDLLSHPFIKKFEDKDID 338
            P   S +  S + + + KDP++R      +   D+  HPF   F  +++D
Sbjct: 239 -PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF---F--RNVD 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  155 bits (395), Expect = 7e-44
 Identities = 67/267 (25%), Positives = 120/267 (44%), Gaps = 18/267 (6%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV-QELKINQASQCSHVVVCY 131
           + +GKG+  VV+       G+ +A  II          Q + +E +I +  +  ++V  +
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 132 HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
            S    G   L+ + +  G L + I   +   E   +   +Q+L+ +++ H +  V+HR+
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRN 135

Query: 192 IKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
           +KP NLL+  K +   VK+ DFG++  +         F GT  Y+SPE +    Y    D
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 195

Query: 249 IWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCS 304
           +W+ G  L +L    G  P+   EDQ        L + I       P+   D  +PE   
Sbjct: 196 LWACGVILYILLV--GYPPFW-DEDQH------RLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
            ++  +  +P  R ++ + L HP+I  
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISH 273

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  159 bits (404), Expect = 8e-44
 Identities = 78/325 (24%), Positives = 146/325 (44%), Gaps = 42/325 (12%)

Query: 46  ISEENESRPSDYK--EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK----- 98
           I  +  +R   +K  E +   ++ D    ++IG+G  G V   R    G+++A+K     
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225

Query: 99  -IIQMNIQEEIR--KQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
            I     +      + ++  +       C  +V   ++F+    +S +L+ M+ G L   
Sbjct: 226 RIKMKQGETLALNERIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282

Query: 156 IRQVKTILEP----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           + Q     E     Y A    +++ GL ++HN   V++RD+KP+N+L++  G V+I+D G
Sbjct: 283 LSQHGVFSEADMRFYAA----EIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLG 337

Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERIS-GSTYDYSSDIWSLGLVVLECAIGRFPYMQSE 270
           ++        +    VGT+ YM+PE +  G  YD S+D +SLG ++ +   G  P+ Q +
Sbjct: 338 LACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLS 325
            +      +E+    +        PD FSPE  S +   +Q+D   R       + ++  
Sbjct: 396 TKDK----HEIDRMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449

Query: 326 HPFIKKFEDKDID-LGILVGSLDPP 349
            PF   F  + +D   + +    PP
Sbjct: 450 SPF---F--RSLDWQMVFLQKYPPP 469

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  153 bits (390), Expect = 9e-44
 Identities = 78/287 (27%), Positives = 132/287 (45%), Gaps = 32/287 (11%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKI-NQ 120
               D   +KVIGKGS G V L RHK     +A+K++Q    ++++  K I+ E  +  +
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
             +   +V  + SF     +  VL+Y++ G L   +++ +  LEP    Y A    ++  
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA----EIAS 150

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP 235
            L YLH   ++++RD+KP N+L++ +G + +TDFG+             TF GT  Y++P
Sbjct: 151 ALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAP 208

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E +    YD + D W LG V+ E   G  P+  S +        E+ + I+  P      
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTA------EMYDNILNKPLQL--K 259

Query: 296 DQFSPEFCSFVSACIQKDPRDR----SSSLDLLSHPFIKKFEDKDID 338
              +      +   +QKD   R       +++ SH F   F    I+
Sbjct: 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF---F--SLIN 301

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  152 bits (386), Expect = 1e-43
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 38/281 (13%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-------QMNIQEEIRKQIVQELKINQASQCS 125
           K +G G+ G V+L   +   +  A+KII           + +    +  E++I +  + +
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK--KLN 73

Query: 126 HV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
           H  ++   +F+      +VLE M+ G L D +   K + E    +   Q+L  + YLH E
Sbjct: 74  HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-E 132

Query: 185 RHVIHRDIKPSNLLVNHKGE---VKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERIS 239
             +IHRD+KP N+L++ + E   +KITDFG S +L   S M    T  GT  Y++PE + 
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLV 189

Query: 240 GST---YDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES----PP 290
                 Y+ + D WSLG  L +     G  P+ +   Q        L + I        P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLS--GYPPFSEHRTQV------SLKDQITSGKYNFIP 241

Query: 291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                 + S +    V   +  DP+ R ++ + L HP+++ 
Sbjct: 242 E--VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  152 bits (385), Expect = 2e-43
 Identities = 77/308 (25%), Positives = 131/308 (42%), Gaps = 37/308 (12%)

Query: 39  NQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK 98
           +  GL ++ +  E +     + D++ S +      V+G G  G V    H+  G+  ALK
Sbjct: 8   HSSGLEVLFQGPEPKKYAVTD-DYQLSKQ------VLGLGVNGKVLECFHRRTGQKCALK 60

Query: 99  IIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSL 152
           ++          +  QE+    QAS   H+V C    Y N         +++E M+ G L
Sbjct: 61  LLYD------SPKARQEVDHHWQASGGPHIV-CILDVYENMHHGKRCLLIIMECMEGGEL 113

Query: 153 ADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKI 207
              I  R  +   E   A + + +   + +LH   ++ HRD+KP NLL   K +   +K+
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKL 172

Query: 208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLG--LVVLECAIGRFP 265
           TDFG +           T   T  Y++PE +    YD S D+WSLG  + +L C  G  P
Sbjct: 173 TDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC--GFPP 228

Query: 266 YMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
           +  S   Q+      +   I       P     + S +    +   ++ DP +R +    
Sbjct: 229 F-YSNTGQA--ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285

Query: 324 LSHPFIKK 331
           ++HP+I +
Sbjct: 286 MNHPWINQ 293

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  150 bits (381), Expect = 2e-43
 Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 14/267 (5%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           + ++ +G+G+ G VQL  ++      A+KI+ M    +  + I +E+ IN+     +VV 
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y       +  L LEY   G L D I     + EP       Q++ G+VYLH    + H
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITH 128

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAM--LGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           RDIKP NLL++ +  +KI+DFG++ +    +     +   GT  Y++PE +    +    
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            D+WS G  L  +    G  P+ Q  D        +      E      P  +      +
Sbjct: 189 VDVWSCGIVLTAMLA--GELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +   + ++P  R +  D+    +  K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  151 bits (383), Expect = 2e-43
 Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 28/282 (9%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVC 130
           +V+G G+   V LV+ +  G+LFALK I+ +        +  E+ + +  +  H  +V  
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLK--KIKHENIVTL 71

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHR 190
              +       LV++ +  G L D I +     E   ++V +QVL  + YLH E  ++HR
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHR 130

Query: 191 DIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSS 247
           D+KP NLL     E   + ITDFG+S M  +  G   T  GT  Y++PE ++   Y  + 
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAV 188

Query: 248 DIWSLGLV--VLECAIGRFPYMQSEDQQSWPSFYELLEAI----VESPPPTAPPDQFSPE 301
           D WS+G++  +L C  G +P    E +       +L E I     E   P    D  S  
Sbjct: 189 DCWSIGVITYILLC--G-YPPFYEETES------KLFEKIKEGYYEFESP--FWDDISES 237

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV 343
              F+   ++KDP +R +    LSHP+I        D+   V
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSV 279

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  152 bits (387), Expect = 2e-43
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 31/278 (11%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-------QMNIQEEIRKQIVQELKI-NQASQC 124
            VIG+G   VV+   H+  G  FA+KI+            EE+R+   +E  I  Q +  
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            H++    S+  +  + LV + M +G L D + +   + E     + + +L+ + +LH  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-A 218

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGST- 242
            +++HRD+KP N+L++   +++++DFG S  L    G++     GT  Y++PE +  S  
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYLAPEILKCSMD 276

Query: 243 -----YDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTA 293
                Y    D+W+ G  L  L    G  P+     Q        +L  I+E      + 
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLA--GSPPFW-HRRQI------LMLRMIMEGQYQFSSP 327

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             D  S      +S  +Q DP  R ++   L HPF ++
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  151 bits (384), Expect = 2e-43
 Identities = 66/277 (23%), Positives = 134/277 (48%), Gaps = 22/277 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
           K +G+G   VV+    K  G+ +A K ++     ++ R +I+ E+ +   A  C  V+  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 131 YHSFYHNGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
           +  + +   I L+LEY   G +  +      + + E  +  + KQ+L+G+ YLH + +++
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIV 153

Query: 189 HRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDY 245
           H D+KP N+L++       +KI DFG+S  +G +   R   +GT  Y++PE ++      
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-EIMGTPEYLAPEILNYDPITT 212

Query: 246 SSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPE 301
           ++D+W++G    +L       P++  ED Q      E    I +             S  
Sbjct: 213 ATDMWNIGIIAYMLLT--HTSPFV-GEDNQ------ETYLNISQVNVDYSEETFSSVSQL 263

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
              F+ + + K+P  R ++   LSH ++++++ +++ 
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  151 bits (384), Expect = 2e-43
 Identities = 77/312 (24%), Positives = 145/312 (46%), Gaps = 37/312 (11%)

Query: 40  QKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFA 96
           +  ++ I+  +  +    K           E +KV+G+GS G V LV+        +L+A
Sbjct: 2   EGSIKEIAITHHVKEGHEK-----ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYA 56

Query: 97  LKIIQ-MNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADI 155
           +K+++   ++   R +   E  I        +V  +++F   G + L+L+++  G L   
Sbjct: 57  MKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR 116

Query: 156 IRQVKTILEP----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           + +     E     YLA    ++   L +LH    +I+RD+KP N+L++ +G +K+TDFG
Sbjct: 117 LSKEVMFTEEDVKFYLA----ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFG 171

Query: 212 VSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
           +S        +  +F GT  YM+PE ++   +  S+D WS G+++ E   G  P+ Q +D
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKD 230

Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSH 326
           ++      E +  I+++      P   SPE  S +    +++P +R         ++  H
Sbjct: 231 RK------ETMTMILKAKLGM--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282

Query: 327 PFIKKFEDKDID 338
            F   F    ID
Sbjct: 283 SF---F--STID 289

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  151 bits (383), Expect = 3e-43
 Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 39/304 (12%)

Query: 52  SRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQ 111
              SD+     E     L   +V+ +G    V   +    GR +ALK +  N +EE  + 
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRA 71

Query: 112 IVQELKI-NQASQCSHVVVCYHSFYHNGVIS-------LVLEYMDRGSLADII---RQVK 160
           I+QE+    + S   ++V    +       S       L+L  + +G L + +       
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 161 TILEPYLAVVCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
            +    +  +  Q  + + ++H ++  +IHRD+K  NLL++++G +K+ DFG +  +   
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 220 MGQRD------------TFVGTYNYMSPERI---SGSTYDYSSDIWSLGLVVLECAIGRF 264
                            T   T  Y +PE I   S        DIW+LG ++      + 
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251

Query: 265 PYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
           P+   ED             IV       P D     F S + A +Q +P +R S  +++
Sbjct: 252 PF---ED--------GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

Query: 325 SHPF 328
               
Sbjct: 301 HQLQ 304

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  150 bits (382), Expect = 5e-43
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 29/290 (10%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQ 123
           S+E  E + ++G+GS G+V   R+K  GR+ A+K    +  ++ ++K  ++E+K+ +  +
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82

Query: 124 CSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLH 182
             ++V             LV E++D  ++ D +      L+  +      Q++ G+ + H
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
              ++IHRDIKP N+LV+  G VK+ DFG +  L +     D  V T  Y +PE + G  
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 243 -YDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ--------------SWPSFYELLEAI 285
            Y  + D+W++G +V E  +G  P     S+  Q                  F +     
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 286 VESPPPTAPPD-------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
               P     +       + S         C+  DP  R    +LL H F
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (380), Expect = 5e-43
 Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 43/295 (14%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
            D+  ++ +GKG  G V   R  W G   A+KI   + ++E  K   +E ++       H
Sbjct: 8   RDITLLECVGKGRYGEVW--RGSWQGENVAVKIF--SSRDE--KSWFRETELYNTVMLRH 61

Query: 127 --VV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
             ++        S + +  + L+  Y + GSL D ++   T+       +   +  GL +
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAH 120

Query: 181 LHNERH-------VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF----VGT 229
           LH E         + HRD+K  N+LV   G+  I D G++ M   S  Q D      VGT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 230 YNYMSPERISGS------TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ--------SW 275
             YM+PE +  +            DIW+ GLV+ E A         ED +        + 
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

Query: 276 PSFYELLEAIVE-----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
           PSF ++ + +       + P     D         +  C  ++P  R ++L +  
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  154 bits (392), Expect = 5e-43
 Identities = 67/286 (23%), Positives = 126/286 (44%), Gaps = 33/286 (11%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII------------QMNIQEEIRKQIVQELK 117
             ++ +G G+ G V L + K      A+K+I                 E+  ++I  E+ 
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
           + ++    +++  +  F       LV E+ + G L + I       E   A + KQ+L G
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTFVGTYNYM 233
           + YLH + +++HRDIKP N+L+ +K     +KI DFG+S+        +    +GT  Y+
Sbjct: 159 ICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYI 215

Query: 234 SPERISGSTYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP- 290
           +PE +    Y+   D+WS G  + +L C  G  P+    DQ       ++++ + +    
Sbjct: 216 APEVLKKK-YNEKCDVWSCGVIMYILLC--GYPPFGGQNDQ-------DIIKKVEKGKYY 265

Query: 291 -PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
                    S E    +   +  D   R ++ + L+  +IKK+ + 
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  150 bits (380), Expect = 5e-43
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 49/297 (16%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
                IGKGS GVV+L  ++     +A+K++    ++++ +Q     +            
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS---KKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 130 CYHS----------------FYHNGVISL--------------VLEYMDRGSLADIIRQV 159
           C                     H  V+ L              V E +++G + ++    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 160 KTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS 218
              L    A    + +++G+ YLH  + +IHRDIKPSNLLV   G +KI DFGVS     
Sbjct: 133 P--LSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 219 SMGQRDTFVGTYNYMSPERISGSTYDYS---SDIWSLGLVVLECAI-GRFPYMQSEDQQS 274
           S       VGT  +M+PE +S +   +S    D+W++G V L C + G+ P+    D+  
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTLYCFVFGQCPF---MDE-- 243

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                 L   I             + +    ++  + K+P  R    ++  HP++ +
Sbjct: 244 --RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  149 bits (380), Expect = 7e-43
 Identities = 74/288 (25%), Positives = 140/288 (48%), Gaps = 37/288 (12%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQ----ELKIN 119
           +SL+D + ++ +G GS G V L+R +  GR +A+K+  +  +  +R + V+    E  + 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLML 60

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVL 175
                  ++  + +F     I ++++Y++ G L  ++R+ +    P    Y A    +V 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVC 116

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
             L YLH  + +I+RD+KP N+L++  G +KITDFG +  +        T  GT +Y++P
Sbjct: 117 LALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAP 172

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E +S   Y+ S D WS G+++ E   G  P+    +        +  E I+ +      P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTM------KTYEKILNAELRF--P 223

Query: 296 DQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
             F+ +    +S  I +D   R     + + D+ +HP+   F  K++ 
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW---F--KEVV 266

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  151 bits (383), Expect = 1e-42
 Identities = 34/307 (11%), Positives = 84/307 (27%), Gaps = 55/307 (17%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKII------------QMNIQEEIRKQIVQEL 116
           L    V+G+           +  G  F + +             QM  +    + +    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 117 KINQASQCSHVVVCYHSFYHNGVISLV-------------------LEYMDRGSLADIIR 157
              QA      +  +          ++                       +  +  +++ 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 158 QVKTILEPYLAVVC----KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
              +  +  +         QV++ L  LH    ++H  ++P +++++ +G V +T F   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 214 AMLGS-SMGQRDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYM 267
              G+ ++             +   +           ++ D W+LGL +        P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP 327
                    +     E I  S               + +   ++    DR   L  +  P
Sbjct: 319 DD-------AALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAMETP 365

Query: 328 FIKKFED 334
             ++   
Sbjct: 366 EYEQLRT 372

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  149 bits (379), Expect = 1e-42
 Identities = 76/325 (23%), Positives = 127/325 (39%), Gaps = 45/325 (13%)

Query: 39  NQKGLRLISEENESRPS--DYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFA 96
             + LR + E+++S  S             + ++ +K IGKG  G V     KW G   A
Sbjct: 7   PGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVW--MGKWRGEKVA 64

Query: 97  LKIIQMNIQEEIRKQIVQELKINQASQCSH--VV----VCYHSFYHNGVISLVLEYMDRG 150
           +K+      EE      +E +I Q     H  ++               + L+ +Y + G
Sbjct: 65  VKVF--FTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120

Query: 151 SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-------VIHRDIKPSNLLVNHKG 203
           SL D ++   T+    +  +    + GL +LH E         + HRD+K  N+LV   G
Sbjct: 121 SLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 204 EVKITDFGVSAMLGSSMGQRD----TFVGTYNYMSPERISGST------YDYSSDIWSLG 253
              I D G++    S   + D    T VGT  YM PE +  S           +D++S G
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 254 LVVLECAIGRFPYMQSEDQQ--------SWPSFYELLEAIVE-----SPPPTAPPDQFSP 300
           L++ E A         E+ Q        S PS+ ++ E +       S P     D+   
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLS 325
           +    ++ C   +P  R ++L +  
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKK 324

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  150 bits (380), Expect = 2e-42
 Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 44/294 (14%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALK------IIQMNIQEEIR--KQIVQE 115
             +++ E I+V+GKGS G V L R K  G L+A+K      I+Q +  E     K+I+  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS- 78

Query: 116 LKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVC 171
                A     +   +  F     +  V+E+++ G L   I++ +   E     Y A   
Sbjct: 79  ----LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--- 131

Query: 172 KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTY 230
            +++  L++LH ++ +I+RD+K  N+L++H+G  K+ DFG+    G   G    TF GT 
Sbjct: 132 -EIISALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-KEGICNGVTTATFCGTP 188

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
           +Y++PE +    Y  + D W++G+++ E   G  P+ ++E++       +L EAI+    
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENED------DLFEAILNDEV 241

Query: 291 PTAPPDQFSPEFCSFVSACIQKDPRDR------SSSLDLLSHPFIKKFEDKDID 338
               P     +    + + + K+P  R           +L HPF   F  K+ID
Sbjct: 242 VY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF---F--KEID 288

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  150 bits (382), Expect = 2e-42
 Identities = 85/291 (29%), Positives = 148/291 (50%), Gaps = 29/291 (9%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKI-NQ 120
             L+D + ++VIG+GS   V LVR K   R++A+++++  +   +E    +  E  +  Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
           AS    +V  +  F     +  V+EY++ G L   +++ + + E     Y A    ++  
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EISL 164

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP 235
            L YLH ER +I+RD+K  N+L++ +G +K+TD+G+    G   G    TF GT NY++P
Sbjct: 165 ALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSTFCGTPNYIAP 222

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
           E + G  Y +S D W+LG+++ E   GR  F  + S D     +   L + I+E      
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 281

Query: 294 PPDQFSPEFCSFVSACIQKDPRDR------SSSLDLLSHPFIKKFEDKDID 338
            P   S +  S + + + KDP++R      +   D+  HPF   F  +++D
Sbjct: 282 -PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF---F--RNVD 326

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  148 bits (375), Expect = 2e-42
 Identities = 66/286 (23%), Positives = 124/286 (43%), Gaps = 25/286 (8%)

Query: 58  KEFDFEFSLEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQEL 116
           +   F+ +++DL    + +G G+ G V LV  +  G    +K I  +  +   +QI  E+
Sbjct: 12  ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI 71

Query: 117 KINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYL----AVVCK 172
           ++ ++    +++  +  F     + +V+E  + G L + I   +   +       A + K
Sbjct: 72  EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQR-DTFVG 228
           Q++  L Y H  +HV+H+D+KP N+L         +KI DFG++ +  S   +      G
Sbjct: 132 QMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAG 188

Query: 229 TYNYMSPERISGSTYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV 286
           T  YM+PE        +  DIWS G  +  L    G  P+  +  +       E+ +   
Sbjct: 189 TALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLT--GCLPFTGTSLE-------EVQQKAT 238

Query: 287 ESPPP-TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
              P         +P+    +   + KDP  R S+  +L H + K+
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  154 bits (390), Expect = 2e-42
 Identities = 73/287 (25%), Positives = 132/287 (45%), Gaps = 29/287 (10%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKINQAS 122
           +       +V+GKG  G V   + +  G+++A K ++     + +     + E +I +  
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL--EP----YLAVVCKQVLQ 176
               VV   +++     + LVL  M+ G L   I  +      E     Y A    ++  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA----EICC 297

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPE 236
           GL  LH ER +++RD+KP N+L++  G ++I+D G++  +      +   VGT  YM+PE
Sbjct: 298 GLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-GRVGTVGYMAPE 355

Query: 237 RISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
            +    Y +S D W+LG ++ E   G+ P+ Q   ++      E+   + E P      +
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKI--KREEVERLVKEVPEEY--SE 410

Query: 297 QFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
           +FSP+  S  S  + KDP +R      S+ ++  HP    F  K ++
Sbjct: 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL---F--KKLN 452

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  149 bits (379), Expect = 2e-42
 Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKI-NQ 120
             L D   + V+GKGS G V L   K    L+A+KI+   + IQ++  +  + E ++   
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
             +   +   +  F     +  V+EY++ G L   I+QV    EP    Y A    ++  
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----EIAI 132

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP 235
           GL +L   + +I+RD+K  N++++ +G +KI DFG+        G    TF GT +Y++P
Sbjct: 133 GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTTKTFCGTPDYIAP 190

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E I+   Y  S D W+ G+++ E   G+ P+ + ED+       EL ++I+E       P
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDED------ELFQSIMEHNVAY--P 241

Query: 296 DQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
              S E  +     + K P  R         D+  H F   F  + ID
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF---F--RYID 284

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  149 bits (378), Expect = 3e-42
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 20/281 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH 132
             +G+G+  +V   + K   + +ALK+++  + ++I   +  E+ +       +++    
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---VRTEIGVLLRLSHPNIIKLKE 115

Query: 133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDI 192
            F     ISLVLE +  G L D I +     E   A   KQ+L+ + YLH E  ++HRD+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDL 174

Query: 193 KPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           KP NLL         +KI DFG+S ++        T  GT  Y +PE + G  Y    D+
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 250 WSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSF 305
           WS+G    +L C  G  P+      Q       +   I+       +   D+ S      
Sbjct: 234 WSVGIITYILLC--GFEPFYDERGDQ------FMFRRILNCEYYFISPWWDEVSLNAKDL 285

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSL 346
           V   I  DP+ R ++   L HP++       + +      L
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKL 326

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  153 bits (388), Expect = 3e-42
 Identities = 85/321 (26%), Positives = 150/321 (46%), Gaps = 32/321 (9%)

Query: 46  ISEENESRPSDYKEFDFE-FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QM 102
           +      R   +K  + +    +     +V+G+G  G V   + K  G+L+A K +  + 
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222

Query: 103 NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSL----ADIIRQ 158
             + +  +  + E KI        +V   ++F     + LV+  M+ G +     ++   
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282

Query: 159 VKTILEP----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
                EP    Y A    Q++ GL +LH +R++I+RD+KP N+L++  G V+I+D G++ 
Sbjct: 283 NPGFQEPRAIFYTA----QIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

Query: 215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
            L +   +   + GT  +M+PE + G  YD+S D ++LG+ + E    R P+ ++  ++ 
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKV 396

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFI 329
                EL + ++E       PD+FSP    F  A +QKDP  R      S   L +HP  
Sbjct: 397 ENK--ELKQRVLEQAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL- 451

Query: 330 KKFEDKDID-LGILVGSLDPP 349
             F  +DI    +  G L PP
Sbjct: 452 --F--RDISWRQLEAGMLTPP 468

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (372), Expect = 5e-42
 Identities = 55/284 (19%), Positives = 113/284 (39%), Gaps = 43/284 (15%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM------NIQEEIRKQ 111
           K      +  ++E  K IGKG  G+V   R      + A+K + +          E  ++
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 112 IVQELKINQASQCSH--VV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP 165
             +E+ I   S  +H  +V    + ++         +V+E++  G L   +      ++ 
Sbjct: 70  FQREVFI--MSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHPIKW 121

Query: 166 YLAV-VCKQVLQGLVYLHNERH-VIHRDIKPSNLLVNHKGE-----VKITDFGVSAMLGS 218
            + + +   +  G+ Y+ N+   ++HRD++  N+ +    E      K+ DFG+S     
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181

Query: 219 SMGQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP 276
           S+      +G + +M+PE I     +Y   +D +S  +++     G  P+ +    +   
Sbjct: 182 SVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK- 237

Query: 277 SFYELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                +  I E    P     P+   P   + +  C   DP+ R
Sbjct: 238 ----FINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKR 274

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  147 bits (374), Expect = 5e-42
 Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 43/306 (14%)

Query: 48  EENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE 107
             + S   D    +  F    L+ ++V  +G  G V   +        A+KI    IQ++
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKI--FPIQDK 60

Query: 108 IRKQIVQELKINQASQCSH--VV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT 161
             +    E ++       H  ++            +  + L+  + ++GSL+D ++    
Sbjct: 61  --QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NV 117

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERH---------VIHRDIKPSNLLVNHKGEVKITDFGV 212
           +    L  + + + +GL YLH +           + HRDIK  N+L+ +     I DFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 213 SAMLGSSMGQRDT--FVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFP 265
           +    +     DT   VGT  YM+PE + G+           D++++GLV+ E A     
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 266 YMQSEDQQ---------SWPSFYELLEAIVE-----SPPPTAPPDQFSPEFCSFVSACIQ 311
                D+            PS  ++ E +V                     C  +  C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 312 KDPRDR 317
            D   R
Sbjct: 298 HDAEAR 303

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (374), Expect = 6e-42
 Identities = 57/289 (19%), Positives = 122/289 (42%), Gaps = 32/289 (11%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQ 105
           S   ++  +     +++   E LE  ++IGKG  G V     +W G + A+++I +    
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVY--HGRWHGEV-AIRLIDIERDN 69

Query: 106 EEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL 163
           E+  K   +E+      Q  H  VV+   +      ++++       +L  ++R  K +L
Sbjct: 70  EDQLKAFKREVMA--YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127

Query: 164 EPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ 222
           +      + +++++G+ YLH  + ++H+D+K  N+  ++ G+V ITDFG+ ++ G     
Sbjct: 128 DVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAG 185

Query: 223 RDT-----FVGTYNYMSPERISGST---------YDYSSDIWSLGLVVLECAIGRFPYMQ 268
           R         G   +++PE I   +         +   SD+++LG +  E     +P+  
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-- 243

Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            + Q        ++  +     P         E    +  C   +  +R
Sbjct: 244 -KTQ----PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  146 bits (371), Expect = 7e-42
 Identities = 64/285 (22%), Positives = 123/285 (43%), Gaps = 29/285 (10%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQ 105
              +    S     D+E     +   + IG GS G V   + KW G + A+K++ +    
Sbjct: 4   GHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPT 60

Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-----ISLVLEYMDRGSLADIIRQVK 160
            +  +    E+ +    +  HV +    F   G      +++V ++ +  SL   +   +
Sbjct: 61  PQQLQAFKNEVGV--LRKTRHVNIL--LFM--GYSTAPQLAIVTQWCEGSSLYHHLHASE 114

Query: 161 TILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
           T  E    + + +Q  +G+ YLH  + +IHRD+K +N+ ++    VKI DFG++      
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173

Query: 220 MGQRD--TFVGTYNYMSPERI---SGSTYDYSSDIWSLGLVVLECAIGRFPY--MQSEDQ 272
            G        G+  +M+PE I     + Y + SD+++ G+V+ E   G+ PY  + + DQ
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

Query: 273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                  E++     SP  +             ++ C++K   +R
Sbjct: 234 -----IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  147 bits (373), Expect = 8e-42
 Identities = 63/279 (22%), Positives = 125/279 (44%), Gaps = 28/279 (10%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQELKINQASQCSHV 127
           + +G G   +V+  R K  G  +A K I     + + +   R++I +E+ I +     +V
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  +  + +   + L+LE +  G L D + Q +++ E       KQ+L G+ YLH  + +
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-TKKI 136

Query: 188 IHRDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
            H D+KP N+++  K      +K+ DFG++  +   +  +    GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIVNYEPL 195

Query: 244 DYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES----PPPTAPPDQ 297
              +D+WS+G    +L    G  P++  + +Q      E L  I                
Sbjct: 196 GLEADMWSIGVITYILLS--GASPFL-GDTKQ------ETLANITSVSYDFDEE--FFSH 244

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            S     F+   + K+ R R +  + L HP+I   +++ 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  147 bits (373), Expect = 8e-42
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 34/296 (11%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-IRKQIVQELKINQASQC 124
           +E  E I  IG+GS GVV   R++  G++ A+K    +  +  I+K  ++E+++ +  + 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHN 183
            ++V     F     + LV EY D  ++   + + +  +  +L   +  Q LQ + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH- 119

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
           + + IHRD+KP N+L+     +K+ DFG + +L       D  V T  Y SPE + G T 
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 244 DYSS--DIWSLGLVVLECAIGRFPYMQ--SEDQQ--------------SWPSFYELLEAI 285
            Y    D+W++G V  E   G  P     S+  Q                  F       
Sbjct: 180 -YGPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 286 VESPPPTAPPDQF-------SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
               P     +         S      +  C+  DP +R +   LL HP+   FE+
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY---FEN 290

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  147 bits (373), Expect = 9e-42
 Identities = 55/277 (19%), Positives = 122/277 (44%), Gaps = 21/277 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYH 132
           + +G+G  G+V         + +  K +   ++   +  + +E+ I   ++  +++  + 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 133 SFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRD 191
           SF     + ++ E++    + + I      + E  +     QV + L +LH   ++ H D
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFD 127

Query: 192 IKPSNLLVNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDI 249
           I+P N++   +    +KI +FG +  L      R  F     Y +PE         ++D+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVHQHDVVSTATDM 186

Query: 250 WSLGLV--VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSF 305
           WSLG +  VL    G  P++ +E  Q      +++E I+ +          + S E   F
Sbjct: 187 WSLGTLVYVLLS--GINPFL-AETNQ------QIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGIL 342
           V   + K+ + R ++ + L HP++K+ + + +   ++
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ-KIERVSTKVI 273

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  147 bits (373), Expect = 9e-42
 Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 14/267 (5%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           + ++ +G+G+ G VQL  ++      A+KI+ M    +  + I +E+ IN+     +VV 
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y       +  L LEY   G L D I     + EP       Q++ G+VYLH    + H
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITH 128

Query: 190 RDIKPSNLLVNHKGEVKITDFGVSAM--LGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           RDIKP NLL++ +  +KI+DFG++ +    +     +   GT  Y++PE +    +    
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            D+WS G  L  +    G  P+ Q  D        +      E      P  +      +
Sbjct: 189 VDVWSCGIVLTAMLA--GELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +   + ++P  R +  D+    +  K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  146 bits (370), Expect = 1e-41
 Identities = 64/278 (23%), Positives = 126/278 (45%), Gaps = 24/278 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQELKINQASQCSHV 127
           + +G G   +V+  R K  G+ +A K I       + +   R++I +E+ I +  +  ++
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  +  F +   + L+LE +  G L D + + +++ E       KQ+L G+ YLH  + +
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH-SKRI 129

Query: 188 IHRDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
            H D+KP N+++  K      +K+ DFG++  + +    +    GT  +++PE ++    
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK-NIFGTPEFVAPEIVNYEPL 188

Query: 244 DYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFS 299
              +D+WS+G    +L    G  P++  E +Q      E L  I               S
Sbjct: 189 GLEADMWSIGVITYILLS--GASPFL-GETKQ------ETLTNISAVNYDFDEEYFSNTS 239

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI 337
                F+   + KDP+ R +    L H +IK    +++
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  148 bits (376), Expect = 1e-41
 Identities = 80/325 (24%), Positives = 139/325 (42%), Gaps = 36/325 (11%)

Query: 34  GDLLLNQKGLRLISEENESRPSDYKEFDFEF--------------SLEDLETI-KVIGKG 78
           G    +  G ++  + +  + +DY +F  +               S+ D   I + +G G
Sbjct: 3   GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62

Query: 79  SGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHN 137
           + GVV     K  GR+F  K I      + +  +  E+ I NQ      ++  + +F   
Sbjct: 63  AFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHH-PKLINLHDAFEDK 120

Query: 138 GVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
             + L+LE++  G L D I  +   + E  +    +Q  +GL ++H E  ++H DIKP N
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPEN 179

Query: 197 LLVNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGL 254
           ++   K    VKI DFG++  L      + T   T  + +PE +      + +D+W++G+
Sbjct: 180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 255 V--VLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSPEFCSFVSACI 310
           +  VL    G  P+   ED        E L+ +               SPE   F+   +
Sbjct: 239 LGYVLLS--GLSPFA-GEDDL------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289

Query: 311 QKDPRDRSSSLDLLSHPFIKKFEDK 335
           QK+PR R +  D L HP++K     
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDHSN 314

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (372), Expect = 1e-41
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 21/268 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIRKQIVQELKINQASQCSHVV 128
             +K IGKG+   V+L RH   GR  A+KII    +     +++ +E++I +     ++V
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
             +        + L++EY   G + D +     + E       +Q++  + Y H  + ++
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-KRIV 136

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYD-YS 246
           HRD+K  NLL++    +KI DFG S     ++G + D F G   Y +PE   G  YD   
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYE-LLEAIVESPPPTAPPDQFSPEFC 303
            D+WSLG  L  L    G  P+    D Q+     E +L      P         S +  
Sbjct: 195 VDVWSLGVILYTLVS--GSLPF----DGQNLKELRERVLRGKYRIPF------YMSTDCE 242

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           + +   +  +P  R +   ++   +I  
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINA 270

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  148 bits (374), Expect = 1e-41
 Identities = 49/311 (15%), Positives = 99/311 (31%), Gaps = 38/311 (12%)

Query: 48  EENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQM 102
           E     P+   + +F+   + +    ++G+G+   V              + F LK+ + 
Sbjct: 46  EWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP 105

Query: 103 NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-- 160
               E      Q ++  + S     +  Y +        LV E    G+L + I   K  
Sbjct: 106 ANPWEF-YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 161 ---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-----------KGEVK 206
               + +  +     ++L  +  +H +  +IH DIKP N ++ +              + 
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 207 ITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRF 264
           + D G S  +              T  +   E +S   ++Y  D + +   V     G +
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 265 PYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
             +++E  +                      D ++     F    +         SLDLL
Sbjct: 284 MKVKNEGGE---------CKPEGLFRRLPHLDMWNE----FFHVMLNIPDCHHLPSLDLL 330

Query: 325 SHPFIKKFEDK 335
                K F+  
Sbjct: 331 RQKLKKVFQQH 341

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  147 bits (374), Expect = 1e-41
 Identities = 63/281 (22%), Positives = 126/281 (44%), Gaps = 32/281 (11%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQELKINQASQCSHV 127
           + +G G   +V+  R K  G  +A K I     + + +   R++I +E+ I +     ++
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  +  + +   + L+LE +  G L D + Q +++ E       KQ+L G+ YLH  + +
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-TKKI 136

Query: 188 IHRDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
            H D+KP N+++  K      +K+ DFG++  +   +  +    GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPEFVAPEIVNYEPL 195

Query: 244 DYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV------ESPPPTAPP 295
              +D+WS+G    +L    G  P++  + +Q      E L  I       +        
Sbjct: 196 GLEADMWSIGVITYILLS--GASPFL-GDTKQ------ETLANITAVSYDFDEE----FF 242

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            Q S     F+   + K+ R R +  + L HP+I   + + 
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  149 bits (378), Expect = 1e-41
 Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 35/307 (11%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEE 107
             ++P   K        ED E +KVIG+G+ G V +V+ K   ++FA+KI+     ++  
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116

Query: 108 IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EP- 165
                 +E  +        +   +++F  +  + LV++Y   G L  ++ + +  L E  
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 166 ---YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA-MLGSSMG 221
              YLA    +++  +  +H   H +HRDIKP N+L++  G +++ DFG    ++     
Sbjct: 177 ARFYLA----EMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 222 QRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP 276
           Q    VGT +Y+SPE +         Y    D WSLG+ + E   G  P+  +E      
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--- 287

Query: 277 SFYELLEAIVESPPPTAPP---DQFSPEFCSFVSACIQKDPR--DRSSSLDLLSHPFIKK 331
              E    I+        P      S      +   I        ++   D   HPF   
Sbjct: 288 ---ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF--- 341

Query: 332 FEDKDID 338
           F    ID
Sbjct: 342 F--SGID 346

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  145 bits (368), Expect = 2e-41
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 39/276 (14%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI---RKQIVQELKI 118
            E    +L   ++IG G  G V   R  W+G   A+K  + +  E+I    + + QE K+
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59

Query: 119 NQASQCSH--VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVL 175
              +   H  ++           + LV+E+   G L  ++      + P + V    Q+ 
Sbjct: 60  --FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIA 115

Query: 176 QGLVYLH--NERHVIHRDIKPSNLLVNHKGE--------VKITDFGVSAMLGSSMGQRDT 225
           +G+ YLH      +IHRD+K SN+L+  K E        +KITDFG++     +   + +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMS 173

Query: 226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY--MQSEDQQSWPSFYELLE 283
             G Y +M+PE I  S +   SD+WS G+++ E   G  P+  +             +  
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI---------DGLAVAY 224

Query: 284 AIVES--PPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            +  +    P   P      F   +  C   DP  R
Sbjct: 225 GVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSR 258

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  146 bits (370), Expect = 2e-41
 Identities = 71/276 (25%), Positives = 109/276 (39%), Gaps = 34/276 (12%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII---------QMNIQEEIRKQIVQELKINQ 120
               ++GKG  G V            A+K+I          ++       ++    K+  
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGS-LADIIRQVKTILEPYLAVVCKQVLQGLV 179
                 V+     F       LVLE       L D I +   + E        QV+  + 
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           + H+ R V+HRDIK  N+L++  +G  K+ DFG  A+L         F GT  Y  PE I
Sbjct: 154 HCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWI 210

Query: 239 SGSTYD-YSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           S   Y    + +WSLG  L  + C  G  P+   E  Q      E+LEA +  P      
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVC--GDIPF---ERDQ------EILEAELHFPA----- 254

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
              SP+ C+ +  C+   P  R S  ++L  P+++ 
Sbjct: 255 -HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  145 bits (369), Expect = 3e-41
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 24/258 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSH- 126
              +++G+G  G V         R+ ALK++   +      R ++ +E +   A +    
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEP 94

Query: 127 -VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNE 184
            VV  +     +G + + +  ++   LA ++R+    L P  AV + +Q+   L   H  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAH-A 152

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFG-VSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
               HRD+KP N+LV+      + DFG  SA     + Q    VGT  YM+PER S S  
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP--- 300
            Y +DI++L  V+ EC  G  PY Q +          ++ A +    P   P    P   
Sbjct: 213 TYRADIYALTCVLYECLTGSPPY-QGDQLS-------VMGAHINQAIP--RPSTVRPGIP 262

Query: 301 -EFCSFVSACIQKDPRDR 317
             F + ++  + K+P DR
Sbjct: 263 VAFDAVIARGMAKNPEDR 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  148 bits (375), Expect = 3e-41
 Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 41/311 (13%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ---MNIQE 106
             + P   +  +     +D E +KVIG+G+   V +V+ K  G+++A+KI+    M  + 
Sbjct: 44  QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG 103

Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP- 165
           E+     +E  +        +   + +F     + LV+EY   G L  ++ +    +   
Sbjct: 104 EV-SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 166 ----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
               YLA    +++  +  +H     +HRDIKP N+L++  G +++ DFG    L +   
Sbjct: 163 MARFYLA----EIVMAIDSVH-RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 222 QR-DTFVGTYNYMSPERISG-------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            R    VGT +Y+SPE +          +Y    D W+LG+   E   G+ P+  ++   
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA 276

Query: 274 SWPSFYELLEAIVESP---PPTAPPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHP 327
                 E    IV            +    E   F+   +   P  R     + D  +HP
Sbjct: 277 ------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329

Query: 328 FIKKFEDKDID 338
           F   F    +D
Sbjct: 330 F---F--FGLD 335

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  150 bits (381), Expect = 3e-41
 Identities = 66/308 (21%), Positives = 130/308 (42%), Gaps = 22/308 (7%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ 105
           I ++   +P + K        +  +  + +G G+ GVV  V  +  G  FA K +    +
Sbjct: 139 IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195

Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILE 164
            + ++ + +E++     +   +V  + +F  +  + ++ E+M  G L + +  +   + E
Sbjct: 196 SD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254

Query: 165 PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMGQ 222
                  +QV +GL ++H E + +H D+KP N++   K    +K+ DFG++A L      
Sbjct: 255 DEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLV--VLECAIGRFPYMQSEDQQSWPSFYE 280
           + T  GT  + +PE   G    Y +D+WS+G++  +L    G  P+   E+        E
Sbjct: 314 KVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS--GLSPFG-GENDD------E 363

Query: 281 LLEAIVESPP--PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
            L  +         +     S +   F+   +  DP  R +    L HP++        D
Sbjct: 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423

Query: 339 LGILVGSL 346
             I     
Sbjct: 424 SQIPSSRY 431

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  145 bits (369), Expect = 4e-41
 Identities = 75/290 (25%), Positives = 139/290 (47%), Gaps = 36/290 (12%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQ---ELKI 118
             E  E ++V+GKG  G V  VR       G++FA+K+++  +     K       E  I
Sbjct: 15  RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQV 174
            +  +   +V   ++F   G + L+LEY+  G L   + +    +E     YLA    ++
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA----EI 130

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYM 233
              L +LH ++ +I+RD+KP N+++NH+G VK+TDFG+        G    TF GT  YM
Sbjct: 131 SMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYM 188

Query: 234 SPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
           +PE +  S ++ + D WSLG ++ +   G  P+   E+++      + ++ I++      
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK------KTIDKILKCKLNL- 240

Query: 294 PPDQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
            P   + E    +   ++++   R       + ++ +HPF   F  + I+
Sbjct: 241 -PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF---F--RHIN 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (368), Expect = 6e-41
 Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 24/277 (8%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQELKINQASQCSHV 127
           + +G G   VV+  R K  G  +A K I     + + +   R+ I +E+ I +  Q  +V
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  +  + +   + L+LE +  G L D + + +++ E       KQ+L G+ YLH    +
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH-SLQI 135

Query: 188 IHRDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
            H D+KP N+++  +      +KI DFG++  +      +    GT  +++PE ++    
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEFVAPEIVNYEPL 194

Query: 244 DYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFS 299
              +D+WS+G    +L    G  P++  + +Q      E L  +               S
Sbjct: 195 GLEADMWSIGVITYILLS--GASPFL-GDTKQ------ETLANVSAVNYEFEDEYFSNTS 245

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
                F+   + KDP+ R +  D L HP+IK  + + 
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  145 bits (368), Expect = 9e-41
 Identities = 82/331 (24%), Positives = 157/331 (47%), Gaps = 34/331 (10%)

Query: 27  ASGTFHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLV 86
           +SG            G +L++ ++E R ++      +  +E+ E +KV+G G+ G V LV
Sbjct: 14  SSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLV 73

Query: 87  RH---KWVGRLFALKIIQ---MNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGV 139
           R       G+L+A+K+++   +  + +  +    E ++     Q   +V  +++F     
Sbjct: 74  RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 140 ISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQGLVYLHNERHVIHRDIKPS 195
           + L+L+Y++ G L   + Q +   E     Y+     +++  L +LH +  +I+RDIK  
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIVLALEHLH-KLGIIYRDIKLE 188

Query: 196 NLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSPERISGSTYDY--SSDIWSL 252
           N+L++  G V +TDFG+S    +   +R   F GT  YM+P+ + G    +  + D WSL
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248

Query: 253 GLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQK 312
           G+++ E   G  P+    ++ S     E+   I++S PP   P + S      +   + K
Sbjct: 249 GVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEPPY--PQEMSALAKDLIQRLLMK 303

Query: 313 DPRDR-----SSSLDLLSHPFIKKFEDKDID 338
           DP+ R       + ++  H F   F  + I+
Sbjct: 304 DPKKRLGCGPRDADEIKEHLF---F--QKIN 329

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  146 bits (370), Expect = 1e-40
 Identities = 82/318 (25%), Positives = 139/318 (43%), Gaps = 38/318 (11%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR 109
           +  + +  K  D     ED E +KVIG+G+ G VQLVRHK   +++A+K+  ++  E I+
Sbjct: 52  SRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIK 109

Query: 110 KQIVQ----ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP 165
           +        E  I   +    VV  +++F  +  + +V+EYM  G L +++     + E 
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEK 168

Query: 166 ----YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
               Y A    +V+  L  +H     IHRD+KP N+L++  G +K+ DFG    +     
Sbjct: 169 WARFYTA----EVVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 222 QR-DTFVGTYNYMSPERISG----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP 276
            R DT VGT +Y+SPE +        Y    D WS+G+ + E  +G  P+  ++      
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLV--- 279

Query: 277 SFYELLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKK 331
                   I+        PD    S E  + + A +  D   R   +   ++  H F   
Sbjct: 280 ---GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF--- 332

Query: 332 FEDKDIDLGILVGSLDPP 349
           F++        +     P
Sbjct: 333 FKNDQWAW-ETLRDTVAP 349

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  144 bits (365), Expect = 1e-40
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 32/292 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ-MNIQEEIR----KQIVQELKINQ--AS 122
           +   ++G G  G V            A+K ++   I +        ++  E+ + +  +S
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMD-RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
             S V+     F       L+LE  +    L D I +   + E        QVL+ + + 
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165

Query: 182 HNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           HN   V+HRDIK  N+L++ ++GE+K+ DFG  A+L         F GT  Y  PE I  
Sbjct: 166 HN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRY 222

Query: 241 STYD-YSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
             Y   S+ +WSLG  L  + C  G  P+   E  +      E++   V          +
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVC--GDIPF---EHDE------EIIRGQVFFRQ------R 265

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
            S E    +  C+   P DR +  ++ +HP+++          I + SL P 
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  145 bits (368), Expect = 2e-40
 Identities = 66/272 (24%), Positives = 127/272 (46%), Gaps = 21/272 (7%)

Query: 68  DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSH 126
            +   +++G G  G V        G   A KII+    ++ ++++  E+ + NQ     +
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHA-N 147

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLAD-IIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           ++  Y +F     I LV+EY+D G L D II +   + E    +  KQ+ +G+ ++H + 
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-QM 206

Query: 186 HVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
           +++H D+KP N+L  ++    +KI DFG++         +  F GT  +++PE ++    
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFV 265

Query: 244 DYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFS 299
            + +D+WS+G    +L    G  P++  ++        E L  I+              S
Sbjct: 266 SFPTDMWSVGVIAYMLLS--GLSPFL-GDNDA------ETLNNILACRWDLEDEEFQDIS 316

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            E   F+S  + K+   R S+ + L HP++  
Sbjct: 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  146 bits (369), Expect = 2e-40
 Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 35/277 (12%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKINQASQCSHVVVC 130
           +V+G G  G V  + +K     FALK++Q     + E+  ++         SQC H+V  
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV--ELHWRA-----SQCPHIVRI 120

Query: 131 YHSFYHNGVIS-----LVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHN 183
               Y N         +V+E +D G L   I  R  +   E   + + K + + + YLH 
Sbjct: 121 -VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178

Query: 184 ERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERI 238
             ++ HRD+KP NLL   K     +K+TDFG +      +S+    T   T  Y++PE +
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVL 235

Query: 239 SGSTYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAP 294
               YD S D+WSLG  + +L C  G  P+  S    +      +   I       P   
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLC--GYPPF-YSNHGLAISP--GMKTRIRMGQYEFPNPE 290

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             + S E    +   ++ +P  R +  + ++HP+I +
Sbjct: 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  149 bits (377), Expect = 3e-40
 Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKI-NQ 120
             L D   + V+GKGS G V L   K    L+A+KI+   + IQ++  +  + E ++   
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP----YLAVVCKQVLQ 176
             +   +   +  F     +  V+EY++ G L   I+QV    EP    Y A    ++  
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----EIAI 453

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR-DTFVGTYNYMSP 235
           GL +L   + +I+RD+K  N++++ +G +KI DFG+        G    TF GT +Y++P
Sbjct: 454 GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTTKTFCGTPDYIAP 511

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E I+   Y  S D W+ G+++ E   G+ P+ + ED+       EL ++I+E       P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDED------ELFQSIMEHNVAY--P 562

Query: 296 DQFSPEFCSFVSACIQKDPRDR-----SSSLDLLSHPFIKKFEDKDID 338
              S E  +     + K P  R         D+  H F   F  + ID
Sbjct: 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF---F--RYID 605

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (363), Expect = 3e-40
 Identities = 74/320 (23%), Positives = 118/320 (36%), Gaps = 45/320 (14%)

Query: 43  LRLISEENESRPSDY--KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII 100
           L+ +  +  +  S               +   + IGKG  G V   R KW G   A+KI 
Sbjct: 16  LKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIF 73

Query: 101 QMNIQEEIRKQIVQELKINQASQCSH------VVVCYHSFYHNGVISLVLEYMDRGSLAD 154
             + +EE  +   +E +I Q     H      +            + LV +Y + GSL D
Sbjct: 74  --SSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129

Query: 155 IIRQVKTILEPYLAVVCKQVLQGLVYLHNERH-------VIHRDIKPSNLLVNHKGEVKI 207
            + +  T+    +  +      GL +LH E         + HRD+K  N+LV   G   I
Sbjct: 130 YLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188

Query: 208 TDFGVSAMLGSSMGQRDTF----VGTYNYMSPERISGST------YDYSSDIWSLGLVVL 257
            D G++    S+    D      VGT  YM+PE +  S           +DI+++GLV  
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

Query: 258 ECAIGRFPYMQSEDQQ--------SWPSFYELLEAIVE-----SPPPTAPPDQFSPEFCS 304
           E A         ED Q        S PS  E+ + + E     + P      +       
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 308

Query: 305 FVSACIQKDPRDRSSSLDLL 324
            +  C   +   R ++L + 
Sbjct: 309 IMRECWYANGAARLTALRIK 328

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  142 bits (359), Expect = 1e-39
 Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 30/273 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII-------QMNIQEEIRKQIVQELKINQAS 122
            T+  +G G+ G V     K   +   +K I          I++    ++  E+ I    
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGS-LADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
           + ++++     F + G   LV+E    G  L   I +   + EP  + + +Q++  + YL
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
              + +IHRDIK  N+++     +K+ DFG +A L        TF GT  Y +PE + G+
Sbjct: 147 RL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGN 204

Query: 242 TYD-YSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
            Y     ++WSLG  L  L       P            F EL E  VE+     PP   
Sbjct: 205 PYRGPELEMWSLGVTLYTLVF--EENP------------FCELEE-TVEA--AIHPPYLV 247

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           S E  S VS  +Q  P  R++   L++ P++ +
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  139 bits (352), Expect = 3e-39
 Identities = 52/295 (17%), Positives = 114/295 (38%), Gaps = 39/295 (13%)

Query: 55  SDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIV 113
           + +   DF+     L  +  + +   G +   + +W G    +K++++ +      +   
Sbjct: 2   NKHSGIDFK----QLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTRKSRDFN 55

Query: 114 QELKINQASQCSH--VV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI-LEPY 166
           +E         SH  V+     C      +   +L+  +M  GSL +++ +     ++  
Sbjct: 56  EECPR--LRIFSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQS 111

Query: 167 LAV-VCKQVLQGLVYLHN-ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD 224
            AV     + +G+ +LH  E  +    +   +++++     +I+   V         Q  
Sbjct: 112 QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSP 166

Query: 225 TFVGTYNYMSPERISGSTYDY---SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL 281
             +    +++PE +     D    S+D+WS  +++ E      P+    D     S  E+
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADL----SNMEI 219

Query: 282 LEAIV-ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
              +  E   PT PP   SP     +  C+ +DP  R     ++    ++K +DK
Sbjct: 220 GMKVALEGLRPTIPPG-ISPHVSKLMKICMNEDPAKRPKFDMIVPI--LEKMQDK 271

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  138 bits (351), Expect = 1e-38
 Identities = 83/323 (25%), Positives = 148/323 (45%), Gaps = 44/323 (13%)

Query: 43  LRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM 102
           +      +  R + Y    F+  +E  + ++ +G+G+ GVV   +    GR+ ALK I++
Sbjct: 1   MHHHHHHSSGRENLY----FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL 55

Query: 103 NIQEE------IRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII 156
           + ++E      IR     E+ + +     ++V      +    ++LV E+M++  L  ++
Sbjct: 56  DAEDEGIPSTAIR-----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL 109

Query: 157 RQVKTILEPYLA-VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM 215
            + KT L+     +   Q+L+G+ + H +  ++HRD+KP NLL+N  G +K+ DFG++  
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCH-QHRILHRDLKPQNLLINSDGALKLADFGLARA 168

Query: 216 LGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ 272
            G  +      V T  Y +P+ + GS  Y  S DIWS+G +  E   G+  FP +  +DQ
Sbjct: 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228

Query: 273 -------------QSWPSFYELLEAIVESPPPTAPPD------QFSPEFCSFVSACIQKD 313
                        + WP   EL      +               F  E    +S  +  D
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288

Query: 314 PRDRSSSLDLLSHPFIKKFEDKD 336
           P  R S+ D ++HP+   F+D D
Sbjct: 289 PNKRISARDAMNHPY---FKDLD 308

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  139 bits (352), Expect = 1e-38
 Identities = 64/304 (21%), Positives = 109/304 (35%), Gaps = 54/304 (17%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
           +    L++L+ +++IG+G  G V   +     R  A+K+   +      +  + E  I +
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVY--KGSLDERPVAVKV--FSFANR--QNFINEKNIYR 60

Query: 121 ASQCSH--VVVCY-----HSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQ 173
                H  +          +        LV+EY   GSL   +    T        +   
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHS 119

Query: 174 VLQGLVYLHNERH--------VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD- 224
           V +GL YLH E          + HRD+   N+LV + G   I+DFG+S  L  +   R  
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 225 -------TFVGTYNYMSPERISGS-------TYDYSSDIWSLGLVVLECA---IGRFPYM 267
                  + VGT  YM+PE + G+       +     D+++LGL+  E        FP  
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 268 QSEDQQ--------SWPSFYELLEAIVES------PPPTAPPDQFSPEFCSFVSACIQKD 313
              + Q        + P+F ++   +         P                +  C  +D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 314 PRDR 317
              R
Sbjct: 300 AEAR 303

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  137 bits (348), Expect = 1e-38
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 20/268 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHV 127
                +G G+ G V++  H+  G   A+KI+  Q     ++  +I +E++  +  +  H+
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  Y          +V+EY+  G L D I +   + E     + +Q+L  + Y H    V
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMV 132

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           +HRD+KP N+L++     KI DFG+S M+ S      T  G+ NY +PE ISG  Y    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYE-LLEAIVESPPPTAPPDQFSPEFC 303
            DIWS G  L  L C  G  P+    D +  P+ ++ +   +   P         +    
Sbjct: 192 VDIWSCGVILYALLC--GTLPF----DDEHVPTLFKKIRGGVFYIPE------YLNRSVA 239

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           + +   +Q DP  R++  D+  H + K+
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  137 bits (348), Expect = 2e-38
 Identities = 82/299 (27%), Positives = 139/299 (46%), Gaps = 39/299 (13%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKIN 119
           +E    ++ IG+G+ GVV   ++   G  FALK I++  ++E      IR     E+ I 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-----EISIL 54

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGL 178
           +  + S++V  Y   +    + LV E++D+  L  ++   +  LE   A     Q+L G+
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            Y H +R V+HRD+KP NLL+N +GE+KI DFG++   G  + +    + T  Y +P+ +
Sbjct: 114 AYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 239 SGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELL 282
            GS  Y  + DIWS+G +  E   G   FP +   DQ             ++WP+  EL 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 283 EAIVESPPPTAPP-----DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           +           P               +S  ++ DP  R ++   L H +   F++ +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY---FKENN 288

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  138 bits (350), Expect = 2e-38
 Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 28/294 (9%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           +E    +  +G+G+   V   + K    L ALK I++  +E      ++E+ + +  + +
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGLVYLHNE 184
           ++V  +   +    ++LV EY+D+  L   +     I+  +   +   Q+L+GL Y H  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH-R 118

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
           + V+HRD+KP NLL+N +GE+K+ DFG++          D  V T  Y  P+ + GST Y
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178

Query: 244 DYSSDIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELLEAIVES 288
               D+W +G +  E A GR  FP    E+Q             ++WP      E    +
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238

Query: 289 PPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            P            +   +    ++  +Q + R+R S+ D + HPF   F    
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF---FLSLG 289

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  136 bits (346), Expect = 4e-38
 Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 38/293 (12%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKIN 119
           ++  E ++ IG+G+ G V   +++    + ALK ++++  +E      +R     E+ + 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-----EICLL 55

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLA-VVCKQVLQGL 178
           +  +  ++V  +   + +  ++LV E+ D+  L          L+P +      Q+L+GL
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
            + H  R+V+HRD+KP NLL+N  GE+K+ +FG++   G  +      V T  Y  P+ +
Sbjct: 115 GFCH-SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 239 SGST-YDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ--------------SWPSFYEL 281
            G+  Y  S D+WS G +  E A    P       D Q               WPS  +L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 282 LEAIVESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            +     P   A         + +      +   ++ +P  R S+ + L HP+
Sbjct: 234 PDY-KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  136 bits (346), Expect = 6e-38
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 43/300 (14%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQI----VQELKI-N 119
           +    E +  IG G+ G V   R    G   ALK +++         +    V+E+ +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 120 QASQCSHV-------VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVC- 171
           +     H        V           ++LV E++D+  L   + +      P   +   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 172 -KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF---V 227
            +Q L+GL +LH    ++HRD+KP N+LV   G VK+ DFG    L      +      V
Sbjct: 126 MRQFLRGLDFLH-ANCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMALTPVV 180

Query: 228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ------------ 273
            T  Y +PE +  STY    D+WS+G +  E    + P     SE  Q            
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGLPP 239

Query: 274 --SWPSFYELLEAIVESPPPTAPPDQF---SPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
              WP    L         P                 +   +  +P  R S+   L H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  136 bits (346), Expect = 9e-38
 Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 43/307 (14%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKI 118
           S++    I  +G+G+ G V            A+K I++  +EE      IR     E+ +
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-----EVSL 86

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
            +  Q  +++      +HN  + L+ EY +   L   + +   +    +     Q++ G+
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 179 VYLHNERHVIHRDIKPSNLLVN-----HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM 233
            + H  R  +HRD+KP NLL++         +KI DFG++   G  + Q    + T  Y 
Sbjct: 146 NFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204

Query: 234 SPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPS 277
            PE + GS  Y  S DIWS+  +  E  +    FP     DQ              +WP 
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 278 FYELLEAIVESPPPTAP------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
              L +     P                 E    ++A ++ DP  R S+ + L HP+   
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY--- 321

Query: 332 FEDKDID 338
           F   D D
Sbjct: 322 FSHNDFD 328

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  136 bits (346), Expect = 1e-37
 Identities = 70/292 (23%), Positives = 127/292 (43%), Gaps = 33/292 (11%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQI----VQELKINQ 120
             +  E +  +G+G    V   R K   ++ A+K I++  + E +  I    ++E+K+ Q
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV---CKQVLQG 177
                +++    +F H   ISLV ++M+   L  II+    +L P  + +       LQG
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP--SHIKAYMLMTLQG 124

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L YLH +  ++HRD+KP+NLL++  G +K+ DFG++   GS        V T  Y +PE 
Sbjct: 125 LEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 238 ISGST-YDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ--------------SWPSFYE 280
           + G+  Y    D+W++G ++ E  +   P++   S+  Q               WP    
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242

Query: 281 LLEAIVESPPPTAPPDQ----FSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
           L + +     P  P          +    +      +P  R ++   L   +
Sbjct: 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  136 bits (345), Expect = 2e-37
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 14/267 (5%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           + +K IG G+ GV +L+R K    L A+K I       I + + +E+  +++ +  ++V 
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVR 80

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
                     +++++EY   G L + I       E       +Q+L G+ Y H+   + H
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICH 139

Query: 190 RDIKPSNLLV--NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           RD+K  N L+  +    +KI DFG S        Q  + VGT  Y++PE +    YD   
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
           +D+WS G  L V+    G +P+   ED +    + + ++ I+          + SPE C 
Sbjct: 199 ADVWSCGVTLYVMLV--GAYPF---EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +S     DP  R S  ++ +H +  K
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLK 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (341), Expect = 2e-37
 Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 24/259 (9%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSH- 126
           + +  +G G    V L     +    A+K I      +EE  K+  +E+    +SQ SH 
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQ 71

Query: 127 -VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNE 184
            +V        +    LV+EY++  +L++ I      L    A+    Q+L G+ + H +
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAH-D 129

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFG-VSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
             ++HRDIKP N+L++    +KI DFG   A+  +S+ Q +  +GT  Y SPE+  G   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI--VESPPPTAPPD---QF 298
           D  +DI+S+G+V+ E  +G  P+   E   S         AI  ++   P    D     
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF-NGETAVSI--------AIKHIQDSVPNVTTDVRKDI 240

Query: 299 SPEFCSFVSACIQKDPRDR 317
                + +    +KD  +R
Sbjct: 241 PQSLSNVILRATEKDKANR 259

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  133 bits (338), Expect = 7e-37
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 28/276 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII---QMNIQEEIRKQIVQELKINQASQCSH 126
               ++G+GS G V+ V         A+KI+   ++         + +E+++ +  +  +
Sbjct: 8   LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 127 VVVCYHSFYH--NGVISLVLEYMDRGS--LADIIRQVKTILEPYLAVVC-KQVLQGLVYL 181
           V+      Y+     + +V+EY   G   + D + + +       A     Q++ GL YL
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYL 125

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERIS 239
           H+ + ++H+DIKP NLL+   G +KI+  GV+  L          T  G+  +  PE  +
Sbjct: 126 HS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 240 GS-TYD-YSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           G  T+  +  DIWS G  L  +    G +P+   E      + Y+L E I +       P
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITT--GLYPF---EG----DNIYKLFENIGKGSYAI--P 233

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
               P     +   ++ +P  R S   +  H + +K
Sbjct: 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  133 bits (336), Expect = 2e-36
 Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 54/311 (17%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRH-KWVGRLFALKIIQMNIQEE------IRK-QIVQEL 116
           + +  E +  IG+G+ G V   R  K  GR  ALK +++   EE      IR+  +++ L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68

Query: 117 KINQASQCSHV-------VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV 169
           +        H        V           ++LV E++D+  L   + +V     P   +
Sbjct: 69  E-----TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI 122

Query: 170 VC--KQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF- 226
                Q+L+GL +LH    V+HRD+KP N+LV   G++K+ DFG    L      +    
Sbjct: 123 KDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALT 177

Query: 227 --VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ--------- 273
             V T  Y +PE +  S+Y    D+WS+G +  E    + P  +  S+  Q         
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIG 236

Query: 274 -----SWPSFYELLEAIVESPPPTAPPDQF---SPEFCSFVSACIQKDPRDRSSSLDLLS 325
                 WP    L      S                    +  C+  +P  R S+   LS
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296

Query: 326 HPFIKKFEDKD 336
           HP+   F+D +
Sbjct: 297 HPY---FQDLE 304

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  134 bits (339), Expect = 1e-35
 Identities = 77/268 (28%), Positives = 128/268 (47%), Gaps = 20/268 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHV 127
                +G G+ G V++ +H+  G   A+KI+  Q     ++  +I +E++  +  +  H+
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  Y        I +V+EY+  G L D I +   + E     + +Q+L G+ Y H    V
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMV 137

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           +HRD+KP N+L++     KI DFG+S M+ S      T  G+ NY +PE ISG  Y    
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPE 196

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYE-LLEAIVESPPPTAPPDQFSPEFC 303
            DIWS G  L  L C  G  P+    D    P+ ++ + + I  +P         +P   
Sbjct: 197 VDIWSSGVILYALLC--GTLPF----DDDHVPTLFKKICDGIFYTPQ------YLNPSVI 244

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           S +   +Q DP  R++  D+  H + K+
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  131 bits (333), Expect = 1e-35
 Identities = 74/325 (22%), Positives = 120/325 (36%), Gaps = 68/325 (20%)

Query: 57  YKEFDFEF--SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------I 108
           Y   +  F   +   E +  IG+G+ G V   RH+  G+  ALK + M  ++E      +
Sbjct: 5   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 64

Query: 109 RKQIVQELKINQASQCSHVV----VCY----HSFYHNGVISLVLEYM--DRGSLADIIR- 157
           R     E+KI Q  +  +VV    +C           G I LV ++   D   L   +  
Sbjct: 65  R-----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119

Query: 158 -----QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
                ++K ++        + +L GL Y+H    ++HRD+K +N+L+   G +K+ DFG+
Sbjct: 120 KFTLSEIKRVM--------QMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGL 170

Query: 213 SAMLGSSMGQRDTF----VGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYM 267
           +     +   +       V T  Y  PE + G   Y    D+W  G ++ E      P M
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIM 229

Query: 268 Q--SEDQQ--------------SWPSFYELLEAIVESPPPTAPPD--------QFSPEFC 303
           Q  +E  Q               WP+                              P   
Sbjct: 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 289

Query: 304 SFVSACIQKDPRDRSSSLDLLSHPF 328
             +   +  DP  R  S D L+H F
Sbjct: 290 DLIDKLLVLDPAQRIDSDDALNHDF 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  130 bits (330), Expect = 1e-35
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 48/303 (15%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE------IRKQIVQELKI 118
           S    + ++ +G G+   V    +K  G   ALK ++++  EE      IR     E+ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPSTAIR-----EISL 56

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY---LAVV---CK 172
            +  +  ++V  Y   +    ++LV E+MD   L   +        P    L +V     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY 232
           Q+LQGL + H E  ++HRD+KP NLL+N +G++K+ DFG++   G  +    + V T  Y
Sbjct: 116 QLLQGLAFCH-ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 233 MSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ--------------SW 275
            +P+ + GS  Y  S DIWS G ++ E   G+ P     ++++Q               W
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLW 233

Query: 276 PSFYELLEAIVESPP----------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
           PS  +L +                      +        F+   +Q +P  R S+   L 
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293

Query: 326 HPF 328
           HP+
Sbjct: 294 HPW 296

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  131 bits (331), Expect = 2e-35
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 19/267 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSHV 127
              + +G+GS G V+L  H    +  ALK I  Q+  + ++  ++ +E+   +  +  H+
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
           +  Y        I +V+EY   G L D I + K + E       +Q++  + Y H    +
Sbjct: 72  IKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKI 129

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YS 246
           +HRD+KP NLL++    VKI DFG+S ++ +      T  G+ NY +PE I+G  Y    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188

Query: 247 SDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
            D+WS G  L V+    GR P+   +D         L + +         PD  SP   S
Sbjct: 189 VDVWSCGIVLYVMLV--GRLPF---DD----EFIPNLFKKVNSCVYVM--PDFLSPGAQS 237

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIKK 331
            +   I  DP  R +  ++   P+   
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNV 264

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (339), Expect = 5e-35
 Identities = 50/260 (19%), Positives = 95/260 (36%), Gaps = 36/260 (13%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWV-GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH-- 126
           E    I  G  G + L   + V GR   LK +  +   E +   + E +    ++  H  
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVVHPS 140

Query: 127 VVVCY----HSFYHNGVIS-LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVY 180
           +V  +    H+  H   +  +V+EY+   SL     Q    L    A+    ++L  L Y
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSY 197

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           LH    +++ D+KP N+++  +  +K+ D G      S +       GT  + +PE +  
Sbjct: 198 LH-SIGLVYNDLKPENIMLTEEQ-LKLIDLGAV----SRINSFGYLYGTPGFQAPEIVRT 251

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
                ++DI+++G  +    +                       +   P           
Sbjct: 252 GPTV-ATDIYTVGRTLAALTLDLPTRNG--------------RYVDGLPEDDPVLKT-YD 295

Query: 301 EFCSFVSACIQKDPRDRSSS 320
            +   +   I  DPR R ++
Sbjct: 296 SYGRLLRRAIDPDPRQRFTT 315

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (325), Expect = 6e-35
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 31/190 (16%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVN 200
           +V+EY+D  +L DI+   +  + P  A+ V     Q L + H +  +IHRD+KP+N++++
Sbjct: 93  IVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMIS 150

Query: 201 HKGEVKITDFGV---SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVL 257
               VK+ DFG+    A  G+S+ Q    +GT  Y+SPE+  G + D  SD++SLG V+ 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210

Query: 258 ECAIGRFP----------YMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVS 307
           E   G  P          Y    +               +  PP+A  +  S +  + V 
Sbjct: 211 EVLTGEPPFTGDSPVSVAYQHVRE---------------DPIPPSARHEGLSADLDAVVL 255

Query: 308 ACIQKDPRDR 317
             + K+P +R
Sbjct: 256 KALAKNPENR 265

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  125 bits (315), Expect = 1e-32
 Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
              KVIG GS GVV   +    G L A+K +  + + + R     EL+I +     ++V 
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVR 111

Query: 130 CYHSFYHNG------VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK----QVLQGLV 179
             + FY +G       ++LVL+Y+   ++  + R      +    +  K    Q+ + L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           Y+H+   + HRDIKP NLL++     +K+ DFG SA          +++ +  Y +PE I
Sbjct: 171 YIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 239 SGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYELL 282
            G+T Y  S D+WS G V+ E  +G+  FP     DQ             +      E+ 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR---EMN 285

Query: 283 EAIVESPPPTAPPDQF--------SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
               E   P      +         PE  +  S  ++  P  R + L+  +H F  +  D
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

Query: 335 KDIDL 339
            ++ L
Sbjct: 346 PNVKL 350

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  124 bits (313), Expect = 1e-32
 Identities = 70/326 (21%), Positives = 125/326 (38%), Gaps = 74/326 (22%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI----NQASQ-- 123
             ++ +G G    V L +        A+KI++ +  +   +    E+K+    N A    
Sbjct: 22  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTK 79

Query: 124 -----CSHVVVCYHSFYHNGVIS----LVLEYMDRGSLADIIRQ--VKTILEPYLAVVCK 172
                 +H++     F H G       +V E +   +L  +I++   + I   Y+  + K
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNH------KGEVKITDFGVSAMLGSSMGQRDTF 226
           Q+L GL Y+H    +IH DIKP N+L+          ++KI D G +A            
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYD--EHYTNS 195

Query: 227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSWPSFYELLEA 284
           + T  Y SPE + G+ +   +DIWS   ++ E   G   F     ++  S+    + +  
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE---PDEGHSYTKDDDHIAQ 252

Query: 285 IVES--PPPTA--------------------------------------PPDQFSPEFCS 304
           I+E     P+                                            + E   
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 305 FVSACIQKDPRDRSSSLDLLSHPFIK 330
           F+S  +Q DPR R+ +  L++HP++K
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLK 338

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  122 bits (307), Expect = 2e-32
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 52/275 (18%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKINQASQCSHVVVC 130
           +V+G G  G V  + +K     FALK++Q     + E+  ++         SQC H +V 
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV--ELHWRA-----SQCPH-IVR 75

Query: 131 YHSFYHNGVIS-----LVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGLVYLHN 183
               Y N         +V+E +D G L   I  R  +   E   + + K + + + YLH 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134

Query: 184 ERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
             ++ HRD+KP NLL   K     +K+TDFG                      + E  +G
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKE-TTG 172

Query: 241 STYDYSSDIWSLG--LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPD 296
             YD S D+WSLG  + +L C  G +P   S    +      +   I       P     
Sbjct: 173 EKYDKSCDMWSLGVIMYILLC--G-YPPFYSNHGLAISP--GMKTRIRMGQYEFPNPEWS 227

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
           + S E    +   ++ +P  R +  + ++HP+I +
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  118 bits (298), Expect = 3e-31
 Identities = 36/256 (14%), Positives = 70/256 (27%), Gaps = 48/256 (18%)

Query: 74  VIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQASQCSH--VVV 129
             G              + R  AL  +  Q  + +++ ++ +        S+     V  
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR--LSRIDKPGVAR 95

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQGLVYLHNERHVI 188
                +      +V E++  GSL ++         P  A+   + +       H    V 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH-RAGVA 151

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSD 248
                PS + V+  G+V +                         M          +   D
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------NPQDD 184

Query: 249 IWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP----EFCS 304
           I  +G  +    + R+P      +    S     E      P    P         +  +
Sbjct: 185 IRGIGASLYALLVNRWPL----PEAGVRSGLAPAERDTAGQPI--EPADIDRDIPFQISA 238

Query: 305 FVSACIQKDPRDRSSS 320
             +  +Q D   RS+S
Sbjct: 239 VAARSVQGDGGIRSAS 254

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  120 bits (302), Expect = 3e-31
 Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 45/309 (14%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           +  ++ G+G+ G VQL + K  G   A+K +  + +   R   +Q ++        ++V 
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--ELQIMQDLAVLHHPNIVQ 83

Query: 130 CYHSFYHNGV-------ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK----QVLQGL 178
               FY  G        +++V+EY+   +L    R           ++ K    Q+++ +
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142

Query: 179 VYLHNERH-VIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMSP 235
             LH     V HRDIKP N+LVN   G +K+ DFG +  L     + +  ++ +  Y +P
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYICSRYYRAP 200

Query: 236 ERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYELLEAI 285
           E I G+  Y  + DIWS+G +  E  +G   F    S  Q          PS  E+L  +
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS-REVLRKL 259

Query: 286 ----VESPPPTAPPDQFS-----------PEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
                +     +    +S            E    +SA +Q  P +R    + L HP+  
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319

Query: 331 KFEDKDIDL 339
           +  D    L
Sbjct: 320 ELHDPATKL 328

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  119 bits (300), Expect = 1e-30
 Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 49/306 (16%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
              KVIG GS GVV   +        A+K +  + + + R     EL+I +  +  +VV 
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-----ELQIMRIVKHPNVVD 96

Query: 130 CYHSFYHNG------VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCK----QVLQGLV 179
               FY NG       ++LVLEY+   ++    R    + +    ++ K    Q+L+ L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 180 YLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI 238
           Y+H+   + HRDIKP NLL++   G +K+ DFG SA +  +     +++ +  Y +PE I
Sbjct: 156 YIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGEPNVSYICSRYYRAPELI 213

Query: 239 SGSTYDYSS--DIWSLGLVVLECAIGR--FPYMQSEDQ-------------QSWPSFYEL 281
            G+T +Y++  DIWS G V+ E   G+  FP     DQ             +       +
Sbjct: 214 FGAT-NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK---TM 269

Query: 282 LEAIVESPPPTAPPDQFS--------PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE 333
               +E   P   P  FS        P+    +S  ++  P  R ++++ L HPF  +  
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329

Query: 334 DKDIDL 339
             +  +
Sbjct: 330 TGEARM 335

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  113 bits (285), Expect = 6e-29
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 43/298 (14%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSH--VV 128
              +G G+ G V     K  G   A+K +    Q EI  K+  +EL + +     H  V+
Sbjct: 29  PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK--HMQHENVI 86

Query: 129 VCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
                F     +       LV+ +M    L  I+       E  +  +  Q+L+GL Y+H
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIH 143

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
           +   V+HRD+KP NL VN   E+KI DFG++    + M     +V T  Y +PE I    
Sbjct: 144 S-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---YVVTRWYRAPEVILSWM 199

Query: 243 -YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYELLEAI------- 285
            Y+ + DIWS+G ++ E   G+  F      DQ +        P   E ++ +       
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKLNDKAAKS 258

Query: 286 -VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            ++S P T   D      + SP+    +   ++ D   R ++   L+HPF + F D +
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (286), Expect = 1e-28
 Identities = 78/340 (22%), Positives = 133/340 (39%), Gaps = 70/340 (20%)

Query: 56  DYKEFDFEFSLEDL-----ETIKVIGKGS-GGVVQLVRHKWVGRLFALKII----QMNIQ 105
           D  +  +     D      E +KVIGKGS G VV+   HK V +  ALK++    + + Q
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKRFHRQ 139

Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEP 165
                +I++ L+        +V+    +F     I +  E +   +L ++I++ K     
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFS 198

Query: 166 YLAV--VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMG 221
              V      +LQ L  LH  R +IH D+KP N+L+    +  +K+ DFG S      + 
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257

Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR--FP-------------- 265
              T++ +  Y +PE I G+ Y    D+WSLG ++ E   G    P              
Sbjct: 258 ---TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

Query: 266 -----------------YMQSEDQQSWPSFYELLEAIVESPPP-------TAPPDQFS-- 299
                            ++ S+    + +   L +  V              PP+     
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374

Query: 300 --------PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                   P F  F+  C++ DP  R +    L HP++++
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  111 bits (279), Expect = 4e-28
 Identities = 61/323 (18%), Positives = 134/323 (41%), Gaps = 47/323 (14%)

Query: 44  RLISEENESRPS---DYKEFDFEFSL-EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKI 99
           R+ ++ N  RP    DY+    E+   +D + ++ +G+G    V    +        +KI
Sbjct: 9   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 68

Query: 100 IQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFY--HNGVISLVLEYMDRGSLADII 156
           ++       +K+I +E+KI +      +++          +   +LV E+++      + 
Sbjct: 69  LK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124

Query: 157 RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAM 215
           + +      +      ++L+ L Y H+   ++HRD+KP N++++H+  ++++ D+G+ A 
Sbjct: 125 QTLTDYDIRFY---MYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGL-AE 179

Query: 216 LGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFP--------- 265
                 + +  V +  +  PE +     YDYS D+WSLG ++      + P         
Sbjct: 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239

Query: 266 -------YMQSEDQQSWPSFY--ELLEAIVESPP-----------PTAPPDQFSPEFCSF 305
                   + +ED   +   Y  EL     +               +      SPE   F
Sbjct: 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 299

Query: 306 VSACIQKDPRDRSSSLDLLSHPF 328
           +   ++ D + R ++ + + HP+
Sbjct: 300 LDKLLRYDHQSRLTAREAMEHPY 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  112 bits (281), Expect = 9e-28
 Identities = 74/323 (22%), Positives = 132/323 (40%), Gaps = 57/323 (17%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVVVC 130
           +K IG G+ G+V       + R  A+K +    Q +   K+  +EL + +     +++  
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 131 YHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            + F     +       LV+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+ 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS- 182

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
             +IHRD+KPSN++V     +KI DFG++   G+S      +V T  Y +PE I G  Y 
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYK 241

Query: 245 YSSDIWSLGLVVLECAIGR--FP--------------------------------YMQSE 270
            + DIWS+G ++ E    +  FP                                Y+++ 
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301

Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
            + +  +F +L       P  +      + +    +S  +  DP  R S  D L HP+I 
Sbjct: 302 PKYAGLTFPKLFPD-SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

Query: 331 KFEDKDIDLGILVGSLDPPVNCP 353
            + D            +     P
Sbjct: 361 VWYDPA----------EVEAPPP 373

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  109 bits (275), Expect = 1e-27
 Identities = 68/329 (20%), Positives = 124/329 (37%), Gaps = 78/329 (23%)

Query: 70  ETIKVIGKGS-GGVVQLVRHKWVGRLFALKIIQMNI-------QEEIRKQIVQELKINQA 121
           E +  +G+G+ G VV+ + HK  GR  A+KI++ N+       + EI+  +++ L     
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQ--VLEHLNTTDP 73

Query: 122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV--VCKQVLQGLV 179
           +     V     F H+G I +V E +   S  D I++   +      +  +  Q+ + + 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 180 YLHNERHVIHRDIKPSNLLVNH-------------------KGEVKITDFGVSAMLGSSM 220
           +LH+ + + H D+KP N+L                        ++K+ DFG      S+ 
Sbjct: 133 FLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------SAT 185

Query: 221 GQRD---TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR--FP---------Y 266
              +   T V T +Y +PE I    +    D+WS+G +++E  +G   FP          
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 267 MQS--------------------EDQQSWPSFYELLEAIVESPPPT----APPDQFSPEF 302
           M+                      D+  W         +  +  P        D      
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
              +   ++ DP  R +  + L HPF   
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDL 334

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  109 bits (275), Expect = 2e-27
 Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 47/306 (15%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVVVC 130
           +K IG G+ G+V       + R  A+K +    Q +   K+  +EL + +     +++  
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 131 YHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            + F     +       +V+E MD  +L  +I+    +    ++ +  Q+L G+ +LH+ 
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS- 145

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYD 244
             +IHRD+KPSN++V     +KI DFG++   G+S      +V T  Y +PE I G  Y 
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYK 204

Query: 245 YSSDIWSLGLVVLECAIGR--FP--------------------------------YMQSE 270
            + DIWS+G ++ E   G   FP                                Y+++ 
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264

Query: 271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
            + +  SF +L    V  P  +      + +    +S  +  D   R S  + L HP+I 
Sbjct: 265 PKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323

Query: 331 KFEDKD 336
            + D  
Sbjct: 324 VWYDPS 329

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  109 bits (275), Expect = 3e-27
 Identities = 73/393 (18%), Positives = 132/393 (33%), Gaps = 116/393 (29%)

Query: 47  SEENESRPSDYKEFDF------EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII 100
            ++ +  P+DY +  +      +        I+ +G G    V L       +  A+K++
Sbjct: 11  DDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV 70

Query: 101 QMNIQEEIRKQIVQELKI----NQASQ----CSHVVVCYHSFYHNGV----ISLVLEYMD 148
                E   +  + E+++      +         VV     F  +GV    I +V E + 
Sbjct: 71  --KSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL- 127

Query: 149 RGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN------ 200
              L   I +   + +  P +  + +QVLQGL YLH +  +IH DIKP N+L++      
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187

Query: 201 -------------------------------------------HKGEVKITDFGVSAMLG 217
                                                       K +VKI D G +A   
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG-NACWV 246

Query: 218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS 277
                    + T  Y S E + GS Y+  +DIWS   +  E A G + + +    + +  
Sbjct: 247 HK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF-EPHSGEEYTR 303

Query: 278 FYELLEAIVE--SPPP----------------------------------TAPPDQFSPE 301
             + +  I+E     P                                       ++S E
Sbjct: 304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363

Query: 302 ----FCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
               F  F+   ++  P  R+++ + L HP++ 
Sbjct: 364 EAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (273), Expect = 3e-27
 Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 42/298 (14%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSH---- 126
           +  +G G+ G V        G   A+K +    Q  I  K+  +EL++ +     H    
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK--HMKHENVI 91

Query: 127 ----VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
               V     S      + LV   M    L +I++  + + + ++  +  Q+L+GL Y+H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH 149

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
           +   +IHRD+KPSNL VN   E+KI DFG++      M     +V T  Y +PE +    
Sbjct: 150 S-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG---YVATRWYRAPEIMLNWM 205

Query: 243 -YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYELLEAI------- 285
            Y+ + DIWS+G ++ E   GR  FP     DQ          P   ELL+ I       
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264

Query: 286 -VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            ++S       +        +P     +   +  D   R ++   L+H +  ++ D D
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (270), Expect = 1e-26
 Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 38/296 (12%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVVVC 130
           ++ +G G+ G V        G   A+K +    Q E+  K+  +EL++ +  +  +V+  
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89

Query: 131 YHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
              F  +  +       LV+ +M    L  +++  + + E  +  +  Q+L+GL Y+H  
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA- 146

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
             +IHRD+KP NL VN   E+KI DFG++    S M     +V T  Y +PE I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG---YVVTRWYRAPEVILNWMRY 203

Query: 244 DYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYELLEAI--------V 286
             + DIWS+G ++ E   G+  F      DQ          P   E ++ +        +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP-AEFVQRLQSDEAKNYM 262

Query: 287 ESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
           +  P     D        SP   + +   +  D   R ++ + L+HP+ +   D +
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  107 bits (269), Expect = 1e-26
 Identities = 65/357 (18%), Positives = 122/357 (34%), Gaps = 91/357 (25%)

Query: 56  DYKEFDFEFSLEDL-----ETIKVIGKGS-GGVVQLVRHKWVGRLFALKIIQMNI----- 104
           D KE      + D      E +  +G+G+ G VV+ + H       ALKII+ N+     
Sbjct: 3   DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYRE 61

Query: 105 --QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTI 162
             + EI   +++++K          V+    F  +G + +  E + + +  + +++    
Sbjct: 62  AARLEIN--VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQ 118

Query: 163 LEPYLAV--VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH------------------- 201
             P   V  +  Q+   L +LH  + + H D+KP N+L  +                   
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 202 KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI 261
              +++ DFG +           T V T +Y  PE I    +    D+WS+G ++ E   
Sbjct: 178 NTSIRVADFGSATFDHEHHT---TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVE--SPPPT--------------------------- 292
           G F   Q+ +        E L  + +   P P+                           
Sbjct: 235 G-FTLFQTHEN------REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287

Query: 293 -------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
                                +    +   ++ DP  R +  + L HPF      ++
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (269), Expect = 1e-26
 Identities = 60/328 (18%), Positives = 113/328 (34%), Gaps = 62/328 (18%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR----------KQIVQELKIN 119
              + I  GS G V        G   A+K +   + +             K++++E+++ 
Sbjct: 25  TVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 120 QASQCSHVVVCYHSFYHNGV-----ISLVLEYMDRGSLADIIRQVKTILEP----YLAVV 170
                 +++     F H        + LV E M    LA +I   + ++ P    Y    
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY- 141

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
              +L GL  LH    V+HRD+ P N+L+    ++ I DF ++    +   +   +V   
Sbjct: 142 --HILLGLHVLHE-AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH-YVTHR 197

Query: 231 NYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYE 280
            Y +PE +     +    D+WS G V+ E    +  F      +Q +        P   E
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK-IE 256

Query: 281 LLEAI--------VESPPPTAPPDQF-------SPEFCSFVSACIQKDPRDRSSSLDLLS 325
            +           + +     P   +        P     ++  ++ +P+ R S+   L 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

Query: 326 HPFIKKFEDKDIDLGILVGSLDPPVNCP 353
           HP+ +   D            D      
Sbjct: 317 HPYFESLFDPL----------DLTEGLS 334

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  106 bits (266), Expect = 3e-26
 Identities = 68/316 (21%), Positives = 132/316 (41%), Gaps = 62/316 (19%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSH-- 126
           +   ++G+G+ GVV    HK  G + A+K I+    + +   + ++E+KI +     H  
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILK--HFKHEN 70

Query: 127 VVVCYHSFYHNGV-----ISLVLEYMDRGSLADIIR-------QVKTILEPYLAVVCKQV 174
           ++  ++    +       + ++ E M    L  +I         ++  +  Y      Q 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI--Y------QT 121

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM- 233
           L+ +  LH   +VIHRD+KPSNLL+N   ++K+ DFG++ ++  S        G  + M 
Sbjct: 122 LRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 234 ---------SPERI-SGSTYDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW------ 275
                    +PE + + + Y  + D+WS G ++ E  + R  FP      Q         
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240

Query: 276 -PSFYELLEAI--------VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSS 320
            P     L  I        ++S P            + +P+    +   +  DP  R ++
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300

Query: 321 LDLLSHPFIKKFEDKD 336
            + L HP+++ + D +
Sbjct: 301 KEALEHPYLQTYHDPN 316

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (266), Expect = 4e-26
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 24/235 (10%)

Query: 70  ETIKVIGKGS-GGVVQLVRHKWVGRLFALKII----QMNIQEEIRKQIVQELKINQASQC 124
           E   +IGKGS G VV+           A+KII        Q +I  ++++ +  +     
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV--VCKQVLQGLVYLH 182
            ++V     F     + LV E +   +L D++R                +Q+   L++L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 183 NER-HVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
                +IH D+KP N+L+ +  +  +KI DFG S  LG  +     ++ +  Y SPE + 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYRSPEVLL 231

Query: 240 GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE--SPPPT 292
           G  YD + D+WSLG +++E   G  P     ++       + +  IVE    PP 
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTG-EPLFSGANE------VDQMNKIVEVLGIPPA 279

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  105 bits (265), Expect = 7e-26
 Identities = 72/348 (20%), Positives = 127/348 (36%), Gaps = 90/348 (25%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA 121
            E S +     K +G GS G+V  V     G+ FALK +   +Q+   K   +EL I + 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKN--RELDIMKV 56

Query: 122 SQCSHVVVCYHSFYHNGV--------------------------------------ISLV 143
               +++     FY  G                                       ++++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 144 LEYMDRGSLADIIRQVKTILEPYLAVVCK----QVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +EY+   +L  +++            +      Q+ + + ++H+   + HRDIKP NLLV
Sbjct: 117 MEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG-ICHRDIKPQNLLV 174

Query: 200 N-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVL 257
           N     +K+ DFG SA           ++ +  Y +PE + G+T Y  S D+WS+G V  
Sbjct: 175 NSKDNTLKLCDFG-SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 258 ECAIGR--FPYMQSEDQQSWPSFYELLEAIVE---SPP----------------PTAPPD 296
           E  +G+  F    S DQ         L  I++   +P                 PT    
Sbjct: 234 ELILGKPLFSGETSIDQ---------LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 297 QFS--------PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            +               +   ++ +P  R +  + ++HPF     +  
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSY 332

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (263), Expect = 1e-25
 Identities = 68/323 (21%), Positives = 118/323 (36%), Gaps = 71/323 (21%)

Query: 75  IGKGSGGVVQLVRHKWV--GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV---- 128
           +G+G+ G V   + K     + +ALK I+      I     +E+ + +  +  +V+    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVISLQK 85

Query: 129 VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV---------CKQVLQGLV 179
           V       +  + L+ +Y +   L  II+  +        V            Q+L G+ 
Sbjct: 86  VFLSH--ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 180 YLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAMLGS---SMGQRDTFVGTYNY 232
           YLH    V+HRD+KP+N+LV      +G VKI D G + +  S    +   D  V T+ Y
Sbjct: 143 YLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 233 MSPERISGST-YDYSSDIWSLGLVVLECAIGR--FP---------YMQSEDQ-------- 272
            +PE + G+  Y  + DIW++G +  E       F               DQ        
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 273 -----QSWPSFYELLEAIVESPPPTAPP----------DQFSPEFCSFVSACIQK----D 313
                + W    ++ E                      ++   +  S     +QK    D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 314 PRDRSSSLDLLSHPFIKKFEDKD 336
           P  R +S   +  P+   F +  
Sbjct: 322 PIKRITSEQAMQDPY---FLEDP 341

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (257), Expect = 2e-25
 Identities = 60/287 (20%), Positives = 113/287 (39%), Gaps = 50/287 (17%)

Query: 51  ESRPSDYKEF---DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE 107
               +   EF    +  ++++L+ ++ IGKG  G V  +   + G   A+K I+ +   +
Sbjct: 2   GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ 59

Query: 108 IRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQV--KT 161
                + E  +    + S++V    V        G + +V EYM +GSL D +R      
Sbjct: 60  ---AFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYMAKGSLVDYLRSRGRSV 113

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
           +    L      V + + YL    + +HRD+   N+LV+     K++DFG++        
Sbjct: 114 LGGDCLLKFSLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------- 164

Query: 222 QRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQS 274
            ++             + +PE +    +   SD+WS G+++ E    GR PY        
Sbjct: 165 -KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PR 217

Query: 275 WPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            P   +++  + +      P   PP  +       +  C   D   R
Sbjct: 218 IPL-KDVVPRVEKGYKMDAPDGCPPAVY-----EVMKNCWHLDAAMR 258

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  103 bits (258), Expect = 5e-25
 Identities = 73/364 (20%), Positives = 129/364 (35%), Gaps = 91/364 (25%)

Query: 47  SEENESRPSDY--KEFDFEFSLEDL-----ETIKVIGKGS-GGVVQLVRHKWVGRLFALK 98
           S   E+       +   F +    L       I+ +G G+ G V+         + +A+K
Sbjct: 8   SSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVK 66

Query: 99  IIQMNIQEEIRKQIVQELKI-----NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLA 153
           +++ NI++   +    E  I     N     +++V  +  F +   + L+ E +   SL 
Sbjct: 67  VVR-NIKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLY 123

Query: 154 DIIRQVKTILEPYLAV--VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---------- 201
           +II +          +   C ++L+ L YL     + H D+KP N+L++           
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITV 182

Query: 202 ---------------KGEVKITDFGVSAMLGSSMGQRD---TFVGTYNYMSPERISGSTY 243
                             +K+ DFG       +  + D   + + T  Y +PE I    +
Sbjct: 183 RRVTDGKKIQIYRTKSTGIKLIDFG------CATFKSDYHGSIINTRQYRAPEVILNLGW 236

Query: 244 DYSSDIWSLGLVVLECAIGR--FP--------------------YM-------------- 267
           D SSD+WS G V+ E   G   F                      M              
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN 296

Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFS-PEFCSFVSACIQKDPRDRSSSLDLLSH 326
           + E + +WP     + +I                 FC F+ + +Q DP  R S  +LL H
Sbjct: 297 KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356

Query: 327 PFIK 330
            F++
Sbjct: 357 KFLE 360

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  103 bits (258), Expect = 6e-25
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 51/280 (18%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
            +  + EDL   + IG+G+ G V   R +    L A+K  +  +  +++ + +QE +I +
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167

Query: 121 ASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQ 173
                ++V         GV +      +V+E +  G     +R     L    L  +   
Sbjct: 168 QYSHPNIVRLI------GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY- 232
              G+ YL   +  IHRD+   N LV  K  +KI+DFG+S         R+   G Y   
Sbjct: 222 AAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMS---------REEADGVYAAS 271

Query: 233 ----------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYEL 281
                      +PE ++   Y   SD+WS G+++ E  ++G  PY       +  +  + 
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY------PNLSN-QQT 324

Query: 282 LEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E + +      P   P           +  C   +P  R
Sbjct: 325 REFVEKGGRLPCPELCP-----DAVFRLMEQCWAYEPGQR 359

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  101 bits (253), Expect = 1e-24
 Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 46/308 (14%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-------EIR-------KQIVQE 115
             +K +G G  G+V         +  A+K I +   +       EI+         IV+ 
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73

Query: 116 LKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL 175
            +I   S              N V  +V EYM+   LA+++ Q   +LE +  +   Q+L
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVY-IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLL 130

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMGQRDT---FVGTYN 231
           +GL Y+H+  +V+HRD+KP+NL +N +   +KI DFG++ ++      +      + T  
Sbjct: 131 RGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 232 YMSPERISGST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYEL 281
           Y SP  +     Y  + D+W+ G +  E   G+  F      +Q              E 
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH-EED 248

Query: 282 LEAI-------VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF 328
            + +       + +                S E   F+   +   P DR ++ + LSHP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 329 IKKFEDKD 336
           +  +    
Sbjct: 309 MSIYSFPM 316

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (252), Expect = 1e-24
 Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 51/300 (17%)

Query: 52  SRPSDYKEFD-FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQE 106
           S      E D   F    L+ I+ +G+G  G V+L R+   G       A+K ++     
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64

Query: 107 EIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-T 161
                + +E++I +     ++V    +C     +   I L++E++  GSL + + + K  
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPKNKNK 122

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
           I          Q+ +G+ YL   R  +HRD+   N+LV  + +VKI DFG++        
Sbjct: 123 INLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLT-------- 173

Query: 222 QRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE----CAIGRFP 265
            +        Y             +PE +  S +  +SD+WS G+ + E    C     P
Sbjct: 174 -KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232

Query: 266 YMQSEDQQSWP----SFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                          +   L+  + E      PP  P      E    +  C +  P +R
Sbjct: 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNR 287

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  101 bits (254), Expect = 1e-24
 Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 42/300 (14%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSH--VV 128
           +  IG+G+ G+V            A+K I    + +   ++ ++E+KI    +  H  ++
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL--RFRHENII 88

Query: 129 VCYHSFYHNGV-----ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN 183
                     +     + +V + M+   L  +++  + +   ++     Q+L+GL Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS 146

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTYNYMSPERISG 240
             +V+HRD+KPSNLL+N   ++KI DFG++ +             +V T  Y +PE +  
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

Query: 241 ST-YDYSSDIWSLGLVVLECAIGR--FPYMQSEDQQSW-------PSFYELLEAI----- 285
           S  Y  S DIWS+G ++ E    R  FP     DQ +        PS  E L  I     
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS-QEDLNCIINLKA 264

Query: 286 ---VESPPPTAPPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
              + S P                +    +   +  +P  R      L+HP+++++ D  
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  100 bits (251), Expect = 2e-24
 Identities = 62/281 (22%), Positives = 120/281 (42%), Gaps = 38/281 (13%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQL----VRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI 118
            F    L+ I+ +G+G  G V L      +   G + A+K ++ +   + R    QE+ I
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 119 NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQV 174
            +     H++     C  +   +  + LV+EY+  GSL D + +  +I    L +  +Q+
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQI 143

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN--- 231
            +G+ YLH  +H IHRD+   N+L+++   VKI DFG++  +       + +    +   
Sbjct: 144 CEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDS 199

Query: 232 ---YMSPERISGSTYDYSSDIWSLGLVVLE----CAIGRFPYMQSEDQQSWP----SFYE 280
              + +PE +    + Y+SD+WS G+ + E    C   + P  +  +         +   
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259

Query: 281 LLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           L E +        P   P + +       +  C + +   R
Sbjct: 260 LTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFR 295

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (252), Expect = 2e-24
 Identities = 68/283 (24%), Positives = 106/283 (37%), Gaps = 66/283 (23%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLF----------ALKIIQMNIQEEIRKQIVQEL 116
            + + IKV+G G+ G V      + G             A+K ++     +  K+I+ E 
Sbjct: 15  TEFKKIKVLGSGAFGTV------YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68

Query: 117 KINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-TILEPYLAVV 170
            +  +    HV          G+       L+ + M  G L D +R+ K  I   YL   
Sbjct: 69  YVMASVDNPHVCRLL------GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           C Q+ +G+ YL  +R ++HRD+   N+LV     VKITDFG++         +       
Sbjct: 123 CVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLA---------KLLGAEEK 172

Query: 231 NY-----------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSF 278
            Y           M+ E I    Y + SD+WS G+ V E    G  PY         P+ 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA- 225

Query: 279 YELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E+   + +      PP    D         +  C   D   R
Sbjct: 226 SEISSILEKGERLPQPPICTID-----VYMIMRKCWMIDADSR 263

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  101 bits (253), Expect = 3e-24
 Identities = 71/324 (21%), Positives = 112/324 (34%), Gaps = 79/324 (24%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----------- 95
                +  +       E   +++  I+ +G G+ G V      + G++            
Sbjct: 51  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQV 104

Query: 96  ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDR 149
           A+K +     E+     + E  I       ++V C       GV        ++LE M  
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI------GVSLQSLPRFILLELMAG 158

Query: 150 GSLADIIR-------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           G L   +R       Q  ++    L  V + +  G  YL  E H IHRDI   N L+   
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCP 217

Query: 203 GE---VKITDFGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSS 247
           G     KI DFG++         RD +   Y Y            M PE      +   +
Sbjct: 218 GPGRVAKIGDFGMA---------RDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKT 267

Query: 248 DIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEF 302
           D WS G+++ E   +G  PY    +Q       E+LE +       PP   P        
Sbjct: 268 DTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCP-----GPV 315

Query: 303 CSFVSACIQKDPRDRSSSLDLLSH 326
              ++ C Q  P DR +   +L  
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILER 339

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (255), Expect = 3e-24
 Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 47/303 (15%)

Query: 32  HDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV 91
            D D L  +     + E   +   ++    +  ++++L+ ++ IGKG  G V  +   + 
Sbjct: 158 TDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYR 215

Query: 92  GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYM 147
           G   A+K I+ +   +     + E  +    + S++V    V        G + +V EYM
Sbjct: 216 GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYM 269

Query: 148 DRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV 205
            +GSL D +R      +    L      V + + YL    + +HRD+   N+LV+     
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVA 328

Query: 206 KITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLEC 259
           K++DFG++         ++             + +PE +    +   SD+WS G+++ E 
Sbjct: 329 KVSDFGLT---------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

Query: 260 A-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDP 314
              GR PY         P   +++  + +      P   P     P     +  C   D 
Sbjct: 380 YSFGRVPY------PRIPL-KDVVPRVEKGYKMDAPDGCP-----PAVYDVMKNCWHLDA 427

Query: 315 RDR 317
             R
Sbjct: 428 ATR 430

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  100 bits (251), Expect = 6e-24
 Identities = 74/349 (21%), Positives = 134/349 (38%), Gaps = 82/349 (23%)

Query: 59  EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELK 117
             D        E +K +GKG+ G+V     +  G + A+K I    Q     ++  +E+ 
Sbjct: 2   RVDRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM 60

Query: 118 I-NQASQCSHVVVCYHSFY--HNGVISLVLEYMDRGSLADIIR-------QVKTILEPYL 167
           I  + S   ++V   +     ++  + LV +YM+   L  +IR         + ++  Y 
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVV--Y- 116

Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV 227
                Q+++ + YLH    ++HRD+KPSN+L+N +  VK+ DFG+S    +     +   
Sbjct: 117 -----QLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 228 GTYN---------------------YMSPERISGST-YDYSSDIWSLGLVVLECAIGR-- 263
            + N                     Y +PE + GST Y    D+WSLG ++ E   G+  
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

Query: 264 FP---------------------------------YMQS---EDQQSWPSFYELLEAIVE 287
           FP                                  ++S   + +    +  ++      
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
                 P    + E    +   +Q +P  R S+ D L HPF+  F + +
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 70/304 (23%), Positives = 109/304 (35%), Gaps = 71/304 (23%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNIQEEIRKQIVQE 115
           E   +++  I+ +G G+ G V     +  G          A+K +     E+     + E
Sbjct: 26  EVPRKNITLIRGLGHGAFGEV--YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83

Query: 116 LKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIR-------QVKTI 162
             I       ++V C       GV        +++E M  G L   +R       Q  ++
Sbjct: 84  ALIISKFNHQNIVRCI------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137

Query: 163 LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSS 219
               L  V + +  G  YL  E H IHRDI   N L+   G     KI DFG++      
Sbjct: 138 AMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------ 190

Query: 220 MGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPY 266
              RD +  +Y Y            M PE      +   +D WS G+++ E   +G  PY
Sbjct: 191 ---RDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

Query: 267 MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD 322
               +Q       E+LE +       PP   P           ++ C Q  P DR +   
Sbjct: 247 PSKSNQ-------EVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCWQHQPEDRPNFAI 294

Query: 323 LLSH 326
           +L  
Sbjct: 295 ILER 298

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 64/301 (21%), Positives = 121/301 (40%), Gaps = 37/301 (12%)

Query: 31  FHDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKW 90
           ++          L  +   ++ +     +  +E   E L     +G+G  G V      W
Sbjct: 148 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV--WMGTW 205

Query: 91  VGRLF-ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVL 144
            G    A+K ++        +  +QE ++ +  +   +V  Y       V+S     +V 
Sbjct: 206 NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLY------AVVSEEPIYIVT 257

Query: 145 EYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           EYM +GSL D ++    K +  P L  +  Q+  G+ Y+    + +HRD++ +N+LV   
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGEN 316

Query: 203 GEVKITDFGVS-AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA- 260
              K+ DFG++  +  +    R        + +PE      +   SD+WS G+++ E   
Sbjct: 317 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRD 316
            GR PY    ++       E+L+ +        PP  P           +  C +K+P +
Sbjct: 377 KGRVPYPGMVNR-------EVLDQVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEE 424

Query: 317 R 317
           R
Sbjct: 425 R 425

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 51/307 (16%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVV---QLVRHKWVGRLFALKIIQM 102
           +S  N       +      S   +   +VIG+G  G V    L+ +       A+K +  
Sbjct: 68  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 127

Query: 103 NIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQ 158
                   Q + E  I +     +V+    +C  S    G   +VL YM  G L + IR 
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRN 184

Query: 159 VKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG 217
                    L     QV +G+ +L   +  +HRD+   N +++ K  VK+ DFG++    
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLA---- 239

Query: 218 SSMGQRDTFVGTYNY-------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGR 263
                RD +   ++              M+ E +    +   SD+WS G+++ E    G 
Sbjct: 240 -----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294

Query: 264 FPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS 319
            PY          +F ++   +++      P   P           +  C       R S
Sbjct: 295 PPY------PDVNTF-DITVYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPS 342

Query: 320 SLDLLSH 326
             +L+S 
Sbjct: 343 FSELVSR 349

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 63/314 (20%), Positives = 113/314 (35%), Gaps = 61/314 (19%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVV---QLVRHKWVGRLFALKIIQM 102
           IS+E + +  D          +     +++GKG  G V   QL +        A+K+++ 
Sbjct: 7   ISDELKEKLEDV-----LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61

Query: 103 NIQEEIRKQ-IVQELKINQASQCSHVV----VCYHS--FYHNGVISLVLEYMDRGSLADI 155
           +I      +  ++E    +     HV     V   S       +  ++L +M  G L   
Sbjct: 62  DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121

Query: 156 IRQVKTILEPY------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           +   +    P+      L      +  G+ YL + R+ IHRD+   N ++     V + D
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL-SSRNFIHRDLAARNCMLAEDMTVCVAD 180

Query: 210 FGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVL 257
           FG+S         R  + G Y Y            ++ E ++ + Y   SD+W+ G+ + 
Sbjct: 181 FGLS---------RKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230

Query: 258 ECA-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQK 312
           E    G+ PY          +  E+   ++       PP         E    +  C   
Sbjct: 231 EIMTRGQTPY------AGIENA-EIYNYLIGGNRLKQPPECM-----EEVYDLMYQCWSA 278

Query: 313 DPRDRSSSLDLLSH 326
           DP+ R S   L   
Sbjct: 279 DPKQRPSFTCLRME 292

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 67/293 (22%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEI 108
            EF  E    ++   KV+G G  G V        GRL          A+K +++   E+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEV------CSGRLKLPSKKEISVAIKTLKVGYTEKQ 89

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTI 162
           R+  + E  I       +++         GV++      +V EYM+ GSL   +R+    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLE------GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 163 LEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
                L  + + +  G+ YL ++   +HRD+   N+L+N     K++DFG+         
Sbjct: 144 FTVIQLVGMLRGIASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLG-------- 194

Query: 222 QRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQ 268
            R                      SPE I+   +  +SD+WS G+V+ E    G  PY +
Sbjct: 195 -RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

Query: 269 SEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             +Q       ++++A+ E     PP   P   +       +  C QKD  +R
Sbjct: 254 MSNQ-------DVIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNR 294

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 65/293 (22%), Positives = 108/293 (36%), Gaps = 67/293 (22%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEI 108
           + F  E     +   K+IG G  G V        GRL          A+K ++    E  
Sbjct: 40  RSFTREIEASRIHIEKIIGSGDSGEV------CYGRLRVPGQRDVPVAIKALKAGYTERQ 93

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTI 162
           R+  + E  I       +++         GV++      +V EYM+ GSL   +R     
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLE------GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147

Query: 163 LEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
                L  + + V  G+ YL ++   +HRD+   N+LV+     K++DFG+S        
Sbjct: 148 FTIMQLVGMLRGVGAGMRYL-SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS-------- 198

Query: 222 QRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQ 268
            R                      +PE I+  T+  +SD+WS G+V+ E    G  PY  
Sbjct: 199 -RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257

Query: 269 SEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             ++       +++ ++ E      P   P           +  C  KD   R
Sbjct: 258 MTNR-------DVISSVEEGYRLPAPMGCPHALH-----QLMLDCWHKDRAQR 298

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.5 bits (241), Expect = 3e-23
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 66/288 (22%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEIRKQ 111
           D+E   E +E  + IG+G  G V        G            A+K  +    + +R++
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDV------HQGIYMSPENPALAVAIKTCKNCTSDSVREK 62

Query: 112 IVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-TILEP 165
            +QE    +     H+V         GVI+     +++E    G L   ++  K ++   
Sbjct: 63  FLQEALTMRQFDHPHIVKLI------GVITENPVWIIMELCTLGELRSFLQVRKYSLDLA 116

Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            L +   Q+   L YL   +  +HRDI   N+LV+    VK+ DFG+S         R  
Sbjct: 117 SLILYAYQLSTALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---------RYM 166

Query: 226 FVGTYNY-----------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQ 273
              TY Y           M+PE I+   +  +SD+W  G+ + E    G  P+   ++  
Sbjct: 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN- 224

Query: 274 SWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                 +++  I        PP  PP  +     S ++ C   DP  R
Sbjct: 225 ------DVIGRIENGERLPMPPNCPPTLY-----SLMTKCWAYDPSRR 261

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 50/286 (17%)

Query: 57  YKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----------ALKIIQMNIQE 106
             +F  E     +   KVIG G  G V      + G L           A+K ++    E
Sbjct: 34  VLKFTTEIHPSCVTRQKVIGAGEFGEV------YKGMLKTSSGKKEVPVAIKTLKAGYTE 87

Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVK 160
           + R   + E  I       +++         GVIS      ++ EYM+ G+L   +R+  
Sbjct: 88  KQRVDFLGEAGIMGQFSHHNIIRLE------GVISKYKPMMIITEYMENGALDKFLREKD 141

Query: 161 -TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS 219
                  L  + + +  G+ YL    + +HRD+   N+LVN     K++DFG+S +L   
Sbjct: 142 GEFSVLQLVGMLRGIAAGMKYL-ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

Query: 220 MGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSW 275
                T  G      + +PE IS   +  +SD+WS G+V+ E    G  PY +  +    
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--- 257

Query: 276 PSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
               E+++AI +      P   P   +       +  C Q++   R
Sbjct: 258 ----EVMKAINDGFRLPTPMDCPSAIY-----QLMMQCWQQERARR 294

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 60/319 (18%), Positives = 110/319 (34%), Gaps = 61/319 (19%)

Query: 52  SRPSDYKEFDFEFSLEDLETIKVIGKGSGGVV---QLVRHKWVGRLFA---LKIIQMNIQ 105
           S     K  D       L   K++G+G  G V    L +        A   +K+   + +
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78

Query: 106 EEIRKQIVQELKINQASQCSHVV----VCYHS-FYHNGVISLVLEYMDRGSLADIIRQVK 160
           E   ++ + E    +     +V+    VC            ++L +M  G L   +   +
Sbjct: 79  E--IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136

Query: 161 TILEPY------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
               P       L      +  G+ YL + R+ +HRD+   N ++     V + DFG+S 
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYL-SNRNFLHRDLAARNCMLRDDMTVCVADFGLS- 194

Query: 215 MLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA-I 261
                   +  + G Y Y            ++ E ++   Y   SD+W+ G+ + E A  
Sbjct: 195 --------KKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

Query: 262 GRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           G  PY          +  E+ + ++       P          E    + +C + DP DR
Sbjct: 246 GMTPY------PGVQNH-EMYDYLLHGHRLKQPEDCL-----DELYEIMYSCWRTDPLDR 293

Query: 318 SSSLDLLSH--PFIKKFED 334
            +   L       ++   D
Sbjct: 294 PTFSVLRLQLEKLLESLPD 312

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 71/314 (22%), Positives = 139/314 (44%), Gaps = 44/314 (14%)

Query: 32  HDGDLLLNQKGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKW- 90
           HD D+   +      +  +     D  +F+       L+ ++ +GKG+ G V++ R+   
Sbjct: 10  HDYDIPTTENLYFQGAMGSAFEDRDPTQFE----ERHLKFLQQLGKGNFGSVEMCRYDPL 65

Query: 91  ---VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLV 143
               G + A+K +Q + +E +R    +E++I ++ Q  ++V    VCY +   N  + L+
Sbjct: 66  QDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLI 122

Query: 144 LEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK 202
           +EY+  GSL D +++ K  I    L     Q+ +G+ YL   +  IHRD+   N+LV ++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENE 181

Query: 203 GEVKITDFGVSAMLGSSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVV 256
             VKI DFG++ +L      ++ +           + +PE ++ S +  +SD+WS G+V+
Sbjct: 182 NRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238

Query: 257 LE-------CAIGRFPYMQSEDQQSWP--SFYELLEAIVE----SPPPTAPPDQFSPEFC 303
            E              +M+            + L+E +        P   P + +     
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY----- 293

Query: 304 SFVSACIQKDPRDR 317
             ++ C   +   R
Sbjct: 294 MIMTECWNNNVNQR 307

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 79/314 (25%)

Query: 57  YKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-----------ALKIIQMNIQ 105
           Y   ++E + E +   + +G+GS G+V      + G              A+K +     
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMV------YEGVAKGVVKDEPETRVAIKTVNEAAS 68

Query: 106 EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQV 159
              R + + E  + +   C HVV         GV+S      +++E M RG L   +R +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLL------GVVSQGQPTLVIMELMTRGDLKSYLRSL 122

Query: 160 KTILEPY----------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
           +  +             +  +  ++  G+ YL N    +HRD+   N +V     VKI D
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTVKIGD 181

Query: 210 FGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVL 257
           FG++         RD +   Y Y            MSPE +    +   SD+WS G+V+ 
Sbjct: 182 FGMT---------RDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231

Query: 258 ECA-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQK 312
           E A +   PY    ++       ++L  ++E      P   P           +  C Q 
Sbjct: 232 EIATLAEQPYQGLSNE-------QVLRFVMEGGLLDKPDNCP-----DMLFELMRMCWQY 279

Query: 313 DPRDRSSSLDLLSH 326
           +P+ R S L+++S 
Sbjct: 280 NPKMRPSFLEIISS 293

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 70/290 (24%), Positives = 129/290 (44%), Gaps = 54/290 (18%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKW----VGRLFALKIIQMNIQEEIRKQIVQELKI 118
           +F    L+ ++ +GKG+ G V++ R+       G + A+K +Q + +E +R    +E++I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEI 64

Query: 119 NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQ 173
            ++ Q  ++V    VCY +   N  + L++EY+  GSL D +++ K  I    L     Q
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN-- 231
           + +G+ YL   +  IHRD+   N+LV ++  VKI DFG++ +L      ++ F       
Sbjct: 123 ICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGE 178

Query: 232 ----YMSPERISGSTYDYSSDIWSLGLVVLE----------------CAIGRFPYMQSED 271
               + +PE ++ S +  +SD+WS G+V+ E                  IG     Q   
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 272 QQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                    L+E +        P   P + +       ++ C   +   R
Sbjct: 239 F-------HLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQR 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 37/281 (13%)

Query: 51  ESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-ALKIIQMNIQEEIR 109
           + +     +  +E   E L     +G+G  G V      W G    A+K ++        
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV--WMGTWNGTTRVAIKTLKPGTMS--P 306

Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIR--QVKTI 162
           +  +QE ++ +  +   +V  Y       V+S     +V EYM +GSL D ++    K +
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 163 LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-AMLGSSMG 221
             P L  +  Q+  G+ Y+    + +HRD++ +N+LV      K+ DFG++  +  +   
Sbjct: 361 RLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419

Query: 222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYE 280
            R        + +PE      +   SD+WS G+++ E    GR PY    ++       E
Sbjct: 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------E 472

Query: 281 LLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           +L+ +        PP  P           +  C +K+P +R
Sbjct: 473 VLDQVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEER 508

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 60/304 (19%), Positives = 108/304 (35%), Gaps = 63/304 (20%)

Query: 55  SDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQ 105
           ++ K+           + +VIGKG  GVV      + G            A+K +    +
Sbjct: 9   AEVKDVLIPHERVVTHSDRVIGKGHFGVV------YHGEYIDQAQNRIQCAIKSLSRITE 62

Query: 106 EEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKT 161
            +  +  ++E  + +     +V+    +        G+  ++L YM  G L   IR  + 
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---EGLPHVLLPYMCHGDLLQFIRSPQR 119

Query: 162 IL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
                 L     QV +G+ YL  E+  +HRD+   N +++    VK+ DFG++       
Sbjct: 120 NPTVKDLISFGLQVARGMEYL-AEQKFVHRDLAARNCMLDESFTVKVADFGLA------- 171

Query: 221 GQRDTFVGTYNY-------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPY 266
             RD     Y                + E +    +   SD+WS G+++ E    G  PY
Sbjct: 172 --RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

Query: 267 MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLD 322
                 +    F +L   + +      P   P           +  C + DP  R +   
Sbjct: 230 ------RHIDPF-DLTHFLAQGRRLPQPEYCP-----DSLYQVMQQCWEADPAVRPTFRV 277

Query: 323 LLSH 326
           L+  
Sbjct: 278 LVGE 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 53/299 (17%)

Query: 55  SDYKEFDFEFSLEDLETIKVIGKGSGGVV---QLVRHKWVGRLFALKIIQMNIQEEIRKQ 111
              +      S   +   +VIG+G  G V    L+ +       A+K +          Q
Sbjct: 13  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 72

Query: 112 IVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY- 166
            + E  I +     +V+    +C  S    G   +VL YM  G L + IR          
Sbjct: 73  FLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129

Query: 167 LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF 226
           L     QV +G+ YL   +  +HRD+   N +++ K  VK+ DFG++         RD +
Sbjct: 130 LIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLA---------RDMY 179

Query: 227 VGTYNY--------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSED 271
              Y Y              M+ E +    +   SD+WS G+++ E    G  PY     
Sbjct: 180 DKEY-YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----- 233

Query: 272 QQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                +F ++   +++      P   P           +  C       R S  +L+S 
Sbjct: 234 -PDVNTF-DITVYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSELVSR 285

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 64/299 (21%)

Query: 49  ENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKI 99
           + E   +     D+E   E +E  + IG+G  G V        G            A+K 
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDV------HQGIYMSPENPAMAVAIKT 425

Query: 100 IQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLAD 154
            +    + +R++ +QE    +     H+V         GVI+     +++E    G L  
Sbjct: 426 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLI------GVITENPVWIIMELCTLGELRS 479

Query: 155 IIRQVKTILEPY-LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
            ++  K  L+   L +   Q+   L YL   +  +HRDI   N+LV+    VK+ DFG+S
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538

Query: 214 AMLGSSMGQRDTFVGTY----------NYMSPERISGSTYDYSSDIWSLGLVVLE-CAIG 262
                    R     TY           +M+PE I+   +  +SD+W  G+ + E    G
Sbjct: 539 ---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589

Query: 263 RFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             P+      Q   +  +++  I        PP  PP  +     S ++ C   DP  R
Sbjct: 590 VKPF------QGVKN-NDVIGRIENGERLPMPPNCPPTLY-----SLMTKCWAYDPSRR 636

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 77/373 (20%), Positives = 130/373 (34%), Gaps = 98/373 (26%)

Query: 52  SRPSDYKEFDFEFSLED-LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR- 109
            R + Y +      + D      +IG+GS G V L   K   +  A+K +    ++ I  
Sbjct: 10  GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC 69

Query: 110 KQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIR------- 157
           K+I++E+ I    +  +++  Y     + ++      +VLE  D   L  + +       
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTE 128

Query: 158 -QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
             +KTIL  Y       +L G  ++H E  +IHRD+KP+N L+N    VK+ DFG++  +
Sbjct: 129 EHIKTIL--Y------NLLLGENFIH-ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 217 GSSMGQRDTFVGTYN----------------------YMSPERISGST-YDYSSDIWSLG 253
            S            N                      Y +PE I     Y  S DIWS G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 254 ----------LVVLECAIGR---FP--------YMQSEDQQSWPSFYELLEAIVE---SP 289
                        +     R   FP          ++  +    S  + L  I     +P
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299

Query: 290 P-------------------PTAPPDQF-------SPEFCSFVSACIQKDPRDRSSSLDL 323
                               P   P          S +  + + + ++ +P  R +    
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359

Query: 324 LSHPFIKKFEDKD 336
           L HP++K    K 
Sbjct: 360 LDHPYLKDVRKKK 372

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.4 bits (233), Expect = 4e-22
 Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 66/288 (22%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEIRKQ 111
            +  + ED+   +++G+G  G V      + G            A+K  + +   + +++
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEV------YEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 59

Query: 112 IVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-TILEP 165
            + E  I +     H+V         G+I      +++E    G L   + + K ++   
Sbjct: 60  FMSEAVIMKNLDHPHIVKLI------GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL 113

Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            L +   Q+ + + YL    + +HRDI   N+LV     VK+ DFG+S         R  
Sbjct: 114 TLVLYSLQICKAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLS---------RYI 163

Query: 226 FVGTYNY-----------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQ 273
               Y Y           MSPE I+   +  +SD+W   + + E    G+ P+   E++ 
Sbjct: 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK- 221

Query: 274 SWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                 +++  + +      P   PP  +     + ++ C   DP DR
Sbjct: 222 ------DVIGVLEKGDRLPKPDLCPPVLY-----TLMTRCWDYDPSDR 258

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 59/292 (20%), Positives = 102/292 (34%), Gaps = 66/292 (22%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----------ALKIIQMNIQEE 107
           K     F   +L  +KV+G G  G V        G              +K+I+     +
Sbjct: 4   KVLARIFKETELRKLKVLGSGVFGTV------HKGVWIPEGESIKIPVCIKVIEDKSGRQ 57

Query: 108 IRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-T 161
             + +   +    +   +H+V         G+       LV +Y+  GSL D +RQ +  
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLL------GLCPGSSLQLVTQYLPLGSLLDHVRQHRGA 111

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
           +    L     Q+ +G+ YL  E  ++HR++   N+L+    +V++ DFGV+        
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVA-------- 162

Query: 222 QRDTFVGTYNY-----------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQS 269
                                 M+ E I    Y + SD+WS G+ V E    G  PY   
Sbjct: 163 -DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY--- 218

Query: 270 EDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                     E+ + + +    + P     D +       +  C   D   R
Sbjct: 219 ---AGLRL-AEVPDLLEKGERLAQPQICTIDVY-----MVMVKCWMIDENIR 261

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 68/283 (24%), Positives = 107/283 (37%), Gaps = 66/283 (23%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLF----------ALKIIQMNIQEEIRKQIVQEL 116
            + + IKV+G G+ G V      + G             A+K ++     +  K+I+ E 
Sbjct: 15  TEFKKIKVLGSGAFGTV------YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68

Query: 117 KINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-TILEPYLAVV 170
            +  +    HV          G+       L+ + M  G L D +R+ K  I   YL   
Sbjct: 69  YVMASVDNPHVCRLL------GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           C Q+ +G+ YL  +R ++HRD+   N+LV     VKITDFG++         +       
Sbjct: 123 CVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLA---------KLLGAEEK 172

Query: 231 NY-----------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSF 278
            Y           M+ E I    Y + SD+WS G+ V E    G  PY         P+ 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA- 225

Query: 279 YELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E+   + +      PP    D +       +  C   D   R
Sbjct: 226 SEISSILEKGERLPQPPICTIDVY-----MIMVKCWMIDADSR 263

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 40/298 (13%)

Query: 47  SEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQL----VRHKWVGRLFALKIIQM 102
              + ++    ++    F    L+ I  +GKG+ G V+L          G L A+K +Q 
Sbjct: 4   HHHHHAQLYACQD-PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH 62

Query: 103 NIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQ 158
           +   + ++   +E++I +A     +V    V Y     +  + LV+EY+  G L D +++
Sbjct: 63  S-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQR 119

Query: 159 VK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG 217
            +  +    L +   Q+ +G+ YL   R  +HRD+   N+LV  +  VKI DFG++ +L 
Sbjct: 120 HRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

Query: 218 SSMGQRDTFVGTYN------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSE 270
                +D +V          + +PE +S + +   SD+WS G+V+ E           S 
Sbjct: 179 LD---KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235

Query: 271 DQQSW-------PSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           +           P+   LLE + E      PP  P +         +  C    P+DR
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSPQDR 288

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 55/201 (27%), Positives = 77/201 (38%), Gaps = 41/201 (20%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL-------------QGLVYLHNERHVI 188
           LV  YM  GSL D +  +               L              G+ +LH E H I
Sbjct: 107 LVYVYMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANGINFLH-ENHHI 155

Query: 189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ-----RDTFVGTYNYMSPERISGSTY 243
           HRDIK +N+L++     KI+DFG+ A       Q     R   VGT  YM+PE + G   
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGL-ARASEKFAQTVMTSR--IVGTTAYMAPEALRGEIT 212

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQS-----WPSFYE--LLEAIVESPPPTAPPD 296
              SDI+S G+V+LE   G     +  + Q           E   +E  ++     A   
Sbjct: 213 P-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271

Query: 297 QFSPEFCSFVSACIQKDPRDR 317
                  S  S C+ +    R
Sbjct: 272 SVE-AMYSVASQCLHEKKNKR 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 79/348 (22%), Positives = 121/348 (34%), Gaps = 85/348 (24%)

Query: 29  GTFHDGDLLLNQKGLRLISEENESRPSDYKEFDF--EFSLEDLETIKVIGKGSGGVVQLV 86
           G    G  L   +G     + +      Y            D+     +G+G+ G V   
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKV--- 57

Query: 87  RHKWVGRLFALKIIQMNIQ----------EEIRKQIVQELKINQASQCSHVVVCYHSFYH 136
              ++     L   Q  +           E  R+   +E ++    Q  H+V  +     
Sbjct: 58  ---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF----- 109

Query: 137 NGVIS------LVLEYMDRGSLADIIR---------------QVKTILEPYLAVVCKQVL 175
            GV +      +V EYM  G L   +R                   +    L  V  QV 
Sbjct: 110 -GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY--- 232
            G+VYL    H +HRD+   N LV     VKI DFG+S         RD +   Y Y   
Sbjct: 169 AGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS---------RDIYSTDY-YRVG 217

Query: 233 ---------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYELL 282
                    M PE I    +   SD+WS G+V+ E    G+ P+ Q  +        E +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EAI 270

Query: 283 EAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
           + I +      P   P     PE  + +  C Q++P+ R S  D+ + 
Sbjct: 271 DCITQGRELERPRACP-----PEVYAIMRGCWQREPQQRHSIKDVHAR 313

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 92.3 bits (230), Expect = 8e-22
 Identities = 73/297 (24%), Positives = 119/297 (40%), Gaps = 57/297 (19%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-ALKIIQMNIQEEIRKQIVQELKINQA 121
           E   E++  +K +G G  GVV     KW G+   A+K+I+     E   +  QE +    
Sbjct: 4   ELKREEITLLKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMK 59

Query: 122 SQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPY-LAVVCKQV 174
                +V  Y      GV S      +V EY+  G L + +R     LEP  L  +C  V
Sbjct: 60  LSHPKLVKFY------GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY-- 232
            +G+ +L      IHRD+   N LV+    VK++DFG++         R      Y    
Sbjct: 114 CEGMAFL-ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT---------RYVLDDQYVSSV 163

Query: 233 --------MSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYELLE 283
                    +PE      Y   SD+W+ G+++ E   +G+ PY        + +  E++ 
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------DLYTN-SEVVL 216

Query: 284 AIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
            + +      P  A    +       + +C  + P  R +   LLS   I+   +KD
Sbjct: 217 KVSQGHRLYRPHLASDTIY-----QIMYSCWHELPEKRPTFQQLLS--SIEPLREKD 266

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 55/297 (18%), Positives = 114/297 (38%), Gaps = 43/297 (14%)

Query: 48  EENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKI---IQMNI 104
            +            +E    D+     +G G  G V      + G      +   ++   
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEV------YEGVWKKYSLTVAVKTLK 254

Query: 105 QEEIRKQ-IVQELKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIR 157
           ++ +  +  ++E  + +  +  ++V         GV +      ++ E+M  G+L D +R
Sbjct: 255 EDTMEVEEFLKEAAVMKEIKHPNLVQLL------GVCTREPPFYIITEFMTYGNLLDYLR 308

Query: 158 QV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS-A 214
           +   + +    L  +  Q+   + YL  +++ IHR++   N LV     VK+ DFG+S  
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

Query: 215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQ 273
           M G +            + +PE ++ + +   SD+W+ G+++ E    G  PY       
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------- 420

Query: 274 SWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                 ++ E + +      P   P      +    + AC Q +P DR S  ++   
Sbjct: 421 PGIDLSQVYELLEKDYRMERPEGCP-----EKVYELMRACWQWNPSDRPSFAEIHQA 472

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 68/280 (24%), Positives = 119/280 (42%), Gaps = 55/280 (19%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-ALKIIQMNIQEEIRKQIVQELKIN 119
            +E   +DL  +K +G G  GVV     KW G+   A+K+I+         + ++E K+ 
Sbjct: 18  SWEIDPKDLTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVM 73

Query: 120 QASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILE-PYLAVVCK 172
                  +V  Y      GV +      ++ EYM  G L + +R+++   +   L  +CK
Sbjct: 74  MNLSHEKLVQLY------GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
            V + + YL   +  +HRD+   N LVN +G VK++DFG+S         R      Y  
Sbjct: 128 DVCEAMEYL-ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS---------RYVLDDEYTS 177

Query: 232 ---------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYEL 281
                    +  PE +  S +   SDIW+ G+++ E   +G+ PY      + + +  E 
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERF-TNSET 230

Query: 282 LEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E I +      P  A    +     + + +C  +   +R
Sbjct: 231 AEHIAQGLRLYRPHLASEKVY-----TIMYSCWHEKADER 265

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 72/364 (19%), Positives = 118/364 (32%), Gaps = 109/364 (29%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHV- 127
           E   +IG GS G V     K   R+ A+K I    ++ I  K+I++E+ I    + +H  
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN--RLNHDH 113

Query: 128 ------VVCYHSFYHNGVISLVLEYMDRGSLADIIR--------QVKTILEPYLAVVCKQ 173
                 +V          + +VLE  D      + R         +KT+L  Y       
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL--Y------N 164

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN-- 231
           +L G+ Y+H    ++HRD+KP+N LVN    VK+ DFG++  +            +    
Sbjct: 165 LLVGVKYVH-SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 232 -------------------------YMSPERISGST-YDYSSDIWSLG-----------L 254
                                    Y +PE I     Y  + D+WS+G            
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 255 VVLECAIGR--FP---YMQSEDQQSWPSFYEL--------LEAIVE---SPP-------- 290
            V   A     FP          Q   + ++         L  I     +P         
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343

Query: 291 -----------PTAPPDQF-------SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
                      P              S +    +   +  +P  R +  + L+HPF K+ 
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 333 EDKD 336
              +
Sbjct: 404 RIAE 407

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 63/301 (20%), Positives = 108/301 (35%), Gaps = 77/301 (25%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNIQEEIRKQIVQE 115
           E SL  +  ++ +G+   G V   +    G          A+K ++   +  +R++   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKV--YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 116 LKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQ----------- 158
             +    Q  +VV         GV++      ++  Y   G L + +             
Sbjct: 63  AMLRARLQHPNVVCLL------GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116

Query: 159 -----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
                   +  P    +  Q+  G+ YL +  HV+H+D+   N+LV  K  VKI+D G+ 
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

Query: 214 AMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA- 260
                    R+ +   Y Y            M+PE I    +   SDIWS G+V+ E   
Sbjct: 176 ---------REVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

Query: 261 IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRD 316
            G  PY    +Q       +++E I        P   P         + +  C  + P  
Sbjct: 226 YGLQPYCGYSNQ-------DVVEMIRNRQVLPCPDDCP-----AWVYALMIECWNEFPSR 273

Query: 317 R 317
           R
Sbjct: 274 R 274

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.3 bits (225), Expect = 5e-21
 Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 55/278 (19%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-ALKIIQMNIQEEIRKQIVQELKINQA 121
           E   E L+ ++ +G G  G V      + G    A+K ++           + E  + + 
Sbjct: 9   EVPRETLKLVERLGAGQFGEV--WMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQ 64

Query: 122 SQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQV 174
            Q   +V  Y       V++     ++ EYM+ GSL D ++      +    L  +  Q+
Sbjct: 65  LQHQRLVRLY------AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN--- 231
            +G+ ++  ER+ IHRD++ +N+LV+     KI DFG++         R      Y    
Sbjct: 119 AEGMAFI-EERNYIHRDLRAANILVSDTLSCKIADFGLA---------RLIEDNEYTARE 168

Query: 232 -------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYELLE 283
                  + +PE I+  T+   SD+WS G+++ E    GR PY          +  E+++
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY------PGMTN-PEVIQ 221

Query: 284 AIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            +        P   P      E    +  C ++ P DR
Sbjct: 222 NLERGYRMVRPDNCP-----EELYQLMRLCWKERPEDR 254

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 90.0 bits (224), Expect = 5e-21
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 63/282 (22%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-----ALKIIQMNIQEEIRKQIVQELK 117
                +L  ++ IG G  G+V       +G        A+K I+     E  +  ++E +
Sbjct: 4   VIDPSELTFVQEIGSGQFGLV------HLGYWLNKDKVAIKTIREGAMSE--EDFIEEAE 55

Query: 118 INQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILE-PYLAVV 170
           +        +V  Y      GV        LV E+M+ G L+D +R  + +     L  +
Sbjct: 56  VMMKLSHPKLVQLY------GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109

Query: 171 CKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTY 230
           C  V +G+ YL  E  VIHRD+   N LV     +K++DFG++         R      Y
Sbjct: 110 CLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMT---------RFVLDDQY 159

Query: 231 N----------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFY 279
                      + SPE  S S Y   SD+WS G+++ E    G+ PY      ++  +  
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------ENRSN-S 212

Query: 280 ELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           E++E I        P  A    +       ++ C ++ P DR
Sbjct: 213 EVVEDISTGFRLYKPRLASTHVY-----QIMNHCWRERPEDR 249

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 68/304 (22%), Positives = 110/304 (36%), Gaps = 84/304 (27%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----------EEIRKQI 112
                D+   + +G+G+ G V      ++   + L   +  +              RK  
Sbjct: 11  HIKRRDIVLKRELGEGAFGKV------FLAECYNLSPTKDKMLVAVKALKDPTLAARKDF 64

Query: 113 VQELKINQASQCSHVVVCYHSFYHNGV------ISLVLEYMDRGSLADIIR--------- 157
            +E ++    Q  H+V  Y      GV      + +V EYM  G L   +R         
Sbjct: 65  QREAELLTNLQHEHIVKFY------GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 158 -------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
                      +    +  +  Q+  G+VYL   +H +HRD+   N LV     VKI DF
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDF 177

Query: 211 GVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE 258
           G+S         RD +   Y Y            M PE I    +   SD+WS G+++ E
Sbjct: 178 GMS---------RDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227

Query: 259 CA-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKD 313
               G+ P+ Q  +        E++E I +      P   P      E    +  C Q++
Sbjct: 228 IFTYGKQPWFQLSNT-------EVIECITQGRVLERPRVCP-----KEVYDVMLGCWQRE 275

Query: 314 PRDR 317
           P+ R
Sbjct: 276 PQQR 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.0 bits (224), Expect = 7e-21
 Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 48/283 (16%)

Query: 58  KEFDFEFSLEDLE-TIKVIGKGSGGVVQLVRHKWVGRLF--------ALKIIQMN-IQEE 107
           +  +     + L    K +G G+ G V        G           A+KI++       
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTV------KKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 108 IRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVKTI 162
           ++ +++ E  + Q     ++V         G+       LV+E  + G L   ++Q + +
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMI------GICEAESWMLVMEMAELGPLNKYLQQNRHV 114

Query: 163 LEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ 222
            +  +  +  QV  G+ YL  E + +HRD+   N+L+  +   KI+DFG+S  L +    
Sbjct: 115 KDKNIIELVHQVSMGMKYL-EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

Query: 223 RDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSF 278
                       + +PE I+   +   SD+WS G+++ E    G+ PY   +        
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------ 227

Query: 279 YELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E+   + +      P   P + +       ++ C   D  +R
Sbjct: 228 -EVTAMLEKGERMGCPAGCPREMY-----DLMNLCWTYDVENR 264

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 51/286 (17%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNI--QE 106
           +        +DL  ++ +G GS GVV        G            A+K ++ ++  Q 
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVV------RRGEWDAPSGKTVSVAVKCLKPDVLSQP 62

Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK- 160
           E     ++E+    +    +++  Y      GV+      +V E    GSL D +R+ + 
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLY------GVVLTPPMKMVTELAPLGSLLDRLRKHQG 116

Query: 161 TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
             L   L+    QV +G+ YL   +  IHRD+   NLL+  +  VKI DFG+   L  + 
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

Query: 221 GQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWP 276
                       + + +PE +   T+ ++SD W  G+ + E    G+ P+          
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGLN 229

Query: 277 SFYELLEAIVES-----PPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
              ++L  I +       P   P D +     + +  C    P DR
Sbjct: 230 G-SQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDR 269

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 48/295 (16%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIK-VIGKGSGGVVQLVRHKWVGRLF--------A 96
           + E   S P + K+       ++L      +G G+ G V        G           A
Sbjct: 314 VFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSV------RQGVYRMRKKQIDVA 367

Query: 97  LKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGS 151
           +K+++   ++   +++++E +I       ++V         GV       LV+E    G 
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI------GVCQAEALMLVMEMAGGGP 421

Query: 152 LADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
           L   +   +  I    +A +  QV  G+ YL  E++ +HR++   N+L+ ++   KI+DF
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHRNLAARNVLLVNRHYAKISDF 480

Query: 211 GVSAMLGSSMGQRDTFVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPY 266
           G+S  LG+                + +PE I+   +   SD+WS G+ + E    G+ PY
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

Query: 267 MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            + +         E++  I +      PP  PP+ +     + +S C      DR
Sbjct: 541 KKMKGP-------EVMAFIEQGKRMECPPECPPELY-----ALMSDCWIYKWEDR 583

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 71/319 (22%), Positives = 117/319 (36%), Gaps = 83/319 (26%)

Query: 52  SRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNI 104
               + K    E+   ++E ++ IG+G+ G V   + +  G L        A+K+++   
Sbjct: 32  PLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV--FQARAPGLLPYEPFTMVAVKMLKEEA 89

Query: 105 QEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIR--- 157
             +++    +E  +       ++V    VC         + L+ EYM  G L + +R   
Sbjct: 90  SADMQADFQREAALMAEFDNPNIVKLLGVCAVG----KPMCLLFEYMAYGDLNEFLRSMS 145

Query: 158 ---------------------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN 196
                                    +       + +QV  G+ YL +ER  +HRD+   N
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRN 204

Query: 197 LLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYD 244
            LV     VKI DFG+S         R+ +   Y Y            M PE I  + Y 
Sbjct: 205 CLVGENMVVKIADFGLS---------RNIYSADY-YKADGNDAIPIRWMPPESIFYNRYT 254

Query: 245 YSSDIWSLGLVVL-ECA-IGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQF 298
             SD+W+ G VVL E    G  PY     +       E++  + +    + P   P    
Sbjct: 255 TESDVWAYG-VVLWEIFSYGLQPYYGMAHE-------EVIYYVRDGNILACPENCP---- 302

Query: 299 SPEFCSFVSACIQKDPRDR 317
             E  + +  C  K P DR
Sbjct: 303 -LELYNLMRLCWSKLPADR 320

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 73/317 (23%), Positives = 119/317 (37%), Gaps = 74/317 (23%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALK 98
           + E  E  P D  ++  EF  + L+  K +G+G+ G V  +     G          A+K
Sbjct: 8   LDEHCERLPYDASKW--EFPRDRLKLGKPLGRGAFGQV--IEADAFGIDKTATCRTVAVK 63

Query: 99  IIQMNIQEEIRKQIVQELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLA 153
           +++        + ++ ELKI        +VV     C       G + +++E+   G+L+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLS 120

Query: 154 DIIRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNL 197
             +R  +    PY                L     QV +G+ +L   R  IHRD+   N+
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNI 179

Query: 198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDY 245
           L++ K  VKI DFG++         RD +     Y            M+PE I    Y  
Sbjct: 180 LLSEKNVVKICDFGLA---------RDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTI 229

Query: 246 SSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSP 300
            SD+WS G+++ E  ++G  PY             E    + E      P         P
Sbjct: 230 QSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFCRRLKEGTRMRAPDYTT-----P 278

Query: 301 EFCSFVSACIQKDPRDR 317
           E    +  C   +P  R
Sbjct: 279 EMYQTMLDCWHGEPSQR 295

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 60/291 (20%), Positives = 118/291 (40%), Gaps = 55/291 (18%)

Query: 50  NESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-ALKIIQMNIQEEI 108
           +      +++  +E   E L+  K +G G  G V      +      A+K ++       
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEV--WMATYNKHTKVAVKTMKPGSMS-- 226

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK--T 161
            +  + E  + +  Q   +V  +       V++     ++ E+M +GSL D ++  +   
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLH------AVVTKEPIYIITEFMAKGSLLDFLKSDEGSK 280

Query: 162 ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG 221
              P L     Q+ +G+ ++  +R+ IHRD++ +N+LV+     KI DFG++        
Sbjct: 281 QPLPKLIDFSAQIAEGMAFI-EQRNYIHRDLRAANILVSASLVCKIADFGLA-------- 331

Query: 222 QRDTFVGTYN----------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSE 270
            R      Y           + +PE I+  ++   SD+WS G++++E    GR PY    
Sbjct: 332 -RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY---- 386

Query: 271 DQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
                 +  E++ A+        P   P      E  + +  C +  P +R
Sbjct: 387 --PGMSN-PEVIRALERGYRMPRPENCP-----EELYNIMMRCWKNRPEER 429

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 48/280 (17%)

Query: 61  DFEFSLEDLETIKV-IGKGSGGVVQLVRHKWVGRLF--------ALKIIQMNIQEEIRKQ 111
                 ++L    + +G G+ G V        G           A+K+++   ++   ++
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSV------RQGVYRMRKKQIDVAIKVLKQGTEKADTEE 56

Query: 112 IVQELKINQASQCSHVVVCYHSFYHNGVIS-----LVLEYMDRGSLADIIRQVK-TILEP 165
           +++E +I       ++V         GV       LV+E    G L   +   +  I   
Sbjct: 57  MMREAQIMHQLDNPYIVRLI------GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS 110

Query: 166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT 225
            +A +  QV  G+ YL  E++ +HRD+   N+L+ ++   KI+DFG+S  LG+       
Sbjct: 111 NVAELLHQVSMGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169

Query: 226 FVGT---YNYMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYEL 281
                    + +PE I+   +   SD+WS G+ + E    G+ PY + +         E+
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EV 222

Query: 282 LEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
           +  I +      PP  PP+ +     + +S C      DR
Sbjct: 223 MAFIEQGKRMECPPECPPELY-----ALMSDCWIYKWEDR 257

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 71/298 (23%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNIQEEIRKQIVQE 115
           EF   +L+  K +G G+ G V  V     G          A+K+++     + ++ ++ E
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKV--VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99

Query: 116 LKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY---- 166
           LKI +   Q  ++V     C H     G + ++ EY   G L + +R+   +LE      
Sbjct: 100 LKIMSHLGQHENIVNLLGACTH----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155

Query: 167 ----------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
                     L     QV QG+ +L   ++ IHRD+   N+L+ +    KI DFG++   
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA--- 211

Query: 217 GSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLECA-IGR 263
                 RD    +  Y            M+PE I    Y   SD+WS G+++ E   +G 
Sbjct: 212 ------RDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264

Query: 264 FPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            PY             +  + + +    + P  AP         S + AC   +P  R
Sbjct: 265 NPY------PGILVNSKFYKLVKDGYQMAQPAFAP-----KNIYSIMQACWALEPTHR 311

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 57/280 (20%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF--ALKIIQMNIQEEIRKQIVQELKINQ 120
           E    D+     +G G  G V      W       A+K ++ +  E   ++ ++E  + +
Sbjct: 9   EMERTDITMKHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMK 64

Query: 121 ASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQV--KTILEPYLAVVCK 172
             +  ++V         GV +      ++ E+M  G+L D +R+   + +    L  +  
Sbjct: 65  EIKHPNLVQLL------GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 173 QVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYN- 231
           Q+   + YL  +++ IHRD+   N LV     VK+ DFG+S         R     TY  
Sbjct: 119 QISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS---------RLMTGDTYTA 168

Query: 232 ---------YMSPERISGSTYDYSSDIWSLGLVVLECA-IGRFPYMQSEDQQSWPSFYEL 281
                    + +PE ++ + +   SD+W+ G+++ E A  G  PY             ++
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL-SQV 221

Query: 282 LEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
            E + +      P   P   +       + AC Q +P DR
Sbjct: 222 YELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDR 256

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 69/304 (22%), Positives = 111/304 (36%), Gaps = 75/304 (24%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNIQEEIRKQIV 113
            +EF    L   K +G G+ G V  V     G +        A+K+++ +     R+ ++
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKV--VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74

Query: 114 QELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIR----------- 157
            ELK+ +      ++V     C       G   ++ EY   G L + +R           
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130

Query: 158 -------QVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
                      +    L     QV +G+ +L   ++ IHRD+   N+L+ H    KI DF
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITKICDF 189

Query: 211 GVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE 258
           G++         RD    +  Y            M+PE I    Y + SD+WS G+ + E
Sbjct: 190 GLA---------RDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239

Query: 259 -CAIGRFPYMQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKD 313
             ++G  PY         P   +  + I E      P  AP      E    +  C   D
Sbjct: 240 LFSLGSSPY------PGMPVDSKFYKMIKEGFRMLSPEHAP-----AEMYDIMKTCWDAD 288

Query: 314 PRDR 317
           P  R
Sbjct: 289 PLKR 292

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 77/327 (23%), Positives = 124/327 (37%), Gaps = 84/327 (25%)

Query: 47  SEENESRPSDYKEFDF----EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF------- 95
           S +NE    D++E+++    EF  E+LE  KV+G G+ G V  +     G          
Sbjct: 21  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV--MNATAYGISKTGVSIQV 78

Query: 96  ALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRG 150
           A+K+++       R+ ++ ELK+  Q     ++V     C      +G I L+ EY   G
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL----SGPIYLIFEYCCYG 134

Query: 151 SLADIIRQ-----------------------VKTILEPYLAVVCKQVLQGLVYLHNERHV 187
            L + +R                        +  +    L     QV +G+ +L   +  
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-EFKSC 193

Query: 188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY------------MSP 235
           +HRD+   N+LV H   VKI DFG++         RD    +  Y            M+P
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLA---------RDIMSDSN-YVVRGNARLPVKWMAP 243

Query: 236 ERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVE----SPP 290
           E +    Y   SD+WS G+++ E  ++G  PY         P      + I        P
Sbjct: 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------PGIPVDANFYKLIQNGFKMDQP 297

Query: 291 PTAPPDQFSPEFCSFVSACIQKDPRDR 317
             A       E    + +C   D R R
Sbjct: 298 FYAT-----EEIYIIMQSCWAFDSRKR 319

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 70/330 (21%), Positives = 120/330 (36%), Gaps = 88/330 (26%)

Query: 42  GLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF------ 95
           G   +S +      D K   +EF  ++L   K +G+G  G V  V+              
Sbjct: 1   GPLSLSVDAFKILEDPK---WEFPRKNLVLGKTLGEGEFGKV--VKATAFHLKGRAGYTT 55

Query: 96  -ALKIIQMNIQEEIRKQIVQELKINQASQCSHVV----VCYHSFYHNGVISLVLEYMDRG 150
            A+K+++ N      + ++ E  + +     HV+     C      +G + L++EY   G
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYG 111

Query: 151 SLADIIRQVKTILEPY------------------------LAVVCKQVLQGLVYLHNERH 186
           SL   +R+ + +   Y                        L     Q+ QG+ YL  E  
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMK 170

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY------------MS 234
           ++HRD+   N+LV    ++KI+DFG+S         RD +     Y            M+
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLS---------RDVYEEDS-YVKRSQGRIPVKWMA 220

Query: 235 PERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY--MQSEDQQSWPSFYELLEAIVE---- 287
            E +    Y   SD+WS G+++ E   +G  PY  +  E          L   +      
Sbjct: 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---------RLFNLLKTGHRM 271

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             P          E    +  C +++P  R
Sbjct: 272 ERPDNCS-----EEMYRLMLQCWKQEPDKR 296

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 45/234 (19%), Positives = 86/234 (36%), Gaps = 48/234 (20%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF-------ALKIIQMNIQEEIRKQIVQE 115
           +   EDL   + +G+G+   +     + VG           LK++         +   + 
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEA 62

Query: 116 LKINQASQCSHVVVCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILE-PYLA 168
             +       H+V+ Y      GV        LV E++  GSL   +++ K  +   +  
Sbjct: 63  ASMMSKLSHKHLVLNY------GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116

Query: 169 VVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--------VKITDFGVSAMLGSSM 220
            V KQ+   + +L  E  +IH ++   N+L+  + +        +K++D G+S       
Sbjct: 117 EVAKQLAAAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------- 168

Query: 221 GQRDTFVGTYNY------MSPERIS-GSTYDYSSDIWSLGLVVLE-CAIGRFPY 266
                             + PE I      + ++D WS G  + E C+ G  P 
Sbjct: 169 --ITVLPKDI-LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 76/304 (25%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVV------QLVRHKWVGRLF-ALKIIQMNIQEEIRKQIV 113
            +EF  + L   K +G+G+ G V       + + K    +  A+K+++ +  E+    +V
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88

Query: 114 QELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY-- 166
            E+++     +  +++     C      +G + +++EY  +G+L + +R  +     Y  
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144

Query: 167 --------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV 212
                         L     Q+ +G+ YL   +  IHRD+   N+LV     +KI DFG+
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGL 203

Query: 213 SAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE-C 259
           +         RD     Y Y            M+PE +    Y + SD+WS G+++ E  
Sbjct: 204 A---------RDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

Query: 260 AIGRFPY--MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKD 313
            +G  PY  +  E         EL + + E      P          E    +  C    
Sbjct: 254 TLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAV 299

Query: 314 PRDR 317
           P  R
Sbjct: 300 PSQR 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 35/200 (17%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYLA-----VVCKQVLQGLVYLHNERHVIHRDIKPSN 196
           L+ +YM+ G+L   +          ++      +C    +GL YLH  R +IHRD+K  N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSIN 169

Query: 197 LLVNHKGEVKITDFGVSAMLGSSMGQRDTFV-----GTYNYMSPERISGSTYDYSSDIWS 251
           +L++     KITDFG+S   G+ + Q  T +     GT  Y+ PE          SD++S
Sbjct: 170 ILLDENFVPKITDFGIS-KKGTELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYS 226

Query: 252 LGLVVLECAIGRFP--YMQSEDQQS---WPSFY---ELLEAIVESPPPTAP--PDQFSPE 301
            G+V+ E    R         +  +   W         LE IV+      P   D+  PE
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPE 280

Query: 302 ----FCSFVSACIQKDPRDR 317
               F      C+     DR
Sbjct: 281 SLRKFGDTAVKCLALSSEDR 300

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 41/205 (20%)

Query: 142 LVLEYMDRGSLADIIRQVKTILEPYL-----AVVCKQVLQGLVYLHNE--RHVIHRDIKP 194
           LV  YM  GS+A  +R+ +   +P L       +     +GL YLH+     +IHRD+K 
Sbjct: 104 LVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162

Query: 195 SNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV-----GTYNYMSPERISGSTYDYSSDI 249
           +N+L++ + E  + DFG+ A L   M  +DT V     GT  +++PE +S       +D+
Sbjct: 163 ANILLDEEFEAVVGDFGL-AKL---MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 218

Query: 250 WSLGLVVLECAIGRFP--YMQSEDQQS-------WP-----SFYELLEAIVESPPPTAPP 295
           +  G+++LE   G+      +  +                     L++  ++        
Sbjct: 219 FGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE-- 276

Query: 296 DQFSPEFCSFV---SACIQKDPRDR 317
                E    +     C Q  P +R
Sbjct: 277 -----EVEQLIQVALLCTQSSPMER 296

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 80/306 (26%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEIRKQ 111
            +EF  + L   K +G+G  G V  V  + VG            A+K+++ +  E+    
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQV--VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132

Query: 112 IVQELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY 166
           +V E+++     +  +++     C      +G + +++EY  +G+L + +R  +     Y
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEY 188

Query: 167 ----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
                           L     Q+ +G+ YL   +  IHRD+   N+LV     +KI DF
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADF 247

Query: 211 GVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE 258
           G++         RD     Y Y            M+PE +    Y + SD+WS G+++ E
Sbjct: 248 GLA---------RDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297

Query: 259 -CAIGRFPY--MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQ 311
              +G  PY  +  E         EL + + E      P          E    +  C  
Sbjct: 298 IFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT-----NELYMMMRDCWH 343

Query: 312 KDPRDR 317
             P  R
Sbjct: 344 AVPSQR 349

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 90/317 (28%)

Query: 49  ENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF--------ALKII 100
           +N   P+ Y   D      D++   VIG+G+ G V         R+         A+K +
Sbjct: 11  KNNPDPTIYPVLD----WNDIKFQDVIGEGNFGQV------LKARIKKDGLRMDAAIKRM 60

Query: 101 QMNIQEEIRKQIVQELKI-NQASQCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADI 155
           +    ++  +    EL++  +     +++     C H     G + L +EY   G+L D 
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDF 116

Query: 156 IRQVKTILEPY----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV 199
           +R+ + +                    L      V +G+ YL +++  IHRD+   N+LV
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQFIHRDLAARNILV 175

Query: 200 NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNY------------MSPERISGSTYDYSS 247
                 KI DFG+S         R        Y            M+ E ++ S Y  +S
Sbjct: 176 GENYVAKIADFGLS---------RG----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222

Query: 248 DIWSLGLVVLE-CAIGRFPY--MQSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSP 300
           D+WS G+++ E  ++G  PY  M            EL E + +      P          
Sbjct: 223 DVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEKLPQGYRLEKPLNCD-----D 268

Query: 301 EFCSFVSACIQKDPRDR 317
           E    +  C ++ P +R
Sbjct: 269 EVYDLMRQCWREKPYER 285

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 67/354 (18%), Positives = 127/354 (35%), Gaps = 91/354 (25%)

Query: 24  FLTASGTFHDGDLLL-----NQKGLRLISEENESRPSDYKEFDF------EFSLEDLETI 72
             T +  F+           +       +   +   +   E++       E   + L   
Sbjct: 15  PTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLG 74

Query: 73  KVIGKGSGGVVQLVRHKWVGRLF---------ALKIIQMNIQEEIRKQIVQELKI-NQAS 122
           K +G+G+ G V  V  + +G            A+K+++ +  E+    ++ E+++     
Sbjct: 75  KPLGEGAFGQV--VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 123 QCSHVV----VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY------------ 166
           +  +++     C      +G + +++EY  +G+L + ++  +     Y            
Sbjct: 133 KHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 167 ----LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ 222
               L     QV +G+ YL   +  IHRD+   N+LV     +KI DFG++         
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTEDNVMKIADFGLA--------- 238

Query: 223 RDTFVGTYNY------------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPY--M 267
           RD     Y Y            M+PE +    Y + SD+WS G+++ E   +G  PY  +
Sbjct: 239 RDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297

Query: 268 QSEDQQSWPSFYELLEAIVE----SPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
             E         EL + + E      P          E    +  C    P  R
Sbjct: 298 PVE---------ELFKLLKEGHRMDKPSNCT-----NELYMMMRDCWHAVPSQR 337

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 35/218 (16%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
            + IG+GS GV+    +    +  A   I+   +     Q+  E +     + C+ +   
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQGLVYLHNE 184
           Y+         LV++ +   SL D++        VKT+      +  KQ+L  +  +H E
Sbjct: 72  YYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVA-----MAAKQMLARVQSIH-E 124

Query: 185 RHVIHRDIKPSNLLV-----NHKGEVKITDFGVSAMLGSSMG-------QRDTFVGTYNY 232
           + +++RDIKP N L+      +   + + DFG+       +        ++    GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 233 MSP---ERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           MS         S  D   D+ +LG V +    G  P+ 
Sbjct: 185 MSINTHLGREQSRRD---DLEALGHVFMYFLRGSLPWQ 219

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.2 bits (180), Expect = 8e-15
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 33/216 (15%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
            + IG GS G + L      G   A   I++   +    Q+  E KI         +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQGLVYLHNE 184
                      +V+E +   SL D+         +KT+L     ++  Q++  + Y+H+ 
Sbjct: 71  RWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVL-----LLADQMISRIEYIHS- 123

Query: 185 RHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMS 234
           ++ IHRD+KP N L+        V I DFG++     +         +     GT  Y S
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 235 ---PERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
                 I  S  D   D+ SLG V++   +G  P+ 
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQ 216

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 50/276 (18%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
            K IG G  G++ L          A  ++++  QE     +  ELK   + ++   +   
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE--NGPLFSELKFYQRVAKKDCIKKW 99

Query: 131 YHS----------FYHNGVIS--------LVLEYMDRGSLADIIRQ-----VKTILEPYL 167
                        FY +G+          +V+E +    L  I  Q       T+L   L
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVL--QL 156

Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT--DFGVSAMLGSS------ 219
            +   ++L  L Y+H E   +H DIK +NLL+ +K   ++   D+G+S     +      
Sbjct: 157 GI---RMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 220 -MGQRDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQ--SEDQQ 273
               R    GT  + S   +    G      SD+  LG  +L    G+ P+ Q   +   
Sbjct: 213 QENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269

Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSAC 309
              +   LL+ + +S    AP      E   F+   
Sbjct: 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 43/164 (26%), Positives = 64/164 (39%), Gaps = 31/164 (18%)

Query: 167 LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF 226
           L     QV +G+ +L   R  IHRD+   N+L++ K  VKI DFG++         RD +
Sbjct: 195 LICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLA---------RDIY 244

Query: 227 VGTYNY-----------MSPERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQS 274
                            M+PE I    Y   SD+WS G+++ E  ++G  PY      + 
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKI 301

Query: 275 WPSFYELLEA-IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDR 317
              F   L+       P         PE    +  C   +P  R
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQR 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 36/175 (20%), Positives = 67/175 (38%), Gaps = 18/175 (10%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-------RLFALK 98
           + E  E  P D  ++  EF  + L+  K +G+G+ G V  +     G       R  A+K
Sbjct: 3   LDEHCERLPYDASKW--EFPRDRLKLGKPLGRGAFGQV--IEADAFGIDKTATCRTVAVK 58

Query: 99  IIQMNIQEEIRKQIVQELKINQASQC-SHVVVCY-HSFYHNGVISLVLEYMDRGSLADII 156
           +++        + ++ ELKI        +VV          G + +++E+   G+L+  +
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

Query: 157 RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG 211
           R  +    PY      +  QG  Y+      I  D+K     +        + F 
Sbjct: 119 RSKRNEFVPYKTKGA-RFRQGKDYVGA----IPVDLKRRLDSITSSQSSASSGFV 168

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 53/266 (19%), Positives = 104/266 (39%), Gaps = 49/266 (18%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRK----QIVQELKI-NQASQCSH 126
            K IG G+ G ++L ++ +     A+K+       E  K    Q+  E +   Q      
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKL-------EPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQGLVY 180
           +   Y+        ++VLE +   SL D+         +KT+L     ++  Q++  + Y
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVL-----MIAIQLISRMEY 120

Query: 181 LHNERHVIHRDIKPSNLLV-----NHKGEVKITDFGVSAMLGSSMG-------QRDTFVG 228
           +H+ +++I+RD+KP N L+       +  + I DF ++               +  +  G
Sbjct: 121 VHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179

Query: 229 TYNYMSP---ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI 285
           T  YMS         S  D   D+ +LG + +    G  P+   +      +  E  + I
Sbjct: 180 TARYMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKI 232

Query: 286 VESPPPTAPPD--QFSPEFCSFVSAC 309
            ++   T      +  PE  +++   
Sbjct: 233 GDTKRATPIEVLCENFPEMATYLRYV 258

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 33/214 (15%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVC 130
            + IG GS G + L  +       A+K+  +  +     Q++ E KI       + +   
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNV 68

Query: 131 YHSFYHNGVISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQGLVYLHNE 184
                      LV++ +   SL D+         +KT+L     ++  Q++  + ++H  
Sbjct: 69  RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVL-----MLADQMINRVEFVH-S 121

Query: 185 RHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMS 234
           +  +HRDIKP N L+       +V I DFG++     +         +     GT  Y S
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 235 ---PERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
                 I  S  D   D+ SLG V++    G  P
Sbjct: 182 VNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.9 bits (170), Expect = 1e-13
 Identities = 51/342 (14%), Positives = 93/342 (27%), Gaps = 78/342 (22%)

Query: 55  SDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR----- 109
                F      E L+  + IG+G  G V            A+KII +   + +      
Sbjct: 8   KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQK 65

Query: 110 --KQIVQELKINQASQCSHVVVCYH----------------------------------- 132
             ++I+ E+ I++        VC                                     
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 133 ----SFYHNGVISLVLEYMDRG-SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHV 187
                F+ +  + +VLE+   G  L  +  ++ ++       +  Q+   L         
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRF 183

Query: 188 IHRDIKPSNLLVNHKGEVKITD-----------FGVSAMLGSSMGQRDTFVGTYNYMSPE 236
            HRD+   N+L+      K+              G+   +      R    G   +    
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 237 R---ISGSTYDYSSDIWSL-GLVVLECAIGRFPYMQSEDQQSWPSF---YELLEAIVESP 289
               +     DY  DI+ L             PY        W  +     L +   ++ 
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKTK 299

Query: 290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
             T    Q   +   F    +        S+ DLL    + K
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 41/228 (17%), Positives = 78/228 (34%), Gaps = 41/228 (17%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRL--------FALKIIQMN---------IQEEIRKQIVQ 114
                + + G++                   F+LK+   +          Q   +   V 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 115 ELKINQASQCSHVVVCYHSFYHNGVIS-LVLEYMDRGSLADIIRQ-------VKTILEPY 166
           + K   ++    +  C     H      LVL  + R SL   +          +++L+  
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQ-- 163

Query: 167 LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV--NHKGEVKITDFGVSAMLGSS----- 219
           +A    ++L  L +LH E   +H ++   N+ V    + +V +  +G +     S     
Sbjct: 164 VAC---RLLDALEFLH-ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 220 --MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP 265
              G R    G   ++S +   G      SD+ SLG  +L+   G  P
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 41/236 (17%), Positives = 87/236 (36%), Gaps = 53/236 (22%)

Query: 72  IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR------KQIVQELKINQASQCS 125
              IG+G  G +      ++  + + + +  +    ++        +  ELK  Q +   
Sbjct: 40  GLPIGQGGFGCI------YLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93

Query: 126 HVVVCYH-----------SFYHNGVIS--------LVLEYMDRGSLADIIRQ------VK 160
             +  +             ++ +G+          ++++      L  I          K
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152

Query: 161 TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT--DFGVSAMLGS 218
           T+L   L++   ++L  L Y+H E   +H DIK SNLL+N+K   ++   D+G++     
Sbjct: 153 TVL--QLSL---RILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 219 S-------MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
                      +    GT  + S +  +G       D+  LG  +++   G  P+ 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 1e-04
 Identities = 63/382 (16%), Positives = 110/382 (28%), Gaps = 84/382 (21%)

Query: 31  FHDGDLLLNQKGLRLISEENESRPSDYKEF-DFE---FSLEDLETIKVIGKGSGGVVQLV 86
           F  G+     K +  + E+      D K+  D      S E+++ I      S   V   
Sbjct: 9   FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHII----MSKDAVSGT 64

Query: 87  RHKWVGRLFALKIIQMNIQEEIRKQIVQE-LKIN-------------QASQCSHVVVCYH 132
                 RLF      ++ QEE+ ++ V+E L+IN             Q S  + + +   
Sbjct: 65  L-----RLF---WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116

Query: 133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVV------C-KQVLQGLVYLHNER 185
              +N         + R      +RQ    L P   V+        K  +   V L  + 
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176

Query: 186 HV-----IH-----RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
                  I          P  +L   +  +   D   ++    S   +         +  
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR- 235

Query: 236 ERISGSTYDYS----SDIWSLGLVV---LECAI--------------GRFPYMQSEDQQS 274
             +    Y+       ++ +        L C I                     S D  S
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 275 WPSFYE-----LLEAIVESPPPTAPPD--QFSPEFCSFVSACIQKDPRDRSSSLDLLSHP 327
                      LL   ++  P   P +    +P   S ++  I    RD  ++ D   H 
Sbjct: 296 MT-LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI----RDGLATWDNWKHV 350

Query: 328 FIKKFEDKDIDLGILVGSLDPP 349
              K     I+  + V  L+P 
Sbjct: 351 NCDKLTTI-IESSLNV--LEPA 369

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	354
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.72
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.13
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.49
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.18
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.97
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.96
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.78
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.69
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.56
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.97
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.7
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.42
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.68

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.4e-68  Score=477.77  Aligned_cols=265  Identities=27%  Similarity=0.467  Sum_probs=236.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..  ..+..+.+.+|+++++.++|||||+++++|.+++.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3578999999999999999999999999999999997643  22335678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC--c
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--M  220 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~  220 (354)
                      |||||+||+|.+++++.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+...  .
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999998999999999999999999999998 99999999999999999999999999999987533  2


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..       ++...+.....  ..+..+++
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~--~~p~~~s~  259 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLEY--DFPEKFFP  259 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC--CCCTTCCH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC--CCCcccCH
Confidence            3345679999999999999999999999999999999999999999765432       45556665543  34567999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHH------HhcCccccccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLD------LLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~e------il~hp~~~~~~~~~~~~  339 (354)
                      ++.+||.+||++||++|||++|      +++||||+.+.|.++..
T Consensus       260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  304 (311)
T ss_dssp             HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence            9999999999999999999987      68999999999988764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.9e-68  Score=476.03  Aligned_cols=273  Identities=25%  Similarity=0.405  Sum_probs=229.7

Q ss_pred             CcccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ..++|++++.||+|+||+||+|++.   .+++.||||++++.. .......+.+|+.+++.++|||||++++++.+++.+
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            3578999999999999999999974   468899999997543 111223577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999999999999999999999999999998 999999999999999999999999999998766555


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..       ++...+.....  ..+..+|+
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~--~~p~~~s~  251 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------ETMTMILKAKL--GMPQFLSP  251 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCH
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------HHHHHHHcCCC--CCCCcCCH
Confidence            5566789999999999999999999999999999999999999999876543       44555555543  34567999


Q ss_pred             HHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCC
Q 018532          301 EFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLD  347 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~  347 (354)
                      ++.+||.+||++||++|||     ++|+++||||+.+++.++......+|+-
T Consensus       252 ~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~  303 (304)
T 3ubd_A          252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFK  303 (304)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSC
T ss_pred             HHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcC
Confidence            9999999999999999998     5799999999999887775544444443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.6e-67  Score=479.56  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=225.1

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ++++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999997653 455677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          144 LEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||||+||+|.+++...+  .+++..++.|+.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999997653  57899999999999999999998 9999999999999999999999999999987765434


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..       +++..+.....+ ..+..+|++
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~~-~~~~~~s~~  252 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------NLVLKIISGSFP-PVSLHYSYD  252 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCC-CCCTTSCHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCC-CCCccCCHH
Confidence            445678999999999999999999999999999999999999999765432       455555555443 345679999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.+||.+||++||++|||++|+|+||||++-
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.2e-67  Score=475.90  Aligned_cols=259  Identities=34%  Similarity=0.583  Sum_probs=230.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35699999999999999999999999999999999764322 23568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      ||+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+..........+
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            9999999999976 679999999999999999999998 99999999999999999999999999999988766666677


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCCCHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQFSPEFCS  304 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  304 (354)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..       +.+..+..... ....+..+++++.+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPRLKNLHKVSPSLKG  302 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCCCCCccccCCHHHHH
Confidence            89999999999999999999999999999999999999999765433       34444444433 23344578999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ||.+||++||++|||++|+|+||||++...
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999999997643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-65  Score=477.86  Aligned_cols=259  Identities=34%  Similarity=0.583  Sum_probs=230.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+++.++|+|||+++++|.+++.+|+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            46799999999999999999999999999999999765322 23568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      ||+||+|.++++. +.+++.++..++.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|+.+........+
T Consensus       229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            9999999999876 679999999999999999999998 99999999999999999999999999999988766666677


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCCCHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQFSPEFCS  304 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  304 (354)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..       +.+..+..... ....+..+++++.+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCCCCcccccCCHHHHH
Confidence            89999999999999999999999999999999999999999765433       34444444432 33445679999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ||.+||++||++|||++|+|+||||++...
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999999997643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-65  Score=456.43  Aligned_cols=252  Identities=27%  Similarity=0.457  Sum_probs=220.5

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeEEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVISLVL  144 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~  144 (354)
                      ++.++||+|+||+||+|.++.++..||+|++.... .....+.+.+|+.+++.++|||||++++++.+    ++.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999999999999999997543 45556789999999999999999999999875    35689999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEcc-CCcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNH-KGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |||+||+|.+++.+.+.+++..+..++.||+.||.|||+ +|  |+||||||+|||++. +|.+||+|||+|+....  .
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence            999999999999998999999999999999999999998 77  999999999999985 79999999999986433  3


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....      ..+...+..+..+...+..++++
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCCccCCHH
Confidence            4456799999999999875 6999999999999999999999999765432      24455555555555556678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      +.+||.+||++||++|||++|+|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.7e-66  Score=456.25  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=210.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++..  ..+....+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997653  233456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |||| +|+|.+++.+.+.+++.++..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence            9999 67999999998999999999999999999999998 99999999999999999999999999999876543 334


Q ss_pred             cccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+.       .++.+.+......  .+..+|+++
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~  239 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISNGVYT--LPKFLSPGA  239 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC--CCTTSCHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCCHHH
Confidence            56799999999999999886 5799999999999999999999976532       2444555554433  456799999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      .+||.+||++||++|||++|+++||||+.
T Consensus       240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-64  Score=459.20  Aligned_cols=260  Identities=26%  Similarity=0.421  Sum_probs=224.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ....+.|.+.+.||+|+||+||+|+++.+|+.||||+++....      ..+|+.+++.++|||||++++++.+++.+|+
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3456788999999999999999999999999999999976432      2469999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  221 (354)
                      |||||+||+|.+++++.+.+++..+..++.||+.||.|||+ +|||||||||+|||++.+| .+||+|||+|+.......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999999999998999999999999999999999998 9999999999999999988 699999999987654321


Q ss_pred             -----CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-CCCC
Q 018532          222 -----QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-TAPP  295 (354)
Q Consensus       222 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  295 (354)
                           .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.       ...+....++ ...+
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~  279 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASEPPPIREIP  279 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHSCCGGGGSC
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcCCCCchhcC
Confidence                 22346899999999999999999999999999999999999999987665532       2333333322 3356


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHH-------------hcCcccccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDL-------------LSHPFIKKFEDKD  336 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~ei-------------l~hp~~~~~~~~~  336 (354)
                      ..+++++.+||.+||++||++|||+.|+             ++|||+.+..+.+
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            6899999999999999999999999998             5799998876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-62  Score=474.87  Aligned_cols=281  Identities=26%  Similarity=0.447  Sum_probs=241.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ..+.++|+++++||+|+||+||+|+++.+|+.||||++++..     ..........++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            567899999999999999999999999999999999997542     112222233446677788999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      +.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+|++||+|||+|+...
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999999999999999999999999999999998 999999999999999999999999999998775


Q ss_pred             CCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..  ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.....    ..++...+.....  ..+.
T Consensus       344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~~~~--~~p~  415 (689)
T 3v5w_A          344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTMAV--ELPD  415 (689)
T ss_dssp             SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHHCCC--CCCT
T ss_pred             CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcCCCC--CCCc
Confidence            43  3456799999999999975 579999999999999999999999997654332    2234444444433  3456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      .+|+++.+||.+||++||++|++     ++||++||||+.+.|..+......+|+-|++..
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~  476 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE  476 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTC
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCC
Confidence            79999999999999999999998     799999999999999998777778888887653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-62  Score=442.42  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=207.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-------  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-------  138 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+.+++.++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3679999999999999999999999999999999987766667788999999999999999999999987654       


Q ss_pred             -----eEEEEEeccCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          139 -----VISLVLEYMDRGSLADIIRQVKT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       139 -----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                           .+|+|||||+||+|.+++.....   ..+..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccC
Confidence                 47999999999999999987644   4456788999999999999998 99999999999999999999999999


Q ss_pred             ccccccCCCcC------------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH
Q 018532          211 GVSAMLGSSMG------------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF  278 (354)
Q Consensus       211 g~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  278 (354)
                      |+|+.......            ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||....      ..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~  233 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ER  233 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HH
Confidence            99987654321            1234689999999999999999999999999999999996   774321      11


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ...+..+.....+. .....++.+.+||.+||++||++|||+.|+++||||+.+.+.+
T Consensus       234 ~~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          234 VRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            22333333333221 1234567788999999999999999999999999999886643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-61  Score=448.55  Aligned_cols=264  Identities=29%  Similarity=0.441  Sum_probs=220.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee------cCe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH------NGV  139 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------~~~  139 (354)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+++.++|+|||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999997543 34455778999999999999999999998754      368


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+|||||+ |+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            999999996 5899999988899999999999999999999998 99999999999999999999999999999876432


Q ss_pred             ----cCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC-----
Q 018532          220 ----MGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP-----  289 (354)
Q Consensus       220 ----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  289 (354)
                          .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....    +.......     
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~----I~~~~g~p~~~~~  287 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL----IMMVLGTPSPAVI  287 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH----HHHHHCCCCGGGT
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH----HHHhcCCCChHHh
Confidence                2234567999999999998876 469999999999999999999999987654321111    11111110     


Q ss_pred             ---------------CCCC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          290 ---------------PPTA------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 ---------------~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                                     +...      ....+++++.+||.+||.+||++|||++|+|+||||++..+..
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence                           0000      0135789999999999999999999999999999999886544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-61  Score=434.91  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=222.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      .+..++|.+.+.||+|+||+||+|++.     .++..||||+++.. ..+..+.+.+|+.+++.++|||||++++++.++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            466788999999999999999999875     36788999999754 445567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      +.+++|||||++|+|.++++..             ..+++.++..++.||+.||.|||+ ++|+||||||+|||+++++.
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCCc
Confidence            9999999999999999999864             358999999999999999999998 89999999999999999999


Q ss_pred             EEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHH
Q 018532          205 VKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYEL  281 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  281 (354)
                      +||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..       ++
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~  239 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EV  239 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence            99999999986643322  2233579999999999999999999999999999999998 89999876543       45


Q ss_pred             HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ...+..+..+ ..+..+|+++.+||.+||+.||++|||+.++  ++|++++..
T Consensus       240 ~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~  289 (299)
T 4asz_A          240 IECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAK  289 (299)
T ss_dssp             HHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHH
T ss_pred             HHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHh
Confidence            5555555433 3456799999999999999999999999999  568876644

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-60  Score=427.94  Aligned_cols=256  Identities=21%  Similarity=0.356  Sum_probs=211.2

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      ..|++..+++.+.+.||+|+||+||+|+..   ..||||+++.. ...+..+.+.+|+.+++.++|||||++++++. ++
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD  104 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence            458889999999999999999999999864   35999998754 34556788999999999999999999999765 46


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .+++|||||+||+|.+++... ..+++.++..|+.||+.||.|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            789999999999999999765 579999999999999999999998 899999999999999999999999999998764


Q ss_pred             CC--cCCCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--
Q 018532          218 SS--MGQRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--  290 (354)
Q Consensus       218 ~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  290 (354)
                      ..  .......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+...      .+...+..+..  
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p  257 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASP  257 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCC
Confidence            32  223455689999999999964   358999999999999999999999997655331      22233333322  


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          291 -PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       291 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                       ....+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             223456789999999999999999999999987653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-60  Score=430.97  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=219.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ++..+++++.+.||+|+||+||+|...     .+++.||||+++........+.+.+|+.+++.++|||||++++++.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            456678889999999999999999853     467899999997665555667899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH  201 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~  201 (354)
                      +.+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+ ++||||||||+|||+++
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEECC
Confidence            9999999999999999999753                358899999999999999999998 89999999999999999


Q ss_pred             CCcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhH
Q 018532          202 KGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSF  278 (354)
Q Consensus       202 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  278 (354)
                      ++.+||+|||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||+| |..||.+....      
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------  254 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------  254 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------
Confidence            9999999999998764332  23345689999999999999999999999999999999998 89999876543      


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                       ++...+..+.. ...+..+++++.+|+.+||+.||++|||+.||+++
T Consensus       255 -~~~~~i~~~~~-~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          255 -DVVEMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHcCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             44555555443 33467899999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.7e-60  Score=429.22  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=212.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      .+..++|.+.++||+|+||+||+|+..     .+++.||||+++.. .....+.+.+|+.+++.++|||||++++++.+.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            456788999999999999999999864     46889999999754 445567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQV---------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK  202 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~  202 (354)
                      +.+|+|||||++|+|.++++..               +.+++.++..|+.||+.||.|||+ ++|+||||||+|||++++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence            9999999999999999999753               358999999999999999999998 899999999999999999


Q ss_pred             CcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHH
Q 018532          203 GEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       203 ~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  279 (354)
                      +.+||+|||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....       
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------  267 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------  267 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-------
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-------
Confidence            999999999998764332  22344679999999999999999999999999999999999 89999876543       


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +....+..+.. ...+..+++++.+|+.+||+.||++|||+.||+++
T Consensus       268 ~~~~~i~~g~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          268 EAIDCITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCC-CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            34455555433 34456899999999999999999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.9e-60  Score=434.27  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=223.2

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC-CceEEeee
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQIVQELKINQASQC-SHVVVCYH  132 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~  132 (354)
                      ...|++..++|++.+.||+|+||+||+|.+..+     ++.||||+++........+.+.+|+.++..+.| +|||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            345788999999999999999999999997654     367999999877767777889999999999966 89999999


Q ss_pred             eeeec-CeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCC
Q 018532          133 SFYHN-GVISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPS  195 (354)
Q Consensus       133 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~  195 (354)
                      ++... +.+++|||||++|+|.++++..                ..+++..+..++.||+.||.|||+ ++||||||||+
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~  214 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAAR  214 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcc
Confidence            98764 5789999999999999999863                237899999999999999999998 89999999999


Q ss_pred             CEEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcC
Q 018532          196 NLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQ  272 (354)
Q Consensus       196 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  272 (354)
                      |||+++++.+||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654322  2345679999999999999999999999999999999998 99999876543


Q ss_pred             CChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +      .+...+..+ .....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       295 ~------~~~~~i~~g-~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          295 E------EFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             H------HHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H------HHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2      223333333 3344567899999999999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.3e-59  Score=431.23  Aligned_cols=261  Identities=21%  Similarity=0.346  Sum_probs=208.9

Q ss_pred             cccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~  141 (354)
                      .++|++.+.||+|+||+||+|+++   .+++.||+|++.....   ...+.+|+++++.+ +|+|||++++++.+.+++|
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            467999999999999999999875   3678999999865533   24578899999887 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-CcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||++||+|.+++   +.+++.+++.++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+......
T Consensus        97 lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           97 IAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            999999999999988   469999999999999999999998 999999999999999877 799999999997654321


Q ss_pred             ----------------------------CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 018532          221 ----------------------------GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSED  271 (354)
Q Consensus       221 ----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~  271 (354)
                                                  ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||....+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                        112345899999999999876 489999999999999999999999965543


Q ss_pred             CC-ChhhHHH-------------------------------HHHHHH--------------cCCCCCCCCCCCCHHHHHH
Q 018532          272 QQ-SWPSFYE-------------------------------LLEAIV--------------ESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       272 ~~-~~~~~~~-------------------------------~~~~~~--------------~~~~~~~~~~~~~~~l~~l  305 (354)
                      .. ....+..                               ..+.+.              ...........+++++.||
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            21 1000000                               000000              0000112235689999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      |.+||++||++|+|++|+|+||||++++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-58  Score=450.49  Aligned_cols=262  Identities=23%  Similarity=0.388  Sum_probs=230.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++..... ...+.+.+|+.+++.++|||||+++++|.+.+.+|+||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            35789999999999999999999999999999999976543 34567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC--CcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK--GEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |||+||+|.+++.. .+.+++.++..++.||+.||.|||+ +||+||||||+|||++.+  +.+||+|||+|+.+... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence            99999999999864 3679999999999999999999998 999999999999999864  89999999999987543 3


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  299 (354)
                      .....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..       +.+..+......  ......++
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  384 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGIS  384 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCCCCCSGGGTTSC
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCCCCCcccccCCC
Confidence            345568999999999999999999999999999999999999999876543       445555554332  33346789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +++.+||.+||+.||++|||+.|+|+||||+...+..
T Consensus       385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            9999999999999999999999999999999866543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.2e-57  Score=414.71  Aligned_cols=278  Identities=29%  Similarity=0.514  Sum_probs=243.2

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|+++...  .......+.+|+.+++.++|+||+++++.+...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            35689999999999999999999999999999999997543  1223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||++||+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++........
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999987554445


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..       +....+.....  ..+..++++
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~  231 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC--CCCCCCCHH
Confidence            556678999999999999999999999999999999999999999765432       33344444332  345678999


Q ss_pred             HHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +.+||.+||+.||++||     ++.++++||||+.+.+..+......+|+.|.+.
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~  286 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT  286 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCS
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCC
Confidence            99999999999999999     899999999999999888766666677776654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-57  Score=422.68  Aligned_cols=287  Identities=26%  Similarity=0.470  Sum_probs=243.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      .+..++|++++.||+|+||+||+|+++.+++.||+|++++..  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            456789999999999999999999999999999999998653  233345678888888776 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999875545


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC--hhhHHHHHHHHHcCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS--WPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ......+.+.+.....  ..+..
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~  284 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRS  284 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTT
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCc
Confidence            4556677999999999999999999999999999999999999999975432211  1111223344444432  34567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCH------HHHhcCccccccccccccccccccCCCCCCCC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSS------LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      ++.++.+||.+||+.||++||++      +|+++||||+.+.+..+......+|+.|.+..
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~  345 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG  345 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCC
Confidence            89999999999999999999985      79999999999999888776777888877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-57  Score=418.07  Aligned_cols=279  Identities=25%  Similarity=0.472  Sum_probs=235.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      .+..++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|..++..+ +|+||+++++.+.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            355789999999999999999999999999999999997643  223345678899999887 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999875555


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..       +....+......  .+..++
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~--~p~~~~  248 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEVV--YPTWLH  248 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--CCTTSC
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC--CCCCCC
Confidence            45556678999999999999988999999999999999999999999776543       444555554332  345689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCH------HHHhcCccccccccccccccccccCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSSS------LDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +++.+||.+||+.||++||++      .++++||||+.+.+..+......+|+.|.+.
T Consensus       249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~  306 (353)
T 3txo_A          249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK  306 (353)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence            999999999999999999999      8999999999999887765566666666554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.2e-56  Score=408.47  Aligned_cols=285  Identities=27%  Similarity=0.476  Sum_probs=241.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|++++.||+|+||+||+|+++.+++.||+|+++...  .......+.+|..++..+ +|+||+++++++.+.+.+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45689999999999999999999999999999999997653  345567788999999887 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++.......
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999999999999988899999999999999999999998 999999999999999999999999999998754444


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC--hhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS--WPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||........  ..........+.....  ..+..+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCC
Confidence            455667899999999999999999999999999999999999999975322110  0112223344444332  345678


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCH------HHHhcCccccccccccccccccccCCCCCCC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSS------LDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +.++.+||.+||+.||++||++      .++++||||+.+.+..+......+|+.|.+.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~  301 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS  301 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCC
Confidence            9999999999999999999995      8999999999998877765556666666554

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-56  Score=410.89  Aligned_cols=280  Identities=26%  Similarity=0.429  Sum_probs=242.2

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      ....++|++++.||+|+||+||+|+++.+++.||+|+++....  ......+..|..++..+ +|+||+++++.+.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            3457899999999999999999999999999999999976431  12345678899998877 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999875444


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..       ++...+.....  ..+..++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s  245 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV--AYPKSMS  245 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSC
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCCC--CCCCCCC
Confidence            44556678999999999999999999999999999999999999999765433       34445554433  2356789


Q ss_pred             HHHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      .++.+||.+||+.||++||+     +.++++||||+.+.+..+......+|+.|.++.
T Consensus       246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~  303 (353)
T 2i0e_A          246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG  303 (353)
T ss_dssp             HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCC
Confidence            99999999999999999995     699999999999999888766777777776653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.6e-56  Score=412.10  Aligned_cols=279  Identities=24%  Similarity=0.459  Sum_probs=235.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      ....++|.+.+.||+|+||+||+|+++.+|+.||||+++....  .+....+..|..++..+ +|+||+++++.+.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            4567899999999999999999999999999999999976431  12345577888888775 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999865444


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+.....  ..+..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s  242 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNP--FYPRWLE  242 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSC
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCCC--CCCcccC
Confidence            44456678999999999999999999999999999999999999999765533       34444444432  2355789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHH-HHhcCccccccccccccccccccCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSSSL-DLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~-eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +++.+||.+||+.||++||++. ++++||||+.+.+..+......+|+.|.+.
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~  295 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK  295 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC-------
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCC
Confidence            9999999999999999999998 999999999999877765555566655543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-55  Score=401.69  Aligned_cols=275  Identities=27%  Similarity=0.511  Sum_probs=240.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +..++|++.+.||+|+||+||+|+++.+|+.||+|+++.....  .....+.+|..+++.++|+||+++++.+.+.+.+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            3568999999999999999999999999999999999764321  23456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++......  
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            999999999999999998899999999999999999999998 99999999999999999999999999999876432  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..       +....+.....  ..+..++++
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~~  229 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAEL--RFPPFFNED  229 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCC--CCCTTSCHH
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC--CCCCCCCHH
Confidence             34568999999999999999999999999999999999999999765432       33444444432  234578999


Q ss_pred             HHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +.+||.+||+.||++||     +++++++||||+.+.+.++......+|+.|++.
T Consensus       230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~  284 (318)
T 1fot_A          230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ  284 (318)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred             HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence            99999999999999999     899999999999999888766566677777764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-55  Score=400.15  Aligned_cols=261  Identities=25%  Similarity=0.444  Sum_probs=230.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...++|.+++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            34678999999999999999999999999999999997653 44556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++|++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...... ..
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  169 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GK  169 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CG
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Cc
Confidence            99999999999999988999999999999999999999998 99999999999999999999999999999876543 33


Q ss_pred             CcccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..       +....+..+...  .+..++++
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~--~p~~~s~~  240 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGKYR--IPFYMSTD  240 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--CCTTSCHH
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC--CCCCCCHH
Confidence            4556899999999999988865 7899999999999999999999765432       344445444332  34568999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +.+||.+||+.||++|||++|+++||||+...+.
T Consensus       241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            9999999999999999999999999999976553

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.3e-55  Score=404.35  Aligned_cols=276  Identities=28%  Similarity=0.438  Sum_probs=241.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|+++.....  .....+.+|+.+++.++|+||+++++.+.+.+.+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            4578999999999999999999999999999999999754321  23456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++......  
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999988899999999999999999999998 99999999999999999999999999999876543  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+.....  ..+..++.+
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~~  264 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKV--RFPSHFSSD  264 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTCCHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCCC--CCCCCCCHH
Confidence             34568999999999999999999999999999999999999999765432       34445554433  335678999


Q ss_pred             HHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      +.+||.+||+.||++||+     ++++++||||+...+..+......+|+-|.+..
T Consensus       265 ~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~  320 (350)
T 1rdq_E          265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG  320 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred             HHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCC
Confidence            999999999999999999     999999999999988777655666666665543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.8e-56  Score=399.99  Aligned_cols=254  Identities=24%  Similarity=0.277  Sum_probs=199.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC----eEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG----VISL  142 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~l  142 (354)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++.....+  .....|+..+..++|||||++++++..++    .+|+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4678889999999999999986  58999999997543322  23345666777899999999999998754    6899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER--------HVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      |||||++|+|.++++. ..++++.+..++.|++.||.|||+ +        +|+||||||+|||++.++++||+|||+|+
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999986 578999999999999999999997 5        89999999999999999999999999998


Q ss_pred             ccCCCcC----CCcccccCCcccccccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC--------hh
Q 018532          215 MLGSSMG----QRDTFVGTYNYMSPERISGS------TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS--------WP  276 (354)
Q Consensus       215 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~  276 (354)
                      .......    .....+||+.|||||++.+.      .++.++|||||||++|||+||..||......+.        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            7654322    22345899999999999764      367899999999999999999887754332211        11


Q ss_pred             hHHHHHHHHHcCCCCCCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          277 SFYELLEAIVESPPPTAPPDQ-----FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ...+....+......+..+..     .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            233344444444333333322     23578899999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.3e-55  Score=407.26  Aligned_cols=280  Identities=27%  Similarity=0.447  Sum_probs=234.4

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHH-HhhcCCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ....++|++++.||+|+||+||+|+++.+++.||+|++++...  ......+..|..+ ++.++|+||+++++.+.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3457899999999999999999999999999999999976542  2334556677766 567899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999875544


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..       +....+.....  ..+..++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~--~~~~~~~  263 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPL--QLKPNIT  263 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHHSCC--CCCSSSC
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhccc--CCCCCCC
Confidence            45556779999999999999999999999999999999999999999765433       34444444432  2345789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCH----HHHhcCccccccccccccccccccCCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSSS----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      .++.+||.+||+.||++||++    .++++||||+.+.|..+......+|+.|.+..
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~  320 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSG  320 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC
T ss_pred             HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCC
Confidence            999999999999999999997    69999999999999887655666677666543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.6e-55  Score=392.66  Aligned_cols=261  Identities=30%  Similarity=0.564  Sum_probs=228.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....... ...+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            4578999999999999999999999999999999987543322 356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||++|++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             ECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            99999999999977 579999999999999999999998 8999999999999999999999999999988766555556


Q ss_pred             ccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 018532          225 TFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS  304 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  304 (354)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ...............+..++..+.+
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCCCccccCHHHHH
Confidence            6789999999999999999999999999999999999999997654321      2222223333444455678999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ||.+||+.||++|||+.|+++||||+....
T Consensus       249 li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            999999999999999999999999997654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.2e-55  Score=417.58  Aligned_cols=280  Identities=28%  Similarity=0.492  Sum_probs=233.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|++++.||+|+||.||+|++..+|+.||||+++...  .......+.+|+.+++.++|+||+++++.+...+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            456789999999999999999999999999999999997542  334446678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||++|++|.+++...+.+++..+..++.||+.||.|||+++||+||||||+|||++.++.+||+|||+|.......
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999999999999889999999999999999999999964789999999999999999999999999998755554


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..       .....+.....  ..+..+++
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~~~  374 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEI--RFPRTLGP  374 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCC--CCCccCCH
Confidence            5556678999999999999999999999999999999999999999766533       33344443332  23567899


Q ss_pred             HHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          301 EFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      ++.+||.+||+.||++||     +++|+++||||+.+.+..+......+|+.|.+.
T Consensus       375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~  430 (446)
T 4ejn_A          375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVT  430 (446)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCS
T ss_pred             HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCC
Confidence            999999999999999999     999999999999998888766666677777664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-55  Score=405.04  Aligned_cols=280  Identities=27%  Similarity=0.457  Sum_probs=240.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|.+++.||+|+||.||+|++..+++.||+|++.....  ......+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567899999999999999999999999999999999875431  22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||+.||+|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++...... 
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999999988899999999999999999999998 99999999999999999999999999999876543 


Q ss_pred             CCCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......    ..+....+....  ...+..
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~--~~~p~~  242 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTV--VTYPSA  242 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCC--CCCCTT
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhcc--cCCCCc
Confidence            33456789999999999974   458999999999999999999999997654432    223333333332  233567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCC-HHHHhcCccccccccccccccccccCCCCCC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSS-SLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps-~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      ++.++.+||.+||+.||++||+ ++++++||||+.+.+..+......+++.|..
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~  296 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK  296 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence            8999999999999999999999 8999999999999998877666667776654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-55  Score=412.59  Aligned_cols=282  Identities=26%  Similarity=0.408  Sum_probs=238.5

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +....++|++++.||+|+||+||+|+++.+++.||+|++++....  .....+.+|+.++..++|+||+++++++.+.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            456788999999999999999999999999999999999753211  112347789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.++++. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999999999999976 579999999999999999999998 99999999999999999999999999999876543


Q ss_pred             cC-CCcccccCCcccccccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--CCC
Q 018532          220 MG-QRDTFVGTYNYMSPERISGST----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP--PPT  292 (354)
Q Consensus       220 ~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  292 (354)
                      .. ...+.+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+..       +....+....  ...
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLTF  294 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccccccC
Confidence            22 234668999999999998765    789999999999999999999999876543       2333333221  122


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccccccccccccCCCCCCCC
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNC  352 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  352 (354)
                      .....+++++.+||.+||+.+|.+  |++++|+++||||+.+.+.........+|+-|.+..
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~  356 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS  356 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence            223468999999999999999988  999999999999999998877766777777777653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-54  Score=396.22  Aligned_cols=278  Identities=24%  Similarity=0.420  Sum_probs=226.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      .+..++|++.+.||+|+||+||+|++.   .+++.||+|+++...   .......+.+|+.+++.++|+||+++++.+..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            345789999999999999999999985   689999999997653   22334567889999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.+|.+||+|||++...
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999988899999999999999999999998 89999999999999999999999999999865


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+.....  ..+.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~--~~p~  242 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKCKL--NLPP  242 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCC--CCCT
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCC--CCCC
Confidence            54444455668999999999999999999999999999999999999999766433       33344444332  2345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      .++.++.+||.+||+.||++||     ++.++++||||+.+.+.........+++.|.+
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~  301 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLL  301 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCc
Confidence            7899999999999999999999     88999999999998887765545555555544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-54  Score=398.96  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=226.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH-----HHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-----IRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .++|.+.+.||+|+||+||+|+++.+|+.||+|+++......     ....+.+|+.+++.++||||+++++.+.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999999999999999997653221     246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~  216 (354)
                      ++||||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999999999888889999999999999999999998 9999999999999998877    7999999999876


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--C
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--P  294 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  294 (354)
                      ... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+........  .
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITAVSYDFDEEF  241 (361)
T ss_dssp             CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCCCCCHHH
T ss_pred             CCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCchh
Confidence            543 2334568999999999999999999999999999999999999999776533       34444544433221  2


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +..+++.+.+||.+||..||++|||+.|+++||||+...+
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            3568999999999999999999999999999999996654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.4e-55  Score=411.57  Aligned_cols=280  Identities=24%  Similarity=0.369  Sum_probs=233.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .....++|++.++||+|+||+||+|+++.+++.||+|+++.....  .....+.+|..++..++|+||+++++.+.+.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            356678999999999999999999999999999999999753211  112337889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      +|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            9999999999999999987 4689999999999999999999998 9999999999999999999999999999977654


Q ss_pred             CcC-CCcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC---C
Q 018532          219 SMG-QRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES---P  289 (354)
Q Consensus       219 ~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~  289 (354)
                      ... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+..       +....+...   .
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~  300 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERF  300 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhhccccc
Confidence            332 233468999999999997     456899999999999999999999999876543       222222221   1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCC--CCCHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRD--RSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      ..+.....+++++.+||.+||..+|++  |++++|+++||||+.+.|..+.  ...+|+-|++.
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~--~~~~p~~P~~~  362 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR--NCEAPYIPEVS  362 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG--GSCCSCCCCCS
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh--hCCCCCCCcCC
Confidence            112223468999999999999888888  9999999999999999998874  34556666554

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.1e-54  Score=406.41  Aligned_cols=259  Identities=23%  Similarity=0.394  Sum_probs=227.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            478999999999999999999999999999999997654 3445677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc---cCCcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN---HKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||++||+|.+.+...+.+++..+..++.||+.||.|||+ .||+||||||+|||++   .++.+||+|||++........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            999999999999998899999999999999999999998 8999999999999998   457899999999988766555


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  299 (354)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+..+...  ......++
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCCCTTTTTTSC
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCCCCccccccCC
Confidence            555678999999999999999999999999999999999999999765433       344444444332  22335789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-54  Score=405.00  Aligned_cols=278  Identities=23%  Similarity=0.379  Sum_probs=230.5

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .....++|++++.||+|+||+||+|+++.+|+.||+|++++...  ......+.+|..++..++|+||+++++.+.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            35667899999999999999999999999999999999975321  1223447889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      +|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||+ .||+||||||+|||++.+|++||+|||++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            999999999999999998764 79999999999999999999998 9999999999999999999999999999987654


Q ss_pred             CcC-CCcccccCCccccccccc-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC--
Q 018532          219 SMG-QRDTFVGTYNYMSPERIS-------GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--  288 (354)
Q Consensus       219 ~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  288 (354)
                      ... .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+.+..       +....+...  
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~  287 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHYKE  287 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccc
Confidence            332 223468999999999997       356899999999999999999999999876543       222222221  


Q ss_pred             -CCCCCCCCCCCHHHHHHHHHhhhhCCCCC---CCHHHHhcCccccccccccccccccccCCCCCC
Q 018532          289 -PPPTAPPDQFSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       289 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                       ...+.....+++++.+||.+||+ +|++|   ++++|+++||||+.+.|..+..  ..+|+.|.+
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~--~~~p~~p~~  350 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD--SVPPFTPDF  350 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTT--SCCSCCCC-
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhh--cCCCCCCcC
Confidence             11122235789999999999999 99998   5999999999999999988752  345555544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.5e-54  Score=392.81  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=224.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++++.||+|+||+||+|++..+++.||+|++......+..+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            47899999999999999999999999999999999766555555778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC--cCCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--MGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~  223 (354)
                      |++|++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......  ....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            99999999999887889999999999999999999998 99999999999999999999999999999865322  2223


Q ss_pred             cccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......      ..................+++.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcccccCCccccCCHHH
Confidence            45689999999999988775 778999999999999999999997665432      12223333333333346789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+||.+||+.||++|||+.|+++||||++...++
T Consensus       239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  272 (323)
T 3tki_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (323)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhhChhhccccccc
Confidence            9999999999999999999999999999765443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-54  Score=426.27  Aligned_cols=279  Identities=26%  Similarity=0.441  Sum_probs=243.2

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~  139 (354)
                      .+..++|++++.||+|+||+||+|+++.+++.||||+++...  .......+..|..++..+ +|++|+.+++.+.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            456789999999999999999999999999999999997542  122345677888888876 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++||+|.++++..+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|......
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999875554


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..       ++...+.....  ..+..++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s  566 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV--AYPKSMS  566 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHSSCC--CCCTTSC
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCCC--CCCccCC
Confidence            45566779999999999999999999999999999999999999999876543       45566665543  3456799


Q ss_pred             HHHHHHHHHhhhhCCCCCCCH-----HHHhcCccccccccccccccccccCCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRSSS-----LDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +++.+||.+||+.||++||++     +||++||||+.+.|..+......+|+.|.+.
T Consensus       567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~  623 (674)
T 3pfq_A          567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS  623 (674)
T ss_dssp             HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred             HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence            999999999999999999997     9999999999999988876666777776553

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-53  Score=382.58  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=217.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++++.||+|+||+||+|++..+++.||+|+++... .......+.+|+.+++.++|+||+++++.+.+++.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            68999999999999999999999999999999997554 33445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+.+.. .+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            9986 66666554 5789999999999999999999998 8999999999999999999999999999988766555556


Q ss_pred             ccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC------------
Q 018532          225 TFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP------------  291 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------  291 (354)
                      ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||....+..   ...............            
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhhhhhcccccc
Confidence            678999999999998766 8999999999999999999888864433221   111111111111100            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          292 ------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       292 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                                  ......++.++.+||.+||+.||++|||++|+++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                        011235789999999999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-53  Score=413.85  Aligned_cols=280  Identities=26%  Similarity=0.442  Sum_probs=239.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +..++|.+.+.||+|+||.||+|+++.+|+.||+|++......  .....+.+|+.+++.++|+||+++++.+.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            5678899999999999999999999999999999999754221  22356789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          142 LVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +||||++||+|.+++...+  .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999999998754  39999999999999999999998 89999999999999999999999999999876543


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                      . .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+........   ++...+....  ...+..++
T Consensus       340 ~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~--~~~p~~~s  413 (576)
T 2acx_A          340 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVP--EEYSERFS  413 (576)
T ss_dssp             C-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCC--CCCCTTSC
T ss_pred             c-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhccc--ccCCccCC
Confidence            2 2344689999999999999899999999999999999999999998765433222   2233333322  23346789


Q ss_pred             HHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCC
Q 018532          300 PEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      +++.+||.+||+.||++||     +++|+++||||+.+.+..+......+|+.|.+
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~  469 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP  469 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence            9999999999999999999     79999999999999998877666666776654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.5e-53  Score=410.54  Aligned_cols=282  Identities=28%  Similarity=0.453  Sum_probs=241.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ....++|.+.+.||+|+||.||+|+++.+|+.||+|++......  .....+.+|+.+++.++|+||+++++.+...+.+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            35678999999999999999999999999999999999754322  2235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      |+||||++||+|.+++...    ..+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++...
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999999764    369999999999999999999998 99999999999999999999999999999887


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.......   .++...+.....  ..+.
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~~~--~~p~  414 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQAV--TYPD  414 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHCCC--CCCT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhccc--CCCc
Confidence            65544455568999999999999999999999999999999999999999876543222   233344444332  3356


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCCC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      .+++++.+||.+||+.||++||+     ++++++||||+.+.+..+......+|+.|..
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~  473 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS  473 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence            78999999999999999999996     5899999999999998877666667776654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.6e-53  Score=386.80  Aligned_cols=267  Identities=25%  Similarity=0.449  Sum_probs=208.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++++.||+|+||+||+|.+..+|+.||+|+++..........+.+|+.+++.++|+||+++++.+..++.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46899999999999999999999999999999999765544444668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          146 YMDRGSLADIIRQV------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       146 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      |++ ++|.+++...      ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            998 5999998765      358999999999999999999998 99999999999999999999999999999887655


Q ss_pred             cCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-------
Q 018532          220 MGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-------  291 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  291 (354)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+...    .+.........       
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK----LIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHHHCSCCTTTCGGGG
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHHHhCCCChhHhhhhh
Confidence            4455566899999999999874 68999999999999999999999998765432111    11111111000       


Q ss_pred             ----------------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          292 ----------------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       292 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                                            ......++.++.+||.+||+.||++|||+.|+++||||++.......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence                                  01123578899999999999999999999999999999998776543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-53  Score=384.69  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=216.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-------------------------HHHHHHHHHHHHH
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-------------------------EIRKQIVQELKIN  119 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~~~  119 (354)
                      ..++|.+.+.||+|+||+||+|++..+++.||||++......                         ...+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            467899999999999999999999999999999998754311                         1235688999999


Q ss_pred             hhcCCCceEEeeeeeee--cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          120 QASQCSHVVVCYHSFYH--NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       120 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +.++|+||+++++.+.+  .+.+++||||+++++|.+++. .+.+++..+..++.||+.||.|||+ .||+||||||+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHE
Confidence            99999999999999886  568999999999999987654 3679999999999999999999998 8999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  274 (354)
                      +++.++.+||+|||++..............||+.|+|||++.+..   ++.++|||||||++|+|++|..||......  
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM--  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH--
Confidence            999999999999999987765444445568999999999998765   478899999999999999999999765322  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                           .....+............+++++.+||.+||+.||++|||+.|+++||||++
T Consensus       247 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          247 -----CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -----HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -----HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                 3334444444444444578999999999999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-53  Score=391.77  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=225.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|++.... .....+.+.+|+.+++.++|+||+++++.+.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999999999999999997543 4455677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++   .+||+|||++...... .
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~  185 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  185 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence            999999999999887889999999999999999999998 8999999999999998654   5999999999876543 2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  299 (354)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+.......  .....++
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTGGGGSC
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCC
Confidence            334568999999999999999999999999999999999999999765432       3344444443322  2234689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +++.+||.+||+.||++|||+.++++||||+..
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5e-53  Score=391.64  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=216.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      ...++|.+++.||+|+||+||++++..+++.||+|++......  ...+.+|+.+++.++|+||+++++++...+.+++|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            3467899999999999999999999999999999999754322  24577999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc--EEEeecccccccCCCcC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMG  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  221 (354)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.  +||+|||++...... .
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~  172 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  172 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-C
Confidence            9999999999999988899999999999999999999998 99999999999999987765  999999999754332 2


Q ss_pred             CCcccccCCcccccccccCCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYS-SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......   +......+............+++
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCCCCCCcCCCCH
Confidence            2344579999999999998887665 8999999999999999999987665433   33444555555444444557899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ++.+||.+||+.||++|||+.|+++||||.+...
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            9999999999999999999999999999976533

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-53  Score=391.77  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=221.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      .++|++.+.||+|+||+||+|.++.+++.||||+++.....    ...+.+.+|+.+++.++|+||+++++.+...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            36799999999999999999999999999999998643211    12466889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeeccccc
Q 018532          142 LVLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSA  214 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~  214 (354)
                      +||||++|++|.+++...    ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.   +||+|||++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            999999999999888653    248999999999999999999998 99999999999999987665   9999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC-
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA-  293 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  293 (354)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...        +....+........ 
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKYKMNP  253 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCCCCCH
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCCCCCc
Confidence            876654445566899999999999999999999999999999999999999976431        23334443332221 


Q ss_pred             -CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          294 -PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       294 -~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                       ....++.++.+||.+||+.||++|||+.++++||||+...
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence             1246899999999999999999999999999999998643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-53  Score=385.65  Aligned_cols=265  Identities=26%  Similarity=0.508  Sum_probs=218.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +.-.++|++++.||+|+||+||+|++. +|+.||+|++..... ......+.+|+.+++.++|+||+++++.+.+.+.++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            344689999999999999999999985 599999999975432 234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99999985 888888764 459999999999999999999998 999999999999999999999999999998876555


Q ss_pred             CCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC------
Q 018532          221 GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA------  293 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------  293 (354)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..    ......+..      
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS----ILGTPNPREWPQVQE  249 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH----HHCCCCTTTSGGGTT
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----HHCCCChHHhhhhhc
Confidence            55555689999999999977 4689999999999999999999999987766543222211    111111100      


Q ss_pred             -------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          294 -------------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       294 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                         ....+++++.+||.+||+.||++|||++|+++||||+.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                               11346789999999999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-53  Score=392.65  Aligned_cols=279  Identities=41%  Similarity=0.744  Sum_probs=240.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++..++|.+.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            45568999999999999999999999999999999999887777777889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++|++|.+++...+.+++..+..++.|++.||.|||+..||+||||||+||+++.++.+||+|||++......  .
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  186 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  186 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999999999998899999999999999999999998238999999999999999999999999999765332  2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC----------------------------
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS----------------------------  274 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------------------------  274 (354)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.                            
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            3345899999999999999999999999999999999999999976442210                            


Q ss_pred             -------hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccc
Q 018532          275 -------WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILV  343 (354)
Q Consensus       275 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~  343 (354)
                             .....+....+.....+......++.++.+||.+||+.||++|||++|+++||||+......++...|.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~  342 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL  342 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhhHHHHH
Confidence                   001223344445555555555678999999999999999999999999999999999988888766654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.9e-52  Score=390.42  Aligned_cols=275  Identities=26%  Similarity=0.404  Sum_probs=222.1

Q ss_pred             cccCccccccccccccc--CceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIKVIGKG--SGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +....++|++++.||+|  +||+||+|++..+|+.||||+++... ..+..+.+.+|+.+++.++|+||+++++++...+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34457899999999999  99999999999999999999997654 3456677899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+++||||+++++|.+++...  ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||.+...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999999999876  679999999999999999999998 99999999999999999999999999988654


Q ss_pred             CCCc-------CCCcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH-HHHHHH
Q 018532          217 GSSM-------GQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE-LLEAIV  286 (354)
Q Consensus       217 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~  286 (354)
                      ....       ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+....+....... ....+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            3211       12233478999999999988  5799999999999999999999999987654431110000 000000


Q ss_pred             ------------------------------------cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          287 ------------------------------------ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       287 ------------------------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                                                          ........+..+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                00001112346789999999999999999999999999999999


Q ss_pred             ccccccc
Q 018532          331 KFEDKDI  337 (354)
Q Consensus       331 ~~~~~~~  337 (354)
                      ...+...
T Consensus       339 ~~~~~~~  345 (389)
T 3gni_B          339 QIKRRAS  345 (389)
T ss_dssp             GC---CC
T ss_pred             HHhhcch
Confidence            9876543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-53  Score=386.33  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      +.||+|+||+||+|.+..+++.||+|++....    ...+.+|+.+++.+. |+||+++++.+.+.+..|+||||++|++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            78999999999999999999999999997542    345678999999886 9999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeecccccccCCCcCCCccccc
Q 018532          152 LADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       152 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      |.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++   .+||+|||++.............+|
T Consensus        93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  171 (325)
T 3kn6_A           93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF  171 (325)
T ss_dssp             HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCC
Confidence            99999998899999999999999999999998 9999999999999998766   8999999999877655555566789


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC--CCCCCHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP--PDQFSPEFCSFV  306 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  306 (354)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||.............+....+..+......  ...+++++.+||
T Consensus       172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  251 (325)
T 3kn6_A          172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI  251 (325)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHH
T ss_pred             CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHH
Confidence            999999999999999999999999999999999999998765543333444556666555433222  135899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .+||+.||++|||+.++++||||+....
T Consensus       252 ~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          252 QGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             HHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             HHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            9999999999999999999999987644

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-53  Score=387.95  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=221.3

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++......  +....+.+|+.+++.++|+||+++++++...+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            357899999999999999999999999999999999754322  223568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||+ +|+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... ..
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~  163 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NF  163 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BT
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cc
Confidence            99999 67999999888999999999999999999999998 89999999999999999999999999999876543 33


Q ss_pred             CcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........       ..+.  ......+..++++
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~--~~~~~~p~~~s~~  234 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVN--SCVYVMPDFLSPG  234 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCC--SSCCCCCTTSCHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHH--cCCCCCcccCCHH
Confidence            445689999999999998876 78999999999999999999999765433211       1111  1123345678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.+||.+||+.||.+|||++|+++||||+..
T Consensus       235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-53  Score=385.71  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=224.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH-----HHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-----IRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .++|.+.+.||+|+||+||+|.+..+|+.||+|+++......     ....+.+|+.+++.++|+||+++++.+...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999999999999999997643211     246688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~  216 (354)
                      ++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++    .+||+|||++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999999999887889999999999999999999998 9999999999999999887    8999999999876


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--AP  294 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  294 (354)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+.......  ..
T Consensus       169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             CTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTCCCCCHHH
T ss_pred             CCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcCCCcCccc
Confidence            543 2334568999999999999999999999999999999999999999765433       2233333222211  12


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ...++..+.+||.+||+.||++|||+.++++||||+....
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            2467999999999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-53  Score=386.31  Aligned_cols=257  Identities=20%  Similarity=0.342  Sum_probs=223.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....  .....+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            468999999999999999999999999999999987543  334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--CCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |++|++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.  ++.+||+|||++...... ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cc
Confidence            99999999999765 369999999999999999999998 99999999999999987  789999999999876543 23


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  300 (354)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+........  ....++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCCCChhhhccCCH
Confidence            34567999999999999988999999999999999999999999776543       33444444433222  1246899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ++.+||.+||..||++|||+.|+++||||++..
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999999998753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=380.70  Aligned_cols=271  Identities=26%  Similarity=0.411  Sum_probs=216.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999999999999999986554 3445677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999998887889999999999999999999998 9999999999999999999999999999988765545555


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH--------HHHH-----cCCC
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL--------EAIV-----ESPP  290 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~-----~~~~  290 (354)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+....        ....     ....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            6689999999999976 568999999999999999999999998765432111111100        0000     0000


Q ss_pred             CCC---------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          291 PTA---------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       291 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ...         ....++.++.+||.+||+.||++|||++|+++||||+++.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            000         01357889999999999999999999999999999999876543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-51  Score=369.94  Aligned_cols=263  Identities=26%  Similarity=0.419  Sum_probs=228.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999999999999999997643 4455677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~~  221 (354)
                      ||+++++|.+.+...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.   +||+|||++....... 
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            999999999999988899999999999999999999998 99999999999999987665   9999999998765432 


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--CCCCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  299 (354)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||......       .....+.....  +......++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhccccCCchhhcccC
Confidence            234468999999999999999999999999999999999999999765433       23333333322  222335789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      +++.+||.+||+.||++|||+.|+++||||++..+...
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            99999999999999999999999999999998765443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-52  Score=388.81  Aligned_cols=282  Identities=27%  Similarity=0.461  Sum_probs=234.2

Q ss_pred             ccCcccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhc-CCCceEEeeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNI---QEEIRKQIVQELKINQAS-QCSHVVVCYHSFY  135 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~  135 (354)
                      ....++|++.+.||+|+||+||+|++.   .+++.||||+++...   .......+.+|+.+++.+ +|+||+++++.+.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            456789999999999999999999984   589999999986432   112234566788888888 6999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ..+.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            999999999999999999999988899999999999999999999998 8999999999999999999999999999986


Q ss_pred             cCCCc-CCCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          216 LGSSM-GQRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       216 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ..... ......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||..........   ++...+....+  
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~~--  283 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEP--  283 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCCC--
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH---HHHHHHhccCC--
Confidence            54322 223446899999999999863  47899999999999999999999998665443322   33333333322  


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCC
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPV  350 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  350 (354)
                      ..+..++..+.+||.+||..||++||     ++.++++||||+...+........++++.|-.
T Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~  346 (355)
T 1vzo_A          284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI  346 (355)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcc
Confidence            23457899999999999999999999     99999999999999888777666666665544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.8e-53  Score=384.80  Aligned_cols=265  Identities=25%  Similarity=0.440  Sum_probs=212.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +++|.+++.||+|+||+||+|++..+++.||+|+++..........+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            36899999999999999999999999999999999765444433456689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            9975 999998875 458999999999999999999998 9999999999999999999999999999987665545555


Q ss_pred             ccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC----------
Q 018532          225 TFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA----------  293 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  293 (354)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.    ...+...........          
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhhhcchhh
Confidence            6688999999999987 5689999999999999999999999987654321    111122211111110          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          294 ---------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       294 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                                     ....+++++.+||.+||+.||++|||++|+++||||....++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                           0125788999999999999999999999999999999886643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-52  Score=385.96  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=220.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|.++.+++.||+|+++....     ...+|+.++..+ +|+||+++++.+.+.+.+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4689999999999999999999999999999999976532     234577777666 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC----CcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK----GEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||++.++    +.+||+|||++.......
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            999999999999988889999999999999999999998 999999999999998543    359999999998876555


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQF  298 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  298 (354)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....    ...++...+..+....  ..+..+
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCCcccCccccccC
Confidence            5556678999999999999888999999999999999999999999764332    1224444554443332  234578


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++++.+||.+||..||++|||+.++++||||...
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999999653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-52  Score=390.05  Aligned_cols=265  Identities=26%  Similarity=0.425  Sum_probs=209.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecC--eEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNG--VIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~--~~~  141 (354)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.+. |+||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            578999999999999999999999999999999986543 3445577889999999997 999999999987544  799


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC--
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--  219 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--  219 (354)
                      +||||++ ++|..++.. +.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999997 599999876 679999999999999999999998 99999999999999999999999999999865321  


Q ss_pred             -------------------cCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH
Q 018532          220 -------------------MGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       220 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  279 (354)
                                         .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               112334689999999999987 578999999999999999999999998765432211111


Q ss_pred             HHHHHHHcCCC--------------------------C----------------CCCCCCCCHHHHHHHHHhhhhCCCCC
Q 018532          280 ELLEAIVESPP--------------------------P----------------TAPPDQFSPEFCSFVSACIQKDPRDR  317 (354)
Q Consensus       280 ~~~~~~~~~~~--------------------------~----------------~~~~~~~~~~l~~li~~~l~~~p~~R  317 (354)
                          .......                          .                ......+++++.+||.+||+.||++|
T Consensus       245 ----~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          245 ----GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             ----HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             ----HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence                0000000                          0                01123678999999999999999999


Q ss_pred             CCHHHHhcCccccccccccc
Q 018532          318 SSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       318 ps~~eil~hp~~~~~~~~~~  337 (354)
                      ||++|+|+||||+.+....-
T Consensus       321 ~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCGGG
T ss_pred             CCHHHHhCCHHHHHhcCCcc
Confidence            99999999999998765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-52  Score=384.29  Aligned_cols=265  Identities=23%  Similarity=0.385  Sum_probs=211.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...++|.+++.||+|+||+||+|++..+++.||||+++.... ......+.+|+.+++.++|+||+++++.+..++.+++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            457899999999999999999999999999999999976543 3345667899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc-----cCCcEEEeecccccccC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-----HKGEVKITDFGVSAMLG  217 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~-----~~~~~kl~Dfg~a~~~~  217 (354)
                      ||||+++ +|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++     .++.+||+|||++....
T Consensus       111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999985 999999998889999999999999999999998 8999999999999994     45569999999998776


Q ss_pred             CCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC--
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP--  294 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  294 (354)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+   ......... ........  
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~-~~~~~~~~~~  264 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVL-GLPDDTTWPG  264 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHH-CCCCTTTSTT
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHh-CCCchhhhhh
Confidence            554555566889999999999875 48999999999999999999999997765432   111111111 11110000  


Q ss_pred             -----------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          295 -----------------------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       295 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                             ...+++++.+||.+||+.||++|||+.|+++||||+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                   0116789999999999999999999999999999998765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-52  Score=374.99  Aligned_cols=259  Identities=27%  Similarity=0.463  Sum_probs=211.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++..... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999998 6899999999865432 2233567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++ +|.+++... +.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            9986 999998764 679999999999999999999998 9999999999999999999999999999987655444445


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC------------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP------------  291 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------  291 (354)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.   ....... ......            
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRI-LGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH-HCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH-HCCCChhhchhhhccccc
Confidence            56789999999999764 589999999999999999999999977653321   1111111 111000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          292 ------------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       292 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                                  ......+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        01124578999999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.3e-52  Score=378.31  Aligned_cols=257  Identities=36%  Similarity=0.632  Sum_probs=222.6

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEecc
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      .|...+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            366777899999999999999999999999999754332 2456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccc
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV  227 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  227 (354)
                      +|++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..............
T Consensus       125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            99999998865 579999999999999999999998 8999999999999999999999999999988765544555678


Q ss_pred             cCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-CCCCCCCCHHHHHHH
Q 018532          228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-TAPPDQFSPEFCSFV  306 (354)
Q Consensus       228 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  306 (354)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||......       +....+.....+ ......+++.+.+||
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li  275 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPPPKLKNSHKVSPVLRDFL  275 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence            999999999999999999999999999999999999999765432       233333333322 223346899999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .+||+.||++|||+.++++||||.+...
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~  303 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTGL  303 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCCC
Confidence            9999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.5e-52  Score=370.55  Aligned_cols=262  Identities=31%  Similarity=0.501  Sum_probs=224.5

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|++.+.||+|+||+||+|.+..++..||+|++......  .....+.+|+.+++.++|+||+++++.+.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            45678999999999999999999999999999999998654322  2346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999999999999988899999999999999999999998 99999999999999999999999999998655432 


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                       ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......       +....+....  ...+..+++
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~--~~~~~~~~~  232 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVE--FTFPDFVTE  232 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC--CCCCTTSCH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhCC--CCCCCcCCH
Confidence             234457999999999999999999999999999999999999999765432       2333333332  223456899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+.+||.+||+.||++|||+.|+++||||+......
T Consensus       233 ~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          233 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            999999999999999999999999999999865543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7e-52  Score=371.66  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=213.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||+|+||+||+|.+..++..||+|++.........+.+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            47899999999999999999999999999999999766544445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCC
Q 018532          146 YMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       146 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  218 (354)
                      |+++++|.+++...    ..+++..+..++.||+.||.|||+ .||+||||||+||++   +.++.+||+|||++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            99999999998653    679999999999999999999998 999999999999999   4567899999999986654


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPDQ  297 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  297 (354)
                      . .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+....       +........ .........
T Consensus       180 ~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          180 D-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCCC--CC
T ss_pred             c-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhccCCcccccccCc
Confidence            3 2234557999999999986 46899999999999999999999999765432       222232222 222223345


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +++++.+||.+||+.||++|||+.|+++||||+++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            79999999999999999999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-52  Score=397.39  Aligned_cols=258  Identities=28%  Similarity=0.450  Sum_probs=226.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|.+.+.||+|+||.||+|++..+|+.||||+++.....  +....+.+|+.+++.++|+||+++++.+...+.++
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4567899999999999999999999999999999999754322  23467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... .
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~  170 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E  170 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-C
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-c
Confidence            999999999999999888889999999999999999999998 99999999999999999999999999999876543 3


Q ss_pred             CCcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......       .....+..+..  ..+..+++
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~  241 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDGIF--YTPQYLNP  241 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTTCC--CCCTTCCH
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCc--CCCccCCH
Confidence            3445689999999999998775 68999999999999999999999765432       34445554432  23557899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++.+||.+||+.||++|||+.++++||||+..
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-52  Score=370.01  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=226.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......+..+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            46899999999999999999999999999999999765544556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc--CCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--GQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~  223 (354)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++.......  ...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999999877789999999999999999999998 999999999999999999999999999998654221  223


Q ss_pred             cccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.......      .....+............++..+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHhhhcccccCchhhcCHHH
Confidence            45679999999999988775 778999999999999999999997765432      12223333333333345689999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+||.+||+.||++|||+.|+++||||++...++
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             HHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            9999999999999999999999999999875544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-52  Score=381.58  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-------  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-------  138 (354)
                      .++|++.+.||+|+||.||+|+++.+|+.||||+++........+.+.+|+.+++.++|+||+++++.+.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4689999999999999999999999999999999986655556678999999999999999999999886543       


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHHHHhC---CCCHH
Q 018532          139 --------------------------------------------------VISLVLEYMDRGSLADIIRQVK---TILEP  165 (354)
Q Consensus       139 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~---~~~~~  165 (354)
                                                                        .+++||||++|++|.+++....   ...+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3899999999999999998753   35566


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc------------CCCcccccCCccc
Q 018532          166 YLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM------------GQRDTFVGTYNYM  233 (354)
Q Consensus       166 ~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~gt~~y~  233 (354)
                      .+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.......            .......||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            789999999999999998 999999999999999999999999999998775542            1233457999999


Q ss_pred             ccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhC
Q 018532          234 SPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKD  313 (354)
Q Consensus       234 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  313 (354)
                      |||++.+..++.++|||||||++|+|++|..|+.         ..............+ ......++++.+||.+||+.|
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSS
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHHHHHhhccCCC-cccccCChhHHHHHHHHccCC
Confidence            9999999999999999999999999999877652         112223333333221 122345778999999999999


Q ss_pred             CCCCCCHHHHhcCcccccc
Q 018532          314 PRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       314 p~~Rps~~eil~hp~~~~~  332 (354)
                      |++|||+.|+++||||+++
T Consensus       314 p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          314 PTERPEATDIIENAIFENL  332 (332)
T ss_dssp             GGGSCCHHHHHHSTTCCCC
T ss_pred             CCcCCCHHHHhhchhhhcC
Confidence            9999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-51  Score=367.67  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=230.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+...+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34678999999999999999999999999999999987653  3455677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            999999999999999988899999999999999999999998 8999999999999999999999999999987765444


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||......       +....+....  ...+..++..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~  241 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE--YSIPKHINPV  241 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC--CCCCTTSCHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhcc--CCCccccCHH
Confidence            455568999999999999988999999999999999999999999765432       2233333332  2335578999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +.++|.+||+.||++|||+.++++||||+......
T Consensus       242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            99999999999999999999999999998765433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-52  Score=385.78  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=222.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            57899999999999999999999999999999999765433 34578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--CCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |++|++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.  ++.+||+|||++...... ..
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~  206 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  206 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence            99999999998765 378999999999999999999998 99999999999999974  467999999999876543 22


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--CCCCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  300 (354)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+.....  +......+++
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCccccccCCH
Confidence            34457999999999999999999999999999999999999999875432       23333333322  2233457899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++.+||.+||+.||++|||+.|+++||||+..
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.4e-52  Score=382.50  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=210.0

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...   ..+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3567999999999999999999999999999999997643   2356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.   ++.+||+|||++...... .
T Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~  205 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V  205 (349)
T ss_dssp             CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence            999999999999888889999999999999999999998 89999999999999976   889999999999876433 2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  299 (354)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .....+.......  .....++
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCCCCTTTTTTSC
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCccCCchhhhCC
Confidence            2345679999999999999999999999999999999999999997654321      2334444433222  2235789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .++.+||.+||+.||++|||+.|+++||||+......
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  316 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF  316 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch
Confidence            9999999999999999999999999999998765543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.9e-52  Score=377.25  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=225.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH-----HHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE-----IRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|+++......     ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            567999999999999999999999999999999997543211     246688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~  216 (354)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999999999987889999999999999999999998 9999999999999999888    7999999999876


Q ss_pred             CCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--C
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--P  294 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  294 (354)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +....+........  .
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITSVSYDFDEEF  241 (321)
T ss_dssp             CTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCCCCCHHH
T ss_pred             Cccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccccChhh
Confidence            5432 234557999999999999999999999999999999999999999765433       33344443322211  1


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ...++..+.+||.+||+.||++|||+.|+++||||+...+.
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            24688999999999999999999999999999999976543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-51  Score=388.36  Aligned_cols=271  Identities=25%  Similarity=0.327  Sum_probs=215.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----Ce
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~  139 (354)
                      .++|.+.+.||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+++.++|+||+++++.+...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999999999999999997543 344567889999999999999999999998766     67


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||++ ++|.+++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+.....
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            999999996 5999999987889999999999999999999998 99999999999999999999999999999876543


Q ss_pred             cC----------------------CCcccccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCC---------
Q 018532          220 MG----------------------QRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAIGRFPYM---------  267 (354)
Q Consensus       220 ~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~---------  267 (354)
                      ..                      .....+||+.|+|||++ .+..++.++|||||||++|||++|..||.         
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            21                      23567899999999986 45569999999999999999998544443         


Q ss_pred             --CCCcCC----------ChhhHHHHH------------------------HHHHcCCCCCCC-----CCCCCHHHHHHH
Q 018532          268 --QSEDQQ----------SWPSFYELL------------------------EAIVESPPPTAP-----PDQFSPEFCSFV  306 (354)
Q Consensus       268 --~~~~~~----------~~~~~~~~~------------------------~~~~~~~~~~~~-----~~~~~~~l~~li  306 (354)
                        +.+...          ........+                        ..+.........     ...+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence              222100          000000111                        111111111100     135799999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      .+||+.||++|||++|+|+||||+.+.+...+
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e  374 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKKLE  374 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence            99999999999999999999999999887654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-51  Score=367.41  Aligned_cols=260  Identities=28%  Similarity=0.391  Sum_probs=224.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||+|+||+||+|.+..++..||+|++....... .+.+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            467999999999999999999999999999999987654322 4568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++...... ..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~  164 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM  164 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence            99999999999988899999999999999999999998 999999999999999   78889999999999876543 23


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC--CCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP--PDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  300 (354)
                      .....||+.|+|||++.+. ++.++|||||||++|+|++|..||......       +....+.........  ...+++
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCCCchhhhcCCH
Confidence            3456799999999998764 899999999999999999999999776543       333444444322211  136899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+.+||.+||+.||++|||+.++++||||++.....
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            999999999999999999999999999998765543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-51  Score=394.04  Aligned_cols=271  Identities=25%  Similarity=0.313  Sum_probs=204.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-----cCe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH-----NGV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~  139 (354)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+++.++|+||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999999999999999986543 34456778999999999999999999999854     357


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||||+. ++|.+++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+.....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999999985 6999999888889999999999999999999998 89999999999999999999999999999876432


Q ss_pred             c---------------------------CCCcccccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHc----------
Q 018532          220 M---------------------------GQRDTFVGTYNYMSPERI-SGSTYDYSSDIWSLGLVVLECAI----------  261 (354)
Q Consensus       220 ~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~----------  261 (354)
                      .                           ......+||+.|+|||++ .+..++.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           123456789999999986 45669999999999999999999          


Q ss_pred             -CCCCCCCCCcCCCh-------------hhHHHHHHH---HH--------------------cCCCC------CCCCCCC
Q 018532          262 -GRFPYMQSEDQQSW-------------PSFYELLEA---IV--------------------ESPPP------TAPPDQF  298 (354)
Q Consensus       262 -g~~pf~~~~~~~~~-------------~~~~~~~~~---~~--------------------~~~~~------~~~~~~~  298 (354)
                       |+++|.+.......             ....+.+..   +.                    ...+.      ......+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             66677554311000             000011111   11                    00000      0112356


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ++++.+||.+||..||++|||++|+|+||||+.+.+...+
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e  409 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE  409 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence            8999999999999999999999999999999999876654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=373.10  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=208.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHH-hhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKIN-QASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.... ..........|+..+ +...|+||+++++.+.+.+.+++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986543 223334444555444 445999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |||+ +++|.+++...+ .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....... .
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~  212 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A  212 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence            9999 569999887754 69999999999999999999998 899999999999999999999999999998765432 2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .....||+.|+|||++.+ .++.++|||||||++|||++|..|+....          ....+.....+...+..+++++
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l  281 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPPEFTAGLSSEL  281 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCHHHHTTSCHHH
T ss_pred             CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCcccccCCCHHH
Confidence            344579999999999886 78999999999999999999976664321          1233333333333345789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      .+||.+||+.||++|||+.|+++||||++
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          282 RSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.9e-51  Score=365.92  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=222.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~  138 (354)
                      .....|.+.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++.++|+||+++++.+..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34456888999999999999999999999999999987543 45567789999999999999999999998875    35


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEc-cCCcEEEeecccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVN-HKGEVKITDFGVSAM  215 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~  215 (354)
                      .+++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .|  |+||||||+||+++ .++.+||+|||++..
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            689999999999999999988899999999999999999999998 88  99999999999998 789999999999976


Q ss_pred             cCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......      ......+.....+...+
T Consensus       182 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          182 KRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG
T ss_pred             cccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccccC
Confidence            5432  2344579999999998875 5899999999999999999999999765432      23444455554455555


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ...++++.+||.+||+.||++|||+.++++||||++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            677899999999999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.6e-51  Score=365.96  Aligned_cols=260  Identities=31%  Similarity=0.485  Sum_probs=226.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+..++|.+.+.||+|+||+||+|++..+++.||+|++......  .....+.+|+.+++.++|+||+++++.+...+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999998654321  2245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999999999988899999999999999999999998 99999999999999999999999999998765432 


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|..||......       +....+.....  ..+..++.
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~--~~~~~~~~  237 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNVDL--KFPPFLSD  237 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC--CCCTTSCH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhcccc--CCCCcCCH
Confidence             234457999999999999999999999999999999999999999765432       23333433322  23457899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ++.++|.+||+.||++|||+.++++||||+....
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            9999999999999999999999999999987554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-52  Score=375.41  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=208.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhhc---CCCceEEeeeeeeec
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ----EEIRKQIVQELKINQAS---QCSHVVVCYHSFYHN  137 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~~~  137 (354)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.....    ......+.+|+.+++.+   .|+||+++++.+...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35789999999999999999999999999999999874321    11123345566655554   599999999998875


Q ss_pred             C-----eEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          138 G-----VISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       138 ~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                      .     .++++|||+. ++|.+++.....  +++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            5     5899999997 599999987644  8999999999999999999998 89999999999999999999999999


Q ss_pred             ccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       211 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      |++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+..   ..+... .....
T Consensus       165 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~-~~~~~  239 (308)
T 3g33_A          165 GLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDL-IGLPP  239 (308)
T ss_dssp             SCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHH-HCCCC
T ss_pred             ccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH-hCCCC
Confidence            999876543 3334568999999999999999999999999999999999999999876543211   111111 11111


Q ss_pred             CCC----------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          291 PTA----------------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       291 ~~~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ...                      ....+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            100                      0135789999999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-51  Score=370.77  Aligned_cols=269  Identities=36%  Similarity=0.660  Sum_probs=212.8

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHH-HHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI-RKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +++..++|++.+.||+|+||+||+|++..+|+.||+|+++....... ...+.++...++.++|+||+++++.+...+..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            45677899999999999999999999999999999999976544433 34445555567889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          141 SLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+ + ||+||||||+||+++.++.+||+|||++..
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999999975 88887764    3679999999999999999999998 7 999999999999999999999999999987


Q ss_pred             cCCCcCCCcccccCCcccccccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERI----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ..... ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||......      ............+
T Consensus       160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~  232 (290)
T 3fme_A          160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEPSP  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSCCC
T ss_pred             ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccCCC
Confidence            65432 22334799999999996    4567899999999999999999999999754321      1233344444444


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~  339 (354)
                      ......+++++.+||.+||+.||++|||+.|+++||||+.....+.+.
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~~  280 (290)
T 3fme_A          233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV  280 (290)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCH
T ss_pred             CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccCH
Confidence            555567899999999999999999999999999999999876655443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=366.16  Aligned_cols=261  Identities=28%  Similarity=0.444  Sum_probs=199.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||+|++......  +....+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3467899999999999999999999999999999998754321  22467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999999875 578999999999999999999998 899999999999999999999999999998776444


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......+       ....+...  ....+..++.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~--~~~~~~~~~~  237 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TLNKVVLA--DYEMPSFLSI  237 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS--CCCCCTTSCH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HHHHHhhc--ccCCccccCH
Confidence            44445689999999999999889999999999999999999999997665432       12222111  2234556899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ++.+||.+||+.||++|||+.++++||||.....
T Consensus       238 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999999999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.4e-51  Score=371.46  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=214.0

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ..++.+..++|++.+.||+|+||+||+|++  +|..||+|++.... ..+..+.+.+|+.+++.++|+||+++++.+...
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            345667789999999999999999999976  58899999987543 445567789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCcEEEeeccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      +.+++||||+++++|.+++...+   .+++..+..++.|++.||.|||+ .|  |+||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            99999999999999999998754   39999999999999999999998 89  99999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      +..............||+.|+|||++.+..++.++|||||||++|+|++|+.||......       +....+.......
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~  258 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCKRL  258 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCCCC
T ss_pred             CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCC
Confidence            986655444445668999999999999999999999999999999999999999766533       3333443344445


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc--Ccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS--HPFIK  330 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~--hp~~~  330 (354)
                      ..+..+++++.+||.+||+.||++|||+.++++  .++++
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            566789999999999999999999999999987  34444

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-51  Score=384.80  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=208.5

Q ss_pred             Cccccccc-ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hhcCCCceEEeeeeeee----cC
Q 018532           65 SLEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVVVCYHSFYH----NG  138 (354)
Q Consensus        65 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~----~~  138 (354)
                      ..++|.+. +.||+|+||+||++.+..+|+.||||+++..      ..+.+|+.++ +..+|+||+++++.+..    .+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            35678776 6899999999999999999999999998643      2355677765 45689999999998876    56


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeecccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVS  213 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a  213 (354)
                      .+|+||||++||+|.+++...+  .+++..+..++.||+.||.|||+ .||+||||||+|||++.   ++.+||+|||++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            8999999999999999998643  59999999999999999999998 99999999999999998   789999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--C
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--P  291 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  291 (354)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+............   .+..+..  +
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~i~~~~~~~~  287 (400)
T 1nxk_A          212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRMGQYEFP  287 (400)
T ss_dssp             EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---HHHHTCCCCC
T ss_pred             cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---HHHcCcccCC
Confidence            876533 233456899999999999999999999999999999999999999987654432222222   2222222  2


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ......++.++.+||.+||+.||++|||+.++++||||....
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            223357899999999999999999999999999999998643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-51  Score=395.70  Aligned_cols=260  Identities=25%  Similarity=0.425  Sum_probs=222.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH------------HHHHHHHHHHHHHhhcCCCceEEeeee
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE------------EIRKQIVQELKINQASQCSHVVVCYHS  133 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~l~h~~iv~~~~~  133 (354)
                      .++|.+++.||+|+||+||+|.++.+++.||+|++......            ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            57899999999999999999999999999999999754321            234678999999999999999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeec
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDF  210 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Df  210 (354)
                      +.+.+.+++||||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999999999999988899999999999999999999998 8999999999999998876   6999999


Q ss_pred             ccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          211 GVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       211 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      |++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....       +....+.....
T Consensus       194 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~  264 (504)
T 3q5i_A          194 GLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DIIKKVEKGKY  264 (504)
T ss_dssp             TTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC
T ss_pred             CCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC
Confidence            999876543 23345689999999999875 6899999999999999999999999876543       34455554433


Q ss_pred             CCC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          291 PTA--PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       291 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ...  .+..+++++.+||.+||+.||.+|||+.|+|+||||++....
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            222  125689999999999999999999999999999999876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-50  Score=371.57  Aligned_cols=261  Identities=28%  Similarity=0.410  Sum_probs=229.8

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            34678999999999999999999999999999999987653  3456677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999999988899999999999999999999998 8999999999999999999999999999987765444


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||......       +....+....  ...+..++..
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~--~~~~~~~~~~  267 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE--YSIPKHINPV  267 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC--CCCCTTSCHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcCC--CCCCccCCHH
Confidence            455668999999999999999999999999999999999999999765432       2223333332  2234578999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +.+||.+||+.||++|||+.|+++||||.....
T Consensus       268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          268 AASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999999987644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.6e-51  Score=372.10  Aligned_cols=267  Identities=27%  Similarity=0.418  Sum_probs=213.2

Q ss_pred             cccccc-ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh-cCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA-SQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ++|.+. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++.. .+|+||+++++.+...+.+++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            567775 789999999999999999999999999976532 234568899999888 57999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeecccccccCCCc-
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAMLGSSM-  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~-  220 (354)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.   +||+|||++....... 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999999988899999999999999999999998 89999999999999998776   9999999987654221 


Q ss_pred             ------CCCcccccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC-h------h-hHHHH
Q 018532          221 ------GQRDTFVGTYNYMSPERISG-----STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS-W------P-SFYEL  281 (354)
Q Consensus       221 ------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~------~-~~~~~  281 (354)
                            ......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+....+. |      . .....
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                  11224469999999999975     4588999999999999999999999987643220 0      0 11223


Q ss_pred             HHHHHcCCCCCCC--CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          282 LEAIVESPPPTAP--PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       282 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      ...+.........  ...++..+.+||.+||+.||++|||+.|+++||||+.....
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence            3444444332211  14689999999999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-51  Score=395.53  Aligned_cols=261  Identities=25%  Similarity=0.441  Sum_probs=223.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|.+++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999999999999999986432 1123466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc---cCCcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN---HKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||+.|++|.+.+...+.+++..+..++.||+.||.|||+ .||+||||||+||+++   .++.+||+|||++...... .
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~  178 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T  178 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-C
Confidence            999999999999888999999999999999999999998 9999999999999995   4567999999999876543 2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  299 (354)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....       +....+........  .+..++
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCSCSGGGGGSC
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCCcccCCCC
Confidence            3345689999999999986 5999999999999999999999999776533       34444544433322  235689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +++.+||.+||+.||++|||+.++|+||||+......
T Consensus       251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            9999999999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-51  Score=375.43  Aligned_cols=256  Identities=31%  Similarity=0.518  Sum_probs=221.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .+.|.+++.||+|+||+||+|++..+++.||||++....  ..+..+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            356899999999999999999999999999999997543  344557789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |||+. |+|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++......   
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            99997 588888864 4679999999999999999999998 89999999999999999999999999999866432   


Q ss_pred             CcccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          223 RDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                       ....||+.|+|||++.   +..++.++|||||||++|+|++|+.||......       .....+.....+......++
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  279 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWS  279 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCCCTTSC
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCCCCCC
Confidence             3458999999999985   467899999999999999999999999765432       22333444444445556789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +.+.+||.+||+.||++|||+.++++||||.....
T Consensus       280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999999999976543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1e-50  Score=376.69  Aligned_cols=257  Identities=26%  Similarity=0.492  Sum_probs=221.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeec
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-------QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHN  137 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~  137 (354)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||+++...       ..+..+.+.+|+.+++.+ +|+||+++++.+...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            467999999999999999999999999999999987543       123456788999999998 899999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      +..++||||++|++|.+++.....+++..+..++.||+.||.|||+ .||+|+||||+||+++.+|.+||+|||++....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999999988899999999999999999999998 899999999999999999999999999998765


Q ss_pred             CCcCCCcccccCCcccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISG------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      .. ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||......       .....+......
T Consensus       252 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~  323 (365)
T 2y7j_A          252 PG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LMLRMIMEGQYQ  323 (365)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC
T ss_pred             CC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC
Confidence            43 23345689999999999863      35889999999999999999999999765432       233334333332


Q ss_pred             CC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          292 TA--PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       292 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      ..  ....++..+.+||.+||+.||++|||+.++++||||++
T Consensus       324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            22  12467899999999999999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-51  Score=394.36  Aligned_cols=259  Identities=30%  Similarity=0.447  Sum_probs=220.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|.+++.||+|+||+||+|+++.++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4679999999999999999999999999999999976432 223466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||++||+|.+.+.....+++..+..++.||+.||.|||+ +||+||||||+||+++..   +.+||+|||++....... 
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            999999999999988899999999999999999999998 999999999999999764   459999999998765442 


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  299 (354)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....       +....+........  ....++
T Consensus       194 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCSGGGTTSC
T ss_pred             cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCchhcccCC
Confidence            3345689999999999864 6999999999999999999999999876543       34445544433322  235789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +.+.+||.+||+.||++|||+.++|+||||+....
T Consensus       266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             HHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            99999999999999999999999999999998644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.8e-51  Score=367.43  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=221.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|.+.+.||+|+||+||+|++..+|+.||+|+++.... .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4689999999999999999999999999999999976432 233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||++   +.++.+||+|||++......  .
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~  163 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--I  163 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--T
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--c
Confidence            99999999999888899999999999999999999998 899999999999999   77889999999998765432  2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  300 (354)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......       +....+......  ......++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCCCccccccCCH
Confidence            34457999999999999999999999999999999999999999765432       333444444322  233457899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ++.+||.+||+.||++|||+.++++||||+...
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-51  Score=380.17  Aligned_cols=263  Identities=25%  Similarity=0.413  Sum_probs=217.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....    .....+.+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            578999999999999999999999999999999987542    2344577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 018532          142 LVLEYMDRGSLADIIRQV----------------------------------------KTILEPYLAVVCKQVLQGLVYL  181 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~----------------------------------------~~~~~~~~~~i~~qi~~~l~~L  181 (354)
                      +||||++||+|.+++...                                        ..+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988421                                        1235677889999999999999


Q ss_pred             HhCCCceecCCCCCCEEEccCC--cEEEeecccccccCCCcC----CCcccccCCcccccccccC--CCCCcchhHHHHH
Q 018532          182 HNERHVIHRDIKPSNLLVNHKG--EVKITDFGVSAMLGSSMG----QRDTFVGTYNYMSPERISG--STYDYSSDIWSLG  253 (354)
Q Consensus       182 H~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG  253 (354)
                      |+ .||+||||||+||+++.++  .+||+|||++........    ......||+.|+|||++.+  ..++.++||||||
T Consensus       185 H~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          185 HN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            98 8999999999999998777  899999999986543211    2345679999999999976  5789999999999


Q ss_pred             HHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          254 LVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       254 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      |++|+|++|+.||.+....       +....+........  ....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       264 ~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            9999999999999776543       23333333332222  22347999999999999999999999999999999999


Q ss_pred             ccccc
Q 018532          332 FEDKD  336 (354)
Q Consensus       332 ~~~~~  336 (354)
                      ..++-
T Consensus       337 ~~~~~  341 (345)
T 3hko_A          337 FSDKI  341 (345)
T ss_dssp             TSSCS
T ss_pred             ChHhh
Confidence            87643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-51  Score=376.92  Aligned_cols=269  Identities=25%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            35789999999999999999999999999999999986543 34556778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999888777889999999999999999999998 89999999999999999999999999999876655445


Q ss_pred             CcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH-----------HHHH--HcC
Q 018532          223 RDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-----------LEAI--VES  288 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----------~~~~--~~~  288 (354)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+...           ....  ..+
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            5566899999999999876 6899999999999999999999999876543211111100           0000  000


Q ss_pred             CCCCC---------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          289 PPPTA---------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       289 ~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .....         ....+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            00000         0125789999999999999999999999999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-50  Score=364.52  Aligned_cols=264  Identities=25%  Similarity=0.464  Sum_probs=223.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--------cHHHHHHHHHHHHHHhhcC-CCceEEeeeeeee
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--------QEEIRKQIVQELKINQASQ-CSHVVVCYHSFYH  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~  136 (354)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++...        .....+.+.+|+.+++.+. |+||+++++.+..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            578999999999999999999999999999999997542        1234567889999999995 9999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+..++||||+++++|.+++.....+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999988899999999999999999999998 99999999999999999999999999999876


Q ss_pred             CCCcCCCcccccCCccccccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERIS------GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      ... .......||+.|+|||++.      ...++.++|||||||++|+|++|..||......       .....+.....
T Consensus       175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  246 (298)
T 1phk_A          175 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSGNY  246 (298)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC
T ss_pred             CCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHHHHhcCCc
Confidence            543 2334457999999999985      456889999999999999999999999765432       23333333332


Q ss_pred             CCC--CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          291 PTA--PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       291 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ...  ....++..+.+||.+||+.||++|||+.++++||||++...+++.
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred             ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence            222  224689999999999999999999999999999999988776543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-51  Score=374.58  Aligned_cols=260  Identities=25%  Similarity=0.430  Sum_probs=216.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCC--CceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQC--SHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h--~~iv~~~~~~~~~~~  139 (354)
                      .+..++|++++.||+|+||+||++.+. +++.||||++.... .....+.+.+|+.++..+.|  +||+++++++...+.
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            445678999999999999999999885 68999999997543 44556778999999999977  999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +++|||+ .+++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++ ++.+||+|||++......
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9999995 577999999998899999999999999999999998 8999999999999996 688999999999876543


Q ss_pred             cC--CCcccccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          220 MG--QRDTFVGTYNYMSPERISG-----------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       220 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ..  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......      ......+.
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHHh
Confidence            22  2335679999999999865           56899999999999999999999999754321      23344445


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ........+...+.++.+||.+||+.||++|||+.|+++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            5555555666788999999999999999999999999999999854

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.8e-52  Score=397.58  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=226.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            578999999999999999999999999999999986542  123356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCc
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |||+.|++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||++   +.++.+||+|||++...... 
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  182 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-  182 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence            9999999999999988899999999999999999999998 899999999999999   46789999999999876543 


Q ss_pred             CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCC
Q 018532          221 GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQF  298 (354)
Q Consensus       221 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  298 (354)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....       +....+........  .+..+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~  254 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYTFELPQWKKV  254 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCCSGGGGGS
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCCCCcccccC
Confidence            23345679999999999977 6899999999999999999999999876543       44455555443322  23568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ++++.+||.+||+.||++|||+.|+|+||||+......
T Consensus       255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence            99999999999999999999999999999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-51  Score=378.52  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=212.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999999999999999986543 345567789999999999999999999998765      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            569999999 7899999987 679999999999999999999998 9999999999999999999999999999987653


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------  282 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  282 (354)
                      .   ....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       181 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  257 (367)
T 1cm8_A          181 E---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  257 (367)
T ss_dssp             S---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             c---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence            2   345689999999999987 679999999999999999999999998765432211111100               


Q ss_pred             -HHHHcCCC------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          283 -EAIVESPP------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       283 -~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                       .......+      ........++.+.+||.+||+.||++|||+.++|+||||+...+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence             00000000      0112245789999999999999999999999999999999886644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-51  Score=366.17  Aligned_cols=263  Identities=24%  Similarity=0.415  Sum_probs=222.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++.....     ...+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            6799999999999999999999999999999998754321     12467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeecccccccC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAMLG  217 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~  217 (354)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+ .|++||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999999999999999988899999999999999999999998 9999999999999998877    89999999998765


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APP  295 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  295 (354)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....       +....+.......  ...
T Consensus       164 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~  235 (283)
T 3bhy_A          164 AGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVNYDFDEEYF  235 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCCCCCHHHH
T ss_pred             CCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhcccCCcchhc
Confidence            432 233457999999999999999999999999999999999999999765432       2333333332221  112


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ..++..+.+||.+||+.||++|||+.++++||||+....+...
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence            4678999999999999999999999999999999998776543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.6e-51  Score=390.11  Aligned_cols=264  Identities=28%  Similarity=0.442  Sum_probs=209.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++|+||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999999999999999997653 345567789999999999999999999998654      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            68999999976 6777664  359999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH---------------HH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL---------------LE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------~~  283 (354)
                      . ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.               ..
T Consensus       217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             C-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            3 2344568999999999999999999999999999999999999999876543222211111               01


Q ss_pred             HHHcCCCCCCC-------CCC-----------CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          284 AIVESPPPTAP-------PDQ-----------FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       284 ~~~~~~~~~~~-------~~~-----------~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ......+....       +..           .++++.+||.+||+.||++|||++|+|+||||+...+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence            11111110000       000           1467999999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.1e-51  Score=379.61  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      ...+.||+|+||.||+|.+..+|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++.+...+.+++||||+++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            335689999999999999999999999999976543 3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE--ccCCcEEEeecccccccCCCcCCCccc
Q 018532          150 GSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV--NHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       150 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      ++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||+  +.++.+||+|||++....... .....
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~  248 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVN  248 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCC
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccc
Confidence            9999988764 469999999999999999999998 999999999999999  567789999999998765432 23345


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCCHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFSPEFCS  304 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~  304 (354)
                      +||+.|+|||++.+..++.++|||||||++|+|++|..||.+....       +.+..+......  ......+++++.+
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~  321 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWDLEDEEFQDISEEAKE  321 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCChhhhccCCHHHHH
Confidence            7999999999999989999999999999999999999999876543       233344333222  2223568999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          305 FVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       305 li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ||.+||+.||++|||+.|+++||||+....
T Consensus       322 li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          322 FISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             HHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence            999999999999999999999999997643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-50  Score=375.82  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=212.8

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-----CCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-----CSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~iv~~~~~~~~~~  138 (354)
                      ...++|.+++.||+|+||+||+|++..+++.||||+++..  .........|+.+++.+.     |+||+++++.+...+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            3467899999999999999999999999999999998643  344556778899888886     999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---------------
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---------------  201 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---------------  201 (354)
                      ..++||||+ +++|.+++....  .+++..+..++.||+.||.|||+ .||+||||||+|||++.               
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcccc
Confidence            999999999 889999998754  58999999999999999999998 99999999999999975               


Q ss_pred             ----------CCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc
Q 018532          202 ----------KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED  271 (354)
Q Consensus       202 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  271 (354)
                                ++.+||+|||+|......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                      789999999999865432   2345899999999999999999999999999999999999999977654


Q ss_pred             CCChhhHHHHHHHHHcCCCC-----------------------------------------CCCCCCCCHHHHHHHHHhh
Q 018532          272 QQSWPSFYELLEAIVESPPP-----------------------------------------TAPPDQFSPEFCSFVSACI  310 (354)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~l~~li~~~l  310 (354)
                      .+.    ...+.......+.                                         .......++.+.+||.+||
T Consensus       265 ~~~----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          265 MEH----LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             HHH----HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             HHH----HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            321    1111111111000                                         0000112477889999999


Q ss_pred             hhCCCCCCCHHHHhcCcccc
Q 018532          311 QKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       311 ~~~p~~Rps~~eil~hp~~~  330 (354)
                      +.||++|||++|+|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999996

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.8e-51  Score=367.49  Aligned_cols=260  Identities=34%  Similarity=0.554  Sum_probs=227.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|.+++.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35689999999999999999999999999999999866544556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.+||+|||++............
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            9999999999875 679999999999999999999998 99999999999999999999999999999877655444456


Q ss_pred             cccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          226 FVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       226 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||......       .....+.... ....+..++..+.+|
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNN-PPTLEGNYSKPLKEF  250 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCCCSSCCHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhcCC-CCCCccccCHHHHHH
Confidence            68999999999999999999999999999999999999999765432       2222333332 333456789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          306 VSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      |.+||+.||++|||+.++++||||.....+
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             HHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence            999999999999999999999999875443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=378.06  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=218.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-------EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++....       ......+.+|+.+++.++|+||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4789999999999999999999999999999999976431       112345678999999999999999999999999


Q ss_pred             eEEEEEeccCCC-CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRG-SLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999998766 999999988889999999999999999999998 899999999999999999999999999998765


Q ss_pred             CCcCCCcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      .. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......             .  ......+.
T Consensus       182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~--~~~~~~~~  245 (335)
T 3dls_A          182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------V--EAAIHPPY  245 (335)
T ss_dssp             TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------T--TTCCCCSS
T ss_pred             CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------H--hhccCCCc
Confidence            43 23345689999999999998876 78999999999999999999999653321             1  11223345


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            6899999999999999999999999999999998743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-50  Score=378.41  Aligned_cols=261  Identities=25%  Similarity=0.426  Sum_probs=218.1

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcC--CCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQ--CSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~  139 (354)
                      .....+|.+.+.||+|+||+||+|.+.. ++.||||++.... .......+.+|+.+++.+.  |+||+++++++...+.
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            3445679999999999999999999874 9999999997643 4556678999999999986  5999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+||| +.+++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++ ++.+||+|||++......
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999999 5578999999988889999999999999999999998 9999999999999995 689999999999876543


Q ss_pred             cC--CCcccccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          220 MG--QRDTFVGTYNYMSPERISG-----------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       220 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      ..  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||......      ...+..+.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHHh
Confidence            22  2345689999999999875           36889999999999999999999999754321      13344555


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ........+...+.++.+||.+||+.||++|||+.|+++||||+...
T Consensus       282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            55555555666789999999999999999999999999999998643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=366.33  Aligned_cols=263  Identities=36%  Similarity=0.632  Sum_probs=220.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++.....   ...+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            45779999999999999999999999999999999976432   355788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++..........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            99999999999974 4679999999999999999999998 999999999999999999999999999998776554445


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC  303 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  303 (354)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ................+..++..+.
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCcccCCcccCCHHHH
Confidence            5668999999999999999999999999999999999999999765432      1111112222223333456799999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          304 SFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       304 ~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      +||.+||..||++|||+.++++||||+.......
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~  290 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI  290 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGG
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhcCCcchH
Confidence            9999999999999999999999999998765443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-51  Score=371.13  Aligned_cols=270  Identities=33%  Similarity=0.577  Sum_probs=197.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+.+..++|.+.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++.+...+..
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            35667789999999999999999999999999999999987654445567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          141 SLVLEYMDRGSLADIIRQ--------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ++||||+++++|.+++..        ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||+
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999999975        3458999999999999999999998 8999999999999999999999999999


Q ss_pred             ccccCCCc-----CCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHH
Q 018532          213 SAMLGSSM-----GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV  286 (354)
Q Consensus       213 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  286 (354)
                      +.......     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......      .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~  241 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQ  241 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhc
Confidence            87664321     11234579999999999876 568999999999999999999999997765432      1111111


Q ss_pred             cCCCC-------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          287 ESPPP-------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       287 ~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      .....       ......++.++.+||.+||+.||++|||+.++++||||++...++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence            11111       1223567899999999999999999999999999999998876653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3e-50  Score=360.55  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=212.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++... .......+.+|+..+..+ +|+||+++++.+...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999999999999999997643 233456788899888888 999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-----------------
Q 018532          144 LEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-----------------  202 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-----------------  202 (354)
                      |||+++++|.+++...    ..+++..+..++.||+.||.|||+ +||+||||||+||+++.+                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            9999999999999875    568999999999999999999998 999999999999999844                 


Q ss_pred             --CcEEEeecccccccCCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH
Q 018532          203 --GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY  279 (354)
Q Consensus       203 --~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  279 (354)
                        ..+||+|||.+......    ....||+.|+|||++.+. .++.++|||||||++|+|++|..++....         
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------  235 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------  235 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred             CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence              47999999999876543    234689999999999876 56789999999999999999998764332         


Q ss_pred             HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          280 ELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                       ....+..... ...+..+++++.+||.+||+.||++|||+.++++||||+....
T Consensus       236 -~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          236 -QWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             -HHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             -HHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence             2233333332 3345678999999999999999999999999999999997653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-51  Score=376.77  Aligned_cols=266  Identities=23%  Similarity=0.392  Sum_probs=213.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ...++|.+.+.||+|+||+||+|++..+|+.||+|+++.....    .....+.+|+.+++.++|+||+++++.+...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3467899999999999999999999999999999998754322    223467899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++||||+++ +|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            9999999986 898888764 468899999999999999999998 9999999999999999999999999999988765


Q ss_pred             CcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC----
Q 018532          219 SMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA----  293 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  293 (354)
                      ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.   +..+..... ......    
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~-~~~~~~~~~~  240 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLG-TPTEEQWPDM  240 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC-CCCTTTSSST
T ss_pred             CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcC-CCChhhhhhh
Confidence            55555566899999999999764 489999999999999999999999977654321   111122111 110000    


Q ss_pred             -------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          294 -------------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       294 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                                         ....++.++.+||.+||+.||++|||+.|+++||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                               014567899999999999999999999999999999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=364.15  Aligned_cols=270  Identities=30%  Similarity=0.503  Sum_probs=218.1

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .+.+..++|.....||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            344556777777899999999999999999999999999876533 3456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~  216 (354)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.+||+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            99999999999999998752   45688899999999999999998 99999999999999988 899999999999877


Q ss_pred             CCCcCCCcccccCCcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ...........||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.......     ......... ......
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~-~~~~~~  247 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMF-KVHPEI  247 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHH-CCCCCC
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccc-cccccc
Confidence            55444445568999999999997654  8899999999999999999999996543221     111111111 222334


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      +..++.++.+||.+||+.||++|||+.++++||||+....++..
T Consensus       248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~  291 (295)
T 2clq_A          248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT  291 (295)
T ss_dssp             CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-------
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCC
Confidence            56789999999999999999999999999999999988765543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.8e-51  Score=387.20  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=211.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-------QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....       .......+.+|+.+++.++|+||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            478999999999999999999999999999999997542       1122335789999999999999999999874 56


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeecccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAM  215 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  215 (354)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++   .+||+|||++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            689999999999999999887889999999999999999999998 8999999999999997654   599999999987


Q ss_pred             cCCCcCCCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .... ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........      ....+.......
T Consensus       292 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i~~~~~~~  364 (419)
T 3i6u_A          292 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNF  364 (419)
T ss_dssp             CC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHHHTTCCCC
T ss_pred             cCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHHhcCCCCC
Confidence            6543 33345689999999999864   5688899999999999999999999987654432      222333332222


Q ss_pred             --CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          293 --APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       293 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                        .....+++.+.+||.+||+.||++|||++|+++||||+....++
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  410 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHH
Confidence              11246899999999999999999999999999999998765543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=369.50  Aligned_cols=262  Identities=35%  Similarity=0.641  Sum_probs=215.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeee-----
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYH-----  136 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~-----  136 (354)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++......  ...+.+|+.+++.+ +|+||+++++.+..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34567899999999999999999999999999999998754322  35678899999888 89999999999987     


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          137 -NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       137 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                       .+.+++||||+++++|.+++...  ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence             56899999999999999999874  568999999999999999999998 89999999999999999999999999999


Q ss_pred             cccCCCcCCCcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      ..............||+.|+|||++.     +..++.++|||||||++|+|++|..||......       .....+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~  249 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRN  249 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcC
Confidence            87655444445568999999999997     456899999999999999999999999765432       223334444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..+......++..+.+||.+||..||++|||+.++++||||+....
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            4444455678999999999999999999999999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.8e-50  Score=371.12  Aligned_cols=267  Identities=22%  Similarity=0.352  Sum_probs=220.7

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~  141 (354)
                      ++|.+++.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++|+||+++++.+...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            58999999999999999999999999999999998666666678899999999999999999999988654     4799


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+++ +|.+++.. +.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus       107 iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            99999975 99999876 679999999999999999999998 9999999999999999999999999999987654322


Q ss_pred             ---CCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------
Q 018532          222 ---QRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------  282 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  282 (354)
                         .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+....               
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence               12445899999999987654 58999999999999999999999998776543222221100               


Q ss_pred             --HHHHcCCCCCC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          283 --EAIVESPPPTA-----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       283 --~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                        ...........     ....+++++.+||.+||+.||++|||+.|+++||||++.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence              00000000000     1145789999999999999999999999999999999875543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-51  Score=373.67  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=216.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC----e
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG----V  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~  139 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...  ..+....+.+|+.+++.++|+||+++++.+....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999999999999999997653  4455678899999999999999999999887654    3


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            59999999999999999988899999999999999999999998 89999999999999999999999999999876443


Q ss_pred             cC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCC
Q 018532          220 MG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAP  294 (354)
Q Consensus       220 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  294 (354)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....       +...........  ...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCHHHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCcccc
Confidence            22   223457999999999999999999999999999999999999999765532       222222222211  122


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ...++.++.++|.+||+.||++||++.+++.|+|++......
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            356899999999999999999999999999999998755443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-50  Score=361.48  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=215.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +..++|.+.+.||+|+||.||+|.+..+|+.||+|++......  +....+.+|+.+++.++|+||+++++.+...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            4567899999999999999999999999999999998754321  23457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++....... 
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            999999999999999988899999999999999999999998 999999999999999999999999999998765432 


Q ss_pred             CCcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......       .....+.....  ..+..++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~--~~~~~~~~  236 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF--YIPEYLNR  236 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc--cCchhcCH
Confidence            2334578999999999988765 68999999999999999999999765432       23333433322  23456899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      .+.++|.+||+.||++|||+.++++||||++.
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.5e-51  Score=368.43  Aligned_cols=262  Identities=32%  Similarity=0.616  Sum_probs=218.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            578999999999999999999999999999999986542 2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |+++++|.+++... ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++...........
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            99999999998764 679999999999999999999998 8999999999999999999999999999765433222334


Q ss_pred             ccccCCcccccccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc-CCCCCCCCCCC
Q 018532          225 TFVGTYNYMSPERI-----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-SPPPTAPPDQF  298 (354)
Q Consensus       225 ~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  298 (354)
                      ...||+.|+|||++     .+..++.++|||||||++|+|++|..||...+..       .....+.. ..+....+..+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  248 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPPTLLTPSKW  248 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSSGGGS
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCcccCCcccc
Confidence            45799999999998     3567899999999999999999999999765432       22223333 33333345678


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +..+.++|.+||+.||++|||+.++++||||+.....+
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence            99999999999999999999999999999999887654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9e-51  Score=371.62  Aligned_cols=264  Identities=23%  Similarity=0.440  Sum_probs=219.9

Q ss_pred             ccccccc-ccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEE
Q 018532           66 LEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        66 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|+++.... ......+.+|+.++..+ .|+||+++++.+...+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4567776 889999999999999999999999999875432 22346688999999888 56999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeecccccccC
Q 018532          143 VLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVSAMLG  217 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~  217 (354)
                      ||||+++++|.+++...  +.+++..+..++.||+.||.|||+ .||+||||||+||+++.   ++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            99999999999988543  679999999999999999999998 89999999999999988   7899999999998765


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc--CCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE--SPPPTAPP  295 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  295 (354)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......       +....+..  ...+....
T Consensus       186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~  257 (327)
T 3lm5_A          186 HAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQVNVDYSEETF  257 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTT
T ss_pred             Ccc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHhcccccCchhh
Confidence            432 234468999999999999999999999999999999999999999776543       22222222  22333344


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      ..+++.+.+||.+||+.||++|||++++++||||+........
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence            5789999999999999999999999999999999998877654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.9e-50  Score=373.40  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=221.0

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-------WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYH  132 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~  132 (354)
                      .+.+..++|.+.+.||+|+||+||+|++.       .++..||+|+++..........+.+|+.+++.+ +|+||+++++
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            35667899999999999999999999875       345679999998776677778899999999999 8999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      .+...+.+|+||||+++|+|.+++...+                .+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N  233 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  233 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence            9999999999999999999999998753                47889999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      ||++.++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... 
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9999999999999999987654322  2233467889999999999999999999999999999999 99999876543 


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            +....+.... ....+..++.++.++|.+||+.||++|||+.|++++
T Consensus       313 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ------ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ------GHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  2233333332 334456789999999999999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.1e-50  Score=361.85  Aligned_cols=262  Identities=22%  Similarity=0.381  Sum_probs=218.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...  ...+..+.+.+|+.++..++|+||+++++.+...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999999999999999998643  2455667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-CC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-GQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~  222 (354)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....... ..
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999999999999998899999999999999999999998 999999999999999999999999999998765432 22


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC---CCCCCCC
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT---APPDQFS  299 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  299 (354)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+....       ...........+.   .....++
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccCCCcchhcccCCC
Confidence            33457999999999999999999999999999999999999999765432       1222222222221   2345689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +.+.++|.+||..||++||+..+.+.+.|.+-..+.
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            999999999999999999977777777776655443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-50  Score=361.53  Aligned_cols=261  Identities=30%  Similarity=0.483  Sum_probs=221.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVIS  141 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~  141 (354)
                      ..++|++.+.||+|+||+||++++..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++.+..  .+.++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3578999999999999999999999999999999997643 45566789999999999999999999998754  57899


Q ss_pred             EEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCC-----ceecCCCCCCEEEccCCcEEEeeccc
Q 018532          142 LVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGLVYLHNERH-----VIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||+ .|     |+||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999998643    38999999999999999999998 88     99999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      +..............||+.|+|||++.+..++.++|||||||++|+|++|..||......       +....+..... .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~-~  234 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKF-R  234 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC-C
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhccc-c
Confidence            987654433334457899999999999989999999999999999999999999766432       33344444433 2


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..+..++.++.++|.+||+.||++|||+.++++|+|+..-..
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            345578999999999999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.8e-51  Score=381.43  Aligned_cols=264  Identities=14%  Similarity=0.166  Sum_probs=198.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhc--CCCceEEeee-------e
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQAS--QCSHVVVCYH-------S  133 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l--~h~~iv~~~~-------~  133 (354)
                      ...+|.+.+.||+|+||+||+|++..+|+.||||++....  .......+.+|+.+++.+  +|+||++++.       .
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3456999999999999999999999999999999998754  334456677785444443  6999887653       3


Q ss_pred             eeec-----------------CeEEEEEeccCCCCHHHHHHHh-CCCCHHHH------HHHHHHHHHHHHHHHhCCCcee
Q 018532          134 FYHN-----------------GVISLVLEYMDRGSLADIIRQV-KTILEPYL------AVVCKQVLQGLVYLHNERHVIH  189 (354)
Q Consensus       134 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~LH~~~~iiH  189 (354)
                      +...                 ..+|+||||++ ++|.+++... ..+.+...      ..++.||+.||.|||+ +||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivH  217 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVH  217 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCcc
Confidence            3322                 34899999998 7999999874 34454445      6778999999999998 99999


Q ss_pred             cCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 018532          190 RDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPYM  267 (354)
Q Consensus       190 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~  267 (354)
                      |||||+|||++.+|.+||+|||+|.......   ....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765332   13467799999999987  679999999999999999999999998


Q ss_pred             CCCcCCC--hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          268 QSEDQQS--WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       268 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .......  +...  .................+++.+.+||.+||+.||++|||+.++++||||+++.+.
T Consensus       295 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          295 LVTPGIKGSWKRP--SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             BCCTTCTTCCCBC--CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             CcCcccccchhhh--hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            7643211  0000  0000001111222235789999999999999999999999999999999988664

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2e-50  Score=372.76  Aligned_cols=266  Identities=26%  Similarity=0.387  Sum_probs=216.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee-------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH-------  136 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-------  136 (354)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++..... ......+.+|+.+++.++|+||+++++.+..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            46899999999999999999999999999999999865432 2233567789999999999999999999877       


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          137 -NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       137 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                       .+.+++||||+++ +|.+.+... ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             4578999999975 887777654 679999999999999999999998 999999999999999999999999999998


Q ss_pred             ccCCC----cCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          215 MLGSS----MGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       215 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      .....    ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....    ....+.......
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~  248 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSI  248 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCC
Confidence            76422    122344578999999999976 458999999999999999999999998765432    222222222222


Q ss_pred             CCCCCCCC---------------------------CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          290 PPTAPPDQ---------------------------FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 ~~~~~~~~---------------------------~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      .+...+..                           .++.+.+||.+||+.||++|||++|+++||||+......
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            22111110                           267899999999999999999999999999998755443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-50  Score=375.57  Aligned_cols=262  Identities=26%  Similarity=0.416  Sum_probs=221.7

Q ss_pred             CcccccccCcccccccccccccCceEEEEEE-----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEe
Q 018532           57 YKEFDFEFSLEDLETIKVIGKGSGGVVQLVR-----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVC  130 (354)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~  130 (354)
                      +....|++..++|.+.+.||+|+||.||+|+     +..+++.||||+++........+.+.+|+.++..+ +|+||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3344677889999999999999999999999     55677899999998776666678899999999999 78999999


Q ss_pred             eeeeeecC-eEEEEEeccCCCCHHHHHHHhCC------------------------------------------------
Q 018532          131 YHSFYHNG-VISLVLEYMDRGSLADIIRQVKT------------------------------------------------  161 (354)
Q Consensus       131 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------  161 (354)
                      ++.+...+ .+++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988754 59999999999999999986533                                                


Q ss_pred             ------------------CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC--
Q 018532          162 ------------------ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--  221 (354)
Q Consensus       162 ------------------~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--  221 (354)
                                        +++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++........  
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                              8899999999999999999998 8999999999999999999999999999986643322  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (354)
                      ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+      .....+.. ......+..+++
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~  323 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKE-GTRMRAPDYTTP  323 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHH-TCCCCCCTTCCH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHc-CCCCCCCCCCCH
Confidence            2334578899999999999999999999999999999998 999997765432      22222222 233344567899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++.++|.+||+.||++|||+.++++|
T Consensus       324 ~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          324 EMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHH
Confidence            99999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=368.01  Aligned_cols=259  Identities=21%  Similarity=0.333  Sum_probs=214.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC--eEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l  142 (354)
                      ..++|.+.+.||+|+||+||+|++..+++.||||+++........+.+.+|+.+++.++|+||+++++.+...+  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            35789999999999999999999999999999999976544444566789999999999999999999988655  8899


Q ss_pred             EEeccCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE----ccCCcEEEeecccccc
Q 018532          143 VLEYMDRGSLADIIRQVKT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAM  215 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  215 (354)
                      ||||+++++|.+++.....   +++..+..++.||+.||.|||+ .||+||||||+||++    +.++.+||+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999999987543   8999999999999999999998 999999999999999    7788899999999987


Q ss_pred             cCCCcCCCcccccCCccccccccc--------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERIS--------GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      ..... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.........   .+.+..+..
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~  241 (319)
T 4euu_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKIIT  241 (319)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHHHHH
T ss_pred             cCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHHHhc
Confidence            65443 334457999999999986        567899999999999999999999999755433221   233333333


Q ss_pred             CCCCC-----------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          288 SPPPT-----------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       288 ~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      +.+..                       .....++..+.+||.+||+.||++|||++|+++||=
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            22211                       111234567899999999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-50  Score=378.24  Aligned_cols=263  Identities=24%  Similarity=0.400  Sum_probs=210.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-------
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-------  136 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-------  136 (354)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||||++.....     ...+|+.+++.++|+||+++++++..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            456789999999999999999999999999999999865422     23469999999999999999998854       


Q ss_pred             -------------------------------cCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH
Q 018532          137 -------------------------------NGVISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYL  181 (354)
Q Consensus       137 -------------------------------~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L  181 (354)
                                                     ...+++||||+++ +|.+.+..    .+.+++..+..++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348999999985 88777754    46799999999999999999999


Q ss_pred             HhCCCceecCCCCCCEEEc-cCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCC-CCcchhHHHHHHHHHHH
Q 018532          182 HNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLEC  259 (354)
Q Consensus       182 H~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el  259 (354)
                      |+ .||+||||||+||+++ .++.+||+|||+|....... ......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus       158 H~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          158 HS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            98 9999999999999998 68899999999998765432 334567899999999998754 89999999999999999


Q ss_pred             HcCCCCCCCCCcCCChhhHHHHH--------HHHHcC----CCC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCC
Q 018532          260 AIGRFPYMQSEDQQSWPSFYELL--------EAIVES----PPP--------TAPPDQFSPEFCSFVSACIQKDPRDRSS  319 (354)
Q Consensus       260 l~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~----~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps  319 (354)
                      ++|+.||.+....+....+....        ......    ..+        ...+..+++++.+||.+||+.||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999998765432211111100        000000    000        0123457899999999999999999999


Q ss_pred             HHHHhcCcccccccc
Q 018532          320 SLDLLSHPFIKKFED  334 (354)
Q Consensus       320 ~~eil~hp~~~~~~~  334 (354)
                      +.|+++||||+.+.+
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999999999998755

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.5e-52  Score=385.68  Aligned_cols=253  Identities=15%  Similarity=0.173  Sum_probs=206.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHH---HHhhcCCCceEEee-------
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELK---INQASQCSHVVVCY-------  131 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~---~~~~l~h~~iv~~~-------  131 (354)
                      ...++|.+.+.||+|+||+||+|++..+|+.||||++....  .....+.+.+|+.   +++.++|+||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34578999999999999999999999999999999997432  2344577889994   55556899999988       


Q ss_pred             eeeeecC-----------------eEEEEEeccCCCCHHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHHhCCCc
Q 018532          132 HSFYHNG-----------------VISLVLEYMDRGSLADIIRQVKTILE-------PYLAVVCKQVLQGLVYLHNERHV  187 (354)
Q Consensus       132 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~~i  187 (354)
                      +.+...+                 ..|++|||+ +|+|.+++...+.+++       ..+..++.||+.||.|||+ .||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            5544443                 388999999 5799999987665665       7788899999999999998 899


Q ss_pred             eecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCC-----------CCCcchhHHHHHHHH
Q 018532          188 IHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-----------TYDYSSDIWSLGLVV  256 (354)
Q Consensus       188 iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il  256 (354)
                      +||||||+|||++.++.+||+|||+|.....   .....+| +.|+|||++.+.           .++.++|||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999999999999999999986543   2334577 999999999887           799999999999999


Q ss_pred             HHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          257 LECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       257 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      |+|++|+.||.+.........       +.      .....+++++.+||.+||+.||++|||+.++++||||+.+.+.
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~-------~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEW-------IF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             HHHHHSSCCC------CCSGG-------GG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhh-------hh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence            999999999976554332211       11      1125689999999999999999999999999999999987653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-49  Score=375.88  Aligned_cols=264  Identities=28%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc------CCCceEEeeeeeeecC
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS------QCSHVVVCYHSFYHNG  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~~~  138 (354)
                      ...+|++++.||+|+||+||+|.+..+++.||||+++..  ......+.+|+.+++.+      +|+||+.+++.+...+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            456799999999999999999999999999999999753  34455677788777765      6779999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc--EEEeeccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSA  214 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~  214 (354)
                      .+++||||+. ++|.+++....  .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.  +||+|||+|.
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9999999996 59999998754  48999999999999999999998 89999999999999999987  9999999997


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH-----------
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-----------  283 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------  283 (354)
                      .....   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+...           
T Consensus       251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          251 YEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             ETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             ecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            65432   3346899999999999999999999999999999999999999987664422211111100           


Q ss_pred             ---HHHc-CCCCC-----------------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHh
Q 018532          284 ---AIVE-SPPPT-----------------------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLL  324 (354)
Q Consensus       284 ---~~~~-~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil  324 (354)
                         .... ...+.                                   ......++.+.+||.+||+.||++|||++|+|
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L  407 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL  407 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence               0000 00000                                   01123478899999999999999999999999


Q ss_pred             cCccccccccc
Q 018532          325 SHPFIKKFEDK  335 (354)
Q Consensus       325 ~hp~~~~~~~~  335 (354)
                      +||||++...+
T Consensus       408 ~Hpw~~~~~~~  418 (429)
T 3kvw_A          408 RHPWLRRRLPK  418 (429)
T ss_dssp             TSTTTC-----
T ss_pred             CChhhccCCCC
Confidence            99999986543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.5e-50  Score=365.20  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=219.1

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      +..++..++|.+.+.||+|+||+||+|.+..++.   .||||+++........+.+.+|+.+++.++|+||+++++++.+
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3445677899999999999999999999986655   5999999877677777889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .+..++||||++|++|.+++... +.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999999999765 579999999999999999999998 9999999999999999999999999999987


Q ss_pred             cCCCcCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          216 LGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       216 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      .......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....+... ..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~-~~  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEG-YR  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTT-CC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcC-CC
Confidence            6543222   223356778999999998899999999999999999999 99999766543       334444443 23


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ...+..+++.+.+||.+||+.||++|||+.++++
T Consensus       273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3345678999999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-50  Score=373.41  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=200.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------C
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------G  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~  138 (354)
                      .++|.+++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++.+...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            378999999999999999999999999999999986543 344567788999999999999999999988653      5


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+++....
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            689999999 6799998876 679999999999999999999998 9999999999999999999999999999987543


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------  282 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  282 (354)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            2   344689999999999987 678999999999999999999999998765432211111100               


Q ss_pred             -HHHHcCCCCCC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          283 -EAIVESPPPTA------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       283 -~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                       ...........      .....++.+.+||.+||+.||++|||+.|+|+||||+...+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence             00000000000      0135688999999999999999999999999999999876644

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6e-50  Score=359.31  Aligned_cols=260  Identities=25%  Similarity=0.445  Sum_probs=222.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            5789999999999999999999999999999999875432 233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+ .|++||||||+||+++.++   .+||+|||++....... 
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-  178 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence            999999999999888899999999999999999999998 8999999999999997644   69999999998765432 


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC--CCCCCC
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA--PPDQFS  299 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  299 (354)
                      ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+....       +....+........  ....++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCCSGGGTTSC
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCCchhhhhcC
Confidence            2334568999999999876 4899999999999999999999999775432       33444444433222  225689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      +++.++|.+||+.||++|||+.++++||||++...+
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence            999999999999999999999999999999987653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3e-50  Score=367.97  Aligned_cols=269  Identities=35%  Similarity=0.647  Sum_probs=203.2

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHH-HHhhcCCCceEEeeeeeeecC
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK-INQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      ..+.+..++|++.+.||+|+||.||+|.+..+|+.||||+++..........+..|+. +++.++|+||+++++.+...+
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            3456778999999999999999999999999999999999987665555556666666 777789999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEccCCcEEEeeccc
Q 018532          139 VISLVLEYMDRGSLADIIRQ-----VKTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ..++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+ . ||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            99999999985 88888864     4678999999999999999999998 7 999999999999999999999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERI----SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      +........ .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.......      +....+...
T Consensus       173 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~  245 (327)
T 3aln_A          173 SGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQLTQVVKG  245 (327)
T ss_dssp             SCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCS
T ss_pred             ceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HHHHHHhcC
Confidence            987654322 2334799999999999    45668999999999999999999999997643211      111122222


Q ss_pred             CCCC---CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          289 PPPT---APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       289 ~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ..+.   .....+++.+.+||.+||+.||++|||+.++++||||....++..
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~  297 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV  297 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHH
Confidence            2111   122468999999999999999999999999999999998776654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=358.91  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=217.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +..++|.+.+.||+|+||+||+|.+..+++.||+|++.. ......+.+.+|+.+++.++|+||+++++.+.+++..++|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            456899999999999999999999999999999998854 3455667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          144 LEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999999987 4679999999999999999999998 99999999999999999999999999999876443221


Q ss_pred             C--------------cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC--hhhHHHHHHHHH
Q 018532          223 R--------------DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS--WPSFYELLEAIV  286 (354)
Q Consensus       223 ~--------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~  286 (354)
                      .              ...+||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence            1              145799999999999999999999999999999999999999876443221  0111111111  


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          287 ESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       287 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                            ..+..+++.+.+++.+||+.||++|||+.++++  |++.+.
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                  123567889999999999999999999999987  555543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-50  Score=367.46  Aligned_cols=260  Identities=28%  Similarity=0.431  Sum_probs=214.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-------EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....       ......+.+|+.+++.++|+||+++++.+..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4689999999999999999999999999999999865421       122345889999999999999999999886654


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeecccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGVSAM  215 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  215 (354)
                       .++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.   +||+|||++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence             89999999999999999888889999999999999999999998 99999999999999987664   99999999987


Q ss_pred             cCCCcCCCcccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ..... ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........      ....+.......
T Consensus       167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~  239 (322)
T 2ycf_A          167 LGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNF  239 (322)
T ss_dssp             CCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHHHTCCCC
T ss_pred             ccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHHhCcccc
Confidence            64331 223457999999999974   45689999999999999999999999976654432      122222222211


Q ss_pred             --CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          293 --APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       293 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                        .....++..+.+||.+||+.||++|||+.++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence              122467999999999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-50  Score=373.13  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------  138 (354)
                      .++|.+++.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++|+||+++++.+...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            578999999999999999999999999999999997643 3455677889999999999999999999987654      


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..++||||+++ +|.+++.  ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            78999999975 8888885  468999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH---------------HHH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE---------------LLE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------------~~~  283 (354)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.+               ...
T Consensus       180 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             c-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            3 223446899999999999999999999999999999999999999987654321111100               000


Q ss_pred             HHHcCCCCCC------------CCC------CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          284 AIVESPPPTA------------PPD------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       284 ~~~~~~~~~~------------~~~------~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ......+...            .+.      ..+.++.+||.+||+.||++|||++|+++||||+...+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence            0000100000            000      01567999999999999999999999999999987544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.4e-50  Score=373.48  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=221.3

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|.+..++|.+.+.||+|+||+||+|.+..+++.||||+++.....+....+.+|+.+++.++|+||+++++.+...+.+
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            56778899999999999999999999999999999999998766666677899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999998754 69999999999999999999998 99999999999999999999999999999865432


Q ss_pred             cCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          220 MGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       220 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ...  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....       +....+..+ .....+.
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~  338 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKG-GRLPCPE  338 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTT-CCCCCCT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC-CCCCCCC
Confidence            211  112245778999999998889999999999999999998 99999766532       223333333 3334456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+++.+.+||.+||+.||++|||+.++++
T Consensus       339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            78999999999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.8e-49  Score=363.08  Aligned_cols=260  Identities=20%  Similarity=0.380  Sum_probs=212.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeee--cCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYH--NGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~--~~~~~l  142 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...    .+.+.+|+.+++.+. |+||+++++.+..  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            578999999999999999999999999999999987543    355788999999997 9999999999987  678999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||||+++++|.++++   .+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++....... 
T Consensus       111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-  185 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  185 (330)
T ss_dssp             EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence            999999999998874   48999999999999999999998 9999999999999999777 89999999998765432 


Q ss_pred             CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC-ChhhHH------HHHHHHHcCCC---
Q 018532          222 QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ-SWPSFY------ELLEAIVESPP---  290 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~------~~~~~~~~~~~---  290 (354)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.      .....+.....   
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            3345589999999999987 668999999999999999999999996543221 000000      00011111100   


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          291 -------------------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       291 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                         .......+++++.+||.+||+.||++|||++|+|+||||+.+.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                               01112237999999999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-50  Score=371.97  Aligned_cols=261  Identities=23%  Similarity=0.343  Sum_probs=221.5

Q ss_pred             ccCcccccccccccccCceEEEEEE-----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVR-----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ++..++|.+.+.||+|+||+||+|+     +..+++.||||+++..........+.+|+.+++.++|+||+++++.+...
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4567899999999999999999999     45578899999997766666677899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC---cEEE
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK-------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG---EVKI  207 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl  207 (354)
                      +..++||||++||+|.+++...+       .+++..+..++.||+.||.|||+ +||+||||||+|||++.+|   .+||
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999998753       48899999999999999999998 9999999999999999655   5999


Q ss_pred             eecccccccCCC--cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHH
Q 018532          208 TDFGVSAMLGSS--MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEA  284 (354)
Q Consensus       208 ~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  284 (354)
                      +|||++......  ........||+.|+|||++.+..++.++|||||||++|||++ |..||......       +....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~  298 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEF  298 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH
Confidence            999999765322  122334578999999999999999999999999999999998 99999776533       34444


Q ss_pred             HHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.... ....+..++..+.+||.+||+.||++|||+.+++++.|+-..
T Consensus       299 i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          299 VTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            44443 333456789999999999999999999999999999776543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.6e-49  Score=363.69  Aligned_cols=264  Identities=25%  Similarity=0.423  Sum_probs=217.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----CeE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GVI  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~  140 (354)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++|+||+++++.+...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999999999999999997666666677889999999999999999999987654     689


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99999997 599999876 679999999999999999999998 999999999999999999999999999998765322


Q ss_pred             CC----------CcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          221 GQ----------RDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       221 ~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      ..          ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..    ..........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~  242 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL----LLIFGIIGTP  242 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHHHhCCC
Confidence            11          223578999999998765 67899999999999999999999999876532111    1111111100


Q ss_pred             ---------------------CCC------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          290 ---------------------PPT------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       290 ---------------------~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                                           +..      .....+++++.+||.+||+.||++|||+.++++||||+...+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                                 000      01136789999999999999999999999999999999877654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-49  Score=360.31  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=221.7

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      .+++..++|.+.+.||+|+||.||+|.+.     .++..||+|+++........+.+.+|+.+++.++|+||+++++.+.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            45677899999999999999999999983     4568999999987766677788999999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVKT------------------------ILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                      ..+..++||||+++++|.+++...+.                        +++..+..++.||+.||.|||+ .||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~d  175 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHRD  175 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcccc
Confidence            99999999999999999999987543                        7899999999999999999998 8999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ  268 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  268 (354)
                      |||+||+++.++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987644322  2233467889999999999889999999999999999999 9999987


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ....       +....+... .....+..+++++.++|.+||+.||++|||+.+++++
T Consensus       256 ~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPE-------RLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGG-------GHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHH-------HHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6543       222333333 2334456789999999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-49  Score=356.43  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=216.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhhcCCCceEEeeeeee--ecCeE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---EEIRKQIVQELKINQASQCSHVVVCYHSFY--HNGVI  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~  140 (354)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++....   ......+.+|+.+++.++|+||+++++.+.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4689999999999999999999999999999999975432   134567899999999999999999999884  45689


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||||++++ |.+++...  +.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9999999875 88877763  568999999999999999999998 8999999999999999999999999999987643


Q ss_pred             Cc--CCCcccccCCcccccccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          219 SM--GQRDTFVGTYNYMSPERISGST--YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       219 ~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..  .......||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+....       +....+.....  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~--~~  232 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSY--AI  232 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC--CC
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCC--CC
Confidence            21  2223457899999999998754  478999999999999999999999765432       33344444332  33


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      +..+++.+.+||.+||+.||++|||+.++++||||++.....
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            557899999999999999999999999999999999876544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-49  Score=366.21  Aligned_cols=259  Identities=27%  Similarity=0.367  Sum_probs=217.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      +|++..++|.+.+.||+|+||+||+|.+.     .++..||+|+++..........+.+|+.++..+ +|+||+++++.+
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            56788899999999999999999999973     356789999998665555667899999999999 999999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK-----------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                      ...+..++||||+++|+|.+++....                       .+++..+..++.||+.||.|||+ .||+|||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D  197 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  197 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence            99999999999999999999998653                       27889999999999999999998 9999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ  268 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  268 (354)
                      |||+||+++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987644322  1233467889999999999899999999999999999998 9999977


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCc
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP  327 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp  327 (354)
                      .....       ..............+..+++++.+||.+||+.||++|||+.++++|-
T Consensus       278 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          278 IPVDA-------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCCSH-------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcHH-------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            65431       22222333334444567899999999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-49  Score=362.15  Aligned_cols=276  Identities=25%  Similarity=0.396  Sum_probs=215.5

Q ss_pred             cccccccccccccCceEEEEEEEc-cCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhc---CCCceEEeeeeee-----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHK-WVGRLFALKIIQMNIQE-EIRKQIVQELKINQAS---QCSHVVVCYHSFY-----  135 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~h~~iv~~~~~~~-----  135 (354)
                      .++|++.+.||+|+||+||+|++. .+|+.||+|+++..... .....+.+|+.+++.+   .|+||+++++.+.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 67899999998754321 1122345666666555   8999999999887     


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      .....++||||++ ++|.+++....  .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence            4568999999998 59999998753  48999999999999999999998 99999999999999999999999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-----
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-----  288 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  288 (354)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......   ...+.......     
T Consensus       168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGS
T ss_pred             ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcccC
Confidence            8765332 23445789999999999999999999999999999999999999987654321   11111111000     


Q ss_pred             ----------------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccccCCC
Q 018532          289 ----------------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLD  347 (354)
Q Consensus       289 ----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~  347 (354)
                                      .........++..+.+||.+||+.||++|||+.++++||||+.............++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~  318 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQ  318 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCCC---------
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhhhhccCCCCcc
Confidence                            00011234688999999999999999999999999999999998876655444444443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-49  Score=375.97  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------Ce
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------GV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~~  139 (354)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++....     ....+|+.+++.++|+||+++++++...      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            457899999999999999999999999999999986542     1234699999999999999999988542      24


Q ss_pred             EEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-CcEEEeeccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-GEVKITDFGVSA  214 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~  214 (354)
                      +++||||+++ +|.+.+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.+ +.+||+|||+++
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            7799999976 77776653    3679999999999999999999998 999999999999999965 578999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HHHH
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LEAI  285 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~  285 (354)
                      ...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+...        +...
T Consensus       206 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          206 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             ECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            765432 23456899999999999775 6999999999999999999999999876543221111110        0011


Q ss_pred             HcCCCCCC------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          286 VESPPPTA------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       286 ~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ........            ....+++++.+||.+||+.||++|||+.|+++||||+.+.+...
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence            00000000            12356899999999999999999999999999999998876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-49  Score=361.23  Aligned_cols=258  Identities=23%  Similarity=0.398  Sum_probs=212.6

Q ss_pred             cccccccccccccCceEEEEEEE-ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC------ceEEeeeeeeecC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRH-KWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS------HVVVCYHSFYHNG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~------~iv~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|+++..  ......+.+|+.+++.++|+      +++++++.+...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            46899999999999999999998 568899999998643  34456678888888877654      4999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---------------
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---------------  201 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---------------  201 (354)
                      ..++||||+ +++|.+++...+  .+++..+..++.||+.||.|||+ +||+||||||+||+++.               
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            999999999 789999998765  68899999999999999999998 99999999999999987               


Q ss_pred             ----CCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh
Q 018532          202 ----KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS  277 (354)
Q Consensus       202 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  277 (354)
                          ++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+    
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----  241 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE----  241 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH----
T ss_pred             ccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH----
Confidence                668999999999865432   234589999999999999999999999999999999999999997665432    


Q ss_pred             HHHHHHHHHcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhhCCCCCC
Q 018532          278 FYELLEAIVESPPP---------------------------------------TAPPDQFSPEFCSFVSACIQKDPRDRS  318 (354)
Q Consensus       278 ~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp  318 (354)
                      ............+.                                       .......++++.+||.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            11122222111100                                       011122357799999999999999999


Q ss_pred             CHHHHhcCcccccccc
Q 018532          319 SSLDLLSHPFIKKFED  334 (354)
Q Consensus       319 s~~eil~hp~~~~~~~  334 (354)
                      |+.|+++||||+.++.
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-49  Score=372.40  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=209.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC--------CCceEEeeeeee--
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ--------CSHVVVCYHSFY--  135 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------h~~iv~~~~~~~--  135 (354)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  ......+.+|+.+++.+.        |+||+++++.+.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            47899999999999999999999999999999999754  344567889999988875        788999999887  


Q ss_pred             --ecCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEccCC-------
Q 018532          136 --HNGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNHKG-------  203 (354)
Q Consensus       136 --~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~-------  203 (354)
                        ....+++||||+ +++|.+.+...  ..+++..+..++.||+.||.|||+ + ||+||||||+|||++.++       
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence              456899999999 55777777654  469999999999999999999998 7 999999999999998775       


Q ss_pred             ------------------------------------------cEEEeecccccccCCCcCCCcccccCCcccccccccCC
Q 018532          204 ------------------------------------------EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS  241 (354)
Q Consensus       204 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  241 (354)
                                                                .+||+|||++......   .....||+.|+|||++.+.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence                                                      7999999999876543   3345799999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH--HHHHHHcCCCC----------------------------
Q 018532          242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE--LLEAIVESPPP----------------------------  291 (354)
Q Consensus       242 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~----------------------------  291 (354)
                      .++.++|||||||++|+|++|+.||..............  .+.......+.                            
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            999999999999999999999999987654432221111  11111111000                            


Q ss_pred             ---------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          292 ---------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       292 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                               ...+...+..+.+||.+||+.||++|||++|+|+||||+.
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                     0011223467889999999999999999999999999973

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-49  Score=361.22  Aligned_cols=268  Identities=20%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      +.+..++|.+.+.||+|+||+||+|++..++.   .||+|+++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            45567899999999999999999999887765   89999987543 234457789999999999999999999998876


Q ss_pred             CeE------EEEEeccCCCCHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          138 GVI------SLVLEYMDRGSLADIIRQVK------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       138 ~~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                      +..      ++||||+++++|.+++....      .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCCCE
Confidence            654      99999999999999997653      58999999999999999999998 899999999999999999999


Q ss_pred             EEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHH
Q 018532          206 KITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELL  282 (354)
Q Consensus       206 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  282 (354)
                      ||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....       +..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~  249 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-------EIY  249 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------HHH
Confidence            9999999987644322  2223456789999999999999999999999999999999 99999876654       233


Q ss_pred             HHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCC-------HHHHhcCcccccccccccc
Q 018532          283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSS-------SLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-------~~eil~hp~~~~~~~~~~~  338 (354)
                      ..+.... ....+..+++++.+||.+||+.||++|||       ++++++|+|+....+..+.
T Consensus       250 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          250 NYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             HHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            3333333 33345678999999999999999999999       7888999999987766543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-49  Score=367.27  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=213.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI----  140 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~----  140 (354)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++.+...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            368999999999999999999999999999999997643 445567889999999999999999999999876654    


Q ss_pred             --EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 --SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                        ++||||+. ++|.+++.  ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence              99999997 58888773  469999999999999999999998 8999999999999999999999999999986543


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH---------------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL---------------  282 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  282 (354)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  273 (371)
T 4exu_A          197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  273 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred             C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence            3   334578999999999987 679999999999999999999999998765332111111000               


Q ss_pred             -HHHHcCCCCC------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          283 -EAIVESPPPT------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       283 -~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                       ..........      .....+++.+.+||.+||+.||++|||+.|+++||||+.......
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence             0000000000      012357899999999999999999999999999999998766543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-49  Score=359.01  Aligned_cols=259  Identities=23%  Similarity=0.365  Sum_probs=221.6

Q ss_pred             cccccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      ..|++..++|.+.+.||+|+||+||+|.+     ..+++.||+|+++........+.+.+|+.+++.+ +|+||+++++.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            34677889999999999999999999985     4577899999998776666678899999999999 99999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCC
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQVK------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPS  195 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~  195 (354)
                      +...+..++||||+++|+|.+++....                  .+++..+..++.||+.||.|||+ .||+||||||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~  174 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence            999999999999999999999998754                  38999999999999999999998 99999999999


Q ss_pred             CEEEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcC
Q 018532          196 NLLVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQ  272 (354)
Q Consensus       196 NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  272 (354)
                      ||+++.++.+||+|||++.........  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999876544321  233467889999999999899999999999999999998 99999776543


Q ss_pred             CChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .      .....+ ........+..++..+.++|.+||+.||++|||+.+++++
T Consensus       255 ~------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 S------KFYKMI-KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             H------HHHHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h------HHHHHh-ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            1      111222 2223333456789999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=359.03  Aligned_cols=275  Identities=31%  Similarity=0.606  Sum_probs=210.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHH-HHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIR-KQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .+....++|++.+.||+|+||+||+|.+..+|+.||||++......... +.+.++..+++.++|+||+++++.+...+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            3456788999999999999999999999999999999999876544333 444555567888899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .++||||+ ++.+..+... ...+++..+..++.|++.||.|||+ . |++||||||+||+++.++.+||+|||++....
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            99999999 5566666554 4679999999999999999999997 5 89999999999999999999999999997664


Q ss_pred             CCcCCCcccccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC-
Q 018532          218 SSMGQRDTFVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP-  291 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  291 (354)
                      ... ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||......      .+....+.....+ 
T Consensus       177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEPPL  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCCCC
T ss_pred             CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCCCC
Confidence            432 233457999999999995     456889999999999999999999999764322      1333333333322 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccccccccc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVG  344 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~  344 (354)
                      ......++.++.+||.+||+.||++|||+.++++||||++.....++...|..
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  302 (318)
T 2dyl_A          250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK  302 (318)
T ss_dssp             CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHH
T ss_pred             CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhh
Confidence            22234689999999999999999999999999999999998877766555543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=365.16  Aligned_cols=257  Identities=22%  Similarity=0.390  Sum_probs=222.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC-------CcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-------GRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYH  132 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~  132 (354)
                      .+++..++|.+.+.||+|+||+||+|++..+       +..||+|+++..........+.+|+.+++.+ +|+||+++++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            4567789999999999999999999997543       3579999998777777778899999999999 9999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      .+...+..++||||+++|+|.+++....                .+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  221 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  221 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGG
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcce
Confidence            9999999999999999999999998754                48999999999999999999998 899999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      |+++.++.+||+|||++.......  .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999999998765432  22334467889999999999999999999999999999999 99999765432 


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            +....+.... ....+..+++++.+||.+||+.||++|||+.+++++
T Consensus       301 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ------ELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------HHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  3344444333 334456789999999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-49  Score=363.47  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=221.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      .+++..++|.+.+.||+|+||.||+|++.     .+++.||+|+++.....+....+.+|+.+++.++|+||+++++.+.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            45677899999999999999999999987     3558999999987766777788999999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQV------------------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                      ..+..++||||+++++|.+++...                        ..+++..++.++.||+.||.|||+ +||+|||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D  199 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  199 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence            999999999999999999999874                        568899999999999999999998 9999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ  268 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  268 (354)
                      |||+||+++.++.+||+|||++.......  .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999998654322  22234568899999999998899999999999999999999 9999976


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ....       +....+..... ...+..++.++.+||.+||+.||++|||+.+++++
T Consensus       280 ~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          280 MAHE-------EVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             SCHH-------HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CChH-------HHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            5432       33444444433 33456789999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-49  Score=370.78  Aligned_cols=264  Identities=27%  Similarity=0.419  Sum_probs=208.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC------e
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------V  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------~  139 (354)
                      ..+|.+.+.||+|+||+||+|++..++. ||+|++.....     ...+|+.+++.++|+||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4679999999999999999999987766 88887754321     1236899999999999999999986544      3


Q ss_pred             EEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc-cCCcEEEeeccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSA  214 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~  214 (354)
                      +++||||+++ ++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||+|.
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8899999986 55444432    4679999999999999999999998 9999999999999999 79999999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH--------HHHH
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL--------LEAI  285 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~  285 (354)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...        +...
T Consensus       191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            764432 33456889999999999775 5899999999999999999999999876543211111110        0000


Q ss_pred             H----cCCCCC--------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          286 V----ESPPPT--------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       286 ~----~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                      .    ....+.        ..+..+++++.+||.+||+.||++|||+.|+++||||+.+.+....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  334 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR  334 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence            0    000000        1123478999999999999999999999999999999998776543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.3e-50  Score=369.29  Aligned_cols=263  Identities=26%  Similarity=0.442  Sum_probs=221.9

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHH----------------HHHHHHHHHHHHhhcCCCceE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEE----------------IRKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~e~~~~~~l~h~~iv  128 (354)
                      ..++|.+.+.||+|+||.||+|.+  +++.||+|++.......                ....+.+|+.+++.++|+||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            467999999999999999999998  89999999986532111                116788999999999999999


Q ss_pred             EeeeeeeecCeEEEEEeccCCCCHHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc
Q 018532          129 VCYHSFYHNGVISLVLEYMDRGSLADI------IRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN  200 (354)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~  200 (354)
                      ++++.+...+..++||||+++++|.++      +..  ...+++..+..++.|++.||.|||+..|++||||||+||+++
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            999999999999999999999999998      655  467999999999999999999999647899999999999999


Q ss_pred             cCCcEEEeecccccccCCCcCCCcccccCCcccccccccCC-CCCc-chhHHHHHHHHHHHHcCCCCCCCCCcCCChhhH
Q 018532          201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS-TYDY-SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSF  278 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  278 (354)
                      .++.+||+|||++......  ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......      
T Consensus       187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------  258 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------  258 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------
T ss_pred             CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------
Confidence            9999999999999876443  23445799999999999887 6666 999999999999999999999876542      


Q ss_pred             HHHHHHHHcCCCCCCC-----------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          279 YELLEAIVESPPPTAP-----------------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      .+....+.........                 ...++.++.+||.+||+.||++|||+.|+++||||+.......
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~  334 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL  334 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHH
Confidence            1334444443322221                 1568999999999999999999999999999999998776554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.7e-49  Score=348.75  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=217.0

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |.+..++|++.+.||+|+||+||++.+. +++.||+|++......  .+.+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            5667889999999999999999999987 5778999999765432  245889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999999999764 458999999999999999999998 999999999999999999999999999998654322


Q ss_pred             -CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 -GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                       .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....+... .....+..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~  232 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG-FRLYKPRLA  232 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT-CCCCCCTTS
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcC-ccCCCCCcC
Confidence             12233467788999999998899999999999999999999 99999765433       334444443 233445668


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++.+.+++.+||+.||++|||+.++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-49  Score=366.95  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=209.0

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEc---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      ++..++..++|.+.+.||+|+||+||+|++.   .++..||||+++........+.+.+|+.+++.++|+||+++++++.
T Consensus        37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4445667789999999999999999999987   4677899999987766677788999999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ..+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            9999999999999999999998753 69999999999999999999998 899999999999999999999999999998


Q ss_pred             ccCCCcCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          215 MLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       215 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      ........   .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......       +....+.... 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~~-  267 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGY-  267 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTTE-
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-
Confidence            76543221   122345778999999999999999999999999999998 99999765432       3333333332 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....+..++..+.++|.+||+.||++||++.++++
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            23334578999999999999999999999999886

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-49  Score=367.12  Aligned_cols=270  Identities=25%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe---
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV---  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---  139 (354)
                      ....++|.+.+.||+|+||+||+|++..+|+.||||++.....  ......++++.+..++|+||+++++++...+.   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            3457899999999999999999999999999999999865421  12345667777888899999999999876443   


Q ss_pred             ----EEEEEeccCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH--hCCCceecCCCCCCEEEcc-CCcEEEe
Q 018532          140 ----ISLVLEYMDRGSLADIIR----QVKTILEPYLAVVCKQVLQGLVYLH--NERHVIHRDIKPSNLLVNH-KGEVKIT  208 (354)
Q Consensus       140 ----~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~iiH~Dlkp~NIll~~-~~~~kl~  208 (354)
                          +++||||+++ +|...+.    ....+++..+..++.|++.||.|||  + .||+||||||+||+++. ++.+||+
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEe
Confidence                8899999986 6655544    3467899999999999999999999  8 89999999999999997 8999999


Q ss_pred             ecccccccCCCcCCCcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH------
Q 018532          209 DFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL------  281 (354)
Q Consensus       209 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------  281 (354)
                      |||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+...      
T Consensus       175 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          175 DFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            999998765432 334557899999999997654 899999999999999999999999876543221111110      


Q ss_pred             --HHHHHcCCC---------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          282 --LEAIVESPP---------------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       282 --~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                        .........               ........++++.+||.+||+.||++|||+.|+++||||+...+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence              000000000               00112235788999999999999999999999999999999876544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=361.60  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=212.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe-----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-----  139 (354)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++.+...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999999999999999999997543 34556778999999999999999999999887653     


Q ss_pred             -EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 -ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                       +++||||+. ++|.+++.  ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence             599999997 58887764  359999999999999999999998 9999999999999999999999999999986543


Q ss_pred             CcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH----------------
Q 018532          219 SMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL----------------  281 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------  281 (354)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                
T Consensus       179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence            2   234578999999999987 67899999999999999999999999776532211111100                


Q ss_pred             HHHHHcCC------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          282 LEAIVESP------PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       282 ~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ........      ........+++++.+||.+||+.||++|||++++++||||+.......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence            00000000      011123467999999999999999999999999999999998766443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.3e-49  Score=351.19  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ++++..++|++.+.||+|+||+||+|.+..+   +..||+|+++........+.+.+|+.+++.++|+||+++++.+ .+
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence            3566788999999999999999999998654   4579999987766667778899999999999999999999987 45


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            67899999999999999998754 68999999999999999999998 99999999999999999999999999999876


Q ss_pred             CCCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....       +....+.... ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-------~~~~~i~~~~-~~~~  238 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGE-RLPM  238 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTC-CCCC
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-------HHHHHHHcCC-CCCC
Confidence            54322 1223456789999999998899999999999999999996 99999876544       2233333333 2334


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +..+++.+.++|.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            56789999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-48  Score=352.07  Aligned_cols=260  Identities=26%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             ccCcccccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--  136 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--  136 (354)
                      .+..++|++++.||+|+||+||+|+    +..+++.||+|++... .....+.+.+|+.+++.++|+||+++++.+..  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3456899999999999999999998    5678999999998754 34455778999999999999999999998864  


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ...+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            456899999999999999998754 59999999999999999999998 9999999999999999999999999999987


Q ss_pred             cCCCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC---------CChhhHHHHHH
Q 018532          216 LGSSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ---------QSWPSFYELLE  283 (354)
Q Consensus       216 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~  283 (354)
                      ......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||......         ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            644321   222345778899999999999999999999999999999999998653211         11111122333


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+... .....+..+++++.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          244 LLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33333 334446689999999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-49  Score=357.54  Aligned_cols=266  Identities=25%  Similarity=0.403  Sum_probs=207.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee----------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY----------  135 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~----------  135 (354)
                      .++|.+++.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++.+.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            468999999999999999999999999999999987543 445677899999999999999999998763          


Q ss_pred             ----ecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc-cCCcEEEeec
Q 018532          136 ----HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDF  210 (354)
Q Consensus       136 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~Df  210 (354)
                          ..+..++||||++ |+|.+++.. +.+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                3468999999997 599999865 679999999999999999999998 9999999999999997 5679999999


Q ss_pred             ccccccCCCc---CCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH-----
Q 018532          211 GVSAMLGSSM---GQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL-----  281 (354)
Q Consensus       211 g~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----  281 (354)
                      |++.......   .......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+....+...     
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            9998764321   22334567999999998876 67899999999999999999999999876543211111000     


Q ss_pred             ---HHHHHc---------CCCC----CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          282 ---LEAIVE---------SPPP----TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       282 ---~~~~~~---------~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                         ......         ...+    ......++.++.+||.+||+.||++|||+.|+++||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence               000000         0000    01124689999999999999999999999999999999876543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-48  Score=362.52  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=208.9

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CC-----ceEEeeeeeeecC
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CS-----HVVVCYHSFYHNG  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~-----~iv~~~~~~~~~~  138 (354)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||+++..  ......+..|+.+++.+. |+     +++.+++.+...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            367999999999999999999999999999999999743  344566777888877764 44     4999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh-CCCceecCCCCCCEEEc--cCCcEEEeecccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHN-ERHVIHRDIKPSNLLVN--HKGEVKITDFGVS  213 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~-~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a  213 (354)
                      ..++||||+++ +|.+++...  +.+++..+..++.|++.||.|||+ ..||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99999999965 999999875  468999999999999999999995 37899999999999995  4778999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH----HHHcCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE----AIVESP  289 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~  289 (354)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....    ......
T Consensus       209 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          209 CQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             EETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             eecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            876543   3346899999999999999999999999999999999999999987654322111111000    000000


Q ss_pred             ----------CC--------------CCCCC-----------------------C----CCHHHHHHHHHhhhhCCCCCC
Q 018532          290 ----------PP--------------TAPPD-----------------------Q----FSPEFCSFVSACIQKDPRDRS  318 (354)
Q Consensus       290 ----------~~--------------~~~~~-----------------------~----~~~~l~~li~~~l~~~p~~Rp  318 (354)
                                +.              ...+.                       .    .++++.+||.+||+.||++||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                      00              00000                       0    013789999999999999999


Q ss_pred             CHHHHhcCcccccccc
Q 018532          319 SSLDLLSHPFIKKFED  334 (354)
Q Consensus       319 s~~eil~hp~~~~~~~  334 (354)
                      |++|+|+||||++..+
T Consensus       366 ta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          366 QPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CHHHHTTSGGGCC---
T ss_pred             CHHHHhcCcccccCCC
Confidence            9999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-48  Score=346.16  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=215.7

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +++..++|++.+.||+|+||+||++.+. ++..||+|+++.....  .+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            4567789999999999999999999876 6778999999765432  245889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999998764 59999999999999999999998 999999999999999999999999999998664432


Q ss_pred             C-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 G-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      . ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......       +....+.... ....+..+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~  230 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGH-RLYRPHLA  230 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC-CCCCCTTS
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCC-CCCCCCcC
Confidence            1 1223456778999999999889999999999999999999 99999765433       2333333332 33345568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++.+.++|.+||+.||++|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-48  Score=355.07  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=221.1

Q ss_pred             cccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF  134 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  134 (354)
                      ..|++..++|.+.+.||+|+||+||+|.+.     .+++.||+|++...........+.+|+.+++.++|+||+++++.+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            356677899999999999999999999877     467889999998766666677899999999999999999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQV----------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      ...+..++||||+++++|.+++...          ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTCC
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCCe
Confidence            9999999999999999999999764          346899999999999999999998 89999999999999999999


Q ss_pred             EEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHH
Q 018532          205 VKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYEL  281 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  281 (354)
                      +||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....       +.
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  249 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QV  249 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HH
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HH
Confidence            99999999986543321  1223467889999999999899999999999999999999 89999765432       33


Q ss_pred             HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ...+..... ...+..++..+.+||.+||+.||++|||+.++++|
T Consensus       250 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          250 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            344444332 33456789999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-48  Score=353.34  Aligned_cols=262  Identities=25%  Similarity=0.431  Sum_probs=215.9

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcC--CCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQ--CSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~  138 (354)
                      +.+..++|.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++..+.  |+||+++++.+...+
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            4556788999999999999999999986 58999999997543 4455678899999999987  599999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..++||| +.+++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++ ++.+||+|||++.....
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            9999999 4578999999988899999999999999999999998 8999999999999996 58999999999987644


Q ss_pred             CcC--CCcccccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHH
Q 018532          219 SMG--QRDTFVGTYNYMSPERISG-----------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI  285 (354)
Q Consensus       219 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  285 (354)
                      ...  ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......      .......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~  252 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHHH
Confidence            322  2234578999999999876           46888999999999999999999999754322      1233444


Q ss_pred             HcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .........+...+.++.++|.+||+.||++|||+.++++||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            444444455667789999999999999999999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-48  Score=350.42  Aligned_cols=256  Identities=31%  Similarity=0.514  Sum_probs=207.7

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.+++.++|+||+++++.+...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            467899999999999999999999999999999998753  245566788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          143 VLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999999975    3568999999999999999999998 9999999999999999999999999999987655


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                      .........|++.|+|||++.+..++.++|||||||++|+|++|..||.+....     .......+.....+......+
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  263 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYPPLPSDHY  263 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHHHHHHTTCSCCCCTTTS
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHHHHhhcccCCCCccccc
Confidence            444445567999999999999999999999999999999999999999764322     223444455554444455678


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +.++.+||.+||+.||++|||+.+++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-48  Score=359.70  Aligned_cols=263  Identities=21%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             cccccccccccccCceEEEEEEEccCC-cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc------eEEeeeeeeecC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVG-RLFALKIIQMNIQEEIRKQIVQELKINQASQCSH------VVVCYHSFYHNG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~------iv~~~~~~~~~~  138 (354)
                      .++|++.+.||+|+||+||+|.+..++ +.||+|+++..  ......+.+|+.+++.+.|++      ++.+++.+...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            578999999999999999999998777 68999998753  344566788888888876655      889999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE-----------------
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV-----------------  199 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll-----------------  199 (354)
                      ..++||||+ +++|.+++....  .+++..+..++.||+.||.|||+ .||+||||||+||++                 
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccccccc
Confidence            999999999 568888777653  68999999999999999999998 999999999999999                 


Q ss_pred             --ccCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh
Q 018532          200 --NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS  277 (354)
Q Consensus       200 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  277 (354)
                        +.++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.   
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---  247 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---  247 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred             cccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence              56789999999999865432   2345899999999999999999999999999999999999999987654321   


Q ss_pred             HHHHHHHHHcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhhCCCCCC
Q 018532          278 FYELLEAIVESPPP---------------------------------------TAPPDQFSPEFCSFVSACIQKDPRDRS  318 (354)
Q Consensus       278 ~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp  318 (354)
                       ...+.......+.                                       .......+.++.+||.+||+.||++||
T Consensus       248 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 -LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             -HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence             1112222111100                                       001112245789999999999999999


Q ss_pred             CHHHHhcCccccccccccccc
Q 018532          319 SSLDLLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       319 s~~eil~hp~~~~~~~~~~~~  339 (354)
                      |+.|+++||||+.+.+...+.
T Consensus       327 t~~e~l~hp~f~~~~~~~~~~  347 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPEERSF  347 (355)
T ss_dssp             CHHHHTTSGGGGGCCHHHHC-
T ss_pred             CHHHHhcChhhcCCChhhccc
Confidence            999999999999987766543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-48  Score=351.24  Aligned_cols=259  Identities=25%  Similarity=0.433  Sum_probs=209.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee---------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH---------  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---------  136 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...  ......+.+|+.+++.++|+||+++++.+.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            36799999999999999999999999999999998643  4455778999999999999999999998765         


Q ss_pred             ----cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecc
Q 018532          137 ----NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFG  211 (354)
Q Consensus       137 ----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  211 (354)
                          .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                45789999999999999999864 357889999999999999999998 899999999999999999999999999


Q ss_pred             cccccCCCc--------------CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChh
Q 018532          212 VSAMLGSSM--------------GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP  276 (354)
Q Consensus       212 ~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  276 (354)
                      ++.......              .......||+.|+|||++.+. .++.++|||||||++|+|++   ||....      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~------  232 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM------  232 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch------
Confidence            998664321              122345789999999999865 68999999999999999998   553221      


Q ss_pred             hHHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          277 SFYELLEAIVES--PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       277 ~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ...+....+...  ..+.......+..+.++|.+||+.||++|||+.++++||||+...+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE  294 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence            112333333332  223334456788899999999999999999999999999998765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-48  Score=348.33  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=215.4

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..|.+..++|++++.||+|+||+||++.+. ++..||+|+++.....  .+.+.+|+.+++.++|+||+++++.+...+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            356778899999999999999999999886 6778999999765432  2458899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999999999987 4679999999999999999999998 9999999999999999999999999999986643


Q ss_pred             Cc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          219 SM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       219 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      .. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......       +....+... .....+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQG-LRLYRPH  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTT-CCCCCCT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcc-cCCCCCC
Confidence            21 12233456788999999998899999999999999999998 99999765533       333444433 2333456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+++.+.++|.+||+.||++|||+.++++|
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            789999999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-48  Score=347.80  Aligned_cols=251  Identities=25%  Similarity=0.434  Sum_probs=204.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH---HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE---EIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ++..++|.+.+.||+|+||+||+|.+.  ++.||+|+++.....   ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            456789999999999999999999974  889999998754332   234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC---ceecCCCCCCEEEcc--------CCcEEEe
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH---VIHRDIKPSNLLVNH--------KGEVKIT  208 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~---iiH~Dlkp~NIll~~--------~~~~kl~  208 (354)
                      .++||||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|   |+||||||+||+++.        ++.+||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999998864 689999999999999999999998 88   899999999999986        6789999


Q ss_pred             ecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC
Q 018532          209 DFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES  288 (354)
Q Consensus       209 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  288 (354)
                      |||++.......  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+....       .........
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~  229 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVAMN  229 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHTS
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhhcC
Confidence            999998665432  23457999999999999989999999999999999999999999765532       333444445


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          289 PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       289 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ......+..+++.+.++|.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            55555667899999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.3e-49  Score=364.21  Aligned_cols=263  Identities=26%  Similarity=0.438  Sum_probs=208.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-----------CCceEEeee
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-----------CSHVVVCYH  132 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~~iv~~~~  132 (354)
                      +..++|.+.+.||+|+||+||+|++..+++.||||++...  ......+.+|+.+++.+.           |+||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3457899999999999999999999999999999998753  334466788888888765           889999999


Q ss_pred             eeeecC----eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC-CceecCCCCCCEEEcc----
Q 018532          133 SFYHNG----VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNER-HVIHRDIKPSNLLVNH----  201 (354)
Q Consensus       133 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-~iiH~Dlkp~NIll~~----  201 (354)
                      .+...+    .++++||++ +++|.+++...  ..+++..+..++.||+.||.|||+ + ||+||||||+||+++.    
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCC
Confidence            988654    899999999 78999999874  459999999999999999999998 7 9999999999999953    


Q ss_pred             --CCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh--
Q 018532          202 --KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS--  277 (354)
Q Consensus       202 --~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--  277 (354)
                        .+.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              347999999999876543   2345789999999999999999999999999999999999999986543221111  


Q ss_pred             -HHHHHHHHHcCCC-------------------------------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCC
Q 018532          278 -FYELLEAIVESPP-------------------------------------PTAPPDQFSPEFCSFVSACIQKDPRDRSS  319 (354)
Q Consensus       278 -~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps  319 (354)
                       ...+.. .....+                                     ....+..++.++.+||.+||+.||++|||
T Consensus       249 ~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          249 HIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence             111111 111000                                     00112234678999999999999999999


Q ss_pred             HHHHhcCcccccccc
Q 018532          320 SLDLLSHPFIKKFED  334 (354)
Q Consensus       320 ~~eil~hp~~~~~~~  334 (354)
                      ++|+++||||+....
T Consensus       328 ~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHHTCGGGTTCTT
T ss_pred             HHHHhhChhhhcccC
Confidence            999999999998644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.2e-49  Score=359.61  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=186.1

Q ss_pred             cccccccc-cccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeE
Q 018532           66 LEDLETIK-VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVI  140 (354)
Q Consensus        66 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~  140 (354)
                      .++|.+.+ .||+|+||+||+|.+..+++.||||++....  ....   +....++.+.|+||+++++.+..    ...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            57888865 6999999999999999999999999986542  2222   22234566799999999999876    4568


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEEeecccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKITDFGVSAM  215 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~  215 (354)
                      ++||||++||+|.+++...+  .+++..++.++.||+.||.|||+ +||+||||||+||+++.+   +.+||+|||++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            99999999999999998753  69999999999999999999998 899999999999999864   4599999999986


Q ss_pred             cCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.................. .....+....
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  257 (336)
T 3fhr_A          181 TTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-GQYGFPNPEW  257 (336)
T ss_dssp             C------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTTS
T ss_pred             cccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-cccccCchhh
Confidence            6532  233457899999999998888999999999999999999999999766543221111111111 1111222233


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      ..+++++.+||.+||+.||++|||+.|+++||||++..
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            57899999999999999999999999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-49  Score=361.90  Aligned_cols=269  Identities=25%  Similarity=0.358  Sum_probs=220.8

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhhcC--CCceEEeeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELKINQASQ--CSHVVVCYHSFY  135 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~  135 (354)
                      +...++|++.+.||+|+||+||+|.+..+++.||||++......     .....+.+|+.+++.+.  |+||+++++.+.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34467899999999999999999999999999999999754321     12234667888888886  599999999999


Q ss_pred             ecCeEEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc-cCCcEEEeecccc
Q 018532          136 HNGVISLVLEYMDR-GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVS  213 (354)
Q Consensus       136 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a  213 (354)
                      ..+..++|+|++.+ ++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++ +++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999976 8999999988899999999999999999999998 9999999999999999 7899999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....             .+...  ..
T Consensus       198 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~~--~~  260 (320)
T 3a99_A          198 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRG--QV  260 (320)
T ss_dssp             EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHC--CC
T ss_pred             cccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhcc--cc
Confidence            876543  2334579999999999987765 678999999999999999999995431             11111  12


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccccccccccCCCCC
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      ..+..+++++.+||.+||+.||++|||+.++++||||+.................|+
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~p~  317 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG  317 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHHHHHHHTC-----
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccccccccccccCCC
Confidence            234578999999999999999999999999999999998876544333333333333

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-49  Score=356.92  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=219.5

Q ss_pred             cccccCcccccccccccccCceEEEEEEE-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRH-----KWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      ..+.+..++|.+.+.||+|+||+||+|.+     ..+++.||+|+++........+.+.+|+.++..+ +|+||+++++.
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            35667789999999999999999999985     3567899999998776666677899999999998 78999999999


Q ss_pred             eeecC-eEEEEEeccCCCCHHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          134 FYHNG-VISLVLEYMDRGSLADIIRQVKT----------------ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       134 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      +...+ .+++||||+++++|.+++.....                +++..+..++.|++.||.|||+ .||+||||||+|
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~N  178 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARN  178 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccce
Confidence            87754 59999999999999999987543                7899999999999999999998 899999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      |+++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999999987644322  1234567889999999999999999999999999999998 999997765431


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            .....+.... ....+..+++++.++|.+||+.||++|||+.++++|
T Consensus       259 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 ------EFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             ------HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHhccCc-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  2222333322 233456689999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-48  Score=358.23  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=220.1

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCc-----EEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR-----LFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .+++..++|.+.+.||+|+||+||+|.+..++.     .||+|++......+....+.+|+.+++.+ +|+||+++++.+
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            467788999999999999999999999877664     79999998776666778899999999999 899999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQV--------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN  200 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~  200 (354)
                      ...+..++||||+++|+|.+++...              ..+++..+..++.||+.||.|||+ .||+||||||+||+++
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence            9999999999999999999999753              357899999999999999999998 8999999999999999


Q ss_pred             cCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhh
Q 018532          201 HKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPS  277 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  277 (354)
                      .++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....    
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----  274 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----  274 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence            999999999999986543322  1233467889999999999899999999999999999998 999997765431    


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          278 FYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                         ..............+..+++.+.++|.+||+.||++|||+.+++++
T Consensus       275 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          275 ---KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             ---HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence               1222222223334456689999999999999999999999999873

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=366.62  Aligned_cols=263  Identities=22%  Similarity=0.369  Sum_probs=194.4

Q ss_pred             ccccc-cccccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEE
Q 018532           67 EDLET-IKVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVIS  141 (354)
Q Consensus        67 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~  141 (354)
                      +.|.+ .++||+|+||+||+|+++  .+++.||||++.....   ...+.+|+.+++.++|+||+++++++..  ...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            44555 457999999999999976  5688999999875432   2357789999999999999999999965  67899


Q ss_pred             EEEeccCCCCHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE----ccCCcEEEe
Q 018532          142 LVLEYMDRGSLADIIRQVK---------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKIT  208 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~  208 (354)
                      +||||+.+ +|.+++....         .+++..++.++.||+.||.|||+ .||+||||||+|||+    +.++.+||+
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999975 8988886432         48999999999999999999998 999999999999999    677899999


Q ss_pred             ecccccccCCCc---CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC------ChhhH
Q 018532          209 DFGVSAMLGSSM---GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ------SWPSF  278 (354)
Q Consensus       209 Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~  278 (354)
                      |||+|.......   ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....      ....+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999998765432   223456899999999999884 58999999999999999999999997654321      00111


Q ss_pred             HHHHHHHHcCCCCC---------------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          279 YELLEAIVESPPPT---------------------------------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       279 ~~~~~~~~~~~~~~---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+... .......                                 ......++.+.+||.+||+.||++|||++|+|+
T Consensus       255 ~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNV-MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHH-HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHh-hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111 1110000                                 001123778999999999999999999999999


Q ss_pred             Cccccccccc
Q 018532          326 HPFIKKFEDK  335 (354)
Q Consensus       326 hp~~~~~~~~  335 (354)
                      ||||+.....
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999876543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-48  Score=356.25  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=218.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-------WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYH  132 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~  132 (354)
                      .|.+..++|.+.+.||+|+||+||+|.+.       .++..||+|+++..........+.+|+.+++.+ +|+||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            35677899999999999999999999975       467889999998776667778899999999999 9999999999


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      .+...+..++||||+++++|.+++....                .+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence            9999999999999999999999998654                38899999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  273 (354)
                      |+++.++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... 
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence            9999999999999999987654321  2233467889999999998889999999999999999999 99999765432 


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            +....+.... ....+..++.++.++|.+||+.||++|||+.+++++
T Consensus       267 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ------ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ------HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  2333333332 233456789999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-48  Score=349.34  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=213.1

Q ss_pred             cCcccccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--  137 (354)
                      +...+|++.+.||+|+||.||+|+    +..+++.||+|++...........+.+|+.+++.++|+||+++++.+...  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            446779999999999999999999    56789999999997655444557789999999999999999999998876  


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            6799999999999999999654 579999999999999999999998 99999999999999999999999999999876


Q ss_pred             CCCc---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------cCCChhhHHHHHHHH
Q 018532          217 GSSM---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE--------DQQSWPSFYELLEAI  285 (354)
Q Consensus       217 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~~  285 (354)
                      ....   .......||..|+|||++.+..++.++|||||||++|+|++|..|+....        ..............+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            5443   22334568889999999999899999999999999999999999864321        001111222333333


Q ss_pred             HcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ... .....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       257 ~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          257 KEG-KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hcc-CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            333 334455678999999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-48  Score=356.94  Aligned_cols=253  Identities=19%  Similarity=0.282  Sum_probs=209.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|.+.+.||+|+||+||+|++..+++.||||++.....   ...+.+|+.+++.+ +|+||+++++.+...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            3679999999999999999999999999999999875432   23577899999999 9999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc-----EEEeecccccccCC
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-----VKITDFGVSAMLGS  218 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~  218 (354)
                      ||+ +++|.+++... +.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.     +||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999 88999999874 679999999999999999999998 89999999999999999887     99999999987654


Q ss_pred             CcCC-------CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          219 SMGQ-------RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       219 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ....       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..+..... ..+.
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~  241 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-ATPI  241 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HSCH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cCCH
Confidence            3221       2456899999999999999999999999999999999999999987654432222222211111 1111


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......++ ++.+++..||+.||.+||+++++++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11122345 9999999999999999999998876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-48  Score=355.72  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=209.7

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-  138 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-  138 (354)
                      .++.+..++|++.+.||+|+||+||+|++.  ++.||||++.....  .......|+.++..++|+||+++++.+.... 
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            345677899999999999999999999875  89999999975432  2344566899999999999999999998754 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC----------CceecCCCCCCEEEccCCcE
Q 018532          139 ---VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER----------HVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       139 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------~iiH~Dlkp~NIll~~~~~~  205 (354)
                         .+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+ .          ||+||||||+||+++.++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence               47999999999999999977 569999999999999999999997 7          99999999999999999999


Q ss_pred             EEeecccccccCCCcC--CCcccccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChh--
Q 018532          206 KITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGS-----TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP--  276 (354)
Q Consensus       206 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--  276 (354)
                      ||+|||++........  ......||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.+..+....+  
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999987654322  23345799999999999873     46678999999999999999999998765432211  


Q ss_pred             -------hHHHHHHHHHcCCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          277 -------SFYELLEAIVESPPPTAPPD-----QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       277 -------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                             ...............+....     ..++++.+||.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   12222333333332222221     12456999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.1e-49  Score=364.28  Aligned_cols=267  Identities=21%  Similarity=0.306  Sum_probs=206.3

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc----------cHHHHHHHHHHHHHHhhcCCCceEEeeee
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI----------QEEIRKQIVQELKINQASQCSHVVVCYHS  133 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  133 (354)
                      ...++|.+.+.||+|+||.||+|.+.. |+.||||++....          .....+.+.+|+.+++.++|+||+++++.
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345789999999999999999999864 9999999985432          23445789999999999999999999999


Q ss_pred             eee-----cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          134 FYH-----NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       134 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                      +..     ...+++||||++ |+|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCCCEEE
Confidence            854     347899999997 5888888754 468999999999999999999998 89999999999999999999999


Q ss_pred             eecccccccCCCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHH----
Q 018532          208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELL----  282 (354)
Q Consensus       208 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----  282 (354)
                      +|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.+..    
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999765433 22344578999999999987 678999999999999999999999998765332111111100    


Q ss_pred             ------------HHHHcCCCCC-------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          283 ------------EAIVESPPPT-------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       283 ------------~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                  ..........       .....+++.+.+||.+||+.||++|||+.|+++||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                        0000000000       012356889999999999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.4e-48  Score=347.76  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=219.6

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|++..++|++.+.||+|+||+||+|.+..++..||+|++.....  ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            466778999999999999999999999999999999999975433  346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||||++|++|.+++...  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999999874  458999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          219 SMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       219 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+       ....+... .....+.
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~~  235 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD-YRMERPE  235 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTT-CCCCCCT
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcc-CCCCCCC
Confidence            322 2233457889999999998899999999999999999999 999997765432       22222222 3334456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+++.+.+||.+||..||++|||+.++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            78999999999999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.4e-48  Score=355.52  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEE----EEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +..++|++.+.||+|+||+||+|++..+++.+    |+|.++........+.+.+|+.+++.++|+||+++++++.... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            45678999999999999999999998887754    7777765444455678999999999999999999999988654 


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+|.....
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            78899999999999999874 579999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          219 SMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       219 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ....  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+       ....+... .....+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~  241 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKG-ERLPQP  241 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTT-CCCCCC
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcC-CCCCCC
Confidence            3222  223456889999999999999999999999999999999 999998765432       22223222 333345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..++.++.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            6789999999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.2e-48  Score=343.14  Aligned_cols=248  Identities=14%  Similarity=0.261  Sum_probs=213.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--Ce
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GV  139 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~  139 (354)
                      .+..++|.+.+.||+|+||+||+|++.  ++.||+|+++... .....+.+.+|+.+++.++|+||+++++.+...  +.
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            456789999999999999999999985  8899999997653 445567799999999999999999999999876  78


Q ss_pred             EEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+ .|  ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999999998765  48999999999999999999998 88  99999999999999999999999988754


Q ss_pred             cCCCcCCCcccccCCcccccccccCCCCCc---chhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISGSTYDY---SSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ...     ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||......       +............
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  230 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLRP  230 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCCC
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCCC
Confidence            322     2347899999999998765544   799999999999999999999765432       2333444444445


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+..+++++.++|.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            566789999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.3e-48  Score=347.63  Aligned_cols=255  Identities=20%  Similarity=0.244  Sum_probs=212.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....   ...+.+|+.+++.+ +|+|++.+++.+......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            4679999999999999999999999999999999865432   23467888988888 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc-----EEEeecccccccCC
Q 018532          145 EYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE-----VKITDFGVSAMLGS  218 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~  218 (354)
                      ||+ +++|.+++...+ .+++..+..++.||+.||.|||+ +||+||||||+||+++.++.     +||+|||++.....
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            999 889999998754 59999999999999999999998 99999999999999987776     99999999987654


Q ss_pred             CcC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          219 SMG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       219 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ...       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......... .+.
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  242 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPL  242 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-ccH
Confidence            322       234567999999999999999999999999999999999999999876544322222222222111 111


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          292 TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       292 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ......+++++.+++.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22234689999999999999999999999998763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.7e-49  Score=358.46  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=209.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcE----EEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRL----FALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +..++|++.+.||+|+||+||+|.+..+++.    ||+|++...........+.+|+.+++.++|+||+++++++. .+.
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            4567899999999999999999999888876    67777654332233345678999999999999999999875 567


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            89999999999999999874 578999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          219 SMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       219 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....       +....+... .....+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~  239 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------EVPDLLEKG-ERLAQP  239 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------HHHHHHHTT-CBCCCC
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------HHHHHHHcC-CCCCCC
Confidence            322  2344568889999999999899999999999999999999 99999876543       223333333 233445


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..++.++.++|.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5688899999999999999999999999886

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-48  Score=354.07  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=212.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEE--EEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF--ALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|++.+.||+|+||.||+|++..++..+  |+|.++........+.+.+|+.+++.+ +|+||+++++.+...+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            45689999999999999999999999888865  999987655555667789999999999 999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      ++||||+++++|.+++...+                .+++..++.++.||+.||.|||+ .||+||||||+||+++.++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGC
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCCCe
Confidence            99999999999999998654                68999999999999999999998 99999999999999999999


Q ss_pred             EEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHH
Q 018532          205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      +||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....       +...
T Consensus       181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  252 (327)
T ss_dssp             EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred             EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHH
Confidence            999999998754322 22233467889999999998889999999999999999998 99999766432       3344


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+.... ....+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          253 KLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            444332 233456789999999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-47  Score=365.19  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=212.7

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-e
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-V  139 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~  139 (354)
                      .|.+..++|++.+.||+|+||+||++.+.  ++.||||+++...   ..+.+.+|+.+++.++|+||+++++.+.... .
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            46778899999999999999999999875  7899999997653   3456889999999999999999999887655 7


Q ss_pred             EEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      +++||||+++|+|.+++...+.  +++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999987654  7899999999999999999998 999999999999999999999999999998654


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..   .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+       ....+..+ .....+.
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~-~~~~~p~  409 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKG-YKMDAPD  409 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTT-CCCCCCT
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-CCCCCCC
Confidence            32   223367889999999999999999999999999999998 999998765542       23333333 2344566


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+++.+.+||.+||+.||++|||+.++++
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            89999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-47  Score=348.03  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=205.8

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4678999999999999999999999999999999987543  34556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc-C
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM-G  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~  221 (354)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....... .
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999999999999988899999999999999999999998 899999999999999999999999999997664432 2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC-CCCCCCCCCH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP-PTAPPDQFSP  300 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  300 (354)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......       .....+..... +...+..++.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGTSTTCCT
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCccccCCCCCH
Confidence            233457899999999999999999999999999999999999999765422       22222222222 2234567899


Q ss_pred             HHHHHHHHhhhhCCCCCC-CHHHHhc
Q 018532          301 EFCSFVSACIQKDPRDRS-SSLDLLS  325 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rp-s~~eil~  325 (354)
                      ++.++|.+||+.||++|| +++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999999 7777765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=344.51  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=217.7

Q ss_pred             cccCcccccccc-cccccCceEEEEEEEc--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIK-VIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +.+..++|.+.+ .||+|+||+||+|.+.  .++..||+|+++........+.+.+|+.+++.++|+||+++++.+ ..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            345677888887 9999999999999854  468889999998776667778899999999999999999999998 566


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            799999999999999999654 569999999999999999999998 999999999999999999999999999998765


Q ss_pred             CCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          218 SSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       218 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ....   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....+.... ...
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~-~~~  233 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGK-RME  233 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTC-CCC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCC-cCC
Confidence            3322   1223456889999999998889999999999999999998 99999766543       3333444433 233


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      .+..+++++.++|.+||+.||++|||+.+++++.+
T Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            45678999999999999999999999999998743

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8e-48  Score=345.31  Aligned_cols=251  Identities=21%  Similarity=0.370  Sum_probs=211.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc---HHHH---HHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---EEIR---KQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~---~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++.....   ....   +.+.+|+.+++.++|+||+++++.+.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            456789999999999999999999999999999999865432   1111   6788999999999999999999988765


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCc-----EEEee
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGE-----VKITD  209 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~-----~kl~D  209 (354)
                      .  ++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|  |+||||||+||+++.++.     +||+|
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            5  6999999999999888654 478999999999999999999998 89  999999999999988876     99999


Q ss_pred             cccccccCCCcCCCcccccCCccccccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          210 FGVSAMLGSSMGQRDTFVGTYNYMSPERIS--GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       210 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      ||++.....   ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||.......     .........
T Consensus       173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~  244 (287)
T 4f0f_A          173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIRE  244 (287)
T ss_dssp             CTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHHHH
T ss_pred             CCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHHhc
Confidence            999975443   234457999999999994  4457899999999999999999999997655431     122334444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .......+..+++.+.++|.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            55555566789999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=351.81  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=213.5

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVG----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF  134 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  134 (354)
                      .+..++..++|.+.+.||+|+||+||+|.+..++    ..||+|+++..........+.+|+.+++.++|+||+++++.+
T Consensus        36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4455677889999999999999999999987553    459999998766666677899999999999999999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            9999999999999999999999875 579999999999999999999998 89999999999999999999999999999


Q ss_pred             cccCCCcCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          214 AMLGSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       214 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      .........   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....+....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~  267 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGF  267 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCC
Confidence            876543221   122346788999999999999999999999999999998 99999765432       3344444442


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      . ...+..++..+.++|.+||+.||++||++.+++++
T Consensus       268 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 R-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             C-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             c-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 33355789999999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.9e-48  Score=353.98  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=216.2

Q ss_pred             ccCcccccccccccccCceEEEEEE-----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVR-----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ++..++|.+.+.||+|+||+||+|+     +..++..||+|++...........+.+|+.+++.++|+||+++++.+...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            3456889999999999999999999     55678899999997666666667899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC---CcEEE
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK-------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK---GEVKI  207 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl  207 (354)
                      +..++||||+++++|.+++....       .+++..+..++.||+.||.|||+ .||+||||||+||+++.+   ..+||
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999998753       48899999999999999999998 999999999999999854   46999


Q ss_pred             eecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHH
Q 018532          208 TDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEA  284 (354)
Q Consensus       208 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  284 (354)
                      +|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEF  257 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHH
Confidence            9999997653322  22234568899999999998899999999999999999998 99999765432       33444


Q ss_pred             HHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +.... ....+..++..+.++|.+||+.||++|||+.++++|.|+-..
T Consensus       258 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          258 VTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            44433 333456789999999999999999999999999999886543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-47  Score=345.26  Aligned_cols=255  Identities=21%  Similarity=0.319  Sum_probs=213.1

Q ss_pred             ccccCcccccccc-cccccCceEEEEEE--EccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           61 DFEFSLEDLETIK-VIGKGSGGVVQLVR--HKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        61 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      ++.+..++|.+.+ .||+|+||+||+|.  +..+++.||+|+++.... ....+.+.+|+.+++.++|+||+++++.+ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            4456678899988 99999999999995  456788999999975532 34467799999999999999999999988 6


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+..++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            67889999999999999999988889999999999999999999998 89999999999999999999999999999876


Q ss_pred             CCCcCC---CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          217 GSSMGQ---RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       217 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......       +....+.... ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~  239 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE-RM  239 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC-CC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-CC
Confidence            543221   222356788999999998889999999999999999999 99999775532       3333333333 33


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+..+++.+.++|.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            445678999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.7e-48  Score=372.44  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=219.3

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|++..++|.+.+.||+|+||+||+|.++.++..||||+++.....  .+.+.+|+.+++.++|+||+++++++...+.+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            4677889999999999999999999999999999999999754322  46689999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999999999999874  458999999999999999999998 9999999999999999999999999999987643


Q ss_pred             Cc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          219 SM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       219 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      .. .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+       ....+.. ......+.
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~-~~~~~~~~  442 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK-DYRMERPE  442 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHT-TCCCCCCT
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc-CCCCCCCC
Confidence            22 12233456789999999998899999999999999999999 999998765432       2233332 33344566


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+++.+.+||.+||+.||++|||+.++++
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            78999999999999999999999999976

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-47  Score=343.43  Aligned_cols=255  Identities=21%  Similarity=0.327  Sum_probs=212.4

Q ss_pred             cccCcccccccccccccCceEEEEEEEcc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +.+..++|.+.+.||+|+||+||+|.+..   ++..||+|++......+..+.+.+|+.+++.++|+||+++++.+.+ +
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            45667899999999999999999998654   3456999999877666667889999999999999999999998764 4


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            568999999999999999875 459999999999999999999998 999999999999999999999999999998765


Q ss_pred             CCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          218 SSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       218 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      .... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+       ....+.... ....+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~~~~-~~~~~  236 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGD-RLPKP  236 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHHHTC-CCCCC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHhcCC-CCCCC
Confidence            4322 1233457889999999998899999999999999999998 999997655432       222222222 22335


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..+++.+.++|.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            5689999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-47  Score=340.27  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=216.5

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      |.+..++|.+.+.||+|+||.||++.+. ++..||+|++......  .+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            5667789999999999999999999986 6788999999765432  256889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999999999875 468999999999999999999998 999999999999999999999999999998654321


Q ss_pred             -CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          221 -GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       221 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                       .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......       +....+.... ....+..+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~~-~~~~~~~~  230 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGF-RLYKPRLA  230 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTC-CCCCCTTS
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcCC-cCCCCccC
Confidence             12233467889999999998889999999999999999999 89999765432       3344444433 23345568


Q ss_pred             CHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          299 SPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +..+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-47  Score=341.99  Aligned_cols=251  Identities=20%  Similarity=0.276  Sum_probs=209.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE-E
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI-S  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~-~  141 (354)
                      .-.|.+.+.||+|+||+||+|.+..++.   .||+|++.........+.+.+|+.+++.++|+||+++++.+...+.. +
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            3456677999999999999999766554   79999998766667778899999999999999999999999876554 9


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ++|||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999863 568999999999999999999998 899999999999999999999999999998654321


Q ss_pred             ----CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          221 ----GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP-YMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       221 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                          .......+|+.|+|||.+.+..++.++|||||||++|+|++|..| |...+..       +....+... .....+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~-~~~~~~  250 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQG-RRLPQP  250 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHHHHTT-CCCCCC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHHhhcC-CCCCCC
Confidence                223345688999999999999999999999999999999996555 4433322       222333333 233445


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+++.+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            678999999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-47  Score=350.00  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=216.7

Q ss_pred             cCcccccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee--ec
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY--HN  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~  137 (354)
                      +..++|++.+.||+|+||+||+|+    +..+++.||+|++... .....+.+.+|+.+++.++|+||+++++.+.  ..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            456899999999999999999999    5678999999999765 3444577899999999999999999999886  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            6799999999999999999874 569999999999999999999998 99999999999999999999999999999876


Q ss_pred             CCCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC--------CChhhHHHHHHHH
Q 018532          217 GSSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ--------QSWPSFYELLEAI  285 (354)
Q Consensus       217 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~  285 (354)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......        ............+
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            54322   223446888899999999988999999999999999999999998654321        1111222333333


Q ss_pred             HcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          286 VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       286 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ... .....+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       258 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          258 EEG-QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcc-cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333 3344466789999999999999999999999999764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.2e-48  Score=346.78  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=207.7

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCC-------cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVG-------RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      ++..++|.+.+.||+|+||+||+|.+..++       ..||+|++.... ....+.+.+|+.+++.++|+||+++++.+.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            356789999999999999999999998877       479999986543 234567899999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc--------EE
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVKT-ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE--------VK  206 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--------~k  206 (354)
                      ..+..++||||+++++|.+++...+. +++..+..++.||+.||.|||+ +||+||||||+||+++.++.        +|
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999987654 9999999999999999999998 99999999999999998887        99


Q ss_pred             EeecccccccCCCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCC-CCCCCCCcCCChhhHHHHHHH
Q 018532          207 ITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGR-FPYMQSEDQQSWPSFYELLEA  284 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~  284 (354)
                      |+|||++......    ....||+.|+|||++.+ ..++.++|||||||++|+|++|. .||......       .....
T Consensus       162 l~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~~~~~  230 (289)
T 4fvq_A          162 LSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------RKLQF  230 (289)
T ss_dssp             ECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHH
T ss_pred             eccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------HHHHH
Confidence            9999998755332    33568999999999988 67999999999999999999955 444433221       11111


Q ss_pred             HHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          285 IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       285 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .. .  ....+...+.++.+||.+||+.||++|||+.++++|
T Consensus       231 ~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 YE-D--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HH-T--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hh-c--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11 1  122334568889999999999999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-48  Score=351.54  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEE----EEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----ALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +..++|++.+.||+|+||+||+|.+..+++.+    |+|.+.........+.+.+|+.+++.++|+||+++++.+.... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            45678999999999999999999998888765    6666654444445577899999999999999999999987654 


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++++|++.+|+|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            78899999999999999874 579999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          219 SMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       219 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+       ....+... .....+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~  241 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKG-ERLPQP  241 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTT-CCCCCC
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcC-CCCCCC
Confidence            322  2223456889999999999999999999999999999999 999998765442       22233333 333345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..++.++.++|.+||+.||++|||+.++++
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-47  Score=349.95  Aligned_cols=264  Identities=23%  Similarity=0.268  Sum_probs=214.5

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +.....++|.+.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            44556789999999999999999999964 789999999865433 3356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ++||||+++++|.+++....    .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999999986543    48899999999999999999998 99999999999999999999999999999865


Q ss_pred             CCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC----
Q 018532          217 GSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP----  290 (354)
Q Consensus       217 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  290 (354)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+.................    
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            4322  1223456899999999999889999999999999999999999999876554332221111111111111    


Q ss_pred             ----CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCc
Q 018532          291 ----PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP  327 (354)
Q Consensus       291 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp  327 (354)
                          .......++..+.+++.+||+.||++|||+.+++++-
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                1111223456789999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-47  Score=363.63  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=215.4

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      ...|++..++|.+.+.||+|+||+||+|.+. ++..||||+++....  ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3457888999999999999999999999986 577899999976432  2467899999999999999999999876 66


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+++||||+++|+|.++++..  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            789999999999999999754  368999999999999999999998 89999999999999999999999999999876


Q ss_pred             CCCc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....       +....+..+. ....
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~-~~~~  406 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGY-RMPR  406 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHHTC-CCCC
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCC
Confidence            4321 11223356789999999998899999999999999999999 99999766533       3333443332 2334


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..+++++.+||.+||+.||++|||+.++++
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            5678999999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=351.08  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhhc----CCCceEEeeeeee
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELKINQAS----QCSHVVVCYHSFY  135 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l----~h~~iv~~~~~~~  135 (354)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.++..+    +|+||+++++.+.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            357899999999999999999999999999999999654321     1233456788888887    8999999999999


Q ss_pred             ecCeEEEEEec-cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc-cCCcEEEeecccc
Q 018532          136 HNGVISLVLEY-MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN-HKGEVKITDFGVS  213 (354)
Q Consensus       136 ~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a  213 (354)
                      ..+..++|+|+ +.+++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            99999999999 7889999999988889999999999999999999998 8999999999999999 8899999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYD-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      ......  ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....         +    +...  ..
T Consensus       188 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~----~~~~--~~  250 (312)
T 2iwi_A          188 ALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E----ILEA--EL  250 (312)
T ss_dssp             EECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----HHHT--CC
T ss_pred             hhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H----Hhhh--cc
Confidence            876543  23445799999999999877664 58999999999999999999995431         1    1111  12


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ..+..++.++.+||.+||+.||++|||+.|+++||||+...+
T Consensus       251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            234678999999999999999999999999999999998755

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-47  Score=342.69  Aligned_cols=254  Identities=21%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      .+++..++|.+.+.||+|+||+||++++.   ..||+|+++... .....+.+.+|+.+++.++|+||++++++ ...+.
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~   93 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQ   93 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSS
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCc
Confidence            35677889999999999999999999764   359999997554 44556789999999999999999999984 45667


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEEccceecccccc
Confidence            89999999999999999643 568999999999999999999998 9999999999999999999999999999976543


Q ss_pred             C--cCCCcccccCCccccccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC---C
Q 018532          219 S--MGQRDTFVGTYNYMSPERIS---GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP---P  290 (354)
Q Consensus       219 ~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~  290 (354)
                      .  ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||......+      .....+....   .
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~  246 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCC
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcc
Confidence            2  22234457999999999987   5678899999999999999999999997654331      2222222222   2


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .......+++.+.+||.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22334578999999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.6e-47  Score=341.48  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee-eecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF-YHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+|+.+++.+.|++++..+..+ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            368999999999999999999999999999999875432   224577899999999988877666655 5677899999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+ +++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||||+||++   +.++.+||+|||++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            999 8899999985 3679999999999999999999998 999999999999999   788999999999998765432


Q ss_pred             C-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          221 G-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       221 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......... +...
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hhhh
Confidence            2       2235679999999999999999999999999999999999999998766554433333333332222 1112


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....+++++.+||.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            23567999999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-47  Score=341.90  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=211.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee---------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH---------  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---------  136 (354)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|+++...     ..+.+|+.+++.++|+||+++++.+..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            367899999999999999999999999999999997653     246689999999999999999998754         


Q ss_pred             -------cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEE
Q 018532          137 -------NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKI  207 (354)
Q Consensus       137 -------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  207 (354)
                             ...+++||||+++++|.+++...  ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEE
Confidence                   45689999999999999999865  578999999999999999999998 89999999999999999999999


Q ss_pred             eecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          208 TDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       208 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      +|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+...         ......+..
T Consensus       164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~  233 (284)
T 2a19_B          164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRD  233 (284)
T ss_dssp             CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHT
T ss_pred             Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhc
Confidence            9999998775442 233457999999999999999999999999999999999999887421         122233333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       288 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ..    .+..++..+.++|.+||+.||++|||+.++++|.|.-+-
T Consensus       234 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          234 GI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            22    235689999999999999999999999999999876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.3e-47  Score=338.10  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=215.0

Q ss_pred             cccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           58 KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        58 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ...+|++..++|++.+.||+|+||+||+|.+. ++..||+|++......  .+.+.+|+.+++.++|+||+++++.+. .
T Consensus         4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   79 (279)
T 1qpc_A            4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-Q   79 (279)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             chhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence            34467788899999999999999999999975 6778999998754322  356889999999999999999999876 4


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            56899999999999999997543  79999999999999999999998 9999999999999999999999999999987


Q ss_pred             cCCCc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          216 LGSSM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       216 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....       +....+... ....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~-~~~~  230 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERG-YRMV  230 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT-CCCC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHHHHHhcc-cCCC
Confidence            65432 12233457889999999998889999999999999999999 99999765432       333344333 2334


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+++.+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            45678999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-48  Score=354.29  Aligned_cols=267  Identities=19%  Similarity=0.295  Sum_probs=210.9

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      ++....++|.+.+.||+|+||+||+|++. +++.||+|++...........+.+|+.+++.++|+||+++++++...+..
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            45567789999999999999999999854 78999999997654443344688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---CceecCCCCCCEEEccCCcEEEeecccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK----TILEPYLAVVCKQVLQGLVYLHNER---HVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ++||||+++++|.+++....    .+++..+..++.|++.||.|||+ .   ||+||||||+||+++.++.+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            99999999999999998643    38999999999999999999998 7   9999999999999999999999999999


Q ss_pred             cccCCCcCC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC-ChhhHHHHHHHHHcCCC-
Q 018532          214 AMLGSSMGQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ-SWPSFYELLEAIVESPP-  290 (354)
Q Consensus       214 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-  290 (354)
                      ......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ................. 
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            876533222 334469999999999998889999999999999999999999995211000 00011111111111110 


Q ss_pred             --------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          291 --------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       291 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                              ........+..+.+++.+||+.||++|||+.++++|-+-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                    001111234679999999999999999999999997543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.9e-47  Score=339.38  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             cccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           58 KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        58 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ....|.+..++|++.+.||+|+||+||++.+.  |+.||+|+++...   ..+.+.+|+.+++.++|+||+++++.+...
T Consensus        12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             ---CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            33456778899999999999999999999874  8899999987543   345688999999999999999999986544


Q ss_pred             -CeEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          138 -GVISLVLEYMDRGSLADIIRQVKT--ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       138 -~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                       +..++||||+++++|.+++...+.  +++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeeccccc
Confidence             579999999999999999987543  8999999999999999999998 999999999999999999999999999987


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ......   ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......       +....+... ....
T Consensus       166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~-~~~~  234 (278)
T 1byg_A          166 EASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKG-YKMD  234 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTT-CCCC
T ss_pred             cccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcC-CCCC
Confidence            654332   23467889999999998899999999999999999998 99999766543       222333332 3344


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+++.+.++|.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            55678999999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=347.25  Aligned_cols=257  Identities=22%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----c
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH----N  137 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~  137 (354)
                      +.+..++|++.+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++.++|+||+++++.+..    .
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            445678999999999999999999999999999999998654 34456778999999999999999999998873    3


Q ss_pred             CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      ...++||||+++++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            478999999999999999986    3568999999999999999999998 89999999999999999999999999998


Q ss_pred             cccCCCcCC---------CcccccCCcccccccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH
Q 018532          214 AMLGSSMGQ---------RDTFVGTYNYMSPERISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL  281 (354)
Q Consensus       214 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  281 (354)
                      .........         .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........     ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~  256 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-----SV  256 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----CH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----hh
Confidence            765422111         12235799999999997654   68999999999999999999999954221110     01


Q ss_pred             HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          282 LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ...... .........++..+.++|.+||+.||++|||+.+++++
T Consensus       257 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          257 ALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            111222 22233345789999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=362.06  Aligned_cols=257  Identities=21%  Similarity=0.341  Sum_probs=211.1

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC--eEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG--VISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l  142 (354)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||+++..........+.+|+.+++.++|+||+++++.+...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            35789999999999999999999999999999999976544444566789999999999999999999988755  7899


Q ss_pred             EEeccCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE----ccCCcEEEeecccccc
Q 018532          143 VLEYMDRGSLADIIRQVKT---ILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV----NHKGEVKITDFGVSAM  215 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  215 (354)
                      ||||+++++|.+++.....   +++..+..++.||+.||.|||+ .||+||||||+||++    +.++.+||+|||++..
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999999976533   9999999999999999999998 999999999999999    7778899999999987


Q ss_pred             cCCCcCCCcccccCCcccccccccC--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          216 LGSSMGQRDTFVGTYNYMSPERISG--------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       216 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      ..... ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........   .+.+..+..
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~~~  241 (396)
T 4eut_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKIIT  241 (396)
T ss_dssp             CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHHHH
T ss_pred             ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHHhc
Confidence            65443 2344679999999999865        46788999999999999999999999765433221   233344443


Q ss_pred             CCCCCC-----------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          288 SPPPTA-----------------------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       288 ~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +.+...                       ....++..+.++|.+||+.||++|||+.+++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            332210                       112345678899999999999999999998653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-46  Score=339.26  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=209.2

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee-eecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF-YHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||+||+|++..+++.||+|++......   ..+.+|+.+++.+.|++++..+..+ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            36899999999999999999999999999999998754322   3478899999999988876666554 5677889999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            999 8899999984 3579999999999999999999998 999999999999999   488899999999998765433


Q ss_pred             C-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          221 G-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       221 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........... ...
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hHH
Confidence            2       12456799999999999999999999999999999999999999987654433333333333222221 111


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....+++++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            23568999999999999999999999999876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-46  Score=339.81  Aligned_cols=252  Identities=22%  Similarity=0.266  Sum_probs=208.5

Q ss_pred             CcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeee-eecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSF-YHNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-~~~~~~  140 (354)
                      ...+|++.+.||+|+||+||+|.+..+   +..||+|.+.........+.+.+|+.+++.++|+||+++++.+ ..++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            456788999999999999999997543   3468999998766667778899999999999999999999985 456688


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            9999999999999999764 568999999999999999999998 99999999999999999999999999999876443


Q ss_pred             c----CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          220 M----GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       220 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      .    .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||......+       ....+.... ....
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~  253 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGR-RLLQ  253 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTTC-CCCC
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcCC-CCCC
Confidence            2    12234467889999999999999999999999999999999 566665554432       222333332 3334


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..++..+.+++.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5678999999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.2e-47  Score=344.30  Aligned_cols=257  Identities=21%  Similarity=0.306  Sum_probs=205.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEcc---CCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      ++.+..++|.+.+.||+|+||+||+|.+..   ++..||+|+++... .....+.+.+|+.+++.++|+||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            345667899999999999999999998765   45689999987543 44556778999999999999999999999876


Q ss_pred             cC-----eEEEEEeccCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcE
Q 018532          137 NG-----VISLVLEYMDRGSLADIIRQ------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       137 ~~-----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  205 (354)
                      .+     ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTSCE
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcE
Confidence            54     45999999999999999953      2468999999999999999999998 999999999999999999999


Q ss_pred             EEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHH
Q 018532          206 KITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELL  282 (354)
Q Consensus       206 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  282 (354)
                      ||+|||++.......  .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......       +..
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~  259 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------EMY  259 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHH
Confidence            999999998764332  12233457889999999999999999999999999999999 89999776544       223


Q ss_pred             HHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          283 EAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..+.... ....+..+++.+.++|.+||..||++|||+.+++++
T Consensus       260 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          260 DYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333332 333456789999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.8e-47  Score=345.52  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=211.3

Q ss_pred             cccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec--CeEE
Q 018532           68 DLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN--GVIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~  141 (354)
                      .|++++.||+|+||+||++.    +..+++.||||+++..........+.+|+.+++.++|+||+++++++.+.  ..++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            34999999999999998775    44578999999998777677778899999999999999999999999874  6899


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +||||+++++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus       112 lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             EEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            99999999999999976 459999999999999999999998 9999999999999999999999999999987754322


Q ss_pred             ---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcC--------CChhhHHHHHHHHHcCCC
Q 018532          222 ---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQ--------QSWPSFYELLEAIVESPP  290 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~  290 (354)
                         ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......        ............ .....
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  268 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGE  268 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH-HHTTC
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH-Hhccc
Confidence               223446888999999999988999999999999999999999999653211        001111122222 33333


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....+..++.++.+||.+||+.||++|||+.++++
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44456689999999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-47  Score=342.10  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh--cCCCceEEeeeeeee----cC
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA--SQCSHVVVCYHSFYH----NG  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~iv~~~~~~~~----~~  138 (354)
                      ..++|.+.+.||+|+||+||++++  +++.||||++.....    ..+..|..++..  ++|+||+++++.+..    ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            457899999999999999999987  699999999865432    334455555555  899999999998654    35


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH--------NERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                      .+++||||+++|+|.++++. ..+++..+..++.|++.||.|||        + .||+||||||+||+++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            68999999999999999965 67999999999999999999999        7 89999999999999999999999999


Q ss_pred             ccccccCCCcCC----CcccccCCcccccccccCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 018532          211 GVSAMLGSSMGQ----RDTFVGTYNYMSPERISGS------TYDYSSDIWSLGLVVLECAIG----------RFPYMQSE  270 (354)
Q Consensus       211 g~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~pf~~~~  270 (354)
                      |++.........    .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999765443221    2334799999999999886      455799999999999999999          88886654


Q ss_pred             cCCChhhHHHHHHHHHcCCCCCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          271 DQQSWPSFYELLEAIVESPPPTAPP-----DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....  ..................+     ..+++.+.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDP--SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCc--chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            3322  1122222222222222222     224578999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-47  Score=352.63  Aligned_cols=257  Identities=16%  Similarity=0.225  Sum_probs=203.5

Q ss_pred             cCcccccccccccccCceEEEEEEEccC-----CcEEEEEEeeccccHHH----------HHHHHHHHHHHhhcCCCceE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEI----------RKQIVQELKINQASQCSHVV  128 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~h~~iv  128 (354)
                      ...++|.+.+.||+|+||+||+|.+..+     ++.||||++........          ......|+..+..++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4456899999999999999999998765     57899999876532111          11244566677888999999


Q ss_pred             Eeeeeeeec----CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc--c
Q 018532          129 VCYHSFYHN----GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN--H  201 (354)
Q Consensus       129 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~--~  201 (354)
                      ++++.+...    ...++||||+ |++|.+++... +.+++..+..++.||+.||.|||+ .||+||||||+|||++  .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            999998764    5689999999 89999999876 679999999999999999999998 8999999999999999  8


Q ss_pred             CCcEEEeecccccccCCCcC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC
Q 018532          202 KGEVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS  274 (354)
Q Consensus       202 ~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  274 (354)
                      ++.+||+|||++........       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            89999999999987643321       12345699999999999999999999999999999999999999976433211


Q ss_pred             hhhHHH-----HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          275 WPSFYE-----LLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       275 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ......     ....+....   .....++.++.+++..||..||++||++.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKC---FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHH---SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHh---cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            110000     001111110   112467999999999999999999999998876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=353.41  Aligned_cols=259  Identities=20%  Similarity=0.224  Sum_probs=204.2

Q ss_pred             cCcccccccccccccCceEEEEEEEcc---CCcEEEEEEeeccccHH----------HHHHHHHHHHHHhhcCCCceEEe
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKW---VGRLFALKIIQMNIQEE----------IRKQIVQELKINQASQCSHVVVC  130 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~~~~l~h~~iv~~  130 (354)
                      ...++|.+.+.||+|+||+||+|.+..   ++..||+|++.......          ....+.+|+.+++.++|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            445789999999999999999999987   78899999987653211          11236678888999999999999


Q ss_pred             eeeeee----cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC--c
Q 018532          131 YHSFYH----NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG--E  204 (354)
Q Consensus       131 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--~  204 (354)
                      ++.+..    ....++||||+ +++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTTS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCCc
Confidence            999888    67899999999 89999999887889999999999999999999998 8999999999999999887  9


Q ss_pred             EEEeecccccccCCCcC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhh
Q 018532          205 VKITDFGVSAMLGSSMG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS  277 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  277 (354)
                      +||+|||++........       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~  269 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VA  269 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HH
Confidence            99999999987643221       1244579999999999999999999999999999999999999996432211  11


Q ss_pred             HHHHHHHHHcCCCC----CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          278 FYELLEAIVESPPP----TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       278 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ............+.    ......+++++.++|.+||+.||++|||+.++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            11222222211111    01122689999999999999999999999999873

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-47  Score=352.53  Aligned_cols=253  Identities=21%  Similarity=0.261  Sum_probs=202.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee-ecCeE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVG---RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY-HNGVI  140 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~  140 (354)
                      ....|.+.+.||+|+||+||+|.+..++   ..||+|.++........+.+.+|+.+++.++|+||+++++++. .++..
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4456788899999999999999976443   4689999876555566788999999999999999999999865 45688


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999999865 458899999999999999999998 99999999999999999999999999999865432


Q ss_pred             cC----CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          220 MG----QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       220 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..    ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+       ....+..+. ....
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------~~~~~~~~~-~~~~  317 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGR-RLLQ  317 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------HHHHHHTTC-CCCC
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------HHHHHHcCC-CCCC
Confidence            11    1233467889999999999999999999999999999999 778887665442       222333332 3334


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +..++..+.++|.+||+.||++|||+.+++++
T Consensus       318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            56789999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.2e-47  Score=339.95  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=206.3

Q ss_pred             ccCcccccccccccccCceEEEEEEEcc-CCc--EEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKW-VGR--LFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      .+..++|++.+.||+|+||+||+|++.. ++.  .||+|+++...  ..+..+.+.+|+.+++.++|+||+++++.+...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4556899999999999999999998653 333  68999987543  234567789999999999999999999998765


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      . .++|+||+++++|.+++... +.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++...
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            5 88999999999999999875 579999999999999999999998 89999999999999999999999999999876


Q ss_pred             CCCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          217 GSSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       217 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .....   ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+....       +....+.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGERL  244 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHccCCCC
Confidence            54322   1223467889999999998889999999999999999999 99999766533       4445555555555


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+..++.++.++|.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            556789999999999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.2e-47  Score=347.10  Aligned_cols=257  Identities=22%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-----c
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-----N  137 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~  137 (354)
                      .+..++|++.+.||+|+||+||++++  +++.||||++........  ....++..+..++|+||+++++.+..     .
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNF--INEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhH--HHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            45678999999999999999999975  689999999975533222  22344444556899999999975542     3


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---------CceecCCCCCCEEEccCCcEEEe
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER---------HVIHRDIKPSNLLVNHKGEVKIT  208 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------~iiH~Dlkp~NIll~~~~~~kl~  208 (354)
                      ..+++||||+++|+|.+++.. ...++..+..++.||+.||.|||+ .         ||+||||||+|||++.++.+||+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEEe
Confidence            367899999999999999976 455889999999999999999998 7         99999999999999999999999


Q ss_pred             ecccccccCCCc--------CCCcccccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC
Q 018532          209 DFGVSAMLGSSM--------GQRDTFVGTYNYMSPERISG-------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ  273 (354)
Q Consensus       209 Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  273 (354)
                      |||++.......        .......||+.|+|||++.+       ..++.++|||||||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764321        12234579999999999987       356778999999999999999987765433221


Q ss_pred             Ch-----------hhHHHHHHHHHcCCCCCCCCCC------CCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          274 SW-----------PSFYELLEAIVESPPPTAPPDQ------FSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       274 ~~-----------~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+           +..................+..      +++.+.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            11           1111222222222222222222      3457999999999999999999999965

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=369.80  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=209.2

Q ss_pred             cccCcccccccc-cccccCceEEEEEEEcc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           62 FEFSLEDLETIK-VIGKGSGGVVQLVRHKW--VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        62 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +.+..+++.+.+ .||+|+||+||+|.++.  ++..||||+++........+.+.+|+.+++.++|+||+++++++.. +
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            444556666666 79999999999998763  5667999999876544456789999999999999999999999875 5


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            699999999999999999754 469999999999999999999998 899999999999999999999999999998764


Q ss_pred             CCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          218 SSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       218 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ....   ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....       +....+..+. ...
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~-~~~  559 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGK-RME  559 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHTTC-CCC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCC-CCC
Confidence            3322   1222346789999999998899999999999999999998 99999876543       3344444443 334


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+++++.+||.+||+.||++||++.++++
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            45679999999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.1e-46  Score=370.37  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=208.0

Q ss_pred             ccCccccccc-ccccccCceEEEEEEE--ccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           63 EFSLEDLETI-KVIGKGSGGVVQLVRH--KWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        63 ~~~~~~~~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .+....+.+. +.||+|+||+||+|.+  ..+++.||||+++.... ....+.+.+|+.+++.++|+||+++++++. .+
T Consensus       364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~  442 (635)
T 4fl3_A          364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE  442 (635)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            3334444443 4799999999999954  45678999999976432 334577999999999999999999999885 45


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ..++||||+++|+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|.....
T Consensus       443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            689999999999999999988889999999999999999999998 9999999999999999999999999999987654


Q ss_pred             CcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          219 SMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       219 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ...   ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....       +....+..+. ....
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~-~~~~  593 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE-RMGC  593 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC-CCCC
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCC
Confidence            322   2223456789999999999999999999999999999998 99999876543       3344444433 3445


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..+++++.+||.+||+.||++|||+.++++
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            5679999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-46  Score=358.66  Aligned_cols=253  Identities=23%  Similarity=0.397  Sum_probs=209.8

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..|++..++|.+.+.||+|+||+||++.+.. +..||||+++.....  .+.+.+|+.+++.++|+||+++++.+.. +.
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            4577888999999999999999999999874 467999999764322  3568899999999999999999998765 67


Q ss_pred             EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            89999999999999999753  569999999999999999999998 999999999999999999999999999998764


Q ss_pred             CCc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          218 SSM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       218 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....       +....+..+. ....+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~-~~~~~  403 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY-RMPCP  403 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC-CCCCC
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCCC
Confidence            322 12233457789999999998899999999999999999999 99999766533       3344444432 33345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..+++.+.+||.+||+.||++|||++++++
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            678999999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=344.04  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=195.1

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeee---
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFY---  135 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~---  135 (354)
                      ..+++...+|.+.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.++..+. |+||+++++.+.   
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            34566677999999999999999999999999999999998654 3444567889999999985 999999999884   


Q ss_pred             -----ecCeEEEEEeccCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEccCCcE
Q 018532          136 -----HNGVISLVLEYMDRGSLADIIRQ---VKTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVNHKGEV  205 (354)
Q Consensus       136 -----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~  205 (354)
                           ....++++|||+. |+|.+++..   .+.+++..+..++.||+.||.|||+ .|  |+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCE
Confidence                 3446899999996 699998875   3569999999999999999999998 88  9999999999999999999


Q ss_pred             EEeecccccccCCCcCC------------CcccccCCcccccccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 018532          206 KITDFGVSAMLGSSMGQ------------RDTFVGTYNYMSPERI---SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSE  270 (354)
Q Consensus       206 kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  270 (354)
                      ||+|||++.........            .....||+.|+|||++   .+..++.++|||||||++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999876543221            1144689999999998   56678999999999999999999999996543


Q ss_pred             cCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcc
Q 018532          271 DQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPF  328 (354)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~  328 (354)
                      ..           .+.............+..+.+||.+||+.||++|||+.|+++|-+
T Consensus       258 ~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          258 KL-----------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HH-----------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            32           111222233334567888999999999999999999999998743

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=342.35  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHh--hcCCCceEEeeeeeeec----
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ--ASQCSHVVVCYHSFYHN----  137 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~--~l~h~~iv~~~~~~~~~----  137 (354)
                      ...++|++.+.||+|+||+||+|++.  ++.||||++......    ....|..++.  .++|+||+++++.+...    
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA----SWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc----hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            34578999999999999999999875  899999998654322    2333444444  45999999999998877    


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceecCCCCCCEEEccCCcEEEee
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER--------HVIHRDIKPSNLLVNHKGEVKITD  209 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------~iiH~Dlkp~NIll~~~~~~kl~D  209 (354)
                      ..+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+ .        ||+||||||+||+++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            789999999999999999976 579999999999999999999997 7        999999999999999999999999


Q ss_pred             cccccccCCCcCC----CcccccCCcccccccccCCCCCcc------hhHHHHHHHHHHHHcC----------CCCCCCC
Q 018532          210 FGVSAMLGSSMGQ----RDTFVGTYNYMSPERISGSTYDYS------SDIWSLGLVVLECAIG----------RFPYMQS  269 (354)
Q Consensus       210 fg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g----------~~pf~~~  269 (354)
                      ||++.........    .....||+.|+|||++.+..++..      +|||||||++|||++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999776443222    224579999999999988766655      9999999999999999          6677554


Q ss_pred             CcCCChhhHHHHHHHHHcCCCCCCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          270 EDQQSWPSFYELLEAIVESPPPTAPP-----DQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .....  ..................+     ..+++++.+||.+||+.||++|||+.++++|
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          266 VPSDP--SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCC--chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            33321  1222222222222222222     2456779999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=337.21  Aligned_cols=247  Identities=27%  Similarity=0.471  Sum_probs=200.6

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      +..++|++.+.||+|+||+||++++.  ++.||+|++...   ...+.+.+|+.+++.++|+||+++++.+.  +..++|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv   77 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV   77 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence            45688999999999999999999874  788999998643   33467889999999999999999999876  347899


Q ss_pred             EeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC--CCceecCCCCCCEEEccCCc-EEEeecccccccC
Q 018532          144 LEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNE--RHVIHRDIKPSNLLVNHKGE-VKITDFGVSAMLG  217 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~--~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~  217 (354)
                      |||+++++|.+++....   .++...+..++.|++.||.|||+.  +||+||||||+||+++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999999998654   378899999999999999999963  57999999999999998886 7999999997654


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     ........... .......
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~~~~~~  228 (307)
T 2eva_A          158 TH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGT-RPPLIKN  228 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHHHHHTTC-CCCCBTT
T ss_pred             cc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHHHHhcCC-CCCcccc
Confidence            32   223468999999999999999999999999999999999999997654321     12222233332 3334567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ++..+.++|.+||+.||++|||+.+++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            89999999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=341.88  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=212.5

Q ss_pred             ccCcccccccccccccCceEEEEEE----EccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVR----HKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .+..++|++++.||+|+||.||+|+    +..+++.||+|++.... .+..+.+.+|+.+++.++|+||+++++.+...+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            3456789999999999999999998    46689999999997653 344577899999999999999999999876543


Q ss_pred             --eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          139 --VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       139 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                        .+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence              789999999999999999876 458999999999999999999998 9999999999999999999999999999987


Q ss_pred             cCCCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---------CCChhhHHHHHH
Q 018532          216 LGSSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED---------QQSWPSFYELLE  283 (354)
Q Consensus       216 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~~~~~~~  283 (354)
                      ......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||.....         .........+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            654322   12234577889999999988899999999999999999999999864310         000011112223


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+... .....+..++.++.+||.+||+.||++|||+.++++
T Consensus       275 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          275 LLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhcC-CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33333 233345678999999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=347.19  Aligned_cols=252  Identities=17%  Similarity=0.228  Sum_probs=205.9

Q ss_pred             CcccccccccccccCceEEEEEEEccC--------CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEE-------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWV--------GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV-------  129 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~-------  129 (354)
                      ..++|.+.+.||+|+||+||+|++..+        ++.||+|++...      ..+.+|+.+++.++|+||++       
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            357899999999999999999999874        889999998754      35778999999999999887       


Q ss_pred             --------eeeeeee-cCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEE
Q 018532          130 --------CYHSFYH-NGVISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLL  198 (354)
Q Consensus       130 --------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIl  198 (354)
                              +++.+.. ++..++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+ .||+||||||+||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl  191 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIF  191 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEE
Confidence                    5556655 67899999999 89999999986  789999999999999999999998 89999999999999


Q ss_pred             EccCC--cEEEeecccccccCCCcC-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 018532          199 VNHKG--EVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQS  269 (354)
Q Consensus       199 l~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  269 (354)
                      ++.++  .+||+|||++........       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  999999999987653322       123457999999999999999999999999999999999999999765


Q ss_pred             CcCCChhhHHHHHHHHHcCCCCCC----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          270 EDQQSWPSFYELLEAIVESPPPTA----PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ...  ...+...............    ....+++++.+||.+||+.||++|||+.++++.
T Consensus       272 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPN--TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTC--HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcC--HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            422  1222233333332222111    113579999999999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=348.29  Aligned_cols=249  Identities=16%  Similarity=0.194  Sum_probs=201.0

Q ss_pred             cccccCcccccccccccccCceEEEEE-----EEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC---CCceEEee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLV-----RHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ---CSHVVVCY  131 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~iv~~~  131 (354)
                      ..+.+..++|.+.+.||+|+||+||+|     .+..+++.||+|+++....    ..+..|+.++..++   |+|++.++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            445677889999999999999999999     4677899999999976543    23556666666665   89999999


Q ss_pred             eeeeecCeEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-----
Q 018532          132 HSFYHNGVISLVLEYMDRGSLADIIRQ-----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-----  201 (354)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-----  201 (354)
                      +.+...+..++||||++||+|.+++..     .+.+++..+..++.||+.||.|||+ .||+||||||+|||++.     
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCc
Confidence            999999999999999999999999985     3569999999999999999999998 99999999999999998     


Q ss_pred             ------CCcEEEeecccccccCC--CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCC
Q 018532          202 ------KGEVKITDFGVSAMLGS--SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ  273 (354)
Q Consensus       202 ------~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  273 (354)
                            ++.+||+|||+|.....  ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976532  2223345689999999999999999999999999999999999999996543321


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..           ..  ........++.+.+++..||+.+|.+|++..+.+.+
T Consensus       293 ~~-----------~~--~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 CK-----------PE--GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EE-----------EC--SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ee-----------ec--hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            00           00  000111246789999999999999999765554443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=360.41  Aligned_cols=258  Identities=23%  Similarity=0.339  Sum_probs=199.2

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +.+...+|.+.+.||+|+||+|+ .....+++.||||++.....    ..+.+|+.+++.+ +|+||+++++.+.+.+..
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEccEEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            34455679999999999999976 34557899999999865432    2245789999988 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---C--CcEEEeeccccc
Q 018532          141 SLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---K--GEVKITDFGVSA  214 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~a~  214 (354)
                      |+||||+. |+|.+++.... ...+..+..++.||+.||.|||+ .||+||||||+||+++.   +  ..+||+|||+|.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            99999996 59999998653 35556678999999999999998 99999999999999953   2  358899999998


Q ss_pred             ccCCCc---CCCcccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHc
Q 018532          215 MLGSSM---GQRDTFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVE  287 (354)
Q Consensus       215 ~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  287 (354)
                      ......   ......+||+.|+|||++.+   ..++.++|||||||++|+|++ |..||......        .......
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~  243 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLG  243 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTT
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhc
Confidence            765332   22345679999999999984   567889999999999999999 99999544321        1112222


Q ss_pred             CCCC--CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          288 SPPP--TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       288 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ....  .......+..+.+||.+||+.||++|||+.++++||||....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            1111  1112234566899999999999999999999999999987543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.2e-47  Score=358.21  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=191.3

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEEEEec
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      .|.+.+.||+|+||+||.+ ...+|+.||||++....    ...+.+|+.++..+ +||||+++++.+.+.+.+++||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3455688999999999865 45689999999987543    23467899998875 899999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCC-------HHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC-------------CcEE
Q 018532          147 MDRGSLADIIRQVKTIL-------EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK-------------GEVK  206 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~-------------~~~k  206 (354)
                      +. |+|.+++.......       +..+..++.||+.||.|||+ .||+||||||+|||++.+             +.+|
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            96 59999998654322       22456799999999999998 999999999999999754             4899


Q ss_pred             EeecccccccCCCcC----CCcccccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          207 ITDFGVSAMLGSSMG----QRDTFVGTYNYMSPERISG-------STYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       207 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      |+|||++........    .....+||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......  
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--  246 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--  246 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence            999999987754322    1234579999999999976       568999999999999999999 99999654321  


Q ss_pred             hhhHHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          275 WPSFYELLEAIVESPP-PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                         ............. .......++.++.+||.+||+.||++|||+.++++||||..
T Consensus       247 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 ---ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             ---HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ---HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence               1111111111000 01111234578999999999999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.9e-46  Score=356.00  Aligned_cols=254  Identities=21%  Similarity=0.287  Sum_probs=207.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc-eEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH-VVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~-iv~~~~~~~~~~~~~lv~  144 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......   ..+.+|+.+++.+.|.+ +..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999999999999999998754332   34778999999998744 555555666778999999


Q ss_pred             eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEE---ccCCcEEEeecccccccCCCc
Q 018532          145 EYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       145 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      ||+ +++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.+||+|||++.......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            999 8899999986 4679999999999999999999998 999999999999999   688999999999998765432


Q ss_pred             C-------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          221 G-------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       221 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..+........ ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-IEA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-HHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-HHH
Confidence            2       12356899999999999999999999999999999999999999987665433333322222222111 111


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ....++.++.+||..||+.+|++||++.+|++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22467999999999999999999999987665

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.6e-48  Score=377.14  Aligned_cols=268  Identities=23%  Similarity=0.381  Sum_probs=213.4

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee------cC
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH------NG  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------~~  138 (354)
                      ..++|.+.+.||+|+||+||+|.+..+|+.||||+++..........+.+|+.+++.++|+||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            357899999999999999999999999999999999876667777889999999999999999999988655      67


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc---EEEeeccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVK---TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE---VKITDFGV  212 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~  212 (354)
                      ..++||||++||+|.+++....   .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.   +||+|||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            8899999999999999998754   58899999999999999999998 99999999999999997765   99999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH--HHHHHHH----
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY--ELLEAIV----  286 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~----  286 (354)
                      +....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........+....  .......    
T Consensus       171 a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          171 AKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            98765442 3345689999999999999999999999999999999999999996542110000000  0000000    


Q ss_pred             -cC--------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          287 -ES--------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       287 -~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                       .+        ..+......+++.+.+||.+||..||++|||+.++++||||+.+.+
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence             00        0011122336788999999999999999999999999999998654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-45  Score=333.58  Aligned_cols=238  Identities=26%  Similarity=0.450  Sum_probs=191.8

Q ss_pred             Cccccccc-ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hhcCCCceEEeeeeeee----cC
Q 018532           65 SLEDLETI-KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVVVCYHSFYH----NG  138 (354)
Q Consensus        65 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~----~~  138 (354)
                      ..++|.+. +.||+|+||+||+|.+..+++.||+|+++..      ..+.+|+.++ +..+|+||+++++.+..    .+
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            35678777 7899999999999999999999999998643      3456677776 66799999999999887    67


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeecccc
Q 018532          139 VISLVLEYMDRGSLADIIRQVK--TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVS  213 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a  213 (354)
                      .+++||||++|++|.+++....  .+++..+..++.|++.||.|||+ .||+||||||+||+++.   ++.+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            8999999999999999998754  69999999999999999999998 99999999999999998   788999999998


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ....                      +..++.++|||||||++|+|++|..||............   ...+........
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~  222 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYEFP  222 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CCSSCTTCCSSC
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HHHHhhccccCC
Confidence            6432                      235788999999999999999999999765432110000   000000000000


Q ss_pred             --CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          294 --PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       294 --~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                        ....+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence              01468999999999999999999999999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-46  Score=361.50  Aligned_cols=253  Identities=23%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ..|++..++|++.+.||+|+||+||++.+.. +..||||+++.....  .+.+.+|+.+++.++|+||+++++++.. +.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            4577888999999999999999999999874 467999999764322  3568899999999999999999998765 67


Q ss_pred             EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            89999999999999999753  568999999999999999999998 999999999999999999999999999998764


Q ss_pred             CCc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          218 SSM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       218 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      ... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....       +....+..+. ....+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~-~~~~~  486 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY-RMPCP  486 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTTC-CCCCC
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC-CCCCC
Confidence            321 11223456789999999998899999999999999999999 99999766432       3344444432 33345


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      ..++..+.+||.+||+.||++|||+.++++
T Consensus       487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          487 PECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-45  Score=334.05  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=205.7

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      |...+.||+|+||+||+|.+  +++.||+|++....   ..+..+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            34558899999999999986  68899999986532   23456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQV---KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999999743   458999999999999999999998 99999999999999999999999999999876543221


Q ss_pred             --CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHH-------HHcCCCCCC
Q 018532          223 --RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEA-------IVESPPPTA  293 (354)
Q Consensus       223 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~  293 (354)
                        .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||......+....+......       ..... ...
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  267 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK-MND  267 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS-CSC
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc-ccc
Confidence              234578999999999876 5889999999999999999999999876655433333221111       11111 111


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+...+..+.+++.+||+.||++|||+.+++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            223345779999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=341.81  Aligned_cols=261  Identities=20%  Similarity=0.357  Sum_probs=211.3

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      ..+++..++|++.+.||+|+||.||+|.+..   .||+|+++.... ....+.+.+|+.+++.++|+||+++++.+...+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            4567778999999999999999999998753   499999875432 222345678999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..++||||++|++|.+++...+ .+++..+..++.||+.||.|||+ .|++||||||+||+++ ++.+||+|||++....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999999998754 68999999999999999999998 8999999999999998 7899999999987643


Q ss_pred             CC-----cCCCcccccCCcccccccccC---------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH
Q 018532          218 SS-----MGQRDTFVGTYNYMSPERISG---------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       218 ~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  283 (354)
                      ..     ........||+.|+|||++.+         ..++.++|||||||++|+|++|..||......       ....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~  253 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIW  253 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH
Confidence            21     122234468999999999875         34788999999999999999999999765432       3344


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      .+.....+......++.++.++|.+||+.||++|||+.++++  .++.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence            455555555555578999999999999999999999999987  3444443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.3e-45  Score=363.07  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=214.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      ++++..++|++.+.||+|+||+||+|.+..+   +..||+|+++........+.+.+|+.+++.++|+||+++++.+. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            4566788999999999999999999998654   46799999887666677788999999999999999999999874 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +..++||||+++|+|.++++..+ .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            67899999999999999998654 68999999999999999999998 89999999999999999999999999999876


Q ss_pred             CCCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....       +....+..... ...
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~-~~~  613 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGER-LPM  613 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCC-CCC
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCC-CCC
Confidence            54322 1223457789999999998899999999999999999997 99999776543       33344444332 234


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +..+++.+.+||.+||..||++|||+.++++.
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            56789999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-45  Score=337.57  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=204.3

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhh--cCCCceEEeeeeeeecC----
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA--SQCSHVVVCYHSFYHNG----  138 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~iv~~~~~~~~~~----  138 (354)
                      ..++|.+.+.||+|+||+||++++  +++.||||++....    ...+.+|..++..  ++|+||+++++.+....    
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            357899999999999999999987  58999999986542    2446678887776  79999999999988765    


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceecCCCCCCEEEccCCcEEEeec
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH--------NERHVIHRDIKPSNLLVNHKGEVKITDF  210 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~iiH~Dlkp~NIll~~~~~~kl~Df  210 (354)
                      .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||        + .||+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            89999999999999999976 57999999999999999999999        7 88999999999999999999999999


Q ss_pred             ccccccCCCcC----CCcccccCCcccccccccCCC------CCcchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 018532          211 GVSAMLGSSMG----QRDTFVGTYNYMSPERISGST------YDYSSDIWSLGLVVLECAIG----------RFPYMQSE  270 (354)
Q Consensus       211 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g----------~~pf~~~~  270 (354)
                      |++........    ......||+.|+|||++.+..      ++.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99987654332    234457999999999998762      34689999999999999999          78887654


Q ss_pred             cCCChhhHHHHHHHHHcCCCCCCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          271 DQQSWPSFYELLEAIVESPPPTAPPD-----QFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ....  ........+.........+.     .++..+.+||.+||+.||++|||+.++++|
T Consensus       272 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSC--CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcc--cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            3321  12233333333332222222     234679999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-46  Score=351.07  Aligned_cols=251  Identities=16%  Similarity=0.195  Sum_probs=198.0

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhhcCC-Cce--------------
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE--EIRKQIVQELKINQASQC-SHV--------------  127 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h-~~i--------------  127 (354)
                      ...+|...+.||+|+||+||+|.+..+|+.||||+++.....  ...+.+.+|+.+++.+.| .|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688889999999999999999999999999998744332  235678899999988877 221              


Q ss_pred             -EEe------eeeeee-----cCeEEEEEeccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCCce
Q 018532          128 -VVC------YHSFYH-----NGVISLVLEYMDRGSLADIIRQV-------KTILEPYLAVVCKQVLQGLVYLHNERHVI  188 (354)
Q Consensus       128 -v~~------~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~ii  188 (354)
                       +.+      ...+..     ...++++|+++ +++|.++++..       +.+++..+..++.||+.||.|||+ +||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ii  233 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV  233 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Confidence             111      011111     23467888877 56999998522       346677888999999999999998 9999


Q ss_pred             ecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcccccCCcccccccc----------cCCCCCcchhHHHHHHHHHH
Q 018532          189 HRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI----------SGSTYDYSSDIWSLGLVVLE  258 (354)
Q Consensus       189 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~e  258 (354)
                      ||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++          .+..++.++|||||||++|+
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999999999999999999876543   344577 999999999          55568899999999999999


Q ss_pred             HHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          259 CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       259 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      |++|+.||......+....       +..      ....+++++.+||.+||+.||++|||+.++++||||+.+.+
T Consensus       310 lltg~~Pf~~~~~~~~~~~-------~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEW-------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGG-------GGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHH-------HHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999999987655432221       111      12367899999999999999999999999999999998754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-45  Score=338.76  Aligned_cols=247  Identities=21%  Similarity=0.214  Sum_probs=192.6

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhhcC---------CCc
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-------EEIRKQIVQELKINQASQ---------CSH  126 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~---------h~~  126 (354)
                      .+..++|++.+.||+|+||+||+|++  +|+.||||+++....       ....+.+.+|+.+++.++         |+|
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            35578999999999999999999997  689999999976531       222356778888877765         666


Q ss_pred             eEEeeee-----------------eee-------------cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHH
Q 018532          127 VVVCYHS-----------------FYH-------------NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQ  176 (354)
Q Consensus       127 iv~~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~  176 (354)
                      |+++.+.                 +..             .+.+|+||||+++|++.+.+.+ +.+++..++.++.||+.
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence            6655554                 332             6899999999999977666644 67899999999999999


Q ss_pred             HHHHHH-hCCCceecCCCCCCEEEccCC--------------------cEEEeecccccccCCCcCCCcccccCCccccc
Q 018532          177 GLVYLH-NERHVIHRDIKPSNLLVNHKG--------------------EVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP  235 (354)
Q Consensus       177 ~l~~LH-~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP  235 (354)
                      ||.||| + .||+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+||
T Consensus       173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP  246 (336)
T 2vuw_A          173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred             HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence            999999 8 8999999999999999987                    8999999999876532     34899999999


Q ss_pred             ccccCCCCCcchhHHHHHHH-HHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCC----CCCCCCHHHHHHHHHh
Q 018532          236 ERISGSTYDYSSDIWSLGLV-VLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTA----PPDQFSPEFCSFVSAC  309 (354)
Q Consensus       236 E~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~l~~li~~~  309 (354)
                      |++.+.. +.++||||||++ .+++++|..||....      ........+... .....    ....+++++.+||.+|
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence            9999876 899999998777 777888999983210      001122222211 11111    1224678999999999


Q ss_pred             hhhCCCCCCCHHHHh-cCcccc
Q 018532          310 IQKDPRDRSSSLDLL-SHPFIK  330 (354)
Q Consensus       310 l~~~p~~Rps~~eil-~hp~~~  330 (354)
                      |+.|     |++|+| +||||+
T Consensus       320 L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          320 LNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GGSS-----SHHHHHHHCGGGC
T ss_pred             hccC-----CHHHHHhcCCCcC
Confidence            9986     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-44  Score=360.10  Aligned_cols=244  Identities=19%  Similarity=0.261  Sum_probs=205.6

Q ss_pred             cccccccccccccCceEEEEEEEcc-CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe-----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKW-VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV-----  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-----  139 (354)
                      .++|.+.+.||+|+||+||++.+.. +|+.||||++......+....+.+|+.++..++|+||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999986 7899999998766666667788999999999999999999999987665     


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .|+||||++|++|.+++..  .+++..+..++.||+.||.|||+ .||+||||||+||+++.+ .+||+|||++......
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            7999999999999988754  79999999999999999999998 999999999999999875 9999999999876543


Q ss_pred             cCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS  299 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (354)
                          ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......               +........+
T Consensus       235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~~~~~~~~~~  294 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------PEDDPVLKTY  294 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------CTTCHHHHHC
T ss_pred             ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------cccccccccC
Confidence                345799999999998765 48899999999999999999998865322110               0000011236


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      +.+.+||.+||+.||++||+..+.+.|+|+....
T Consensus       295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999987543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.1e-43  Score=315.61  Aligned_cols=232  Identities=13%  Similarity=0.078  Sum_probs=190.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ..+..+.+.+|+.++..++|+||+++++.+...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999999999999999997653  355667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCC
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR  223 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  223 (354)
                      |||++|++|.++++.  .....++..++.|++.||.|||+ +||+||||||+||+++.+|.+||+++|            
T Consensus       110 ~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             EEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence            999999999999954  34666788999999999999998 999999999999999999999998543            


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCCHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFSPE  301 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  301 (354)
                              |++       .++.++|||||||++|+|++|+.||.+....+......    ........  ......++++
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTTSCBCCHHHHCTTSCHH
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhccCCCChhhcccCCCHH
Confidence                    233       36889999999999999999999998766532110000    00001000  1123468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +.+||.+||+.||++| |+.++++.  ++++..
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~--L~~~~~  265 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNL--MQQATA  265 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHH--HHHHHC
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHH--HHHHhc
Confidence            9999999999999999 99999873  444433

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.6e-37  Score=301.34  Aligned_cols=188  Identities=14%  Similarity=0.157  Sum_probs=140.2

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccc---------cHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeEEE
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---------QEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...+.|++|.+..++....|+.||+|++....         .+...+++.+|+.+++.+ .|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            34778888888888888899999999997542         233456799999999998 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++|++|.+++.+.+.+++.   .|+.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|+........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            99999999999999988888764   488999999999998 99999999999999999999999999999988766666


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFP  265 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  265 (354)
                      ..+.+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            7778999999999999874 67789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3.1e-30  Score=250.11  Aligned_cols=184  Identities=16%  Similarity=0.192  Sum_probs=145.8

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-------QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ...+.||+|+||+||++.  ..+..+++|+.....       .....+.+.+|+.+++.++|+||+.+.......+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  568889999864321       11234568999999999999999966555557777899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++|++|.+++..        +..++.|++.||.|||+ +||+||||||+|||++.  .+||+|||+|+........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999999865        56899999999999998 99999999999999998  9999999999987553221


Q ss_pred             -------CcccccCCcccccccccC--CCCCcchhHHHHHHHHHHHHcCCCCC
Q 018532          223 -------RDTFVGTYNYMSPERISG--STYDYSSDIWSLGLVVLECAIGRFPY  266 (354)
Q Consensus       223 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf  266 (354)
                             ....+||+.|||||++.+  ..|+..+|+||.++-..+.+.++-+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   235689999999999987  56888899999999888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=3.7e-27  Score=210.28  Aligned_cols=144  Identities=17%  Similarity=0.140  Sum_probs=116.7

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----------------HHHHHHHHHHHHHhhcCCCceEEeee
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----------------EIRKQIVQELKINQASQCSHVVVCYH  132 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~~~~l~h~~iv~~~~  132 (354)
                      .+.+.||+|+||.||+|.+ .+|+.||+|+++.....                 .....+.+|+.+++.++  | +.+.+
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3449999999999999999 78999999998643211                 23567899999999998  5 66666


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      .+.. +..++||||++|++|.+ +.      ......++.|++.||.|||+ .||+||||||+|||++ +|.+||+|||+
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            5544 55699999999999987 31      13355799999999999998 9999999999999999 99999999999


Q ss_pred             ccccCCCcCCCcccccCCcccccccccC
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSPERISG  240 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aPE~~~~  240 (354)
                      |..             +..++|||.+..
T Consensus       239 a~~-------------~~~~~a~e~l~r  253 (282)
T 1zar_A          239 SVE-------------VGEEGWREILER  253 (282)
T ss_dssp             CEE-------------TTSTTHHHHHHH
T ss_pred             CeE-------------CCCCCHHHHHHH
Confidence            863             335689998754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.1e-22  Score=179.16  Aligned_cols=138  Identities=19%  Similarity=0.254  Sum_probs=107.0

Q ss_pred             ccccccccccCceEEEEEEEccCCcE--EEEEEeeccccH-----------------------HHHHHHHHHHHHHhhcC
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRL--FALKIIQMNIQE-----------------------EIRKQIVQELKINQASQ  123 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  123 (354)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                       .....+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999999778999  999997643211                       11236788999999888


Q ss_pred             CCce--EEeeeeeeecCeEEEEEeccCC-C----CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCCceecCCCCC
Q 018532          124 CSHV--VVCYHSFYHNGVISLVLEYMDR-G----SLADIIRQVKTILEPYLAVVCKQVLQGLVYLH-NERHVIHRDIKPS  195 (354)
Q Consensus       124 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~iiH~Dlkp~  195 (354)
                      |+++  ...+..    +..++||||+.+ |    +|.++...   .++..+..++.|++.||.||| + .||+||||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~-~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE-AELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT-SCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHH
Confidence            7754  222221    356899999942 3    67665432   234567889999999999999 7 99999999999


Q ss_pred             CEEEccCCcEEEeeccccccc
Q 018532          196 NLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       196 NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      |||++.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=2.8e-19  Score=163.99  Aligned_cols=139  Identities=17%  Similarity=0.199  Sum_probs=100.0

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeecccc-----------------HHH----HHHHHHHHHHHhhcCCCce
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-----------------EEI----RKQIVQELKINQASQCSHV  127 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~~~----~~~~~~e~~~~~~l~h~~i  127 (354)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++....                 ...    +....+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            788899999999999999985 799999999753210                 011    1123456666666644433


Q ss_pred             EEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----
Q 018532          128 VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----  203 (354)
Q Consensus       128 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----  203 (354)
                      . ....+.... .++||||++|++|..+.      ..+....++.||+.+|.+||+ .|||||||||.|||++++|    
T Consensus       176 ~-vp~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 P-VPEPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             S-CCCEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECSSC
T ss_pred             C-CCeeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCccc
Confidence            2 111122222 26999999998885432      223456788999999999998 8999999999999998877    


Q ss_pred             ------cEEEeecccccccC
Q 018532          204 ------EVKITDFGVSAMLG  217 (354)
Q Consensus       204 ------~~kl~Dfg~a~~~~  217 (354)
                            .+.|+||+-+....
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETT
T ss_pred             ccccccceEEEEeCCcccCC
Confidence                  38999999886544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=4.6e-13  Score=117.56  Aligned_cols=141  Identities=16%  Similarity=0.098  Sum_probs=108.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      .+.|.+...++.|+.+.||++...  +..+++|+...... .....+.+|+.+++.+. +.++.++++.....+..|+||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            356778888999999999999753  68899999864321 11234778888888774 556777888888888999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE----------------------------------------  184 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------------------------------  184 (354)
                      |+++|.+|.+.+.     +......++.+++.+|..||+.                                        
T Consensus        90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999999876521     2223457888999999999971                                        


Q ss_pred             ------------------CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 ------------------RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ------------------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                                        ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              338999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=4.1e-12  Score=111.01  Aligned_cols=135  Identities=13%  Similarity=-0.002  Sum_probs=95.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc--eEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~~~~~~~~~lv~  144 (354)
                      ..+.+....+.|..+.||++.. .+|..+++|+.....    ...+.+|+.+++.+.+.+  +.+++......+..++||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            3444433344666799999964 467789999976431    134667888877775444  445777777777899999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER---------------------------------------  185 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------  185 (354)
                      ||++|.+|.  .   ....   ...++.+++..|..||+..                                       
T Consensus        95 e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998874  1   1122   2356677777778887611                                       


Q ss_pred             ------------------CceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          186 ------------------HVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       186 ------------------~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                                        .++|+|++|.||++++++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                              19999999999999877667899999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=1e-11  Score=114.06  Aligned_cols=141  Identities=13%  Similarity=0.207  Sum_probs=103.1

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEee--ccccHHHHHHHHHHHHHHhhcCC--CceEEeeeeeeec---CeEEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ--MNIQEEIRKQIVQELKINQASQC--SHVVVCYHSFYHN---GVISLV  143 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~~~~l~h--~~iv~~~~~~~~~---~~~~lv  143 (354)
                      .++.|+.|.++.||++...  +..+++|+..  ..........+.+|+.+++.+..  .++.+++..+.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4567899999999998764  4678899875  33222223467889999888864  3466777666655   458999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE---------------------------------------  184 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------  184 (354)
                      |||++|..+.+.  ....++..+...++.+++.+|..||+.                                       
T Consensus       120 me~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999999777431  123467888888999999999999961                                       


Q ss_pred             ------------------CCceecCCCCCCEEEccCCc--EEEeecccccc
Q 018532          185 ------------------RHVIHRDIKPSNLLVNHKGE--VKITDFGVSAM  215 (354)
Q Consensus       185 ------------------~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  215 (354)
                                        ..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              45899999999999997753  69999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=8.1e-11  Score=105.55  Aligned_cols=181  Identities=15%  Similarity=0.211  Sum_probs=119.2

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCc--eEEeeeeeeecC---eEEEEEe
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSH--VVVCYHSFYHNG---VISLVLE  145 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~--iv~~~~~~~~~~---~~~lv~e  145 (354)
                      ++.++.|....||++.     ..+++|+....   .....+.+|..+++.+. +..  +...+......+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3458999999999863     45889986432   34466888999887763 322  223333322222   4578999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE-----------------------------------------  184 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  184 (354)
                      +++|.+|.....  ..++..+...++.|++..+..||+.                                         
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988865432  3577777888888888888888850                                         


Q ss_pred             ----------------CCceecCCCCCCEEEcc--CCcEEEeecccccccCCCcCCCcccccCCcc---cccccccC---
Q 018532          185 ----------------RHVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMGQRDTFVGTYNY---MSPERISG---  240 (354)
Q Consensus       185 ----------------~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y---~aPE~~~~---  240 (354)
                                      ..++|+|++|.||+++.  ++.+.|+||+.+.........    .....+   ..|+....   
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl----~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF----ISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH----HTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH----HHHHhhccccCHHHHHHHHH
Confidence                            13799999999999998  456899999988653221100    001111   12222110   


Q ss_pred             --C---------CCCcchhHHHHHHHHHHHHcCCCCC
Q 018532          241 --S---------TYDYSSDIWSLGLVVLECAIGRFPY  266 (354)
Q Consensus       241 --~---------~~~~~~DiwslG~il~ell~g~~pf  266 (354)
                        .         ......+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              0         0122368999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.72  E-value=1.2e-07  Score=84.89  Aligned_cols=135  Identities=15%  Similarity=0.165  Sum_probs=91.1

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC---ceEEeeeeee-ecCeEEEEEecc
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS---HVVVCYHSFY-HNGVISLVLEYM  147 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~  147 (354)
                      ++.++.|....||++     |..+++|+...   ......+.+|..+++.+.+.   .+.+.+.... ..+..++|||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            345788888899988     46688898532   23456788999999888653   2334444332 345678999999


Q ss_pred             CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018532          148 DRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHN--------------------------------------------  183 (354)
Q Consensus       148 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  183 (354)
                      +|.++....  ...++..+...++.++...|..||+                                            
T Consensus        96 ~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            998887632  1234444455555555555555553                                            


Q ss_pred             ---------------CCCceecCCCCCCEEEcc---CCc-EEEeeccccccc
Q 018532          184 ---------------ERHVIHRDIKPSNLLVNH---KGE-VKITDFGVSAML  216 (354)
Q Consensus       184 ---------------~~~iiH~Dlkp~NIll~~---~~~-~kl~Dfg~a~~~  216 (354)
                                     ...++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           123599999999999987   455 589999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.67  E-value=3.1e-07  Score=80.39  Aligned_cols=132  Identities=14%  Similarity=0.055  Sum_probs=92.6

Q ss_pred             ccccCce-EEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC-CceEEeeeeeeecCeEEEEEeccCCCCH
Q 018532           75 IGKGSGG-VVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC-SHVVVCYHSFYHNGVISLVLEYMDRGSL  152 (354)
Q Consensus        75 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L  152 (354)
                      +..|..| .||+......+..+++|+-...    ....+.+|..+++.+.. -.+.+++....+.+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            3445444 6899888777888999986543    23456778888777642 2355667777788899999999999888


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 018532          153 ADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE------------------------------------------------  184 (354)
Q Consensus       153 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------------  184 (354)
                      .+.....    ......+..++...|..||+.                                                
T Consensus       108 ~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          108 FQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             cccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            7765431    122234555566666666631                                                


Q ss_pred             ---------CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 ---------RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ---------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                               ..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     016999999999999987777899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=7e-07  Score=82.85  Aligned_cols=77  Identities=17%  Similarity=0.076  Sum_probs=46.4

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeecccc---HH---HHHHHHHHHHHHhhcCC--Cc-eEEeeeeeeecCeEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ---EE---IRKQIVQELKINQASQC--SH-VVVCYHSFYHNGVISL  142 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~---~~~~~~~e~~~~~~l~h--~~-iv~~~~~~~~~~~~~l  142 (354)
                      .+.||.|..+.||++....+++.+++|.......   .+   ....+..|..+++.+..  +. +.+++..  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4578999999999998766678899998643211   00   12345667777766532  23 3344432  4455689


Q ss_pred             EEeccCCC
Q 018532          143 VLEYMDRG  150 (354)
Q Consensus       143 v~e~~~~~  150 (354)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.29  E-value=1.4e-05  Score=72.16  Aligned_cols=31  Identities=16%  Similarity=0.345  Sum_probs=27.9

Q ss_pred             CCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       184 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3679999999999999888899999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=2.8e-06  Score=77.51  Aligned_cols=82  Identities=6%  Similarity=0.082  Sum_probs=49.0

Q ss_pred             ccccc-cccCceEEEEEEEcc------CCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCC---CceEEeeeeeeec-
Q 018532           71 TIKVI-GKGSGGVVQLVRHKW------VGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQC---SHVVVCYHSFYHN-  137 (354)
Q Consensus        71 ~~~~l-g~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h---~~iv~~~~~~~~~-  137 (354)
                      ..+.| +.|....+|++....      ++..+++|+......  ......+.+|+.+++.+..   -.+.+++....+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34567 888889999886531      256789998654320  0001235566666665532   2344555554443 


Q ss_pred             --CeEEEEEeccCCCCH
Q 018532          138 --GVISLVLEYMDRGSL  152 (354)
Q Consensus       138 --~~~~lv~e~~~~~~L  152 (354)
                        +..++|||+++|.++
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              356899999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.13  E-value=4.6e-05  Score=63.44  Aligned_cols=136  Identities=19%  Similarity=0.163  Sum_probs=92.8

Q ss_pred             CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc
Q 018532          150 GSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG  228 (354)
Q Consensus       150 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  228 (354)
                      .+|.++|+.. .+++++++|.++.|.+.+|.-+-..+.-..+=+.|..|++..+|.|.+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            4799999875 68999999999999999988762112222334457899999999988764 1111            11


Q ss_pred             CCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 018532          229 TYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSA  308 (354)
Q Consensus       229 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  308 (354)
                      ...+.|||... ...+.+.=|||||++||..+--..|-                          .....+|+.+.+||..
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e--------------------------~eE~eLS~~LE~LL~~  152 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE--------------------------NEERELSPPLEQLIDH  152 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT--------------------------TEEECCCHHHHHHHHH
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc--------------------------ccchhhCHHHHHHHHH
Confidence            22456888764 34567889999999999988544332                          1134689999999999


Q ss_pred             hhhh-------------------------CCCCCCCHHHHhc
Q 018532          309 CIQK-------------------------DPRDRSSSLDLLS  325 (354)
Q Consensus       309 ~l~~-------------------------~p~~Rps~~eil~  325 (354)
                      |..-                         .+..|.+.++|++
T Consensus       153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            9765                         2468889998876

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=2.8e-05  Score=72.54  Aligned_cols=77  Identities=13%  Similarity=0.186  Sum_probs=46.9

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccccc--CCcccccccccCC---CCCcchhHHHHHHHHHHH
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVG--TYNYMSPERISGS---TYDYSSDIWSLGLVVLEC  259 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il~el  259 (354)
                      ..++|+|++|.||+++.++ ++|+||+.+......... .....  ...|.+|+.....   .-....++.++...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6799999999999998877 999999988643211110 00010  1245566554321   112234556777777777


Q ss_pred             HcCC
Q 018532          260 AIGR  263 (354)
Q Consensus       260 l~g~  263 (354)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.78  E-value=5.1e-05  Score=67.37  Aligned_cols=29  Identities=28%  Similarity=0.287  Sum_probs=25.0

Q ss_pred             CceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       186 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3899999999999 5677889999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00013  Score=65.05  Aligned_cols=76  Identities=16%  Similarity=0.089  Sum_probs=56.2

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC---CCceEEeeeeeeecCeEEEEEecc
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ---CSHVVVCYHSFYHNGVISLVLEYM  147 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~~~~~~~lv~e~~  147 (354)
                      ..+.|+.|....+|++..  ++..+++|+.....    ...+..|...++.+.   ...+.+.+......+..++|||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            346789999999999874  46788999876432    345677887777663   345667777666678899999999


Q ss_pred             CCCCH
Q 018532          148 DRGSL  152 (354)
Q Consensus       148 ~~~~L  152 (354)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.49  E-value=0.00041  Score=61.02  Aligned_cols=77  Identities=13%  Similarity=0.009  Sum_probs=50.2

Q ss_pred             ccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC---ceEEeeeeeeecCeEEEEEe
Q 018532           69 LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS---HVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        69 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~---~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ...++.+|.|..+.||++... +|+.|++|+...... .....+..|+..++.+.-.   .+.+.+..  +  .-++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e   90 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME   90 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence            344567999999999999864 788999998653321 1123467788888776432   23333332  2  2368999


Q ss_pred             ccCCCC
Q 018532          146 YMDRGS  151 (354)
Q Consensus       146 ~~~~~~  151 (354)
                      +++++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.00033  Score=62.53  Aligned_cols=140  Identities=14%  Similarity=0.142  Sum_probs=74.8

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-----CCceEEee-e--eeeecCeEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-----CSHVVVCY-H--SFYHNGVISL  142 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~iv~~~-~--~~~~~~~~~l  142 (354)
                      .++.|+.|....+|++... +| .+++|+......   ...+..|..+++.+.     .|.++... +  .....+..++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            3456788888999998753 34 588998865211   122344555544432     23333221 1  1123467789


Q ss_pred             EEeccCCCCHH-----------HH---HHHh-CCC--------CHHHHHH---------------HHHHHHHHHHHHHh-
Q 018532          143 VLEYMDRGSLA-----------DI---IRQV-KTI--------LEPYLAV---------------VCKQVLQGLVYLHN-  183 (354)
Q Consensus       143 v~e~~~~~~L~-----------~~---l~~~-~~~--------~~~~~~~---------------i~~qi~~~l~~LH~-  183 (354)
                      ++++++|..+.           ..   ++.. ..+        .......               +...+...+..+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            99999885431           11   1111 111        1000000               00113344455542 


Q ss_pred             -----CCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          184 -----ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       184 -----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                           ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 14599999999999998876668999997753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.39  E-value=0.00039  Score=62.50  Aligned_cols=32  Identities=28%  Similarity=0.375  Sum_probs=27.6

Q ss_pred             CCceecCCCCCCEEEccC----CcEEEeeccccccc
Q 018532          185 RHVIHRDIKPSNLLVNHK----GEVKITDFGVSAML  216 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~  216 (354)
                      ..++|||+.+.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            569999999999999875    68999999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.18  E-value=0.00096  Score=62.31  Aligned_cols=74  Identities=20%  Similarity=0.174  Sum_probs=45.9

Q ss_pred             ccccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCce-EEeeeeeeecCeEEE
Q 018532           71 TIKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGVISL  142 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~l  142 (354)
                      .++.|+.|....||++....       ++..+++|+......   ...+..|..+++.+...++ .++++.+.  +  .+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            34568888889999998653       257899999843212   1234467777776643333 34444432  2  28


Q ss_pred             EEeccCCCC
Q 018532          143 VLEYMDRGS  151 (354)
Q Consensus       143 v~e~~~~~~  151 (354)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899998633

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.0029  Score=56.51  Aligned_cols=137  Identities=14%  Similarity=0.102  Sum_probs=73.7

Q ss_pred             ccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCc--eEEeeee-----eeecCeEEEEEe
Q 018532           73 KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH--VVVCYHS-----FYHNGVISLVLE  145 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--iv~~~~~-----~~~~~~~~lv~e  145 (354)
                      ..++ |....||++... +|+.+++|+.......  ...+..|..+++.+....  +..++..     ....+..+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3466 888899987643 4667999998633111  123445665555442111  2333322     223567789999


Q ss_pred             ccCCCCHH-----H------H---HHHh-C--------CCCHHHH----------------------HHHHHHHHHHHHH
Q 018532          146 YMDRGSLA-----D------I---IRQV-K--------TILEPYL----------------------AVVCKQVLQGLVY  180 (354)
Q Consensus       146 ~~~~~~L~-----~------~---l~~~-~--------~~~~~~~----------------------~~i~~qi~~~l~~  180 (354)
                      +++|.++.     .      .   ++.. .        .......                      ...+.+++..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99874321     1      1   1110 0        1111110                      0111222222222


Q ss_pred             HH---hCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          181 LH---NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       181 LH---~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      +-   ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            21   124589999999999998 4 899999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.97  E-value=0.00048  Score=63.16  Aligned_cols=137  Identities=16%  Similarity=0.135  Sum_probs=76.6

Q ss_pred             cccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCce-EEeeeeeeecCeEEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGVISLV  143 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~lv  143 (354)
                      ++.|.-|-...+|++....       +++.|++|+.....  .....+.+|..+++.+...++ .++++.+.  +  .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence            3467777778889987642       35789999863321  112345578888776643333 33444332  2  289


Q ss_pred             EeccCCCCHH--------------HHHHH---h-----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 018532          144 LEYMDRGSLA--------------DIIRQ---V-----KTIL--EPYLAVVCKQVLQ-------------------GLVY  180 (354)
Q Consensus       144 ~e~~~~~~L~--------------~~l~~---~-----~~~~--~~~~~~i~~qi~~-------------------~l~~  180 (354)
                      |||++|.+|.              +.+.+   .     +...  ..++..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999875432              11111   1     1111  2444555444322                   1222


Q ss_pred             HH----h---CCCceecCCCCCCEEEccC----CcEEEeeccccc
Q 018532          181 LH----N---ERHVIHRDIKPSNLLVNHK----GEVKITDFGVSA  214 (354)
Q Consensus       181 LH----~---~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~  214 (354)
                      |.    .   ...++|+|+.+.||+++.+    +.+.|+||..|.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22    1   1348999999999999876    789999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.96  E-value=0.0078  Score=54.17  Aligned_cols=31  Identities=26%  Similarity=0.445  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888999999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.90  E-value=0.0014  Score=59.72  Aligned_cols=74  Identities=16%  Similarity=0.201  Sum_probs=40.1

Q ss_pred             cccccccCceEEEEEEEccC--------CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCce-EEeeeeeeecCeEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWV--------GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGVISL  142 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~l  142 (354)
                      ++.|+.|....+|++.....        +..+++|+....... . .....|..+++.+...++ .++++..  .+  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            45678888889999986531        368899987543211 0 112456666655533232 2444332  22  68


Q ss_pred             EEeccCCCC
Q 018532          143 VLEYMDRGS  151 (354)
Q Consensus       143 v~e~~~~~~  151 (354)
                      |+||++|.+
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.78  E-value=0.004  Score=58.49  Aligned_cols=74  Identities=18%  Similarity=0.213  Sum_probs=44.8

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCce-EEeeeeeeecCeEEEEEeccCCC
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHV-VVCYHSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~  150 (354)
                      ++.|+.|-...+|++.....+..+++|+....... . -....|..+++.+...++ .++++.+  .+  .+|+||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-I-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-C-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-h-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCc
Confidence            45677888899999987644578999987543211 0 011467887777765554 3455544  22  2599999874


Q ss_pred             C
Q 018532          151 S  151 (354)
Q Consensus       151 ~  151 (354)
                      +
T Consensus       187 ~  187 (458)
T 2qg7_A          187 A  187 (458)
T ss_dssp             E
T ss_pred             c
Confidence            4

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.56  E-value=0.012  Score=54.51  Aligned_cols=29  Identities=28%  Similarity=0.583  Sum_probs=25.8

Q ss_pred             CceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       186 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      .++|+|+.+.||+ +.++.+.++||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7888999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.97  E-value=0.21  Score=45.77  Aligned_cols=29  Identities=28%  Similarity=0.494  Sum_probs=24.7

Q ss_pred             ceecCCCCCCEEE------ccCCcEEEeecccccc
Q 018532          187 VIHRDIKPSNLLV------NHKGEVKITDFGVSAM  215 (354)
Q Consensus       187 iiH~Dlkp~NIll------~~~~~~kl~Dfg~a~~  215 (354)
                      ++|+|+.+.||++      ++++.+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3456799999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.70  E-value=0.26  Score=40.79  Aligned_cols=115  Identities=7%  Similarity=0.019  Sum_probs=80.1

Q ss_pred             cCCCceEEeeeeeeecCeEEEEEeccC-CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc
Q 018532          122 SQCSHVVVCYHSFYHNGVISLVLEYMD-RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN  200 (354)
Q Consensus       122 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~  200 (354)
                      ..+++++.. ..-..++.+.+.++.-+ +-++..    -+..+....+.++.+|+....++++   -+|--|+|+||+++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~  113 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFT  113 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEEC
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEc
Confidence            467777755 44455666666666544 223322    2567888999999999998876665   47999999999999


Q ss_pred             cCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 018532          201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY  266 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  266 (354)
                      .++.+++.-.|+-..+                 +|.     ..+...=+-.+=|++..+++++..|
T Consensus       114 ~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             TTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999987764322                 221     1122222346788999999999888

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.42  E-value=0.31  Score=40.47  Aligned_cols=115  Identities=13%  Similarity=0.087  Sum_probs=78.4

Q ss_pred             cCCCceEEeeeeeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHHhCCCceecCCCCCCEEEc
Q 018532          122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV-YLHNERHVIHRDIKPSNLLVN  200 (354)
Q Consensus       122 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~iiH~Dlkp~NIll~  200 (354)
                      ..|+++  -...-.+++.+.+.++.-+++.=...+   +.++....+.++.+|+.... ++++   -+|--|+|+||+++
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~NL~f~  118 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPENLMFN  118 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGGEEEC
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCceEEEe
Confidence            367777  333335677777777765443323333   46888899999999988887 6654   58899999999999


Q ss_pred             cCCcEEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 018532          201 HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY  266 (354)
Q Consensus       201 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  266 (354)
                      .++.+++.-.|+-..+                 +|.-     .+..-=+-.+=|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999988864322                 2221     111112236778888888888877

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.68  E-value=0.12  Score=48.52  Aligned_cols=63  Identities=6%  Similarity=-0.073  Sum_probs=17.5

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEE------EEeecc-ccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFAL------KIIQMN-IQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      .+.+.||   ||.||.+........||+      |..+.. ...+....+.+|..+.+.++|+|+++.+.+..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   999999887655567888      655432 23344456788888888899999988877543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	354
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-74
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-73
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-72
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-70
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-67
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-67
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-65
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-65
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-65
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-64
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-63
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-62
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-62
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-61
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-58
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-58
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-57
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-54
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-48
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-47
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  258 bits (660), Expect = 5e-85
 Identities = 116/313 (37%), Positives = 175/313 (55%), Gaps = 37/313 (11%)

Query: 62  FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQA 121
            E   +D E I  +G G+GGVV  V HK  G + A K+I + I+  IR QI++EL++   
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
               ++V  Y +FY +G IS+ +E+MD GSL  ++++   I E  L  V   V++GL YL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
             +  ++HRD+KPSN+LVN +GE+K+ DFGVS  L  SM   ++FVGT +YMSPER+ G+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT 178

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------------------------- 273
            Y   SDIWS+GL ++E A+GR+P    + ++                            
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 274 -------SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                     + +ELL+ IV  PPP  P   FS EF  FV+ C+ K+P +R+    L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298

Query: 327 PFIKKFEDKDIDL 339
            FIK+ + +++D 
Sbjct: 299 AFIKRSDAEEVDF 311

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 9e-77
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 14/271 (5%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQ 120
           +++LED E  + +GKG  G V L R K    + ALK++      +  +  Q+ +E++I  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
             +  +++  Y  F+    + L+LEY   G++   ++++    E   A    ++   L Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
            H  + VIHRDIKP NLL+   GE+KI DFG S    SS  +R T  GT +Y+ PE I G
Sbjct: 122 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178

Query: 241 STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSP 300
             +D   D+WSLG++  E  +G+ P+          ++ E  + I         PD  + 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFVTE 229

Query: 301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
                +S  ++ +P  R    ++L HP+I  
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 5e-74
 Identities = 90/290 (31%), Positives = 154/290 (53%), Gaps = 17/290 (5%)

Query: 57  YKEFDFEFSLEDL-ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQE 115
           Y+    + + ED  E I  +G G+ G V   ++K    L A K+I    +EE  +  + E
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVE 59

Query: 116 LKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQV 174
           + I  +    ++V    +FY+   + +++E+   G++  ++ +++  L E  + VVCKQ 
Sbjct: 60  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
           L  L YLH +  +IHRD+K  N+L    G++K+ DFGVSA    ++ +RD+F+GT  +M+
Sbjct: 120 LDALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 235 PERISGST-----YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP 289
           PE +   T     YDY +D+WSLG+ ++E A    P+ +            +L  I +S 
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-------RVLLKIAKSE 231

Query: 290 PPTAP-PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
           PPT   P ++S  F  F+  C++K+   R ++  LL HPF+    +K I 
Sbjct: 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 3e-73
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 10/269 (3%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS 125
           +ED + ++ +G+G+ G VQL  ++      A+KI+ M    +  + I +E+ IN+     
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           +VV  Y       +  L LEY   G L D I     + EP       Q++ G+VYLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GI 122

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR--DTFVGTYNYMSPERISGSTY 243
            + HRDIKP NLL++ +  +KI+DFG++ +   +  +R  +   GT  Y++PE +    +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 244 D-YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
                D+WS G+V+     G  P+ Q  D        +      E      P  +     
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP 236

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            + +   + ++P  R +  D+    +  K
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNK 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 2e-72
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 19/274 (6%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCS 125
           ED E +  IG GS G  Q +R K  G++   K +   ++ E  ++ +V E+ + +  +  
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 126 HVVVCYHSFYH--NGVISLVLEYMDRGSLADII----RQVKTILEPYLAVVCKQVLQGLV 179
           ++V  Y       N  + +V+EY + G LA +I    ++ + + E ++  V  Q+   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 180 YLH----NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
             H        V+HRD+KP+N+ ++ K  VK+ DFG++ +L         FVGT  YMSP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP 295
           E+++  +Y+  SDIWSLG ++ E      P+     +       EL   I E       P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRR-IP 235

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI 329
            ++S E    ++  +      R S  ++L +P I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  220 bits (561), Expect = 2e-70
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 21/288 (7%)

Query: 64  FSLEDLET----IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELK 117
           F  +D E     ++ IG GS G V   R      + A+K +  +     E  + I++E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
             Q  +  + +     +       LV+EY    +   +    K + E  +A V    LQG
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           L YLH   ++IHRD+K  N+L++  G VK+ DFG +    S M   ++FVGT  +M+PE 
Sbjct: 128 LAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEV 182

Query: 238 ISGST---YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           I       YD   D+WSLG+  +E A  + P                L  I ++  P   
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQ 235

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGIL 342
              +S  F +FV +C+QK P+DR +S  LL H F+ +     + + ++
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-69
 Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 9/265 (3%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +     + IG+G+ G V        G+  A++ + +  Q+  ++ I+ E+ + + ++  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPN 78

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V    S+     + +V+EY+  GSL D++ +   + E  +A VC++ LQ L +LH    
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH-SNQ 136

Query: 187 VIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYS 246
           VIHRDIK  N+L+   G VK+TDFG  A +     +R T VGT  +M+PE ++   Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 247 SDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV 306
            DIWSLG++ +E   G  PY+     +       L        P    P++ S  F  F+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRDFL 250

Query: 307 SACIQKDPRDRSSSLDLLSHPFIKK 331
           + C+  D   R S+ +LL H F+K 
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKI 275

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 6e-67
 Identities = 70/269 (26%), Positives = 124/269 (46%), Gaps = 16/269 (5%)

Query: 69  LETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQCSHV 127
           L+    IG+GS   V            A   +Q   + +  R++  +E ++ +  Q  ++
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 128 VVCYHSFY----HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH- 182
           V  Y S+         I LV E M  G+L   +++ K +    L   C+Q+L+GL +LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 183 NERHVIHRDIKPSNLLVNHK-GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
               +IHRD+K  N+ +    G VKI D G++ +  +S       +GT  +M+PE     
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK 188

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            YD S D+++ G+ +LE A   +PY + ++        ++   +     P +      PE
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFDKVAIPE 241

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
               +  CI+++  +R S  DLL+H F +
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  209 bits (534), Expect = 9e-67
 Identities = 70/283 (24%), Positives = 134/283 (47%), Gaps = 26/283 (9%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--------IQEEIRKQIVQELKI 118
           E+ E  +++G+G   VV+   HK   + +A+KII +           +E+R+  ++E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 119 -NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
             + S   +++    ++  N    LV + M +G L D + +  T+ E     + + +L+ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           +  LH + +++HRD+KP N+L++    +K+TDFG S  L     +     GT +Y++PE 
Sbjct: 123 ICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI 180

Query: 238 ISGST------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP 291
           I  S       Y    D+WS G+++     G  P+   +          +L  I+     
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSGNYQ 233

Query: 292 TAPP--DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF 332
              P  D +S      VS  +   P+ R ++ + L+HPF +++
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-65
 Identities = 70/292 (23%), Positives = 138/292 (47%), Gaps = 14/292 (4%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---QEEIRKQIVQELKINQAS 122
           +ED    K++GKGS G V L   K   + FA+K ++ ++    +++   +V++  ++ A 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
           +   +   + +F     +  V+EY++ G L   I+               +++ GL +LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
             + +++RD+K  N+L++  G +KI DFG+         + +TF GT +Y++PE + G  
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           Y++S D WS G+++ E  IG+ P+   +++       EL  +I    P    P     E 
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNPF--YPRWLEKEA 230

Query: 303 CSFVSACIQKDPRDR-SSSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
              +     ++P  R     D+  HP  ++   ++++   +     P V  P
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP 282

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-65
 Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 20/281 (7%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQASQC 124
           ED +  K++G+GS   V L R     R +A+KI++    I+E     + +E  +      
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
              V  Y +F  +  +   L Y   G L   IR++ +  E        +++  L YLH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH-G 126

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGST 242
           + +IHRD+KP N+L+N    ++ITDFG + +L   S   + ++FVGT  Y+SPE ++  +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
              SSD+W+LG ++ +   G  P+    +       Y + + I++       P++F P+ 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD--FPEKFFPKA 237

Query: 303 CSFVSACIQKDPRDRSSS------LDLLSHPFIKKFEDKDI 337
              V   +  D   R           L +HPF +    +++
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  208 bits (529), Expect = 4e-65
 Identities = 63/285 (22%), Positives = 121/285 (42%), Gaps = 15/285 (5%)

Query: 59  EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKI 118
           E   +  L+  +  + +G G+ GVV  V  +  G  FA K +    + + ++ + +E++ 
Sbjct: 18  EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQT 76

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII-RQVKTILEPYLAVVCKQVLQG 177
               +   +V  + +F  +  + ++ E+M  G L + +  +   + E       +QV +G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHK--GEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSP 235
           L ++H E + +H D+KP N++   K   E+K+ DFG++A L           GT  + +P
Sbjct: 137 LCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAP 194

Query: 236 ERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--PPPTA 293
           E   G    Y +D+WS+G++      G  P+    D        E L  +         +
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMDDS 247

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID 338
                S +   F+   +  DP  R +    L HP++        D
Sbjct: 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (516), Expect = 9e-64
 Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 14/278 (5%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +  +   V+G G+   V L   K   +L A+K I     E     +  E+ +    +  +
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH 186
           +V     +   G + L+++ +  G L D I +     E   + +  QVL  + YLH +  
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH-DLG 127

Query: 187 VIHRDIKPSNLLV---NHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
           ++HRD+KP NLL    +   ++ I+DFG+S M         T  GT  Y++PE ++   Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY 186

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP--DQFSPE 301
             + D WS+G++      G  P+    D        +L E I+++      P  D  S  
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEYEFDSPYWDDISDS 239

Query: 302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDL 339
              F+   ++KDP  R +    L HP+I      D ++
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  203 bits (517), Expect = 4e-63
 Identities = 75/297 (25%), Positives = 135/297 (45%), Gaps = 20/297 (6%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQ-----MNIQEEIRKQIVQELKIN 119
           ++ D    ++IG+G  G V   R    G+++A+K +      M   E +       L + 
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
               C  +V   ++F+    +S +L+ M+ G L   + Q     E  +     +++ GL 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERI- 238
           ++H  R V++RD+KP+N+L++  G V+I+D G++        +    VGT+ YM+PE + 
Sbjct: 122 HMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
            G  YD S+D +SLG ++ +   G  P+     Q      +E+    +        PD F
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPF----RQHKTKDKHEIDRMTLTMAVE--LPDSF 232

Query: 299 SPEFCSFVSACIQKDPRDRSSSL-----DLLSHPFIKKFEDKDIDLGILVGSLDPPV 350
           SPE  S +   +Q+D   R   L     ++   PF +  + + + L      L PP 
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  200 bits (509), Expect = 1e-62
 Identities = 73/297 (24%), Positives = 142/297 (47%), Gaps = 20/297 (6%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQA 121
           +SL+D + ++ +G GS G V L+R +  GR +A+K+++    ++ +  +    E  +   
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 122 SQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
                ++  + +F     I ++++Y++ G L  ++R+ +    P       +V   L YL
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 182 HNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGS 241
           H  + +I+RD+KP N+L++  G +KITDFG +  +        T  GT +Y++PE +S  
Sbjct: 121 H-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTK 176

Query: 242 TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE 301
            Y+ S D WS G+++ E   G  P+  S          +  E I+ +      P  F+ +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAELR--FPPFFNED 227

Query: 302 FCSFVSACIQKDPRDRSSSL-----DLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
               +S  I +D   R  +L     D+ +HP+ K+   + +    +    +PP+   
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQG 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-62
 Identities = 58/274 (21%), Positives = 122/274 (44%), Gaps = 17/274 (6%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-IQEEIRKQIVQELKIN 119
           D+E     +   + IG GS G V   +        A+K++ +     +  +    E+ + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGV- 57

Query: 120 QASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV-VCKQVLQG 177
              +  HV ++ +  +     +++V ++ +  SL   +  ++T  E    + + +Q  QG
Sbjct: 58  -LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSP 235
           + YLH  + +IHRD+K +N+ ++    VKI DFG++ +     G  Q +   G+  +M+P
Sbjct: 117 MDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 236 ERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
           E I     + Y + SD+++ G+V+ E   G+ PY    +  +      ++     SP  +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIFMVGRGYLSPDLS 232

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                        ++ C++K   +R     +L+ 
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  200 bits (510), Expect = 3e-62
 Identities = 69/300 (23%), Positives = 125/300 (41%), Gaps = 18/300 (6%)

Query: 41  KGLRLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII 100
           K    I ++   +P + K+       +  + ++ +G G+ GVV     K  GR+F  K I
Sbjct: 6   KFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI 62

Query: 101 QMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK 160
                 + +  +  E+ I        ++  + +F     + L+LE++  G L D I    
Sbjct: 63  NTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121

Query: 161 TIL-EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLV--NHKGEVKITDFGVSAMLG 217
             + E  +    +Q  +GL ++H E  ++H DIKP N++        VKI DFG++  L 
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPS 277
                      T  + +PE +      + +D+W++G++      G  P+   +D      
Sbjct: 181 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----- 234

Query: 278 FYELLEAIVES--PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK 335
             E L+ +               SPE   F+   +QK+PR R +  D L HP++K     
Sbjct: 235 --ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-61
 Identities = 82/296 (27%), Positives = 139/296 (46%), Gaps = 17/296 (5%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN--IQEEIRKQIVQELKINQAS 122
           ++ D + +K++GKG+ G V LVR K  GR +A+KI++    I ++     V E ++ Q +
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
           +   +    ++F  +  +  V+EY + G L   + + +   E        +++  L YLH
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
             R V++RDIK  NL+++  G +KITDFG+     S      TF GT  Y++PE +  + 
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           Y  + D W LG+V+ E   GR P+              L E I+        P   SPE 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHERLFELILMEEIR--FPRTLSPEA 232

Query: 303 CSFVSACIQKDPRDRSSSL-----DLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
            S ++  ++KDP+ R         +++ H F      +D+    L+    P V   
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 288

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-59
 Identities = 55/279 (19%), Positives = 118/279 (42%), Gaps = 21/279 (7%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELK 117
           KE       E     + +G+G  G+V         + +  K +++   +++   + +E+ 
Sbjct: 1   KEL-----YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEIS 53

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQ 176
           I   ++  +++  + SF     + ++ E++    + + I      L E  +     QV +
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 177 GLVYLHNERHVIHRDIKPSNLLVNHKGE--VKITDFGVSAMLGSSMGQRDTFVGTYNYMS 234
            L +LH   ++ H DI+P N++   +    +KI +FG +  L               Y +
Sbjct: 114 ALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYA 171

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES--PPPT 292
           PE         ++D+WSLG +V     G  P++   +Q       +++E I+ +      
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTFDE 224

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
               + S E   FV   + K+ + R ++ + L HP++K+
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 9e-59
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 21/268 (7%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQAS 122
             ++++L+ ++ IGKG  G V L  ++  G   A+K I+    +   +  + E  +    
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQL 57

Query: 123 QCSHVVVCYHSFYH-NGVISLVLEYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLV 179
           + S++V          G + +V EYM +GSL D +R      +    L      V + + 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERIS 239
           YL    + +HRD+   N+LV+     K++DFG++    S+    DT      + +PE + 
Sbjct: 118 YLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALR 173

Query: 240 GSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
              +   SD+WS G+++ E  + GR PY +           +++  + +     AP    
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRVEKGYKMDAPDG-C 225

Query: 299 SPEFCSFVSACIQKDPRDRSSSLDLLSH 326
            P     +  C   D   R S L L   
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  188 bits (479), Expect = 1e-58
 Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 19/275 (6%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQC 124
           +  E  +++G G    V L R   + R  A+K+++ ++        +  +E +   A   
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 125 SHVVVCYHSFYH----NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
             +V  Y +         +  +V+EY+D  +L DI+     +       V     Q L +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 181 LHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML---GSSMGQRDTFVGTYNYMSPER 237
            H +  +IHRD+KP+N++++    VK+ DFG++  +   G+S+ Q    +GT  Y+SPE+
Sbjct: 127 SH-QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIV--ESPPPTAPP 295
             G + D  SD++SLG V+ E   G  P+       +  S   +    V  +  PP+A  
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-------TGDSPVSVAYQHVREDPIPPSARH 238

Query: 296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
           +  S +  + V   + K+P +R  +   +    ++
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 3e-58
 Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 19/269 (7%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKIN-QASQCSHVV--- 128
           +V+G G  G V  + +K     FALK++Q         +  +E++++ +ASQC H+V   
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIV 71

Query: 129 -VCYHSFYHNGVISLVLEYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNER 185
            V  + +     + +V+E +D G L   I+    +   E   + + K + + + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SI 130

Query: 186 HVIHRDIKPSNLLVNH---KGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
           ++ HRD+KP NLL         +K+TDFG +    +S     T   T  Y++PE +    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVLGPEK 189

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           YD S D+WSLG+++     G  P+  +      P     +  + +   P     + S E 
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNPEWSEVSEEV 248

Query: 303 CSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
              +   ++ +P  R +  + ++HP+I +
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-58
 Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 25/285 (8%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN----IQEEIRKQIVQELKINQASQCS 125
           E +  +G+G    V   R K   ++ A+K I++      ++ I +  ++E+K+ Q     
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 126 HVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           +++    +F H   ISLV ++M+      I      +   ++       LQGL YLH + 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QH 119

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-YD 244
            ++HRD+KP+NLL++  G +K+ DFG++   GS        V T  Y +PE + G+  Y 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 245 YSSDIWSLGLVVLECAIGRFPY---------------MQSEDQQSWPSFYELLEAIVESP 289
              D+W++G ++ E  +                    + +  ++ WP    L + +    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 290 PPTAPPDQF----SPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
            P  P          +    +      +P  R ++   L   +  
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 8e-58
 Identities = 81/296 (27%), Positives = 137/296 (46%), Gaps = 20/296 (6%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKII--QMNIQEEIRKQIVQELKINQAS 122
            L+  + IK +G GS G V LV+HK  G  +A+KI+  Q  ++ +  +  + E +I QA 
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 123 QCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
               +V    SF  N  + +V+EY+  G +   +R++    EP+      Q++    YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
               +I+RD+KP NLL++ +G +++TDFG +       G+  T  GT   ++PE I    
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 243 YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF 302
           Y+ + D W+LG+++ E A G  P+   +  Q       + E IV        P  FS + 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR--FPSHFSSDL 265

Query: 303 CSFVSACIQKDPRDRSSSL-----DLLSHPFIKKFEDKDIDLGILVGSLDPPVNCP 353
              +   +Q D   R  +L     D+ +H +    +   I    +     P    P
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGP 321

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 9e-57
 Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 24/299 (8%)

Query: 64  FSLEDL----ETIKVIGKGSGGVVQLVRHKWVGRLFALKII-----QMNIQEEIRKQIVQ 114
           F  E++    +T + +G G   VV+  R K  G  +A K I     + + +   R+ I +
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQV 174
           E+ I +  Q  +V+  +  + +   + L+LE +  G L D + + +++ E       KQ+
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 175 LQGLVYLHNERHVIHRDIKPSNLLVNHKGE----VKITDFGVSAMLGSSMGQRDTFVGTY 230
           L G+ YLH    + H D+KP N+++  +      +KI DFG++  +     +     GT 
Sbjct: 123 LNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTP 180

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP 290
            +++PE ++       +D+WS+G++      G  P++    Q++  +        V    
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-----VNYEF 235

Query: 291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVGSLDPP 349
                   S     F+   + KDP+ R +  D L HP+IK  + +      L  +   P
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ----ALSSAWSHP 290

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 7e-56
 Identities = 79/325 (24%), Positives = 153/325 (47%), Gaps = 21/325 (6%)

Query: 44  RLISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRH---KWVGRLFALKII 100
           +L++ ++E R ++      +  +E+ E +KV+G G+ G V LVR       G+L+A+K++
Sbjct: 1   QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60

Query: 101 ---QMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII 156
               +  + +  +    E ++     Q   +V  +++F     + L+L+Y++ G L   +
Sbjct: 61  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 157 RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
            Q +   E  + +   +++  L +LH +  +I+RDIK  N+L++  G V +TDFG+S   
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 217 GSSMGQR-DTFVGTYNYMSPERISGSTYDYS--SDIWSLGLVVLECAIGRFPYMQSEDQQ 273
            +   +R   F GT  YM+P+ + G    +    D WSLG+++ E   G  P+    ++ 
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

Query: 274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSL-----DLLSHPF 328
              S  E+   I++S PP   P + S      +   + KDP+ R         ++  H F
Sbjct: 240 ---SQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294

Query: 329 IKKFEDKDIDLGILVGSLDPPVNCP 353
            +K    D+    +     P +   
Sbjct: 295 FQKINWDDLAAKKVPAPFKPVIRDE 319

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-55
 Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 44/316 (13%)

Query: 47  SEENESRPSDYKEFDF----EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRL-----FAL 97
           S +NE    D++E+++    EF  E+LE  KV+G G+ G V       + +       A+
Sbjct: 13  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72

Query: 98  KIIQMNIQEEIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII 156
           K+++       R+ ++ ELK+  Q     ++V    +   +G I L+ EY   G L + +
Sbjct: 73  KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132

Query: 157 RQ-----------------------VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIK 193
           R                        +  +    L     QV +G+ +L   +  +HRD+ 
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLA 191

Query: 194 PSNLLVNHKGEVKITDFGVSAML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWS 251
             N+LV H   VKI DFG++  +   S+   R        +M+PE +    Y   SD+WS
Sbjct: 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251

Query: 252 LGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACI 310
            G+++ E  ++G  PY                  ++++      P   + E    + +C 
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVD-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCW 304

Query: 311 QKDPRDRSSSLDLLSH 326
             D R R S  +L S 
Sbjct: 305 AFDSRKRPSFPNLTSF 320

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  180 bits (457), Expect = 3e-55
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 24/288 (8%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQC 124
           +E    ++ IG+G+ GVV   ++   G  FALK I++    E I    ++E+ I +  + 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
           S++V  Y   +    + LV E++D+     +      +          Q+L G+ Y H +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-D 118

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
           R V+HRD+KP NLL+N +GE+KI DFG++   G  + +    + T  Y +P+ + GS  Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 244 DYSSDIWSLGLVVLECAIGRFPY---------------MQSEDQQSWPSFYELLEA---- 284
             + DIWS+G +  E   G   +               + + + ++WP+  EL +     
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 285 -IVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK 331
            + E  P  +            +S  ++ DP  R ++   L H + K+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 7e-55
 Identities = 58/279 (20%), Positives = 114/279 (40%), Gaps = 26/279 (9%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRH--KWVGRLFALKIIQMNI-QEEIRKQIVQELKIN 119
             +LED    K +G G+ G V+   +  K V +  A+KI++       ++ +++ E  + 
Sbjct: 7   LLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV- 61

Query: 120 QASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGL 178
              Q  +  +V            LV+E  + G L   ++Q + + +  +  +  QV  G+
Sbjct: 62  -MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMSP 235
            YL    + +HRD+   N+L+  +   KI+DFG+S  L +       +        + +P
Sbjct: 121 KYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 236 ERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           E I+   +   SD+WS G+++ E  + G+ PY   +         E+   + +      P
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCP 232

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSS---LDLLSHPFIK 330
                 E    ++ C   D  +R         L + +  
Sbjct: 233 AG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 65/279 (23%), Positives = 115/279 (41%), Gaps = 19/279 (6%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQ 114
           +EF  E  +  ++  +VIG G  G V     K  G+     A+K ++    E+ R+  + 
Sbjct: 17  REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76

Query: 115 ELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQ 173
           E  I       +V+        +  + ++ E+M+ GSL   +RQ         L  + + 
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-----FVG 228
           +  G+ YL +  + +HRD+   N+LVN     K++DFG+S  L                 
Sbjct: 137 IAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 229 TYNYMSPERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVE 287
              + +PE I    +  +SD+WS G+V+ E  + G  PY    +Q       +++ AI +
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQ 248

Query: 288 SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                 PP          +  C QKD   R     +++ 
Sbjct: 249 DYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 65/292 (22%), Positives = 129/292 (44%), Gaps = 24/292 (8%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQC 124
           ++  E ++ IG+G+ G V   +++    + ALK +++ +  E +    ++E+ + +  + 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE 184
            ++V  +   + +  ++LV E+ D+            +    +     Q+L+GL + H+ 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119

Query: 185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST-Y 243
           R+V+HRD+KP NLL+N  GE+K+ +FG++   G  +      V T  Y  P+ + G+  Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 244 DYSSDIWSLGLVVLECAIGRFPYMQSED----------------QQSWPSFYELLEAIVE 287
             S D+WS G +  E A    P     D                ++ WPS  +L +    
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 288 SPPPTAP-----PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
              P          + +      +   ++ +P  R S+ + L HP+   F  
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-54
 Identities = 65/263 (24%), Positives = 119/263 (45%), Gaps = 15/263 (5%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
           +DL  +K +G G  GVV+  + +      A+K+I+     E   + ++E K+        
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEK 60

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGLVYLHNER 185
           +V  Y        I ++ EYM  G L + +R+++       L  +CK V + + YL + +
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-K 119

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMSPERISGSTYD 244
             +HRD+   N LVN +G VK++DFG+S  +                +  PE +  S + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 245 YSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFC 303
             SDIW+ G+++ E  ++G+ PY +  +        E  E I +       P   S +  
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLRLY-RPHLASEKVY 231

Query: 304 SFVSACIQKDPRDRSSSLDLLSH 326
           + + +C  +   +R +   LLS+
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-54
 Identities = 60/273 (21%), Positives = 118/273 (43%), Gaps = 18/273 (6%)

Query: 57  YKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQEL 116
           +++ ++E   E L+ ++ +G G  G V +  +       A+K ++           + E 
Sbjct: 4   WED-EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEA 59

Query: 117 KINQASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPY--LAVVCKQ 173
            +    Q  H  +V  ++      I ++ EYM+ GSL D ++    I      L  +  Q
Sbjct: 60  NL--MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML-GSSMGQRDTFVGTYNY 232
           + +G+ ++  ER+ IHRD++ +N+LV+     KI DFG++ ++  +    R+       +
Sbjct: 118 IAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176

Query: 233 MSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT 292
            +PE I+  T+   SD+WS G+++ E                     E+++ +       
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMV 230

Query: 293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
             PD    E    +  C ++ P DR +   L S
Sbjct: 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (451), Expect = 3e-54
 Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 39/299 (13%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQI 112
           K    E+   ++E ++ IG+G+ G V   R   +       + A+K+++     +++   
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 113 VQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAV--- 169
            +E  +       ++V           + L+ EYM  G L + +R +       L+    
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 170 ---------------------VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKIT 208
                                + +QV  G+ YL  ER  +HRD+   N LV     VKI 
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIA 182

Query: 209 DFGVSAMLGSS--MGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPY 266
           DFG+S  + S+              +M PE I  + Y   SD+W+ G+V+ E        
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 267 MQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
                 +      E++  + +     A P+    E  + +  C  K P DR S   +  
Sbjct: 243 YYGMAHE------EVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-54
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 24/292 (8%)

Query: 66  LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQC 124
           +E+ + ++ IG+G+ GVV   R+K  G + ALK I+++ + E +    ++E+ + +    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 125 SHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILE-PYLAVVCKQVLQGLVYLHN 183
            ++V      +    + LV E++ +     +     T +  P +     Q+LQGL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119

Query: 184 ERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTY 243
              V+HRD+KP NLL+N +G +K+ DFG++   G  +      V T  Y +PE + G  Y
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 244 -DYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------------SWPSFYELLEAIVE 287
              + DIWSLG +  E    R  +    +                  WP    + +    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 288 SPPPTAPP-----DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
            P                +  S +S  +  DP  R S+   L+HPF +    
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-54
 Identities = 56/278 (20%), Positives = 110/278 (39%), Gaps = 17/278 (6%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
            +E   E L     +G+G  G V +          A+K ++        +  +QE ++ +
Sbjct: 11  AWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP--EAFLQEAQVMK 67

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGL 178
             +   +V  Y       +  +V EYM +GSL D +     K +  P L  +  Q+  G+
Sbjct: 68  KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-MGQRDTFVGTYNYMSPER 237
            Y+    + +HRD++ +N+LV      K+ DFG++ ++  +    R        + +PE 
Sbjct: 127 AYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
                +   SD+WS G+++ E              +      E+L+ +        PP+ 
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRMPCPPE- 238

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLS--HPFIKKFE 333
                   +  C +K+P +R +   L +    +    E
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 60/279 (21%), Positives = 120/279 (43%), Gaps = 26/279 (9%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
              + D+E    +G G+ G V+   ++        A+K+++   ++   +++++E +I  
Sbjct: 9   NLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-- 62

Query: 121 ASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQGL 178
             Q  +  +V          + LV+E    G L   +   +  +    +A +  QV  G+
Sbjct: 63  MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMSP 235
            YL   ++ +HRD+   N+L+ ++   KI+DFG+S  LG+       R        + +P
Sbjct: 123 KYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 236 ERISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           E I+   +   SD+WS G+ + E  + G+ PY + +         E++  I +      P
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMECP 234

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDL---LSHPFIK 330
           P+   PE  + +S C      DR   L +   +   +  
Sbjct: 235 PE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-52
 Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 28/271 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMN-----IQEEIRKQIVQELKINQASQC 124
           +   ++G G  G V            A+K ++ +      +     ++  E+ + +    
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 125 SH--VVVCYHSFYHNGVISLVLEYMD-RGSLADIIRQVKTILEPYLAVVCKQVLQGLVYL 181
               V+     F       L+LE  +    L D I +   + E        QVL+ + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 182 HNERHVIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISG 240
           H    V+HRDIK  N+L++ ++GE+K+ DFG  A+L  ++     F GT  Y  PE I  
Sbjct: 127 H-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRY 183

Query: 241 STY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFS 299
             Y   S+ +WSLG+++ +   G  P+   E+      F+                 + S
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------------RQRVS 228

Query: 300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIK 330
            E    +  C+   P DR +  ++ +HP+++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 16/272 (5%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHK---WVGRLFALKIIQMNIQEEIRKQIVQELK 117
           D+E   E +E  + IG+G  G V    +          A+K  +    + +R++ +QE  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 118 INQASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVL 175
                Q  H  +V          + +++E    G L   ++  K  L    L +   Q+ 
Sbjct: 61  T--MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT-FVGTYNYMS 234
             L YL   +  +HRDI   N+LV+    VK+ DFG+S  +  S   + +       +M+
Sbjct: 119 TALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           PE I+   +  +SD+W  G+ + E  +      Q           +++  I        P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMP 231

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
           P+   P   S ++ C   DP  R    +L + 
Sbjct: 232 PN-CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (438), Expect = 3e-52
 Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 21/289 (7%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
              + IG GS G + L      G   A+K+  +   +    Q+  E KI +  Q    + 
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIP 66

Query: 130 CYHSFYHNG-VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVI 188
                   G    +V+E +            +      + ++  Q++  + Y+H  ++ I
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFI 125

Query: 189 HRDIKPSNLLVNHKG---EVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMSPERI 238
           HRD+KP N L+        V I DFG++     +         +     GT  Y S    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 239 SGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF 298
            G       D+ SLG V++   +G     Q     +    YE +     S P       +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 299 SPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKK--FEDKDIDLGIL 342
             EF ++++ C      D+   S    L  + F ++    D   D  +L
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-52
 Identities = 65/262 (24%), Positives = 104/262 (39%), Gaps = 13/262 (4%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
            +L  ++ IG G  G+V L          A+K I+     E  +  ++E ++        
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPK 61

Query: 127 VVVCYHSFYHNGVISLVLEYMDRGSLADI-IRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
           +V  Y        I LV E+M+ G L+D    Q        L  +C  V +G+ YL  E 
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EA 120

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS-MGQRDTFVGTYNYMSPERISGSTYD 244
            VIHRD+   N LV     +K++DFG++  +                + SPE  S S Y 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 245 YSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCS 304
             SD+WS G+++ E         ++          E++E I         P   S     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLY-KPRLASTHVYQ 233

Query: 305 FVSACIQKDPRDRSSSLDLLSH 326
            ++ C ++ P DR +   LL  
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 1e-51
 Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 38/304 (12%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQM-NIQEEIRKQIVQELKINQASQ 123
            +   E +  IG+G+ G V   RH+  G+  ALK + M N +E      ++E+KI Q  +
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 124 CSHVVVCYHSFY--------HNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVL 175
             +VV                 G I LV ++ +      +   +       +  V + +L
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 176 QGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG----SSMGQRDTFVGTYN 231
            GL Y+H    ++HRD+K +N+L+   G +K+ DFG++        S   +    V T  
Sbjct: 128 NGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 232 YMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------------SW 275
           Y  PE + G   Y    D+W  G ++ E          + +Q                 W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 276 PSF--------YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHP 327
           P+          EL++                P     +   +  DP  R  S D L+H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 328 FIKK 331
           F   
Sbjct: 307 FFWS 310

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-51
 Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 31/303 (10%)

Query: 52  SRPSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQE 106
           S    Y   ++E + E +   + +G+GS G+V     K V         A+K +      
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 107 EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL--- 163
             R + + E  + +   C HVV             +++E M RG L   +R ++  +   
Sbjct: 65  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124

Query: 164 -------EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML 216
                     +  +  ++  G+ YL+     +HRD+   N +V     VKI DFG++  +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183

Query: 217 GSSMGQR--DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
             +   R     +    +MSPE +    +   SD+WS G+V+ E A       Q    + 
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE- 242

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS------HPF 328
                ++L  ++E       PD         +  C Q +P+ R S L+++S       P 
Sbjct: 243 -----QVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296

Query: 329 IKK 331
            ++
Sbjct: 297 FRE 299

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 71/298 (23%), Positives = 122/298 (40%), Gaps = 31/298 (10%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRH-KWVGRLFALKIIQM-NIQEEIRKQIVQELKI-NQA 121
           + +  E +  IG+G+ G V   R  K  GR  ALK +++   +E +    ++E+ +    
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 122 SQCSH--VVVCYHSFY-----HNGVISLVLEYMDRGSLADI-IRQVKTILEPYLAVVCKQ 173
               H  VV  +             ++LV E++D+     +       +    +  +  Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYM 233
           +L+GL +LH    V+HRD+KP N+LV   G++K+ DFG++ +  S      + V T  Y 
Sbjct: 125 LLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYR 182

Query: 234 SPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------------SWPSF 278
           +PE +  S+Y    D+WS+G +  E    +  +  S D                  WP  
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 279 YELLEAIVES---PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE 333
             L      S    P               +  C+  +P  R S+   LSHP+ +  E
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 3e-51
 Identities = 52/268 (19%), Positives = 106/268 (39%), Gaps = 13/268 (4%)

Query: 61  DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ 120
            +E    D+     +G G  G V     K      A+K ++ +  E   ++ ++E  + +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMK 68

Query: 121 ASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADII--RQVKTILEPYLAVVCKQVLQGL 178
             +  ++V             ++ E+M  G+L D +     + +    L  +  Q+   +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 179 VYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV-GTYNYMSPER 237
            YL  +++ IHRD+   N LV     VK+ DFG+S ++                + +PE 
Sbjct: 129 EYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
           ++ + +   SD+W+ G+++ E A          D          +  ++E       P+ 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEG 240

Query: 298 FSPEFCSFVSACIQKDPRDRSSSLDLLS 325
              +    + AC Q +P DR S  ++  
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-51
 Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 32/292 (10%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF--ALKIIQMNIQEEIRKQ 111
           P+ Y   D+     D++   VIG+G+ G V   R K  G     A+K ++    ++  + 
Sbjct: 1   PTIYPVLDWN----DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 112 IVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQ------------ 158
              EL++  +     +++    +  H G + L +EY   G+L D +R+            
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 159 ----VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA 214
                 T+    L      V +G+ YL  ++  IHRD+   N+LV      KI DFG+ +
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGL-S 174

Query: 215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
                  ++        +M+ E ++ S Y  +SD+WS G+++ E                
Sbjct: 175 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 233

Query: 275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                EL E + +      P +    E    +  C ++ P +R S   +L  
Sbjct: 234 -----ELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 1e-50
 Identities = 59/273 (21%), Positives = 111/273 (40%), Gaps = 21/273 (7%)

Query: 65  SLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNI--QEEIRKQIVQELKIN 119
             +DL  ++ +G GS GVV+              A+K ++ ++  Q E     ++E+   
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA- 64

Query: 120 QASQCSHV-VVCYHSFYHNGVISLVLEYMDRGSLADII-RQVKTILEPYLAVVCKQVLQG 177
                 H  ++  +       + +V E    GSL D + +     L   L+    QV +G
Sbjct: 65  -MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ---RDTFVGTYNYMS 234
           + YL   +  IHRD+   NLL+  +  VKI DFG+   L  +      ++     + + +
Sbjct: 124 MGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 235 PERISGSTYDYSSDIWSLGLVVLE-CAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA 293
           PE +   T+ ++SD W  G+ + E    G+ P++            ++L  I +      
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGERLP 235

Query: 294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
            P+    +  + +  C    P DR + + L   
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 62/270 (22%), Positives = 104/270 (38%), Gaps = 16/270 (5%)

Query: 64  FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLF----ALKIIQMNIQEEIRKQIVQELKIN 119
               + + IKV+G G+ G V        G       A+K ++     +  K+I+ E  + 
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 120 QASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLV 179
            +    HV         + V  +         L  +      I   YL   C Q+ +G+ 
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 180 YLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT--FVGTYNYMSPER 237
           YL + R ++HRD+   N+LV     VKITDFG++ +LG+   +           +M+ E 
Sbjct: 126 YLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 238 ISGSTYDYSSDIWSLGLVVLEC-AIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD 296
           I    Y + SD+WS G+ V E    G  PY      +        + +I+E       P 
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERLPQPP 236

Query: 297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
             + +    +  C   D   R    +L+  
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 5e-50
 Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 16/271 (5%)

Query: 63  EFSLEDLETIKVIGKGSGGVVQLVRHK----WVGRLFALKIIQMNIQEEIRKQIVQELKI 118
           E     +   KVIG G  G V     K          A+K ++    E+ R   + E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 119 NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTIL-EPYLAVVCKQVLQG 177
                  +++           + ++ EYM+ G+L   +R+         L  + + +  G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF---VGTYNYMS 234
           + YL N  + +HRD+   N+LVN     K++DFG+S +L        T         + +
Sbjct: 123 MKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 235 PERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP 294
           PE IS   +  +SD+WS G+V+ E                     E+++AI +      P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFRLPTP 235

Query: 295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS 325
            D         +  C Q++   R    D++S
Sbjct: 236 MD-CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  168 bits (425), Expect = 5e-50
 Identities = 59/325 (18%), Positives = 135/325 (41%), Gaps = 47/325 (14%)

Query: 44  RLISEENESRPSDYKEFDFE----FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKI 99
           R+ ++ N  RP +Y +++       + +D + ++ +G+G    V    +        +KI
Sbjct: 8   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 67

Query: 100 IQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH---NGVISLVLEYMDRGSLADII 156
           ++       +K+I +E+KI +  +    ++          +   +LV E+++      + 
Sbjct: 68  LK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123

Query: 157 RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAM 215
              +T+ +  +     ++L+ L Y H    ++HRD+KP N++++H+  ++++ D+G++  
Sbjct: 124 ---QTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 216 LGSSMGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS 274
                 + +  V +  +  PE +     YDYS D+WSLG ++      + P+    D   
Sbjct: 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 275 -------------------------WPSFYELLEAIV----ESPPPTAPPDQFSPEFCSF 305
                                     P F ++L        E    +      SPE   F
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 306 VSACIQKDPRDRSSSLDLLSHPFIK 330
           +   ++ D + R ++ + + HP+  
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPYFY 323

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-50
 Identities = 57/293 (19%), Positives = 109/293 (37%), Gaps = 33/293 (11%)

Query: 58  KEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEIRKQI 112
            +  +EF    L   K +G G+ G V       +         A+K+++ +     R+ +
Sbjct: 14  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73

Query: 113 VQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK----------- 160
           + ELK+ +      ++V    +    G   ++ EY   G L + +R+ +           
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 161 -------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVS 213
                   +    L     QV +G+ +L   ++ IHRD+   N+L+ H    KI DFG++
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 214 AML--GSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSED 271
             +   S+   +        +M+PE I    Y + SD+WS G+ + E             
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 272 QQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
             S          +++       P+    E    +  C   DP  R +   ++
Sbjct: 253 VDSK------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  166 bits (421), Expect = 9e-50
 Identities = 51/277 (18%), Positives = 97/277 (35%), Gaps = 19/277 (6%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVV 129
           +  + IG+GS GV+    +    +  A+K           +   +  K+   + C+ +  
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL--LAGCTGIPN 65

Query: 130 CYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIH 189
            Y+         LV++ +       +    +      +A+  KQ+L  +  +H E+ +++
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVY 124

Query: 190 RDIKPSNLLVN-----HKGEVKITDFGVSAMLGSSMG-------QRDTFVGTYNYMSPER 237
           RDIKP N L+      +   + + DFG+       +        ++    GT  YMS   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 238 ISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ 297
             G       D+ +LG V +    G  P+ Q     +    YE +    +S P       
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELCAG 243

Query: 298 FSPEFCSFVSACIQKDPRDR---SSSLDLLSHPFIKK 331
           F  EF  ++                   L S    + 
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-49
 Identities = 57/299 (19%), Positives = 119/299 (39%), Gaps = 37/299 (12%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR-------LFALKIIQMNIQE 106
           P D +   +E   + L   K +G+G+ G V L     + +         A+K+++ +  E
Sbjct: 3   PEDPR---WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59

Query: 107 EIRKQIVQELKI-NQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVK----- 160
           +    ++ E+++     +  +++    +   +G + +++EY  +G+L + ++  +     
Sbjct: 60  KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119

Query: 161 -----------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITD 209
                       +    L     QV +G+ YL   +  IHRD+   N+LV     +KI D
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIAD 178

Query: 210 FGVSAMLGSSMGQRDTFV--GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYM 267
           FG++  +      + T        +M+PE +    Y + SD+WS G+++ E         
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 268 QSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                +      EL + + E      P +  + E    +  C    P  R +   L+  
Sbjct: 239 PGVPVE------ELFKLLKEGHRMDKPSN-CTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 58/297 (19%), Positives = 117/297 (39%), Gaps = 32/297 (10%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV- 128
             +  IG+G+ G+V            A+K I     +   ++ ++E+KI    +  +++ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 129 ---VCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNER 185
              +             ++ ++    L  +++  + +   ++     Q+L+GL Y+H   
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH-SA 128

Query: 186 HVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS---MGQRDTFVGTYNYMSPERISGST 242
           +V+HRD+KPSNLL+N   ++KI DFG++ +        G    +V T  Y +PE +  S 
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188

Query: 243 -YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE-------------- 287
            Y  S DIWS+G ++ E    R  +              +L +  +              
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248

Query: 288 --------SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD 336
                     P          +    +   +  +P  R      L+HP+++++ D  
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 72/316 (22%), Positives = 121/316 (38%), Gaps = 43/316 (13%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIV 113
           P   +E  +          KVIG GS GVV   +    G L A+K +  +     ++   
Sbjct: 14  PDRPQEVSYTD-------TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKN 61

Query: 114 QELKINQASQCSHVVVCYHSFYHNG------VISLVLEYMDRGSLADI---IRQVKTILE 164
           +EL+I +     ++V   + FY +G       ++LVL+Y+            R  +T+  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 165 PYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEV-KITDFGVSAMLGSSMGQR 223
            Y+ +   Q+ + L Y+H    + HRDIKP NLL++    V K+ DFG +  L       
Sbjct: 122 IYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180

Query: 224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ---------- 273
                 Y          + Y  S D+WS G V+ E  +G+  +                 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 274 ---------SWPSFYEL-LEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDL 323
                      P++ E     I   P       +  PE  +  S  ++  P  R + L+ 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 324 LSHPFIKKFEDKDIDL 339
            +H F  +  D ++ L
Sbjct: 301 CAHSFFDELRDPNVKL 316

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-47
 Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 34/298 (11%)

Query: 54  PSDYKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWV-----GRLFALKIIQMNIQEEI 108
           P D  ++  EF  + L+  K +G+G+ G V       +      R  A+K+++       
Sbjct: 2   PYDASKW--EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 109 RKQIVQELKINQASQCSHVVVCYHSFYH--NGVISLVLEYMDRGSLADIIRQVKTILEPY 166
            + ++ ELKI         VV          G + +++E+   G+L+  +R  +    PY
Sbjct: 60  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 167 ----------------LAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDF 210
                           L     QV +G+ +L   R  IHRD+   N+L++ K  VKI DF
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDF 178

Query: 211 GVSAMLGS--SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQ 268
           G++  +       ++        +M+PE I    Y   SD+WS G+++ E          
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238

Query: 269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
                            ++       PD  +PE    +  C   +P  R +  +L+ H
Sbjct: 239 GVKIDEE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 67/295 (22%), Positives = 122/295 (41%), Gaps = 36/295 (12%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVV 128
             ++ +G G+ G V        G   A+K +    Q E   K+  +EL++ +  +  +V+
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 129 VCYHSFYHNGVIS------LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLH 182
                F  +  +       LV+ +M  G+    + + + + E  +  +  Q+L+GL Y+H
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 183 NERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGST 242
               +IHRD+KP NL VN   E+KI DFG++    S M     +V T  Y +PE I    
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWM 194

Query: 243 -YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAI---------------- 285
            Y  + DIWS+G ++ E   G+  +  S+         ++                    
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 286 ------VESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED 334
                 +E     +     SP   + +   +  D   R ++ + L+HP+ +   D
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 9e-45
 Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 46/320 (14%)

Query: 56  DYKEFDFEFS-LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIV 113
             +  D  F+ L+  + +K IG G+ G+V       + R  A+K +    Q +   K+  
Sbjct: 5   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64

Query: 114 QELKINQASQCSHVVVCYHSFYHNGV------ISLVLEYMDRGSLADIIRQVKTILEPYL 167
           +EL + +     +++   + F           + LV+E MD      I  ++       +
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERM 121

Query: 168 AVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFV 227
           + +  Q+L G+ +LH+    IHRD+KPSN++V     +KI DFG++   G+S      +V
Sbjct: 122 SYLLYQMLCGIKHLHSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 179

Query: 228 GTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ-------------- 273
            T  Y +PE I G  Y  + DIWS+G ++ E    +  +   +                 
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239

Query: 274 -SWPSFYELLEAIVESPPPTAP------------------PDQFSPEFCSFVSACIQKDP 314
                    +   VE+ P  A                       + +    +S  +  DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 315 RDRSSSLDLLSHPFIKKFED 334
             R S  D L HP+I  + D
Sbjct: 300 AKRISVDDALQHPYINVWYD 319

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 43/294 (14%)

Query: 67  EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSH 126
             +   + IGKG  G V   + +  G   A+KI     +    +    E +I Q     H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFR----EAEIYQTVMLRH 56

Query: 127 ------VVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVY 180
                 +            + LV +Y + GSL D + +  T+    +  +      GL +
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAH 115

Query: 181 LHNE-------RHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD----TFVGT 229
           LH E         + HRD+K  N+LV   G   I D G++    S+    D      VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 230 YNYMSPERISGS------TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSW-------- 275
             YM+PE +  S           +DI+++GLV  E A         ED Q          
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 276 PSFYELLEAIVE-----SPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLL 324
           PS  E+ + + E     + P      +        +  C   +   R ++L + 
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 54/290 (18%), Positives = 102/290 (35%), Gaps = 17/290 (5%)

Query: 46  ISEENESRPSDYKEFDFEFSLEDLETIKVIGKGSGGVV---QLVRHKWVGRLFALKIIQM 102
           +S  N       +      S   +   +VIG+G  G V    L+ +       A+K +  
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65

Query: 103 NIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGVISLVLEYMDRGSLADIIRQVKT 161
                   Q + E  I +     +V+          G   +VL YM  G L + IR    
Sbjct: 66  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125

Query: 162 ILEPYLAV-VCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM 220
                  +    QV +G+ +L + +  +HRD+   N +++ K  VK+ DFG++  +    
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184

Query: 221 GQRDTF----VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWP 276
                          +M+ E +    +   SD+WS G+++ E      P     +     
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--- 241

Query: 277 SFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH 326
              ++   +++       P+         +  C       R S  +L+S 
Sbjct: 242 ---DITVYLLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-43
 Identities = 69/316 (21%), Positives = 126/316 (39%), Gaps = 37/316 (11%)

Query: 53  RPSDYK----EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEI 108
           RP+ Y+    +  +E   E  + +  +G G+ G V        G   A+K +    Q  I
Sbjct: 1   RPTFYRQELNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 109 -RKQIVQELKINQASQCSHVVVCYHSFYHNGVI----SLVLEYMDRGSLADIIRQVKTIL 163
             K+  +EL++ +  +  +V+     F     +     + L     G+  + I + + + 
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119

Query: 164 EPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQR 223
           + ++  +  Q+L+GL Y+H    +IHRD+KPSNL VN   E+KI DFG++      M   
Sbjct: 120 DDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--- 175

Query: 224 DTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQ--------- 273
             +V T  Y +PE +     Y+ + DIWS+G ++ E   GR  +  ++            
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 274 ------SWPSFYELLEAIVESPPPTAPPDQF-------SPEFCSFVSACIQKDPRDRSSS 320
                                     P   F       +P     +   +  D   R ++
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 321 LDLLSHPFIKKFEDKD 336
              L+H +  ++ D D
Sbjct: 296 AQALAHAYFAQYHDPD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 5e-37
 Identities = 63/326 (19%), Positives = 120/326 (36%), Gaps = 62/326 (19%)

Query: 70  ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ--------- 120
             ++ +G G    V L +        A+KI++ +  +   +    E+K+ Q         
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 121 --ASQCSHVVVCYHSFYHNGVISLVLEYMD-----RGSLADIIRQVKTILEPYLAVVCKQ 173
             +   +H++     F H G   + +  +               + + I   Y+  + KQ
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 174 VLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT---FVGTY 230
           +L GL Y+H    +IH DIKP N+L+      +       A LG++    +     + T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 231 NYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVE--- 287
            Y SPE + G+ +   +DIWS   ++ E   G F + + ++  S+    + +  I+E   
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIELLG 252

Query: 288 SPPPTAP-------------------------------------PDQFSPEFCSFVSACI 310
             P                                             + E   F+S  +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 311 QKDPRDRSSSLDLLSHPFIKKFEDKD 336
           Q DPR R+ +  L++HP++K     +
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 3e-19
 Identities = 28/204 (13%), Positives = 61/204 (29%), Gaps = 36/204 (17%)

Query: 73  KVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE---------------EIRKQIVQELK 117
           K++G+G    V     +       +K  ++                    +        +
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 118 INQASQCSHVVVCYHSFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQG 177
                +   + V     +      +++E +D         ++  +       V   +L+ 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNA--VLMELIDAK-------ELYRVRVENPDEVLDMILEE 115

Query: 178 LVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTFVGTYNYMSPER 237
           +   +  R ++H D+   N+LV  +  + I DF  S  +G    +               
Sbjct: 116 VAKFY-HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE------ILERDVRN 167

Query: 238 IS---GSTYDYSSDIWSLGLVVLE 258
           I      TY    DI S    +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	354
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.03
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.93
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.54

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-66  Score=456.67  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=225.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++.....+..+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46899999999999999999999999999999999876555556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC--cCCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS--MGQR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~  223 (354)
                      ||+||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....  ....
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99999999999887889999999999999999999998 99999999999999999999999999999876432  2234


Q ss_pred             cccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ...+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......      ..................+++++
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCCCCccccCCHHH
Confidence            55689999999999998876 578999999999999999999997655432      22233344444444456789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                      .+||.+||+.||++|||++|+++||||++--.+
T Consensus       237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         237 LALLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            999999999999999999999999999865443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-65  Score=449.33  Aligned_cols=256  Identities=32%  Similarity=0.507  Sum_probs=228.0

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ++.++|++.+.||+|+||+||+|+++.+++.||+|++.+...  ....+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            457899999999999999999999999999999999875432  223567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +|||||+||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|......  
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999999999999998999999999999999999999998 99999999999999999999999999999876543  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..       +....+.....  ..+..++++
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~  230 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVEF--TFPDFVTEG  230 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC--CCCTTSCHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC--CCCccCCHH
Confidence            334568999999999999999999999999999999999999999765432       44455554433  345678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      +.+||.+||++||++|||++|+++||||+.
T Consensus       231 ~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         231 ARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-66  Score=467.73  Aligned_cols=280  Identities=41%  Similarity=0.739  Sum_probs=240.9

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      ++..++|++++.||+|+||+||+|+++.+|+.||+|+++..........+.+|+.+++.++|||||++++++.+++.+|+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45578999999999999999999999999999999999876666667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++||+|.+++.+.+.+++..+..++.||+.||.|||+.+||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~  159 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  159 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--T
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--c
Confidence            99999999999999998999999999999999999999997248999999999999999999999999999876432  3


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC----------------------------
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS----------------------------  274 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------------------------  274 (354)
                      ..+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            3457999999999999999999999999999999999999999976543210                            


Q ss_pred             -------hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccccccccc
Q 018532          275 -------WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDIDLGILVG  344 (354)
Q Consensus       275 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~~~~~~~  344 (354)
                             .....+....+....++......++.++.+||.+||+.||++|||++|+|+||||++..++.++...|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~~~~  316 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC  316 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccHHHHHH
Confidence                   0011223333444444444445678999999999999999999999999999999999988888766654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-64  Score=459.87  Aligned_cols=275  Identities=29%  Similarity=0.513  Sum_probs=242.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +++++|++++.||+|+||+||+|+++.+|+.||||++++...  .+..+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            467899999999999999999999999999999999976532  233567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999999999999999999999999999999998 9999999999999999999999999999998766555


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..       ++.+.+.....  ..+..+|++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~  231 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcCCC--CCCccCCHH
Confidence            666789999999999999999999999999999999999999999876543       44455555443  346679999


Q ss_pred             HHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCC
Q 018532          302 FCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDP  348 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~  348 (354)
                      +.+||.+||++||++|++     ++|+++||||+.+.+.++......+|+.|
T Consensus       232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P  283 (337)
T d1o6la_         232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCC
Confidence            999999999999999995     89999999999988766654444444443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-64  Score=452.35  Aligned_cols=258  Identities=31%  Similarity=0.564  Sum_probs=227.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            5799999999999999999999999999999999765432 246689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      |+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+............
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            999999998776 679999999999999999999998 999999999999999999999999999999876655556677


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFV  306 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  306 (354)
                      +||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..      ..+........+....+..+++++.+||
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence            8999999999999999999999999999999999999999765432      1222233334444455677999999999


Q ss_pred             HHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          307 SACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       307 ~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .+||+.||++|||++|+|+||||+...
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999998643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-64  Score=448.68  Aligned_cols=264  Identities=27%  Similarity=0.465  Sum_probs=230.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLV  143 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv  143 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++...  ....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999975432  23346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc--C
Q 018532          144 LEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM--G  221 (354)
Q Consensus       144 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~  221 (354)
                      ||||+||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++++|.+||+|||+|+......  .
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999998999999999999999999999998 999999999999999999999999999998775432  2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..       ++...+.....  ..+..++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~  236 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIKLEY--DFPEKFFPK  236 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC--CCCTTCCHH
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHcCCC--CCCccCCHH
Confidence            334568999999999999999999999999999999999999999865432       44555555543  345679999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHH------HhcCccccccccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLD------LLSHPFIKKFEDKDIDL  339 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~e------il~hp~~~~~~~~~~~~  339 (354)
                      +.+||.+||++||++|||++|      +++||||+.+.+.++..
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence            999999999999999999987      68899999999888764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-64  Score=442.50  Aligned_cols=255  Identities=30%  Similarity=0.494  Sum_probs=212.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee--cCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH--NGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~l  142 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++... .+...+.+.+|+++++.++|||||++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999997654 45556789999999999999999999998864  467899


Q ss_pred             EEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceecCCCCCCEEEccCCcEEEeecccc
Q 018532          143 VLEYMDRGSLADIIRQV----KTILEPYLAVVCKQVLQGLVYLHNERH-----VIHRDIKPSNLLVNHKGEVKITDFGVS  213 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg~a  213 (354)
                      |||||+||+|.+++.+.    +.+++..++.++.||+.||.|||+ +|     |+||||||+|||++.++.+||+|||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998643    579999999999999999999998 54     999999999999999999999999999


Q ss_pred             cccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          214 AMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       214 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      +............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..       ++...+.....+ .
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~-~  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFR-R  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCC-C
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCC-C
Confidence            98766555556778999999999999999999999999999999999999999765432       344555554433 3


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFI  329 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~  329 (354)
                      .+..+|+++.+||.+||+.||++|||++|+++|||+
T Consensus       234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            456799999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-63  Score=449.31  Aligned_cols=275  Identities=27%  Similarity=0.510  Sum_probs=239.4

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      +++++|++++.||+|+||+||+|+++.+|+.||||+++....  ....+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            357899999999999999999999999999999999975432  223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      +|||||+||+|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999999999999998999999999999999999999998 99999999999999999999999999999887543  


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                       ..+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..       +....+.....  ..+..++++
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~  227 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAEL--RFPPFFNED  227 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCC--CCCTTSCHH
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCCC--CCCCCCCHH
Confidence             33568999999999999999999999999999999999999999775433       44555555433  335678999


Q ss_pred             HHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          302 FCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +.++|.+||.+||++|+     |++++++||||+.+.+..+......+|+.|++.
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~  282 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ  282 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcC
Confidence            99999999999999996     899999999999998776544444455555543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-64  Score=446.21  Aligned_cols=259  Identities=32%  Similarity=0.578  Sum_probs=224.6

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      +.|++++.||+|+||+||+|+++.+|+.||+|+++.... +..+.+.+|+.+++.++|||||++++++.+++.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            468999999999999999999999999999999976533 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCcc
Q 018532          147 MDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDT  225 (354)
Q Consensus       147 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  225 (354)
                      |+||+|.+++.+. +.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|...........+
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            9999999997764 569999999999999999999998 99999999999999999999999999999876544334456


Q ss_pred             cccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC-CCCCCCCCCCC
Q 018532          226 FVGTYNYMSPERIS-----GSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES-PPPTAPPDQFS  299 (354)
Q Consensus       226 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  299 (354)
                      .+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.+..+       .+..+... .+....+..++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~s  242 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWS  242 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCCCccccCC
Confidence            78999999999984     4568999999999999999999999998765542       33334433 33344456789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          300 PEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       300 ~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      +++.+||.+||+.||++|||++|+++||||+.-..
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~  277 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN  277 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            99999999999999999999999999999986443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-63  Score=447.38  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=210.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35699999999999999999999999999999999876555555678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc---cCCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN---HKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||+||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||++.   +++.+||+|||+|+..... ..
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~  165 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SV  165 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Ce
Confidence            99999999999988899999999999999999999998 9999999999999995   4789999999999876543 33


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  300 (354)
                      ..+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+....       +....+.......  .....+|+
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  238 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEYEFDSPYWDDISD  238 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCCCCCCccccCCCH
Confidence            44568999999999999999999999999999999999999999765433       3445555544332  33457899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++.+||.+||++||++|||++|+++||||+..
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999854

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-62  Score=435.22  Aligned_cols=251  Identities=27%  Similarity=0.457  Sum_probs=219.4

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee----cCeEEEEE
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH----NGVISLVL  144 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~  144 (354)
                      ++.++||+|+||+||+|++..+++.||+|++.... .....+.+.+|+++++.++|||||++++++.+    ...+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55668999999999999999999999999987543 45556789999999999999999999999875    35689999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceecCCCCCCEEEc-cCCcEEEeecccccccCCCcC
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERH--VIHRDIKPSNLLVN-HKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||++||+|.+++.+.+.+++..+..++.||+.||.|||+ ++  |+||||||+|||++ +++.+||+|||+|+....  .
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--C
Confidence            999999999999998999999999999999999999998 77  99999999999996 578999999999986543  2


Q ss_pred             CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          222 QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ...+.+||+.|||||++.+ .++.++|||||||++|||++|+.||.+..+.      .++.+.+..+..+...+..++++
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccCccCCHH
Confidence            3446689999999999876 5999999999999999999999999765432      24455555555555556678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      +.+||.+||++||++|||++|+|+||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-62  Score=442.35  Aligned_cols=255  Identities=30%  Similarity=0.492  Sum_probs=225.8

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +.|+.++.||+|+||+||+|++..+|+.||||+++...  ..+..+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999999999999999997653  3455677999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |||.+|+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.....    ..
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~  169 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN  169 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence            999999998888877899999999999999999999998 9999999999999999999999999999986543    23


Q ss_pred             ccccCCcccccccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          225 TFVGTYNYMSPERISG---STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      ..+||+.|||||++.+   +.|+.++|||||||++|||++|..||.+....       +.+..+.....+...+..+|++
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~s~~  242 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEY  242 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSCTTSCHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCCCCCCCCCHH
Confidence            4689999999999864   45899999999999999999999999765432       3444555555555556779999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      +.+||.+||+.||++|||++|+|+||||.+..
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-62  Score=447.77  Aligned_cols=274  Identities=28%  Similarity=0.445  Sum_probs=238.2

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++...  ....+.+.+|+++++.++|||||++++++...+.+++
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            35899999999999999999999999999999999875432  2234668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|+.....   
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            99999999999999998999999999999999999999998 99999999999999999999999999999887543   


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ..+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..       .....+......  .+..+++++
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~  265 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR--FPSHFSSDL  265 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--CCTTCCHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHHhcCCCC--CCccCCHHH
Confidence            34568999999999999999999999999999999999999999765432       444555555432  356799999


Q ss_pred             HHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          303 CSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      .+||.+||++||.+|+     |++++++||||+...+..+......+|+-|...
T Consensus       266 ~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~  319 (350)
T d1rdqe_         266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK  319 (350)
T ss_dssp             HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             HHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence            9999999999999995     899999999999988766654444455555443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-61  Score=446.59  Aligned_cols=276  Identities=26%  Similarity=0.453  Sum_probs=231.5

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-----HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-----EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      ++++|++.+.||+|+||+||+|+++.+|+.||||++.+...     .........++.+++.++|||||++++++.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            57899999999999999999999999999999999865321     1112223345677788899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      +|+|||||+||+|.+++.+...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999877543


Q ss_pred             cCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCC
Q 018532          220 MGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQF  298 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (354)
                        .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.....    ..++....  .......+..+
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~--~~~~~~~~~~~  232 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMT--LTMAVELPDSF  232 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHS--SSCCCCCCSSS
T ss_pred             --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhc--ccCCCCCCCCC
Confidence              3345689999999999975 468999999999999999999999998755432    12222222  22334446679


Q ss_pred             CHHHHHHHHHhhhhCCCCCCC-----HHHHhcCccccccccccccccccccCCCCC
Q 018532          299 SPEFCSFVSACIQKDPRDRSS-----SLDLLSHPFIKKFEDKDIDLGILVGSLDPP  349 (354)
Q Consensus       299 ~~~l~~li~~~l~~~p~~Rps-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  349 (354)
                      ++++.+||.+||++||++|||     ++|+++||||+.+.+..+......+|+-|+
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~  288 (364)
T d1omwa3         233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP  288 (364)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCC
Confidence            999999999999999999999     799999999999988776554444454443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-62  Score=445.01  Aligned_cols=263  Identities=25%  Similarity=0.472  Sum_probs=229.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc--HHHHHHHHHHHHHH-hhcCCCceEEeeeeeeecCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ--EEIRKQIVQELKIN-QASQCSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~-~~l~h~~iv~~~~~~~~~~~~~l  142 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++...  .+....+..|..++ +.++|||||++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            3689999999999999999999999999999999975431  22234556666655 46899999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||||++||+|.+++.....+++.++..++.||+.||.|||+ +||+||||||+|||++++|++||+|||+|+........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999999999999998999999999999999999999998 89999999999999999999999999999877665556


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..       ++...+....+  ..+..+|+++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~--~~p~~~s~~~  230 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNP--FYPRWLEKEA  230 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CCCTTSCHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC--CCCccCCHHH
Confidence            66678999999999999999999999999999999999999999876543       44455554433  3456789999


Q ss_pred             HHHHHHhhhhCCCCCCCHH-HHhcCcccccccccccc
Q 018532          303 CSFVSACIQKDPRDRSSSL-DLLSHPFIKKFEDKDID  338 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~-eil~hp~~~~~~~~~~~  338 (354)
                      .+||.+||+.||++|||+. ++++||||+.+++....
T Consensus       231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~  267 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE  267 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred             HHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence            9999999999999999995 89999999988765543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-62  Score=436.91  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=225.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++++....     ...+.+.+|+.+++.++|||||++++++.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999999999999999999754321     23567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC----cEEEeecccccccC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG----EVKITDFGVSAMLG  217 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~  217 (354)
                      +|||||+||+|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+||+++.++    .+||+|||+|....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999998999999999999999999999998 9999999999999998876    59999999998775


Q ss_pred             CCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APP  295 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  295 (354)
                      .. ....+..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..       +....+.......  ..+
T Consensus       169 ~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         169 FG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             TS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCCCCCHHHH
T ss_pred             CC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCCCCCchhc
Confidence            44 3344568999999999999999999999999999999999999999876543       3444454443322  223


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ..+|+++.+||.+||+.||++|||++|+++||||+...+...
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            578999999999999999999999999999999998776554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9e-62  Score=444.35  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=227.7

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5789999999999999999999999999999999976543 345778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc--CCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH--KGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||+||+|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.  ++.+||+|||+|+..... ..
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~  181 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QS  181 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cc
Confidence            9999999999854 4679999999999999999999998 99999999999999964  578999999999877543 33


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  300 (354)
                      .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..       +.+..+......  ......+++
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCCH
Confidence            44568999999999999999999999999999999999999999766433       344444444332  223356899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKD  336 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~  336 (354)
                      ++.+||.+||++||++|||++|+|+||||+......
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence            999999999999999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-61  Score=441.65  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=225.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46799999999999999999999999999999999765433 34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEc--cCCcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVN--HKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||+||+|.+++... ..+++.+++.++.||+.||.|||+ +||+||||||+|||++  .++.+||+|||+|...... ..
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~  184 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  184 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence            99999999887654 469999999999999999999998 9999999999999998  5789999999999887643 33


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC--CCCCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP--PTAPPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  300 (354)
                      .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..       +.+..+.....  +......+++
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCCH
Confidence            44568999999999999999999999999999999999999999776543       34444444433  3334467999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++.+||.+||++||++|||++|+|+||||+..
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-60  Score=422.60  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=225.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--------cHHHHHHHHHHHHHHhhcC-CCceEEeeeeeee
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--------QEEIRKQIVQELKINQASQ-CSHVVVCYHSFYH  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~  136 (354)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++..        .....+.+.+|+.+++.++ |+||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999997643        1234567889999999997 9999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ++.+|+||||++||+|.++++..+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+|+..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999998999999999999999999999998 99999999999999999999999999999887


Q ss_pred             CCCcCCCcccccCCcccccccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC
Q 018532          217 GSSMGQRDTFVGTYNYMSPERISG------STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP  290 (354)
Q Consensus       217 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  290 (354)
                      .... .....+||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.+..       +....+..+..
T Consensus       161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~~~~  232 (277)
T d1phka_         161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSGNY  232 (277)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC
T ss_pred             cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHhCCC
Confidence            6543 3345689999999999853      34788999999999999999999999876543       33444444433


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          291 --PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       291 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                        +......+|+++.+||.+||++||++|||++|+++||||++.
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence              222334799999999999999999999999999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-60  Score=428.79  Aligned_cols=256  Identities=20%  Similarity=0.363  Sum_probs=223.8

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.....  ...+.+|+.+++.++|+|||++++++.+++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57899999999999999999999999999999999765433  3568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccC--CcEEEeecccccccCCCcCC
Q 018532          146 YMDRGSLADIIRQVK-TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHK--GEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||+||+|.+++...+ .+++.+++.++.||+.||.|||+ .||+||||||+|||++.+  +.+||+|||++...... ..
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence            999999999998765 79999999999999999999998 999999999999999854  48999999999876543 33


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--CCCCCCCH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--APPDQFSP  300 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  300 (354)
                      .....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..       +....+.......  .....+++
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCChhhccCCCH
Confidence            44568999999999999999999999999999999999999999876543       3445555443322  12246899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          301 EFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       301 ~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      ++.+||.+||.+||++|||++|+++||||++.
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-60  Score=425.82  Aligned_cols=258  Identities=23%  Similarity=0.376  Sum_probs=213.0

Q ss_pred             ccccccccCceEEEEEEEccCCcEEEEEEeeccccH----HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEec
Q 018532           71 TIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE----EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEY  146 (354)
Q Consensus        71 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~  146 (354)
                      .+++||+|+||+||+|+++.+|+.||||+++.....    ...+.+.+|+.+++.++|+|||++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999999999999999998754322    2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCccc
Q 018532          147 MDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRDTF  226 (354)
Q Consensus       147 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  226 (354)
                      +.++++..+......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.............
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9988777776666789999999999999999999998 999999999999999999999999999998877665566667


Q ss_pred             ccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC-------------
Q 018532          227 VGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT-------------  292 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  292 (354)
                      +||+.|+|||++.+. .|+.++|||||||++|||++|..||.+..+.+....+   .+ ........             
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~-~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FE-TLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-HHCCCCTTTSSSTTSSTTCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HH-hcCCCChhhccchhccchhhh
Confidence            899999999998754 5899999999999999999999999876544211111   11 11110000             


Q ss_pred             ----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          293 ----------APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       293 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                                .....+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                      00125688999999999999999999999999999998644

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=419.69  Aligned_cols=265  Identities=26%  Similarity=0.478  Sum_probs=217.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-EIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +++|++++.||+|+||+||+|++..+|+.||||+++..... .....+.+|+++++.++|+|||++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            36899999999999999999999999999999999755432 33567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCC
Q 018532          145 EYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  222 (354)
                      ||+.+ ++.+++..  .+.+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|.........
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            99976 55555543  3569999999999999999999998 99999999999999999999999999999888766666


Q ss_pred             CcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC----------
Q 018532          223 RDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP----------  291 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------  291 (354)
                      .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+.   +.............          
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccccccc
Confidence            66778999999999987766 57899999999999999999999987654321   11111111000000          


Q ss_pred             --CC-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          292 --TA-----------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       292 --~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                        ..           ....+++++.+||.+||+.||++|||++|+++||||+++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence              00           012567899999999999999999999999999999887553

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-59  Score=423.20  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=219.1

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCc-----EEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR-----LFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSF  134 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~  134 (354)
                      .|++..++|++.+.||+|+||+||+|++..+++     .||+|.+...........+.+|+.++..+ +|||||++++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            467888999999999999999999999876554     69999987665566667889999999887 899999999999


Q ss_pred             eecCeEEEEEeccCCCCHHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          135 YHNGVISLVLEYMDRGSLADIIRQVK-----------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       135 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                      .+.+.+++|||||++|+|.++++..+                       .+++..+..++.||+.||.|||+ +||+|||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence            99999999999999999999997542                       47889999999999999999998 8999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCcCC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSMGQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQ  268 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  268 (354)
                      |||+||+++.++.+||+|||+|+........  ..+..||+.|||||++.+..++.++|||||||++|||+| |..||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322  234578999999999999999999999999999999997 8999987


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ....       +.+..+.........+..+++++.+||.+||+.||++|||++||++|
T Consensus       270 ~~~~-------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVD-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCS-------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHH-------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6544       22333444444555667899999999999999999999999999976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-59  Score=414.28  Aligned_cols=260  Identities=20%  Similarity=0.328  Sum_probs=222.1

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      .|++..++|++.+.||+|+||+||+|+++.+++.||||+++.+...  .+.+.+|+.+++.++|||||++++++.+++.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3788889999999999999999999999999999999998765432  35689999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++|||||++|+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999999999999764  568999999999999999999998 8999999999999999999999999999987654


Q ss_pred             CcCC-CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          219 SMGQ-RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       219 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .... .....||+.|+|||++.+..|+.++|||||||++|||++|..||....+.      .++.+.+.. ......+..
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~-~~~~~~~~~  240 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEK-DYRMERPEG  240 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHT-TCCCCCCTT
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhc-CCCCCCCcc
Confidence            3322 23346899999999999999999999999999999999977766443322      133333333 334455678


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +++++.+||.+||+.||++|||++|+++  +|+.+
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            9999999999999999999999999965  45443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=410.93  Aligned_cols=255  Identities=20%  Similarity=0.364  Sum_probs=209.8

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCe
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGV  139 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  139 (354)
                      +|++..++|++.+.||+|+||+||+|+.+   ..||||+++... ..+..+.+.+|+.+++.++|||||++++++. ++.
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            57888899999999999999999999753   359999987543 3445678999999999999999999998754 567


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          140 ISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      +++|||||+||+|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            89999999999999999765 569999999999999999999998 8999999999999999999999999999987653


Q ss_pred             Cc--CCCcccccCCcccccccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCC---
Q 018532          219 SM--GQRDTFVGTYNYMSPERISGS---TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPP---  290 (354)
Q Consensus       219 ~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  290 (354)
                      ..  .......||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+.....      .....+..+..   
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~  230 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPD  230 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCC
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCc
Confidence            22  233456899999999999653   48999999999999999999999997765431      22222222222   


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          291 PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       291 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ....+..+++++.+||.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            223456789999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-59  Score=425.73  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             cccccccc-cccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-hcCCCceEEeeeeeee----cCe
Q 018532           66 LEDLETIK-VIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQ-ASQCSHVVVCYHSFYH----NGV  139 (354)
Q Consensus        66 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~----~~~  139 (354)
                      .++|.++. .||+|+||+||+|++..+++.||||+++..      ..+.+|+.++. ..+|||||+++++|.+    +..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            57898875 599999999999999999999999999753      34567888765 4589999999999876    467


Q ss_pred             EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeeccccc
Q 018532          140 ISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVSA  214 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~  214 (354)
                      +|+|||||+||+|.+++.+.  ..+++.+++.++.||+.||.|||+ +||+||||||+|||++.   ++.+||+|||+|+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence            99999999999999999874  368999999999999999999998 99999999999999986   4579999999998


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC--
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT--  292 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  292 (354)
                      ..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+........   .+...+.......  
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         163 ETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYEFPN  238 (335)
T ss_dssp             ECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT
T ss_pred             eccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCCCCCC
Confidence            77554 33455689999999999999999999999999999999999999997765442211   1111121121111  


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      .....+|+++.+||.+||+.||++|||+.|+++||||++.
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            1123579999999999999999999999999999999754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-58  Score=412.06  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=211.6

Q ss_pred             cccccCcccccccccccccCceEEEEEEEccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGR---LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH  136 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  136 (354)
                      |..++..++|++.+.||+|+||+||+|+++.+++   .||||.+.........+.+.+|+.+++.++|||||++++++..
T Consensus        19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            3445667889999999999999999999987764   5899998777777777889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ++.+++|||||++|+|.+++... +.+++.++..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceE
Confidence            99999999999999999988874 568999999999999999999998 9999999999999999999999999999987


Q ss_pred             cCCCcCC-----CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCC
Q 018532          216 LGSSMGQ-----RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESP  289 (354)
Q Consensus       216 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  289 (354)
                      .......     .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....       ++...+..+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~~~~~i~~~~  250 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQDY  250 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC
Confidence            6543221     122457999999999999999999999999999999998 89999766543       4445555443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          290 PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       290 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      . ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       251 ~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         251 R-LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             C-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3 33456799999999999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-59  Score=411.18  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=213.9

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhhcC--CCceEEeeeeeeecCe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQE-----EIRKQIVQELKINQASQ--CSHVVVCYHSFYHNGV  139 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~  139 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.....     .....+.+|+.+++.++  |+|||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999999999999999998754211     11234668999999886  8999999999999999


Q ss_pred             EEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-CCcEEEeecccccccC
Q 018532          140 ISLVLEYMDR-GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-KGEVKITDFGVSAMLG  217 (354)
Q Consensus       140 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~  217 (354)
                      .++||||+.+ +++.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 6888999888899999999999999999999998 99999999999999985 4799999999998764


Q ss_pred             CCcCCCcccccCCcccccccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCC
Q 018532          218 SSMGQRDTFVGTYNYMSPERISGSTY-DYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPD  296 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (354)
                      ..  ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+             .+....  ...+.
T Consensus       163 ~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~--~~~~~  225 (273)
T d1xwsa_         163 DT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ--VFFRQ  225 (273)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC--CCCSS
T ss_pred             cc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc--cCCCC
Confidence            43  3345689999999999987765 567999999999999999999996431             122222  23456


Q ss_pred             CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          297 QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       297 ~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                      .+|+++.+||.+||+.||++|||++|+++||||++..
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            7899999999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=405.67  Aligned_cols=261  Identities=23%  Similarity=0.369  Sum_probs=218.9

Q ss_pred             ccccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           59 EFDFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        59 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      .-+|++..++|++.+.||+|+||+||+|+++ ++..||||+++.....  .+.+.+|+.+++.++|+|||++++++. ++
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-QE   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence            3457788899999999999999999999986 6788999999754332  356899999999999999999999765 45


Q ss_pred             eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          139 VISLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      .+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+|+..
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEc
Confidence            679999999999999977543  369999999999999999999998 99999999999999999999999999999877


Q ss_pred             CCCc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          217 GSSM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       217 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+||..|+......      .+....+..+. ....+
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~-~~~~p  232 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGY-RMVRP  232 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-CCCCC
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC-CCCCc
Confidence            5432 2334457899999999999889999999999999999999965554333221      23444554443 33446


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhc--Cccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLS--HPFIKK  331 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~--hp~~~~  331 (354)
                      ..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            789999999999999999999999999998  788853

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-58  Score=412.16  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=213.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +++|+++++||+|+||+||+|+++ +|+.||||+++.... +...+.+.+|+.+++.++|+||+++++.+.+++..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            468999999999999999999986 889999999976532 333567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      |++.++.+..+.+..+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||.|...........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999887777777767889999999999999999999998 8999999999999999999999999999988766555555


Q ss_pred             ccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--------------
Q 018532          225 TFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP--------------  289 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  289 (354)
                      ...|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...   ..........              
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCChhhccchhhhhhcc
Confidence            66799999999999765 47899999999999999999999997665432111   1111110000              


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          290 ---------PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       290 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                               +.......+++++.+||++||++||++|||+.|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     001113457889999999999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=405.17  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=219.3

Q ss_pred             cCccccccccc-ccccCceEEEEEEEcc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKV-IGKGSGGVVQLVRHKW--VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||||+++........+.+.+|+++++.++|||||++++++.. +.+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            34567777774 9999999999998764  4557999999877777777889999999999999999999998864 568


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          141 SLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      |+||||+++|+|.+++... +.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+|+.....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999998654 579999999999999999999998 99999999999999999999999999999877543


Q ss_pred             c---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCC
Q 018532          220 M---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPP  295 (354)
Q Consensus       220 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (354)
                      .   .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....       ++...+..+.. ...+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~-~~~p  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR-MECP  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCC-CCCC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC-CCCC
Confidence            2   22334578999999999999999999999999999999998 99999876533       34445554443 3445


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHH---hcCcccccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDL---LSHPFIKKF  332 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~ei---l~hp~~~~~  332 (354)
                      ..+|+++.+||.+||+.||++|||+.++   |+|+|+.-.
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            6899999999999999999999999888   568887543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=411.87  Aligned_cols=281  Identities=26%  Similarity=0.457  Sum_probs=235.6

Q ss_pred             CcccccccccccccCceEEEEEEE---ccCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhhcCC-CceEEeeeeeeec
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRH---KWVGRLFALKIIQMNI---QEEIRKQIVQELKINQASQC-SHVVVCYHSFYHN  137 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~  137 (354)
                      .+++|++++.||+|+||+||+|++   +.+|+.||||++++..   .....+.+.+|+.+++.++| +||+++++.+.+.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            468899999999999999999987   4478999999986532   22234567899999999977 7999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          138 GVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..++++|||+.+|+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||+|....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999999999999999999999999999999999998 899999999999999999999999999998764


Q ss_pred             CC-cCCCcccccCCcccccccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          218 SS-MGQRDTFVGTYNYMSPERISGS--TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       218 ~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      .. ........|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+....+....   +........+  ..
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~~--~~  255 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSEP--PY  255 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCCC--CC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCCC--CC
Confidence            33 2334556899999999999765  468899999999999999999999987766544332   3333333322  23


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCC-----CHHHHhcCccccccccccccccccccCCCCCCC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRS-----SSLDLLSHPFIKKFEDKDIDLGILVGSLDPPVN  351 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  351 (354)
                      +..+++++.+||.+||++||++||     |++|+++||||+.+.+.........+|+-|-..
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~  317 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR  317 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence            457899999999999999999999     489999999999988877776666666666443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=404.72  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=208.9

Q ss_pred             ccccccCceEEEEEEEc--cCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEeccCC
Q 018532           73 KVIGKGSGGVVQLVRHK--WVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLEYMDR  149 (354)
Q Consensus        73 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  149 (354)
                      ++||+|+||+||+|.+.  .+++.||||+++... .....+.+.+|+.+++.++|||||++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999864  356789999997543 33456789999999999999999999998854 567899999999


Q ss_pred             CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC---CCccc
Q 018532          150 GSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG---QRDTF  226 (354)
Q Consensus       150 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~  226 (354)
                      |+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.......   .....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999998899999999999999999999998 8999999999999999999999999999987654322   22345


Q ss_pred             ccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 018532          227 VGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSF  305 (354)
Q Consensus       227 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  305 (354)
                      .||+.|||||++.+..++.++|||||||++|||+| |+.||.+....       ++...+..+. ....+..+|+++.+|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~-~~~~p~~~~~~~~~l  242 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE-RMGCPAGCPREMYDL  242 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCcccCHHHHHH
Confidence            78999999999999999999999999999999998 89999875432       3444444443 344566899999999


Q ss_pred             HHHhhhhCCCCCCCHHHHh---cCcccccc
Q 018532          306 VSACIQKDPRDRSSSLDLL---SHPFIKKF  332 (354)
Q Consensus       306 i~~~l~~~p~~Rps~~eil---~hp~~~~~  332 (354)
                      |.+||+.||++|||+++++   +|+|++-+
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence            9999999999999999984   56666544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-57  Score=402.95  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=212.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC----eE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG----VI  140 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~  140 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.+.  ..+....+.+|+.+++.++||||+++++.+...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999999999999999997654  3456678999999999999999999999988654    48


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          141 SLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      |+||||++|++|.+++...+.+++.++..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||.+.......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            9999999999999999998999999999999999999999998 999999999999999999999999999987654332


Q ss_pred             ---CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC--CCCC
Q 018532          221 ---GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP--TAPP  295 (354)
Q Consensus       221 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  295 (354)
                         ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..       +.........+.  ....
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCGGGTS
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCCCchhc
Confidence               2344568999999999999999999999999999999999999999765432       233333333222  2334


Q ss_pred             CCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccc
Q 018532          296 DQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIK  330 (354)
Q Consensus       296 ~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~  330 (354)
                      ..+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            67899999999999999999999555556677765

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=409.88  Aligned_cols=265  Identities=25%  Similarity=0.378  Sum_probs=210.8

Q ss_pred             cccccccccccccCceEEEEEEEccC-CcEEEEEEeeccccH-HHHHHHHHHHHHHhh---cCCCceEEeeeeeee----
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWV-GRLFALKIIQMNIQE-EIRKQIVQELKINQA---SQCSHVVVCYHSFYH----  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~---l~h~~iv~~~~~~~~----  136 (354)
                      .++|++++.||+|+||+||+|++..+ ++.||||+++..... .....+.+|+.+++.   .+||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999766 677999998754322 122335566666655   489999999998853    


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          137 -NGVISLVLEYMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       137 -~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                       ...++++|||++++.+...... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence             3578999999988666544433 3568999999999999999999998 999999999999999999999999999988


Q ss_pred             ccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcC------
Q 018532          215 MLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVES------  288 (354)
Q Consensus       215 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  288 (354)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....   +.......      
T Consensus       165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCGGGSC
T ss_pred             hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCchhccc
Confidence            65433 334566899999999999999999999999999999999999999987654322111   11111000      


Q ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          289 ---------------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       289 ---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                                     .........+++.+.+||.+||++||++|||++|+|+||||+.++.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence                           00011234678999999999999999999999999999999988653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=399.38  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=203.3

Q ss_pred             CcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           65 SLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        65 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      ..++|++.+.||+|+||+||+|++. ++..||||+++.....  .+.+.+|+.+++.++|||||++++++..++.+++||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            3468899999999999999999986 5778999999764432  356899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-C
Q 018532          145 EYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-Q  222 (354)
Q Consensus       145 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~  222 (354)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....... .
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998765 568899999999999999999998 9999999999999999999999999999987654322 2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPE  301 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (354)
                      .....||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....       .++...+..+. ....+..++++
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~-~~~~p~~~~~~  230 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGF-RLYKPRLASTH  230 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHHHHHHTC-CCCCCTTSCHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHhcC-CCCCccccCHH
Confidence            2345789999999999999999999999999999999995 555544332       23344444443 33345678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          302 FCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       302 l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +.+||.+||+.||++|||++|+++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=393.58  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=217.4

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEEe
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      .++|++.++||+|+||+||+|+++ +++.||||+++.....  .+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            468899999999999999999985 7889999999865432  3568999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC-CC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG-QR  223 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~  223 (354)
                      |+++|+|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||+|+....... ..
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            99999999997654 678999999999999999999998 8999999999999999999999999999986644322 23


Q ss_pred             cccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          224 DTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       224 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....       ++...+..+. ....+..+++++
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~~-~~~~p~~~~~~l  230 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGL-RLYRPHLASEKV  230 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTC-CCCCCTTCCHHH
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhCC-CCCCcccccHHH
Confidence            34578999999999999999999999999999999998 89999776543       4455555543 344567899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+||.+||+.||++|||++++++|
T Consensus       231 ~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         231 YTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-57  Score=399.24  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=211.3

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWV---GRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN  137 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~  137 (354)
                      +|++..++|++.+.||+|+||+||+|++..+   +..||||.++........+.+.+|+.+++.++|||||++++++. +
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            4778889999999999999999999998654   35699999877666777788999999999999999999999885 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          138 GVISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       138 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      +.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+|+..
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhheec
Confidence            6789999999999999987664 568999999999999999999998 99999999999999999999999999999876


Q ss_pred             CCCcC-CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          217 GSSMG-QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       217 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....       ++...+..+.. ...
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------~~~~~i~~~~~-~~~  230 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGER-LPM  230 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTCC-CCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC-CCC
Confidence            54322 2334578999999999999999999999999999999998 89999876654       33444444433 345


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +..+|+++.+||.+||+.||++|||+.||++|
T Consensus       231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            66899999999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=396.58  Aligned_cols=255  Identities=23%  Similarity=0.301  Sum_probs=210.0

Q ss_pred             ccCcccccccccccccCceEEEEEEEccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           63 EFSLEDLETIKVIGKGSGGVVQLVRHKWVG----RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        63 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      ++..+.|++.+.||+|+||+||+|.++.++    ..||||+++.....+....+.+|+.+++.++|+|||++++++.+.+
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            445677889999999999999999987654    4799999987777777778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      ..++||||+.++++.+++... +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999999988765 579999999999999999999998 999999999999999999999999999998764


Q ss_pred             CCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          218 SSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       218 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|..|+......      .++...+..+. ....
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~-~~~~  234 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGF-RLPT  234 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC-CCCC
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccC-CCCC
Confidence            4322   223346899999999999999999999999999999999976665433221      23444554443 3344


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      +..++.++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            5679999999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=398.91  Aligned_cols=264  Identities=23%  Similarity=0.390  Sum_probs=224.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEEEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVISLVL  144 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~  144 (354)
                      +++|++++.||+|+||+||+|++..+|+.||||+++... .......+.+|+.+++.++|+||+++++.+.+....++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            368999999999999999999999999999999997654 3345678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcCCCc
Q 018532          145 EYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMGQRD  224 (354)
Q Consensus       145 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  224 (354)
                      +++.+++|..++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.|...........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            999999999998888899999999999999999999998 9999999999999999999999999999998876665666


Q ss_pred             ccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCC--------------
Q 018532          225 TFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESP--------------  289 (354)
Q Consensus       225 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  289 (354)
                      ...+++.|+|||++.+.. ++.++|||||||++|||++|+.||....+..   .............              
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH---HHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            667889999999988765 6899999999999999999999975443321   1111111111111              


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccc
Q 018532          290 ----------PPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFE  333 (354)
Q Consensus       290 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~  333 (354)
                                ........+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      01112245688999999999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=397.08  Aligned_cols=260  Identities=21%  Similarity=0.346  Sum_probs=213.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeE
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~  140 (354)
                      +|+++.++|++.+.||+|+||+||+|+++.+ ..||||+++.....  .+.+.+|+.+++.++|+|||++++++. ++.+
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~   86 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   86 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence            4677889999999999999999999998755 56999999755432  356899999999999999999999885 4567


Q ss_pred             EEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||||+++|+|..++..  .+.+++.++..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            899999999999998864  3579999999999999999999998 8999999999999999999999999999987643


Q ss_pred             Cc-CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          219 SM-GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       219 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|..||......      .+.+..+..... ...+..
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~-~~~~~~  238 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYR-MPCPPE  238 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCC-CCCCTT
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCC-CCCCcc
Confidence            32 2233457899999999999999999999999999999999976665443322      244455554433 335668


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhc--Ccccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLS--HPFIKKF  332 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~--hp~~~~~  332 (354)
                      +++++.+||.+||+.||++|||+++|++  ++||...
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999999999999988  8888654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=399.64  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=207.2

Q ss_pred             cccccCcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      ..|++..++|++.+.||+|+||+||+|.+..     +++.||||+++........+.+.+|..++..+ +|+||+.+++.
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3467788999999999999999999999754     44689999998766666667778888777665 68899999988


Q ss_pred             eeec-CeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCC
Q 018532          134 FYHN-GVISLVLEYMDRGSLADIIRQVK----------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSN  196 (354)
Q Consensus       134 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~N  196 (354)
                      +... +.+++|||||++|+|.++++..+                .+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~N  164 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARN  164 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccc
Confidence            7654 57899999999999999997542                37899999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCC
Q 018532          197 LLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQ  273 (354)
Q Consensus       197 Ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~  273 (354)
                      ||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+....+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987644322  23456799999999999999999999999999999999986 56786654431


Q ss_pred             ChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          274 SWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                            .....+..+ .....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       245 ------~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 ------EFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             ------HHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHhcC-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                  222333333 3344567799999999999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=407.89  Aligned_cols=264  Identities=25%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG------  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------  138 (354)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+.+|+.+++.++|+|||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999999999999999997543 4455678999999999999999999999987654      


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+||||+ +.+|..+++. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceeccCC
Confidence            579999999 5678777654 789999999999999999999998 9999999999999999999999999999987654


Q ss_pred             CcCCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH----------------
Q 018532          219 SMGQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL----------------  281 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------  281 (354)
                      .   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+...........                
T Consensus       174 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         174 E---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             S---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             c---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence            3   3456899999999998775 5789999999999999999999999876543211111100                


Q ss_pred             ----HHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          282 ----LEAIVES--PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       282 ----~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                          .......  .........+++++.+||.+||+.||++|||+.|+|+||||+.+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                0000000  00011234678999999999999999999999999999999987653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=400.73  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=209.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhhcCCCceEEeeeeeee--------
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-EEIRKQIVQELKINQASQCSHVVVCYHSFYH--------  136 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--------  136 (354)
                      .++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+++.++|+|++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            6899999999999999999999999999999999865432 2344668899999999999999999998754        


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccccccc
Q 018532          137 NGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAML  216 (354)
Q Consensus       137 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  216 (354)
                      ++.+++||||+.++.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            45689999999887666665566789999999999999999999998 99999999999999999999999999999766


Q ss_pred             CCCc----CCCcccccCCcccccccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCC
Q 018532          217 GSSM----GQRDTFVGTYNYMSPERISGS-TYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPP  291 (354)
Q Consensus       217 ~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  291 (354)
                      ....    ....+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+..    ..............
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~  243 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSITP  243 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCT
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHhcCCCCh
Confidence            4322    223445799999999999865 68999999999999999999999997655432    11222222222111


Q ss_pred             CCCCC---------------------------CCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccc
Q 018532          292 TAPPD---------------------------QFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKK  331 (354)
Q Consensus       292 ~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~  331 (354)
                      .....                           ..++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            11000                           12677899999999999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-56  Score=408.32  Aligned_cols=264  Identities=26%  Similarity=0.388  Sum_probs=209.7

Q ss_pred             cccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec------CeEE
Q 018532           68 DLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHN------GVIS  141 (354)
Q Consensus        68 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~~~~  141 (354)
                      +|..+++||+|+||+||+|+++.+|+.||||+++....     ...+|+.+++.++|+||+++++++...      .+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            68889999999999999999999999999999976432     234799999999999999999988643      3589


Q ss_pred             EEEeccCCCCHHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccC
Q 018532          142 LVLEYMDRGSLADII---RQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLG  217 (354)
Q Consensus       142 lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  217 (354)
                      +|||||+++.+..+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999999865333332   233579999999999999999999998 9999999999999999775 89999999998765


Q ss_pred             CCcCCCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHH--------HHHHHHc-
Q 018532          218 SSMGQRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYE--------LLEAIVE-  287 (354)
Q Consensus       218 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~-  287 (354)
                      .. ....+.+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+..        ....... 
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            43 33445689999999998876 4689999999999999999999999977654321111110        0000000 


Q ss_pred             ---CCCC--------CCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccccccc
Q 018532          288 ---SPPP--------TAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDID  338 (354)
Q Consensus       288 ---~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~~  338 (354)
                         ...+        ......+++++.+||.+||+.||++|||+.|+|+||||+++.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  315 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  315 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCC
Confidence               0000        01123578999999999999999999999999999999998776543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=402.97  Aligned_cols=266  Identities=21%  Similarity=0.327  Sum_probs=212.5

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC-----eEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG-----VIS  141 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~  141 (354)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+.+++.++|+||+++++.+....     .++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            569999999999999999999999999999999987666667788999999999999999999999987643     355


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC
Q 018532          142 LVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      ++ +++.||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|........
T Consensus        88 l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          88 LV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            55 55568899999976 579999999999999999999998 9999999999999999999999999999987643322


Q ss_pred             ---CCcccccCCcccccccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH----------------
Q 018532          222 ---QRDTFVGTYNYMSPERISG-STYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL----------------  281 (354)
Q Consensus       222 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------  281 (354)
                         .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.............                
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence               2345679999999999855 45789999999999999999999999776532211111000                


Q ss_pred             -HHHHHcCCCCC-----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccc
Q 018532          282 -LEAIVESPPPT-----APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDK  335 (354)
Q Consensus       282 -~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~  335 (354)
                       ...........     .....+++++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence             00011110000     0123578899999999999999999999999999999976554

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-55  Score=394.35  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=222.4

Q ss_pred             ccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeee
Q 018532           61 DFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFY  135 (354)
Q Consensus        61 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  135 (354)
                      ++++..++|++.+.||+|+||+||+|+.+     .+++.||||+++.....+..+.+.+|+.+++.++|+||+++++.+.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            46677889999999999999999999975     3567899999987777777788999999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecC
Q 018532          136 HNGVISLVLEYMDRGSLADIIRQVK------------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRD  191 (354)
Q Consensus       136 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~D  191 (354)
                      ..+..+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||+ .+|+|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence            9999999999999999999997532                        37888999999999999999998 9999999


Q ss_pred             CCCCCEEEccCCcEEEeecccccccCCCc--CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCC
Q 018532          192 IKPSNLLVNHKGEVKITDFGVSAMLGSSM--GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR-FPYMQ  268 (354)
Q Consensus       192 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~  268 (354)
                      |||+|||++.++.+||+|||+|+......  ....+..||+.|+|||.+.+..|+.++|||||||++|||++|. .||.+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998654332  2233567899999999999999999999999999999999986 57766


Q ss_pred             CCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          269 SEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      .+..       +....+..+. ....+..+++++.+||.+||+.||++|||+.||++  +++++
T Consensus       246 ~~~~-------e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i  299 (301)
T d1lufa_         246 MAHE-------EVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  299 (301)
T ss_dssp             SCHH-------HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             CCHH-------HHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence            5443       4455555554 34456689999999999999999999999999954  44443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=397.84  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=206.9

Q ss_pred             cccccccccccccCceEEEEEEEccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecCeEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGR----LFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNGVIS  141 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~  141 (354)
                      .++|++++.||+|+||+||+|.+..+|+    .||+|.++.....+..+.+.+|+.+++.++|||||++++++.++ ..+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            3579999999999999999999988876    57888886655555667899999999999999999999998764 567


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCc
Q 018532          142 LVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSM  220 (354)
Q Consensus       142 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  220 (354)
                      +++|++.+++|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            888999999999988765 578999999999999999999998 899999999999999999999999999998765433


Q ss_pred             CC--CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          221 GQ--RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       221 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      ..  .....||+.|+|||++.++.|+.++|||||||++|||+| |..||.+....       ++...+..+. ....+..
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~~~~-~~~~p~~  237 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGE-RLPQPPI  237 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHHHTC-CCCCCTT
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCcc
Confidence            22  233468999999999999999999999999999999998 88999776543       2233333333 2334567


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      +++++.+||.+||+.||++|||+.|+++|
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=395.46  Aligned_cols=260  Identities=20%  Similarity=0.376  Sum_probs=211.6

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeee--cCeEEE
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYH--NGVISL  142 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~--~~~~~l  142 (354)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++...    .+.+.+|+.+++.++ |+||+++++.+..  ...+++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            478999999999999999999999999999999987543    345788999999985 9999999999874  457999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCC-cEEEeecccccccCCCcC
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKG-EVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  221 (354)
                      ||||+.+++|..+.   +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|...... .
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~  184 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q  184 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence            99999999987653   579999999999999999999998 9999999999999998765 6999999999876544 3


Q ss_pred             CCcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC-hhhHHHHH------HHHHcC-----
Q 018532          222 QRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS-WPSFYELL------EAIVES-----  288 (354)
Q Consensus       222 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~------~~~~~~-----  288 (354)
                      .....++|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||....+... ...+....      ......     
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            345568999999999988754 79999999999999999999999976554211 00111000      000000     


Q ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          289 -----------------PPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       289 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                                       .........+++++.+||++||++||++|||++|+|+||||+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                             0011112347889999999999999999999999999999998765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=384.49  Aligned_cols=252  Identities=25%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cCeE
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGVI  140 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~  140 (354)
                      |+++.++|++.+.||+|+||.||+|+.+  |..||||+++.+.   ..+.+.+|+.+++.++||||+++++++.+ .+.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            7888999999999999999999999974  7889999997643   23568899999999999999999998854 5678


Q ss_pred             EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          141 SLVLEYMDRGSLADIIRQV--KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.+|.+||+|||+++....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999999999764  358999999999999999999998 8999999999999999999999999999987543


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCC
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQ  297 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (354)
                      .   .....+|+.|+|||++.+..++.++|||||||++|||+| |++||......       ++...+..+. .+..+..
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~~~~i~~~~-~~~~~~~  224 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGY-KMDAPDG  224 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTTC-CCCCCTT
T ss_pred             C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCcc
Confidence            3   234478999999999999999999999999999999998 78888765443       2333443333 3344667


Q ss_pred             CCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccc
Q 018532          298 FSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKF  332 (354)
Q Consensus       298 ~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~  332 (354)
                      +++++.+||.+||+.||++|||+.+++++  ++++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~--L~~i  257 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHI  257 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHH
Confidence            89999999999999999999999999874  4444

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=390.49  Aligned_cols=266  Identities=24%  Similarity=0.377  Sum_probs=226.6

Q ss_pred             CcccccccCcccccccccccccCceEEEEEEEcc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEee
Q 018532           57 YKEFDFEFSLEDLETIKVIGKGSGGVVQLVRHKW-----VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCY  131 (354)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  131 (354)
                      |-+.+|++..++|++.+.||+|+||+||+|.+..     ++..||||+++..........+.+|+.+++.++|+||++++
T Consensus        10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            3344688889999999999999999999998753     45789999998766666677899999999999999999999


Q ss_pred             eeeeecCeEEEEEeccCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc
Q 018532          132 HSFYHNGVISLVLEYMDRGSLADIIRQV----------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH  201 (354)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~  201 (354)
                      +.+..++..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC
Confidence            9999999999999999999999998753          236888999999999999999998 89999999999999999


Q ss_pred             CCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCcCCChhhH
Q 018532          202 KGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIG-RFPYMQSEDQQSWPSF  278 (354)
Q Consensus       202 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~  278 (354)
                      ++++||+|||+|+.......  ......||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+....      
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------  242 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------  242 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999987654322  22334789999999999999999999999999999999998 4777655433      


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc------Cccccc
Q 018532          279 YELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS------HPFIKK  331 (354)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~------hp~~~~  331 (354)
                       +....+..+.. ...+..+++.+.+||.+||+.||++|||+.++++      +|+|++
T Consensus       243 -~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         243 -QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             -HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             -HHHHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence             44455555443 4445679999999999999999999999999998      566553

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=385.32  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=206.1

Q ss_pred             cCcccccccccccccCceEEEEEEEccC-C--cEEEEEEeeccc--cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWV-G--RLFALKIIQMNI--QEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG  138 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  138 (354)
                      +..++|++++.||+|+||+||+|+...+ +  ..||||+++...  ..+..+.+.+|+.+++.++|+||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            3457899999999999999999986533 3  368999987543  23445779999999999999999999999865 5


Q ss_pred             eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccC
Q 018532          139 VISLVLEYMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLG  217 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  217 (354)
                      .+++||||+++|++.+++... +.+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            678999999999999887654 579999999999999999999998 899999999999999999999999999999875


Q ss_pred             CCcC---CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCChhhHHHHHHHHHcCCCCCC
Q 018532          218 SSMG---QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQSWPSFYELLEAIVESPPPTA  293 (354)
Q Consensus       218 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (354)
                      ....   ......||..|+|||++.+..++.++|||||||++|||+| |..||.+.+..       +....+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGERLP  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCCCCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhCCCCCC
Confidence            4322   2233467889999999999999999999999999999998 89999766543       45566666665566


Q ss_pred             CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          294 PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       294 ~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .+..+|+++.+||.+||+.||++|||+.+|++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67789999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=387.82  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=216.3

Q ss_pred             cccCcccccccccccccCceEEEEEEEccCC-------cEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           62 FEFSLEDLETIKVIGKGSGGVVQLVRHKWVG-------RLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        62 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      |++..++|++.+.||+|+||.||+|++..++       ..||||+++..........+.+|...+..+ +|+|||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            7788899999999999999999999976554       479999998877777778888998888777 89999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCE
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNL  197 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NI  197 (354)
                      +.+++.+++||||+++|+|.+++...                ..+++.++..++.||+.||.|||+ .+|+||||||+||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~Ni  166 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  166 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccce
Confidence            99999999999999999999999754                248999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcCCC
Q 018532          198 LVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQQS  274 (354)
Q Consensus       198 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  274 (354)
                      |++.++.+||+|||++........  ......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+....  
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence            999999999999999987754332  2344578999999999999999999999999999999998 78888765432  


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          275 WPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                           ++...+..+ .....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       245 -----~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 -----ELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             -----HHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                 344444444 344556789999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=391.04  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=212.7

Q ss_pred             cCcccccccccccccCceEEEEEEEccCCcE--EEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeeeeeecCeE
Q 018532           64 FSLEDLETIKVIGKGSGGVVQLVRHKWVGRL--FALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHSFYHNGVI  140 (354)
Q Consensus        64 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~  140 (354)
                      +..++|++.+.||+|+||+||+|+++.+|..  ||||.++.....+..+.+.+|+.++..+ +|+|||++++++.+++.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            4568999999999999999999999988874  6778776555555667899999999998 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc
Q 018532          141 SLVLEYMDRGSLADIIRQV----------------KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE  204 (354)
Q Consensus       141 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  204 (354)
                      ++||||++||+|.++++..                ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGC
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCCCc
Confidence            9999999999999999753                468999999999999999999998 99999999999999999999


Q ss_pred             EEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCcCCChhhHHHHHH
Q 018532          205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGR-FPYMQSEDQQSWPSFYELLE  283 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~  283 (354)
                      +||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..       ++..
T Consensus       166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------~~~~  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  237 (309)
T ss_dssp             EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred             eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-------HHHH
Confidence            9999999998655432 233457899999999999999999999999999999999965 567655432       4455


Q ss_pred             HHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          284 AIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+..+. ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       238 ~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555543 334456799999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=388.43  Aligned_cols=258  Identities=22%  Similarity=0.360  Sum_probs=221.0

Q ss_pred             cccccCcccccccccccccCceEEEEEEEc-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhhc-CCCceEEeeee
Q 018532           60 FDFEFSLEDLETIKVIGKGSGGVVQLVRHK-----WVGRLFALKIIQMNIQEEIRKQIVQELKINQAS-QCSHVVVCYHS  133 (354)
Q Consensus        60 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~  133 (354)
                      ..|++..++|++.+.||+|+||.||+|+..     .+++.||||+++..........+.+|+.++..+ +|+|||++++.
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            357788899999999999999999999863     467789999998777677777899999999998 69999999999


Q ss_pred             eeecCeEEEEEeccCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCC
Q 018532          134 FYHNGVISLVLEYMDRGSLADIIRQVK------------------TILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPS  195 (354)
Q Consensus       134 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~  195 (354)
                      +.+.+.+++|||||++|+|.++++...                  .+++..+..++.||+.||.|||+ +|++||||||+
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~  174 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence            999999999999999999999997643                  58899999999999999999998 89999999999


Q ss_pred             CEEEccCCcEEEeecccccccCCCcC--CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCcC
Q 018532          196 NLLVNHKGEVKITDFGVSAMLGSSMG--QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAI-GRFPYMQSEDQ  272 (354)
Q Consensus       196 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  272 (354)
                      ||+++.++.+||+|||+++.......  ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654322  2334688999999999999999999999999999999999 55556554433


Q ss_pred             CChhhHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          273 QSWPSFYELLEAIVESPPPTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                             +.+..+.........+..+++++.+||.+||+.||++|||++++++
T Consensus       255 -------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 -------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             -------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                   2233333334445556778999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=397.58  Aligned_cols=267  Identities=23%  Similarity=0.340  Sum_probs=212.1

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeeec-----Ce
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYHN-----GV  139 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~  139 (354)
                      .++|++++.||+|+||+||+|++..+|+.||||+++... .....+.+.+|+.+++.++|+|+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            478999999999999999999999999999999997653 344556789999999999999999999988632     33


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCC
Q 018532          140 ISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       140 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  219 (354)
                      .+++++++.||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+|++|||+|......
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhcccCcc
Confidence            4566677789999999865 679999999999999999999998 99999999999999999999999999999765433


Q ss_pred             cCCCcccccCCcccccccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHH----------------H
Q 018532          220 MGQRDTFVGTYNYMSPERISGST-YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYEL----------------L  282 (354)
Q Consensus       220 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------~  282 (354)
                         ..+..||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+...                .
T Consensus       175 ---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         175 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             ---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             ---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence               34457999999999977764 688999999999999999999999876533211111000                0


Q ss_pred             HHHHcCCCCCC------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCccccccccccc
Q 018532          283 EAIVESPPPTA------PPDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFEDKDI  337 (354)
Q Consensus       283 ~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~~~~  337 (354)
                      ...........      ....+++++.+||.+||+.||++|||++|+|+||||++..+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence            00000000000      11357899999999999999999999999999999998765443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=397.13  Aligned_cols=264  Identities=27%  Similarity=0.411  Sum_probs=203.5

Q ss_pred             cccccccccccccCceEEEEEEEccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhhcCCCceEEeeeeeee------cC
Q 018532           66 LEDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI-QEEIRKQIVQELKINQASQCSHVVVCYHSFYH------NG  138 (354)
Q Consensus        66 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------~~  138 (354)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+++.++|+||+++++++..      .+
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999999999999999997653 34556778999999999999999999999863      46


Q ss_pred             eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCC
Q 018532          139 VISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGS  218 (354)
Q Consensus       139 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  218 (354)
                      .+|+|||||.+ ++.+.+  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+|++|||++.....
T Consensus        96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhhcccc
Confidence            89999999976 555544  3579999999999999999999998 8999999999999999999999999999887654


Q ss_pred             CcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHH---------------HHHH
Q 018532          219 SMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFY---------------ELLE  283 (354)
Q Consensus       219 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------------~~~~  283 (354)
                      . ......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.               ....
T Consensus       172 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             c-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            3 33345689999999999999999999999999999999999999998765332111111               0011


Q ss_pred             HHHcCCCCCCC------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHhcCcccccccc
Q 018532          284 AIVESPPPTAP------------------PDQFSPEFCSFVSACIQKDPRDRSSSLDLLSHPFIKKFED  334 (354)
Q Consensus       284 ~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~eil~hp~~~~~~~  334 (354)
                      ...........                  ....++++.+||.+||+.||++|||++|+|+||||+...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence            11111111100                  0113567899999999999999999999999999997543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=376.28  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=206.8

Q ss_pred             cccccccCceEEEEEEEccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeee-cCeEEEEEecc
Q 018532           72 IKVIGKGSGGVVQLVRHKWVG---RLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYH-NGVISLVLEYM  147 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~  147 (354)
                      .++||+|+||+||+|++..++   ..||||+++........+.+.+|+++++.++||||+++++++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            467999999999999986643   36999999876677777889999999999999999999998775 56899999999


Q ss_pred             CCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeecccccccCCCcC----C
Q 018532          148 DRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGVSAMLGSSMG----Q  222 (354)
Q Consensus       148 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~  222 (354)
                      ++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.......    .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            999999998854 457788899999999999999998 9999999999999999999999999999987653322    2


Q ss_pred             CcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCCCCCCCHHH
Q 018532          223 RDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAPPDQFSPEF  302 (354)
Q Consensus       223 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  302 (354)
                      .....||+.|+|||.+.+..++.++||||||+++|||+||..||.......      +....+..+. ....+..+++++
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~------~~~~~i~~g~-~~~~p~~~~~~l  263 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGR-RLLQPEYCPDPL  263 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTC-CCCCCTTCCHHH
T ss_pred             cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCC-CCCCcccCcHHH
Confidence            233568999999999999999999999999999999999888876543321      2333444443 334566789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          303 CSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       303 ~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      .+||.+||+.||++|||+.||++|
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-51  Score=369.23  Aligned_cols=259  Identities=21%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEe-eeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVC-YHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~-~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....   ...+..|+++++.++|+|++.. ...+...+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            469999999999999999999999999999999876432   2347789999999987775554 555677789999999


Q ss_pred             ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc---CCcEEEeecccccccCCCcC
Q 018532          146 YMDRGSLADIIRQ-VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH---KGEVKITDFGVSAMLGSSMG  221 (354)
Q Consensus       146 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~  221 (354)
                      |+. ++|...+.. .+.+++..+..++.|++.||+|||+ +||+||||||+|||++.   +..+||+|||+|+.......
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            995 577666654 4679999999999999999999998 99999999999999864   45799999999997754322


Q ss_pred             -------CCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCCCC
Q 018532          222 -------QRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPTAP  294 (354)
Q Consensus       222 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (354)
                             ......||+.|||||++.+..++.++|||||||++|||++|+.||...................... +....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  240 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEVL  240 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-ChhHh
Confidence                   2345689999999999999999999999999999999999999998765543332222222221111 12223


Q ss_pred             CCCCCHHHHHHHHHhhhhCCCCCCCHH---HHhcCccccc
Q 018532          295 PDQFSPEFCSFVSACIQKDPRDRSSSL---DLLSHPFIKK  331 (354)
Q Consensus       295 ~~~~~~~l~~li~~~l~~~p~~Rps~~---eil~hp~~~~  331 (354)
                      ...+|+++.+||..||+.||++||++.   ++|+|+|.+.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            457899999999999999999999987   4567777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-51  Score=365.46  Aligned_cols=255  Identities=24%  Similarity=0.278  Sum_probs=198.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceEEeeeeeeecC----eEEE
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVVVCYHSFYHNG----VISL  142 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~l  142 (354)
                      .+|.+.+.||+|+||+||+|+.  +|+.||||+++.....+  .....|+..+..++|||||++++++...+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5678889999999999999985  68999999987543322  22334666666789999999999988654    6899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceecCCCCCCEEEccCCcEEEeecccccc
Q 018532          143 VLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE-------RHVIHRDIKPSNLLVNHKGEVKITDFGVSAM  215 (354)
Q Consensus       143 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~  215 (354)
                      ||||+++|+|.+++++ ..+++..+..++.|++.||.|||+.       +||+||||||+|||++.++.+||+|||++..
T Consensus        79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999999987 5789999999999999999999962       5899999999999999999999999999987


Q ss_pred             cCCCcC----CCcccccCCcccccccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCCCCcCCC--------hhh
Q 018532          216 LGSSMG----QRDTFVGTYNYMSPERISGST------YDYSSDIWSLGLVVLECAIGRFPYMQSEDQQS--------WPS  277 (354)
Q Consensus       216 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~~  277 (354)
                      ......    ......||+.|+|||++.+..      ++.++|||||||++|||+||..||......+.        ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            654322    233567999999999987643      56789999999999999999988754332211        112


Q ss_pred             HHHHHHHHHcCCCCCCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHhcC
Q 018532          278 FYELLEAIVESPPPTAPPDQ-----FSPEFCSFVSACIQKDPRDRSSSLDLLSH  326 (354)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~eil~h  326 (354)
                      ..............+..+..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            22333333333332222222     23458999999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-50  Score=359.51  Aligned_cols=253  Identities=20%  Similarity=0.244  Sum_probs=208.1

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC-CceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC-SHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.....   ..+.+|+++++.+.| +|++.+++.+......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            5799999999999999999999999999999998654322   346678888888866 899999999999999999999


Q ss_pred             ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEcc-----CCcEEEeecccccccCCC
Q 018532          146 YMDRGSLADIIRQV-KTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNH-----KGEVKITDFGVSAMLGSS  219 (354)
Q Consensus       146 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~  219 (354)
                      |+ +++|.+++... ..++...+..++.|++.||+|||+ +||+||||||+||+++.     ++.+||+|||+|+.....
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            99 67999998775 469999999999999999999998 99999999999999974     578999999999876533


Q ss_pred             c-------CCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHHHHHcCCCCC
Q 018532          220 M-------GQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLEAIVESPPPT  292 (354)
Q Consensus       220 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (354)
                      .       ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.................. ..+..
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~  238 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLR  238 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCChH
Confidence            2       123456899999999999999999999999999999999999999987655433222222222211 11222


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          293 APPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       293 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                      .....+|+++.+++..|+..+|++||+++.+.+
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            233568999999999999999999999887654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-48  Score=358.26  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=197.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-----------CCceEEeeeeee
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-----------CSHVVVCYHSFY  135 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~~iv~~~~~~~  135 (354)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++...  ...+.+.+|+.+++.++           |+||+++++.+.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            56999999999999999999999999999999997542  33456677887776654           578999998876


Q ss_pred             e--cCeEEEEEeccCCCCHH-HHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCc------
Q 018532          136 H--NGVISLVLEYMDRGSLA-DIIRQ--VKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGE------  204 (354)
Q Consensus       136 ~--~~~~~lv~e~~~~~~L~-~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~------  204 (354)
                      .  ....+++++++..+... .....  ...+++..++.++.||+.||.|||+..||+||||||+|||++.++.      
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            4  35666777766554433 32222  2578999999999999999999997688999999999999987653      


Q ss_pred             EEEeecccccccCCCcCCCcccccCCcccccccccCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCcCCChhhHHHHHH-
Q 018532          205 VKITDFGVSAMLGSSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGLVVLECAIGRFPYMQSEDQQSWPSFYELLE-  283 (354)
Q Consensus       205 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-  283 (354)
                      ++++|||.|......   ....+||+.|+|||++.+..++.++||||+||++++|++|+.||................. 
T Consensus       171 ~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         171 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            999999999865433   3446899999999999999999999999999999999999999976543221111100000 


Q ss_pred             -HHHcC-------------------CC------------------CCCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHhc
Q 018532          284 -AIVES-------------------PP------------------PTAPPDQFSPEFCSFVSACIQKDPRDRSSSLDLLS  325 (354)
Q Consensus       284 -~~~~~-------------------~~------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~eil~  325 (354)
                       .....                   ..                  ........++++.+||.+||+.||++|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             00000                   00                  00011234678999999999999999999999999


Q ss_pred             Ccccccccc
Q 018532          326 HPFIKKFED  334 (354)
Q Consensus       326 hp~~~~~~~  334 (354)
                      ||||++...
T Consensus       328 Hp~f~~~~~  336 (362)
T d1q8ya_         328 HPWLKDTLG  336 (362)
T ss_dssp             CGGGTTCTT
T ss_pred             CcccCCCCC
Confidence            999996643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=5.7e-27  Score=195.14  Aligned_cols=165  Identities=19%  Similarity=0.157  Sum_probs=121.3

Q ss_pred             cccccccccCceEEEEEEEccCCcEEEEEEeecccc-----------------HHHHHHHHHHHHHHhhcCCCceEEeee
Q 018532           70 ETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQ-----------------EEIRKQIVQELKINQASQCSHVVVCYH  132 (354)
Q Consensus        70 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~e~~~~~~l~h~~iv~~~~  132 (354)
                      .+.+.||+|+||+||+|.+. +|+.||||+++.+..                 .........|...+..+.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            46788999999999999985 789999998753211                 112344567888888999999887765


Q ss_pred             eeeecCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCCceecCCCCCCEEEccCCcEEEeeccc
Q 018532          133 SFYHNGVISLVLEYMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNERHVIHRDIKPSNLLVNHKGEVKITDFGV  212 (354)
Q Consensus       133 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~  212 (354)
                      ..  .  .+++|||+++..+.       .++...+..++.|++.||.|||+ .||+||||||+|||++++ .++|+|||.
T Consensus        82 ~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          82 WE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             ec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-CEEEEECCC
Confidence            42  2  26899999886542       35566678899999999999998 999999999999999865 489999999


Q ss_pred             ccccCCCcCCCcccccCCccccc--c---cccCCCCCcchhHHHHHHHH
Q 018532          213 SAMLGSSMGQRDTFVGTYNYMSP--E---RISGSTYDYSSDIWSLGLVV  256 (354)
Q Consensus       213 a~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DiwslG~il  256 (354)
                      |.....+...        .|...  +   .+..+.|+.++|+||+.--+
T Consensus       149 a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9766433211        11111  0   01235688999999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=3.2e-07  Score=77.81  Aligned_cols=140  Identities=16%  Similarity=0.091  Sum_probs=87.0

Q ss_pred             ccccccccccccCceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcC-CCceEEeeeeeeecCeEEEEEe
Q 018532           67 EDLETIKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQ-CSHVVVCYHSFYHNGVISLVLE  145 (354)
Q Consensus        67 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e  145 (354)
                      +.|.+++..+-++.+.||++.  .++..+++|......... ...+.+|...+..+. +-.+.+++.....++..++||+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            455556555555567899885  356677888875432211 123556776665543 2224555666677889999999


Q ss_pred             ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 018532          146 YMDRGSLADIIRQVKTILEPYLAVVCKQVLQGLVYLHNE-----------------------------------------  184 (354)
Q Consensus       146 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  184 (354)
                      +++|.++.+....     ......++.++...+..||+.                                         
T Consensus        91 ~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             ecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            9999877554311     111122333344444444420                                         


Q ss_pred             -----------------CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 -----------------RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 -----------------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                                       ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                             127999999999999877777899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.03  E-value=6.6e-06  Score=73.94  Aligned_cols=78  Identities=13%  Similarity=-0.019  Sum_probs=44.5

Q ss_pred             cccccccCceEEEEEEEccCCcEEEEEEeeccc---c---HHHHHHHHHHHHHHhhcC---CCceEEeeeeeeecCeEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKWVGRLFALKIIQMNI---Q---EEIRKQIVQELKINQASQ---CSHVVVCYHSFYHNGVISL  142 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~---~~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~~~~~~~l  142 (354)
                      .+.||.|....||++.+..+++.+++|.-....   .   .....+...|...++.+.   ...+.+++.  .++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            346899999999999988788899999643210   0   001122345666555442   223444443  34555678


Q ss_pred             EEeccCCCC
Q 018532          143 VLEYMDRGS  151 (354)
Q Consensus       143 v~e~~~~~~  151 (354)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.93  E-value=1.1e-05  Score=67.71  Aligned_cols=73  Identities=11%  Similarity=-0.017  Sum_probs=46.7

Q ss_pred             ccccC-ceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCC--ceEEeeeeeeecCeEEEEEeccCCCC
Q 018532           75 IGKGS-GGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQCS--HVVVCYHSFYHNGVISLVLEYMDRGS  151 (354)
Q Consensus        75 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~  151 (354)
                      +..|. -+.||++... ++..+++|.......    ..+..|...++.+...  .+.+++....+.+..++||++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            34444 3678988754 566688898654432    2345566666554332  24556666677788999999998865


Q ss_pred             H
Q 018532          152 L  152 (354)
Q Consensus       152 L  152 (354)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.01  E-value=0.0018  Score=55.92  Aligned_cols=68  Identities=16%  Similarity=0.114  Sum_probs=40.7

Q ss_pred             ceEEEEEEEccCCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCC-----CceEEee--eeeeecCeEEEEEeccCCC
Q 018532           80 GGVVQLVRHKWVGRLFALKIIQMNIQEEIRKQIVQELKINQASQC-----SHVVVCY--HSFYHNGVISLVLEYMDRG  150 (354)
Q Consensus        80 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-----~~iv~~~--~~~~~~~~~~lv~e~~~~~  150 (354)
                      --.||++... +|..|++|+.+.....  .+.+..|...+..|..     +..+..-  ..+...+..+.++++++|.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            3579998764 7888999998754321  2335566666555432     1112211  1234567788899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.0016  Score=55.77  Aligned_cols=30  Identities=23%  Similarity=0.279  Sum_probs=27.1

Q ss_pred             CCceecCCCCCCEEEccCCcEEEeeccccc
Q 018532          185 RHVIHRDIKPSNLLVNHKGEVKITDFGVSA  214 (354)
Q Consensus       185 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~  214 (354)
                      .|+||+|+.++||+++.+...-|+||+.++
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            569999999999999988878899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.54  E-value=0.003  Score=55.95  Aligned_cols=74  Identities=23%  Similarity=0.201  Sum_probs=45.7

Q ss_pred             cccccccCceEEEEEEEcc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhhcCCCceE-EeeeeeeecCeEEEE
Q 018532           72 IKVIGKGSGGVVQLVRHKW-------VGRLFALKIIQMNIQEEIRKQIVQELKINQASQCSHVV-VCYHSFYHNGVISLV  143 (354)
Q Consensus        72 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~~lv  143 (354)
                      ++.|+-|-.=.+|++....       ..+.|.+++.-.... .  -...+|..+++.+.-.++. ++++.+.  +  ++|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~--idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E--SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H--HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-h--hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence            3568778888999988653       346688888753222 1  2345677777766433443 5555443  2  578


Q ss_pred             EeccCCCCH
Q 018532          144 LEYMDRGSL  152 (354)
Q Consensus       144 ~e~~~~~~L  152 (354)
                      +||++|.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987443